FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Barros, J
   Grenho, L
   Manuel, CM
   Ferreira, C
   Melo, L
   Nunes, OC
   Monteiro, FJ
   Ferraz, MP
AF Barros, J.
   Grenho, L.
   Manuel, C. M.
   Ferreira, C.
   Melo, L.
   Nunes, O. C.
   Monteiro, F. J.
   Ferraz, M. P.
TI Influence of nanohydroxyapatite surface properties on Staphylococcus
   epidermidis biofilm formation
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE nanohydroxyapatite; biofilm formation; Inoculum concentration;
   biomaterial surface area; biomaterial roughness
ID HYDROXYAPATITE CERAMICS; MEDICAL APPLICATIONS; BACTERIAL ADHERENCE;
   CELL-ADHESION; GLASS; BONE; SIZE; HYDROPHOBICITY; PROLIFERATION;
   MICROSPHERES
AB Nanohydroxyapatite (nanoHA), due to its chemical properties, has appeared as an exceptionally promising bioceramic to be used as bone regeneration material. Staphylococcus epidermidis have emerged as major nosocomial pathogens associated with infections of implanted medical devices. In this work, the purpose was to study the influence of the nanoHA surface characteristics on S. epidermidis RP62A biofilm formation. Therefore, two different initial inoculum concentrations (C-i) were used in order to check if these would affect the biofilm formed on the nanoHA surfaces. Biofilm formation was followed by the enumeration of cultivable cells and by scanning electron microscopy. Surface topography, contact angle, total surface area and porosimetry of the biomaterials were studied and correlated with the biofilm data. The surface of nanoHA sintered at 830celcius (nanoHA830) showed to be more resistant to S. epidermidis attachment and accumulation than that of nanoHA sintered at 1000celcius (nanoHA1000). The biofilm formed on nanoHA830 presented differences in terms of structure, surface coverage and EPS production when compared to the one formed on nanoHA1000 surface. It was observed that topography and surface area of nanoHA surfaces had influence on the bacterial attachment and accumulation. C-i influenced bacteria attachment and accumulation on nanoHA surfaces over time. The choice of the initial inoculum concentration was relevant proving to have an effect on the extent of adherence thus being a critical point for human health if these materials are used in implantable devices. This study showed that the initial inoculum concentration and surface material properties determine the rate of microbial attachment to substrata and consequently are related to biofilm-associated infections in biomaterials.
C1 [Barros, J.; Grenho, L.; Monteiro, F. J.; Ferraz, M. P.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Barros, J.; Grenho, L.; Monteiro, F. J.] Univ Porto, FEUP Fac Med, Dept Met & Mat Engn, P-4150180 Oporto, Portugal.
   [Ferraz, M. P.] Univ Fernando Pessoa, CEBIMED Ctr Estudos Biomed, Oporto, Portugal.
   [Barros, J.; Manuel, C. M.; Ferreira, C.; Melo, L.; Nunes, O. C.] Univ Porto, Fac Engn, Dept Engn Quim, LEPAE, P-4150180 Oporto, Portugal.
   [Manuel, C. M.] ULP, Oporto, Portugal.
RP Barros, J (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM joanabarros@fe.up.pt
RI Grenho, Liliana/I-4540-2015; Ferraz, Maria/M-6316-2013
OI Grenho, Liliana/0000-0001-9476-2839; Ferraz, Maria/0000-0002-0274-106X;
   Melo, Luis/0000-0002-8469-4462; Monteiro, Fernando/0000-0002-1361-4605;
   Barros, Joana/0000-0002-8205-5675; Duarte Manuel, Candida
   Maria/0000-0002-7030-1525; Nunes, Olga/0000-0003-4742-2537
FU FEDER funds through COMPETE; FCT - Fundacao para a Ciencia e a
   Tecnologia [PTDC/SAU-BMA/111233/2009]
FX J.B. is supported by a research grant from FEDER funds through COMPETE
   and by FCT - Fundacao para a Ciencia e a Tecnologia in the framework of
   the project NanoBiofilm (PTDC/SAU-BMA/111233/2009).
CR Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Bazaka K, 2012, APPL MICROBIOL BIOT, V95, P299, DOI 10.1007/s00253-012-4144-7
   Carlen A, 2001, BIOMATERIALS, V22, P481, DOI 10.1016/S0142-9612(00)00204-0
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   Cerca N, 2004, LETT APPL MICROBIOL, V39, P420, DOI 10.1111/j.1472-765X.2004.01601.x
   Chin MYH, 2007, BIOMATERIALS, V28, P2032, DOI 10.1016/j.biomaterials.2006.12.014
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Fenoglio I, 2011, ADV DRUG DELIVER REV, V63, P1186, DOI 10.1016/j.addr.2011.08.001
   Ferraz MP, 2007, J BIOMED MATER RES A, V81A, P994, DOI 10.1002/jbm.a.31151
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Ferraz MP, 2001, BIOMATERIALS, V22, P3105, DOI 10.1016/S0142-9612(01)00059-X
   Fonseca AP, 2001, J MATER SCI-MATER M, V12, P543, DOI 10.1023/A:1011227915575
   Furuzono T, 2001, J MATER SCI LETT, V20, P111, DOI 10.1023/A:1006725931450
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   He ZM, 2005, BIOMATERIALS, V26, P1613, DOI 10.1016/j.biomaterials.2004.05.027
   Ho TA, 2011, P NATL ACAD SCI USA, V108, P16170, DOI 10.1073/pnas.1105189108
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Katsikogianni MG, 2010, ACTA BIOMATER, V6, P1107, DOI 10.1016/j.actbio.2009.08.006
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Kolenbrander PE, 2000, S SOC GEN MICR
   Laranjeira MS, 2010, J BIOMED MATER RES A, V95A, P891, DOI 10.1002/jbm.a.32916
   Li BK, 2004, COLLOID SURFACE B, V36, P81, DOI 10.1016/j.colsurfb.2004.05.006
   Lopes MA, 1999, J BIOMED MATER RES, V45, P370, DOI 10.1002/(SICI)1097-4636(19990615)45:4<370::AID-JBM12>3.0.CO;2-0
   McCann MT, 2008, J PHARM PHARMACOL, V60, P1551, DOI 10.1211/jpp/60.12.0001
   Melo LF, 1997, EXP THERM FLUID SCI, V14, P375, DOI 10.1016/S0894-1777(96)00139-2
   Mizunaga S, 2005, J ANTIMICROB CHEMOTH, V56, P91, DOI 10.1093/jac/dki163
   Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001
   Montag D, 2012, BIOFOULING, V28, P315, DOI 10.1080/08927014.2012.673219
   Muralithran G, 2000, CERAM INT, V26, P221, DOI 10.1016/S0272-8842(99)00046-2
   O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582
   Mateus AYP, 2008, J BIOMED MATER RES A, V86A, P483, DOI 10.1002/jbm.a.31.634
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P742, DOI 10.1002/jbm.a.31103
   Pereira MA, 2000, J IND MICROBIOL BIOT, V24, P181, DOI 10.1038/sj.jim.2900799
   Pereni CI, 2006, COLLOID SURFACE B, V48, P143, DOI 10.1016/j.colsurfb.2006.02.004
   Quirynen M, 2000, HDB BACTERIAL ADHESI, P91
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Rohde H, 2010, EUR J CELL BIOL, V89, P103, DOI 10.1016/j.ejcb.2009.10.005
   Sanders DL, 2013, SURG ENDOSC, V27, P978, DOI 10.1007/s00464-012-2545-4
   Schwarz F, 2007, ORAL MAXILLOFAC SURG, V11, P333, DOI 10.1007/s10006-007-0079-z
   Singh C, 2011, NANOSCALE, V3, P3244, DOI 10.1039/c1nr10215j
   Sousa C, 2009, INT J BIOMATER, DOI 10.1155/2009/718017
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   Tampieri A, 2001, BIOMATERIALS, V22, P1365, DOI 10.1016/S0142-9612(00)00290-8
   Tihan TG, 2009, MATER CHEM PHYS, V118, P265, DOI 10.1016/j.matchemphys.2009.03.019
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vandiver J, 2005, BIOMATERIALS, V26, P271, DOI 10.1016/j.biomaterials.2004.02.053
   WANG IW, 1993, J INFECT DIS, V167, P329, DOI 10.1093/infdis/167.2.329
   Yao YF, 2005, INFECT IMMUN, V73, P1856, DOI 10.1128/IAI.73.3.1856-1860.2005
NR 50
TC 11
Z9 12
U1 1
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1325
EP 1335
DI 10.1177/0885328213507300
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700004
PM 24122400
DA 2018-10-19
ER

PT J
AU Jabaiah, A
   Wang, X
   Raman, SK
   Ragan, R
   Da Silva, NA
   Wang, SW
AF Jabaiah, Abeer
   Wang, Xi
   Raman, Senthil Kumar
   Ragan, Regina
   Da Silva, Nancy A.
   Wang, Szu-Wen
TI Nanoscale architecture and cellular adhesion of biomimetic collagen
   substrates
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE stability; biomaterial; Collagen; cell adhesion; biomimetic; recombinant
   protein; atomic force microscopy
ID ATOMIC-FORCE MICROSCOPY; ADSORBED COLLAGEN; TRIPLE-HELIX; THIN-FILMS; I
   COLLAGEN; ADSORPTION; STABILITY; PEPTIDE; POLYSTYRENE; SURFACES
AB The ability to engineer bioactive sites within the biopolymer collagen has significant potential to dictate cellular microenvironments and processes. We have developed a novel recombinant DNA platform that enables such molecular-level control over this important material. In this investigation, we demonstrated the production of synthetic human collagen using yeast strains that were engineered with human prolyl hydroxylase alpha and beta genes integrated into the genome and a codon-optimized collagen gene carried on a plasmid. To understand the extent to which this synthetic collagen can mimic native human collagen, we examined the relationships between the structural topology and physical stability with the ability to support adhesion of HT-1080 cells. Characterization of these biopolymers included evaluation using circular dichroism spectroscopy, atomic force microscopy, and MTT metabolic activity assays. Although the apparent melting temperatures of the recombinant collagens were similar to 3-5celcius less than native sources, the recombinant and native collagens exhibited comparable triple helical structure, polymeric dimensions, adsorption on polystyrene, and cellular adhesion properties below their respective melting temperature values. These results support the feasibility of producing molecularly-engineered collagens that can mimic native substrates for therapeutic and tissue engineering applications.
C1 [Jabaiah, Abeer; Wang, Xi; Raman, Senthil Kumar; Ragan, Regina; Da Silva, Nancy A.; Wang, Szu-Wen] Univ Calif Irvine, Dept Chem Engn & Mat Sci, Irvine, CA 92697 USA.
RP Wang, SW (reprint author), Univ Calif Irvine, Dept Chem Engn & Mat Sci, 916 Engn Tower, Irvine, CA 92697 USA.
EM ndasilva@uci.edu; wangsw@uci.edu
FU National Science Foundation [CBET-1034566, DMR-1006999, CHE-0748912]
FX We gratefully acknowledge Dr Matthew Shindel's assistance in initial AFM
   studies, Dr Polly Chan and Richard Que for assistance in expression and
   purification of proteins, and Dr Sarah Adams and Daniel Kha Le for
   assistance in polystyrene spin-coating. This work was funded by the
   National Science Foundation (CBET-1034566, DMR-1006999, and
   CHE-0748912).
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   BIRK DE, 1991, CELL BIOL EXTRACELLU, P221
   Chan SWP, 2010, BIOMACROMOLECULES, V11, P1460, DOI 10.1021/bm100052y
   Chan SWP, 2012, THESIS U CALIFORNIA
   Chan SWP, 2012, BMC BIOTECHNOL, P12
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   Dewez JL, 1997, J COLLOID INTERF SCI, V191, P1, DOI 10.1006/jcis.1997.4908
   Dupont-Gillain CC, 2001, LANGMUIR, V17, P7261, DOI 10.1021/la010042g
   Elliott JT, 2003, LANGMUIR, V19, P1506, DOI 10.1021/la026216r
   Emsley J, 2004, J MOL BIOL, V335, P1019, DOI 10.1016/j.jmb.2003.11.030
   Engel J, 2005, TOP CURR CHEM, V247, P7, DOI 10.1007/b103818
   Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241
   Gaudet C, 2003, BIOPHYS J, V85, P3329, DOI 10.1016/S0006-3495(03)74752-3
   Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202
   Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204
   Jacquemart I, 2004, J COLLOID INTERF SCI, V278, P63, DOI 10.1016/j.jcis.2004.05.040
   Keresztes Z, 2006, J BIOMED MATER RES A, V76A, P223, DOI 10.1002/jbm.a.30472
   Kim JK, 2005, J BIOL CHEM, V280, P32512, DOI 10.1074/jbc.M502431200
   Knotts TA, 2008, BIOPHYS J, V94, P4473, DOI 10.1529/biophysj.107.123158
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Koutsopoulos S, 2004, LANGMUIR, V20, P6401, DOI 10.1021/la049821y
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   Li Y, 2007, LANGMUIR, V23, P9785, DOI 10.1021/la0636311
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Maeda H, 1999, LANGMUIR, V15, P8505, DOI 10.1021/la981738l
   Majsterek I, 2003, PROTEIN SCI, V12, P2063, DOI 10.1110/ps.0385103
   Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458
   MORTON LF, 1995, BIOCHEM J, V306, P337, DOI 10.1042/bj3060337
   Pamula E, 2004, J COLLOID INTERF SCI, V271, P80, DOI 10.1016/j.jcis.2003.11.012
   Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Wang SW, 2004, J PHARM SCI-US, V93, P2755, DOI 10.1002/jps.20183
   Yamamoto S, 2000, J ELECTRON MICROSC, V49, P423, DOI 10.1093/oxfordjournals.jmicro.a023824
   Zoungrana T, 1997, J COLLOID INTERF SCI, V190, P437, DOI 10.1006/jcis.1997.4895
NR 36
TC 5
Z9 5
U1 0
U2 18
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1354
EP 1365
DI 10.1177/0885328213508328
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700007
PM 24146435
DA 2018-10-19
ER

PT J
AU Lisman, A
   Butruk, B
   Wasiak, I
   Ciach, T
AF Lisman, Anna
   Butruk, Beata
   Wasiak, Iga
   Ciach, Tomasz
TI Dextran/Albumin hydrogel sealant for Dacron (R) vascular prosthesis
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE dextran; Albumin; vascular prosthesis; sealant; dextran oxidation;
   hydrogel
ID DEXTRAN-BASED HYDROGELS; POLYALDEHYDE DEXTRAN; ARTERIAL PROSTHESES;
   BLOOD COMPATIBILITY; OXIDIZED DEXTRAN; PROTEIN-BINDING; CROSS-LINKING;
   HUMAN-SERUM; GELATIN; RELEASE
AB In this paper, the authors describe a novel type of hydrogel coating prepared from the copolymer of human serum albumin and oxidized dextran. The material was designed as a hydrogel sealant for polyester (Dacron (R))-based vascular grafts. Dextran was chosen as a coating material due to its anti-thrombogenic properties. Prepared hydrogels were compared with similar, already known biomaterial made from gelatine with the same cross-linking agent. Obtained hydrogels, prepared from various ratios of oxidized dextran/albumin or oxidized dextran/gelatine, showed different cross-linking densities, which caused differences in swelling, degradation rate and mechanical properties. Permeability tests confirmed the complete tightness of the hydrogel-modified prosthesis. Results showed that application of the hydrogel coating provided leakage-free prosthesis and eliminated the need of pre-clotting.
C1 [Lisman, Anna; Butruk, Beata; Wasiak, Iga; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00645 Warsaw, Poland.
RP Ciach, T (reprint author), Warsaw Univ Technol, Fac Chem & Proc Engn, Warynskiego St 1, PL-00645 Warsaw, Poland.
EM t.ciach@ichip.pw.edu.pl
OI Ciach, Tomasz/0000-0002-8726-8944; Butruk-Raszeja,
   Beata/0000-0002-2074-1944
CR Battersby J, 1996, J CONTROL RELEASE, V42, P143, DOI 10.1016/0168-3659(96)01370-3
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Bhatia SK, 2007, BIOTECHNOL LETT, V29, P1645, DOI 10.1007/s10529-007-9465-8
   Butruk B, 2012, MAT SCI ENG C-MATER, V32, P1601, DOI 10.1016/j.msec.2012.04.050
   Carballal S, 2007, AMINO ACIDS, V32, P543, DOI 10.1007/s00726-006-0430-y
   Chiba Y, 1999, SURG TODAY, V29, P1225
   DAY JF, 1979, J BIOL CHEM, V254, P595
   Dhaneshwar Suneela S., 2006, Indian Journal of Pharmaceutical Sciences, V68, P705
   Dhillon S, 2011, DRUGS, V71, P1893, DOI 10.2165/11207700-000000000-00000
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fuentes M, 2004, PROTEOMICS, V4, P2602, DOI 10.1002/pmic.200300766
   GUIDOIN R, 1989, BIOMATERIALS, V10, P156, DOI 10.1016/0142-9612(89)90018-5
   Heindel ND, 1990, BIOCONJUGATE CHEM, V1, P77, DOI 10.1021/bc00001a010
   Khaffaf AI- H, 1996, J VASC SURG, V23, P686
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Liu G, 2009, MACROMOL SYMP, V279, P151, DOI 10.1002/masy.200950523
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Maia J, 2009, ACTA BIOMATER, V5, P1948, DOI 10.1016/j.actbio.2009.02.008
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   Miksa D, 2004, MAT RES SOC S P E, V826E
   Muangsiri W, 2006, INT J PHARM, V315, P30, DOI 10.1016/j.ijpharm.2006.02.016
   Neishlos AL, 2004, RUSS J APPL CHEM+, V77, P128, DOI 10.1023/B:RJAC.0000024592.71970.98
   Nonami Y., 1994, Japanese Journal of Artificial Organs, V23, P821
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Phaneuf MD, 2001, BIOMATERIALS, V22, P463, DOI 10.1016/S0142-9612(00)00202-7
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   SAWYER PN, 1979, J BIOMED MATER RES, V13, P937, DOI 10.1002/jbm.820130611
   Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3
   SHEEHAN SJ, 1989, BIOMATERIALS, V10, P75, DOI 10.1016/0142-9612(89)90034-3
   Suvorova OB, 2001, RUSS J APPL CHEM+, V74, P1016, DOI 10.1023/A:1013011911022
   Weng L, 2008, BIOMATERIALS, V29, P3905, DOI 10.1016/j.biomaterials.2008.06.025
   Yasim A, 2006, EUR J VASC ENDOVASC, V32, P425, DOI 10.1016/j.ejvs.2006.03.014
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   ZHAO H, 1991, PHARMACEUT RES, V8, P400, DOI 10.1023/A:1015866104055
   Ziaja K, 2001, POL SURG, V3, P179
NR 36
TC 6
Z9 6
U1 0
U2 30
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAY
PY 2014
VL 28
IS 9
BP 1386
EP 1396
DI 10.1177/0885328213509676
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF3UB
UT WOS:000334636700010
PM 24221140
DA 2018-10-19
ER

PT J
AU Niu, LN
   Jiao, K
   Wang, TD
   Zhang, W
   Camilleri, J
   Bergeron, BE
   Feng, HL
   Mao, J
   Chen, JH
   Pashley, DH
   Tay, FR
AF Niu, Li-na
   Jiao, Kai
   Wang, Tian-da
   Zhang, Wei
   Camilleri, Josette
   Bergeron, Brian E.
   Feng, Hai-lan
   Mao, Jing
   Chen, Ji-hua
   Pashley, David H.
   Tay, Franklin R.
TI A review of the bioactivity of hydraulic calcium silicate cements
SO JOURNAL OF DENTISTRY
LA English
DT Review
DE Bioactivity; Calcium silicate; Hydraulic cement; In vitro; In vivo
ID MINERAL TRIOXIDE AGGREGATE; END FILLING MATERIALS; OSTEOBLAST-LIKE
   CELLS; SIMULATED BODY-FLUID; IN-VITRO BIOACTIVITY; C-S-H; TRANSMISSION
   ELECTRON-MICROSCOPY; PERIODONTAL-LIGAMENT FIBROBLASTS; BONELIKE APATITE
   FORMATION; PHOSPHATE-CONTAINING FLUID
AB Objectives: In tissue regeneration research, the term "bioactivity" was initially used to describe the resistance to removal of a biomaterial from host tissues after intraosseous implantation. Hydraulic calcium silicate cements (HCSCs) are putatively accepted as bioactive materials, as exemplified by the increasing number of publications reporting that these cements produce an apatite-rich surface layer after they contact simulated body fluids.
   Methods: In this review, the same definitions employed for establishing in vitro and in vivo bioactivity in glass-ceramics, and the proposed mechanisms involved in these phenomena are used as blueprints for investigating whether HCSCs are bioactive.
   Results: The literature abounds with evidence that HCSCs exhibit in vitro bioactivity; however, there is a general lack of stringent methodologies for characterizing the calcium phosphate phases precipitated on HCSCs. Although in vivo bioactivity has been demonstrated for some HCSCs, a fibrous connective tissue layer is frequently identified along the bone-cement interface that is reminiscent of the responses observed in bioinert materials, without accompanying clarifications to account for such observations.
   Conclusions: As bone-bonding is not predictably achieved, there is insufficient scientific evidence to substantiate that HCSCs are indeed bioactive. Objective appraisal criteria should be developed for more accurately defining the bioactivity profiles of HCSCs designed for clinical use. Published by Elsevier B.V.
C1 [Niu, Li-na; Chen, Ji-hua] Fourth Mil Med Univ, Sch Stomatol, Dept Prosthodont, Xian 710032, Peoples R China.
   [Jiao, Kai] Fourth Mil Med Univ, Sch Stomatol, Dept Oral Anat & Physiol & TMD, Xian 710032, Peoples R China.
   [Wang, Tian-da; Feng, Hai-lan] Peking Univ, Sch Stomatol, Dept Prosthodont, Beijing 100871, Peoples R China.
   [Zhang, Wei; Mao, Jing] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Wuhan 430074, Peoples R China.
   [Camilleri, Josette] Univ Malta, Fac Dent Surg, Dept Restorat Dent, Msida, Malta.
   [Bergeron, Brian E.; Tay, Franklin R.] Georgia Regents Univ, Coll Dent Med, Dept Endodont, Augusta, GA USA.
   [Pashley, David H.; Tay, Franklin R.] Georgia Regents Univ, Coll Grad Studies, Augusta, GA USA.
RP Chen, JH (reprint author), Fourth Mil Med Univ, Sch Stomatol, Xian 710032, Peoples R China.
EM jhchen@fmmu.edu.cn; ftay@gru.edu
RI Bergeron, Brian/O-3110-2016; Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365
FU NIDCR [R01 DE015306-06]; National Nature Science Foundation of China
   [81130078, 81300898]
FX This work was supported by grant R01 DE015306-06 from NIDCR (PI. David H
   Pashley), grant 81130078 (PI. Jihua Chen) and grant 81300898 (PI. Kai
   Jiao) from the National Nature Science Foundation of China.
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   Andersen MD, 2003, INORG CHEM, V42, P2280, DOI 10.1021/ic020607b
   Cintra LTA, 2010, J APPL ORAL SCI, V18, P75, DOI 10.1590/S1678-77572010000100013
   Asefa T, 2009, ANALYST, V134, P1980, DOI 10.1039/b911965p
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Balto HA, 2004, J ENDODONT, V30, P25, DOI 10.1097/00004770-200401000-00005
   Bird DC, 2012, J ENDODONT, V38, P1093, DOI 10.1016/j.joen.2012.04.017
   Bodier-Houlle P, 1998, ACTA CRYSTALLOGR D, V54, P1377, DOI 10.1107/S0907444998005769
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   Bonson S, 2004, J DENT RES, V83, P408, DOI 10.1177/154405910408300511
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Bozeman TB, 2006, J ENDODONT, V32, P425, DOI 10.1016/j.joen.2005.08.009
   Branda F, 2002, BIOMATERIALS, V23, P711, DOI 10.1016/S0142-9612(01)00173-9
   Brouwers HJH, 2003, CEMENT CONCRETE RES, V33, P191, DOI 10.1016/S0008-8846(02)01022-0
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   BROWN WE, 1962, NATURE, V196, P1048, DOI 10.1038/1961048b0
   Budiraharjo R, 2010, INT ENDOD J, V43, P930, DOI 10.1111/j.1365-2591.2010.01771.x
   Cado G, 2013, ADV FUNCT MATER, V23, P4801, DOI 10.1002/adfm.201300416
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2013, DENT MATER, V29, P580, DOI 10.1016/j.dental.2013.03.007
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chen W, 2010, CEMENT CONCRETE RES, V40, P716, DOI 10.1016/j.cemconres.2009.12.007
   Chiang TY, 2013, J MED BIOL ENG
   CHICKERUR NS, 1980, CALCIFIED TISSUE INT, V32, P55, DOI 10.1007/BF02408521
   Cho SB, 1996, J BIOMED MATER RES, V33, P145, DOI 10.1002/(SICI)1097-4636(199623)33:3<145::AID-JBM4>3.0.CO;2-Q
   Cintra LTA, 2006, J ENDODONT, V32, P556, DOI 10.1016/j.joen.2005.07.007
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   DAMEN JJM, 1992, J DENT RES, V71, P453, DOI 10.1177/00220345920710030601
   Darvell BW, 2011, DENT MATER, V27, P407, DOI 10.1016/j.dental.2011.02.001
   Davies JE, 1993, BONE BIOMATERIAL INT
   Dey A, 2010, NAT MATER, V9, P1010, DOI 10.1038/NMAT2900
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Dorvee JR, 2013, J STRUCT BIOL, V183, P278, DOI 10.1016/j.jsb.2013.06.007
   Eanes E D, 2001, Monogr Oral Sci, V18, P130
   EIDELMAN N, 1987, CALCIFIED TISSUE INT, V41, P18, DOI 10.1007/BF02555126
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   Elliot JC, 1994, STUDIES INORGANIC CH
   Formosa LM, 2013, DENT MATER, V29, pE11, DOI 10.1016/j.dental.2012.11.006
   Formosa LM, 2012, DENT MATER, V28, P584, DOI 10.1016/j.dental.2012.02.006
   FOWLER BO, 1993, CHEM MATER, V5, P1417, DOI 10.1021/cm00034a009
   Gandolfi MG, 2011, INT ENDOD J, V44, P938, DOI 10.1111/j.1365-2591.2011.01907.x
   Gandolfi MG, 2010, INT ENDOD J, V43, P917, DOI 10.1111/j.1365-2591.2010.01768.x
   Gandolfi MG, 2013, J BIOMED MATER RES B, V101, P1107, DOI 10.1002/jbm.b.32920
   Gandolfi MG, 2011, MAT SCI ENG C-MATER, V31, P1412, DOI 10.1016/j.msec.2011.05.012
   Gandolfi MG, 2011, DENT MATER, V27, pE134, DOI 10.1016/j.dental.2011.03.011
   Gandolfi M, 2010, CLIN ORAL INVEST, V14, P659, DOI 10.1007/s00784-009-0356-3
   Gandolfi MG, 2010, DENT MATER, V26, P974, DOI 10.1016/j.dental.2010.06.002
   Gandolfi MG, 2010, J ENDODONT, V36, P851, DOI 10.1016/j.joen.2009.12.007
   Garcia AJ, 1998, J BIOMED MATER RES, V40, P48, DOI 10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R
   Gerhardt LC, 2013, J BIOMED MATER RES A, V101, P827, DOI 10.1002/jbm.a.34373
   Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032
   Gomes JE, 2011, J ENDODONT, V37, P250, DOI 10.1016/j.joen.2010.11.005
   Gomes-Filho JE, 2010, ORAL SURG ORAL MED O, V110, pE93, DOI 10.1016/j.tripleo.2010.05.065
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Gou ZG, 2005, J BIOMED MATER RES B, V73B, P244, DOI 10.1002/jbm.b.30203
   GREENSPAN DC, 1976, J BIOMED MATER RES, V10, P503, DOI 10.1002/jbm.820100405
   Greenspan DC, 1999, TANDLAKARTIDNINGEN A, V91
   Hakki SS, 2012, INT ENDOD J, V45, P240, DOI 10.1111/j.1365-2591.2011.01968.x
   Han L, 2013, INT ENDOD J, V46, P808, DOI 10.1111/iej.12062
   Han L, 2011, INT ENDOD J, V44, P1081, DOI 10.1111/j.1365-2591.2011.01924.x
   Han LL, 2010, DENT MATER J, V29, P512, DOI 10.4012/dmj.2009-133
   Han S, 2013, CELL BIOL TOXICOL, V29, P75, DOI 10.1007/s10565-013-9239-0
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   HENCH LL, 1974, J BIOMED MATER RES, V8, P49, DOI 10.1002/jbm.820080307
   Hench LL, 1988, ANN NY ACAD SCI, V523, P554
   HENCH LL, 1993, INTRO BIOCERAMICS, P41
   HENCH LL, 1982, BIOMATERIALS INTERFA
   Hench LL, 1991, J AM CERAM SOC, V74, P1487
   HENCH LL, 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   Katsamakis S, 2013, J CLIN PERIODONTOL, V40, P334, DOI 10.1111/jcpe.12058
   KITSUGI T, 1987, J BIOMED MATER RES, V21, P1255, DOI 10.1002/jbm.820211008
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Koh ET, 1997, J BIOMED MATER RES, V37, P432, DOI 10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Labbez C, 2006, J PHYS CHEM B, V110, P9219, DOI 10.1021/jp057096+
   LEGEROS RZ, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P3
   LeGeros RZ, 1991, CALCIUM PHOSPHATE OR
   Leu A, 2009, TISSUE ENG PT A, V15, P877, DOI 10.1089/ten.tea.2008.0018
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105
   Mahamid J, 2011, CELLS TISSUES ORGANS, V194, P92, DOI 10.1159/000324229
   Mahamid J, 2010, P NATL ACAD SCI USA, V107, P6316, DOI 10.1073/pnas.0914218107
   Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mathew M, 2001, J RES NATL INST STAN, V106, P1035, DOI 10.6028/jres.106.054
   MERWIN GE, 1982, OTOLARYNG HEAD NECK, V90, P461, DOI 10.1177/019459988209000417
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Miyazaki T, 2001, J CERAM SOC JPN, V109, P929, DOI 10.2109/jcersj.109.1275_929
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   Nakayama A, 2005, INT ENDOD J, V38, P203, DOI 10.1111/j.1365-2591.2004.00917.x
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Niu LN, 2013, DENT MAT
   Pan HH, 2010, CHEM COMMUN, V46, P7415, DOI 10.1039/c0cc00971g
   Pardal X, 2009, CEMENT CONCRETE RES, V39, P637, DOI 10.1016/j.cemconres.2009.05.001
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Parirokh M, 2010, J ENDODONT, V36, P16, DOI 10.1016/j.joen.2009.09.006
   Peltola T, 1998, J BIOMED MATER RES, V41, P504, DOI 10.1002/(SICI)1097-4636(19980905)41:3<504::AID-JBM22>3.0.CO;2-G
   Primus C, 2011, Patent, Patent No. [US 7,892,342 B2, 7892342]
   Qia YP, 2012, ACTA BIOMATER, V8, P836, DOI 10.1016/j.actbio.2011.10.033
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Rahimi S, 2012, MED ORAL PATOL ORAL, V17, pE907, DOI 10.4317/medoral.18136
   Maia FR, 2013, ACTA BIOMATER, V9, P8773, DOI 10.1016/j.actbio.2013.08.004
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Richardson IG, 2008, CEMENT CONCRETE RES, V38, P137, DOI 10.1016/j.cemconres.2007.11.005
   RICHARDSON IG, 1993, J AM CERAM SOC, V76, P2285, DOI 10.1111/j.1151-2916.1993.tb07765.x
   Roberts HW, 2008, DENT MATER, V24, P149, DOI 10.1016/j.dental.2007.04.007
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Samara A, 2011, J ENDODONT, V37, P865, DOI 10.1016/j.joen.2011.03.011
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   Saravanapavan P, 2003, J BIOMED MATER RES A, V66A, P110, DOI 10.1002/jbm.a.10532
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Schroder HC, 2012, J CELL BIOCHEM, V113, P3197, DOI 10.1002/jcb.24196
   SEITZ TL, 1982, J BIOMED MATER RES, V16, P195, DOI 10.1002/jbm.820160303
   Shaw CA, 2013, IMMUNOL RES, V56, P304, DOI 10.1007/s12026-013-8403-1
   Shokouhinejad N, 2012, INT ENDOD J, V45, P1127, DOI 10.1111/j.1365-2591.2012.02083.x
   Shrikant Sharma, 2011, International Journal BIOAutomation, V15, P223
   Silver IA, 2001, BIOMATERIALS, V22, P175, DOI 10.1016/S0142-9612(00)00173-3
   Sousa CJA, 2004, INT ENDOD J, V37, P738, DOI 10.1111/j.1365-2591.2004.00861.x
   Taddei P, 2009, J MOL STRUCT, V924, P548, DOI 10.1016/j.molstruc.2008.11.002
   Taddei P, 2009, J RAMAN SPECTROSC, V40, P1858, DOI 10.1002/jrs.2333
   TAVES DR, 1963, NATURE, V200, P1312, DOI 10.1038/2001312a0
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Tingey MC, 2008, J ENDODONT, V34, P45, DOI 10.1016/j.joen.2007.09.013
   Tjaderhane L, 2013, DENT MATER, V29, P999, DOI 10.1016/j.dental.2013.07.016
   Torabinejad M, 1998, J ENDODONT, V24, P468, DOI 10.1016/S0099-2399(98)80048-4
   Torabinejad M, 2005, J ENDODONT, V31, P563, DOI 10.1097/01.don.0000164137.28104.2f
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   Torabinejad M., 1993, US Patent, Patent No. 5415547
   Tseng YH, 2006, J AM CHEM SOC, V128, P6909, DOI 10.1021/ja060336u
   Uchida M, 2001, J AM CERAM SOC, V84, P2041
   Valerio P, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045011
   Wan XH, 2005, MAT SCI ENG C-BIO S, V25, P455, DOI 10.1016/j.msec.2004.12.003
   Willershausen I, 2013, ARCH ORAL BIOL, V58, P1232, DOI 10.1016/j.archoralbio.2013.04.002
   Williams D. F., 1987, DEFINITIONS BIOMATER
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WILSON J, 1990, HDB BIOACTIVE CERAMI, V1
   Xin RL, 2006, J CRYST GROWTH, V289, P339, DOI 10.1016/j.jcrysgro.2005.11.010
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Yang Q, 2011, J BONE MINER RES, V26, P1188, DOI 10.1002/jbmr.337
   Zhang LF, 2013, J TOXICOL SCI, V38, P255, DOI 10.2131/jts.38.255
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
   Zhong J, 1995, P 8 INT S CER MED BI, V8, P489
   Zhong J. P., 1994, BIOCERAMICS, P61
   Zhu Q, 2000, J ENDODONT, V26, P404, DOI 10.1097/00004770-200007000-00006
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 159
TC 34
Z9 36
U1 2
U2 73
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
EI 1879-176X
J9 J DENT
JI J. Dent.
PD MAY
PY 2014
VL 42
IS 5
BP 517
EP 533
DI 10.1016/j.jdent.2013.12.015
PG 17
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AF5HQ
UT WOS:000334745000002
PM 24440449
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Qu, T
   Tomar, V
AF Qu, Tao
   Tomar, Vikas
TI An analysis of the effects of temperature and structural arrangements on
   the thermal conductivity and thermal diffusivity of
   tropocollagen-hydroxyapatite interfaces
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Tropocollagen; Hydroxyapatite; Thermal diffusivity; Thermal
   conductivity; Molecular dynamics
ID COLLAGEN-LIKE PEPTIDE; NANOSCALE MECHANICAL-BEHAVIOR;
   MOLECULAR-DYNAMICS; ELASTIC PROPERTIES; HARD BIOMATERIALS; YOUNGS
   MODULUS; BONE; FIBRILS; STRENGTH; FRACTURE
AB The ability of a biomaterial to transport energy by conduction is best characterized in the steady state by its thermal conductivity and in the non-steady state by its thermal diffusivity. The complex hierarchical structure of most biomaterials makes the direct determination of the thermal diffusivity and thermal conductivity difficult using experimental methods. This study presents a classical molecular simulation based approach for the thermal diffusivity and thermal conductivity prediction for a set of tropocollagen and hydroxyapatite based idealized biomaterial interfaces. The thermal diffusivity and thermal conductivity values are calculated using the presented approach at three different temperatures (300 K, 500 K and 700 K). The effects of temperature, structural arrangements, and size of simulated systems on the thermal properties are analyzed. Analyses point out important role played by the interface orientation, interface area, and structural hierarchy. Ensuing discussions establish that the interface structural arrangement and interface orientation combined with biomimetic structural hierarchy can lead to non-intuitive thermal property variations as a function of structural features. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Qu, Tao; Tomar, Vikas] Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
RP Tomar, V (reprint author), Purdue Univ, Sch Aeronaut & Astronaut, W Lafayette, IN 47907 USA.
EM tomar@purdue.edu
FU U.S. Department of Energy, Office of Science, Basic Energy Sciences
   [DE-SC0008619]
FX This work was supported by the U.S. Department of Energy, Office of
   Science, Basic Energy Sciences, under Award DE-SC0008619 (Program
   Manager: Dr. Michael Markowitz).
CR Algaer E. A., 2011, SOFT MATER, V10, P42
   Anderson D., 2005, COLLAGEN SELF ASSEMB
   Autumn K, 2000, NATURE, V405, P681
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   BIYIKLI S, 1986, J BIOMED MATER RES, V20, P1335, DOI 10.1002/jbm.820200908
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2006, J MATER RES, V21, P1947, DOI 10.1557/JMR.2006.0236
   Dubey D.K., 2010, APPL PHYS LETT, V96
   Dubey D. K., 2009, J PHYS CONDENS MATTE, V21
   Dubey DK, 2010, J COMPUT THEOR NANOS, V7, P1306, DOI 10.1166/jctn.2010.1485
   Dubey DK, 2010, ANN BIOMED ENG, V38, P2040, DOI 10.1007/s10439-010-9988-3
   Dubey DK, 2010, J MATER SCI-MATER M, V21, P161, DOI 10.1007/s10856-009-3837-7
   Dubey DK, 2009, J MECH PHYS SOLIDS, V57, P1702, DOI 10.1016/j.jmps.2009.07.002
   Dubey DK, 2009, ACTA BIOMATER, V5, P2704, DOI 10.1016/j.actbio.2009.02.035
   Dubey DK, 2009, MAT SCI ENG C-MATER, V29, P2133, DOI 10.1016/j.msec.2009.04.015
   ELLIOTT JC, 1973, SCIENCE, V180, P1055, DOI 10.1126/science.180.4090.1055
   Eppell SJ, 2006, J ROY SOC INTERFACE, V3, P117, DOI 10.1098/rsif.2005.0100
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Gao HJ, 2006, INT J FRACTURE, V138, P101, DOI 10.1007/s10704-006-7156-4
   Gupta HS, 2006, INT J FRACTURE, V139, P425, DOI 10.1007/s10704-006-6635-y
   Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103
   Handgraaf JW, 2006, PROTEINS, V64, P711, DOI 10.1002/prot.21019
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hopkins P. E., 2013, ISRN MECH ENG, V2013
   Huang C C, 1998, Pac Symp Biocomput, P349
   Huang XP, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/9/095416
   Huiskes R., 1980, ACTA ORTHOP SCAND, V51, P43
   Isgro J.P. Tim, 2012, ANAL SPECIFIC HEAT, P50
   Jager I, 2000, BIOPHYS J, V79, P1737
   Jeng M.-S., 2008, J HEAT TRANSF, V130
   Ji BH, 2008, J BIOMECH, V41, P259, DOI 10.1016/j.jbiomech.2007.09.022
   Klein TE, 1999, BIOPOLYMERS, V49, P167
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Landis WJ, 1996, J STRUCT BIOL, V117, P24, DOI 10.1006/jsbi.1996.0066
   Landis WJ, 1996, MICROSC RES TECHNIQ, V33, P192
   Liang LH, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/36/365201
   Lorenzo AC, 2005, J BIOMECH, V38, P1527, DOI 10.1016/j.jbiomech.2004.07.011
   MOSES WM, 1995, EXP THERM FLUID SCI, V11, P34, DOI 10.1016/0894-1777(94)00109-L
   Nadareishvili M., 2012, PULSED DIFFERENTIAL
   NELSON JS, 1988, LASER SURG MED, V8, P494, DOI 10.1002/lsm.1900080508
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27
   Radmer RJ, 2004, BIOCHEMISTRY-US, V43, P5314, DOI 10.1021/bi035676w
   Samvedi V., 2010, J PHYS D, V43
   Samvedi V., 2009, J APPL PHYS, V105
   Samvedi V., 2009, NANOTECHNOLOGY, V20
   Samvedi V, 2009, J APPL PHYS, V105, DOI 10.1063/1.3056135
   Sarnvedi V., 2011, J ENG MATER-T ASME, V133
   SASAKI N, 1995, J BIOMECH, V28, P809, DOI 10.1016/0021-9290(94)00130-V
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Sasaki N, 1996, J BIOMECH, V29, P655, DOI 10.1016/0021-9290(95)00110-7
   Schelling PK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144306
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   WEINER S, 1983, INT J BIOL MACROMOL, V5, P325, DOI 10.1016/0141-8130(83)90055-7
   WIGGINS KL, 1976, J BIOMECH, V9, P553, DOI 10.1016/0021-9290(76)90095-6
   Yang R., 2005, PHYS REV B, P72
   Yang R., 2004, PHYS REV B, P69
   Zelenov E., 1986, MECH COMPOS MATER, V21, P759
   Zhang DJ, 2007, ANN BIOMED ENG, V35, P1216, DOI 10.1007/s10439-007-9296-8
   Zhou Y., 2007, J CHEM PHYS, V127
NR 64
TC 5
Z9 5
U1 3
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2014
VL 38
BP 28
EP 38
DI 10.1016/j.msec.2014.01.039
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AF8RX
UT WOS:000334984400004
PM 24656349
DA 2018-10-19
ER

PT J
AU Kandiah, K
   Muthusamy, P
   Mohan, S
   Venkatachalam, R
AF Kandiah, Kavitha
   Muthusamy, Prabhu
   Mohan, Selvam
   Venkatachalam, Rajendran
TI TiO2-graphene nanocomposites for enhanced osteocalcin induction
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Titania-graphene; Cytotoxicity; Biocompatibility; Osteocalcin; MG-63
   cell line; Surface area
ID GRAPHENE OXIDE; BIOMEDICAL APPLICATIONS; TIO2 NANOPARTICLES; COMPOSITE
   COATINGS; IN-VITRO; CHITOSAN; FABRICATION; NANOSHEETS; CELLS; BONE
AB Bone defects and damages are common these days, which increases the usage of biomaterial for humans. To prepare a potential biomaterial, we synthesised a series of titania-graphene nanocomposites (TGS) (2:x (0.25, 0.5, 1.0, 2.0, and 4.0 g)) using in situ sol-gel method. The obtained structural results show that the prepared TGS nanocomposites are an irregular sheet with spherical TiO2 intercalated morphology. The SSA of the nanocomposites ranging from 167.98 to 234.56 m(2) g(-1) with mesoporosity and swelling tendency ranging from 11.55 to 26.13% leads to an enhancement in human cell attachment as well as avoids the migration and agglomeration of the nanoparticles in the body. Further, the biological analysis in simulated body fluid and human cell lines (AGS and MG-63) collectively reveals that the TG2 (2:2) and TG4 (2:4) samples are found to be more favourable materials for biomimic bone action among the prepared TGS nanocomposites. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kandiah, Kavitha; Muthusamy, Prabhu; Mohan, Selvam; Venkatachalam, Rajendran] KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
RP Venkatachalam, R (reprint author), KS Rangasamy Coll Technol, Ctr Nano Sci & Technol, Tiruchengode 637215, Tamil Nadu, India.
EM veerajendran@gmail.com
RI VENKATACHALAM, RAJENDRAN/H-5099-2012
OI VENKATACHALAM, RAJENDRAN/0000-0001-9471-5311
FU UGC-DAE-Consortium for Scientific Research, Kalpakkam
   [CSR/Acctts/2010-11/1136]
FX This work was financially supported by UGC-DAE-Consortium for Scientific
   Research, Kalpakkam (CSR/Acctts/2010-11/1136 dt.06.01.2011). The authors
   thank Dr. G. Amarendra (Head, Metal Physics Section, Indira Gandhi
   Centre for Atomic Research, Kalpakkam node) for constructive
   suggestions. The authors also thank Dr. G. Kumaresan and Mr. P.
   Jayaprakash (Department of Genetics, School of Biological Sciences,
   Madurai Kamaraj University) for their technical support in the toxicity
   studies.
CR Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x
   Amin KAM, 2012, POLYMERS-BASEL, V4, P590, DOI 10.3390/polym4010590
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Bitounis D, 2013, ADV MATER, V25, P2258, DOI 10.1002/adma.201203700
   Chen HW, 2012, NANO RES, V5, P815, DOI 10.1007/s12274-012-0265-7
   Compton OC, 2012, ACS NANO, V6, P2008, DOI 10.1021/nn202928w
   Condon J. B., 2006, SURFACE AREA POROSIT
   Hua D, 2007, T NONFERR METAL SOC, V17, pS700
   DREW WL, 1972, APPL MICROBIOL, V24, P240
   Duraisamy N, 2012, THIN SOLID FILMS, V520, P5070, DOI 10.1016/j.tsf.2012.03.003
   Fan Y, 2011, COLLOID SURFACE B, V83, P78, DOI 10.1016/j.colsurfb.2010.10.048
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Guo JJ, 2011, ULTRASON SONOCHEM, V18, P1082, DOI 10.1016/j.ultsonch.2011.03.021
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Huang YW, 2012, COLLOID SURFACE A, V401, P97, DOI 10.1016/j.colsurfa.2012.03.031
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Kalbacova M, 2010, CARBON, V48, P4323, DOI 10.1016/j.carbon.2010.07.045
   Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763
   KASPERK C, 1995, J CLIN ENDOCR METAB, V80, P2511, DOI 10.1210/jc.80.8.2511
   Kavitha K, 2013, CURR NANOSCI, V9, P308, DOI 10.2174/1573413711309030003
   Kavitha K, 2013, CARBOHYD POLYM, V93, P731, DOI 10.1016/j.carbpol.2012.12.031
   Krishnamoorthy K, 2013, ULTRASON SONOCHEM, V20, P644, DOI 10.1016/j.ultsonch.2012.09.007
   Krishnamoorthy K, 2012, J PHYS CHEM C, V116, P17280, DOI 10.1021/jp3047054
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Lambert TN, 2011, NANOSCALE, V3, P188, DOI 10.1039/c0nr00638f
   Liang YY, 2010, NANO RES, V3, P701, DOI 10.1007/s12274-010-0033-5
   Lim HN, 2011, INT J NANOMED, V6, P1817, DOI 10.2147/IJN.S23392
   Luo YB, 2009, APPL SURF SCI, V255, P6795, DOI 10.1016/j.apsusc.2009.02.074
   Ma XM, 2013, EUR POLYM J, V49, P389, DOI 10.1016/j.eurpolymj.2012.10.034
   Nathanael AJ, 2010, THIN SOLID FILMS, V518, P7333, DOI 10.1016/j.tsf.2010.04.105
   Nayak TR, 2011, ACS NANO, V5, P4670, DOI 10.1021/nn200500h
   Rajkumar M, 2013, MAT SCI ENG C-MATER, V33, P3237, DOI 10.1016/j.msec.2013.04.005
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Rani VVD, 2011, CARBOHYD POLYM, V83, P858, DOI 10.1016/j.carbpol.2010.08.065
   Remya NS, 2013, MAT SCI ENG C-MATER, V33, P575, DOI 10.1016/j.msec.2012.09.015
   Seidi A, 2011, ACTA BIOMATER, V7, P1441, DOI 10.1016/j.actbio.2011.01.011
   Selvam M., 2013, B MAT SCI, V36
   Siriphannon P, 2002, J EUR CERAM SOC, V22, P511, DOI 10.1016/S0955-2219(01)00301-6
   Song P, 2012, NANOSCALE, V4, P1800, DOI 10.1039/c2nr11938b
   Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Varma HK, 1999, BIOMATERIALS, V20, P879, DOI 10.1016/S0142-9612(98)00243-9
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Zhang XY, 2010, J MATER CHEM, V20, P2801, DOI 10.1039/b917240h
   Zhang XY, 2012, INT J HYDROGEN ENERG, V37, P811, DOI 10.1016/j.ijhydene.2011.04.053
   Zhang XY, 2012, TOXICOL RES-UK, V1, P62, DOI 10.1039/c2tx20006f
   Zhang Y, 2012, NANOSCALE, V4, P3833, DOI 10.1039/c2nr31040f
   Zhou H., 2011, ACTA BIOMATER, V7, P2269
NR 50
TC 18
Z9 19
U1 2
U2 48
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAY 1
PY 2014
VL 38
BP 252
EP 262
DI 10.1016/j.msec.2014.02.010
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AF8RX
UT WOS:000334984400031
PM 24656376
DA 2018-10-19
ER

PT J
AU Vasilev, K
AF Vasilev, Krasimir
TI Nanoengineered Plasma Polymer Films for Biomaterial Applications
SO PLASMA CHEMISTRY AND PLASMA PROCESSING
LA English
DT Article
DE Plasma polymerization; Thin films; Surface modification; Biomaterials;
   Nanostructures; Antibacterial surfaces; Drug release
ID ANTIBACTERIAL SURFACES; ZINC ACETYLACETONATE; CONTAINING MONOMERS;
   BIOMEDICAL DEVICES; GLOW-DISCHARGE; CELL-ADHESION; THIN-FILMS; COATINGS;
   GENERATION; DEPOSITION
AB Plasma polymerization has evolved in an important technology for generation of thin films that have found numerous advanced applications. The orthodox view to plasma polymers is as continuous, homogeneous and pinhole-free coatings. However, there is an emerging trend towards creating more advanced films though engineering them at the nanoscale. This paper presents a summary of our work and published studies, from other groups, which demonstrate the potential of plasma polymerization to generate advanced nanostructured interfaces. The focus is on applications in the area of biomaterials. Strategies for generation of antibacterial coatings through inclusion of metallic nanoparticles in plasma polymer films are described. Drug delivery platforms developed via templating and incorporation of drug particles are outlined. A record of recent progress in fabrication of cell guidance surfaces facilitated by nanoengineering of plasma polymer film is also included. The paper concludes with the author's view to the future outlook of the niche area of nanoengineered plasma polymer films.
C1 [Vasilev, Krasimir] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
   [Vasilev, Krasimir] Univ S Australia, Sch Engn, Mawson Lakes, SA 5095, Australia.
RP Vasilev, K (reprint author), Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
EM krasimir.vasilev@unisa.edu.au
FU ARC [FT100100292]
FX The author thanks ARC for Fellowship No. FT100100292.
CR Alissawi N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0928-z
   BIEDERMAN H, 1990, VACUUM, V40, P377, DOI 10.1016/0042-207X(90)90095-G
   Biederman H, 1996, VACUUM, V47, P1385, DOI 10.1016/S0042-207X(96)00185-6
   BIEDERMAN H, 1994, INT J ELECTRON, V76, P937, DOI 10.1080/00207219408926001
   Boldyryeva H, 2003, THIN SOLID FILMS, V442, P86, DOI 10.1016/S0040-6090(03)00950-7
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Di Mundo R, 2010, PLASMA PROCESS POLYM, V7, P212, DOI 10.1002/ppap.200900112
   Favia P, 2002, VIDE, V57, P40
   Favia P, 2001, SURF COAT TECH, V142, P1, DOI 10.1016/S0257-8972(01)01191-4
   Foerch R, 2007, CHEM VAPOR DEPOS, V13, P280
   Fracassi F, 1996, THIN SOLID FILMS, V272, P60, DOI 10.1016/0040-6090(95)06971-2
   GOODMAN J, 1960, J POLYM SCI, V44, P551, DOI 10.1002/pol.1960.1204414428
   Goreham RV, 2013, RSC ADV, V3, P10309, DOI 10.1039/c3ra23193c
   Goreham RV, 2013, THIN SOLID FILMS, V528, P106, DOI 10.1016/j.tsf.2012.04.087
   Goreham RV, 2011, J PHYS CHEM C, V115, P3429, DOI 10.1021/jp111221g
   Hopp I, 2013, BIOMATERIALS, V34, P5070, DOI 10.1016/j.biomaterials.2013.03.075
   Intranuovo F, 2011, BIOMACROMOLECULES, V12, P380, DOI 10.1021/bm101136n
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Kumar V, 2013, J BIOMED MATER RES A, V101, P1121, DOI 10.1002/jbm.a.34419
   Linder EG, 1931, J PHYS CHEM-US, V35, P3649, DOI 10.1021/j150330a017
   Lopez LC, 2006, ADV FUNCT MATER, V16, P1417, DOI 10.1002/adfm.200500502
   Losic D, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245704
   Lotz A, 2012, J MATER CHEM, V22, P19455, DOI 10.1039/c2jm30344b
   Malzahn K, 2013, PLASMA PROCESS POLYM, V10, P243, DOI 10.1002/ppap.201200106
   McInnes SJP, 2012, ACS APPL MATER INTER, V4, P3566, DOI 10.1021/am300621k
   Michelmore A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415601
   Michelmore A, 2011, PLASMA PROCESS POLYM, V8, P367, DOI 10.1002/ppap.201000140
   Mierczynska A, 2012, SOFT MATTER, V8, P8399, DOI 10.1039/c2sm25221j
   Ostrikov K, 2013, ADV PHYS, V62, P113, DOI 10.1080/00018732.2013.808047
   Ostrikov K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/17/174001
   Ploux L, 2012, J NANOMATER, DOI 10.1155/2012/674145
   Robinson DE, 2008, ADV MATER, V20, P1166, DOI 10.1002/adma.200702586
   Rosso F, 2006, J CELL PHYSIOL, V207, P636, DOI 10.1002/jcp.20595
   Sardella E, 2008, PLASMA PROCESS POLYM, V5, P540, DOI 10.1002/ppap.200800005
   Sekine R, 2013, ENVIRON SCI TECHNOL, V47, P9308, DOI 10.1021/es400839h
   Simovic S, 2011, PHARM TECHNOL, V35, P68
   Simovic S, 2010, CHEM COMMUN, V46, P1317, DOI 10.1039/b919840g
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Susut C, 2005, INT J PHARM, V288, P253, DOI 10.1016/j.ijpharm.2004.10.004
   Vasilev K, 2008, J PHYS CHEM B, V112, P10915, DOI 10.1021/jp803678w
   Vasilev K, 2011, ACS APPL MATER INTER, V3, P4831, DOI 10.1021/am201320a
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2010, PLASMA PROCESS POLYM, V7, P824, DOI 10.1002/ppap.201000030
   Vasilev K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215102
   Vasilev K, 2010, NANO LETT, V10, P202, DOI 10.1021/nl903274q
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Vasilev K, 2010, BIOMATERIALS, V31, P392, DOI 10.1016/j.biomaterials.2009.09.056
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Vasilev K, 2009, J PHYS CHEM B, V113, P7059, DOI 10.1021/jp807986k
   Vasilev K, 2009, CHEM COMMUN, P3600, DOI 10.1039/b904367e
   WESTWOOD AR, 1971, EUR POLYM J, V7, P363, DOI 10.1016/0014-3057(71)90007-3
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   Zanini S, 2013, MATER CHEM PHYS, V138, P850, DOI 10.1016/j.matchemphys.2012.12.070
   Zhu T, 2003, LANGMUIR, V19, P9518, DOI 10.1021/la035157u
NR 54
TC 19
Z9 19
U1 2
U2 53
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4324
EI 1572-8986
J9 PLASMA CHEM PLASMA P
JI Plasma Chem. Plasma Process.
PD MAY
PY 2014
VL 34
IS 3
SI SI
BP 545
EP 558
DI 10.1007/s11090-013-9506-0
PG 14
WC Engineering, Chemical; Physics, Applied; Physics, Fluids & Plasmas
SC Engineering; Physics
GA AF0WI
UT WOS:000334434800012
DA 2018-10-19
ER

PT J
AU Conway, A
   Schaffer, DV
AF Conway, Anthony
   Schaffer, David V.
TI Biomaterial Microenvironments to Support the Generation of New Neurons
   in the Adult Brain
SO STEM CELLS
LA English
DT Article
DE Stem cell-microenvironment interactions; Neural stem cells; Neural
   differentiation; Adult stem cells
ID NEURAL STEM-CELLS; DE-NOVO NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; SONIC
   HEDGEHOG; IN-VIVO; PROGENITOR PROLIFERATION; DENTATE GYRUS;
   REGENERATION; MICE; QUIESCENT
AB Neural stem cells (NSC) in two regions of the adult mammalian brain-the subventricular zone (SVZ) and hippocampus-continuously generate new neurons, enabled by a complex repertoire of factors that precisely regulate the activation, proliferation, differentiation, and integration of the newborn cells. A growing number of studies also report low-level neurogenesis in regions of the adult brain outside these established neurogenic niches-potentially via NSC recruitment or activation of local, quiescent NSCs-under perturbations such as ischemia, cell death, or viral gene delivery of proneural growth factors. We have explored whether implantation of engineered biomaterials can stimulate neurogenesis in normally quiescent regions of the brain. Specifically, recombinant versions of factors found within the NSC microenvironment, Sonic hedgehog, and ephrin-B2 were conjugated to long polymers, thereby creating highly bioactive, multivalent ligands that begin to emulate components of the neurogenic niche. In this engineered biomaterial microenvironment, new neuron formation was observed in normally non-neurogenic regions of the brain, the striatum, and the cortex, and combining these multivalent biomaterials with stromal cell-derived factor-1 alpha increased neuronal commitment of newly divided cells seven- to eightfold in these regions. Additionally, the decreased hippocampal neurogenesis of geriatric rodents was partially rescued toward levels of young animals. We thus demonstrate for the first time de novo neurogenesis in both the cortex and striatum of adult rodents stimulated solely by delivery of synthetic biomaterial forms of proteins naturally found within adult neurogenic niches, offering the potential to replace neurons lost in neurodegenerative disease or injury as an alternative to cell implantation. Stem Cells 2014;32:1220-1229
C1 [Conway, Anthony; Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.
RP Schaffer, DV (reprint author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley Stem Cell Ctr, Berkeley, CA 94720 USA.
EM schaffer@berkeley.edu
FU NIH [R21 EB007295]; California Institute for Regenerative Medicine
   (CIRM) grant [RT2-02022]; CIRM [T1-00007]
FX We thank T. Miyamoto (Keio University) for mouse ephrin-B2 cDNA. This
   work was supported by NIH R21 EB007295 and California Institute for
   Regenerative Medicine (CIRM) grant RT2-02022. A.C. was partially
   supported by training grant fellowships from CIRM (T1-00007).
CR Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747
   Ashton RS, 2012, NAT NEUROSCI, V15, P1399, DOI 10.1038/nn.3212
   Benraiss A, 2012, GENE THER, V19, P582, DOI 10.1038/gt.2011.182
   Berg DA, 2010, DEVELOPMENT, V137, P4127, DOI 10.1242/dev.055541
   Bhattacharyya BJ, 2008, J NEUROSCI, V28, P6720, DOI 10.1523/JNEUROSCI.1677-08.2008
   Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395
   Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107
   Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215
   Conway A, METHOD MOL BIOL, DOI [10.1007/7651_2013_32, DOI 10.1007/7651_2013_32]
   Conway A, 2013, NAT NANOTECHNOL, V8, P831, DOI [10.1038/NNANO.2013.205, 10.1038/nnano.2013.205]
   Conway A, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt141
   DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638
   Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018
   Itoh T, 2009, NEUROL RES, V31, P90, DOI 10.1179/174313208X332995
   Iwai M, 2001, Hum Cell, V14, P27
   Jiang W, 2001, STROKE, V32, P1201, DOI 10.1161/01.STR.32.5.1201
   Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x
   Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Kuhn HG, 1996, J NEUROSCI, V16, P2027
   Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Leuner B, 2009, J COMP NEUROL, V517, P123, DOI 10.1002/cne.22107
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017
   Magavi SS, 2000, NATURE, V405, P951
   Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016
   Miranda CJ, 2012, AGING CELL, V11, P542, DOI 10.1111/j.1474-9726.2012.00816.x
   Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473
   Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697
   Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393
   Petrie TA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001002
   Pierce AA, 2010, J NEUROSCI, V30, P723, DOI 10.1523/JNEUROSCI.2479-09.2010
   Politis M, 2010, SCI TRANSL MED, V2, DOI DOI 10.1126/SCITRANSLMED.3000976
   Pritchard CD, 2011, BIOMATERIALS, V32, P587, DOI 10.1016/j.biomaterials.2010.08.106
   Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001
   Shan XY, 2006, STEM CELLS, V24, P1280, DOI 10.1634/stemcells.2005-0487
   Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023
   Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x
   Vazin T, 2014, BIOMATERIALS, V35, P941, DOI 10.1016/j.biomaterials.2013.10.025
   Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357
   Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k
NR 50
TC 14
Z9 14
U1 1
U2 22
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1066-5099
EI 1549-4918
J9 STEM CELLS
JI Stem Cells
PD MAY
PY 2014
VL 32
IS 5
BP 1220
EP 1229
DI 10.1002/stem.1650
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA AF3FP
UT WOS:000334597200016
PM 24449485
OA Bronze
DA 2018-10-19
ER

PT J
AU Braghirolli, DI
   Steffens, D
   Quintiliano, K
   Acasigua, GAX
   Gamba, D
   Fleck, RA
   Petzhold, CL
   Pranke, P
AF Braghirolli, Daikelly Iglesias
   Steffens, Daniela
   Quintiliano, Kerlin
   Xavier Acasigua, Gerson Arisoly
   Gamba, Douglas
   Fleck, Roland A.
   Petzhold, Cesar L.
   Pranke, Patricia
TI The effect of sterilization methods on electronspun
   poly(lactide-co-glycolide) and subsequent adhesion efficiency of
   mesenchymal stem cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE PLGA; biomaterials; electrospinning; nanofibers; sterilization
ID SCAFFOLDS; IRRADIATION
AB The sterilization of scaffolds is an essential step for tissue engineering in vitro and, mainly, clinical biomaterial use. However, this process can cause changes in the structure and surface of the scaffolds. Therefore, the objective of this study was to investigate the effect of sterilization by ethanol, ultraviolet radiation (UVR) or antimicrobial solution (AMS) on poly(lactide-co-glycolide) (PLGA) scaffolds produced by the electrospinning technique. The properties of nanofibers and the cellular adhesion of mesenchymal stem cells to the scaffolds were analyzed after the treatments. All methods generated sterile scaffolds but showed some kind of damage to the scaffolds. Ethanol and AMS caused changes in the morphology and scaffold dimensions, which were not observed when using the UVR method. However, UVR caused a greater reduction in polymeric molecular weight, which increased proportionally with exposure time of treatment. Nanofibers sterilized with AMS for 1 h and 2 h showed greater cellular adhesion than the other methods, demonstrating their potential as a method for sterilizing PLGA nanofibers. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 700-708, 2014.
C1 [Braghirolli, Daikelly Iglesias; Steffens, Daniela; Quintiliano, Kerlin; Xavier Acasigua, Gerson Arisoly; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
   [Braghirolli, Daikelly Iglesias; Steffens, Daniela; Pranke, Patricia] Univ Fed Rio Grande do Sul, Post Grad Programme Mat Sci, BR-91501970 Porto Alegre, RS, Brazil.
   [Quintiliano, Kerlin] Univ Fed Rio Grande do Sul, Post Grad Programme Neurosci, BR-90050170 Porto Alegre, RS, Brazil.
   [Xavier Acasigua, Gerson Arisoly] Univ Fed Rio Grande do Sul, Post Grad Programme Dent, BR-90035003 Porto Alegre, RS, Brazil.
   [Gamba, Douglas; Petzhold, Cesar L.] Univ Fed Rio Grande do Sul, Inst Chem, BR-91501970 Porto Alegre, RS, Brazil.
   [Fleck, Roland A.] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England.
   [Pranke, Patricia] Stem Cell Res Inst, BR-90020010 Porto Alegre, RS, Brazil.
RP Pranke, P (reprint author), Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
EM patriciapranke@ufrgs.br
RI Petzhold, Cesar/F-8001-2012; Gamba, Douglas/A-7872-2013
OI Petzhold, Cesar/0000-0002-5919-8133; Gamba, Douglas/0000-0003-1889-2601
FU National Counsel of Technological and Scientific Development (CNPq);
   Stem Cell Research Institute
FX Contract grant sponsor: National Counsel of Technological and Scientific
   Development (CNPq) and Stem Cell Research Institute
CR Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Cottam E, 2009, MED ENG PHYS, V31, P221, DOI 10.1016/j.medengphy.2008.07.005
   Dong YX, 2008, TISSUE ENG PT A, V14, P1321, DOI 10.1089/ten.tea.2007.0395
   Heunis TD, 2010, J BIOMED BIOTECHNOL, V2010
   Holy CE, 2001, BIOMATERIALS, V22, P25, DOI 10.1016/S0142-9612(00)00136-8
   Hwang CM, 2009, BIOMED MICRODEVICES, V11, P739, DOI 10.1007/s10544-009-9287-7
   Inanc B, 2009, J BIOMED MATER RES A, V90A, P186, DOI 10.1002/jbm.a.32066
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Kim SJ, 2010, POLYMER, V51, P1320, DOI 10.1016/j.polymer.2010.01.025
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lim SH, 2009, ADV DRUG DELIVER REV, V61, P1084, DOI 10.1016/j.addr.2009.07.011
   Lucas E. F., 2001, CARACTERIZACAO POLIM
   Ma JQ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/812135
   Odelius K, 2008, BIOMATERIALS, V29, P129, DOI 10.1016/j.biomaterials.2007.08.046
   Olivas-Armendariz I, 2012, J BIOMATER NANOBIOTE, V3, P440
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Seo S, 2011, BIOTECHNOL, V2011, P806
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Siritientong T, 2011, AAPS PHARMSCITECH, V12, P771, DOI 10.1208/s12249-011-9641-y
NR 22
TC 15
Z9 16
U1 0
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 700
EP 708
DI 10.1002/jbm.b.33049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300007
PM 24259451
DA 2018-10-19
ER

PT J
AU Gao, Y
   Liu, LJ
   Blatnik, JA
   Krpata, DM
   Anderson, JM
   Criss, CN
   Posielski, N
   Novitsky, YW
AF Gao, Yue
   Liu, Li-Jia
   Blatnik, Jeffrey A.
   Krpata, David M.
   Anderson, James M.
   Criss, Corry N.
   Posielski, Natasza
   Novitsky, Yuri W.
TI Methodology of fibroblast and mesenchymal stem cell coating of surgical
   meshes: A pilot analysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cell culture; foreign body reactions (response); biocompatibility/soft
   tissue; fibroblasts; stem cells
ID RANDOMIZED CONTROLLED-TRIAL; VENTRAL HERNIA REPAIR; TERM-FOLLOW-UP;
   INCISIONAL HERNIA; RAT MODEL; IN-VITRO; ADHESION; SCAFFOLD; TITANIUM;
   BIOMATERIAL
AB Coating of various synthetic, absorbable, and biologic meshes with mesenchymal stem cells (MSCs) and fibroblasts was analyzed qualitatively and quantitatively. Five hernia meshes-light weight monofilament polypropylene (Soft Mesh), polyester (Parietex-TET), polylactide composite (TIGR), heavy weight monofilament polypropylene (Marlex), and porcine dermal collagen (Strattice)-were coated with three cell lines: human dermal fibroblasts (HFs), rat kidney fibroblasts (NRKs), and rat MSCs. Cell densities were determined at different time points. Samples also underwent histology and transmission electron microscopic (TEM) analyses. It required HFs 3 weeks to cover the entire mesh, while only 2 weeks for NRKs and MSCs to do so. MSCs had no preference for any of the meshes and produced the highest cell densities on Parietex and TIGR. Substrate-preference accounted for the significantly lower fibroblast densities on TIGR than Parietex. Fibroblasts failed to coat Marlex. Strattice, which had the least surface area, generated comparable cell densities to Parietex. Both histology and TEM confirmed cell coating of mesh surface. Various prosthetics can be coated by certain cell strains. Both mesh composition and cell preference dramatically influence the coating process. This methodology provides foundation for novel avenues of modulation of host response to various modern synthetic and biologic meshes. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 797-805, 2014.
C1 [Gao, Yue; Liu, Li-Jia; Blatnik, Jeffrey A.; Krpata, David M.; Anderson, James M.; Criss, Corry N.; Posielski, Natasza; Novitsky, Yuri W.] Case Western Reserve Univ, Dept Surg, Case Comprehens Hernia Ctr, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
RP Novitsky, YW (reprint author), Case Western Reserve Univ, Dept Surg, Case Comprehens Hernia Ctr, Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA.
EM yuri.novitsky@uhhospitals.org
FU Department of Surgery University Hospitals Case Medical Center
FX Contract grant sponsor: Department of Surgery University Hospitals Case
   Medical Center
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Bakhshandeh H, 2011, INT J NANOMED, V6, P1509, DOI 10.2147/IJN.S19011
   Binnebosel M, 2012, BMC SURG, V12, DOI 10.1186/1471-2482-12-1
   Blakeney BA, 2011, BIOMATERIALS, V32, P1583, DOI 10.1016/j.biomaterials.2010.10.056
   Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012
   Bonfield TL, 2010, J INFLAMM-LOND, V25, P51
   Brandt CJ, 2011, J BIOMED MATER RES A, V99A, P335, DOI 10.1002/jbm.a.33136
   Bras LED, 2012, HERNIA, V16, P77, DOI 10.1007/s10029-011-0859-0
   Burger JWA, 2004, ANN SURG, V240, P578
   Burger JWA, 2004, ANN SURG, V240, P583
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carman CV, 2009, J CELL SCI, V122, P3025, DOI 10.1242/jcs.047522
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Deeken CR, 2012, HERNIA, V16, P69, DOI 10.1007/s10029-011-0854-5
   Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580
   Ding F, 2010, TISSUE ENG PT A, V16, P3779, DOI [10.1089/ten.tea.2010.0299, 10.1089/ten.TEA.2010.0299]
   Dolce CJ, 2010, SURG ENDOSC, V24, P2687, DOI 10.1007/s00464-010-1026-x
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Gongadze E, 2011, INT J NANOMED, V6, P1801, DOI [10.2147/IJN.S21755, 10.2147/IJN.S16982]
   Hamdan M, 2006, CLIN IMPLANT DENT R, V8, P32, DOI 10.2310/6480.2005.00028
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Junge K, 2011, LANGENBECKS ARCH SUR
   Kapischke M, 2005, SURG ENDOSC, V19, P791, DOI 10.1007/s00464-004-9222-1
   Kral JG, 1999, PLAST RECONSTR SURG, V104, P1732, DOI 10.1097/00006534-199911000-00018
   Kyzer S, 1997, EUR SURG RES, V29, P84, DOI 10.1159/000129511
   Lancaster J, 2010, TISSUE ENG PT A, V16, P3065, DOI [10.1089/ten.tea.2009.0589, 10.1089/ten.TEA.2009.0589]
   Langer C, 2005, CHIRURG, V76, P876, DOI 10.1007/s00104-005-1036-8
   Lavenus S, 2011, ACTA BIOMATER, V7, P1525, DOI 10.1016/j.actbio.2010.12.033
   Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494
   Ma T, 2010, J BIOL CHEM, V285, P29911, DOI 10.1074/jbc.M109.099697
   McPhee G, 2010, MED BIOL ENG COMPUT, V48, P1043, DOI 10.1007/s11517-010-0657-3
   Monroy A, 2007, INT J PEDIATR OTORHI, V71, P547, DOI 10.1016/j.ijporl.2006.11.025
   Orenstein SB, 2011, SURG ENDOSC, V25, P1452, DOI 10.1007/s00464-010-1413-3
   Otto WR, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-20
   Patel M, 2010, TISSUE ENG PT A, V16, P55, DOI [10.1089/ten.tea.2009.0027, 10.1089/ten.TEA.2009.0027]
   Pierce LM, 2009, AM J OBSTET GYNECOL, V200, pe1
   Prockop DJ, 2012, MOL THER, V20, P14, DOI 10.1038/mt.2011.211
   Raimondo T, 2010, INT J NANOMED, V5, P647, DOI 10.2147/IJN.S13047
   Ribeiro C, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035004
   Rosen M J, 2007, Hernia, V11, P435, DOI 10.1007/s10029-007-0255-y
   Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008
   Skala CE, 2009, REGEN MED, V4, P197, DOI 10.2217/17460751.4.2.197
   Song Y, 2011, J BIOMED MAT RES A
   Svensson HG, 2008, EUR J IMMUNOL, V38, P818, DOI 10.1002/eji.200737331
   Tolde O, 2010, EUR J CELL BIOL, V89, P674, DOI 10.1016/j.ejcb.2010.04.003
   Urita Y, 2008, PEDIATR SURG INT, V24, P1041, DOI 10.1007/s00383-008-2212-y
   Weil BR, 2011, J SURG RES, V167, P78, DOI 10.1016/j.jss.2010.07.019
   Wilshaw SP, 2009, J BIOMED MATER RES B, V88B, P49, DOI 10.1002/jbm.b.31148
   Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3
NR 50
TC 6
Z9 7
U1 2
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 797
EP 805
DI 10.1002/jbm.b.33061
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300018
PM 24142485
DA 2018-10-19
ER

PT J
AU Stoppel, WL
   White, JC
   Horava, SD
   Henry, AC
   Roberts, SC
   Bhatia, SR
AF Stoppel, Whitney L.
   White, Joseph C.
   Horava, Sarena D.
   Henry, Anna C.
   Roberts, Susan C.
   Bhatia, Surita R.
TI Terminal sterilization of alginate hydrogels: Efficacy and impact on
   mechanical properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE Pluronic (R) F68; alginate; rheology; composite hydrogel; terminal
   sterilization
ID HYDROPHOBICALLY-MODIFIED ALGINATE; MOLECULAR-WEIGHT DISTRIBUTION;
   DRUG-DELIVERY SYSTEMS; WOUND DRESSINGS; IN-VITRO; DEGRADATION;
   ENCAPSULATION; TRANSPORT; FIBER
AB Terminal, or postprocessing, sterilization of composite biomaterials is crucial for their use in wound healing and tissue-engineered devices. Recent research has focused on optimizing traditional biomaterial formulations to create better products for commercial and academic use which incorporate hydrophobic compounds or secondary gel networks. To use a hydrogel in a clinical setting, terminal sterilization is necessary to ensure patient safety. Lyophilization, gamma-irradiation, and ethylene oxide treatment all have negative consequences when applied to alginate scaffolds for clinical use. Here, we aim to find alternative terminal sterilization methods for alginate and alginate-based composite hydrogels which maintain the structure of composite alginate networks for use in biomedical applications. A thorough investigation of the effect of common sterilization methods on swollen alginate-based hydrogels has not been reported and therefore, this work examines autoclaving, ethanol washing, and ultraviolet light as sterilization techniques for alginate and alginate/Pluronic (R) F68 composite hydrogels. Preservation of structural integrity is evaluated using shear rheology and analysis of water retention, and efficacy of sterilization is determined via bacterial persistence within the hydrogel. Results indicate that ethanol sterilization is the best method of those investigated because ethanol washing results in minimal effects on mechanical properties and water retention and eliminates bacterial persistence. Furthermore, this study suggests that ethanol treatment is an efficacious method for terminally sterilizing interpenetrating networks or other composite hydrogel systems. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 877-884, 2014.
C1 [Stoppel, Whitney L.; White, Joseph C.; Horava, Sarena D.; Henry, Anna C.; Roberts, Susan C.; Bhatia, Surita R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
   [Bhatia, Surita R.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA.
   [Bhatia, Surita R.] Brookhaven Natl Lab, Ctr Funct Nanomat, Upton, NY 11793 USA.
RP Stoppel, WL (reprint author), Univ Texas Austin, Austin, TX 78712 USA.
EM surita.bhatia@stonybrook.edu
RI White, Joe/I-8148-2015; Bhatia, Surita/B-4536-2008
FU National Science Foundation (NSF) [CMMI-0531171]; University of
   Massachusetts Commercial Ventures and Intellectual Property Office; NSF
   [DMR-0213695, DGE-0654128]; National Research Service Award from the
   National Institutes of Health [T32 GM08515]; University of Massachusetts
   Commonwealth Honors College; University of Massachusetts Amherst
   Institute for Cellular Engineering NSF Research Experience for
   Undergraduates [EEC-1005083]
FX Contract grant sponsor: National Science Foundation (NSF)-sponsored
   Center for Hierarchical Manufacturing;; contract grant number:
   CMMI-0531171; Contract grant sponsor: University of Massachusetts
   Commercial Ventures and Intellectual Property Office; Contract grant
   sponsor: NSF-funded Materials Research Science and Engineering Center
   (MRSEC) on Polymers;; contract grant number: DMR-0213695; Contract grant
   sponsor: National Research Service Award from the National Institutes of
   Health (to W. L. S.);; contract grant number: T32 GM08515; Contract
   grant sponsor: NSF-sponsored Institute for Cellular Engineering IGERT
   program;; contract grant number: DGE-0654128 (to W. L. S.); Contract
   grant sponsor: NSF-sponsored Institute for Cellular Engineering IGERT
   program (to J.C.W.);; contract grant number: DGE-0654128; Contract grant
   sponsor: University of Massachusetts Commonwealth Honors College (to S.
   D. H); Contract grant sponsor: University of Massachusetts Amherst
   Institute for Cellular Engineering NSF Research Experience for
   Undergraduates (to A. C. H.);; contract grant number: EEC-1005083
CR Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BRANNONPEPPAS L, 1991, CHEM ENG SCI, V46, P715, DOI 10.1016/0009-2509(91)80177-Z
   Choudhary S, 2009, 2009 35TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P18
   Choudhary S, 2009, MRS S P E
   Choudhary S, 2012, CARBOHYD POLYM, V87, P524, DOI 10.1016/j.carbpol.2011.08.025
   Choudhary S, 2011, RHEOL ACTA, V50, P39, DOI 10.1007/s00397-010-0499-9
   Doyle JW, 1996, J BIOMED MATER RES, V32, P561, DOI 10.1002/(SICI)1097-4636(199612)32:4<561::AID-JBM9>3.0.CO;2-P
   DRAGET KI, 1990, CARBOHYD POLYM, V14, P159
   Fraker CA, 2011, J PHYS CHEM B, V115, P10547, DOI 10.1021/jp204146n
   Galant C, 2006, J PHYS CHEM B, V110, P190, DOI 10.1021/jp0518759
   Gattas-Asfura KM, 2012, J BIOMED MATER RES A, V100A, P1963, DOI 10.1002/jbm.a.34052
   GILCHRIST T, 1983, BIOMATERIALS, V4, P317, DOI 10.1016/0142-9612(83)90036-4
   Hilton JR, 2004, CLIN INFECT DIS, V39, pS100, DOI 10.1086/383270
   Huebsch N, 2005, J BIOMED MATER RES B, V74B, P440, DOI 10.1002/jbm.b.30155
   Kanjickal D, 2008, J BIOMED MATER RES A, V87A, P608, DOI 10.1002/jbm.a.31811
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee DW, 2003, J AGR FOOD CHEM, V51, P4819, DOI 10.1021/jf021053y
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Li QA, 2011, J AGR FOOD CHEM, V59, P1962, DOI 10.1021/jf1020347
   Lin HY, 2012, BIO-MED MATER ENG, V22, P321, DOI [10.3233/BME-2012-0722, 10.4161/biom.22817]
   Mei L, 2009, J PHARM SCI-US, V98, P2040, DOI 10.1002/jps.21581
   Oh KT, 2004, J CONTROL RELEASE, V94, P411, DOI 10.1016/j.jcornel.2003.10.018
   Pawar HV, 2013, COLLOID SURFACE B, V102, P102, DOI 10.1016/j.colsurfb.2012.08.014
   PEPPAS NA, 1985, J BIOMED MATER RES, V19, P397, DOI 10.1002/jbm.820190405
   Qin YM, 2006, J APPL POLYM SCI, V100, P2516, DOI 10.1002/app.23668
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Saarai A, 2013, J MECH BEHAV BIOMED, V18, P152, DOI 10.1016/j.jmbbm.2012.11.010
   Sahu A, 2011, J BIOMATER APPL, V25, P619, DOI 10.1177/0885328209357110
   Stoppel WL, 2011, ACTA BIOMATER, V7, P3988, DOI 10.1016/j.actbio.2011.07.009
   Suzuki Y, 1998, J BIOMED MATER RES, V39, P317, DOI 10.1002/(SICI)1097-4636(199802)39:2<317::AID-JBM20>3.0.CO;2-8
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   White JC, 2013, J BIOMED MATER RES A, V101, P438, DOI 10.1002/jbm.a.34344
   Yang JS, 2012, CARBOHYD POLYM, V87, P1503, DOI 10.1016/j.carbpol.2011.09.046
   Yao BL, 2010, BIOPROC BIOSYST ENG, V33, P457, DOI 10.1007/s00449-009-0349-2
NR 37
TC 15
Z9 15
U1 5
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2014
VL 102
IS 4
BP 877
EP 884
DI 10.1002/jbm.b.33070
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE8IT
UT WOS:000334244300026
PM 24259507
DA 2018-10-19
ER

PT J
AU Fukushima, A
   Mayanagi, G
   Nakajo, K
   Sasaki, K
   Takahashi, N
AF Fukushima, A.
   Mayanagi, G.
   Nakajo, K.
   Sasaki, K.
   Takahashi, N.
TI Microbiologically Induced Corrosive Properties of the Titanium Surface
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE microbiologically induced corrosion; bacterial metabolism; Streptococcus
   mutans; electrochemical behavior; biofilm-metal interface; oxygen
   concentration cells
ID COMMERCIALLY PURE TITANIUM; HYDROGEN-PEROXIDE; IMPLANT FAILURE;
   RESISTANCE; BIOMATERIAL; SENSITIVITY; BACTERIA; BEHAVIOR; STEEL; ACID
AB Corrosion of titanium is the major concern when it is used for dental treatment. This study aimed to investigate the mechanism of the microbiologically induced corrosive properties of titanium. An experimental well was made of polymethyl methacrylate with pure titanium at the bottom. Viable or killed cells of Streptococcus mutans were packed into the well, and pH at the bacteria-titanium interface was monitored with and without glucose. Before and after 90-minute incubation, the electrochemical behavior on the titanium surface was measured by means of a potentiostat. The oxygen concentration under bacterial cells was monitored with oxygen-sensitive fluorescent film. The amount of titanium eluted was measured by inductively coupled plasma-mass spectrometry. The corrosion current and passive current under killed cells were low and stable during 90 min, while those under viable cells increased, regardless of the glucose-induced pH fall. The polarization resistance and oxygen concentration under killed cells were high and stable, while those under viable cells decreased. No elution of titanium was detected. Viable bacterial cells may form 'oxygen concentration cells' through metabolism-coupled oxygen consumption and subsequently induce corrosive properties of the titanium surface.
C1 [Fukushima, A.; Sasaki, K.] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan.
   [Fukushima, A.; Nakajo, K.; Takahashi, N.] Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 980, Japan.
   [Mayanagi, G.] Tohoku Univ, Grad Sch Dent, Res Unit Interface Oral Hlth Sci, Sendai, Miyagi 980, Japan.
RP Takahashi, N (reprint author), Tohoku Univ, Grad Sch Dent, Div Oral Ecol & Biochem, Sendai, Miyagi 980, Japan.
EM nobu-t@dent.tohoku.ac.jp
FU MEXT, Japan [23792270, 23792201]
FX This study was supported in part by Research and Education Funding for
   Inter-University Research Project (Highly-Functional Interface Science)
   and a program to enhance the university's research function based on its
   specialty (Innovative Research for Biosis-Abiosis Intelligent
   Interface), and in part by Grants-in-Aid for Young Scientists B
   (23792270 and 23792201) from MEXT, Japan. The authors declare no
   potential conflicts of interest with respect to the authorship and/or
   publication of this article.
CR ABBE K, 1991, Proceedings of the Finnish Dental Society, V87, P477
   ABDALLAH HI, 1994, ANN THORAC SURG, V57, P1017, DOI 10.1016/0003-4975(94)90228-3
   [Anonymous], 2000, T0302 JIS
   Bai Y, 2013, J MAT SCI ENG C, V33, P2159
   Barbour ME, 2007, J MATER SCI-MATER M, V18, P1439, DOI 10.1007/s10856-007-0141-2
   Bearinger JP, 2003, J BIOMED MATER RES A, V67A, P702, DOI 10.1002/jbm.a.10116
   Guindy JS, 2004, INT J ORAL MAX IMPL, V19, P826
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Koike M, 2001, BIOMATERIALS, V22, P2931, DOI 10.1016/S0142-9612(01)00040-0
   LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25
   Mabilleau G, 2006, ACTA BIOMATER, V2, P121, DOI 10.1016/j.actbio.2005.09.004
   Massaro C, 2002, J MATER SCI-MATER M, V13, P535, DOI 10.1023/A:1015170625506
   Mayanagi G, 2011, J DENT RES, V90, P1446, DOI 10.1177/0022034511423392
   Merritt K, 1996, CLIN ORTHOP RELAT R, P71
   Page CL, 1988, 60CSC RILEM, P3
   Pan J, 1996, J BIOMED MATER RES, V30, P393
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   QUIRYNEN M, 1994, CLIN ORAL IMPLAN RES, V5, P239, DOI 10.1034/j.1600-0501.1994.050407.x
   Raupach M, 1996, CONSTR BUILD MATER, V10, P329, DOI 10.1016/0950-0618(95)00018-6
   Scarano Antonio, 2005, J Oral Implantol, V31, P269, DOI 10.1563/753.1
   Souza JCM, 2010, BIOFOULING, V26, P471, DOI 10.1080/08927011003767985
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   TAKAHASHI N, 1991, ORAL MICROBIOL IMMUN, V6, P299, DOI 10.1111/j.1399-302X.1991.tb00497.x
   Traudt M, 1996, ARCH ORAL BIOL, V41, P965, DOI 10.1016/S0003-9969(96)00044-1
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Videla HA, 2005, INT MICROBIOL, V8, P169
   Zhang SM, 2013, J MATER SCI-MATER M, V24, P1229, DOI 10.1007/s10856-013-4888-3
NR 27
TC 8
Z9 8
U1 3
U2 22
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD MAY
PY 2014
VL 93
IS 5
BP 525
EP 529
DI 10.1177/0022034514524782
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AE8PZ
UT WOS:000334265100015
PM 24554541
DA 2018-10-19
ER

PT J
AU Horisberger, M
   Paul, J
   Wiewiorski, M
   Henninger, HB
   Khalifa, MS
   Barg, A
   Valderrabano, V
AF Horisberger, Monika
   Paul, Jochen
   Wiewiorski, Martin
   Henninger, Heath B.
   Khalifa, Muhammad S.
   Barg, Alexej
   Valderrabano, Victor
TI Commercially Available Trabecular Metal Ankle Interpositional Spacer for
   Tibiotalocalcaneal Arthrodesis Secondary to Severe Bone Loss of the
   Ankle
SO JOURNAL OF FOOT & ANKLE SURGERY
LA English
DT Article
DE complication; intramedullary nail; nonunion; tantalum; total ankle
   replacement
ID COATED ACETABULAR COMPONENTS; POROUS TANTALUM BIOMATERIAL; TOTAL KNEE
   ARTHROPLASTY; DONOR SITE MORBIDITY; ILIAC CREST; TIBIAL COMPONENT;
   SALVAGE; REPLACEMENT; REVISION; GRAFT
AB Retrograde tibiotalocalcaneal nailing arthrodesis has proved to be a viable salvage procedure; however, extended bone loss around the ankle has been associated with high rates of nonunion and considerable shortening of the hindfoot. We present the surgical technique and the first 2 cases in which a trabecular metal((TM)) interpositional spacer, specifically designed for tibiotalocalcaneal nailing arthrodesis, was used. The spacer can be implanted using either an anterior or a lateral approach. An integrated hole in the spacer allows a retrograde nail to be inserted, which provides excellent primary stability of the construct. Trabecular metal((TM)) is a well-established and well-described material used to supplement deficient bone stock in surgery of the spine, hip, and knee. It has shown excellent incorporation and reduces the need for auto- and allografts. The trabecular metal((TM)) interpositional ankle spacer is the first trabecular metal spacer designed specifically for ankle surgery. Its shape and variable size will make it a valuable tool for reconstructing bone loss in tibiotalocalcaneal nailing arthrodesis. (C) 2014 by the American College of Foot and Ankle Surgeons. All rights reserved.
C1 [Horisberger, Monika; Paul, Jochen; Wiewiorski, Martin; Barg, Alexej; Valderrabano, Victor] Univ Basel Hosp, Dept Orthopaed, CH-4031 Basel, Switzerland.
   [Henninger, Heath B.] Univ Utah, Dept Orthopaed, Harold K Dunn Orthopaed Res Lab, Salt Lake City, UT USA.
   [Khalifa, Muhammad S.] Rashid Hosp, Dept Orthopaed, Dubai, U Arab Emirates.
RP Valderrabano, V (reprint author), Univ Basel Hosp, Dept Orthopaed, Spitalstr 21, CH-4031 Basel, Switzerland.
EM Monika.Horisberger@hotmail.com
CR Abolghasemian M, 2013, BONE JOINT J, V95B, P166, DOI 10.1302/0301-620X.95B2.30608
   Berkowitz MJ, 2012, FOOT ANKLE CLIN, V17, P725, DOI 10.1016/j.fcl.2012.08.009
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Borland WS, 2012, ACTA ORTHOP, V83, P347, DOI 10.3109/17453674.2012.718518
   Bouchard M, 2004, FOOT ANKLE INT, V25, P39, DOI 10.1177/107110070402500109
   Conti SF, 2002, FOOT ANKLE INT, V23, P521, DOI 10.1177/107110070202300609
   D'Angelo F, 2008, INDIAN J ORTHOP, V42, P275, DOI 10.4103/0019-5413.39553
   Delawi D, 2007, SPINE, V32, P1865, DOI 10.1097/BRS.0b013e318107674e
   Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033
   Donnenwerth MP, 2013, CLIN PODIATR MED SUR, V30, P199, DOI 10.1016/j.cpm.2012.10.007
   ENGH CA, 1993, J BONE JOINT SURG AM, V75A, P814, DOI 10.2106/00004623-199306000-00003
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   Ferrao P, 2012, FOOT ANKLE INT, V33, P173, DOI 10.3113/FAI.2012.0173
   Frigg A, 2010, CLIN ORTHOP RELAT R, V468, P209, DOI 10.1007/s11999-009-0948-x
   Ghalayini SRA, 2012, KNEE, V19, P872, DOI 10.1016/j.knee.2012.05.001
   GROTH HE, 1987, CLIN ORTHOP RELAT R, P244
   Heary RF, 2002, NEUROSURGERY, V50, P510, DOI 10.1097/00006123-200203000-00015
   Henricson A, 2010, ACTA ORTHOP, V81, P745, DOI 10.3109/17453674.2010.533936
   Hopgood P, 2006, J BONE JOINT SURG BR, V88B, P1032, DOI 10.1302/0301-620X.88B8
   Jager M, 2005, ORTHOPADE, V34, P976, DOI 10.1007/s00132-005-0839-0
   Jehan S, 2011, ACTA ORTHOP BELG, V77, P644
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kitaoka H B, 1992, J Arthroplasty, V7, P277, DOI 10.1016/0883-5403(92)90049-V
   KITAOKA HB, 1991, CLIN ORTHOP RELAT R, P37
   Klein GR, 2008, J ARTHROPLASTY, V23, P619, DOI 10.1016/j.arth.2007.05.004
   Klos K, 2013, ORTHOPADE, V42, P364, DOI 10.1007/s00132-013-2086-0
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Niedhart C, 2003, Z ORTHOP GRENZGEB, V141, P481, DOI 10.1055/s-2003-41565
   Ochman S, 2012, J FOOT ANKLE SURG, V51, P675, DOI 10.1053/j.jfas.2012.04.015
   Owens JB, 2012, J ARTHROPLASTY, V27, P1251, DOI 10.1016/j.arth.2012.01.025
   PIDHORZ LE, 1993, J ARTHROPLASTY, V8, P213
   Rammelt S, 2013, FOOT ANKLE INT, V34, P1245, DOI 10.1177/1071100713487526
   Sagherian BH, 2012, FOOT ANKLE INT, V33, P179, DOI 10.3113/FAI.2012.0179
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   SAVIO JA, 1994, CLIN MATER, V15, P101
   Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008
   Skytta ET, 2011, J ARTHROPLASTY, V26, P342, DOI 10.1016/j.arth.2010.01.106
   Sternheim A, 2012, J BONE JOINT SURG BR, V94B, P158, DOI 10.1302/0301-620X.94B2.27871
   Thomas RL, 2012, J AM ACAD ORTHOP SUR, V20, P1, DOI 10.5435/JAAOS-20-01-001
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
NR 43
TC 10
Z9 11
U1 1
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1067-2516
EI 1542-2224
J9 J FOOT ANKLE SURG
JI J. Foot Ankle Surg.
PD MAY-JUN
PY 2014
VL 53
IS 3
BP 383
EP 387
DI 10.1053/j.jfas.2013.11.004
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA AF1YD
UT WOS:000334508900031
PM 24666978
DA 2018-10-19
ER

PT J
AU Bai, L
   Zhan, KH
   Hu, Q
   Xu, JM
AF Bai, Lun
   Zhan, Kuihua
   Hu, Qi
   Xu, Jianmei
TI Endothelial tubes form from intracellular vacuoles in implanted
   biomaterial in vivo of rat
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID POROUS SILK FIBROIN; GROWTH-FACTOR; TUMOR ANGIOGENESIS; FIBROBLAST
   CELLS; HYPOXIA; ATTACHMENT; CULTURE
AB When the porous biomaterials are used to implant in vivo of animal for repairing wound, the angiogenesis in microenvironment of porous biomaterial is a key process in order to achieve the goal of treatment. While clarifying the process of vascularization and its mechanism is of great significance for design and development of medical biomaterials. In this area, it is noted that the endothelial tubes of new capillaries are formed by intracellular vacuoles, which has been proved in vitro model of angiogenesis. However, there is still no conclusive evidence in vivo model for mammals. By experimental tracking and observation of angiogenesis in the biomaterials implanted in rats, the angiogenesis process and the characteristics were explored. This study focused on the behavior of endothelial cell (EC)s and the capillary lumen formatting from EC cord in sprouting. Through marking and observing the ECs, the experimental evidences of angiogenesis after implanted materials into rats were obtained, which including various stages, such as rapidly proliferating of ECs, assembling of ECs to build up cell cord and vacuoles formation in ECs. An important mechanism of lumen formation for mammal in vivo was proved, which complemented the experimental results of the assembly of endothelial tubes in vivo through the formation and fusion of vacuoles for transgenic zebrafish. Our results provide support for the model of lumen formation of new capillary in mammal.
C1 [Bai, Lun; Zhan, Kuihua; Hu, Qi; Xu, Jianmei] Soochow Univ, Sch Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Bai, Lun] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
   [Zhan, Kuihua] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215006, Peoples R China.
RP Bai, L (reprint author), Soochow Univ, Sch Text & Clothing Engn, Suzhou 215021, Peoples R China.
EM bailun1948@gmail.com
OI Zhan, Kuihua/0000-0003-3638-9743
CR Acker T, 2003, CELL TISSUE RES, V314, P145, DOI 10.1007/s00441-003-0763-8
   Altankov G, 2010, NATO SCI PEACE SEC A, P19, DOI 10.1007/978-90-481-8790-4_2
   Bai L, 2007, J MATER SCI-MATER M, V18, P1917
   Bai L, 2011, J MATER SCI-MATER M, V22, P927, DOI 10.1007/s10856-011-4258-y
   Downs KM, 2003, MICROCIRCULATION, V10, P5, DOI 10.1038/sj.mn.7800171
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   FOLKMAN J, 1980, T OPHTHAL SOC UK, V100, P346
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kremer C, 1997, CANCER RES, V57, P3852
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   Liu Y, 2005, MICROCIRCULATION MAP, P182
   Lun B, 2009, FIBER BIOENG INFORM, V2, P150
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0
   Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
NR 21
TC 2
Z9 2
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2014
VL 25
IS 5
BP 1275
EP 1282
DI 10.1007/s10856-014-5148-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1VZ
UT WOS:000334503300007
PM 24464724
DA 2018-10-19
ER

PT J
AU Durao, SF
   Gomes, PS
   Colaco, BJ
   Silva, JC
   Fonseca, HM
   Duarte, JR
   Felino, AC
   Fernandes, MH
AF Durao, S. F.
   Gomes, P. S.
   Colaco, B. J.
   Silva, J. C.
   Fonseca, H. M.
   Duarte, J. R.
   Felino, A. C.
   Fernandes, M. H.
TI The biomaterial-mediated healing of critical size bone defects in the
   ovariectomized rat
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE Animal model; Biomaterial; Bone regeneration; Osteoporosis
ID ESTROGEN-RECEPTOR-BETA; CALVARIAL DEFECTS; OSTEOPENIC RATS;
   OSTEOPOROSIS; HYDROXYAPATITE; MODEL; MICE; REGENERATION; PHOSPHATE;
   CAPACITY
AB This study demonstrated an impaired biomaterial-mediated bone regeneration in a critical sized calvarial defect established within an ovariectomized rat model. Histological and microtomographic evidences were supported by an impaired osteoblastic gene expression and altered expression of estrogen receptors and adipogenic markers.
   This work aims to address the bone regeneration process in the ovariectomized rat model, by assessing a calvarial critical size defect implanted with a biocompatible bovine bone mineral graft.
   Animals were randomly divided into two groups: Ovx (bilateral ovariectomy) and Sham (control surgery). Following 8 weeks, all animals were submitted to a surgical bicortical craniotomy (5-mm circular critical size defect), which was filled with a biocompatible mineral graft. Animals were euthanized at 1, 3, and 6 months following graft implantation (n = 10), and results on the orthotopic bone regeneration process were blindly evaluated by radiographic, microtomographic, histological, histomorphometric, and gene expression techniques.
   In the attained model, in both Sham and Ovx groups, the bone regenerative process was found to occur in a slow-paced manner. Likewise, a qualitative evaluation of the microtomographic and histological analysis, as well as quantitative data from histomorphometric indexes, revealed reduced bone regeneration in Ovx animals, at the assayed time points. Significant differences were attained at the 3 and 6 months. Gene expression analysis revealed a reduced expression of osteoblastic-related genes and an altered expression of estrogen receptors and adipogenic markers, within the regenerating bone of Ovx animals.
   Due to the similarities between the osteoporotic animal model and the human condition of postmenopausal osteoporosis, it might be relevant to consider the potential clinical implication of the osteoporotic condition in the biomaterial-mediated bone tissue healing/regeneration process.
C1 [Durao, S. F.; Felino, A. C.] Univ Porto, Fac Med Dent, Dept Surg, P-4200393 Oporto, Portugal.
   [Gomes, P. S.; Silva, J. C.; Fernandes, M. H.] Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, P-4200393 Oporto, Portugal.
   [Colaco, B. J.] Univ Tras Os Montes & Alto Douro, ECAV, Ctr Study Anim Sci CECA, Dept Zootechny, P-5001801 Vila Real, Portugal.
   [Fonseca, H. M.; Duarte, J. R.] Univ Porto, Fac Sports, Dept Biochem, P-4200450 Oporto, Portugal.
   [Gomes, P. S.; Fernandes, M. H.] Univ Porto, Ctr Drug Discovery & Innovat Med, MedInUP, P-4200319 Oporto, Portugal.
RP Gomes, PS (reprint author), Univ Porto, Fac Med Dent, Lab Bone Metab & Regenerat, Rua Dr Manuel Pereira Silva, P-4200393 Oporto, Portugal.
EM pgomes@fmd.up.pt
RI Fernandes, Maria Helena/K-6917-2014; Gomes, Pedro/K-2433-2014; Colaco,
   Bruno/K-8682-2013
OI Gomes, Pedro/0000-0001-5365-2123; Colaco, Bruno/0000-0003-4879-8624;
   Fonseca, Helder/0000-0002-9002-8976; Duarte, Jose
   Alberto/0000-0003-4756-5917; Fernandes, Maria Helena/0000-0001-9391-9574
FU Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/DES/103047/2008]
FX Financial support from the Fundacao para a Ciencia e Tecnologia (FCT),
   project PTDC/DES/103047/2008, is greatly acknowledged.
CR Asarian L, 2002, HORM BEHAV, V42, P461, DOI 10.1006/hbeh.2002.1835
   Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Brown LM, 2010, J STEROID BIOCHEM, V122, P65, DOI 10.1016/j.jsbmb.2009.12.005
   Chagin AS, 2004, J BONE MINER RES, V19, P72, DOI 10.1359/JBMR.0301203
   Ribeiro DCD, 2012, MICROSC RES TECHNIQ, V75, P133, DOI 10.1002/jemt.21035
   Dominguez Ligia J, 2010, Acta Biomed, V81 Suppl 1, P55
   Durao SFO, 2012, INT J ORAL MAX IMPL, V27, P1400
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Fini M, 2000, J MATER SCI-MATER M, V11, P579, DOI 10.1023/A:1008932303913
   Fuegl A, 2011, CLIN ORAL IMPLAN RES, V22, P524, DOI 10.1111/j.1600-0501.2010.02048.x
   Gomes PS, 2011, LAB ANIM-UK, V45, P14, DOI 10.1258/la.2010.010085
   Hara T, 2001, ARCH ORAL BIOL, V46, P443, DOI 10.1016/S0003-9969(00)00135-7
   Hatano H, 2004, J BONE MINER METAB, V22, P224, DOI 10.1007/s00774-003-0482-y
   HAYASHI K, 1994, BIOMATERIALS, V15, P11, DOI 10.1016/0142-9612(94)90189-9
   Hayashi K, 1989, J Arthroplasty, V4, P257, DOI 10.1016/S0883-5403(89)80022-1
   He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   IWASHITA Y, 1992, J APPL BIOMATER, V3, P259, DOI 10.1002/jab.770030404
   Ke HZ, 2005, J BONE MINER METAB, V23, P84, DOI 10.1007/BF03026330
   Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JC133612
   Komlev VS, 2010, EUR CELLS MATER, V19, P136, DOI 10.22203/eCM.v019a14
   Lelovas PP, 2008, COMPARATIVE MED, V58, P424
   Leppanen O, 2008, PLOS ONE, V2, pe2540
   Luvizuto ER, 2011, BIOMATERIALS, V32, P3855, DOI 10.1016/j.biomaterials.2011.01.076
   Mikosch P, 2012, PRINCIPLES OF OSTEOIMMUNOLOGY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, P137
   NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis and Therapy, 2001, J AM MED ASS, V285, P785
   Okazaki A, 2000, BIOMATERIALS, V21, P483, DOI 10.1016/S0142-9612(99)00198-2
   Rodriguez JP, 2008, CURR STEM CELL RES T, V3, P208, DOI 10.2174/157488808785740325
   Poole K.E., 2011, PLOS ONE, V6
   Rawlinson S, 2008, J DENT RES, V88, P615
   Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.3.CO;2-3
   Saxon LK, 2005, BONE, V36, P185, DOI 10.1016/j.bone.2004.08.003
   Surve VV, 2001, ACTA ORTHOP SCAND, V72, P525, DOI 10.1080/000164701753532880
   Tami AE, 2009, BONE, V45, P1117, DOI 10.1016/j.bone.2009.07.090
   Teofilo JM, 2004, ARCH ORAL BIOL, V49, P755, DOI 10.1016/j.archoralbio.2004.02.013
   Thomsen JS, 2005, J MICROSC-OXFORD, V218, P171, DOI 10.1111/j.1365-2818.2005.01469.x
   Turner R T, 2001, Rev Endocr Metab Disord, V2, P117, DOI 10.1023/A:1010067326811
   Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367
   Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504
NR 41
TC 16
Z9 18
U1 2
U2 11
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD MAY
PY 2014
VL 25
IS 5
BP 1535
EP 1545
DI 10.1007/s00198-014-2656-y
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AF0OU
UT WOS:000334414700013
PM 24573401
DA 2018-10-19
ER

PT J
AU Emoto, S
   Yamaguchi, H
   Kamei, T
   Ishigami, H
   Suhara, T
   Suzuki, Y
   Ito, T
   Kitayama, J
   Watanabe, T
AF Emoto, Shigenobu
   Yamaguchi, Hironori
   Kamei, Takao
   Ishigami, Hironori
   Suhara, Takashi
   Suzuki, Yukimitsu
   Ito, Taichi
   Kitayama, Joji
   Watanabe, Toshiaki
TI Intraperitoneal administration of cisplatin via an in situ
   cross-linkable hyaluronic acid-based hydrogel for peritoneal
   dissemination of gastric cancer
SO SURGERY TODAY
LA English
DT Article
DE Intraperitoneal chemotherapy; Hyaluronic acid; Hydrogel; Cisplatin;
   Peritoneal dissemination
ID DRUG-DELIVERY; OVARIAN-CANCER; ANTITUMOR BIOCONJUGATE; MESOTHELIAL
   CELLS; REGIONAL DELIVERY; PACLITAXEL; CHEMOTHERAPY; CARCINOMATOSIS;
   PREVENTION; ADHESION
AB To develop a drug-delivery system for the prolonged retention of intraperitoneally (i.p.) administered cisplatin (CDDP) to deliver intraperitoneal chemotherapy against peritoneal carcinomatosis effectively.
   CDDP was encapsulated inside an in situ cross-linkable hyaluronic acid (HA)-based hydrogel. The gelation and degradation kinetics of the hydrogel and the release kinetics of CDDP were investigated in vitro, and the antitumor effect was investigated in a mouse model of peritoneal dissemination of human gastric cancer.
   The gelation time varied according to the concentration of two polymers: HA-adipic dihydrazide and HA-aldehyde. CDDP was released from the hydrogel for more than 4 days. A cell proliferation assay showed that the polymers themselves were not cytotoxic toward MKN45P, a human gastric cancer cell line. By mixing the two polymers in the peritoneum, in situ gelation was achieved. The weight of peritoneal nodules decreased in the hydrogel-conjugated CDDP group, whereas no significant antitumor effect was observed in the free CDDP group.
   In situ cross-linkable HA hydrogels represent a promising biomaterial to prolong the retention and sustain the release of intraperitoneally administered CDDP in the peritoneal cavity and to enhance its antitumor effects against peritoneal dissemination.
C1 [Emoto, Shigenobu; Yamaguchi, Hironori; Kamei, Takao; Ishigami, Hironori; Kitayama, Joji; Watanabe, Toshiaki] Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan.
   [Suhara, Takashi; Suzuki, Yukimitsu; Ito, Taichi] Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138655, Japan.
   [Ito, Taichi] Univ Tokyo, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan.
RP Emoto, S (reprint author), Univ Tokyo, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.
EM semoto-tky@umin.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Ministry of Health, Labor and Welfare of Japan
FX This study was funded by the Ministry of Education, Culture, Sports,
   Science and Technology of Japan and the Ministry of Health, Labor and
   Welfare of Japan. We thank Kikkoman for providing HA. We thank Nippon
   Kayaku for providing CDDP. We thank Baxter for providing the dual
   syringes.
CR Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603
   Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985
   Auzenne E, 2007, NEOPLASIA, V9, P479, DOI 10.1593/neo.07229
   Bajaj G, 2012, J CONTROL RELEASE, V158, P386, DOI 10.1016/j.jconrel.2011.12.001
   Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z
   Brigand C, 2004, DIGEST DIS, V22, P366, DOI 10.1159/000083600
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   Cai S, 2008, J SURG RES, V147, P247, DOI 10.1016/j.jss.2008.02.048
   Cai SA, 2010, J PHARM SCI-US, V99, P2664, DOI 10.1002/jps.22016
   De Stefano I, 2011, CANCER CHEMOTH PHARM, V68, P107, DOI 10.1007/s00280-010-1462-2
   Dedrick RL, 1997, J NATL CANCER I, V89, P480, DOI 10.1093/jnci/89.7.480
   Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P170
   Echarri Gonzalez MJ, 2011, ONCOLOGY WILLISTON P, V25, P156
   FRANCIS P, 1995, J CLIN ONCOL, V13, P2961, DOI 10.1200/JCO.1995.13.12.2961
   Hahn SK, 2007, J BIOMED MATER RES A, V80A, P916, DOI 10.1002/jbm.a.30997
   He CL, 2008, J CONTROL RELEASE, V127, P189, DOI 10.1016/j.jconrel.2008.01.005
   Howell SB, 2008, INT J GYNECOL CANCER, V18, P20, DOI 10.1111/j.1525-1438.2007.01099.x
   Ikeguchi M, 2009, SURG TODAY, V39, P290, DOI 10.1007/s00595-008-3860-1
   Isayeva I, 2010, J BIOMED MATER RES B, V95B, P9, DOI 10.1002/jbm.b.31677
   Ishigami H, 2010, ANN ONCOL, V21, P67, DOI 10.1093/annonc/mdp260
   Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6
   Ito T, 2007, BIOMATERIALS, V28, P975, DOI 10.1016/j.biomaterials.2006.10.021
   Jeong YI, 2008, J PHARM SCI-US, V97, P1268, DOI 10.1002/jps.21103
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   Kamei T, 2010, CANCER SCI, V102, P200
   Kodera Y, 2007, HEPATO-GASTROENTEROL, V54, P960
   Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-204S(08)70035-4
   Kondo A, 1996, BRIT J CANCER, V73, P1166, DOI 10.1038/bjc.1996.225
   Kwak MK, 2010, INVEST NEW DRUG, V28, P284, DOI 10.1007/s10637-009-9253-5
   Lessan K, 1999, AM J PATHOL, V154, P1525, DOI 10.1016/S0002-9440(10)65406-5
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 1999, BIOCONJUGATE CHEM, V10, P755, DOI 10.1021/bc9900338
   Luo Y, 2000, BIOMACROMOLECULES, V1, P208, DOI 10.1021/bm000283n
   Markman M, 2006, J CLIN ONCOL, V24, P988, DOI 10.1200/JCO.2005.05.2456
   MARKMAN M, 1992, J CLIN ONCOL, V10, P1485, DOI 10.1200/JCO.1992.10.9.1485
   Markman M, 2003, LANCET ONCOL, V4, P277, DOI 10.1016/S1470-2045(03)01074-X
   Oertl A, 2005, WORLD J GASTROENTERO, V11, P6243, DOI 10.3748/wjg.v11.i40.6243
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Sako A, 2004, CANCER RES, V64, P3624, DOI 10.1158/0008-5472.CAN-04-0304
   Sugarbaker PH, 2005, ONCOLOGIST, V10, P112, DOI 10.1634/theoncologist.10-2-112
   TAKAHASHI K, 1985, JPN J CANCER RES, V76, P68
   Tsujitani S, 1999, ONCOLOGY-BASEL, V57, P77, DOI 10.1159/000012004
   Wang YY, 2010, RES J BIOTECHNOL, V5, P5
   Wu W, 2011, INT J PHARMACEUT, V416, P104, DOI 10.1016/j.ijpharm.2011.06.015
   Yamada J, 2008, CANCER LETT, V272, P307, DOI 10.1016/j.canlet.2008.07.024
   Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Yu J, 2012, INVEST NEW DRUG, V30, P1, DOI 10.1007/s10637-010-9499-y
   Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023
NR 50
TC 26
Z9 27
U1 1
U2 34
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0941-1291
EI 1436-2813
J9 SURG TODAY
JI Surg. Today
PD MAY
PY 2014
VL 44
IS 5
BP 919
EP 926
DI 10.1007/s00595-013-0674-6
PG 8
WC Surgery
SC Surgery
GA AF2DW
UT WOS:000334523800019
PM 23887848
DA 2018-10-19
ER

PT J
AU de Melo, WM
   de Oliveira, FS
   Marcantonio, E
   Beloti, MM
   de Oliveira, PT
   Rosa, AL
AF de Melo, Willian M.
   de Oliveira, Fabiola S.
   Marcantonio, Elcio, Jr.
   Beloti, Marcio M.
   de Oliveira, Paulo T.
   Rosa, Adalberto L.
TI Autogenous bone combined with anorganic bovine bone for maxillary sinus
   augmentation: analysis of the osteogenic potential of cells derived from
   the donor and the grafted sites
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE osteoblast; autogenous bone; maxillary sinus augmentation; gene
   expression; cell culture; bone grafts; anorganic bovine bone
ID FLOOR AUGMENTATION; IMPLANT PLACEMENT; IN-VITRO; GROWTH-FACTORS;
   FOLLOW-UP; SURVIVAL; ASSAY; DOG; BIO-OSS((R)); BIOMATERIAL
AB Objectives
   This study aimed to comparatively evaluate the in vitro osteogenic potential of cells obtained from the mandibular ramus (MR, autogenous bone donor site) and from the maxillary sinus (MS) bone grafted with a mixture of anorganic bovine bone (ABB) and MR prior to titanium implant placement (MS, grafted implant site).
   Material and methods
   Cells were obtained from three patients subjected to MS floor augmentation with a 1:1 mixture of ABB (GenOx Inorg((R))) and MR. At the time of the sinus lift procedure and after 8months, prior to implant placement, bone fragments were taken from MR and MS, respectively, and subjected to trypsin-collagenase digestion for primary cell culturing. Subcultured cells were grown under osteogenic condition for up to 21days and assayed for proliferation/viability, osteoblast marker mRNA levels, alkaline phosphatase (ALP) activity and calcium content/Alizarin red staining. ALP activity was also determined in primary explant cultures exposed to GenOx Inorg((R)) (1:1 with MR) for 7days. Data were compared using either the Mann-Whitney U-test or the Kruskal-Wallis test.
   Results
   MS cultures exhibited a significantly lower osteogenic potential compared with MR cultures, with a progressive increase in cell proliferation together with a decrease in osteoblast markers, reduced ALP activity and calcium content. Exposure of MR-derived primary cultures to GenOx Inorg((R)) inhibited ALP activity.
   Conclusion
   These results suggest that the use of GenOx Inorg((R)) in combination with MR fragments for MS floor augmentation inhibits the osteoblast cell differentiation at the implant site in the long term.
C1 [de Melo, Willian M.; de Oliveira, Fabiola S.; Beloti, Marcio M.; de Oliveira, Paulo T.; Rosa, Adalberto L.] Univ Sao Paulo, Sch Dent Ribeirao Preto, BR-14040904 Ribeirao Preto, SP, Brazil.
   [Marcantonio, Elcio, Jr.] Sao Paulo State Univ, Sch Dent Araraquara, Araraquara, SP, Brazil.
RP Rosa, AL (reprint author), Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Oral & Maxillofacial Surg & Periodontol, BR-14040904 Ribeirao Preto, SP, Brazil.
EM adalrosa@forp.usp.br
RI Oliveira, Fabiola/J-6915-2014; Beloti, Marcio/E-7473-2012; Tambasco de
   Oliveira, Paulo/F-9749-2010; Rosa, Adalberto/A-6314-2008
OI Oliveira, Fabiola/0000-0003-0855-5118; Beloti,
   Marcio/0000-0003-0149-7189; Tambasco de Oliveira,
   Paulo/0000-0002-6662-0486; Rosa, Adalberto/0000-0002-6495-2778;
   Marcantonio Junior, Elcio/0000-0003-1294-2305; Marcantonio Junior,
   Elcio/0000-0002-9660-4524
FU FAPESP; CAPES (Brazil)
FX The authors would like to thank FAPESP for financial support. Willian
   Morais de Melo was the recipient of a Masters fellowship from CAPES
   (Brazil). Roger Rodrigo Fernandes is acknowledged for technical
   assistance in cell culture experiments.
CR Accorsi-Mendonça Thais, 2008, Braz. oral res., V22, P5, DOI 10.1590/S1806-83242008000100002
   Araujo M, 2009, CLIN ORAL IMPLAN RES, V20, P1, DOI 10.1111/j.1600-0501.2008.01606.x
   Beloti MM, 2008, CLIN ORAL IMPLAN RES, V19, P48, DOI 10.1111/j.1600-0501.2007.01420.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Bernhardt A, 2011, CLIN ORAL IMPLAN RES, V22, P651, DOI 10.1111/j.1600-0501.2010.02015.x
   Botticelli D, 2004, CLIN ORAL IMPLAN RES, V15, P285, DOI 10.1046/j.1600-0501.2003.01008.x
   Carmagnola D, 2000, J CLIN PERIODONTOL, V27, P799, DOI 10.1034/j.1600-051x.2000.027011799.x
   Chaushu G, 2009, J PERIODONTOL, V80, P422, DOI [10.1902/jop.2009.080451, 10.1902/jop.2009.080451 ]
   Cho-Lee GY, 2010, INT J ORAL MAX IMPL, V25, P1019
   de Oliva MA, 2009, J HISTOCHEM CYTOCHEM, V57, P265, DOI 10.1369/jhc.2008.952713
   de Oliveira PT, 2008, J HISTOCHEM CYTOCHEM, V56, P629, DOI 10.1369/jhc.2008.950758
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   Bernabe PFE, 2012, CLIN ORAL IMPLAN RES, V23, P384, DOI 10.1111/j.1600-0501.2011.02166.x
   Bernabe PFE, 2010, ORAL SURG ORAL MED O, V109, P309, DOI 10.1016/j.tripleo.2009.07.019
   Ferreira CEA, 2009, J PERIODONTOL, V80, P1920, DOI 10.1902/jop.2009.090263
   Galindo-Moreno P, 2010, CLIN ORAL IMPLAN RES, V21, P122, DOI 10.1111/j.1600-0501.2009.01814.x
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hatano M., 2004, CLIN ORAL IMPLAN RES, V15, P339
   Hausamen J E, 1992, Eur Arch Otorhinolaryngol Suppl, V1, P163
   Herten M, 2009, CLIN ORAL INVEST, V13, P149, DOI 10.1007/s00784-008-0214-8
   Iezzi G, 2008, J PERIODONTOL, V79, P192, DOI 10.1902/jop.2008.070105 
   Jensen T, 2013, CLIN ORAL IMPLAN RES, V24, P635, DOI 10.1111/j.1600-0501.2012.02438.x
   Jensen T, 2012, CLIN ORAL IMPLAN RES, V23, P263, DOI 10.1111/j.1600-0501.2011.02168.x
   Kahnberg KE, 2011, CLIN IMPLANT DENT R, V13, P231, DOI 10.1111/j.1708-8208.2009.00201.x
   Kim YK, 2009, ORAL SURG ORAL MED O, V107, pE21, DOI 10.1016/j.tripleo.2008.09.033
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P295, DOI [10.1089/ten.teb.2009.0558, 10.1089/ten.TEB.2009.0558]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Mladenovic Z, 2013, CLIN ORAL IMPLAN RES, V24, P329, DOI 10.1111/j.1600-0501.2011.02334.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Patel K. S., 2012, CLOUD COMP EM MARK C, P1, DOI DOI 10.1111/J.1600-0501.2012.02500.X
   Sbordone L, 2009, INT J ORAL MAX IMPL, V24, P316
   Serra E, 2006, J ORAL MAXILLOFAC SU, V64, P931
   Sohn DS, 2010, IMPLANT DENT, V19, P259, DOI 10.1097/ID.0b013e3181df1406
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Trubiani O, 2010, EUR CELLS MATER, V20, P72
NR 38
TC 3
Z9 4
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2014
VL 25
IS 5
BP 603
EP 609
DI 10.1111/clr.12100
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA AE6BD
UT WOS:000334072400010
PM 23289911
DA 2018-10-19
ER

PT J
AU Amensag, S
   McFetridge, PS
AF Amensag, Salma
   McFetridge, Peter S.
TI Tuning scaffold mechanics by laminating native extracellular matrix
   membranes and effects on early cellular remodeling
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE rolling approach; tissue engineering; early remodeling
ID PERIPHERAL-NERVE REGENERATION; HUMAN AMNIOTIC MEMBRANE; HEART-VALVES;
   TISSUE; CELLS; DECELLULARIZATION; RECELLULARIZATION; TRANSPLANTATION;
   PERMEABILITY; CULTURE
AB At approximately 50 mu m thin, the human amniotic membrane (hAM) has been shown to be a versatile biomaterial with applications ranging from ocular transplants to skin and nerve regeneration. These investigations describe laminating layers of the hAM into a multilayered, conformation creating a thicker, more robust biomaterial for applications requiring more supportive structures. Amniotic membranes were decellularized using 4 M NaCl and prepared as either flat single-layered sheets or rolled into concentric five-layered configurations. Constructs were seeded with human vascular smooth muscle cells and cultured over 40 days to quantify biological and mechanical changes that occurred during early remodeling events. By day 40 single-layered constructs displayed a decreasing trend in cellular densities and glycosaminoglycan (GAG) concentration, comparative to multilayered constructs with increasing cell densities (from 9.1 to 32 x 10(6) cells/g) and GAG concentrations (from 6.07 to 17.4 mg/g). Oxygen diffusion was calculated and found to be sufficient to maintain cell populations through the constructs full thickness. Although an overall decrease in the modulus of elasticity was noted, the modulus in the failure range of rolled constructs stabilized at values 25 times higher than single-layered constructs. Rolled constructs typically displayed an upregulation of contractile and matrix remodeling markers (alpha-actin, SM22 and type 1 collagen, MMP-2 respectively) indicating biological adaptation. Considerable design flexibility can be achieved by varying the number of scaffold layers, allowing the possibility of tuning the constructs physical dimensions, shape and tensile properties to suit specific targeted vascular locations. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1325-1333, 2014.
C1 [Amensag, Salma; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
FU NHLBI NIH HHS [R01 HL088207]
CR Amensag S, 2012, TISSUE ENG PART C-ME, V18, P903, DOI [10.1089/ten.tec.2012.0119, 10.1089/ten.TEC.2012.0119]
   Cheema U, 2009, INT J ARTIF ORGANS, V32, P318
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Guarino RD, 2004, BIOTECHNOL BIOENG, V86, P775, DOI 10.1002/bit.20072
   Jin CZ, 2007, TISSUE ENG, V13, P693, DOI 10.1089/ten.2006.0184
   Kheirkhah A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1059, DOI 10.1001/archopht.126.8.1059
   Kim WG, 2002, INT J ARTIF ORGANS, V25, P791
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Lim LS, 2009, MOL VIS, V15, P1962
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Maharajan VS, 2007, CLIN EXP OPHTHALMOL, V35, P140, DOI 10.1111/j.1442-9071.2006.01408.x
   McFetridge PS, 2007, ASAIO J, V53, P623, DOI 10.1097/MAT.0b013e31812f3b7e
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Mohammad J, 2000, PLAST RECONSTR SURG, V105, P660, DOI 10.1097/00006534-200002000-00027
   Moore M, 2012, J BIOMED MATER RES A, V100A, P2194, DOI 10.1002/jbm.a.34092
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   PORTA M, 1989, BIOCHIM BIOPHYS ACTA, V980, P220, DOI 10.1016/0005-2736(89)90402-1
   Portmann-Lanz CB, 2007, PLACENTA, V28, P6, DOI 10.1016/j.placenta.2006.01.004
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Tamhane A, 2005, OPHTHALMOLOGY, V112, P1963, DOI 10.1016/j.ophtha.2005.05.022
   Tosun Z, 2013, BIOTECHNOL BIOENG, V110, P2035, DOI 10.1002/bit.24934
   Uzarski JS, 2013, J BIOMED MATER RES A, V101, P123, DOI 10.1002/jbm.a.34308
   Vadapalli A, 2000, AM J PHYSIOL-HEART C, V279, pH657
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145
   Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117
   Xu CC, 2007, TISSUE ENG, V13, P551, DOI 10.1089/ten.2006.0169
   Yoshita T, 2004, AM J OPHTHALMOL, V138, P486, DOI 10.1016/j.ajo.2004.03.021
NR 31
TC 10
Z9 10
U1 2
U2 23
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1325
EP 1333
DI 10.1002/jbm.a.34791
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600012
PM 23666819
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Dixon, AR
   Moraes, C
   Csete, ME
   Thouless, MD
   Philbert, MA
   Takayama, S
AF Dixon, Angela R.
   Moraes, Christopher
   Csete, Marie E.
   Thouless, M. D.
   Philbert, Martin A.
   Takayama, Shuichi
TI One-dimensional patterning of cells in silicone wells via
   compression-induced fracture
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE compression; polydimethyl siloxane; patterning; fracture; biomaterial
   design
ID MESENCHYMAL STEM-CELLS; MATRIX ADHESIONS; SOFT LITHOGRAPHY; NUCLEAR
   SHAPE; 3D; DIFFERENTIATION; 3RD-DIMENSION; CULTURE; LINEAGE; SURFACE
AB We have adapted our existing compression-induced fracture technology to cell culture studies by generating linear patterns on a complex cell culture well structure rather than on simple solid constructs. We present a simple method to create one-dimensional (1D), submicron, and linear patterns of extracellular matrix on a multilayer silicone material. We identified critical design parameters necessary to optimize compression-induced fracture patterning on the wells, and applied stresses using compression Hoffman clamps. Finite-element analyses show that the incorporation of the well improves stress homogeneity (stress variation = 25%), and, thus, crack uniformity over the patterned region. Notably, a shallow well with a thick base (vs. deeper wells with thinner bases) reduces out-of-plane deflections by greater than a sixth in the cell culture region, improving clarity for optical imaging. The comparison of cellular and nuclear shape indices of a neuroblast line cultured on patterned 1D lines and unpatterned 2D surfaces reveals significant differences in cellular morphology, which could impact many cellular functions. Because 1D cell cultures recapitulate many important phenotypical traits of 3D cell cultures, our culture system offers a simple means to further study the relationship between 1D and 3D cell culture environments, without demanding expensive engineering techniques and expertise. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1361-1369, 2014.
C1 [Dixon, Angela R.; Philbert, Martin A.] Univ Michigan, Sch Publ Hlth, Toxicol Program, Ann Arbor, MI 48109 USA.
   [Dixon, Angela R.; Moraes, Christopher; Takayama, Shuichi] Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] Univ Michigan, Sch Med, Dept Anesthesiol, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.
   [Csete, Marie E.] AABB Ctr Cellular Therapies, Bethesda, MD USA.
   [Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mech Engn, Ann Arbor, MI 48109 USA.
   [Thouless, M. D.] Univ Michigan, Coll Engn, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   [Takayama, Shuichi] Univ Michigan, Coll Engn, Macromol Sci & Engn Program, Ann Arbor, MI 48109 USA.
RP Takayama, S (reprint author), Univ Michigan, Coll Engn, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM takayama@umich.edu
OI Moraes, Christopher/0000-0002-8950-2212
FU University of Michigan National Center for Institutional Diversity
   postdoctoral fellowship program; Natural Sciences and Engineering
   Research Council of Canada/Banting postdoctoral fellowship programs; NIH
   [EB 003793, HG 004653]; NSF [CMMI 0700232]
FX Contract grant sponsors: University of Michigan National Center for
   Institutional Diversity postdoctoral fellowship program to ARD and the
   Natural Sciences and Engineering Research Council of Canada/Banting
   postdoctoral fellowship programs to CM; Contract grant sponsor: NIH;
   contract grant number: EB 003793 and HG 004653; Contract grant sponsor:
   NSF; contract grant number: CMMI 0700232
CR Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Green A, 2007, ADV DRUG DELIV REV, V59, P1293
   Harunaga JS, 2011, MATRIX BIOL, V30, P363, DOI 10.1016/j.matbio.2011.06.001
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kraehenbuehl TP, 2011, NAT METHODS, V8, P731, DOI 10.1038/nmeth.1671
   Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Levina EM, 2001, J CELL SCI, V114, P4335
   Li F, 2008, CELL MOTIL CYTOSKEL, V65, P332, DOI 10.1002/cm.20263
   Martinez E, 2008, NANOMEDICINE, V4, P65
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Moraes C, 2012, ANN BIOMED ENG, V40, P1211, DOI 10.1007/s10439-011-0455-6
   Moraes C, 2011, INTEGR BIOL-UK, V3, P959, DOI 10.1039/c1ib00056j
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Nathan AS, 2011, ACTA BIOMATER, V7, P57, DOI 10.1016/j.actbio.2010.08.007
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Picone R., 2010, PLOS BIOL, P8
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242
   ten Elshof JE, 2010, J EUR CERAM SOC, V30, P1555, DOI 10.1016/j.jeurceramsoc.2010.01.016
   Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150
   Thouless MD, 2011, J MECH PHYS SOLIDS, V59, P1927, DOI 10.1016/j.jmps.2011.04.009
   Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107
   Uchida T, 2009, LANGMUIR, V25, P3102, DOI 10.1021/la801986k
   van Kooten TG, 1998, J BIOMED MATER RES, V43, P1
   Vignaud T, 2012, TRENDS CELL BIOL, V22, P671, DOI 10.1016/j.tcb.2012.08.012
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zhou W, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149513
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 46
TC 4
Z9 4
U1 3
U2 14
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1361
EP 1369
DI 10.1002/jbm.a.34814
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600016
PM 23733484
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Halpern, JM
   Urbanski, R
   Weinstock, AK
   Iwig, DF
   Mathers, RT
   von Recum, HA
AF Halpern, Jeffrey M.
   Urbanski, Richard
   Weinstock, Allison K.
   Iwig, David F.
   Mathers, Robert T.
   von Recum, Horst A.
TI A biodegradable thermoset polymer made by esterification of citric acid
   and glycerol
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE glycerol; degradable polymers; citric acid; polyester; controlled drug
   release
ID ANTIMICROBIAL ACTIVITY; DRUG-DELIVERY; ELASTOMERS; SCAFFOLDS; IMPLANT;
   AGENTS
AB A new biomaterial, a degradable thermoset polymer, was made from simple, economical, biocompatable monomers without the need for a catalyst. Glycerol and citric acid, nontoxic and renewable reagents, were crosslinked by a melt polymerization reaction at temperatures from 90 to 150 degrees C. Consistent with a condensation reaction, water was determined to be the primary byproduct. The amount of crosslinking was controlled by the reaction conditions, including temperature, reaction time, and ratio between glycerol and citric acid. Also, the amount of crosslinking was inversely proportional to the rate of degradation. As a proof-of-principle for drug delivery applications, gentamicin, an antibiotic, was incorporated into the polymer with preliminary evaluations of antimicrobial activity. The polymers incorporating gentamicin had significantly better bacteria clearing of Staphylococcus aureus compared to non-gentamicin gels for up to 9 days. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1467-1477, 2014.
C1 [Halpern, Jeffrey M.; von Recum, Horst A.] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Urbanski, Richard; Weinstock, Allison K.; Mathers, Robert T.] Penn State Univ, Dept Chem, New Kensington, PA 15068 USA.
   [Iwig, David F.] Alcoa Tech Ctr, Alcoa Ctr, PA 15069 USA.
RP von Recum, HA (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM hav1@case.edu
OI Halpern, Jeffrey/0000-0003-0814-1986
FU Alcoa Foundation; National Institutes of Health Ruth L. Kirschstein
   National Research Service Award [T32 AR007505]
FX Contract grant sponsor: National Institutes of Health Ruth L.
   Kirschstein National Research Service Award; contract grant number: T32
   AR007505
CR Anand A, 2009, INDIAN J PHARM SCI, V71, P377, DOI 10.4103/0250-474X.57285
   [Anonymous], 2010, E214910 ASTM INT
   Bettinger CJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P341, DOI 10.1016/B978-012370615-7/50028-7
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bhatta RS, 2012, INT J PHARMACEUT, V432, P105, DOI 10.1016/j.ijpharm.2012.04.060
   BORDWELL FG, 1988, ACCOUNTS CHEM RES, V21, P456, DOI 10.1021/ar00156a004
   Bretti C, 2006, J CHEM ENG DATA, V51, P1660, DOI 10.1021/je060132t
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chung EJ, 2011, J MATER SCI-MATER M, V22, P2131, DOI 10.1007/s10856-011-4393-5
   Doi Y., 2002, BIOPOLYMERS POLYESTE
   Engineer C, 2011, TRENDS BIOMATER ARTI, V25, P79
   Guarda A, 2011, INT J FOOD MICROBIOL, V146, P144, DOI 10.1016/j.ijfoodmicro.2011.02.011
   Halpern JM, 2014, BIOMATERIALS AND REGENERATIVE MEDICINE, P419
   Haynes W.M., 2010, CRC HDB CHEM PHYS, P8
   Holland TA, 2006, ADV BIOCHEM ENG BIOT, V102, P161, DOI 10.1007/b137205
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lee DW, 2012, BONE, V50, P974, DOI 10.1016/j.bone.2012.01.007
   Manzer LE, 2006, FEEDSTOCKS FUTURE RE
   Mathers RT, 2011, GREEN POLYM METHODS
   Naeini AT, 2010, NANOMED-NANOTECHNOL, V6, P556, DOI 10.1016/j.nano.2009.11.008
   Nam HY, 2009, BIOMATERIALS, V30, P665, DOI 10.1016/j.biomaterials.2008.10.013
   Namazi H, 2007, COLLOID POLYM SCI, V285, P1527, DOI 10.1007/s00396-007-1717-6
   Namazi H, 2005, BIOMATERIALS, V26, P1175, DOI 10.1016/j.biomaterials.2004.04.014
   Namazi H, 2011, J POLYM RES, V18, P1431, DOI 10.1007/s10965-010-9548-4
   Otera J., 2010, ESTERIFICATION METHO
   Pachence JM, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P323, DOI 10.1016/B978-012370615-7/50027-5
   Parmanick D, 1988, POLYM B, V19, P365
   Porter W. L., 1980, AUTOXIDATION FOOD BI, P295
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Scholz MS, 2011, COMPOS SCI TECHNOL, V71, P1791, DOI 10.1016/j.compscitech.2011.08.017
   Sharma Monica, 2009, Reviews in Environmental Science and Bio/Technology, V8, P343, DOI 10.1007/s11157-009-9175-x
   Silici S, 2006, LETT APPL MICROBIOL, V43, P318, DOI 10.1111/j.1472-765X.2006.01949.x
   Sousa Simone Maria Galvão de, 2005, Braz. Dent. J., V16, P3, DOI 10.1590/S0103-64402005000100001
   Thatiparti TR, 2010, BIOMATERIALS, V31, P2335, DOI 10.1016/j.biomaterials.2009.11.087
   TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149
   Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wiskur SL, 2004, CHEM-EUR J, V10, P3792, DOI 10.1002/chem.200305737
   WITOWSKI J, 1994, INT J ARTIF ORGANS, V17, P252
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yin HQ, 1999, J BURN CARE REHABIL, V20, P195, DOI 10.1097/00004630-199905000-00006
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
NR 43
TC 37
Z9 38
U1 3
U2 93
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1467
EP 1477
DI 10.1002/jbm.a.34821
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600028
PM 23737239
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Zhu, CL
   Li, F
   Zhou, XY
   Lin, L
   Zhang, TY
AF Zhu, Changlai
   Li, Feng
   Zhou, Xinyang
   Lin, Lin
   Zhang, Tianyi
TI Kombucha-synthesized bacterial cellulose: Preparation, characterization,
   and biocompatibility evaluation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Schwann cells; characterization; Kampuchea; biocompatibility; cellulose
ID PERIPHERAL-NERVE REGENERATION; SILK FIBROIN; IN-VITRO; CELLS; ADDITIVES;
   SCAFFOLD; GROWTH
AB Bacterial cellulose (BC) is a natural biomaterial with unique properties suitable for tissue engineering applications, but it has not yet been used for preparing nerve conduits to repair peripheral nerve injuries. The objectives of this study were to prepare and characterize the Kampuchea-synthesized bacterial cellulose (KBC) and further evaluate the biocompatibility of KBC with peripheral nerve cells and tissues in vitro and in vivo. KBC membranes were composed of interwoven ribbons of about 20-100 nm in width, and had a high purity and the same crystallinity as that of cellulose I alpha. The results from light and scanning electron microscopy, MTT assay, flow cytometry, and RT-PCR indicated that no significant differences in the morphology and cell function were observed between Schwann cells (SCs) cultured on KBC membranes and glass slips. We also fabricated a nerve conduit using KBC, which was implanted into the spatium intermusculare of rats. At 1, 3, and 6 weeks post-implantation, clinical chemistry and histochemistry showed that there were no significant differences in blood counts, serum biochemical parameters, and tissue reactions between implanted rats and sham-operated rats. Collectively, our data indicated that KBC possessed good biocompatibility with primary cultured SCs and KBC did not exert hematological and histological toxic effects on nerve tissues in vivo. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1548-1557, 2014.
C1 [Zhu, Changlai; Zhou, Xinyang; Lin, Lin; Zhang, Tianyi] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
   [Li, Feng] Nantong Univ, Affiliated Hosp, Nantong 226001, Jiangsu, Peoples R China.
RP Zhang, TY (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
EM pro_zty001@163.com
CR ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Dufresne C, 2000, FOOD RES INT, V33, P409, DOI 10.1016/S0963-9969(00)00067-3
   Feng YY, 2012, CARBOHYD POLYM, V87, P644, DOI 10.1016/j.carbpol.2011.08.039
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   GRIESSER HJ, 1994, J BIOMAT SCI-POLYM E, V5, P531, DOI 10.1163/156856294X00194
   Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002
   Hall S, 2001, J HAND SURG-BRIT EUR, V26, P129, DOI 10.1054/jhsb.2000.0497
   Hirai A, 1998, CELLULOSE, V5, P201, DOI 10.1023/A:1009233323237
   Hood B, 2009, NEUROSURG FOCUS, V26, P1770
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Kim G, 2010, BIOMATERIALS, V31, P2517, DOI 10.1016/j.biomaterials.2009.12.013
   Lee JH, 1998, J BIOMED MATER RES, V40, P314, DOI 10.1002/(SICI)1097-4636(199805)40:2<314::AID-JBM17>3.0.CO;2-L
   Maeda H, 2006, J MATER SCI, V41, P5646, DOI 10.1007/s10853-006-0297-z
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Nakamura T, 2004, BRAIN RES, V1027, P18, DOI 10.1016/j.brainres.2004.08.040
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Seves A, 2001, MACROMOL MATER ENG, V286, P524, DOI 10.1002/1439-2054(20010901)286:9<524::AID-MAME524>3.3.CO;2-2
   Shalumon KT, 2011, J BIOMED NANOTECHNOL, V7, P609, DOI 10.1166/jbn.2011.1337
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zhang Y, 2012, MATER LETT, V68, P218, DOI 10.1016/j.matlet.2011.10.061
   Zhijiang C., 2012, CARBOHYD POLYM, V87, P1073, DOI DOI 10.1016/J.CARBP0L.2011.08.037
NR 32
TC 11
Z9 11
U1 6
U2 93
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1548
EP 1557
DI 10.1002/jbm.a.34796
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600036
PM 23666905
DA 2018-10-19
ER

PT J
AU Dishowitz, MI
   Zhu, FC
   Sundararaghavan, HG
   Ifkovits, JL
   Burdick, JA
   Hankenson, KD
AF Dishowitz, Michael I.
   Zhu, Fengchang
   Sundararaghavan, Harini G.
   Ifkovits, Jamie L.
   Burdick, Jason A.
   Hankenson, Kurt D.
TI Jagged1 immobilization to an osteoconductive polymer activates the Notch
   signaling pathway and induces osteogenesis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Notch signaling; osteoblast differentiation; Jagged1; osteoinduction;
   translational medicine
ID ALAGILLE-SYNDROME; OSTEOBLAST DIFFERENTIATION; CELL-DIFFERENTIATION;
   FUTURE-DIRECTIONS; BONE REGENERATION; FRACTURES; PROLIFERATION;
   MUTATIONS; INTERFACE; CHILDREN
AB Treatment of nonunion fractures is a significant problem. Common therapeutics, including autologous bone grafts and bone morphogenetic proteins, show well-established limitations. Therefore, a need persists for the identification of novel clinical therapies to promote healing. The Notch signaling pathway regulates bone development. Clinically, loss-of-function mutations to the Notch ligand Jagged1 decrease bone mass and increase fracture risk. Jagged1 is also the most highly upregulated ligand during fracture repair, identifying it as a potential target to promote bone formation. Therefore, the objective of this study was to develop a clinically translatable construct comprised of Jagged1 and an osteoconductive scaffold, and characterize its activity in human mesenchymal stem cells (hMSC). We first evaluated the effects of Jagged1 directly immobilized to a novel poly(beta-amino ester) relative to indirect coupling via antibody. Direct was more effective at activating hMSC Notch target gene expression and osteogenic activity. We then found that directly immobilized Jagged1 constructs induced osteoblast differentiation. This is the first study to demonstrate that Jagged1 delivery transiently activates Notch signaling and increases osteogenesis. A positive correlation was found between Jagged1-induced Notch and osteogenic expression. Collectively, these results indicate that Jagged1 coupled to an osteogenic biomaterial could promote bone tissue formation during fracture healing. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1558-1567, 2014.
C1 [Dishowitz, Michael I.; Sundararaghavan, Harini G.; Ifkovits, Jamie L.; Burdick, Jason A.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Zhu, Fengchang; Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Philadelphia, PA 19104 USA.
   [Hankenson, Kurt D.] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA.
RP Hankenson, KD (reprint author), 311 Hill Pavilion,380 S Univ Ave, Philadelphia, PA 19103 USA.
EM kdhank@vet.upenn.edu
OI Hankenson, Kurt/0000-0001-6361-143X
FU Congressionally Directed Medical Research Program [W81XWH-10-1-0825];
   Osteosynthesis and Trauma Care Foundation, the Penn Center for
   Musculoskeletal Disorders [NIH/NIAMS P30 AR050950]; Ruth L. Kirschstein
   National Research Service Award [NIH/NIDCR F31DE020231]
FX Contract grant sponsor: Congressionally Directed Medical Research
   Program; contract grant number: W81XWH-10-1-0825; Contract grant
   sponsor: Osteosynthesis and Trauma Care Foundation, the Penn Center for
   Musculoskeletal Disorders; contract grant number: NIH/NIAMS P30
   AR050950; Contract grant sponsor: Ruth L. Kirschstein National Research
   Service Award; contract grant number: NIH/NIDCR F31DE020231
CR Anderson DG, 2006, ADV MATER, V18, P2614, DOI 10.1002/adma.200600529
   Audige L, 2005, CLIN ORTHOP RELAT R, P221, DOI 10.1097/01.blo.0000163836.66906.74
   Bales CB, 2010, J PEDIATR GASTR NUTR, V51, P66, DOI 10.1097/MPG.0b013e3181cb9629
   Beckstead BL, 2006, J BIOMED MATER RES A, V79A, P94, DOI 10.1002/jbm.a.30760
   Beckstead BL, 2009, J BIOMED MATER RES A, V91A, P436, DOI 10.1002/jbm.a.32214
   Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025
   Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x
   Brey DM, 2010, J BIOMED MATER RES A, V93A, P807, DOI 10.1002/jbm.a.32769
   Carragee EJ, 2011, SPINE J, V11, P695, DOI 10.1016/j.spinee.2011.08.418
   Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66
   Dishowitz MI, 2012, J ORTHOP RES, V30, P296, DOI 10.1002/jor.21518
   Dong YF, 2010, DEVELOPMENT, V137, P1461, DOI 10.1242/dev.042911
   Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Goncalves RM, 2009, BIOMATERIALS, V30, P6879, DOI 10.1016/j.biomaterials.2009.09.010
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716
   Kohn A, 2012, DEVELOPMENT, V139, P1198, DOI 10.1242/dev.070649
   Kramer H, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.29.pe1
   Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978
   Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243
   Mead TJ, 2009, P NATL ACAD SCI USA, V106, P14420, DOI 10.1073/pnas.0902306106
   Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200
   Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235
   Oldershaw RA, 2008, STEM CELLS, V26, P666, DOI 10.1634/stemcells.2007-0806
   Olsen IE, 2005, J PEDIATR GASTR NUTR, V40, P76, DOI 10.1097/00005176-200501000-00014
   Osathanon T, 2013, J BIOMED MATER RES A, V101, P358, DOI 10.1002/jbm.a.34332
   Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022
   Sekine C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3758
   Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115
   Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231
   Vas V, 2004, J LEUKOCYTE BIOL, V75, P714, DOI 10.1189/jlb.1003462
   Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140
   Zhu FC, 2013, STEM CELLS, V31, P1181, DOI 10.1002/stem.1353
NR 34
TC 14
Z9 17
U1 1
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1558
EP 1567
DI 10.1002/jbm.a.34825
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600037
PM 23775982
DA 2018-10-19
ER

PT J
AU Leong, NL
   Petrigliano, FA
   McAllister, DR
AF Leong, Natalie L.
   Petrigliano, Frank A.
   McAllister, David R.
TI Current tissue engineering strategies in anterior cruciate ligament
   reconstruction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Review
DE anterior cruciate ligament; tissue engineering; scaffold; review; growth
   factor
ID MESENCHYMAL STEM-CELLS; MEDIAL COLLATERAL LIGAMENT; MARROW STROMAL
   CELLS; EPIDERMAL-GROWTH-FACTOR; POLYMER FIBER SCAFFOLD; BRAID-TWIST
   SCAFFOLD; IN-VITRO; ACL RECONSTRUCTION; GENE-EXPRESSION; SILK SCAFFOLD
AB Rupture of the anterior cruciate ligament (ACL) is one of the most common ligamentous injuries of the knee. Limitations of allografts and autografts in ACL reconstruction as well as recent advancements in biology and materials science have spurred interest in developing tissue-engineered ACL replacements that have the potential to mimic the native ACL in terms of both biological and mechanical properties. This article reviews the current literature regarding contemporary tissue engineering strategies. The four basic components of tissue engineering, biomaterial scaffolds, cell sources, growth factors, and mechanical stimuli, as applied to the development of tissue-engineered ACL replacement grafts, will be systematically addressed. In addition, animal models that have been used to test these tissue-engineered ACL replacements will also be reviewed. To date, there is no tissue-engineered ACL construct that has been successfully implanted in humans. We expect that continued progress in designing a viable tissue-engineered ACL replacement will accompany rapidly advancing techniques in materials science and biology. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1614-1624, 2014.
C1 [Leong, Natalie L.; Petrigliano, Frank A.; McAllister, David R.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.
RP Leong, NL (reprint author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90095 USA.
EM NLeong@mednet.ucla.edu
OI Leong, Natalie/0000-0001-6556-9781
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   AMIEL D, 1995, MED SCI SPORT EXER, V27, P844
   Andersson C, 1991, Clin Orthop Relat Res, P255
   ANGELLO JC, 1987, J CELL PHYSIOL, V132, P125, DOI 10.1002/jcp.1041320117
   Bedi A, 2010, J BONE JOINT SURG AM, V92A, P2387, DOI 10.2106/JBJS.I.01270
   Bedi Asheesh, 2009, HSS J, V5, P51, DOI 10.1007/s11420-008-9096-1
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Berry CC, 2003, TISSUE ENG, V9, P613, DOI 10.1089/107632703768247313
   Berry CC, 2003, BIORHEOLOGY, V40, P337
   BOLTON CW, 1985, CLIN ORTHOP RELAT R, P202
   Bourke SL, 2004, TISSUE ENG, V10, P43, DOI 10.1089/107632704322791682
   Buma P, 2004, INT ORTHOP, V28, P91, DOI 10.1007/s00264-003-0515-0
   BUSS DD, 1993, J BONE JOINT SURG AM, V75A, P1346, DOI 10.2106/00004623-199309000-00009
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Cardwell RD, 2012, J TISSUE ENG REGEN M
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chung AS, 2012, J BIOMED MATER RES B, V100B, P274, DOI 10.1002/jbm.b.31950
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Dagher E, 2009, CLIN ORTHOP RELAT R, V467, P281, DOI 10.1007/s11999-008-0512-0
   Darabos N, 2011, KNEE SURG SPORT TR A, V19, pS36, DOI 10.1007/s00167-011-1458-4
   Date H, 2010, J ORTHOP RES, V28, P225, DOI 10.1002/jor.20981
   Dennis JE, 1999, J BONE MINER RES, V14, P700, DOI 10.1359/jbmr.1999.14.5.700
   DESROSIERS EA, 1993, ANN CHIR, V47, P874
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   Eagan MJ, 2012, J TISSUE ENG REGEN M, V6, P702, DOI 10.1002/term.474
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Fan HB, 2009, BIOMATERIALS, V30, P4967, DOI 10.1016/j.biomaterials.2009.05.048
   Fennema EM, 2009, ACTA ORTHOP, V80, P618, DOI 10.3109/17453670903278241
   Fetto J F, 1980, Clin Orthop Relat Res, P29
   Fisher MB, 2012, KNEE SURG SPORT TR A, V20, P1357, DOI 10.1007/s00167-011-1800-x
   FLICKINGER KS, 1992, EXP CELL RES, V203, P466, DOI 10.1016/0014-4827(92)90022-Z
   FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602
   Freeman JW, 2007, J BIOMECH, V40, P2029, DOI 10.1016/j.jbiomech.2006.09.025
   Freeman JW, 2011, J BIOMECH, V44, P694, DOI 10.1016/j.jbiomech.2010.10.043
   Freeman JW, 2009, J BIOMAT SCI-POLYM E, V20, P1709, DOI 10.1163/156856208X386282
   Fu SC, 2012, KNEE SURG SPORT TR A, V26, P6857
   Fulzele S, 2010, J ORTHOP RES, V28, P1113, DOI 10.1002/jor.21112
   Garcia-Olmo D, 2009, INT J COLORECTAL DIS, V24, P27, DOI 10.1007/s00384-008-0559-0
   GIRGIS FG, 1975, CLIN ORTHOP RELAT R, P216
   Goulet F, 2011, PRINCIPLES TISSUE EN, P911
   Gudi SRP, 1998, AM J PHYSIOL-CELL PH, V274, pC1424, DOI 10.1152/ajpcell.1998.274.5.C1424
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Haddad-Weber M, 2010, CYTOTHERAPY, V12, P505, DOI 10.3109/14653241003709652
   Hankemeier S, 2005, TISSUE ENG, V11, P41, DOI 10.1089/ten.2005.11.41
   Hansson A, 2012, CARBOHYD POLYM, V90, P1494, DOI 10.1016/j.carbpol.2012.07.020
   Harrison RD, 2005, J BIOMED MATER RES A, V75A, P841, DOI 10.1002/jbm.a.30486
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Hays PL, 2008, J BONE JOINT SURG AM, V90A, P565, DOI 10.2106/JBJS.F.00531
   HEFTI FL, 1991, J BONE JOINT SURG AM, V73A, P373, DOI 10.2106/00004623-199173030-00008
   Henshaw DR, 2006, J ORTHOP RES, V24, P481, DOI 10.1002/jor.20050
   Hildebrand KA, 1998, AM J SPORT MED, V26, P549, DOI 10.1177/03635465980260041401
   Hofstaetter JG, 2007, BBA-GEN SUBJECTS, V1770, P997, DOI 10.1016/j.bbagen.2007.02.006
   Horan Rebecca L, 2009, J Knee Surg, V22, P82
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Joshi SM, 2009, AM J SPORT MED, V37, P2401, DOI 10.1177/0363546509339915
   Juncosa-Melvin N, 2007, TISSUE ENG, V13, P1219, DOI 10.1089/ten.2006.0339
   Kaeding CC, 2011, SPORTS HEALTH, V3, P73, DOI 10.1177/1941738110386185
   Kawamura S, 2005, J ORTHOP RES, V23, P1425, DOI 10.1016/j.orthres.2005.01.014
   Kimura Y, 2008, TISSUE ENG PT C-METH, V14, P47, DOI 10.1089/tec.2007.0286
   Kobayashi D, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P189, DOI 10.1007/s001670050049
   Koob TJ, 2001, J BIOMED MATER RES, V56, P40, DOI 10.1002/1097-4636(200107)56:1<40::AID-JBM1066>3.3.CO;2-9
   Kreja L, 2012, J MATER SCI-MATER M, V23, P2575, DOI 10.1007/s10856-012-4710-7
   Langan P, 1987, Orthop Rev, V16, P317
   Larson R V, 1996, Instr Course Lect, V45, P235
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Laurent CP, 2012, J MECH BEHAV BIOMED, V12, P184, DOI 10.1016/j.jmbbm.2012.03.005
   Li F, 2007, KNEE SURG SPORT TR A, V15, P1219, DOI 10.1007/s00167-007-0385-x
   Li H, 2011, PLAST RECONSTR SURG, V128, P663, DOI 10.1097/PRS.0b013e318221db33
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lin VS, 1999, TISSUE ENG, V5, P443, DOI 10.1089/ten.1999.5.443
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Ma JJ, 2012, TISSUE ENG PT A, V18, P103, DOI [10.1089/ten.tea.2011.0231, 10.1089/ten.TEA.2011.0231]
   Madry H, 2013, AM J SPORT MED, V41, P194, DOI 10.1177/0363546512465840
   Majima T, 2007, P I MECH ENG H, V221, P537, DOI 10.1243/09544119JEIM203
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Marui T, 1997, J ORTHOPAED RES, V15, P18, DOI 10.1002/jor.1100150104
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Matava MJ, 2005, SPORTS MED, V5
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Millard SM, 2012, BIOESSAYS
   Mizutani N, 2013, J ARTIF ORGANS, V16, P49, DOI 10.1007/s10047-012-0665-1
   MODY BS, 1993, J BONE JOINT SURG BR, V75, P818
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Muller AM, 2010, EUR CELLS MATER, V19, P127
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   Murray MM, 2006, J ORTHOP RES, V24, P820, DOI 10.1002/jor.20073
   Murray MM, 2000, J ORTHOP RES, V18, P557, DOI 10.1002/jor.1100180407
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Palmer I, 2007, CLIN ORTHOP RELAT R, P17, DOI 10.1097/BLO.0b013e31802c7915
   Panas-Perez E, 2013, J MATER SCI-MATER M, V24, P257, DOI 10.1007/s10856-012-4781-5
   Park SA, 2006, J BIOSCI BIOENG, V102, P402, DOI 10.1263/jbb.102.402
   Pascher A, 2004, MOL THER, V10, P327, DOI 10.1016/j.ymthe.2004.03.012
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Pedicini A, 2003, POLYMER, V44, P6857, DOI 10.1016/j.polymer.2003.08.040
   Petrigliano FA, 2006, ARTHROSCOPY, V22, P441, DOI 10.1016/j.arthro.2006.01.017
   Petrigliano FA, 2007, TISSUE ENG, V13, P2721, DOI 10.1089/ten.2006.0434
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   RICHMOND JC, 1992, AM J SPORT MED, V20, P24, DOI 10.1177/036354659202000107
   Riggs JW, 2013, STEM CELLS DEV, V22, P37, DOI 10.1089/scd.2012.0375
   Ritchie JR, 1996, CLIN ORTHOP RELAT R, P65
   Robayo LM, 2011, WOUND REPAIR REGEN, V19, P38, DOI 10.1111/j.1524-475X.2010.00640.x
   Rodeo SA, 2007, J BONE JOINT SURG AM, V89A, P2250, DOI 10.2106/JBJS.F.00409
   Sahoo S, 2010, DIFFERENTIATION, V79, P102, DOI 10.1016/j.diff.2009.11.001
   Savarese A, 1993, Ital J Orthop Traumatol, V19, P79
   Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209
   SCHMIDT CC, 1995, J ORTHOP RES, V13, P184, DOI 10.1002/jor.1100130206
   Seo YK, 2009, J ORTHOP RES, V27, P495, DOI 10.1002/jor.20752
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Shao HJ, 2010, J BIOMED MATER RES A, V93A, P1297, DOI 10.1002/jbm.a.32629
   SIMONDS RJ, 1992, NEW ENGL J MED, V326, P726, DOI 10.1056/NEJM199203123261102
   Spalazzi JP, 2008, J BIOMED MATER RES A, V86A, P1, DOI 10.1002/jbm.a.32073
   Steinert AF, 2008, BIOMATERIALS, V29, P904, DOI 10.1016/j.biomaterials.2007.10.054
   Tempfer H, 2009, HISTOCHEM CELL BIOL, V131, P733, DOI 10.1007/s00418-009-0581-5
   Tischer T, 2007, ARCH ORTHOP TRAUM SU, V127, P735, DOI 10.1007/s00402-007-0320-0
   Tovar N, 2012, J BIOMED MATER RES A, V100A, P2913, DOI 10.1002/jbm.a.34229
   Tremblay P, 2011, CELL TRANSPLANT, V20, P535, DOI 10.3727/096368910X536482
   van Aalst JA, 2008, ANN PLAS SURG, V60, P577, DOI 10.1097/SAP.0b013e318168db3e
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Vavken P, 2010, J ORTHOP RES, V28, P1107, DOI 10.1002/jor.21111
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wada N, 2011, STEM CELLS DEV, V20, P647, DOI 10.1089/scd.2010.0246
   Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532
   WOO SLY, 1987, AM J SPORT MED, V15, P22, DOI 10.1177/036354658701500104
   WOO SLY, 1982, BIORHEOLOGY, V19, P397
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   WOO SLY, 1987, J BONE JOINT SURG AM, V69A, P1200, DOI 10.2106/00004623-198769080-00014
   Woo SLY, 1999, AM J SPORT MED, V27, P533, DOI 10.1177/03635465990270042301
   Woo YK, 2007, J ORTHOP RES, V25, P73, DOI 10.1002/jor.20266
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zantop T, 2006, KNEE SURG SPORT TR A, V14, P982, DOI 10.1007/s00167-006-0076-z
   Zhang GC, 2012, STEM CELLS DEV, V21, P955, DOI 10.1089/scd.2011.0649
   Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135
NR 141
TC 44
Z9 46
U1 9
U2 78
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2014
VL 102
IS 5
BP 1614
EP 1624
DI 10.1002/jbm.a.34820
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD4JB
UT WOS:000333215600042
PM 23737190
DA 2018-10-19
ER

PT J
AU Song, J
   Cheng, HX
   Shen, XY
   Hu, JX
   Tong, H
AF Song, Juan
   Cheng, Haixia
   Shen, Xinyu
   Hu, Jingxiao
   Tong, Hua
TI Characterization of calcium carbonate crystals in pigeon yolk sacs with
   different incubation times
SO MICRON
LA English
DT Article
DE Biomineralization; Pigeon; Yolk sac; Calcium carbonate; Vaterite
ID ARAGONITE; CHICK; BIOMINERALIZATION; VATERITE; MINERALIZATION;
   MORPHOLOGIES; PATHWAYS; PROTEINS; EGGSHELL; EMBRYOS
AB Calcium carbonate crystals are known to form in the yolk sacs of fertile pigeon eggs at late stages of incubation. The composition and structure of these crystals were investigated, the crystallization environment was inspected, and the physical chemistry constants of the yolk fluid were determined through the incubation period. Polarized light microscopy was used to observe the generation and distribution of calcium carbonate crystals in the yolk sac. In addition, X-ray diffraction was employed to analyze the composition and crystal phase of the yolk sac. A decalcification and deproteination method was established to analyze the ultrastructure and composition of the crystals, as well as the internal relationship between inorganic and organic phases of the crystals. Additionally, scanning electron microscopy, transmission electron microscopy, X-ray energy dispersive spectroscopy, and Fourier transform infrared spectroscopy were used to evaluate the characteristics of the crystals. Our results demonstrated that the calcium carbonate crystals were mainly composed of vaterite and calcite, with vaterite being the major component. Vaterite, a type of biomaterial generated by an organic template control, presented as a concentric hierarchical spherical structure. The organic nature of the biomaterial prevented vaterite from transforming into calcite, which is more thermodynamically stable than vaterite. Additionally, the configuration, size, and aggregation of vaterite were also mediated by the organic template. This bio-vaterite was found during the incubation period and is valuable in calcium transport during embryonic development. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Song, Juan; Cheng, Haixia; Shen, Xinyu; Hu, Jingxiao; Tong, Hua] Wuhan Univ, Coll Chem & Mol Sci, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Peoples R China.
   [Song, Juan] Hubei Univ Technol, Analyt & Testing Ctr, Wuhan 430068, Peoples R China.
RP Tong, H (reprint author), Wuhan Univ, Coll Chem & Mol Sci, Key Lab Analyt Chem Biol & Med, Minist Educ, Wuhan 430072, Peoples R China.
EM huatong09@126.com
FU National Natural Science Foundation of China [31071265]
FX Financial support of this research was received from the National
   Natural Science Foundation of China (31071265) (to H. Tong)
CR ADLER HH, 1962, AM MINERAL, V47, P700
   Arias J.L., 2007, BIOMINERALIZATION PA
   Arias JL, 2003, MATER CHARACT, V50, P189, DOI 10.1016/S1044-5803(03)00088-3
   BEHRENS P, 2007, HDB BIOMINERALIZATIO
   Bentov S, 2010, J STRUCT BIOL, V171, P207, DOI 10.1016/j.jsb.2010.04.007
   CHEVILLE N, 1984, AM J VET RES, V45, P2458
   CORRADINO RA, 1973, J CELL BIOL, V58, P64, DOI 10.1083/jcb.58.1.64
   Dauphin Y., 2006, ZOOLOGY, V109, P95
   Faatz M, 2005, MAT SCI ENG C-BIO S, V25, P153, DOI 10.1016/j.msec.2005.01.005
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Gago-Duport L, 2008, J STRUCT BIOL, V162, P422, DOI 10.1016/j.jsb.2008.02.007
   Gautron J, 1997, CONNECT TISSUE RES, V36, P195, DOI 10.3109/03008209709160220
   Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548
   HART LE, 1992, J COMP PHYSIOL B, V162, P535
   He HP, 1978, J WUHAN U NATURE SCI, V4, P32
   HINCKE MT, 1992, BRIT POULTRY SCI, V33, P505, DOI NO_DOI
   JUURLINK BH, 1973, CAN J ZOOL, V51, P509, DOI 10.1139/z73-076
   Killian C.E., 2008, CHEM REV, V11, P4463
   Kuther J, 1998, J MATER CHEM, V8, P641, DOI 10.1039/a705859d
   Lowenstam HA, 1989, BIOMINERALIZATION
   Lu X.F., 1999, J CAP NORM U NAT SCI, V3, P66
   Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015
   Mann S, 2001, BIOMINERALIZATION PR, P198
   Meldrum FC, 2008, CHEM REV, V108, P4332, DOI 10.1021/cr8002856
   MOBBS IG, 1981, AM J ANAT, V160, P285, DOI 10.1002/aja.1001600307
   Nudelman F, 2006, J STRUCT BIOL, V153, P176, DOI 10.1016/j.jsb.2005.09.009
   ONO T, 1991, DEV BIOL, V144, P167, DOI 10.1016/0012-1606(91)90488-O
   Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028
   Sethmann I, 2008, MICRON, V39, P209, DOI 10.1016/j.micron.2007.01.006
   Shepherd N., 2007, AM J PHYSIOL-CELL PH, V292C, P1942
   Soldati AL, 2008, MINERAL MAG, V72, P579, DOI 10.1180/minmag.2008.072.2.579
   Song SM, 2011, KOREAN J CHEM ENG, V28, P1749, DOI 10.1007/s11814-011-0022-8
   Spanos N, 1998, J CRYST GROWTH, V191, P783, DOI 10.1016/S0022-0248(98)00385-6
   Takahashi K, 2004, CHEM COMMUN, P996, DOI 10.1039/b315478e
   Tang RK, 2004, ANGEW CHEM INT EDIT, V43, P2697, DOI 10.1002/anie.200353652
   TOWE KM, 1967, J ULTRA MOL STRUCT R, V17, P1, DOI 10.1016/S0022-5320(67)80015-7
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
   WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x
   Yadgary L, 2010, POULTRY SCI, V89, P2441, DOI 10.3382/ps.2010-00681
   Yu JG, 2004, J SOLID STATE CHEM, V177, P681, DOI 10.1016/j.jssc.2003.08.017
   Zhou GT, 2004, NEW J CHEM, V28, P1027, DOI 10.1039/b315198k
NR 41
TC 3
Z9 4
U1 1
U2 36
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0968-4328
J9 MICRON
JI Micron
PD MAY
PY 2014
VL 60
BP 39
EP 48
DI 10.1016/j.micron.2014.01.003
PG 10
WC Microscopy
SC Microscopy
GA AE2DD
UT WOS:000333782600005
PM 24602270
DA 2018-10-19
ER

PT J
AU Ngai, TL
   Lu, L
   Chen, JB
   Zhang, JH
   Li, YY
AF Ngai, Tungwai Leo
   Lu, Lu
   Chen, Jingbao
   Zhang, Junhong
   Li, Yuanyuan
TI Preparation of SiC reinforced Ti3SiC2-base composite and its
   biocompatibility evaluation
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Ti3SiC2; Biomedical applications; Composite; Powders-solid state
   reaction; SiC
ID HIGH-PURITY TI3SIC2; ELEMENTAL POWDERS; RAPID SYNTHESIS; SINTERING
   TECHNIQUE; LIQUID REACTION; POROUS TI3SIC2; DENSE TI3SIC2; TEMPERATURE;
   CARBIDE; FABRICATION
AB Soft Ti3SiC2 ceramic is a new class of potential biomaterial for orthopaedic applications and dental implants. Introducing SiC into Ti3SiC2 can compensate for the relatively low hardness of the Ti3SiC2 implants. In this study, SiC reinforced Ti3SiC2-base composites were fabricated by reactive sintering of powder compacts. Mechanical properties and phase constitution of the prepared samples were studied. Biocompatibility of the composite was evaluated by implanting the material onto the shaft surface of the femur of a rabbit, while, biostability was studied by immersing the material into human blood plasma and also into a simulated body fluid (Hank's) for prolonged time. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Ngai, Tungwai Leo; Lu, Lu; Zhang, Junhong; Li, Yuanyuan] S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou, Guangdong, Peoples R China.
   [Chen, Jingbao] Guangdong Prov Hosp Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China.
RP Ngai, TL (reprint author), S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou, Guangdong, Peoples R China.
EM dhni@scut.edu.cn
FU National Natural Science Foundation of China [51074077, 50774036];
   Guangdong Provincial Natural Science Foundation [8151064101000029]
FX The work was supported by National Natural Science Foundation of China
   (Grant no. 51074077 and Grant no. 50774036) and also by Guangdong
   Provincial Natural Science Foundation (Grant no. 8151064101000029).
CR Barsoum MW, 2000, PROG SOLID STATE CH, V28, P201, DOI 10.1016/S0079-6786(00)00006-6
   Barsoum MW, 2003, NAT MATER, V2, P107, DOI 10.1038/nmat814
   Barsoum MW, 1997, SCRIPTA MATER, V36, P535, DOI 10.1016/S1359-6462(96)00418-6
   Barsoum MW, 1999, METALL MATER TRANS A, V30, P363, DOI 10.1007/s11661-999-0325-0
   Barsoum MW, 1996, J AM CERAM SOC, V79, P1953, DOI 10.1111/j.1151-2916.1996.tb08018.x
   Daculsi G., 2004, MICROMACROPOROUS CAL, P117
   Fraczkiewicz M, 2006, ACTA MATER, V54, P5261, DOI 10.1016/j.actamat.2006.06.052
   Gao NF, 2002, J EUR CERAM SOC, V22, P2365, DOI 10.1016/S0955-2219(02)00021-3
   Gao NF, 1999, J MATER SCI, V34, P4385, DOI 10.1023/A:1004664500254
   Gao NF, 2002, J MATER SCI LETT, V21, P783, DOI 10.1023/A:1015753826417
   Hwang SS, 2005, J ALLOY COMPD, V392, P285, DOI 10.1016/j.jallcom.2004.08.089
   JEITSCHKO W, 1967, MONATSH CHEM, V98, P329, DOI 10.1007/BF00899949
   Kuang YH, 2009, MATER SCI FORUM, V610-613, P1263, DOI 10.4028/www.scientific.net/MSF.610-613.1263
   Li H, 2004, CERAM INT, V30, P2289, DOI 10.1016/j.ceramint.2004.01.009
   Li H, 2004, MATER LETT, V58, P1741, DOI 10.1016/j.matlet.2003.10.057
   Li SB, 2005, MAT SCI ENG A-STRUCT, V407, P315, DOI 10.1016/j.msea.2005.07.043
   Li XD, 2005, J BIOMED MATER RES B, V72B, P353, DOI 10.1002/jbm.b.30168
   Liang BY, 2008, J ALLOY COMPD, V460, P440, DOI 10.1016/j.jallcom.2007.05.074
   Lis J, 1997, SOLID STATE IONICS, V101, P59, DOI 10.1016/S0167-2738(97)84009-X
   LIS J, 1993, CERAM INT, V19, P219, DOI 10.1016/0272-8842(93)90052-S
   MOROZUMI S, 1985, J MATER SCI, V20, P3976, DOI 10.1007/BF00552387
   Ngai TL, 2012, CERAM INT, V38, P463, DOI 10.1016/j.ceramint.2011.07.028
   Orthner HR, 2002, MAT SCI ENG A-STRUCT, V336, P202, DOI 10.1016/S0921-5093(01)01963-3
   Poon B, 2011, J MECH PHYS SOLIDS, V59, P2238, DOI 10.1016/j.jmps.2011.03.012
   Radhakrishnan R, 1999, J ALLOY COMPD, V285, P85, DOI 10.1016/S0925-8388(99)00003-1
   Sun ZM, 1999, SCRIPTA MATER, V41, P61
   Sun ZM, 2005, ACTA MATER, V53, P4359, DOI 10.1016/j.actamat.2005.05.034
   Tang K, 2001, J EUR CERAM SOC, V21, P617, DOI 10.1016/S0955-2219(00)00246-6
   Villars P., 1997, HDB TERNARY ALLOY PH
   Zhang JF, 2007, J ALLOY COMPD, V437, P203, DOI 10.1016/j.jallcom.2006.07.059
   Zhang ZF, 2002, J EUR CERAM SOC, V22, P2957, DOI 10.1016/S0955-2219(02)00044-4
   Zhang ZF, 2001, SCRIPTA MATER, V45, P1461, DOI 10.1016/S1359-6462(01)01184-8
   Zhang ZF, 2002, METALL MATER TRANS A, V33, P3321, DOI 10.1007/s11661-002-0320-1
   Zhou WB, 2005, MATER LETT, V59, P1547, DOI 10.1016/j.matlet.2005.01.019
   Zou Y, 2008, CERAM INT, V34, P119, DOI 10.1016/j.ceramint.2006.08.010
   Zou Y, 2007, J ALLOY COMPD, V441, P192, DOI 10.1016/j.jallcom.2006.08.342
NR 36
TC 5
Z9 5
U1 0
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAY
PY 2014
VL 40
IS 4
BP 5343
EP 5348
DI 10.1016/j.ceramint.2013.10.113
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA AC1PJ
UT WOS:000332268200033
DA 2018-10-19
ER

PT J
AU Shen, Y
   Fu, Y
   Wang, J
   Li, G
   Zhang, X
   Xu, YZ
   Lin, YF
AF Shen, Yun
   Fu, Yao
   Wang, Jing
   Li, Guo
   Zhang, Xu
   Xu, Yuanzhi
   Lin, Yunfeng
TI Biomaterial and Mesenchymal Stem Cell for Articular Cartilage
   Reconstruction
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Articular cartilage; chondrogenic differentiation; hypertrophy;
   mesenchymal stem cells; regenerative medicine; tissue engineering
ID GROWTH-FACTOR-BETA; HUMAN BONE-MARROW; HUMAN ADIPOSE-TISSUE; AUTOLOGOUS
   OSTEOCHONDRAL MOSAICPLASTY; HUMAN OSTEOGENIC PROTEIN-1; IN-VITRO
   CHONDROGENESIS; SIGNALING CROSS-TALK; UMBILICAL-CORD BLOOD;
   AGE-RELATED-CHANGES; STROMAL CELLS
AB Cartilage has poor ability of spontaneous repair. Traditional treatments such as microfracture, bone drilling and autologous osteochondral graft were not fully satisfactory to fulfill the clinical needs. The idea of mesenchymal stem cell (MSCs-based cartilage regeneration has been put forward for decades. Large number of studies have been conducted on the biological properties of MSCs, the factors which might facilitate chondrogenic differentiation of MSCs, as well as the scaffold materials for tissue engineering. Promising results have been reported for cartilage repair in animal models. But before massive clinical application of MSCs, more efforts are needed on: differentiation improvement toward mature cartilage chondrocytes instead of hypertrophic chondrocyes and in vitro/in vivo phenotype maintenance; engineering an ideal biomaterial, which can meet the needs of the cartilage regeneration; and performing more studies on critical defects of large animals.
C1 [Shen, Yun; Wang, Jing; Zhang, Xu; Xu, Yuanzhi] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Stomatol, Shanghai 200072, Peoples R China.
   [Fu, Yao; Li, Guo; Lin, Yunfeng] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Sichuan Provinc, Peoples R China.
RP Xu, YZ (reprint author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Stomatol, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.
EM amyxyz01@hotmail.com; yunfenglin@scu.edu.cn
RI Fu, Yao/M-1937-2018; Lin, Yunfeng/H-3393-2011; Lin, Yunfeng/M-5438-2013
OI Fu, Yao/0000-0001-7571-8699; Lin, Yunfeng/0000-0003-1224-6561; Lin,
   Yunfeng/0000-0003-1224-6561
FU National Natural Science Foundation of China [31170929]; Doctoral Fund
   of Ministry of Education of China [20130181110012]
FX This work was funded by National Natural Science Foundation of China
   (31170929), Doctoral Fund of Ministry of Education of China
   (20130181110012).
CR Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200
   Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8
   Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335
   Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105
   da Silva MLA, 2010, BIOMACROMOLECULES, V11, P3228, DOI 10.1021/bm100476r
   An CH, 2010, ANN BIOMED ENG, V38, P1647, DOI 10.1007/s10439-009-9892-x
   Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   Archer Charles W., 2003, Birth Defects Research, V69, P144, DOI 10.1002/bdrc.10015
   Atoui R, 2008, ANN THORAC SURG, V86, P327, DOI 10.1016/j.athoracsur.2008.03.038
   Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Bai XD, 2011, MED BIOL ENG COMPUT, V49, P687, DOI 10.1007/s11517-010-0729-4
   Barcellos-Hoff MH, 2005, SEMIN CANCER BIOL, V15, P138, DOI 10.1016/j.semcancer.2004.08.010
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bartha L, 2006, J ORTHOP SPORT PHYS, V36, P739, DOI 10.2519/jospt.2006.2182
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bertram H, 2009, STEM CELLS DEV, V18, P881, DOI 10.1089/scd.2008.0306
   Brian EG, 2013, CELLS BONE RES, V2013, P12
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487
   Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Callahan LA, 2013, ACTA BIOMATER
   Caplan AI, 1997, CLIN ORTHOP RELAT R, P254
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   Chang CH, 2011, J ORTHOP RES, V29, P1874, DOI 10.1002/jor.21461
   Chen GP, 2004, BIOCHEM BIOPH RES CO, V322, P50, DOI 10.1016/j.bbrc.2004.07.071
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Choi S, 2013, INT J ORAL SCI, V5, P7, DOI 10.1038/ijos.2013.19
   Chubinskaya S, 2002, BBA-MOL BASIS DIS, V1588, P126, DOI 10.1016/S0925-4439(02)00158-8
   Chubinskaya Susan, 2008, J Knee Surg, V21, P192
   Coates EE, 2012, J BIOMED MAT RES A
   Coleman CM, 2013, STEM CELLS DEV
   Darling EM, 2005, J ORTHOP RES, V23, P425, DOI 10.1016/j.orthres.2004.08.008
   Davatchi F, 2011, INT J RHEUM DIS, V14, P211, DOI 10.1111/j.1756-185X.2011.01599.x
   de la Cruz-Merino L, 2009, CLIN TRANSL ONCOL, V11, P715, DOI 10.1007/s12094-009-0433-8
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Deutsch D, 2011, EUR J ORAL SCI, V119, P55, DOI 10.1111/j.1600-0722.2011.00861.x
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Fan Z, 2004, CLIN EXP RHEUMATOL, V22, P103
   Farrell E, 2009, TISSUE ENG PART C-ME, V15, P285, DOI 10.1089/ten.tec.2008.0297
   Feng G, 2008, GROWTH FACTORS, V26, P132, DOI 10.1080/08977190802105917
   Festy F, 2005, HISTOCHEM CELL BIOL, V124, P113, DOI 10.1007/s00418-005-0014-z
   Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200
   Flechtenmacher J, 1996, ARTHRITIS RHEUM-US, V39, P1896, DOI 10.1002/art.1780391117
   Fortier LA, 2002, J BONE JOINT SURG BR, V84B, P276, DOI 10.1302/0301-620X.84B2.11167
   FREED LE, 1994, J BIOMED MATER RES, V28, P891, DOI 10.1002/jbm.820280808
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8
   Gawlitta D, 2012, TISSUE ENG PT A, V18, P1957, DOI [10.1089/ten.TEA.2011.0657, 10.1089/ten.tea.2011.0657]
   Ge ZG, 2006, ARTHRIT RHEUM-ARTHR, V55, P493, DOI 10.1002/art.21994
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gemmiti CV, 2006, TISSUE ENG, V12, P469, DOI 10.1089/ten.2006.12.469
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Grottkau BE, 2013, BONE RES, V1, P282, DOI 10.4248/BR201303006
   Guimont P, 2007, AM J PHYSIOL-CELL PH, V293, pC172, DOI 10.1152/ajpcell.00349.2006
   Hagmann S, 2013, CELL PROLIFERAT, V46, P396, DOI 10.1111/cpr.12046
   Hangody L, 2008, INJURY, V39, pS32, DOI 10.1016/j.injury.2008.01.041
   Harris DT, 2008, STEM CELL REV, V4, P269, DOI 10.1007/s12015-008-9039-8
   Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019
   Havlas V, 2011, ACTA CHIR ORTHOP TR, V78, P138
   Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178
   Hayes AJ, 2008, J HISTOCHEM CYTOCHEM, V56, P125, DOI 10.1369/jhc.7A7320.20071
   Hellingman CA, 2011, TISSUE ENG PT A, V17, P1157, DOI [10.1089/ten.tea.2010.0043, 10.1089/ten.TEA.2010.0043]
   Hoffman AS, 2001, ANN NY ACAD SCI, V944, P62
   HOLDER N, 1977, J EMBRYOL EXP MORPH, V39, P115
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Hu MY, 2013, BONE RES, V1, DOI 10.4248/BR201301007
   Hu XH, 2009, MACROMOL BIOSCI, V9, P1194, DOI 10.1002/mabi.200900275
   Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998
   Huch K, 1997, ARTHRITIS RHEUM, V40, P2157, DOI 10.1002/art.1780401209
   Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010
   Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6
   Iwasaki N, 2007, AM J SPORT MED, V35, P2096, DOI 10.1177/0363546507306465
   Izadpanah R, 2008, CANCER RES, V68, P4229, DOI 10.1158/0008-5472.CAN-07-5272
   Izuta Y, 2005, KNEE, V12, P217, DOI 10.1016/j.knee.2001.06.001
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446
   Kannan RY, 2006, J BIOMATER APPL, V21, P5, DOI 10.1177/0885328206065728
   Karagiannides I, 2001, AM J PHYSIOL-REG I, V280, pR1772
   Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kim M, 2012, BIOMACROMOLECULES, V13, P2287, DOI 10.1021/bm3005353
   Kim TK, 2003, OSTEOARTHR CARTILAGE, V11, P653, DOI 10.1016/S1063-4584(03)00120-1
   KIMURA T, 1984, CLIN ORTHOP RELAT R, P231
   King JA, 1996, ANN NY ACAD SCI, V785, P70, DOI 10.1111/j.1749-6632.1996.tb56245.x
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Koepp HE, 1999, INFLAMM RES, V48, P199, DOI 10.1007/s000110050446
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kou I, 2004, J BIOL CHEM, V279, P50942, DOI 10.1074/jbc.M406786200
   Kundu J, 2013, J TISSUE ENG REGEN M
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Roith D, 2001, TRENDS ENDOCRIN MET, V12, P48
   Lee CCI, 2006, STEM CELLS DEV, V15, P209, DOI 10.1089/scd.2006.15.209
   Lee J, 2008, BIOMATERIALS, V29, P1872, DOI 10.1016/j.biomaterials.2007.12.029
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Lee KBL, 2012, ANN ACAD MED SINGAP, V41, P511
   Lee YH, 2011, GENESIS, V49, P200, DOI 10.1002/dvg.20717
   Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137
   Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Liu CX, 2012, BIOMATERIALS, V33, P1052, DOI 10.1016/j.biomaterials.2011.10.041
   Liu X, 2012, INT J MOL MED
   Loeser RF, 2003, ARTHRITIS RHEUM, V48, P2188, DOI 10.1002/art.11209
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Madonna R, 2011, EUR J CLIN INVEST, V41, P126, DOI 10.1111/j.1365-2362.2010.02384.x
   Madonna R, 2009, ARTERIOSCL THROM VAS, V29, P1723, DOI 10.1161/ATVBAHA.109.187179
   Maniwa S, 2001, ACTA ORTHOP SCAND, V72, P299, DOI 10.1080/00016470152846664
   Mankin H J, 1964, Clin Orthop Relat Res, V34, P170
   MANKIN HJ, 1964, LAB INVEST, V13, P465
   Mareschi K, 2006, J CELL BIOCHEM, V97, P744, DOI 10.1002/jcb.20681
   Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCoy RJ, 2010, TISSUE ENG PART B-RE, V16, P587, DOI [10.1089/ten.teb.2010.0370, 10.1089/ten.TEB.2010.0370]
   Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932
   Minas T, 1999, Instr Course Lect, V48, P629
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   MITROVIC D, 1978, AM J ANAT, V151, P475, DOI 10.1002/aja.1001510403
   Miyakoshi N, 2005, ARCH ORTHOP TRAUM SU, V125, P683, DOI 10.1007/s00402-005-0052-y
   Miyamoto C, 2007, J ORTHOP SCI, V12, P555, DOI 10.1007/s00776-007-1176-4
   Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009
   Mohan N, 2009, J MATER SCI-MATER M, V20, P49, DOI 10.1007/s10856-008-3481-7
   Mosna F, 2010, STEM CELLS DEV, V19, P1449, DOI 10.1089/scd.2010.0140
   Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370
   Mueller MB, 2013, INT ORTHOP, V37, P945, DOI 10.1007/s00264-013-1800-1
   Mukherjee N, 2001, J ORTHOPAED RES, V19, P524, DOI 10.1016/S0736-0266(00)00045-0
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   Nishida Y, 2004, OSTEOARTHR CARTILAGE, V12, P374, DOI 10.1016/j.joca.2004.01.008
   Nishida Y, 2000, ARTHRITIS RHEUM, V43, P206, DOI 10.1002/1529-0131(200001)43:1<206::AID-ANR25>3.0.CO;2-1
   Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404
   Nochi H, 2004, J BONE MINER RES, V19, P111, DOI 10.1359/jbmr.2004.19.1.111
   Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638
   Okada-Ban M, 1999, ONCOGENE, V18, P6719, DOI 10.1038/sj.onc.1203092
   OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3
   Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7
   Pachon-Pena G, 2011, J CELL PHYSIOL, V226, P843, DOI 10.1002/jcp.22408
   Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010
   Panepucci RA, 2004, STEM CELLS, V22, P1263, DOI 10.1634/stemcells.2004-0024
   Park KH, 2008, J BIOSCI BIOENG, V106, P74, DOI 10.1263/jbb.106.74
   Pelaia G, 2007, J CELL PHYSIOL, V210, P489, DOI 10.1002/jcp.20884
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Pountos I, 2010, J ORTHOP TRAUMA, V24, P552, DOI 10.1097/BOT.0b013e3181efa8fe
   Pozzobon M, 2010, PEDIATR SURG INT, V26, P3, DOI 10.1007/s00383-009-2478-8
   Qi MC, 2009, INT J ORAL SCI, V1, P143, DOI 10.4248/IJOS.09021
   Qi YY, 2012, MOL BIOL REP, V39, P1231, DOI 10.1007/s11033-011-0853-8
   Ramasamy R, 2012, CELL PROLIFERAT, V45, P132, DOI 10.1111/j.1365-2184.2012.00808.x
   Rampichova M, 2013, CELL PROLIFERAT, V46, P23, DOI 10.1111/cpr.12001
   Reiss M, 1999, MICROBES INFECT, V1, P1327, DOI 10.1016/S1286-4579(99)00251-8
   Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Saad B, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00775
   Saad B, 1999, INT J BIOL MACROMOL, V25, P293, DOI 10.1016/S0141-8130(99)00044-6
   Sahar DE, 2005, DEV BIOL, V280, P344, DOI 10.1016/j.ydbio.2005.01.022
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Schulz RM, 2007, EUR BIOPHYS J BIOPHY, V36, P539, DOI 10.1007/s00249-007-0139-1
   Shafiee A, 2011, J BIOMED MATER RES A, V99A, P467, DOI 10.1002/jbm.a.33206
   Shakibaei M, 1997, CELL BIOL INT, V21, P115, DOI 10.1006/cbir.1996.0118
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   Sheehy EJ, 2012, BIOCHEM BIOPH RES CO, V417, P305, DOI 10.1016/j.bbrc.2011.11.105
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   Shen G, 2005, Orthod Craniofac Res, V8, P11, DOI 10.1111/j.1601-6343.2004.00308.x
   Shibata S, 2003, J ANAT, V203, P425, DOI 10.1046/j.1469-7580.2003.00226.x
   Shieh SJ, 2004, BIOMATERIALS, V25, P1545, DOI 10.1016/S0142-9612(03)00501-5
   Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102
   Siebert CH, 2003, ARTHROSCOPY, V19, P182, DOI 10.1053/jars.2003.50000
   Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100
   Silva MMCG, 2006, BIOMATERIALS, V27, P5909, DOI 10.1016/j.biomaterials.2006.08.010
   Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697
   Steadman J Richard, 2002, J Knee Surg, V15, P170
   Steadman JR, 2003, J KNEE SURG, V16, P83
   Steinert A, 2003, J ORTHOPAED RES, V21, P1090, DOI 10.1016/S0736-0266(03)00100-1
   Stewart A, 2010, J CELL PHYSIOL, V223, P658, DOI 10.1002/jcp.22064
   Stewart AA, 2007, AM J VET RES, V68, P941, DOI 10.2460/ajvr.68.9.941
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Tagil M, 1999, J ORTHOPAED RES, V17, P200, DOI 10.1002/jor.1100170208
   Tatebe M, 2005, CYTOTHERAPY, V7, P520, DOI 10.1080/14653240500361350
   Thorpe SD, 2010, ANN BIOMED ENG, V38, P2896, DOI 10.1007/s10439-010-0059-6
   Tsai CL, 2002, ARTIF ORGANS, V26, P18, DOI 10.1046/j.1525-1594.2002.06732.x
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   Tuxhorn JA, 2002, CANCER RES, V62, P6021
   Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wakitani S, 2003, RHEUMATOLOGY, V42, P162, DOI 10.1093/rheumatology/keg024
   Wang W, 2010, BIOMATERIALS, V31, P8964, DOI 10.1016/j.biomaterials.2010.08.018
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   Ween MP, 2012, INT J MOL SCI, V13, P10461, DOI 10.3390/ijms130810461
   Weiss S, 2010, J CELL PHYSIOL, V223, P84, DOI 10.1002/jcp.22013
   Welt C, 2002, EXP BIOL MED, V227, P724
   Wescoe KE, 2008, CELL BIOCHEM BIOPHYS, V52, P85, DOI 10.1007/s12013-008-9029-0
   Wilke MM, 2007, J ORTHOP RES, V25, P913, DOI 10.1002/jor.20382
   WOODRUFF TK, 1995, ANNU REV PHYSIOL, V57, P219
   Yamasaki T, 2005, J BIOMED MATER RES A, V75A, P23, DOI 10.1002/jbm.a.30369
   Yang YQ, 2012, INT J ORAL SCI, V4, P64, DOI 10.1038/ijos.2012.33
   Yokoo N, 2005, ARTHRITIS RHEUM, V52, P164, DOI 10.1002/art.20739
   Yoo JU, 1998, J BONE JOINT SURG AM, V80A, P1745, DOI 10.2106/00004623-199812000-00004
   Yoon DM, 2008, TISSUE ENG PT A, V14, P1263, DOI 10.1089/ten.tea.2007.0172
   Yoon DM, 2006, ADV EXP MED BIOL, V585, P67
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Yoshioka M, 1997, OSTEOARTHR CARTILAGE, V5, P251, DOI 10.1016/S1063-4584(97)80021-0
   Yue B, 2005, CALCIFIED TISSUE INT, V77, P395, DOI 10.1007/s00223-005-0180-y
   Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042
   Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052
   Zscharnack M, 2009, CELLS TISSUES ORGANS, V190, P81, DOI 10.1159/000178024
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuscik MJ, 2008, J CLIN INVEST, V118, P429, DOI 10.1172/JC134174
NR 224
TC 7
Z9 8
U1 0
U2 45
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD MAY
PY 2014
VL 9
IS 3
BP 254
EP 267
DI 10.2174/1574888X09666140213202700
PG 14
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA AD0QQ
UT WOS:000332939600012
PM 24524788
DA 2018-10-19
ER

PT J
AU Zeglinski, J
   Nolan, M
   Thompson, D
   Tofail, SAM
AF Zeglinski, Jacek
   Nolan, Michael
   Thompson, Damien
   Tofail, Syed A. M.
TI Reassigning the most stable surface of hydroxyapatite to the water
   resistant hydroxyl terminated (010) surface
SO SURFACE SCIENCE
LA English
DT Article
DE Biomaterial nanostructure; Hydroxyapatite; Implant biocompatibility;
   Surface structure; Surface wetting; Density functional theory
ID MOLECULAR-DYNAMICS SIMULATION; GLYCINE ADSORPTION; B3LYP; INTERFACES;
   PROTEIN
AB Understanding the surface stability and crystal growth morphology of hydroxyapatite is important to comprehend bone growth and repair processes and to engineer protein adsorption, cellular adhesion and biomineralization on calcium phosphate based bone grafts and implant coatings. It has generally been assumed from electronic structure calculations that the most stable hydroxyapatite surface is the (001) surface, terminated just above hydroxyl ions perpendicular to the (001) crystal plane. However, this is inconsistent with the known preferential growth direction of hydroxyapatite crystals and previous experimental work which indicates that, contrary to currently accepted theoretical predictions, it is actually the (010) surface that is preferentially exposed. The surface structure of the (010) face is still debated and needs reconciliation. In this work, we use a large set of density functional theory calculations to model the interaction of water with hydroxyapatite surfaces and probe the surface stability and resistance to hydrolytic remodeling of a range of surface faces including the (001) surface and the phosphate-exposed, calcium-exposed, and hydroxyl-exposed terminations of the (010) surface. For the (001) surface and the phosphate-exposed (010) surface, dissociative water adsorption is favorable. In contrast, the hydroxyl-terminated (010) surface will not split water and only molecular adsorption of water is possible. Our calculations show, overall, that the hydroxyl-terminated (010) surface is the most stable and thus should be the predominant form of the hydroxyapatite surface exposed in experiments. This finding reconciles discrepancies between the currently proposed surface terminations of hydroxyapatite and the experimentally observed crystal growth direction and surface stability, which may aid efforts to accelerate biomineralization and better control bone-repair processes on hydroxyapatite surfaces. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Zeglinski, Jacek; Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
   [Zeglinski, Jacek; Tofail, Syed A. M.] Univ Limerick, Dept Phys & Energy, Limerick, Ireland.
   [Nolan, Michael; Thompson, Damien] Natl Univ Ireland Univ Coll Cork, Tyndall Natl Inst, Cork, Ireland.
RP Zeglinski, J (reprint author), Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
EM jacek.zeglinski@ul.ie; tofail.syed@ul.ie
RI Nolan, Michael/A-9319-2008; thompson, damien/G-6138-2015
OI Nolan, Michael/0000-0002-5224-8580; thompson,
   damien/0000-0003-2340-5441; Zeglinski, Jacek/0000-0002-0022-2653
FU Science Foundation Ireland (SFI); Higher Education Authority; SFI
   Starting Investigator Research Grant Program, project "EMOIN" [SFI
   09/SIRG/I1620]; SFI [SFI 11/SIRG/B2111]
FX We acknowledge the Science Foundation Ireland (SFI) and Higher Education
   Authority funded Irish Centre for High End Computing (ICHEC) for the
   access to the computational facilities. MN acknowledges support from the
   SFI Starting Investigator Research Grant Program, project "EMOIN" grant
   number SFI 09/SIRG/I1620. DT thanks SFI for the financial support under
   grant number SFI 11/SIRG/B2111.
CR Almora-Barrios N, 2012, CRYST GROWTH DES, V12, P756, DOI 10.1021/cg201092s
   Almora-Barrios N, 2010, CRYSTENGCOMM, V12, P960, DOI 10.1039/b917179g
   Almora-Barrios N, 2009, LANGMUIR, V25, P5018, DOI 10.1021/la803842g
   Astala R, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075427
   Bhowmik R, 2007, POLYMER, V48, P664, DOI 10.1016/j.polymer.2006.11.015
   Canepa P, 2011, PHYS CHEM CHEM PHYS, V13, P1099, DOI 10.1039/c0cp01143f
   Chen X, 2007, J PHYS CHEM C, V111, P1284, DOI 10.1021/jp0646630
   Chiatti F, 2012, J PHYS CHEM C, V116, P6108, DOI 10.1021/jp212595d
   Corno M, 2007, EUR J MINERAL, V19, P757, DOI 10.1127/0935-1221/2007/0019-1764
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   de Leeuw NH, 2010, J MATER CHEM, V20, P5376, DOI 10.1039/b921400c
   Hochbaum AI, 2010, NANO LETT, V10, P3717, DOI 10.1021/nl102290k
   Jimenez-Izal E, 2012, J PHYS CHEM C, V116, P14561, DOI 10.1021/jp304473p
   Juang HY, 1996, BIOMATERIALS, V17, P2059, DOI 10.1016/0142-9612(96)88882-X
   Kobayashi T, 2012, CRYSTENGCOMM, V14, P1143, DOI 10.1039/c1ce06114c
   Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169
   KRESSE G, 1994, J PHYS-CONDENS MAT, V6, P8245, DOI 10.1088/0953-8984/6/40/015
   Lou ZY, 2012, APPL SURF SCI, V258, P4911, DOI 10.1016/j.apsusc.2012.01.116
   Ma XY, 2008, BIOMATERIALS, V29, P257, DOI 10.1016/j.biomaterials.2007.10.001
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Ospina CA, 2012, COLLOID SURFACE B, V89, P15, DOI 10.1016/j.colsurfb.2011.08.016
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671
   Pieske O., 2009, TRAUMA MANAGE OUTCOM, V3, P11
   Reuter K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.035406
   Rimola A, 2012, J AM CHEM SOC, V134, P10899, DOI 10.1021/ja302262y
   Rimola A, 2012, PHILOS T R SOC A, V370, P1478, DOI 10.1098/rsta.2011.0236
   Rimola A, 2011, J PHYS CHEM LETT, V2, P1390, DOI 10.1021/jz200457x
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Sato K, 2002, J AM CERAM SOC, V85, P3054
   SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701
   SUDARSANAN K, 1969, ACTA CRYSTALL B-STRU, VB 25, P1534, DOI 10.1107/S0567740869004298
   Zahn D, 2003, PHYS CHEM CHEM PHYS, V5, P4004, DOI 10.1039/b306358e
NR 35
TC 7
Z9 7
U1 0
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
EI 1879-2758
J9 SURF SCI
JI Surf. Sci.
PD MAY
PY 2014
VL 623
BP 55
EP 63
DI 10.1016/j.susc.2014.01.008
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA AD0FO
UT WOS:000332910100009
DA 2018-10-19
ER

PT J
AU Rao, PJ
   Pelletier, MH
   Walsh, WR
   Mobbs, RJ
AF Rao, Prashanth J.
   Pelletier, Matthew H.
   Walsh, William R.
   Mobbs, Ralph J.
TI Spine Interbody Implants: Material Selection and Modification,
   Functionalization and Bioactivation of Surfaces to Improve
   Osseointegration
SO ORTHOPAEDIC SURGERY
LA English
DT Review
DE Bioactive conversion; Interbody spinal implant; Osseointegration
ID BONE MORPHOGENETIC PROTEIN-2; FIBER-REINFORCED POLY(ETHERETHERKETONE);
   ANTERIOR CERVICAL DISKECTOMY; PLASMA-SPRAYED TITANIUM; SILICON-NITRIDE;
   FUSION CAGES; IN-VIVO; TANTALUM IMPLANTS; BONDING ABILITY;
   HEAT-TREATMENT
AB The clinical outcome of lumbar spinal fusion is correlated with achievement of bony fusion. Improving interbody implant bone on-growth and in-growth may enhance fusion, limiting pseudoarthrosis, stress shielding, subsidence and implant failure. Polyetheretherketone (PEEK) and titanium (Ti) are commonly selected for interbody spacer construction. Although these materials have desirable biocompatibility and mechanical properties, they require further modification to support osseointegration. Reports of extensive research on this topic are available in biomaterial-centric published reports; however, there are few clinical studies concerning surface modification of interbody spinal implants. The current article focuses on surface modifications aimed at fostering osseointegration from a clinician's point of view. Surface modification of Ti by creating rougher surfaces, modifying its surface topography (macro and nano), physical and chemical treatment and creating a porous material with high interconnectivity can improve its osseointegrative potential and bioactivity. Coating the surface with osteoconductive materials like hydroxyapatite (HA) can improve osseointegration. Because PEEK spacers are relatively inert, creating a composite by adding Ti or osteoconductive materials like HA can improve osseointegration. In addition, PEEK may be coated with Ti, effectively bio-activating the coating.
C1 [Rao, Prashanth J.; Mobbs, Ralph J.] Prince Wales Hosp, Neurospine Clin, Sydney, NSW, Australia.
   [Rao, Prashanth J.; Pelletier, Matthew H.; Walsh, William R.; Mobbs, Ralph J.] Univ New S Wales, Sydney, NSW, Australia.
   [Rao, Prashanth J.; Pelletier, Matthew H.; Walsh, William R.] Surg & Orthopaed Res Lab, Sydney, NSW, Australia.
RP Rao, PJ (reprint author), Prince Wales Private Hosp, Suite 7A,Level 7,Barker St, Sydney, NSW, Australia.
EM prashanthdr@gmail.com
OI Mobbs, Ralph/0000-0001-6542-6836
CR Adogwa O, 2011, J NEUROSURG-SPINE, V15, P393, DOI 10.3171/2011.4.SPINE10822
   Anderson MC, 2010, J BIOMED MATER RES A, V92A, P1598, DOI 10.1002/jbm.a.32498
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Bal BS, 2012, ACTA BIOMATER, V8, P2889, DOI 10.1016/j.actbio.2012.04.031
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Barkarmo S, 2013, J BIOMED MATER RES A, V101, P465, DOI 10.1002/jbm.a.34358
   Bertollo N, 2012, J ARTHROPLASTY, V27, P1429, DOI 10.1016/j.arth.2012.02.025
   Bonfield W, 1988, Ann N Y Acad Sci, V523, P173, DOI 10.1111/j.1749-6632.1988.tb38510.x
   BRANTIGAN JW, 1993, SPINE, V18, P2106, DOI 10.1097/00007632-199310001-00030
   Burkus JK, 2009, J BONE JOINT SURG AM, V91A, P1181, DOI 10.2106/JBJS.G.01485
   Burkus JK, 2003, SPINE, V28, P372, DOI 10.1097/00007632-200302150-00012
   Carragee EJ, 2013, J BONE JOINT SURG AM, V95A, P1537, DOI 10.2106/JBJS.L.01483
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   dos Santos MV, 2011, CLIN IMPLANT DENT R, V13, P215, DOI 10.1111/j.1708-8208.2009.00202.x
   Fernandez-Fairen M, 2008, SPINE, V33, P465, DOI 10.1097/BRS.0b013e3181657f49
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fujibayashi S, 2011, EUR SPINE J, V20, P1486, DOI 10.1007/s00586-011-1728-3
   GLOWACKI J, 1985, CLIN PLAST SURG, V12, P233
   GOODMAN S, 1992, BIOMATERIALS, V13, P944, DOI 10.1016/0142-9612(92)90118-8
   Gorth DJ, 2012, INT J NANOMED, V7, P4829, DOI 10.2147/IJN.S35190
   Guedes e Silva CC, 2008, J BIOMED MATER RES A, V84, P337
   Ha SW, 1997, J MATER SCI-MATER M, V8, P891, DOI 10.1023/A:1018562023599
   Ha SW, 1997, J MATER SCI-MATER M, V8, P881, DOI 10.1023/A:1018557922690
   Han CM, 2010, BIOMATERIALS, V31, P3465, DOI 10.1016/j.biomaterials.2009.12.030
   Hasegawa Toru, 2005, Spine J, V5, P239, DOI 10.1016/j.spinee.2004.11.010
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ito Z, 2010, SPINE, V35, pE1101, DOI 10.1097/BRS.0b013e3181de4f2e
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Kim HM, 2000, BIOMATERIALS, V21, P353, DOI 10.1016/S0142-9612(99)00190-8
   Kim IY, 2009, J BIOMATER APPL, V24, P105, DOI 10.1177/0885328208094557
   Kim P, 1998, J NEUROSURG, V88, P21, DOI 10.3171/jns.1998.88.1.0021
   Kim YJ, 2005, SPINE, V30, P468, DOI 10.1097/01.brs.0000153392.74639.ea
   Krayenbuhl N, 2008, J CLIN NEUROSCI, V15, P11, DOI 10.1016/j.jocn.2006.12.011
   Kroppenstedt S, 2008, SPINE, V33, P2083, DOI 10.1097/BRS.0b013e31818448a9
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007
   Lee JH, 2011, SPINE J, V11, P647, DOI 10.1016/j.spinee.2011.04.029
   Leucht P, 2007, BONE, V40, P919, DOI 10.1016/j.bone.2006.10.027
   Lin A, 2009, INT J ORAL MAX IMPL, V24, P808
   LU DR, 1991, J BIOMAT SCI-POLYM E, V3, P127, DOI 10.1163/156856291X00232
   Mobbs RJ, 2013, ORTHOP SURG, V5, P77, DOI 10.1111/os.12030
   Mroz TE, 2010, SPINE, V35, pS86, DOI 10.1097/BRS.0b013e3181d81ef2
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Nishiguchi S, 1999, J BIOMED MATER RES, V48, P689, DOI 10.1002/(SICI)1097-4636(1999)48:5<689::AID-JBM13>3.3.CO;2-3
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Niu CC, 2010, J SPINAL DISORD TECH, V23, P310, DOI 10.1097/BSD.0b013e3181af3a84
   Olivares-Navarrete R, 2012, SPINE J, V12, P265, DOI 10.1016/j.spinee.2012.02.002
   Park HW, 2009, SPINE, V34, pE591, DOI 10.1097/BRS.0b013e3181ab8b9a
   Pelletier M, 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31826851a4, DOI 10.1097/BSD.0B013E31826851A4]
   Pflugmacher R, 2004, SPINE, V29, P1717, DOI 10.1097/01.BRS.0000134565.17078.4C
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sanden B, 2002, J BONE JOINT SURG BR, V84B, P387, DOI 10.1302/0301-620X.84B3.12388
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P905, DOI 10.1163/016942409X12598231567989
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Sinclair SK, 2012, SPINE, V37, pE571, DOI 10.1097/BRS.0b013e318240f981
   Stadelmann VA, 2008, BONE, V42, P358, DOI 10.1016/j.bone.2007.09.055
   Steinberg EL, 2013, J MECH BEHAV BIOMED, V17, P221, DOI 10.1016/j.jmbbm.2012.09.013
   Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435
   Tarnita D, 2009, ROM J MORPHOL EMBRYO, V50, P15
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   Vaidya R, 2007, EUR SPINE J, V16, P1257, DOI 10.1007/s00586-007-0351-9
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Webster TJ, 2012, ACTA BIOMATER, V8, P4447, DOI 10.1016/j.actbio.2012.07.038
   Wong KL, 2009, BIOMATERIALS, V30, P3810, DOI 10.1016/j.biomaterials.2009.04.016
   Wu XM, 2012, INT J NANOMED, V7, P1215, DOI 10.2147/IJN.S28101
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 80
TC 45
Z9 46
U1 10
U2 74
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1757-7853
EI 1757-7861
J9 ORTHOP SURG
JI Orthop. Surg.
PD MAY
PY 2014
VL 6
IS 2
BP 81
EP 89
DI 10.1111/os.12098
PG 9
WC Orthopedics
SC Orthopedics
GA CS5AG
UT WOS:000362087100001
PM 24890288
OA Bronze
DA 2018-10-19
ER

PT J
AU Renberg, B
   Andersson-Svahn, H
   Hedhammar, M
AF Renberg, Bjorn
   Andersson-Svahn, Helene
   Hedhammar, My
TI Mimicking silk spinning in a microchip
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Spider silk; Microfluidics; Spinning
ID SPIDER SILK; PROTEINS; FIBERS; MICROSPHERES; MICROFLUIDICS; BIOMATERIAL
AB Nature's high performance material, spider silk, is formed during the passage of a protein solution through a spinning duct. Herein we present a microfluidic device with dual laminar mobile phases where silk formation can be mimicked and investigated. Recombinant miniature spidroins, with or without the pH-switching N-terminal domain, were used to investigate spinning conditions into silk-like fibers using this setup. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Renberg, Bjorn; Andersson-Svahn, Helene] Royal Inst Technol, Sch Biotechnol, Div Nanobiotechnol, Stockholm, Sweden.
   [Hedhammar, My] Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
RP Hedhammar, M (reprint author), Swedish Univ Agr Sci, Biomed Ctr, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden.
EM My.Hedhammar@slu.se
FU Swedish Foundation for strategic research; Swedish Research Council
FX This work was supported by The Swedish Foundation for strategic research
   and the Swedish Research Council. We thank Spider Technologies AB for
   providing proteins. Andreas Barth and Nadja Eremina are acknowledged for
   help with FTIR measurements.
CR Arcidiacono Steven, 2013, Methods Mol Biol, V996, P43, DOI 10.1007/978-1-62703-354-1_3
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Breslauer DN, 2010, BIOMACROMOLECULES, V11, P643, DOI 10.1021/bm901209u
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936
   Hedhammar M, 2008, BIOCHEMISTRY-US, V47, P3407, DOI 10.1021/bi702432y
   Hermanson KD, 2007, PHYS CHEM CHEM PHYS, V9, P6442, DOI 10.1039/b709808a
   Jaudzems K, 2012, J MOL BIOL, V422, P477, DOI 10.1016/j.jmb.2012.06.004
   Karjalainen EL, 2011, J PHYS CHEM B, V115, P749, DOI 10.1021/jp109918c
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Landreh M, 2010, J MOL BIOL, V404, P328, DOI 10.1016/j.jmb.2010.09.054
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Motriuk-Smith D, 2005, BIOMACROMOLECULES, V6, P3152, DOI 10.1021/bm050472b
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rising A, 2011, CELL MOL LIFE SCI, V68, P169, DOI 10.1007/s00018-010-0462-z
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Sponner A, 2005, BIOCHEM BIOPH RES CO, V338, P897, DOI 10.1016/j.bbrc.2005.10.048
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Vollrath F, 1998, P ROY SOC B-BIOL SCI, V265, P817, DOI 10.1098/rspb.1998.0365
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
NR 34
TC 12
Z9 12
U1 3
U2 60
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAY
PY 2014
VL 195
BP 404
EP 408
DI 10.1016/j.snb.2014.01.023
PG 5
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA AC3KQ
UT WOS:000332417600054
DA 2018-10-19
ER

PT J
AU Zhang, ZH
   Liu, SL
   Shi, Y
   Dou, J
   Fang, SM
AF Zhang, Zhihong
   Liu, Shunli
   Shi, Yu
   Dou, Jun
   Fang, Shaoming
TI DNA Detection and Cell Adhesion on Plasma-Polymerized Pyrrole
SO BIOPOLYMERS
LA English
DT Article
DE plasma polymerization; DNA immobilization; hybridization; cell adhesion;
   electrochemical impedance spectroscopy
ID QUARTZ-CRYSTAL MICROBALANCE; INDUCED GRAFT-POLYMERIZATION;
   PROTEIN-ADSORPTION; PROBE IMMOBILIZATION; SURFACE; FILMS; HYBRIDIZATION;
   POLYPYRROLE; ALLYLAMINE; TITANIUM
AB This study investigates the application of Plasma-polymerized pyrrole (ppPY) as bioactive platform for DNA immobilization and cell adhesion based on the fundamental properties of ppPY, such as chemical structure, electrochemical property, and protein adsorption. Variations in electrochemical properties of the ppPY film deposited under different plasma conditions before and after DNA immobilization were measured using electrochemical impedance spectroscopy (EIS). The equilibrium concentration of the probe DNA immobilized on the ppPY surface was deduced by detecting the variations in the surface charge transfer resistance (R-ct) of the ppPY films after DNA immobilization with different concentrations. In addition, the detection limit of the target DNA hybridization with probe DNA, the association constant, K-a, and the dissociation constant were deduced from Langmuir isotherm equations simulated using the experimental data collected by EIS. Moreover, inverted microscope was used to observe the cell adhesions onto the surface of the ppPY films prepared under different plasma conditions. Different adhesive behaviors of cells were observed, demonstrating that ppPY films could be an alternative biomaterial used as the sensitive layer for DNA sensor or cell adhesion. (c) 2013 Wiley Periodicals, Inc. Biopolymers 101: 496-503, 2014.
C1 [Zhang, Zhihong; Liu, Shunli; Shi, Yu; Dou, Jun; Fang, Shaoming] Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, Zhengzhou 450002, Peoples R China.
RP Zhang, ZH (reprint author), Zhengzhou Univ Light Ind, Henan Prov Key Lab Surface & Interface Sci, 5 Dong Feng Rd, Zhengzhou 450002, Peoples R China.
EM mainzhh@163.com
FU National Natural Science Foundation of China (NSFC) [51173172]
FX Contract grant sponsor: National Natural Science Foundation of China
   (NSFC); Contract grant number: 51173172
CR Barbier V, 2006, LANGMUIR, V22, P5230, DOI 10.1021/la053289c
   Chen KS, 2007, MAT SCI ENG C-BIO S, V27, P716, DOI 10.1016/j.msec.2006.07.004
   Chen Q, 2004, CHEM MATER, V16, P614, DOI 10.1021/cm034529h
   Chu LQ, 2008, BIOSENS BIOELECTRON, V24, P118, DOI 10.1016/j.bios.2008.03.026
   Chu LQ, 2006, PLASMA PROCESS POLYM, V3, P498, DOI 10.1002/ppap.200600010
   Dhillon A, 2010, PROG ORG COAT, V69, P396, DOI 10.1016/j.porgcoat.2010.08.002
   Ding Z, 2004, BIOMATERIALS, V25, P1059, DOI 10.1016/S0142-9612(03)00615-X
   Dultsev FN, 2012, LANGMUIR, V28, P13793, DOI 10.1021/la302907r
   Finke B, 2007, BIOMATERIALS, V28, P4521, DOI 10.1016/j.biomaterials.2007.06.028
   Goktas H, 2009, SYNTHETIC MET, V159, P2001, DOI 10.1016/j.synthmet.2009.07.003
   Goodrich TT, 2004, J AM CHEM SOC, V126, P4086, DOI 10.1021/ja039823p
   Gu HR, 2005, J PHYS CHEM B, V109, P13611, DOI 10.1021/jp050625p
   Gu MH, 2012, BIOMATERIALS, V33, P1261, DOI 10.1016/j.biomaterials.2011.11.001
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hayakawa T, 2004, BIOMATERIALS, V25, P119, DOI 10.1016/S0142-9612(03)00484-8
   Hosono K, 2004, MATER LETT, V58, P1371, DOI 10.1016/j.matlet.2003.09.029
   Hu YW, 2011, CHEM COMMUN, V47, P1743, DOI 10.1039/c0cc04514d
   Kannan B, 2011, ANAL CHEM, V83, P3415, DOI 10.1021/ac1033243
   KUMAR GS, 1995, CANCER LETT, V92, P27, DOI 10.1016/0304-3835(95)03753-J
   Li AX, 2007, BIOSENS BIOELECTRON, V22, P1716, DOI 10.1016/j.bios.2006.07.033
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   Miyachi H, 2000, BIOTECHNOL BIOENG, V69, P323, DOI 10.1002/1097-0290(20000805)69:3<323::AID-BIT10>3.0.CO;2-T
   Miyachi H, 2004, BIOSENS BIOELECTRON, V20, P184, DOI 10.1016/j.bios.2004.02.022
   Nastase F, 2005, COMPOS PART A-APPL S, V36, P503, DOI 10.1016/j.compositesa.2004.10.010
   Olayo R, 2008, J MATER SCI-MATER M, V19, P817, DOI 10.1007/s10856-007-3080-z
   Porath D, 2000, NATURE, V403, P635, DOI 10.1038/35001029
   SCHWEIGERER L, 1985, P NATL ACAD SCI USA, V82, P5751, DOI 10.1073/pnas.82.17.5751
   Su XD, 2002, BIOCHEM BIOPH RES CO, V290, P962, DOI 10.1006/bbrc.2001.6297
   Tong ZS, 1997, APPL SURF SCI, V119, P93, DOI 10.1016/S0169-4332(97)00166-9
   Twite RL, 1998, PROG ORG COAT, V33, P91, DOI 10.1016/S0300-9440(98)00015-0
   Wang JG, 2004, THIN SOLID FILMS, V446, P205, DOI 10.1016/j.tsf.2003.09.074
   Zanini S, 2010, J COLLOID INTERF SCI, V341, P53, DOI 10.1016/j.jcis.2009.09.012
   Zhang Z, 2005, MACROMOLECULES, V38, P1271, DOI 10.1021/ma049716v
   Zhang ZH, 2003, MACROMOLECULES, V36, P7689, DOI 10.1021/ma034673o
   Zhang ZH, 2007, APPL SURF SCI, V253, P8915, DOI 10.1016/j.apsusc.2007.05.027
   Zhang ZH, 2008, BIOMACROMOLECULES, V9, P1613, DOI 10.1021/bm800111a
   Zhang ZH, 2011, PLASMA PROCESS POLYM, V8, P923, DOI 10.1002/ppap.201000156
   Zou L, 2011, J MEMBRANE SCI, V369, P420, DOI 10.1016/j.memsci.2010.12.023
NR 39
TC 1
Z9 1
U1 0
U2 51
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD MAY
PY 2014
VL 101
IS 5
BP 496
EP 503
DI 10.1002/bip.22408
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AB2KE
UT WOS:000331620800006
PM 24122355
DA 2018-10-19
ER

PT J
AU Aina, V
   Magistris, C
   Cerrato, G
   Martra, G
   Viscardi, G
   Lusvardi, G
   Malavasi, G
   Menabue, L
AF Aina, Valentina
   Magistris, Claudio
   Cerrato, Giuseppina
   Martra, Gianmario
   Viscardi, Guido
   Lusvardi, Gigliola
   Malavasi, Gianluca
   Menabue, Ledi
TI New Formulation of Functionalized Bioactive Glasses to Be Used as
   Carriers for the Development of pH-Stimuli Responsive Biomaterials for
   Bone Diseases
SO LANGMUIR
LA English
DT Article
ID DRUG-DELIVERY; BIONANOTECHNOLOGY; HYPERTHERMIA; BIOCERAMICS;
   TEMPERATURE; LIPOSOME; SYSTEMS; MODEL
AB The aim of the present contribution is to prepare a functionalized bioactive glass potentially useful as prosthetic material, but also able to release organic molecules in response to a change of the pH environment. By this approach it is possible to develop devices which can be used for a triggered drug release in response to specific stimuli; this is an attractive research field, in order to avoid either systemic and/or local toxic effects of drugs. In particular, in the present paper we report data related to the development of a new formulation of bioactive glasses, their functionalization with organic molecules to obtain a pH-sensitive bond, their physicochemical characterization and in vitro bioactivity in simulated biological fluids (SBF), and organic molecule delivery tests at different pH. The glass functionalization, by means of a covalent reaction, allows us to produce a model of pH-responsive bioactive biomaterial: when it is exposed to specific pH changes, it can favor the release of the organic molecules directly at the target site. Cysteamine and 5-aminofluorescein are used as model molecules to simulate a drug. The materials, before and after the different functionalization steps and in vitro release tests at different pH, have been characterized by means of different experimental techniques such as X-ray powder diffraction (XRPD), Raman, FTIR and fluorescence spectroscopies, N-2 adsorption, thermogravimetric (TGA) and elemental analysis.
C1 [Aina, Valentina; Magistris, Claudio; Cerrato, Giuseppina; Martra, Gianmario; Viscardi, Guido] Univ Turin, Interdept Ctr Nanostruct Interfaces & Surface NIS, Dept Chem, INSTM Italian Natl Consortium Mat Sci & Technol, I-10125 Turin, Italy.
   [Lusvardi, Gigliola; Malavasi, Gianluca; Menabue, Ledi] Univ Modena & Reggio Emilia, Dept Chem & Geol Sci, I-41125 Modena, Italy.
RP Aina, V (reprint author), Univ Turin, Interdept Ctr Nanostruct Interfaces & Surface NIS, Dept Chem, INSTM Italian Natl Consortium Mat Sci & Technol, Via P Giuria 7, I-10125 Turin, Italy.
EM valentina.aina@unito.it
RI Malavasi, Gianluca/H-4658-2013; Viscardi, Guido/N-1111-2015; Menabue,
   Ledi/L-7324-2015; Lusvardi, Gigliola/L-6941-2015
OI Malavasi, Gianluca/0000-0002-4557-8135; Viscardi,
   Guido/0000-0002-9387-2849; Menabue, Ledi/0000-0002-7984-3208; Lusvardi,
   Gigliola/0000-0002-0772-6037; Martra, Gianmario/0000-0002-8012-5342
FU Compagnia di San Paolo [ORTO11RRTS]; Fondazione di Vignola
FX The authors acknowledge Dr. C. Giovannoli for acid-base titration
   measurements, Prof. E. Diana for Raman measurements, and Dr. R Buscaino
   for mass spectrometry. The authors thank Ms. F. Malafronte and Mr. W.
   Intelisano for their valuable commitment and help. V.A., G.C., and G.M.
   acknowledge Compagnia di San Paolo for the financial support (Project:
   ORTO11RRTS). G.L. acknowledges Fondazione di Vignola for the financial
   support (Progetto "Materiali per la teranostica: progettazione di
   sistemi contenenti nanoparticelle e molecole di interesse biologico").
CR Aina V, 2011, J PHYS CHEM C, V115, P22461, DOI 10.1021/jp207217a
   Arcos D, 2013, ACTA MATER, V61, P890, DOI 10.1016/j.actamat.2012.10.039
   BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126
   Branda F, 2007, COLLOID SURFACE A, V299, P252, DOI 10.1016/j.colsurfa.2006.11.048
   Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023
   Caldorera-Moore M, 2009, ADV DRUG DELIVER REV, V61, P1391, DOI 10.1016/j.addr.2009.09.002
   Franchini M, 2012, MAT SCI ENG C-MATER, V32, P1401, DOI 10.1016/j.msec.2012.04.016
   Gao WW, 2010, MOL PHARMACEUT, V7, P1913, DOI 10.1021/mp100253e
   Gregg S. J., 1995, ADSORPTION SURFACE A
   Gupta G, 2006, INDIAN J CHEM B, V45, P697
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Kataoka K, 2000, J CONTROL RELEASE, V64, P143, DOI 10.1016/S0168-3659(99)00133-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Lin S, 2009, J MATER CHEM, V19, P1276, DOI 10.1039/b814292k
   LIPPENS BC, 1965, J CATAL, V4, P319, DOI 10.1016/0021-9517(65)90307-6
   Lusvardi G, 2010, LANGMUIR, V26, P10303, DOI 10.1021/la100472p
   Manzano M, 2012, PROG SOLID STATE CH, V40, P17, DOI 10.1016/j.progsolidstchem.2012.05.001
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   McCoy CP, 2010, EXPERT OPIN DRUG DEL, V7, P605, DOI 10.1517/17425241003677731
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Needham D, 2000, CANCER RES, V60, P1197
   Pardoe H, 2003, MAGN RESON IMAGING, V21, P483, DOI 10.1016/S0730-725X(03)00072-9
   Park JW, 2002, BREAST CANCER RES, V4, P93
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Rapoport N, 2004, INT J PHARMACEUT, V277, P155, DOI 10.1016/j.ijpharm.2003.09.048
   SHEN WC, 1981, BIOCHEM BIOPH RES CO, V102, P1048, DOI 10.1016/0006-291X(81)91644-2
   Shruti S., 2013, MAT SCI ENG C, V33, P3190
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Ulbrich K, 2004, ADV DRUG DELIVER REV, V56, P1023, DOI 10.1016/j.addr.2003.10.040
   Verne E, 2009, J BIOMED MATER RES A, V90A, P981, DOI 10.1002/jbm.a.32153
   Vitale-Brovarone C, 2004, J MATER SCI-MATER M, V15, P209, DOI 10.1023/B:JMSM.0000015480.49061.e1
   Zhang HT, 2011, EUR J PHARM SCI, V42, P517, DOI 10.1016/j.ejps.2011.02.006
NR 33
TC 5
Z9 5
U1 0
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD APR 29
PY 2014
VL 30
IS 16
BP 4703
EP 4715
DI 10.1021/la5003989
PG 13
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AG3DZ
UT WOS:000335297300022
PM 24701982
DA 2018-10-19
ER

PT J
AU Li, QL
   Ning, TY
   Cao, Y
   Zhang, WB
   Mei, ML
   Chu, CH
AF Li, Quan-Li
   Ning, Tian-Yun
   Cao, Ying
   Zhang, Wei-bo
   Mei, May Lei
   Chu, Chun Hung
TI A novel self-assembled oligopeptide amphiphile for biomimetic
   mineralization of enamel
SO BMC BIOTECHNOLOGY
LA English
DT Article
DE Amelogenin; Peptide; Remineralization; Enamel; Biomimetic;
   Mineralization; Self-assemble
ID AMELOGENIN NANOSPHERES; CALCIUM-PHOSPHATE; TOOTH ENAMEL;
   REMINERALIZATION; DENTIN; PEPTIDE; CRYSTALLIZATION; HYDROXYAPATITE;
   REGENERATION; PERSPECTIVE
AB Background: Researchers are looking for biomimetic mineralization of ena/mel to manage dental erosion. This study evaluated biomimetic mineralization of demineralized enamel induced by a synthetic and self-assembled oligopeptide amphiphile (OPA).
   Results: The results showed that the OPA self-assembled into nano-fibres in the presence of calcium ions and in neutral acidity. The OPA was alternately immersed in calcium chloride and sodium hypophosphate solutions to evaluate its property of mineralization. Transmission electron microscopy (TEM) and scanning electron microscopy (SEM) showed nucleation and growth of amorphous calcium phosphate along the self-assembled OPA nano-fibres when it was repetitively exposed to solutions with calcium and phosphate ions. Energy dispersive spectrometry (EDS) confirmed that these nano-particles contained calcium and phosphate. Furthermore, electron diffraction pattern suggested that the nano-particles precipitated on OPA nano-fibres were comparable to amorphous calcium phosphate. Acid-etched human enamel slices were incubated at 37 degrees C in metastable calcium phosphate solution with the OPA for biomimetic mineralization. SEM and X-ray diffraction indicated that the OPA induced the formation of hydroxyapatite crystals in organized bundles on etched enamel. TEM micrographs revealed there were 20-30 nm nano-amorphous calcium phosphate precipitates in the biomimetic mineralizing solution. The particles were found separately bound to the oligopeptide fibres. Biomimetic mineralization with or without the oligopeptide increased demineralized enamel microhardness.
   Conclusions: A novel OPA was successfully fabricated, which fostered the biomimetic mineralization of demineralized enamel. It is one of the primary steps towards the design and construction of novel biomaterial for future clinical therapy of dental erosion.
C1 [Li, Quan-Li; Cao, Ying; Zhang, Wei-bo] Anhui Med Univ, Coll & Hosp Stomatol, Hefei 230032, Peoples R China.
   [Ning, Tian-Yun; Cao, Ying; Mei, May Lei; Chu, Chun Hung] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.
RP Li, QL (reprint author), Anhui Med Univ, Coll & Hosp Stomatol, Hefei 230032, Peoples R China.
EM ql-li@126.com; chchu@hku.hk
RI Chu, Chun Hung/F-7838-2010
OI Chu, Chun Hung/0000-0002-3239-3051; Chu, Chun Hung/0000-0002-8167-0430
FU NSFC [30973352]; NSFC/RGC Joint Research Scheme [N_HKU 776/10,
   81061160511]; Youth Foundation of Anhui Provincial Natural Science
   Foundation [1208085QH144]
FX This study was supported by NSFC (No.30973352) and NSFC/RGC Joint
   Research Scheme (N_HKU 776/10 and No.81061160511), and Youth Foundation
   of Anhui Provincial Natural Science Foundation (No.1208085QH144).
CR Bertassoni LE, 2009, CARIES RES, V43, P70, DOI 10.1159/000201593
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cao Y, 2013, J DENT, V41, P818, DOI 10.1016/j.jdent.2013.06.008
   Chen HF, 2006, ADV MATER, V18, P1846, DOI 10.1002/adma.200502401
   Chu CH, 2008, J DENT, V36, P387, DOI 10.1016/j.jdent.2008.02.013
   Chu C. H., 2011, General Dentistry, V59, P115
   Chu CH, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-13
   Cochrane NJ, 2010, J DENT RES, V89, P1187, DOI 10.1177/0022034510376046
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Fan Y, 2012, J BIOACT COMPAT POLY, V27, P14
   Fan YW, 2007, BIOMATERIALS, V28, P3034, DOI 10.1016/j.biomaterials.2007.02.016
   Fan Y, 2009, BIOMATERIALS, V30, P478, DOI 10.1016/j.biomaterials.2008.10.019
   Featherstone J D B, 2009, Adv Dent Res, V21, P4, DOI 10.1177/0895937409335590
   Fowler CE, 2005, J MATER CHEM, V15, P3317, DOI 10.1039/b503312h
   Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hosseinkhani H, 2006, J BIOACT COMPAT POL, V21, P277, DOI 10.1177/0883911506066934
   Jee SS, 2010, ACTA BIOMATER, V6, P3676, DOI 10.1016/j.actbio.2010.03.036
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Luo JJ, 2012, KEY ENG MATER, V512-515, P1727, DOI 10.4028/www.scientific.net/KEM.512-515.1727
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Ning TY, 2012, J BIOMED MATER RES B, V100B, P138, DOI 10.1002/jbm.b.31931
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Semino CE, 2008, J DENT RES, V87, P606, DOI 10.1177/154405910808700710
   Uskokovic V, 2011, J CRYST GROWTH, V316, P106, DOI 10.1016/j.jcrysgro.2010.12.005
   Yamagishi K, 2005, NATURE, V433, P819, DOI 10.1038/433819a
   Yamane S, 2009, J BIOACT COMPAT POL, V24, P151, DOI 10.1177/0883911508101554
   Yang S, 2011, CHEM COMMUN, V47, P10100, DOI 10.1039/c1cc13661e
   Ye W, 2007, MATER LETT, V61, P4062, DOI 10.1016/j.matlet.2007.01.040
   Zhou YZ, 2012, ACS APPL MATER INTER, V4, P6900, DOI 10.1021/am302041b
NR 32
TC 17
Z9 17
U1 1
U2 68
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6750
J9 BMC BIOTECHNOL
JI BMC Biotechnol.
PD APR 27
PY 2014
VL 14
AR 32
DI 10.1186/1472-6750-14-32
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AG3ZS
UT WOS:000335359100001
PM 24766767
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Steinhagen, M
   Hoffmeister, PG
   Nordsieck, K
   Hotzel, R
   Baumann, L
   Hacker, MC
   Schulz-Siegmund, M
   Beck-Sickinger, AG
AF Steinhagen, Max
   Hoffmeister, Peter-Georg
   Nordsieck, Karoline
   Hoetzel, Rudi
   Baumann, Lars
   Hacker, Michael C.
   Schulz-Siegmund, Michaela
   Beck-Sickinger, Annette G.
TI Matrix Metalloproteinase 9 (MMP-9) Mediated Release of MMP-9 Resistant
   Stromal Cell-Derived Factor 1 alpha (SDF-1 alpha) from Surface Modified
   Polymer Films
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Stromal cell-derived factor 1 alpha; cross-linked macromer;
   immobilization; matrix metalloproteinase 9; release; tissue regeneration
ID EXPRESSED PROTEIN LIGATION; MESENCHYMAL STEM-CELLS; FACTOR-I;
   PEPTIDASE-IV; MOBILIZATION; CXCR4; SDF-1; FACTOR-1-ALPHA; SDF-1/CXCL12;
   RECRUITMENT
AB Preparation of smart materials by coatings of established surfaces with biomolecules will lead to the next generation of functionalized biomaterials. Rejection of implants is still a major problem in medical applications but masking the implant material with protein coatings is a promising approach. These layers not only disguise the material but also equip it with a certain biological function. The anti-inflammatory chemokine stromal cell-derived factor 1 alpha (SDF-1 alpha) is well suited to take over this function, because it efficiently attracts stem cells and promotes their differentiation and proliferation. At least the initial stem cell homing requires the formation of a concentration gradient. Thus, a reliable and robust release mechanism of SDF-1 alpha from the material is essential. Several proteases, most notably matrix metalloproteinases, are upregulated during inflammation, which, in principle, can be exploited for a tightly controlled release of SDF-1 alpha. Herein, we present the covalent immobilization of M-[S4V]-SDF-1 alpha on novel biodegradable polymer films, which consist of heterobifunctional poly(ethylene glycol) and oligolactide-based functionalized macromers. A peptidic linker with a trimeric matrix metalloproteinase 9 (MMP-9) cleavage site (MCS) was used as connection and the linkage between the three components was achieved by combination of expressed protein ligation and Cu(I) catalyzed azide/alkyne cycloaddition. The MCS was used for MMP-9 mediated release of M4S4V]-SDF-1 alpha from the biomaterial and the released SDF-1 alpha derivative was biologically active and induced strong cell migration, which demonstrates the great potential of this system.
C1 [Steinhagen, Max; Nordsieck, Karoline; Baumann, Lars; Beck-Sickinger, Annette G.] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, D-04103 Leipzig, Germany.
   [Hoffmeister, Peter-Georg; Hoetzel, Rudi; Hacker, Michael C.; Schulz-Siegmund, Michaela] Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Pharm, D-04317 Leipzig, Germany.
RP Beck-Sickinger, AG (reprint author), Univ Leipzig, Fac Biosci Pharm & Psychol, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.
EM beck-sickinger@uni-leipzig.de
RI Hacker, Michael/D-3935-2011; Baumann, Lars/H-7991-2015
OI Hacker, Michael/0000-0002-4776-2294
FU DFG [TRR67, A1, A4]; Graduate School "Leipzig School of Natural Sciences
   - Building with Molecules and Nanoobjects" (BuildMoNa); European Union;
   Free State of Saxony (ESF)
FX The authors gratefully thank Regina Reppich-Sacher for excellent
   technical assistance in mass spectrometry, Janet Schwesinger for her
   help in molecular biology and Kristin Lobner for the assistance in cell
   culture. We also thank Benno Muller for his help with contact angle
   measurements. The financial support of the DFG (TRR67, A1 and A4) and
   the Graduate School "Leipzig School of Natural Sciences - Building with
   Molecules and Nanoobjects" (BuildMoNa) is kindly acknowledged. The
   project was funded by the European Union and the Free State of Saxony
   (ESF).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200
   Baumann L, 2013, METHODS MOL BIOL, V1047, P103, DOI 10.1007/978-1-62703-544-6_7
   Baumann L, 2012, J CONTROL RELEASE, V162, P68, DOI 10.1016/j.jconrel.2012.04.049
   Baumann L, 2010, BIOPOLYMERS, V94, P771, DOI 10.1002/bip.21465
   Bridges JF, 2000, BIOMATERIALS, V21, P199, DOI 10.1016/S0142-9612(99)00172-6
   Cencioni C, 2012, CARDIOVASC RES, V94, P400, DOI 10.1093/cvr/cvs132
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
   Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996
   Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618
   Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941
   Delgado MB, 2001, EUR J IMMUNOL, V31, P699, DOI 10.1002/1521-4141(200103)31:3<699::AID-IMMU699>3.0.CO;2-6
   Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169
   Hassert R, 2012, BIOCONJUGATE CHEM, V23, P2129, DOI 10.1021/bc3003875
   Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354
   Hazama Y, 2010, INFLAMM REGEN, V30, P193
   Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044
   Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402
   Huang YC, 2012, ACTA BIOMATER, V8, P1048, DOI 10.1016/j.actbio.2011.12.009
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Kostenis E, 2001, TRENDS PHARMACOL SCI, V22, P560, DOI 10.1016/S0165-6147(00)01810-1
   Lambeir AM, 2003, CRIT REV CL LAB SCI, V40, P209, DOI 10.1080/713609354
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Lipfert J, 2013, NEUROPATH APPL NEURO, V39, P667, DOI 10.1111/nan.12015
   Maquet V, 2000, J BIOMED MATER RES, V52, P639, DOI 10.1002/1097-4636(20001215)52:4<639::AID-JBM8>3.0.CO;2-G
   Mariner PD, 2013, J ORTHOP RES, V31, P401, DOI 10.1002/jor.22243
   Marquez-Curtis L, 2008, STEM CELLS, V26, P1211, DOI 10.1634/stemcells.2007-0725
   Marshall D, 1996, BRIT J CANCER, V73, P565, DOI 10.1038/bjc.1996.99
   McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705
   Nordsieck K, 2012, CHEMBIOCHEM, V13, P2558, DOI 10.1002/cbic.201200467
   Ohtsuki T, 1998, FEBS LETT, V431, P236, DOI 10.1016/S0014-5793(98)00763-7
   Otto TE, 1996, J BIOMED MATER RES, V32, P513, DOI 10.1002/(SICI)1097-4636(199612)32:4<513::AID-JBM3>3.0.CO;2-U
   Ozawa T, 2002, CIRCULATION, V106, P1176
   Penk A, 2013, MAGN RESON MED, V70, P925, DOI 10.1002/mrm.24541
   Ray P, 2012, BIOCHEM J, V442, P433, DOI 10.1042/BJ20111341
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Sanchez-Martin L, 2013, TRENDS MOL MED, V19, P12, DOI 10.1016/j.molmed.2012.10.004
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Schmider E, 2010, METHODOLOGY-EUR, V6, P147, DOI 10.1027/1614-2241/a000016
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053
   Tomoe C. W., 2002, J ORG CHEM, V67, P3057, DOI DOI 10.1021/JO011148J
   Tuomisto TT, 2004, ATHEROSCLEROSIS, V174, P111, DOI 10.1016/j.atherosclerosis.2004.01.015
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200
   Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev
   Werkmeister J. A., 1992, BIOMATERIALS CLIN MA, V9, P137
   Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22
   Yousef M, 2012, PHARMACOL RES, V66, P66, DOI 10.1016/j.phrs.2012.03.013
NR 54
TC 11
Z9 11
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD APR 23
PY 2014
VL 6
IS 8
BP 5891
EP 5899
DI 10.1021/am500794q
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AG0DR
UT WOS:000335086000068
PM 24646074
DA 2018-10-19
ER

PT J
AU Alves, D
   Pereira, MO
AF Alves, Diana
   Pereira, Maria Olivia
TI Mini-review: Antimicrobial peptides and enzymes as promising candidates
   to functionalize biomaterial surfaces
SO BIOFOULING
LA English
DT Review
DE antimicrobial peptides; antibacterial coatings; biofilm-dispersing
   enzymes; biomaterial-associated infections
ID MEDIATES BIOFILM FORMATION; HOST-DEFENSE PEPTIDES; COVALENT
   IMMOBILIZATION; ANTIBACTERIAL COATINGS; POLYMER BRUSHES; POLYELECTROLYTE
   MULTILAYERS; STAPHYLOCOCCUS-AUREUS; TISSUE INTEGRATION; BACTERIAL
   BIOFILMS; CATIONIC PEPTIDES
AB Biomaterial-associated infections remain a serious concern in modern healthcare. The development of materials that can resist or prevent bacterial attachment constitutes a promising approach to dealing with this problem. Antimicrobial peptides (AMPs) and enzymes have been recognized as promising candidates for the new generation of antimicrobial surfaces. AMPs have been the focus of great interest in recent years owing to a low propensity for developing bacterial resistance, broad-spectrum activity, high efficacy at very low concentrations, target specificity, and synergistic action with classical antibiotics. Biofilm-dispersing enzymes have been shown to inhibit biofilm formation, detach established biofilm, and increase biofilm susceptibility to other antimicrobials. This review critically examines the potential of these protein-like compounds for developing antibacterial coatings by reporting their immobilization into different substrata using different immobilization strategies.
C1 [Alves, Diana; Pereira, Maria Olivia] Univ Minho, IBB, Ctr Biol Engn, P-4710057 Braga, Portugal.
RP Pereira, MO (reprint author), Univ Minho, IBB, Ctr Biol Engn, Campus Gualtar, P-4710057 Braga, Portugal.
EM mopereira@deb.uminho.pt
RI Pereira, Maria/O-4859-2015
OI Pereira, Maria/0000-0002-4307-3985; Alves, Diana/0000-0001-8750-5439
FU IBB-CEB; Portuguese Foundation for Science and Technology
   [SFRH/BD/78063/2011, PTDC/SAUSAP/113196/2009 /
   FCOMP-01-0124-FEDER-016012]
FX The authors acknowledge financial support from IBB-CEB and the
   Portuguese Foundation for Science and Technology (PhD grant
   SFRH/BD/78063/2011 and project PTDC/SAUSAP/113196/2009 /
   FCOMP-01-0124-FEDER-016012).
CR Altman H, 2006, J ANTIMICROB CHEMOTH, V58, P198, DOI 10.1093/jac/dkl181
   Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
   Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Ariga K, 2007, PHYS CHEM CHEM PHYS, V9, P2319, DOI 10.1039/b700410a
   Asri LATW, 2014, ADV FUNCT MATER, V24, P346, DOI 10.1002/adfm.201301686
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Bieser AM, 2011, MACROMOL BIOSCI, V11, P526, DOI 10.1002/mabi.201000398
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Bryers JD, 2008, BIOTECHNOL BIOENG, V100, P1, DOI 10.1002/bit.21838
   Busscher H. J., 2012, SCI TRANSL MED, V4
   Caro A, 2010, J COLLOID INTERF SCI, V349, P13, DOI 10.1016/j.jcis.2009.12.001
   Caro A, 2009, J PHYS CHEM B, V113, P2101, DOI 10.1021/jp805284s
   Chaignon P, 2007, APPL MICROBIOL BIOT, V75, P125, DOI 10.1007/s00253-006-0790-y
   Chen GL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/46/465706
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   CHIPMAN DM, 1969, SCIENCE, V165, P454, DOI 10.1126/science.165.3892.454
   Cho WM, 2007, BIOORG MED CHEM LETT, V17, P5772, DOI 10.1016/j.bmcl.2007.08.056
   Chua PH, 2008, BIOMATERIALS, V29, P1412, DOI 10.1016/j.biomaterials.2007.12.019
   Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005
   Cordeiro AL, 2011, J ADHES SCI TECHNOL, V25, P2317, DOI 10.1163/016942411X574961
   Cordeiro AL, 2011, BIOTECHNOL LETT, V33, P1897, DOI 10.1007/s10529-011-0643-3
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cotton L. A., 2009, J EXP MICROBIOL IMMU, V13, P58
   Darouiche RO, 2009, J ANTIMICROB CHEMOTH, V64, P88, DOI 10.1093/jac/dkp158
   David AE, 2011, METHODS MOL BIOL, V679, P49, DOI 10.1007/978-1-60761-895-9_6
   Davis N, 1999, J BONE JOINT SURG BR, V81B, P886, DOI 10.1302/0301-620X.81B5.9545
   de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49
   del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.2007.6100247
   Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897
   Dunne WM, 2002, CLIN MICROBIOL REV, V15, P155, DOI 10.1128/CMR.15.2.155-166.2002
   El-Asrar Ahmed M. Abu, 1997, International Ophthalmology, V21, P71
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gao GZ, 2011, BIOMACROMOLECULES, V12, P3715, DOI 10.1021/bm2009697
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Ghasemi M, 2011, J PHYS CHEM B, V115, P10228, DOI 10.1021/jp204097a
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   Green J-BD, 2011, SCI MICROBIAL PATHOG, V1
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004
   Guyomard A, 2008, ADV FUNCT MATER, V18, P758, DOI 10.1002/adfm.200700793
   Hale JD, 2007, EXPERT REV ANTI-INFE, V5, P951, DOI 10.1586/14787210.5.6.951
   Han H, 2011, LANGMUIR, V27, P4010, DOI 10.1021/la1046904
   Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hanefeld U, 2013, CHEM SOC REV, V42, P6211, DOI 10.1039/c3cs90042h
   Hangler M, 2009, BIOFOULING, V25, P667, DOI 10.1080/08927010903096008
   Hansen EH, 2003, APPL ENVIRON MICROB, V69, P4611, DOI 10.1128/AEM.69.8.4611-4617.2003
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hequet A, 2011, COLLOID SURFACE B, V84, P301, DOI 10.1016/j.colsurfb.2011.01.012
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   HOGT AH, 1986, J BIOMED MATER RES, V20, P533, DOI 10.1002/jbm.820200409
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   Iconomopoulou SM, 2005, J CONTROL RELEASE, V102, P223, DOI 10.1016/j.jconrel.2004.10.006
   Itoh Y, 2005, J BACTERIOL, V187, P382, DOI 10.1128/JB.187.1.382-387.2005
   Izano EA, 2008, MICROB PATHOGENESIS, V44, P52, DOI 10.1016/j.micpath.2007.08.004
   Izano EA, 2007, MICROB PATHOGENESIS, V43, P1, DOI 10.1016/j.micpath.2007.02.004
   Johansen C, 1997, APPL ENVIRON MICROB, V63, P3724
   Kaplan JB, 2010, J DENT RES, V89, P205, DOI 10.1177/0022034509359403
   Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4692.2003
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545
   Kazmierska Katarzyna A., 2009, Recent Patents on Biomedical Engineering, V2, P1, DOI 10.2174/1874764710902010001
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knappe D, 2010, ANTIMICROB AGENTS CH, V54, P4003, DOI 10.1128/AAC.00300-10
   Koszalka P, 2011, ACTA BIOCHIM POL, V58, P111
   Kristensen JB, 2008, BIOTECHNOL ADV, V26, P471, DOI 10.1016/j.biotechadv.2008.05.005
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Kupferwasser LI, 1999, ANTIMICROB AGENTS CH, V43, P2395, DOI 10.1128/AAC.43.10.2395
   Lamppa JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017042
   Leroy C, 2008, BIOFOULING, V24, P11, DOI 10.1080/08927010701784912
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x
   Lopez-Gallego F, 2005, J BIOTECHNOL, V119, P70, DOI 10.1016/j.jbiotec.2005.05.021
   Maathuis PGM, 2007, BIOMATERIALS MODERN
   Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2
   Mecikoglu M, 2006, J BONE JOINT SURG AM, V88A, P1208, DOI 10.2106/JBJS.E.00007
   Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095
   Minier M, 2005, LANGMUIR, V21, P5957, DOI 10.1021/la0501278
   Mitchell BA, 1998, ANTIMICROB AGENTS CH, V42, P475
   Mohorcic M, 2010, J MATER SCI-MATER M, V21, P2775, DOI 10.1007/s10856-010-4136-z
   Mowery BP, 2007, J AM CHEM SOC, V129, P15474, DOI 10.1021/ja077288d
   Muszanska AK, 2011, BIOMATERIALS, V32, P6333, DOI 10.1016/j.biomaterials.2011.05.016
   Nablo BJ, 2005, BIOMATERIALS, V26, P917, DOI 10.1016/j.biomaterials.2004.03.031
   Nobile CJ, 2007, CURR BIOL, V17, pR349, DOI 10.1016/j.cub.2007.02.035
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Otto M, 2009, CONTRIB MICROBIOL, V16, P136, DOI 10.1159/000219377
   Pavlukhina SV, 2012, ACS APPL MATER INTER, V4, P4708, DOI 10.1021/am3010847
   Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405
   Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023
   Prakash B, 2003, CURR SCI INDIA, V85, P1299
   Ramos R, 2013, BIOTECHNOL PROGR, V29, P17, DOI 10.1002/btpr.1650
   Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Roosjen A, 2006, PROG COLL POL SCI S, V132, P138, DOI 10.1007/2882_026
   Schneeberger PM, 2002, J HOSP INFECT, V51, P179, DOI 10.1053/jhin.2002.1256
   Shafer WM, 1998, P NATL ACAD SCI USA, V95, P1829, DOI 10.1073/pnas.95.4.1829
   SHAFER WM, 1984, INFECT IMMUN, V45, P29
   Shah A, 2004, ANTIMICROB AGENTS CH, V48, P2704, DOI 10.1128/AAC.48.7.2704-2707.2004
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   Shalev T, 2012, J MATER CHEM, V22, P2026, DOI 10.1039/c1jm13994k
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h
   Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#
   Statz AR, 2008, BIOFOULING, V24, P439, DOI 10.1080/08927010802331829
   Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738
   Steven MD, 2008, J APPL POLYM SCI, V110, P2665, DOI 10.1002/app.27638
   Strauss J, 2010, COLLOID SURFACE B, V75, P156, DOI 10.1016/j.colsurfb.2009.08.026
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Swartjes JJTM, 2013, ADV FUNCT MATER, P1
   Tasso M, 2009, MACROMOL BIOSCI, V9, P922, DOI 10.1002/mabi.200900005
   Tew GN, 2002, P NATL ACAD SCI USA, V99, P5110, DOI 10.1073/pnas.082046199
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   Vreuls C, 2010, J MATER CHEM, V20, P8092, DOI 10.1039/c0jm01419b
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   Xavier JB, 2005, MICROBIOL-SGM, V151, P3817, DOI 10.1099/mic.0.28165-0
   Yala JF, 2011, APPL MICROBIOL BIOT, V89, P623, DOI 10.1007/s00253-010-2930-7
   Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4
   Yuan SJ, 2011, LANGMUIR, V27, P2761, DOI 10.1021/la104442f
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 135
TC 57
Z9 59
U1 11
U2 206
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PD APR 21
PY 2014
VL 30
IS 4
BP 483
EP 499
DI 10.1080/08927014.2014.889120
PG 17
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA AE5HS
UT WOS:000334019000009
PM 24666008
DA 2018-10-19
ER

PT J
AU Kubiak, K
   Kurzawa, M
   Jedrzejczak-Krzepkowska, M
   Ludwicka, K
   Krawczyk, M
   Migdalski, A
   Kacprzak, MM
   Loska, D
   Krystynowicz, A
   Bielecki, S
AF Kubiak, Katarzyna
   Kurzawa, Marta
   Jedrzejczak-Krzepkowska, Marzena
   Ludwicka, Karolina
   Krawczyk, Mariusz
   Migdalski, Andrzej
   Kacprzak, Magdalena M.
   Loska, Damian
   Krystynowicz, Alina
   Bielecki, Stanislaw
TI Complete genome sequence of Gluconacetobacter xylinus E25
   strain-Valuable and effective producer of bacterial nanocellulose
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Bacterial nanocellulose; Next generation sequencing (NGS); Cellulose
   synthase operon; Gluconacetobacter xylinus genome
ID ACETOBACTER-XYLINUM; CELLULOSE
AB This study reports the release of complete genome sequence of the producer of bacterial nanocellulose (BNC) - Gluconacetobacter xylinus E25, a vinegar-isolated strain. Preliminary sequence analysis revealed complexity of the genome structure and familiarized genetic basis of productive properties of E25 strain. The genome consists of one chromosome and five plasmids. Whole genome sequencing has opened up new perspectives for further bioinformatics and experimental studies allowing the elucidation of molecular mechanisms responsible for regulation of production of BNC - a valuable biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kubiak, Katarzyna; Kurzawa, Marta; Jedrzejczak-Krzepkowska, Marzena; Ludwicka, Karolina; Krystynowicz, Alina; Bielecki, Stanislaw] Lodz Univ Technol, Inst Tech Biochem, PL-90924 Lodz, Poland.
   [Krawczyk, Mariusz; Migdalski, Andrzej; Kacprzak, Magdalena M.; Loska, Damian] Genomed SA, PL-02971 Warsaw, Poland.
   [Krawczyk, Mariusz; Loska, Damian] Polish Japanese Inst Informat Technol, PL-02008 Warsaw, Poland.
RP Kubiak, K (reprint author), Lodz Univ Technol, Inst Tech Biochem, Stefanowskiego 4-10, PL-90924 Lodz, Poland.
EM katarzyna.kubiak@p.lodz.pl
RI Kacprzak, Michal/S-9714-2016
OI Kubiak, Katarzyna/0000-0003-3815-1712
FU European Community from the European Social Fund within the INTERKADRA
   project
FX Part of this work was financially supported by the European Community
   from the European Social Fund within the INTERKADRA project.
CR Andres J, 2013, GENOME BIOL EVOL, V5, P934, DOI 10.1093/gbe/evt061
   Brown A. J., 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Chevreux B., 1999, COMPUTER SCIENCE AND, V99, P45
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Finan TM, 2001, P NATL ACAD SCI USA, V98, P9889, DOI 10.1073/pnas.161294698
   Gama M, 2013, PERSPECT NANOTECHNOL, P1
   Hu SQ, 2010, P NATL ACAD SCI USA, V107, P17957, DOI 10.1073/pnas.1000601107
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Iyer PR, 2010, J BACTERIOL, V192, P4256, DOI 10.1128/JB.00588-10
   Koo HM, 1998, BIOSCI BIOTECH BIOCH, V62, P2257, DOI 10.1271/bbb.62.2257
   Kowalska-Ludwicka K, 2013, ARCH MED SCI, V9, P527, DOI 10.5114/aoms.2013.33433
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   Mazur A, 2013, ARCH MICROBIOL, V195, P255, DOI 10.1007/s00203-013-0874-x
   Ogino H, 2011, J BACTERIOL, V193, P6997, DOI 10.1128/JB.06158-11
   SAXENA IM, 1994, J BACTERIOL, V176, P5735
   Shelud'ko AV, 2012, FOLIA MICROBIOL, V57, P5, DOI 10.1007/s12223-011-0074-5
   Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361
   Weidner S., 2013, GENOME ANNOUNC, V1, DOI [DOI 10.1128/GENOMEA.00013-12, 10.1128/genomeA.00013-12]
   Yasutake Y, 2006, PROTEINS, V64, P1069, DOI 10.1002/prot.21052
   Yu CG, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-52
NR 20
TC 17
Z9 17
U1 1
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD APR 20
PY 2014
VL 176
BP 18
EP 19
DI 10.1016/j.jbiotec.2014.02.006
PG 2
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AD8SA
UT WOS:000333534700003
PM 24556328
DA 2018-10-19
ER

PT J
AU Achak, M
   Hafidi, A
   Mandi, L
   Ouazzani, N
AF Achak, M.
   Hafidi, A.
   Mandi, L.
   Ouazzani, N.
TI Removal of phenolic compounds from olive mill wastewater by adsorption
   onto wheat bran
SO DESALINATION AND WATER TREATMENT
LA English
DT Article
DE Wheat bran; Adsorption; Phenolic compounds; Olive mill wastewaters;
   Desorption
ID AQUEOUS-SOLUTIONS; ACTIVATED CARBON; LIQUID-PHASE; SUBSTANCES;
   ISOTHERMS; SLURRY
AB The use of wheat bran for the removal of phenolic compounds from olive mill wastewater (OMW) at different adsorbent doses (10-60g/L), pH (3-11), and contact time (0.25-24h) was investigated. Our findings demonstrate that wheat bran, an inexpensive and easily available biomaterial, can be an alternative for the more costly adsorbents used for the removal of phenolic compounds from OMW. Increase in the wheat bran dosage from 10 to 50g/L significantly increased the phenolic compounds adsorption rate from 45 to 67%. Increase in pH to high alkalinity resulted in an increase in the phenolic compounds' adsorption capacity. The adsorption process was found to be relatively fast, and it reached equilibrium in 4h of contact time. The Freundlich and Langmuir adsorption models were used for the mathematical description of the adsorption equilibrium and it was found that the experimental data fitted very well in the Freundlich model. Batch adsorption models based on the assumption of the pseudo-first-order, pseudo-second-order, and intraparticle diffusion mechanism were applied to examine the kinetics of the adsorption. The results showed that kinetic data followed more closely the pseudo-second-order model, than the pseudo-first-order and intraparticle diffusion. Desorption studies showed that at low pH value, the desorption of phenolic compounds was efficient.
C1 [Achak, M.; Mandi, L.; Ouazzani, N.] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Hydrobiol Ecotoxicol & Assainissment, Marrakech 2390, Morocco.
   [Mandi, L.; Ouazzani, N.] Univ Cadi Ayyad, Ctr Natl Etud & Rech Eau & Energie, Marrakech 40000, Morocco.
   [Hafidi, A.] Univ Cadi Ayyad, Fac Sci Semlalia, Lab Sci Aliments, Marrakech 2390, Morocco.
RP Ouazzani, N (reprint author), Univ Cadi Ayyad, Fac Sci Semlalia, Lab Hydrobiol Ecotoxicol & Assainissment, Blvd Prince Moulay Abdelah, Marrakech 2390, Morocco.
EM ouazzani@ucam.ac.ma
OI Hafidi, Abdellatif/0000-0002-6439-8340
FU pole of competences of Water and Environment (PC2E); PROTARS II [34 2005
   - 2010]; European project, FP7 SOWAEUMED (Network in Solid Waste and
   Water Treatment between Europe and Mediterranean Countries) [245843]
FX This work was supported by:; The pole of competences of Water and
   Environment (PC2E).; PROTARS II contract No 34 2005 - 2010.; European
   project, FP7 SOWAEUMED (Network in Solid Waste and Water Treatment
   between Europe and Mediterranean Countries, Contract No 245843).
CR Achak M, 2009, J HAZARD MATER, V166, P117, DOI 10.1016/j.jhazmat.2008.11.036
   Achak M., 2008, REV SCI EAU, V21, P53
   AFNOR, 1983, REC NORM FRANC EAU M, P621
   Ahmaruzzaman M, 2005, J COLLOID INTERF SCI, V287, P14, DOI 10.1016/j.jcis.2005.01.075
   Aksu Z, 2001, WASTE MANAGE, V21, P695, DOI 10.1016/S0956-053X(01)00006-X
   Allouche N, 2004, J AGR FOOD CHEM, V52, P267, DOI 10.1021/jf034944u
   APHA, 1992, STAND METH AN WAST W
   Balicen V., 1984, GRASAS ACEITES, V25, P178
   Banat F, 2004, CHEM ENG TECHNOL, V27, P80, DOI 10.1002/ceat.200401868
   Bhatnagar A, 2007, J HAZARD MATER, V139, P93, DOI 10.1016/j.jhazmat.2006.06.139
   BOX JD, 1983, WATER RES, V17, P511, DOI 10.1016/0043-1354(83)90111-2
   Brenes M, 1999, J AGR FOOD CHEM, V47, P3535, DOI 10.1021/jf990009o
   Calace N, 2002, ENVIRON POLLUT, V118, P315, DOI 10.1016/S0269-7491(01)00303-7
   Cichelli A, 1984, RIV MERCEOL, V22, P55
   Dabrowski A, 2005, CHEMOSPHERE, V58, P1049, DOI 10.1016/j.chemosphere.2004.09.067
   Din ATM, 2009, J HAZARD MATER, V161, P1522, DOI 10.1016/j.jhazmat.2008.05.009
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Dursun G, 2005, J HAZARD MATER, V125, P175, DOI 10.1016/j.jhazmat.2005.05.023
   Garcia-Araya JF, 2003, ADSORPTION, V9, P107, DOI 10.1023/A:1024228708675
   Goud V. V., 2005, CHEM ENG TECHNOL, V28, P814, DOI 10.1002/(ISSN)1521-4125
   Ho S., 2002, PROCESS BIOCHEM, V37, P1421
   HUNT GM, 1980, PHYTOCHEMISTRY, V19, P1415, DOI 10.1016/0031-9422(80)80185-3
   Iqbal Y., 2005, INT J ENVIRON STUD, V62, P47, DOI 10.1080/ 0020723042000253875
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Laszlo K, 2003, LANGMUIR, V19, P5287, DOI 10.1021/la026761s
   Li H, 2004, CHROMATOGRAPHIA, V60, P425, DOI 10.1365/s10337-004-0403-9
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   NAMASIVAYAM C, 1992, J CHEM TECHNOL BIOT, V53, P153
   NAMASIVAYAM C, 1992, WATER AIR SOIL POLL, V65, P101, DOI 10.1007/BF00482752
   Ozer A, 1997, PROCESS BIOCHEM, V32, P319, DOI 10.1016/S0032-9592(96)00091-X
   Ranalli A., 1991, OLIVAE, V37, P30
   Razmkhab S, 2002, J AGR FOOD CHEM, V50, P7432, DOI 10.1021/jf025733c
   Richard D, 2009, CHEM ENG J, V148, P1, DOI 10.1016/j.cej.2008.07.023
   RODIER J, 1984, ANAL EAU EAUX NATURE, P1365
   Sathishkumar M, 2007, BIORESOURCE TECHNOL, V98, P866, DOI 10.1016/j.biortech.2006.03-002
   Stasinakis AS, 2008, J HAZARD MATER, V160, P408, DOI 10.1016/j.jhazmat.2008.03.012
   Sthishkumar M., 2007, BIORESOURCE TECHNOL, V98, P866
   Thawornchaisit U, 2007, BIORESOURCE TECHNOL, V98, P140, DOI 10.1016/j.biortech.2005.11.004
   Vazequez-Roncero A., 1974, GRASAS ACEITES, V25, P341
   Vazquez I, 2007, J HAZARD MATER, V147, P395, DOI 10.1016/j.jhazmat.2007.01.019
   Vinciguerra V., 1993, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V58, P1811
   Wagner H., 1984, PLANT DRUG ANAL, P42
   Wang SB, 2005, CHEMOSPHERE, V60, P1401, DOI 10.1016/j.chemosphere.2005.01.091
   Xiaoli C., 2006, J HAZARD MAT B, VB137, P410
   Zenjari B., 1999, AGROCHEM, VXLIII1, P276
   Zhou ML, 1998, WATER RES, V32, P1109, DOI 10.1016/S0043-1354(96)00148-0
NR 46
TC 9
Z9 9
U1 0
U2 16
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 520 CHESTNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1944-3994
EI 1944-3986
J9 DESALIN WATER TREAT
JI Desalin. Water Treat.
PD APR 16
PY 2014
VL 52
IS 13-15
BP 2875
EP 2885
DI 10.1080/19443994.2013.819166
PG 11
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA AE3NY
UT WOS:000333884400061
DA 2018-10-19
ER

PT J
AU Picaud, L
   Thibault, B
   Mery, E
   Ouali, M
   Martinez, A
   Delord, JP
   Couderc, B
   Ferron, G
AF Picaud, Laetitia
   Thibault, Benoit
   Mery, Eliane
   Ouali, Monia
   Martinez, Alejandra
   Delord, Jean-Pierre
   Couderc, Bettina
   Ferron, Gwenael
TI Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose
   barrier on ovarian tumor progression
SO JOURNAL OF OVARIAN RESEARCH
LA English
DT Article
DE Ovarian adenocarcinoma; Surgery; Anti-adhesion membranes; Hyaluronic
   acid
ID HA-CMC BARRIER; CANCER CELLS; IN-VITRO; GYNECOLOGIC MALIGNANCIES;
   MEMBRANE SEPRAFILM; ADHESION FORMATION; MEDIATED MOTILITY;
   MOLECULAR-WEIGHT; CD44; METASTASIS
AB Background: Hyaluronic acid is a prognostic factor in ovarian cancers. It is also a component of Hyaluronic Acid-Carboxymethyl Cellulose (HA-CMC) barrier, an anti-adhesion membrane widely used during abdominal surgeries in particular for ovarian carcinosis. 70% of patients who undergo ovarian surgery will relapse due to the persistence of cancer cells. This study's objective was to determine the oncological risk from use of this material, in the presence of residual disease, despite the benefit gained by it decreasing post-surgical adhesions in order to provide an unambiguous assessment of its appropriateness for use in ovarian surgical management.
   Methods: We assessed the effects of HA-CMC barrier on the in vitro proliferation of human ovarian tumor cell lines (OVCAR-3, IGROV-1 and SKOV-3). We next evaluated, in vivo in nude mice, the capacity of this biomaterial to regulate the tumor progression of subcutaneous and intraperitoneal models of ovarian tumor xenografts.
   Results: We showed that HA-CMC barrier does not increase in vitro proliferation of ovarian cancer cell lines compared to control. In vivo, HA-CMC barrier presence with subcutaneous xenografts induced neither an increase in tumor volume nor cell proliferation (Ki67 and mitotic index). With the exception of an increased murine carcinosis score in peritoneum, the presence of HA-CMC barrier with intraperitoneal xenografts modified neither macro nor microscopic tumor growth. Finally, protein analysis of survival (Akt), proliferation (ERK) and adhesion (FAK) pathways highlighted no activation on the xenografts imputable to HA-CMC barrier.
   Conclusions: For the most part, our results support the lack of tumor progression activation due to HA-CMC barrier. We conclude that the benefits gained from using HA-CMC barrier membrane during ovarian cancer surgeries seem to outweigh the potential oncological risks.
C1 [Picaud, Laetitia; Thibault, Benoit; Mery, Eliane; Delord, Jean-Pierre; Couderc, Bettina; Ferron, Gwenael] Inst Claudius Regaud, EA4553, F-31052 Toulouse, France.
   [Picaud, Laetitia; Martinez, Alejandra; Ferron, Gwenael] Inst Claudius Regaud, Dept Surg, F-31052 Toulouse, France.
   [Ouali, Monia] Inst Claudius Regaud, Biostat Unit, F-31052 Toulouse, France.
   [Delord, Jean-Pierre; Couderc, Bettina] Univ Toulouse 3, F-31062 Toulouse, France.
RP Couderc, B (reprint author), Inst Claudius Regaud, EA4553, 20-24 Rue Pont St Pierre, F-31052 Toulouse, France.
EM couderc.bettina@claudiusregaud.fr
RI Mery-Lamarche, Eliane/P-2795-2014; Martinez, Alejandra/A-4097-2015;
   Couderc, Bettina/P-1576-2014; Ferron, Gwenael/P-6193-2014; Thibault,
   Benoit/A-1682-2016; DELORD, Jean-Pierre/I-8866-2014
OI Mery-Lamarche, Eliane/0000-0002-0354-4519; Martinez,
   Alejandra/0000-0002-7633-3536; Couderc, Bettina/0000-0002-4530-5508;
   Ferron, Gwenael/0000-0002-8545-4700; Thibault,
   Benoit/0000-0003-3250-1988; DELORD, Jean-Pierre/0000-0001-7305-5561
FU Groupe de Recherche Institut Claudius Regaud
FX We are grateful to the Groupe de Recherche Institut Claudius Regaud for
   the grant support. We are grateful to Lourdes Gasquet and Jocelyne
   Meilhon at the animal facility. The manuscript was revised by
   Angloscribe (Clarensac) for English language editing.
CR Anttila MA, 2000, CANCER RES, V60, P150
   Bae DS, 2013, J KOREAN SURG SOC, V85, P199, DOI 10.4174/jkss.2013.85.5.199
   Baiocchi G, 2011, J SURG ONCOL, V104, P250, DOI 10.1002/jso.21940
   Bashir S, 2013, DIS COLON RECTUM, V56, P1174, DOI 10.1097/DCR.0b013e31829ec889
   Bourdel N, 2008, J MINIM INVAS GYN, V15, P321, DOI 10.1016/j.jmig.2008.02.004
   Bourguignon LYW, 2007, J BIOL CHEM, V282, P1265, DOI 10.1074/jbc.M604672200
   Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200
   Bristow RE, 2005, GYNECOL ONCOL, V99, P301, DOI 10.1016/j.ygyno.2005.06.057
   Bristow RE, 2007, GYNECOL ONCOL, V104, P739, DOI 10.1016/j.ygyno.2006.09.029
   CANNISTRA SA, 1993, CANCER RES, V53, P3830
   Carpenter PM, 2003, ANTICANCER RES, V23, P3985
   Chereau E, 2009, B CANCER, V96, P1189, DOI 10.1684/bdc.2009.0985
   Diamond MP, 2012, GYNECOL SURG, V9, P237, DOI 10.1007/s10397-012-0741-9
   Gardner MJ, 1996, CLIN EXP METASTAS, V14, P325, DOI 10.1007/BF00123391
   Gladieff L, 2009, B CANCER, V96, P1235, DOI 10.1684/bdc.2009.0982
   Hiltunen ELJ, 2002, CANCER RES, V62, P6410
   Hubbard SC, 2002, DIS COLON RECTUM, V45, P334
   Hubbard SC, 2002, DIS COLON RECTUM, V45, P341
   JONES LMH, 1995, CLIN EXP METASTAS, V13, P373
   Kayastha S, 1999, CLIN CANCER RES, V5, P1073
   Kouvidi K, 2011, J BIOL CHEM, V286, P38509, DOI 10.1074/jbc.M111.275875
   Krill LS, 2011, GYNECOL ONCOL, V120, P220, DOI 10.1016/j.ygyno.2010.10.037
   Kusunoki M, 2005, SURG TODAY, V35, P940, DOI 10.1007/s00595-005-3061-0
   Leitao MM, 2010, GYNECOL ONCOL, V119, P208, DOI 10.1016/j.ygyno.2010.07.027
   Li CZ, 2008, FOLIA BIOL-PRAGUE, V54, P180
   Misra S, 2011, FEBS J, V278, P1429, DOI 10.1111/j.1742-4658.2011.08071.x
   Mizrahy S, 2011, J CONTROL RELEASE, V156, P231, DOI 10.1016/j.jconrel.2011.06.031
   Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102
   Oikonomakis L, 2002, DIS COLON RECTUM, V45, P1376, DOI 10.1097/01.DCR.0000029589.75029.17
   Pucciarelli S, 2003, BRIT J SURG, V90, P66, DOI 10.1002/bjs.4006
   Ricciardelli C, 2006, SEMIN REPROD MED, V24, P270, DOI 10.1055/s-2006-948556
   Tabata T, 2010, INT J GYNECOL CANCER, V20, P188, DOI 10.1111/IGC.0b013e3181c7fe84
   Tan A, 2009, ANN SURG ONCOL, V16, P499, DOI 10.1245/s10434-008-0235-1
   Tan B, 2001, BRIT J SURG, V88, P246, DOI 10.1046/j.1365-2168.2001.01664.x
   Thibault B, 2013, CANCER METAST REV, V33, P17, DOI DOI 10.1007/S10555-013-9456-2
   Ward BC, 2011, J SURG RES, V165, P91, DOI 10.1016/j.jss.2009.09.015
   Ween MP, 2011, CLIN EXP METASTAS, V28, P113, DOI 10.1007/s10585-010-9363-7
   Yabushita H, 2004, ONCOL REP, V12, P739
NR 38
TC 6
Z9 7
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1757-2215
J9 J OVARIAN RES
JI J. Ovarian Res.
PD APR 16
PY 2014
VL 7
AR 40
DI 10.1186/1757-2215-7-40
PG 12
WC Reproductive Biology
SC Reproductive Biology
GA AF7DO
UT WOS:000334873900001
PM 24739440
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Sah, MK
   Pramanik, K
AF Sah, Mahesh Kumar
   Pramanik, Krishna
TI Soluble-Eggshell-Membrane-Protein-Modified Porous Silk Fibroin Scaffolds
   with Enhanced Cell Adhesion and Proliferation Properties
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biocompatibility; bioengineering; biomaterials; porous materials;
   properties and characterization
ID TISSUE ENGINEERING-SCAFFOLD; IN-VITRO; BIOMATERIAL SCAFFOLDS;
   MECHANICAL-PROPERTIES; SURFACE MODIFICATION; POLYMER SCAFFOLDS; MATRIX
   PROTEINS; CROSS-LINKING; EGG-SHELL; CARTILAGE
AB In this study, a porous silk fibroin (SF) scaffold was modified with soluble eggshell membrane protein (SEP) with the aim of improving the cell affinity properties of the scaffold for tissue regeneration. The pore size and porosity of the prepared scaffold were in the ranges 200-300 m and 85-90%, respectively. The existence of SEP on the scaffold surface and the structural and thermal stability were confirmed by energy-dispersive X-ray spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy, differential scanning calorimetry, and thermogravimetric analysis. The cell culture study indicated a significant improvement in the cell adhesion and proliferation of mesenchymal stem cells (MSCs) on the SF scaffold modified with SEP. The cytocompatibility of the SEP-conjugated SF scaffold was confirmed by a 3-(4,5-dimethyltriazol-2-y1)-2,5-diphenyl tetrazolium assay. Thus, this study demonstrated that the biomimic properties of the scaffold could be enhanced by surface modification with SEP. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 40138.
C1 [Sah, Mahesh Kumar; Pramanik, Krishna] Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, India.
RP Pramanik, K (reprint author), Natl Inst Technol, Dept Biotechnol & Med Engn, Rourkela 769008, India.
EM kpr@nitrkl.ac.in
RI Pramanik, Krishna/M-3729-2018
OI Pramanik, Krishna/0000-0002-5676-7740
FU National Institute of Technology (Rourkela, India)
FX The authors are thankful to the Department of Biotechnology (New Delhi,
   India) and the Government of India for providing the research facility
   and the National Institute of Technology (Rourkela, India) for providing
   a fellowship to one of the authors.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Ahlborn G, 2005, POULTRY SCI, V84, P1935, DOI 10.1093/ps/84.12.1935
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Araki Y, 2001, ENDOSCOPY, V33, P85, DOI 10.1055/s-2001-11178
   BAKER J. R., 1962, BIOCHEM JOUR, V82, P352
   Burdick JA, 2011, BIOMATERIALS FOR TISSUE ENGINEERING APPLICATIONS: A REVIEW OF THE PAST AND FUTURE TRENDS, P1, DOI 10.1007/978-3-7091-0385-2_1
   Burley R. W., 1989, AVIAN EGG CHEM BIOL, P472
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Carrino DA, 1996, CONNECT TISSUE RES, V35, P325, DOI 10.3109/03008209609029207
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   CORY AH, 1991, CANCER COMMUN, V3, P207
   CROMBIE G, 1981, BIOCHIM BIOPHYS ACTA, V640, P365, DOI 10.1016/0005-2736(81)90560-5
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Dobkowski J, 1999, J BIOMED MATER RES, V47, P234, DOI 10.1002/(SICI)1097-4636(199911)47:2<234::AID-JBM14>3.0.CO;2-X
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Gil ES, 2007, MAT SCI ENG C-BIO S, V27, P426, DOI 10.1016/j.msec.2006.05.017
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jung H, 2008, COLLOID SURFACE A, V313, P562, DOI 10.1016/j.colsurfa.2007.05.070
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HM, 1999, J BIOMED MATER RES, V46, P228, DOI 10.1002/(SICI)1097-4636(199908)46:2<228::AID-JBM12>3.0.CO;2-J
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kodali VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018187
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEACH RM, 1981, ARCH BIOCHEM BIOPHYS, V207, P353, DOI 10.1016/0003-9861(81)90042-4
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Lu Q, 2007, BIOMATERIALS, V28, P2306, DOI 10.1016/j.biomaterials.2007.01.031
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MA PX, 2005, ENCY POLYM SCI TECHN, V12, P261
   MAEDA K, 1982, BURNS, V8, P313, DOI 10.1016/0305-4179(82)90029-8
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mayer J, 2000, J CONTROL RELEASE, V64, P81, DOI 10.1016/S0168-3659(99)00136-4
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakano T, 2003, POULTRY SCI, V82, P510, DOI 10.1093/ps/82.3.510
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nys Y, 2001, WORLD POULTRY SCI J, V57, P401, DOI 10.1079/WPS20010029
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Oki A, 2006, MATER LETT, V60, P2751, DOI 10.1016/j.matlet.2006.01.084
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Remy M, 1999, BIOMATERIALS, V20, P241, DOI 10.1016/S0142-9612(98)00167-7
   Rice MA, 2005, OTOLARYNG CLIN N AM, V38, P199, DOI 10.1016/j.otc.2004.10.010
   Rose MLH, 2009, CELL MOL LIFE SCI, V66, P2707, DOI 10.1007/s00018-009-0046-y
   Sah MK, 2011, AFR J BIOTECHNOL, V10, P7878
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   SUREWICZ WK, 1988, BIOCHIM BIOPHYS ACTA, V952, P115, DOI 10.1016/0167-4838(88)90107-0
   SUYAMA K, 1977, J AGR FOOD CHEM, V25, P799, DOI 10.1021/jf60212a045
   Takahashi K, 1996, BIOSCI BIOTECH BIOCH, V60, P1299, DOI 10.1271/bbb.60.1299
   TAVASSOLI M, 1983, EXPERIENTIA, V39, P411, DOI 10.1007/BF01963153
   Torres FG, 2007, COMPOS SCI TECHNOL, V67, P1139, DOI 10.1016/j.compscitech.2006.05.018
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Wang JL, 2011, COLLOID SURFACE B, V85, P241, DOI 10.1016/j.colsurfb.2011.02.035
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wilson A. P, 2000, ANIMAL CELL CULTURE, P175
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
   Yaylaoglu MB, 1999, BIOMATERIALS, V20, P1513, DOI 10.1016/S0142-9612(99)00062-9
   Yi F, 2004, BIOMATERIALS, V25, P4591, DOI 10.1016/j.biomaterials.2003.11.052
   Yi F, 2003, MACROMOL BIOSCI, V3, P234, DOI 10.1002/mabi.200390030
   Zund G, 1999, EUR J CARDIO-THORAC, V15, P519, DOI 10.1016/S1010-7940(99)00068-8
NR 71
TC 8
Z9 8
U1 5
U2 42
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD APR 15
PY 2014
VL 131
IS 8
AR 40138
DI 10.1002/app.40138
PG 11
WC Polymer Science
SC Polymer Science
GA AE2MC
UT WOS:000333806100066
DA 2018-10-19
ER

PT J
AU Zang, SS
   Zhuo, Q
   Chang, X
   Qiu, GX
   Wu, ZH
   Yang, G
AF Zang, Shanshan
   Zhuo, Qi
   Chang, Xiao
   Qiu, Guixing
   Wu, Zhihong
   Yang, Guang
TI Study of osteogenic differentiation of human adipose-derived stem cells
   (HASCs) on bacterial cellulose
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Bacterial cellulose; Human adipose-derived stem cells; Bone tissue
   engineering; Biomaterials; Artificial scaffold
ID BIOMEDICAL APPLICATIONS; EXTRACELLULAR-MATRIX; MICROBIAL CELLULOSE;
   GENE-EXPRESSION; BONE-MARROW; TISSUE; HYDROXYAPATITE; NANOCOMPOSITES;
   CARTILAGE; BIOCOMPATIBILITY
AB Bacterial cellulose (BC) has been proposed as a biomaterial applied in biomedical scope due to its good biocompatibility. Recent reports showed that human adipose-derived stem cells (HASCs) have become a new choice to be used as seeding cells in tissue engineering. The objective of this study is to explore the potential of using BC and HASCs as scaffold and seeding cells in bone tissue engineering. The osteogenic differentiation was investigated by Von Kossa, Alizarin Red, ALP cellular staining and RT-PCR. The results showed that HASCs took a successful osteogenic differentiation on BC. Moreover, the in vivo animal test also provided the confirmation of the repair ability of BC on damaged bone. In conclusion, the author demonstrates the osteogenic differentiation of HASCs on BC and the feasibility of using BC and HASCs as scaffold and seeding cells in bone tissue engineering. Crown Copyright (C) 2014 Published by Elsevier Ltd. All rights reserved.
C1 [Zang, Shanshan; Yang, Guang] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China.
   [Zhuo, Qi] Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed Surg, Beijing 100853, Peoples R China.
   [Chang, Xiao; Qiu, Guixing; Wu, Zhihong] Peking Union Med Coll, Dept Orthopaed, Beijing 100730, Peoples R China.
RP Wu, ZH (reprint author), Peking Union Med Coll, Dept Orthopaed, Beijing 100730, Peoples R China.
EM wuzh3000@126.com; yang_sunny@yahoo.com
OI Qiu, Guixing/0000-0002-4597-9350
FU National Natural Science Foundation of P.R. China [21074041, 81201404]
FX This work was supported by the National Natural Science Foundation of
   P.R. China (21074041, 81201404).
CR Aravamudhan A, 2013, J BIOMED NANOTECHNOL, V9, P719, DOI 10.1166/jbn.2013.1574
   Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Coelho MJ, 2000, BIOMATERIALS, V21, P1095, DOI 10.1016/S0142-9612(99)00192-1
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Fu LN, 2012, J MATER CHEM, V22, P12349, DOI 10.1039/c2jm00134a
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Hu YY, 2011, CHEM MATER, V23, P2481, DOI 10.1021/cm200355n
   Huang JI, 2002, PLAST RECONSTR SURG, V109, P1033, DOI 10.1097/00006534-200203000-00037
   Hutchens SA, 2006, BIOMATERIALS, V27, P4661, DOI 10.1016/j.biomaterials.2006.04.032
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Izadpanah R, 2006, J CELL BIOCHEM, V99, P1285, DOI 10.1002/jcb.20904
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Mizuno H, 2002, PLAST RECONSTR SURG, V109, P199, DOI 10.1097/00006534-200201000-00030
   Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371
   OWEN M, 1988, CIBA F SYMP, V136, P42
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schlichting KE, 2011, ACTA BIOMATER, V7, P3094, DOI 10.1016/j.actbio.2011.04.010
   Shi ZJ, 2012, RSC ADV, V2, P1040, DOI 10.1039/c1ra00719j
   Sommerfeldt DW, 2001, EUR SPINE J, V10, pS86, DOI 10.1007/s005860100283
   Stylios G, 2007, INJURY, V38, pS63, DOI 10.1016/j.injury.2007.02.011
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wang Q, 2011, J BIOMED MATER RES A, V96A, P520, DOI 10.1002/jbm.a.33000
   Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 45
TC 7
Z9 8
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 15
PY 2014
VL 104
BP 158
EP 165
DI 10.1016/j.carbpol.2014.01.019
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AE2FC
UT WOS:000333787700022
PM 24607173
DA 2018-10-19
ER

PT J
AU Chetibi, L
   Hamana, D
   Achour, S
AF Chetibi, Loubna
   Hamana, Djamel
   Achour, Slimane
TI Growth and characterization of hydroxyapatite nanorice on TiO2
   nanofibers
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Biomaterial; XPS; SEM; TEM; Electron probe; Corrosion
ID SIMULATED BODY-FLUID; ELECTROPHORETIC DEPOSITION; TITANIUM SUBSTRATE;
   COATINGS; SURFACE; ELECTRODEPOSITION; NANOTUBES; OXIDATION; CORROSION;
   ALLOY
AB Hydroxyapatite (HA) coating with nanoparticles like nanorice is fabricated on chemically pretreated titanium (Ti) surface, through an electrochemical deposition approach, for biomaterial applications. The Ti surface was chemically patterned with anatase TiO2 nanofibers. These nanofibers were prepared by in situ oxidation of Ti foils in a concentrated solution of H2O2 and NaOH, followed by proton exchange and calcinations. Afterward, TiO2 nanofibers on Ti substrate were coated with HA nanoparticles like nanorice. The obtained samples were annealed at high temperature to produce inter diffusion between TiO2 and HA layers. The resultant layers were characterized by Scanning Electron Microscopy (SEM), Transmission Electron Microscopy (TEM), X-ray Photoelectron Spectroscopy (XPS), X-ray Diffraction (XRD), Infrared Spectroscopy (FTIR), corrosion tests in SBF solution, and Electron Probe Micro Analysis (EPMA). It was found that only Ti from the titanium substrate diffuses into the HA coating and a good corrosion resistance in simulated body fluid was obtained. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Chetibi, Loubna; Hamana, Djamel] Univ Constantine, Unit Mat Sci & Applicat, Constantine 25000, Algeria.
   [Achour, Slimane] Univ Constantine, Ceram Lab, Constantine 25000, Algeria.
RP Achour, S (reprint author), Univ Constantine, Ceram Lab, Constantine 25000, Algeria.
EM Ch_loubna@hotmail.com; d_hamana@yahoo.fr; achourslimane11@yahoo.fr
FU King Abdullah University of Science and Technology (KAUST)
FX The authors acknowledge C. Sahraoui from King Abdullah University of
   Science and Technology (KAUST) for his funding and assistance in
   analysis.
CR Abidov A., 2013, J MAT MECH MANUF, V1, P294
   Advincula MC, 2007, J BIOMED MATER RES B, V80B, P107, DOI 10.1002/jbm.b.30575
   Afshar A, 2006, MAT SCI ENG B-SOLID, V128, P243, DOI 10.1016/j.mseb.2005.11.022
   Anselme K., 2011, J OSTEOPOROS INT, V22, P2037
   Armstong A.R., 2004, J CHEM INT EDN, V43, P2286
   BAN S, 1993, JPN J APPL PHYS 2, V32, pL1577, DOI 10.1143/JJAP.32.L1577
   Belyakov AV, 1997, GLASS CERAM+, V54, P317, DOI 10.1007/BF02765866
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Chern Lin J.H., 1995, J MAT CHEM PHYS, V41, P282
   Conforto E, 2008, ACTA BIOMATER, V4, P1934, DOI 10.1016/j.actbio.2008.05.001
   Dreyer DR, 2010, CHEM SOC REV, V39, P228, DOI 10.1039/b917103g
   Fan HY, 2012, APPL CATAL B-ENVIRON, V119, P49, DOI 10.1016/j.apcatb.2012.02.016
   Gu YW, 2004, BIOMATERIALS, V25, P4127, DOI 10.1016/j.biomaterials.2003.11.030
   HAYASHI K, 1990, J BIOMED MATER RES, V24, P1111, DOI 10.1002/jbm.820240813
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Kasuga T, 1999, ADV MATER, V11, P1307, DOI 10.1002/(SICI)1521-4095(199910)11:15<1307::AID-ADMA1307>3.0.CO;2-H
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kunze J, 2008, ELECTROCHIM ACTA, V53, P6995, DOI 10.1016/j.electacta.2008.01.027
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Laik A, 2006, METALL MATER TRANS A, V37A, P2919, DOI 10.1007/s11661-006-0173-0
   Langer R., 2004, J NAT, P428
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Macwan DP, 2011, J MATER SCI, V46, P3669, DOI 10.1007/s10853-011-5378-y
   Mohan L, 2012, CERAM INT, V38, P3435, DOI 10.1016/j.ceramint.2011.12.056
   Okido M, 2002, SOLID STATE IONICS, V151, P47, DOI 10.1016/S0167-2738(02)00603-3
   Park JH, 2005, SURF COAT TECH, V195, P252, DOI 10.1016/j.surfcoat.2004.08.185
   Park JH, 2006, MATER LETT, V60, P2573, DOI 10.1016/j.matlet.2005.07.091
   Rath PC, 2012, CERAM INT, V38, P3209, DOI 10.1016/j.ceramint.2011.12.026
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   Scanlon DO, 2013, NAT MATER, V12, P798, DOI [10.1038/NMAT3697, 10.1038/nmat3697]
   Shashwat S.B., 2011, J ADV BIOMATER, V13, P11
   Shaylin S., 2012, J ACTA BIOMATER, V8, P20
   Sobon G, 2012, OPT EXPRESS, V20, P19463, DOI 10.1364/OE.20.019463
   Souto RM, 2003, BIOMATERIALS, V24, P4213, DOI 10.1016/S0142-9612(03)00362-4
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Voigts F, 2009, SURF SCI, V603, P40, DOI 10.1016/j.susc.2008.10.016
   Wang LQ, 1995, SURF SCI, V344, P237, DOI 10.1016/0039-6028(95)00859-4
   Wang YQ, 2008, T NONFERR METAL SOC, V18, P631, DOI 10.1016/S1003-6326(08)60110-7
   Wang ZW, 2011, CURR APPL PHYS, V11, P1405, DOI 10.1016/j.cap.2011.04.011
   Wu Y, 2009, J NANOTECHNOL, V20
   Xiao XF, 2006, SURF COAT TECH, V200, P4406, DOI 10.1016/j.surfcoat.2005.02.205
   Xiaoli J., 2012, INT J MOL SCI, V13, P5242
   Yan XB, 2006, J PHYS CHEM B, V110, P25844, DOI 10.1021/jp065434g
   Yao ZQ, 2010, ACTA BIOMATER, V6, P2816, DOI 10.1016/j.actbio.2009.12.053
   Yingchao S., 2012, I J ELECTROCHEM SCI, V7, P11497
   Yoshida R, 2005, J SOLID STATE CHEM, V178, P2179, DOI 10.1016/j.jssc.2005.04.025
   You CK, 2001, J SOL-GEL SCI TECHN, V21, P49, DOI 10.1023/A:1011253431489
   Zhang BK, 2011, J MATER SCI-MATER M, V22, P2249, DOI 10.1007/s10856-011-4416-2
   Zhang ZT, 2002, MATER RES SOC SYMP P, V703, P291
   Zhao XH, 2009, CHINESE J CHEM ENG, V17, P667, DOI 10.1016/S1004-9541(08)60261-X
   Zhu L, 2006, J BIOMED MATER RES A, V78A, P515, DOI 10.1002/jbm.e.30745
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 53
TC 6
Z9 6
U1 2
U2 49
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD APR 15
PY 2014
VL 144
IS 3
BP 301
EP 309
DI 10.1016/j.matchemphys.2013.12.037
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AD8CF
UT WOS:000333493400013
DA 2018-10-19
ER

PT J
AU Franca, R
   Samani, TD
   Bayade, G
   Yahia, L
   Sacher, E
AF Franca, Rodrigo
   Samani, Taraneh Djavanbakht
   Bayade, Ghislaine
   Yahia, L'Hocine
   Sacher, Edward
TI Nanoscale surface characterization of biphasic calcium phosphate, with
   comparisons to calcium hydroxyapatite and p-tricalcium phosphate
   bioceramics
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Biphasic calcium phosphate; FTIR; Hydroxyapatite; beta-tricalcium
   phosphate; Porosity; SEM; TOF-SIMS; XPS; XRD
ID BONE-GRAFT SUBSTITUTES; CERAMICS IN-VITRO; PROTEIN ADSORPTION;
   SOFT-TISSUE; VIVO; POROSITY; XPS; TCP; NANOPARTICLES; BIOACTIVITY
AB Objectives: It is our aim to understand the mechanisms that make calcium phosphates, such as bioactive calcium hydroxyapatite (HA), and biphasic calcium (BCP) and p-tricalcium (I3-TCP) phosphates, desirable for a variety of biological applications, such as the filling of bone defects. Methods: Here, we have characterized these materials by X-ray photoelectron spectroscopy (XPS), X-ray diffraction (XRD), scanning electron microscopy (SEM), Fourier-transform infrared (FTIR), time-of-flight secondary ion mass spectroscopy (TOP-SIMS) and laser granulometry. Results: SEM shows clearly that BCP is a matrix made of macro-organized microstructure, giving insight to the specially chosen composition of the BCP that offers both an adequate scaffold and good porosity for further bone growth. As revealed by laser granulometry, the particles exhibit a homogeneous size distribution, centered at a value somewhat larger than the expected 500 p.m. XPS has revealed the presence of adventitious carbon at all sample surfaces, and has shown that Ca/P and 0/Ca ratios in the outer layers of all the samples differ significantly from those expected. A peak-by-peak XPS comparison for all samples has revealed that TCP and BCP are distinct from one another in the relative intensities of their oxygen peaks. The PO/PO i and CaOH+/Ca+ TOF-SIMS intensity ratios were used to distinguish among the samples, and to demonstrate that the OH- fragment, present in all the samples, is not formed during fragmentation but exists at the sample surface, probably as a contaminant. Conclusions: This study provides substantial insight into the nanoscale surface properties of BCP, HA and 13-TCP. Further research is required to help identify the effect of surfaces of these bioceramics with proteins and several biological fluids. Clinical relevance: The biological performance of implanted synthetic graft bone biomaterials is strongly influenced by their nanosurface characteristics, the structures and properties of the outer layer of the biomaterial. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Franca, Rodrigo; Samani, Taraneh Djavanbakht; Bayade, Ghislaine; Yahia, L'Hocine; Sacher, Edward] Ecole Polytech, Lab Innovat & Anal Bioperformance, Montreal, PQ H3C 3A7, Canada.
   [Franca, Rodrigo] Univ Manitoba, Dent Biomat Res Lab, Dept Restorat Dent, Fac Dent, Winnipeg, MB R3E 0W2, Canada.
   [Sacher, Edward] Ecole Polytech, Dept Genie Phys, Montreal, PQ H3C 3A7, Canada.
RP Franca, R (reprint author), Univ Manitoba, Dent Biomat Res Lab, Dept Restorat Dent, Fac Dent, 780 Bannatyne Ave, Winnipeg, MB R3E 0W2, Canada.
EM rodrigo_franca@umanitoba.ca
OI Franca, Rodrigo/0000-0003-2905-3803
FU ITI Foundation for the Promotion of Implantology
FX Financial support, by the ITI Foundation for the Promotion of
   Implantology, is gratefully acknowledged. We thank Straumann, Inc., for
   furnishing the Straumann BoneCeramic 500.
CR Anselme K, 2010, ACTA BIOMATER, V6, P3824, DOI 10.1016/j.actbio.2010.04.001
   Bayazit V., 2010, DIG J NANOMATER BIOS, V7, P267
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Chusuei CC, 1999, ANAL CHEM, V71, P149, DOI 10.1021/ac9806963
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Daculsi G., 2008, BIOCERAMICS THEIR CL
   Dietze S., 2006, Folia Morphologica, V65, P63
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Franca R, 2013, J COLLOID INTERF SCI, V389, P292, DOI 10.1016/j.jcis.2012.08.065
   Franca R, 2013, J BIOMED MATER RES B, V101, P1444, DOI 10.1002/jbm.b.32964
   Frenken JWFH, 2010, CLIN ORAL IMPLAN RES, V21, P201, DOI 10.1111/j.1600-0501.2009.01821.x
   Hayakawa S., 2008, BIOCERAMICS THEIR CL
   Hench L.L., 1991, J AM CERAM SOC, V74, P487
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jensen SS, 2007, CLIN ORAL IMPLAN RES, V18, P752, DOI 10.1111/j.1600-0501.2007.01417.x
   Kasten P, 2008, ACTA BIOMATER, V4, P1904, DOI 10.1016/j.actbio.2008.05.017
   Kauschke E., 2006, Folia Morphologica, V65, P37
   KIM HM, 2003, SOLID STATE MAT SCI, V7, P289
   Knabe C., 2008, BIOCERAMICS THEIR CL
   LANGFORD JI, 1978, J APPL CRYSTALLOGR, V11, P102, DOI 10.1107/S0021889878012844
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Lu HB, 2000, ANAL CHEM, V72, P2886, DOI 10.1021/ac990812h
   Marchi J, 2009, INT J APPL CERAM TEC, V6, P60, DOI 10.1111/j.1744-7402.2008.02254.x
   Mbeh DA, 2012, J BIOMED MATER RES A, V100A, P1637, DOI 10.1002/jbm.a.34096
   McLeod K, 2010, APPL SURF SCI, V256, P7178, DOI 10.1016/j.apsusc.2010.05.047
   McLeod K, 2006, APPL SURF SCI, V253, P2644, DOI 10.1016/j.apsusc.2006.05.031
   MORENO EC, 1991, CALCIFIED TISSUE INT, V49, P6, DOI 10.1007/BF02555895
   Ni SY, 2007, J BIOMED MATER RES B, V80B, P174, DOI 10.1002/jbm.b.30582
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Rumpel E., 2006, Folia Morphologica, V65, P43
   Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98, DOI [DOI 10.1007/978-3-662-33915-2, 10.1007/978-3-662-33915-2_7]
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tas AC, 1997, J MATER SCI-MATER M, V8, P91
   Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084
   Xin RL, 2005, BIOMATERIALS, V26, P6477, DOI 10.1016/j.biomaterials.2005.04.028
   Yamada S, 1997, BIOMATERIALS, V18, P1037, DOI 10.1016/S0142-9612(97)00036-7
   Yoganand CP, 2010, CERAM INT, V36, P1757, DOI 10.1016/j.ceramint.2010.02.048
   Yuan HP, 2001, J MATER SCI-MATER M, V12, P7, DOI 10.1023/A:1026792615665
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zhu XD, 2010, ACTA BIOMATER, V6, P1536, DOI 10.1016/j.actbio.2009.10.032
   Zhu XD, 2009, ACTA BIOMATER, V5, P1311, DOI 10.1016/j.actbio.2008.11.024
NR 43
TC 24
Z9 25
U1 1
U2 60
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 2014
VL 420
BP 182
EP 188
DI 10.1016/j.jcis.2013.12.055
PG 7
WC Chemistry, Physical
SC Chemistry
GA AC2RN
UT WOS:000332351800025
PM 24559717
DA 2018-10-19
ER

PT J
AU Dempsey, DK
   Robinson, JL
   Iyer, AV
   Parakka, JP
   Bezwada, RS
   Cosgriff-Hernandez, EM
AF Dempsey, David K.
   Robinson, Jennifer L.
   Iyer, Ananth V.
   Parakka, James P.
   Bezwada, Rao S.
   Cosgriff-Hernandez, Elizabeth M.
TI Characterization of a resorbable poly(ester urethane) with biodegradable
   hard segments
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydrolysis; mechanical properties; resorbable; aromatic isocyanate;
   cytocompatibility; polyurethanes
ID DEGRADABLE POLYURETHANE ELASTOMERS; STRUCTURE-PROPERTY RELATIONSHIPS;
   TYROSINE-BASED POLYURETHANES; WOUND DRESSING APPLICATIONS; IN-VITRO
   DEGRADATION; POLY(ETHYLENE GLYCOL); TRANSFECTION EFFICIENCY; BIOMATERIAL
   APPLICATIONS; MECHANICAL-PROPERTIES; EPSILON-CAPROLACTONE
AB The rapid growth of regenerative medicine and drug delivery fields has generated a strong need for improved polymeric materials that degrade at a controlled rate into safe, non-cytotoxic by-products. Polyurethane thermoplastic elastomers offer several advantages over other polymeric materials including tunable mechanical properties, excellent fatigue strength, and versatile processing. The variable segmental chemistry in developing resorbable polyurethanes also enables fine control over the degradation profile as well as the mechanical properties. Linear aliphatic isocyanates are most commonly used in biodegradable polyurethane formulations; however, these aliphatic polyurethanes do not match the mechanical properties of their aromatic counterparts. In this study, a novel poly(ester urethane) (PEsU) synthesized with biodegradable aromatic isocyanates based on glycolic acid was characterized for potential use as a new resorbable material in medical devices. Infrared spectral analysis confirmed the aromatic and phase-separated nature of the PEsU. Uniaxial tensile testing displayed stress-strain behavior typical of a semi-crystalline polymer above its T-g, in agreement with calorimetric findings. PEsU outperformed aliphatic PCL-based polyurethanes likely due to the enhanced cohesion of the aromatic hard domains. Accelerated degradation of the PEsU using 0.1 M sodium hydroxide resulted in hydrolysis of the polyester soft segment on the surface, reduced molecular weight, surface cracking, and a 30% mass loss after four weeks. Calorimetric studies indicated a disruption of the soft segment crystallinity after incubation which corresponded with a drop in initial modulus of the PEsU. Finally, cytocompatibility testing with 3T3 mouse fibroblasts exhibited cell viability on PEsU films comparable to a commercial poly(ether urethane urea) after 24 h followed by 85% cell viability at 72 h. Overall, this new resorbable polyurethane shows strong potential for use in wide range of biomedical applications.
C1 [Dempsey, David K.; Robinson, Jennifer L.; Cosgriff-Hernandez, Elizabeth M.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
   [Iyer, Ananth V.; Parakka, James P.] DSM Biomed, Berkeley, CA 94710 USA.
   [Bezwada, Rao S.] Bezwada Biomed LLC, Hillsborough, NJ 08844 USA.
RP Cosgriff-Hernandez, EM (reprint author), Texas A&M Univ, Dept Biomed Engn, 5033 Emerging Technol Bldg, College Stn, TX 77843 USA.
EM cosgriff.hernandez@tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
CR Adhikari R, 2010, J MATER SCI-MATER M, V21, P1081, DOI 10.1007/s10856-009-3955-2
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Ayres E, 2007, EUR POLYM J, V43, P3510, DOI 10.1016/j.eurpolymj.2007.05.014
   Bachelder EM, 2008, MOL PHARMACEUT, V5, P876, DOI 10.1021/mp800068x
   Bense CA, 1999, J BIOMED MATER RES, V46, P305, DOI 10.1002/(SICI)1097-4636(19990905)46:3<305::AID-JBM1>3.0.CO;2-A
   Bernacca GM, 2002, J BIOMED MATER RES, V61, P138, DOI 10.1002/jbm.10149
   Bezwada R, 2006, US patent, Patent No. [20060188547 A1, 20060188547A1]
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Chan-Chan LH, 2010, ACTA BIOMATER, V6, P2035, DOI 10.1016/j.actbio.2009.12.010
   Chiono V, 2011, MACROMOL BIOSCI, V11, P245, DOI 10.1002/mabi.201000354
   Choi T, 2011, J BIOMAT SCI-POLYM E, V22, P973, DOI 10.1163/092050610X540684
   COURY A, 2004, BIOMATERIALS SCI INT, P411
   da Silva GR, 2010, POLYM DEGRAD STABIL, V95, P491, DOI 10.1016/j.polymdegradstab.2010.01.001
   David G, 2011, DIG J NANOMATER BIOS, V6, P1575
   Dawlee S, 2011, BIOMED MATER, V6, P1
   deGroot JH, 1996, BIOMATERIALS, V17, P163, DOI 10.1016/0142-9612(96)85761-9
   Dempsey D, 2012, SZYCHERS HDB POLYURE, P671
   Dillon J, 1989, INFARED SPECTROSCOPI
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   GOLDBERG D, 1995, J ENVIRON POLYM DEGR, V3, P61, DOI 10.1007/BF02067481
   Gong CY, 2009, J APPL POLYM SCI, V113, P1111, DOI 10.1002/app.29946
   Gorna K, 2002, POLYM DEGRAD STABIL, V75, P113, DOI 10.1016/S0141-3910(01)00210-5
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guelcher S, 2007, TISSUE ENG, V13, P2321, DOI 10.1089/ten.2006.0395
   Gultekin G, 2009, J MATER SCI-MATER M, V20, P421, DOI 10.1007/s10856-008-3572-5
   Han J, 2009, FRONT MAT SCI CHINA, V3, P25, DOI [10.1007/s11706-009-0013-4, DOI 10.1007/S11706-009-0013-4]
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   HERGENROTHER RW, 1993, BIOMATERIALS, V14, P449, DOI 10.1016/0142-9612(93)90148-U
   Hirsch DJ, 1997, ARTIF ORGANS, V21, P349
   Hung WC, 2009, J CONTROL RELEASE, V133, P68, DOI 10.1016/j.jconrel.2008.09.082
   Jaffe M, 2003, POLYMER, V44, P6033, DOI 10.1016/S0032-3861(03)00559-7
   Jiang X, 2007, EUR POLYM J, V43, P1838, DOI 10.1016/j.eurpolymj.2007.02.029
   Khosroshahi ME, 2004, IRAN POLYM J, V13, P503
   Kim SE, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044106
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Legendre D, 2003, ARTIF ORGANS, V27, P457, DOI 10.1046/j.1525-1594.2003.07238.x
   LELAH MD, 1986, J BIOMED MATER RES, V20, P433, DOI 10.1002/jbm.820200403
   LELAH MD, 1987, POLYURETHANES MED
   Li ZBA, 2009, J BIOMAT SCI-POLYM E, V20, P1179, DOI 10.1163/156856209X452944
   Liu XY, 2009, BIOMATERIALS, V30, P6665, DOI 10.1016/j.biomaterials.2009.08.052
   Madra H, 2009, POLYM TEST, V28, P773, DOI 10.1016/j.polymertesting.2009.05.013
   MCCOY TJ, 1990, J BIOMED MATER RES, V24, P107, DOI 10.1002/jbm.820240110
   Moravek S, 2007, POLYM PREPR, V48, P568
   NATHAN A, 1992, MACROMOLECULES, V25, P4476, DOI 10.1021/ma00044a004
   PAVLOVA M, 1993, BIOMATERIALS, V14, P1024, DOI 10.1016/0142-9612(93)90196-9
   Reddy TT, 2006, MACROMOL SYMP, V242, P241, DOI 10.1002/masy.200651033
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Schawe JEK, 1998, J THERM ANAL CALORIM, V54, P565, DOI 10.1023/A:1010142510263
   SHARMA CP, 1983, CURR SCI INDIA, V52, P1057
   Shau MD, 2006, J BIOMED MATER RES A, V77A, P736, DOI 10.1002/jbm.a.30605
   Skarja GA, 2000, J APPL POLYM SCI, V75, P1522, DOI 10.1002/(SICI)1097-4628(20000321)75:12<1522::AID-APP11>3.3.CO;2-1
   Skarja GA, 1998, J BIOMAT SCI-POLYM E, V9, P271, DOI 10.1163/156856298X00659
   Spaans C, 1999, POLYM PREPR, V40, P589
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   STOKES K, 1982, BIOMATERIALS, V3, P225, DOI 10.1016/0142-9612(82)90024-2
   Szycher M., 1999, SZYCHERS HDB POLYURE
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Thomas V, 2008, J MATER SCI-MATER M, V19, P2721, DOI 10.1007/s10856-008-3367-8
   Thomas V, 2009, J BIOMED MATER RES A, V89A, P192, DOI 10.1002/jbm.a.31937
   Tseng SJ, 2005, BIOCONJUGATE CHEM, V16, P1375, DOI 10.1021/bc050005r
   ULUBAYRAM K, 1992, POLYMER, V33, P2084, DOI 10.1016/0032-3861(92)90874-V
   Visscher SH, 2009, J BIOMED MATER RES B, V91B, P957, DOI 10.1002/jbm.b.31481
   WALPOTH B, 1986, Life Support Systems, V4, P82
   Ward R, 1994, 8 CIMTEC FOR NEW MAT
   Yang TF, 2004, BIOMACROMOLECULES, V5, P1926, DOI 10.1021/bm049763v
   Yucedag F, 2010, J APPL POLYM SCI, V115, P1347, DOI 10.1002/app.30788
   Zhang DW, 2011, J POLYM SCI POL CHEM, V49, P754, DOI 10.1002/pola.24488
   Zhang SB, 2004, J CONTROL RELEASE, V100, P165, DOI 10.1016/j.jconrel.2004.08.019
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 73
TC 8
Z9 8
U1 4
U2 68
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD APR 13
PY 2014
VL 25
IS 6
BP 535
EP 554
DI 10.1080/09205063.2014.880247
PG 20
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AE5RN
UT WOS:000334046600001
PM 24483140
DA 2018-10-19
ER

PT J
AU Schellenberg, A
   Ross, R
   Abagnale, G
   Joussen, S
   Schuster, P
   Arshi, A
   Pallua, N
   Jockenhoevel, S
   Gries, T
   Wagner, W
AF Schellenberg, Anne
   Ross, Robin
   Abagnale, Giulio
   Joussen, Sylvia
   Schuster, Philipp
   Arshi, Annahit
   Pallua, Norbert
   Jockenhoevel, Stefan
   Gries, Thomas
   Wagner, Wolfgang
TI 3D Non-Woven Polyvinylidene Fluoride Scaffolds: Fibre Cross Section and
   Texturizing Patterns Have Impact on Growth of Mesenchymal Stromal Cells
SO PLOS ONE
LA English
DT Article
ID HUMAN PLATELET LYSATE; FIBROBLASTS IN-VITRO; STEM-CELLS; CULTURE
   EXPANSION; DIFFERENTIATION; PROLIFERATION; ADHESION; MATRIX; REPAIR;
   PVDF
AB Several applications in tissue engineering require transplantation of cells embedded in appropriate biomaterial scaffolds. Such structures may consist of 3D non-woven fibrous materials whereas little is known about the impact of mesh size, pore architecture and fibre morphology on cellular behavior. In this study, we have developed polyvinylidene fluoride (PVDF) non-woven scaffolds with round, trilobal, or snowflake fibre cross section and different fibre crimp patterns (10, 16, or 28 needles per inch). Human mesenchymal stromal cells (MSCs) from adipose tissue were seeded in parallel on these scaffolds and their growth was compared. Initial cell adhesion during the seeding procedure was higher on non-wovens with round fibres than on those with snowflake or trilobal cross sections. All PVDF non-woven fabrics facilitated cell growth over a time course of 15 days. Interestingly, proliferation was significantly higher on non-wovens with round or trilobal fibres as compared to those with snowflake profile. Furthermore, proliferation increased in a wider, less dense network. Scanning electron microscopy (SEM) revealed that the MSCs aligned along the fibres and formed cellular layers spanning over the pores. 3D PVDF non-woven scaffolds support growth of MSCs, however fibre morphology and mesh size are relevant: proliferation is enhanced by round fibre cross sections and in rather wide-meshed scaffolds.
C1 [Schellenberg, Anne; Abagnale, Giulio; Joussen, Sylvia; Wagner, Wolfgang] Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.
   [Ross, Robin; Schuster, Philipp; Arshi, Annahit; Jockenhoevel, Stefan; Gries, Thomas] Rhein Westfal TH Aachen, Inst Text Technol, Aachen, Germany.
   [Pallua, Norbert] Rhein Westfal TH Aachen, Burn Ctr, Dept Plast & Reconstruct Surg, Aachen, Germany.
   [Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, Dept Appl Med Engn, Aachen, Germany.
RP Wagner, W (reprint author), Rhein Westfal TH Aachen, Sch Med, Helmholtz Inst Biomed Engn, Aachen, Germany.
EM wwagner@ukaachen.de
RI Gries, Thomas/M-8206-2018
OI Gries, Thomas/0000-0002-2480-8333; Wagner, Wolfgang/0000-0002-1971-3217;
   Jockenhoevel, Stefan/0000-0003-0584-9444
FU Stem Cell Network North Rhine Westphalia; Else-Kroner-Fresenius
   Stiftung; German Research Foundation [WA 1706/3-2, SPP1327]
FX This work was supported by the Stem Cell Network North Rhine Westphalia,
   by the Else-Kroner-Fresenius Stiftung, and by the German Research
   Foundation (WA 1706/3-2 within SPP1327). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Baumchen F, 2009, ORAL SURG ORAL MED O, V108, P505, DOI 10.1016/j.tripleo.2009.05.004
   Berger D, 2009, HERNIA, V13, P167, DOI 10.1007/s10029-008-0435-4
   Cardwell RD, 2012, J TISSUE ENG REGEN M
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chandrasekaran AR, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015001
   Cholewa D, 2011, CELL TRANSPLANT, V20, P1409, DOI 10.3727/096368910X557218
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Edwards SL, 2011, TISSUE ENG PART C-ME, V17, P123, DOI [10.1089/ten.tec.2010.0182, 10.1089/ten.TEC.2010.0182]
   Emans PJ, 2013, J TISSUE ENG REGEN M, V7, P751, DOI 10.1002/term.1477
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Garcia JL, 2010, MOLECULES, V15, P2845, DOI 10.3390/molecules15042845
   GL de, 2013, CURR PHARM DESIGN, V19, P2459
   Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Hegewald AA, 2013, J TISSUE ENG REGEN M
   Horn P, 2011, METHODS MOL BIOL, V698, P23, DOI 10.1007/978-1-60761-999-4_3
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Klinge U, 2002, BIOMATERIALS, V23, P3487, DOI 10.1016/S0142-9612(02)00070-4
   Klink CD, 2011, J INVEST SURG, V24, P292, DOI 10.3109/08941939.2011.589883
   LAROCHE G, 1995, J BIOMED MATER RES, V29, P1525, DOI 10.1002/jbm.820291209
   Leisten I, 2012, BIOMATERIALS, V33, P1736, DOI 10.1016/j.biomaterials.2011.11.034
   Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154
   Lohmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037839
   Luna SM, 2011, J BIOMATER APPL, V26, P101, DOI 10.1177/0885328210362924
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Mary C, 1998, ASAIO J, V44, P199, DOI 10.1097/00002480-199805000-00015
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Morgan SM, 2009, BIOMATERIALS, V30, P1910, DOI 10.1016/j.biomaterials.2008.12.033
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Pasquinelli G, 2008, J ANAT, V213, P520, DOI 10.1111/j.1469-7580.2008.00974.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puppi D, 2012, BIOMED MICRODEVICES, V14, P1115, DOI 10.1007/s10544-012-9677-0
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269
   Sarkar S, 2005, ACTA BIOMATER, V1, P93, DOI 10.1016/j.actbio.2004.08.003
   Schallmoser K, 2007, TRANSFUSION, V47, P1436, DOI 10.1111/j.1537-2995.2007.01220.x
   Schellenberg A, 2012, CYTOTHERAPY, V14, P401, DOI 10.3109/14653249.2011.640669
   Schellenberg A, 2011, AGING-US, V3, P873, DOI 10.18632/aging.100391
   Sensebe L., 2009, VOX SANG, V98, P93
   Sun T, 2009, J MATER SCI-MATER M, V20, P1483, DOI 10.1007/s10856-009-3703-7
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Tschoeke B, 2008, ARTIF ORGANS, V32, P800, DOI 10.1111/j.1525-1594.2008.00601.x
   Tuzlakoglu K, 2009, TISSUE ENG PART B-RE, V15, P17, DOI 10.1089/ten.teb.2008.0016
   URBAN E, 1994, ASAIO J, V40, P145
   Walenda G, 2012, TISSUE ENG PART C-ME, V18, P924, DOI [10.1089/ten.tec.2011.0541, 10.1089/ten.TEC.2011.0541]
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 56
TC 6
Z9 6
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2014
VL 9
IS 4
AR e94353
DI 10.1371/journal.pone.0094353
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AI3CI
UT WOS:000336736200066
PM 24728045
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Choi, BH
   Cheong, H
   Jo, YK
   Bahn, SY
   Seo, JH
   Cha, HJ
AF Choi, Bong-Hyuk
   Cheong, Hogyun
   Jo, Yun Kee
   Bahn, So Yeong
   Seo, Jeong Hyun
   Cha, Hyung Joon
TI Highly purified mussel adhesive protein to secure biosafety for in vivo
   applications
SO MICROBIAL CELL FACTORIES
LA English
DT Article
DE Mussel adhesive protein; Gram-negative Escherichia coli; High resolution
   purification; Biosafety; Lipopolysaccharide; Endotoxin; In vivo standard
ID ENDOTOXIN REMOVAL; ESCHERICHIA-COLI; MYTILUS-EDULIS; TRITON X-114;
   RECOMBINANT; EXPRESSION
AB Background: Unique adhesive and biocompatibility properties of mussel adhesive proteins (MAPs) are known for their great potential in many tissue engineering and biomedical applications. Previously, it was successfully demonstrated that redesigned hybrid type MAP, fp-151, mass-produced in Gram-negative bacterium Escherichia coli, could be utilized as a promising adhesive biomaterial. However, purification of recombinant fp-151 has been unsatisfactory due to its adhesive nature and polarity which make separation of contaminants (especially, lipopolysaccharide, a toxic Gram-negative cell membrane component) very difficult.
   Results: In the present work, we devised a high resolution purification approach to secure safety standards of recombinant fp-151 for the successful use in in vivo applications. Undesirable impurities were remarkably eliminated as going through sequential steps including treatment with multivalent ion and chelating agent for cell membrane washing, mechanical cell disruption, non-ionic surfactant treatment for isolated inclusion body washing, acid extraction of washed inclusion body, and ion exchange chromatography purification of acid extracted sample. Through various analyses, such as high performance liquid chromatographic purity assay, limulus amoebocyte lysate endotoxin assay, and in vitro mouse macrophage cell tests on inflammation, viability, cytotoxicity, and apoptosis, we confirmed the biological safety of bacterial-derived purified recombinant fp-151.
   Conclusions: Through this purification design, recombinant fp-151 achieved 99.90% protein purity and 99.91% endotoxin reduction that nearly no inflammation response was observed in in vitro experiments. Thus, the highly purified recombinant MAP would be successfully used as a safety-secured in vivo bioadhesive for tissue engineering and biomedical applications.
C1 [Choi, Bong-Hyuk; Cheong, Hogyun; Jo, Yun Kee; Seo, Jeong Hyun; Cha, Hyung Joon] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   [Bahn, So Yeong; Cha, Hyung Joon] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, South Korea.
   [Seo, Jeong Hyun] Yeungnam Univ, Sch Chem Engn, Kyongsan 712749, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr
FU Marine Biotechnology program; Ministry of Oceans and Fisheries, Korea
   and Rising Star program -; POSTECH
FX This work was supported by the Marine Biotechnology program funded by
   the Ministry of Oceans and Fisheries, Korea and Rising Star program
   funded by POSTECH.
CR AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   DOVE J, 1986, J AM DENT ASSOC, V112, P879
   EDELSTEIN C, 1984, J LIPID RES, V25, P630
   El-Moghazy ANA, 2011, J SCI IND RES INDIA, V70, P55
   FILPULA DR, 1990, BIOTECHNOL PROGR, V6, P171, DOI 10.1021/bp00003a001
   Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200
   Hedhammar M, 2010, BIOMACROMOLECULES, V11, P953, DOI 10.1021/bm9014039
   Hwang DS, 2007, BIOMATERIALS, V28, P3560, DOI 10.1016/j.biomaterials.2007.04.039
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   Kim BJ, 2012, ANGEW CHEM INT EDIT, V51, P675, DOI 10.1002/anie.201105789
   Kumar A, 2012, PROTEIN EXPRES PURIF, V83, P226, DOI 10.1016/j.pep.2012.04.002
   LEIVE L, 1968, J BIOL CHEM, V243, P6384
   LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x
   Lezin G, 2011, BIOTECHNOL BIOENG
   Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0
   Ma R, 2012, ANAL BIOCHEM, V424, P124, DOI 10.1016/j.ab.2012.02.015
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   Miernikiewicz P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038902
   Petsch D, 2000, J BIOTECHNOL, V76, P97, DOI 10.1016/S0168-1656(99)00185-6
   Reichelt P, 2006, PROTEIN EXPRES PURIF, V46, P483, DOI 10.1016/j.pep.2005.09.027
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   Silverman HG, 2007, MAR BIOTECHNOL, V9, P661, DOI 10.1007/s10126-007-9053-x
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1
   Wilson MJ, 2001, J BIOTECHNOL, V88, P67, DOI 10.1016/S0168-1656(01)00256-5
NR 30
TC 12
Z9 12
U1 4
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1475-2859
J9 MICROB CELL FACT
JI Microb. Cell. Fact.
PD APR 11
PY 2014
VL 13
AR 52
DI 10.1186/1475-2859-13-52
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AF4YE
UT WOS:000334719700001
PM 24725543
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU McKinnon, DD
   Domaille, DW
   Cha, JN
   Anseth, KS
AF McKinnon, Daniel D.
   Domaille, Dylan W.
   Cha, Jennifer N.
   Anseth, Kristi S.
TI Bis-Aliphatic Hydrazone-Linked Hydrogels Form Most Rapidly at
   Physiological pH: Identifying the Origin of Hydrogel Properties with
   Small Molecule Kinetic Studies
SO CHEMISTRY OF MATERIALS
LA English
DT Article
ID 3-DIMENSIONAL POLYMERS; BULK DEGRADATION; RELEASE; NETWORKS; MODEL;
   NANOPARTICLES; TEMPERATURE; ELASTICITY; ASSEMBLIES; COPOLYMERS
AB Rheological and small molecule kinetic studies were performed to study the formation and hydrolysis of the bis-aliphatic hydrazone bond. The rate of gelation was found to correspond closely with the rate of bond formation and the rate of gel relaxation with the rate of hydrolysis, indicating that small molecule kinetic studies can play an important role in material design. Furthermore, unlike aryl or acyl hydrazone bonds, the bis-aliphatic hydrazone bond forms rapidly under physiological conditions without requiring aniline catalysis yet maintains a pH-dependent rate of hydrolysis. These results suggest the bis-aliphatic hydrazone bond should find use alongside existing bioorthogonal click chemistries for bioconjugation, biomaterial synthesis, and controlled release applications.
C1 [McKinnon, Daniel D.; Domaille, Dylan W.; Cha, Jennifer N.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
   [McKinnon, Daniel D.; Anseth, Kristi S.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80303 USA.
   [Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80303 USA.
RP Cha, JN (reprint author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80303 USA.
EM Jennifer.Cha@colorado.edu; Kristi.Anseth@colorado.edu
OI Domaille, Dylan Wythe/0000-0003-0127-7485; DOMAILLE,
   DYLAN/0000-0003-2694-2832
FU Office of Naval Research [N00014-13-1-0283]; National Science Foundation
   [CBET 1236662]; Howard Hughes Medical Institute
FX Office of Naval Research (N00014-13-1-0283), the National Science
   Foundation (CBET 1236662), and the Howard Hughes Medical Institute
   funded this work.
CR Adzima BJ, 2010, ADV MATER, V22, P2784, DOI 10.1002/adma.200904138
   Azagarsamy MA, 2013, ANGEW CHEM INT EDIT, V52, P13803, DOI 10.1002/anie.201308174
   Azagarsamy MA, 2012, BIOMACROMOLECULES, V13, P2219, DOI 10.1021/bm300646q
   BAXANDALL LG, 1989, MACROMOLECULES, V22, P1982, DOI 10.1021/ma00194a076
   Blanden AR, 2011, BIOCONJUGATE CHEM, V22, P1954, DOI 10.1021/bc2001566
   CARPINO LA, 1994, J CHEM SOC CHEM COMM, P201, DOI 10.1039/c39940000201
   Chang BS, 2013, CHEM MATER, V25, P574, DOI 10.1021/cm3037197
   Chen XX, 2002, SCIENCE, V295, P1698, DOI 10.1126/science.1065879
   Crisalli P, 2013, J ORG CHEM, V78, P1184, DOI 10.1021/jo302746p
   Deng GH, 2010, MACROMOLECULES, V43, P1191, DOI 10.1021/ma9022197
   Dirksen A, 2006, J AM CHEM SOC, V128, P15602, DOI 10.1021/ja067189k
   Dirksen A, 2010, ANGEW CHEM INT EDIT, V49, P2023, DOI 10.1002/anie.200906756
   Dirksen A, 2008, BIOCONJUGATE CHEM, V19, P2543, DOI 10.1021/bc800310p
   Domaille DW, 2013, CHEM COMMUN, V49, P1759, DOI 10.1039/c3cc38871a
   Dong HC, 2009, CHEM MATER, V21, P3965, DOI 10.1021/cm901143e
   Flory PJ, 1942, J PHYS CHEM-US, V46, P132, DOI 10.1021/j150415a016
   FLORY PJ, 1979, POLYMER, V20, P1317, DOI 10.1016/0032-3861(79)90268-4
   Flory PJ, 1941, J AM CHEM SOC, V63, P3083, DOI 10.1021/ja01856a061
   Gillies ER, 2004, J AM CHEM SOC, V126, P11936, DOI 10.1021/ja0463738
   Gillies ER, 2005, BIOCONJUGATE CHEM, V16, P361, DOI 10.1021/bc049851c
   Griffin DR, 2012, ACS MACRO LETT, V1, P1330, DOI 10.1021/mz300366s
   Griffin DR, 2012, J AM CHEM SOC, V134, P13103, DOI 10.1021/ja305280w
   Gumbley P, 2014, CHEM MATER, V26, P1450, DOI 10.1021/cm403979p
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Jing J, 2013, CHEM MATER, V25, P3867, DOI 10.1021/cm4019925
   Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Kool ET, 2013, J AM CHEM SOC, V135, P17663, DOI 10.1021/ja407407h
   McKinnon DD, 2014, ADV MATER, V26, P865, DOI 10.1002/adma.201303680
   Metters A, 2005, BIOMACROMOLECULES, V6, P290, DOI 10.1021/bm049607o
   Metters AT, 2000, J PHYS CHEM B, V104, P7043, DOI 10.1021/jp000523t
   Metters AT, 2001, J PHYS CHEM B, V105, P8069, DOI 10.1021/jp004083h
   Nguyen R, 2003, CHEM COMMUN, P942, DOI 10.1039/b211645f
   OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5
   Rodriguez-Hernandez J, 2005, J AM CHEM SOC, V127, P2026, DOI 10.1021/ja043920g
   Rubinstein M., 2003, POLYM PHYS
   Scott TF, 2005, SCIENCE, V308, P1615, DOI 10.1126/science.1110505
   Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516
   Wang H, 2013, P NATL ACAD SCI USA, V110, P19336, DOI 10.1073/pnas.1306369110
   Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039969
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Zhang J, 2000, MACROMOLECULES, V33, P102, DOI 10.1021/ma991398q
NR 44
TC 41
Z9 41
U1 1
U2 67
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0897-4756
EI 1520-5002
J9 CHEM MATER
JI Chem. Mat.
PD APR 8
PY 2014
VL 26
IS 7
BP 2382
EP 2387
DI 10.1021/cm5007789
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AF2WD
UT WOS:000334572300024
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Ng, SS
   Wang, YL
   Feng, HX
   Chen, WN
   Chan-Park, MB
   Li, C
   Chan, V
AF Zhang, Ying
   Ng, Soon Seng
   Wang, Yilei
   Feng, Huixing
   Chen, Wei Ning
   Chan-Park, Mary B.
   Li, Chuan
   Chan, Vincent
TI Collective cell traction force analysis on aligned smooth muscle cell
   sheet between three-dimensional microwalls
SO INTERFACE FOCUS
LA English
DT Article
DE micropatterned scaffold; cell traction force microscopy; aligned smooth
   muscle cell sheet; mechanical stress
ID CYTOSKELETAL TENSION; CONTACT INHIBITION; GEOMETRIC CONTROL; E-CADHERIN;
   LC-MS/MS; ADHESION; MECHANOTRANSDUCTION; SUBSTRATE; MECHANICS; HYDROGELS
AB During the past two decades, novel biomaterial scaffold for cell attachment and culture has been developed for applications in tissue engineering, biosensing and regeneration medicine. Tissue engineering of blood vessels remains a challenge owing to the complex three-layer histology involved. In order to engineer functional blood vessels, it is essential to recapitulate the characteristics of vascular smooth muscle cells (SMCs) inside the tunica media, which is known to be critical for vasoconstriction and vasodilation of the circulatory system. Until now, there has been a lack of understanding on the mechanotransduction of the SMC layer during the transformation from viable synthetic to quiescent contractile phenotypes. In this study, microfabricated arrays of discontinuous microwalls coated with fluorescence microbeads were developed to probe the mechanotransduction of the SMC layer. First, the system was exploited for stimulating the formation of a highly aligned orientation of SMCs in native tunica medium. Second, atomic force microscopy in combination with regression analysis was applied to measure the elastic modulus of a polyacrylamide gel layer coated on the discontinuous microwall arrays. Third, the conventional traction force assay for single cell measurement was extended for applications in three-dimensional cell aggregates. Then, the biophysical effects of discontinuous microwalls on the mechanotransduction of the SMC layer undergoing cell alignment were probed. Generally, the cooperative multiple cell-cell and cell-microwall interactions were accessed quantitatively by the newly developed assay with the aid of finite-element modelling. The results show that the traction forces of highly aligned cells lying in the middle region between two opposing microwalls were significantly lower than those lying adjacent to the microwalls. Moreover, the spatial distributions of Von Mises stress during the cell alignment process were dependent on the collective cell layer orientation. Immunostaining of the SMC sheet further demonstrated that the collective mechanotransduction induced by three-dimensional topographic cues was correlated with the reduction of actin and vinculin expression. In addition, the online twodimensional LC-MS/MS analysis verified the modulation of focal adhesion formation under the influence of microwalls through the regulation in the expression of three key cytoskeletal proteins.
C1 [Zhang, Ying; Ng, Soon Seng; Wang, Yilei; Feng, Huixing; Chen, Wei Ning; Chan-Park, Mary B.; Chan, Vincent] Nanyang Technol Univ, Ctr Biotechnol, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
   [Li, Chuan] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
   [Li, Chuan] Natl Cent Univ, Dept Mech Engn, Tao Yuan 32001, Taiwan.
RP Li, C (reprint author), Natl Yang Ming Univ, Dept Biomed Engn, Taipei 11221, Taiwan.
EM cli10@ncu.edu.tw; mvchan@ntu.edu.sg
RI Chan-Park, Mary/G-6196-2010; Chan, Vincent/G-6197-2010
OI Chan-Park, Mary/0000-0003-3761-7517; Chan, Vincent/0000-0003-2149-4479
CR ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128
   Abercrombie M, 1967, Natl Cancer Inst Monogr, V26, P249
   Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109
   Borghi N, 2010, P NATL ACAD SCI USA, V107, P13324, DOI 10.1073/pnas.1002662107
   Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Cao Y, 2010, BIOMATERIALS, V31, P6228, DOI 10.1016/j.biomaterials.2010.04.059
   CASTOR LN, 1968, J CELL PHYSIOL, V72, P161, DOI 10.1002/jcp.1040720304
   Chan-Park MB, 2009, J BIOMED MATER RES A, V91A, P629, DOI 10.1002/jbm.a.32597
   Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X
   Danjo Y, 1998, J CELL SCI, V111, P3323
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Feng HX, 2010, J PROTEOMICS, V73, P1421, DOI 10.1016/j.jprot.2009.12.004
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Garcia-Castro MI, 2000, SCIENCE, V288, P1047, DOI 10.1126/science.288.5468.1047
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545
   Gui L, 2000, EXP FLUIDS, V28, P36, DOI 10.1007/s003480050005
   Gui LC, 1996, EXP FLUIDS, V21, P465, DOI 10.1007/BF00189049
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Hall MS, 2013, EXP CELL RES, V319, P2396, DOI 10.1016/j.yexcr.2013.06.009
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316
   Jensen A, 2001, EXP FLUIDS, V30, P500, DOI 10.1007/s003480000229
   Kandow CE, 2007, METHOD CELL BIOL, V83, P29, DOI 10.1016/S0091-679X(07)83002-0
   Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476
   Krauss P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036575
   Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148
   Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007
   Li L, 2012, CELL MOL LIFE SCI, V69, P2779, DOI 10.1007/s00018-012-0951-3
   MARTZ E, 1972, J CELL PHYSIOL, V79, P189, DOI 10.1002/jcp.1040790205
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McGregor E, 2004, MOL CELL PROTEOMICS, V3, P115, DOI 10.1074/mcp.M300046-MCP200
   Mertz AF, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.198101
   Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102
   Ng SS, 2011, INTERFACE FOCUS, V1, P777, DOI 10.1098/rsfs.2011.0036
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062
   Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109
   Shen JY, 2006, TISSUE ENG, V12, P2229, DOI 10.1089/ten.2006.12.2229
   Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102
   Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200
   Sveen J., 2004, QUANTITATIVE IMAGING
   Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/nmat3025, 10.1038/NMAT3025]
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   TAN KL, 1993, MACROMOLECULES, V26, P2832, DOI 10.1021/ma00063a030
   Thakar RG, 2003, BIOCHEM BIOPH RES CO, V307, P883, DOI 10.1016/S0006-291X(03)01285-3
   Thurner PJ, 2009, WIRES NANOMED NANOBI, V1, P624, DOI 10.1002/wnan.56
   Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269
   Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005
   Yu F, 2011, J PEDIATR SURG, V46, P1948, DOI 10.1016/j.jpedsurg.2011.06.024
   Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586
NR 71
TC 5
Z9 6
U1 2
U2 33
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD APR 6
PY 2014
VL 4
IS 2
SI SI
AR 20130056
DI 10.1098/rsfs.2013.0056
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CR
UT WOS:000332393100003
PM 24748953
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Chen, JL
   Duan, L
   Zhu, WM
   Xiong, JY
   Wang, DP
AF Chen, Jie-Lin
   Duan, Li
   Zhu, Weimin
   Xiong, Jianyi
   Wang, Daping
TI Extracellular matrix production in vitro in cartilage tissue engineering
SO JOURNAL OF TRANSLATIONAL MEDICINE
LA English
DT Review
DE Cartilage; Tissue engineering; Extracellular matrix; Collagen type II
ID MESENCHYMAL STEM-CELLS; HUMAN ARTICULAR CHONDROCYTES; TRANSFORMING
   GROWTH-FACTOR-BETA-1 TGF-BETA-1; INTERMITTENT HYDROSTATIC-PRESSURE; BONE
   MORPHOGENETIC PROTEIN-2; II COLLAGEN-SYNTHESIS; CHONDROGENIC
   DIFFERENTIATION; GENE-EXPRESSION; GROWTH-FACTOR; DOWN-REGULATION
AB Cartilage tissue engineering is arising as a technique for the repair of cartilage lesions in clinical applications. However, fibrocartilage formation weakened the mechanical functions of the articular, which compromises the clinical outcomes. Due to the low proliferation ability, dedifferentiation property and low production of cartilage-specific extracellular matrix (ECM) of the chondrocytes, the cartilage synthesis in vitro has been one of the major limitations for obtaining high-quality engineered cartilage constructs. This review discusses cells, biomaterial scaffolds and stimulating factors that can facilitate the cartilage-specific ECM production and accumulation in the in vitro culture system. Special emphasis has been put on the factors that affect the production of ECM macromolecules such as collagen type II and proteoglycans in the review, aiming at providing new strategies to improve the quality of tissue-engineered cartilage.
C1 [Chen, Jie-Lin; Duan, Li; Zhu, Weimin; Xiong, Jianyi; Wang, Daping] Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Tissue Engn, Shenzhen 518035, Guangdong, Peoples R China.
   [Chen, Jie-Lin; Duan, Li] Sun Yat Sen Univ, Sch Med, Guangzhou 510182, Guangdong, Peoples R China.
   [Chen, Jie-Lin; Duan, Li; Zhu, Weimin; Xiong, Jianyi; Wang, Daping] Shenzhen Second Peoples Hosp, Dept Orthoped, Shenzhen 518035, Guangdong, Peoples R China.
RP Wang, DP (reprint author), Shenzhen Univ, Affiliated Hosp 1, Shenzhen Peoples Hosp 2, Shenzhen Key Lab Tissue Engn, Shenzhen 518035, Guangdong, Peoples R China.
EM dapingwang1963@qq.com
FU Shenzhen Science and Technology Key Project [201001013]; Shenzhen
   Science and Technology International Cooperative Project
   [20130326210545]
FX Our work was funded by Shenzhen Science and Technology Key Project
   (Project NO. 201001013) and Shenzhen Science and Technology
   International Cooperative Project (Project NO. 20130326210545).
CR Abazari A, 2013, CRYOBIOLOGY, V66, P201, DOI 10.1016/j.cryobiol.2013.03.001
   Abukawa H, 2013, J CRANIOFAC SURG, V24, P1026, DOI 10.1097/SCS.0b013e31827ff323
   Albrecht C, 2013, INT ORTHOP, V37, P2297, DOI 10.1007/s00264-013-2009-z
   Ando W, 2012, EUR CELLS MATER, V24, P292, DOI 10.22203/eCM.v024a21
   Barbero A, 2006, J CELL BIOCHEM, V98, P1140, DOI 10.1002/jcb.20754
   Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004
   BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9
   Bueno EM, 2005, TISSUE ENG, V11, P1699, DOI 10.1089/ten.2005.11.1699
   Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200
   Chen WC, 2011, CYTOTECHNOLOGY, V63, P13, DOI 10.1007/s10616-010-9314-9
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Diekman BO, 2012, P NATL ACAD SCI USA, V109, P19172, DOI 10.1073/pnas.1210422109
   DUNKELMAN NS, 1995, BIOTECHNOL BIOENG, V46, P299, DOI 10.1002/bit.260460402
   Endres M, 2012, J ORTHOP TRAUMA RES, V7, P1
   Enochson L, 2012, BIORESEARCH OPEN ACC, V1, P306, DOI 10.1089/biores.2012.0277
   Forsey RW, 2012, BIOTECHNOL APPL BIOC, V59, P142, DOI 10.1002/bab.1009
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   Furumatsu T, 2013, J BIOMECH, V46, P1508, DOI 10.1016/j.jbiomech.2013.03.028
   GALERA P, 1992, EXP CELL RES, V200, P379, DOI 10.1016/0014-4827(92)90186-C
   GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322
   Garza-Veloz I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4260
   Giannoni P, 2005, OSTEOARTHR CARTILAGE, V13, P589, DOI 10.1016/j.joca.2005.02.015
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   Grogan SP, 2007, ARTHRITIS RHEUM, V56, P586, DOI 10.1002/art.22408
   Grogan SP, 2013, TISSUE ENG PART A, V20, P264
   Hamada T, 2013, NAGOYA J MED SCI, V75, P101
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   Henrotin YE, 2006, J RHEUMATOL, V33, P1668
   Hicks DL, 2007, OTOLARYNG HEAD NECK, V136, P373, DOI 10.1016/j.otohns.2006.10.040
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   Hu JC, 2006, TISSUE ENG, V12, P1337, DOI 10.1089/ten.2006.12.1337
   Huang AH, 2010, J BIOMECH, V43, P128, DOI 10.1016/j.jbiomech.2009.09.018
   Itoh S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071156
   Iwasa J, 2009, KNEE SURG SPORT TR A, V17, P561, DOI 10.1007/s00167-008-0663-2
   Jiang YZ, 2011, CELL TRANSPLANT, V20, P593, DOI 10.3727/096368910X532738
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Kaitainen S, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025009
   Kanazawa T, 2012, J ORTHOP RES, V30, P468, DOI 10.1002/jor.21528
   Kon E, 2012, J KNEE SURG, V25, P17, DOI 10.1055/s-0031-1299651
   Kubota S, 2011, J CELL COMMUN SIGNAL, V5, P209, DOI 10.1007/s12079-011-0123-5
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lee CR, 2003, J BIOMED MATER RES A, V64A, P560, DOI 10.1002/jbm.a.10443
   Lee HS, 2013, PHYTOTHER RES, V27, P1414, DOI 10.1002/ptr.4857
   Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200
   Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]
   Li D, 2012, OSTEOARTHR CARTILAGE, V20, P1647, DOI 10.1016/j.joca.2012.08.009
   Lu HX, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/4/045011
   Lyu SR, 2013, COLLOID SURFACE B, V103, P304, DOI 10.1016/j.colsurfb.2012.11.002
   Ma KG, 2013, J MATER SCI-MATER M, V24, P405, DOI 10.1007/s10856-012-4811-3
   Madry H, 2005, GENE THER, V12, P1171, DOI 10.1038/sj.gt.3302515
   Mafi P, 2012, CURR STEM CELL RES T, V7, P302, DOI 10.2174/157488812800793045
   Mahmoudifar N, 2012, TRENDS BIOTECHNOL, V30, P166, DOI 10.1016/j.tibtech.2011.09.002
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Meretoja VV, 2013, BIOMATERIALS, V34, P4266, DOI 10.1016/j.biomaterials.2013.02.064
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Park JS, 2012, BIOMATERIALS, V33, P7151, DOI 10.1016/j.biomaterials.2012.06.023
   Petrera M, 2013, ARTHROSCOPY, V29, P1685, DOI 10.1016/j.arthro.2013.07.259
   Qu CJ, 2013, INT J BIOCHEM CELL B, V45, P1802, DOI 10.1016/j.biocel.2013.05.029
   Rosenzweig DH, 2013, ACTA BIOMATER, V9, P9360, DOI 10.1016/j.actbio.2013.07.024
   Rutgers M, 2013, TISSUE ENG PT A, V19, P59, DOI [10.1089/ten.tea.2011.0416, 10.1089/ten.TEA.2011.0416]
   Ryu B, 2012, CARBOHYD RES, V350, P55, DOI 10.1016/j.carres.2011.12.028
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Scherer K, 2004, BIORHEOLOGY, V41, P323
   Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650
   Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119
   Shao XX, 2013, CHINESE MED J-PEKING, V126, P2523, DOI 10.3760/cma.j.issn.0366-6999.20112153
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Song J, 2013, BIOCHEM BIOPH RES CO, V431, P210, DOI 10.1016/j.bbrc.2012.12.133
   Tomita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059226
   Tong JC, 2007, J BIOACT COMPAT POL, V22, P232, DOI 10.1177/0883911507076460
   Vats A, 2006, TISSUE ENG, V12, P1687, DOI 10.1089/ten.2006.12.1687
   Vinardell T, 2012, TISSUE ENG PT A, V18, P1161, DOI [10.1089/ten.TEA.2011.0544, 10.1089/ten.tea.2011.0544]
   Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007
   Wang J, 2004, ANN RHEUM DIS, V63, P61, DOI 10.1136/ard.2002.005298
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Xia ZD, 2013, CELL TISSUE BANK, V14, P267, DOI 10.1007/s10561-012-9328-y
   Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679
   Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037
   Yang YH, 2012, STEM CELL TRANSL MED, V1, P843, DOI 10.5966/sctm.2012-0083
   Yasuda T, 2002, ARTHRITIS RHEUM, V46, P138, DOI 10.1002/1529-0131(200201)46:1<138::AID-ART10051>3.0.CO;2-K
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z
   Zhang F, 2015, J TISSUE ENG REGEN M, V9, P1036, DOI 10.1002/term.1656
   Zhang L, 2012, PHYTOTHER RES, V26, P1385, DOI 10.1002/ptr.3733
   Zhang XQ, 2009, BIOMATERIALS, V30, P2632, DOI 10.1016/j.biomaterials.2009.01.021
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 89
TC 20
Z9 22
U1 1
U2 40
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1479-5876
J9 J TRANSL MED
JI J. Transl. Med.
PD APR 5
PY 2014
VL 12
AR 88
DI 10.1186/1479-5876-12-88
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AI5QW
UT WOS:000336925200003
PM 24708713
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Allouche, FN
   Guibal, E
   Mameri, N
AF Allouche, Fella-Naouel
   Guibal, Eric
   Mameri, Nabil
TI Preparation of a new chitosan-based material and its application for
   mercury sorption
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article
DE Chitosan; Foams; Hg(II); Biosorption; Modeling
ID MODIFIED MAGNETIC CHITOSAN; AQUEOUS-SOLUTIONS; METAL-IONS; HEAVY-METALS;
   HG(II) IONS; GEL BEADS; EQUILIBRIUM; ADSORPTION; REMOVAL; BIOSORPTION
AB A novel chitosan sponge-like structure has been prepared by freeze-drying technique and then tested to remove Hg(II). Chitosan as biosorbent has been used in the form of flakes and cylindrical foams. In this study, column experiment on recirculation mode was conducted in order to determine the sorption properties of the cylindrical foams in various operating conditions (pH, initial metal ion concentration, flow rate, depth of column). The sorption behavior of the materials was examined through equilibrium, kinetic experiments. Hg(II) equilibrium isotherm data is very well fitted by the Langmuir model. Based on the sorption capacity, it was shown that a chitosan flake was more effective than foam. At pH 4, the sorption capacities (qm) were found up to 850 mg of Hg g(-1) for chitosan flake and only 350 mg of Hg g(-1) for chitosan foam. Two-region model performed for predicting and determining the sorption capacity of foam were distinguished. The pseudo-second-order chemisorption kinetic has shown success for short sorption times, while the cylindrical diffusion model was able to predict the end of the sorption times. The nature and morphology of the biomaterial before and after mercury sorption was studied by SEM-EDAX analysis. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Allouche, Fella-Naouel] CDER, Lab Bioenergie & Environm, Algiers 16340, Algeria.
   [Guibal, Eric] Ecole Mines Ales, Ctr Mat Mines Ales, MPA BCI C2MA, F-30319 Ales, France.
   [Mameri, Nabil] Ecole Natl Polytech, Lab Biotechnol Environm & Genie Proc BIOGEP, El Harrach Algiers, Algeria.
RP Allouche, FN (reprint author), CDER, Lab Bioenergie & Environm, BP 62 Route Observ Bouzareah, Algiers 16340, Algeria.
EM allouchenaouel2000@yahoo.fr
RI Guibal, Eric/H-4915-2012
OI Guibal, Eric/0000-0002-2767-6305
FU Grant PNE (Programme National Exceptionnel, Ministere de l'Enseignement
   Superieur et de la Recherche Scientifique-Algerie)
FX This research was financially supported by Grant PNE (Programme National
   Exceptionnel, Ministere de l'Enseignement Superieur et de la Recherche
   Scientifique-Algerie). The authors acknowledge the personal J.-M.
   Taulemesse (from Centre des Materiaux de Grande Diffusion, Ecole des
   Mines d'Ales) for SEM/SEM-EDAX. Sincere thanks go to Pr E-Benyoussef
   (from Ecole Nationale Polytechnique-Alger).
CR Allouche FN, 2011, CHEM ENG J, V168, P1174, DOI 10.1016/j.cej.2011.02.005
   Arvanitoyannis IS, 1998, CARBOHYD POLYM, V37, P371, DOI 10.1016/S0144-8617(98)00083-6
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Bassi R, 2000, SEPAR SCI TECHNOL, V35, P547, DOI 10.1081/SS-100100175
   Bhatnagar A, 2010, CHEM ENG J, V157, P277, DOI 10.1016/j.cej.2010.01.007
   Carro L, 2011, J HAZARD MATER, V192, P284, DOI 10.1016/j.jhazmat.2011.05.017
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   de Godoi FC, 2013, CHEM ENG J, V234, P423, DOI 10.1016/j.cej.2013.09.006
   Donia AM, 2008, J HAZARD MATER, V151, P372, DOI 10.1016/j.jhazmat.2007.05.083
   Erosa MSD, 2001, HYDROMETALLURGY, V61, P157
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Green-Ruiz C, 2006, BIORESOURCE TECHNOL, V97, P1907, DOI 10.1016/j.biortech.2005.08.014
   Guibal E, 1998, IND ENG CHEM RES, V37, P1454, DOI 10.1021/ie9703954
   Guibal E, 1999, INT J BIOL MACROMOL, V24, P49, DOI 10.1016/S0141-8130(98)00067-1
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Guibal E., 2007, SEP SCI TECHNOL, V43, P2406
   Herrero R, 2005, WATER RES, V39, P3199, DOI 10.1016/j.watres.2005.05.041
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Jeon C, 2005, WATER RES, V39, P3938, DOI 10.1016/j.watres.2005.07.020
   Jeon C, 2003, WATER RES, V37, P4770, DOI 10.1016/S0043-1354(03)00431-7
   Jouannin C, 2011, APPL CATAL B-ENVIRON, V103, P444, DOI 10.1016/j.apcatb.2011.02.008
   Kapoor A, 1995, BIORESOURCE TECHNOL, V53, P195, DOI 10.1016/0960-8524(95)00072-1
   Kapoor K., 2008, BIOTECHNOL ADV, V26, P266
   KURITA K, 1979, J APPL POLYM SCI, V23, P511, DOI 10.1002/app.1979.070230221
   Kushwaha S, 2011, CARBOHYD POLYM, V86, P1055, DOI 10.1016/j.carbpol.2011.06.028
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Liu CX, 2006, J MEMBRANE SCI, V279, P336, DOI 10.1016/j.memsci.2005.12.019
   Ma F, 2009, J HAZARD MATER, V172, P792, DOI 10.1016/j.jhazmat.2009.07.066
   Merrifield JD, 2004, WATER RES, V38, P3132, DOI 10.1016/j.watres.2004.04.008
   Miretzky P, 2009, J HAZARD MATER, V167, P10, DOI 10.1016/j.jhazmat.2009.01.060
   Monier M, 2012, J HAZARD MATER, V209, P240, DOI 10.1016/j.jhazmat.2012.01.015
   Ng JCY, 2002, J COLLOID INTERF SCI, V255, P64, DOI 10.1006/jcis.2002.8664
   Pillai CKS, 2009, PROG POLYM SCI, V34, P641, DOI 10.1016/j.progpolymsci.2009.04.001
   Qu RJ, 2009, J HAZARD MATER, V167, P717, DOI 10.1016/j.jhazmat.2009.01.043
   Rae IB, 2009, J HAZARD MATER, V164, P1601, DOI 10.1016/j.jhazmat.2008.09.052
   Rao MM, 2009, J ENVIRON MANAGE, V90, P634, DOI 10.1016/j.jenvman.2007.12.019
   Reategui M, 2010, APPL BIOCHEM BIOTECH, V162, P805, DOI 10.1007/s12010-010-8912-5
   Roberts G, 1992, CHITIN CHEM
   Romera E, 2007, BIORESOURCE TECHNOL, V98, P3344, DOI 10.1016/j.biotech.2006.09.026
   Shafaei A, 2007, CHEM ENG J, V133, P311, DOI 10.1016/j.cej.2007.02.016
   Shawky H-A., 2012, J APPL POLYM SCI, V125, P93
   Shinde RN, 2013, WATER RES, V47, P3497, DOI 10.1016/j.watres.2013.03.059
   Tuzun I, 2005, J ENVIRON MANAGE, V77, P85, DOI 10.1016/j.jenvman.2005.01.028
   Vieira RS, 2011, COLLOID SURFACE A, V374, P108, DOI 10.1016/j.colsurfa.2010.11.022
   Vieira RS, 2006, WATER RES, V40, P1726, DOI 10.1016/j.watres.2006.02.027
   Vieira RS, 2005, ADSORPTION, V11, P731, DOI 10.1007/s10450-005-6015-3
   Vincent T, 2004, ENVIRON SCI TECHNOL, V38, P4233, DOI 10.1021/es034862m
   Wang L, 2010, INT J BIOL MACROMOL, V46, P524, DOI 10.1016/j.ijbiomac.2010.03.003
   Wang Y, 2013, J HAZARD MATER, V260, P9, DOI 10.1016/j.jhazmat.2013.05.001
   WANNGAH WS, 2002, REACT FUNCT POLYM, V50, P181, DOI DOI 10.1016/S1381-5148(01)00113-4
   World Health Organization (W.H.O), 1993, MERC DRINK WAT GUID, V1
   Xiong CH, 2013, CARBOHYD POLYM, V98, P1222, DOI 10.1016/j.carbpol.2013.07.034
   Zeroual Y, 2003, BIORESOURCE TECHNOL, V90, P349, DOI 10.1016/S0960-8524(03)00122-6
   Zhou L, 2007, MOD CHEM IND, V27, P175
   Zhou LM, 2009, J HAZARD MATER, V161, P995, DOI 10.1016/j.jhazmat.2008.04.078
NR 55
TC 24
Z9 25
U1 3
U2 70
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
EI 1873-4359
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD APR 5
PY 2014
VL 446
BP 224
EP 232
DI 10.1016/j.colsurfa.2014.01.025
PG 9
WC Chemistry, Physical
SC Chemistry
GA AD8AF
UT WOS:000333488200028
DA 2018-10-19
ER

PT J
AU Depanche, K
   Bennett, JA
   Mikheenko, IP
   Omajali, J
   Wells, AS
   Meadows, RE
   Wood, J
   Macaskie, LE
AF Depanche, K.
   Bennett, J. A.
   Mikheenko, I. P.
   Omajali, J.
   Wells, A. S.
   Meadows, R. E.
   Wood, J.
   Macaskie, L. E.
TI Catalytic activity of biomass-supported Pd nanoparticles: Influence of
   the biological component in catalytic efficacy and potential application
   in 'green' synthesis of fine chemicals and pharmaceuticals
SO APPLIED CATALYSIS B-ENVIRONMENTAL
LA English
DT Article
DE Catalysis; Cr(VI) reduction; Heck coupling; Hydrogenase; Suzuki reaction
ID SULFATE-REDUCING BACTERIA; SHEWANELLA-ONEIDENSIS MR-1; S-LAYER PROTEINS;
   ESCHERICHIA-COLI; DESULFOVIBRIO-DESULFURICANS; BACILLUS-SPHAERICUS;
   PALLADIUM CATALYSTS; COUPLING REACTIONS; PRECIOUS METALS; HECK REACTION
AB Five gram negative and two gram positive bacterial strains known for their heavy metal tolerance or ability to reduce metal ions were coated with Pd(0) nanoparticles (NPs) via reduction of soluble Pd(II) ions under H-2 following an initial uptake of PdCl42- without added electron donor ('biosorption'), where the gram negative strains had a similar to 5-fold greater capacity for Pd(II). Cupriavidis metallidurans accumulated Pd(II) exceptionally; the possibility of reduction to Pd(0) via an endogenous electron donor was not discounted. The initial rate of subsequent H-2-mediated Pd(II) reduction correlated with the Pd(II) removed during biosorption (r(2) = 0.9). TEM showed strain-specific variations of Pd-NPs. At a 1:3 loading of Pd:biomass the cell surfaces of Escherichia coli and Desulfovibrio desulfuricans showed uniform coverage with small NPs with the other strains showing larger aggregates. NPs made by the gram positive cells appeared larger than their gram negative counterparts. At a loading of 1:19 all were active catalysts in Cr(VI) reduction and in two Heck coupling reactions. BioPd(E. coli) and bioPd(D. desulfuricans) and bioPd(A. oxydans) were consistently the best and worst catalysts respectively. BioPd(E. culi) was further tested as a process catalyst according to industrial protocols in Fleck and Suzuki coupling reactions. Laboratory and industrial tests (coupling of phenyl iodide and ethyl acrylate) gave 75% and 78% conversion to ethyl cinnamate, respectively. The biomaterial catalysed Heck and Suzuki reactions using bromoacetophenone and 4-bromoanisole (Heck) and 4-chloroanisole (Suzuki) but not 3-chlorotoluene. In accordance with known chemical catalysis the catalytic efficacy was related to electron-withdrawing substituents on the phenyl ring, with more than 90% conversion (Suzuki) using 4-bromobenzotrifluoride. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Depanche, K.; Mikheenko, I. P.; Omajali, J.; Macaskie, L. E.] Univ Birmingham, Sch Biosci, Unit Funct Bionanomat, Birmingham B15 2TT, W Midlands, England.
   [Bennett, J. A.; Wood, J.] Univ Birmingham, Dept Chem Engn, Birmingham B15 2TT, W Midlands, England.
   [Wells, A. S.; Meadows, R. E.] AstraZeneca R&D Charnwood, Loughborough LE11 5RH, Leics, England.
RP Macaskie, LE (reprint author), Univ Birmingham, Sch Biosci, Unit Funct Bionanomat, Birmingham B15 2TT, W Midlands, England.
EM l.e.macaskie@bham.ac.uk
OI Mikheenko, Iryna/0000-0001-6361-6740; Deplanche,
   Kevin/0000-0002-2068-8637; Omajali, PhD, Jacob B./0000-0002-5438-7613
FU BBSRC [BB/C516128/1]; EPSRC [EP/I007806/1, EP/D05768X/1]; British
   Council Entente Cordiale fellowship; BBSRC/Royal Society Industrial
   Fellowship; Biotechnology and Biological Sciences Research Council
   [BB/C516128/1, BB/E003788/1]; Engineering and Physical Sciences Research
   Council [EP/I007806/1, EP/H029567/1, EP/D05768X/1]
FX This work was supported by the BBSRC (Grant No. BB/C516128/1), EPSRC
   (grants no EP/I007806/1 and EP/D05768X/1) and by a British Council
   Entente Cordiale fellowship to K.D. L.E.M. was supported by a
   BBSRC/Royal Society Industrial Fellowship. We thank Mr. Graham Burns
   (School of Chemistry, University of Birmingham, U.K.) for his help with
   HPLC analysis and Prof G. Attard (University of Cardiff) for useful
   discussions.
CR Allan VJM, 2002, MICROBIOL-SGM, V148, P277, DOI 10.1099/00221287-148-1-277
   Angelov A, 2006, J BIOTECHNOL, V126, P3, DOI 10.1016/j.jbiotec.2006.02.017
   [Anonymous], 2008, Resource Efficiency KTN, Material Security - Ensuring Resource Avail-ability for the UK Economy, Patent No. [WO/2006/087334, 200605094]
   [Anonymous], 2008, RESOURCE EFFICIENCY
   Astana T.V., 2004, CURR MICROBIOL, V49, P321
   Attard G, 2012, LANGMUIR, V28, P5267, DOI 10.1021/la204495z
   Baxter-Plant V, 2003, BIODEGRADATION, V14, P83, DOI 10.1023/A:1024084611555
   Beauregard DA, 2010, BIOTECHNOL BIOENG, V107, P11, DOI 10.1002/bit.22791
   Beeby A, 2004, NEW J CHEM, V28, P600, DOI 10.1039/b401077a
   Beletskaya IP, 2000, CHEM REV, V100, P3009, DOI 10.1021/cr9903048
   Bennett JA, 2013, APPL CATAL B-ENVIRON, V140, P700, DOI 10.1016/j.apcatb.2013.04.022
   BEVERIDGE TJ, 1990, J BACTERIOL, V172, P1609, DOI 10.1128/jb.172.3.1609-1620.1990
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   Bonthrone KM, 2000, ENVIRON TECHNOL, V21, P123, DOI 10.1080/09593330.2000.9618893
   Briggs BD, 2012, J PHYS CHEM LETT, V3, P405, DOI 10.1021/jz2016473
   CABRI W, 1995, ACCOUNTS CHEM RES, V28, P2, DOI 10.1021/ar00049a001
   Camargo FAO, 2003, J ENVIRON QUAL, V32, P1228, DOI 10.2134/jeq2003.1228
   Chariot G., 1978, DOSAGES ABSORPTIOMET, P380
   CHURCHILL SA, 1995, J ENVIRON ENG-ASCE, V121, P706, DOI 10.1061/(ASCE)0733-9372(1995)121:10(706)
   Coelho AV, 2007, TETRAHEDRON LETT, V48, P7671, DOI 10.1016/j.tetlet.2007.08.091
   Creamer NJ, 2007, CATAL TODAY, V128, P80, DOI 10.1016/j.cattod.2007.04.014
   Creamer NJ, 2006, BIOTECHNOL LETT, V28, P1475, DOI 10.1007/s10529-006-9120-9
   De Corte S, 2012, MICROB BIOTECHNOL, V5, P5, DOI 10.1111/j.1751-7915.2011.00265.x
   de Vargas I, 2004, J CHEM TECHNOL BIOT, V79, P49, DOI 10.1002/jctb.928
   De Vargas I., 2005, 16 INT BIOH S CAP TO, P605
   DEMOPOULOS GP, 1989, CIM BULL, V82, P165
   Deplanche K, 2009, ENVIRON TECHNOL, V30, P681, DOI 10.1080/09593330902860712
   Deplanche K., 2011, NANOMATERIALS
   DEPLANCHE K, 2008, THESIS U BIRMINGHAM
   Deplanche K, 2012, J R SOC INTERFACE, V9, P1705, DOI 10.1098/rsif.2012.0003
   Deplanche K, 2010, MICROBIOL-SGM, V156, P2630, DOI 10.1099/mic.0.036681-0
   Edwards R.I., 1986, GMELIN HDB INORG S A, V1, P1
   Fahmy K, 2006, BIOPHYS J, V91, P996, DOI 10.1529/biophysj.105.079137
   Foulkes JM, 2011, ACS CATAL, V1, P1589, DOI 10.1021/cs200400t
   Greenwood N. N., 1984, CHEM ELEMENTS, P1328
   Guibal E, 2004, SEP PURIF TECHNOL, V38, P43, DOI 10.1016/j.seppur.2003.10.004
   Haferburg G, 2007, J BASIC MICROB, V47, P474, DOI 10.1002/jobm.200700256
   Heidenreich RG, 2002, J MOL CATAL A-CHEM, V182, P499, DOI 10.1016/S1381-1169(01)00499-X
   Hewitt CJ, 2000, BIOTECHNOL BIOENG, V70, P381, DOI 10.1002/1097-0290(20001120)70:4<381::AID-BIT3>3.0.CO;2-0
   Humphries AC, 2004, BIOTECHNOL LETT, V26, P1529, DOI 10.1023/B:BILE.0000044457.80314.4d
   Jana S, 2009, TETRAHEDRON LETT, V50, P4820, DOI 10.1016/j.tetlet.2009.05.098
   Kamionka M, 2011, CURR PHARM BIOTECHNO, V12, P268, DOI 10.2174/138920111794295693
   Ledrich ML, 2005, BIOMETALS, V18, P643, DOI 10.1007/s10534-005-3858-8
   Leung WC, 2000, WATER SCI TECHNOL, V41, P233
   Lie TJ, 1996, ARCH MICROBIOL, V166, P204, DOI 10.1007/s002030050376
   Lin Z., 2012, CHINESE SCI BULL, V47, P1262
   Lin ZY, 2002, CHINESE SCI BULL, V47, P1262, DOI 10.1360/02tb9279
   Liu CX, 2002, BIOTECHNOL BIOENG, V80, P637, DOI 10.1002/bit.10430
   Lloyd JR, 1997, BIOTECHNOL BIOENG, V55, P505, DOI 10.1002/(SICI)1097-0290(19970805)55:3<505::AID-BIT6>3.0.CO;2-G
   Lloyd JR, 1998, APPL ENVIRON MICROB, V64, P4607
   Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4
   Lloyd JR, 2003, FEMS MICROBIOL REV, V27, P411, DOI 10.1016/S0168-6445(03)00044-5
   Lloyd JR, 1997, J BACTERIOL, V179, P2014, DOI 10.1128/jb.179.6.2014-2021.1997
   Lo W, 2001, APPL BIOCHEM BIOTECH, V92, P1
   LOVLEY DR, 1995, J IND MICROBIOL, V14, P85, DOI 10.1007/BF01569889
   LOVLEY DR, 1992, APPL ENVIRON MICROB, V58, P850
   LOVLEY DR, 1991, MICROBIOL REV, V55, P259
   LOVLEY DR, 1994, APPL ENVIRON MICROB, V60, P726
   Lovley DR, 2004, ADV MICROB PHYSIOL, V49, P219, DOI 10.1016/S0065-2911(04)49005-5
   Mabbett A.N., 2001, BIOHYDROMETALLURGY F, P335
   Mabbett AN, 2006, ENVIRON SCI TECHNOL, V40, P1015, DOI 10.1021/es0509836
   Mabbett AN, 2004, BIOTECHNOL BIOENG, V87, P104, DOI 10.1002/bit.20105
   Mabbett AN, 2002, J CHEM TECHNOL BIOT, V77, P1169, DOI 10.1002/jctb.693
   Macaskie L. E., 2011, COMPREHENSIVE BIOTEC, P719
   Macaskie LE, 2005, BIOCHEM SOC T, V33, P76, DOI 10.1042/BST0330076
   Macaskie LE, 2012, J CHEM TECHNOL BIOT, V87, P1430, DOI 10.1002/jctb.3763
   Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x
   Marshall ST, 2010, NAT MATER, V9, P853, DOI [10.1038/nmat2849, 10.1038/NMAT2849]
   Megharaj M, 2003, CURR MICROBIOL, V47, P51, DOI 10.1007/s00284-002-3889-0
   Merroun ML, 2005, APPL ENVIRON MICROB, V71, P5532, DOI 10.1128/AEM.71.9.5532-5543.2005
   Meshulam-Simon G, 2007, APPL ENVIRON MICROB, V73, P1153, DOI 10.1128/AEM.01588-06
   Messner P., 2010, MICROBIAL GLYCOBIOLO, P109
   Mikheenko IP, 2008, APPL ENVIRON MICROB, V74, P6144, DOI 10.1128/AEM.02538-07
   Mikheenko I.P., 2001, BIOHYDROMETALLURGY F, P525
   MIKHEENKO IP, 2004, THESIS U BIRMINGHAM
   Mondaca M.A., 2002, TheScientificWorldJOURNAL, V2, P972
   Nakajima A, 2004, J RADIOANAL NUCL CH, V260, P13, DOI 10.1023/B:JRNC.0000027055.16768.1e
   Orozco RL, 2010, BIOTECHNOL LETT, V32, P1837, DOI 10.1007/s10529-010-0383-9
   Parkin A, 2012, FEBS LETT, V586, P536, DOI 10.1016/j.febslet.2011.07.044
   Pollmann K, 2005, MICROBIOL-SGM, V151, P2961, DOI 10.1099/mic.0.28201-0
   Raszka A, 2006, ACTA HYDROCH HYDROB, V34, P411, DOI 10.1002/aheh.200500640
   Reith F, 2006, SCIENCE, V313, P233, DOI 10.1126/science.1125878
   Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106
   Rotaru AE, 2012, BIOTECHNOL BIOENG, V109, P1889, DOI 10.1002/bit.24500
   Rousset M., 2006, International Application, Patent No. [2006087334, PCT/EP2006/05094]
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   Selenska-Pobell S, 1999, FEMS MICROBIOL ECOL, V29, P59, DOI 10.1016/S0168-6496(98)00130-5
   SHEN H, 1994, J ENVIRON ENG-ASCE, V120, P560, DOI 10.1061/(ASCE)0733-9372(1994)120:3(560)
   Skibar W., 2005, NOVEL PRECIOUS METAL
   Tagata T, 2003, J ORG CHEM, V68, P9412, DOI 10.1021/jo034970r
   Taylor S., 2012, THESIS U BIRMINGHAM
   Van Nostrand JD, 2007, MICROB ECOL, V53, P670, DOI 10.1007/s00248-006-9160-7
   Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102
   Vincent T, 2004, ENVIRON SCI TECHNOL, V38, P4233, DOI 10.1021/es034862m
   Visconti CG, 2007, APPL CATAL A-GEN, V330, P49, DOI 10.1016/j.apcata.2007.07.009
   Volesky B., 1999, BIOHYDROMETALLURGY E
   von Rozycki T, 2005, COMP FUNCT GENOM, V6, P17, DOI 10.1002/cfg.454
   Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057
   Wiatrowski HA, 2006, ENVIRON SCI TECHNOL, V40, P6690, DOI 10.1021/es061046g
   Wolfe JP, 1999, J AM CHEM SOC, V121, P9550, DOI 10.1021/ja992130h
   Wolfe JP, 1999, ANGEW CHEM INT EDIT, V38, P2413, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2413::AID-ANIE2413>3.0.CO;2-H
   WOOLFOLK CA, 1962, J BACTERIOL, V84, P647
   YANKE LJ, 1995, ANAEROBE, V1, P61, DOI 10.1016/S1075-9964(95)80457-9
   Yin LX, 2007, CHEM REV, V107, P133, DOI 10.1021/cr0505674
   Yong P, 2007, BIOTECHNOL LETT, V29, P539, DOI 10.1007/s10529-006-9283-4
   Yong P, 2002, BIOTECHNOL BIOENG, V80, P369, DOI 10.1002/bit.10369
   Yong P, 2003, ENVIRON TECHNOL, V24, P289, DOI 10.1080/09593330309385561
   Yong P., 2002, J CHEM TECHNOL BIOT, V77, P1
   Yong P, 2010, BIOTECHNOL LETT, V32, P1821, DOI 10.1007/s10529-010-0378-6
   Zhao FY, 2000, CHEM-EUR J, V6, P843, DOI 10.1002/(SICI)1521-3765(20000303)6:5<843::AID-CHEM843>3.0.CO;2-G
   Zhu J., 2011, C P HYBR MAT 2 INT C
NR 111
TC 12
Z9 12
U1 5
U2 107
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-3373
EI 1873-3883
J9 APPL CATAL B-ENVIRON
JI Appl. Catal. B-Environ.
PD APR 5
PY 2014
VL 147
BP 651
EP 665
DI 10.1016/j.apcatb.2013.09.045
PG 15
WC Chemistry, Physical; Engineering, Environmental; Engineering, Chemical
SC Chemistry; Engineering
GA 300UL
UT WOS:000330489400071
OA Other Gold
DA 2018-10-19
ER

PT J
AU Coppoolse, JMS
   Van Kooten, TG
   Heris, HK
   Mongeau, L
   Li, NYK
   Thibeault, SL
   Pitaro, J
   Akinpelu, O
   Daniel, SJ
AF Coppoolse, Jiska M. S.
   Van Kooten, T. G.
   Heris, Hossein K.
   Mongeau, Luc
   Li, Nicole Y. K.
   Thibeault, Susan L.
   Pitaro, Jacob
   Akinpelu, Olubunmi
   Daniel, Sam J.
TI An In Vivo Study of Composite Microgels Based on Hyaluronic Acid and
   Gelatin for the Reconstruction of Surgically Injured Rat Vocal Folds
SO JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH
LA English
DT Article
DE injectable biomaterial; composite hydrogel; tissue engineering; wound
   healing; vocal fold lamina propria; scarring
ID EXTRACELLULAR-MATRIX; RABBIT MODEL; HISTOLOGIC CHARACTERIZATION;
   GRANULATION-TISSUE; LAMINA PROPRIA; CANINE MODEL; COLLAGEN; REPAIR;
   SCAR; CORD
AB Purpose: The objective of this study was to investigate local injection with a hierarchically microstructured hyaluronic acid-gelatin (HA-Ge) hydrogel for the treatment of acute vocal fold injury using a rat model.
   Method: Vocal fold stripping was performed unilaterally in 108 Sprague-Dawley rats. A volume of 25 mu l saline (placebo controls), HA-bulk, or HA-Ge hydrogel was injected into the lamina propria (LP) 5 days after surgery. The vocal folds were harvested at 3, 14, and 28 days after injection and analyzed using hematoxylin and eosin staining and immunohistochemistry staining for macrophages, myofibroblasts, elastin, collagen type I, and collagen type III.
   Results: The macrophage count was statistically significantly lower in the HA-Ge group than in the saline group (p < .05) at Day 28. Results suggested that the HA-Ge injection did not induce inflammatory or rejection response. Myofibroblast counts and elastin were statistically insignificant across treatment groups at all time points. Increased elastin deposition was qualitatively observed in both HA groups from Day 3 to Day 28, and not in the saline group. Significantly more elastin was observed in the HA-bulk group than in the uninjured group at Day 28. Significantly more collagen type I was observed in the HA-bulk and HA-Ge groups than in the saline group (p < .05) at Day 28. The collagen type I concentration in the HA-Ge and saline groups was found to be comparable to that in the uninjured controls at Day 28. The concentration of collagen type III in all treatment groups was similar to that in uninjured controls at Day 28.
   Conclusion: Local HA-Ge and HA-bulk injections for acute injured vocal folds were biocompatible and did not induce adverse response.
C1 [Coppoolse, Jiska M. S.; Van Kooten, T. G.] Univ Groningen, NL-9700 AB Groningen, Netherlands.
   [Heris, Hossein K.; Mongeau, Luc; Pitaro, Jacob; Akinpelu, Olubunmi; Daniel, Sam J.] McGill Univ, Montreal, PQ, Canada.
   [Li, Nicole Y. K.] Univ Maryland, College Pk, MD 20742 USA.
   [Thibeault, Susan L.] Univ Wisconsin, Madison, WI 53706 USA.
RP Mongeau, L (reprint author), McGill Univ, Montreal, PQ, Canada.
EM luc.mongeau@mcgill.ca
OI Mongeau, Luc/0000-0003-0344-227X
FU National Institute on Deafness and Other Communication Disorders (NIDCD)
   [DC 005788]; NIDCD [DC 004336]
FX This work has been supported by the National Institute on Deafness and
   Other Communication Disorders (NIDCD) Grant DC 005788 (L. Mongeau, PI).
   We acknowledge the support of NIDCD Grant DC 004336 (Thibeault, PI) for
   the collagen III staining and analysis, performed at the University of
   Wisconsin. We thank the staffs of the Bone Centre and Imaging Centre of
   McGill University for the use of their facilities and of the University
   of Wisconsin-Madison for their technical support. We acknowledge Drew
   Roenneburg and Sarah Wang for staining of histological slides against
   collagen III and associated image analysis. We also acknowledge Mario
   Mujica-Mota for helping with the surgeries.
CR ARNOLD GE, 1963, ARCHIV OTOLARYNGOL, V78, P179
   ARONSON AE, 1966, J SPEECH HEAR DISORD, V31, P115, DOI 10.1044/jshd.3102.115
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   BRANDENBURG JH, 1992, LARYNGOSCOPE, V102, P495, DOI 10.1288/00005537-199205000-00005
   Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x
   Chan RW, 1999, LARYNGOSCOPE, V109, P1142, DOI 10.1097/00005537-199907000-00026
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Courey MS, 1996, ANN OTO RHINOL LARYN, V105, P525, DOI 10.1177/000348949610500706
   DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   FORD CN, 1984, LARYNGOSCOPE, V94, P513, DOI 10.1288/00005537-198404000-00016
   Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   Gilbert TW, 2009, LARYNGOSCOPE, V119, P1856, DOI 10.1002/lary.20575
   Gonzales R.C., 2001, DIGITAL IMAGE PROCES
   Gray SD, 1999, ANN OTO RHINOL LARYN, V108, P1
   Gray SD, 2000, ANN OTO RHINOL LARYN, V109, P77, DOI 10.1177/000348940010900115
   Greenspan DS, 2005, TOP CURR CHEM, V247, P149, DOI 10.1007/b103822
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P225, DOI 10.1177/000348940611500311
   Hahn MS, 2006, ANN OTO RHINOL LARYN, V115, P156, DOI 10.1177/000348940611500213
   Hahn MS, 2005, ANN OTO RHINOL LARYN, V114, P451, DOI 10.1177/000348940511400607
   Hallen L, 1999, ACTA OTO-LARYNGOL, V119, P107
   Hammond TH, 1997, J VOICE, V11, P59, DOI 10.1016/S0892-1997(97)80024-0
   Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005
   Hansen JK, 2005, ANN OTO RHINOL LARYN, V114, P662, DOI 10.1177/000348940511400902
   Heris HK, 2013, J MECH BEHAV BIOMED, V28, P383, DOI 10.1016/j.jmbbm.2013.05.026
   Heris HK, 2012, MACROMOL BIOSCI, V12, P202, DOI 10.1002/mabi.201100335
   Hertegard S, 2002, LARYNGOSCOPE, V112, P2211, DOI 10.1097/00005537-200212000-00016
   Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112
   HIRANO M, 1974, FOLIA PHONIATR, V26, P89, DOI 10.1159/000263771
   Hirano S, 2009, J VOICE, V23, P399, DOI 10.1016/j.jvoice.2007.12.002
   Hirano Shigeru, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P143, DOI 10.1097/01.moo.0000162261.49739.b7
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kazemirad S, 2013, J ACOUST SOC AM, V133, P3186, DOI 10.1121/1.4798668
   Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961
   KOUFMAN JA, 1986, LARYNGOSCOPE, V96, P726
   Krischke S, 2005, J VOICE, V19, P132, DOI 10.1016/j.jvoice.2004.01.007
   Perazzo PSL, 2009, J VOICE, V23, P95, DOI 10.1016/j.jvoice.2007.05.006
   Miri AK, 2013, ACTA BIOMATER, V9, P7957, DOI 10.1016/j.actbio.2013.04.044
   Miri AK, 2012, LARYNGOSCOPE, V122, P356, DOI 10.1002/lary.22460
   Petersen A, 2012, TISSUE ENG PT A, V18, P1804, DOI [10.1089/ten.tea.2011.0514, 10.1089/ten.TEA.2011.0514]
   Rousseau B, 2004, J VOICE, V18, P116, DOI 10.1016/j.jvoice.2003.06.001
   Rousseau B, 2003, LARYNGOSCOPE, V113, P620, DOI 10.1097/00005537-200304000-00007
   Sahiner N, 2008, J BIOMAT SCI-POLYM E, V19, P223, DOI 10.1163/156856208783432462
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Suehiro A, 2012, LARYNGOSCOPE, V122, P600, DOI 10.1002/lary.22470
   Tateya T, 2006, ANN OTO RHINOL LARYN, V115, P285, DOI 10.1177/000348940611500406
   Tateya T, 2005, ANN OTO RHINOL LARYN, V114, P183, DOI 10.1177/000348940511400303
   Tateya T, 2007, ANN OTO RHINOL LARYN, V116, P156, DOI 10.1177/000348940711600212
   Thibeault SL, 2004, LARYNGOSCOPE, V114, P760, DOI 10.1097/00005537-200404000-00031
   Thibeault SL, 2002, J VOICE, V16, P96, DOI 10.1016/S0892-1997(02)00078-4
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Ward PD, 2002, J VOICE, V16, P303, DOI 10.1016/S0892-1997(02)00101-7
   WEIGEL PH, 1986, J THEOR BIOL, V119, P219, DOI 10.1016/S0022-5193(86)80076-5
   Welham NV, 2009, J SPEECH LANG HEAR R, V52, P1008, DOI 10.1044/1092-4388(2009/08-0049)
NR 58
TC 10
Z9 10
U1 1
U2 15
PU AMER SPEECH-LANGUAGE-HEARING ASSOC
PI ROCKVILLE
PA 10801 ROCKVILLE PIKE, ROCKVILLE, MD 20852-3279 USA
SN 1092-4388
EI 1558-9102
J9 J SPEECH LANG HEAR R
JI J. Speech Lang. Hear. Res.
PD APR
PY 2014
VL 57
IS 2
BP S658
EP S673
DI 10.1044/2014_JSLHR-S-12-0292
PG 16
WC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
SC Audiology & Speech-Language Pathology; Linguistics; Rehabilitation
GA AZ4MM
UT WOS:000348195600005
PM 24687141
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Eliseeff, J
AF Eliseeff, Jennifer
TI Biomaterial scaffolds in regenerative medicine
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 26-30, 2014
CL San Diego, CA
SP Cenveo, LI COR, Wiley, Mead Johnson Pediat Nutr Inst, IPRECIO, F1000 Res, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut
C1 [Eliseeff, Jennifer] Johns Hopkins Univ, Translat Tissue Engn Ctr, Baltimore, MD USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2014
VL 28
IS 1
SU S
MA 81.2
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA AX0MP
UT WOS:000346646704413
DA 2018-10-19
ER

PT J
AU Ahad, IU
   Budner, B
   Korczyc, B
   Fiedorowicz, H
   Bartnik, A
   Kostecki, J
   Burdynska, S
   Brabazon, D
AF Ahad, I. U.
   Budner, B.
   Korczyc, B.
   Fiedorowicz, H.
   Bartnik, A.
   Kostecki, J.
   Burdynska, S.
   Brabazon, D.
TI Polycarbonate Polymer Surface Modification by Extreme Ultraviolet (EUV)
   Radiation
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 48th Zakopane-School-of-Physics International Symposium on Breaking
   Frontiers - Submicron Structures in Physics and Biology
CY MAY 20-25, 2013
CL Zakopane, POLAND
ID LASER; BIOMATERIALS; IRRADIATION; ABLATION
AB The degree of the biocompatibility of polycarbonate (PC) polymer used as biomaterial can be controlled by surface modification for various biomedical engineering applications. In the past, PC samples were treated by excimer laser for surface reorganization however associated process alteration of bulk properties is reported. Extreme ultraviolet radiation can be employed in order to avoid bulk material alteration due to its limited penetration. In this study, a 10 Hz laser-plasma EUV source based on a double-stream gas-puff target irradiated with a 3 ns and 0.8 J Nd:YAG laser pulse was used to irradiate PC samples. The PC samples were irradiated with different number of EUV shots. Pristine and EUV treated samples were investigated by scanning electron microscopy and atomic force microscopy for detailed morphological characterization of micropatterns introduced by the EUV irradiation. Associated chemical modifications were investigated by X-ray photoelectron spectroscopy. Pronounced wall-type micro- and nanostructures appeared on the EUV modified surface resulting in a change of surface roughness and wettability.
C1 [Ahad, I. U.; Budner, B.; Korczyc, B.; Fiedorowicz, H.; Bartnik, A.; Kostecki, J.; Burdynska, S.] Mil Univ Technol, Inst Optoelect, PL-00908 Warsaw, Poland.
   [Ahad, I. U.; Brabazon, D.] Dublin City Univ, Fac Engn & Comp, Sch Mech & Mfg Engn, Adv Proc Technol Res Ctr, Dublin 9, Ireland.
RP Ahad, IU (reprint author), Mil Univ Technol, Inst Optoelect, S Kaliskiego 2, PL-00908 Warsaw, Poland.
EM iuahad@wat.edu.pl
RI Ahad, Inam Ul/M-6262-2017
OI Ahad, Inam Ul/0000-0002-3802-6156; Fiedorowicz,
   Henryk/0000-0002-7022-3408; Budner, Boguslaw/0000-0002-9395-6073;
   Kostecki, Jerzy/0000-0003-0105-0109; Brabazon,
   Dermot/0000-0003-3214-6381
FU EU [FPA-2012-0033]; 7th Framework Programme's Laser lab Europe project
   [284464]
FX Authors acknowledge financial support from the EU FP7 Erasmus Mundus
   Joint Doctorate Programme EXTATIC under framework partnership agreement
   FPA-2012-0033. With support from the 7th Framework Programme's Laser lab
   Europe project (No. 284464).
CR Ahad I.U., 2013, EUR CELLS MAT S6, V26, P145
   Ahad I.U., 2013, J BIOMED MAT RES A
   Antonio PD, 2012, BBA-BIOMEMBRANES, V1818, P3141, DOI 10.1016/j.bbamem.2012.08.001
   ARENHOLZ E, 1991, APPL PHYS A-MATER, V53, P330, DOI 10.1007/BF00357196
   Bartnik A, 2011, NUCL INSTRUM METH A, V647, P125, DOI 10.1016/j.nima.2011.05.033
   Bartnik A, 2012, APPL PHYS A-MATER, V109, P39, DOI 10.1007/s00339-012-7243-5
   FIEDOROWICZ H, 1993, APPL PHYS LETT, V62, P2778, DOI 10.1063/1.109232
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Hadjizadeh A, 2010, J MECH BEHAV BIOMED, V3, P574, DOI 10.1016/j.jmbbm.2010.07.002
   Heitz J, 1997, APPL PHYS A-MATER, V65, P259, DOI 10.1007/s003390050575
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Jorgensen J. F., 1993, Nanotechnology, V4, P152, DOI 10.1088/0957-4484/4/3/004
   Laurens P, 2000, APPL SURF SCI, V154, P211, DOI 10.1016/S0169-4332(99)00443-2
   Lippert T, 1996, MACROMOLECULES, V29, P6301, DOI 10.1021/ma9517198
   Liu YM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862775
   Reisinger B, 2010, APPL PHYS A-MATER, V100, P511, DOI 10.1007/s00339-010-5845-3
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
NR 17
TC 10
Z9 10
U1 0
U2 9
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD APR
PY 2014
VL 125
IS 4
BP 924
EP 928
DI 10.12693/APhysPolA.125.924
PG 5
WC Physics, Multidisciplinary
SC Physics
GA AM4NA
UT WOS:000339830200018
OA Bronze
DA 2018-10-19
ER

PT J
AU Carinci, F
   Santarelli, A
   Laino, L
   Pezzetti, E
   De Lillo, A
   Parisi, D
   Bambini, F
   Procaccini, M
   Testa, NF
   Cocchi, R
   Lo Muzio, L
AF Carinci, F.
   Santarelli, A.
   Laino, L.
   Pezzetti, E.
   De Lillo, A.
   Parisi, D.
   Bambini, F.
   Procaccini, M.
   Testa, N. F.
   Cocchi, R.
   Lo Muzio, L.
TI PRE-CLINICAL EVALUATION OF A NEW CORAL-BASED BONE SCAFFOLD
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE bone; coral; scaffold; polymer; cDNA microarray
ID MANDIBULAR DISTRACTION OSTEOGENESIS; IMPLANT SOFT-TISSUES;
   CALCIUM-CARBONATE; MORPHOGENETIC PROTEINS; MICROARRAY TECHNOLOGY;
   GENE-EXPRESSION; LOCALIZATION; TITANIUM; SULFATE; RALOXIFENE
AB Coral is used worldwide for bone reconstruction. The favorable characteristics that make this material desirable for implantation are (i) osteoinduction, (ii) and osteoconduction. These proprieties have been demonstrated by in vivo studies with animal models and clinical trials over a twenty-year period. Also poly(2-hydroxyethylmethacrylate) [poly(HEMA)] is a widely used biomaterial. By using coral and poly(HEMA), a scaffold for bone reconstruction application has been recently synthesized. Cytological, histological and genetic analyses were performed to characterize this new alloplastic material. Four samples were analyzed: (a) white coral (WC), (b) red coral (RC), (c) WC plus polymer (WCP) and (d) RC plus polymer (RCP). Quantification of mitochondrial dehydrogenase activity by MTT assay was performed as indirect detector of cytotoxicity. In vivo effects were revealed by implanting corals and coral-based polymers in rabbit tibia. Samples were collected after 4 weeks and subjected to histological analysis. To evaluate the genetic response of cells to corals and coral-derived polymers an osteoblast, like cell line (i.e. MG63) was cultured in wells containing (a) medium, (b) medium plus corals and (c) medium plus two types of scaffolds (RCP or WCP). RNAs extracted from cells were retro-transcribed and hybridized on DNA 19.2K microarrays. No cytotoxicity was detected in corals and coral-based biopolymers. No inflammation or adverse effect was revealed by histological examination. By microarray analysis 154 clones were differentially expressed between RC and WC (81 up and 73 down regulated) whereas only 15 clones were repressed by the polymer. Histological evaluation not only confirmed that coral is a biocompatible material, but also that the polymer has no adverse effect Microarray results were in agreement with cytological and histological analyses and provided further data regarding the genetic effects of RC, WC and the new polymer.
C1 [Carinci, F.] Univ Ferrara, Dept Expt Morphol Surg & Med, I-44100 Ferrara, Italy.
   [Santarelli, A.; Bambini, F.; Procaccini, M.] Marche Polytech Univ, Dept Clin Specialist & Stomatol Sci, Ancona, Italy.
   [Laino, L.; De Lillo, A.; Parisi, D.; Lo Muzio, L.] Foggia Univ, Dept Clin & Expt Med, Foggia, Italy.
   [Pezzetti, E.] Univ Bologna, Dept Specialist Diagnost & Expt Med, Bologna, Italy.
   [Testa, N. F.] Univ Bari, Interdisciplinary Dept Med, Bari, Italy.
   [Cocchi, R.] S Giovanni Rotondo, IRCCS Casa Sollievo Sofferenza, Foggia, Italy.
RP Lo Muzio, L (reprint author), Via Rovelli 48, I-71122 Foggia, Italy.
EM lorenzo.lomuzio@unifg.it
RI Cocchi, Roberto/C-4598-2017; Santarelli, Andrea/P-6310-2014
OI Cocchi, Roberto/0000-0001-6080-0016; Santarelli,
   Andrea/0000-0003-4218-3354; PARISI, DOMENICO/0000-0002-7755-9115; testa,
   nunzio francesco/0000-0001-5710-3877
FU National Scientific Research Programme PRIN [20087BNE3K_003]; University
   of Ferrara, Italy; Guya-bioscience, Ferrara, Italy; Fondazione CARISBO;
   National Research Council (C.N.R.), Rome, Italy (AP); Ministry of
   Education, University and Research (M.I.U.R.), Rome, Italy (AP); AROD
   (Research Association for Dentistry and Dermatology), Chieti, Italy (AP)
FX This work was supported in whole or in part by the National Scientific
   Research Programme PRIN 2008 number 20087BNE3K_003; by grants from
   University of Ferrara, Italy (F.C.), Guya-bioscience, Ferrara, Italy
   (F.C.), and Fondazione CARISBO (F.P.); by the National Research Council
   (C.N.R.), Rome, Italy (AP); by the Ministry of Education, University and
   Research (M.I.U.R.), Rome, Italy (AP) and by AROD (Research Association
   for Dentistry and Dermatology), Chieti, Italy (AP).
CR Alvarez J, 2002, DEVELOPMENT, V129, P1913
   Atzet S, 2008, BIOMACROMOLECULES, V9, P3370, DOI 10.1021/bm800686h
   Bambini F, 2007, EUR J INFLAMM, V5, P121, DOI 10.1177/1721727X0700500302
   Bambini F, 2006, INT J IMMUNOPATH PH, V19, P905, DOI 10.1177/039463200601900420
   Bambini F, 2013, EUR J INFLAMM, V11, P305, DOI 10.1177/1721727X1301100133
   Campisi P, 2003, PLAST RECONSTR SURG, V111, P201, DOI 10.1097/01.PRS.0000034932.99249.34
   Campisi P, 2003, PLAST RECONSTR SURG, P9
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4
   DAMIEN CJ, 1994, CALCIFIED TISSUE INT, V55, P151, DOI 10.1007/BF00297191
   De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397
   GRILLO MC, 1993, MAR BIOL, V117, P119, DOI 10.1007/BF00346433
   JAMMET P, 1994, J CRANIO MAXILL SURG, V22, P103, DOI 10.1016/S1010-5182(05)80019-8
   Lepore S, 2013, J BIOL REG HOMEOS AG, V27, P531
   Li G, 2000, CELL BIOL INT, V24, P25, DOI 10.1006/cbir.1999.0449
   Li XN, 2013, CLIN ORTHOP RELAT R, V471, P2540, DOI 10.1007/s11999-012-2644-5
   Lo Muzio L, 2013, EUR J INFLAMM, V11, P797
   Marchac D, 1994, J Craniofac Surg, V5, P213, DOI 10.1097/00001665-199409000-00003
   Piattelli A, 1997, BIOMATERIALS, V18, P623, DOI 10.1016/S0142-9612(96)00158-5
   POLLICK S, 1995, J ORAL MAXIL SURG, V53, P915, DOI 10.1016/0278-2391(95)90281-3
   Saini Rajesh, 2012, Methods Mol Biol, V906, P321, DOI 10.1007/978-1-61779-953-2_26
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Santarelli A, 2009, Minerva Stomatol, V58, P445
   Santin M, 1996, BIOMATERIALS, V17, P1459, DOI 10.1016/0142-9612(96)89769-9
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   Steinbrech DS, 2000, PLAST RECONSTR SURG, V105, P2028, DOI 10.1097/00006534-200005000-00018
   Su J, 2009, EXP EYE RES, V88, P445, DOI 10.1016/j.exer.2008.10.029
   Suhag GS, 2008, J BIOMAT SCI-POLYM E, V19, P1189, DOI 10.1163/156856208785540118
   TABAS JA, 1991, GENOMICS, V9, P283, DOI 10.1016/0888-7543(91)90254-C
   Yazawa M, 2003, J ORAL MAXIL SURG, V61, P587, DOI 10.1053/joms.2003.50116
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 31
TC 1
Z9 1
U1 2
U2 11
PU BIOLIFE SAS
PI SILVA MARINA (TE)
PA VIA S STEFANO 39 BIS, 64029 SILVA MARINA (TE), ITALY
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD APR-JUN
PY 2014
VL 27
IS 2
BP 221
EP 234
DI 10.1177/039463201402700209
PG 14
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA AL1RT
UT WOS:000338904500009
PM 25004834
OA Bronze
DA 2018-10-19
ER

PT J
AU Idrus, RBH
   Rameli, MAB
   Low, KC
   Law, JX
   Chua, KH
   Latiff, MB
   Bin Saim, A
AF Idrus, Ruszymah Bt Hj
   Rameli, Mohd Adha Bin P.
   Low, Kiat Cheong
   Law, Jia Xian
   Chua, Kien Hui
   Latiff, Mazlyzam Bin Abdul
   Bin Saim, Aminuddin
TI Full-Thickness Skin Wound Healing Using Autologous Keratinocytes and
   Dermal Fibroblasts with Fibrin: Bilayered Versus Single-Layered
   Substitute
SO ADVANCES IN SKIN & WOUND CARE
LA English
DT Article
DE autologous skin substitute; keratinocytes; fibroblasts; fibrin; sheep
   model
ID ENDOTHELIAL GROWTH-FACTOR; BIOENGINEERED SKIN; RECONSTRUCTION;
   MANAGEMENT; BURNS; REGENERATION; SCAFFOLDS; CELLS
AB Split-skin grafting (SSG) is the gold standard treatment for full-thickness skin defects. For certain patients, however, an extensive skin lesion resulted in inadequacies of the donor site. Tissue engineering offers an alternative approach by using a very small portion of an individual's skin to harvest cells for propagation and biomaterials to support the cells for implantation. The objective of this study was to determine the effectiveness of autologous bilayered tissue-engineered skin (BTES) and single-layer tissue-engineered skin composed of only keratinocytes (SLTES-K) or fibroblasts (SLTES-F) as alternatives for full-thickness wound healing in a sheep model. Full-thickness skin biopsies were harvested from adult sheep. Isolated fibroblasts were cultured using medium Ham's F12: Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum, whereas the keratinocytes were cultured using Define Keratinocytes Serum Free Medium. The BTES, SLTES-K, and SLTES-F were constructed using autologous fibrin as a biomaterial. Eight full-thickness wounds were created on the dorsum of the body of the sheep. On 4 wounds, polyvinyl chloride rings were used as chambers to prevent cell migration at the edge. The wounds were observed at days 7, 14, and 21. After 3 weeks of implantation, the sheep were euthanized and the skins were harvested. The excised tissues were fixed in formalin for histological examination via hematoxylin-eosin, Masson trichrome, and elastin van Gieson staining. The results showed that BTES, SLTES-K, and SLTES-F promote wound healing in nonchambered and chambered wounds, and BTES demonstrated the best healing potential. In conclusion, BTES proved to be an effective tissue-engineered construct that can promote the healing of full-thickness skin lesions. With the support of further clinical trials, this procedure could be an alternative to SSG for patients with partial-and full-thickness burns.
C1 [Idrus, Ruszymah Bt Hj; Rameli, Mohd Adha Bin P.; Chua, Kien Hui] Ampang Puteri Specialist Hosp, Tissue Engn Ctr, Ampang, Selangor, Malaysia.
   [Idrus, Ruszymah Bt Hj; Law, Jia Xian; Chua, Kien Hui] Ampang Puteri Specialist Hosp, Fac Med, Dept Physiol, Ampang, Selangor, Malaysia.
   [Low, Kiat Cheong] Ampang Puteri Specialist Hosp, Fac Med, Lab Anim Resource Unit, Ampang, Selangor, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Ampang Puteri Specialist Hosp, Fac Hlth Sci, Sch Diagnost, Ampang, Selangor, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Ampang Puteri Specialist Hosp, Fac Hlth Sci, Sch Appl Hlth Sci, Ampang, Selangor, Malaysia.
   [Bin Saim, Aminuddin] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Ampang, Selangor, Malaysia.
RP Idrus, RBH (reprint author), Ampang Puteri Specialist Hosp, Tissue Engn Ctr, Ampang, Selangor, Malaysia.
RI Law, Jia Xian/M-9728-2017
OI Law, Jia Xian/0000-0001-9045-5145
FU Ministry of Science, Technology and Innovation (MOSTI), Malaysia
   [06-02-02-0003-BTK/ER/022]
FX The authors have disclosed that they have no financial relationships
   related to this article. This work was financially supported by a
   research grant from the Ministry of Science, Technology and Innovation
   (MOSTI), Malaysia 06-02-02-0003-BTK/ER/022. Submitted April 12, 2013;
   accepted in revised form October 18, 2013.
CR Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002
   Bello Y M, 2001, Am J Clin Dermatol, V2, P305, DOI 10.2165/00128071-200102050-00005
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Braziulis E, 2012, TISSUE ENG PART C-ME, V18, P464, DOI [10.1089/ten.TEC.2011.0561, 10.1089/ten.tec.2011.0561]
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   Epstein FH, 1999, NEW ENGL J MED, V341, P738, DOI DOI 10.1056/NEJM199909023411006.PMID:10471461
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Guo R, 2011, BIOMATERIALS, V32, P1019, DOI 10.1016/j.biomaterials.2010.08.087
   Huzaira M, 2001, J INVEST DERMATOL, V116, P846, DOI 10.1046/j.0022-202x.2001.01337.x
   Khan MAA, 2010, J PLAST RECONSTR AES, V63, P2168, DOI 10.1016/j.bjps.2010.03.017
   Kielty CM, 2002, J CELL SCI, V115, P2817
   Llames SG, 2004, TRANSPLANTATION, V77, P350, DOI 10.1097/01.TP.0000112381.80964.85
   Majewska I, 2011, ACTA BIOCHIM POL, V58, P449
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Mazlyzam A L, 2008, Med J Malaysia, V63 Suppl A, P32
   Moiemen NS, 2010, BURNS, V36, P764, DOI 10.1016/j.burns.2010.04.011
   PERTOVAARA L, 1994, J BIOL CHEM, V269, P6271
   Pham C, 2007, BURNS, V33, P946, DOI 10.1016/j.burns.2007.03.020
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Ring A, 2006, BURNS, V32, P35, DOI 10.1016/j.burns.2005.07.009
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Tonello C, 2005, FASEB J, V19, P1546, DOI 10.1096/fj.05-3804fje
   Wong VW, 2012, EXP DERMATOL, V21, P729, DOI 10.1111/j.1600-0625.2012.01542.x
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
NR 27
TC 14
Z9 17
U1 0
U2 21
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1527-7941
EI 1538-8654
J9 ADV SKIN WOUND CARE
JI Adv. Skin Wound Care
PD APR
PY 2014
VL 27
IS 4
BP 171
EP 180
DI 10.1097/01.ASW.0000445199.26874.9d
PG 10
WC Dermatology; Nursing; Surgery
SC Dermatology; Nursing; Surgery
GA AI2ZK
UT WOS:000336727500005
PM 24637651
DA 2018-10-19
ER

PT J
AU Bychuk, MA
   Kil'deeva, NR
   Cherdyntseva, TA
AF Bychuk, M. A.
   Kil'deeva, N. R.
   Cherdyntseva, T. A.
TI Films of a Biodegradable Polyester Mixture with Antimicrobial and
   Proteolytic Activity
SO PHARMACEUTICAL CHEMISTRY JOURNAL
LA English
DT Article
DE polyhydroxybutyrate; polycaprolactone
AB The possibility of preparing a biomaterial based on a mixture of biocompatible and biodegradable polymers, polyhydroxybutyrate and polycaprolactone, was studied. Samples for laboratory tests were prepared by forming films from an emulsion of solutions of biologically active compounds in a solution of the polymers in an organic solvent. Trypsin was used as the proteolytic component. Films containing chlorhexidine digluconate, pefloxacin, and furazolidone were studied in order to find the optimum antimicrobial component. The optimum composition of the molding mixture for preparing films with the optimal properties, i.e., trypsin activity 52.5% of the initial value, vapor permeability 4.5 mg/cm2, furazolidone desorption rate 25% C (tau)/C (a), and properties 90% stable after storing in normal saline, was determined.
C1 [Bychuk, M. A.; Kil'deeva, N. R.] Moscow State Univ Design & Technol, Moscow 115535, Russia.
   [Cherdyntseva, T. A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia.
RP Bychuk, MA (reprint author), Moscow State Univ Design & Technol, Moscow 115535, Russia.
CR [Anonymous], TU 9393 001 0269944
   Blatun L. A., 2007, KHIRURGIVA, P9
   Budnevskii S. V., 2004, THESIS MOSCOW
   Dai ZW, 2009, BIOMATERIALS, V30, P3075, DOI 10.1016/j.biomaterials.2009.02.015
   Dong HQ, 2008, COLLOID SURFACE B, V66, P26, DOI 10.1016/j.colsurfb.2008.05.007
   Fedorov M B, 2007, Prikl Biokhim Mikrobiol, V43, P685
   Foster LJR, 2009, POLYM INT, V58, P1442, DOI 10.1002/pi.2682
   Kapritchkoff FM, 2006, J BIOTECHNOL, V122, P453, DOI 10.1016/j.jbiotec.2005.09.009
   Kil'deeva N R, 2006, Prikl Biokhim Mikrobiol, V42, P716
   Kil'deeva N. R., 2000, KHIM VOLOKNA*, P24
   Lutsevich O E, 2011, Khirurgiia (Mosk), P72
   Ol'khov A. A., 2012, ENTSIKL INZH KHIM, P17
   Romanovskaya I. I., 2009, DOP NATS AKAD NAUK U, P182
NR 13
TC 2
Z9 2
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0091-150X
EI 1573-9031
J9 PHARM CHEM J+
JI Pharm. Chem. J.
PD APR
PY 2014
VL 48
IS 1
BP 60
EP 64
DI 10.1007/s11094-014-1047-1
PG 5
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AI7NG
UT WOS:000337077900017
DA 2018-10-19
ER

PT J
AU Lau, NS
   Ch'ng, DHE
   Chia, KH
   Wong, YM
   Sudesh, K
AF Lau, Nyok-Sean
   Ch'ng, Diana Hooi-Ean
   Chia, Kim-Hou
   Wong, Yoke-Ming
   Sudesh, Kumar
TI Advances in Polyhydroxyalkanoate (PHA): Unraveling the Development and
   New Perspectives
SO JOURNAL OF BIOBASED MATERIALS AND BIOENERGY
LA English
DT Review
DE Bioplastics; Polyhydroxyalkanoate; PHA Producer; PHA Biosynthesis; PHA
   Synthase
ID RECOMBINANT ESCHERICHIA-COLI; FED-BATCH CULTURE; RALSTONIA-EUTROPHA;
   BIOTECHNOLOGICAL PRODUCTION; BIODEGRADABLE PLASTICS; ALCALIGENES-LATUS;
   POLY(3-HYDROXYBUTYRATE) PRODUCTION; BACTERIAL POLYHYDROXYALKANOATES;
   CHROMOBACTERIUM-VIOLACEUM; PSEUDOMONAS-AERUGINOSA
AB Polyhydroxyalkanoate (PHA), a naturally-occurring carbon and energy storage compound in microorganisms, is a potential biomaterial for various biotechnological applications. Despite numerous favorable properties, the development of this biodegradable plastic for commercialization is slowed down by its comparably higher production cost compared to synthetic plastics. Extensive efforts have been directed towards lowering the cost of production in order to make this bioplastic competitive with conventional plastics. The strategies taken include the development of "super bugs" capable of maximizing the production of PHA from the carbon feedstock fed, identification of inexpensive, renewable and non-food grade carbon sources and the implementation of various efficient fermentation and extraction procedures. Among the more than 300 PHA producers identified, only a few of them are suitable candidates for large scale PHA production. This review highlights the most extensively-studied PHA producers and summarizes the advantages of using them for PHA production. The use of genetically engineered microbes that confer benefits that are not found in wild type strain has become increasingly important. Examples on the expression of PHA biosynthetic enzymes in recombinant microorganism for the metabolic engineering of PHA are also discussed.
C1 [Lau, Nyok-Sean; Ch'ng, Diana Hooi-Ean; Chia, Kim-Hou; Wong, Yoke-Ming; Sudesh, Kumar] Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
RP Sudesh, K (reprint author), Univ Sains Malaysia, Sch Biol Sci, Ecobiomat Res Lab, George Town 11800, Malaysia.
EM ksudesh@usm.my
RI Sudesh, Kumar/C-2942-2011
OI Sudesh, Kumar/0000-0003-4756-9192; Lau, Nyok Sean/0000-0002-0708-5970
FU Ministry of Science, Technology and innovation, Malaysia (MOSTI);
   Universiti Sains Malaysia Graduate Assistant Scheme; APEX DE grant;
   Universiti Sains Malaysia Fellowship
FX N.-S. Lau, D.H.-E. Ch'ng and Y.-M. Wong are recipients of the Universiti
   Sains Malaysia Fellowship. K.-H. Chia thanks My Master program supported
   by The Ministry of Science, Technology and innovation, Malaysia (MOSTI)
   and Universiti Sains Malaysia Graduate Assistant Scheme. APEX DE grant
   supported this study.
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Andreessen B, 2010, APPL ENVIRON MICROB, V76, P622, DOI 10.1128/AEM.02097-09
   Antonio RV, 2000, FEMS MICROBIOL LETT, V182, P111, DOI 10.1111/j.1574-6968.2000.tb08883.x
   Bhubalan K, 2010, MALAYS J MICROBIOL, V6, P81, DOI 10.21161/mjm.21809
   Bhubalan K, 2011, APPL ENVIRON MICROB, V77, P2926, DOI 10.1128/AEM.01997-10
   Bhubalan K, 2010, POLYM DEGRAD STABIL, V95, P1436, DOI 10.1016/j.polymdegradstab.2009.12.018
   Braunegg G, 1998, J BIOTECHNOL, V65, P127, DOI 10.1016/S0168-1656(98)00126-6
   CALLOWAY DH, 1969, APPL MICROBIOL, V17, P176
   Ch'ng DHE, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-22
   Chee JY, 2010, J POLYM ENVIRON, V18, P584, DOI 10.1007/s10924-010-0204-1
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   Chia KH, 2010, POLYM DEGRAD STABIL, V95, P2226, DOI 10.1016/j.polymdegradstab.2010.09.011
   Choi MH, 2010, BIORESOURCE TECHNOL, V101, P4540, DOI 10.1016/j.biortech.2010.01.082
   Chuah JA, 2013, APPL ENVIRON MICROB, V79, P3813, DOI 10.1128/AEM.00564-13
   Dennis D, 1998, J BIOTECHNOL, V64, P177, DOI 10.1016/S0168-1656(98)00110-2
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   DOI Y, 1988, APPL MICROBIOL BIOT, V28, P330, DOI 10.1007/BF00268190
   Don TM, 2006, J BIOMAT SCI-POLYM E, V17, P1425, DOI 10.1163/156856206778937208
   Fukui T, 1998, APPL MICROBIOL BIOT, V49, P333, DOI 10.1007/s002530051178
   Fukui T, 1997, J BACTERIOL, V179, P4821, DOI 10.1128/jb.179.15.4821-4830.1997
   Grothe E, 2000, BIOPROCESS ENG, V22, P441, DOI 10.1007/s004490050757
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Hiraishi T, 2009, MINI-REV ORG CHEM, V6, P44, DOI 10.2174/157019309787316139
   Hofer P, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-70
   HOLMES PA, 1985, PHYS TECHNOL, V16, P32, DOI 10.1088/0305-4624/16/1/305
   Hori K, 2011, BIOCHEM ENG J, V53, P196, DOI 10.1016/j.bej.2010.10.011
   Houmiel KL, 1999, PLANTA, V209, P547, DOI 10.1007/s004250050760
   Hu PH, 1999, APPL BIOCHEM BIOTECH, V77-9, P445
   HUIJBERTS GNM, 1992, APPL ENVIRON MICROB, V58, P536
   Jacquel N, 2008, BIOCHEM ENG J, V39, P15, DOI 10.1016/j.bej.2007.11.029
   Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838
   Kahar P, 2004, POLYM DEGRAD STABIL, V83, P79, DOI 10.1016/S0141-3910(03)00227-1
   Kamilah H, 2013, MALAYS J MICROBIOL, V9, P51, DOI 10.21161/mjm.45012
   Keenan TM, 2006, J IND MICROBIOL BIOT, V33, P616, DOI 10.1007/s10295-006-0131-2
   Keenan TM, 2004, BIOTECHNOL PROGR, V20, P1697, DOI 10.1021/bp049873d
   Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053
   Kim DY, 2000, INT J BIOL MACROMOL, V28, P23, DOI 10.1016/S0141-8130(00)00150-1
   Kim JS, 2005, BIOCHEM ENG J, V23, P169, DOI 10.1016/j.bej.2005.01.016
   Kolibachuk D, 1999, APPL ENVIRON MICROB, V65, P3561
   Koller M, 2008, BIORESOURCE TECHNOL, V99, P4854, DOI 10.1016/j.biortech.2007.09.049
   Koller M, 2007, MACROMOL SYMP, V253, P33, DOI 10.1002/masy.200750704
   Kunasundari B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078528
   Laroche M, 2001, J CONSUM MARK, V18, P503, DOI 10.1108/EUM0000000006155
   Lau NS, 2010, BIORESOURCE TECHNOL, V101, P7916, DOI 10.1016/j.biortech.2010.05.049
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Lee SY, 1998, POLYM DEGRAD STABIL, V59, P387, DOI 10.1016/S0141-3910(97)00176-6
   Lee SY, 1996, TRENDS BIOTECHNOL, V14, P431, DOI 10.1016/0167-7799(96)10061-5
   Lee WH, 2008, BIORESOURCE TECHNOL, V99, P6844, DOI 10.1016/j.biortech.2008.01.051
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c
   Loo C.Y., 2007, MALAYS POLYM J, V3, P31
   Loo CY, 2005, BIOTECHNOL LETT, V27, P1405, DOI 10.1007/s10529-005-0690-8
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   Madison LL, 1999, MICROBIOL MOL BIOL R, V63, P21
   Marsudi S, 2008, APPL MICROBIOL BIOT, V78, P955, DOI 10.1007/s00253-008-1388-3
   Matsumoto K, 2009, BIOMACROMOLECULES, V10, P686, DOI 10.1021/bm8013878
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Mooney BP, 2009, BIOCHEM J, V418, P219, DOI 10.1042/BJ20081769
   Nomura CT, 2007, APPL MICROBIOL BIOT, V73, P969, DOI 10.1007/s00253-006-0566-4
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pohlmann A., 2006, NAT BIOTECHNOL, V10, P1227
   POIRIER Y, 1992, SCIENCE, V256, P520, DOI 10.1126/science.256.5056.520
   POIRIER Y, 1995, BIO-TECHNOL, V13, P142, DOI 10.1038/nbt0295-142
   Poirier Y, 2001, BIOPOLYESTERS, V3A, P401
   Quillaguaman J, 2008, APPL MICROBIOL BIOT, V78, P227, DOI 10.1007/s00253-007-1297-x
   Quillaguaman J, 2010, APPL MICROBIOL BIOT, V85, P1687, DOI 10.1007/s00253-009-2397-6
   RAMSAY BA, 1989, APPL ENVIRON MICROB, V55, P584
   RAMSAY BA, 1990, APPL ENVIRON MICROB, V56, P2093
   Rathbone S, 2010, J BIOMED MATER RES A, V93A, P1391, DOI 10.1002/jbm.a.32641
   Rathi DN, 2013, MALAYS J MICROBIOL, V9, P140, DOI 10.21161/mjm.47012
   Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2
   Rehm BHA, 2003, BIOCHEM J, V376, P15, DOI 10.1042/BJ20031254
   Reinecke F, 2009, J MOL MICROB BIOTECH, V16, P91, DOI 10.1159/000142897
   RODRIGUES MFA, 1995, APPL MICROBIOL BIOT, V43, P880
   Shin HD, 2002, BIOTECHNOL LETT, V24, P539, DOI 10.1023/A:1014899607533
   Shozui F, 2010, APPL MICROBIOL BIOT, V85, P949, DOI 10.1007/s00253-009-2100-y
   Somleva MN, 2008, PLANT BIOTECHNOL J, V6, P663, DOI 10.1111/j.1467-7652.2008.00350.x
   STEINBUCHEL A, 1993, APPL MICROBIOL BIOT, V39, P443, DOI 10.1007/BF00205030
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Sudesh K, 2007, MACROMOL BIOSCI, V7, P1199, DOI 10.1002/mabi.200700086
   Suriyamongkol P, 2007, BIOTECHNOL ADV, V25, P148, DOI 10.1016/j.biotechadv.2006.11.007
   Taguchi S, 2004, MACROMOL BIOSCI, V4, P145, DOI 10.1002/mabi.200300111
   Taguchi S, 2003, BIOCHEM ENG J, V16, P107, DOI 10.1016/S1369-703X(03)00027-5
   Tanadchangsaeng N, 2009, BIOMACROMOLECULES, V10, P2866, DOI 10.1021/bm900696c
   Tsuge T, 2004, MACROMOL BIOSCI, V4, P238, DOI 10.1002/mabi.200300077
   Tsuge T, 2010, POLYM DEGRAD STABIL, V95, P1345, DOI 10.1016/j.polymdegradstab.2010.01.028
   Valentin HE, 1999, MACROMOLECULES, V32, P7389, DOI 10.1021/ma9905167
   van Beilen JB, 2008, PLANT J, V54, P684, DOI 10.1111/j.1365-313X.2008.03431.x
   Wang FL, 1997, APPL ENVIRON MICROB, V63, P4765
   Xu Y, 2010, PROCESS BIOCHEM, V45, P153, DOI 10.1016/j.procbio.2009.09.001
   Yamada M, 2010, BIOMACROMOLECULES, V11, P815, DOI 10.1021/bm901437z
   Yamane T, 1996, BIOTECHNOL BIOENG, V50, P197
   Zhu CJ, 2010, BIOTECHNOL PROGR, V26, P424, DOI 10.1002/btpr.355
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 98
TC 5
Z9 5
U1 8
U2 107
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1556-6560
EI 1556-6579
J9 J BIOBASED MATER BIO
JI J. Biobased Mater. Bioenergy
PD APR
PY 2014
VL 8
IS 2
SI SI
BP 118
EP 129
DI 10.1166/jbmb.2014.1418
PG 12
WC Chemistry, Applied; Energy & Fuels; Materials Science, Biomaterials
SC Chemistry; Energy & Fuels; Materials Science
GA AH8XE
UT WOS:000336420700002
DA 2018-10-19
ER

PT J
AU Schafer-Nolte, F
   Hennecke, K
   Reimers, K
   Schnabel, R
   Allmeling, C
   Vogt, PM
   Kuhbier, JW
   Mirastschijski, U
AF Schaefer-Nolte, Franziska
   Hennecke, Kathleen
   Reimers, Kerstin
   Schnabel, Reinhild
   Allmeling, Christina
   Vogt, Peter M.
   Kuhbier, Joern W.
   Mirastschijski, Ursula
TI Biomechanics and Biocompatibility of Woven Spider Silk Meshes During
   Remodeling in a Rodent Fascia Replacement Model
SO ANNALS OF SURGERY
LA English
DT Article
DE biomaterial; degradation; hernia mesh; immune response; spider silk
ID CLAVIPES DRAGLINE SILK; CONGENITAL DIAPHRAGMATIC-HERNIA;
   SMALL-INTESTINAL SUBMUCOSA; NEPHILA-CLAVIPES; EXTRACELLULAR-MATRIX;
   MECHANICAL-PROPERTIES; PROSTHETIC MESHES; ESCHERICHIA-COLI;
   IMMUNE-RESPONSE; RABBIT MODEL
AB Objective: The aim of this study was to investigate biomechanical and immunogenic properties of spider silk meshes implanted as fascia replacement in a rat in vivo model.
   Background: Meshes for hernia repair require optimal characteristics with regard to strength, elasticity, and cytocompatibility. Spider silk as a biomaterial with outstanding mechanical properties is potentially suitable for this application.
   Methods: Commercially available meshes used for hernia repair (Surgisis and Ultrapro) were compared with handwoven meshes manufactured from native dragline silk of Nephila spp. All meshes were tied onto the paravertebral fascia, whereas sham-operated rats were sutured without mesh implantation. After 4 or 14 days, 4 weeks, and 4 or 8 months, tissue samples were analyzed concerning inflammation and biointegration both by histological and biochemical methods and by biomechanical stability tests.
   Results: Histological sections revealed rapid cell migration into the spider silk meshes with increased numbers of giant cells compared with controls with initial decomposition of silk fibers after 4 weeks. Four months postoperatively, spider silk was completely degraded with the formation of a stable scar verified by constant tensile strength values. Surgisis elicited excessive stability loss from day 4 to day 14 (P < 0.001), with distinct inflammatory reaction demonstrated by lymphocyte and neutrophil invasion. Ultrapro also showed decreasing strength and poor elongation behavior, whereas spider silk samples had the highest relative elongation (P < 0.05).
   Conclusions: Hand-manufactured spider silk meshes with good biocompatibility and beneficial mechanical properties seem superior to standard biological and synthetic meshes, implying an innovative alternative to currently used meshes for hernia repair.
C1 [Schaefer-Nolte, Franziska; Hennecke, Kathleen; Reimers, Kerstin; Schnabel, Reinhild; Allmeling, Christina; Vogt, Peter M.; Kuhbier, Joern W.; Mirastschijski, Ursula] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-30625 Hannover, Germany.
RP Kuhbier, JW (reprint author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM Kuhbier.Joern@mh-hannover.de
RI Mirastschijski, Ursula/F-2708-2015
OI Mirastschijski, Ursula/0000-0003-3964-8851
FU Else-Kroner-Fresenius-Stiftung; StrucMed program of Hannover Medical
   School
FX Supported by funding from the Else-Kroner-Fresenius-Stiftung and the
   StrucMed program of Hannover Medical School.
CR Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480
   Agnarsson I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011234
   Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ansaloni L, 2007, J INVEST SURG, V20, P237, DOI 10.1080/08941930701481296
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Bellon JM, 2007, J LAPAROENDOSC ADV S, V17, P160, DOI 10.1089/lap.2006.0028
   Bellon JM, 2012, SURG ENDOSC, V26, P27, DOI 10.1007/s00464-011-1823-x
   Bohm G, 2011, J BIOMATER APPL, V25, P771, DOI 10.1177/0885328209360423
   Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Brown CP, 2012, ACS NANO, V6, P1961, DOI 10.1021/nn300130q
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Clark RH, 1998, J PEDIATR SURG, V33, P1004, DOI 10.1016/S0022-3468(98)90522-X
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DONG ZY, 1991, ARCH BIOCHEM BIOPHYS, V284, P53, DOI 10.1016/0003-9861(91)90262-H
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Foelix RF, 2011, BIOL SPIDERS
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Liang MK, 2013, WORLD J SURG, V37, P530, DOI 10.1007/s00268-012-1873-9
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mirastschijski U, 2005, EUR SURG RES, V37, P68, DOI 10.1159/000083150
   Moss RL, 2001, J PEDIATR SURG, V36, P152
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990
   Raeder RH, 2002, TRANSPL IMMUNOL, V10, P15, DOI 10.1016/S0966-3274(01)00044-2
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Shah BC, 2011, HERNIA, V15, P165, DOI 10.1007/s10029-010-0768-7
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833
   WORK RW, 1982, J ARACHNOL, V10, P1
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
NR 55
TC 12
Z9 12
U1 1
U2 30
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
EI 1528-1140
J9 ANN SURG
JI Ann. Surg.
PD APR
PY 2014
VL 259
IS 4
BP 781
EP 792
DI 10.1097/SLA.0b013e3182917677
PG 12
WC Surgery
SC Surgery
GA AH6NK
UT WOS:000336247400042
PM 23873006
DA 2018-10-19
ER

PT J
AU Gogoi, D
   Choudhury, AJ
   Chutia, J
   Pal, AR
   Khan, M
   Choudhury, M
   Pathak, P
   Das, G
   Patil, DS
AF Gogoi, Dolly
   Choudhury, Arup Jyoti
   Chutia, Joyanti
   Pal, Arup Ratan
   Khan, Mojibur
   Choudhury, Manash
   Pathak, Pallabi
   Das, Gouranga
   Patil, Dinkar S.
TI Development of Advanced Antimicrobial and Sterilized Plasma
   Polypropylene Grafted Muga (antheraea assama) Silk as Suture Biomaterial
SO BIOPOLYMERS
LA English
DT Article
DE Silk suture; plasma graft polymerization; sterilization; antibacterial;
   histopathology
ID TISSUE ENGINEERING APPLICATIONS; PHYSICAL-PROPERTIES; BOMBYX-MORI;
   RAMAN-SPECTROSCOPY; NONWOVEN SCAFFOLD; FIBROIN FILMS; FIBERS;
   METHACRYLATE; FABRICATION; ACID
AB Surface modification of silk fibroin (SF) materials using environmentally friendly and non-hazardous process to tailor them for specific application as biomaterials has drawn a great deal of interest in the field of biomedical research. To further explore this area of research, in this report, polypropylene (PP) grafted muga (Antheraea assama) SF (PP-AASF) suture is developed using plasma treatment and plasma graft polymerization process. For this purpose, AASF is first sterilized in argon (Ar) plasma treatment followed by grafting PP onto its surface. AASF is a non-mulberry variety having superior qualities to mulberry SF and is still unexplored in the context of suture biomaterial. AASF, Ar plasma treated AASF (AASF(Ar)) and PP-AASF are subjected to various characterization techniques for better comparison and the results are attempted to correlate with their observed properties. Excellent mechanical strength, hydrophobicity, antibacterial behavior, and remarkable wound healing activity of PP-AASF over AASF and AASF(Ar) make it a promising candidate for application as sterilized suture biomaterial. (C) 2013 Wiley Periodicals, Inc.
C1 [Gogoi, Dolly; Choudhury, Arup Jyoti; Chutia, Joyanti; Pal, Arup Ratan] Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, India.
   [Khan, Mojibur] Inst Adv Study Sci & Technol, Div Life Sci, Gauhati 781035, India.
   [Choudhury, Manash] Assam Agr Univ, Dept Vet Surg & Radiol, Gauhati 781022, India.
   [Pathak, Pallabi; Das, Gouranga] Assam Agr Univ, Dept Parasitol, Gauhati 781022, India.
   [Patil, Dinkar S.] Bhabha Atom Res Ctr, Div Laser & Plasma Technol, Bombay 400085, Maharashtra, India.
RP Chutia, J (reprint author), Inst Adv Study Sci & Technol, Div Phys Sci, Gauhati 781035, India.
EM joyanti_c@sify.com
RI Khan, Mojibur/H-9741-2014; PAL, ARUP/C-6711-2012
OI PAL, ARUP/0000-0003-3893-1305
FU Board of Research in Nuclear Sciences, Department of Atomic Energy;
   Government of India [2007/34/16-BRNS/1370]
FX Contract grant sponsor: Board of Research in Nuclear Sciences,
   Department of Atomic Energy; Government of India; Contract grant number:
   2007/34/16-BRNS/1370
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Boothe H. W., 1993, SUTURE MAT TISSUE AD, P235
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Celeste C., 2008, SELECTION SUTURE MAT, P194
   Chu C. C., 2002, TEXTILE BASED BIOMAT, P501
   Cohen I.K., 1992, WOUND HEALING BIOCH
   Correia C, 2012, ACTA BIOMATER, V8, P2483, DOI 10.1016/j.actbio.2012.03.019
   Das A, 2001, J APPL POLYM SCI, V81, P2633, DOI 10.1002/app.1707
   Das A, 2000, BIORESOURCE TECHNOL, V74, P213, DOI 10.1016/S0960-8524(00)00020-1
   Devi D, 2011, J TEXT I, V102, P527, DOI 10.1080/00405000.2010.498172
   Domenech J., 2007, RES PROGR METALLOTHE, P21
   Edwards H. G. M., 2005, CASE STUDY ANCIENT T, P318
   EDWARDS HGM, 1995, J RAMAN SPECTROSC, V26, P901, DOI 10.1002/jrs.1250260842
   FREDDI G, 1994, J APPL POLYM SCI, V52, P775, DOI 10.1002/app.1994.070520608
   Fridman A., 2008, PLASMA CHEM, P642
   Frushour B. G., 1975, RAMAN SPECTROSCOPY P, P35
   Garcia-Fuentes M, 2009, BIOMATERIALS, V30, P5068, DOI 10.1016/j.biomaterials.2009.06.008
   Garg N., 2007, TXB ENDODONTICS, P308
   Ghosh G. K., 1995, INDIAN TEXTILES PRES, P71
   Ghosh P., 2003, FIBER SCI TECHNOLOGY, P98
   Glisovic A., 2010, MULBERRY SILK SPIDER, P239
   Gogoi D, 2012, PLASMA CHEM PLASMA P, V32, P1293, DOI 10.1007/s11090-012-9410-z
   Gogoi D, 2011, APPL SURF SCI, V258, P126, DOI 10.1016/j.apsusc.2011.08.018
   Han YH, 2007, COMPOS INTERFACE, V14, P559, DOI 10.1163/156855407781291272
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Karmakar S. R., 1999, TEXTILE SCI TECHNOLO, V12, P15
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Kasoju N, 2010, ADV ENG MATER, V12, pB139, DOI 10.1002/adem.200980055
   Kasoju N, 2009, MATER LETT, V63, P2466, DOI 10.1016/j.matlet.2009.08.037
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Khan M. M. R., 2007, Journal of Silk Science and Technology of Japan, V16, P107
   Khan MMR, 2010, BIORESOURCE TECHNOL, V101, P8439, DOI 10.1016/j.biortech.2010.05.100
   Krimm S., 1986, VIB SPECTROSC, P181
   Kudur MH, 2009, INDIAN J DERMATOL VE, V75, P425, DOI 10.4103/0378-6323.53155
   Liew A. W. C., 2005, DATA MINING BIOINFOR, P95
   LUCAS F, 1958, ADV PROTEIN CHEM, V13, P107, DOI 10.1016/S0065-3233(08)60599-9
   Mackenzie D, 1973, Med Hist, V17, P158
   Matsumoto A., 2006, HDB FIBER CHEM, P400
   Monti P, 1998, J RAMAN SPECTROSC, V29, P297, DOI 10.1002/(SICI)1097-4555(199804)29:4<297::AID-JRS240>3.0.CO;2-G
   MOORE WH, 1976, BIOPOLYMERS, V15, P2465, DOI 10.1002/bip.1976.360151211
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nielsen AS, 2002, POLYMER, V43, P2671, DOI 10.1016/S0032-3861(02)00053-8
   Painter P. C., 1976, RAMAN SPECTROSCOPY P, P575
   Pudner R., 2005, WOUND HEALING SURG P, P53
   Quin G., 2011, SILK BASED BIOMATERI, P422
   Sergent F, 2010, AM J SURG, V200, P406, DOI 10.1016/j.amjsurg.2009.09.024
   Souza C. H. M., 2011, SUTURE MAT BASIC SUT, P155
   Tau A. T., 1982, RAMAN SPECTROSCOPY B, P65
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1407, DOI 10.1002/polb.1994.090320812
   TSUKADA M, 1995, J POLYM SCI POL PHYS, V33, P1995, DOI 10.1002/polb.1995.090331402
   Tsukada M, 1998, J APPL POLYM SCI, V67, P1393, DOI 10.1002/(SICI)1097-4628(19980222)67:8<1393::AID-APP5>3.0.CO;2-9
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P1175, DOI 10.1002/polb.1994.090320705
   XUE G, 1994, PROG POLYM SCI, V19, P317, DOI 10.1016/0079-6700(94)90009-4
   Yool D. A., 2012, SMALL ANIMAL SOFT TI, P31
   Zhang JF, 2009, THIN SOLID FILMS, V517, P3850, DOI 10.1016/j.tsf.2009.01.161
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 57
TC 12
Z9 12
U1 1
U2 43
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3525
EI 1097-0282
J9 BIOPOLYMERS
JI Biopolymers
PD APR
PY 2014
VL 101
IS 4
BP 355
EP 365
DI 10.1002/bip.22369
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AI0XZ
UT WOS:000336575300006
PM 23913788
DA 2018-10-19
ER

PT J
AU Herrmann, FEM
   Lehner, A
   Hollweck, T
   Haas, U
   Fano, C
   Fehrenbach, D
   Kozlik-Feldmann, R
   Wintermantel, E
   Eissner, G
   Hagl, C
   Akra, B
AF Herrmann, Florian E. M.
   Lehner, Anja
   Hollweck, Trixi
   Haas, Ulrike
   Fano, Cornelia
   Fehrenbach, David
   Kozlik-Feldmann, Rainer
   Wintermantel, Erich
   Eissner, Gunther
   Hagl, Christian
   Akra, Bassil
TI In vitro biological and mechanical evaluation of various scaffold
   materials for myocardial tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; cell transplantation; heart disease; stem cells; tissue
   engineering
ID POLYURETHANE VASCULAR GRAFTS; BONE-MARROW-CELLS; INTRACORONARY
   INJECTION; STEM-CELLS; CARDIOMYOCYTES; CHALLENGES; INFARCTION; ADHESION;
   MATRIX
AB A cardiac patch is a construct devised in regenerative medicine to replace necrotic heart tissue after myocardial infarctions. The cardiac patch consists of a scaffold seeded with stem cells. To identify the best scaffold for cardiac patch construction we compared polyurethane, Collagen Cell Carriers, ePTFE, and ePTFE SSP1-RGD regarding their receptiveness to seeding with mesenchymal stem cells isolated from umbilical cord tissue. Seeding was tested at an array of cell seeding densities. The bioartificial patches were cultured for up to 35 days and evaluated by scanning electron microscopy, microscopy of histological stains, fluorescence microscopy, and mitochondrial assays. Polyurethane was the only biomaterial which resulted in an organized multilayer (seeding density: 0.750 x 10(6) cells/cm(2)). Cultured over 35 days at this seeding density the mitochondrial activity of the cells on polyurethane patches continually increased. There was no decrease in the E Modulus of polyurethane once seeded with cells. Seeding of CCC could only be realized at a low seeding density and both ePTFE and ePTFE SSP1-RGD were found to be unreceptive to seeding. Of the tested scaffolds polyurethane thus crystallized as the most appropriate for seeding with mesenchymal stem cells in the framework of myocardial tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 958-966, 2014.
C1 [Herrmann, Florian E. M.; Lehner, Anja; Hollweck, Trixi; Haas, Ulrike; Eissner, Gunther; Hagl, Christian; Akra, Bassil] Univ Munich, Grosshadern Med Ctr, Dept Cardiac Surg, Lab Tissue Engn, D-81377 Munich, Germany.
   [Lehner, Anja; Kozlik-Feldmann, Rainer] Univ Munich, Grosshadern Med Ctr, Dept Pediat Cardiol & Pediat Intens Care, D-81377 Munich, Germany.
   [Fano, Cornelia] Inst Text Technol & Proc Engn, D-73770 Denkendorf, Germany.
   [Fehrenbach, David; Wintermantel, Erich] Tech Univ Munich, Chair Med Engn, D-85748 Garching, Germany.
RP Akra, B (reprint author), Univ Munich, Grosshadern Med Ctr, Dept Cardiac Surg, Lab Tissue Engn, Marchioninistr 15, D-81377 Munich, Germany.
EM bassil.akra@med.uni-muenchen.de
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Beitnes JO, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq116
   Bergmeister H, 2012, ARTIF ORGANS, V36, P54, DOI 10.1111/j.1525-1594.2011.01297.x
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Ciardelli G, 2006, POLYM ADVAN TECHNOL, V17, P786, DOI 10.1002/pat.781
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gulbins H, 2006, THORAC CARDIOV SURG, V54, P102, DOI 10.1055/s-2005-865916
   Hollweck T, 2010, BIOMED MATER, P5
   Hudson JE, 2011, TISSUE ENG PT A, V17, P2279, DOI [10.1089/ten.TEA.2010.0743, 10.1089/ten.tea.2010.0743]
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Kawase T, 2010, J MATER SCI-MATER M, V21, P731, DOI 10.1007/s10856-009-3896-9
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388
   Seshareddy K, 2008, METHOD CELL BIOL, V86, P101, DOI 10.1016/S0091-679X(08)00006-X
   Tee R, 2010, ANZ J SURG, V80, P683, DOI 10.1111/j.1445-2197.2010.05435.x
   Tse JR, 2011, PLOS ONE, V6
   Tsuji H, 2010, CIRC RES, V106, P1613, DOI 10.1161/CIRCRESAHA.109.205260
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069
NR 24
TC 6
Z9 6
U1 0
U2 37
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 958
EP 966
DI 10.1002/jbm.a.34786
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700005
PM 23650018
DA 2018-10-19
ER

PT J
AU Tobaben, NE
   Domann, JP
   Arnold, PM
   Friis, EA
AF Tobaben, Nicholas E.
   Domann, John P.
   Arnold, Paul M.
   Friis, Elizabeth A.
TI Theoretical model of a piezoelectric composite spinal fusion interbody
   implant
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE piezoelectric; composite; electrical stimulation; spine; fusion
ID ELECTRIC-POWER GENERATION; STIMULATION; ALLOGRAFT; CERAMICS; WALKING;
   LOADS
AB Failure rates of spinal fusion are high in smokers and diabetics. The authors are investigating the development of a piezoelectric composite biomaterial and interbody device design that could generate clinically relevant levels of electrical stimulation to help improve the rate of fusion for these patients. A lumped parameter model of the piezoelectric composite implant was developed based on a model that has been utilized to successfully predict power generation for piezoceramics. Seven variables (fiber material, matrix material, fiber volume fraction, fiber aspect ratio, implant cross-sectional area, implant thickness, and electrical load resistance) were parametrically analyzed to determine their effects on power generation within reasonable implant constraints. Influences of implant geometry and fiber aspect ratio were independent of material parameters. For a cyclic force of constant magnitude, implant thickness was directly and cross-sectional area inversely proportional to power generation potential. Fiber aspect ratios above 30 yielded maximum power generation potential while volume fractions above 15% showed superior performance. This investigation demonstrates the feasibility of using composite piezoelectric biomaterials in medical implants to generate therapeutic levels of direct current electrical stimulation. The piezoelectric spinal fusion interbody implant shows promise for helping increase success rates of spinal fusion. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 975-981, 2014.
C1 [Tobaben, Nicholas E.; Domann, John P.; Friis, Elizabeth A.] Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
   [Arnold, Paul M.] Univ Kansas, Med Ctr, Dept Neurosurg, Kansas City, KS 66160 USA.
RP Friis, EA (reprint author), Univ Kansas, Dept Mech Engn, Lawrence, KS 66045 USA.
EM lfriis@ku.edu
RI Domann, John/J-8981-2018
OI Domann, John/0000-0001-6970-571X
FU Institute for Advancing Medical Innovation
FX Contract grant sponsor: Institute for Advancing Medical Innovation
CR AN HS, 1995, J SPINAL DISORD, V8, P131
   Biomet, 2009, IMPL SPIN FUS STIM P
   CAPPOZZO A, 1984, Journal of Orthopaedic Research, V1, P292
   Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023
   Cheng CK, 1998, BIO-MED MATER ENG, V8, P155
   Cook Stephen D, 2004, Spine J, V4, P300
   CROMWELL R, 1989, J ORTHOPAED RES, V7, P371, DOI 10.1002/jor.1100070309
   Dejardin L M, 2001, Spine J, V1, P341, DOI 10.1016/S1529-9430(01)00100-0
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P115, DOI 10.4103/2152-7806.83929
   Epstein Nancy E, 2011, Surg Neurol Int, V2, P10, DOI 10.4103/2152-7806.76147
   Glazer PA, 2002, ORTHOP J HARVARD MED, V4, P63
   Green S., PEEK OPTIMA POLYM IM
   KANE WJ, 1988, SPINE, V13, P363, DOI 10.1097/00007632-198803000-00026
   KHOO BCC, 1995, MED ENG PHYS, V17, P27, DOI 10.1016/1350-4533(95)90374-K
   Kucharzyk DW, 1999, SPINE, V24, P465, DOI 10.1097/00007632-199903010-00012
   Lei A, 2011, PROC IEEE MICR ELECT, P125, DOI 10.1109/MEMSYS.2011.5734377
   Ltd I, 2004, TYP MAT PROP GRAN
   MERIL AJ, 1994, SPINE, V19, P2393, DOI 10.1097/00007632-199411000-00004
   MOONEY V, 1990, SPINE, V15, P708, DOI 10.1097/00007632-199007000-00016
   NINDS, 2011, LOW BACK PAIN FACT S
   Platt SR, 2005, IEEE-ASME T MECH, V10, P455, DOI 10.1109/TMECH.2005.852482
   Platt SR, 2005, IEEE-ASME T MECH, V10, P240, DOI 10.1109/TMECH.2005.844704
   Roundy S., 2003, ENERGY SCAVENGING WI
   Tobaben N., 2012, DEV NOVEL PIEZOELECT
   Toth JM, 2000, SPINE, V25, P2580, DOI 10.1097/00007632-200010150-00007
   Tsuang YH, 2009, MED ENG PHYS, V31, P565, DOI 10.1016/j.medengphy.2008.11.012
   Van den Ende D, 2010, J APPL PHYS, V107
   van den Ende DA, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729814
   Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439
   Wang M, 2008, MAT SCI ENG R, V63, P1, DOI 10.1016/j.mser.2008.07.001
   Wilson SA, 1999, THESIS CRANFIELD U
   Yoshida T, 2009, J ORTHOP SCI, V14, P320, DOI 10.1007/s00776-009-1333-z
NR 32
TC 5
Z9 5
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 975
EP 981
DI 10.1002/jbm.a.34750
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700007
PM 23589373
DA 2018-10-19
ER

PT J
AU Wang, XJ
   Cui, J
   Zhang, BQ
   Zhang, HY
   Bi, Y
   Kang, Q
   Wang, N
   Bie, P
   Yang, ZY
   Wang, HZ
   Liu, XD
   Haydon, RC
   Luu, HH
   Tang, N
   Dong, JH
   He, TC
AF Wang, Xiaojun
   Cui, Jing
   Zhang, Bing-Qiang
   Zhang, Hongyu
   Bi, Yang
   Kang, Quan
   Wang, Ning
   Bie, Ping
   Yang, Zhanyu
   Wang, Huaizhi
   Liu, Xiangde
   Haydon, Rex C.
   Luu, Hue H.
   Tang, Ni
   Dong, Jiahong
   He, Tong-Chuan
TI Decellularized liver scaffolds effectively support the proliferation and
   differentiation of mouse fetal hepatic progenitors
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell transplantation; liver progenitor cells; immortalized progenitors;
   decellularized scaffolds; tissue engineering; regenerative medicine
ID BMP-9-INDUCED OSTEOGENIC DIFFERENTIATION; SUPPRESSES TUMOR-GROWTH;
   MESENCHYMAL STEM-CELLS; HUMAN OSTEOSARCOMA; OSTEOBLAST DIFFERENTIATION;
   RECOMBINANT ADENOVIRUSES; MATRIX SCAFFOLDS; PROTEIN; SYSTEM; TISSUE
AB Decellularized whole organs represent ideal scaffolds for engineering new organs and/or cell transplantation. Here, we investigate whether decellularized liver scaffolds provide cell-friendly biocompatible three-dimensional (3-D) environment to support the proliferation and differentiation of hepatic progenitor cells. Mouse liver tissues are efficiently decellularized through portal vein perfusion. Using the reversibly immortalized mouse fetal hepatic progenitor cells (iHPCs), we are able to effectively recellularize the decellularized liver scaffolds. The perfused iHPCs survive and proliferate in the 3-D scaffolds in vitro for 2 weeks. When the recellularized scaffolds are implanted into the kidney capsule of athymic nude mice, cell survival and proliferation of the implanted scaffolds are readily detected by whole body imaging for 10 days. Furthermore, epidermal growth factor (EGF) is shown to significantly promote the proliferation and differentiation of the implanted iHPCs. Histologic and immunochemical analyzes indicate that iHPCs are able to proliferate and differentiate to mature hepatocytes upon EGF stimulation in the scaffolds. The recellularization of the biomaterial scaffolds is accompanied with vascularization. Taken together, these results indicate that decullarized liver scaffolds effectively support the proliferation and differentiation of iHPCs, suggesting that decellularized liver matrix may be used as ideal biocompatible scaffolds for hepatocyte transplantation. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1017-1025, 2014.
C1 [Wang, Xiaojun; Wang, Ning; Bie, Ping; Yang, Zhanyu; Wang, Huaizhi; Liu, Xiangde; Dong, Jiahong] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing 400038, Peoples R China.
   [Wang, Xiaojun; Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Wang, Ning; Haydon, Rex C.; Luu, Hue H.; Tang, Ni; He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Surg, Chicago, IL 60637 USA.
   [Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Tang, Ni; He, Tong-Chuan] Chongqing Med Univ, Chinese Minist Educ, Key Lab Diagnost Med Designated, Chongqing 400016, Peoples R China.
   [Cui, Jing; Zhang, Bing-Qiang; Zhang, Hongyu; Bi, Yang; Kang, Quan; Tang, Ni; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing 400016, Peoples R China.
   [Dong, Jiahong] Chinese Peoples Liberat Army Gen Hosp, Hosp & Inst Hepatobiliary Surg, Chinese PLA Postgrad Med Sch, Beijing 100853, Peoples R China.
RP He, TC (reprint author), Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Surg, Chicago, IL 60637 USA.
EM dongjh301@163.com; tche@uchicago.edu
FU National Institutes of Health; Natural Science Foundation of China
   (NSFC) [81100309, 30972586, 31171307]; Key National S T Program
   [2013ZX10002002-005-003, 2012ZX10002005-003-002]
FX Contract grant sponsor: National Institutes of Health (to TCH, RCH, and
   HHL); Contract grant sponsor: Natural Science Foundation of China
   (NSFC); contract grant numbers: #81100309 (to YB) and #30972586 and
   #31171307 (to NT); Contract grant sponsor: Key National S & T Program;
   contract grant numbers: #2013ZX10002002-005-003 and
   #2012ZX10002005-003-002 (to NT)
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254
   Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519
   Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133
   Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017
   Fukumitsu K, 2011, TRANSPL P, V43, P2137, DOI 10.1016/j.transproceed.2011.05.014
   Gilbert TW, 2012, J CELL BIOCHEM, V113, P2217, DOI 10.1002/jcb.24130
   Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719
   Haydon RC, 2002, CLIN CANCER RES, V8, P1288
   He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668
   He BC, 2011, INT J ONCOL, V38, P437, DOI 10.3892/ijo.2010.858
   He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231
   Huang E, 2012, PLOS ONE, V7
   Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622
   Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x
   Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298
   Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130
   Kang Yu-Zhan, 2009, Zhonghua Yi Xue Za Zhi, V89, P1135
   Liu J., 2011, PLOS ONE, V6
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200
   Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98
   Orlando Giuseppe, 2011, Transpl Int, V24, P223, DOI 10.1111/j.1432-2277.2010.01182.x
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200
   Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182
   Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200
   Shupe T, 2010, ORGANOGENESIS, V6, P134, DOI 10.4161/org.6.2.11546
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97
   Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023
   Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x
   Traphagen S, 2009, REGEN MED, V4, P747, DOI 10.2217/RME.09.38
   Westerman KA, 1996, P NATL ACAD SCI USA, V93, P8971, DOI 10.1073/pnas.93.17.8971
   Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145
   Zhang W, 2010, PLOS ONE, V5
   Zhou P, 2011, LIVER TRANSPLANT, V17, P418, DOI 10.1002/lt.22270
NR 40
TC 22
Z9 28
U1 1
U2 36
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1017
EP 1025
DI 10.1002/jbm.a.34764
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700012
PM 23625886
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ni, YS
   Jiang, Y
   Wen, JC
   Shao, ZZ
   Chen, X
   Sun, S
   Yu, HQ
   Li, W
AF Ni, Yusu
   Jiang, Yi
   Wen, Jianchuan
   Shao, Zhenzhong
   Chen, Xin
   Sun, Shan
   Yu, Huiqian
   Li, Wen
TI Construction of a functional silk-based biomaterial complex with
   immortalized chondrocytes in vivo
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; cytocompatibility; cartilage; silk fibroin
ID MANDIBULAR CONDYLAR CARTILAGE; FIBROIN 3D SCAFFOLDS; HUMAN FIBROBLASTS;
   EPITHELIAL-CELLS; VITRO; PROLIFERATION; DEGRADATION; TELOMERASE;
   SENESCENCE; CULTURE
AB To explore the feasibility of constructing a functional biomaterial complex with regenerated silk fibroin membrane and immortalized chondrocytes in vivo. Rat auricular chondrocytes (RACs) were transfected with the lentivirus vector pGC-FU-hTERT-3FLAG or pGC-FU-GFP-3FLAG, encoding the human telomerase reverse transcriptase (hTERT) or GFP gene. The effects of regenerated silk fibroin film on the adhesion, growth of immortalized chondrocytes and expression of collagen II in vitro were analyzed with immunofluorescent histochemistry. Immortalized RACs were transformed. Induction by nutrient medium promoted higher expression levels of collagen II in transformed chondrocytes. The regenerated silk fibroin film was not cytotoxic to immortalized chondrocytes and had no adverse influence on their adhesion. Collagen II expression was good in the immortalized chondrocytes in vivo. The construction of a silk-based biomaterial complex with immortalized chondrocytes may provide a feasible kind of functional biomaterial for the repair of cartilage defects in clinical applications. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1071-1078, 2014.
C1 [Ni, Yusu; Sun, Shan; Yu, Huiqian; Li, Wen] Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.
   [Jiang, Yi] Tongji Univ, Dongfang Hosp, Dept Ophthalmol, Shanghai 200092, Peoples R China.
   [Wen, Jianchuan; Shao, Zhenzhong; Chen, Xin] Fudan Univ, Key Lab Mol Engn Polymer, MOE, Shanghai 200433, Peoples R China.
   [Wen, Jianchuan; Shao, Zhenzhong; Chen, Xin] Fudan Univ, Dept Macromol Sci, Shanghai 200433, Peoples R China.
RP Ni, YS (reprint author), Fudan Univ, Shanghai Med Sch, Eye & ENT Hosp, Dept Otolaryngol, Shanghai 200433, Peoples R China.
EM niyusu@yahoo.com.cn
RI Chen, Xin/F-6802-2015
OI Chen, Xin/0000-0001-7706-4166; Wen, Jianchuan/0000-0002-0993-1042
FU Shanghai Science and Technology Committee [10411962100]; Shanghai Health
   Pudong New Area Bureau [PW2012A-41]
FX Contract grant sponsor: Shanghai Science and Technology Committee;
   contract grant number: 10411962100; Contract grant sponsor: Shanghai
   Health Pudong New Area Bureau; contract grant number: PW2012A-41
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   ENGEL FE, 1990, J DENT RES, V69, P1753, DOI 10.1177/00220345900690110801
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   GIRDLER NM, 1993, INT J ORAL MAX SURG, V22, P178, DOI 10.1016/S0901-5027(05)80248-6
   GOLDRING MB, 1986, J BIOL CHEM, V261, P9049
   Granger MP, 2002, CRIT REV ONCOL HEMAT, V41, P29, DOI 10.1016/S1040-8428(01)00188-3
   HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Illeperuma RP, 2012, J MATER SCI-MATER M, V23, P753, DOI 10.1007/s10856-011-4473-6
   Ke MW, 2012, REPROD DOMEST ANIM, V47, P553, DOI 10.1111/j.1439-0531.2011.01916.x
   KormannBortolotto MH, 1996, MECH AGEING DEV, V89, P45, DOI 10.1016/0047-6374(96)01742-3
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MORI H, 2000, REV MOL BIOTECHNOL, V74, P95, DOI DOI 10.1016/S1389-0352(00)00004-0
   Murata K, 2007, IN VITRO CELL DEV-AN, V43, P235, DOI 10.1007/s11626-007-9048-y
   Ni Y, 2008, OTOLARYNG HEAD NECK, V139, P256, DOI 10.1016/j.otohns.2008.03.028
   Shao ZZ, 2004, China Patent Z L, Patent No. [200410024711.9, 2004100247119]
   Steinert S, 2000, BIOCHEM BIOPH RES CO, V273, P1095, DOI 10.1006/bbrc.2000.3080
   Stewart SA, 2002, ONCOGENE, V21, P627, DOI 10.1038/sj.onc.1205062
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Xie Y, 2013, IN VITRO CELL DEV-AN, V49, P8, DOI 10.1007/s11626-012-9554-4
   Yang SY, 2000, ANN PLAS SURG, V44, P405, DOI 10.1097/00000637-200044040-00009
NR 24
TC 3
Z9 3
U1 1
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1071
EP 1078
DI 10.1002/jbm.a.34763
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700018
PM 23625883
DA 2018-10-19
ER

PT J
AU Lin, CY
   Li, LT
   Su, WT
AF Lin, Chuang-Yu
   Li, Li-Tzu
   Su, Wen-Ta
TI Study of subcellular dynamics on cell-substrate interactions by live
   cell imaging
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell-substrate interaction; membrane expansion; live cell imaging;
   confocal microscopy
ID FIBROBLASTS; ATTACHMENT; SRC
AB Cellular adhesiveness to biomaterial is one of the important properties for the success of tissue engineering. The cell-biomaterial interactions involve close cooperation of adhesion proteins, plasma membrane, and cytoskeletons to form focal adhesions during the process of anchoring. Dynamic development of the plasma membrane in the process reflects the cellular biocompatibility and motility. The process of cell attachment beginning from seeding, contact, attachment, and spreading has not been investigated. In this study, we monitored the whole process of cells attaching to the substrate surface by time-lapse confocal microscopy. We observed that the surface configuration of the substratum effects plasma membrane expansion and genomic materials distribution. In contrast to the cells grown on the plate, the cells attached on pillars are with rounded nuclei and with prominent lamellipodia spreading out. Membrane expansion is involved in dynamic development of the plasma membrane and lamellipodia formation for attachment, migration, or proliferation and reflects the cellular physiology status of the cells. This study provides a platform for investigation of cell behavior and dynamic development of subcellular structures regarding cell-biomaterial interactions. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1149-1154, 2014.
C1 [Lin, Chuang-Yu; Su, Wen-Ta] Natl Taipei Univ Technol, Dept Chem Engn, Taipei 106, Taiwan.
   [Li, Li-Tzu] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan.
RP Su, WT (reprint author), Natl Taipei Univ Technol, Dept Chem Engn, Taipei 106, Taiwan.
EM f10549@ntut.edu.tw
FU National Science Council, Taiwan [97-2221-E-027-099]
FX Contract grant sponsor: National Science Council, Taiwan; contract grant
   number: 97-2221-E-027-099
CR Altmann B, 2012, BIOMED MICRODEVICES, V14, P291, DOI 10.1007/s10544-011-9605-8
   AMIEVA MR, 1995, EXP CELL RES, V219, P180, DOI 10.1006/excr.1995.1218
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Clark AG, 2011, RESULTS PROBL CELL D, V53, P31, DOI 10.1007/978-3-642-19065-0_3
   Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000
   Kolind K, 2010, BIOMATERIALS, V31, P9182, DOI 10.1016/j.biomaterials.2010.08.048
   Kumari T. V., 2002, TRENDS BIOMATER ARTI, V15, P37
   Mas-Moruno C, 2013, J BIOMED MATER RES A, V101, P87, DOI 10.1002/jbm.a.34303
   Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127
   Sperry AO, 2012, BIOL CELL, V104, P297, DOI 10.1111/boc.201100102
   Su WT, 2006, MICRON, V37, P699, DOI 10.1016/j.micron.2006.03.007
   Su WT, 2011, BIOMED MICRODEVICES, V13, P11, DOI 10.1007/s10544-010-9466-6
   Su WT, 2010, J BIOMED MATER RES A, V93A, P1463, DOI 10.1002/jbm.a.32643
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Trichet L, 2007, BIOPHYS J, V92, P1081, DOI 10.1529/biophysj.106.091884
   Wang HG, 2013, J BIOMED MATER RES A, V101, P413, DOI 10.1002/jbm.a.34339
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Wong T, 2007, BRIT J DERMATOL, V156, P1149, DOI 10.1111/j.1365-2133.2007.07914.x
   Zawislak JD, 2009, PHYS STATUS SOLIDI A, V206, P1356, DOI 10.1002/pssa.200881037
NR 19
TC 5
Z9 5
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1149
EP 1154
DI 10.1002/jbm.a.34771
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700027
PM 23630045
DA 2018-10-19
ER

PT J
AU Rahmanian-Schwarz, A
   Held, M
   Knoeller, T
   Stachon, S
   Schmidt, T
   Schaller, HE
   Just, L
AF Rahmanian-Schwarz, Afshin
   Held, Manuel
   Knoeller, Tabea
   Stachon, Susanne
   Schmidt, Timo
   Schaller, Hans-Eberhard
   Just, Lothar
TI biocompatibility and biodegradation of a novel thin and mechanically
   stable collagen scaffold
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen; scaffold; tissue engineering; biomaterial; in vivo;
   biocompatibility
ID CROSS-LINKING; DEHYDROTHERMAL TREATMENT; GAG SCAFFOLDS; TISSUE;
   EXPRESSION; FIBERS; BOVINE; BIOMATERIALS; DELIVERY; DISEASE
AB The demand for scaffolds comprised of natural materials such as collagen has increased in recent years. However, many scaffolds rely on chemical or physical modifications in order to comply with the necessary requirements for biomedical engineering. We evaluated the in vivo biocompatibility and biodegradation of a novel, thin, mechanically stable, and chemically non-crosslinked collagen cell carrier (CCC). CCC was implanted subcutaneously into 25 adult Lewis rats and biopsies were taken on days 7, 14, 21, 42, and 84 after surgery. For histological analysis, paraffin sections of implanted skin were immunolabeled for CD68 and stained by hematoxylin-eosin and Masson-Goldner's trichrome method. Macroscopic analysis of skin surface during wound healing process showed a normal physiological reaction. Biodegradation of CCC was completed 42 days after subcutaneous implantation. Histological evaluation revealed no evidence of encapsulation, scar formation, or long-term vascularization and inflammation. The collagen type I based biomaterial demonstrated a high in vivo biocompatibility, low irritability, complete resorption, and replacement by autologous tissue. The in vivo biocompatibility and degradation behavior encourage for further evaluation of CCC in surgical applications and regenerative medicine. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 1173-1179, 2014.
C1 [Rahmanian-Schwarz, Afshin; Held, Manuel; Knoeller, Tabea; Schaller, Hans-Eberhard] Univ Tubingen, BG Trauma Ctr, Dept Plast Reconstruct Hand & Burn Surg, Tubingen, Germany.
   [Stachon, Susanne; Schmidt, Timo; Just, Lothar] Univ Tubingen, Ctr Regenerat Biol & Med, Inst Anat, Tubingen, Germany.
RP Rahmanian-Schwarz, A (reprint author), Univ Tubingen, BG Trauma Ctr, Dept Plast Reconstruct Hand & Burn Surg, Tubingen, Germany.
EM arahmanian@bgu-tuebingen.de
CR Alexakis C, 2006, NEPHRON EXP NEPHROL, V102, pE71, DOI 10.1159/000089684
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Bou-Akl T, 2013, J BIOMED MAT RES A
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chajra H, 2008, BIO-MED MATER ENG, V18, pS33
   CHIGNIER E, 1985, J BIOMED MATER RES, V19, P115, DOI 10.1002/jbm.820190203
   Chvapil M, 1973, Int Rev Connect Tissue Res, V6, P1
   Ekaputra AK, 2011, BIOMATERIALS, V32, P8108, DOI 10.1016/j.biomaterials.2011.07.022
   Fernandes H, 2009, TISSUE ENG PT A, V15, P3857, DOI 10.1089/ten.tea.2009.0011
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2009, J BIOMED MATER RES A, V89A, P363, DOI 10.1002/jbm.a.31955
   Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Lai ES, 2011, ACTA BIOMATER, V7, P2448, DOI 10.1016/j.actbio.2011.03.012
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Leong J, 2011, J BIOMATER APPL
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Parenteau-Bareil R, 2011, ACTA BIOMATER, V7, P3757, DOI 10.1016/j.actbio.2011.06.020
   QUTEISH D, 1990, J BIOMED MATER RES, V24, P749, DOI 10.1002/jbm.820240609
   Rodrigues MT, 2012, J TISSUE ENG REGEN M
   Schmidt T, 2011, TISSUE ENG PART C-ME, V17, P1161, DOI [10.1089/ten.tec.2011.0201, 10.1089/ten.TEC.2011.0201]
   Schroder A, 1988, Eur J Vasc Surg, V2, P315, DOI 10.1016/S0950-821X(88)80007-0
   Sehgal PK, 2009, EXPERT OPIN DRUG DEL, V6, P687, DOI 10.1517/17425240903025736
   Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240
   Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221
   Takasaki Yoshinari, 2009, Nihon Rinsho, V67, P458
   Thompson KJ, 2011, WORLD J GASTROENTERO, V17, P2473, DOI 10.3748/wjg.v17.i20.2473
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Zhao Xiang, 2011, Orthop Surg, V3, P127, DOI 10.1111/j.1757-7861.2011.00128.x
NR 35
TC 20
Z9 22
U1 0
U2 31
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2014
VL 102
IS 4
BP 1173
EP 1179
DI 10.1002/jbm.a.34793
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB1LH
UT WOS:000331552700030
PM 23666868
DA 2018-10-19
ER

PT J
AU Correia, CO
   Caridade, SG
   Mano, JF
AF Correia, Cristina O.
   Caridade, Sofia G.
   Mano, Joao F.
TI Chitosan Membranes Exhibiting Shape Memory Capability by the Action of
   Controlled Hydration
SO POLYMERS
LA English
DT Article
DE shape memory; glass transition dynamics; biopolymers; biomaterials;
   smart systems
ID VISCOELASTIC PROPERTIES; POLYMER; DERIVATIVES; MISCIBILITY; MOISTURE;
   BLENDS
AB Chitosan membranes can undergo a glass transition at room temperature triggered by hydration. The mechanical properties of the membranes were followed by a tension test and dynamic mechanical analysis (DMA), with the sample in wet conditions after being immersed in varying compositions of water/ethanol mixtures. Results show that with the increasing of water content, the Young's and storage modulus decrease systematically. For water contents of ca. 35 vol%, chitosan (CHT) exhibits a glass transition, showing an elastomeric plateau in the elastic modulus above this hydration level and the occurrence of a peak in the loss factor. Due to the semi-crystalline nature of CHT, membranes of this biomaterial present a shape memory capability induced by water uptake. By fixation of the permanent shape by further covalent cross-linking, the membranes can have different permanent shapes appropriate for different applications, including in the biomedical area.
C1 [Correia, Cristina O.; Caridade, Sofia G.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Correia, Cristina O.; Caridade, Sofia G.; Mano, Joao F.] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM cristina.oliveira.correia@gmail.com; sofia.caridade@dep.uminho.pt;
   jmano@dep.uminho.pt
RI Caridade, Sofia/P-1925-2015; Group, 3Bs/E-4374-2012; Mano,
   Joao/A-4418-2009
OI Caridade, Sofia/0000-0002-0448-1871; Group, 3Bs/0000-0002-5195-3456;
   Mano, Joao/0000-0002-2342-3765
FU Portuguese Foundation for Science and Technology Foundation (FCT)
   [PTDC/FIS/115048/2009]
FX This work was supported by the Portuguese Foundation for Science and
   Technology Foundation (FCT) through project PTDC/FIS/115048/2009.
CR Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Caridade SG, 2009, CARBOHYD POLYM, V75, P651, DOI 10.1016/j.carbpol.2008.09.011
   Chen MC, 2007, BIOMACROMOLECULES, V8, P2774, DOI 10.1021/bm7004615
   Chen MC, 2009, BIOMATERIALS, V30, P5560, DOI 10.1016/j.biomaterials.2009.06.039
   Cheung MK, 2002, J APPL POLYM SCI, V86, P1253, DOI 10.1002/app.11091
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Du HY, 2010, SOFT MATTER, V6, P3370, DOI 10.1039/b922220k
   Fan K, 2011, EXPRESS POLYM LETT, V5, P409, DOI 10.3144/expresspolymlett.2011.40
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Lv HB, 2008, ADV ENG MATER, V10, P592, DOI 10.1002/adem.200800002
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   Mota J, 2012, ACTA BIOMATER, V8, P4173, DOI 10.1016/j.actbio.2012.06.040
   Pierce BF, 2011, INT J ARTIF ORGANS, V34, P172, DOI 10.5301/IJAO.2011.6413
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Toffey A, 2001, CELLULOSE, V8, P35, DOI 10.1023/A:1016695522968
   Wang CC, 2012, COMPOS SCI TECHNOL, V72, P1178, DOI 10.1016/j.compscitech.2012.03.027
   Xie T, 2011, POLYMER, V52, P4985, DOI 10.1016/j.polymer.2011.08.003
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang B, 2004, SMART MATER STRUCT, V13, P191, DOI 10.1088/0964-1726/13/1/022
NR 20
TC 9
Z9 10
U1 1
U2 42
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 2073-4360
J9 POLYMERS-BASEL
JI Polymers
PD APR
PY 2014
VL 6
IS 4
BP 1178
EP 1186
DI 10.3390/polym6041178
PG 9
WC Polymer Science
SC Polymer Science
GA AH1QR
UT WOS:000335896500013
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Veliz, DS
   Alam, C
   Toivola, DM
   Toivakka, M
   Alam, P
AF Veliz, Diosangeles Soto
   Alam, Catharina
   Toivola, Diana M.
   Toivakka, Martti
   Alam, Parvez
TI On the non-linear attachment characteristics of blood to bacterial
   cellulose/kaolin biomaterials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Wound; Bacterial cellulose; Kaolin; Blood; Adhesion; Tribology
ID PROTEIN ADSORPTION; REGENERATION; BONE
AB In this communication, we report a non-linear variation in the strength of blood attachment to bacterial cellulose/kaolin biomaterials as the fractions of bacterial cellulose to kaolin are increased. The changes observed for attachment strength are elucidated following both experimental and numerical investigations on both the biomaterial and the blood-biomaterial interface. Our research reveals that the non-linear strength of attachment of blood is related to topographical characteristics on the surface of the biomaterial, the maleability of the biomaterial and the intermolecular strength of attraction between clotted blood proteins (fibrinogen) with the cellulose/kaolin components of the biomaterial. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Veliz, Diosangeles Soto; Toivakka, Martti; Alam, Parvez] Abo Akad Univ, Ctr Funct Mat, Lab Paper Coating & Converting, SF-20500 Turku, Finland.
   [Alam, Catharina; Toivola, Diana M.] Abo Akad Univ, Dept Biosci, SF-20500 Turku, Finland.
RP Alam, P (reprint author), Abo Akad Univ, Ctr Funct Mat, Lab Paper Coating & Converting, Porthaninkatu 3, SF-20500 Turku, Finland.
EM parvez.alam@abo.fi
CR Alam P, 2007, CHEM ENG SCI, V62, P3142, DOI 10.1016/j.ces.2007.03.018
   Asfa-Wossen L., 2013, MAT WORLD MAG, V7
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Chambliss D.F., 2012, MAKING SENSE SOCIAL, P154
   Chen YM, 2009, J BIOACT COMPAT POL, V24, P137, DOI 10.1177/0883911509102710
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   HOFFMAN AS, 1982, ADV CHEM SER, P3
   Hsieh YC, 2008, CELLULOSE, V15, P507, DOI 10.1007/s10570-008-9206-8
   IWANAGA S, 1969, EUR J BIOCHEM, V8, P189, DOI 10.1111/j.1432-1033.1969.tb00514.x
   Kalaskar DM, 2008, SOFT MATTER, V4, P1059, DOI 10.1039/b719706n
   MARGOLIS J, 1958, J CLIN PATHOL, V11, P406, DOI 10.1136/jcp.11.5.406
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Rechendorff K, 2006, LANGMUIR, V22, P10885, DOI 10.1021/la0621923
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RUCKENSTEIN E, 1984, J COLLOID INTERF SCI, V101, P436, DOI 10.1016/0021-9797(84)90055-9
   Solway DR, 2010, WOUNDS, V22, P17
   Touaiti F., 2009, MAT SCI ENG A-STRUCT, V527, P2363
   Trabattoni D, 2012, INT J CARDIOL, V156, P53, DOI 10.1016/j.ijcard.2010.10.030
   Vaiana CA, 2011, BIOMACROMOLECULES, V12, P3139, DOI 10.1021/bm200616v
   Varley S.J., 1986, CLIN MAT, V1, P37
   Wanna D., 2013, ADV NAT SCI NANOSCI, V4
   Watson NFS, 2005, SURGERY, V23, P52
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yang LJ, 2006, J PHYS CHEM B, V110, P13166, DOI 10.1021/jp060163v
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
NR 30
TC 3
Z9 3
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 176
EP 182
DI 10.1016/j.colsurfb.2013.12.038
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100023
PM 24457185
DA 2018-10-19
ER

PT J
AU Young, TH
   Wang, IJ
   Hu, FR
   Wang, TJ
AF Young, Tai-Horng
   Wang, I-Jong
   Hu, Fung-Rong
   Wang, Tsung-Jen
TI Fabrication of a bioengineered corneal endothelial cell sheet using
   chitosan/polycaprolactone blend membranes
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Corneal endothelial cells; Chitosan; Polycaprolactone; Blends
ID CHITOSAN-POLYCAPROLACTONE BLENDS; TISSUE ENGINEERING APPLICATIONS;
   COLLAGEN PRODUCTION; IN-VITRO; EX-VIVO; TRANSPLANTATION; CARRIER;
   BIOMATERIALS; SCAFFOLD; DIFFERENTIATION
AB Our previous study has demonstrated cultivation of bovine corneal endothelial cells (BCECs) on the chitosan polycaprolactone (PCL) blends. BCECs could grow well and express physiological phenotypes after PCL was introduced into chitosan by means of blending. The feasibility of using chitosan-PCL-blended membranes as scaffold and carrier for corneal endothelial cell (CEC) transplantation is worthy of more investigation. In this work, we attempt to manufacture various blended membranes to bring BCEC cultivation into harmony by hybridizing two polymers with fine adjustment. Therefore, chitosan, which does not promote BCECs maturation, and PCL, which supports, BCEC proliferation, are combined to prepare the blends. Analyses of transmittance, proliferative, abilities, phenotypic expressions, extracellular matrix (ECM) protein production, and hemotoxylin and eosin (H&E) staining were executed step-by-step. From our observations, the blended membranes united respective characteristics. The cultured BCECs on the blends illustrated normal appearance and good proliferative abilities. Immunohistochemical staining verified physiologically phenotypic expressions of ZO-1 and Na-K ATPase. Western blot analysis also confirmed the existence of collagen type IV proteins. Furthermore, the formation of a continuous monolayer of cells attached on the blended membrane was confirmed by H&E staining. These results suggested that chitosan PCL blended membranes may be an optimized biomaterial to fabricate bioengineered corneal endothelium and show potential to facilitate CEC transplantation in the future. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Young, Tai-Horng; Wang, Tsung-Jen] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei, Taiwan.
   [Young, Tai-Horng; Wang, Tsung-Jen] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan.
   [Wang, I-Jong; Hu, Fung-Rong; Wang, Tsung-Jen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Wang, I-Jong; Hu, Fung-Rong; Wang, Tsung-Jen] Coll Med, Taipei, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.
   [Wang, Tsung-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Ophthalmol, Taipei, Taiwan.
RP Wang, TJ (reprint author), 252 Wu Hsing St, Taipei 10051, Taiwan.
EM tjw@tmu.edu.tw
OI Wang, I-Jong/0000-0002-3045-0614; HU, FUNG-RONG/0000-0002-2102-5317
FU National Science Council, Taipei, Taiwan [NCS 102-2320-B-038-012];
   Taipei Medical University [TMU101-AEI-B65]
FX The authors thank the National Science Council, Taipei, Taiwan (No. NCS
   102-2320-B-038-012) and Taipei Medical University (TMU101-AEI-B65) for
   their financial support of this research.
CR Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010
   Chen KH, 2001, CORNEA, V20, P731, DOI 10.1097/00003226-200110000-00012
   Choi JS, 2010, BIOMATERIALS, V31, P6738, DOI 10.1016/j.biomaterials.2010.05.020
   Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   ENGELMANN K, 1988, INVEST OPHTH VIS SCI, V29, P1656
   Engler C, 2009, CORNEA, V28, P1050, DOI 10.1097/ICO.0b013e3181a165a3
   GOSPODAROWICZ D, 1980, P NATL ACAD SCI-BIOL, V77, P4094, DOI 10.1073/pnas.77.7.4094
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Huang TW, 2010, BIOMATERIALS, V31, P6701, DOI 10.1016/j.biomaterials.2010.05.054
   Ishino Y, 2004, INVEST OPHTH VIS SCI, V45, P800, DOI 10.1167/iovs.03-0016
   Joyce NC, 2003, PROG RETIN EYE RES, V22, P359, DOI 10.1016/S1350-9462(02)00065-4
   JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135
   Koh SWM, 2008, INVEST OPHTH VIS SCI, V49, P3491, DOI 10.1167/iovs.07-1543
   Koh SWM, 2009, INVEST OPHTH VIS SCI, V50, P1801, DOI 10.1167/iovs.08-2590
   LANGE TM, 1993, J CATARACT REFR SURG, V19, P232, DOI 10.1016/S0886-3350(13)80947-9
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li W, 2007, INVEST OPHTH VIS SCI, V48, P614, DOI 10.1167/iovs.06-1126
   Lin SJ, 2006, BIOMATERIALS, V27, P5079, DOI 10.1016/j.biomaterials.2006.05.035
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   Miyata K, 2001, CORNEA, V20, P59, DOI 10.1097/00003226-200101000-00012
   Marquez SP, 2009, ACTA BIOMATER, V5, P1839, DOI 10.1016/j.actbio.2009.02.011
   Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x
   Rasband W, 1997, IMAGEJ
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   TSENG SCG, 1981, J BIOL CHEM, V256, P3361
   Wang TJ, 2012, MOL VIS, V18, P255
   Wang TJ, 2012, COLLOID SURFACE B, V90, P236, DOI 10.1016/j.colsurfb.2011.10.043
   Wang TJ, 2012, J BIOMED MATER RES A, V100A, P252, DOI 10.1002/jbm.a.33274
   Watanabe R, 2011, TISSUE ENG PT A, V17, P2213, DOI [10.1089/ten.tea.2010.0568, 10.1089/ten.TEA.2010.0568]
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693
NR 36
TC 14
Z9 16
U1 3
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 403
EP 410
DI 10.1016/j.colsurfb.2014.01.024
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100053
PM 24531150
DA 2018-10-19
ER

PT J
AU Kunze, A
   Hesse, C
   Svedhem, S
AF Kunze, Angelika
   Hesse, Camilla
   Svedhem, Sofia
TI Real-time monitoring of surface-confined platelet activation on TiO2
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Platelet activation; Aggregation; TiO2; QCM-D
ID QUARTZ-CRYSTAL MICROBALANCE; CELL-ADHESION; DISSIPATION; FILMS
AB For the development of advanced hemocompatible biomaterial functions, there is an unmet demand for in vitro evaluation techniques addressing platelet-surface interactions. We show that the quartz crystal microbalance with dissipation (QCM-D) monitoring technique, here combined with light microscopy, provides a surface sensitive technique that allows for real-time monitoring of the activation and aggregation of the surface-confined platelets on TiO2. The QCM-D signal monitored during adhesion and activation of platelets on TiO2 coated surfaces was found to be different in platelet-poor and platelet-rich environment although light microscopy images taken for each of the two cases looked essentially the same. Interestingly, aggregation of activated platelets was only observed in a protein-rich environment. Our results show that a layer of plasma proteins between the TiO2 surface and the platelets strongly influences the coupling between the platelets and the underlying substrate, explaining both the observed QCM-D signals and the ability of the platelets to aggregate. (C) 2014 The Authors. Published by Elsevier B.V. All rights reserved.
C1 [Kunze, Angelika; Svedhem, Sofia] Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
   [Hesse, Camilla] Univ Gothenburg, Sahlgrenska Acad, S-41345 Gothenburg, Sweden.
RP Kunze, A (reprint author), Chalmers, Dept Appl Phys, S-41296 Gothenburg, Sweden.
EM angelika.kunze@chalmers.se
FU Swedish Research Council (VR); Linnaeus program SUPRA; European Union
   [NMP4-SL2009-229292]
FX Financial support was received from the Swedish Research Council (VR),
   the Linnaeus program SUPRA and the European Union Seventh Framework
   Program (FP7/2007-2013) under grant agreement no NMP4-SL2009-229292
   ("Find & Bind").
CR Fatisson J, 2008, LANGMUIR, V24, P3294, DOI 10.1021/1a7023204
   Fatisson J, 2011, J R SOC INTERFACE, V8, P988, DOI 10.1098/rsif.2010.0617
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   Gupta S., 2012, BIOINTERPHASES, V7
   JOHANNSMANN D, 1992, PHYS REV B, V46, P7808, DOI 10.1103/PhysRevB.46.7808
   Johannsmann D, 2009, ANAL CHEM, V81, P8167, DOI 10.1021/ac901381z
   KASEMO B, 1983, J PROSTHET DENT, V49, P832, DOI 10.1016/0022-3913(83)90359-1
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   Lord MS, 2006, BIOMATERIALS, V27, P4529, DOI 10.1016/j.biomaterials.2006.04.006
   Muratsugu M, 1997, ANAL CHIM ACTA, V342, P23, DOI 10.1016/S0003-2670(96)00576-4
   PARK K, 1990, BIOMATERIALS, V11, P24, DOI 10.1016/0142-9612(90)90047-T
   PARSEGIAN VA, 1983, J PROSTHET DENT, V49, P838, DOI 10.1016/0022-3913(83)90360-8
   Saitakis M, 2012, CELL MOL LIFE SCI, V69, P357, DOI 10.1007/s00018-011-0854-8
   Santos-Martinez MJ, 2012, INT J NANOMED, V7, P243, DOI 10.2147/IJN.S26679
   Sinn S., 2010, ANALYST, V135, P2939
   Tymchenko N., 2012, BIOINTERPHASES, P7
   Voinova MV, 2002, BIOSENS BIOELECTRON, V17, P835, DOI 10.1016/S0956-5663(02)00050-7
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Xi J., 2013, J BIOCHIPS TISSUE CH, VS5, P001, DOI 10.4172/2153-0777.S5-001
NR 19
TC 5
Z9 6
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD APR 1
PY 2014
VL 116
BP 446
EP 451
DI 10.1016/j.colsurfb.2014.01.025
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG8YZ
UT WOS:000335706100059
PM 24549046
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Lee, HS
   Lee, JH
   Yang, JW
AF Lee, Hye Sook
   Lee, Ji Hyun
   Yang, Jae Wook
TI Effect of porcine chondrocyte-derived extracellular matrix on the
   pterygium in mouse model
SO GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
LA English
DT Article
DE Pterygium; Porcine chondrocyte-derived extracellular matrix (PCDECM);
   Athymic nude mouse
ID IN-VIVO; OCULAR ANGIOGENESIS; AMNIOTIC MEMBRANE; CELLS; PATHOGENESIS;
   SCAFFOLD; TISSUE; RECONSTRUCTION; INVASION; EYE
AB Purpose To investigate the effect of porcine chondrocyte-derived extracellular matrix (PCDECM) on an experimental mouse model of human pterygial epithelial cells.
   Methods Cultured human pterygial epithelial cells (hPECs) were stained with pan-cytokeratin (CK), CK3/2p, vimentin, and CK13 antibodies to characterize the cells. A pterygium mouse model was developed by injecting 1X10(4) hPECs into the nasal subconjunctival space in athymic nude mice. PCDECM (25 mg/mL, 10 mu L) was injected into the nasal subconjunctival space in the right eye 7, 10 and 14 days after the epithelial cell injection (PCDECM group). Image analysis was performed using ImageJ (R) to compare the lesion size. A histopathological analysis of the cornea was conducted to evaluate the state of the epithelium and the expression of pterygial epithelial cell markers.
   Results The isolated pterygial cells were positive for pan-CK, CK3/2p and vimentin, and they were negative for CK13 under immunofluorescence microscopy. On day 17 after epithelial cell injection, the size of the lesion compared to the entire cornea was increased to 37.1 % in the control group. However, in the PCDECM group, the lesion covered only 26.3 % of the entire cornea. The corneas of the pterygium mice showed an epithelium of irregular thickness, proliferation of the stroma, extracellular matrix breakdown and overexpression of pterygium-positive markers. However, these changes were significantly suppressed by the application of PCDEDM.
   Conclusions Our findings suggest that PCDECM seems to suppress pterygial epithelial cell growth and it could be used as a promising biomaterial for the noninvasive treatment of pterygium.
C1 [Yang, Jae Wook] Inje Univ, Coll Med, Dept Ophthalmol, Pusan 614735, South Korea.
   [Lee, Hye Sook; Lee, Ji Hyun; Yang, Jae Wook] Inje Univ, Busan Paik Hosp, Ocular Neovasc Dis Res Ctr, Pusan 614735, South Korea.
RP Yang, JW (reprint author), Inje Univ, Coll Med, Dept Ophthalmol, Pusan 614735, South Korea.
EM oculoplasty@gmail.com
FU Korea Healthcare Technology R&D Project, Ministry of Health and Welfare
   Affairs, Republic of Korea [HI12C0005]
FX This study was supported by a grant from the Korea Healthcare Technology
   R&D Project, Ministry of Health and Welfare Affairs, Republic of Korea
   (grant #: HI12C0005).
CR Ang LPK, 2007, CURR OPIN OPHTHALMOL, V18, P308, DOI 10.1097/ICU.0b013e3281a7ecbb
   AUSTIN P, 1983, OPHTHALMOLOGY, V90, P96
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2001, EXP HEMATOL, V29, P1310, DOI 10.1016/S0301-472X(01)00729-9
   Bradley JC, 2010, BRIT J OPHTHALMOL, V94, P815, DOI 10.1136/bjo.2008.151852
   Choi KH, 2012, TISSUE ENG REGEN MED, V9, P43, DOI 10.1007/s13770-012-0043-3
   Choi KH, 2010, BIOMATERIALS, V31, P5355, DOI 10.1016/j.biomaterials.2010.03.053
   Chui J, 2011, AM J PATHOL, V78, P817
   Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9
   COGAN DG, 1949, ARCH OPHTHALMOL-CHIC, V41, P406, DOI 10.1001/archopht.1949.00900040416002
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037
   de Rotth A, 1940, ARCH OPHTHALMOL-CHIC, V23, P522
   Di Girolamo N, 2004, PROG RETIN EYE RES, V23, P195, DOI 10.1016/j.preteyers.2004.02.002
   Di Girolamo N, 1999, BRIT J OPHTHALMOL, V83, P1077, DOI 10.1136/bjo.83.9.1077
   Dua HS, 2010, BRIT J OPHTHALMOL, V94, P963, DOI 10.1136/bjo.2009.157941
   Dushku N, 2001, ARCH OPHTHALMOL-CHIC, V119, P695, DOI 10.1001/archopht.119.5.695
   Dushu N, 1994, CURR EYE RES, V21, P473
   Jin CZ, 2007, ARTIF ORGANS, V31, P183, DOI 10.1111/j.1525-1594.2007.00363.x
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Kivela T, 1998, PROG RETIN EYE RES, V17, P385, DOI 10.1016/S1350-9462(98)00001-9
   Lippincott SW, 1943, J NATL CANCER I, V3, P545
   Livezeanu C, 2011, ROM J MORPHOL EMBRYO, V52, P837
   Montezuma SR, 2009, SEMIN OPHTHALMOL, V24, P52, DOI 10.1080/08820530902800017
   Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752
   Reid TW, 2010, EYE CONTACT LENS, V36, P290, DOI 10.1097/ICL.0b013e3181eea8fe
   SORSBY A, 1946, BRIT J OPHTHALMOL, V30, P337, DOI 10.1136/bjo.30.6.337
   WILLIAMS KA, 1985, TRANSPLANTATION, V39, P242, DOI 10.1097/00007890-198503000-00004
NR 28
TC 6
Z9 6
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0721-832X
EI 1435-702X
J9 GRAEF ARCH CLIN EXP
JI Graefes Arch. Clin. Exp. Ophthalmol.
PD APR
PY 2014
VL 252
IS 4
BP 609
EP 618
DI 10.1007/s00417-014-2592-8
PG 10
WC Ophthalmology
SC Ophthalmology
GA AG8HN
UT WOS:000335659500008
PM 24562465
DA 2018-10-19
ER

PT J
AU Wang, L
   La, DM
   Yang, B
   Jiang, ZP
   Zhang, YC
   Zhou, J
   Lai, W
   Chen, S
AF Wang, Liang
   La, Dong-ming
   Yang, Bin
   Jiang, Zhi-peng
   Zhang, Yu-chao
   Zhou, Jun
   Lai, Wei
   Chen, Shuang
TI Reconstruction of abdominal wall defects using small intestinal
   submucosa coated with gelatin hydrogel incorporating basic fibroblast
   growth factor(1)
SO ACTA CIRURGICA BRASILEIRA
LA English
DT Article
DE Abdominal Wall; Biocompatible Materials; Intestinal; Fibroblast Growth
   Factor 2; Rats
ID BONE REGENERATION; REPAIR; MODEL; MATRIX; RATS; VASCULARIZATION;
   ANGIOGENESIS; PREVENTION; RELEASE; IMPROVE
AB PURPOSE: To construct a new biomaterial-small intestinal submucosa coated with gelatin hydrogel incorporating basic fibroblast growth factor, and to evaluate the new biomaterials for the reconstruction of abdominal wall defects.
   METHODS: Thirty six Sprague-Dawley rats were used in the animal experiments and randomly divided into three groups. The new biomaterial was constructed by combining small intestinal submucosa with gelatin hydrogel for basic fibroblast growth factor release. Abdominal wall defects were created in rats, and repaired using the new biomaterials (group B), compared with small intestinal submucosa (group S) and ULTRAPRO (TM) mesh (group P). Six rats in each group were sacrificed at three and eight weeks postoperatively to examine the gross effects, inflammatory responses, collagen deposition and neovascularization.
   RESULTS: After implantation, mild adhesion was caused in groups B and S. Group B promoted more neovascularization than group S at three weeks after implantation, and induced significantly more amount of collagen deposition and better collagen organization than groups S and P at eight weeks after implantation.
   CONCLUSION: Small intestinal submucosa coated with gelatin hydrogel incorporating basic fibroblast growth factor could promote better regeneration and remodeling of host tissues for the reconstruction of abdominal wall defects.
C1 [Wang, Liang; La, Dong-ming; Yang, Bin; Jiang, Zhi-peng; Zhang, Yu-chao; Zhou, Jun; Lai, Wei; Chen, Shuang] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, South China Training Ctr Hernia Therapy, Dept Surg Disciplines, Guangzhou 510120, Guangdong, Peoples R China.
RP Chen, S (reprint author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, South China Training Ctr Hernia Therapy, Dept Surg Disciplines, Guangzhou 510120, Guangdong, Peoples R China.
EM chensh2@mail.sysu.edu.cn
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   ARNOLD F, 1991, PHARMACOL THERAPEUT, V52, P407, DOI 10.1016/0163-7258(91)90034-J
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   De Coppi P, 2006, TISSUE ENG, V12, P1929, DOI 10.1089/ten.2006.12.1929
   Dubay DA, 2004, ANN SURG, V240, P179, DOI 10.1097/01.sla.0000131576.12153.ab
   Epstein SE, 2001, CARDIOVASC RES, V49, P532, DOI 10.1016/S0008-6363(00)00217-0
   FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664
   Franz MG, 2001, J SURG RES, V97, P109, DOI 10.1006/jsre.2001.6083
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Ikada Y., 1998, ADV DRUG DELIV REV, V31, P287
   Iwakura A, 2000, ANN THORAC SURG, V70, P824, DOI 10.1016/S0003-4975(00)01645-3
   Konstantinovic ML, 2005, BJOG-INT J OBSTET GY, V112, P1554, DOI 10.1111/j.1471-0528.2005.00688.x
   Krishnamoorthy L, 2001, J Wound Care, V10, P173
   MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297
   Muniruzzaman Tabata Y, 1998, J BIOMAT SCI-POLYM E, V9, P459
   Nurata H, 2009, J CLIN NEUROSCI, V16, P542, DOI 10.1016/j.jocn.2008.05.021
   Okazaki Y, 2000, ARCH ORAL BIOL, V45, P911, DOI 10.1016/S0003-9969(00)00035-2
   RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484
   Rieck P., 1993, Ophthalmologe, V90, P646
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Stocum DL, 1997, SCIENCE, V276, P15, DOI 10.1126/science.276.5309.15
   Tabata Y, 1998, BIOMATERIALS, V19, P807, DOI 10.1016/S0142-9612(98)00233-6
   Taipale J, 1997, FASEB J, V11, P51
   Takaoka R, 2009, J BIOMAT SCI-POLYM E, V20, P1483, DOI 10.1163/092050609X12457419038465
   Unger EF, 2000, AM J CARDIOL, V85, P1414, DOI 10.1016/S0002-9149(00)00787-6
   van't Riet M, 2003, ANN SURG, V237, P123, DOI 10.1097/00000658-200301000-00017
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
   Wasserberg N, 2007, J SURG RES, V141, P294, DOI 10.1016/j.jss.2006.12.541
   Xie JL, 2008, WOUND REPAIR REGEN, V16, P576, DOI 10.1111/j.1524-475X.2008.00405.x
   Yamamoto M, 2000, J CONTROL RELEASE, V64, P133, DOI 10.1016/S0168-3659(99)00129-7
   Yamamoto M, 2001, J BIOMAT SCI-POLYM E, V12, P77, DOI 10.1163/156856201744461
   Zhao WX, 2007, J BIOMED MATER RES A, V82A, P630, DOI 10.1002/bjm.a.31179
NR 33
TC 3
Z9 3
U1 1
U2 5
PU ACTA CIRURGICA BRASILEIRA
PI SAO PAULO
PA ALAMEDA RIO CLARO, 179-41, SAO PAULO, SP 01332-010, BRAZIL
SN 0102-8650
EI 1678-2674
J9 ACTA CIR BRAS
JI Acta Cir. Bras.
PD APR
PY 2014
VL 29
IS 4
BP 252
EP 260
DI 10.1590/S0102-86502014000400006
PG 9
WC Surgery
SC Surgery
GA AF8WT
UT WOS:000334997000006
PM 24760026
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Rnjak-Kovacina, J
   Wray, LS
   Golinski, JM
   Kaplan, DL
AF Rnjak-Kovacina, Jelena
   Wray, Lindsay S.
   Golinski, Julianne M.
   Kaplan, David L.
TI Arrayed Hollow Channels in Silk-Based Scaffolds Provide Functional
   Outcomes for Engineering Critically Sized Tissue Constructs
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE silk; tissue engineering; oxygen; nutrient delivery; vascularization;
   porous scaffolds
ID VASCULARIZATION STRATEGIES; FIBROIN; NETWORKS; DEGRADATION; FABRICATION;
   DELIVERY; VESSELS; SYSTEM
AB In the field of regenerative medicine there is a need for scaffolds that support large, critically-sized tissue formation. Major limitations in reaching this goal are the delivery of oxygen and nutrients throughout the bulk of the engineered tissue as well as host tissue integration and vascularization upon implantation. To address these limitations, the development of a porous scaffold platform made from biodegradable silk protein that contains an array of vascular-like structures that extend through the bulk of the scaffold was previously reported. Here, the hollow channels play a pivotal role in enhancing cell infiltration, delivering oxygen and nutrients to the scaffold bulk, and promoting in vivo host tissue integration and vascularization. The unique features of this protein biomaterial system, including the vascular structures and tunable material properties, render this scaffold a robust and versatile tool for implementation in a variety of tissue engineering, regenerative medicine, and disease modeling applications.
C1 [Rnjak-Kovacina, Jelena; Wray, Lindsay S.; Golinski, Julianne M.; Kaplan, David L.] Ctr Sci & Technol, Dept Biomed Engn, Medford, MA 02155 USA.
RP Rnjak-Kovacina, J (reprint author), Ctr Sci & Technol, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU NIH [NIH P41 EB002520, EY020856]; National Science Foundation Graduate
   Research Fellowship Program [NSF DGE 0806676]
FX J.R.-K. and L. S. W. contributed equally to this work. The authors thank
   the NIH (NIH P41 EB002520; EY020856) and the National Science Foundation
   Graduate Research Fellowship Program (NSF DGE 0806676) for support. The
   authors are grateful to Dr. Bruce Paniliatis for assistance with animal
   surgeries.
CR Bagnaninchi PO, 2007, TISSUE ENG, V13, P323, DOI 10.1089/ten.2006.0168
   Baranski JD, 2013, P NATL ACAD SCI USA, V110, P7586, DOI 10.1073/pnas.1217796110
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Du YA, 2011, BIOTECHNOL BIOENG, V108, P1693, DOI 10.1002/bit.23102
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   King KR, 2004, ADV MATER, V16, P2007, DOI 10.1002/adma.200306522
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4
   Lokmic Z, 2008, TISSUE ENG PART B-RE, V14, P87, DOI 10.1089/teb.2007.0299
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Lovett M, 2010, TISSUE ENG PART C-ME, V16, P1565, DOI [10.1089/ten.tec.2010.0241, 10.1089/ten.TEC.2010.0241]
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nazhat SN, 2007, BIOMACROMOLECULES, V8, P543, DOI 10.1021/bm060715f
   Phelps EA, 2009, REGEN MED, V4, P65, DOI 10.2217/17460751.4.1.65
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wray LS, 2012, BIOMATERIALS, V33, P9214, DOI 10.1016/j.biomaterials.2012.09.017
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang WJ, 2011, BIOMATERIALS, V32, P9415, DOI 10.1016/j.biomaterials.2011.08.047
NR 33
TC 21
Z9 22
U1 0
U2 40
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD APR
PY 2014
VL 24
IS 15
BP 2188
EP 2196
DI 10.1002/adfm.201302901
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA AE8VQ
UT WOS:000334281400007
PM 25395920
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Winnett, J
   Mallick, KK
AF Winnett, James
   Mallick, Kajal K.
TI Parametric Characterization of Porous 3D Bioscaffolds Fabricated by an
   Adaptive Foam Reticulation Technique
SO JOM
LA English
DT Article
ID HYDROXYAPATITE SCAFFOLDS; BONE; CHEMISTRY; CERAMICS; POROSITY
AB Commercially pure titanium (Ti) and its alloys, in particular, titanium-vanadium-aluminium (Ti-6Al-4V), have been used as biomaterials due to their mechanical similarities to bone, good biocompatibility, and inertness in vivo. The introduction of porosity to the scaffolds leads to optimized mechanical properties and enhanced biological activity. The adaptive foam reticulation (AFR) technique has been previously used to generate hydroxyapatite bio-scaffolds with enhanced cell behavior due to the generation of macroporous structures with microporous struts that provided routes for cell infiltration as well as attachment sites. Sacrificial polyurethane templates of 45 ppi and 90 ppi were coated in biomaterial-based slurries containing either Ti or Ti-6Al-4V as the biomaterial and camphene as the porogen. The resultant macropore sizes of 100-550 mu m corresponded well with the initial template pore sizes while camphene produced micropores of 1-10 mu m, with the level of microporosity related to the amount of porogen inclusion.
C1 [Winnett, James; Mallick, Kajal K.] Univ Warwick, Coventry CV4 7AL, W Midlands, England.
RP Winnett, J (reprint author), Univ Warwick, Coventry CV4 7AL, W Midlands, England.
EM j.winnett@warwick.ac.uk
FU Engineering and Physical Science Research Council (EPSRC)
FX The authors are grateful to Mr Martin Davis of the School of Engineering
   for the use of facilities and assistance, Science City Futures Project
   for use of XRD facilities, and Engineering and Physical Science Research
   Council (EPSRC) for a Doctoral Training Grant.
CR Ahmad S., 2010, INT J MECH MAT ENG, V5, P244
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chu P.K., 2008, BIOMATERIALS FABRICA, P19
   Cunningham E., 2011, SCI ENG S, V1, P1
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jo IH, 2009, MATER LETT, V63, P1702, DOI 10.1016/j.matlet.2009.05.017
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Li JP, 2007, KEY ENG MATER, V330-332, P999, DOI 10.4028/www.scientific.net/KEM.330-332.999
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Mahendra A., 2009, INJURY, V38, pS7
   Mallick KK, 2012, J BIOMED MATER RES A, V100A, P2948, DOI 10.1002/jbm.a.34238
   Mallick KK, 2009, J AM CERAM SOC, V92, pS85, DOI 10.1111/j.1551-2916.2008.02784.x
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Nan BY, 2011, J AM CERAM SOC, V94, P969, DOI 10.1111/j.1551-2916.2010.04257.x
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Vallet-Regis M., 2001, J CHEM SOC DA, V2, P97
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yang J, 2011, J EUR CERAM SOC, V31, P2569, DOI 10.1016/j.jeurceramsoc.2010.12.035
   Yook SW, 2008, MATER LETT, V62, P4506, DOI 10.1016/j.matlet.2008.08.010
NR 27
TC 0
Z9 0
U1 1
U2 12
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
EI 1543-1851
J9 JOM-US
JI JOM
PD APR
PY 2014
VL 66
IS 4
BP 590
EP 597
DI 10.1007/s11837-014-0937-8
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA AG6BM
UT WOS:000335503400007
DA 2018-10-19
ER

PT J
AU Filardo, G
   Drobnic, M
   Perdisa, F
   Kon, E
   Hribernik, M
   Marcacci, M
AF Filardo, G.
   Drobnic, M.
   Perdisa, F.
   Kon, E.
   Hribernik, M.
   Marcacci, M.
TI Fibrin glue improves osteochondral scaffold fixation: study on the human
   cadaveric knee exposed to continuous passive motion
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE Knee joint; Articular cartilage lesion; Osteochondral scaffold; Scaffold
   fixation; Post-operative rehabilitation; Fibrin glue
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; COMPOSITE MULTILAYERED BIOMATERIAL;
   ARTICULAR-CARTILAGE DEFECTS; SURGICAL-TREATMENT; SHEEP MODEL; FOLLOW-UP;
   ARTHROSCOPIES; REGENERATION; INJURIES; REPAIR
AB Objective: To evaluate stability and integrity of bi-layer and three-layer collagen-hydroxyapatite (C-HA) osteochondral scaffolds in a human cadaveric knee exposed to continuous passive motion (CPM) with and without loading and the role of added fibrin glue to improve the press-fit fixation of C-HA scaffolds.
   Design: Osteochondral lesions (2.0 x 1.5 cm) were chiseled out on both condyles and trochlea in eight human cadaveric knees. A total of 24 bi-layer (5 mm, four in each condyle) or three-layer C-HA scaffolds (8 mm, eight in the trochlea, four in each condyle) were first press-fit implanted and underwent testing with CPM, 90 cycles, 0 degrees -90 degrees. The second set of 24 scaffolds was implanted in cleaned lesions with the addition of fibrin glue. Two knees with fibrin glue fixation were additionally exposed to 15 kg loading, with 30 cycles of CPM, 0 degrees -30 degrees. Then, the knees were reopened and the scaffolds were evaluated using semi-quantitative Drobnic and modified Bekkers scores.
   Results: All but two scaffolds remained in the lesions site throughout CPM. Two implants failed: both were bi-layer osteochondral scaffolds, press-fit implanted at the lateral femoral condyle (LFC). A statistically significant difference was obtained between press-fit and fibrin glue implants with both Drobnic (2.9 +/- 0.7 vs 4.3 +/- 0.1, P < 0.0005) and Bekkers (3.3 +/- 1.0 vs 5.0 +/- 0.1, P < 0.0005) scores. Additional knee loading did not affect fibrin glue scaffold fixation or integrity.
   Conclusion: This cadaveric study showed fibrin glue notably improved bi-layer or three-layer C-HA scaffold press-fit fixation regardless of lesion location. It is therefore recommended that fibrin glue be used during surgery to improve early post-operative C-HA scaffold stability and integrity. (C) 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 [Filardo, G.; Kon, E.] Rizzoli Orthopaed Inst, Nanobiotechnol Lab, Orthopaed Clin 2, I-40136 Bologna, Italy.
   [Perdisa, F.; Marcacci, M.] Rizzoli Orthopaed Inst, Biomech Lab, Orthopaed Clin 2, I-40136 Bologna, Italy.
   [Drobnic, M.] Univ Ljubljana, Fac Med, Orthopaed Clin, Ljubljana 61000, Slovenia.
   [Hribernik, M.] Univ Ljubljana, Fac Med, Inst Anat, Ljubljana 61000, Slovenia.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
CR Aroen A, 2004, AM J SPORT MED, V32, P211, DOI 10.1177/0363546503259345
   Bekkers JEJ, 2010, OSTEOARTHR CARTILAGE, V18, P266, DOI 10.1016/j.joca.2009.09.001
   BUCKWALTER JA, 1995, J ORTHOPAED RES, V13, P155, DOI 10.1002/jor.1100130202
   Curl WW, 1997, ARTHROSCOPY, V13, P456, DOI 10.1016/S0749-8063(97)90124-9
   Della Villa S, 2010, AM J SPORT MED, V38, P68, DOI 10.1177/0363546509348490
   Drobnic M, 2006, OSTEOARTHR CARTILAGE, V14, P337, DOI 10.1016/j.joca.2005.11.007
   Ebert JR, 2012, ARTHROSCOPY, V28, P952, DOI 10.1016/j.arthro.2011.12.022
   Efe T, 2012, INT ORTHOP, V36, P1315, DOI 10.1007/s00264-011-1437-x
   Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112
   Filardo G, 2012, CARTILAGE, V3, P288, DOI 10.1177/1947603512436371
   Filardo G, 2014, AM J SPORTS MED
   Filardo G, 2013, KNEE
   Filardo G, 2013, AM J SPORT MED, V41, P1786, DOI 10.1177/0363546513490658
   Filardo G, 2013, ARTHROSCOPY, V29, P174, DOI 10.1016/j.arthro.2012.05.891
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P468, DOI 10.1007/s00167-011-1714-7
   Gomoll AH, 2012, KNEE SURG SPORT TR A, V20, P450, DOI 10.1007/s00167-011-1780-x
   Gratz KR, 2008, BIORHEOLOGY, V45, P193, DOI 10.3233/BIR-2008-0475
   HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212
   Hambly K, 2006, AM J SPORT MED, V34, P1020, DOI 10.1177/0363546505281918
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   Kim MK, 2010, KNEE SURG SPORT TR A, V18, P528, DOI 10.1007/s00167-009-0905-y
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2012, KNEE SURG SPORT TR A, V20, P436, DOI 10.1007/s00167-011-1713-8
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kon E, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-220
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, KNEE SURG SPORT TR A, V17, P1312, DOI 10.1007/s00167-009-0819-8
   Marcacci M, 2013, KNEE SURG SPORTS TRA, V21
   Marlovits S, 2005, KNEE SURG SPORT TR A, V13, P451, DOI 10.1007/s00167-004-0535-3
   Nehme A, 2005, CLIN ORTHOP RELAT R, P232, DOI 10.1097/01.blo.0000137546.14953.57
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Rannou F., 2001, Annales de Readaptation et de Medecine Physique, V44, P259, DOI 10.1016/S0168-6054(01)00099-X
   Scotti C, 2010, KNEE SURG SPORT TR A, V18, P1400, DOI 10.1007/s00167-009-1014-7
   Vahdati A, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007748
   Widuchowski W, 2007, KNEE, V14, P177, DOI 10.1016/j.knee.2007.02.001
NR 38
TC 12
Z9 12
U1 0
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1063-4584
EI 1522-9653
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD APR
PY 2014
VL 22
IS 4
BP 557
EP 565
DI 10.1016/j.joca.2014.01.004
PG 9
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA AG1WT
UT WOS:000335207600005
PM 24487043
OA Bronze
DA 2018-10-19
ER

PT J
AU Sun, JG
   Graeter, SV
   Tang, J
   Huang, JH
   Liu, P
   Lai, YX
   Yu, L
   Majer, G
   Spatz, JP
   Ding, JD
AF Sun JianGuo
   Graeter, Stefan, V
   Tang Jian
   Huang JingHuan
   Liu Peng
   Lai YuXiao
   Yu Lin
   Majer, Guenter
   Spatz, Joachim P.
   Ding JianDong
TI Preparation of stable micropatterns of gold on cell-adhesion-resistant
   hydrogels assisted by a hetero-bifunctional macromonomer linker
SO SCIENCE CHINA-CHEMISTRY
LA English
DT Article
DE biomaterials; hydrogels; micropattern; macromonomer; cell adhesion
ID ESCHERICHIA-COLI THIOREDOXIN; STEM-CELLS; SURFACE MODIFICATION;
   DIFFERENTIATION; MICROSTRUCTURES; REACTIVITY; PHOTOLITHOGRAPHY;
   NANOPARTICLES; LITHOGRAPHY; FABRICATION
AB Surface patterning is very useful in biomaterial studies, yet it is not easy to prepare a micropattern with cell-adhesion contrast that is stable in a wet environment. Recently, a platform technique of transfer photolithography was invented to fabricate stable metal microarrays on the surface of a cell-adhesion resistant and mechanically biomimetic poly(ethylene glycol) hydrogel; the linker is the key chemical in such a transfer strategy. This article reports the design and synthesis of a hetero-bifunctional macromonomer linker with a thiol group at one end and an acryloyl group at the other end. The bifunctional linker was characterized by GPC and H-1 NMR, and the average number of thiol groups in the bifunctional linker was detected by Ellman's reagent. The regent stability under wet conditions was also confirmed by the model reactants. The resultant micropatterned surfaces are meaningful for future studies of cell behaviors on mechanically biomimetic matrixes.
C1 [Sun JianGuo; Graeter, Stefan, V; Tang Jian; Huang JingHuan; Liu Peng; Lai YuXiao; Yu Lin; Ding JianDong] Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Sun JianGuo] Fudan Univ, Res Ctr, Eye & ENT Hosp, Shanghai 200030, Peoples R China.
   [Graeter, Stefan, V; Majer, Guenter; Spatz, Joachim P.] Max Planck Inst Intelligent Syst, Dept New Mat & Biosyst, D-370569 Stuttgart, Germany.
   [Graeter, Stefan, V; Majer, Guenter; Spatz, Joachim P.] Heidelberg Univ, Inst Phys Chem, D-25369120 Heidelberg, Germany.
RP Ding, JD (reprint author), Fudan Univ, Dept Macromol Sci, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
EM jdding1@fudan.edu.cn
RI Spatz, Joachim/A-1107-2017
OI Spatz, Joachim/0000-0003-3419-9807
FU National Natural Science Foundation of China [21034002, 91127028,
   51273046]; Ministry of Science and Technology of China [2011CB606203];
   Science and Technology Development Foundation of Shanghai [13XD1401000];
   DAAD Scholarship
FX This work was financially supported by the National Natural Science
   Foundation of China (21034002, 91127028, 51273046), the Ministry of
   Science and Technology of China (2011CB606203), and the Science and
   Technology Development Foundation of Shanghai (13XD1401000). We also
   appreciate the DAAD Scholarship for Visiting Ph.D. Students (working in
   China) awarded to S. V. Graeter.
CR Aktary M, 2003, J VAC SCI TECHNOL B, V21, pL5, DOI 10.1116/1.1596216
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen W, 2010, MACROMOLECULES, V43, P201, DOI 10.1021/ma901897y
   Deng X, 2012, CHEM COMMUN, V48, P9741, DOI 10.1039/c2cc35010f
   Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a
   Escobar NI, 1996, NUCL MED BIOL, V23, P641, DOI 10.1016/0969-8051(96)00028-5
   Fu CY, 2011, TISSUE ENG PART C-ME, V17, P871, DOI [10.1089/ten.tec.2010.0690, 10.1089/ten.TEC.2010.0690]
   Gou HL, 2010, ACS APPL MATER INTER, V2, P1324, DOI 10.1021/am100196z
   Graeter SV, 2007, NANO LETT, V7, P1413, DOI 10.1021/nl070098g
   Guo LJ, 2004, J PHYS D APPL PHYS, V37, pR123, DOI 10.1088/0022-3727/37/11/R01
   He HX, 2000, LANGMUIR, V16, P3846, DOI 10.1021/la991356v
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Kruss S, 2012, LAB CHIP, V12, P3285, DOI [10.1039/c2lc40611j, 10.1039/c2lc40611]
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee W, 2012, ADV HEALTHC MATER, V1, P635, DOI 10.1002/adhm.201200158
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Liu JJ, 2012, SCI CHINA CHEM, V55, P494, DOI 10.1007/s11426-012-4538-5
   Liu P, 2010, NANOSCALE, V2, P122, DOI 10.1039/b9nr00124g
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Ma XL, 2010, ANGEW CHEM INT EDIT, V49, P5537, DOI 10.1002/anie.201000766
   Nobs L, 2003, INT J PHARM, V250, P327, DOI 10.1016/S0378-5173(02)00542-2
   Oh HH, 2012, ADV MATER, V24, P4311, DOI 10.1002/adma.201200237
   Pan Z, 2012, BIOMATERIALS, V33, P1730, DOI 10.1016/j.biomaterials.2011.11.023
   Peng R, 2012, BIOMATERIALS, V33, P6008, DOI 10.1016/j.biomaterials.2012.05.010
   Peng R, 2011, BIOMATERIALS, V32, P8048, DOI 10.1016/j.biomaterials.2011.07.035
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Song W, 2011, LANGMUIR, V27, P6155, DOI 10.1021/la200487w
   Sun JG, 2008, BIOMACROMOLECULES, V9, P2569, DOI 10.1021/bm800477s
   Sun ZQ, 2011, SCI CHINA CHEM, V54, P275, DOI 10.1007/s11426-010-4195-5
   Takahashi N, 1996, BIOCHEMISTRY-US, V35, P8342, DOI 10.1021/bi960465v
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tekin H, 2011, J AM CHEM SOC, V133, P12944, DOI 10.1021/ja204266a
   Wang B, 2007, MACROMOL RAPID COMM, V28, P567, DOI 10.1002/marc.200600730
   Wang X, 2013, BIOMATERIALS, V34, P2865, DOI 10.1016/j.biomaterials.2013.01.021
   Wang YZ, 2011, SCI CHINA CHEM, V54, P405, DOI 10.1007/s11426-010-4213-7
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Wright SK, 1998, ANAL BIOCHEM, V265, P8, DOI 10.1006/abio.1998.2858
   Yan C, 2011, BIOMATERIALS, V32, P3931, DOI 10.1016/j.biomaterials.2011.01.078
   Yao X, 2013, ADV MATER, V25, P5257, DOI 10.1002/adma.201301762
   Yao X, 2013, BIOMATERIALS, V34, P9001, DOI 10.1016/j.biomaterials.2013.08.013
   Yao X, 2013, BIOMATERIALS, V34, P930, DOI 10.1016/j.biomaterials.2012.10.052
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhao YC, 2012, CHINESE J CHEM, V30, P491, DOI 10.1002/cjoc.201100252
   Zhao YC, 2012, CHINESE SCI BULL, V57, P234, DOI 10.1007/s11434-011-4904-2
NR 49
TC 10
Z9 10
U1 7
U2 74
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7291
EI 1869-1870
J9 SCI CHINA CHEM
JI Sci. China-Chem.
PD APR
PY 2014
VL 57
IS 4
SI SI
BP 645
EP 653
DI 10.1007/s11426-013-5057-8
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AF0HP
UT WOS:000334395200019
DA 2018-10-19
ER

PT J
AU Cui, HT
   Liu, YD
   Cheng, YL
   Zhang, Z
   Zhang, PB
   Chen, XS
   Wei, Y
AF Cui, Haitao
   Liu, Yadong
   Cheng, Yilong
   Zhang, Zhe
   Zhang, Peibiao
   Chen, Xuesi
   Wei, Yen
TI In Vitro Study of Electroactive Tetraaniline-Containing Thermosensitive
   Hydrogels for Cardiac Tissue Engineering
SO BIOMACROMOLECULES
LA English
DT Article
ID INJECTABLE ACELLULAR HYDROGELS; EMBRYONIC STEM-CELLS;
   ELECTRICAL-STIMULATION; CARBON NANOTUBES; CARDIOMYOCYTE DIFFERENTIATION;
   MYOCARDIAL-INFARCTION; ANTIOXIDANT ACTIVITY; REPERFUSION INJURY; REPAIR;
   MODEL
AB Injectable hydrogels made of degradable biomaterials can function as both physical support and cell scaffold in preventing infarct expansion and promoting cardiac repair in myocardial infarction therapy. Here, we report in situ hydrogels consisting of thermosensitive PolyNIPAM-based copolymers and electroactive tetraaniline (TA). Studies showed that the addition of 2-methylene-1,3-dioxepane (MDO) provided the PolyNIPAM-based gel with biodegradability, and the introduction of tetraaniline endowed these copolymers with desirable electrical properties and antioxidant activities. The encapsulated H9c2 cells (rat cardiac myoblast) remained highly viable in the gel matrices. In vivo gel formation and histological analyses were performed in rats by subcutaneous injection and excellent biocompatibility was observed. Furthermore, the proliferation and intracellular calcium transients of H9c2 cells were also studied with (and without) electrical stimuli. Both in vitro and in vivo results demonstrated that electroactive hydrogel may be used as a promising injectable biomaterial for cardiac tissue engineering.
C1 [Cui, Haitao; Liu, Yadong; Cheng, Yilong; Zhang, Zhe; Zhang, Peibiao; Chen, Xuesi] Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
   [Cui, Haitao; Cheng, Yilong] Univ Chinese Acad Sci, Beijing 100039, Peoples R China.
   [Wei, Yen] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
RP Chen, XS (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, Key Lab Polymer Ecomat, Changchun 130022, Peoples R China.
EM xschen@ciac.jl.cn; weiyen@tsinghua.edu.cn
RI Cheng, Yilong/G-3061-2017; Wei, Yen/H-5329-2012
OI Cheng, Yilong/0000-0002-4996-8456; 
FU National Natural Science Foundation of China [51233004, 50973109,
   51021003, 20111310585]; Ministry of Science and Technology of China
   (International Cooperation and Communication Program) [2010DFB50890,
   2011DFR51090]
FX This work was supported by grants from the National Natural Science
   Foundation of China (Projects 51233004, 50973109, 51021003, and
   20111310585) and the Ministry of Science and Technology of China
   (International Cooperation and Communication Program 2010DFB50890,
   2011DFR51090). We thank Dr. Pan He for help in animal experiments.
CR Annabi N, 2013, ADV FUNCT MATER, V23, P4950, DOI 10.1002/adfm.201300570
   Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.TEB.2012.0183, 10.1089/ten.teb.2012.0183]
   Bidez PR, 2006, J BIOMAT SCI-POLYM E, V17, P199, DOI 10.1163/156856206774879180
   Borriello A, 2011, J MATER SCI-MATER M, V22, P1053, DOI 10.1007/s10856-011-4259-x
   Braunersreuther V, 2012, CURR PHARM BIOTECHNO, V13, P97, DOI 10.2174/138920112798868782
   Cui HT, 2013, BIOMACROMOLECULES, V14, P1904, DOI 10.1021/bm4002766
   Cui HT, 2012, BIOMACROMOLECULES, V13, P2881, DOI 10.1021/bm300897j
   Fu JD, 2006, ACTA PHARMACOL SIN, V27, P901, DOI 10.1111/j.1745-7254.2006.00380.x
   Gizdavic-Nikolaidis M, 2004, CURR APPL PHYS, V4, P347, DOI 10.1016/j.cap.2003.11.045
   Gorman RC, 2011, J CARDIOVASC TRANSL, V4, P543, DOI 10.1007/s12265-011-9297-8
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Guo B, 2011, BIOMACROMOLECULES, V12, P2601, DOI 10.1021/bm200389t
   Guo BL, 2011, CHEM MATER, V23, P1254, DOI 10.1021/cm103498s
   Guo BL, 2010, MACROMOLECULES, V43, P4472, DOI 10.1021/ma100530k
   Hsiao CW, 2013, BIOMATERIALS, V34, P1063, DOI 10.1016/j.biomaterials.2012.10.065
   Huang LH, 2008, BIOMACROMOLECULES, V9, P850, DOI 10.1021/bm7011828
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Li ZQ, 2012, ACTA BIOMATER, V8, P3586, DOI 10.1016/j.actbio.2012.06.024
   Li ZQ, 2011, BIOMATERIALS, V32, P3220, DOI 10.1016/j.biomaterials.2011.01.050
   Lorgis L, 2010, ATHEROSCLEROSIS, V213, P616, DOI 10.1016/j.atherosclerosis.2010.09.018
   Martinelli V, 2013, ACS NANO, V7, P5746, DOI 10.1021/nn4002193
   Martinelli V, 2012, NANO LETT, V12, P1831, DOI 10.1021/nl204064s
   Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021
   Mooney E, 2012, BIOMATERIALS, V33, P6132, DOI 10.1016/j.biomaterials.2012.05.032
   Moura RM, 2011, ARTIF ORGANS, V35, P471, DOI 10.1111/j.1525-1594.2011.01257.x
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Pedrotty DM, 2005, AM J PHYSIOL-HEART C, V288, pH1620, DOI 10.1152/ajpheart.00610.2003
   Piras AM, 2011, MACROMOLECULES, V44, P848, DOI 10.1021/ma102309m
   Pok S, 2012, ACTA BIOMATER, V9, P5630
   Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200
   Prabhakaran MP, 2011, MAT SCI ENG C-MATER, V31, P503, DOI 10.1016/j.msec.2010.12.017
   Radisic M, 2005, J SERB CHEM SOC, V70, P541, DOI 10.2298/JSC0503541R
   Rahimi N, 2012, BIOMACROMOLECULES, V13, P1448, DOI 10.1021/bm300161r
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Saikia JP, 2010, COLLOID SURFACE B, V81, P158, DOI 10.1016/j.colsurfb.2010.07.005
   Sauer H, 1999, J CELL BIOCHEM, V75, P710, DOI 10.1002/(SICI)1097-4644(19991215)75:4<710::AID-JCB16>3.0.CO;2-Z
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shimizu T, 2002, J BIOMED MATER RES, V60, P110, DOI 10.1002/jbm.1284
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   Stout DA, 2012, INT J NANOMED, V7, P5653, DOI 10.2147/IJN.S34574
   Sugamura K, 2011, FREE RADICAL BIO MED, V51, P978, DOI 10.1016/j.freeradbiomed.2011.05.004
   Sundelacruz S, 2013, BIOMATERIALS, V34, P6695, DOI 10.1016/j.biomaterials.2013.05.040
   Titushkin I, 2009, BIOPHYS J, V96, P717, DOI 10.1016/j.bpj.2008.09.035
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Turer AT, 2010, AM J CARDIOL, V106, P360, DOI 10.1016/j.amjcard.2010.03.032
   Undin J, 2012, POLYM CHEM-UK, V3, P1260, DOI 10.1039/c2py20034a
   Won YW, 2010, J CONTROL RELEASE, V144, P181, DOI 10.1016/j.jconrel.2010.02.014
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Zhang SS, 2013, BBA-MOL CELL RES, V1833, P876, DOI 10.1016/j.bbamcr.2012.10.020
NR 51
TC 49
Z9 49
U1 5
U2 150
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1115
EP 1123
DI 10.1021/bm4018963
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600003
PM 24597966
DA 2018-10-19
ER

PT J
AU Yang, MY
   Shuai, YJ
   Zhang, C
   Chen, YY
   Zhu, LJ
   Mao, CB
   OuYang, HW
AF Yang, Mingying
   Shuai, Yajun
   Zhang, Can
   Chen, Yuyin
   Zhu, Liangjun
   Mao, Chuanbin
   OuYang, Hongwei
TI Biomimetic Nucleation of Hydroxyapatite Crystals Mediated by Antheraea
   pernyi Silk Sericin Promotes Osteogenic Differentiation of Human Bone
   Marrow Derived Mesenchymal Stem Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID BIOLOGICAL NANOFIBERS; STRUCTURAL-CHANGES; PROTEIN SERICIN; STROMAL
   CELLS; FIBROIN; APATITE; MINERALIZATION; SCAFFOLDS; DEPOSITION;
   INTERFACE
AB Biomacromolecules have been used as templates to grow hydroxyapatite crystals (HAps) by biomineralization to fabricate mineralized materials for potential application in bone tissue engineering. Silk sericin is a protein with features desirable as a biomaterial, such as increased hydrophilicity and biodegradation. Mineralization of the silk sericin from Antheraea pernyi (A. pernyi) silkworm has rarely been reported. Here, for the first time, nucleation of HAps on A. pernyi silk sericin (AS) was attempted through a wet precipitation method and consequently the cell viability and osteogenic differentiation of BMSCs on mineralized AS were investigated. It was found that AS mediated the nucleation of HAps in the form of nanoneedles while self-assembling into beta-sheet conformation, leading to the formation of a biomineralized protein based biomaterial. The cell viability assay of BMSCs showed that the mineralization of AS stimulated cell adhesion and proliferation, showing that the resultant AS biomaterial is biocompatible. The differentiation assay confirmed that the mineralized AS significantly promoted the osteogenic differentiation of BMSCs when compared to nonmineralized AS as well as other types of sericin (B. mori sericin), suggesting that the resultant mineralized AS biomaterial has potential in promoting bone formation. This result represented the first work proving the osteogenic differentiation of BMSCs directed by silk sericin. Therefore, the biomineralization of A. pernyi silk sericin coupled with seeding BMSCs on the resultant mineralized biomaterials is a useful strategy to develop the potential application of this unexplored silk sericin in the field of bone tissue engineering. This study lays the foundation for the use of A. pernyi silk sericin as a potential scaffold for tissue engineering.
C1 [Yang, Mingying; Shuai, Yajun; Chen, Yuyin; Zhu, Liangjun] Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Hangzhou 310058, Zhejiang, Peoples R China.
   [Zhang, Can; OuYang, Hongwei] Zhejiang Univ, Sch Med, Ctr Stem Cell & Tissue Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Mao, Chuanbin] Univ Oklahoma, Dept Chem & Biochem, Stephenson Life Sci Res Ctr, Norman, OK 73019 USA.
RP Yang, MY (reprint author), Zhejiang Univ, Coll Anim Sci, Inst Appl Bioresource Res, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.
EM yangm@zju.edu.cn; cbmao@ou.edu
OI Mao, Chuanbin/0000-0002-8142-3659
FU National High Technology Research and Development Program 863
   [2013AA102507]; Zhejiang Provincial Natural Science Foundation of China
   [LZ12C17001]; National Natural Science Foundation of China [20804037,
   21172194]; Silkworm Industry Science and Technology Innovation Team
   [2011R50028]; Projects of Zhejiang Provincial Science and Technology
   Plans [2012C12910]; National Institutes of Health [EB015190, HL092526];
   National Science Foundation [CBET-0854465, CMMI-1234957, CBET-0854414,
   DMR-0847758]; Department of Defense Peer Reviewed Medical Research
   Program [W81XWH-12-1-0384]; Oklahoma Center for Adult Stem Cell Research
   [434003]; Oklahoma Center for the Advancement of Science and Technology
   [HR11-006]
FX M.Y. acknowledges the support of National High Technology Research and
   Development Program 863 (2013AA102507), Zhejiang Provincial Natural
   Science Foundation of China (LZ12C17001), National Natural Science
   Foundation of China (20804037 and 21172194), and Silkworm Industry
   Science and Technology Innovation Team (2011R50028). Y.Y. would like to
   thank the financial support from Projects of Zhejiang Provincial Science
   and Technology Plans (2012C12910). C.B.M. would like to thank the
   financial support from National Institutes of Health (EB015190 and
   HL092526), National Science Foundation (CBET-0854465, CMMI-1234957,
   CBET-0854414, and DMR-0847758), Department of Defense Peer Reviewed
   Medical Research Program (W81XWH-12-1-0384), Oklahoma Center for Adult
   Stem Cell Research (434003), and Oklahoma Center for the Advancement of
   Science and Technology (HR11-006).
CR Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200
   Biswas A, 2010, BIOMACROMOLECULES, V11, P2545, DOI 10.1021/bm1009359
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Cai YR, 2009, J MATER CHEM, V19, P5751, DOI 10.1039/b901620a
   Cheng C, 2008, ADV FUNCT MATER, V18, P2172, DOI 10.1002/adfm.200701130
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   He PF, 2013, J BIOMED MATER RES A, V101, P555, DOI 10.1002/jbm.a.34333
   He PF, 2012, BIOMACROMOLECULES, V13, P2692, DOI 10.1021/bm300651q
   He T, 2010, SMALL, V6, P2230, DOI 10.1002/smll.201001108
   Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016
   Kaur J, 2013, BIOMACROMOLECULES, V14, P3660, DOI 10.1021/bm401023h
   Khire TS, 2010, SOFT MATTER, V6, P2066, DOI 10.1039/b924530h
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001
   Lin F, 2008, MATER CHEM PHYS, V111, P92, DOI 10.1016/j.matchemphys.2008.03.019
   Liu L, 2008, J BIOMAT SCI-POLYM E, V19, P325, DOI 10.1163/156856208783721010
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Nishida A, 2011, INT J PHARMACEUT, V407, P44, DOI 10.1016/j.ijpharm.2011.01.006
   Padamwar Mahesh N, 2005, J Cosmet Dermatol, V4, P250, DOI 10.1111/j.1473-2165.2005.00200.x
   Rai RK, 2011, J PHYS CHEM C, V115, P14219, DOI 10.1021/jp2025768
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   Rosa Adalberto Luiz, 2002, Pesqui Odontol Bras, V16, P209, DOI 10.1590/S1517-74912002000300005
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   RUSSEL WB, 1981, ANNU REV FLUID MECH, V13, P425, DOI 10.1146/annurev.fl.13.010181.002233
   Shchukin DG, 2003, CHEM MATER, V15, P3947, DOI 10.1021/cm0341585
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Takeuchi A, 2003, J BIOMED MATER RES A, V65A, P283, DOI 10.1002/jbm.a.10456
   Wang FK, 2010, CHEM MATER, V22, P3630, DOI 10.1021/cm902727s
   Wang G, 2010, J BONE JOINT SURG BR, V92B, P320, DOI 10.1302/0301-620X.92B2.22602
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Xu H, 2011, BIOMACROMOLECULES, V12, P2193, DOI 10.1021/bm200274r
   Yang MY, 2013, J POLYM SCI POL PHYS, V51, P742, DOI 10.1002/polb.23249
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2007, J NUTR SCI VITAMINOL, V53, P297, DOI 10.3177/jnsv.53.297
   Zhu HB, 2011, BIOMATERIALS, V32, P4744, DOI 10.1016/j.biomaterials.2011.03.030
   Zou XH, 2009, CELL TRANSPLANT, V18, P433, DOI 10.3727/096368909788809839
NR 38
TC 48
Z9 52
U1 8
U2 114
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1185
EP 1193
DI 10.1021/bm401740x
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600010
PM 24666022
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Hodgkinson, T
   Chen, Y
   Bayat, A
   Yuan, XF
AF Hodgkinson, Tom
   Chen, Ying
   Bayat, Ardeshir
   Yuan, Xue-Feng
TI Rheology and Electrospinning of Regenerated Bombyx mori Silk Fibroin
   Aqueous Solutions
SO BIOMACROMOLECULES
LA English
DT Article
ID POLYMER-SOLUTIONS; MOLECULAR-WEIGHT; DRUG-DELIVERY; NANOFIBERS; FIBERS;
   SCAFFOLDS; BIOMATERIALS; PARAMETERS; MATS; MORPHOLOGY
AB Bombyx mori silk fibroin (BMSF) has received considerable research interest as a potential biomaterial owing to its excellent mechanical properties and benign, versatile material fabrication options, including electrospinning. Despite this, characterizations of regenerated BMSF aqueous solutions and electrospun materials resulting from them are still very limited in the literature. This report details the theological characterization of regenerated aqueous BMSF solutions under shear and elongational deformation. Well-characterized regenerated BMSF solutions were then systematically electrospun over a range of concentrations and process parameters to determine their effects on electrospinning processing windows and fiber morphology. BMSF solutions could not be electrospun successfully if BMSF concentration was below 20 wt % or the relaxation time measured using the CaBER rheometer was below 0.001 s. Electrospun BMSF fiber diameter was found to increase with solution concentration when stable electrospinning was achieved. An upper threshold of 30 wt % BMSF solution was identified for the formation of fibers with a circular cross section. Adding small amount of high molecular weight poly(ethylene oxide) was an effective rheological modifier that greatly improved the electrospinnability of BMSF solutions. Electrospinning BMSF-PEO solutions over a range of parameters significantly altered the fiber products. Increasing voltage from 0.5 to 1 kV/cm was found to decrease fiber diameter by approximately 50% (p < 0.001). Flow rate was found to have a significant effect on fiber diameter, which decreased with spinneret height. The results presented here provide valuable guidance in the production of BMSF electrospun materials with specific properties for tissue engineering and regenerative medicine.
C1 [Hodgkinson, Tom; Chen, Ying; Bayat, Ardeshir; Yuan, Xue-Feng] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
   [Hodgkinson, Tom; Chen, Ying; Yuan, Xue-Feng] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England.
RP Yuan, XF (reprint author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.
EM xue-feng.yuan@manchester.ac.uk
RI Hodgkinson, Tom/E-5767-2016
OI Hodgkinson, Tom/0000-0002-3242-1593; BAYAT, ARDESHIR/0000-0002-4116-6491
FU University of Manchester; School of Chemical Engineering and Analytical
   Science; Biotechnology and Biological Sciences Research Council
   [BB/K011146/1]
FX The authors would like to thank the University of Manchester and the
   School of Chemical Engineering and Analytical Science for the
   scholarship awarded to Tom Hodgkinson that made this work possible.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bayram C, 2013, MACROMOL RES, V21, P339, DOI 10.1007/s13233-013-1037-2
   Berli CLA, 1999, FOOD HYDROCOLLOID, V13, P507, DOI 10.1016/S0268-005X(99)00036-3
   Bhattacharjee P., 2011, ELECTROSPINNING POLY
   Cao H, 2009, MAT SCI ENG C-MATER, V29, P2270, DOI 10.1016/j.msec.2009.05.012
   Chang CE, 2010, NANO LETT, V10, P726, DOI 10.1021/nl9040719
   CROSS MM, 1965, J COLL SCI IMP U TOK, V20, P417, DOI 10.1016/0095-8522(65)90022-X
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Ekemen Z, 2013, BIOMACROMOLECULES, V14, P1412, DOI 10.1021/bm400068k
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Hashimdeen SH, 2013, MAT SCI ENG C-MATER, V33, P3309, DOI 10.1016/j.msec.2013.04.020
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Jarusuwannapoom T, 2005, EUR POLYM J, V41, P409, DOI 10.1016/j.eurpolymj.2004.10.010
   Jeong L, 2007, KEY ENG MATER, V342-343, P813, DOI 10.4028/www.scientific.net/KEM.342-343.813
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Koombhongse S, 2001, J POLYM SCI POL PHYS, V39, P2598, DOI 10.1002/polb.10015
   Koski A, 2004, MATER LETT, V58, P493, DOI 10.1016/S0167-577X(03)00532-9
   Lee JS, 2004, J APPL POLYM SCI, V93, P1638, DOI 10.1002/app.20602
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li Z, 2011, J NON-NEWTON FLUID, V166, P951, DOI 10.1016/j.jnnfm.2011.04.010
   Luo CJ, 2012, CHEM SOC REV, V41, P4708, DOI 10.1039/c2cs35083a
   Mahalingam S, 2013, MACROMOL RAPID COMM, V34, P1134, DOI 10.1002/marc.201300339
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Mo CL, 2009, BIOMACROMOLECULES, V10, P2724, DOI 10.1021/bm900452u
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Pritchard EM, 2011, EXPERT OPIN DRUG DEL, V8, P797, DOI 10.1517/17425247.2011.568936
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sinha-Ray S, 2011, BIOMACROMOLECULES, V12, P2357, DOI 10.1021/bm200438v
   So Hyun K., 2003, POLYMER, V35, P185
   Sukigara S, 2004, POLYMER, V45, P3701, DOI 10.1016/j.polymer.2004.03.059
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Sun DH, 2006, NANO LETT, V6, P839, DOI 10.1021/nl0602701
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2006, J APPL POLYM SCI, V101, P961, DOI 10.1002/app.24024
   Wang H, 2005, J MATER SCI, V40, P5359, DOI 10.1007/s10853-005-4332-2
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Yao YY, 2005, ACTA POLYM SIN, P687
   Zainuddin, 2008, BIOMATERIALS, V29, P4268, DOI 10.1016/j.biomaterials.2008.07.041
   Zhang KH, 2010, J BIOMED MATER RES A, V93A, P976, DOI 10.1002/jbm.a.32497
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
   Zhu JX, 2007, INT J BIOL MACROMOL, V41, P469, DOI 10.1016/j.ijbiomac.2007.06.006
NR 53
TC 12
Z9 13
U1 9
U2 147
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2014
VL 15
IS 4
BP 1288
EP 1298
DI 10.1021/bm4018319
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AF2VW
UT WOS:000334571600021
PM 24661009
DA 2018-10-19
ER

PT J
AU Gao, A
   Hang, RQ
   Huang, XB
   Zhao, LZ
   Zhang, XY
   Wang, L
   Tang, B
   Ma, SL
   Chu, PK
AF Gao, Ang
   Hang, Ruiqiang
   Huang, Xiaobo
   Zhao, Lingzhou
   Zhang, Xiangyu
   Wang, Lin
   Tang, Bin
   Ma, Shengli
   Chu, Paul K.
TI The effects of titania nanotubes with embedded silver oxide
   nanoparticles on bacteria and osteoblasts
SO BIOMATERIALS
LA English
DT Article
DE TiO2 nanotubes; Ag2O nanoparticles; Anodization; Antibacterial activity;
   Osteoblasts
ID TIO2 NANOTUBES; ESCHERICHIA-COLI; IN-VITRO; STAPHYLOCOCCUS-AUREUS;
   OSTEOGENIC DIFFERENTIATION; SURFACES; INFECTIONS; ARRAYS; CELLS; ION
AB A versatile strategy to endow biomaterials with long-term antibacterial ability without compromising the cytocompatibility is highly desirable to combat biomaterial related infection. TiO2 nanotube (NT) arrays can significantly enhance the functions of many cell types including osteoblasts thus having promising applications in orthopedics, orthodontics, as well as other biomedical fields. In this study, TiO2 NT arrays with Ag2O nanoparticle embedded in the nanotube wall (NT-Ag2O arrays) are prepared on titanium (Ti) by TiAg magnetron sputtering and anodization. Well-defined NT arrays containing Ag concentrations in a wide range from 0 to 15 at % are formed. Ag incorporation has little influence on the NT diameter, but significantly decreases the tube length. Crystallized Ag2O nanoparticles with diameters ranging from 5 nm to 20 nm are embedded in the amorphous TiO2 nanotube wall and this unique structure leads to controlled release of Ag+ that generates adequate antibacterial activity without showing cytotoxicity. The NT-Ag2O arrays can effectively kill Escherichia coli and Staphylococcus aureus even after immersion for 28 days, demonstrating the long lasting antibacterial ability. Furthermore, the NT-Ag2O arrays have no appreciable influence on the osteoblast viability, proliferation, and differentiation compared to the Ag free TiO2 NT arrays. Ag incorporation even shows some favorable effects on promoting cell spreading. The technique reported here is a versatile approach to develop biomedical coatings with different functions. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Gao, Ang; Hang, Ruiqiang; Huang, Xiaobo; Zhang, Xiangyu; Tang, Bin] Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
   [Zhao, Lingzhou] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol & Oral Med, Xian 710032, Peoples R China.
   [Wang, Lin] Ningbo Univ Technol, Inst Mat, Ningbo 315016, Zhejiang, Peoples R China.
   [Ma, Shengli] Xi An Jiao Tong Univ, State Key Lab Mech Behav Mat, Xian 710049, Peoples R China.
   [Chu, Paul K.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
RP Hang, RQ (reprint author), Taiyuan Univ Technol, Res Inst Surface Engn, Taiyuan 030024, Peoples R China.
EM hangruiqiang@tyut.edu.cn; zhaolingzhou1983@hotmail.com
RI Chu, Paul/B-5923-2013; Zhao, Lingzhou/B-4408-2014
OI Chu, Paul/0000-0002-5581-4883; 
FU National Natural Science Foundation of China [51171125, 31300808,
   31200716]; Specialized Research Fund for the Doctoral Program of Higher
   Education of China [20131402120006]; Natural Science Foundation of
   Shanxi Province [2013021011-1, 2012021021-7]; School Foundation of
   Taiyuan University of Technology [2013T013]; City University of Hong
   Kong Applied Research Grants (ARG) [9667066, 9667069]; Hong Kong
   Research Grants Council (RGC) General Research Funds (GRF) [112212]
FX This work is jointly supported by the National Natural Science
   Foundation of China (51171125, 31300808, 31200716), Specialized Research
   Fund for the Doctoral Program of Higher Education of China
   (20131402120006), Natural Science Foundation of Shanxi Province
   (2013021011-1, 2012021021-7), School Foundation of Taiyuan University of
   Technology (2013T013), City University of Hong Kong Applied Research
   Grants (ARG) Nos. 9667066 and 9667069, as well as Hong Kong Research
   Grants Council (RGC) General Research Funds (GRF) No. 112212.
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arnell RD, 1999, SURF COAT TECH, V112, P170, DOI 10.1016/S0257-8972(98)00749-X
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Gong D, 2001, J MATER RES, V16, P3331, DOI 10.1557/JMR.2001.0457
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07
   Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Kumar R, 2005, J BIOMED MATER RES B, V75B, P311, DOI 10.1002/jbm.b.30306
   Li XM, 2013, J BIOMED MATER RES A, V101, P2424, DOI 10.1002/jbm.a.34539
   Li XM, 2012, BIOMATERIALS, V33, P4818, DOI 10.1016/j.biomaterials.2012.03.045
   Ma MH, 2012, J BIOMED MATER RES A, V100A, P278, DOI 10.1002/jbm.a.33251
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Musil J, 1999, THIN SOLID FILMS, V343, P47, DOI 10.1016/S0040-6090(98)01567-3
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Park EJ, 2010, TOXICOL IN VITRO, V24, P872, DOI 10.1016/j.tiv.2009.12.001
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Premchand YD, 2006, ELECTROCHEM COMMUN, V8, P1840, DOI 10.1016/j.elecom.2006.08.028
   Roy P, 2011, ANGEW CHEM INT EDIT, V50, P2904, DOI 10.1002/anie.201001374
   Rupp ME, 2004, AM J INFECT CONTROL, V32, P445, DOI 10.1016/j.ajic.2004.05.002
   Samuel U, 2004, INT J ANTIMICROB AG, V23, pS75, DOI 10.1016/j.ijantimicag.2003.12.004
   Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Strathmann M, 2004, INT J ANTIMICROB AG, V24, P234, DOI 10.1016/j.ijantimicag.2003.03.001
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wassail M, 1998, J BIOMED MATER RES A, V36, P325
   Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005
   Yang WJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/8/085102
   Zhao LZ, 2013, BIOMATERIALS, V34, P19, DOI 10.1016/j.biomaterials.2012.09.041
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 53
TC 142
Z9 143
U1 25
U2 272
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 13
BP 4223
EP 4235
DI 10.1016/j.biomaterials.2014.01.058
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AF1NQ
UT WOS:000334481000031
PM 24529392
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Pieretti, EF
   Manhabosco, SM
   Dick, LFP
   Hinder, S
   Costa, I
AF Pieretti, Eurico F.
   Manhabosco, Sara M.
   Dick, Luis F. P.
   Hinder, Steve
   Costa, Isolda
TI Localized corrosion evaluation of the ASTM F139 stainless steel marked
   by laser using scanning vibrating electrode technique, X-ray
   photoelectron spectroscopy and Mott-Schottky techniques
SO ELECTROCHIMICA ACTA
LA English
DT Article; Proceedings Paper
CT 10th International Symposium on Electrochemical Methods in Corrosion
   Research (EMCR)
CY NOV 18-23, 2012
CL Maragogi, BRAZIL
SP CAPES, FAPESP, CNPq
DE Localized Corrosion; ASTM F139; Biomaterials; SVET; XPS; Mott-Schottky
ID PASSIVE FILMS; SEMICONDUCTING PROPERTIES; OXIDE-FILMS; BEHAVIOR;
   SURFACE; SVET
AB The effect of laser engraving on the corrosion resistance of ASTM F139 stainless steel (SS) has been investigated by electrochemical techniques. The nucleation of localized corrosion on this biomaterial was evaluated by scanning vibrating electrode technique (SVET) in a phosphate buffered saline solution (PBS) of pH 7.4. The Mott-Schottky approach was used to determine the electronic properties of the passive film, also chemically characterized by X-ray photoelectron spectroscopy (XPS). SVET allowed the identification of the anodic zones on the surface of the SS marked by laser technique that were associated with the heat-affected areas. Metallic drops solidified on the laser marked surface dissolved actively at OCP and favoured the nucleation of crevice corrosion, while at the pitting potential, pits nucleate preferentially on the laser marks. XPS results showed that laser engraving caused large chemical modification of the surface. Mott-Schottky results indicated a more defective oxide layer with a larger number of donors on the laser marked surface comparatively to that without marks. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Pieretti, Eurico F.; Costa, Isolda] Inst Pesquisas Energet & Nucl IPEN CNEN, BR-05422970 Sao Paulo, Brazil.
   [Manhabosco, Sara M.; Dick, Luis F. P.] Univ Fed Rio Grande do Sul, Lab Proc Eletroquim & Corrosao, BR-91501970 Porto Alegre, RS, Brazil.
   [Hinder, Steve] Univ Surrey, Fac Engn & Phys Sci, Guildford GU2 5XH, Surrey, England.
RP Pieretti, EF (reprint author), Inst Pesquisas Energet & Nucl IPEN CNEN, Av Prof Lineu Prestes 2242, BR-05422970 Sao Paulo, Brazil.
EM efpieretti@usp.br; lfdick@ufrgs.br; s.hinder@surrey.ac.uk;
   icosta@ipen.br
CR Amar H, 2011, CORROS SCI, V53, P3215, DOI 10.1016/j.corsci.2011.05.066
   Da Cunha Belo M, 1999, ELECTROCHIM ACTA, V44, P2473
   Feng ZC, 2010, CORROS SCI, V52, P3646, DOI 10.1016/j.corsci.2010.07.013
   Gittens RA, 2011, J DENT RES, V90, P1389, DOI 10.1177/0022034511408428
   Hakiki NE, 2000, CORROS SCI, V42, P687, DOI 10.1016/S0010-938X(99)00082-7
   HAKIKI NE, 1995, CORROS SCI, V37, P1809, DOI 10.1016/0010-938X(95)00084-W
   Hakiki NE, 1998, J ELECTROCHEM SOC, V145, P3821, DOI 10.1149/1.1838880
   ISAACS HS, 1988, CORROS SCI, V28, P547, DOI 10.1016/0010-938X(88)90023-6
   Kallip S, 2010, CORROS SCI, V52, P3146, DOI 10.1016/j.corsci.2010.05.018
   Kallip S, 2012, ELECTROCHEM COMMUN, V20, P101, DOI 10.1016/j.elecom.2012.04.007
   Lamaka SV, 2008, ELECTROCHEM COMMUN, V10, P259, DOI 10.1016/j.elecom.2007.12.003
   Lyman D. J., 1974, MAT SCI, V4, P415
   Moulder J. F., 1992, HDB XRAY PHOTOELECTR
   Nascente PAP, 2005, J MOL CATAL A-CHEM, V228, P145, DOI 10.1016/j.molcata.2004.09.075
   Ningshen S, 2007, CORROS SCI, V49, P481, DOI 10.1016/j.corsci.2006.05.041
   SCHMUKI P, 1995, J ELECTROCHEM SOC, V142, P1705, DOI 10.1149/1.2048644
   Shahryari A, 2008, MAT SCI ENG C-BIO S, V28, P94, DOI 10.1016/j.msec.2007.09.002
   Taveira LV, 2010, CORROS SCI, V52, P2813, DOI 10.1016/j.corsci.2010.04.021
   Taveira LV, 2005, CORROS SCI, V47, P757, DOI 10.1016/j.corsci.2004.07.012
   Vuillemin B, 2003, CORROS SCI, V45, P1143, DOI 10.1016/S0010-938X(02)00222-6
NR 20
TC 15
Z9 15
U1 1
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0013-4686
EI 1873-3859
J9 ELECTROCHIM ACTA
JI Electrochim. Acta
PD APR 1
PY 2014
VL 124
SI SI
BP 150
EP 155
DI 10.1016/j.electacta.2013.10.137
PG 6
WC Electrochemistry
SC Electrochemistry
GA AG0MM
UT WOS:000335109600019
DA 2018-10-19
ER

PT J
AU Mehmood, MS
   Walters, BM
   Yasin, T
   Ahmad, M
   Jahan, MS
   Mishra, SR
   Ikram, M
AF Mehmood, Malik Sajjad
   Walters, Benjamin Michael
   Yasin, Tariq
   Ahmad, Manzoor
   Jahan, Muhammad Shah
   Mishra, Sanjay R.
   Ikram, Masroor
TI Correlation of residual radical's with three phase morphology of UHMWPE:
   Analysis for the dependence on heat involved during vitamin E diffusion
SO EUROPEAN POLYMER JOURNAL
LA English
DT Article
DE UHMWPE; ESR analysis; Vitamin E; Three phase morphology; Raman
   spectroscopy
ID MOLECULAR-WEIGHT POLYETHYLENE; INDUCED CRYSTALLINITY CHANGES;
   ELECTRON-BEAM IRRADIATION; ALPHA-TOCOPHEROL; LINEAR POLYETHYLENE;
   CROSS-LINKING; ENVIRONMENTS; RESISTANCE; OXIDATION; POLYMER
AB Ultra-high molecular weight polyethylene (UHMWPE) is often used as a biomaterial component of hip and knee implants. Alpha-tocopherol (vitamin E) is an antioxidant that is sometimes diffused into the UHMWPE during the manufacturing process to help in eliminating free radicals and preventing these implants from oxidation. In order to diffuse vitamin E into the UHMWPE, the UHMWPE is heated while submerged in a hot bath of vitamin E. The aim of this study is to investigate the effect of this heat on polyenyl radicals (-center dot CH-[CH=CH-](m)-) with m > 3, and oxygen-centered dienyl or trienyl radicals (center dot OCH- [CH=CH-](m)-) with m = 2 or 3] and their correlation with the three phase morphology of irradiated, vitamin E-doped UHMWPE. Free radical analysis via electron spin resonance (ESR) reveal that heat involved during vitamin E diffusion is responsible for the decay of similar to 98% of the primary trapped radicals, just as in the control samples without vitamin E. However, for vitamin E-doped UHMWPE, the vitamin E is then present for subsequent protection, and control samples (heated without vitamin E) suffer more during shelf-aging of 6 months. Differential scanning calorimetry (DSC), wide angle X-ray scattering (WAXS), and Raman spectroscopic methods conclude that the % interphase contents of UHMWPE control samples are 9.70 +/- 1.00, 6.06 +/- 1.20, 2.61 +/- 0.80, and 1.50 +/- 0.71, while for vitamin E-doped samples are 15.43 +/- 1.66, 11.48 +/- 1.46, 7.74 +/- 1.54, and 5.54 +/- 1.31, for sample heated/doped for 10 min, 30 min, 1 h, and 2 h, respectively. Moreover, it is also found that the % interphase contents of UHMWPE are in direct correlation with total amount of residual radicals, arid oxygen centered di- or tri-enyl radicals regardless of samples initial treatment before the shelf aging. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Mehmood, Malik Sajjad] Univ Engn & Technol, Dept Basic Sci & Humanities, Taxila 47050, Pakistan.
   [Mehmood, Malik Sajjad; Yasin, Tariq; Ahmad, Manzoor; Ikram, Masroor] Pakistan Inst Engn & Appl Sci, Islamabad 45650, Pakistan.
   [Mehmood, Malik Sajjad; Walters, Benjamin Michael; Jahan, Muhammad Shah; Mishra, Sanjay R.] Univ Memphis, Dept Phys, Biomat Res Lab, Memphis, TN 38152 USA.
RP Mehmood, MS (reprint author), Univ Engn & Technol, Dept Basic Sci & Humanities, Taxila 47050, Pakistan.
EM msajjad.82@gmail.com
RI Malik, Sajjad Mehmood/E-5729-2015; Ikram, Masroor/G-3359-2015
OI Malik, Sajjad Mehmood/0000-0002-5026-8203; 
FU NSF/Biosurfaces center at the University of Memphis, Memphis, TN, USA
FX Dr. Malik Sajjad Mehmood would like to acknowledge Engr. Hafiz Irfan
   Arshad, and Ms. Fareeha Zaheer from UET, Taxila for their moral support
   in compiling this work. This work was also supported by NSF/Biosurfaces
   center at the University of Memphis, Memphis, TN, USA.
CR Barron D, 2008, J MATER SCI-MATER M, V19, P2293, DOI 10.1007/s10856-007-3333-x
   Barron D, 2008, POLYMER, V49, P3111, DOI 10.1016/j.polymer.2008.05.004
   BHATEJA SK, 1990, J MACROMOL SCI PHYS, VB29, P1, DOI 10.1080/00222349008212332
   BHATEJA SK, 1983, J APPL POLYM SCI, V28, P861, DOI 10.1002/app.1983.070280236
   BHATEJA SK, 1995, J MACROMOL SCI R M C, VC35, P581, DOI 10.1080/15321799508021752
   Bracco P, 2007, POLYM DEGRAD STABIL, V92, P2155, DOI 10.1016/j.polymdegradstab.2007.02.023
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Costa L, 2009, POLYM DEGRAD STABIL, V94, P1542, DOI 10.1016/j.polymdegradstab.2009.04.023
   James Runt IRH, 1980, THERMAL ANAL POLYM M
   Joo YL, 2000, POLYMER, V41, P1355, DOI 10.1016/S0032-3861(99)00272-4
   Joon BP, 2013, ENCY BIOMATER BIOMED, P1690
   Kelly JM, 2002, J MACROMOL SCI-POL R, VC42, P355, DOI 10.1081/MC-120006452
   Kornacka EM, 2013, RADIAT PHYS CHEM, V84, P151, DOI 10.1016/j.radphyschem.2012.06.027
   Kurtz SM, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P1
   Mehmood MS, 2012, POLYM SCI SER A+, V54, P343, DOI 10.1134/S0965545X12040062
   Mehmood MS, 2013, POLYM DEGRAD STABIL, V98, P1256, DOI 10.1016/j.polymdegradstab.2013.03.001
   Mehmood MS, 2013, APPL MAGN RESON, V44, P531, DOI 10.1007/s00723-012-0421-y
   Oral E, 2005, BIOMATERIALS, V26, P6657, DOI 10.1016/j.biomaterials.2005.04.026
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2008, BIOMATERIALS, V29, P3557, DOI 10.1016/j.biomaterials.2008.05.004
   Oral E, 2007, NUCL INSTRUM METH B, V265, P18, DOI 10.1016/j.nimb.2007.08.022
   Oral E, 2007, BIOMATERIALS, V28, P5225, DOI 10.1016/j.biomaterials.2007.08.025
   Oral E, 2006, BIOMATERIALS, V27, P5580, DOI 10.1016/j.biomaterials.2006.07.017
   Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y
   Oral E, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P221, DOI 10.1016/B978-0-12-374721-1.00015-8
   Oral E, 2009, BIOMATERIALS, V30, P1870, DOI 10.1016/j.biomaterials.2008.12.029
   Ridley MD, 2007, NUCL INSTRUM METH B, V265, P62, DOI 10.1016/j.nimb.2007.08.026
   Ridley MD, 2009, J BIOMED MATER RES A, V88A, P1097, DOI 10.1002/jbm.a.32042
   Russell KE, 1997, POLYMER, V38, P1409, DOI 10.1016/S0032-3861(96)00643-X
   Sobieraj MC, 2009, J MECH BEHAV BIOMED, V2, P433, DOI 10.1016/j.jmbbm.2008.12.006
   Torrisi L, 2004, RADIAT EFF DEFECT S, V159, P259, DOI 10.1080/10420150410001711813
   Visco AM, 2010, INT J POLYM ANAL CH, V15, P424, DOI 10.1080/1023666X.2010.510109
   Walters BM, 2009, 4 INT UHMWPE M TOR I
   WANG LH, 1991, MACROMOLECULES, V24, P5535, DOI 10.1021/ma00020a009
NR 34
TC 8
Z9 8
U1 0
U2 27
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0014-3057
EI 1873-1945
J9 EUR POLYM J
JI Eur. Polym. J.
PD APR
PY 2014
VL 53
BP 13
EP 21
DI 10.1016/j.eurpolymj.2014.01.013
PG 9
WC Polymer Science
SC Polymer Science
GA AF1NT
UT WOS:000334481300002
DA 2018-10-19
ER

PT J
AU Gaur, PK
   Mishra, S
AF Gaur, Praveen Kumar
   Mishra, Shikha
TI Diclofenac Loaded Nanoparticles Fabricated with Biomaterial (Ceramide 2)
   for Transdermal Delivery
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Biomaterial; Ceramide 2; Diclofenac; Permeation; Pharmacokinetics
ID SOLID LIPID NANOPARTICLES; IN-VITRO PERMEATION; EX-VIVO; SKIN
   PENETRATION; DRUG-DELIVERY; FORMULATION; RELEASE; GEL; MICROPARTICLES;
   LIPOSOMES
AB Objective: Solid lipid nano particles loaded with model drug Diclofenac sodium were formulated using a biomaterial (ceramide 2) and evaluated for physicochemical properties, in vitro/ex vivo permeation and pharmacokinetic/ pharmacodynamic studies. Methods: The SLNs were prepared using modified emulsion/solvent evaporation method and characterized for physical parameters, in vitro drug release, accelerated stability studies. Then SLNs were formulated into gels and compared with a commercial formulation (CEG) and carbopol gel containing plain drug (CG) for ex vivo, in vivo drug permeation and anti-inflammatory activity. Key findings: The SLNs were stable with optimum physical parameters. GN-3 and SN-3 gave highest in vitro drug release. CNG-3 has shown higher drug permeation (158.49 mu g/cm(2)) into receptor fluid in ex vivo permeation study in comparison to CEG (1.35 mu g/cm(2)). The enhancement ratio of CNG-3 was 43.249 (with respect to CG). CNG-3 has shown almost 8.5 times C-max then CEO at 4 hours. The AUC value of CNG-3 was 16 times than CEG whereas CNG-3 provided 99.81% edema inhibition in 6 hours. Conclusion: Physicochemical properties of major lipid component govern the characteristics and permeation profile of SLN. SLN made up of ceramide-2 showed good physical properties with acceptable stability. It also showed promising transdermal permeation.
C1 [Gaur, Praveen Kumar] ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
   [Mishra, Shikha] Jamia Hamdard, Dept Pharmacognosy & Phytochem, New Delhi 110062, India.
RP Gaur, PK (reprint author), ITS Paramed Pharm Coll, Dept Pharmaceut, Ghaziabad 201206, UP, India.
EM gaurmpharma@rediffmail.com
OI Gaur, Praveen/0000-0002-4221-1485
CR AGUIAR AJ, 1969, J PHARM SCI, V58, P210, DOI 10.1002/jps.2600580215
   Akhter S, 2008, CURR NANOSCI, V4, P381, DOI 10.2174/157341308786306071
   Babu R. J., 2006, FATTY ALCOHOLS FATTY, P137
   Batheja Priya, 2006, Expert Opin Drug Deliv, V3, P127
   Baydoun L, 2003, EUR J PHARM BIOPHARM, V56, P73, DOI 10.1016/S0939-6411(03)00036-5
   Bhaskar K, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-6
   Chime SA, 2013, J MICROENCAPSUL, V30, P335, DOI 10.3109/02652048.2012.726284
   Denet AR, 2004, ADV DRUG DELIVER REV, V56, P659, DOI 10.1016/j.addr.2003.10.027
   Dragicevic-Curic N, 2008, J CONTROL RELEASE, V127, P59, DOI 10.1016/j.jconrel.2007.12.013
   Dugard P. H., 1976, ADV MOD TOXICOL, P525
   DURRHEIM H, 1980, J PHARM SCI, V69, P781, DOI 10.1002/jps.2600690709
   El-Kamel Amal H, 2008, Curr Drug Deliv, V5, P20, DOI 10.2174/156720108783331014
   El-Leithy ES, 2010, AAPS PHARMSCITECH, V11, P1695, DOI 10.1208/s12249-010-9544-3
   Furuishi T, 2008, BIOL PHARM BULL, V31, P1439, DOI 10.1248/bpb.31.1439
   Gaur P. K., 2013, PHARM DEV T IN PRESS
   Gaur P. K., 2013, DRUG DEV IN IN PRESS
   Gaur PK, 2013, BIOMED RES INT, V2013, P10
   Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011
   Haigh JM, 1998, INT J PHARM, V170, P151, DOI 10.1016/S0378-5173(98)00064-7
   HIGUCHI T, 1960, J SOC COSMET CHEM, V11, P85
   Ishida T, 2002, INT J PHARM, V232, P59, DOI 10.1016/S0378-5173(01)00896-1
   Jasper AW, 2005, J PHYS CHEM B, V109, P3915, DOI 10.1021/jp044805v
   Jukanti R, 2011, J PHARM SCI-US, V100, P3208, DOI 10.1002/jps.22542
   Kitagawa S, 1995, INT J PHARM, V126, P49, DOI 10.1016/0378-5173(95)04075-7
   Kobayashi N, 1999, CHEM PHARM BULL, V47, P199
   Kwon TK, 2011, J IND ENG CHEM, V17, P10, DOI 10.1016/j.jiec.2010.10.001
   Lee JW, 2011, J CONTROL RELEASE, V154, P58, DOI 10.1016/j.jconrel.2011.05.003
   Liu CH, 2011, COLLOID SURFACE B, V82, P63, DOI 10.1016/j.colsurfb.2010.08.018
   Liu DF, 2011, J NANOPART RES, V13, P2375, DOI 10.1007/s11051-010-9998-y
   Manconi M, 2011, EUR J PHARM BIOPHARM, V78, P27, DOI 10.1016/j.ejpb.2010.12.010
   Manosroi A, 2008, INT J PHARM, V360, P156, DOI 10.1016/j.ijpharm.2008.04.033
   Mishra D, 2007, J PHARM SCI, V96, P147
   Morel S, 1996, INT J PHARM, V132, P259, DOI 10.1016/0378-5173(95)04388-8
   Patel NA, 2009, PHARM DEV TECHNOL, V14, P80, DOI 10.1080/10837450802409438
   PHILLIPS CA, 1995, J PHARM SCI, V84, P1427, DOI 10.1002/jps.2600841208
   Reithmeier H, 2001, INT J PHARM, V218, P133, DOI 10.1016/S0378-5173(01)00620-2
   SCHWARZ C, 1994, J CONTROL RELEASE, V30, P83, DOI 10.1016/0168-3659(94)90047-7
   Shekar BC, 2011, J DISPER SCI TECHNOL, V32, P1158, DOI 10.1080/01932691.2010.498248
   Touitou E, 2000, J CONTROL RELEASE, V65, P403, DOI 10.1016/S0168-3659(99)00222-9
   Vasiljevic D, 2006, INT J PHARM, V309, P171, DOI 10.1016/j.ijpharm.2005.11.034
   Walters K. A., 2002, STRUCTURE FUNCTION S
   Wartewig S, 2007, SKIN PHARMACOL PHYS, V20, P220, DOI 10.1159/00010442
   YARDLEY HJ, 1981, PHARMACOL THERAPEUT, V13, P357, DOI 10.1016/0163-7258(81)90006-1
NR 43
TC 4
Z9 4
U1 0
U2 15
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD APR
PY 2014
VL 6
IS 4
BP 736
EP 745
DI 10.1166/sam.2014.1762
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AF0GQ
UT WOS:000334392600014
DA 2018-10-19
ER

PT J
AU Hamidi, S
   Letourneur, D
   Aid-Launais, R
   Di Stefano, A
   Vainchenker, W
   Norol, F
   Le Visage, C
AF Hamidi, Sofiane
   Letourneur, Didier
   Aid-Launais, Rachida
   Di Stefano, Antonio
   Vainchenker, William
   Norol, Francoise
   Le Visage, Catherine
TI Fucoidan Promotes Early Step of Cardiac Differentiation from Human
   Embryonic Stem Cells and Long-Term Maintenance of Beating Areas
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID PREVENTS NEOINTIMAL HYPERPLASIA; ENDOTHELIAL PROGENITOR CELLS;
   HEPARIN/HEPARAN SULFATE; IN-VITRO; GROWTH; HEART; POLYSACCHARIDE;
   EXPRESSION; SCAFFOLDS; HYDROGEL
AB Somatic stem cells require specific niches and three-dimensional scaffolds provide ways to mimic this microenvironment. Here, we studied a scaffold based on Fucoidan, a sulfated polysaccharide known to influence morphogen gradients during embryonic development, to support human embryonic stem cells (hESCs) differentiation toward the cardiac lineage. A macroporous (pore 200 mu m) Fucoidan scaffold was selected to support hESCs attachment and proliferation. Using a protocol based on the cardiogenic morphogen bone morphogenic protein 2 (BMP2) and transforming growth factor (TGF beta) followed by tumor necrosis factor (TNF alpha), an effector of cardiopoietic priming, we examined the cardiac differentiation in the scaffold compared to culture dishes and embryoid bodies (EBs). At day 8, Fucoidan scaffolds supported a significantly higher expression of the 3 genes encoding for transcription factors marking the early step of embryonic cardiac differentiation NKX2.5 (p<0.05), MEF2C (p<0.01), and GATA4 (p<0.01), confirmed by flow cytometry analysis for MEF2C and NKX2.5. The ability of Fucoidan scaffolds to locally concentrate and slowly release TGF beta and TNF alpha was confirmed by Luminex technology. We also found that Fucoidan scaffolds supported the late stage of embryonic cardiac differentiation marked by a significantly higher atrial natriuretic factor (ANF) expression (p<0.001), although only rare beating areas were observed. We postulated that absence of mechanical stress in the soft hydrogel impaired sarcomere formation, as confirmed by molecular analysis of the cardiac muscle myosin MYH6 and immunohistological staining of sarcomeric alpha-actinin. Nevertheless, Fucoidan scaffolds contributed to the development of thin filaments connecting beating areas through promotion of smooth muscle cells, thus enabling maintenance of beating areas for up to 6 months. In conclusion, Fucoidan scaffolds appear as a very promising biomaterial to control cardiac differentiation from hESCs that could be further combined with mechanical stress to promote sarcomere formation at terminal stages of differentiation.
C1 [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William; Norol, Francoise] Inst Gustave Roussy, INSERM, UMR 1009, F-94805 Villejuif, France.
   [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William] Univ Paris 11, Inst Gustave Roussy, UMR 1009, Villejuif, France.
   [Hamidi, Sofiane; Di Stefano, Antonio; Vainchenker, William] Inst Gustave Roussy, Villejuif, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] X Bichat Hosp, INSERM, U698, F-75018 Paris, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] Univ Paris 13, Sorbonne Paris Cite, F-93430 Villetaneuse, France.
   [Letourneur, Didier; Aid-Launais, Rachida; Le Visage, Catherine] Univ Paris Diderot, Paris, France.
   [Norol, Francoise] Hop La Pitie Salpetriere, AP HP, Serv Biotherapie, Paris, France.
RP Le Visage, C (reprint author), X Bichat Hosp, INSERM, U698, F-75018 Paris, France.
EM catherine.levisage@inserm.fr
RI Di Stefano, Antonio/M-1478-2018; Le Visage, Catherine/E-5460-2011;
   Didier, letourneur/H-5268-2012
OI Le Visage, Catherine/0000-0003-1816-1649; Didier,
   letourneur/0000-0003-2197-9468
FU Medicen Paris region (consortium Ingecell); Agence Nationale de la
   Recherche [ANR-08-BIOT-012, ANR-12-TECSAN-0011]; INSERM; University
   Paris 7; University Paris 13; StemPole Ile de France
FX This work was supported in part by grants from Medicen Paris region
   (consortium Ingecell), Agence Nationale de la Recherche
   (ANR-08-BIOT-012, ANR-12-TECSAN-0011), INSERM, and Universities Paris 7
   and Paris 13. SH was supported by a fellowship from the StemPole Ile de
   France. We are grateful for the assistance of S.M. Derkaoui (Inserm
   U698, Paris) for scaffolds preparation and characterization and S.
   Benadda (Institut Claude Bernard IFR2, Universite Paris Diderot) for
   confocal imaging.
CR Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200
   Autissier A, 2007, J BIOMED MATER RES A, V82A, P336, DOI 10.1002/jbm.a.30998
   Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Blin G, 2010, BIOMATERIALS, V31, P1742, DOI 10.1016/j.biomaterials.2009.11.055
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Clause KC, 2009, TISSUE ENG PT A, V15, P1373, DOI 10.1089/ten.tea.2008.0169
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Deux JF, 2002, ARTERIOSCL THROM VAS, V22, P1604, DOI 10.1161/01.ATV.0000032034.91020.0A
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaibani M, 2009, TISSUE ENG PT A, V15, P2447, DOI 10.1089/ten.tea.2008.0301
   Freguin-Bouilland C, 2007, TRANSPLANTATION, V83, P1234, DOI 10.1097/01.tp.0000261109.97928.9c
   Gomez-Lopez S, 2011, GLIA, V59, P1588, DOI 10.1002/glia.21201
   Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x
   Jacot JG, 2010, J BIOMECH, V43, P93, DOI 10.1016/j.jbiomech.2009.09.014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Klaus A, 2009, PEDIATR CARDIOL, V30, P609, DOI 10.1007/s00246-008-9352-7
   Klump H, 2005, ANN NY ACAD SCI, V1044, P6, DOI 10.1196/annals.1349.002
   Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   Lavergne M, 2012, MACROMOL BIOSCI, V12, P901, DOI 10.1002/mabi.201100431
   Le Visage C, 2012, TISSUE ENG PT A, V18, P35, DOI [10.1089/ten.tea.2011.0053, 10.1089/ten.TEA.2011.0053]
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li SWC, 2009, CELL BIOL INT, V33, P255, DOI 10.1016/j.cellbi.2008.11.009
   Liu H, 2006, BIOMATERIALS, V27, P5978, DOI 10.1016/j.biomaterials.2006.05.053
   MCCAFFREY TA, 1994, J CELL PHYSIOL, V159, P51, DOI 10.1002/jcp.1041590108
   Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758
   Nakamura S, 2008, J BIOMED MATER RES A, V85A, P619, DOI 10.1002/jbm.a.31563
   Nogami K, 2004, J BIOL CHEM, V279, P8219, DOI 10.1074/jbc.M307304200
   Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051
   Religa P, 2000, EUR J VASC ENDOVASC, V20, P419, DOI 10.1053/ejvs.2000.1220
   Russell B, 2010, J MOL CELL CARDIOL, V48, P817, DOI 10.1016/j.yjmcc.2010.02.016
   Sarlon G, 2012, J THROMB HAEMOST, V10, P38, DOI 10.1111/j.1538-7836.2011.04554.x
   Schenke-Layland K, 2011, BIOMATERIALS, V32, P2748, DOI 10.1016/j.biomaterials.2010.12.046
   Senni K, 2006, ARCH BIOCHEM BIOPHYS, V445, P56, DOI 10.1016/j.abb.2005.11.001
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI 10.1089/ten.TEA.2009.0798
   Small EA, 2003, DEV BIOL, V261, P116, DOI 10.1016/S0012-1606(03)00306-3
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003
   Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103
   Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902
   Votteler M, 2010, MACROMOL BIOSCI, V10, P1302, DOI 10.1002/mabi.201000102
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   White E, 2011, PFLUG ARCH EUR J PHY, V462, P177, DOI 10.1007/s00424-011-0963-0
   Zemani F, 2005, BIOCHEM PHARMACOL, V70, P1167, DOI 10.1016/j.bcp.2005.07.014
NR 48
TC 12
Z9 12
U1 1
U2 22
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR 1
PY 2014
VL 20
IS 7-8
BP 1285
EP 1294
DI 10.1089/ten.tea.2013.0149
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AE6NG
UT WOS:000334110000016
PM 24354596
OA Green Published
DA 2018-10-19
ER

PT J
AU Moghaddam, AS
   Raji, A
   Movaffagh, J
   Yazdi, AT
   Mahmoudi, M
AF Moghaddam, Atieh Seyedian
   Raji, Ahmadreza
   Movaffagh, Jebraiel
   Yazdi, Abbas Tabatabaee
   Mahmoudi, Mahmoud
TI Effects of Autologous Keratinocyte Cell Spray With and Without Chitosan
   on Third Degree Burn Healing: An Animal Experiment
SO WOUNDS-A COMPENDIUM OF CLINICAL RESEARCH AND PRACTICE
LA English
DT Article
DE burn; cultured keratinocyte suspension; chitosan; wound healing
ID MURINE EPIDERMAL-KERATINOCYTES; LONG-TERM CULTURE; IN-VITRO;
   PHOTOCROSSLINKABLE CHITOSAN; GEL FORMULATION; CHITIN; PROLIFERATION;
   FIBROBLASTS; WOUNDS; GROWTH
AB Treatment of extensive third degree burns, especially in the case of limited skin donor sites for obtaining autologous split-thickness skin grafts (STSG), has led to in vitro expansion of keratinocytes. Cultured epidermal autograft (CEA) sheets have been used for burn treatment for several years. However, time consuming processes of isolation and Cultivation of keratinocytes, as Well as difficult procedures of detachment of CEA from cultured flask, led scientists to develop the technique of spraying cultured single :keratinocytes (CSK) instead of using CEA. Chitosan is a well-known wound dressing biomaterial that has both biological and medical applications. In this study, the application method of CSK was used to determine whether there would be any significant difference between the treatment Of burns with CSK alone in comparison to burns treated with CSK and covered with chitosan gel at a neutral pH. Materials and Methods. Thirty male,Wistar rats were selected and their keratinocytes were isolated and cultured from small skin biopsy. Rats were divided randomly into 3 equal groups and 3 full-thickness round burn wounds Were created on their backs. Rats were treated with either normal saline (control group), CSK (test group A), or CSK + neutral chitosan (CSK + NCH) (test group B). The wounds were photographed on days 0, 3, 5, 7, 10, and 14, and the percentage of wound contraction was calculated with an image analyzer. Biopsy samples were taken for histological studies. Results. The results showed faster wound contraction for test groups A and B during the 14-day period than the control group (P < 0.05). Also, more contraction was found in test groups A and B in 7 days (P < 0.05). Histological observations showed significant difference in inflammation and fibrotic tissue formation between groups, but other parameters did not show any remarkable difference. Conclusion. Based on the findings of this study, the authors concluded that chitosan can prevent cells from dripping out of the wound, speed up wound contraction, and extend fibrotic tissue formation. Chitosan did not, however, have any effect on fastening the reepithelialilation and granulation tissue formation during the first 14 days.
C1 [Moghaddam, Atieh Seyedian; Raji, Ahmadreza] Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Iran.
   [Movaffagh, Jebraiel] Mashhad Univ Med Sci, Targeted Drug Delivery Res Ctr, Mashhad, Iran.
   [Movaffagh, Jebraiel] Mashhad Univ Med Sci, Sch Pharm, Dept Pharmaceut, Mashhad, Iran.
   [Yazdi, Abbas Tabatabaee] Mashhad Univ Med Sci, Fac Med, Dept Pathol, Mashhad, Iran.
   [Mahmoudi, Mahmoud] Mashhad Univ Med Sci, Fac Med, Dept Immunol, Mashhad, Iran.
RP Moghaddam, AS (reprint author), Ferdowsi Univ Mashhad, Fac Vet Med, Dept Basic Sci, Mashhad, Iran.
EM at_se553@stu.um.ac.ir
CR Alemdaroglu C, 2006, BURNS, V32, P319, DOI 10.1016/j.burns.2005.10.015
   Alsarra IA, 2009, INT J BIOL MACROMOL, V45, P16, DOI 10.1016/j.ijbiomac.2009.03.010
   Balakrishnan B, 2005, BIOMATERIALS, V26, P6335, DOI 10.1016/j.biomaterials.2005.04.012
   Currie LJ, 2003, BURNS, V29, P677, DOI 10.1016/S0305-4179(03)00155-4
   DESAI M H, 1991, Journal of Burn Care and Rehabilitation, V12, P540, DOI 10.1097/00004630-199111000-00009
   Fraulin FOG, 1998, J BURN CARE REHABIL, V19, P337, DOI 10.1097/00004630-199807000-00012
   Fredriksson C, 2008, BURNS, V34, P212, DOI 10.1016/j.burns.2007.03.008
   FRESHNEY RI, 2002, CULTURE EPITHELIAL C
   GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665
   Hager B, 1999, J INVEST DERMATOL, V112, P971, DOI 10.1046/j.1523-1747.1999.00605.x
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Kamolz LP, 2008, EUR SURG, V40, P19, DOI 10.1007/s10353-008-0380-6
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   NASEEMA A, 1995, CURR SCI INDIA, V69, P461
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Oloumi M. M., 2008, Iranian Journal of Veterinary Surgery, V3, P47
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Purna S K, 2000, Burns, V26, P54
   Rheinwald J G, 1980, Methods Cell Biol, V21A, P229, DOI 10.1016/S0091-679X(08)60769-4
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Suzuki Y, 2000, CARBOHYD POLYM, V42, P307, DOI 10.1016/S0144-8617(99)00161-7
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Yano S, 2005, BRIT J DERMATOL, V153, P1101, DOI 10.1111/j.1365-2133.2005.06832.x
NR 26
TC 1
Z9 1
U1 1
U2 9
PU H M P COMMUNICATIONS
PI MALVERN
PA 83 GENERAL WARREN BLVD, STE 100, MALVERN, PA 19355 USA
SN 1044-7946
J9 WOUNDS
JI Wounds-Compend. Clin. Res. Pract.
PD APR
PY 2014
VL 26
IS 4
BP 108
EP 117
PG 10
WC Dermatology; Surgery
SC Dermatology; Surgery
GA AF7NQ
UT WOS:000334902200005
DA 2018-10-19
ER

PT J
AU Manecka, GM
   Labrash, J
   Rouxel, O
   Dubot, P
   Lalevee, J
   Andaouss, SA
   Renard, E
   Langlois, V
   Versace, DL
AF Manecka, G. M.
   Labrash, J.
   Rouxel, O.
   Dubot, P.
   Lalevee, J.
   Andaouss, S. Abbad
   Renard, E.
   Langlois, V.
   Versace, D. L.
TI Green Photoinduced Modification of Natural
   Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Surface for Antibacterial
   Applications
SO ACS SUSTAINABLE CHEMISTRY & ENGINEERING
LA English
DT Article
DE Photochemistry; Poly(3-hydroxybutyrate-co-3-hydroxyvalerate);
   Photografting; Antibacterial activities
ID SELF-ASSEMBLED MONOLAYERS; TRANSFER RADICAL POLYMERIZATION; TISSUE
   ENGINEERING APPLICATIONS; BIOLOGICALLY-ACTIVE POLYMERS; ANTIMICROBIAL
   ACTIVITY; QUATERNIZED CHITOSAN; ZWITTERIONIC POLYSULFOBETAINE;
   MECHANICAL-PROPERTIES; SILVER NANOPARTICLES; PROTEIN ADSORPTION
AB A green photoinduced method for the modification of a biodegradable and biocompatible polymer, poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV), has been successfully carried out using three types of monomers with potential antibacterial effects, i.e., 2-[(methacryloyloxy)-ethyl] trimethylammonium chloride (META), 2-[(methacryloylethyl)]-dimethyl-(3-sulfopropyl) ammonium (MESA) and 2-hydroxyethyl methacrylate (HEMA). The photografting process is conducted through a photoinduced free radical process employing a ketone-based photoinitiator in an aqueous medium. Under appropriate conditions, the photogenerated radicals abstract hydrogen atoms from the PHBHV backbone, thus initiating the UV-mediated photopolymerization of derived-(meth)acrylate monomers from the surface of PHBHV film. The photochemical mechanism of the ketones photolysis is entirely described by a electron spin resonance/spin trapping technique, and the modified-PHBHV films are extensively characterized by ATR-FTIR and water contact angle and XPS measurements. Finally, a primary investigation is conducted to support the antibacterial activity of the new functionalized biomaterial against Escherichia coli and Staphylococcus aureus.
C1 [Manecka, G. M.; Labrash, J.; Rouxel, O.; Dubot, P.; Renard, E.; Langlois, V.; Versace, D. L.] Univ Paris Est Creteil Val de Marne, CNRS, Inst Chim & Mat Paris Est, UMR 7182,Equipe Syst Polymeres Complexes, F-94320 Thiais, France.
   [Lalevee, J.] Inst Sci Mat Mulhouse, IS2M LRC 7228, F-68057 Mulhouse, France.
   [Andaouss, S. Abbad] Univ Paris Est Creteil Val de Marne, CNRS, UMR 7618, Unite Bioemco,Equipe IBIOS, F-94010 Thiais, France.
RP Versace, DL (reprint author), Univ Paris Est Creteil Val de Marne, CNRS, Inst Chim & Mat Paris Est, UMR 7182,Equipe Syst Polymeres Complexes, 2-8 Rue Henri Dunant, F-94320 Thiais, France.
EM versace@icmpe.cnrs.fr
RI LANGLOIS, Valerie/C-2584-2016; Versace, Davy-Louis/D-8124-2016
FU CNRS institute; UPEC
FX The authors would like to thank the CNRS institute and UPEC for
   financial supports.
CR Al-Muaikel NS, 2000, J APPL POLYM SCI, V77, P740, DOI 10.1002/(SICI)1097-4628(20000725)77:4<740::AID-APP4>3.0.CO;2-P
   Albert M, 2003, BIOMACROMOLECULES, V4, P1811, DOI 10.1021/bm0342180
   Amarjargal A, 2012, MATER CHEM PHYS, V135, P277, DOI 10.1016/j.matchemphys.2012.05.078
   Amna T, 2012, APPL MICROBIOL BIOT, V93, P743, DOI 10.1007/s00253-011-3459-0
   Babinot J, 2012, CHEM COMMUN, V48, P5364, DOI 10.1039/c2cc30482a
   Babinot J, 2012, J COLLOID INTERF SCI, V375, P88, DOI 10.1016/j.jcis.2012.02.042
   Chang Y, 2008, LANGMUIR, V24, P5453, DOI 10.1021/la800228c
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   Chung DW, 2003, INT J FOOD SCI TECH, V38, P165, DOI 10.1046/j.1365-2621.2003.00657.x
   Decraene V, 2006, APPL ENVIRON MICROB, V72, P4436, DOI 10.1128/AEM.02945-05
   El Habnouni S, 2011, ADV FUNCT MATER, V21, P3321, DOI 10.1002/adfm.201100412
   Elzatahry AA, 2012, INT J NANOMED, V7, P2829, DOI 10.2147/IJN.S31810
   Feiertag P, 2003, MACROMOL RAPID COMM, V24, P567, DOI 10.1002/marc.200390085
   Fouassier J.-P., 1993, RAD CURING POLYM SCI
   Fouassier JP, 2013, PHOTOINITIATORS POLY
   Genzer J, 2006, BIOFOULING, V22, P339, DOI 10.1080/08927010600980223
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Hazer DB, 2012, MAT SCI ENG C-MATER, V32, P637, DOI 10.1016/j.msec.2012.01.021
   Herold BC, 2002, J VIROL, V76, P11236, DOI 10.1128/JVI.76.22.11236-11244.2002
   Iemma F, 2010, J APPL POLYM SCI, V115, P784, DOI 10.1002/app.31067
   Ignatova M, 2007, EUR POLYM J, V43, P1112, DOI 10.1016/j.eurpolymj.2007.01.012
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Ignatova M, 2012, MACROMOL BIOSCI, V12, P104, DOI 10.1002/mabi.201100178
   JANZEN EG, 1973, J PHYS CHEM-US, V77, P139, DOI 10.1021/j100620a031
   Jon SY, 2003, LANGMUIR, V19, P9989, DOI 10.1021/la034839e
   Ke Y, 2007, J APPL POLYM SCI, V104, P4088, DOI 10.1002/app.25678
   Kenawy ER, 2006, REACT FUNCT POLYM, V66, P419, DOI 10.1016/j.reactfunctpolym.2005.09.002
   Kenawy ER, 2003, MACROMOL BIOSCI, V3, P107, DOI 10.1002/mabi.200390016
   Kim SH, 2003, J MEMBRANE SCI, V211, P157, DOI 10.1016/S0376-7388(02)00418-0
   Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205
   Knetsch MLW, 2011, POLYMERS-BASEL, V3, P340, DOI 10.3390/polym3010340
   Knoll H, 1981, REACT KINET CATAL LE, V15, P431
   Lao HK, 2007, BIOMACROMOLECULES, V8, P416, DOI 10.1021/bm0609700
   Lao HK, 2011, J APPL POLYM SCI, V120, P184, DOI 10.1002/app.32967
   Lao HK, 2010, J APPL POLYM SCI, V116, P288, DOI 10.1002/app.31507
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Li X, 2009, ACTA BIOMATER, V5, P2002, DOI 10.1016/j.actbio.2009.01.035
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lim KS, 2012, POLYM INT, V61, P1519, DOI 10.1002/pi.4239
   Lin J, 2002, BIOTECHNOL LETT, V24, P801, DOI 10.1023/A:1015584423358
   Linhart W, 2006, J MATER SCI, V41, P4806, DOI 10.1007/s10853-006-0023-x
   Lu J, 2001, J APPL POLYM SCI, V82, P300, DOI 10.1002/app.1852.abs
   Ma HM, 2000, MACROMOLECULES, V33, P331, DOI 10.1021/ma990821s
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pant HR, 2011, J HAZARD MATER, V189, P465, DOI 10.1016/j.jhazmat.2011.02.062
   Park KD, 1998, BIOMATERIALS, V19, P851, DOI 10.1016/S0142-9612(97)00245-7
   Perni S, 2009, BIOMATERIALS, V30, P89, DOI 10.1016/j.biomaterials.2008.09.020
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   Ruckh TT, 2012, J MATER SCI-MATER M, V23, P1411, DOI 10.1007/s10856-012-4609-3
   Rupp B, 2010, GREEN CHEM, V12, P1796, DOI 10.1039/c0gc00066c
   Sakuragi M, 2010, MAT SCI ENG C-MATER, V30, P316, DOI 10.1016/j.msec.2009.11.006
   Sampedro MF, 2007, INFECT DIS CLIN N AM, V21, P785, DOI 10.1016/j.idc.2007.07.001
   SCHAKENRAAD JM, 1988, BIOMATERIALS, V9, P116, DOI 10.1016/0142-9612(88)90082-8
   Schmitt MA, 2004, J AM CHEM SOC, V126, P6848, DOI 10.1021/ja048546z
   Schmitt MA, 2007, J AM CHEM SOC, V129, P417, DOI 10.1021/ja0666553
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Versace DL, 2013, J MATER CHEM B, V1, P4834, DOI 10.1039/c3tb20869a
   Versace DL, 2013, ADV HEALTHC MATER, V2, P1008, DOI 10.1002/adhm.201200269
   Versace DL, 2012, GREEN CHEM, V14, P788, DOI 10.1039/c2gc16399c
   Wang HL, 2004, J POLYM SCI POL CHEM, V42, P253, DOI 10.1002/pola.11022
   Wang YY, 2011, BIOMACROMOLECULES, V12, P551, DOI 10.1021/bm100886w
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Xing ZC, 2012, J NANOMATER, V2012, P1
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Ye SH, 2010, COLLOID SURFACE B, V79, P357, DOI 10.1016/j.colsurfb.2010.04.018
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Zhao T, 2008, J APPL MICROBIOL, V104, P824, DOI 10.1111/j.1365-2672.2007.03616.x
NR 79
TC 10
Z9 10
U1 2
U2 67
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2168-0485
J9 ACS SUSTAIN CHEM ENG
JI ACS Sustain. Chem. Eng.
PD APR
PY 2014
VL 2
IS 4
BP 996
EP 1006
DI 10.1021/sc400564r
PG 11
WC Chemistry, Multidisciplinary; GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;
   Engineering, Chemical
SC Chemistry; Science & Technology - Other Topics; Engineering
GA AE6IA
UT WOS:000334092600057
DA 2018-10-19
ER

PT J
AU Walters, BD
   Stegemann, JP
AF Walters, B. D.
   Stegemann, J. P.
TI Strategies for directing the structure and function of three-dimensional
   collagen biomaterials across length scales
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Collagen; Scaffold; Fabrication; Structure; Biomaterial
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS;
   SMOOTH-MUSCLE-CELLS; CROSS-LINKED COLLAGEN; BIOMIMETIC NANOFIBROUS
   SCAFFOLDS; HUMAN-SKIN FIBROBLASTS; RAT-TAIL COLLAGEN;
   MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; MIMETIC PEPTIDE
AB Collagen type I is a widely used natural biomaterial that has found utility in a variety of biological and medical applications. Its well-characterized structure and role as an extracellular matrix protein make it a highly relevant material for controlling cell function and mimicking tissue properties. Collagen type I is abundant in a number of tissues, and can be isolated as a purified protein. This review focuses on hydrogel biomaterials made by reconstituting collagen type I from a solubilized form, with an emphasis on in vitro studies in which collagen structure can be controlled. The hierarchical structure of collagen from the nanoscale to the macroscale is described, with an emphasis on how structure is related to function across scales. Methods of reconstituting collagen into hydrogel materials are presented, including molding of macroscopic constructs, creation of microscale modules and electrospinning of nanoscale fibers. The modification of collagen biomaterials to achieve the desired structures and functions is also addressed, with particular emphasis on mechanical control of collagen structure, creation of collagen composite materials and crosslinking of collagenous matrices. Biomaterials scientists have made remarkable progress in rationally designing collagen-based biomaterials and in applying them both to the study of biology and for therapeutic benefit. This broad review illustrates recent examples of techniques used to control collagen structure and thereby to direct its biological and mechanical functions. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Walters, B. D.; Stegemann, J. P.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Stegemann, JP (reprint author), Univ Michigan, Dept Biomed Engn, 1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM jpsteg@umich.edu
FU National Institutes of Health [R21-AR062709]; Tissue Engineering at
   Michigan (TEAM) training grant [T32-DE007057]
FX The authors are grateful to their colleagues in the field of
   biomaterials and tissue engineering for their valuable insight and
   discussions on the topic of collagen and its biomedical applications. In
   this review, the authors have used selected examples of published
   studies to illustrate strategies to control the structure and function
   of collagen-based biomaterials. The authors apologize to those whose
   work could not be included due to space limitations. Support from the
   National Institutes of Health through grant R21-AR062709 (to JPS) and
   the Tissue Engineering at Michigan (TEAM) training grant (T32-DE007057,
   to BDW) is gratefully acknowledged.
CR Achilli M, 2010, POLYMERS-BASEL, V2, P664, DOI 10.3390/polym2040664
   Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
   Alekseeva T, 2012, EUR CELLS MATER, V23, P28, DOI 10.22203/eCM.v023a03
   Amruthwar SS, 2013, J BIOMED MATER RES A, V101, P2383, DOI 10.1002/jbm.a.34514
   Ananta M, 2009, TISSUE ENG PT A, V15, P1667, DOI 10.1089/ten.tea.2008.0194
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Bai X, 2011, BIOMED MATER, P6
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Batorsky A, 2005, BIOTECHNOL BIOENG, V92, P492, DOI 10.1002/bit.20614
   Baxter SC, 2008, CELL BIOCHEM BIOPHYS, V51, P33, DOI 10.1007/s12013-008-9013-8
   Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593
   Berglund JD, 2004, TISSUE ENG, V10, P1526, DOI 10.1089/ten.2004.10.1526
   Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bitar M, 2007, J MATER SCI-MATER M, V18, P237, DOI 10.1007/s10856-006-0685-1
   BORNSTEIN MB, 1958, LAB INVEST, V7, P134
   Bornstein P, 1964, J CLIN INVEST, V43, P1812
   Bou-Akl T, 2013, J BIOMED MATER RES A, V101, P2507, DOI 10.1002/jbm.a.34549
   Browning MB, 2012, ACTA BIOMATER, V8, P1010, DOI 10.1016/j.actbio.2011.11.015
   Burck J, 2013, LANGMUIR, V29, P1562
   Butler MJ, 2012, TISSUE ENG PT A, V18, P1628, DOI [10.1089/ten.tea.2011.0467, 10.1089/ten.TEA.2011.0467]
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Caldwell D, 2012, ADV HLTH MAT
   Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731
   Cao Y, 2007, J NANOSCI NANOTECHNO, V7, P447, DOI 10.1166/jnn.2007.137
   Carey S, 2011, C P IEEE ENG MED BIO
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111
   Chamberlain MD, 2012, TISSUE ENG PT A, V18, P285, DOI [10.1089/ten.TEA.2011.0393, 10.1089/ten.tea.2011.0393]
   Chan BP, 2007, BIOMATERIALS, V28, P4652, DOI 10.1016/j.biomaterials.2007.07.041
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chandran PL, 2012, CONNECT TISSUE RES, V53, P285, DOI 10.3109/03008207.2011.640760
   Chang SH, 2010, PLAST RECONSTR SURG, V125, P1393, DOI 10.1097/PRS.0b013e3181d62aab
   Cheema U., 2006, EUR CELLS MATER, V11, P32
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Chen L, 2011, J BIOMED MATER RES A, V99A, P395, DOI 10.1002/jbm.a.33202
   Chen S, 2011, ACTA BIOMATER, V7, P644, DOI 10.1016/j.actbio.2010.09.014
   Chen ZG, 2010, ACTA BIOMATER, V6, P372, DOI 10.1016/j.actbio.2009.07.024
   Cheng HW, 2011, BIOMATERIALS, V32, P1526, DOI 10.1016/j.biomaterials.2010.10.021
   Chicatun F, 2011, BIOMACROMOLECULES, V12, P2946, DOI 10.1021/bm200528z
   Chiu CT, 2007, ARTIF CELL BLOOD SUB, V35, P309, DOI 10.1080/10731190701378626
   Cirka HA, 2012, ANN BIOMED ENG, V40, P1654, DOI 10.1007/s10439-012-0532-5
   Clark GL, 1935, J AM CHEM SOC, V57, P1509, DOI 10.1021/ja01311a504
   Cliche S, 2003, POULTRY SCI, V82, P503, DOI 10.1093/ps/82.3.503
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Crouzier T, 2008, LANGMUIR, V24, P13173, DOI 10.1021/la801999n
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Davis GE, 2001, J CELL SCI, V114, P917
   de Jonge N., 2012, ANN BIOMED ENG, V41, P763
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   DeVolder RJ, 2012, TISSUE ENG PT A, V18, P1642, DOI [10.1089/ten.tea.2011.0547, 10.1089/ten.TEA.2011.0547]
   Dewitt DD, 2009, TISSUE ENG PT A, V15, P2785, DOI [10.1089/ten.tea.2008.0406, 10.1089/ten.TEA.2008.0406]
   Ding T, 2011, REGEN MED, V6, P437, DOI [10.2217/rme.11.39, 10.2217/RME.11.39]
   Dong B, 2009, MACROMOL RAPID COMM, V30, P539, DOI 10.1002/marc.200800634
   Drexler J, 2010, TISSUE ENG, P17
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   EHRMANN RL, 1956, J NATL CANCER I, V16, P1375
   Ekaputra A, 2009, TISSUE ENG, V15, P3770
   Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Everaerts F, 2008, J BIOMED MATER RES A, V85A, P547, DOI 10.1002/jbm.a.31524
   Fernandez P, 2009, INTEGR BIOL, V1, P252, DOI 10.1039/b822897c
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Fischer RL, 2012, J MATER SCI-MATER M, V23, P1645, DOI 10.1007/s10856-012-4641-3
   Forgacs G, 2003, BIOPHYS J, V84, P1272, DOI 10.1016/S0006-3495(03)74942-X
   FRANCIS G, 1975, BIOCHEM J, V145, P287, DOI 10.1042/bj1450287
   Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014
   Franz S, 2013, ACTA BIOMATER, V9, P5621, DOI 10.1016/j.actbio.2012.11.016
   Galie PA, 2012, EXP CELL RES, V318, P75, DOI 10.1016/j.yexcr.2011.10.008
   Galie PA, 2011, ANN BIOMED ENG, V39, P2767, DOI 10.1007/s10439-011-0371-9
   Ghezzi CE, 2011, BIOMATERIALS, V32, P4761, DOI 10.1016/j.biomaterials.2011.03.043
   Gillette BM, 2008, NAT MATER, V7, P636, DOI 10.1038/nmat2203
   Gillette BM, 2011, BIOMATERIALS, V32, P8067, DOI 10.1016/j.biomaterials.2011.05.043
   Girton TS, 2000, J BIOMECH ENG-T ASME, V122, P216, DOI 10.1115/1.429652
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3786
   Gough J, 2002, J BIOMED MATER RES, V61, P121
   Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ICO.0000028326.06702.9C
   GRINNELL F, 1984, J CELL SCI, V66, P51
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Guarnieri D, 2007, J MATER SCI-MATER M, V18, P245, DOI 10.1007/s10856-006-0686-5
   Guo C, 2007, BIOMATERIALS, V28, P1105, DOI 10.1016/j.biomaterials.2006.10.010
   Gupta R, 2011, TISSUE ENG PT A, V17, P2005, DOI [10.1089/ten.tea.2010.0542, 10.1089/ten.TEA.2010.0542]
   Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200
   Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7
   Herchenhan A, 2012, BIOMECH MODEL MECHAN, V11, P449, DOI 10.1007/s10237-011-0324-0
   HILLIS WD, 1959, EXP CELL RES, V17, P557, DOI 10.1016/0014-4827(59)90086-2
   Holzwarth JM, 2011, BIOMATERIALS, V32, P9622, DOI 10.1016/j.biomaterials.2011.09.009
   Hong H, 2007, BIOMATERIALS, V28, P3824, DOI 10.1016/j.biomaterials.2007.05-007
   Hong H, 2008, J BIOMAT SCI-POLYM E, V19, P1279, DOI 10.1163/156856208786052380
   Hong SM, 2012, LAB CHIP, V12, P3277, DOI 10.1039/c2lc40558j
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Huang G., 2012, BIOFABRICATION, V4, P1
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Huang Z, 2009, BIOMED MATER, P4
   Hui TY, 2008, BIOMATERIALS, V29, P3201, DOI 10.1016/j.biomaterials.2008.04.001
   Hwang YJ, 2011, ACS APPL MATER INTER, V3, P2579, DOI 10.1021/am200416h
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jeng LB, 2009, J BIOMED MATER RES A, V91A, P886, DOI 10.1002/jbm.a.32293
   Ji J, 2012, J MECH BEHAV BIOMED, V13, P185, DOI 10.1016/j.jmbbm.2012.04.016
   Jiang QR, 2013, J BIOMED MATER RES A, V101, P1237, DOI 10.1002/jbm.a.34422
   Johnson T, 2011, NANOTECHNOLOGY, V22, P1
   Kalson NS, 2010, MATRIX BIOL, V29, P678, DOI 10.1016/j.matbio.2010.08.009
   KANDA K, 1994, CELL TRANSPLANT, V3, P481, DOI 10.1177/096368979400300605
   Karamichos D, 2007, INVEST OPHTH VIS SCI, V48, P5030, DOI 10.1167/iovs.07-0443
   Khaing ZZ, 2012, NEUROSCI LETT, V519, P103, DOI 10.1016/j.neulet.2012.02.027
   Kittiphattanabawon P, 2010, EUR FOOD RES TECHNOL, V230, P475, DOI 10.1007/s00217-009-1191-0
   Koch L, 2012, BIOTECHNOL BIOENG, V109, P1855, DOI 10.1002/bit.24455
   Krishna OD, 2009, BIOMACROMOLECULES, V10, P2626, DOI 10.1021/bm900551c
   Krishnamoorthy G, 2013, J BIOMAT SCI-POLYM E, V24, P344, DOI 10.1080/09205063.2012.690280
   Lai V, 2012, J BIOMED ENG, V134, P11001
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Legant WR, 2009, P NATL ACAD SCI USA, V106, P10097, DOI 10.1073/pnas.0900174106
   Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]
   Li JS, 2008, J BIOMED MATER RES B, V86B, P381, DOI 10.1002/jbm.b.31031
   Liao E, 2007, TISSUE ENG, V13, P2007
   Liao S, 2005, BIOMATERIALS, V26, P7564, DOI 10.1016/j.biomaterials.2005.05.050
   Liu DC, 2001, ASIAN AUSTRAL J ANIM, V14, P1638, DOI 10.5713/ajas.2001.1638
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Liu T, 2012, J BIOMED MATER RES, V95, P276
   Love SA, 2012, ANNU REV ANAL CHEM, V5, P181, DOI 10.1146/annurev-anchem-062011-143134
   Lu SH, 2012, J TISSUE ENG REGEN M, V6, P786, DOI 10.1002/term.484
   Lund AW, 2008, J BIOMED MATER RES B, V87B, P213, DOI 10.1002/jbm.b.31098
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Madhavan K, 2011, J BIOMED MATER RES A, V97A, P16, DOI 10.1002/jbm.a.33006
   Madhavan K, 2010, ACTA BIOMATER, V6, P1413, DOI 10.1016/j.actbio.2009.09.028
   Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016
   Martin-Martin B, 2011, EUR J CELL BIOL, V90, P26, DOI 10.1016/j.ejcb.2010.09.008
   Matmaroh K, 2011, FOOD CHEM, V129, P1179, DOI 10.1016/j.foodchem.2011.05.099
   Matsunaga YT, 2011, ADV MATER, V23, pH90, DOI 10.1002/adma.201004375
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McClure M, 2011, J VISUAL EXP EXP, P4
   McGuigan A, 2008, PLOS ONE, P3
   McGuigan AP, 2006, NAT PROTOC, V1, P2963, DOI 10.1038/nprot.2006.443
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Mekhail M, 2010, J BIOMAT SCI-POLYM E, p[22, 2241]
   Moon S, 2010, TISSUE ENG PART C-ME, V16, P157, DOI [10.1089/ten.tec.2009.0179, 10.1089/ten.TEC.2009.0179]
   Morimoto Y, 2013, ADV HEALTHC MATER, V2, P261, DOI 10.1002/adhm.201200189
   Mu CD, 2013, J BIOMED MATER RES A, V101, P385, DOI 10.1002/jbm.a.34338
   Mu Z, 2013, LAB CHIP, V13, P1612
   Nagai N, 2008, J BIOMATER APPL, V23, P275, DOI 10.1177/0885328208092109
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Nalinanon S, 2007, FOOD CHEM, V104, P593, DOI 10.1016/j.foodchem.2006.12.035
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nazhat SN, 2007, BIOMACROMOLECULES, V8, P543, DOI 10.1021/bm060715f
   Ng C, 2006, ANN BIOMED ENG, P34
   NG C. P., 2003, AM J PHYSIOL-HEART C, V284, P1771
   Nguyen TD, 2009, TISSUE ENG PT A, V15, P957, DOI 10.1089/ten.tea.2007.0384
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   O'Leary LER, 2011, NAT CHEM, V3, P821, DOI [10.1038/nchem.1123, 10.1038/NCHEM.1123]
   Paten JA, 2013, BIOMATERIALS, V34, P2577, DOI 10.1016/j.biomaterials.2012.12.028
   Perka C, 2000, CLIN EXP RHEUMATOL, V18, P13
   Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   RAMACHANDRAN GN, 1956, NATURE, V177, P710, DOI 10.1038/177710b0
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   Rao RR, 2013, J BIOMED MATER RES A, V101, P1531, DOI 10.1002/jbm.a.34611
   Raub CB, 2007, BIOPHYS J, V92, P2212, DOI 10.1529/biophysj.106.097998
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   ROSENBLATT J, 1994, BIOMATERIALS, V15, P985, DOI 10.1016/0142-9612(94)90079-5
   Rowe S, 2009, J BIOMECHANICAL ENG, V131
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Saeidi N, 2012, BIOMATERIALS, V33, P7366, DOI 10.1016/j.biomaterials.2012.06.041
   Satyam A, 2012, J TISSUE ENG REGEN M
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Serpooshan V, 2011, J BIOMED MATER RES A, V96A, P609, DOI 10.1002/jbm.a.33008
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   SIMKOVIC D, 1959, EXP CELL RES, V17, P573, DOI 10.1016/0014-4827(59)90090-4
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Soares ALF, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003870
   Solorio L, 2010, J TISSUE ENG REGEN M, V4, P514, DOI 10.1002/term.267
   Somers P, 2008, J HEART VALVE DIS, V17, P682
   Song JJ, 2011, TRENDS MOL MED, V17, P424, DOI 10.1016/j.molmed.2011.03.005
   Stahl PJ, 2010, BIOMACROMOLECULES, V11, P2336, DOI 10.1021/bm100465q
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Tang MD, 2004, ADV MATER, V16, P1345, DOI 10.1002/adma.200400766
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tonelli FMP, 2012, INT J NANOMED, V7, P4511, DOI 10.2147/IJN.S33612
   TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057
   Tosun Z, 2010, J NEURAL ENG, V7, P1
   Tovell VE, 2012, INVEST OPHTH VIS SCI, V53, P4682, DOI 10.1167/iovs.11-8577
   Townley WA, 2008, J HAND SURG-AM, V33A, P1608, DOI 10.1016/j.jhsa.2008.06.013
   Usha R, 2000, J APPL POLYM SCI, V75, P1577
   Vader D, 2009, PLOS ONE, V4, P35902
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Voge C, 2012, J BIOMED MATER RES, V101, P231
   Voge CM, 2008, J BIOMED MATER RES A, V86A, P269, DOI 10.1002/jbm.a.32029
   Walters VI, 2012, CONNECT TISSUE RES, V53, P255, DOI 10.3109/03008207.2011.634532
   Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2
   Wang LM, 2013, CELLS TISSUES ORGANS, V197, P333, DOI 10.1159/000348359
   Wang LM, 2011, ACTA BIOMATER, V7, P2410, DOI 10.1016/j.actbio.2011.02.029
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wen F, 2008, J BIOMED MATER RES B, V87B, P154, DOI [10.1002/jbm.b.31086, 10.1002/jbm.b.31080]
   White DJ, 2004, INT J BIOCHEM CELL B, V36, P1405, DOI 10.1016/j.biocel.2003.08.016
   Wilson CG, 2009, BIOMATERIALS, V30, P5639, DOI 10.1016/j.biomaterials.2009.07.011
   WOODLEY DT, 1991, J INVEST DERMATOL, V97, P580, DOI 10.1111/1523-1747.ep12481920
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Wyckoff R W, 1935, Science, V82, P175, DOI 10.1126/science.82.2121.175
   Xu B., 2011, INT J BIOMATER, P12, DOI [10.1155/2011/172389, DOI 10.1155/2011/172389]
   Xu T, 2013, BIOFABRICATION, V5, P1
   Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209
   Yahyouche A, 2011, ACTA BIOMATER, V7, P278, DOI 10.1016/j.actbio.2010.08.005
   Yan LP, 2010, J BIOMED MATER RES A, V95A, P465, DOI 10.1002/jbm.a.32869
   Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yin AL, 2013, J BIOMED MATER RES A, V101, P1292, DOI 10.1002/jbm.a.34434
   Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243
   Zheng WF, 2010, ADV ENG MATER, V12, pB451, DOI 10.1002/adem.200980087
   Zhou JA, 2010, INT J BIOL MACROMOL, V47, P514, DOI 10.1016/j.ijbiomac.2010.07.010
   Zhou WD, 2013, J BIOMAT SCI-POLYM E, V24, P301, DOI 10.1080/09205063.2012.690277
NR 231
TC 76
Z9 77
U1 12
U2 204
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1488
EP 1501
DI 10.1016/j.actbio.2013.08.038
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700002
PM 24012608
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Brown, AC
   Barker, TH
AF Brown, Ashley C.
   Barker, Thomas H.
TI Fibrin-based biomaterials: Modulation of macroscopic properties through
   rational design at the molecular level
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Fibrin; Biomaterial design; Fibrin glue; Wound repair; Tissue
   engineering
ID MESENCHYMAL STEM-CELLS; KNOB-HOLE INTERACTIONS; ALPHA-C-DOMAINS;
   POLY(ETHYLENE GLYCOL) HYDROGELS; HEPARIN-CONJUGATED FIBRIN; ANGIOGENESIS
   IN-VITRO; LINKED GAMMA-CHAINS; B-B INTERACTIONS; MECHANICAL-PROPERTIES;
   CLOT STRUCTURE
AB Fibrinogen is one of the primary components of the coagulation cascade and rapidly forms an insoluble matrix following tissue injury. In addition to its important role in hemostasis, fibrin acts as a scaffold for tissue repair and provides important cues for directing cell phenotype following injury. Because of these properties and the ease of polymerization of the material, fibrin has been widely utilized as a biomaterial for over a century. Modifying the macroscopic properties of fibrin, such as elasticity and porosity, has been somewhat elusive until recently, yet with a molecular-level rational design approach it can now be somewhat easily modified through alterations of molecular interactions key to the protein's polymerization process. This review outlines the biochemistry of fibrin and discusses methods for modification of molecular interactions and their application to fibrin based biomaterials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Brown, Ashley C.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA.
   [Barker, Thomas H.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Barker, TH (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
EM thomas.barker@bme.gatech.edu
FU NIBIB NIH HHS [R21 EB013743, R01 EB011566]
CR Ahmann KA, 2010, TISSUE ENG PT A, V16, P3261, DOI 10.1089/ten.TEA.2009.0708
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Akpalo E, 2011, ACTA BIOMATER, V7, P2418, DOI 10.1016/j.actbio.2011.03.002
   Alsberg E, 2006, TISSUE ENG, V12, P3247, DOI 10.1089/ten.2006.12.3247
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Averett RD, 2012, BIOPHYS J, V103, P1537, DOI 10.1016/j.bpj.2012.08.038
   Bachli EB, 2003, J THROMB HAEMOST, V1, P1935, DOI 10.1046/j.1538-7836.2003.00363.x
   Bagoly Z, 2012, THROMB RES, V129, P382, DOI 10.1016/j.thromres.2011.11.040
   BALE MD, 1988, THROMB RES, V52, P565, DOI 10.1016/0049-3848(88)90129-6
   BARADET TC, 1995, BIOPHYS J, V68, P1551, DOI 10.1016/S0006-3495(95)80327-9
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bergel S., 1909, DTSCH MED WOCHENSCHR, V35
   Bielecki T, 2012, CURR PHARM BIOTECHNO, V13, P1121, DOI 10.2174/138920112800624292
   Bootle-Wilbraham C. A., 2001, Angiogenesis, V4, P269
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Burton RA, 2007, BIOCHEMISTRY-US, V46, P8550, DOI 10.1021/bi700606v
   Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006
   CARR ME, 1995, BLOOD COAGUL FIBRIN, V6, P567, DOI 10.1097/00001721-199509000-00011
   CARR ME, 1986, BIOCHEM J, V239, P513, DOI 10.1042/bj2390513
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chekanov VS, 2003, VASC MED, V8, P157, DOI 10.1191/1358863x03vm491oa
   Chen ZW, 2011, J MICROENCAPSUL, V28, P344, DOI 10.3109/02652048.2011.569764
   Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879
   Chung E, 2013, INT J NANOMED, V8, P325, DOI 10.2147/IJN.S36711
   Chung W, 2009, AM J SURG, V197, P604, DOI 10.1016/j.amjsurg.2008.12.013
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034
   Collen A, 2000, CANCER RES, V60, P6196
   Collet JP, 2005, BLOOD, V106, P3824, DOI 10.1182/blood-2005-05-2150
   Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Cronkite EP, 1944, J AMER MED ASSOC, V124, P976, DOI 10.1001/jama.1944.02850140022006
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Cushman M, 2003, BLOOD, V101, P1243, DOI 10.1182/blood-2002-05-1416
   Davis HE, 2011, ACTA BIOMATER, V7, P691, DOI 10.1016/j.actbio.2010.09.007
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767
   Drinnan CT, 2010, J CONTROL RELEASE, V147, P180, DOI 10.1016/j.jconrel.2010.03.026
   Duong H, 2009, TISSUE ENG PT A, V15, P1865, DOI 10.1089/ten.tea.2008.0319
   Elvin CM, 2010, J BIOMED MATER RES A, V93A, P687, DOI 10.1002/jbm.a.32572
   Elvin CM, 2009, BIOMATERIALS, V30, P2059, DOI 10.1016/j.biomaterials.2008.12.059
   ERICKSON HP, 1983, ANN NY ACAD SCI, V408, P146, DOI 10.1111/j.1749-6632.1983.tb23242.x
   Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129
   EVERSE SJ, 1995, PROTEIN SCI, V4, P1013
   Falvo MR, 2010, BIOPHYS CHEM, V152, P15, DOI 10.1016/j.bpc.2010.08.009
   Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x
   Feng Xiaodong, 2013, Int J Cell Biol, V2013, P231279, DOI 10.1155/2013/231279
   Ferguson J, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P225, DOI 10.1007/978-3-7091-0286-2_15
   Ferris D, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/691605
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   Fezza JP, 2002, PLAST RECONSTR SURG, V110, P658, DOI 10.1097/00006534-200208000-00044
   Fogelson AL, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051922
   Fortelny RH, 2008, HERNIA, V12, P499, DOI 10.1007/s10029-008-0365-1
   Frisman I, 2011, BIOMATERIALS, V32, P7839, DOI 10.1016/j.biomaterials.2011.06.078
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   FURLAN M, 1976, THROMB HAEMOSTASIS, V36, P582
   GABRIEL DA, 1992, J BIOL CHEM, V267, P24259
   Gaffney PJ, 2001, ANN NY ACAD SCI, V936, P594
   Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487
   Geer CB, 2007, J THROMB HAEMOST, V5, P2344, DOI 10.1111/j.1538-7836.2007.02774.x
   Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x
   GERTH C, 1974, BIOPHYS CHEM, V2, P208, DOI 10.1016/0301-4622(74)80046-3
   Gorodetsky R, 1998, J LAB CLIN MED, V131, P269, DOI 10.1016/S0022-2143(98)90100-7
   GRAY AJ, 1990, J CELL SCI, V96, P271
   GREENBERG CS, 1985, BLOOD, V66, P466
   GREENBERG CS, 1982, J BIOL CHEM, V257, P6096
   Gross TJ, 1997, THROMB HAEMOSTASIS, V77, P894
   Gugerell A, 2012, J BIOMED MATER RES A, V100A, P1239, DOI 10.1002/jbm.a.34007
   Hanson AJ, 2002, J BIOMED MATER RES, V61, P474, DOI 10.1002/jbm.10196
   He M, 2013, J PLAST SURG HAND SU
   Helms CC, 2012, BIOPHYS J, V102, P168, DOI 10.1016/j.bpj.2011.11.4016
   HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Houser JR, 2010, BIOPHYS J, V99, P3038, DOI 10.1016/j.bpj.2010.08.060
   Huang NF, 2009, REGEN MED, V4, P527, DOI [10.2217/rme.09.32, 10.2217/RME.09.32]
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jennewein C, 2011, MOL MED, V17, P568, DOI 10.2119/molmed.2010.00146
   Jiang B, 2013, TISSUE ENG PT A, V19, P224, DOI 10.1089/ten.tea.2012.0120
   Jing P, 2008, BIOMACROMOLECULES, V9, P2438, DOI 10.1021/bm800459v
   Kang H, 2009, J PHYS CHEM B, V113, P3799, DOI 10.1021/jp807749f
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   KIM JP, 1992, J CELL PHYSIOL, V151, P443, DOI 10.1002/jcp.1041510303
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Kubo M, 2001, J INVEST DERMATOL, V117, P1369, DOI 10.1046/j.0022-202x.2001.01551.x
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   KUNITADA S, 1992, BLOOD, V79, P1420
   Kupcsik L, 2009, TISSUE ENG PT A, V15, P2309, DOI 10.1089/ten.tea.2008.0400
   Lai VK, 2012, ACTA BIOMATER, V8, P4031, DOI 10.1016/j.actbio.2012.07.010
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028
   LAUDANO AP, 1981, SCIENCE, V212, P457, DOI 10.1126/science.7209542
   LAUDANO AP, 1983, ANN NY ACAD SCI, V408, P315, DOI 10.1111/j.1749-6632.1983.tb23254.x
   Lawrie AS, 1998, J CLIN PATHOL, V51, P462, DOI 10.1136/jcp.51.6.462
   Le Guehennec L, 2004, EUROPEAN CELLS MAT, V8, p[1, 10], DOI DOI 10.22203/ECM.V008A01
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Lee CR, 2005, TISSUE ENG, V11, P1562, DOI 10.1089/ten.2005.11.1562
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   LEWIS SD, 1985, J BIOL CHEM, V260, P192
   Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200
   Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039
   Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j
   Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910
   Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x
   Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Lounes KC, 2002, BIOCHEMISTRY-US, V41, P5291, DOI 10.1021/bi011988s
   Marci M, 2000, Minerva Cardioangiol, V48, P97
   Martino MM, 2009, BIOMATERIALS, V30, P1089, DOI 10.1016/j.biomaterials.2008.10.047
   Medved L, 2003, THROMB HAEMOSTASIS, V89, P409
   MOCKROS LF, 1974, BIOPHYS CHEM, V2, P164, DOI 10.1016/0301-4622(74)80037-2
   Morin KT, 2011, BIOMATERIALS, V32, P6111, DOI 10.1016/j.biomaterials.2011.05.018
   Morris TA, 2011, AM J RESP CRIT CARE, V184, P708, DOI 10.1164/rccm.201104-0624OC
   Mosesson MW, 2004, J THROMB HAEMOST, V2, P388, DOI 10.1111/j.1538-7933.2004.00613.x
   MOSESSON MW, 1993, BLOOD, V82, P1517
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Murciano JC, 2002, AM J PHYSIOL-LUNG C, V282, pL529, DOI 10.1152/ajplung.00112.2001
   NAIR CH, 1986, THROMB RES, V42, P809, DOI 10.1016/0049-3848(86)90117-9
   Naito M, 2000, THROMB RES, V98, P165, DOI 10.1016/S0049-3848(99)00202-9
   Namani R, 2009, J BIOMECH, V42, P2047, DOI 10.1016/j.jbiomech.2009.06.007
   Neidert MR, 2006, TISSUE ENG, V12, P891, DOI 10.1089/ten.2006.12.891
   NELB GW, 1976, BIOPHYS CHEM, V5, P377, DOI 10.1016/0301-4622(76)80050-6
   NELB GW, 1981, BIOPHYS CHEM, V13, P15, DOI 10.1016/0301-4622(81)80020-8
   Nurnberger S, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P237, DOI 10.1007/978-3-7091-0286-2_16
   NUSSENZWEIG V, 1961, ANN I PASTEUR PARIS, V100, P490
   Okumura N, 2007, J THROMB HAEMOST, V5, P2352, DOI 10.1111/j.1538-7836.2007.02793.x
   Pandi L, 2009, BIOCHEMISTRY-US, V48, P7201, DOI 10.1021/bi900647g
   Ping LF, 2011, BIOCHEMISTRY-US, V50, P9066, DOI 10.1021/bi201094v
   Potier E, 2010, J MATER SCI, V45, P2494, DOI 10.1007/s10853-010-4221-1
   Rahmany MB, 2013, BIOMATERIALS, V34, P2492, DOI 10.1016/j.biomaterials.2012.12.008
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   RICHARDSON DL, 1976, BRIT J HAEMATOL, V32, P507, DOI 10.1111/j.1365-2141.1976.tb00953.x
   Ricles LM, 2011, INT J NANOMED, V6, P407, DOI 10.2147/IJN.S16354
   Riedel T, 2011, BLOOD, V117, P1700, DOI 10.1182/blood-2010-08-300301
   ROBERTS W W, 1973, Biorheology, V10, P29
   ROBSON SC, 1994, BRIT J HAEMATOL, V86, P322, DOI 10.1111/j.1365-2141.1994.tb04733.x
   ROSKA FJ, 1982, BIOPOLYMERS, V21, P1811, DOI 10.1002/bip.360210910
   ROSKA FJ, 1982, BIOPOLYMERS, V21, P1833, DOI 10.1002/bip.360210911
   ROSSER RW, 1977, BIOPHYS CHEM, V7, P153, DOI 10.1016/0301-4622(77)80008-2
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Rowe SL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128673
   Ruggiero R, 2008, Minerva Chir, V63, P249
   Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4
   Ryan EA, 1999, BIOPHYS J, V77, P2827, DOI 10.1016/S0006-3495(99)77114-6
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2
   Sawamura Y, 1999, NEUROSURGERY, V44, P332, DOI 10.1097/00006123-199902000-00048
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Seetharaman S, 2011, ACTA BIOMATER, V7, P2787, DOI 10.1016/j.actbio.2011.04.003
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353
   SHAINOFF JR, 1979, SCIENCE, V204, P200, DOI 10.1126/science.155308
   Shats EA, 1997, ATHEROSCLEROSIS, V129, P9, DOI 10.1016/S0021-9150(96)06003-0
   SIEBENLIST KR, 1994, J BIOL CHEM, V269, P28414
   Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050
   Soon ASC, 2010, BIOMATERIALS, V31, P1944, DOI 10.1016/j.biomaterials.2009.10.060
   Soon AS, 2013, ADV HLTH MAT
   Sperzel M, 2007, J THROMB HAEMOST, V5, P2113, DOI 10.1111/j.1538-7836.2007.02717.x
   Spicer PP, 2010, J CONTROL RELEASE, V148, P49, DOI 10.1016/j.jconrel.2010.06.025
   SPOTNITZ WD, 1995, THROMB HAEMOSTASIS, V74, P482
   Spotnitz WD, 2005, TISSUE ADHESIVES CLI, P77
   Spotnitz WD, 2008, TRANSFUSION, V48, P1502, DOI 10.1111/j.1537-2995.2008.01703.x
   Spotnitz WD, 2010, CLIN APPL THROMB-HEM, V16, P497, DOI 10.1177/1076029610363589
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801
   Stabenfeldt SE, 2011, BIOTECHNOL BIOENG
   Standeven KF, 2007, BLOOD, V110, P902, DOI 10.1182/blood-2007-01-066837
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2009, BIOMATERIALS, V30, P6695, DOI 10.1016/j.biomaterials.2009.08.039
   TAKEI A, 1995, IN VITRO CELL DEV-AN, V31, P467
   Tan SM, 2012, BIOSCIENCE REP, V32, P241, DOI 10.1042/BSR20110101
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   THOMPSON DF, 1988, DRUG INTEL CLIN PHAR, V22, P946, DOI 10.1177/106002808802201203
   THOMPSON WD, 1992, J PATHOL, V168, P47, DOI 10.1002/path.1711680109
   Tidrick RT, 1944, SURGERY, V15, P90
   Vaiman M, 2006, ANN OTO RHINOL LARYN, V115, P483, DOI 10.1177/000348940611500701
   Van Lieshout M, 2006, TISSUE ENG, V12, P481, DOI 10.1089/ten.2006.12.481
   VEKLICH YI, 1993, J BIOL CHEM, V268, P13577
   Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988
   Voge CM, 2013, J BIOMED MATER RES A, V101, P231, DOI 10.1002/jbm.a.34310
   Wang H, 2006, MATRIX BIOL, V25, P20, DOI 10.1016/j.matbio.2005.09.004
   Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x
   Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963
   Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   WEISEL JW, 1986, BIOPHYS J, V50, P1079, DOI 10.1016/S0006-3495(86)83552-4
   Weisel JW, 2004, J THROMB HAEMOST, V2, P1467, DOI 10.1111/j.1538-7836.2004.00873.x
   Weisel JW, 2001, ANN NY ACAD SCI, V936, P312
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Xu JH, 1998, J CELL BIOL, V140, P709, DOI 10.1083/jcb.140.3.709
   Xu T, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015001
   Yang HS, 2010, TISSUE ENG PT A, V16, P2113, DOI [10.1089/ten.tea.2009.0673, 10.1089/ten.TEA.2009.0673]
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
   Yucel EA, 2003, J DENT, V31, P569, DOI 10.1016/S0300-5712(03)00113-1
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhao HG, 2009, J MATER SCI-MATER M, V20, P135, DOI 10.1007/s10856-008-3543-x
NR 208
TC 61
Z9 61
U1 4
U2 42
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1502
EP 1514
DI 10.1016/j.actbio.2013.09.008
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700003
PM 24056097
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ceccarelli, J
   Putnam, AJ
AF Ceccarelli, Jacob
   Putnam, Andrew J.
TI Sculpting the blank slate: How fibrin's support of vascularization can
   inspire biomaterial design
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Fibrin; Biomaterial; Extracellular matrix; Angiogenesis
ID HUMAN-ENDOTHELIAL CELLS; ENGINEERED PEG HYDROGELS; MESENCHYMAL
   STEM-CELLS; IN-VITRO; CAPILLARY MORPHOGENESIS; EXTRACELLULAR MATRICES;
   VE-CADHERIN; 3-DIMENSIONAL CELL; STROMAL CELLS; FACTOR XIIIA
AB Fibrin is the primary extracellular constituent of blood clots, and plays an important role as a provisional matrix during wound healing and tissue remodeling. Fibrin-based biomaterials have proven their utility as hemostatic therapies, scaffolds for tissue engineering, vehicles for controlled release, and platforms for culturing and studying cells in three dimensions. Nevertheless, fibrin presents a complex milieu of signals to embedded cells, many of which are not well understood. Synthetic extracellular matrices (ECMs) provide a blank slate that can ostensibly be populated with specific bioactive cues, including growth factors, growth factor binding motifs, adhesive peptides and peptide crosslinks susceptible to proteases, thereby enabling a degree of customization for specific applications. However, the continued evolution and improvement of synthetic ECMs requires parallel efforts to deconstruct native ECMs and decipher the cues they provide to constituent cells. The objective of this review is to reintroduce fibrin, a protein with a well-characterized structure and biochemistry, and its ability to support angiogenesis specifically. Although fibrin's structure function relationships have been studied for decades, opportunities to engineer new and improved synthetic hydrogels can be realized by further exploiting fibrin's inspiring design. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Ceccarelli, Jacob; Putnam, Andrew J.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, 2154 Lurie Biomed Engn Bldg,1101 Beal Ave, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
RI Putnam, Andrew/E-8643-2010
OI Putnam, Andrew/0000-0002-1262-4377
FU National Institutes of Health [R01-HL085339, R21-DE021537]
FX We gratefully acknowledge financial support from the National Institutes
   of Health (R01-HL085339 and R21-DE021537). The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of the NIH.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Bach TL, 1998, J BIOL CHEM, V273, P30719, DOI 10.1074/jbc.273.46.30719
   Barker TH, 2001, J BIOMED MATER RES, V56, P529, DOI 10.1002/1097-4636(20010915)56:4<529::AID-JBM1124>3.0.CO;2-2
   Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Brown AEX, 2009, SCIENCE, V325, P741, DOI 10.1126/science.1172484
   Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2
   BUNCE LA, 1992, J CLIN INVEST, V89, P842, DOI 10.1172/JCI115663
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842
   Ceccarelli J, 2012, CELL MOL BIOENG, V5, P463, DOI 10.1007/s12195-012-0242-y
   CHALUPOWICZ DG, 1995, J CELL BIOL, V130, P207, DOI 10.1083/jcb.130.1.207
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   CHERESH DA, 1989, CELL, V58, P945, DOI 10.1016/0092-8674(89)90946-X
   CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   Cummins PM, 2007, AM J PHYSIOL-HEART C, V292, pH28, DOI 10.1152/ajpheart.00304.2006
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Dunn CJ, 1999, DRUGS, V58, P863, DOI 10.2165/00003495-199958050-00010
   Ehrbar M, 2007, BIOMACROMOLECULES, V8, P3000, DOI 10.1021/bm070228f
   FERRY JD, 1952, P NATL ACAD SCI USA, V38, P566, DOI 10.1073/pnas.38.7.566
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   Flick MJ, 2004, J CLIN INVEST, V113, P1596, DOI 10.1172/JCI200420741
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gjorevski N, 2010, INTEGR BIOL-UK, V2, P424, DOI 10.1039/c0ib00040j
   GORKUN OV, 1994, BIOCHEMISTRY-US, V33, P6986, DOI 10.1021/bi00188a031
   Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.tea.2012.0281, 10.1089/ten.TEA.2012.0281]
   Griffith CK, 2005, TISSUE ENG, V11, P257, DOI 10.1089/ten.2005.11.257
   Guthold M, 2007, CELL BIOCHEM BIOPHYS, V49, P165, DOI 10.1007/s12013-007-9001-4
   Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596
   HAJJAR KA, 1986, J BIOL CHEM, V261, P1656
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7
   Jackson MR, 2001, AM J SURG, V182, P1
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Kachgal S, 2012, J CELL PHYSIOL, V227, P3546, DOI 10.1002/jcp.24056
   Kachgal S, 2011, ANGIOGENESIS, V14, P47, DOI 10.1007/s10456-010-9194-9
   Kim PD, 2009, BIOMATERIALS, V30, P3854, DOI 10.1016/j.biomaterials.2009.04.013
   Kniazeva E, 2012, INTEGR BIOL-UK, V4, P431, DOI 10.1039/c2ib00120a
   Korff T, 1999, J CELL SCI, V112, P3249
   Kotlarchyk MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020201
   Kroon ME, 1999, AM J PATHOL, V154, P1731, DOI 10.1016/S0002-9440(10)65429-6
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MARDER VJ, 1983, ANN NY ACAD SCI, V408, P397, DOI 10.1111/j.1749-6632.1983.tb23260.x
   Martinez J, 2001, ANN NY ACAD SCI, V936, P386
   Matsumoto T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001211
   Medved L, 2003, THROMB HAEMOSTASIS, V89, P409
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Morin KT, 2011, BIOMATERIALS, V32, P6111, DOI 10.1016/j.biomaterials.2011.05.018
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   MOSESSON MW, 1995, J STRUCT BIOL, V115, P88, DOI 10.1006/jsbi.1995.1033
   Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11
   Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.tec.2012.0430, 10.1089/ten.TEC.2012.0430]
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061
   NICOSIA RF, 1990, IN VITRO CELL DEV B, V26, P119
   Odrljin TM, 1996, ARTERIOSCL THROM VAS, V16, P1544, DOI 10.1161/01.ATV.16.12.1544
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pechik I, 2006, BIOCHEMISTRY-US, V45, P3588, DOI 10.1021/bi0525369
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Radosevich M, 1997, VOX SANG, V72, P133, DOI 10.1046/j.1423-0410.1997.7230133.x
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Rao RR, 2012, ANGIOGENESIS, V15, P253, DOI 10.1007/s10456-012-9257-1
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300
   Sander EA, 2011, ANN BIOMED ENG, V39, P714, DOI 10.1007/s10439-010-0192-2
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   SHEN LL, 1975, THROMB RES, V6, P255, DOI 10.1016/0049-3848(75)90073-0
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]
   Soon ASC, 2011, BIOMATERIALS, V32, P4406, DOI 10.1016/j.biomaterials.2011.02.050
   Soon ASC, 2010, BIOMATERIALS, V31, P1944, DOI 10.1016/j.biomaterials.2009.10.060
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003
   Sumpio BE, 1997, AM J PHYSIOL-CELL PH, V273, pC1441
   Trkov S, 2010, J TISSUE ENG REGEN M, V4, P205, DOI 10.1002/term.231
   VERNON RB, 1992, LAB INVEST, V66, P536
   WEISEL JW, 1987, P NATL ACAD SCI USA, V84, P8991, DOI 10.1073/pnas.84.24.8991
   Winer JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006382
   Yakovlev S, 2009, BIOCHEMISTRY-US, V48, P5171, DOI 10.1021/bi900487d
   Yang HS, 2010, TISSUE ENG PT A, V16, P1225, DOI [10.1089/ten.tea.2009.0390, 10.1089/ten.TEA.2009.0390]
   Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2010, ACTA BIOMATER, V6, P3395, DOI 10.1016/j.actbio.2010.03.019
   Zisch AH, 2004, BIOMATERIALS, V25, P3245, DOI 10.1016/j.biomaterials.2003.10.015
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 104
TC 16
Z9 16
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1515
EP 1523
DI 10.1016/j.actbio.2013.07.043
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700004
PM 23933102
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Wise, SG
   Yeo, GC
   Hiob, MA
   Rnjak-Kovacina, J
   Kaplan, DL
   Ng, MKC
   Weiss, AS
AF Wise, Steven G.
   Yeo, Giselle C.
   Hiob, Matti A.
   Rnjak-Kovacina, Jelena
   Kaplan, David L.
   Ng, Martin K. C.
   Weiss, Anthony S.
TI Tropoelastin: A versatile, bioactive assembly module
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Tropoelastin; Elastin; Structure; Elasticity; Biomaterials
ID RECOMBINANT HUMAN TROPOELASTIN; ELASTIN-LIKE POLYPEPTIDES; ENGINEERED
   BLOOD-VESSELS; CROSS-LINKING DOMAIN; SOLID-STATE; CUTIS-LAXA; STRUCTURAL
   DISORDER; HYDROPHOBIC DOMAINS; SECONDARY STRUCTURE; SELF-ASSOCIATION
AB Elastin provides structural integrity, biological cues and persistent elasticity to a range of important tissues, including the vasculature and lungs. Its critical importance to normal physiology makes it a desirable component of biomaterials that seek to repair or replace these tissues. The recent availability of large quantities of the highly purified elastin monomer, tropoelastin, has allowed for a thorough characterization of the mechanical and biological mechanisms underpinning the benefits of mature elastin. While tropoelastin is a flexible molecule, a combination of optical and structural analyses has defined key regions of the molecule that directly contribute to the elastomeric properties and control the cell interactions of the protein. Insights into the structure and behavior of tropoelastin have translated into increasingly sophisticated elastin-like biomaterials, evolving from classically manufactured hydrogels and fibers to new forms, stabilized in the absence of incorporated cross-linkers. Tropoelastin is also compatible with synthetic and natural co-polymers, expanding the applications of its potential use beyond traditional elastin-rich tissues and facilitating finer control of biomaterial properties and the design of next-generation tailored bioactive materials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wise, Steven G.; Hiob, Matti A.; Ng, Martin K. C.] Heart Res Inst, Sydney, NSW 2042, Australia.
   [Wise, Steven G.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Wise, Steven G.; Yeo, Giselle C.; Hiob, Matti A.; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Rnjak-Kovacina, Jelena; Kaplan, David L.] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA.
   [Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia.
   [Weiss, Anthony S.] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia.
   [Weiss, Anthony S.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Wise, Steven/G-2630-2018
OI Wise, Steven/0000-0001-7964-819X; WEISS, ANTHONY/0000-0002-8106-4836;
   Yeo, Giselle/0000-0001-6071-8899
FU Australian Research Council; Australian Defense Health Foundation;
   National Health and Medical Research Council [APP1033079, APP1039072];
   National Institutes of Health [EB014283]; IPRS/IPA
FX We acknowledge funding from the Australian Research Council (A.S.W.),
   Australian Defense Health Foundation (A.S.W.), National Health and
   Medical Research Council (APP1033079 and APP1039072; A.S.W. and
   M.K.C.N.) and National Institutes of Health (EB014283; A.S.W and D.L.K).
   A.S.W. is the Scientific Founder of Elastagen Pty Ltd. G.C.Y. is
   supported by an IPRS/IPA PhD scholarship. The authors declare no
   conflict of interest in this work.
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   Almine JF, 2013, FASEB J
   Annabi N, 2013, BIOMATERIALS, V34, P5496, DOI 10.1016/j.biomaterials.2013.03.076
   Annabi N, 2011, BIOMATERIALS, V32, P1517, DOI 10.1016/j.biomaterials.2010.10.024
   Annabi N, 2010, BIOMATERIALS, V31, P1655, DOI 10.1016/j.biomaterials.2009.11.051
   Baldock C, 2011, P NATL ACAD SCI USA, V108, P4322, DOI 10.1073/pnas.1014280108
   Bax DV, 2011, BIOMATERIALS, V32, P5100, DOI 10.1016/j.biomaterials.2011.03.079
   Bax DV, 2009, ACTA BIOMATER, V5, P3371, DOI 10.1016/j.actbio.2009.05.016
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   BLOOD CH, 1988, J CELL BIOL, V107, P1987, DOI 10.1083/jcb.107.5.1987
   Bochicchio B, 2008, CHIRALITY, V20, P985, DOI 10.1002/chir.20541
   Bochicchio B, 2011, CHIRALITY, V23, P694, DOI 10.1002/chir.20979
   Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200
   BROWN PL, 1992, BIOCHEM BIOPH RES CO, V186, P549, DOI 10.1016/S0006-291X(05)80843-5
   BrownAugsburger P, 1996, BIOCHEM J, V318, P149, DOI 10.1042/bj3180149
   BROWNAUGSBURGER P, 1995, J BIOL CHEM, V270, P17778, DOI 10.1074/jbc.270.30.17778
   Rodriguez-Cabello JC, 2011, NANOMEDICINE-UK, V6, P111, DOI 10.2217/NNM.10.141
   CICILA G, 1985, BIOCHEMISTRY-US, V24, P3075, DOI 10.1021/bi00334a001
   Clarke AW, 2005, BIOCHEMISTRY-US, V44, P10271, DOI 10.1021/bi050530d
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x
   DEBELLE L, 1992, EUR BIOPHYS J BIOPHY, V21, P321
   Debelle L, 1999, INT J BIOCHEM CELL B, V31, P261, DOI 10.1016/S1357-2725(98)00098-3
   Djajamuliadi J, 2009, MATRIX BIOL, V28, P92, DOI 10.1016/j.matbio.2008.12.001
   Dyksterhuis LB, 2007, MATRIX BIOL, V26, P125, DOI 10.1016/j.matbio.2006.10.002
   Dyksterhuis LB, 2010, BIOCHEM BIOPH RES CO, V396, P870, DOI 10.1016/j.bbrc.2010.05.013
   Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001
   Gauvin R, 2012, WIRES NANOMED NANOBI, V4, P235, DOI 10.1002/wnan.171
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   GOSLINE JM, 1975, BIOPOLYMERS, V14, P1811, DOI 10.1002/bip.1975.360140904
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Gronau G, 2012, BIOMATERIALS, V33, P8240, DOI 10.1016/j.biomaterials.2012.06.054
   Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205
   He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005
   He D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046130
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HINEK A, 1994, CELL ADHES COMMUN, V2, P185, DOI 10.3109/15419069409004436
   HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Jensen SA, 2000, J BIOL CHEM, V275, P28449, DOI 10.1074/jbc.M004265200
   KAGAN HM, 1982, METHOD ENZYMOL, V82, P637
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546
   Kozel BA, 2003, J BIOL CHEM, V278, P18491, DOI 10.1074/jbc.M212715200
   Kumashiro KK, 2008, BIOPOLYMERS, V89, P668, DOI 10.1002/bip.20984
   Kumashiro KK, 2006, J BIOL CHEM, V281, P23757, DOI 10.1074/jbc.M510833200
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020
   Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9
   LYERLA JR, 1975, BIOCHEMISTRY-US, V14, P5175, DOI 10.1021/bi00694a024
   Maeda I, 2011, J PEPT SCI, V17, P735, DOI 10.1002/psc.1394
   MAMMI M, 1968, NATURE, V220, P371, DOI 10.1038/220371b0
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Martino M, 2000, INT J BIOL MACROMOL, V27, P59, DOI 10.1016/S0141-8130(99)00118-X
   McCann JT, 2005, J MATER CHEM, V15, P735, DOI 10.1039/b415094e
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   Mecham RP, 1991, ANN N Y ACAD SCI, V624, P137
   Megarbane H, 2009, J INVEST DERMATOL, V129, P1650, DOI 10.1038/jid.2008.450
   Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Mithieux SM, 2009, BIOMATERIALS, V30, P431, DOI 10.1016/j.biomaterials.2008.10.018
   Miyagawa S, 2011, ANN THORAC SURG, V91, P320, DOI 10.1016/j.athoracsur.2010.09.080
   Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1
   Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k
   Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467
   Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/o09-161, 10.1139/O09-161]
   Naumann C, 2009, BIOPOLYMERS, V91, P321, DOI 10.1002/bip.21133
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   OLSEN DR, 1988, J BIOL CHEM, V263, P6465
   Ostuni A, 2007, BIOPHYS J, V93, P3640, DOI 10.1529/biophysj.107.110809
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Pepe A, 2005, MATRIX BIOL, V24, P96, DOI 10.1016/j.matbio.2005.01.004
   Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4
   Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10
   Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Rodriguez-Cabello JC, 1999, MACROMOL CHEM PHYSIC, V200, P1831, DOI 10.1002/(SICI)1521-3935(19990801)200:8<1831::AID-MACP1831>3.0.CO;2-V
   RUCKER RB, 1973, BIOCHIM BIOPHYS ACTA, V317, P193, DOI 10.1016/0005-2795(73)90212-2
   Sato F, 2007, J MOL BIOL, V369, P841, DOI 10.1016/j.jmb.2007.03.060
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   SEPHEL GC, 1989, J INVEST DERMATOL, V93, P147, DOI 10.1111/1523-1747.ep12277389
   TAMBURRO AM, 1992, J BIOMOL STRUCT DYN, V10, P441, DOI 10.1080/07391102.1992.10508661
   Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014
   Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t
   Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i
   Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200
   Tu YD, 2010, MICRON, V41, P268, DOI 10.1016/j.micron.2009.11.003
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Villani V, 1999, ANN NY ACAD SCI, V879, P284, DOI 10.1111/j.1749-6632.1999.tb10433.x
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Yeo GC, 2012, P NATL ACAD SCI USA, V109, P2878, DOI 10.1073/pnas.1111615108
   Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 112
TC 33
Z9 33
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1532
EP 1541
DI 10.1016/j.actbio.2013.08.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700006
PM 23938199
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Jiang, T
   Deng, M
   James, R
   Nair, LS
   Laurencin, CT
AF Jiang, Tao
   Deng, Meng
   James, Roshan
   Nair, Lakshmi S.
   Laurencin, Cato T.
TI Micro- and nanofabrication of chitosan structures for regenerative
   engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Chitosan; Regenerative engineering; Microfabrication; Nanofabrication
ID INJECTABLE THERMOGELLING CHITOSAN; SINTERED MICROSPHERE SCAFFOLDS;
   MESENCHYMAL STEM-CELLS; BONE REGENERATION; SOFT LITHOGRAPHY;
   PHOTOCROSSLINKABLE CHITOSAN; NANOFIBROUS SCAFFOLDS; SUBCHONDRAL BONE;
   BIOMEDICAL APPLICATIONS; ANTIBACTERIAL ACTIVITY
AB Repair and regeneration of human tissues and organs using biomaterials, cells and/or growth factors is the ultimate goal of tissue engineers. One of the grand challenges in this field is to closely mimic the structures and properties of native tissues. Regenerative engineering the convergence of tissue engineering with advanced materials science, stem cell science, and developmental biology represents the next valuable tool to overcome the challenges. This article reviews the recent progress in developing advanced chitosan structures using various fabrication techniques. These chitosan structures, together with stem cells and functional biomolecules, may provide a robust platform to gain insight into cell-biomaterial interactions and may function as excellent artificial extracellular matrices to regenerate complex human tissues and biological systems. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jiang, Tao] Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA.
   [Jiang, Tao; Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, Farmington, CT 06030 USA.
   [Jiang, Tao; Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Ctr Biol Phys & Engn Sc, Farmington, CT 06030 USA.
   [Deng, Meng; James, Roshan; Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.
   [Nair, Lakshmi S.; Laurencin, Cato T.] Univ Connecticut, Dept Chem Mat & Biomol Engn, Storrs, CT 06269 USA.
RP Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Inst Regenerat Engn, 263 Farmington Ave, Farmington, CT 06030 USA.
EM laurencin@uchc.edu
FU National Science Foundation [INT0115595]; Presidential Award for
   Excellence in Science, Engineering, and Math Mentoring [NSF DUE0834313]
FX The authors acknowledge the funding from the National Science Foundation
   grant INT0115595 and the Presidential Award for Excellence in Science,
   Engineering, and Math Mentoring (NSF DUE0834313). C.T.L. was previously
   the recipient of a Presidential Faculty Fellow Award from the National
   Science Foundation.
CR Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Agarwal P, 2012, J MATER SCI, V47, P4262, DOI 10.1007/s10853-012-6276-7
   Allcock HR, 2006, POLYPHOSPHAZENES
   Almodovar J, 2013, BIOTECHNOL BIOENG, V110, P609, DOI 10.1002/bit.24710
   Almodovar J, 2011, MACROMOL BIOSCI, V11, P72, DOI 10.1002/mabi.201000261
   Almodovar J, 2010, BIOMACROMOLECULES, V11, P2629, DOI 10.1021/bm1005799
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Antunes JC, 2011, BIOMACROMOLECULES, V12, P4183, DOI 10.1021/bm2008235
   Belitsky JM, 2007, CHEM BIOL, V14, P1140, DOI 10.1016/j.chembiol.2007.09.007
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bhattacharyya S, 2009, J BIOMED NANOTECHNOL, V5, P69, DOI 10.1166/jbn.2009.032
   Bhattarai N, 2005, J CONTROL RELEASE, V103, P609, DOI 10.1016/j.jconrel.2004.12.019
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bhattarai N, 2009, ADV MATER, V21, P2792, DOI 10.1002/adma.200802513
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Boddohi S, 2008, BIOMACROMOLECULES, V9, P2021, DOI 10.1021/bm8002573
   Boddohi S, 2010, COLLOID SURFACE B, V77, P60, DOI 10.1016/j.colsurfb.2010.01.006
   Boddohi S, 2009, BIOMACROMOLECULES, V10, P1402, DOI 10.1021/bm801513e
   Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Brown JL, 2010, J BIOMED MATER RES A, V95A, P1150, DOI 10.1002/jbm.a.32934
   Brugnerotto J, 2001, POLYMER, V42, P9921, DOI 10.1016/S0032-3861(01)00557-2
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen F, 2008, J BIOMAT SCI-POLYM E, V19, P677, DOI 10.1163/156856208784089661
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   Chen ZG, 2008, CARBOHYD POLYM, V72, P410, DOI 10.1016/j.carbpol.2007.09.018
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Chevrier A, 2007, OSTEOARTHR CARTILAGE, V15, P316, DOI 10.1016/j.joca.2006.08.007
   Cho JH, 2004, BIOMATERIALS, V25, P5743, DOI 10.1016/j.biomaterials.2004.01.051
   Cho Y, 2010, J EXP BIOL, V213, P1513, DOI 10.1242/jeb.035162
   Cooper A, 2011, PHYS CHEM CHEM PHYS, V13, P9969, DOI 10.1039/c0cp02909b
   Cooper A, 2010, J MATER CHEM, V20, P8904, DOI 10.1039/c0jm01841d
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Dautzenberg H., 1994, POLYELECTROLYTES FOR
   Deng M, 2012, IEEE T NANOBIOSCI, V11, P3, DOI 10.1109/TNB.2011.2179554
   Deng M, 2011, ADV FUNCT MATER, V21, P2641, DOI 10.1002/adfm.201100275
   Du J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/12/125707
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   Duan B, 2006, EUR POLYM J, V42, P2013, DOI 10.1016/j.eurpolymj.2006.04.021
   Eser ECCI, 1998, NEUROL RES, V20, P648
   Feng ZQ, 2009, BIOMATERIALS, V30, P2753, DOI 10.1016/j.biomaterials.2009.01.053
   Fernandez JG, 2009, SMALL, V5, P614, DOI 10.1002/smll.200800907
   Foley PL, 2013, BIOMATERIALS, V34, P2539, DOI 10.1016/j.biomaterials.2012.12.035
   Formhals A., 1934, U. S. Patent, Patent No. [1,975,504, 1975504]
   Francis SJ, 2000, BIOMATERIALS, V21, P2589, DOI DOI 10.1016/S0142-9612(00)00126-5
   Frohbergh ME, 2012, BIOMATERIALS, V33, P9167, DOI 10.1016/j.biomaterials.2012.09.009
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Gerentes P, 2002, BIOMATERIALS, V23, P1295, DOI 10.1016/S0142-9612(01)00247-2
   Goh J, 2003, TISSUE ENG S1, V9, P31
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Hoemann CD, 2007, OSTEOARTHR CARTILAGE, V15, P78, DOI 10.1016/j.joca.2006.06.015
   Hoemann CD, 2010, AM J SPORT MED, V38, P1845, DOI 10.1177/0363546510369547
   Hoemann CD, 2005, J BONE JOINT SURG AM, V87A, P2671, DOI 10.2106/JBJS.D.02536
   Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Ignatova M, 2007, EUR POLYM J, V43, P1112, DOI 10.1016/j.eurpolymj.2007.01.012
   Ignatova M, 2006, CARBOHYD RES, V341, P2098, DOI 10.1016/j.carres.2006.05.006
   Ishihara M, 2003, J BIOMED MATER RES A, V64A, P551, DOI 10.1002/jbm.a.10427
   Ishihara M, 2002, BIOMATERIALS, V23, P833, DOI 10.1016/S0142-9612(01)00189-2
   Jacobs V, 2011, CURR NANOSCI, V7, P396, DOI 10.2174/157341311795542570
   James R, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025011
   James R, 2011, FRONT MATER SCI, V5, P342, DOI 10.1007/s11706-011-0151-3
   James R, 2011, METHODS MOL BIOL, V726, P243, DOI 10.1007/978-1-61779-052-2_16
   Jeong SI, 2010, TISSUE ENG PART A, V17, P59
   Jia YT, 2007, CARBOHYD POLYM, V67, P403, DOI 10.1016/j.carbpol.2006.06.010
   Jiang T, 2005, MATER RES SOC SYMP P, V845, P187
   Jiang T, 2012, CHITOSAN BASED SYSTE, P393
   Jiang T, 2008, THESIS U VIRGINIA
   Jiang T, 2008, CURR TOP MED CHEM, V8, P354
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Jiang T, 2010, J BIOMED MATER RES A, V93A, P1193, DOI 10.1002/jbm.a.32615
   Jung KH, 2007, J APPL POLYM SCI, V105, P2816, DOI 10.1002/app.25594
   Karp JM, 2006, BIOMATERIALS, V27, P4755, DOI 10.1016/j.biomaterials.2006.04.028
   Katti DS, 2004, J BIOMED MATER RES B, V70B, P286, DOI 10.1002/jbm.b.30041
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Koev ST, 2010, LAB CHIP, V10, P3026, DOI [10.1039/c0lc00047g, 10.1039/c01c00047g]
   Kong M, 2010, INT J FOOD MICROBIOL, V144, P51, DOI 10.1016/j.ijfoodmicro.2010.09.012
   Kosaka T, 1996, J VET MED SCI, V58, P963, DOI 10.1292/jvms.58.10_963
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kumbar SG, 2008, BIOMEDICAL NANOSTRUCTURES, P261
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kumbar SG, 2007, J BIOMED MATER RES B, V81B, P91, DOI 10.1002/jbm.b.30641
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Laurencin C.T., 2012, SCI TRANSL MED, V4, P160
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liliensiek SJ, 2009, TISSUE ENG PT A, V15, P2643, DOI [10.1089/ten.tea.2008.0284, 10.1089/ten.TEA.2008.0284]
   Liu B, 2006, MACROMOL RAPID COMM, V27, P1859, DOI 10.1002/marc.200600492
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Marchand C, 2011, TISSUE ENG PART A, V18, P508
   McLaughlin SW, 2012, J MATER SCI-MATER M, V23, P2141, DOI 10.1007/s10856-012-4677-4
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   Merrell JG, 2009, CLIN EXP PHARMACOL P, V36, P1149, DOI 10.1111/j.1440-1681.2009.05216.x
   Mincheva R, 2007, EUR POLYM J, V43, P2809, DOI 10.1016/j.eurpolymj.2007.04.020
   Mo Xiumei, 2007, Frontiers of Materials Science in China, V1, P20, DOI 10.1007/s11706-007-0004-2
   Mori T, 2005, J VET MED SCI, V67, P51, DOI 10.1292/jvms.67.51
   Mwale F, 2005, TISSUE ENG, V11, P130, DOI 10.1089/ten.2005.11.130
   Nair LS, 2007, BIOMACROMOLECULES, V8, P3779, DOI 10.1021/bm7006967
   Neamnark A, 2006, CARBOHYD POLYM, V66, P298, DOI 10.1016/j.carbpol.2006.03.015
   Netz RR, 2003, PHYS REP, V380, P1, DOI 10.1016/S0370-1573(03)00118-2
   Nirmala R, 2011, MACROMOL RES, V19, P345, DOI 10.1007/s13233-011-0402-2
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   Pakravan M, 2012, BIOMACROMOLECULES, V13, P412, DOI 10.1021/bm201444v
   Pangestuti R, 2010, MAR DRUGS, V8, P2117, DOI 10.3390/md8072117
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Peach MS, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/4/045016
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Peesan M, 2006, J BIOMAT SCI-POLYM E, V17, P547, DOI 10.1163/156856206776986251
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Prabhakaran MP, 2008, TISSUE ENG PT A, V14, P1787, DOI 10.1089/ten.tea.2007.0393
   Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234
   Rafat M, 2008, BIOMATERIALS, V29, P3960, DOI 10.1016/j.biomaterials.2008.06.017
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001
   Rogers JA, 2005, MATER TODAY, V8, P50, DOI 10.1016/S1369-7021(05)00702-9
   Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Schlenoff J. B., 2003, MULTILAYER THIN FILM
   Schwarz A, 1998, LANGMUIR, V14, P5526, DOI 10.1021/la980359p
   Shalumon KT, 2012, J BIOMED NANOTECHNOL, V8, P405, DOI 10.1166/jbn.2012.1395
   Shim IK, 2008, J BIOMED MATER RES A, V90, P595
   Shin DS, 2003, BIOSENS BIOELECTRON, V19, P485, DOI 10.1016/S0956-5663(03)00228-8
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Silva JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055451
   Singh A, 2006, BIOMACROMOLECULES, V7, P914, DOI 10.1021/bm050752r
   Sogias IA, 2010, MACROMOL CHEM PHYS, V211, P426, DOI 10.1002/macp.200900385
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   Taylor ED, 2010, J BONE JOINT SURG AM, V92A, P170, DOI 10.2106/JBJS.J.01112
   Torres-Giner S, 2008, ENG LIFE SCI, V8, P303, DOI 10.1002/elsc.200700066
   Wan Y, 2008, ACTA BIOMATER, V4, P876, DOI 10.1016/j.actbio.2008.01.001
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Wang W, 2008, J BIOMED MATER RES A, V91, P994
   Wang W, 2010, ACTA BIOMATER, V6, P4027, DOI 10.1016/j.actbio.2010.04.027
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yang DZ, 2008, MACROMOL BIOSCI, V8, P239, DOI 10.1002/mabi.200700221
   Yi HM, 2005, BIOMACROMOLECULES, V6, P2881, DOI 10.1021/bm0504101
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yuxi L, 2012, J COLLOID INTERF SCI, V379, P130
   Zankovych S, 2013, ACTA BIOMATER, V9, P4926, DOI 10.1016/j.actbio.2012.08.013
   Zeleny J, 1914, PHYS REV, V3, P69, DOI 10.1103/PhysRev.3.69
   Zhang Y, 2007, BIOMACROMOLECULES, V9, P136
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhang YY, 2007, COLLOID POLYM SCI, V285, P855, DOI 10.1007/s00396-006-1630-4
   Zhou Y., 2007, BIOMACROMOLECULES, V9, P349
   Zhou YS, 2006, J APPL POLYM SCI, V102, P5692, DOI 10.1002/app.25068
   Zhou ZL, 2013, BIOMACROMOLECULES, V14, P529, DOI 10.1021/bm301785b
NR 160
TC 58
Z9 61
U1 8
U2 193
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1632
EP 1645
DI 10.1016/j.actbio.2013.07.003
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700015
PM 23851172
DA 2018-10-19
ER

PT J
AU Miao, SD
   Wang, P
   Su, ZG
   Zhang, SP
AF Miao, Shida
   Wang, Ping
   Su, Zhiguo
   Zhang, Songping
TI Vegetable-oil-based polymers as future polymeric biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Vegetable-oil; Biomaterial; Polyurethane; Polyester; Polyether
ID EPOXIDIZED SOYBEAN OIL; SOY-BASED POLYOLS; STRUCTURE-PROPERTY
   RELATIONSHIPS; RENEWABLE RESOURCES; PLANT OILS; POLYURETHANE NETWORKS;
   RICINOLEIC ACID; LINSEED OIL; CHEMOENZYMATIC EPOXIDATION; POLYHYDROXY
   TRIGLYCERIDES
AB Vegetable oils are one of the most important classes of bio-resources for producing polymeric materials. The main components of vegetable oils are triglycerides - esters of glycerol with three fatty acids. Several highly reactive sites including double bonds, allylic positions and the ester groups are present in triglycerides from which a great variety of polymers with different structures and functionalities can be prepared. Vegetable-oil-based polyurethane, polyester, polyether and polyolefin are the four most important classes of polymers, many of which have excellent biocompatibilities and unique properties including shape memory. In view of these characteristics, vegetable-oil-based polymers play an important role in biomaterials and have attracted increasing attention from the polymer community. Here we comprehensively review recent developments in the preparation of vegetable-oil-based polyurethane, polyester, polyether and polyolefin, all of which have potential applications as biomaterials. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Miao, Shida; Su, Zhiguo; Zhang, Songping] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
   [Miao, Shida] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.
   [Wang, Ping] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA.
   [Wang, Ping] Univ Minnesota, Dept Bioprod & Biosyst Engn, St Paul, MN 55108 USA.
   [Zhang, Songping] Synerget Innovat Ctr Chem Sci & Engn Tianjin, Tianjin 300072, Peoples R China.
RP Zhang, SP (reprint author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China.
EM spzhang@home.ipe.ac.cn
FU National Natural Science Foundation of China [20728607, 20706054,
   20976180]; 973 Program [2009CB724705]; 863 Project [2008AA10Z302]; Open
   Funding Project of the Guangxi Key Laboratory of Biorefinery, Guangxi,
   China [GXBF11-02]
FX The authors thank support from the National Natural Science Foundation
   of China (Grant Nos. 20728607, 20706054, 20976180), 973 Program
   (2009CB724705) and 863 Project (2008AA10Z302); the Open Funding Project
   of the Guangxi Key Laboratory of Biorefinery, Guangxi, China (No.
   GXBF11-02).
CR Acar M, 2013, J MACROMOL SCI A, V50, P287, DOI 10.1080/10601325.2013.755443
   Adhvaryu A, 2005, IND CROP PROD, V21, P113, DOI 10.1016/j.indcrop.2004.02.001
   Ahamad S, 1999, J APPL POLYM SCI, V72, P1679, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1679::AID-APP4>3.3.CO;2-8
   Alam M, 2011, J POLYM ENVIRON, V19, P391, DOI 10.1007/s10924-011-0281-9
   Andjelkovic DD, 2005, POLYMER, V46, P9674, DOI 10.1016/j.polymer.2005.08.022
   Bakare IO, 2006, J APPL POLYM SCI, V100, P3748
   Biermann U, 2000, ANGEW CHEM INT EDIT, V39, P2206, DOI 10.1002/1521-3773(20000703)39:13<2206::AID-ANIE2206>3.0.CO;2-P
   Biermann U, 2006, EUR J ORG CHEM, P2631, DOI 10.1002/ejoc.200500701
   Biswas A, 2009, J AGR FOOD CHEM, V57, P8136, DOI 10.1021/jf901401s
   Boquillon N, 2000, POLYMER, V41, P8603, DOI 10.1016/S0032-3861(00)00256-1
   Bunker SP, 2002, J POLYM SCI POL CHEM, V40, P451, DOI 10.1002/pola.10130
   Calderon M, 2010, ADV MATER, V22, P190, DOI 10.1002/adma.200902144
   Campanella A, 2004, GREEN CHEM, V6, P330, DOI 10.1039/b404975f
   Ronda JC, 2011, EUR J LIPID SCI TECH, V113, P46, DOI 10.1002/ejlt.201000103
   Cayli G, 2008, J APPL POLYM SCI, V109, P2948, DOI 10.1002/app.28401
   Cayli G, 2010, J APPL POLYM SCI, V116, P2433, DOI 10.1002/app.31846
   Chakrapani S, 1998, J MACROMOL SCI PURE, VA35, P691, DOI 10.1080/10601329808002006
   Chen Qizhi, 2012, PROG BIOMATER, V1, P1, DOI DOI 10.1186/2194-0517-1-2
   Chen ZG, 2010, J COAT TECHNOL RES, V7, P603, DOI 10.1007/s11998-010-9241-x
   Cho HG, 2010, J APPL POLYM SCI, V116, P736, DOI 10.1002/app.31467
   Das B, 2013, IND CROP PROD, V44, P396, DOI 10.1016/j.indcrop.2012.11.028
   de Espinosa LM, 2009, J POLYM SCI POL CHEM, V47, P1159, DOI 10.1002/pola.23225
   de Espinosa LM, 2011, EUR POLYM J, V47, P837, DOI 10.1016/j.eurpolymj.2010.11.020
   Del Rio E, 2010, J POLYM SCI POL CHEM, V48, P4995, DOI 10.1002/pola.24297
   Desroches M, 2012, POLYM REV, V52, P38, DOI 10.1080/15583724.2011.640443
   Desroches M, 2011, MACROMOLECULES, V44, P2489, DOI 10.1021/ma102884w
   Earls JD, 2007, POLYMER, V48, P712, DOI 10.1016/j.polymer.2006.11.060
   Ebata H, 2007, MACROMOL BIOSCI, V7, P798, DOI 10.1002/mabi.200700018
   Esen H, 2003, J APPL POLYM SCI, V89, P3882, DOI 10.1002/app.12594
   FEAIRHELLER SH, 1994, J AM OIL CHEM SOC, V71, P863, DOI 10.1007/BF02540463
   Frey H, 2002, REV MOL BIOTECHNOL, V90, P257, DOI DOI 10.1016/S1389-0352(01)00063-0
   Galia M, 2010, EUR J LIPID SCI TECH, V112, P87, DOI 10.1002/ejlt.200900096
   Gandini A, 2013, GREEN CHEM, V15, P1514, DOI 10.1039/c3gc40358k
   Gandini A, 2008, MACROMOLECULES, V41, P9491, DOI 10.1021/ma801735u
   Gerbase AE, 2002, J AM OIL CHEM SOC, V79, P179, DOI 10.1007/s11746-002-0455-0
   Gerbase AE, 2002, J AM OIL CHEM SOC, V79, P797, DOI 10.1007/s11746-002-0561-z
   Gonzalez-Paz RJ, 2011, J POLYM SCI POL CHEM, V49, P2407, DOI 10.1002/pola.24671
   Goud VV, 2007, CHEM ENG SCI, V62, P4065, DOI 10.1016/j.ces.2007.04.038
   Guner FS, 2006, PROG POLYM SCI, V31, P633, DOI 10.1016/j.progpolymsci.2006.07.001
   Guo A, 2000, J POLYM SCI POL CHEM, V38, P3900, DOI 10.1002/1099-0518(20001101)38:21<3900::AID-POLA70>3.0.CO;2-E
   Guo BC, 2011, BIOMACROMOLECULES, V12, P1312, DOI 10.1021/bm2000378
   Guo YZ, 2007, J AM OIL CHEM SOC, V84, P929, DOI 10.1007/s11746-007-1126-5
   Harry-O'kuru RE, 2002, IND CROP PROD, V15, P51, DOI 10.1016/S0926-6690(01)00095-4
   Harry-O'Kuru RE, 2002, J AGR FOOD CHEM, V50, P3214, DOI 10.1021/jf011464z
   Hilker I, 2001, CHEM ENG SCI, V56, P427, DOI 10.1016/S0009-2509(00)00245-1
   Hojabri L, 2010, J POLYM SCI POL CHEM, V48, P3302, DOI 10.1002/pola.24114
   Hojabri L, 2010, BIOMACROMOLECULES, V11, P911, DOI 10.1021/bm901308c
   Hojabri L, 2009, BIOMACROMOLECULES, V10, P884, DOI 10.1021/bm801411w
   Javni I, 2003, J APPL POLYM SCI, V88, P2912, DOI 10.1002/app.11966
   JIE MSFLK, 1988, LIPIDS, V23, P367, DOI 10.1007/BF02537351
   Johnson NS, 2011, J AM OIL CHEM SOC, V88, P1425, DOI 10.1007/s11746-011-1808-x
   KHOE TH, 1976, J AM OIL CHEM SOC, V53, P17, DOI 10.1007/BF02632517
   Klaas MR, 1999, IND CROP PROD, V9, P125
   Kreye O, 2013, GREEN CHEM, V15, P1431, DOI 10.1039/c3gc40440d
   Kundu PP, 2005, BIOMACROMOLECULES, V6, P797, DOI 10.1021/bm049429z
   La Scala J, 2005, POLYMER, V46, P61, DOI 10.1016/j.polymer.2004.11.002
   La Scala JJ, 2004, POLYMER, V45, P7729, DOI 10.1016/j.polymer.2004.08.056
   Lamba N. M. K., 1998, POLYURETHANES BIOMED
   Li F, 2001, POLYMER, V42, P1567, DOI 10.1016/S0032-3861(00)00546-2
   Liu ZS, 2007, BIOMACROMOLECULES, V8, P233, DOI 10.1021/bm060496y
   Liu ZS, 2011, J AGR FOOD CHEM, V59, P1909, DOI 10.1021/jf1035614
   Liu ZS, 2010, J AM OIL CHEM SOC, V87, P437, DOI 10.1007/s11746-009-1514-0
   Liu ZS, 2009, GREEN CHEM, V11, P1774, DOI 10.1039/b915742p
   Liu ZX, 2013, SOFT MATTER, V9, P5609, DOI 10.1039/c3sm50271f
   Liu ZX, 2012, SOFT MATTER, V8, P5888, DOI 10.1039/c2sm25115a
   Lligadas G, 2006, J POLYM SCI POL CHEM, V44, P634, DOI 10.1002/pola.21201
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P1858, DOI 10.1021/bm070157k
   Lligadas G, 2007, BIOMACROMOLECULES, V8, P686, DOI 10.1021/bm060977h
   Lligadas G, 2013, J POLYM SCI POL CHEM, V51, P2111, DOI 10.1002/pola.26620
   Lligadas G, 2013, MACROMOL CHEM PHYS, V214, P415, DOI 10.1002/macp.201200582
   Lligadas G, 2010, POLYMERS-BASEL, V2, P440, DOI 10.3390/polym2040440
   Lligadas G, 2010, BIOMACROMOLECULES, V11, P2825, DOI 10.1021/bm100839x
   lonescu M., 2007, J POLYM ENVIRON, V15, P237
   Lozada Z, 2009, J APPL POLYM SCI, V113, P2552, DOI 10.1002/app.30209
   Lu YS, 2008, BIOMACROMOLECULES, V9, P3332, DOI 10.1021/bm801030g
   Lu YS, 2009, CHEMSUSCHEM, V2, P136, DOI 10.1002/cssc.200800241
   Luo Q, 2011, MACROMOLECULES, V44, P7149, DOI 10.1021/ma201366e
   Luo XG, 2013, MACROMOL MATER ENG, V298, P412, DOI 10.1002/mame.201200030
   Mauldin TC, 2008, J POLYM SCI POL CHEM, V46, P6851, DOI 10.1002/pola.22995
   Meier MAR, 2007, CHEM SOC REV, V36, P1788, DOI 10.1039/b703294c
   Mello VM, 2013, IND CROP PROD, V43, P56, DOI 10.1016/j.indcrop.2012.07.007
   Metzger JO, 2006, APPL MICROBIOL BIOT, V71, P13, DOI 10.1007/s00253-006-0335-4
   Miao S, 2012, J APPL POLYM SCI, V127, P1929
   Miao S, 2013, BIOTECHNOL LETT
   Miao SD, 2008, J POLYM SCI POL CHEM, V46, P4243, DOI 10.1002/pola.22721
   Miao SD, 2013, J AM OIL CHEM SOC, V90, P1415, DOI 10.1007/s11746-013-2273-5
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1345, DOI 10.1002/ejlt.201200219
   Miao SD, 2012, EUR J LIPID SCI TECH, V114, P1165, DOI [10.1002/ejlt.201200050, 10.1002/ejlt.201290028]
   Miao SD, 2010, J POLYM SCI POL CHEM, V48, P243, DOI 10.1002/pola.23759
   MOHANTY A. K., 2005, NATURAL FIBRES BIOPO, V1, P1
   Mohanty AK, 2002, J POLYM ENVIRON, V10, P19, DOI 10.1023/A:1021013921916
   More AS, 2013, EUR POLYM J, V49, P823, DOI 10.1016/j.eurpolymj.2012.12.013
   Mutlu H, 2010, EUR J LIPID SCI TECH, V112, P10, DOI 10.1002/ejlt.200900138
   Narine SS, 2007, J AM OIL CHEM SOC, V84, P55, DOI 10.1007/s11746-006-1006-4
   Nayak RR, 2004, POLYM-PLAST TECHNOL, V43, P261, DOI 10.1081/PPT-120027475
   Pan X, 2011, BIOMACROMOLECULES, V12, P2416, DOI 10.1021/bm200549c
   Petrovic ZS, 2008, POLYM REV, V48, P109, DOI 10.1080/15583720701834224
   Petrovic ZS, 2008, POLYM INT, V57, P275, DOI 10.1002/pi.2340
   Petrovic ZS, 2013, POLYMER, V54, P372, DOI 10.1016/j.polymer.2012.10.019
   Petrovic ZS, 2010, MACROMOLECULES, V43, P4120, DOI 10.1021/ma100294r
   Petrovic ZS, 2005, BIOMACROMOLECULES, V6, P713, DOI 10.1021/bm049451s
   Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736
   Rao BS, 2008, PROG ORG COAT, V63, P416, DOI 10.1016/j.porgcoat.2008.07.001
   Raquez JM, 2010, PROG POLYM SCI, V35, P487, DOI 10.1016/j.progpolymsci.2010.01.001
   Rengasamy S, 2013, PROG ORG COAT, V76, P78, DOI 10.1016/j.porgcoat.2012.08.012
   ROSCH J, 1993, POLYM BULL, V31, P679, DOI 10.1007/BF00300127
   Samuelsson J, 2004, J POLYM SCI POL CHEM, V42, P6346, DOI 10.1002/pola.20468
   Sharma BK, 2006, J AM OIL CHEM SOC, V83, P129, DOI 10.1007/s11746-006-1185-z
   Sharma BK, 2006, J AGR FOOD CHEM, V54, P9866, DOI 10.1021/jf061896f
   Sharma V, 2008, PROG POLYM SCI, V33, P1199, DOI 10.1016/j.progpolymsci.2008.07.004
   Sharmin E, 2007, EUR J LIPID SCI TECH, V109, P134, DOI 10.1002/ejlt.200600227
   Sharmin E, 2007, INT J BIOL MACROMOL, V40, P407, DOI 10.1016/j.ijbiomac.2006.10.002
   Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648
   Slivniak R, 2005, BIOMACROMOLECULES, V6, P1679, DOI 10.1021/bm049194r
   Slivniak R, 2005, MACROMOLECULES, V38, P5545, DOI 10.1021/ma0503918
   Stemmelen M, 2011, J POLYM SCI POL CHEM, V49, P2434, DOI 10.1002/pola.24674
   Sylvain C, 2012, EUR J LIPID SCI TECH, V114, P1447
   Teomim D, 1999, J BIOMED MATER RES, V45, P258, DOI 10.1002/(SICI)1097-4636(19990605)45:3<258::AID-JBM14>3.0.CO;2-W
   Tian QP, 2002, J AM OIL CHEM SOC, V79, P479, DOI 10.1007/s11746-002-0509-3
   Turunc O, 2010, MACROMOL RAPID COMM, V31, P1822, DOI 10.1002/marc.201000291
   van Beilen JB, 2007, ADV BIOCHEM ENG BIOT, V107, P133, DOI 10.1007/10_2007_056
   Vazquez B, 2002, J BIOMED MATER RES, V63, P88, DOI 10.1002/jbm.10092
   Wang CS, 2009, J APPL POLYM SCI, V114, P125, DOI 10.1002/app.30493
   Wang Z, 2012, MACROMOLECULES, V45, P9010, DOI 10.1021/ma301938a
   Warwel S, 2004, IND CROP PROD, V20, P301, DOI 10.1016/j.indcrop.2003.11.002
   Warwel S, 2001, CHEMOSPHERE, V43, P39, DOI 10.1016/S0045-6535(00)00322-2
   Warwel S, 1995, J MOL CATAL B-ENZYM, V1, P29, DOI 10.1016/1381-1177(95)00004-6
   Wool R. P., 2005, BIOBASED POLYM COMPO
   Xia Y, 2013, J RENEW MATER, V1, P3, DOI 10.7569/JRM.2012.634103
   Xia Y, 2010, GREEN CHEM, V12, P1893, DOI 10.1039/c0gc00264j
   Xu QY, 2010, BIORESOURCE TECHNOL, V101, P3711, DOI 10.1016/j.biortech.2009.12.093
   Zaikov G, 1999, INT J POLYM MATER, V44, P107
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
   Zhao HP, 2008, J APPL POLYM SCI, V110, P647, DOI 10.1002/app.28711
   Zlatanic A, 2004, J POLYM SCI POL PHYS, V42, P809, DOI 10.1002/polb.10737
NR 135
TC 153
Z9 162
U1 18
U2 250
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1692
EP 1704
DI 10.1016/j.actbio.2013.08.040
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700020
PM 24012607
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Miller, T
   Goude, MC
   McDevitt, TC
   Temenoff, JS
AF Miller, Tobias
   Goude, Melissa C.
   McDevitt, Todd C.
   Temenoff, Johnna S.
TI Molecular engineering of glycosaminoglycan chemistry for biomolecule
   delivery
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Glycosaminolgycan; Chemistry; Protein binding; Growth factor; Controlled
   release
ID FIBROBLAST-GROWTH-FACTOR; HYALURONIC-ACID HYDROGELS; CHONDROITIN
   SULFATE-E; CONJUGATED POLYMERIC MICELLE; BONE MORPHOGENETIC PROTEINS;
   MESENCHYMAL STEM-CELLS; HEPARIN-BASED HYDROGEL; CROSS-LINKED COLLAGEN;
   VESSEL WALL INJURY; DERMATAN SULFATE
AB Glycosaminoglycans (GAGs) are linear, negatively charged polysaccharides that interact with a variety of positively charged growth factors. In this review article the effects of engineering GAG chemistry for molecular delivery applications in regenerative medicine are presented. Three major areas of focus at the structure-function-property interface are discussed: (1) macromolecular properties of GAGs; (2) effects of chemical modifications on protein binding; (3) degradation mechanisms of GAGs. GAG-protein interactions can be based on: (1) GAG sulfation pattern; (2) GAG carbohydrate conformation; (3) GAG polyelectrolyte behavior. Chemical modifications of GAGs, which are commonly performed to engineer molecular delivery systems, affect protein binding and are highly dependent on the site of modification on the GAG molecules. The rate and mode of degradation can determine the release of molecules as well as the length of GAG fragments to which the cargo is electrostatically coupled and eventually released from the delivery system. Overall, GAG-based polymers are a versatile biomaterial platform offering novel means to engineer molecular delivery systems with a high degree of control in order to better treat a range of degenerated or injured tissues. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Miller, Tobias; Goude, Melissa C.; McDevitt, Todd C.; Temenoff, Johnna S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Miller, Tobias; Goude, Melissa C.; McDevitt, Todd C.; Temenoff, Johnna S.] Emory Univ, Atlanta, GA 30332 USA.
   [McDevitt, Todd C.; Temenoff, Johnna S.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
FU NIH [R01 AR062006]; NSF [DMR 1207045]
FX The authors were supported by funding from the NIH (R01 AR062006) and
   NSF (DMR 1207045).
CR Almond A, 2007, CELL MOL LIFE SCI, V64, P1591, DOI 10.1007/s00018-007-7032-z
   ARNOTT S, 1974, J MOL BIOL, V88, P175, DOI 10.1016/0022-2836(74)90303-9
   ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A
   Avci FY, 2003, CURR PHARM DESIGN, V9, P2323, DOI 10.2174/1381612033453929
   Bae KH, 2008, BIOMATERIALS, V29, P3376, DOI 10.1016/j.biomaterials.2008.04.035
   Baker JR, 2000, BIOCHEM J, V348, P465, DOI 10.1042/0264-6021:3480465
   Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311
   Bali JP, 2001, SEMIN ARTHRITIS RHEU, V31, P58, DOI 10.1053/sarh.2000.24874
   Banerji S, 2007, NAT STRUCT MOL BIOL, V14, P234, DOI 10.1038/nsmb1201
   BARZU T, 1989, J CELL PHYSIOL, V140, P538, DOI 10.1002/jcp.1041400320
   Baumann H, 1998, CARBOHYD RES, V308, P381, DOI 10.1016/S0008-6215(98)00097-4
   BENDAYAN P, 1994, THROMB HAEMOSTASIS, V71, P576
   Benoit DSW, 2005, ACTA BIOMATER, V1, P461, DOI 10.1016/j.actbio.2005.03.002
   BIENKOWSKI MJ, 1985, J BIOL CHEM, V260, P356
   BIENKOWSKI MJ, 1985, SEMIN THROMB HEMOST, V11, P86, DOI 10.1055/s-2007-1004363
   BOEYENS JCA, 1978, J CRYST MOL STRUCT, V8, P317, DOI 10.1007/BF01200485
   Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109
   Capila I., 2002, ANGEW CHEM INT EDIT, V1, 3, p[41, 390], DOI DOI 10.1002/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.C0;2-B
   Casu B, 2002, SEMIN THROMB HEMOST, V28, P335, DOI 10.1055/s-2002-34302
   Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1
   Chen AL, 2008, BIOMACROMOLECULES, V9, P2447, DOI 10.1021/bm800485x
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Chu HH, 2011, P NATL ACAD SCI USA, V108, P13444, DOI 10.1073/pnas.1110121108
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   DANISHEFSKY I, 1972, THROMB RES, V1, P173
   Das SK, 2001, CHEM-EUR J, V7, P4821
   Das SK, 2001, ANGEW CHEM INT EDIT, V40, P1670, DOI 10.1002/1521-3773(20010504)40:9<1670::AID-ANIE16700>3.3.CO;2-H
   Deepa SS, 2002, J BIOL CHEM, V277, P43707, DOI 10.1074/jbc.M207105200
   DIANCOURT F, 1994, J BIOACT COMPAT POL, V9, P267, DOI 10.1177/088391159400900303
   DOL F, 1990, J LAB CLIN MED, V115, P43
   Dudhia J, 2005, CELL MOL LIFE SCI, V62, P2241, DOI 10.1007/s00018-005-5217-x
   EDWARDS HE, 1977, INT J RADIAT BIOL, V32, P351, DOI 10.1080/09553007714551101
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490
   Esko J.D., 2009, ESSENTIALS GLYCOBIOL
   FERNANDEZ F, 1986, BRIT J HAEMATOL, V64, P309, DOI 10.1111/j.1365-2141.1986.tb04124.x
   Fransson LA, 1993, DERMATAN SULPHATE PR, P11
   Fryer A, 1997, J PHARMACOL EXP THER, V282, P208
   Funderburgh JL, 2000, GLYCOBIOLOGY, V10, P951, DOI 10.1093/glycob/10.10.951
   Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI200113713
   GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V
   Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810
   Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x
   Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x
   Guglieri S, 2008, BIOCHEMISTRY-US, V47, P13862, DOI 10.1021/bi801007p
   Hay E. D., 1981, J CELL BIOL, V91, p205s
   Hennan JK, 2002, J PHARMACOL EXP THER, V301, P1151, DOI 10.1124/jpet.301.3.1151
   Herrera AJ, 2007, CARBOHYD RES, V342, P1876, DOI 10.1016/j.carres.2007.02.025
   Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#
   Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   HIRANO S, 1975, CONNECT TISSUE RES, V3, P73, DOI 10.3109/03008207509152343
   Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686
   Hong TT, 2006, THROMB RES, V117, P333, DOI 10.1016/j.thromres.2005.03.018
   HOOK M, 1984, ANNU REV BIOCHEM, V53, P847
   HOPWOOD JJ, 1973, BIOCHEM J, V135, P631, DOI 10.1042/bj1350631
   Hricovini M, 2002, SEMIN THROMB HEMOST, V28, P325, DOI 10.1055/s-2002-34301
   Huckerby TN, 1998, EUR J BIOCHEM, V253, P499, DOI 10.1046/j.1432-1327.1998.2530499.x
   Huckerby TN, 2002, PROG NUCL MAG RES SP, V40, P35, DOI 10.1016/S0079-6565(01)00040-1
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   Huskisson EC, 2008, J INT MED RES, V36, P1161, DOI 10.1177/147323000803600602
   Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019
   INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8
   ISHIHARA M, 1994, GLYCOBIOLOGY, V4, P817, DOI 10.1093/glycob/4.6.817
   Iwaki J, 2008, BIOCHEM BIOPH RES CO, V373, P206, DOI 10.1016/j.bbrc.2008.05.190
   JASEJA M, 1989, CAN J CHEM, V67, P1449, DOI 10.1139/v89-221
   Jensen M, 2002, EUR J PHARM SCI, V15, P139, DOI 10.1016/S0928-0987(01)00193-2
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Jeon O, 2011, J CONTROL RELEASE, V154, P258, DOI 10.1016/j.jconrel.2011.06.027
   KANTOR TG, 1957, J AM CHEM SOC, V79, P152, DOI 10.1021/ja01558a040
   Kim M, 2010, TISSUE ENG PART C-ME, V16, P1, DOI [10.1089/ten.tec.2008.0548, 10.1089/ten.TEC.2008.0548]
   Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z
   Kobayashi M, 1999, J BIOL CHEM, V274, P10474, DOI 10.1074/jbc.274.15.10474
   Kock L, 2012, CELL TISSUE RES, V347, P613, DOI 10.1007/s00441-011-1243-1
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kuo WJ, 2010, MOL BIOL CELL, V21, P4028, DOI 10.1091/mbc.E10-04-0348
   Lallam-Laroye C, 2006, J BIOMED MATER RES A, V79A, P675, DOI 10.1002/jbm.a.30880
   Lee JS, 2008, INT J PHARM, V346, P57, DOI 10.1016/j.ijpharm.2007.06.025
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Liberda J, 1997, BIOTECHNOL TECH, V11, P265, DOI 10.1023/A:1018446723616
   Lim JJ, 2011, ACTA BIOMATER, V7, P986, DOI 10.1016/j.actbio.2010.10.009
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135
   Loo BM, 2001, J BIOL CHEM, V276, P16868, DOI 10.1074/jbc.M011226200
   Lundin L, 2000, J BIOL CHEM, V275, P24653, DOI 10.1074/jbc.M908930199
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   LYONS H, 1971, J BIOL CHEM, V246, P277
   Maaroufi RM, 2007, THROMB RES, V120, P615, DOI 10.1016/j.thromres.2006.10.023
   MACCARANA M, 1993, J BIOL CHEM, V268, P23898
   Malavaki C, 2008, CONNECT TISSUE RES, V49, P133, DOI 10.1080/03008200802148546
   MALMSTROM A, 1981, BIOCHEM J, V198, P669, DOI 10.1042/bj1980669
   Malmstrom A, 2012, J HISTOCHEM CYTOCHEM, V60, P916, DOI 10.1369/0022155412459857
   Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X
   McNaught AD, 2008, GLYCOSCIENCE, P2727
   Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455
   MEYER K, 1953, J BIOL CHEM, V205, P611
   Miljkovic ND, 2008, OSTEOARTHR CARTILAGE, V16, P1121, DOI 10.1016/j.joca.2008.03.003
   Miyazaki T, 2008, J CELL PHYSIOL, V217, P769, DOI 10.1002/jcp.21557
   Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156
   Mobli M, 2008, GLYCOCONJUGATE J, V25, P401, DOI 10.1007/s10719-007-9081-9
   Mori H, 2005, J BIOSCI BIOENG, V100, P54, DOI 10.1263/jbb.100.54
   Moy FJ, 1997, BIOCHEMISTRY-US, V36, P4782, DOI 10.1021/bi9625455
   Mulloy B, 2012, PURE APPL CHEM, V84, P65, DOI 10.1351/PAC-CON-11-10-27
   Nader HB, 1999, BRAZ J MED BIOL RES, V32, P529, DOI 10.1590/S0100-879X1999000500005
   NAGASAWA K, 1979, J BIOCHEM-TOKYO, V86, P1323, DOI 10.1093/oxfordjournals.jbchem.a132648
   NAGASAWA K, 1986, CARBOHYD RES, V158, P183, DOI 10.1016/0008-6215(86)84016-2
   NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3
   NAGASAWA K, 1992, CARBOHYD RES, V236, P165, DOI 10.1016/0008-6215(92)85014-Q
   Naggi A, 2005, J BIOL CHEM, V280, P12103, DOI 10.1074/jbc.M414217200
   Nilasaroya A, 2012, BIOMATERIALS, V33, P5534, DOI 10.1016/j.biomaterials.2012.04.022
   O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200
   OFOSU FA, 1987, BIOCHEM J, V248, P889, DOI 10.1042/bj2480889
   OGAMO A, 1989, CARBOHYD RES, V193, P165, DOI 10.1016/0008-6215(89)85116-X
   Oprea AM, 2012, CARBOHYD POLYM, V90, P127, DOI 10.1016/j.carbpol.2012.05.004
   Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2
   Pap T, 2013, NAT REV RHEUMATOL, V9, P43, DOI 10.1038/nrrheum.2012.178
   Park K, 2006, J CONTROL RELEASE, V114, P300, DOI 10.1016/j.jconrel.2006.05.017
   Parkinson RJ, 2006, NEUROSURGERY, V59, P812, DOI 10.1227/01.NEU.0000232836.66310.46
   PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257
   Penc SF, 1998, J BIOL CHEM, V273, P28116, DOI 10.1074/jbc.273.43.28116
   Pikas DS, 1998, J BIOL CHEM, V273, P18770, DOI 10.1074/jbc.273.30.18770
   Pogany P, 2009, CARBOHYD RES, V344, P1745, DOI 10.1016/j.carres.2009.05.030
   Ponedel'kina IY, 2006, RUSS J BIOORG CHEM+, V32, P472, DOI 10.1134/S1068162006050104
   PURKERSON ML, 1988, J CLIN INVEST, V81, P69, DOI 10.1172/JCI113312
   Purushothaman A, 2012, J BIOL CHEM, V287, P2935, DOI 10.1074/jbc.R111.298430
   Quantock AJ, 2010, CELL MOL LIFE SCI, V67, P891, DOI 10.1007/s00018-009-0228-7
   Radek KA, 2009, WOUND REPAIR REGEN, V17, P118, DOI 10.1111/j.1524-475X.2008.00449.x
   RAPRAEGER A, 1985, J BIOL CHEM, V260, P1046
   Reis AV, 2011, J APPL POLYM SCI, V121, P2726, DOI 10.1002/app.33705
   Reis AV, 2009, J ORG CHEM, V74, P3750, DOI 10.1021/jo900033c
   Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200
   Rickard SM, 2003, GLYCOBIOLOGY, V13, P419, DOI 10.1093/glycob/cwg046
   Robert L, 2010, PATHOL BIOL, V58, P187, DOI 10.1016/j.patbio.2009.09.010
   ROBERT L, 1986, ANN BIOL CLIN-PARIS, V44, P145
   ROBERTS CR, 1987, BIOCHEM J, V247, P349, DOI 10.1042/bj2470349
   ROBYT JF, 1998, ESSENTIALS CARBOHYDR
   Rodriguez E, 2006, J BIOL CHEM, V281, P18444, DOI 10.1074/jbc.M51231200
   Roughley PJ, 2006, EUR SPINE J, V15, pS326, DOI 10.1007/s00586-006-0127-7
   Rudd TR, 2008, J AM CHEM SOC, V130, P2138, DOI 10.1021/ja077675n
   Ruhaak LR, 2010, ANAL BIOANAL CHEM, V397, P3457, DOI 10.1007/s00216-010-3532-z
   Rullo A, 2010, BIOPOLYMERS, V93, P290, DOI 10.1002/bip.21339
   Sattelle BM, 2013, BIOMACROMOLECULES, V14, P1149, DOI [10.1021/bm400067g, 10.1021/bm4000679g]
   Sattelle BM, 2010, J COMPUT CHEM, V31, P2932, DOI 10.1002/jcc.21589
   Sattelle BM, 2010, CARBOHYD RES, V345, P291, DOI 10.1016/j.carres.2009.11.013
   SCHMUT O, 1994, OPHTHALMIC RES, V26, P340, DOI 10.1159/000267499
   Schwartz NB, 1996, PERSPECT DEV NEUROBI, V3, P291
   Scott JE, 2001, PATHOL BIOL, V49, P284, DOI 10.1016/S0369-8114(01)00152-3
   SCOTT JE, 1995, BIOCHEMISTRY-US, V34, P15467, DOI 10.1021/bi00047a011
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Seto SP, 2012, CELL TISSUE RES, V347, P589, DOI 10.1007/s00441-011-1265-8
   Seyrek E, 2010, ADV COLLOID INTERFAC, V158, P119, DOI 10.1016/j.cis.2010.03.001
   SHAKLEE PN, 1984, BIOCHEM J, V217, P187, DOI 10.1042/bj2170187
   SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005
   Smith RAA, 2011, BIOCHEM SOC T, V39, P383, DOI 10.1042/BST0390383
   SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9
   Stick RV, 2009, CARBOHYDRATES: THE ESSENTIAL MOLECULES OF LIFE, 2ND EDITION, P1
   Sugahara K, 2007, CURR OPIN STRUC BIOL, V17, P536, DOI 10.1016/j.sbi.2007.08.015
   Tae G, 2007, BIOMACROMOLECULES, V8, P1979, DOI 10.1021/bm0701189
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   TANFORD C, 1964, J BIOL CHEM, V239, P4034
   Taylor KR, 2005, J BIOL CHEM, V280, P5300, DOI 10.1074/jbc.m410412200
   Testa G, 2009, INT J PHARMACEUT, V378, P86, DOI 10.1016/j.ijpharm.2009.05.051
   Toida T, 2009, CARBOHYD RES, V344, P888, DOI 10.1016/j.carres.2009.02.010
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Tsurkan MV, 2010, MACROMOL RAPID COMM, V31, P1529, DOI 10.1002/marc.201000155
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   URBAN JPG, 1979, BIORHEOLOGY, V16, P447
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057
   VOLKIN DB, 1993, ARCH BIOCHEM BIOPHYS, V300, P30, DOI 10.1006/abbi.1993.1005
   Vongchan P, 2005, BBA-GEN SUBJECTS, V1721, P1, DOI 10.1016/j.bbagen.2004.09.007
   Wang SC, 2007, INT J PHARM, V329, P103, DOI 10.1016/j.ijpharm.2006.08.041
   Wei Z, 2011, GLYCOCONJUGATE J, V28, P525, DOI 10.1007/s10719-011-9352-3
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200
   Xiao ZP, 2011, J MED CHEM, V54, P603, DOI 10.1021/jm101381k
   Xu RY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.398826
   Yong LCJ, 1997, EXP TOXICOL PATHOL, V49, P409, DOI 10.1016/S0940-2993(97)80129-7
   Yu F, 2007, J AM CHEM SOC, V129, P13288, DOI 10.1021/ja075272h
   Yung S, 2007, PERITON DIALYSIS INT, V27, pS104
   Zamfir A, 2003, GLYCOBIOLOGY, V13, P733, DOI 10.1093/glycob/cwg086
NR 188
TC 31
Z9 31
U1 4
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1705
EP 1719
DI 10.1016/j.actbio.2013.09.039
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700021
PM 24121191
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bryksin, AV
   Brown, AC
   Baksh, MM
   Finn, MG
   Barker, TH
AF Bryksin, Anton V.
   Brown, Ashley C.
   Baksh, Michael M.
   Finn, M. G.
   Barker, Thomas H.
TI Learning from nature - Novel synthetic biology approaches for
   biomaterial design
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Synthetic biology; Biomaterials; Directed evolution; Tissue engineering;
   Virus particles
ID TOBACCO-MOSAIC-VIRUS; IMPRINTED POLYMER NANOPARTICLES; SENSITIZED
   SOLAR-CELLS; M13 THIN-FILMS; EXTRACELLULAR-MATRIX; BUILDING-BLOCKS;
   CROSS-LINKING; SUPRAMOLECULAR STRUCTURES; REGENERATIVE MEDICINE;
   DIRECTED SYNTHESIS
AB Many biomaterials constructed today are complex chemical structures that incorporate biologically active components derived from nature, but the field can still be said to be in its infancy. The need for materials that bring sophisticated properties of structure, dynamics and function to medical and nonmedical applications will only grow. Increasing appreciation of the functionality of biological systems has caused biomaterials researchers to consider nature for design inspiration, and many examples exist of the use of biomolecular motifs. Yet evolution, nature's only engine for the creation of new designs, has been largely ignored by the biomaterials community. Molecular evolution is an emerging tool that enables one to apply nature's engineering principles to non-natural situations using variation and selection. The purpose of this review is to highlight the most recent advances in the use of molecular evolution in synthetic biology applications for biomaterial engineering, and to discuss some of the areas in which this approach may be successfully applied in the future.(c) 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Bryksin, Anton V.; Brown, Ashley C.; Barker, Thomas H.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Bryksin, Anton V.; Brown, Ashley C.; Barker, Thomas H.] Emory Univ, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Baksh, Michael M.; Finn, M. G.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   [Brown, Ashley C.; Baksh, Michael M.; Finn, M. G.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.
RP Barker, TH (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM thomas.barker@bme.gatech.edu
FU NIH [R21EB013743, R01EB011566, R21EB015663]; Georgia Tech Center for
   Bioengineering for Soldier Survivability Seed Grant (DoD)
   [W81XWH1110306]; American Heart Association Postdoctoral Fellowship
FX This work was funded in part by the NIH (R21EB013743, R01EB011566,
   R21EB015663), the Georgia Tech Center for Bioengineering for Soldier
   Survivability Seed Grant (DoD, W81XWH1110306), and an American Heart
   Association Postdoctoral Fellowship to ACB.
CR Adamcik J, 2012, MACROMOLECULES, V45, P1137, DOI 10.1021/ma202157h
   ALAKOKKO L, 1991, J BIOL CHEM, V266, P14175
   Arnold FH, 2003, DIRECTED EVOLUTION L
   Azucena C, 2012, LANGMUIR, V28, P14867, DOI 10.1021/la302774h
   Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868
   Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Banta S, 2010, ANNU REV BIOMED ENG, V12, P167, DOI 10.1146/annurev-bioeng-070909-105334
   Barish RD, 2009, P NATL ACAD SCI USA, V106, P6054, DOI 10.1073/pnas.0808736106
   Barker TH, 2011, BIOMATERIALS, V32, P4211, DOI 10.1016/j.biomaterials.2011.02.027
   Best JP, 2013, LANGMUIR, V29, P9824, DOI 10.1021/la402146t
   Brown AC, 2011, TISSUE ENG PT A, V17, P139, DOI [10.1089/ten.tea.2010.0199, 10.1089/ten.TEA.2010.0199]
   Bundy BC, 2011, J BIOTECHNOL, V154, P230, DOI 10.1016/j.jbiotec.2011.04.011
   Carson AE, 2009, REGEN MED, V4, P593, DOI 10.2217/RME.09.30
   Chaisri P, 2013, BIOTECHNOL J, V8, P1323, DOI 10.1002/biot.201300191
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen PY, 2013, ACS NANO, V7, P6563, DOI 10.1021/nn4014164
   Chen PY, 2013, J MATER CHEM A, V1, P2217, DOI 10.1039/c2ta00771a
   Chung BG, 2007, EXPERT OPIN DRUG DIS, V2, P1653, DOI 10.1517/17460441.2.12.1653
   Chung WJ, 2011, NATURE, V478, P364, DOI 10.1038/nature10513
   Collier JH, 2011, BIOMATERIALS, V32, P4198, DOI 10.1016/j.biomaterials.2011.02.030
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Datta B, 2008, J AM CHEM SOC, V130, P2965, DOI 10.1021/ja0726106
   DiMarco RL, 2012, ADV MATER, V24, P3923, DOI 10.1002/adma.201200051
   Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Faramarzi MA, 2013, ADV COLLOID INTERFAC, V189, P1, DOI 10.1016/j.cis.2012.12.001
   FRAENKELCONRAT H, 1955, P NATL ACAD SCI USA, V41, P690, DOI 10.1073/pnas.41.10.690
   Freer AS, 2013, J COLLOID INTERF SCI, V392, P213, DOI 10.1016/j.jcis.2012.09.072
   Gartner ZJ, 2004, SCIENCE, V305, P1601, DOI 10.1126/science.1102629
   Gasiorowski JZ, 2011, BIOMACROMOLECULES, V12, P3549, DOI 10.1021/bm200763y
   Goldsmith M, 2013, METHOD ENZYMOL, V523, P257, DOI 10.1016/B978-0-12-394292-0.00012-6
   Grayson WL, 2010, P NATL ACAD SCI USA, V107, P3299, DOI 10.1073/pnas.0905439106
   Grelet E, 2011, LANGMUIR, V27, P4334, DOI 10.1021/la200743n
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   He JB, 2009, LANGMUIR, V25, P4979, DOI 10.1021/la803533n
   Henry AA, 2005, CURR OPIN BIOTECH, V16, P370, DOI 10.1016/j.copbio.2005.06.008
   Hoshino Y, 2012, P NATL ACAD SCI USA, V109, P33, DOI 10.1073/pnas.1112828109
   Hoshino Y, 2011, J MATER CHEM, V21, P3517, DOI 10.1039/c0jm03122d
   Hoshino Y, 2010, J AM CHEM SOC, V132, P6644, DOI 10.1021/ja102148f
   Hoshino Y, 2008, J AM CHEM SOC, V130, P15242, DOI 10.1021/ja8062875
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606
   Huang X, 2010, ANN BIOMED ENG, V38, P1965, DOI 10.1007/s10439-010-9986-5
   INDIK Z, 1990, ARCH BIOCHEM BIOPHYS, V280, P80, DOI 10.1016/0003-9861(90)90521-Y
   Ivanovska IL, 2011, P NATL ACAD SCI USA, V108, P12611, DOI 10.1073/pnas.1105586108
   Ji YS, 2009, ANAL BIOANAL CHEM, V395, P1125, DOI 10.1007/s00216-009-3020-5
   Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809
   Khan AA, 2013, LANGMUIR, V29, P2094, DOI 10.1021/la3044126
   Kim TG, 2006, TISSUE ENG, V12, P221, DOI 10.1089/ten.2006.12.221
   Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600
   Korkmaz N, 2013, MACROMOL BIOSCI, V13, P376, DOI 10.1002/mabi.201200290
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee SY, 2012, BIOTECHNOL BIOENG, V109, P16, DOI 10.1002/bit.23328
   Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054
   Leitzel JC, 2001, CHEM REC, V1, P53
   Li T, 2013, ANGEW CHEM INT EDIT, V52, P6638, DOI 10.1002/anie.201209299
   Li Xiaoyu, 2002, Journal of the American Chemical Society, V124, P746, DOI 10.1021/ja017319j
   Li Y, 2006, ANAL CHEM, V78, P317, DOI 10.1021/ac050802i
   Lin Y, 2010, ANGEW CHEM INT EDIT, V49, P868, DOI 10.1002/anie.200904993
   Liu Z, 2012, CHEM SOC REV, V41, P6178, DOI 10.1039/c2cs35108k
   Maeda Y, 2012, SOFT MATTER, V8, P7533, DOI 10.1039/c2sm25352f
   Mallick Kajal K, 2013, Front Biosci (Elite Ed), V5, P341
   Manzenrieder F, 2011, ANGEW CHEM INT EDIT, V50, P2601, DOI 10.1002/anie.201006134
   Mao CB, 2004, SCIENCE, V303, P213, DOI 10.1126/science.1092740
   Markowski MC, 2012, J BIOMED MATER RES A, V100A, P2119, DOI 10.1002/jbm.a.34068
   Martino M. M., 2011, SCI TRANSL MED, V3, DOI DOI 10.1126/SCITRANSLMED.3002614
   McKee ML, 2012, J AM CHEM SOC, V134, P1446, DOI 10.1021/ja2101196
   Mukhatyar VJ, 2011, BIOMATERIALS, V32, P3958, DOI 10.1016/j.biomaterials.2011.02.015
   Murugesan M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01820
   Nam KT, 2008, ACS NANO, V2, P1480, DOI 10.1021/nn800018n
   NIELSEN LE, 1969, J MACROMOL SCI-REV M, VC  3, P69, DOI 10.1080/15583726908545897
   Nishino H, 2006, ANGEW CHEM INT EDIT, V45, P2392, DOI 10.1002/anie.200503760
   Niu J, 2013, NAT CHEM, V5, P282, DOI [10.1038/NCHEM.1577, 10.1038/nchem.1577]
   Okada H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037035
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Patil AJ, 2013, NANOSCALE, V5, P7161, DOI 10.1039/c3nr02796a
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Poma A, 2013, ADV FUNCT MATER, V23, P2821, DOI 10.1002/adfm.201202397
   Poma A, 2010, TRENDS BIOTECHNOL, V28, P629, DOI 10.1016/j.tibtech.2010.08.006
   Quint C, 2011, P NATL ACAD SCI USA, V108, P9214, DOI 10.1073/pnas.1019506108
   Ravichandran Rajeswari, 2009, World J Stem Cells, V1, P55, DOI 10.4252/wjsc.v1.i1.55
   Rego JM, 2013, BIOTECHNOL J, V8, P237, DOI 10.1002/biot.201100504
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   ROBERTSON DE, 2004, PROTEIN ENG
   Rong JH, 2008, CHEM COMMUN, P5185, DOI 10.1039/b811039e
   Ruff AJ, 2013, FEBS J, V280, P2961, DOI 10.1111/febs.12325
   Ruff Y, 2013, J AM CHEM SOC, V135, P6211, DOI 10.1021/ja4008003
   Russell JT, 2005, ANGEW CHEM INT EDIT, V44, P2420, DOI 10.1002/anie.200462653
   Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v
   Sidhu SS, 2003, CURR OPIN CHEM BIOL, V7, P97, DOI 10.1016/S1367-5931(02)00011-x
   Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07
   Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d
   Soon ASC, 2013, ADV HEALTHC MATER, V2, P1045, DOI 10.1002/adhm.201200330
   Stabenfeldt SE, 2012, BIOMATERIALS, V33, P535, DOI 10.1016/j.biomaterials.2011.09.079
   Storhoff JJ, 1999, CHEM REV, V99, P1849, DOI 10.1021/cr970071p
   Straley K, 2009, IEEE ENG MED BIO, P2101, DOI 10.1109/IEMBS.2009.5334310
   Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987
   Tseng RJ, 2006, NAT NANOTECHNOL, V1, P72, DOI 10.1038/nnano.2006.55
   TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121
   Turiel E, 2010, ANAL CHIM ACTA, V668, P87, DOI 10.1016/j.aca.2010.04.019
   Ura Y, 2009, SCIENCE, V325, P73, DOI 10.1126/science.1174577
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Wang GC, 2013, P NATL ACAD SCI USA, V110, P7619, DOI 10.1073/pnas.1300233110
   Wang JL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01242
   Wang PY, 2013, COLLOID SURFACE B, V110, P88, DOI 10.1016/j.colsurfb.2013.04.016
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Wojtowicz AM, 2010, BIOMATERIALS, V31, P2574, DOI 10.1016/j.biomaterials.2009.12.008
   Wu LY, 2011, LANGMUIR, V27, P9490, DOI 10.1021/la201580v
   Wu LQ, 2004, TRENDS BIOTECHNOL, V22, P593, DOI 10.1016/j.tibtech.2004.09.008
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yoo PJ, 2008, ACS NANO, V2, P561, DOI 10.1021/nn700404y
   Zan XJ, 2013, ACS NANO, V7, P8385, DOI 10.1021/nn403908k
   Zeng ZY, 2010, ACS NANO, V4, P199, DOI [10.1021/nn9011256s, 10.1021/nn901256s]
   Zhou K, 2013, BIOMACROMOLECULES, V14, P2593, DOI 10.1021/bm400445m
   Zimmerman SC, 2002, NATURE, V418, P399, DOI 10.1038/nature00877
   Zlotnick A, 2013, BIOPHYS J, V104, P1595, DOI 10.1016/j.bpj.2013.02.005
NR 124
TC 17
Z9 18
U1 3
U2 131
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2014
VL 10
IS 4
BP 1761
EP 1769
DI 10.1016/j.actbio.2014.01.019
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE6WC
UT WOS:000334137700026
PM 24463066
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Brus, VV
   Pidkamin, LJ
   Ilashchuk, MI
   Maryanchuk, PD
AF Brus, Viktor V.
   Pidkamin, Leonid J.
   Ilashchuk, Maria I.
   Maryanchuk, Pavlo D.
TI 11th International Conference " Correlation Optics": Propolis films for
   hybrid biomaterial-inorganic electronics and optoelectronics
SO APPLIED OPTICS
LA English
DT Article
ID ORGANIC SEMICONDUCTORS; SOLAR-CELLS; ELECTRICAL-PROPERTIES; BIOLOGICAL
   TISSUES; BIOELECTRONICS; HETEROJUNCTIONS; TRANSISTORS; ANISOTROPY;
   TRANSPORT; CDTE
AB We report on the analysis of optical, polarimetric, and electrical properties of propolis films and hybrid biomaterial- inorganic heterojunctions based on them. It was shown that the material of the propolis films belongs to wide- bandgap optically active substances with the light- scattering centers, which possess complex optical properties. The values of the specific resistance.rho(P) - 1.9 center dot 10(7) Omega center dot cm and dielectric constant epsilon P - 19.5 of the propolis film were determined from the spectral distribution of the real and imaginary components of its impedance at room temperature, respectively. The dominating current transport mechanisms through the hybrid bioinorganic heterojunction propolis/ p- CdTe were established to be the interface- states- assisted generation- recombination within the depletion region via deep energy levels at forward bias as well as the leakage current through the shunt resistance at reverse bias. (C) 2014 Optical Society of America
C1 [Brus, Viktor V.; Ilashchuk, Maria I.; Maryanchuk, Pavlo D.] Chernivtsi Natl Univ, Dept Elect & Energy Engn, UA-58012 Chernovtsy, Ukraine.
   [Pidkamin, Leonid J.] Chernivtsi Natl Univ, Dept Opt & Spect, UA-58012 Chernovtsy, Ukraine.
RP Brus, VV (reprint author), Chernivtsi Natl Univ, Dept Elect & Energy Engn, Kotsubinsky Str 2, UA-58012 Chernovtsy, Ukraine.
EM v.brus@chnu.edu.ua
RI Brus, Viktor/D-5739-2016; Ilashchuk, Mariya/R-8075-2016; CENAPAD-SP,
   CENAPAD/J-2963-2017; Maryanchuk, Pavlo/D-3996-2016
OI Brus, Viktor/0000-0002-8839-124X; Ilashchuk, Mariya/0000-0002-7618-0437;
   Maryanchuk, Pavlo/0000-0002-5523-4280; Maryanchuk,
   Pavlo/0000-0002-0360-8447
CR Angelsky O. V., 2002, OPTICA APPL, V32, P603
   Angelsky OV, 2002, OPT APPL, V32, P591
   Arkhelyuk A., 2003, P SOC PHOTO-OPT INS, V5227, P219
   Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029
   Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419
   Botushanov P I, 2001, Folia Med (Plovdiv), V43, P28
   Bratter C, 1999, FORSCH KOMPLEMENTMED, V6, P256, DOI 10.1159/000021260
   Brown AR, 1997, SYNTHETIC MET, V88, P37, DOI 10.1016/S0379-6779(97)80881-8
   Brus VV, 2013, ORG ELECTRON, V14, P3109, DOI 10.1016/j.orgel.2013.07.021
   Brus VV, 2012, OPT MATER, V34, P1940, DOI 10.1016/j.optmat.2012.06.007
   Brus VV, 2012, SEMICONDUCTORS+, V46, P1152, DOI 10.1134/S1063782612090059
   Brus VV, 2012, SEMICONDUCTORS+, V46, P1012, DOI 10.1134/S1063782612080040
   Brus VV, 2012, SEMICOND SCI TECH, V27, DOI 10.1088/0268-1242/27/3/035024
   Brus VV, 2011, SEMICOND SCI TECH, V26, DOI 10.1088/0268-1242/26/12/125006
   Brus V. V., 2013, SEMICOND SCI TECH, V28
   Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376
   Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x
   Crone B, 2001, APPL PHYS LETT, V78, P2229, DOI 10.1063/1.1360785
   Davis JJ, 2005, J MATER CHEM, V15, P2160, DOI 10.1039/b417712f
   Drapak SI, 2006, APPL SURF SCI, V253, P279, DOI 10.1016/j.apsusc.2006.05.092
   Drapak SI, 2005, J OPTOELECTRON ADV M, V7, P801
   Drapak SI, 2004, TECH PHYS+, V49, P1529, DOI 10.1134/1.1826206
   GARNIER F, 1993, J AM CHEM SOC, V115, P8716, DOI 10.1021/ja00072a026
   Gerrard A., 1975, INTRO MATRIX METHODS
   Gorley PM, 2008, PHYS STATUS SOLIDI C, V5, P3622, DOI 10.1002/pssc.200780149
   Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z
   Kheiri F, 2011, BIOSENS BIOELECTRON, V26, P4457, DOI 10.1016/j.bios.2011.05.002
   Kyaw AKK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3039076
   Orsi R. O., 2005, J. Venom. Anim. Toxins incl. Trop. Dis, V11, P109, DOI 10.1590/S1678-91992005000200003
   Stakhira P, 2010, THIN SOLID FILMS, V518, P7016, DOI 10.1016/j.tsf.2010.06.051
   Sze S. M., 2007, PHYS SEMICONDUCTOR D
   TOMASBARBERAN FA, 1993, PHYTOCHEMISTRY, V34, P191, DOI 10.1016/S0031-9422(00)90804-5
   Ushenko YA, 2011, OPT SPECTROSC+, V110, P814, DOI 10.1134/S0030400X11050195
   Ushenko YA, 2011, QUANTUM ELECTRON+, V41, P170, DOI 10.1070/QE2011v041n02ABEH014215
   Willner I, 2007, BIOSENS BIOELECTRON, V22, P1841, DOI 10.1016/j.bios.2006.09.018
   Wright M, 2012, SOL ENERG MAT SOL C, V107, P87, DOI 10.1016/j.solmat.2012.07.006
NR 36
TC 7
Z9 7
U1 1
U2 3
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1559-128X
EI 2155-3165
J9 APPL OPTICS
JI Appl. Optics
PD APR 1
PY 2014
VL 53
IS 10
BP B121
EP B127
DI 10.1364/AO.53.00B121
PG 7
WC Optics
SC Optics
GA AE6QC
UT WOS:000334117600018
PM 24787194
DA 2018-10-19
ER

PT J
AU Lu, W
   Ji, K
   Kirkham, J
   Yan, Y
   Boccaccini, AR
   Kellett, M
   Jin, Y
   Yang, XBB
AF Lu, Wei
   Ji, Kun
   Kirkham, Jennifer
   Yan, Yu
   Boccaccini, Aldo R.
   Kellett, Margaret
   Jin, Yan
   Yang, Xuebin B.
TI Bone tissue engineering by using a combination of polymer/Bioglass
   composites with human adipose-derived stem cells
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE Bone tissue engineering; Adipose-derived stem cells; PDLLA/Bioglass (R)
   composite; Biodegradable polymers; In vivo
ID MARROW STROMAL CELLS; BIOGLASS(R)-FILLED POLYLACTIDE FOAMS; IN-VITRO
   CHARACTERIZATION; OSTEOBLAST-LIKE CELLS; BIOACTIVE GLASS; OSTEOGENIC
   DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES;
   SCAFFOLDS; VIVO
AB Translational research in bone tissue engineering is essential for "bench to bedside" patient benefit. However, the ideal combination of stem cells and biomaterial scaffolds for bone repair/regeneration is still unclear. The aim of this study is to investigate the osteogenic capacity of a combination of poly(DL-lactic acid) (PDLLA) porous foams containing 5 wt% and 40 wt% of Bioglass particles with human adipose-derived stem cells (ADSCs) in vitro and in vivo. Live/dead fluorescent markers, confocal microscopy and scanning electron microscopy showed that PDLLA/Bioglass porous scaffolds supported ADSC attachment, growth and osteogenic differentiation, as confirmed by enhanced alkaline phosphatase (ALP) activity. Higher Bioglass content of the PDLLA foams increased ALP activity compared with the PDLLA only group. Extracellular matrix deposition after 8 weeks in the in vitro cultures was evident by Alcian blue/Sirius red staining. In vivo bone formation was assessed by using scaffold/ADSC constructs in diffusion chambers transplanted intraperitoneally into nude mice and recovered after 8 weeks. Histological and immunohistochemical assays indicated significant new bone formation in the 40 wt% and 5 wt% Bioglass constructs compared with the PDLLA only group. Thus, the combination of a well-developed biodegradable bioactive porous PDLLA/Bioglass composite scaffold with a high-potential stem cell source (human ADSCs) could be a promising approach for bone regeneration in a clinical setting.
C1 [Lu, Wei; Ji, Kun; Jin, Yan] Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Lu, Wei; Yang, Xuebin B.] Univ Leeds, Leeds Dent Inst, Dept Oral Biol, Biomat & Tissue Engn Grp, Leeds LS2 9LU, W Yorkshire, England.
   [Lu, Wei] PLA, Dept Dent, Hosp 461, Changchun 130021, Jilin, Peoples R China.
   [Ji, Kun] Fourth Mil Med Univ, Dept Pediat Dent, Sch Stomatol, Xian 710032, Shaanxi, Peoples R China.
   [Kirkham, Jennifer] Univ Leeds, Leeds Dent Inst, Biomineralizat Grp, Leeds LS2 9LU, W Yorkshire, England.
   [Kirkham, Jennifer; Yang, Xuebin B.] Chapel Allerton Hosp, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England.
   [Yan, Yu] Univ Sci & Technol Beijing, Ctr Corros & Protect, Key Lab Environm Fracture MOE, Beijing 100083, Peoples R China.
   [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, D-91058 Erlangen, Germany.
   [Kellett, Margaret] Univ Leeds, Leeds Dent Inst, Dept Periodontol, Leeds LS2 9LU, W Yorkshire, England.
RP Jin, Y (reprint author), Fourth Mil Med Univ, Res & Dev Ctr Tissue Engn, Sch Stomatol, 145 West Changle Rd, Xian 710032, Shaanxi, Peoples R China.
EM yanjin@fmmu.edu.cn; X.B.Yang@leeds.ac.uk
RI Jin, Yan/I-4204-2013; Boccaccini, Aldo/C-7905-2013
OI Yan, Yu/0000-0003-4048-0603
FU China Scholarship Council (CSC); Worldwide Universities Network (WUN);
   NIHR LMBRU; Jilin Province Youth Foundation [20140520051JH]
FX This work was supported by grants from the China Scholarship Council
   (CSC) and Worldwide Universities Network (WUN). It was also partially
   funded by NIHR LMBRU and Jilin Province Youth Foundation
   (20140520051JH).
CR Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Blaker JJ, 2005, ACTA BIOMATER, V1, P643, DOI 10.1016/j.actbio.2005.07.003
   Blaker JJ, 2003, J BIOMED MATER RES A, V67A, P1401, DOI 10.1002/jbm.a.20055
   Boccaccini AR, 2003, J MATER SCI-MATER M, V14, P443, DOI 10.1023/A:1023266902662
   Bosetti M, 2003, J BIOMED MATER RES A, V64A, P189, DOI 10.1002/jbm.a.10415
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Eppley BL, 2005, J CRANIOFAC SURG, V16, P981, DOI 10.1097/01.scs.0000179662.38172.dd
   Gabbay JS, 2006, ANN PLAS SURG, V57, P89, DOI 10.1097/01.sap.0000205378.89052.d3
   GHEYSEN G, 1983, BIOMATERIALS, V4, P81, DOI 10.1016/0142-9612(83)90044-3
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Green D, 2004, J MATER CHEM, V14, P2206, DOI 10.1039/b400486h
   Hattar S., 2002, European Cells & Materials, V4, P61
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1986, CIBA F SYMP, V121, P231
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   Hicok KC, 2004, TISSUE ENG, V10, P371, DOI 10.1089/107632704323061735
   Hofmann A, 2008, BONE, V42, P894, DOI 10.1016/j.bone.2008.01.013
   Horner E, 2008, ADV TISSUE ENG, P763
   Horner EA, 2010, TISSUE ENG PART B-RE, V16, P263, DOI [10.1089/ten.teb.2009.0224, 10.1089/ten.TEB.2009.0224]
   Howard D, 2002, BIOCHEM BIOPH RES CO, V299, P208, DOI 10.1016/S0006-291X(02)02561-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Kokai LE, 2005, PLAST RECONSTR SURG, V116, P1453, DOI 10.1097/01.prs.0000182570.62814.e3
   Lalande C, 2011, EUR CELLS MATER, V21, P341, DOI 10.22203/eCM.v021a25
   Lee JA, 2003, ANN PLAS SURG, V50, P610, DOI 10.1097/01.SAP.0000069069.23266.35
   Lee SJ, 2010, BIOMATERIALS, V31, P5652, DOI 10.1016/j.biomaterials.2010.03.019
   Liao S, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025019
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Loty C, 2001, J BONE MINER RES, V16, P231, DOI 10.1359/jbmr.2001.16.2.231
   Lu W, 2012, CELLS TISSUES ORGANS, V195, P197, DOI 10.1159/000324921
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Maquet V, 2003, J BIOMED MATER RES A, V66A, P335, DOI 10.1002/jbm.a.10587
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Mauney JR, 2004, CALCIFIED TISSUE INT, V74, P458, DOI 10.1007/s00223-003-0104-7
   McIntosh KR, 2009, TISSUE ENG PT A, V15, P2677, DOI 10.1089/ten.TEA.2008.0566
   Mehrkens A, 2012, EUR CELLS MATER, V24, P308, DOI 10.22203/eCM.v024a22
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Niemeyer P, 2007, TISSUE ENG, V13, P111, DOI 10.1089/ten.2006.0114
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Peter SJ, 1998, J BIOMED MATER RES, V43, P422, DOI 10.1002/(SICI)1097-4636(199824)43:4<422::AID-JBM9>3.3.CO;2-T
   Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x
   Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Saha S, 2011, STEM CELL TISSUE ENG, P211
   Saha S, 2013, CELL TISSUE RES, V352, P495, DOI 10.1007/s00441-013-1586-x
   Saha S, 2010, BIOCHEM BIOPH RES CO, V401, P333, DOI 10.1016/j.bbrc.2010.09.042
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Stamboulis A, 2002, J MATER SCI-MATER M, V13, P843, DOI 10.1023/A:1016544211478
   Sterodimas A, 2010, J PLAST RECONSTR AES, V63, P1886, DOI 10.1016/j.bjps.2009.10.028
   Tobita M, 2011, DISCOV MED, V11, P160
   Tsigkou O, 2007, J BIOMED MATER RES A, V80A, P837, DOI 10.1002/jbm.a.30910
   Verrier S, 2004, BIOMATERIALS, V25, P3013, DOI 10.1016/j.biomaterials.2003.09.081
   Wang CZ, 2010, BIOMATERIALS, V31, P8674, DOI 10.1016/j.biomaterials.2010.07.096
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Yang XBB, 2004, TISSUE ENG, V10, P1037, DOI 10.1089/1076327041887718
   Yang XBB, 2006, BIOCHEM BIOPH RES CO, V342, P1098, DOI 10.1016/j.bbrc.2006.02.021
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   Zong C, 2010, EUR CELLS MATER, V20, P109
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 68
TC 27
Z9 29
U1 1
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0302-766X
EI 1432-0878
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD APR
PY 2014
VL 356
IS 1
BP 97
EP 107
DI 10.1007/s00441-013-1770-z
PG 11
WC Cell Biology
SC Cell Biology
GA AE7JY
UT WOS:000334175100010
PM 24408074
DA 2018-10-19
ER

PT J
AU Agathopoulos, S
   Kolettis, TM
AF Agathopoulos, Simeon
   Kolettis, Theofilos M.
TI Novel Strategies for Cardiac Repair Post-Myocardial Infarction
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Editorial Material
ID GROWTH-FACTOR-I; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR MYOCYTES;
   HORMONE; RATS; INFLAMMATION; HYPERTROPHY; CLENBUTEROL; THERAPY;
   PATHOPHYSIOLOGY
AB Myocardial infarction constitutes an important health-related problem worldwide. Despite current treatments that salvage myocardial tissue and unload the left ventricle, chronic heart failure is common and is associated with increased morbidity and mortality. During the past decade, experimental studies, using cell-based therapies and growth factor administration integrated in biomaterial scaffolds, have demonstrated the potential to reduce the infarcted area and to improve regional and global left ventricular function. Some aspects of this rapid progress are reviewed in the present 'special issue' and a number of novel approaches are being introduced. This series of articles, contributed by research groups with different expertise, is a small step towards the combined efforts required to address the challenges associated with regenerating the infarcted myocardium.
C1 [Agathopoulos, Simeon] Univ Ioannina, GR-45110 Ioannina, Greece.
   [Kolettis, Theofilos M.] Univ Ioannina, Sch Med, Dept Cardiol, GR-45110 Ioannina, Greece.
RP Agathopoulos, S (reprint author), Univ Ioannina, 1 Stavrou Niarxou Ave, GR-45110 Ioannina, Greece.
EM sagat@cc.uoi.gr; thkolet@cc.uoi.gr
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Bruel A, 2005, GROWTH HORM IGF RES, V15, P256, DOI 10.1016/j.ghir.2005.04.003
   BUERKE M, 1995, P NATL ACAD SCI USA, V92, P8031, DOI 10.1073/pnas.92.17.8031
   Cavalera M, 2014, CURR PHARM DESIGN, V20, P1971, DOI 10.2174/13816128113199990449
   Chatzinikolaidou M, 2014, CURR PHARM DESIGN, V20, P2030, DOI 10.2174/13816128113199990446
   Chen J, 2014, CURR PHARM DESIGN, V20, P2023, DOI 10.2174/13816128113199990451
   Chen PS, 2001, CARDIOVASC RES, V50, P409, DOI 10.1016/S0008-6363(00)00308-4
   Cittadini A, 1997, J AM COLL CARDIOL, V29, P1109, DOI 10.1016/S0735-1097(97)00010-7
   Daskalopoulos EP, 2014, CURR PHARM DESIGN, V20, P1987, DOI 10.2174/13816128113199990452
   Daskalopoulos EP, 2012, MICROSC MICROANAL, V18, P35, DOI 10.1017/S143192761101227X
   Doyle B, 2008, STEM CELLS DEV, V17, P941, DOI 10.1089/scd.2007.0214
   Elaiopoulos DA, 2007, CLIN SCI, V112, P385, DOI 10.1042/CS20060193
   ENTMAN ML, 1991, FASEB J, V5, P2529
   Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162
   Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292
   Friberg L, 2000, EUR HEART J, V21, P1547, DOI 10.1053/euhj.2000.2125
   Hatzistergos KE, 2008, GROWTH HORM IGF RES, V18, P157, DOI 10.1016/j.ghir.2007.08.002
   Hodonsky C, 2014, CURR PHARM DESIGN, V20, P2012, DOI 10.2174/13816128113199990448
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Kolettis TM, 2013, CURR OPIN PHARMACOL, V13, P210, DOI 10.1016/j.coph.2013.01.001
   Kolettis TM, 2006, CARDIOVASC RES, V69, P299, DOI 10.1016/j.cardiores.2005.12.007
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002
   Li M, 2014, CURR PHARM DESIGN, V20, P1950, DOI 10.2174/13816128113199990447
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Martin K, 2014, CURR PHARM DESIGN, V20, P1930, DOI 10.2174/13816128113199990450
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Mitsi AC, 2006, GROWTH HORM IGF RES, V16, P93, DOI 10.1016/j.ghir.2006.02.001
   Mitsi AC, 2005, MED HYPOTHESES, V64, P582, DOI 10.1016/j.mehy.2004.07.028
   O'Sullivan JF, 2011, CIRC-CARDIOVASC INTE, V4, P327, DOI 10.1161/CIRCINTERVENTIONS.110.960765
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Rao C, 2014, CURR PHARM DESIGN, V20, P2048, DOI 10.2174/13816128113199990442
   REISS K, 1994, J CELL PHYSIOL, V158, P160, DOI 10.1002/jcp.1041580120
   Robbins CS, 2010, CELL MOL LIFE SCI, V67, P2685, DOI 10.1007/s00018-010-0375-x
   Sarapultsev AP, 2014, CURR PHARM DESIGN, V20, P1980, DOI 10.2174/13816128113199990492
   Schuh A, 2014, CURR PHARM DESIGN, V20, P1964, DOI 10.2174/13816128113199990443
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Soppa GKR, 2005, AM J PHYSIOL-HEART C, V288, pH1468, DOI 10.1152/ajpheart.00624.2004
   Sousonis V, 2014, CURR PHARM DESIGN, V20, P2003, DOI 10.2174/13816128113199990445
   Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981
   Tsoporis JN, 2014, CURR PHARM DESIGN, V20, P1941, DOI 10.2174/13816128113199990444
   Tsoporis JN, 2005, EXP CELL RES, V303, P471, DOI 10.1016/j.yexcr.2004.10.018
   van Marion MH, 2014, CURR PHARM DESIGN, V20, P2057, DOI 10.2174/13816128113199990582
   Vilaeti AD, 2013, INT J CARDIOL, V165, P278, DOI 10.1016/j.ijcard.2011.08.036
   Wong K, 1998, CARDIOVASC RES, V37, P115, DOI 10.1016/S0008-6363(97)00190-9
   Yi X, 2014, CURR PHARM DESIGN, V20, P2040, DOI 10.2174/13816128113199990453
NR 52
TC 2
Z9 2
U1 0
U2 5
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 1925
EP 1929
DI 10.2174/138161282012140401153832
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500001
PM 23844729
DA 2018-10-19
ER

PT J
AU Chatzinikolaidou, M
   Kaliva, M
   Batsali, A
   Pontikoglou, C
   Vamvakaki, M
AF Chatzinikolaidou, Maria
   Kaliva, Maria
   Batsali, Aristea
   Pontikoglou, Charalampos
   Vamvakaki, Maria
TI Wharton's Jelly Mesenchymal Stem Cell Response on Chitosan-graft-poly
   (epsilon -caprolactone) Copolymer for Myocardium Tissue Engineering
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Article
DE Wharton's jelly; chitosan grafted poly(epsilon-caprolactone); cell
   adhesion; viability; proliferation; myocardium regeneration
ID HUMAN UMBILICAL-CORD; HEART-FAILURE; IN-VITRO; INFARCTION;
   DIFFERENTIATION; TRANSPLANTATION; CARDIOMYOCYTES; SCAFFOLDS; HYDROGEL;
   OPTION
AB Cell therapy and tissue engineering attract increasing attention as a potential approach for cardiac repair. Although a plethora of interesting concepts in the emerging field of cardiac stem cell-based tissue engineering are reported, there are still challenges that this field needs to overcome to achieve therapeutic translation into the clinical praxis. Engineering biomaterial scaffolds that facilitate stem cell engraftment, survival and homing are crucial for successful cellular cardiomyoplasty after myocardial infarction (MI). In this study we investigate for the first time the cellular response of Wharton's jelly (WJ) Mesenchymal Stem Cells (MSCs) on a copolymeric material comprising chitosan (CS) and poly(epsilon-caprolactone) (PCL). First we synthesize a copolymer consisting of poly(epsilon-caprolactone) grafted on a chemically modified chitosan-backbone (CS-g-PCL). Furthermore, we investigate the morphology, viability and proliferation of WJMSCs on material coatings and examine the cellular response from different donors. Our results show strong cell adhesion on the CS-g-PCL material surface from the first hours in culture, and a proliferation increase after 3 and 7 days. These findings support the potential use of our proposed cell-material combination in myocardium tissue engineering.
C1 [Chatzinikolaidou, Maria; Kaliva, Maria; Vamvakaki, Maria] Univ Crete, Dept Mat Sci & Technol, Iraklion, Greece.
   [Batsali, Aristea; Pontikoglou, Charalampos] Univ Crete, Sch Med, Dept Hematol, Iraklion, Greece.
   [Chatzinikolaidou, Maria; Kaliva, Maria; Vamvakaki, Maria] Fdn Res & Technol Hellas FORTH, Inst Elect Struct & Laser, Hellas, Greece.
RP Chatzinikolaidou, M (reprint author), Univ Crete, Dept Mat Sci & Technol, Iraklion, Greece.
EM mchatzin@materials.uoc.gr
RI Chatzinikolaidou, Maria/H-1061-2014
OI Chatzinikolaidou, Maria/0000-0002-2749-2506
FU Special Account for Research Fund of the University of Crete
FX This work was partly funded by the Special Account for Research Fund of
   the University of Crete. We would like to thank Ms. Aleka Manousaki and
   Ms. Alexandra Siakouli for expert technical assistance with SEM.
CR Breymann C, 2006, STEM CELL REV, V2, P87
   Cai GQ, 2009, MACROMOL BIOSCI, V9, P256, DOI 10.1002/mabi.200800153
   Chachques JC, 2009, EUR J CARDIO-THORAC, V35, P201, DOI 10.1016/j.ejcts.2008.09.028
   Chatzinikolaidou M, 2003, MATERIALWISS WERKST, V34, P1106, DOI 10.1002/mawe.200300714
   Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Conconi MT, 2006, INT J MOL MED, V18, P1089
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Eschenhagen T, 2002, TRANSPL IMMUNOL, V9, P315, DOI 10.1016/S0966-3274(02)00011-4
   Fukuda K, 2006, CIRC RES, V98, P1002, DOI 10.1161/01.RES.0000218272.18669.6e
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hollweck T, 2011, OPEN TISSUE ENG REGE, V4, P95
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Kehat I, 2003, HEART FAIL REV, V8, P229, DOI 10.1023/A:1024709332039
   Koerner MM, 2000, CURR OPIN CARDIOL, V15, P178, DOI 10.1097/00001573-200005000-00010
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kolettis TM, 2011, MINI-REV MED CHEM, V11, P263
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Martinez EC, 2011, J MOL CELL CARDIOL, V50, P312, DOI 10.1016/j.yjmcc.2010.08.009
   Matsuura K, 2004, J BIOL CHEM, V279, P11384, DOI 10.1074/jbc.M310822200
   Piao H, 2007, BIOMATERIALS, V28, P641, DOI 10.1016/j.biomaterials.2006.09.009
   Schmidt D, 2006, TISSUE ENG, V12, P3223, DOI 10.1089/ten.2006.12.3223
   Smith RR, 2008, HEART RHYTHM, V5, P880, DOI 10.1016/j.hrthm.2008.02.011
   Terzaki K, 2013, J BIOMEDICAL MAT R A
   Troyer DL, 2008, STEM CELLS, V26, P591, DOI 10.1634/stemcells.2007-0439
   Wang HB, 2010, J HEART LUNG TRANSPL, V29, P881, DOI 10.1016/j.healun.2010.03.016
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 36
TC 6
Z9 6
U1 3
U2 24
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 2030
EP 2039
DI 10.2174/13816128113199990446
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500012
PM 23844735
DA 2018-10-19
ER

PT J
AU Yi, X
   Li, XY
   Ren, S
   He, YY
   Wan, WG
   Wen, Y
   Jiang, XJ
AF Yi, Xin
   Li, Xiaoyan
   Ren, Shan
   He, Yiyu
   Wan, Weiguo
   Wen, Ying
   Jiang, Xuejun
TI A Novel, Biodegradable, Thermoresponsive Hydrogel Attenuates Ventricular
   Remodeling and Improves Cardiac Function Following Myocardial Infarction
   - a review
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Thermoresponsive hydrogel; ventricular remodeling; cardiac function;
   myocardial infarction; cardiac tissue engineering
ID MATRIX-METALLOPROTEINASE ACTIVITY; ISCHEMIC-HEART FAILURE; INJECTABLE
   HYDROGEL; DRUG-DELIVERY; SKELETAL MYOBLASTS; IN-VITRO; INTRACORONARY
   INJECTION; POLY(ETHYLENE GLYCOL); CULTURE SURFACES; ANGIOTENSIN-II
AB Myocardial infarction (MI) and the subsequent heart failure remain among of the leading causes of morbidity and mortality in world wide. A number of studies have demonstrated that intramyocardial biomaterials injections improve cardiac function after implantation because of their angiogenic potential. Thermoresponsive hydrogels, one member of the hydrogels family, are a kind of biomaterial whose structure is similar to that of extracellular matrix. These hydrogels have been interesting for biomedical uses as they can swell in situ under physiological conditions and provide the advantage of convenient administration. The hydrogel that our team is interested in is a novel biodegradable injectable thermoresponsive hydrogel-the copolymer dextran-poly (epsilon-caprolactone) -2-hydroxylethyl methacrylatepoly (N-isopropylacrylaminde) (Dex-PCL-HEMA/PNIPAAm). Thus, this review will focus on requirements and challenges of injectable synthetic material, and possible mechanism of thermoresponsive hydrogel in treating MI. The main emphases are on the work done and future interesting studies in our laboratory.
C1 [Yi, Xin; Li, Xiaoyan; Ren, Shan; He, Yiyu; Wan, Weiguo; Wen, Ying; Jiang, Xuejun] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan 430060, Peoples R China.
   [Yi, Xin; Li, Xiaoyan; Ren, Shan; He, Yiyu; Wan, Weiguo; Wen, Ying; Jiang, Xuejun] Wuhan Univ, Cardiovasc Res Inst, Wuhan 430060, Peoples R China.
RP Jiang, XJ (reprint author), Wuhan Univ, Renmin Hosp, Cardiovasc Res Inst, Dept Cardiol, Jiefang Rd 238, Wuhan 430060, Peoples R China.
EM xjjiang@whu.edu.cn
FU National Natural Science Foundation of China [81170307]
FX This work was supported by National Natural Science Foundation of China
   Grants 81170307.
CR Adeldoew Catharina A. M., 2007, V140, P125
   Anversa P, 2006, J AM COLL CARDIOL, V47, P1769, DOI 10.1016/j.jacc.2006.02,003
   Beck JB, 2003, J AM CHEM SOC, V125, P13922, DOI 10.1021/ja038521k
   Bleeker CB, 2006, NAT CLIN PRACT CARD, V3, P213
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Chen FM, 2007, J CONTROL RELEASE, V118, P65, DOI 10.1016/j.jconrel.2006.11.016
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Croy SR, 2006, CURR PHARM DESIGN, V12, P4669, DOI 10.2174/138161206779026245
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3
   Dib N, 2002, J ENDOVASC THER, V9, P313, DOI 10.1583/1545-1550(2002)009<0313:ETOASM>2.0.CO;2
   Dib Nabil, 2006, Journal of Pharmacological and Toxicological Methods, V54, P71, DOI 10.1016/j.vascn.2005.12.002
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   He YY, 2012, J CARDIOVASC PHARM
   HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   HUTCHINS GM, 1978, AM J CARDIOL, V41, P1127, DOI 10.1016/0002-9149(78)90869-X
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Izutsu KI, 2005, J PHARM SCI-US, V94, P709, DOI 10.1002/jps.20292
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   JEREMY RW, 1987, J AM COLL CARDIOL, V9, P989, DOI 10.1016/S0735-1097(87)80298-X
   Jiang XJ, 2008, J BIOMED MAT, V90, P472
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kaneko Y, 1999, J BIOMAT SCI-POLYM E, V10, P1079, DOI 10.1163/156856299X00757
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kobayashi S, 2000, BIOMACROMOLECULES, V1, P3, DOI 10.1021/bm990007c
   Kofidis T, 2005, CIRCULATION, V112, P1173
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee J, 2006, BIOMACROMOLECULES, V7, P1729, DOI 10.1021/bm0600062
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lima AC, 2011, PHARM RES-DORDR, V28, P1294, DOI 10.1007/s11095-011-0380-2
   Liu Y, 2007, J CONTROL RELEASE, V117, P387, DOI 10.1016/j.jconrel.2006.11.024
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutz JF, 2006, J AM CHEM SOC, V128, P13046, DOI 10.1021/ja065324n
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006
   Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603
   Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B
   Prabu P, 2006, J BIOMED MATER RES A, V79A, P153, DOI 10.1002/jbm.a.30715
   Rane AA, 2011, PLOS ONE, V6
   Ren S, 2012, J INT MED RES, V40, P2167, DOI 10.1177/030006051204000615
   Rhee SH, 2002, BIOMATERIALS, V23, P4915, DOI 10.1016/S0142-9612(02)00251-X
   Ruiz-Ortega M, 2005, ANTIOXID REDOX SIGN, V7, P1258, DOI 10.1089/ars.2005.7.1258
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   Smits PC, 2003, J AM COLL CARDIOL, V42, P2063, DOI 10.1016/j.jacc.2003.06.017
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8
   Sun Y, 2010, J MOL CELL CARDIOL, V48, P483, DOI 10.1016/j.yjmcc.2009.08.002
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Thomas CV, 1998, CIRCULATION, V97, P1708, DOI 10.1161/01.CIR.97.17.1708
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Tyagi SC, 1996, MOL CELL BIOCHEM, V155, P13, DOI 10.1007/BF00714328
   Venugopal JR, 2012, J R SOC INTERFACE, V9, P1, DOI 10.1098/rsif.2011.0301
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wang Tao, 2010, Zhonghua Yi Xue Za Zhi, V90, P259
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   WEISMAN HF, 1988, CIRCULATION, V78, P186, DOI 10.1161/01.CIR.78.1.186
   Wu De-Qun, 2009, ACS APPL MATER INTER, V2, P319
   Wu J, 2007, BIOMATERIALS, V28, P2220, DOI 10.1016/j.biomaterials.2006.12.024
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Xiao F, 2009, COLLOID SURFACE B, V71, P13, DOI 10.1016/j.colsurfb.2008.12.040
   Xie JW, 2010, CURR PHARM DESIGN, V16, P2331, DOI 10.2174/138161210791920432
   Xu QX, 2010, CURR PHARM DESIGN, V16, P2350, DOI 10.2174/138161210791920469
   Yasuhiko T., 2009, J R SOC INTERFACE, V6, pS311
   Yellepeddi VK, 2009, EXPERT OPIN DRUG DEL, V6, P835, DOI 10.1517/17425240903061251
   Yockman JW, 2008, J CONTROL RELEASE, V132, P260, DOI 10.1016/j.jconrel.2008.06.024
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Zhang XQ, 2007, BIOMACROMOLECULES, V8, P3557, DOI 10.1021/bm700729t
NR 86
TC 4
Z9 6
U1 2
U2 57
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD APR
PY 2014
VL 20
IS 12
BP 2040
EP 2047
DI 10.2174/13816128113199990453
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AE9FY
UT WOS:000334312500013
PM 23844737
DA 2018-10-19
ER

PT J
AU Vuorenpaa, H
   Ikonen, L
   Kujala, K
   Huttala, O
   Sarkanen, JR
   Ylikomi, T
   Aalto-Setala, K
   Heinonen, T
AF Vuorenpaa, Hanna
   Ikonen, Liisa
   Kujala, Kirsi
   Huttala, Outi
   Sarkanen, Jertta-Riina
   Ylikomi, Timo
   Aalto-Setala, Katriina
   Heinonen, Tuula
TI Novel in vitro cardiovascular constructs composed of vascular-like
   networks and cardiomyocytes
SO IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
LA English
DT Article
DE Angiogenesis; Primary cardiomyocytes; Human adipose stromal cells, in
   vitro cardiotoxicity
ID ADIPOSE STROMAL CELLS; ENGINEERED HUMAN MYOCARDIUM; EMBRYONIC
   STEM-CELLS; CARDIAC MYOCYTES; MICROELECTRODE ARRAYS; SCAFFOLD-FREE;
   ADULT-RAT; TISSUE; HEART; MUSCLE
AB The interaction between different cardiac cells has shown to be important for critical biological properties including cell survival, proliferation, differentiation and function. The improvement of culture conditions with different cell types and to study their effects on cardiomyocyte viability and functionality is essential. For practical applications including general toxicity testing, drug development and tissue engineering it is important to study whether co-cultures have additional advantages over cardiomyocyte monoculture. Two multicellular in vitro cardiovascular constructs devoid of added biomaterial were developed in this study. In the first construct, neonatal rat cardiomyocytes (CM) were seeded on vascular-like network formed by human umbilical vein endothelial cells (HUVEC) and human adipose stromal cells (hASC). In the second construct, CMs were seeded on vascular-like network formed by HUVECs and human foreskin fibroblasts. The ability of these two vascular-like networks to support the viability and functionality of CMs was analyzed. Different culture media compositions were evaluated to support the development of optimal cardiovascular construct. Our results demonstrate that both vascular-like networks markedly improved CM viability and functionality. In the constructs, co-localization of CMs and vascular-like networks was seen. Multicellular constructs also allowed synchronized contractility of CMs. Serum-free medium supplemented with vascular endothelial growth factor and basic fibroblast growth factor was found to provide the most optimal conditions for cardiovascular construct as an entity. In conclusion, when combining a vascular-like network with CMs, the viability and functionality of CMs was markedly improved. The results suggest that the cardiovascular constructs developed provide a promising new tool for the assessment of toxicological and safety pharmacological effects of compounds in vitro.
C1 [Vuorenpaa, Hanna; Huttala, Outi; Sarkanen, Jertta-Riina; Ylikomi, Timo; Heinonen, Tuula] Univ Tampere, FICAM, Finnish Ctr Alternat Methods, Sch Med, FIN-33101 Tampere, Finland.
   [Ikonen, Liisa; Kujala, Kirsi; Aalto-Setala, Katriina] Univ Tampere, IBT Inst Biomed Technol, Tampere 33520, Finland.
   [Ikonen, Liisa; Kujala, Kirsi; Aalto-Setala, Katriina] BioMediTech, Tampere 33520, Finland.
   [Ylikomi, Timo] Univ Tampere, Sch Med, Dept Cell Biol, Tampere 33014, Finland.
   [Ylikomi, Timo] Tampere Univ Hosp, Dept Clin Chem, Tampere 33014, Finland.
   [Aalto-Setala, Katriina] Tampere Univ Hosp, Ctr Heart, Tampere 33520, Finland.
RP Vuorenpaa, H (reprint author), Univ Tampere, FICAM, Finnish Ctr Alternat Methods, Sch Med, FIN-33101 Tampere, Finland.
EM hanna.vuorenpaa@uta.fi
FU Pirkanmaa Centers for Economic Development, Transport and the
   Environment; City of Tampere; Ministry of Education and Culture;
   Ministry of Agriculture and Forestry; Finnish Cultural Foundation;
   Academy of Finland; Tekes-the Finnish Funding Agency for Technology and
   Innovation; Paavo Nurmi Foundation; Foundation of Aarne and Aili
   Turunen; Finnish Foundation for Cardiovascular Research; FinPharma
   Doctoral Program
FX Funding for the project was provided by Pirkanmaa Centers for Economic
   Development, Transport and the Environment; City of Tampere; Ministry of
   Education and Culture; Ministry of Agriculture and Forestry; Finnish
   Cultural Foundation; Academy of Finland; Tekes-the Finnish Funding
   Agency for Technology and Innovation; Paavo Nurmi Foundation; Foundation
   of Aarne and Aili Turunen; Finnish Foundation for Cardiovascular
   Research and FinPharma Doctoral Program.
CR Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007.
   Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659
   Bhattacharya S, 2006, CLIN SCI, V111, P35, DOI 10.1042/cs20060003
   Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002
   Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   De Siena R, 2010, EXP CELL RES, V316, P1804, DOI 10.1016/j.yexcr.2010.02.009
   Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   He WJ, 2012, J HEART LUNG TRANSPL, V31, P204, DOI 10.1016/j.healun.2011.11.010
   Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629
   Hussain A, 2013, BIOTECHNOL BIOENG, V110, P637, DOI 10.1002/bit.24727
   Iyer RK, 2011, CURR OPIN BIOTECH, V22, P706, DOI 10.1016/j.copbio.2011.04.004
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kettenhofen R., 2005, DRUG DISCOV TODAY, V13, P702
   Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068
   Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]
   Kujala VJ, 2011, COMPUT METH PROG BIO, V104, P199, DOI 10.1016/j.cmpb.2011.04.001
   KYOSOLA K, 1983, ANN CLIN RES, V15, P156
   Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215
   Lesman A, 2010, ANN NY ACAD SCI, V1188, P46, DOI 10.1111/j.1749-6632.2009.05082.x
   Lexchin J, 2005, CAN MED ASSOC J, V172, P765, DOI 10.1503/cmaj.045021
   Li RK, 2002, HUMAN CELL CULTURE, P118
   Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0
   Montessuit C, 2004, CARDIOVASC RES, V64, P94, DOI 10.1016/j.cardiores.2004.06.005
   NAG AC, 1980, CYTOBIOS, V28, P41
   Narang Deepak, 2004, BMC Pharmacology, V4, P29, DOI 10.1186/1471-2210-4-29
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Radisic M, 2006, BIOTECHNOL BIOENG, V93, P332, DOI 10.1002/bit.20722
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Reppel M, 2004, J ELECTROCARDIOL, V37, P104, DOI 10.1016/j.jelectrocard.2004.08.033
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058
   Sarkanen JR, 2012, CELLS TISSUES ORGANS, V196, P385, DOI 10.1159/000336679
   Sarkanen JR, 2011, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00147
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206
   UUSIMAA PA, 1992, ENDOCRINOLOGY, V130, P2455, DOI 10.1210/en.130.5.2455
   Valarmathi MT, 2010, BIOMATERIALS, V31, P3185, DOI 10.1016/j.biomaterials.2010.01.041
NR 46
TC 8
Z9 8
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1071-2690
EI 1543-706X
J9 IN VITRO CELL DEV-AN
JI In Vitro Cell. Dev. Biol.-Anim.
PD APR
PY 2014
VL 50
IS 4
BP 275
EP 286
DI 10.1007/s11626-013-9703-4
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA AF0NG
UT WOS:000334410700001
PM 24163159
DA 2018-10-19
ER

PT J
AU Karimi, A
   Navidbakhsh, M
   Yousefi, H
AF Karimi, Alireza
   Navidbakhsh, Mahdi
   Yousefi, Hossein
TI Mechanical properties of polyvinyl alcohol sponge under different strain
   rates
SO INTERNATIONAL JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
DE PVA sponge; Mechanical properties; Stress-strain diagram; Energy
   absorption; Tissue engineering
ID HUMAN CORONARY-ARTERIES; UNCONFINED COMPRESSION; PVA HYDROGEL;
   COMPOSITE; TISSUE; HEALTHY; DESIGN
AB Polyvinyl alcohol (PVA) is a suitable material for biomedical and pharmaceutical applications. This paper presents a scientific study on the stiffness, strength, and energy absorption characteristics of a fabricated PVA sponge under different strain rates with a view to using it as an alternative biodegradable and biocompatible material. A range of tensile tests, such as stress failure and cyclic, on PVA sponge have been carried out. The stress strain curves in all strain rates (1, 20, 100 mm min(-1)) indicated a near constant plateau stress over a long strain range, which is ideal for energy absorption applications. It was found that the PVA sponge biomaterial exhibited remarkable stiffness, strength, and energy absorption capacities that are comparable to those of some biomaterials with the same density range. PVA sponge can also bear suitable stress both at low and high strain rates which enables it to be implemented in most tissue engineering scaffolds.
C1 [Karimi, Alireza; Navidbakhsh, Mahdi] Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16844, Iran.
   [Karimi, Alireza; Navidbakhsh, Mahdi] Iran Univ Sci & Technol, Sch Mech Engn, Tissue Engn & Biol Syst Res Lab, Tehran 16844, Iran.
   [Yousefi, Hossein] Univ Tehran, Fac New Sci & Technol, Tehran, Iran.
RP Navidbakhsh, M (reprint author), Iran Univ Sci & Technol, Sch Mech Engn, Tehran 16844, Iran.
EM mnavid@iust.ac.ir
RI Navidbakhsh, Mahdi/S-9351-2018
OI Yousefi, Hossein/0000-0002-6372-5127
FU Iran University of Science and Technology
FX The authors acknowledge Iran University of Science and Technology for
   funding this project.
CR Arabnejad S, 2013, INT J MECH SCI, V77, P249, DOI 10.1016/j.ijmecsci.2013.10.003
   Ashby M.F., 2000, METAL FOAMS DESIGN G
   Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726
   Cadman J, 2013, MAT SCI ENG C-MATER, V33, P3146, DOI 10.1016/j.msec.2013.03.031
   Chang SJ, 2012, CARBOHYD POLYM, V88, P684, DOI 10.1016/j.carbpol.2012.01.017
   Corkhill P H, 1990, Proc Inst Mech Eng H, V204, P147, DOI 10.1243/PIME_PROC_1990_204_249_02
   Davidson JP, 1998, ARCH DERMATOL RES, V290, P1
   Efron DT, 2003, METH MOLEC MED, V78, P83
   Faturechi R., 2014, TISSUE ENG, V4, P25, DOI [10.1166/jbt.2014.1156, DOI 10.1166/JBT.2014.1156]
   Gibson L. J., 2010, CELLULAR MAT NATURE, DOI [10.1038/nature09587, DOI 10.1038/NATURE09587]
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Jiang S, 2011, J MECH BEHAV BIOMED, V4, P1228, DOI 10.1016/j.jmbbm.2011.04.005
   Johnson M, 2010, ACTA BIOMATER, V6, P2181, DOI 10.1016/j.actbio.2009.12.006
   Karimi A., 2013, PERFUSION IN PRESS, DOI [10.1177/0267659113513823, DOI 10.1177/0267659113513823, 10.1177/0267659113513823.]
   Karimi A, 2014, J THERMOPLA IN PRESS, DOI [10.1177/0892705713520176, DOI 10.1177/0892705713520176]
   Karimi A., 2013, MAT TECHNOL IN PRESS
   Karimi A., 2013, PERFUSION IN PRESS, DOI [10.1177/0267659113502835, DOI 10.1177/0267659113502835]
   Karimi A, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40257
   Karimi A, 2014, TISSUE CELL, V46, P97, DOI 10.1016/j.tice.2013.12.004
   Karimi A, 2014, BIOMED ENG-APP BAS C, V26, DOI 10.4015/S1016237214500136
   Karimi A, 2014, J BIOMATER TISS ENG, V4, P46, DOI 10.1166/jbt.2014.1134
   Karimi A, 2013, P I MECH ENG H, V227, P609, DOI 10.1177/0954411913476779
   Karimi A, 2013, MAT SCI ENG C-MATER, V33, P2550, DOI 10.1016/j.msec.2013.02.016
   Karimi A, 2013, P I MECH ENG H, V227, P148, DOI 10.1177/0954411912461239
   Korteweg W., 2004, US Pat, Patent No. 6711879
   Lee CT, 2005, CARBOHYD POLYM, V61, P348, DOI 10.1016/j.carbpol.2005.06.018
   Lee SY, 2009, ACTA BIOMATER, V5, P1919, DOI 10.1016/j.actbio.2009.02.014
   Liu LF, 2012, WATER RES, V46, P1969, DOI 10.1016/j.watres.2012.01.017
   Liu YR, 2010, J MECH BEHAV BIOMED, V3, P203, DOI 10.1016/j.jmbbm.2009.07.001
   Lu G, 2003, ENERGY ABSORPTION ST
   Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2
   Moscato S, 2008, MICRON, V39, P569, DOI 10.1016/j.micron.2007.06.016
   Setiawan L, 2012, J MEMBRANE SCI, V394, P80, DOI 10.1016/j.memsci.2011.12.026
   Shen JH, 2012, J MECH BEHAV BIOMED, V15, P141, DOI 10.1016/j.jmbbm.2012.07.004
   Sionkowska A, 2013, J MOL LIQ, V178, P5, DOI 10.1016/j.molliq.2012.10.042
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Zhang DK, 2012, J BIONIC ENG, V9, P234, DOI 10.1016/S1672-6529(11)60116-9
   Zhang ZQ, 2011, P ROY SOC B-BIOL SCI, V278, P519, DOI 10.1098/rspb.2010.1093
NR 38
TC 33
Z9 35
U1 6
U2 38
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 1862-5282
EI 2195-8556
J9 INT J MATER RES
JI Int. J. Mater. Res.
PD APR
PY 2014
VL 105
IS 4
BP 404
EP 408
DI 10.3139/146.111036
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA AF0HK
UT WOS:000334394700013
DA 2018-10-19
ER

PT J
AU Wigton, E
   Swanner, JC
   Joiner, W
   Feldman, A
   McGwin, G
   Huisingh, C
   Curcio, CA
   Girkin, CA
AF Wigton, Eric
   Swanner, Jason C.
   Joiner, Wade
   Feldman, Alex
   McGwin, Gerald, Jr.
   Huisingh, Carrie
   Curcio, Christine A.
   Girkin, Christopher A.
TI Outcomes of Shunt Tube Coverage With Glycerol Preserved Cornea Versus
   Pericardium
SO JOURNAL OF GLAUCOMA
LA English
DT Article
DE patch graft; glaucoma drainage implant; exposure; pericardium; cornea;
   shunt tube
ID GLAUCOMA DRAINAGE DEVICE; MOLTENO IMPLANT-SURGERY; AMNIOTIC MEMBRANE;
   PATCH GRAFT; POSTOPERATIVE COMPLICATIONS; AQUEOUS SHUNTS; EXPOSURE;
   EROSION; SETONS
AB Pericardium is a biomaterial widely used for covering the outflow tubes of glaucoma drainage devices. Recently, glycerol preserved cornea has been introduced as an alternative that offers durability and improved cosmesis because of its clarity. We retrospectively reviewed 262 patients in the University of Alabama Birmingham Glaucoma Service who underwent shunt procedures using either cornea tissue or pericardium to cover the tube. The primary outcome measure was the number of erosions of the covering material. Nine out of 101 (8.9%) patients in the pericardium covered group experienced an erosion compared with 3 out of 161 (1.9%) in the cornea covered group. A significant difference was reached with P=0.0125. Median follow-up was 440 days for the cornea group and 331 days for the pericardium group. The type of glaucoma (primary open-angle glaucoma vs. secondary glaucoma) was not associated with the risk of erosion (odds ratio, 0.501; 95% confidence interval, 0.204-1.234). The median time to exposure was 252 days in the pericardium group and 440 days in the cornea group (P=0.0017).
C1 [Wigton, Eric; Swanner, Jason C.; Joiner, Wade; Feldman, Alex; McGwin, Gerald, Jr.; Huisingh, Carrie; Curcio, Christine A.; Girkin, Christopher A.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.
RP Wigton, E (reprint author), Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA.
EM ericwigton@yahoo.com
OI Girkin, Chris/0000-0002-9676-4499; Huisingh, Carrie/0000-0002-7010-2024
FU Global Sight Network
FX C.A.C. discloses that she receives partial salary support from Global
   Sight Network, supplier of glycerol-preserved corneas. The remaining
   authors declare no conflict of interest.
CR Ainsworth G, 2006, BRIT J OPHTHALMOL, V90, P417, DOI 10.1136/bjo.2005.084905
   Anand A, 2011, OPHTHAL SURG LAS IM, V42, P184, DOI 10.3928/15428877-20110426-01
   Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016
   Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]
   Feilmeier MR, 2010, MIDDLE EAST AFR J OP, V17, P38, DOI 10.4103/0974-9233.61215
   FREEDMAN J, 1987, OPHTHALMIC SURG LAS, V18, P532
   Gedde SJ, 2007, AM J OPHTHALMOL, V143, P23, DOI 10.1016/j.ajo.2006.07.022
   Gedde SJ, 2011, EXP EYE RES, V93, P284, DOI 10.1016/j.exer.2011.03.013
   Heuer DK, 2001, J GLAUCOMA, V10, P493, DOI 10.1097/00061198-200112000-00010
   Huddleston SM, 2011, J GLAUCOMA
   Irak I, 2004, OPHTHAL SURG LAS IM, V35, P189
   Kalenak JW, 2010, J GLAUCOMA, V19, P5, DOI 10.1097/IJG.0b013e31819aa593
   KREBS DB, 1992, ARCH OPHTHALMOL-CHIC, V110, P174, DOI 10.1001/archopht.1992.01080140024014
   Lama PJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P1243
   Lankaranian D, 2008, J GLAUCOMA, V17, P48, DOI 10.1097/IJG.0b013e318133fc49
   LOTUFO DG, 1991, OPHTHALMIC SURG LAS, V22, P650
   MELAMED S, 1991, AM J OPHTHALMOL, V111, P319, DOI 10.1016/S0002-9394(14)72316-5
   MELAMED S, 1990, SURV OPHTHALMOL, V34, P441, DOI 10.1016/0039-6257(90)90124-E
   Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031
   MINCKLER DS, 1988, OPHTHALMOLOGY, V95, P1181
   Papadaki TG, 2007, J GLAUCOMA, V16, P171, DOI 10.1097/01.ijg.0000212292.93292.80
   Raviv T, 1998, J GLAUCOMA, V7, P27
   Rojanapongpun P, 1996, AM J OPHTHALMOL, V122, P424, DOI 10.1016/S0002-9394(14)72070-7
   Singh M, 2008, CORNEA, V27, P1171, DOI 10.1097/ICO.0b013e3181814d15
   Smith MF, 2002, J GLAUCOMA, V11, P143, DOI 10.1097/00061198-200204000-00010
   Stein JD, 2008, OPTHTHALMOLOGY, V115, P109
   Stewart WC, 2010, EUR J OPHTHALMOL, V20, P124
NR 27
TC 18
Z9 18
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1057-0829
EI 1536-481X
J9 J GLAUCOMA
JI J. Glaucoma
PD APR-MAY
PY 2014
VL 23
IS 4
BP 258
EP 261
DI 10.1097/IJG.0b013e31826a96e8
PG 4
WC Ophthalmology
SC Ophthalmology
GA AE8JG
UT WOS:000334245600012
PM 22955016
DA 2018-10-19
ER

PT J
AU Jiang, RJ
   Yang, B
   Yi, D
   Wang, F
   Han, B
   Zhao, YL
   Liao, XL
   Yang, J
   Gao, CZ
AF Jiang, Rui-Jian
   Yang, Bo
   Yi, Dong
   Wang, Fen
   Han, Bin
   Zhao, Yu-Lin
   Liao, Xia-Li
   Yang, Jian
   Gao, Chuan-Zhu
TI Synthesis and characterization of a series of novel amino
   beta-cyclodextrin-conjugated poly(epsilon-lysine) derivatives
SO JOURNAL OF POLYMER ENGINEERING
LA English
DT Article
DE beta-cyclodextrin; biomaterial; characterization; poly( epsilon-lysine);
   polymer.
ID BIOMEDICAL APPLICATIONS; GENE DELIVERY; PARTICLES; POLYMERS; LYSINE; DNA
AB Soluble poly(epsilon-lysine)s bearing beta-cyclodextrin (beta-CD) moieties were prepared by three amino beta-CD derivatives and N-succinylated poly(epsilon-lysine), in which the poly(e-lysine) and amino beta-CD derivatives were bonded covalently to the end carboxyl groups of succinic acid by peptide bonds. 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDCI) and N-hydroxysuccinimide (NHS) were chosen to assist the reaction. The three poly(epsilon-lysine) derivatives were characterized by H-1 nuclear magnetic resonance (H-1 NMR) and Fourier transform infrared (FT-IR). The synthesis process is simple, feasible and has strong practicability. The target polymers can serve as new polymer biomaterial for use in the biotechnology area.
C1 [Jiang, Rui-Jian; Yang, Bo; Yi, Dong; Wang, Fen; Han, Bin; Liao, Xia-Li; Yang, Jian; Gao, Chuan-Zhu] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Dept Pharmaceut Engn, Kunming 650500, Peoples R China.
   [Zhao, Yu-Lin] Kunming Univ Sci & Technol, Fac Chem Engn, Kunming 650500, Peoples R China.
RP Yang, B (reprint author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Dept Pharmaceut Engn, Kunming 650500, Peoples R China.
EM yangbo6910@sina.com
FU National Natural Science Foundation of China (NNSFC) [21062009]; Natural
   Science Foundation of Yunnan Province [2009ZC045M]
FX This work was supported by the National Natural Science Foundation of
   China (NNSFC) (No. 21062009) and the Natural Science Foundation of
   Yunnan Province (No. 2009ZC045M), which are gratefully acknowledged.
CR Bankar SB, 2013, RSC ADV, V3, P8586, DOI 10.1039/c3ra22596h
   Bellocq NC, 2003, BIOCONJUGATE CHEM, V14, P1122, DOI 10.1021/bc034125f
   Bielinska AU, 1997, BBA-GENE STRUCT EXPR, V1353, P180, DOI 10.1016/S0167-4781(97)00069-9
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Choi HS, 2005, CHEMBIOCHEM, V6, P1986, DOI 10.1002/cbic.200500242
   Davis ME, 2004, CURR MED CHEM, V11, P179, DOI 10.2174/0929867043456179
   Green NK, 2002, CANCER GENE THER, V9, P1036, DOI 10.1038/sj.cgt.7700541
   Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565
   Mishra S, 2006, J CONTROL RELEASE, V116, P179, DOI 10.1016/j.jconrel.2006.06.018
   Nielsen LL, 1998, CANCER GENE THER, V5, P52
   Pun SH, 2004, CANCER BIOL THER, V3, P641, DOI 10.4161/cbt.3.7.918
   Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012
   Shih IL, 2004, MINI-REV MED CHEM, V4, P179, DOI 10.2174/1389557043487420
   Singh B, 2009, J POLYM ENG, V29, P249, DOI 10.1515/POLYENG.2009.29.5.249
   UENO A, 1983, CHEM LETT, P1635, DOI 10.1246/cl.1983.1635
   Ye H, 2013, J POLYM ENG, V33, P285, DOI 10.1515/polyeng-2013-0016
   Yoshida T, 2003, APPL MICROBIOL BIOT, V62, P21, DOI 10.1007/s00253-003-1312-9
   Yu P, 2011, J CHEM RES, P703, DOI 10.3184/174751911X13230201951890
NR 18
TC 3
Z9 3
U1 1
U2 39
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0334-6447
EI 2191-0340
J9 J POLYM ENG
JI J. Polym. Eng.
PD APR
PY 2014
VL 34
IS 2
BP 133
EP 139
DI 10.1515/polyeng-2013-0194
PG 7
WC Polymer Science
SC Polymer Science
GA AE8XZ
UT WOS:000334287600004
DA 2018-10-19
ER

PT J
AU Xing, ZC
   Chang, KW
   Chun, S
   Kim, S
   Kang, IK
AF Xing, Zhi-Cai
   Chang, Ki-Whan
   Chun, Sungsu
   Kim, Sukyoung
   Kang, Inn-Kyu
TI Immobilization of collagen on hydroxyapatite discs by covalent bonding
   and physical adsorption and their interaction with MC3T3-E1 osteoblasts
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE hydroxyapatite; collagen type I; immobilization; osteoblasts
ID CELL-ADHESION; I COLLAGEN; SCAFFOLD; PHENOTYPE; MATRIX; GROWTH;
   DIFFERENTIATION; POLY(L-LACTIDE); NANOPARTICLES; BIOMATERIAL
AB Hydroxyapatite (HA), a type of calcium phosphate mineral, shows high biological affinity to living bone and is widely used as a substitute for filling bone defects. The purpose of this study was to immobilize collagen on HA discs via covalent bonding and physical adsorption and to evaluate their interaction with MC3T3-E1 osteoblasts. Type I collagen was immobilized on the surface of sintered HA discs in two ways. The first way was to immobilize collagen covalently on the surface of a HA disc (HA-C) through a coupling agent, 3-aminopropyltriethoxysilane. The second one was to immobilize collagen on the surface of a HA disc in the manner of physical adsorption (HAhC). The surface properties of HA immobilized with collagen were characterized and compared with non-immobilized HA (control). The potentiality of collagen-immobilized HA discs for use as bone substitutes or scaffolds were assessed by culturing MC3T3-E1 osteoblasts on the discs. The osteoblasts were cultured for 4 and 68 h on HA discs to examine cell adhesion and proliferation, respectively. Alkaline phosphatase (ALP) activity assay was used to study the in vitro differentiation of MC3T3-E1 osteoblasts when cultured on the modified HA discs. From the results, it was apparent that the osteoblasts had proliferated more on the HA-C disc than on the HA-hC disc. The better proliferation was probably attributed to the higher amount of collagen covalently immobilized than that immobilized by physical adsorption. It was found, from the ALP activity assay, that HA-C showed better osteoblastic differentiation than HA-hC. It was considered that the higher ALP activity of HA-C was mainly expressed by the larger amount of collagen immobilized on the HA surface.
C1 [Xing, Zhi-Cai; Kang, Inn-Kyu] Kyungpook Natl Univ, Dept Polymer Sci & Engn, Taegu 702701, South Korea.
   [Chang, Ki-Whan] Daegu Hlth Coll, Dept Dent Technol, Taegu 702722, South Korea.
   [Chang, Ki-Whan; Chun, Sungsu; Kim, Sukyoung] Yeungnam Univ, Sch Mat Sci & Engn, Kyongsan 712749, Gyeonbuk, South Korea.
RP Kim, S (reprint author), Yeungnam Univ, Sch Mat Sci & Engn, Kyongsan 712749, Gyeonbuk, South Korea.
EM sykim@ynu.ac.kr; ikkang@knu.ac.kr
FU Ministry of Education, Science and Technology of Korea [2013 RIA
   2005148]
FX This work was supported from the General Research Program (2013 RIA
   2005148) from the Ministry of Education, Science and Technology of
   Korea.
CR Auclair-Daigle C, 2005, J BIOMED MATER RES A, V73A, P398, DOI 10.1002/jbm.a.30284
   Brunel G, 2001, J PERIODONTOL, V72, P257, DOI 10.1902/jop.2001.72.2.257
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Chiu JB, 2007, J BIOMED MATER RES A, V83A, P1117, DOI 10.1002/jbm.a.31279
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Cui YL, 2003, BIOMATERIALS, V24, P3859, DOI 10.1016/S0142-9612(03)00209-6
   Degirmenbasi N, 2006, COLLOID SURFACE B, V48, P42, DOI 10.1016/j.colsurfb.2006.01.002
   Hanagata N, 2006, BIOCHEM BIOPH RES CO, V344, P1234, DOI 10.1016/j.bbrc.2006.04.021
   Isama K, 2003, BIOMATERIALS, V24, P3303, DOI 10.1016/S0142-9612(03)00216-3
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kobayashi H, 2004, MAT SCI ENG C-BIO S, V24, P729, DOI 10.1016/j.msec.2004.08.038
   Lee DW, 2008, KEY ENG MATER, V396, P41
   Li XM, 2006, MAT SCI ENG C-BIO S, V26, P716, DOI 10.1016/j.msec.2005.06.062
   Lim S, 2012, TISSUE ENG REGEN MED, V9, P51, DOI 10.1007/s13770-012-0051-3
   LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005
   MASI L, 1992, CALCIFIED TISSUE INT, V51, P202, DOI 10.1007/BF00334548
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Monkawa A, 2006, MATER LETT, V60, P3647, DOI 10.1016/j.matlet.2006.03.076
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Richard M, 1998, CALCIFIED TISSUE INT, V62, P437, DOI 10.1007/s002239900456
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Wutticharoenmongkol P, 2007, BIOMACROMOLECULES, V8, P2602, DOI 10.1021/bm700451p
   Yamaura M, 2004, J MAGN MAGN MATER, V279, P210, DOI 10.1016/j.jmmm.2004.01.094
   Yunoki S, 2006, MATER LETT, V60, P999, DOI 10.1016/j.matlet.2005.10.064
NR 27
TC 1
Z9 1
U1 0
U2 19
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD APR
PY 2014
VL 11
IS 2
BP 99
EP 105
DI 10.1007/s13770-013-1107-8
PG 7
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AE7LI
UT WOS:000334179000001
DA 2018-10-19
ER

PT J
AU Zhang, P
   Cao, MY
AF Zhang, Ping
   Cao, Moyuan
TI Preparation of a novel organo-soluble chitosan grafted polycaprolactone
   copolymer for drug delivery
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Amphiphilic copolymer; Drug delivery system
ID CYTOTOXIC ACTIVITIES; RELEASE BEHAVIOR; MOLECULAR-WEIGHT; NANOPARTICLES;
   WATER; DEACETYLATION; DERIVATIVES; PH; TRANSFECTION; BIOMATERIAL
AB The unsatisfactory solubility of chitosan has been a key barrier to its modification and application. To improve its solubility, a novel organo-soluble glycidol grafted chitosan was developed as a potential material for bio-related applications. The hydrophilic glycidol was grafted onto the amino groups of chitosan via a facile and "green" aqueous reaction. The grafting levels of glycidol strongly influenced the organo-solubility and water-solubility of the chitosan due to the inhibition of its intermolecular interactions. The resulting glycidol grafted chitosan (Gly-HCS and Gly-LCS) was directly dissolved in dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). Taking advantage of the improved organo-solubility, an amphiphilic Gly-LCS grafted polycaprolactone (GC-g-PCL) copolymer and its assembly were prepared as an efficient anti-tumour doxorubicin (DOX) carrier. The DOX loaded GC-g-PCL assembly exhibited a control release profile and anti-tumour activity. Acting as a basic substrate, this organo-soluble chitosan derivative has the potential to meet a wide range of requirements in the field of biological macromolecules. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Cao, Moyuan] Beihang Univ, Sch Chem & Environm, Beijing 100191, Peoples R China.
   [Zhang, Ping] Qingdao Municipal Hosp, Qingdao 266011, Peoples R China.
RP Cao, MY (reprint author), Beihang Univ, Sch Chem & Environm, Xueyuan Rd 37, Beijing, Peoples R China.
EM caocmy@gmail.com
RI cao, moyuan/A-4011-2015
OI cao, moyuan/0000-0002-1528-3096
FU National Natural Science Foundation of China [21074112, 20674069];
   National Basic Research Program of China [2009CB930104]
FX We wish to thank Prof. Li-Qun Wang and Prof. Hongliang Jiang for
   assisting with this work. This work was financially supported by the
   National Natural Science Foundation of China (21074112, 20674069) and
   the National Basic Research Program of China (2009CB930104).
CR Abd El-Ghaffar MA, 2012, CARBOHYD POLYM, V89, P667, DOI 10.1016/j.carbpol.2012.03.074
   Anitha A, 2009, CARBOHYD POLYM, V78, P672, DOI 10.1016/j.carbpol.2009.05.028
   Babin M, 2012, CARBOHYD RES, V351, P87, DOI 10.1016/j.carres.2012.01.016
   Cai GQ, 2009, MACROMOL BIOSCI, V9, P256, DOI 10.1002/mabi.200800153
   Cai GQ, 2009, EUR POLYM J, V45, P1674, DOI 10.1016/j.eurpolymj.2009.03.007
   Cao MY, 2013, COLLOID SURFACE B, V109, P154, DOI 10.1016/j.colsurfb.2013.04.001
   Cao MY, 2012, J APPL POLYM SCI, V123, P3137, DOI 10.1002/app.34968
   Chang D, 2012, CARBOHYD POLYM, V88, P663, DOI 10.1016/j.carbpol.2012.01.020
   Chen C, 2011, J BIOMED MATER RES A, V96A, P116, DOI 10.1002/jbm.a.32965
   Chen HY, 2013, INT J BIOL MACROMOL, V55, P258, DOI 10.1016/j.ijbiomac.2013.01.018
   Cho J, 2006, BIOMACROMOLECULES, V7, P2845, DOI 10.1021/bm060436s
   Cui D, 2011, ADV MATER, V23, pH200, DOI 10.1002/adma.201100600
   Duan KR, 2010, CARBOHYD POLYM, V80, P498, DOI 10.1016/j.carbpol.2009.12.013
   Duan KR, 2010, COLLOID SURFACE B, V76, P475, DOI 10.1016/j.colsurfb.2009.12.007
   Honarkar H, 2009, MONATSH CHEM, V140, P1403, DOI 10.1007/s00706-009-0197-4
   JANSSEN MJH, 1985, INT J PHARM, V23, P1, DOI 10.1016/0378-5173(85)90217-0
   Je JY, 2006, BIOORG MED CHEM LETT, V16, P2122, DOI 10.1016/j.bmcl.2006.01.060
   Jiang XA, 2003, CARBOHYD POLYM, V54, P457, DOI 10.1016/j.carbpol.2003.05.004
   Kubota N, 2000, CARBOHYD RES, V324, P268, DOI 10.1016/S0008-6215(99)00263-3
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Layek B, 2012, CARBOHYD POLYM, V89, P403, DOI 10.1016/j.carbpol.2012.03.021
   Lee JK, 2002, BIOORG MED CHEM LETT, V12, P2949, DOI 10.1016/S0960-894X(02)00530-9
   Liu DZ, 2007, CARBOHYD POLYM, V68, P544, DOI 10.1016/j.carbpol.2006.10.019
   Liu L, 2004, EUR POLYM J, V40, P2739, DOI 10.1016/j.eurpolymj.2004.07.016
   Liu L, 2010, REACT FUNCT POLYM, V70, P301, DOI 10.1016/j.reactfunctpolym.2010.02.003
   Ma GP, 2009, CARBOHYD POLYM, V75, P390, DOI 10.1016/j.carbpol.2008.07.035
   Morimoto K, 2003, MOL THER, V7, P254, DOI 10.1016/S1525-0016(02)00053-9
   Nagpal K, 2013, INT J BIOL MACROMOL, V59, P20, DOI 10.1016/j.ijbiomac.2013.04.011
   Peng BL, 2010, CARBOHYD RES, V345, P101, DOI 10.1016/j.carres.2009.10.018
   Prabu P, 2008, J MATER SCI-MATER M, V19, P2157, DOI 10.1007/s10856-007-3307-z
   Qi LF, 2005, BIOORG MED CHEM LETT, V15, P1397, DOI 10.1016/j.bmcl.2005.01.010
   Qin CQ, 2002, POLYM DEGRAD STABIL, V76, P211, DOI 10.1016/S0141-3910(02)00016-2
   Rangel-Mendez JR, 2009, J HAZARD MATER, V162, P503, DOI 10.1016/j.jhazmat.2008.05.073
   Shi BY, 2012, BIOMACROMOLECULES, V13, P146, DOI 10.1021/bm201380e
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   Soo PL, 2002, LANGMUIR, V18, P9996, DOI 10.1021/la026339b
   Tan SC, 1998, TALANTA, V45, P713, DOI 10.1016/S0039-9140(97)00288-9
   Varma AJ, 2004, CARBOHYD POLYM, V55, P77, DOI 10.1016/j.carbpol.2003.08.005
   Varshosaz J, 2012, EXPERT OPIN DRUG DEL, V9, P509, DOI 10.1517/17425247.2012.673580
   Wang CQ, 2005, CHEM COMMUN, P3591, DOI 10.1039/b504428f
   Wang JT, 2011, INT J BIOL MACROMOL, V48, P523, DOI 10.1016/j.ijbiomac.2011.01.016
   Wu J, 2007, J BIOMED MATER RES A, V80A, P800, DOI 10.1002/jbm.a.30972
   Xu PS, 2007, ANGEW CHEM INT EDIT, V46, P4999, DOI 10.1002/anie.200605254
   Xu YM, 2003, BIOMATERIALS, V24, P5015, DOI 10.1016/S0142-9612(03)00408-3
   Zhang JL, 2010, MAR DRUGS, V8, P1962, DOI 10.3390/md8071962
   Zhang YQ, 2006, CARBOHYD POLYM, V65, P229, DOI 10.1016/j.carbpol.2005.08.066
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
NR 48
TC 11
Z9 12
U1 1
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD APR
PY 2014
VL 65
BP 21
EP 27
DI 10.1016/j.ijbiomac.2014.01.009
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AE6ID
UT WOS:000334092900004
PM 24418345
DA 2018-10-19
ER

PT J
AU Karunamoorthi, R
   Kumar, GS
   Prasad, AI
   Vatsa, RK
   Thamizhavel, A
   Girija, EK
AF Karunamoorthi, Rajavel
   Kumar, Govindan Suresh
   Prasad, Amresh Ishwar
   Vatsa, Rajesh Kumar
   Thamizhavel, Arumugum
   Girija, Easwaradas Kreedapathy
TI Fabrication of a Novel Biocompatible Magnetic Biomaterial with
   Hyperthermia Potential
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID BIOMEDICAL APPLICATIONS; NICKEL FERRITE; GLASS-CERAMICS; NANOCRYSTALLINE
   NICKEL; POLYETHYLENE-GLYCOL; COMPOSITE-MATERIAL; THERMAL-STABILITY;
   CANCER-TREATMENT; PARTICLE-SIZE; BONE CANCER
AB Preparation and characterization of a novel biocompatible magnetic biomaterial having hyperthermia potential is reported in this study. Fe3+ and Ni2+ (2:1) cosubstituted hydroxyapatite nanoparticles were synthesized by simple wet precipitation method followed by freeze-drying which on heat treatment at 1150 degrees C yielded the above mentioned biocompatible magnetic biomaterial composed of hydroxyapatite and -tricalcium phosphate along with nickel ferrite. The product was characterized by X-ray diffraction, Fourier transform infrared spectroscopy, and transmission electron microscope along with composition analysis. The magnetic behavior was analyzed by vibrating sample magnetometer and biocompatibility was assessed by testing the toxicity on Hela cells using MTT assay. The hyperthermia potential of the material was studied using induction heating. The prepared material has the potential to generate sufficient heat that could be easily controlled by magnetic field parameters and amount of sample. Hence, it can be a potential candidate for making implantable thermoseed for hyperthermia treatment.
C1 [Karunamoorthi, Rajavel; Kumar, Govindan Suresh; Girija, Easwaradas Kreedapathy] Periyar Univ, Dept Phys, Salem 636011, India.
   [Prasad, Amresh Ishwar; Vatsa, Rajesh Kumar] Bhabha Atom Res Ctr, Div Chem, Bombay 400085, Maharashtra, India.
   [Thamizhavel, Arumugum] Tata Inst Fundamental Res, Dept Condensed Matter Phys, Bombay 400005, Maharashtra, India.
RP Girija, EK (reprint author), Periyar Univ, Dept Phys, Salem 636011, India.
EM girijae@yahoo.com
RI Thamizhavel, Arumugam/A-1801-2011
OI Thamizhavel, Arumugam/0000-0003-1679-4370; Kumar, G.
   Suresh/0000-0003-4441-6107
FU Periyar University; CSIR, India; UGC India [41-1013/2012 SR]
FX One of the authors (RK) thanks Periyar University for providing
   fellowship under URF. Author GSK acknowledges CSIR, India for the award
   of Senior Research Fellowship. Author EKG expresses her thanks to UGC
   India (Project Ref. no. 41-1013/2012 SR) for financial support.
CR Andronescu E, 2010, J MATER SCI-MATER M, V21, P2237, DOI 10.1007/s10856-010-4076-7
   [Anonymous], 1099352009 ISO
   Ansar EB, 2012, J AM CERAM SOC, V95, P2695, DOI 10.1111/j.1551-2916.2011.05033.x
   Arcos D, 2003, J BIOMED MATER RES A, V65A, P71, DOI 10.1002/jbm.a.10445
   Bae S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2420769
   Bodhak S, 2011, MAT SCI ENG C-MATER, V31, P755, DOI 10.1016/j.msec.2011.01.003
   Cullity B. D., 2011, INTRO MAGNETIC MAT
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ergun C, 2008, J EUR CERAM SOC, V28, P2137, DOI 10.1016/j.jeurceramsoc.2008.03.007
   Fultz B, 2008, TRANSMISSION ELECT M
   Ghosh R, 2011, J MATER CHEM, V21, P13388, DOI 10.1039/c1jm10092k
   Girija EK, 2011, CERAM ENG SCI PROC, V32, P3
   Goldman A, 2006, MODERN FERRITES TECH
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hou CH, 2009, BIOMATERIALS, V30, P4700, DOI 10.1016/j.biomaterials.2009.05.018
   Hou CH, 2009, BIOMATERIALS, V30, P3956, DOI 10.1016/j.biomaterials.2009.04.020
   Jadhav NV, 2013, COLLOID SURFACE B, V108, P158, DOI 10.1016/j.colsurfb.2013.02.035
   Jordan A, 1999, J MAGN MAGN MATER, V201, P413, DOI 10.1016/S0304-8853(99)00088-8
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Khot VM, 2013, DALTON T, V42, P1249, DOI 10.1039/c2dt31114c
   Kobayashi H, 2010, J APPL PHYS, V107, DOI 10.1063/1.3355936
   Komath M, 2003, B MATER SCI, V26, P415, DOI 10.1007/BF02711186
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Levy M, 2011, CHEM MATER, V23, P4170, DOI 10.1021/cm201078f
   Levy M, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/20/204133
   Li GD, 2010, MAT SCI ENG C-MATER, V30, P148, DOI 10.1016/j.msec.2009.09.011
   Li YQ, 2012, J MATER SCI, V47, P730, DOI 10.1007/s10853-011-5846-4
   Low HR, 2008, INORG CHEM, V47, P11774, DOI 10.1021/ic801491t
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   Moghimi SM, 2001, PHARMACOL REV, V53, P283
   Mostafa NY, 2005, MATER CHEM PHYS, V94, P333, DOI 10.1016/j.matchemphys.2005.05.011
   Murakami S, 2008, J CERAM SOC JPN, V116, P950, DOI 10.2109/jcersj2.116.950
   Muzquiz-Ramos EM, 2010, MATER LETT, V64, P1117, DOI 10.1016/j.matlet.2010.02.025
   Nabiyouni G, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/12/126401
   Ningthoujam RS, 2012, FUNCTIONAL MATERIALS: PREPARATION, PROCESSING AND APPLICATIONS, P229, DOI 10.1016/B978-0-12-385142-0.00006-4
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Phadatare MR, 2012, J MAGN MAGN MATER, V324, P770, DOI 10.1016/j.jmmm.2011.09.020
   Prasad AI, 2013, DALTON T, V42, P4885, DOI 10.1039/c2dt32508j
   Qiang Y, 2006, J NANOPART RES, V8, P489, DOI 10.1007/s11051-005-9011-3
   Raynaud S, 2002, BIOMATERIALS, V23, P1065, DOI 10.1016/S0142-9612(01)00218-6
   Reyes-Gasga J, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/22/225407
   Salavati-Niasari M, 2009, POLYHEDRON, V28, P1455, DOI 10.1016/j.poly.2009.03.020
   Salimi MN, 2012, POWDER TECHNOL, V218, P109, DOI 10.1016/j.powtec.2011.11.049
   Schweiger C, 2011, INT J PHARMACEUT, V408, P130, DOI 10.1016/j.ijpharm.2010.12.046
   Singh RK, 2008, J MAGN MAGN MATER, V320, P1352, DOI 10.1016/j.jmmm.2007.11.007
   Sivakumar P, 2011, MATER RES BULL, V46, P2208, DOI 10.1016/j.materresbull.2011.09.009
   Sounderyal N., 2008, RECENT PAT BIOMED EN, V1, P34
   Tampieri A, 2012, ACTA BIOMATER, V8, P843, DOI 10.1016/j.actbio.2011.09.032
   Vallet-Regi M., 2008, BIOMIMETRIC NANOCERA
   WALDRON RD, 1955, PHYS REV, V99, P1727, DOI 10.1103/PhysRev.99.1727
   Wu HC, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/16/165601
   Wu SYH, 2010, J NANOPART RES, V12, P1173, DOI 10.1007/s11051-009-9734-7
   Yin H, 2005, BIOMATERIALS, V26, P5818, DOI 10.1016/j.biomaterials.2005.02.036
NR 57
TC 9
Z9 9
U1 3
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0002-7820
EI 1551-2916
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD APR
PY 2014
VL 97
IS 4
BP 1115
EP 1122
DI 10.1111/jace.12746
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AD8YB
UT WOS:000333550500020
DA 2018-10-19
ER

PT J
AU Ming, JF
   Liu, Z
   Bie, SY
   Zhang, F
   Zuo, BQ
AF Ming, Jinfa
   Liu, Zhi
   Bie, Shiyu
   Zhang, Feng
   Zuo, Baoqi
TI Novel silk fibroin films prepared by formic acid/hydroxyapatite
   dissolution method
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Silk fibroin; Hydroxyapatite; Film; Mechanical property
ID PHOSPHATE DIHYDRATE CRYSTALS; BOMBYX-MORI SILKWORM; MIDDLE DIVISION;
   RHEOLOGY; GROWTH; PH; CRYSTALLIZATION; REGENERATION; SCATTERING;
   STABILITY
AB Bombyx mori silk fibroin from the silkworm was firstly found to be soluble in formic acid/hydroxyapatite system. The theological behavior of silk fibroin solution was significantly influenced by HAp contents in dissolved solution. At the same time, silk fibroin nanofibers were observed in dissolved solution with 103.6 +/- 20.4 nm in diameter. Moreover, the structure behavior of SF films prepared by formic acid/hydroxyapatite dissolution method was examined. The secondary structure of silk fibroin films was attributed to silk II structure (beta-sheet), indicating that the hydroxyapatite contents in dissolved solution were not significantly affected by the structure of silk fibroin. The X-ray diffraction results exhibited obviously hydroxyapatite crystalline nature existing in silk fibroin films; however, when the hydroxyapatite content was 5.0 wt.% in dissolved solution, some hydroxyapatite crystals were converted to calcium hydrogen phosphate dehydrate in silk fibroin dissolution process. This result was also confirmed by Fourier transform infrared analysis and DSC measurement. In addition, silk fibroin films prepared by this dissolution method had higher breaking strength and extension at break. Based on these analyses, an understanding of novel SF dissolution method may provide an additional tool for designing and synthesizing advanced materials with more complex structures, which should be helpful in different fields, including biomaterial applications. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Ming, Jinfa; Liu, Zhi; Bie, Shiyu; Zuo, Baoqi] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Ming, Jinfa; Liu, Zhi; Bie, Shiyu; Zuo, Baoqi] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
   [Zhang, Feng] Soochow Univ, Coll Med, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
RP Zuo, BQ (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM jinfa.ming@gmail.com; bqzuo@suda.edu.cn
OI Ming, Jinfa/0000-0002-0791-8987
FU First Phase of Jiangsu Universities' Distinctive Discipline Development
   Program for Textile Science and Engineering of Soochow University;
   National Science Foundation of China [81271723]; Doctoral Candidate
   Academic Award Project of Soochow University [5832003611]; Jiangsu
   Province Ordinary Universities and Colleges Graduate Scientific and
   Innovation Plan [CXLX12_0815]; National Engineering Laboratory for
   Modern Silk
FX We gratefully acknowledged the support of the First Phase of Jiangsu
   Universities' Distinctive Discipline Development Program for Textile
   Science and Engineering of Soochow University, National Science
   Foundation of China (No. 81271723), Doctoral Candidate Academic Award
   Project of Soochow University (No. 5832003611), Jiangsu Province
   Ordinary Universities and Colleges Graduate Scientific and Innovation
   Plan (CXLX12_0815) and National Engineering Laboratory for Modern Silk.
CR Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fan SN, 2013, INT J BIOL MACROMOL, V56, P83, DOI 10.1016/j.ijbiomac.2013.01.033
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Ha SW, 2003, BIOMACROMOLECULES, V4, P488, DOI 10.1021/bm0255948
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762
   Joshi VS, 2003, CRYST RES TECHNOL, V38, P817, DOI 10.1002/crat.200310100
   Madhurambal G, 2009, J THERM ANAL CALORIM, V96, P73, DOI 10.1007/s10973-008-9841-1
   Ming JF, 2012, MATER CHEM PHYS, V137, P421, DOI 10.1016/j.matchemphys.2012.10.001
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   Ng SX, 2010, ACTA BIOMATER, V6, P3772, DOI 10.1016/j.actbio.2010.03.017
   Ochi A, 2002, BIOMACROMOLECULES, V3, P1187, DOI 10.1021/bm020056g
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Rajendran K, 2010, CRYST RES TECHNOL, V45, P939, DOI 10.1002/crat.200900700
   Rajkhowa R, 2011, J BIOMED MATER RES A, V97A, P37, DOI 10.1002/jbm.a.33021
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Suguna K., 2011, J MINER MAT CHARACT, V10, P625
   Sun MJ, 2012, J MATER CHEM, V22, P18372, DOI 10.1039/c2jm32576d
   Takahashi Y, 1999, INT J BIOL MACROMOL, V24, P127, DOI 10.1016/S0141-8130(98)00080-4
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang Q, 2012, BIOMACROMOLECULES, V13, P1875, DOI 10.1021/bm300387z
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang F, 2012, BIOMACROMOLECULES, V13, P798, DOI 10.1021/bm201719s
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
NR 33
TC 13
Z9 14
U1 3
U2 62
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2014
VL 37
BP 48
EP 53
DI 10.1016/j.msec.2013.12.041
PG 6
WC Materials Science, Biomaterials
SC Materials Science
GA AE2HZ
UT WOS:000333795200007
PM 24582221
DA 2018-10-19
ER

PT J
AU Frandsen, CJ
   Brammer, KS
   Noh, K
   Johnston, G
   Jin, S
AF Frandsen, Christine J.
   Brammer, Karla S.
   Noh, Kunbae
   Johnston, Gary
   Jin, Sungho
TI Tantalum coating on TiO2 nanotubes induces superior rate of matrix
   mineralization and osteofunctionality in human osteoblasts
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE TiO2 nanotubes; Tantalum; Osteoblast; Cell adhesion; Alkaline
   phosphatase activity; Matrix mineralization
ID MESENCHYMAL STEM-CELLS; IN-VITRO; SURFACE MODIFICATION; PROTEIN
   ADSORPTION; TITANIUM SURFACES; POROUS TANTALUM; OXIDE-FILMS; BONE;
   PROLIFERATION; ADHESION
AB Nanostructured surface geometries have been the focus of a multitude of recent biomaterial research, and exciting findings have been published. However, only a few publications have directly compared nanostructures of various surface chemistries. The work herein directly compares the response of human osteoblast cells to surfaces of identical nanotube geometries with two well-known orthopedic biomaterials: titanium oxide (TiO2) and tantalum (Ta). The results reveal that the Ta surface chemistry on the nanotube architecture enhances alkaline phosphatase activity, and promotes a similar to 30% faster rate of matrix mineralization and bone-nodule formation when compared to results on bare TiO2 nanotubes. This study implies that unique combinations of surface chemistry and nanostructure may influence cell behavior due to distinctive physico-chemical properties. These findings are of paramount importance to the orthopedics field for understanding cell behavior in response to subtle alterations in nanostructure and surface chemistry, and will enable further insight into the complex manipulation of biomaterial surfaces. With increased focus in the field of orthopedic materials research on nanostructured surfaces, this study emphasizes the need for careful and systematic review of variations in surface chemistry in concurrence with nanotopographical changes. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Frandsen, Christine J.; Brammer, Karla S.; Johnston, Gary; Jin, Sungho] Univ Calif San Diego, La Jolla, CA 92093 USA.
   [Noh, Kunbae] Cheil Ind Inc, Corp Res Inst, Uiwang Si 437711, Gyeonggi Do, South Korea.
RP Jin, S (reprint author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM jin@ucsd.edu
FU K. Iwama Endowed Chair fund at UC San Diego; UC [ele08-128656/Jin]
FX This work was supported by K. Iwama Endowed Chair fund at UC San Diego
   and UC Discovery/Kinamed Grant No. ele08-128656/Jin. The authors thank
   Mr. Clyde Pratt of Kinamed, Inc. for helpful discussions.
CR Balla VK, 2010, ACTA BIOMATER, V6, P2329, DOI 10.1016/j.actbio.2009.11.021
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brammer KS, 2011, ACTA BIOMATER, V7, P2697, DOI 10.1016/j.actbio.2011.02.039
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Dalby MJ, 2007, INT J NANOMED, V2, P373
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2009, NANOMEDICINE-UK, V4, P247, DOI [10.2217/nnm.09.1, 10.2217/NNM.09.1]
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Frandsen CJ, 2011, MAT SCI ENG C-MATER, V31, P1716, DOI 10.1016/j.msec.2011.07.016
   Gough JE, 2004, BIOMATERIALS, V25, P2039, DOI 10.1016/j.biomaterials.2003.07.001
   Hayashi M, 2012, ACTA BIOMATER, V8, P2411, DOI 10.1016/j.actbio.2012.03.010
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P459, DOI 10.1007/s11999-009-1090-5
   Kaivosoja E, 2013, J BIOMATER APPL, V27, P862, DOI 10.1177/0885328211428094
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Liang HC, 2010, SOLID STATE PHENOMEN, V162, P295, DOI 10.4028/www.scientific.net/SSP.162.295
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   McCafferty E, 1999, J ADHES SCI TECHNOL, V13, P1415, DOI 10.1163/156856199X00569
   Meirelles L, 2008, INT J ORAL MAX IMPL, V23, P641
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Miyazaki T, 2001, J SOL-GEL SCI TECHN, V21, P83, DOI 10.1023/A:1011265701447
   MOLLER K, 1994, CELL MATER, V4, P263
   Myllymaa S, 2010, J MATER SCI-MATER M, V21, P329, DOI 10.1007/s10856-009-3836-8
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   PARFITT GD, 1976, PURE APPL CHEM, V48, P415, DOI 10.1351/pac197648040415
   ROSS S, 2002, COLLOIDAL DISPERSION
   Roy M, 2010, ADV ENG MATER, V12, pB637, DOI 10.1002/adem.201080017
   Ruckh T, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045102
   Sagomonyants KB, 2011, J ORTHOP RES, V29, P609, DOI 10.1002/jor.21251
   SAVIO JA, 1994, CLIN MATER, V15, P101
   Schildhauer TA, 2006, J ORTHOP TRAUMA, V20, P476, DOI 10.1097/00005131-200608000-00005
   SHARMA CP, 1992, J BIOMED MATER RES, V26, P1179, DOI 10.1002/jbm.820260908
   Sista S, 2011, J BIOMED MATER RES A, V97A, P27, DOI 10.1002/jbm.a.33013
   Srivastav A., 2011, BIOMEDICAL ENG TREND
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stiehler M, 2008, J BIOMED MATER RES A, V86A, P448, DOI 10.1002/jbm.a.31602
   Sul YT, 2006, CLIN ORAL IMPLAN RES, V17, P521, DOI 10.1111/j.1600-0501.2005.01230.X
   Sul YT, 2005, BIOMATERIALS, V26, P6720, DOI 10.1016/j.biomaterials.2005.04.058
   Welldon KJ, 2008, J BIOMED MATER RES A, V84A, P691, DOI 10.1002/jbm.a.31336
   Yan X.Z., 2013, TISSUE ENG C
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   Zeng Q, 2005, KEY ENG MAT, V288-289, P315, DOI 10.4028/www.scientific.net/KEM.288-289.315
   Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0
NR 63
TC 27
Z9 27
U1 1
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 1
PY 2014
VL 37
BP 332
EP 341
DI 10.1016/j.msec.2014.01.014
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AE2HZ
UT WOS:000333795200043
PM 24582257
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Frese, J
   Morgenroth, A
   Mertens, ME
   Koch, S
   Rongen, L
   Vogg, ATJ
   Zlatopolskiy, BD
   Neumaier, B
   Gesche, VN
   Lammers, T
   Schmitz-Rode, T
   Mela, P
   Jockenhoevel, S
   Mottaghy, FM
   Kiessling, F
AF Frese, Julia
   Morgenroth, Agnieszka
   Mertens, Marianne E.
   Koch, Sabine
   Rongen, Lisanne
   Vogg, Andreas T. J.
   Zlatopolskiy, Boris D.
   Neumaier, Bernd
   Gesche, Valentine N.
   Lammers, Twan
   Schmitz-Rode, Thomas
   Mela, Petra
   Jockenhoevel, Stefan
   Mottaghy, Felix M.
   Kiessling, Fabian
TI Nondestructive monitoring of tissue-engineered constructs
SO BIOMEDICAL ENGINEERING-BIOMEDIZINISCHE TECHNIK
LA English
DT Article
DE extracellular matrix; imaging techniques; nondestructive analysis;
   quality management; tissue engineering
ID ENDOTHELIAL GROWTH-FACTOR; CELL-ADHESION MOLECULE-1; ED-B DOMAIN;
   IN-VIVO; EXTRACELLULAR-MATRIX; MAGNETIC-RESONANCE; MEMBRANE ANTIGEN;
   F-18-FDG PET/CT; PROSTATE-CANCER; TUMOR-DETECTION
AB Tissue engineering as a multidisciplinary field enables the development of living substitutes to replace, maintain, or restore diseased tissue and organs. Since the term was introduced in medicine in 1987, tissue engineering strategies have experienced significant progress. However, up to now, only a few substitutes were able to overcome the gap from bench to bedside and have been successfully approved for clinical use. Substantial donor variability makes it difficult to predict the quality of tissue-engineered constructs. It is essential to collect sufficient data to ensure that poor or immature constructs are not implanted into patients. The fulfillment of certain quality requirements, such as mechanical and structural properties, is crucial for a successful implantation. There is a clear need for new nondestructive and real-time online monitoring and evaluation methods for tissue-engineered constructs, which are applicable on the biomaterial, tissue, cellular, and subcellular levels. This paper reviews current established nondestructive techniques for implant monitoring including biochemical methods and noninvasive imaging.
C1 [Mertens, Marianne E.; Lammers, Twan; Kiessling, Fabian] Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Frese, Julia; Koch, Sabine; Rongen, Lisanne; Schmitz-Rode, Thomas; Mela, Petra; Jockenhoevel, Stefan] Rhein Westfal TH Aachen, Dept Tissue Engn & Text Implants, Helmholtz Inst Biomed Engn, Inst Appl Med Engn, D-52074 Aachen, Germany.
   [Morgenroth, Agnieszka; Vogg, Andreas T. J.; Zlatopolskiy, Boris D.; Mottaghy, Felix M.] Rhein Westfal TH Aachen, Univ Hosp, Dept Nucl Med, D-52074 Aachen, Germany.
   [Zlatopolskiy, Boris D.; Neumaier, Bernd] Max Planck Inst Neurol Res, D-50931 Cologne, Germany.
   [Gesche, Valentine N.] Rhein Westfal TH Aachen, Dept Tissue Engn & Text Implants, Inst Text Tech, D-52074 Aachen, Germany.
RP Kiessling, F (reprint author), Rhein Westfal TH Aachen, Dept Expt Mol Imaging, Helmholtz Inst Biomed Engn, Pauwelsstr 30, D-52074 Aachen, Germany.
EM fkiessling@ukaachen.de
RI Zlatopolskiy, Boris/W-3521-2017
OI Zlatopolskiy, Boris/0000-0001-5818-1260; Neumaier,
   Bernd/0000-0001-5425-3116; Jockenhoevel, Stefan/0000-0003-0584-9444;
   Schmitz-Rode, Thomas/0000-0002-1181-2165
FU European Union (ERDF - European Regional Development Fund - Investing in
   your future); German federal state North Rhine-Westphalia (NRW)
FX This review is a result of a collaboration project between the
   Department of Tissue Engineering and Textile Implants, Institute of
   Applied Medical Engineering of the University Hospital Aachen,
   Department of Nuclear Medicine of the University Hospital Aachen,
   Department of Experimental Molecular Imaging of the University Hospital
   Aachen, Max Planck Institute for Neurological Research of the University
   Hospital Aachen, Department of Tissue Engineering and Textile Implants,
   Institut fur Textiltechnik, RWTH Aachen University. The project is
   cofunded by the European Union (ERDF - European Regional Development
   Fund - Investing in your future) and the German federal state North
   Rhine-Westphalia (NRW), under the operational program "Regional
   Competitiveness and Employment" 2007-2013 (EFRE).
CR Achenbach S, 2004, CIRCULATION, V109, P14, DOI 10.1161/01.CIR.0000111517.69230.0F
   Ansar Malek Masoud, 2012, Adv Biomed Res, V1, P24, DOI 10.4103/2277-9175.98145
   Arima V, 2013, LAB CHIP, V13, P2328, DOI 10.1039/c3lc00055a
   Barrett JA, 2013, J NUCL MED, V54, P380, DOI 10.2967/jnumed.112.111203
   Beckers C, 2006, EUR J NUCL MED MOL I, V33, P275, DOI 10.1007/s00259-005-1952-3
   Boerboom RA, 2007, J STRUCT BIOL, V159, P392, DOI 10.1016/j.jsb.2007.04.008
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Brauchle E, 2013, BIOTECHNOL J, V8, P288, DOI 10.1002/biot.201200163
   Cai WB, 2006, J NUCL MED, V47, P2048
   Charrier-Hisamuddin L, 2008, FASEB J, V22, P641, DOI 10.1096/fj.07-8876rev
   Cheng HLM, 2012, NMR BIOMED, V25, P418, DOI 10.1002/nbm.1617
   Cho SY, 2012, J NUCL MED, V53, P1883, DOI 10.2967/jnumed.112.104661
   Crofford LJ, 1997, J RHEUMATOL, V24, P15
   Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733
   Demartis S, 2001, EUR J NUCL MED, V28, P534, DOI 10.1007/s002590100480
   Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027
   Fite BZ, 2011, TISSUE ENG PART C-ME, V17, P495, DOI 10.1089/ten.tec.2010.0368
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI 10.1089/ten.TEA.2009.0018
   Frese J, 2012, BIOMED TECH S, V57, P87
   Frese J, 2012, BIOMED TECHNOL BE S1, V57, P1065
   Furumoto S, 2003, NUCL MED BIOL, V30, P119, DOI 10.1016/S0969-8051(02)00393-1
   Gordon IO, 2008, MODERN PATHOL, V21, P1421, DOI 10.1038/modpathol.2008.143
   Gremse F, 2011, RADIOLOGY, V260, P709, DOI 10.1148/radiol.11110069
   Grizzle WE, 2009, BIOTECH HISTOCHEM, V84, P185, DOI 10.1080/10520290903039052
   Hagenmueller H, 2007, ANN BIOMED ENG, V35, P1657, DOI 10.1007/s10439-007-9338-2
   Haller N, 2013, ASAIO J, V59, P169, DOI 10.1097/MAT.0b013e31827db6b6
   Herzog H, 2001, RADIOCHIM ACTA, V89, P203, DOI 10.1524/ract.2001.89.4-5.203
   Jayapaul J, 2011, BIOMATERIALS, V32, P5863, DOI 10.1016/j.biomaterials.2011.04.056
   Kalliokoski T, 2005, DIABETES RES CLIN PR, V70, P217, DOI 10.1016/j.diabres.2005.04.008
   Keidar Z, 2007, J NUCL MED, V48, P1230, DOI 10.2967/junmed.107.040253
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Konig K, 2005, BIOMATERIALS, V26, P495, DOI 10.1016/j.biomaterials.2004.02.059
   Kramer NA, 2010, INVEST RADIOL, V45, P477, DOI 10.1097/RLI.0b013e3181e53e38
   Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013
   Kreitz S, 2011, TISSUE ENG PART C-ME, V17, P1021, DOI [10.1089/ten.TEC.2010.0669, 10.1089/ten.tec.2010.0669]
   Lees JG, 2007, REGEN MED, V2, P289, DOI 10.2217/17460751.2.3.289
   LIBBY P, 1993, J CLIN INVEST, V92, P538, DOI 10.1172/JCI116620
   MCAFEE JG, 1976, J NUCL MED, V17, P480
   Mees G, 2012, J NUCL MED, V53, P464, DOI 10.2967/jnumed.111.095794
   Mertens M. E., 2013, ADV FUNCT M IN PRESS
   Meyer U, 2009, FUNDAMENTALS TISSUE, P5, DOI DOI 10.1007/978-3-540-77755-7
   Miyata S, 2007, J BIOMECH, V40, P2990, DOI 10.1016/j.jbiomech.2007.02.002
   Nahrendorf M, 2009, JACC-CARDIOVASC IMAG, V2, P1213, DOI 10.1016/j.jcmg.2009.04.016
   Nakamura A, 2009, TISSUE ENG PART C-ME, V15, P169, DOI 10.1089/ten.tec.2007.0334
   Nelson GN, 2008, FASEB J, V22, P3888, DOI 10.1096/fj.08-107367
   Pandit A, 2003, EUR CELLS MATER, V6, P25
   Papos M, 1996, J NUCL MED, V37, P400
   Pascali G, 2013, NUCL MED BIOL, V40, P776, DOI 10.1016/j.nucmedbio.2013.04.004
   Perea H, 2007, J TISSUE ENG REGEN M, V1, P318, DOI 10.1002/term.32
   Popp JR, 2012, J MED DEVICES, V6, DOI 10.1115/1.4006546
   Potter K, 2006, BONE, V38, P350, DOI 10.1016/j.bone.2005.08.025
   Rice MA, 2009, ACTA BIOMATER, V5, P152, DOI 10.1016/j.actbio.2008.07.036
   Russell AJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P15, DOI 10.1016/B978-012370615-7/50007-X
   Santimaria M, 2003, CLIN CANCER RES, V9, P571
   Schenke-Layland K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1896966
   Schenke-Layland K, 2006, ADV DRUG DELIVER REV, V58, P878, DOI 10.1016/j.addr.2006.07.004
   SEABOLD JE, 1989, AM J ROENTGENOL, V152, P1021, DOI 10.2214/ajr.152.5.1021
   Song G, 2008, TRANSPL P, V40, P2720, DOI 10.1016/j.transproceed.2008.07.110
   Spacek M, 2009, EUR J NUCL MED MOL I, V36, P850, DOI 10.1007/s00259-008-1002-z
   Tuan HS, 2005, COMPUT AIDED DESIGN, V37, P1151, DOI 10.1016/j.cad.2005.02.006
   Tuemen M, 2013, ANN BIOMED ENG, V41, P883, DOI 10.1007/s10439-012-0734-x
   Uddin MJ, 2011, CANCER PREV RES, V4, P1536, DOI 10.1158/1940-6207.CAPR-11-0120
   Uddin MJ, 2011, ACS MED CHEM LETT, V2, P160, DOI 10.1021/ml100232q
   Uddin MJ, 2010, CANCER RES, V70, P3618, DOI 10.1158/0008-5472.CAN-09-2664
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Wang M, 2010, OSTEOARTHR CARTILAGE, V18, P1417, DOI 10.1016/j.joca.2010.08.009
   Weinbaum JS, 2010, TISSUE ENG PART C-ME, V16, P459, DOI [10.1089/ten.tec.2009.0112, 10.1089/ten.TEC.2009.0112]
   WELLS PNT, 1977, PHYS MED BIOL, V22, P629, DOI 10.1088/0031-9155/22/4/001
   Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851
   Yang WF, 2012, EUR J NUCL MED MOL I, V39, P1289, DOI 10.1007/s00259-012-2126-8
   Zanzonico P, 2012, RADIAT RES, V177, P349, DOI 10.1667/RR2577.1
   Zhang JS, 2012, ARTERIOSCL THROM VAS, V32, P1849, DOI 10.1161/ATVBAHA.112.252510
NR 72
TC 3
Z9 3
U1 0
U2 23
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0013-5585
EI 1862-278X
J9 BIOMED ENG-BIOMED TE
JI Biomed. Eng.-Biomed. Tech.
PD APR
PY 2014
VL 59
IS 2
SI SI
BP 165
EP 175
DI 10.1515/bmt-2013-0029
PG 11
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA AE0OM
UT WOS:000333665600010
PM 24021591
DA 2018-10-19
ER

PT J
AU Bassi, G
   Guilloton, F
   Menard, C
   Di Trapani, M
   Pacelli, L
   Carusone, R
   Midolo, M
   Amati, E
   Bezier, I
   Deschaseaux, F
   Sensebe, L
   Baroth, S
   Schrezenmeier, H
   Rojewski, M
   Layrolle, P
   Giordano, R
   Lavazza, C
   Lazzari, L
   Bourin, P
   Dominici, M
   Tarte, K
   Krampera, M
AF Bassi, G.
   Guilloton, F.
   Menard, C.
   Di Trapani, M.
   Pacelli, L.
   Carusone, R.
   Midolo, M.
   Amati, E.
   Bezier, I.
   Deschaseaux, F.
   Sensebe, L.
   Baroth, S.
   Schrezenmeier, H.
   Rojewski, M.
   Layrolle, P.
   Giordano, R.
   Lavazza, C.
   Lazzari, L.
   Bourin, P.
   Dominici, M.
   Tarte, K.
   Krampera, M.
TI EFFECTS OF A NOVEL CERAMIC BIOMATERIAL ON IMMUNE MODULATORY PROPERTIES
   AND DIFFERENTIATION POTENTIAL OF MESENCHYMAL STROMAL CELLS
SO CYTOTHERAPY
LA English
DT Meeting Abstract
C1 [Bassi, G.; Di Trapani, M.; Pacelli, L.; Carusone, R.; Midolo, M.; Amati, E.; Krampera, M.] Univ Verona, Dept Med, Sect Hematol, Stem Cell Res Lab, I-37100 Verona, Veneto, Italy.
   [Guilloton, F.; Deschaseaux, F.; Sensebe, L.; Bourin, P.] Univ Toulouse 3, EFS Pyrenees Mediterranee, UMR5273, INSERM,U1031, F-31062 Toulouse, France.
   [Menard, C.; Bezier, I.; Tarte, K.] Univ Rennes 1, INSERM, U917, Rennes, France.
   [Baroth, S.] Biomatlante SAS, Vigneux De Bretagne, France.
   [Schrezenmeier, H.; Rojewski, M.] Univ Ulm, Inst Transfus Med, D-89069 Ulm, Germany.
   [Schrezenmeier, H.; Rojewski, M.] German Red Cross Blood Donor Serv Baden Wurttembe, Ulm, Germany.
   [Layrolle, P.] Fac Med, INSERM, U957, LPRO, Nantes, France.
   [Giordano, R.; Lavazza, C.; Lazzari, L.] Fdn IRCCS Ca, Milan, Italy.
   [Bourin, P.] CSA21, Toulouse, France.
   [Dominici, M.] Univ Hosp Modena & Reggio Emilia, Modena, Italy.
RI Di Trapani, Mariano/J-9877-2016; Layrolle, Pierre/K-9257-2015; Lavazza,
   Cristiana/D-5661-2013
OI Di Trapani, Mariano/0000-0002-3077-8038; Layrolle,
   Pierre/0000-0001-9800-5210; Lavazza, Cristiana/0000-0002-1167-6167;
   Rojewski, Markus/0000-0003-4265-0442
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1465-3249
EI 1477-2566
J9 CYTOTHERAPY
JI Cytotherapy
PD APR
PY 2014
VL 16
IS 4
SU S
MA 318
BP S90
EP S91
DI 10.1016/j.jcyt.2014.01.336
PG 2
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA AD7IT
UT WOS:000333438100304
DA 2018-10-19
ER

PT J
AU Guarnieri, R
   Placella, R
   Testarelli, L
   Iorio-Siciliano, V
   Grande, M
AF Guarnieri, Renzo
   Placella, Roberto
   Testarelli, Luca
   Iorio-Siciliano, Vincenzo
   Grande, Maurizio
TI Clinical, Radiographic, and Esthetic Evaluation of Immediately Loaded
   Laser Microtextured Implants Placed into Fresh Extraction Sockets in the
   Anterior Maxilla: A 2-Year Retrospective Multicentric Study
SO IMPLANT DENTISTRY
LA English
DT Article
DE immediate implants; immediate loading; maxillary esthetic zone; tooth
   extraction; therapy; laser microtextured collar surface
ID SINGLE-TOOTH IMPLANTS; SOFT-TISSUE RESPONSE; DEFINED BIOMATERIAL
   SURFACES; GUIDED BONE REGENERATION; DENTAL IMPLANTS; CASE SERIES;
   HISTOLOGIC EVIDENCE; HEALED SITES; HARD; PROVISIONALIZATION
AB Objectives:To assess the clinical, radiographic, and esthetic outcomes of implants with a laser microtextured collar placed in the anterior region of the maxilla at the time of tooth extraction and immediately temporized.Methods:Forty-six Tapered Internal Laser-Lok BioHorizons implants were immediately placed and immediately restored with nonfunctional loading in 46 patients (24 men and 22 women) with a thick gingival biotype, ideal gingival level/contour, and postextraction intact walls. Survival rate, cortical bone loss, and periimplant mucosal responses were evaluated at 6, 12, and 24 months.Results:Survival rate was 95.6%. Mean mesial and distal marginal bone loss, 24 months after installation, were 0.58 mm (SD = 0.53; range, 0.17-1.15) and 0.57 mm (SD = 0.70; range, 0.42-1.10), respectively. A mesial and distal papilla regrowth mean of 1.8 and 1.5 mm, respectively, were found. The midfacial soft tissue levels showed 0.12 mm of mean recession after 24 months.Conclusion:Immediate implants with a laser microtextured surface restored at the day of surgery, may be considered as a predictable procedure in terms of implant survival and hard and soft tissue remodeling.
C1 [Testarelli, Luca] Univ Roma La Sapienza, I-00185 Rome, Italy.
   [Iorio-Siciliano, Vincenzo] Univ Naples Federico II, Dept Periodontol, Naples, Italy.
RP Guarnieri, R (reprint author), Via Paolo Emilio,7 Int 5, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
FU Classimplant S.R.L., Rome, Italy
FX The study was supported by Classimplant S.R.L., Rome, Italy, providing
   materials and funding.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   ALBREKTSSON T, 1986, DENT CLIN N AM, V30, P151
   Alexander H, 2009, J BIOMED MATER RES B, V23, P200
   Araujo MG, 2006, CLIN ORAL IMPLAN RES, V17, P615, DOI 10.1111/j.1600-0501.2006.01317.x
   Araujo MG, 2005, J CLIN PERIODONTOL, V32, P645, DOI 10.1111/j.1600-051X.2005.00726.x
   Barone A, 2006, J PERIODONTOL, V77, P1914, DOI 10.1902/jop.2006.060072
   Belser UC, 2009, J PERIODONTOL, V80, P140, DOI [10.1902/jop.2009.080435, 10.1902/jop.2009.080435 ]
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Block MS, 2009, J ORAL MAXIL SURG, V67, P89, DOI 10.1016/j.joms.2009.07.009
   Botos S, 2011, INT J ORAL MAX IMPL, V26, P492
   Botticelli D, 2004, J CLIN PERIODONTOL, V31, P820, DOI 10.1111/j.1600-051X.2004.00565.x
   Buser D, 2004, INT J ORAL MAX IMPL, V19, P43
   Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x
   Buser D, 2009, J PERIODONTOL, V80, P152, DOI [10.1902/jop.2009.080360, 10.1902/jop.2009.080360 ]
   Calvo Guirado JL, 2002, J IR DENT ASS, V48, P43
   Cardaropoli G, 2006, CLIN ORAL IMPLAN RES, V17, P165, DOI 10.1111/j.1600-0501.2005.01210.x
   Chaushu G, 2001, INT J ORAL MAX IMPL, V16, P267
   Chen ST, 2007, CLIN ORAL IMPLAN RES, V18, P552, DOI 10.1111/j.1600-0501.2007.01388.x
   Chen ST, 2009, J PERIODONTOL, V80, P163, DOI [10.1902/jop.2009.080243, 10.1902/jop.2009.080243 ]
   Choquet V, 2001, J PERIODONTOL, V72, P1364, DOI 10.1902/jop.2001.72.10.1364
   Cornelini R, 2005, INT J PERIODONT REST, V25, P439
   Cosyn J, 2012, CLIN IMPLANT DENT R, V14, P517, DOI 10.1111/j.1708-8208.2010.00300.x
   Cosyn J, 2011, J CLIN PERIODONTOL, V38, P746, DOI 10.1111/j.1600-051X.2011.01748.x
   De Bruyn H, 2011, CLIN IMPLANT DENT R, V13, P175, DOI 10.1111/j.1708-8208.2009.00200.x
   De Rouck T, 2008, INT J ORAL MAX IMPL, V23, P897
   De Rouck T, 2008, J CLIN PERIODONTOL, V35, P649, DOI 10.1111/j.1600-051X.2008.01235.x
   De Rouck T, 2009, CLIN ORAL IMPLAN RES, V20, P566, DOI 10.1111/j.1600-0501.2008.01674.x
   den Hartog L, 2008, J CLIN PERIODONTOL, V35, P1073, DOI 10.1111/j.1600-051X.2008.01330.x
   Eghbali A, 2012, CLIN IMPLANT DENT R, V14, P336, DOI 10.1111/j.1708-8208.2010.00283.x
   Evans CDJ, 2008, CLIN ORAL IMPLAN RES, V19, P73, DOI 10.1111/j.1600-0501.2007.01413.x
   Furhauser R, 2005, CLIN ORAL IMPLAN RES, V16, P639, DOI 10.1111/j.1600-0501.2005.01193.x
   Gelb D A, 1993, Int J Oral Maxillofac Implants, V8, P388
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Henriksson K, 2004, CLIN IMPLANT DENT R, V6, P181
   Henry P J, 1996, Int J Oral Maxillofac Implants, V11, P450
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Jemt T, 1997, INT J PERIODONT REST, V17, P327
   Jemt T, 1990, Int J Periodontics Restorative Dent, V10, P340
   Juodzbalys G, 2007, CLIN ORAL IMPLAN RES, V18, P237, DOI 10.1111/j.1600-0501.2006.01312.x
   Kan JYK, 2007, J ORAL MAXIL SURG, V65, P13, DOI 10.1016/j.joms.2007.04.006
   Kan JYK, 2003, J PERIODONTOL, V74, P557, DOI 10.1902/jop.2003.74.4.557
   Kan JYK, 2003, INT J ORAL MAX IMPL, V18, P31
   Lai HC, 2008, CLIN ORAL IMPLAN RES, V19, P560, DOI 10.1111/j.1600-0501.2008.01522.x
   Lang NP, 2012, CLIN ORAL IMPLAN RES, V23, P39, DOI 10.1111/j.1600-0501.2011.02372.x
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Nisapakultorn K, 2010, CLIN ORAL IMPLAN RES, V21, P662, DOI 10.1111/j.1600-0501.2009.01887.x
   Nkenke E, 2006, CLIN ORAL IMPLAN RES, V17, P19, DOI 10.1111/j.1600-0501.2006.01348.x
   Norton MR, 2004, INT J ORAL MAX IMPL, V19, P274
   Ostman PO, 2008, INT J ORAL MAX IMPL, V23, P315
   Ostman PO, 2005, CLIN IMPLANT DENT R, V7, pS60, DOI 10.1111/j.1708-8208.2005.tb00076.x
   Palmer RM, 2000, CLIN ORAL IMPLAN RES, V11, P179, DOI 10.1111/j.1600-0501.2000.tb00012.x
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Raes F, 2011, J CLIN PERIODONTOL, V38, P385, DOI 10.1111/j.1600-051X.2010.01687.x
   Redemagni M, 2009, INT J ESTHET DENT, V4, P328
   Ricci J, 2000, BONE ENG, P282
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Shapoff CA, 2010, INT J PERIODONT REST, V30, P129
   Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x
   Studer S, 1994, Pract Periodontics Aesthet Dent, V6, P51
   Studer S, 1994, PRACT PERIODONTICS A, V6, P62
   TARNOW DP, 1992, J PERIODONTOL, V63, P995, DOI 10.1902/jop.1992.63.12.995
   Testori T, 2004, CLIN ORAL IMPLAN RES, V15, P278, DOI 10.1111/j.1600-0501.2004.01013.x
   Turkyilmaz I, 2007, CLIN IMPLANT DENT R, V9, P222, DOI 10.1111/j.1708-8208.2007.00045.x
   Wennstrom JL, 2005, J CLIN PERIODONTOL, V32, P567, DOI 10.1111/j.1600-051X.2005.00715.x
   Wohrle P S, 1998, Pract Periodontics Aesthet Dent, V10, P1107
   Wohrle PS, 1998, PRACT PERIODONTICS A, V10, P1116
NR 69
TC 9
Z9 9
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1056-6163
J9 IMPLANT DENT
JI Implant Dent.
PD APR
PY 2014
VL 23
IS 2
BP 144
EP 154
DI 10.1097/ID.0000000000000061
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AD9EU
UT WOS:000333568400009
PM 24637532
DA 2018-10-19
ER

PT J
AU Boccafoschi, F
   Mosca, C
   Cannas, M
AF Boccafoschi, F.
   Mosca, C.
   Cannas, M.
TI Cardiovascular biomaterials: when the inflammatory response helps to
   efficiently restore tissue functionality?
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Review
DE device implantation; inflammatory response; synthetic polymers; wound
   healing responses; cardiovascular biomaterials
ID SELF-ASSEMBLED MONOLAYERS; HUMAN-ENDOTHELIAL-CELLS; MULTINUCLEATED
   GIANT-CELLS; FLUID SHEAR-STRESS; EXPANDED MICROPOROUS
   POLYTETRAFLUOROETHYLENE; HYALURONAN-BASED SCAFFOLD; FACTOR PATHWAY
   INHIBITOR; ARTERIAL GRAFT FAILURE; MESENCHYMAL STEM-CELLS; FOREIGN-BODY
   REACTION
AB The evaluation of biological host response to implanted materials permits the determination of the safety and biocompatibility of biomedical devices, prostheses and biomaterials. Once a biomaterial is introduced into the body to a corresponding implant site, a sequence of events occurs promoting the activation of inflammatory mediators such as leukocytes and the release of signaling molecules such as cytokines and growth factors, evoking an inflammatory and wound healing process. This review examines the cellular and molecular mechanisms involved in the foreign body reaction, especially how cytokines impact the overall inflammatory response to devices. It also reviews how these events can be modulated by the physical and chemical properties of the biomaterials such as wettability, chemistry and geometry of surface. Particular attention is dedicated to the cardiovascular field, where the use of synthetic polymers has several limitations such as thrombogenicity and risk of infection. New materials and strategies to improve biomaterial characteristics are discussed. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Boccafoschi, F.; Mosca, C.; Cannas, M.] Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy.
RP Boccafoschi, F (reprint author), Univ Piemonte Orientale, Dept Hlth Sci, I-28100 Novara, Italy.
EM francesca.boccafoschi@med.unipmn.it
OI Boccafoschi, Francesca/0000-0002-6734-5447
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Alcantara EM, 2005, APPL ENG MECH MED
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   Anderson J, 2011, SEMIN IMMUNOPATHOL, V33, P221, DOI 10.1007/s00281-011-0244-1
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 1999, TIS ENGN INTELL UNIT, V1, P197
   Anderson JM, 2004, BIOMATERIALS SCI INT, P771
   Anderson JM, 2004, BIOMATERIAL SCI INTR, P296
   Anderson JM, 2004, BIOMATERIALS SCI INT, P360
   Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Arshady R., 2003, INTRO POLYM BIOMATER, P1
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bellon JM, 1996, J BIOMED MATER RES, V31, P1, DOI 10.1002/(SICI)1097-4636(199605)31:1<1::AID-JBM1>3.0.CO;2-S
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   BHAGYALAKSHMI A, 1989, BIOCHEM BIOPH RES CO, V158, P31, DOI 10.1016/S0006-291X(89)80172-X
   BIRK DE, 1981, EXP EYE RES, V32, P331, DOI 10.1016/0014-4835(81)90038-5
   BLUMENBERG RM, 1991, J VASC SURG, V14, P175
   BORETOS JW, 1967, SCIENCE, V158, P1481, DOI 10.1126/science.158.3807.1481
   Boretos JW, 1984, CONT BIOMATERIALS MA, P232
   Brass LF, 1991, HEMATOLOGY BASIC PRI, P1176
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   BULL DA, 1995, J SURG RES, V58, P58, DOI 10.1006/jsre.1995.1010
   Burkatovskaya M, 2006, BIOMATERIALS, V27, P4157, DOI 10.1016/j.biomaterials.2006.03.028
   Butler DL, 2010, NAT PROTOC, V5, P849, DOI 10.1038/nprot.2010.14
   CAMPBELL CD, 1975, ANN SURG, V182, P138, DOI 10.1097/00000658-197508000-00010
   CAMPBELL CD, 1976, SURGERY, V79, P485
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Clagett GP, 1987, HEMOSTASIS THROMBOSI, P1348
   Clarke ML, 2005, J PHYS CHEM B, V109, P22027, DOI 10.1021/jp054456k
   CLOWES AW, 1986, J VASC SURG, V3, P877, DOI 10.1067/mva.1986.avs0030877
   CLOWES AW, 1985, AM J PATHOL, V118, P43
   Collier TO, 2002, J BIOMED MATER RES, V60, P487, DOI 10.1002/jbm.10043
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   de Mel A, 2009, BIO-MED MATER ENG, V19, P317, DOI 10.3233/BME-2009-0597
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DIAMOND SL, 1989, SCIENCE, V243, P1483, DOI 10.1126/science.2467379
   Duarte ML, 2001, INT J BIOL MACROMOL, V28, P359, DOI 10.1016/S0141-8130(01)00134-9
   ERTEL SI, 1990, J BIOMED MATER RES, V24, P1637, DOI 10.1002/jbm.820241207
   Eskin S. G., 2004, BIOMATERIALS SCI INT, P237
   Evans-Nguyen KM, 2005, BIOCHEMISTRY-US, V44, P15561, DOI 10.1021/bi0514358
   FALK E, 1996, ATHEROSCLEROSIS CORO, V2, P492
   Faries PL, 2000, J VASC SURG, V32, P1080, DOI 10.1067/mva.2000.111279
   Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   Galbusera M, 1997, BLOOD, V90, P1558
   Garlanda C, 1997, ARTERIOSCL THROM VAS, V17, P1193, DOI 10.1161/01.ATV.17.7.1193
   George J, 2008, J BIOMED MATER RES A, V87A, P1103, DOI 10.1002/jbm.a.32277
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Gibbons D.F., 1992, DEGRADATION PHENOMEN, V1994, P97
   Gimbrone MA, 1986, VASCULAR ENDOTHELIUM, P1
   Giordano C, 2006, J BIOMATER APPL, V20, P237, DOI 10.1177/0885328206051811
   Girard PP, 2007, SOFT MATTER, V3, P307, DOI 10.1039/b614008d
   Grabowski EF, 2001, ARTERIOSCL THROM VAS, V21, P157, DOI 10.1161/01.ATV.21.1.157
   Greisler H P, 1990, Ann Vasc Surg, V4, P98, DOI 10.1007/BF02042699
   GUIDOIN R, 1993, BIOMATERIALS, V14, P678, DOI 10.1016/0142-9612(93)90067-C
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HAMILTON KK, 1990, BLOOD, V76, P2572
   Han D, 2006, NANOMED-NANOTECHNOL, V2, P37, DOI 10.1016/j.nano.2006.01.002
   Hao T, 2010, OSTEOARTHR CARTILAGE, V18, P257, DOI 10.1016/j.joca.2009.08.007
   Heden P, 2009, AESTHET PLAST SURG, V33, P274, DOI 10.1007/s00266-008-9303-y
   Helary C, 2010, BIOMATERIALS, V31, P481, DOI 10.1016/j.biomaterials.2009.09.073
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   HERRING M, 1979, ARCH SURG-CHICAGO, V114, P679
   HESS F, 1992, J CARDIOVASC SURG, V33, P358
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   HORBETT TA, 1985, J COLLOID INTERF SCI, V104, P28, DOI 10.1016/0021-9797(85)90006-2
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Ikeda T, 1998, BIOCHEM BIOPH RES CO, V253, P265, DOI 10.1006/bbrc.1998.9702
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014
   Jeschke B, 2002, BIOMATERIALS, V23, P3455, DOI 10.1016/S0142-9612(02)00052-2
   Jin XB, 2008, J BIOMED MATER RES A, V86A, P1077, DOI 10.1002/jbm.a.31656
   JOHNSTON RB, 1988, NEW ENGL J MED, V318, P747, DOI 10.1056/NEJM198803243181205
   JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kenney D, 1998, ASAIO T, V34, P661
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kidoaki S, 1999, LANGMUIR, V15, P7639, DOI 10.1021/la990357k
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   KOGEL H, 1989, THORAC CARDIOV SURG, V37, P119, DOI 10.1055/s-2007-1020302
   KOHLER TR, 1992, SURGERY, V112, P901
   Krane SM, 2008, AMINO ACIDS, V35, P703, DOI 10.1007/s00726-008-0073-2
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Levin EG, 1997, J CELL SCI, V110, P139
   LIBBY P, 1996, ATHEROSCLEROSIS CORO, V1, P585
   Lidington EA, 2000, BLOOD, V96, P2784
   Lim JY, 2008, BIOMATERIALS, V29, P1776, DOI 10.1016/j.biomaterials.2007.12.026
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   LU DR, 1991, J COLLOID INTERF SCI, V144, P271, DOI 10.1016/0021-9797(91)90258-A
   Lu HJ, 2009, J MATER SCI-MATER M, V20, P1937, DOI 10.1007/s10856-009-3744-y
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Maguire T, 2007, BIOTECHNOL BIOENG, V98, P631, DOI 10.1002/bit.21435
   MALEK AM, 1994, CIRC RES, V74, P852, DOI 10.1161/01.RES.74.5.852
   Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137
   Marcacci M, 2006, OPER TECH ORTHOP, V16, P266, DOI 10.1053/j.oto.2006.08.002
   MARCUM JA, 1984, J CLIN INVEST, V74, P341, DOI 10.1172/JCI111429
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   MASSIA SP, 1990, ANAL BIOCHEM, V187, P292, DOI 10.1016/0003-2697(90)90459-M
   Maurus PB, 2004, OPER TECHN SPORT MED, V12, P158, DOI 10.1053/j.otsm.2004.07.015
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mukaida N, 1998, CYTOKINE GROWTH F R, V9, P9, DOI 10.1016/S1359-6101(97)00022-1
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Ni RF, 2009, CARDIOVASC INTER RAD, V32, P313, DOI 10.1007/s00270-008-9426-1
   O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Pandis L, 2010, J BIOMED MATER RES A, V93A, P1289, DOI 10.1002/jbm.a.32626
   Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765
   Pate M, 2010, ADV CLIN CHEM, V52, P109, DOI 10.1016/S0065-2423(10)52004-3
   POBER JS, 1990, TRANSPLANTATION, V50, P537, DOI 10.1097/00007890-199010000-00001
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Purcell EK, 2009, TISSUE ENG PART C-ME, V15, P541, DOI 10.1089/ten.tec.2008.0302
   Raines EW, 1996, ATHEROSCLEROSIS CORO, V1, P539
   Ravi S, 2009, VASCULAR, V17, pS45, DOI 10.2310/6670.2008.00084
   Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Saha P, 2011, ARTERIOSCL THROM VAS, V31, P506, DOI 10.1161/ATVBAHA.110.213405
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Salacinski HJ, 2002, J BIOMED MATER RES, V59, P207
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Sanchez VC, 2009, WIRES NANOMED NANOBI, V1, P511, DOI 10.1002/wnan.41
   Schoen F. J., 2004, BIOMATERIALS SCI INT, P293
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131
   Shi Q, 1997, J VASC SURG, V25, P736, DOI 10.1016/S0741-5214(97)70303-3
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Spatz JP, 2007, METHOD CELL BIOL, V83, P89, DOI 10.1016/S0091-679X(07)83005-6
   STEWART GJ, 1975, J LAB CLIN MED, V85, P208
   STEWART GJ, 1993, HAEMOSTASIS, V23, P127
   Stone CA, 2000, BRIT J PLAST SURG, V53, P601, DOI 10.1054/bjps.2000.3412
   SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410
   TAKADA Y, 1994, BIOCHEM BIOPH RES CO, V205, P1345, DOI 10.1006/bbrc.1994.2813
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tedesco F, 1999, MOL IMMUNOL, V36, P261, DOI 10.1016/S0161-5890(99)90054-8
   Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005
   Ulery BD, 2011, J POLYM SCI POL PHYS, V49, P832, DOI 10.1002/polb.22259
   VANDERWAL AC, 1989, LAB INVEST, V61, P166
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Vasita R, 2008, CURR TOP MED CHEM, V8, P341
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   Ward B, 2007, J BIOMED MATER RES A, V80, P33
   Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997
   WESELOW A, 1984, VASCULAR SURG PRINCI, P93
   WESOLOWSKI S, 1964, CARDIOVASC SURG, V38, P544
   Westmuckett AD, 2000, ARTERIOSCL THROM VAS, V20, P2474, DOI 10.1161/01.ATV.20.11.2474
   Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1
   WHITTEMORE AD, 1989, J VASC SURG, V10, P299, DOI 10.1067/mva.1989.14116
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   WILLIAMS GT, 1983, J CLIN PATHOL, V36, P723, DOI 10.1136/jcp.36.7.723
   Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289
   WU MHD, 1995, J VASC SURG, V21, P862, DOI 10.1016/S0741-5214(05)80019-9
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhou HY, 2008, CARBOHYD POLYM, V73, P265, DOI 10.1016/j.carbpol.2007.11.026
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
   ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529
NR 189
TC 11
Z9 11
U1 1
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2014
VL 8
IS 4
BP 253
EP 267
DI 10.1002/term.1526
PG 15
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AD9EY
UT WOS:000333568800001
PM 22730232
DA 2018-10-19
ER

PT J
AU Kim, MS
   Kim, GH
AF Kim, Min Seong
   Kim, Geun Hyung
TI Highly porous electrospun 3D polycaprolactone/beta-TCP biocomposites for
   tissue regeneration
SO MATERIALS LETTERS
LA English
DT Article
DE Electrospun micro/nanofibers; Polycaprolactone; Tricalcium phosphate;
   Biomaterial
ID MECHANICAL-PROPERTIES; BONE SUBSTITUTES; SCAFFOLDS; FABRICATION; DESIGN;
   PORES
AB Micro/nanofibres can provide outstanding biological activity in tissue regeneration. However, their use as a biomedical scaffold has been limited due to difficulty of three-dimensional (3D) shapability, small pore size, and weak mechanical properties. In this study, we suggest a facile method of fabricating mechanically enhanced 3D polycaprolactone (PCL)/beta-TCP micro/nanofibres with homogeneous micropores using modified wet-electrospinning supplemented with a femtosecond laser. The fabricated scaffolds demonstrated improved mechanical properties and relatively high cellular activities compared to rapid-prototyped 3D PCL/beta-TCP scaffolds. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Kim, Min Seong; Kim, Geun Hyung] Sungkyunkwan Univ, Dept Biomechatron Engn, Coll Biotechnol & Bioengn, Tissue Engn Lab, Suwon, South Korea.
RP Kim, GH (reprint author), Sungkyunkwan Univ, Dept Biomechatron Engn, Coll Biotechnol & Bioengn, Tissue Engn Lab, Suwon, South Korea.
EM gkimbme@skku.edu
CR Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h
   Cipitria A, 2011, J MATER CHEM, V21, P9419, DOI 10.1039/c0jm04502k
   Cui Y, 2009, ACTA BIOMATER, V5, P2680, DOI 10.1016/j.actbio.2009.03.024
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hong S, 2011, APPL PHYS A-MATER, V103, P1009, DOI 10.1007/s00339-011-6381-5
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Kim G, 2011, J MATER CHEM, V21, P6165, DOI 10.1039/c0jm03452e
   Kim YB, 2012, J MATER CHEM, V22, P16880, DOI 10.1039/c2jm33036a
   Lee H, 2011, J MATER CHEM, V21, P6305, DOI 10.1039/c0jm03414b
   Lee J, 2013, MATER LETT, V93, P397, DOI 10.1016/j.matlet.2012.11.124
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sachlos E, 2003, EUR CELLS MATER, V10
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeo M, 2012, J MATER CHEM, V22, P21636, DOI 10.1039/c2jm31165h
   Yokoyama Y, 2009, MATER LETT, V63, P754, DOI 10.1016/j.matlet.2008.12.042
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
NR 28
TC 18
Z9 19
U1 4
U2 67
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD APR 1
PY 2014
VL 120
BP 246
EP 250
DI 10.1016/j.matlet.2014.01.083
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AE2BW
UT WOS:000333779300067
DA 2018-10-19
ER

PT J
AU Jerman, UD
   Veranic, P
   Kreft, ME
AF Jerman, Urska Dragin
   Veranic, Peter
   Kreft, Mateja Erdani
TI Amniotic Membrane Scaffolds Enable the Development of Tissue-Engineered
   Urothelium with Molecular and Ultrastructural Properties Comparable to
   that of Native Urothelium
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID OCULAR SURFACE RECONSTRUCTION; EPITHELIAL-CELLS; BASEMENT-MEMBRANES;
   REGENERATIVE MEDICINE; CULTURE; DIFFERENTIATION; TRANSPLANTATION;
   ANGIOGENESIS; EXPRESSION; SUBSTRATE
AB The amniotic membrane (AM) is a naturally derived biomaterial that possesses biological and mechanical properties of great importance for tissue engineering. The aim of our study was to determine whether the AM enables the formation of a normal urinary bladder epithelium-urothelium- and to reveal any differences in the urothelial cell (UC) growth and differentiation when using different AM scaffolds. Cryopreserved human AM was used as a scaffold in three different ways. Normal porcine UCs were seeded on the AM epithelium (eAM), denuded AM (dAM), and stromal AM (sAM) and were cultured for 3 weeks. UC growth on AM scaffolds was monitored daily. By using electron microscopy, histochemical and immunofluorescence techniques, we here provide evidence that all three AM scaffolds enable the development of the urothelium. The fastest growth and the highest differentiation of UCs were demonstrated on the sAM scaffold, which enables the development of tissue-engineered urothelium with molecular and ultrastructural properties comparable to that of the native urothelium. Most importantly, the highly differentiated urothelia on the sAM scaffolds provide important experimental models for future drug delivery studies and developing tissue engineering strategies considering that subtle differences are identified before translation to the clinical settings.
C1 [Jerman, Urska Dragin; Veranic, Peter; Kreft, Mateja Erdani] Univ Ljubljana, Inst Cell Biol, Fac Med, SI-1000 Ljubljana, Slovenia.
RP Kreft, ME (reprint author), Univ Ljubljana, Inst Cell Biol, Fac Med, Vrazov Trg 2, SI-1000 Ljubljana, Slovenia.
EM mateja.erdani@mf.uni-lj.si
FU Slovenian Research Agency [P3-0108]
FX This work was supported by the Slovenian Research Agency (Grant No.
   P3-0108). The authors would like to express their appreciation to
   Professor Dr. Kristijan Jezernik and Professor Dr. Rok Romih for their
   continuous support. We thank Professor Dr. Tung-Tien Sun (New York
   University, School of Medicine), for uroplakin antibodies, Dr. Tina
   Cirman (Blood Transfusion Centre of Slovenia, Ljubljana) for preparing
   the AM, Eva Lasic for proofreading the manuscript, and Linda Strus and
   Sanja Cabraja for technical assistance.
CR ADINOLFI M, 1982, NATURE, V295, P325, DOI 10.1038/295325a0
   Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584
   Andersson K. E., 2013, NEUROUROL URODYN, DOI 10.1002/nau.22465
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Chen YJ, 2012, BIOMATERIALS, V33, P455, DOI 10.1016/j.biomaterials.2011.09.065
   Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5136, DOI 10.1167/iovs.03-0484
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   HOULIHAN JM, 1995, J IMMUNOL, V154, P5665
   Hsiao Y. C., 2011, BIOMATERIALS, V32, P442
   Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Kreft M. E., 2012, PLOS ONE, V7
   Kreft ME, 2010, ZDR VESTN, V79, P707
   Kreft ME, 2010, PROTOPLASMA, V246, P3, DOI 10.1007/s00709-010-0112-1
   Kreft ME, 2009, ANN NY ACAD SCI, V1152, P18, DOI 10.1111/j.1749-6632.2008.04004.x
   Kreft ME, 2005, FOLIA BIOL-PRAGUE, V51, P126
   Kruse FE, 2000, GRAEF ARCH CLIN EXP, V238, P68, DOI 10.1007/s004170050012
   Liu T, 2012, MOL VIS, V18, P2137
   Mamede AC, 2012, CELL TISSUE RES, V349, P447, DOI 10.1007/s00441-012-1424-6
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   Meller D, 2011, DTSCH ARZTEBL INT, V108, P243, DOI 10.3238/arztebl.2011.0243
   Mermet I, 2007, WOUND REPAIR REGEN, V15, P459, DOI 10.1111/j.1524-475X.2007.00252.x
   Mikek K., 2004, ZDR VESTN, V73, P419
   Mohammadi AA, 2013, BURNS, V39, P349, DOI 10.1016/j.burns.2012.07.010
   Nakamura T, 2008, BIOMATERIALS, V29, P3729, DOI 10.1016/j.biomaterials.2008.05.023
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   Niknejad H, 2008, EUR CELLS MATER, V15, P88
   Ohshima M, 2003, J PERIODONTAL RES, V38, P175, DOI 10.1034/j.1600-0765.2003.01628.x
   Resch MD, 2006, INVEST OPHTH VIS SCI, V47, P1853, DOI 10.1167/iovs.05-0983
   Riau AK, 2010, BIOMATERIALS, V31, P216, DOI 10.1016/j.biomaterials.2009.09.034
   Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4
   SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577
   Sartoneva R., 2001, J R SOC INTERFACE, V58, P671
   Sarwar Iram, 2010, J Ayub Med Coll Abbottabad, V22, P7
   Seidler DG, 2005, BIOCHEM BIOPH RES CO, V332, P1162, DOI 10.1016/j.bbrc.2005.04.175
   Sharifiaghdas Farzaneh, 2007, Urol J, V4, P71
   TALMI YP, 1991, PLACENTA, V12, P285, DOI 10.1016/0143-4004(91)90010-D
   Tanjore H, 2006, AM J PATHOL, V168, P715, DOI 10.2353/ajpath.2006.051321
   Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068
   Vinjar T., 2012, HISTOCHEM CELL BIOL, V137, P177
   Yoshida T, 2010, ARTERIOSCL THROM VAS, V30, P1300, DOI 10.1161/ATVBAHA.109.198994
   YOUNG RL, 1991, FERTIL STERIL, V55, P624
   YURCHENCO PD, 1990, FASEB J, V4, P1577
NR 45
TC 16
Z9 17
U1 0
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD APR 1
PY 2014
VL 20
IS 4
BP 317
EP 327
DI 10.1089/ten.tec.2013.0298
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AE0BA
UT WOS:000333627300006
PM 23947657
OA Green Published
DA 2018-10-19
ER

PT J
AU Li, Y
   Thouas, GA
   Shi, HN
   Chen, QZ
AF Li, Yuan
   Thouas, George A.
   Shi, Hanning
   Chen, Qizhi
TI Enzymatic and oxidative degradation of poly(polyol sebacate)
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE xanthine; xanthine oxidase; enzymatic degradation; esterase; Poly(polyol
   sebacate); FeSO4/H2O2
ID IN-VIVO DEGRADATION; POLY(GLYCEROL SEBACATE); FREE-RADICALS;
   BIODEGRADATION; POLYMERS; HYDROLYSIS; TISSUE; POLY(URETHANE)S;
   BIOMATERIALS; INFLAMMATION
AB Poly(glycerol sebacate) (PGS) and poly(xylitol sebacate) (PXS) are biodegradable elastomers with tremendous potential in soft tissue engineering. This study was aimed at exploring the enzymatic degradation mechanisms of these polyesters, using biochemical conditions similar to those occurring invivo. To this end, PGS and PXS (crosslinked at 130celcius for 2 or 7 (PGS)/12 days (PXS)) were incubated invitro under physiological conditions in tissue culture media supplemented with either a biodegrading enzyme (esterase), an oxidant species (FeSO4/H2O2 with 0.11 molar ratio of Fe2+/H2O2), an oxidant generating enzyme (xanthine oxidase and xanthine) or combinations of these (FeSO4/H2O2 and esterase, or (v) xanthine oxidase/xanthine and esterase), based on their independent effects on polymer degradation. Testing was performed over 35 days of continuous incubation, during which mechanical properties, mass loss, biomaterial thickness and pH value of the culture medium were determined. Degradation kinetics of both PGS and PXS samples were primarily determined by the degree of crosslink density. Esterase and FeSO4/H2O2 accelerated the degradation of both polymers, by promoting hydrolysis and free-radical degradation, although this action was not affected by the presence of xanthine oxidase and xanthine. Degradation of PGS and PXS is primarily mediated by the action of esterase, with free-radical oxidation playing a secondary role, suggesting that both could synergistically affect the biodegradability of biomaterial implants, under more complex biological conditions.
C1 [Li, Yuan; Shi, Hanning; Chen, Qizhi] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Thouas, George A.] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.
RP Chen, QZ (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM qizhi.chen@monash.edu
FU Australian Research Council [DP130101384]
FX The work was supported by Australian Research Council (to QZC,
   DP130101384).
CR ALI SAM, 1994, J APPL POLYM SCI, V51, P1389, DOI 10.1002/app.1994.070510805
   ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   BERGMANN F, 1958, BIOCHEM J, V68, P493, DOI 10.1042/bj0680493
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   Bruggeman JP, 2008, ADV MATER, V20, P1922, DOI 10.1002/adma.200702377
   Chapanian R, 2009, BIOMATERIALS, V30, P295, DOI 10.1016/j.biomaterials.2008.09.038
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Chen QZ, 2012, RSC ADV, V2, P4125, DOI 10.1039/c2ra20113e
   Coleman JW, 2001, INT IMMUNOPHARMACOL, V1, P1397, DOI 10.1016/S1567-5769(01)00086-8
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   GRANGER DN, 1988, AM J PHYSIOL, V255, pH1269
   Ivanova T, 1997, COLLOID SURFACE B, V8, P217, DOI 10.1016/S0927-7765(96)01331-8
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Labow RS, 1999, J BIOMAT SCI-POLYM E, V10, P699, DOI 10.1163/156856299X00595
   Lee KH, 1999, J POLYM SCI POL CHEM, V37, P3558, DOI 10.1002/(SICI)1099-0518(19990915)37:18<3558::AID-POLA2>3.0.CO;2-4
   Li Y, 2012, RSC ADV, V2, P8229, DOI 10.1039/c2ra20736b
   Liang SL, 2011, BIOMATERIALS, V32, P8486, DOI 10.1016/j.biomaterials.2011.07.080
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   MCCORD JM, 1974, SCIENCE, V185, P529, DOI 10.1126/science.185.4150.529
   SANTERRE JP, 1994, J BIOMED MATER RES, V28, P1187, DOI 10.1002/jbm.820281009
   SCHAKENRAAD JM, 1990, J BIOMED MATER RES, V24, P529, DOI 10.1002/jbm.820240502
   SMITH R, 1987, J BIOMED MATER RES, V21, P991, DOI 10.1002/jbm.820210805
   SMITH R, 1987, J BIOMED MATER RES, V21, P1149, DOI 10.1002/jbm.820210908
   Stuckey DJ, 2010, TISSUE ENG PT A, V16, P3395, DOI 10.1089/ten.TEA.2010.0213
   Veress AI, 2005, J BIOMECH ENG-T ASME, V127, P1195, DOI 10.1115/1.2073677
   Wang YD, 2003, J BIOMED MATER RES A, V66A, P192, DOI 10.1002/jbm.a.10534
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WILLIAMS DF, 1977, J BIOENG, V1, P231
   WILLIAMS DF, 1994, INT BIODETER BIODEGR, V34, P95, DOI 10.1016/0964-8305(94)90002-7
   Williams DF, 1981, ENG MED, V10, P5, DOI DOI 10.1243/EMED_JOUR_1981_010_004_02
   Williams DF, 1989, COMPREHEN POLYM SCI, P6
   Yavuz Y, 2007, CHEM ENG TECHNOL, V30, P583, DOI 10.1002/ceat.200600377
NR 36
TC 5
Z9 5
U1 2
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD APR
PY 2014
VL 28
IS 8
BP 1138
EP 1150
DI 10.1177/0885328213499195
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD6VL
UT WOS:000333399200002
PM 23904286
DA 2018-10-19
ER

PT J
AU Sukumar, N
   Ramachandran, T
   Lakshmikantha, CB
AF Sukumar, N.
   Ramachandran, T.
   Lakshmikantha, C. B.
TI Development and characterization of cactus-dextrin- recombinant human
   epidermal growth factor based silk scaffold for wound dressing
   applications
SO JOURNAL OF INDUSTRIAL TEXTILES
LA English
DT Article
DE wound healing; dextrin; EGF; cactus; silk fibroin; Silk scaffold
ID FIBROIN; DEGRADATION; BIOMATERIALS; PROTEIN; STABILITY; RELEASE;
   EXTRACT; FILMS
AB Silk fibroin (SF), a naturally occurring protein polymer, has several unique properties such as biocompatibility, biodegradability, minimal inflammatory reaction, and endowed with excellent mechanical properties and process ability. The existing scaffolds used in medical industry lack the degradation and/or slow in healing practice, so clinically there is a need for the development of efficient and reliable biomaterial scaffolds for wound healing. Silk fibroin has shown greater potential for tissue engineering applications. This work is focused on designing biomaterial with silk as raw material and wound healing effect of SF scaffolds were also tested. The silk blended scaffolds were prepared by using SF as a vehicle with dextrin, other healing agent of cactus and epidermal growth factor (rhEGF) are used as the drug releasing model. Scanning electronic microscope (SEM) was used to observe the morphology of prepared scaffolds for process versatility and the highly specific surface area. The structure was studied by Fourier transform infrared. The SF was treated at different concentrations of cactus and rhEGF, to investigate the growth inhibition effect of bacterial growth. The SF scaffolds show favorable stability by their structural integrity, morphology, mechanical properties, and powerful antibacterial efficacy up to 100% to Escherichia coli and Staphylococcus epidermidis significantly intended to provide improved environments for the zone of incubation when compared with normal scaffolds without rhEGF. Therefore, the results give the evidence for the application of SF blended scaffolds in the treatment of wound.
C1 [Sukumar, N.] KS Rangasamy Coll Technol, Dept Text Technol, Tiruchengode, India.
   [Ramachandran, T.] Karpagam Inst Technol, Coimbatore, Tamil Nadu, India.
   [Lakshmikantha, C. B.] PB Coll Engn, Madras, Tamil Nadu, India.
RP Sukumar, N (reprint author), KS Rangasamy Coll Technol, Dept Text Technol, Tiruchengode, India.
EM sugumaraan@yahoo.com
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Basal G, 2010, FIBER POLYM, V11, P21, DOI [10.1007/s1221-010-0021-0, 10.1007/s12221-010-0021-0]
   Bhardwaj N, 2011, BIOMATERIALS, V32, P5773, DOI 10.1016/j.biomaterials.2011.04.061
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Carvalho J, 2007, EUR POLYM J, V43, P3050, DOI 10.1016/j.eurpolymj.2007.02.046
   Chen SX, 2011, J MED PLANTS RES, V5, P973
   Demidova-Rice TN, 2012, ADV WOUND CARE, V1, P17, DOI 10.1089/wound.2011.0308
   Determan AS, 2006, BIOMATERIALS, V27, P3312, DOI 10.1016/j.biomaterials.2006.01.054
   Edan I, 2010, INT J MICROBIOL, V7, P12
   Fingold SM, 1986, BAILEY SCOTTS DIAGNO
   Hardwicke JT, 2011, J CONTROL RELEASE, V152, P411, DOI 10.1016/j.jconrel.2011.03.016
   He JK, 2012, MATER LETT, V78, P102, DOI 10.1016/j.matlet.2012.03.051
   Hreczuk-Hirst D, 2001, INT J PHARM, V230, P57, DOI 10.1016/S0378-5173(01)00859-6
   Huang XJ, 2009, CELL MOL NEUROBIOL, V29, P1211, DOI 10.1007/s10571-009-9417-z
   Jagur-Grodzinski J, 2006, POLYM ADVAN TECHNOL, V17, P395, DOI 10.1002/pat.729
   Janiga P, 2011, J IND TEXT, V42, P176
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lavin JLS, 2009, J INT MED RES, V37, P1
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lopac SK, 2009, J BIOMED MATER RES B, V91B, P938, DOI 10.1002/jbm.b.31478
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mohan VK, 2007, DIABETES RES CLIN PR, V78, P405, DOI 10.1016/j.diabres.2007.06.004
   Moreira SM, 2008, BMC BIOTECHNOL, V78, P1
   Moreira S, 2010, J BIOACT COMPAT POL, V25, P141, DOI 10.1177/0883911509357865
   Noishiki Y, 2002, J APPL POLYM SCI, V86, P3425, DOI 10.1002/app.11370
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Park EH, 1998, ARCH PHARM RES, V21, P30, DOI 10.1007/BF03216749
   Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003
   Sciences B, 2008, J PHARM SCI, V97, P2892
   Sobajo C, 2008, EPLASTY, V8, P438
   TrejoGonzalez A, 1996, J ETHNOPHARMACOL, V55, P27, DOI 10.1016/S0378-8741(96)01467-5
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
NR 33
TC 3
Z9 4
U1 2
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1528-0837
EI 1530-8057
J9 J IND TEXT
JI J. Ind. Text.
PD APR
PY 2014
VL 43
IS 4
BP 565
EP 576
DI 10.1177/1528083712470159
PG 12
WC Materials Science, Textiles
SC Materials Science
GA AD3MT
UT WOS:000333150900007
DA 2018-10-19
ER

PT J
AU Henstock, JR
   Ruktanonchai, UR
   Canham, LT
   Anderson, SI
AF Henstock, J. R.
   Ruktanonchai, U. R.
   Canham, L. T.
   Anderson, S. I.
TI Porous silicon confers bioactivity to polycaprolactone composites in
   vitro
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID DRUG-DELIVERY; SUBSTITUTED HYDROXYAPATITE; IONIC PRODUCTS; CELLS; VIVO;
   DISSOLUTION; DIFFERENTIATION; PROLIFERATION; BIOGLASS(R); OSTEOBLASTS
AB Silicon is an essential element for healthy bone development and supplementation with its bioavailable form (silicic acid) leads to enhancement of osteogenesis both in vivo and in vitro. Porous silicon (pSi) is a novel material with emerging applications in opto-electronics and drug delivery which dissolves to yield silicic acid as the sole degradation product, allowing the specific importance of soluble silicates for biomaterials to be investigated in isolation without the elution of other ionic species. Using polycaprolactone as a bioresorbable carrier for porous silicon microparticles, we found that composites containing pSi yielded more than twice the amount of bioavailable silicic acid than composites containing the same mass of 45S5 Bioglass. When incubated in a simulated body fluid, the addition of pSi to polycaprolactone significantly increased the deposition of calcium phosphate. Interestingly, the apatites formed had a Ca:P ratio directly proportional to the silicic acid concentration, indicating that silicon-substituted hydroxyapatites were being spontaneously formed as a first order reaction. Primary human osteoblasts cultured on the surface of the composite exhibited peak alkaline phosphatase activity at day 14, with a proportional relationship between pSi content and both osteoblast proliferation and collagen production over 4 weeks. Culturing the composite with J744A.1 murine macrophages demonstrated that porous silicon does not elicit an immune response and may even inhibit it. Porous silicon may therefore be an important next generation biomaterial with unique properties for applications in orthopaedic tissue engineering.
C1 [Henstock, J. R.] Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
   [Ruktanonchai, U. R.] NSTDA, Natl Nanotechnol Ctr NANOTEC, Pathum Thani 12120, Thailand.
   [Canham, L. T.] PSiMedica Ltd, Malvern WR14 3SZ, Worcs, England.
   [Anderson, S. I.] Univ Nottingham, Sch Grad Entry Med & Hlth, Royal Derby Hosp Ctr, Derby DE22 3DT, England.
RP Henstock, JR (reprint author), Keele Univ, Inst Sci & Technol Med, Stoke On Trent ST4 7QB, Staffs, England.
EM j.r.henstock@keele.ac.uk
CR Alvarez SD, 2008, BIOMATERIALS, V30, P26
   Anderson SI, 1998, J MATER SCI-MATER M, V9, P731, DOI 10.1023/A:1008955002955
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Anglin EJ, 2008, ADV DRUG DELIVER REV, V60, P1266, DOI 10.1016/j.addr.2008.03.017
   Arumugam MQ, 2006, KEY ENG MATER, V254, P869
   Canham LT, 1997, PROPERTIES POROUS SI
   Canham T, 1995, ADV MATER, V7, P1033
   CARLISLE EM, 1974, FED PROC, V33, P1758
   CARLISLE EM, 1988, SCI TOTAL ENVIRON, V73, P95, DOI 10.1016/0048-9697(88)90190-8
   Charnay C, 2004, EUR J PHARM BIOPHARM, V57, P533, DOI 10.1016/j.ejph.2003.12.007
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Coffer JL, 2003, PHYS STATUS SOLIDI A, V197, P336, DOI 10.1002/pssa.200306520
   Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064
   Gibson IR, 2002, J AM CERAM SOC, V85, P2771
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Johansson F, 2008, IEEE T BIO-MED ENG, V55, P1447, DOI 10.1109/TBME.2007.912423
   Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225
   KEETING PE, 1992, J BONE MINER RES, V7, P1281, DOI 10.1002/jbmr.5650071107
   Kleveta G, 2012, J CELL BIOCHEM, V113, P80, DOI 10.1002/jcb.23330
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kubo K, 1997, J ORAL REHABIL, V24, P70, DOI 10.1046/j.1365-2842.1997.00462.x
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Porter AE, 2003, BIOMATERIALS, V24, P4609, DOI 10.1016/S0142-9612(03)00355-7
   Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Salonen J, 2008, J PHARM SCI-US, V97, P632, DOI 10.1002/jps.20999
   SAMMONS RL, 1994, BIOMATERIALS, V15, P536, DOI 10.1016/0142-9612(94)90020-5
   SCHWARZ K, 1973, P NATL ACAD SCI USA, V70, P1608, DOI 10.1073/pnas.70.5.1608
   Scotchford CA, 2003, BIOMATERIALS, V24, P4871, DOI 10.1016/S0142-9612(03)00403-4
   Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019
   Sinha VR, 2008, DRUG DELIV, V15, P365, DOI 10.1080/10717540500398092 
   Sripanyakorn S, 2005, NUTR BULL, V30, P222, DOI 10.1111/j.1467-3010.2005.00507.x
   Vaccari L, 2006, MICROELECTRON ENG, V83, P1598, DOI 10.1016/j.mee.2006.01.113
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhang K, 2005, CLIN CANCER RES, V11, P7532, DOI 10.1158/1078-0432.CCR-05-0400
   ZHOU H, 1994, J BONE MINER RES, V9, P1489
NR 41
TC 6
Z9 6
U1 2
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2014
VL 25
IS 4
BP 1087
EP 1097
DI 10.1007/s10856-014-5140-5
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD2VH
UT WOS:000333093300013
PM 24398914
DA 2018-10-19
ER

PT J
AU Petreus, T
   Stoica, BA
   Petreus, O
   Goriuc, A
   Cotrutz, CE
   Antoniac, IV
   Barbu-Tudoran, L
AF Petreus, Tudor
   Stoica, Bogdan Alexandru
   Petreus, Oana
   Goriuc, Ancuta
   Cotrutz, Carmen-Elena
   Antoniac, Iulian-Vasile
   Barbu-Tudoran, Lucian
TI Preparation and cytocompatibility evaluation for hydrosoluble
   phosphorous acid-derivatized cellulose as tissue engineering scaffold
   material
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID REGENERATED CELLULOSE; PHYSICOCHEMICAL PROPERTIES; PHOSPHATES;
   BIOMATERIALS; BIOCOMPATIBILITY; PHOSPHORYLATION; HYDROGELS;
   MINERALIZATION; DISSOLUTION; MEMBRANES
AB Chemical modification of cellulose by phosphorylation enhances its bioactivity and provides new derivatives and materials with specific end uses. In the present study, cellulose derivatized with phosphorous acid was obtained using the reaction of microcrystalline cellulose with phosphorous acid-urea mixture, in molten state, in comparison with others methods that used different solvents and catalysts. Completely water soluble films with a substitution degree close to one were obtained and characterized by analytical and spectral analysis (FT-IR, P-31 NMR), contact angle, metallographic microscopy and atomic force microscopy (AFM). 31P NMR spectra of derivatized cellulose showed a signal at 2.58 ppm (assigned to P-O-C6) while the doublets at 4.99-5.29 and at 7.38 ppm were assigned to P-O-C2 and P-O-C3, respectively; thus, the formation of monosubstituted phosphorous acid esters of cellulose is advocated. Contact angle measurements showed that the work of adhesion is more important in water than in ethylene glycol, for the phosphorous acid derivatized cellulose. The cytocompatibility of this hydrosoluble derivatized cellulose was tested by direct contact and also by indirect assays on normal human dermal fibroblasts and on osteoblast-like cells (human osteosarcoma). Cell growth on phosphorylated cellulose pellicle and the results from viability assays had shown a good cytocompatibility and lack of toxicity. Phosphorous acid derivatized cellulose would offer a promising biomaterial, useful as scaffolds for new biopolymer composites, and subject for further development as an ionic crosslinker.
C1 [Petreus, Tudor; Stoica, Bogdan Alexandru; Goriuc, Ancuta; Cotrutz, Carmen-Elena] Gr T Popa Univ Med & Pharm Iasi, Iasi 700115, Romania.
   [Petreus, Oana] Petru Poni Inst Macromol Chem, Iasi 700487, Romania.
   [Antoniac, Iulian-Vasile] Univ Politehn Bucuresti, Bucharest 06004216, Romania.
   [Barbu-Tudoran, Lucian] Babes Bolyai Univ Cluj Napoca, Cluj Napoca 400084, Romania.
RP Petreus, O (reprint author), Petru Poni Inst Macromol Chem, 41A Alley Grigore Ghica Voda, Iasi 700487, Romania.
EM biotudor@gmail.com; bastoica@umfiasi.ro; opetreus@yahoo.com;
   ancuta.goriuc@yahoo.com; cotrutz@yahoo.com; antoniac.iulian@gmail.com;
   lbarbu@hasdeu.ubbcluj.ro
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494; Barbu-Tudoran,
   Lucian/0000-0003-0360-016X
FU  [IDEI 2560/2008]
FX This paper was supported by the Research Grant IDEI 2560/2008.
CR BARBIE C, 1990, Clinical Materials, V5, P251, DOI 10.1016/0267-6605(90)90023-O
   Barbosa M.A., 2005, ITBM RBM, V26, P212, DOI DOI 10.1016/J.RBMRET.2005.04.006
   Bismarck A, 1999, J COLLOID INTERF SCI, V217, P377, DOI 10.1006/jcis.1999.6345
   CORY AH, 1991, CANCER COMMUN, V3, P207
   CURTIS ASG, 1986, J CELL SCI, V86, P9
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Enderle J., 2000, INTRO BIOMEDICAL ENG
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gospodinova N, 2002, GREEN CHEM, V4, P220, DOI 10.1039/b200295g
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2006, REACT FUNCT POLYM, V66, P728, DOI 10.1016/j.reactfunctpolym.2005.10.027
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   Granja PL, 2001, J APPL POLYM SCI, V82, P3354, DOI 10.1002/app.2194
   Granja PL, 2001, J APPL POLYM SCI, V82, P3341
   Granja PL, 2005, EUR CELLS MATER, V10, P7
   Gunnars S, 2002, CELLULOSE, V9, P239, DOI 10.1023/A:1021196914398
   INAGAKI N, 1976, J APPL POLYM SCI, V20, P2829, DOI 10.1002/app.1976.070201017
   INAGAKI N, 1978, J POLYM SCI POL CHEM, V16, P2771, DOI 10.1002/pol.1978.170161105
   Isogai A, 1998, CELLULOSE, V5, P309, DOI 10.1023/A:1009272632367
   Kennedy JF, 1989, ELLIS HORWOOD SERIES
   Kim SS, 1998, J BIOMED MATER RES, V40, P401, DOI 10.1002/(SICI)1097-4636(19980605)40:3<401::AID-JBM9>3.0.CO;2-J
   Kolowith LC, 2001, LIMNOL OCEANOGR, V46, P309, DOI 10.4319/lo.2001.46.2.0309
   Luneva NK, 2007, RUSS J APPL CHEM+, V80, P1923, DOI [10.1134/S1070427207110298, 10.1134/SI070427207110298]
   MACIEL GE, 1982, MACROMOLECULES, V15, P686, DOI 10.1021/ma00230a097
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   MERZ W, 1959, MICROCHIM ACTA, V47, P456, DOI DOI 10.1007/BF01216866
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Mucalo MR, 2009, COLLOID SURFACE B, V71, P52, DOI 10.1016/j.colsurfb.2009.01.004
   Nifant'ev E. E., 1965, RUSS CHEM REV, V34, P942, DOI DOI 10.1070/RC1965V034N12ABEH001577
   Petreus O, 2003, J APPL POLYM SCI, V90, P327, DOI 10.1002/app.12532
   Petreus O, 2003, CELULOZA SI HARTIE, V52, P20
   PIMENTEL GC, 1956, J CHEM PHYS, V24, P639, DOI 10.1063/1.1742588
   Popescu CM, 2008, CELL CHEM TECHNOL, V42, P525
   Ramos LA, 2005, BIOMACROMOLECULES, V6, P2638, DOI 10.1021/bm0400776
   Rathna GVN, 2008, J MATER SCI-MATER M, V19, P2351, DOI 10.1007/s10856-007-3334-9
   Rozmarin G, 1973, CHIMIA LEMNULUI CELU, P175
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Simionescu Cr., 1973, CELLUL CHEM TECHN, V7, P153
   Suflet DM, 2006, REACT FUNCT POLYM, V66, P1240, DOI 10.1016/j.reactfunctpolym.2006.03.006
   Suzuki M, 2000, POLYMER, V41, P4531, DOI 10.1016/S0032-3861(99)00682-5
   Weil E. D., 2009, FLAME RETARDANTS PLA
   Yamane C, 2006, POLYM J, V38, P819, DOI 10.1295/polymj.PJ2005187
NR 44
TC 4
Z9 4
U1 0
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2014
VL 25
IS 4
BP 1115
EP 1127
DI 10.1007/s10856-014-5146-z
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD2VH
UT WOS:000333093300015
PM 24481532
DA 2018-10-19
ER

PT J
AU Quinci, F
   Dressler, M
   Strickland, AM
   Limbert, G
AF Quinci, Federico
   Dressler, Matthew
   Strickland, Anthony M.
   Limbert, Georges
TI Towards an accurate understanding of UHMWPE visco-dynamic behaviour for
   numerical modelling of implants
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
ID MOLECULAR-WEIGHT POLYETHYLENE; TOTAL KNEE ARTHROPLASTY; TOTAL
   HIP-ARTHROPLASTY; CONTACT STRESSES; ACETABULAR CUPS; CREEP-BEHAVIOR;
   WEAR; REPLACEMENTS; SIMULATION; PENETRATION
AB Considerable progress has been made in understanding implant wear and developing numerical models to predict wear for new orthopaedic devices. However any model of wear could be improved through a more accurate representation of the biomaterial mechanics, including time-varying dynamic and inelastic behaviour such as viscosity and plastic deformation. In particular, most computational models of wear of UHMWPE implement a time-invariant version of Archard's law that links the volume of worn material to the contact pressure between the metal implant and the polymeric tibial insert. During in-vivo conditions, however, the contact area is a time-varying quantity and is therefore dependent upon the dynamic deformation response of the material. From this observation one can conclude that creep deformations of UHMWPE may be very important to consider when conducting computational wear analyses, in stark contrast to what can be found in the literature. In this study, different numerical modelling techniques are compared with experimental creep testing on a unicondylar knee replacement system in a physiologically representative context. Linear elastic, plastic and time-varying visco-dynamic models are benchmarked using literature data to predict contact deformations, pressures and areas. The aim of this study is to elucidate the contributions of viscoelastic and plastic effects on these surface quantities.
   It is concluded that creep deformations have a significant effect on the contact pressure measured (experiment) and calculated (computational models) at the surface of the UHMWPE unicondylar insert. The use of a purely elastoplastic constitutive model for UHMWPE lead to compressive deformations of the insert which are much smaller than those predicted by a creep-capturing viscoelastic model (and those measured experimentally). This shows again the importance of including creep behaviour into a constitutive model in order to predict the right level of surface deformation on a tibial insert. At high compressive loads, inelastic deformation mechanisms (creep and plasticity) dominate the mechanical response of UHMWPE components by altering the surface geometry (penetration depth and so contact area) and therefore the contact pressure. Although generic creep models can provide a good first approximation of material characteristics, for best accuracy both viscous and plastic effects must be captured, and model parameters must be founded upon specific experimental test data. Such high-fidelity numerical creep models will provide a better foundation for the next generation of more robust and accurate in-silico wear prediction tools. (c) 2014 Elsevier Ltd. All rights reserved.
C1 [Quinci, Federico; Limbert, Georges] Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
   [Quinci, Federico; Strickland, Anthony M.; Limbert, Georges] Univ Southampton, Bioengn Sci Res Grp, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
   [Dressler, Matthew] Depuy Synthes Joint Reconstruct, Warsaw, IN USA.
RP Limbert, G (reprint author), Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Fac Engn & Environm, Southampton SO17 1BJ, Hants, England.
EM g.limbert@soton.ac.uk
RI Limbert, Georges/E-5658-2010
OI Limbert, Georges/0000-0002-4268-6106
FU DePuy Synthes Joint Reconstruction; Johnson & Johnson company;
   Engineering and Physical Sciences Research Council (EPSRC)
   [EP/F034296/1]; Engineering and Physical Sciences Research Council
   [EP/F034296/1]
FX Federico Quinci is financially supported by DePuy Synthes Joint
   Reconstruction, a Johnson & Johnson company. Georges Limbert is partly
   funded through an Engineering and Physical Sciences Research Council
   (EPSRC) grant [Grant EP/F034296/1]. This financial support is gratefully
   acknowledged. The authors would also like to thank Steve Leisinger, Zach
   Stookey, and Said Gomaa at DePuy Synthes Joint Reconstruction for their
   technical support.
CR Abdelgaied A, 2011, J BIOMECH, V44, P1108, DOI 10.1016/j.jbiomech.2011.01.027
   [Anonymous], 2012, ABAQUS V 6 12 1 US M
   ARCHARD JF, 1953, J APPL PHYS, V24, P981, DOI 10.1063/1.1721448
   ATKINSON JR, 1985, WEAR, V104, P225, DOI 10.1016/0043-1648(85)90050-X
   Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9
   Bergstrom J., 2011, INT J STRUCT CHANGES, V2, P31
   Bevill SL, 2005, J BIOMECH, V38, P2365, DOI 10.1016/j.jbiomech.2004.10.022
   Bitsakos C, 2005, J BIOMECH, V38, P133, DOI 10.1016/j.jbiomech.2004.03.005
   Carr BC, 2009, MATER DESIGN, V30, P398, DOI 10.1016/j.matdes.2008.03.032
   CHARNLEY J, 1973, CLIN ORTHOP RELAT R, P9
   D'Lima DD, 2008, J ORTHOP RES, V26, P1549, DOI 10.1002/jor.20670
   D'Lima DD, 2008, CLIN ORTHOP RELAT R, V466, P2605, DOI 10.1007/s11999-008-0345-x
   Deng M, 1998, J BIOMED MATER RES, V40, P214, DOI 10.1002/(SICI)1097-4636(199805)40:2<214::AID-JBM6>3.0.CO;2-O
   Dressler MR, 2011, WEAR, V271, P2879, DOI 10.1016/j.wear.2011.06.006
   Fregly BJ, 2003, J BIOMECH, V36, P1659, DOI 10.1016/S0021-9290(03)00176-3
   Godest AC, 2002, J BIOMECH, V35, P267, DOI 10.1016/S0021-9290(01)00179-8
   Gomaa S.T., 2011, ORTH RES SOC ANN M S
   HAILEY JL, 1994, MED ENG PHYS, V16, P223, DOI 10.1016/1350-4533(94)90041-8
   Isaac G H, 1996, Proc Inst Mech Eng H, V210, P209, DOI 10.1243/PIME_PROC_1996_210_414_02
   Jauffres D, 2008, J APPL POLYM SCI, V110, P2579, DOI 10.1002/app.28697
   KABO JM, 1993, J BONE JOINT SURG BR, V75, P254
   Kang L, 2008, J BIOMECH, V41, P340, DOI 10.1016/j.jbiomech.2007.09.005
   Krichen A, 2006, KNEE, V13, P226, DOI 10.1016/j.knee.2006.02.007
   Lavernia CJ, 2001, J ARTHROPLASTY, V16, P446, DOI 10.1054/arth.2001.23509
   Lee KY, 1997, WEAR, V203, P375, DOI 10.1016/S0043-1648(96)07370-X
   Liau Jiann-Jong, 2002, Clinical Biomechanics, V17, P698, DOI 10.1016/S0268-0033(02)00102-X
   Mazzucco D, 2003, WEAR, V254, P514, DOI 10.1016/S0043-1648(03)00135-2
   McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203
   Penmetsa JR, 2006, J ORTHOP RES, V24, P422, DOI 10.1002/jor.20042
   Reeves EA, 1998, P I MECH ENG H, V212, P189, DOI 10.1243/0954411981533971
   Rullkoeter P., 2000, 46 ANN M ORTH RES SO
   Strickland MA, 2012, WEAR, V274, P100, DOI 10.1016/j.wear.2011.08.020
   Strickland MA, 2009, J BIOMECH, V42, P1469, DOI 10.1016/j.jbiomech.2009.04.022
   Strickland MA, 2009, COMPUT METHOD BIOMEC, V12, P709, DOI 10.1080/10255840902895994
   Villa T, 2004, J BIOMECH, V37, P45, DOI 10.1016/S0021-9290(03)00255-0
   Willing R, 2009, J BIOMECH, V42, P2520, DOI 10.1016/j.jbiomech.2009.07.008
   Young W.C., 2002, ROARKS FORMULAS STRE
   Zdero R, 2001, J ARTHROPLASTY, V16, P367, DOI 10.1054/arth.2001.21501
NR 38
TC 3
Z9 3
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2014
VL 32
BP 62
EP 75
DI 10.1016/j.jmbbm.2013.12.023
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AD8AG
UT WOS:000333488300008
PM 24434602
DA 2018-10-19
ER

PT J
AU Chen, JL
   Guo, RQ
   Zhou, Q
   Wang, T
AF Chen, Jinling
   Guo, Ruiqiang
   Zhou, Qing
   Wang, Tao
TI Injection of composite with bone marrow-derived mesenchymal stem cells
   and a novel synthetic hydrogel after myocardial infarction: A protective
   role in left ventricle function
SO KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Bone marrow mesenchymal stem cells; Echocardiography; Hydrogel
   composite; Myocardial infarction
ID HEART-FAILURE; CARDIAC-FUNCTION; ISCHEMIC-HEART; IN-VITRO; DELIVERY;
   DIFFERENTIATION; CARDIOMYOCYTES; ENHANCEMENT; PHENOTYPE; MODEL
AB A number of studies have shown that the transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) into the thinned infarct wall improves regional wall motion. In this study, we hypothesized that the injection of biomaterials and MSCs into the infarcted myocardium can preserve left ventricular (LV) function. To test this hypothesis, anterior acute myocardial infarction (AMI) was induced in 34 rabbits and BMSCs with hydrogel composite were prepared. One week after inducing AMI, 28 of the 34 rabbits were divided into four groups (Groups A-D; three rabbits were used for bone marrow aspiration, and three rabbits died) and all received an epicardial injection. Group A received BMSCs with hydrogel composite marked by 5-bromodeoxyuridine (BrdU); Group B received BMSCs only marked by BrdU; Group C received hydrogel only marked by BrdU; and Group D was the control group, which received fetal bovine serum. Echocardiography was performed before AMI was induced, 1 week after AMI, and 4 weeks after the epicardial injection. The results were compared with those before AMI, and the rabbits of all the four groups had significantly larger LV end-diastolic diameter (LVDd), thinner anterior wall (AW), lower LV ejection fraction (LVEF), lower V-S and V-E (p < 0.05) 1 week after AMI, which were more significant in Group A (p < 0.05). Compared with 1 week after AMI, Group A and Group B had significantly smaller LVDd, thicker AW, larger LVEF, larger V-S and V-E (p < 0.05) 4 weeks after the epicardial injection, which were more significant in Group A (p < 0.05); however, there was no significant difference in Group C and Group D. These results suggested that BMSCs with hydrogel composite could serve as an injectable biomaterial that prevents LV remodeling and dilation, and improves local systolic and diastolic function after AMI. Copyright (C) 2013, Kaohsiung Medical University. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Chen, Jinling; Guo, Ruiqiang; Zhou, Qing; Wang, Tao] Wuhan Univ, Renmin Hosp, Dept Echocardiog, Wuhan 430060, Hubei Province, Peoples R China.
RP Chen, JL (reprint author), Wuhan Univ, Renmin Hosp, Dept Echocardiog, 238 Jiefang Rd, Wuhan 430060, Hubei Province, Peoples R China.
EM cjenny2774@hotmail.com
RI WANG, TAO/B-1888-2013
FU National Key Basic Research Program of China [2005CB623903]
FX This work was supported by the National Key Basic Research Program of
   China (grant no. 2005CB623903).
CR Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD
   Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Kelly D, 2008, EUR J HEART FAIL, V10, P133, DOI 10.1016/j.ejheart.2007.12.009
   Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Li H, 2006, BIOMACROMOLECULES, V7, P1951, DOI 10.1021/bm060064n
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Menasche P, 2008, MOL THER, V16, P1000, DOI 10.1038/mt.2008.75
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Muller-Ehmsen J, 2002, CIRCULATION, V105, P1720, DOI 10.1161/01.CIR.0000013782.76324.92
   Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016
   Park JS, 2004, MACROMOLECULES, V37, P6786, DOI 10.1021/ma049677n
   Peppas NA, 1996, BIOMATERIALS, V17, P1553, DOI 10.1016/0142-9612(95)00307-X
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   STAYTON PS, 1995, NATURE, V378, P472, DOI 10.1038/378472a0
   Temenoff JS, 2004, BIOMACROMOLECULES, V5, P5, DOI 10.1021/bm030067p
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Torres-Lugo M, 1999, MACROMOLECULES, V32, P6646, DOI 10.1021/ma990541c
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Zhang XZ, 2002, LANGMUIR, V18, P2013, DOI 10.1021/la011325b
NR 29
TC 9
Z9 9
U1 0
U2 10
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1607-551X
J9 KAOHSIUNG J MED SCI
JI Kaohsiung J. Med. Sci.
PD APR
PY 2014
VL 30
IS 4
BP 173
EP 180
DI 10.1016/j.kjms.2013.12.004
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA AD6WX
UT WOS:000333403100002
PM 24656157
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zaveri, TD
   Lewis, JS
   Dolgova, NV
   Clare-Salzler, MJ
   Keselowsky, BG
AF Zaveri, Toral D.
   Lewis, Jamal S.
   Dolgova, Natalia V.
   Clare-Salzler, Michael J.
   Keselowsky, Benjamin G.
TI Integrin-directed modulation of macrophage responses to biomaterials
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Integrin; Foreign body response; Adhesion; Immunomodulation;
   Wear debris
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; WEIGHT POLYETHYLENE
   PARTICLES; ACUTE INFLAMMATORY RESPONSES; PLATELET-ACTIVATING-FACTOR;
   TITANIUM PARTICLES; IN-VITRO; ADHERENT ENDOTOXIN; DENDRITIC CELLS;
   BIOLOGICAL RESPONSES
AB Macrophages are the primary mediator of chronic inflammatory responses to implanted biomaterials, in cases when the material is either in particulate or bulk form. Chronic inflammation limits the performance and functional life of numerous implanted medical devices, and modulating macrophage interactions with biomaterials to mitigate this response would be beneficial. The integrin family of cell surface receptors mediates cell adhesion through binding to adhesive proteins nonspecifically adsorbed onto biomaterial surfaces. In this work, the roles of integrin Mac-1 (alpha(M)beta(2)) and RGD-binding integrins were investigated using model systems for both particulate and bulk biomaterials. Specifically, the macrophage functions of phagocytosis and inflammatory cytokine secretion in response to a model particulate material, polystyrene microparticles were investigated. Opsonizing proteins modulated microparticle uptake, and integrin Mac-1 and RGD-binding integrins were found to control microparticle uptake in an opsonin-dependent manner. The presence of adsorbed endotoxin did not affect microparticle uptake levels, but was required for the production of inflammatory cytokines in response to microparticles. Furthermore, it was demonstrated that integrin Mac-1 and RGD-binding integrins influence the in vivo foreign body response to a bulk biomaterial, subcutaneously implanted polyethylene terephthalate. A thinner foreign body capsule was formed when integrin Mac-1 was absent (similar to 30% thinner) or when RGD-binding integrins were blocked by controlled release of a blocking peptide (similar to 45% thinner). These findings indicate integrin Mac-1 and RGD-binding integrins are involved and may serve as therapeutic targets to mitigate macrophage inflammatory responses to both particulate and bulk biomaterials. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Zaveri, Toral D.; Lewis, Jamal S.; Dolgova, Natalia V.; Keselowsky, Benjamin G.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   [Clare-Salzler, Michael J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.
RP Keselowsky, BG (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
EM bgk@ufl.edu
RI Lewis, Jamal/B-1734-2013
OI Zaveri, Toral/0000-0003-0059-9212
FU Arthritis Foundation; National Science Foundation [CMMI-0927918];
   National Institutes of Health [R56DK091658, R01DK091658]
FX This work was supported in part by an Arthritis Investigator Award from
   the Arthritis Foundation, and by grants from the National Science
   Foundation (CMMI-0927918) and the National Institutes of Health
   (R56DK091658 and R01DK091658), to BGK.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Acharya AP, 2011, ACTA BIOMATER, V7, P180, DOI 10.1016/j.actbio.2010.08.026
   Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025
   ALTIERI DC, 1986, J CLIN INVEST, V78, P968, DOI 10.1172/JCI112687
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1981, J BIOMED MATER RES, V15, P889, DOI 10.1002/jbm.820150613
   Bauer TW, 1999, SKELETAL RADIOL, V28, P483, DOI 10.1007/s002560050552
   Belisario MA, 2005, EUR J CELL BIOL, V84, P833, DOI 10.1016/j.ejcb.2005.06.002
   BELLER DI, 1982, J EXP MED, V156, P1000, DOI 10.1084/jem.156.4.1000
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2002, J ORTHOPAED RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0
   Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020
   Bix GJ, 1997, J NEUROSCI METH, V77, P67, DOI 10.1016/S0165-0270(97)00113-1
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1989, J BIOMED MATER RES, V23, P535, DOI 10.1002/jbm.820230602
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Bracco P, 2005, Hernia, V9, P51, DOI 10.1007/s10029-004-0281-y
   Brown EJ, 2003, HANDB EXP PHARM, V158, P111
   Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826
   CHARO IF, 1990, J CELL BIOL, V111, P2795, DOI 10.1083/jcb.111.6.2795
   Choe SW, 2010, ACTA BIOMATER, V6, P3491, DOI 10.1016/j.actbio.2010.03.006
   CHU CC, 1989, SURG GYNECOL OBSTET, V168, P233
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2
   Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017
   Daniels AU, 2000, J BIOMED MATER RES, V49, P469, DOI 10.1002/(SICI)1097-4636(20000315)49:4<469::AID-JBM5>3.3.CO;2-1
   Ding HF, 2012, J MATER SCI-MATER M, V23, P1055, DOI 10.1007/s10856-012-4574-x
   Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9
   FISHER JE, 1993, ENDOCRINOLOGY, V132, P1411, DOI 10.1210/en.132.3.1411
   Flick MJ, 2004, EXP BIOL MED, V229, P1105
   Freischlag J A, 1990, Ann Vasc Surg, V4, P449, DOI 10.1016/S0890-5096(07)60069-7
   GAN ZR, 1988, J BIOL CHEM, V263, P19827
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   GILLIGAN BJ, 1994, DIABETES CARE, V17, P882, DOI 10.2337/diacare.17.8.882
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   Helming L, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159665
   Hooper KA, 2000, J BIOMED MATER RES, V50, P365, DOI 10.1002/(SICI)1097-4636(20000605)50:3<365::AID-JBM10>3.0.CO;2-X
   HORIE S, 1994, J IMMUNOL, V152, P5457
   Hsu CC, 2011, J THROMB HAEMOST, V9, P593, DOI 10.1111/j.1538-7836.2010.04163.x
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Ingram JH, 2004, BIOMATERIALS, V25, P3511, DOI 10.1016/j.biomaterials.2003.10.054
   Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kanse SM, 2004, ARTERIOSCL THROM VAS, V24, P2251, DOI 10.1161/01.ATV.0000146529.68729.8b
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2011, HUM VACCINES, V7, P37, DOI 10.4161/hv.7.1.12916
   Latour RA, 2005, ENCY BIOMATERIALS BI
   LEE JD, 1993, P NATL ACAD SCI USA, V90, P9930, DOI 10.1073/pnas.90.21.9930
   Lee S, 2011, ACTA BIOMATER, V7, P2337, DOI 10.1016/j.actbio.2011.01.006
   Legrand AP, 2005, J MATER SCI-MATER M, V16, P477, DOI 10.1007/s10856-005-6989-0
   Lewis JS, 2012, BIOMATERIALS, V33, P7221, DOI 10.1016/j.biomaterials.2012.06.049
   Lishko VK, 2004, J BIOL CHEM, V279, P44897, DOI 10.1074/jbc.M408012200
   Lishko VK, 2003, EXP CELL RES, V283, P116, DOI 10.1016/S0014-4827(02)00024-1
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Mayadas TN, 2005, TRENDS IMMUNOL, V26, P388, DOI 10.1016/j.it.2005.05.002
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2
   Monick MM, 2002, AM J PHYSIOL-LUNG C, V283, pL390, DOI 10.1152/ajplung.00437.2001
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Olivier V, 2004, COLLOID SURFACE B, V33, P23, DOI 10.1016/j.colsurfb.2003.08.008
   Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574
   Rader CP, 1999, J ARTHROPLASTY, V14, P840, DOI 10.1016/S0883-5403(99)90035-9
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   ROSS GD, 1993, CLIN EXP IMMUNOL, V92, P181
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Salsmann A, 2005, J BIOL CHEM, V280, P33610, DOI 10.1074/jbc.M500146200
   SHANBHAG AS, 1994, J BIOMED MATER RES, V28, P81, DOI 10.1002/jbm.820280111
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sivaraman B, 2011, BIOMATERIALS, V32, P5365, DOI 10.1016/j.biomaterials.2011.04.011
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Stanley E R, 1997, Methods Mol Biol, V75, P301
   Sun DH, 2003, J BIOMED MATER RES A, V65A, P290, DOI 10.1002/jbm.a.10477
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Tatro JM, 2007, J ORTHOP RES, V25, P361, DOI 10.1002/jor.20289
   TOMIDA M, 1984, J BIOL CHEM, V259, P978
   van Bilsen PHJ, 2008, COLLOID SURFACE B, V67, P46, DOI 10.1016/j.colsurfb.2008.07.013
   Vogel S, 2001, J ENDOTOXIN RES, V7, P237, DOI 10.1179/096805101101532747
   WALZOG B, 1995, EXP CELL RES, V218, P28, DOI 10.1006/excr.1995.1127
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Xing ZQ, 2006, J ORTHOP RES, V24, P959, DOI 10.1002/jor.20038
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
NR 91
TC 31
Z9 31
U1 2
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 11
BP 3504
EP 3515
DI 10.1016/j.biomaterials.2014.01.007
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC4ON
UT WOS:000332500700003
PM 24462356
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Martin, JR
   Gupta, MK
   Page, JM
   Yu, F
   Davidson, JM
   Guelcher, SA
   Duvall, CL
AF Martin, John R.
   Gupta, Mukesh K.
   Page, Jonathan M.
   Yu, Fang
   Davidson, Jeffrey M.
   Guelcher, Scott A.
   Duvall, Craig L.
TI A porous tissue engineering scaffold selectively degraded by
   cell-generated reactive oxygen species
SO BIOMATERIALS
LA English
DT Article
DE Polyurethane; Oxidation; Biodegradation; Macrophage; Wound healing;
   Scaffold
ID IN-VIVO; POLYURETHANE SCAFFOLDS; POLYMERIC NANOPARTICLES;
   MECHANICAL-PROPERTIES; DEGRADATION; VITRO; REPAIR; BIOCOMPATIBILITY;
   BIODEGRADATION; RELEASE
AB Biodegradable tissue engineering scaffolds are commonly fabricated from poly(lactide-co-glycolide) (PLGA) or similar polyesters that degrade by hydrolysis. PLGA hydrolysis generates acidic breakdown products that trigger an accelerated, autocatalytic degradation mechanism that can create mismatched rates of biomaterial breakdown and tissue formation. Reactive oxygen species (ROS) are key mediators of cell function in both health and disease, especially at sites of inflammation and tissue healing, and induction of inflammation and ROS are natural components of the in vivo response to biomaterial implantation. Thus, polymeric biomaterials that are selectively degraded by cell-generated ROS may have potential for creating tissue engineering scaffolds with better matched rates of tissue in-growth and cell-mediated scaffold biodegradation. To explore this approach, a series of poly(thioketal) (PTK) urethane (PTK-UR) biomaterial scaffolds were synthesized that degrade specifically by an ROS-dependent mechanism. PTK-UR scaffolds had significantly higher compressive moduli than analogous poly(ester urethane) (PEUR) scaffolds formed from hydrolytically-degradable ester-based diols (p < 0.05). Unlike PEUR scaffolds, the PTK-UR scaffolds were stable under aqueous conditions out to 25 weeks but were selectively degraded by ROS, indicating that their biodegradation would be exclusively cell-mediated. The in vitro oxidative degradation rates of the PTK-URs followed first-order degradation kinetics, were significantly dependent on PTK composition (p < 0.05), and correlated to ROS concentration. In subcutaneous rat wounds, PTK-UR scaffolds supported cellular infiltration and granulation tissue formation, followed first-order degradation kinetics over 7 weeks, and produced significantly greater stenting of subcutaneous wounds compared to PEUR scaffolds. These combined results indicate that ROS-degradable PTK-UR tissue engineering scaffolds have significant advantages over analogous polyester-based biomaterials and provide a robust, cell-degradable substrate for guiding new tissue formation. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Martin, John R.; Gupta, Mukesh K.; Duvall, Craig L.] Vanderbilt Univ, Stevenson Ctr 5824, Nashville, TN 37235 USA.
   [Page, Jonathan M.; Guelcher, Scott A.] Vanderbilt Univ, Nashville, TN 37235 USA.
   [Yu, Fang; Davidson, Jeffrey M.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.
   [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Med Res Serv, Nashville, TN 37212 USA.
RP Duvall, CL (reprint author), Vanderbilt Univ, Stevenson Ctr 5824, PMB 351631, Nashville, TN 37235 USA.
EM craig.duvall@vanderbilt.edu
RI Gupta, Mukesh/B-4180-2016
OI Davidson, Jeffrey/0000-0002-8782-3565
FU Vanderbilt University School of Engineering, the Department of Veterans
   Affairs; NIH [R21EB012750, R01AR056138]; NSF [DMR-1006558]
FX Funding was provided by the Vanderbilt University School of Engineering,
   the Department of Veterans Affairs, the NIH through grants R21EB012750
   and R01AR056138, and the NSF through grant DMR-1006558. The authors
   confirm that there are no known conflicts of interest associated with
   this publication and there has been no significant financial support for
   these efforts that could have influenced their outcome.
CR Adolph EJ, 2012, J BIOMED MATER RES A, V100A, P450, DOI 10.1002/jbm.a.33266
   An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Antheunis H, 2010, BIOMACROMOLECULES, V11, P1118, DOI 10.1021/bm100125b
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936
   ASTM-International, 2008, E189908 ASTM INT
   BEZWADA RS, 1995, BIOMATERIALS, V16, P1141, DOI 10.1016/0142-9612(95)93577-Z
   Broaders KE, 2010, J AM CHEM SOC, V133, P756
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Dumas JE, 2014, TISSUE ENG PT A, V20, P115, DOI [10.1089/ten.tea.2012.0762, 10.1089/ten.TEA.2012.0762]
   Dumas JE, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024112
   Eglin D, 2010, J BIOMAT SCI-POLYM E, V21, P477, DOI 10.1163/156856209X424404
   Fu K, 2000, PHARMACEUT RES, V17, P100, DOI 10.1023/A:1007582911958
   Gogolewski S, 2006, J BIOMED MATER RES A, V77A, P802, DOI 10.1002/jbm.a.30669
   Guelcher S, 2007, TISSUE ENG, V13, P2321, DOI 10.1089/ten.2006.0395
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Gupta MK, 2012, J CONTROL RELEASE, V162, P591, DOI 10.1016/j.jconrel.2012.07.042
   Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z
   Hafeman AE, 2011, BIOMATERIALS, V32, P419, DOI 10.1016/j.biomaterials.2010.08.108
   Harbers GM, 2006, INTRO BIOMATERIALS
   Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hua N, 2008, J MATER SCI-MATER M, V19, P3243, DOI 10.1007/s10856-008-3460-z
   Ibim SEM, 1998, J BIOMED MATER RES, V43, P374, DOI 10.1002/(SICI)1097-4636(199824)43:4<374::AID-JBM5>3.0.CO;2-5
   Ignatius AA, 1996, BIOMATERIALS, V17, P831, DOI 10.1016/0142-9612(96)81421-9
   Jayakumar A, 2008, J PARASITOL, V94, P84, DOI 10.1645/GE-1153.1
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Ku TH, 2011, J AM CHEM SOC, V133, P8392, DOI 10.1021/ja2004736
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   LEONG KW, 1987, MACROMOLECULES, V20, P705, DOI 10.1021/ma00170a001
   Li HM, 2013, ADV FUNCT MATER, V23, P3040, DOI 10.1002/adfm.201202215
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   Lowry KJ, 1997, J BIOMED MATER RES, V36, P536
   lshaug-Riley SL, 1998, BIOMATERIALS, V19, P1405
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Lux CD, 2012, J AM CHEM SOC, V134, P15758, DOI 10.1021/ja303372u
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Nilsson A, 2005, J HAND SURG-AM, V30A, P380, DOI 10.1016/j.jhsa.2004.12.001
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006
   Page JM, 2012, ACTA BIOMATER, V8, P4405, DOI 10.1016/j.actbio.2012.07.037
   Parrott MC, 2010, J AM CHEM SOC, V132, P17928, DOI 10.1021/ja108568g
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pike JK, 1996, CHEM MATER, V8, P856, DOI 10.1021/cm9504596
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Roy D, 2010, PROG POLYM SCI, V35, P278, DOI 10.1016/j.progpolymsci.2009.10.008
   Salvatore RN, 2005, TETRAHEDRON LETT, V46, P8931, DOI 10.1016/j.tetlet.2005.10.062
   Schubert MA, 1997, J BIOMED MATER RES, V34, P519, DOI 10.1002/(SICI)1097-4636(19970315)34:4<519::AID-JBM12>3.0.CO;2-7
   Shim MS, 2013, ANGEW CHEM INT EDIT, V52, P6926, DOI 10.1002/anie.201209633
   Stakleff KS, 2013, ACTA BIOMATER, V9, P5132, DOI 10.1016/j.actbio.2012.08.035
   Thayer AM, 2011, CHEM ENG NEWS, V89, P13
   VISSCHER GE, 1985, J BIOMED MATER RES, V19, P349, DOI 10.1002/jbm.820190315
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   WHANG K, 1995, POLYMER, V36, P837, DOI 10.1016/0032-3861(95)93115-3
   Wilson DS, 2010, NAT MATER, V9, P923, DOI [10.1038/NMAT2859, 10.1038/nmat2859]
   Yu SS, 2011, BIOMACROMOLECULES, V12, P4357, DOI 10.1021/bm201328k
NR 64
TC 43
Z9 46
U1 10
U2 120
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 12
BP 3766
EP 3776
DI 10.1016/j.biomaterials.2014.01.026
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC3OS
UT WOS:000332431700006
PM 24491510
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hayden, RS
   Quinn, KP
   Alonzo, CA
   Georgakoudi, I
   Kaplan, DL
AF Hayden, Rebecca S.
   Quinn, Kyle P.
   Alonzo, Carlo A.
   Georgakoudi, Irene
   Kaplan, David L.
TI Quantitative characterization of mineralized silk film remodeling during
   long-term osteoblast-osteoclast co-culture
SO BIOMATERIALS
LA English
DT Article
DE Bone tissue engineering; Bone remodeling; Scanning electron microscopy;
   Confocal microscopy; Surface topography; Silk
ID MESENCHYMAL STEM-CELLS; OPTICAL CHARACTERIZATION; SURFACE-ROUGHNESS;
   BREAST-CANCER; IN-VIVO; BONE; MICROSCOPY; FEATURES; DIFFERENTIATION;
   BIOMATERIALS
AB The goal of this study was to explore quantitative assessments of mineralized silk protein biomaterial films by co-cultures of human mesenchymal stem cell-derived osteoblasts and human acute monocytic leukemia cell line-derived osteoclasts during long-term culture (8-32 weeks). The remodeled films were quantitatively assessed using three different techniques during this extended cultivation to provide more comprehensive insight into the impact of co-cultures On surface remodeling. Scanning electron microscopy (SEM) with three dimensional surface reconstructions was used to quantitatively determine various surface morphological features and measures of roughness indicative of remodeling by the cells. Additionally, reconstructed surfaces were converted to depth images for Fourier analysis to quantify the potential fractal organization of biomineralization. The long-term remodeled films were also imaged using confocal reflectance microscopy and micro-computed tomography (micro-CT) to further quantify morphological changes. Films remodeled in co-culture demonstrated increased roughness parameters, fractal organization, and volume compared to films remodeled by osteoblasts alone. The combination of these techniques to quantify remodeling of mineralized protein films shows promise for quantifying processes related to mineralized surfaces. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Hayden, Rebecca S.; Quinn, Kyle P.; Alonzo, Carlo A.; Georgakoudi, Irene; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Quinn, Kyle/0000-0002-6876-3608
FU NIH [P41 EB002520]; NIAMS/NIH [F32AR061933]; NIH/NIBIB [R01E13007542];
   National Science Foundation [ECS-0335765]
FX This work has been funded by NIH grant number P41 EB002520 for the
   Tissue Engineering Resource Center. Additional funding support was
   provided by grant number F32AR061933 from NIAMS/NIH and NIH/NIBIB
   R01E13007542. This work was performed in part at the Center for
   Nanoscale Systems (CNS), a member of the National Nanotechnology
   Infrastructure Network (NNIN), which is supported by the National
   Science Foundation under NSF award no. ECS-0335765. CNS is a Harvard
   University affiliate. Funding sources had no role in study design, in
   the collection, analysis and interpretation of data, in the writing of
   the report, or in the decision to submit the paper for publication.
CR Altman Greg, 2002, FASEB Journal, V16, P270
   Bellas E, 2013, TISSUE ENG PART C-ME, V19, P745, DOI [10.1089/ten.tec.2012.0620, 10.1089/ten.TEC.2012.0620]
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Brightman AO, 2000, BIOPOLYMERS, V54, P222
   Cao X, 2011, NAT MED, V17, P1344, DOI 10.1038/nm.2499
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Cuijpers VMJI, 2011, TISSUE ENG PART C-ME, V17, P663, DOI 10.1089/ten.tec.2010.0455
   Degenhardt K, 2010, CIRC-CARDIOVASC IMAG, V3, P314, DOI 10.1161/CIRCIMAGING.109.918482
   Dougherty G, 2001, MED ENG PHYS, V23, P369, DOI 10.1016/S1350-4533(01)00057-1
   Dunn AK, 1996, APPL OPTICS, V35, P3441, DOI 10.1364/AO.35.003441
   Gittens RA, 2011, BIOMATERIALS, V32, P3395, DOI 10.1016/j.biomaterials.2011.01.029
   Goldstein RH, 2010, CANCER RES, V70, P10044, DOI 10.1158/0008-5472.CAN-10-1254
   Gupta S, 2008, BIOMATERIALS, V29, P2359, DOI 10.1016/j.biomaterials.2008.01.034
   Gupta S, 2009, APPL OPTICS, V48, pD45, DOI 10.1364/AO.48.000D45
   Hayden RS, 2014, ADV FUNCT MATER, V24, P472, DOI 10.1002/adfm.201302210
   Hayden RS, 2014, ACTA BIOMATER, V10, P486, DOI 10.1016/j.actbio.2013.09.028
   Heinemann C, 2011, EUR CELLS MATER, V21, P80, DOI 10.22203/eCM.v021a07
   Heinemann S, 2013, ACTA BIOMATER, V9, P4878, DOI 10.1016/j.actbio.2012.10.010
   Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Jakob F, 1997, J STEROID BIOCHEM, V61, P167
   Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Khang D, 2012, BIOMATERIALS, V33, P5997, DOI 10.1016/j.biomaterials.2012.05.005
   Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kirker-Head C, 2007, BONE, V41, P247, DOI 10.1016/j.bone.2007.04.186
   Levitt JM, 2007, OPT LETT, V32, P3305, DOI 10.1364/OL.32.003305
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Nehal KS, 2008, SEMIN CUTAN MED SURG, V27, P37, DOI 10.1016/j.sder.2008.01.006
   Quinn KP, 2012, BIOMATERIALS, V33, P5341, DOI 10.1016/j.biomaterials.2012.04.024
   RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Sengupta S, 2010, BIOMACROMOLECULES, V11, P3592, DOI 10.1021/bm101054q
   Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1
   Stary V, 2014, J BIOMED MATER RES A, V102, P1868, DOI 10.1002/jbm.a.34833
   Sun L, 2011, BIOMATERIALS, V32, P5581, DOI 10.1016/j.biomaterials.2011.04.028
   White WM, 1999, LARYNGOSCOPE, V109, P1709, DOI 10.1097/00005537-199910000-00029
   Xylas J, 2012, OPT EXPRESS, V20, P23442, DOI 10.1364/OE.20.023442
NR 44
TC 9
Z9 9
U1 5
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2014
VL 35
IS 12
BP 3794
EP 3802
DI 10.1016/j.biomaterials.2014.01.034
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC3OS
UT WOS:000332431700009
PM 24484674
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Cairo, F
   Nieri, M
   Pagliaro, U
AF Cairo, Francesco
   Nieri, Michele
   Pagliaro, Umberto
TI Efficacy of periodontal plastic surgery procedures in the treatment of
   localized facial gingival recessions. A systematic review
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE connective tissue graft; coronally advanced flap; gingival recession;
   periodontal plastic surgery; root coverage; systematic review
ID CONNECTIVE-TISSUE GRAFT; CORONALLY ADVANCED FLAP; ACELLULAR DERMAL
   MATRIX; ROOT-COVERAGE PROCEDURES; XENOGENEIC COLLAGEN MATRIX; RANDOMIZED
   CLINICAL-TRIAL; MILLER CLASS-I; POSITIONED FLAP; BIOABSORBABLE MEMBRANE;
   FOLLOW-UP
AB BackgroundThe aim of this Systematic Review (SR) was to assess the clinical efficacy of periodontal plastic surgery procedures in the treatment of localized gingival recessions (Rec) with or without inter-dental clinical attachment loss (iCAL).
   Material and MethodsElectronic and hand searches were performed to identify randomized clinical trials (RCTs) on treatment of single gingival recessions with at least 6months of follow-up. Primary outcome variable was complete root coverage (CRC). Secondary outcome variables were recession reduction (RecRed) and keratinized tissue (KT) gain. To evaluate treatment effect, Odds Ratios were combined for dichotomous data and mean differences in continuous data using a random-effect model.
   ResultsFifty-one RCTs (53 articles) with a total of 1574 treated patients (1744 recessions) were included in this SR. Finally, 30 groups of comparisons were identified and a total of 80 meta-analyses were performed. Coronally Advanced Flap (CAF) was associated with higher probability of CRC and higher amount of RecRed than Semilunar Coronal Positioned Flap (SCPF). The combination CAF plus Connective Tissue Graft (CAF+CTG) or CAF plus Enamel Matrix Derivative (CAF+EMD) was more effective than CAF alone in terms of CRC and RecRed. The combination CAF plus Collagen Matrix (CAF+CM) achieved higher RecRed than CAF alone. In addition, CAF+CTG achieved CRC more frequently than CAF+EMD, SCPF, Free Gingival Graft (FGG) and Laterally Positioned Flap (LPS). CAF+CTG was also associated with higher RecRed than Barrier Membranes (CAF+GTR), CAF+EMD and CAF+CM. GTR was not able to improve the clinical efficacy of CAF. Studies adding Acellular Dermal Matrix (ADM) under CAF showed a large heterogeneity and not significant benefits compared with CAF alone. Multiple combinations, using more than a single graft/biomaterial under the flap, usually provide similar or less benefits than simpler, control procedures in term of root coverage outcomes.
   ConclusionsCAF procedures alone or with CTG, EMD are supported by large evidence in modern periodontal plastic surgery. CAF+CTG achieved the best clinical outcomes in single gingival recessions with or without iCAL.
C1 [Cairo, Francesco; Nieri, Michele] Univ Florence, Tuscan Sch Dent Med, Dept Periodontol & Implant Dent, Florence, Italy.
   [Cairo, Francesco; Nieri, Michele] Univ Siena, Tuscan Sch Dent Med, Dept Periodontol & Implant Dent, I-53100 Siena, Italy.
RP Cairo, F (reprint author), Via Fra Giovanni Angelico 51, I-50121 Florence, Italy.
EM cairofrancesco@virgilio.it
CR Abolfazli N, 2009, MED ORAL PATOL ORAL, V14, pE304
   Aichelmann-Reidy ME, 2001, J PERIODONTOL, V72, P998, DOI 10.1902/jop.2001.72.8.998
   Al-Hamdan K, 2003, J PERIODONTOL, V74, P1520, DOI 10.1902/jop.2003.74.10.1520
   Alkan EA, 2011, J PERIODONTAL RES, V46, P637, DOI 10.1111/j.1600-0765.2011.01381.x
   ALLEN EP, 1989, J PERIODONTOL, V60, P316, DOI 10.1902/jop.1989.60.6.316
   Alves LB, 2012, J CLIN PERIODONTOL, V39, P393, DOI 10.1111/j.1600-051X.2012.01851.x
   Amarante ES, 2000, J PERIODONTOL, V71, P989, DOI 10.1902/jop.2000.71.6.989
   [Anonymous], 2007, J EVID-BASED DENT PR, V7, P45
   Barros R. R. M., 2013, EUROPEAN J IN PRESS
   Bittencourt S, 2009, J PERIODONTOL, V80, P1076, DOI 10.1902/jop.2009.080498
   Borghetti A, 1999, J PERIODONTOL, V70, P123, DOI 10.1902/jop.1999.70.2.123
   Buti J, 2013, J CLIN PERIODONTOL, V40, P372, DOI 10.1111/jcpe.12028
   CAFFESSE RG, 1978, J PERIODONTOL, V49, P357, DOI 10.1902/jop.1978.49.7.357
   CAFFESSE RG, 1980, J PERIODONTOL, V51, P167, DOI 10.1902/jop.1980.51.3.167
   Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x
   Cairo F, 2012, J CLIN PERIODONTOL, V39, P760, DOI 10.1111/j.1600-051X.2012.01903.x
   Cairo F, 2011, J CLIN PERIODONTOL, V38, P661, DOI 10.1111/j.1600-051X.2011.01732.x
   Cairo F, 2010, J PERIODONTOL, V81, P1752, DOI 10.1902/jop.2010.100278
   Cairo F, 2009, J PERIODONTOL, V80, P705, DOI 10.1902/jop.2009.080565
   Castellanos A, 2006, J PERIODONTOL, V77, P7, DOI 10.1902/jop.2006.77.1.7
   Chambrone L, 2008, J DENT, V36, P659, DOI 10.1016/j.jdent.2008.05.007
   Chambrone L, 2012, J PERIODONTOL, V83, P477, DOI 10.1902/jop.2011.110382
   Chambrone L, 2010, J PERIODONTOL, V81, P452, DOI 10.1902/jop.2010.090540
   Chambrone L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007161.pub2
   Chambrone L, 2009, J AM DENT ASSOC, V140, P294, DOI 10.14219/jada.archive.2009.0158
   Cheng YF, 2007, J PERIODONTAL RES, V42, P474, DOI 10.1111/j.1600-0765.2007.00971.x
   Clauser C, 2003, J PERIODONTOL, V74, P741, DOI 10.1902/jop.2003.74.5.741
   Cortellini P, 2009, J CLIN PERIODONTOL, V36, P68, DOI 10.1111/j.1600-051X.2008.01346.x
   Cortes AD, 2004, J PERIODONTOL, V75, P1137
   da Silva RC, 2004, J PERIODONTOL, V75, P413, DOI 10.1902/jop.2004.75.3.413
   Cortes AD, 2006, J CLIN PERIODONTOL, V33, P683, DOI 10.1111/j.1600-051X.2006.00969.x
   Del Pizzo M, 2005, J CLIN PERIODONTOL, V32, P1181, DOI 10.1111/j.1600-051X.2005.00831.x
   Dodge JR, 2000, INT J PERIODONT REST, V20, P399
   Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140
   Espinel M C, 1981, Int J Periodontics Restorative Dent, V1, P30
   FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q
   Fu Jia-Hui, 2012, J Evid Based Dent Pract, V12, P129, DOI 10.1016/S1532-3382(12)70025-8
   Gapski R, 2005, J PERIODONTOL, V76, P1814, DOI 10.1902/jop.2005.76.11.1814
   Guiha R, 2001, J PERIODONTOL, V72, P470, DOI 10.1902/jop.2001.72.4.470
   GUINARD EA, 1978, J PERIODONTOL, V49, P457, DOI 10.1902/jop.1978.49.9.457
   Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD
   Haghighati F, 2009, INT J PERIODONT REST, V29, P179
   Higgins JPT, 2011, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184
   Huang LH, 2005, J PERIODONTOL, V76, P1768, DOI 10.1902/jop.2005.76.10.1768
   Hwang D, 2006, J PERIODONTOL, V77, P1625, DOI 10.1902/jop.2006.060107
   JAHNKE PV, 1993, J PERIODONTOL, V64, P315, DOI 10.1902/jop.1993.64.4.315
   Jankovic S., 2012, INT J PERIODONT REST, V32, P41
   Jankovic Sasha, 2010, Eur J Esthet Dent, V5, P260
   Jepsen K, 1998, J PERIODONTOL, V69, P383, DOI 10.1902/jop.1998.69.3.383
   Jepsen K, 2013, J CLIN PERIODONTOL, V40, P82, DOI 10.1111/jcpe.12019
   Jhaveri HM, 2010, J PERIODONTOL, V81, P616, DOI 10.1902/jop.2009.090530
   Joly JC, 2007, J PERIODONTOL, V78, P1017, DOI 10.1902/jop.2007.060428
   Kerner S, 2009, J CLIN PERIODONTOL, V36, P80, DOI 10.1111/j.1600-051X.2008.01348.x
   Kimble KM, 2004, J PERIODONTOL, V75, P210, DOI 10.1902/jop.2004.75.2.210
   Ko H. Y., 2010, J EXPT CLIN MED, V2, P63
   Leknes KN, 2005, J CLIN PERIODONTOL, V32, P518, DOI 10.1111/j.1600-051X.2005.00706.x
   Liberati A, 2009, ANN INTERN MED, V151, pW65, DOI 10.7326/0003-4819-151-4-200908180-00136
   Lins LHS, 2003, J PERIODONTOL, V74, P168, DOI 10.1902/jop.2003.74.2.168
   Mahajan A, 2007, J PERIODONTOL, V78, P2348, DOI 10.1902/jop.2007.070074
   McGuire MK, 2012, J PERIODONTOL, V83, P1353, DOI 10.1902/jop.2012.110373
   McGuire MK, 2010, J PERIODONTOL, V81, P1108, DOI 10.1902/jop.2010.090698
   McGuire MK, 2009, J PERIODONTOL, V80, P550, DOI 10.1902/jop.2009.080502
   McGuire MK, 2003, J PERIODONTOL, V74, P1110, DOI 10.1902/jop.2003.74.8.1110
   Miller P D Jr, 1985, Int J Periodontics Restorative Dent, V5, P8
   Miller P D Jr, 1993, Pract Periodontics Aesthet Dent, V5, P15
   Modica F, 2000, J PERIODONTOL, V71, P1693, DOI 10.1902/jop.2000.71.11.1693
   Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535
   MORMANN W, 1977, J PERIODONTOL, V48, P681
   Moslemi N, 2011, J CLIN PERIODONTOL, V38, P1122, DOI 10.1111/j.1600-051X.2011.01789.x
   Nazareth CA, 2011, J PERIODONTOL, V82, P700, DOI 10.1902/jop.2010.100434
   Nieri M, 2013, J CLIN PERIODONTOL, V40, P707, DOI 10.1111/jcpe.12114
   Oates Thomas W, 2003, Ann Periodontol, V8, P303, DOI 10.1902/annals.2003.8.1.303
   Pagliaro U, 2003, J PERIODONTOL, V74, P709, DOI 10.1902/jop.2003.74.5.709
   Paolantonio M, 1997, J CLIN PERIODONTOL, V24, P51, DOI 10.1111/j.1600-051X.1997.tb01184.x
   Paolantonio M, 2002, J PERIODONTOL, V73, P1299, DOI 10.1902/jop.2002.73.11.1299
   Paolantonio M, 2002, J PERIODONTOL, V73, P53, DOI 10.1902/jop.2002.73.1.53
   Pilloni A, 2006, J PERIODONTOL, V77, P2031, DOI 10.1902/jop.2006.050390
   Prato GP, 2011, J CLIN PERIODONTOL, V38, P715, DOI 10.1111/j.1600-051X.2011.01744.x
   Rasperini G, 2011, INT J PERIODONT REST, V31, P133
   Ricci G, 1996, INT J PERIODONT REST, V16, P539
   Roccuzzo M, 2002, J CLIN PERIODONTOL, V29, P178, DOI 10.1034/j.1600-051X.29.s3.11.x
   Romagna-Genon C, 2001, J PERIODONTOL, V72, P1258, DOI 10.1902/jop.2000.72.9.1258
   Roman A, 2013, J PERIODONTAL RES, V48, P563, DOI 10.1111/jre.12039
   Santana RB, 2010, J PERIODONTOL, V81, P485, DOI 10.1902/jop.2010.090237
   Santana RB, 2010, J CLIN PERIODONTOL, V37, P651, DOI 10.1111/j.1600-051X.2010.01582.x
   Spahr A, 2005, J PERIODONTOL, V76, P1871, DOI 10.1902/jop.2005.76.11.1871
   Tal H, 2002, J PERIODONTOL, V73, P1405, DOI 10.1902/jop.2002.73.12.1405
   Tatakis DN, 2000, J PERIODONTOL, V71, P299, DOI 10.1902/jop.2000.71.2.299
   Trabulsi M, 2004, J PERIODONTOL, V75, P1446, DOI 10.1902/jop.2004.75.11.1446
   Trombelli L, 1998, J PERIODONTOL, V69, P1271, DOI 10.1902/jop.1998.69.11.1271
   Wang HL, 2001, J PERIODONTOL, V72, P1301, DOI 10.1902/jop.2001.72.10.1301
   WENNSTROM JL, 1994, PROCEEDINGS OF THE 1ST EUROPEAN WORKSHOP ON PERIODONTOLOGY, P193
   Wilson TG, 2005, J PERIODONTOL, V76, P881, DOI 10.1902/jop.2005.76.6.881
   Woodyard JG, 2004, J PERIODONTOL, V75, P44, DOI 10.1902/jop.2004.75.1.44
   Zucchelli G, 1998, J PERIODONTOL, V69, P138, DOI 10.1902/jop.1998.69.2.138
   Zucchelli G, 2012, J CLIN PERIODONTOL, V39, P1082, DOI 10.1111/jcpe.12002
   1996, ANN PERIODONTOL, V1, P702
NR 97
TC 74
Z9 81
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
EI 1600-051X
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD APR
PY 2014
VL 41
SU 15
SI SI
BP S44
EP S62
DI 10.1111/jcpe.12182
PG 19
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AD0WX
UT WOS:000332956100005
PM 24641000
OA Bronze
DA 2018-10-19
ER

PT J
AU Carreira, AC
   Lojudice, FH
   Halcsik, E
   Navarro, RD
   Sogayar, MC
   Granjeiro, JM
AF Carreira, A. C.
   Lojudice, F. H.
   Halcsik, E.
   Navarro, R. D.
   Sogayar, M. C.
   Granjeiro, J. M.
TI Bone Morphogenetic Proteins Facts, Challenges, and Future Perspectives
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Review
DE biomaterial(s); bioengineering; bone remodeling/regeneration; systematic
   reviews and evidence-based medicine; regenerative medicine; growth
   factor(s)
ID GROWTH-FACTOR; DENTAL IMPLANT; PERIODONTAL REGENERATION; SEGMENTAL
   DEFECTS; LUMBAR SPINE; TGF-BETA; BMP; REPAIR; DELIVERY; CELLS
AB Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily, acting as potent regulators during embryogenesis and bone and cartilage formation and repair. Cell and molecular biology approaches have unveiled the great complexity of BMP action, later confirmed by transgenic animal studies. Genetic engineering allows for the production of large amounts of BMPs for clinical use, but they have systematically been associated with a delivery system, such as type I collagen and calcium phosphate ceramics, to ensure controlled release and to maximize their biological activity at the surgical site, avoiding systemic diffusion. Clinical orthopedic studies have shown the benefits of FDA-approved recombinant human BMPs (rhBMPs) 2 and 7, but side effects, such as swelling, seroma, and increased cancer risk, have been reported, probably due to high BMP dosage. Several studies have supported the use of BMPs in periodontal regeneration, sinus lift bone-grafting, and non-unions in oral surgery. However, the clinical use of BMPs is growing mainly in off-label applications, with robust evidence to ascertain rhBMPs' safety and efficacy through well-designed, randomized, and double-blind clinical trials. Here we review and discuss the critical data on BMP structure, mechanisms of action, and possible clinical applications.
C1 [Carreira, A. C.; Lojudice, F. H.; Halcsik, E.; Sogayar, M. C.] Univ Sao Paulo, Dept Biochem, Inst Chem, Sao Paulo, Brazil.
   [Carreira, A. C.; Lojudice, F. H.; Halcsik, E.; Sogayar, M. C.] Univ Sao Paulo, Cell & Mol Therapy Ctr NUCEL NETCEM, Sch Med, Sao Paulo, Brazil.
   [Navarro, R. D.] St Francis Hosp, Oral & Maxillofacial Surg Div, Cambe, PR, Brazil.
   [Navarro, R. D.] Univ Estadual Maringa, Post Grad Program, Dept Dent, Area Oral & Maxillofacial Surg, Maringa, Parana, Brazil.
   [Granjeiro, J. M.] Natl Inst Metrol Qual & Technol, Bioengn Div, BR-25250020 Caxias, RJ, Brazil.
   [Granjeiro, J. M.] Univ Fed Fluminense, Dept Dent Mat, Sch Dent, Niteroi, RJ, Brazil.
RP Granjeiro, JM (reprint author), Natl Inst Metrol Qual & Technol, Bioengn Div, BR-25250020 Caxias, RJ, Brazil.
EM jmgranjeiro@inmetro.gov.br
RI Carreira, Ana Claudia/B-7655-2012
OI Granjeiro, Jose/0000-0002-8027-8293
FU Brazilian Development Bank (BNDES); National Council for Scientific and
   Technological Development (CNPq); Coordination for the Improvement of
   Higher Education Personnel (CAPES); Sao Paulo Research Foundation
   (FAPESP); Rio de Janeiro State Foundation Support Research (FAPERJ);
   Research and Projects Financier (FINEP); Ministry of Science, Technology
   and Innovation (MCTI); Ministry of Health of Brazil/Department of
   Science and Technology (MS-DECIT)
FX The authors acknowledge financial support from the Brazilian Development
   Bank (BNDES), National Council for Scientific and Technological
   Development (CNPq), Coordination for the Improvement of Higher Education
   Personnel (CAPES), Sao Paulo Research Foundation (FAPESP), Rio de
   Janeiro State Foundation Support Research (FAPERJ), Research and
   Projects Financier (FINEP), Ministry of Science, Technology and
   Innovation (MCTI) and Ministry of Health of Brazil/Department of Science
   and Technology (MS-DECIT). The authors declare no potential conflicts of
   interest with respect to the authorship and/or publication of this
   article.
CR Alt V, 2009, INJURY, V40, P1269, DOI 10.1016/j.injury.2009.02.007
   Ben-David D, 2013, BIOMATERIALS, V34, P2902, DOI 10.1016/j.biomaterials.2013.01.035
   BOWERS G, 1991, J PERIODONTOL, V62, P690, DOI 10.1902/jop.1991.62.11.690
   Bustos-Valenzuela JC, 2010, MOL BIOTECHNOL, V46, P118, DOI 10.1007/s12033-010-9287-0
   Bustos-Valenzuela Juan C, 2011, BMC Res Notes, V4, P370, DOI 10.1186/1756-0500-4-370
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Cestari TM, 2009, CLIN ORAL IMPLAN RES, V20, P340, DOI 10.1111/j.1600-0501.2008.01659.x
   Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929
   Chrastil J, 2013, SPINE, V38, pE1020, DOI 10.1097/BRS.0b013e3182982f8e
   Colin C, 2008, MOL BIOTECHNOL, V39, P89, DOI 10.1007/s12033-008-9052-9
   Degat MC, 2005, PATHOL BIOL, V53, P131, DOI 10.1016/j.patbio.2004.03.004
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Devine John G, 2012, Evid Based Spine Care J, V3, P35, DOI 10.1055/s-0031-1298616
   Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x
   Dunn CA, 2005, MOL THER, V11, P294, DOI 10.1016/j.ymthe.2004.10.005
   Garrison KR, 2010, COCHRANE DATABASE SY, V6
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129
   Giannoudis PV, 2009, CLIN ORTHOP RELAT R, V467, P3239, DOI 10.1007/s11999-009-0846-2
   Giannoudis PV, 2005, INJURY, V36, P47, DOI 10.1016/j.injury.2005.07.035
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Granjeiro JM, 2010, ODONTOLOGIA CLASSE M, P109
   Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878
   Hagi TT, 2010, BONE, V46, P1322, DOI 10.1016/j.bone.2010.02.010
   Halcsik E, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-47
   Hong P, 2013, J PLAST RECONSTR AES, V66, P883, DOI 10.1016/j.bjps.2013.03.030
   Hussein KA, 2013, J ORAL MAXIL SURG, V71, P1107, DOI 10.1016/j.joms.2012.12.018
   Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968
   Javier AL, 2012, PLOS ONE, V7
   JOHNSON EE, 1992, CLIN ORTHOP RELAT R, V277, P229
   Kamitakahara M, 2008, J BIOMATER APPL, V23, P197, DOI 10.1177/0885328208096798
   Lan J, 2006, J PERIODONTOL, V77, P357, DOI 10.1902/jop.2006.050016
   Leknes KN, 2008, CLIN ORAL IMPLAN RES, V19, P1027, DOI 10.1111/j.1600-0501.2008.01567.x
   Li JY, 2011, DEVELOPMENT, V138, P1977, DOI 10.1242/dev.061341
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   Lissenberg-Thunnissen SN, 2011, INT ORTHOP, V35, P1271, DOI 10.1007/s00264-011-1301-z
   Lomelino Rde O, 2011, J MATER SCI-MATER M, V23, P781
   Lu H, 2008, BIOMATERIALS, V33, P6140
   Luo T, 2012, CLIN ORAL IMPLAN RES, V23, P467, DOI 10.1111/j.1600-0501.2011.02164.x
   Mitri F, 2012, ARTIF ORGANS, V36, P535, DOI 10.1111/j.1525-1594.2011.01409.x
   Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043
   Neovius E, 2013, J PLAST RECONSTR AES, V66, P37, DOI 10.1016/j.bjps.2012.08.015
   Oh SH, 2011, BIOMATERIALS, V32, P8254, DOI 10.1016/j.biomaterials.2011.07.027
   Onichtchouk D, 1999, NATURE, V401, P480
   Papakostidis C, 2008, SPINE, V33, pE680, DOI 10.1097/BRS.0b013e3181844eca
   Polimeni G, 2008, CLIN IMPLANT DENT R, V10, P99, DOI 10.1111/j.1708-8208.2007.00067.x
   Ritting AW, 2012, J HAND SURG-AM, V37A, P316, DOI 10.1016/j.jhsa.2011.10.007
   Ronga M, 2013, INJURY, V44, pS34, DOI 10.1016/S0020-1383(13)70008-1
   Rotenberg SA, 2011, J PERIODONTOL, V82, P1212, DOI 10.1902/jop.2011.100626
   Rutherford R B, 1992, Int J Oral Maxillofac Implants, V7, P297
   Saito A, 2009, J PERIODONTOL, V80, P961, DOI 10.1902/jop.2009.080568
   Salgado P. C., 2011, J BIOMATER NANOBIOTE, V2, P318, DOI 10.4236/jbnb.2011.23039
   Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006
   Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007
   SIGURDSSON TJ, 1995, J PERIODONTOL, V66, P131, DOI 10.1902/jop.1995.66.2.131
   Simion M, 2008, INT J PERIODONT REST, V28, P239
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Walsh G, 2010, DRUG DISCOV TODAY, V15, P773, DOI 10.1016/j.drudis.2010.06.009
   Wei SJ, 2012, ORTHOPEDICS, V35, pE847, DOI 10.3928/01477447-20120525-23
   Wilkinson L, 2003, J BIOL CHEM, V278, P34181, DOI 10.1074/jbc.M301247200
   Williams BJ, 2011, SPINE, V36, P1685, DOI 10.1097/BRS.0b013e318216d825
   WINN SR, 1999, CLIN ORTHOP S, V367, P95
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yang X, 2012, J BIOMED MA IN PRESS
   Zambuzzi Willian F., 2012, Braz. Dent. J., V23, P315, DOI 10.1590/S0103-64402012000400002
NR 66
TC 128
Z9 139
U1 11
U2 101
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
EI 1544-0591
J9 J DENT RES
JI J. Dent. Res.
PD APR
PY 2014
VL 93
IS 4
BP 335
EP 345
DI 10.1177/0022034513518561
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AC8ZM
UT WOS:000332823600002
PM 24389809
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Wiltschka, O
   Bocking, D
   Miller, L
   Brenner, RE
   Sahlgren, C
   Linden, M
AF Wiltschka, Oliver
   Boecking, Dominique
   Miller, Larissa
   Brenner, Rolf E.
   Sahlgren, Cecilia
   Linden, Mika
TI Preparation, characterization, and preliminary biocompatibility
   evaluation of particulate spin-coated mesoporous silica films
SO MICROPOROUS AND MESOPOROUS MATERIALS
LA English
DT Article
DE Mesoporous silica nanoparticles; Films; Cell substrate; Drug release;
   Stem cells
ID ANODIC POROUS ALUMINA; THIN-FILMS; SUBSTRATE STIFFNESS; DRUG-DELIVERY;
   MIDDLE-EAR; NANOPARTICLES; MORPHOLOGY; FABRICATION; PARTICLES; SURFACES
AB Porous, biocompatible supports are interesting substrates for biological applications, as they allow for release of actives with spatial control. Here we report on the synthesis and characterization of spin-coated thin films made of mesoporous silica nanoparticles of different size and shape on microscopy slides. By controlling processing parameters like spinning-speed and particle concentration, homogeneous films can be prepared with controlled thicknesses ranging from bilayers to several multilayers. Different particle diameters and shapes can be used, thus providing further parameters for film thickness and morphology control. The use of particles in the preparation of the spin-coated films has several advantages. Relatively homogeneous thick films can be prepared in one step with thicknesses exceeding those using molecular precursor solutions. Furthermore, as the morphological properties of the surface are known to influence cell attachment, proliferation, and also differentiation of stem cells, the possibility to influence the morphology of the films is highly attractive from a biomaterial perspective. Preliminary in vitro cell studies indicate that the particles can be endocytosed by cells cultivated on these films, and that model drugs can be released inside the cells showing the potential of these films for local drug delivery applications. The results are important for further optimization of novel scaffolds exhibiting spatial, and temporal control of the delivery of active cues in, for example, tissue engineering applications. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wiltschka, Oliver; Boecking, Dominique; Miller, Larissa; Linden, Mika] Univ Ulm, Inst Inorgan Chem 2, D-89081 Ulm, Germany.
   [Sahlgren, Cecilia] Tech Univ Eindhoven, NL-5600 MB Eindhoven, Netherlands.
   [Brenner, Rolf E.] Univ Ulm, Dept Orthopaed, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany.
RP Linden, M (reprint author), Univ Ulm, Inst Inorgan Chem 2, Albert Einstein Allee 11, D-89081 Ulm, Germany.
EM mlinden@uni-ulm.de
OI , cecilia/0000-0001-6365-6275
CR Asoh H, 2001, J ELECTROCHEM SOC, V148, pB152, DOI 10.1149/1.1355686
   Boarino L, 2011, PHYS STATUS SOLIDI A, V208, P1403, DOI 10.1002/pssa.201000316
   Brinker CJ, 1999, ADV MATER, V11, P579, DOI 10.1002/(SICI)1521-4095(199905)11:7<579::AID-ADMA579>3.0.CO;2-R
   Chattopadhyay S, 2004, J APPL PHYS, V96, P6888, DOI 10.1063/1.1806992
   Chattopadhyay S, 2002, J APPL PHYS, V91, P6134, DOI 10.1063/1.1465123
   Crepaldi EL, 2003, J AM CHEM SOC, V125, P9770, DOI 10.1021/ja030070g
   Ehlert N, 2013, CHEM SOC REV, V42, P3847, DOI 10.1039/c3cs35359a
   Ehlert N, 2011, J MATER CHEM, V21, P752, DOI 10.1039/c0jm01487g
   Graf C, 2003, LANGMUIR, V19, P6693, DOI 10.1021/la0347859
   Hu Y, 2012, ACTA BIOMATER, V8, P439, DOI 10.1016/j.actbio.2011.10.021
   Huh S, 2003, CHEM COMMUN, P2364, DOI 10.1039/b306255d
   Jiang P, 1999, CHEM MATER, V11, P2132, DOI 10.1021/cm990080+
   Juillerat F, 2006, LANGMUIR, V22, P2249, DOI 10.1021/la052304a
   Kobler J, 2008, ACS NANO, V2, P2324, DOI 10.1021/nn800505g
   Lebold T, 2009, NANO LETT, V9, P2877, DOI 10.1021/nl9011112
   Lee JE, 2011, ACCOUNTS CHEM RES, V44, P893, DOI 10.1021/ar2000259
   Lensing R, 2013, ACTA BIOMATER, V9, P4815, DOI 10.1016/j.actbio.2012.08.016
   Lian HY, 2011, J PHYS CHEM C, V115, P6581, DOI 10.1021/jp110852p
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617
   Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018
   Masuda H, 1997, J ELECTROCHEM SOC, V144, pL127, DOI 10.1149/1.1837634
   Masuda H, 1996, JPN J APPL PHYS 2, V35, pL126, DOI 10.1143/JJAP.35.L126
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Masuda H., 1998, JPN J APPL PHYS, V37, pL1340, DOI DOI 10.1143/JJAP.37.L1340
   Mortera R, 2010, ADV ENG MATER, V12, pB256, DOI 10.1002/adem.200980075
   Peng XL, 2012, J BIOMECH, V45, P116, DOI 10.1016/j.jbiomech.2011.09.013
   Prosser JH, 2012, NANO LETT, V12, P5287, DOI 10.1021/nl302555k
   REHG TJ, 1992, AICHE J, V38, P489, DOI 10.1002/aic.690380403
   Rosenholm JM, 2012, NANOMEDICINE-UK, V7, P111, DOI [10.2217/nnm.11.166, 10.2217/NNM.11.166]
   Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b
   Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r
   Rossi L, 2011, SOFT MATTER, V7, P4139, DOI 10.1039/c0sm01246g
   Simovic S, 2011, CURR DRUG DISCOV TEC, V8, P250, DOI DOI 10.2174/157016311796799026
   Tate MP, 2010, LANGMUIR, V26, P4357, DOI 10.1021/la903443p
   Trichet L, 2012, P NATL ACAD SCI USA, V109, P6933, DOI 10.1073/pnas.1117810109
   Vivero-Escoto JL, 2010, SMALL, V6, P1952, DOI 10.1002/smll.200901789
   Yang H., 2012, J COLLOID INTERF SCI, V352, P558
NR 38
TC 5
Z9 5
U1 0
U2 50
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-1811
EI 1873-3093
J9 MICROPOR MESOPOR MAT
JI Microporous Mesoporous Mat.
PD APR
PY 2014
VL 188
BP 203
EP 209
DI 10.1016/j.micromeso.2014.01.006
PG 7
WC Chemistry, Applied; Chemistry, Physical; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AC8WT
UT WOS:000332816500023
DA 2018-10-19
ER

PT J
AU Kajbafzadeh, AM
   Sabetkish, S
   Heidari, R
   Ebadi, M
AF Kajbafzadeh, Abdol-Mohammad
   Sabetkish, Shabnam
   Heidari, Reza
   Ebadi, Maryam
TI Tissue-engineered cholecyst-derived extracellular matrix: a biomaterial
   for in vivo autologous bladder muscular wall regeneration
SO PEDIATRIC SURGERY INTERNATIONAL
LA English
DT Article
DE Gallbladder; Bladder; Augmentation; Scaffold; Transplantation
ID SMALL-INTESTINAL SUBMUCOSA; AUGMENTATION; CELLS; AUTOAUGMENTATION;
   CYSTOPLASTY; REPLACEMENT; CANCERS; RABBIT; MODEL; GRAFT
AB To compare the biocompatibility and histological aspects of cholecyst-derived extra cellular matrix (CDECM) graft, either alone or with application of autologous detrusor muscles small fragments (ADMSF) on rabbit bladder mucosa for bladder augmentation.
   The gallbladders were acellularized and evaluated for preserved acellular matrix scaffold and biophysical properties. Thirty rabbits were divided into five groups. Rabbits in the control group underwent partial detrusorectomy followed by perivesical fat coverage. Groups I and II underwent the same procedure and bladder mucosa was covered either by acellular rabbit gallbladder (ARG) (group I) or acellular sheep gallbladder (ASG) (group II). Groups III and IV underwent detrusorectomy and the bladder mucosal was seeded by ADMSF and covered by ARG (group III), or ASG (group IV). Biopsies were taken at 4, 12, and 24 weeks postoperatively.
   Higher expression of CD34 endothelial progenitor cells, CD31 microvessels, alpha-smooth muscle actin, S100, and cytokeratin with more organized muscular wall generation was demonstrated in groups III and IV. Expression of IHC markers was higher in groups III and IV compared with groups I and II in all the time points.
   The current study confirmed that autologous fragment-seeded CDECM can be considered as a reliable natural collagen scaffold for bladder augmentation.
C1 [Kajbafzadeh, Abdol-Mohammad; Sabetkish, Shabnam; Heidari, Reza; Ebadi, Maryam] Univ Tehran Med Sci, Childrens Hosp Med Ctr, Sect Tissue Engn & Stem Cells Therapy, Pediat Urol Res Ctr, Tehran 1419433151, Iran.
RP Kajbafzadeh, AM (reprint author), Univ Tehran Med Sci, Childrens Hosp Med Ctr, Sect Tissue Engn & Stem Cells Therapy, Pediat Urol Res Ctr, 62 Dr Qaribs St,Keshavarz Blvd, Tehran 1419433151, Iran.
EM kajbafzd@sina.tums.ac.ir
CR Domingos ALA, 2012, INT BRAZ J UROL, V38, P536, DOI 10.1590/S1677-55382012000400014
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Ayyildiz A, 2008, ANZ J SURG, V78, P82, DOI 10.1111/j.1445-2197.2007.04361.x
   Brody S, 2007, BIOMATERIALS, V28, P1461, DOI 10.1016/j.biomaterials.2006.11.030
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P3439, DOI 10.1021/bm700560k
   Coburn JC, 2007, J BIOMED MATER RES A, V81A, P250, DOI 10.1002/jbm.a.30943
   Drewa T, 2006, TRANSPLANT P, V38, P133, DOI 10.1016/j.transproceed.2005.11.086
   FISHMAN IJ, 1987, J UROLOGY, V138, P1291, DOI 10.1016/S0022-5347(17)43586-5
   Greenwell TJ, 2001, BJU INT, V88, P511, DOI 10.1046/j.1464-4096.2001.001206
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, J UROLOGY, V180, P392, DOI 10.1016/j.juro.2008.02.039
   Kaefer M, 1998, J UROLOGY, V160, P2187, DOI 10.1016/S0022-5347(01)62290-0
   Kajbafzadeh A. M., 2012, TISSUE ENG PART A, V18, P882
   Kajbafzadeh AM, 2007, J SURG RES, V139, P189, DOI 10.1016/j.jss.2006.11.003
   Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P317, DOI 10.1016/j.jpurol.2011.02.014
   Kajbafzadeh AM, 2010, J UROLOGY, V183, P1168, DOI [10.1076/j.juro.2009.11.052, 10.1016/j.juro.2009.11.052]
   KAMBIC H, 1992, J UROLOGY, V148, P539, DOI 10.1016/S0022-5347(17)36649-1
   Lai JY, 2005, J PEDIATR SURG, V40, P1869, DOI 10.1016/j.jpedsurg.2005.08.028
   Miyata H, 2000, CLIN CANCER RES, V6, P4859
   Pandit A, 2009, GOOGLE PATENTS
   Perovic SV, 2002, J UROLOGY, V168, P1877, DOI 10.1097/01.ju.0000030041.09225.41
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Stein R, 2012, J PEDIATR UROL, V8, P145, DOI 10.1016/j.jpurol.2011.03.015
   Wongsetthachai P, 2011, RES VET SCI, V90, P156, DOI 10.1016/j.rvsc.2010.05.015
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yoshioka A, 2008, INT J ONCOL, V33, P461, DOI 10.3892/ijo_00000028
NR 27
TC 12
Z9 14
U1 1
U2 16
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0179-0358
EI 1437-9813
J9 PEDIATR SURG INT
JI Pediatr. Surg. Int.
PD APR
PY 2014
VL 30
IS 4
BP 371
EP 380
DI 10.1007/s00383-014-3474-1
PG 10
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA AD2GJ
UT WOS:000333052000002
PM 24468716
DA 2018-10-19
ER

PT J
AU Barua, S
   Dutta, N
   Karmakar, S
   Chattopadhyay, P
   Aidew, L
   Buragohain, AK
   Karak, N
AF Barua, Shaswat
   Dutta, Nipu
   Karmakar, Sanjeev
   Chattopadhyay, Pronobesh
   Aidew, Lipika
   Buragohain, Alak K.
   Karak, Niranjan
TI Biocompatible high performance hyperbranched epoxy/clay nanocomposite as
   an implantable material
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE hyperbranched epoxy; clay; nanocomposite; antibacterial; biomaterial
ID TISSUE ENGINEERING APPLICATIONS; SEALERS IN-VITRO; FABRICATION;
   SCAFFOLDS; TOXICITY; CLAY
AB Polymeric biomaterials are in extensive use in the domain of tissue engineering and regenerative medicine. High performance hyperbranched epoxy is projected here as a potential biomaterial for tissue regeneration. Thermosetting hyperbranched epoxy nanocomposites were prepared with Homalomena aromatica rhizome oil-modified bentonite as well as organically modified montmorillonite clay. Fourier transformed infrared spectroscopy, x-ray diffraction and scanning and transmission electron microscopic techniques confirmed the strong interfacial interaction of clay layers with the epoxy matrix. The poly(amido amine)-cured thermosetting nanocomposites exhibited high mechanical properties like impact resistance (>100 cm), scratch hardness (>10 kg), tensile strength (48-58 MPa) and elongation at break (11.9-16.6%). Cytocompatibility of the thermosets was found to be excellent as evident by MTT and red blood cell hemolytic assays. The nanocomposites exhibited antimicrobial activity against Staphylococcus aureus (ATCC 11632), Escherichia coli (ATCC 10536), Mycobacterium smegmatis (ATCC14468) and Candida albicans (ATCC 10231) strains. In vivo biocompatibility of the best performing nanocomposite was ascertained by histopathological study of the brain, heart, liver and skin after subcutaneous implantation in Wistar rats. The material supported the proliferation of dermatocytes without induction of any sign of toxicity to the above organs. The adherence and proliferation of cells endorse the nanocomposite as a non-toxic biomaterial for tissue regeneration.
C1 [Barua, Shaswat; Dutta, Nipu; Karak, Niranjan] Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
   [Karmakar, Sanjeev; Chattopadhyay, Pronobesh] Def Res Lab, Tezpur, Assam, India.
   [Aidew, Lipika; Buragohain, Alak K.] Tezpur Univ, Dept Mol Biol Biotechnol, Tezpur 784028, Assam, India.
RP Barua, S (reprint author), Tezpur Univ, Dept Chem Sci, Adv Polymer & Nanomat Lab, Tezpur 784028, Assam, India.
EM karakniranjan@yahoo.com
RI Barua, Shaswat/A-5032-2013; Karak, Niranjan/A-1030-2014
OI Barua, Shaswat/0000-0003-0050-3698; Karak, Niranjan/0000-0002-3402-9536
FU NRB [DNRD/05/4003/NRB/251]; SAP (UGC), India [F.3-30/2009(SAP-II)]; FIST
   program (DST), India [SR/FST/CSI-203/209/1]
FX The authors express their gratitude to NRB for financial assistance
   through grant no. DNRD/05/4003/NRB/251, dated 29.02.12., SAP (UGC),
   India, through grant no. F.3-30/2009(SAP-II) and FIST program-2009
   (DST), India, through grant no. SR/FST/CSI-203/209/1, dated 06.05.2010.
   SAIF, NEHU, Shillong is acknowledged for the TEM imaging.
CR Akcya G, 1999, TURK J CHEM, V23, P105
   Banerjee S, 2013, INT J TOXICOL, V32, P308, DOI 10.1177/1091581813489996
   Barua S, 2013, RSC ADV, V3, P1
   Barua S, 2013, ADV SCI ENG MED, V5, P201
   Barua S, 2013, CHEM ENG SCI, V95, P138, DOI 10.1016/j.ces.2013.03.026
   Barua S, 2013, COLLOID SURFACE B, V105, P37, DOI 10.1016/j.colsurfb.2012.12.015
   Borgaonkar P, 2007, MACROMOL BIOSCI, V7, P201, DOI 10.1002/mabi.200600212
   Dabritz F, 2012, J POLYM SCI POL CHEM, V50, P1979, DOI 10.1002/pola.25972
   Das B., 2012, MACROMOL BIOSCI, V13, P126
   Das B, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035003
   Das G, 2009, POLYM DEGRAD STABIL, V94, P1948, DOI 10.1016/j.polymdegradstab.2009.07.028
   De B, 2013, J MATER CHEM A, V1, P348, DOI 10.1039/c2ta00011c
   Deka H, 2009, POLYM ADVAN TECHNOL, V22, P973
   Garcia-Lopez D, 2003, EUR POLYM J, V39, P945, DOI 10.1016/S0014-3057(02)00333-6
   Hosseini MS, 2011, WORLD ACAD SCI ENG T, V60, P1159
   Huang TH, 2002, BIOMATERIALS, V23, P77, DOI 10.1016/S0142-9612(01)00081-3
   Katti KS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034122
   Kiliaris P, 2013, PROG POLYM SCI, V35, P902
   Li C, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/025005
   Lodiene G, 2008, INT ENDOD J, V41, P72, DOI 10.1111/j.1365-2591.2007.01321.x
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Murata H, 2004, SURF SCI, V570, P111, DOI 10.1016/j.susc.2004.06.185
   Newton SM, 2002, J ETHNOPHARMACOL, V79, P57, DOI 10.1016/S0378-8741(01)00350-6
   Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101
   Phua SL, 2012, ACS APPL MATER INTER, V4, P4571, DOI 10.1021/am300947b
   Pramanik S, 2013, RSC ADV, V3, P4574, DOI 10.1039/c3ra22557g
   Sakai R, 2013, MACROMOL MATER ENG, V298, P45, DOI 10.1002/mame.201100436
   Schiraldi C, 2004, BIOMATERIALS, V25, P3645, DOI 10.1016/j.biomaterials.2003.10.059
   Shukla A, 2003, J MACROMOL SCI PURE, VA40, P61, DOI 10.1081/MA-120016674
   Singh G, 2000, FLAVOUR FRAG J, V15, P278, DOI 10.1002/1099-1026(200007/08)15:4<278::AID-FFJ913>3.0.CO;2-L
   Someya T, 2004, P NATL ACAD SCI USA, V101, P9966, DOI 10.1073/pnas.0401918101
   Wen LEI, 2010, SOYBEAN SCI, V1, P1
NR 32
TC 13
Z9 13
U1 0
U2 44
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025006
DI 10.1088/1748-6041/9/2/025006
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900006
PM 24495981
DA 2018-10-19
ER

PT J
AU Hogerheyde, TA
   Suzuki, S
   Stephenson, SA
   Richardson, NA
   Chirila, TV
   Harkin, DG
   Bray, LJ
AF Hogerheyde, Thomas A.
   Suzuki, Shuko
   Stephenson, Sally A.
   Richardson, Neil A.
   Chirila, Traian V.
   Harkin, Damien G.
   Bray, Laura J.
TI Assessment of freestanding membranes prepared from Antheraea pernyi silk
   fibroin as a potential vehicle for corneal epithelial cell
   transplantation
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE corneal epithelium; corneal transplantation; silk fibroin; Bombyx mori;
   Antheraea pernyi
ID FIBROBLAST CELLS; PROTEIN FIBROIN; IN-VITRO; FILM; ATTACHMENT; GROWTH;
   BIOMATERIALS; MULBERRY; GENE; FIBRONECTIN
AB Freestanding membranes created from Bombyx mori silk fibroin (BMSF) offer a potential vehicle for corneal cell transplantation since they are transparent and support the growth of human corneal epithelial (HCE) cells. Fibroin derived from the wild silkworm Antheraea pernyi (APSF) might provide a superior material by virtue of containing putative cell-attachment sites that are absent from BMSF. Thus we have investigated the feasibility of producing transparent, freestanding membranes from APSF and have analysed the behaviour of HCE cells on this material. No significant differences in cell numbers or phenotype were observed in short term HCE cell cultures established on either fibroin. Production of transparent freestanding APSF membranes, however, proved to be problematic as cast solutions of APSF were more prone to becoming opaque, displayed significantly lower permeability and were more brittle than BMSF-membranes. Cultures of HCE cells established on either membrane developed a normal stratified morphology with cytokeratin pair 3/12 being immuno-localized to the superficial layers. We conclude that while it is feasible to produce transparent freestanding membranes from APSF, the technical difficulties associated with this biomaterial, along with an absence of enhanced cell growth, currently favour the continued development of BMSF as a preferred vehicle for corneal cell transplantation. Nevertheless, it remains possible that refinement of techniques for processing APSF might yet lead to improvements in the handling properties and performance of this material.
C1 [Hogerheyde, Thomas A.; Stephenson, Sally A.; Richardson, Neil A.; Harkin, Damien G.; Bray, Laura J.] Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia.
   [Hogerheyde, Thomas A.; Stephenson, Sally A.; Richardson, Neil A.; Harkin, Damien G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia.
   [Hogerheyde, Thomas A.; Suzuki, Shuko; Richardson, Neil A.; Chirila, Traian V.; Harkin, Damien G.; Bray, Laura J.] Queensland Eye Inst, South Brisbane, Qld 4101, Australia.
   [Chirila, Traian V.] Queensland Univ Technol, Fac Sci & Engn, Brisbane, Qld 4001, Australia.
   [Chirila, Traian V.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
   [Chirila, Traian V.] Univ Queensland, Fac Hlth Sci, Herston, Qld 4006, Australia.
   [Chirila, Traian V.] Univ Western Australia, Fac Sci, Crawley, WA 6009, Australia.
   [Bray, Laura J.] Leibniz Inst Polymer Res Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Saxony, Germany.
RP Hogerheyde, TA (reprint author), Queensland Univ Technol, Fac Hlth, Sch Biomed Sci, Brisbane, Qld 4001, Australia.
EM thomas.hogerheyde@qut.edu.au
RI Umlauf, Ursula/D-3356-2014
OI Stephenson, Sally-Anne/0000-0003-3227-2476; Harkin,
   Damien/0000-0002-7358-7987; Bray, Laura/0000-0002-1174-0018
FU National Health & Medical Research Council (NHampMRC), Australia; School
   of Biomedical Sciences at the Queensland University of Technology (QUT;
   Brisbane, Australia); Prevent Blindness Foundation, Queensland,
   Australia; Australia Awards
FX This work was supported in part by a grant from the National Health &
   Medical Research Council (NHampMRC), Australia (awarded to DGH and TVC)
   with supplementary funding from the School of Biomedical Sciences at the
   Queensland University of Technology (QUT; Brisbane, Australia), the
   Prevent Blindness Foundation, Queensland, Australia (supported through
   Viertel's Vision Program), and the Australia Awards (awarded to LJB). We
   are grateful to the Australian Red Cross (Brisbane, Australia) for
   irradiating our feeder cells, and to the staff from the Queensland Eye
   Bank (Brisbane, Australia) and Queensland Eye Hospital (Brisbane,
   Australia) for facilitating our access to donor human tissue. Ethical
   approval was obtained from the QUT Human Research Ethics Committee
   (approval number: 0800000807).
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Benson-Martin J, 2006, EUR J OBSTET GYN R B, V128, P103, DOI 10.1016/j.ejogrb.2005.12.011
   Bray Laura J, 2013, J Funct Biomater, V4, P74, DOI 10.3390/jfb4020074
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI [10.1089/ten.tea.2007.0224, 10.1089/tea.2007.0224]
   Datta A, 2001, COMP BIOCHEM PHYS B, V129, P197, DOI 10.1016/S1096-4959(01)00377-3
   George KA, 2013, MAT SCI ENG C-MATER, V33, P668, DOI 10.1016/j.msec.2012.10.016
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Harkin D G, 2012, CLIN EXPT OPHTHALMOL, V41, P272
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higa K, 2011, J BIOMAT SCI-POLYM E, V22, P2261, DOI 10.1163/092050610X538218
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Luan XY, 2009, CELL BIOL INT, V33, P1127, DOI 10.1016/j.cellbi.2009.07.005
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Mandal BB, 2008, BIOTECHNOL BIOENG, V99, P1482, DOI 10.1002/bit.21699
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Yukuhiro K, 1997, INSECT MOL BIOL, V6, P89, DOI 10.1046/j.1365-2583.1997.00161.x
NR 35
TC 8
Z9 8
U1 0
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025016
DI 10.1088/1748-6041/9/2/025016
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900016
PM 24565906
DA 2018-10-19
ER

PT J
AU Kim, BS
   Kang, HJ
   Yang, SS
   Lee, J
AF Kim, Beom-Su
   Kang, Hyo Jin
   Yang, Sun-Sik
   Lee, Jun
TI Comparison of in vitro and in vivo bioactivity: cuttlefish-bone-derived
   hydroxyapatite and synthetic hydroxyapatite granules as a bone graft
   substitute
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE cuttlefish bone; bone graft substitute; hydroxyapatite; hydrothermal
   reaction
ID MESENCHYMAL STEM-CELLS; POROUS HYDROXYAPATITE; OSTEOBLASTIC CELLS;
   SURFACE-ROUGHNESS; SEPIA-OFFICINALIS; SCAFFOLDS; CEMENT;
   OSTEOCONDUCTION; DIFFERENTIATION; EXPRESSION
AB Bone reconstruction in clinical settings often requires bone substitutes. Hydroxyapatite (HAp) is a widely used bone substitute due to its osteoconductive properties and bone bonding ability. The aim of this study was to evaluate HAp granules derived from cuttlefish bone (CB-HAp) as a substitute biomaterial for bone grafts. In this study, HAp granules were prepared from raw CB by using a hydrothermal reaction. The formation of HAp from CB was confirmed by scanning electron microscopy and x-ray diffraction analysis. The bioactivity of the CB-HAp granules was evaluated both in vitro and in vivo. Our results show that CB-HAp is non-toxic and that CB-HAp granules supported improved cell adhesion, proliferation and differentiation compared to stoichiometric synthetic HAp granules. Furthermore, in vivo bone defect healing experiments show that the formation of bone with CB-HAp is higher than that with pure HAp. These results show that CB-HAp granules have excellent potential for use as a bone graft material.
C1 [Kim, Beom-Su; Yang, Sun-Sik; Lee, Jun] Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
   [Kim, Beom-Su; Kang, Hyo Jin] Bonecell Biotech Inc, Taejon 302830, South Korea.
RP Kim, BS (reprint author), Wonkwang Univ, Wonkwang Bone Regenerat Res Inst, Iksan 570749, South Korea.
EM omslee@wku.ac.kr
FU Fishery Commercialization Technology Development Program of the Ministry
   for Food, Agriculture, Forestry, and Fisheries of the Republic of Korea
   [112092-03-2-CG000]
FX This research was supported by the Fishery Commercialization Technology
   Development Program of the Ministry for Food, Agriculture, Forestry, and
   Fisheries of the Republic of Korea (112092-03-2-CG000).
CR ACKLEY MA, 1980, BIOMATERIALS, V1, P217, DOI 10.1016/0142-9612(80)90021-6
   BIRCHALL JD, 1983, J MATER SCI, V18, P2081, DOI 10.1007/BF00555001
   Boyde A, 1999, BONE, V24, P579, DOI 10.1016/S8756-3282(99)00083-6
   Chang BS, 2000, BIOMATERIALS, V21, P1291, DOI 10.1016/S0142-9612(00)00030-2
   Tran CT, 2011, CELL TISSUE BANK, V12, P247, DOI 10.1007/s10561-010-9208-2
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   Garcia-Enriquez S, 2010, J BIOMAT SCI-POLYM E, V21, P113, DOI 10.1163/156856209X410265
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   HEISE U, 1990, INT ORTHOP, V14, P329
   HOLMES RE, 1987, J ORTHOPAED RES, V5, P114, DOI 10.1002/jor.1100050114
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivankovic H, 2009, J MATER SCI-MATER M, V20, P1039, DOI 10.1007/s10856-008-3674-0
   Jun IK, 2007, J MATER SCI-MATER M, V18, P1071, DOI 10.1007/s10856-007-0137-y
   Kim BS, 2012, J BIOMED MATER RES A, V100A, P1673, DOI 10.1002/jbm.a.34113
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   Liu H, 2006, J BIOMED MATER RES A, V78A, P798, DOI 10.1002/jbm.a.30734
   Manoli F, 2000, J CRYST GROWTH, V217, P422, DOI 10.1016/S0022-0248(00)00515-7
   Miramand P, 2006, SCI TOTAL ENVIRON, V361, P132, DOI 10.1016/j.scitotenv.2005.10.018
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Rocha JHG, 2006, J BIOMED MATER RES A, V77A, P160, DOI 10.1002/jbm.a.30566
   Shirakata Y, 2002, J PERIODONTOL, V73, P1043, DOI 10.1902/jop.2002.73.9.1043
   Stanic V, 2002, BIOMATERIALS, V23, P3833, DOI 10.1016/S0142-9612(02)00119-9
   Weissenbock M, 2006, CELLS TISSUES ORGANS, V182, P79, DOI 10.1159/000093062
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 32
TC 11
Z9 11
U1 0
U2 28
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2014
VL 9
IS 2
AR 025004
DI 10.1088/1748-6041/9/2/025004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB9DU
UT WOS:000332090900004
PM 24487123
DA 2018-10-19
ER

PT J
AU Cao, YJ
   Zhu, D
   Ngai, T
   Qin, L
   Wu, C
   Shen, J
AF Cao, Yu-jie
   Zhu, Dan
   Ngai, To
   Qin, Ling
   Wu, Chi
   Shen, Jian
TI Dielectric investigations on how Mg salt is dispersed in and released
   from polylactic acid
SO CHINESE JOURNAL OF POLYMER SCIENCE
LA English
DT Article
DE Dielectric spectroscopy; Inorganic-polymer composite; Orthopaedic
   biomaterials; Biodegradation; Bioactivity
ID PHASE-SEPARATION; COMPOSITES; CONDUCTION; SCAFFOLDS; METAL; FILMS; IONS
AB Composite biomaterials made of biodegradable polylactic acid (PLA) and bioactive magnesium (Mg) salt are developed for orthopaedic implants or metal implant coatings. The releasing of Mg salt into the biological environment benefits the bone growth, while with the releasing of Mg salt and degradation of PLA there forms a porous scaffold for tissue engineering. The size and morphology of the salt and voids are adjustable with such preparation conditions as salt content, pH of casting solution, and the solidification rate, so that we can control the salt releasing and degradation rate of PLA. Dielectric spectroscopy is used to investigate the dispersive structures of Mg salt and voids in the polymer matrix and to monitor the in situ releasing of Mg salts in the simulated body fluid (SBF). The current study provides us with an orthopedic biomaterial with controllable multi-phase structures, and a tool to investigate the in vivo behaviors of biomaterials.
C1 [Cao, Yu-jie; Zhu, Dan; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210046, Jiangsu, Peoples R China.
   [Ngai, To; Wu, Chi] Chinese Univ Hong Kong, Dept Chem, Shatin, Hong Kong, Peoples R China.
   [Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Shatin, Hong Kong, Peoples R China.
RP Zhu, D (reprint author), Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210046, Jiangsu, Peoples R China.
EM zhudan@njnu.edu.cn
RI Ngai, To/G-1391-2010; Qin, Ling/J-9047-2018
OI Qin, Ling/0000-0001-6173-6167
FU National Natural Scientific Foundation of China [50773077, 20934005,
   51273091]; Hong Kong Special Administration Region Earmarked Projects
   [CUHK4042/09P, 2160396]
FX This work was financially supported by the National Natural Scientific
   Foundation of China (Nos. 50773077, 20934005 and 51273091) and the Hong
   Kong Special Administration Region Earmarked Projects (CUHK4042/09P,
   2160396).
CR Achour ME, 2008, J APPL PHYS, V103, DOI 10.1063/1.2912985
   Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557
   Brosseau C, 2006, J PHYS D APPL PHYS, V39, P1277, DOI 10.1088/0022-3727/39/7/S02
   Chen Y, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025005
   DYRE JC, 1988, J APPL PHYS, V64, P2456, DOI 10.1063/1.341681
   Gu XN, 2012, ACTA BIOMATER, V8, P2360, DOI 10.1016/j.actbio.2012.02.018
   Haas CK, 1997, PHYS REV E, V55, P3191, DOI 10.1103/PhysRevE.55.3191
   Hanai T., 1999, HETEROGENEOUS STRUCT, P61
   Jancar J, 2010, POLYMER, V51, P3321, DOI 10.1016/j.polymer.2010.04.074
   JONSCHER AK, 1977, NATURE, V267, P673, DOI 10.1038/267673a0
   Kremer F., 2002, DIELECTRIC NEWSL APR, V4
   Lasprilla AJR, 2012, BIOTECHNOL ADV, V30, P321, DOI 10.1016/j.biotechadv.2011.06.019
   Lu HB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336494
   McMaster L.P., 1975, COPOLYMERS POLYBLEND, V142, P43
   Mourino V, 2012, J R SOC INTERFACE, V9, P401, DOI 10.1098/rsif.2011.0611
   NAMIKAWA H, 1975, J NON-CRYST SOLIDS, V18, P173, DOI 10.1016/0022-3093(75)90019-8
   Niki Y, 2003, BIOMATERIALS, V24, P1447, DOI 10.1016/S0142-9612(02)00531-8
   Popielarz R, 2001, MACROMOLECULES, V34, P5910, DOI 10.1021/ma001576b
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Steeman P.A.M., 2003, BROADBAND DIELECTRIC, P495
   TANAKA H, 1994, PHYS REV LETT, V72, P1702, DOI 10.1103/PhysRevLett.72.1702
   Tanaka T, 2004, J MEMBRANE SCI, V238, P65, DOI 10.1016/j.memsci.2004.03.020
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Wang GC, 2010, MATERIALS, V3, P3994, DOI 10.3390/ma3073994
   Wang JL, 2012, J BIOMED MATER RES B, V100B, P1691, DOI 10.1002/jbm.b.32707
   Williams G., 1998, NOVOCONTROL APPL NOT, V3, P1
   Wubbenhorst M., 2000, DIELECTRIC NEWSL NOV, P1
   Zhou H, 2012, ACTA BIOMATER, V8, P1999, DOI 10.1016/j.actbio.2012.01.031
   Zhu D, 2007, J POLYM SCI POL PHYS, V45, P1037, DOI 10.1002/polb.21115
   Zhu D, 2012, J PHYS CHEM A, V116, P2024, DOI 10.1021/jp212446n
NR 30
TC 0
Z9 0
U1 0
U2 33
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7679
EI 1439-6203
J9 CHINESE J POLYM SCI
JI Chin. J. Polym. Sci.
PD APR
PY 2014
VL 32
IS 4
BP 497
EP 508
DI 10.1007/s10118-014-1421-1
PG 12
WC Polymer Science
SC Polymer Science
GA AC4HG
UT WOS:000332481200013
DA 2018-10-19
ER

PT J
AU Prabhakaran, MP
   Mobarakeh, LG
   Kai, D
   Karbalaie, K
   Nasr-Esfahani, MH
   Ramakrishna, S
AF Prabhakaran, Molamma P.
   Mobarakeh, Laleh Ghasemi
   Kai, Dan
   Karbalaie, Khadijeh
   Nasr-Esfahani, Mohammad Hossein
   Ramakrishna, Seeram
TI Differentiation of embryonic stem cells to cardiomyocytes on electrospun
   nanofibrous substrates
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE embryoid bodies; cardiac regeneration; electrospinning; embryonic stem
   cells; collagen
ID EXTRACELLULAR-MATRIX; FIBRIN SCAFFOLDS; CULTURE; GROWTH; THERAPY; REPAIR
AB The potential of pluripotent embryonic stem cells (ESCs) isolated from the inner mass of blastocysts are investigated for its ability to differentiate on biocompatible electrospun nanofibers, for regeneration of the myocardially infracted heart. Nanostructured poly(d,l-lactide-co-glycolide)/collagen (PLGA/Col) scaffolds with fiber diameters in the range of 300 +/- 65 nm, was fabricated by electrospinning to mimic the extracellular matrix of the native tissue. During the culture of embryoid bodies outgrowth on the scaffolds, and further differentiation of ESCs to cardiomyocytes, the PLGA/Col nanofibers was found better than that of the electrospun PLGA nanofibers, where a better interaction and growth of ESC differentiated cardiomyocytes was observed on the composite scaffolds. The phenotypical characteristics of ESC-derived cardiomyocytes and molecular protein expression were carried out by scanning electron microscopy and immunocytochemistry, respectively. Our studies highlight the significance of a suitable material, its architecture, and cell-biomaterial interactions that is essential at a nanoscale level signifying the application of a bioengineered cardiac graft for stem cell differentiation and transplantation, which could be an intriguing strategy for cardiac regeneration. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 447-454, 2014.
C1 [Prabhakaran, Molamma P.; Kai, Dan; Ramakrishna, Seeram] Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, Singapore 117576, Singapore.
   [Mobarakeh, Laleh Ghasemi] Isfahan Univ Technol, Dept Text Engn, Esfahan 8415683111, Iran.
   [Karbalaie, Khadijeh; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Cellular Biotechnol, Cell Sci Res Ctr, Tehran, Iran.
RP Prabhakaran, MP (reprint author), Fac Engn, Ctr Nanofibers & Nanotechnol, Nanosci & Nanotechnol Initiat, E305-14, Singapore 117576, Singapore.
EM nnimpp@nus.edu.sg; mh_nasr@med.mui.ac.ir
FU NRF-Technion [R-398-001-065-592]; Nanoscience and Nanotechnology
   Initiative, Faculty of Engineering, National University of Singapore,
   Singapore, Singapore
FX Contract grant sponsor: NRF-Technion; contract grant number:
   R-398-001-065-592; Contract grant sponsor: Nanoscience and
   Nanotechnology Initiative, Faculty of Engineering, National University
   of Singapore, Singapore, Singapore.
CR ALI SAM, 1993, J BIOMED MATER RES, V27, P1409, DOI 10.1002/jbm.820271108
   Atkins BZ, 1999, J SURG RES, V85, P234, DOI 10.1006/jsre.1999.5681
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Baharvand H, 2004, IN VITRO CELL DEV-AN, V40, P76
   Balasubramanian P, 2013, ADV POLYM SCI, V251, P173, DOI 10.1007/12_2012_176
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Czyz J, 2001, DIFFERENTIATION, V68, P67
   Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009
   Dan K, 2010, NANO BIOMED, V2, P1
   Dimarakis I, 2006, J CARDIOTHORAC RENAL, V1, P115
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dorfman J, 1998, J THORAC CARDIOV SUR, V116, P744, DOI 10.1016/S0022-5223(98)00451-6
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Fine GC, 2008, PANMINERVA MED, V50, P129
   Kadivar M, 2006, BIOCHEM BIOPH RES CO, V340, P639, DOI 10.1016/j.bbrc.2005.12.047
   Kajstura J, 1998, P NATL ACAD SCI USA, V95, P8801, DOI 10.1073/pnas.95.15.8801
   Kim S, 2007, STEM CELLS, V25, P2601, DOI 10.1634/stemcells.2006-0814
   Kwon K, 2005, BIOMACROMOLECULES, V6, P2096
   Leor J, 2000, CIRCULATION, V102, P56
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Meng ZX, 2010, MAT SCI ENG C-MATER, V30, P1204, DOI 10.1016/j.msec.2010.06.018
   Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa
   O'Connor KC, 2003, BIOTECHNOL LETT, V25, P1967, DOI 10.1023/B:BILE.0000004386.08923.ab
   O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V8
   Sheridan SD, 2008, METHOD CELL BIOL, V86, P29, DOI 10.1016/S0091-679X(08)00003-4
   Smith LA, 2010, BIOMATERIALS, V31, P5526, DOI 10.1016/j.biomaterials.2010.03.065
   Stojkovic M, 2004, REPRODUCTION, V128, P259, DOI 10.1530/rep.1.00243
   Vacanti JP, 1999, LANCET S1, V354, pSi32
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Willerth SM, 2008, ADV DRUG DELIVER REV, V60, P263, DOI 10.1016/j.addr.2007.08.028
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Yoon BS, 2006, DIFFERENTIATION, V74, P149, DOI 10.1111/j.1432-0436.2006.00063.x
NR 37
TC 14
Z9 15
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 447
EP 454
DI 10.1002/jbm.b.33022
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100005
PM 24039141
DA 2018-10-19
ER

PT J
AU Bajpai, I
   Balani, K
   Basu, B
AF Bajpai, Indu
   Balani, Kantesh
   Basu, Bikramjit
TI Synergistic effect of static magnetic field and HA-Fe3O4 magnetic
   composites on viability of S. aureus and E. coli bacteria
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE static magnetic field; magnetic biocomposites; bactericidal effect
ID IRON-OXIDE NANOPARTICLES; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS;
   HYDROXYAPATITE; BIOCOMPOSITES; CELLS
AB In addressing the issue of prosthetic infection, this work demonstrated the synergistic effect of the application of static magnetic field (SMF) and ferrimagnetic substrate properties on the bactericidal property in vitro. This aspect was studied using hydroxyapatite (HA)-xFe(3)O(4) (x=10, 20, and 40 wt.%) substrates, which have different saturation magnetization properties. During bacteria culture experiments, 100 mT SMF was applied to growth medium (with HA-xFe(3)O(4) substrate) in vitro for 30, 120, and 240 min. A combination of MTT assay, membrane rupture assays, live/dead assay, and fluorescence microscopic analysis showed that the bactericidal effect of SMF increases with the exposure duration as well as increasing Fe3O4 content in biomaterial substrates. Importantly, the synergistic bactericidal effect was found to be independent of bacterial cell type, as similar qualitative trend is measured with both gram negative Escherichia coli (E. coli) and gram positive Staphylococcus aureus (S. aureus) strains. The reduction in E. coli viability was 83% higher on HA-40 Wt % Fe3O4 composite after 4 h exposure to SMF as compared to nonexposed control. Interestingly, any statistically significant difference in ROS was not observed in bacterial growth medium after magnetic field exposure, indicating the absence of ROS enhancement due to magnetic field. Overall, this study illustrates significant role being played by magnetic substrate compositions towards bactericidal property than by magnetic field exposure alone. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 524-532, 2014.
C1 [Bajpai, Indu; Balani, Kantesh] Indian Inst Technol, Dept Mat Sci & Engn, Lab Biomat, Kanpur 208016, Uttar Pradesh, India.
   [Basu, Bikramjit] Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
RP Basu, B (reprint author), Indian Inst Sci, Mat Res Ctr, Bangalore 560012, Karnataka, India.
EM bikram@mrc.iisc.ernet.in
OI Balani, Kantesh/0000-0003-0619-9164
FU Department of Biotechnology; Department of Science and Technology,
   Government of India
FX Contract grant sponsor: Department of Biotechnology and Department of
   Science and Technology, Government of India
CR Afzal MAF, 2013, J BIOMATER APPL, V27, P967, DOI 10.1177/0885328211431856
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   Arcos D, 2002, BIOMATERIALS, V23, P2151, DOI 10.1016/S0142-9612(01)00346-5
   Bajpai I, 2013, J AM CERAM SOC, V96, P2100, DOI 10.1111/jace.12386
   Bajpai I, 2012, J BIOMED MATER RES B, V100B, P1206, DOI 10.1002/jbm.b.32685
   Binhi VN, 2001, BIOELECTROMAGNETICS, V22, P79, DOI 10.1002/1521-186X(200102)22:2<79::AID-BEM1009>3.0.CO;2-7
   El-Housseiny GS, 2010, J AM SCI, V6, P260
   Feng QL, 1998, THIN SOLID FILMS, V335, P214, DOI 10.1016/S0040-6090(98)00956-0
   Fojt L, 2004, BIOELECTROCHEMISTRY, V63, P337, DOI 10.1016/j.bioelechem.2003.11.010
   Fojt L, 2009, MICRON, V40, P918, DOI 10.1016/j.micron.2009.06.009
   Ji WJ, 2009, MICRON, V40, P894, DOI 10.1016/j.micron.2009.05.010
   Kim J, 2008, ANTIMICROB AGENTS CH, V52, P1146
   Kohno, 2000, Pathophysiology, V7, P143, DOI 10.1016/S0928-4680(00)00042-0
   Lui H, 2004, INT J FOOD MICROBIOL, V95, P147
   Maharramov AM, 2011, DIG J NANOMATER BIOS, V6, P419
   Nakahara T, 2002, RADIOLOGY, V224, P817, DOI 10.1148/radiol.2243011300
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Saha N, 2010, J BIOMED MATER RES B, V95B, P430, DOI 10.1002/jbm.b.31734
   She ZC, 2009, INFRARED PHYS TECHN, V52, P138, DOI 10.1016/j.infrared.2009.06.002
   Singh B, 2011, MAT SCI ENG C-MATER, V31, P1320, DOI 10.1016/j.msec.2011.04.015
   Strasak L, 2002, BIOELECTROCHEMISTRY, V55, P161, DOI 10.1016/S1567-5394(01)00152-9
   Tagai H, 1980, PREPARATION SYNTHETI
   Touati D, 2000, ARCH BIOCHEM BIOPHYS, V373, P1, DOI 10.1006/abbi.1999.1518
   Tran N, 2010, INT J NANOMED, V5, P277
NR 24
TC 12
Z9 13
U1 1
U2 50
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 524
EP 532
DI 10.1002/jbm.b.33031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100013
PM 24142888
DA 2018-10-19
ER

PT J
AU Barros, JAG
   Filippin-Monteiro, FB
   de Oliveira, EM
   Campa, A
   Catalani, LH
   Pitombo, RDM
   Polakiewicz, B
AF Galvao Barros, Janaina Aline
   Filippin-Monteiro, Fabiola Branco
   de Oliveira, Edson Mendes
   Campa, Ana
   Catalani, Luiz Henrique
   Moraes Pitombo, Ronaldo de Nogueira
   Polakiewicz, Bronislaw
TI Cytotoxicity of PVPAC-treated bovine pericardium: A potential
   replacement for glutaraldehyde in biological heart valves
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cytotoxicity; glutaraldehyde; poly (vinylpyrrolidone-co-acrolein);
   lyophilized bioprothesis; bovine pericardium; bioprosthesis
ID IN-VITRO; CALCIFICATION; TISSUE; SCAFFOLDS; ENDOTHELIALIZATION;
   DETOXIFICATION; FIBROBLASTS; MATRIX
AB Acellular biological tissues, including bovine pericardium (BP), have been proposed as biomaterial for tissue engineering. BP is usually modified chemically to improve mechanical and biological properties using glutaraldehyde, the standard reagent for preservation of fresh bioprosthetic materials. Glutaraldehyde-fixed BP (Glut-BP), the most widely used material in heart valve manufacture, has been associated with calcification in vivo. In an attempt to reduce this issue and maintain its biocompatibility, this study assesses the physical properties and cytotoxicity of lyophilized BP treated with poly (vinylpyrrolidone-co-acrolein) (PVPAC-BP), a novel copolymer, as a substitute for glutaraldehyde. For that, PVPAC-BP surface ultrastructure, elastic function, water uptake and tissue calcification were evaluated. For the analysis of biocompatibility, fibroblasts (3T3-L1) and endothelial cells (HUVEC) were cultured on PVPAC-BP, Untreated-BP and Glut-BP. Nitric oxide (NO) release assay, fluorescence and SEM images of endothelial cells adhered on scaffolds were also performed. As results, the data show some advantages of PVPAC-BP over the Glut-BP. The PVPAC-BP maintains partially the original ultrastructure and elastic properties, improves scaffold hydration, and presents less calcium phosphate deposits. The cells demonstrated strong attachment, high proliferation rate, and formation of a monolayer on PVPAC-BP. Attached cells were also able to release NO de-monstrating regular metabolism. In conclusion, PVPAC may be considered as a promising alternative to BP treatment improving the efficiency of cell attachment and proliferation and also avoid immunogenicity. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 574-582, 2014.
C1 [Galvao Barros, Janaina Aline; Filippin-Monteiro, Fabiola Branco; de Oliveira, Edson Mendes; Campa, Ana; Moraes Pitombo, Ronaldo de Nogueira; Polakiewicz, Bronislaw] Univ Sao Paulo, Fac Pharmaceut Sci, Sao Paulo, Brazil.
   [Galvao Barros, Janaina Aline; Catalani, Luiz Henrique] Univ Sao Paulo, Inst Chem, Sao Paulo, Brazil.
RP Filippin-Monteiro, FB (reprint author), Univ Sao Paulo, Fac Pharmaceut Sci, 580 BL17, Sao Paulo, Brazil.
EM filippinmonteiro@gmail.com
RI Institute of Chemistry - USP, Dept. of Chemistry/B-8988-2012; Catalani,
   Luiz/E-2841-2010; Campa, Ana/D-4669-2012; Filippin Monteiro,
   Fabiola/D-6509-2018; de Oliveira, Edson/C-9885-2014
OI Catalani, Luiz/0000-0003-3689-1792; Campa, Ana/0000-0002-6183-3378;
   Filippin Monteiro, Fabiola/0000-0003-4313-1783; de Oliveira,
   Edson/0000-0002-7330-7826; Filippin-Monteiro, Fabiola
   Branco/0000-0002-0826-2692
FU FAPESP; CAPES
FX Contract grant sponsors: FAPESP; CAPES
CR Abolhoda A, 1996, ANN THORAC SURG, V62, P169, DOI 10.1016/0003-4975(96)00277-9
   Aravind S, 1998, J BIOMATER APPL, V13, P158
   Barros JAG, 2011, MAT SCI APPL, V2, P12
   BEAUCHAMP RO, 1992, CRIT REV TOXICOL, V22, P143, DOI 10.3109/10408449209145322
   Borgognoni CF, 2010, J APPL BIOMATER BIOM, V8, P186, DOI 10.5301/JABB.2010.6104
   Burrows MC, 2012, MACROMOL BIOSCI, V12, P1660, DOI 10.1002/mabi.201200154
   Chen YM, 2011, CHINESE J POLYM SCI, V29, P23, DOI 10.1007/s10118-010-1021-7
   Ginty PJ, 2008, EUR J PHARM BIOPHARM, V68, P82, DOI 10.1016/j.ejpb.2007.05.023
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   Grases F, 2008, CARDIOVASC PATHOL, V17, P139, DOI 10.1016/j.carpath.2007.08.005
   Guldner NW, 2009, CIRCULATION, V119, P1653, DOI 10.1161/CIRCULATIONAHA.108.823948
   Hafeez Y M, 2004, Med J Malaysia, V59 Suppl B, P117
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim BW, 2007, SURGERY, V141, P832, DOI 10.1016/j.surg.2007.01.034
   Kim HJ, 2007, BIOMED MATER, V2, pS111, DOI 10.1088/1748-6041/2/3/S05
   Kim KM, 1999, AM J PATHOL, V154, P843, DOI 10.1016/S0002-9440(10)65331-X
   Lee C, 2011, EUR J CARDIO-THORAC, V39, P381, DOI 10.1016/j.ejcts.2010.07.015
   Lee WK, 2000, BIOMATERIALS, V21, P2323, DOI 10.1016/S0142-9612(00)00159-9
   Leirner AA, 2001, ARTIF ORGANS, V25, P907, DOI 10.1046/j.1525-1594.2001.06905.x
   Lichtenberg A, 2006, J HEART VALVE DIS, V15, P287
   Maizato MJS, 2011, ARTIF ORGANS, V35, P490, DOI 10.1111/j.1525-1594.2011.01261.x
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Mavrilas D, 2004, J MATER SCI-MATER M, V15, P699, DOI 10.1023/B:JMSM.0000030212.55320.c2
   do Amaral JJM, 2010, REV BRAS CIR CARDIOV, V25, P543, DOI 10.1590/S0102-76382010000400019
   Nogueira GM, 2010, MAT SCI ENG C-MATER, V30, P575, DOI 10.1016/j.msec.2010.02.011
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Quesada A, 2002, EUR J ENDOCRINOL, V147, P117, DOI 10.1530/eje.0.1470117
   Quintero LJ, 1998, J HEART VALVE DIS, V7, P262
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Rodriguez KJ, 2009, J BIOMED MATER RES A, V90A, P1043, DOI 10.1002/jbm.a.32187
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Shen M, 2001, ANN THORAC SURG, V71, pS408, DOI 10.1016/S0003-4975(01)02506-1
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Stacchino C, 1998, J HEART VALVE DIS, V7, P190
   Sun M, 2009, J MATER SCI-MATER M, V20, P1743, DOI 10.1007/s10856-009-3739-8
   Sung H W, 1993, ASAIO J, V39, pM532
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   van Meerloo J, 2011, METHODS MOL BIOL, V731, P237, DOI 10.1007/978-1-61779-080-5_20
   Vasudev SC, 1997, ARTIF ORGANS, V21, P1007
   Vasudev SC, 1999, J MATER SCI-MATER M, V10, P121, DOI 10.1023/A:1008925204988
   Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045
   Wong ML, 2011, BIOMATERIALS, V32, P8129, DOI 10.1016/j.biomaterials.2011.07.030
   Yang CY, 2010, EUR CELLS MATER, V20, P415
NR 45
TC 4
Z9 7
U1 3
U2 34
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 574
EP 582
DI 10.1002/jbm.b.33036
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100018
PM 24123957
DA 2018-10-19
ER

PT J
AU Uhm, SH
   Song, DH
   Kwon, JS
   Lee, SB
   Han, JG
   Kim, KN
AF Uhm, Soo-Hyuk
   Song, Doo-Hoon
   Kwon, Jae-Sung
   Lee, Sang-Bae
   Han, Jeon-Geon
   Kim, Kyoung-Nam
TI Tailoring of antibacterial Ag nanostructures on TiO2 nanotube layers by
   magnetron sputtering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE magnetron sputtering; titanium dioxide; nanotube; antibacterial activity
ID PLASMA ELECTROLYTIC OXIDATION; NANOCOMPOSITE THIN-FILMS; TITANIUM-OXIDE
   NANOTUBES; SILVER NANOPARTICLES; SURFACE-ROUGHNESS; MULTICOLOR
   PHOTOCHROMISM; PHOTOELECTROCHEMICAL PROPERTIES; MC3T3-E1 PREOSTEOBLAST;
   MAGNESIUM ALLOYS; GENE-EXPRESSION
AB To reduce the incidence of postsurgical bacterial infection that may cause implantation failure at the implant-bone interface, surface treatment of titanium implants with antibiotic materials such as silver (Ag) has been proposed. The purpose of this work was to create TiO2 nanotubes using plasma electrolytic oxidation (PEO), followed by formation of an antibacterial Ag nanostructure coating on the TiO2 nanotube layer using a magnetron sputtering system. PEO was performed on commercially pure Ti sheets. The Ag nanostructure was added onto the resulting TiO2 nanotube using magnetron sputtering at varying deposition rates. Field emission scanning electron microscopy and transmission electron microscopy were used to characterize the surface, and Ag content on the TiO2 nanotube layer was analyzed by X-ray diffraction and X-ray photoelectron spectroscopy. Scanning probe microscopy for surface roughness and contact angle measurement were used to indirectly confirm enhanced TiO2 nanotube hydrophilicity. Antibacterial activity of Ag ions in solution was determined by inductively coupled plasma mass spectrometry and antibacterial testing against Staphylococcus aureus (S. aureus). In vitro, TiO2 nanotubes coated with sputtered Ag resulted in significantly reduced S. aureus. Cell viability assays showed no toxicity for the lowest sputtering time group in the osteoblastic cell line MC3T3-E1. These results suggest that a multinanostructured layer with a biocompatible TiO2 nanotube and antimicrobial Ag coating is a promising biomaterial that can be tailored with magnetron sputtering for optimal performance. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 592-603, 2014.
C1 [Uhm, Soo-Hyuk; Song, Doo-Hoon; Kwon, Jae-Sung; Lee, Sang-Bae; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, Seoul 120752, South Korea.
   [Uhm, Soo-Hyuk; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Seoul 120752, South Korea.
   [Han, Jeon-Geon] Sungkyunkwan Univ, Ctr Adv Plasma Surface Technol, NU SKKU Joint Inst Plasma Nano Mat, Suwon 440746, South Korea.
RP Kim, KN (reprint author), Yonsei Univ, Coll Dent, Dept & Res Inst Dent Biomat & Bioengn, 50 Yonsei Ro, Seoul 120752, South Korea.
EM kimkn@yuhs.ac
RI Kwon, Jae-Sung/M-5430-2018
OI Kwon, Jae-Sung/0000-0001-9803-7730
FU National Research Foundation of Korea (NRF) grant; Korea government
   (MSIP) [NRF-2010-0027963]
FX This work was supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIP) (NRF-2010-0027963).
CR Akhavan O, 2010, SURF COAT TECH, V204, P3676, DOI 10.1016/j.surfcoat.2010.04.048
   Akhavan O, 2009, CURR APPL PHYS, V9, P1381, DOI 10.1016/j.cap.2009.03.003
   Alarcon EI, 2012, BIOMATERIALS, V33, P4947, DOI 10.1016/j.biomaterials.2012.03.033
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   [Anonymous], 2009, 109935 ISO
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Blawert C, 2006, ADV ENG MATER, V8, P511, DOI 10.1002/adem.200500257
   Brammer KS, 2011, ACTA BIOMATER, V7, P2697, DOI 10.1016/j.actbio.2011.02.039
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Chang WT, 2013, J MATER CHEM A, V1, P1987, DOI 10.1039/c2ta00806h
   Chang WY, 2011, MICROPOR MESOPOR MAT, V145, P87, DOI 10.1016/j.micromeso.2011.04.035
   Chen M, 2003, J BIOMAT SCI-POLYM E, V14, P917, DOI 10.1163/156856203322381410
   Chen XY, 2013, SURF COAT TECH, V216, P158, DOI 10.1016/j.surfcoat.2012.11.049
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Dale GR, 2009, J NANOSCI NANOTECHNO, V9, P4215, DOI 10.1166/jnn.2009.M35
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Engelsman AF, 2009, ACTA BIOMATER, V5, P1905, DOI 10.1016/j.actbio.2009.01.041
   Ercan B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295102
   Ercan B, 2011, ACTA BIOMATER, V7, P3003, DOI 10.1016/j.actbio.2011.04.002
   Fang D, 2011, APPL SURF SCI, V257, P6451, DOI 10.1016/j.apsusc.2011.02.037
   Geesey GG, 2001, CURR OPIN MICROBIOL, V4, P296, DOI 10.1016/S1369-5274(00)00206-X
   Geoprincy G, 2011, DIG J NANOMATER BIOS, V6, P1557
   Goldschmidt H, 1995, ZBL BAKT-INT J MED M, V283, P215
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Han Y, 2002, SURF COAT TECH, V154, P314, DOI 10.1016/S0257-8972(02)00036-1
   He J, 2008, J MATER SCI-MATER M, V19, P3465, DOI 10.1007/s10856-008-3505-3
   Holthaus MG, 2013, J BIOMATER APPL, V27, P791, DOI 10.1177/0885328211426354
   Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954
   Ilie I, 2012, INT J NANOMED, V7, P3011, DOI 10.2147/IJN.S29975
   ISO, 2002, 1099312 ISO
   Jager M, 2007, J BIOMED BIOTECHNOL, DOI 10.1155/2007/69036
   Kawahara K, 2005, PHYS CHEM CHEM PHYS, V7, P3851, DOI 10.1039/b511489f
   Kheybari S, 2010, DARU, V18, P168
   Kim DY, 2009, ACTA BIOMATER, V5, P2196, DOI 10.1016/j.actbio.2009.02.021
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482
   Kumar A, 2008, NAT MATER, V7, P236, DOI 10.1038/nmat2099
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lee JS, 2013, ADV MATER, V25, P1173, DOI 10.1002/adma.201203370
   Lejeune P, 2003, TRENDS MICROBIOL, V11, P179, DOI 10.1016/S0966-842X(03)00047-7
   Li FY, 1998, CHEM MATER, V10, P2470, DOI 10.1021/cm980163a
   Li Y, 2008, BIOMATERIALS, V29, P2025, DOI 10.1016/j.biomaterials.2008.01.009
   Liang YQ, 2011, J CATAL, V278, P276, DOI 10.1016/j.jcat.2010.12.011
   Liao HB, 1997, APPL PHYS LETT, V70, P1, DOI 10.1063/1.119291
   LIEDBERG H, 1990, BRIT J UROL, V65, P379, DOI 10.1111/j.1464-410X.1990.tb14760.x
   Liu XY, 2008, BIOMED PHARMACOTHER, V62, P526, DOI 10.1016/j.biopha.2008.07.051
   Macak JM, 2008, J ELECTROANAL CHEM, V621, P254, DOI 10.1016/j.jelechem.2008.01.005
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Naoi K, 2005, CHEM COMMUN, P1288, DOI 10.1039/b416139d
   Naoi K, 2004, J AM CHEM SOC, V126, P3664, DOI 10.1021/ja039474z
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Ohko Y, 2003, NAT MATER, V2, P29, DOI 10.1038/nmat796
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   PETROV I, 1994, J VAC SCI TECHNOL A, V12, P2846, DOI 10.1116/1.578955
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Premchand YD, 2006, ELECTROCHEM COMMUN, V8, P1840, DOI 10.1016/j.elecom.2006.08.028
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Raffi M, 2008, J MATER SCI TECHNOL, V24, P192
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   Raja KS, 2005, ELECTROCHIM ACTA, V51, P154, DOI 10.1016/j.electacta.2005.04.011
   Regiel A, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015101
   ROSSNAGEL SM, 1993, APPL PHYS LETT, V63, P3285, DOI 10.1063/1.110176
   Sambhy V, 2005, ABSTR PAP AM CHEM S, V230, pU4334
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Smetana AB, 2008, LANGMUIR, V24, P7457, DOI 10.1021/la800091y
   Song DH, 2012, MATER RES BULL, V47, P2994, DOI 10.1016/j.materresbull.2012.04.085
   Song DH, 2011, THIN SOLID FILMS, V519, P7079, DOI 10.1016/j.tsf.2011.01.385
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song YY, 2012, MICROCHIM ACTA, V177, P129, DOI 10.1007/s00604-012-0769-6
   Toledo-Antonio JA, 2009, LANGMUIR, V25, P10195, DOI 10.1021/la9009702
   Traversa E, 2000, J SOL-GEL SCI TECHN, V19, P733, DOI 10.1023/A:1008787412057
   Traversa E, 2001, J SOL-GEL SCI TECHN, V22, P115, DOI 10.1023/A:1011276622863
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Wang N, 2011, BIOMATERIALS, V32, P6900, DOI 10.1016/j.biomaterials.2011.06.023
   Wu CT, 2009, J R SOC INTERFACE, V6, P159, DOI 10.1098/rsif.2008.0274
   Xiao XF, 2008, J ALLOY COMPD, V466, P356, DOI 10.1016/j.jallcom.2007.11.032
   Xiong YQ, 2000, THIN SOLID FILMS, V375, P300, DOI 10.1016/S0040-6090(00)01253-0
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x
   Yu JG, 2010, APPL CATAL B-ENVIRON, V94, P295, DOI 10.1016/j.apcatb.2009.12.003
   Yu WQ, 2010, ORAL DIS, V16, P624, DOI 10.1111/j.1601-0825.2009.01643.x
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zhao JL, 2007, J ALLOY COMPD, V434, P792, DOI 10.1016/j.jallcom.2006.08.317
   Zhao LZ, 2012, BIOMATERIALS, V33, P2629, DOI 10.1016/j.biomaterials.2011.12.024
   Zhao LZ, 2011, BIOMATERIALS, V32, P5706, DOI 10.1016/j.biomaterials.2011.04.040
   Zhao LZ, 2011, J BIOMED MATER RES A, V96A, P100, DOI 10.1002/jbm.a.32918
   Zhou Y, 2009, ADV MATER, V21, P1742, DOI 10.1002/adma.200803072
   Zuo J, 2007, MATER LETT, V61, P2632, DOI 10.1016/j.matlet.2006.10.010
NR 102
TC 22
Z9 23
U1 6
U2 151
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2014
VL 102
IS 3
BP 592
EP 603
DI 10.1002/jbm.b.33038
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC2CV
UT WOS:000332306100020
PM 24123999
DA 2018-10-19
ER

PT J
AU Kilic, B
   Omay, D
AF Kilic, Bayram
   Omay, Didem
TI In-situ deposition of zinc oxide nanowires onto UV-cured chitin
   derivatives and their antibacterial properties
SO MATERIALS SCIENCE IN SEMICONDUCTOR PROCESSING
LA English
DT Article
DE Chitin; ZnO; Nanowire; Characterization; Antibacterial
ID SENSITIZED SOLAR-CELLS; ZNO-NANOPARTICLES; PERFORMANCE; FILMS; DEVICES
AB ZnO nanowires were synthesized on UV-cured chitin film by using a hydrothermal method. Structural and optical characterization showed that one dimensional nanowires can be produced on the UV-cured chitin film. The morphological analysis indicated that nanowires structures can be obtained at about 30 nm radius and 10 mu m length. Surface morphology of the ZnO coated UV-cured chitin film was also investigated and a three-dimensional surface profile and high surface roughness were obtained. X-ray diffraction analysis of the film showed large and pure crystals of ZnO nanowires with wurtzite structure and UV-visible absorbance spectrum indicated that ZnO nanowires have 3.39 eV band-gap energy and nanostructures have very good transparency of about 80% in blue region. Also ZnO coated film was tested for its biocidal action against Gram positive Staphylococcus aureus using an agar plate method. This newly developed nano-biomaterial exhibited a strong antibacterial effect. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Kilic, Bayram] Yalova Univ, Fac Engn, Dept Energy Syst Engn, TR-77000 Yalova, Turkey.
   [Omay, Didem] Yalova Univ, Fac Engn, Dept Chem & Proc Engn, TR-77000 Yalova, Turkey.
RP Kilic, B (reprint author), Yalova Univ, Fac Engn, Dept Energy Syst Engn, TR-77000 Yalova, Turkey.
EM bayram.kilic@yalova.edu.tr
CR Abramov OV, 2009, SURF COAT TECH, V204, P718, DOI 10.1016/j.surfcoat.2009.09.030
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Baxter JB, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1861510
   Brayner R, 2006, NANO LETT, V6, P866, DOI 10.1021/nl052326h
   Chen DH, 2009, ADV MATER, V21, P2206, DOI 10.1002/adma.200802603
   Darder M, 2007, ADV MATER, V19, P1309, DOI 10.1002/adma.200602328
   Franklin NM, 2007, ENVIRON SCI TECHNOL, V41, P8484, DOI 10.1021/es071445r
   Fu L, 2005, ADV MATER, V17, P217, DOI 10.1002/adma.200400833
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Gouveia I.C., 2010, INT J BIOTECHNOL, V150, P349
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Khor E, 2011, MATERIALS, V4, P1728, DOI 10.3390/ma4101728
   Kilic B, 2013, J NANOSCI NANOTECHNO, V13, P333, DOI 10.1166/jnn.2013.6921
   Lao CS, 2007, NANO LETT, V7, P1323, DOI 10.1021/nl070359m
   Liu Y, 2012, CARBOHYD POLYM, V89, P111, DOI 10.1016/j.carbpol.2012.02.058
   Makhluf S, 2005, ADV FUNCT MATER, V15, P1708, DOI 10.1002/adfm.200500029
   Reddy K.M., 2007, APPL PHYS LETT, V90
   Soga T, 2006, NANOSTRUCTURED MATERIALS FOR SOLAR ENERGY CONVERSION, P1
   Sun HK, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/39/395602
   Talebian N, 2013, J PHOTOCH PHOTOBIO B, V120, P66, DOI 10.1016/j.jphotobiol.2013.01.004
   Talebian N, 2011, APPL SURF SCI, V258, P547, DOI 10.1016/j.apsusc.2011.08.070
   Tankhiwale R, 2012, COLLOID SURFACE B, V90, P16, DOI 10.1016/j.colsurfb.2011.09.031
   Tominaga K, 2004, VACUUM, V74, P683, DOI 10.1016/j.vacuum.2004.01.042
   Tuzemen S, 2006, J APPL PHYS, V100, DOI 10.1063/1.2386926
   Wang H., 2005, J AM CHEM SOC, V127, P812
   Wu JJ, 2002, J PHYS CHEM B, V106, P9546, DOI 10.1021/jp025969j
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Zhang LL, 2010, J NANOPART RES, V12, P1625, DOI 10.1007/s11051-009-9711-1
NR 28
TC 3
Z9 3
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-8001
EI 1873-4081
J9 MAT SCI SEMICON PROC
JI Mater. Sci. Semicond. Process
PD APR
PY 2014
VL 20
BP 35
EP 40
DI 10.1016/j.mssp.2013.12.012
PG 6
WC Engineering, Electrical & Electronic; Materials Science,
   Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Engineering; Materials Science; Physics
GA AC3TW
UT WOS:000332445100007
DA 2018-10-19
ER

PT J
AU de Queiroz, JDF
   Leal, AMD
   Terada, M
   Agnez-Lima, LF
   Costa, I
   Pinto, NCD
   de Medeiros, SRB
AF Freires de Queiroz, Jana Dara
   de Sousa Leal, Angelica Maria
   Terada, Maysa
   Agnez-Lima, Lucymara Fassarela
   Costa, Isolda
   de Souza Pinto, Nadja Cristhina
   Batistuzzo de Medeiros, Silvia Regina
TI Surface modification by argon plasma treatment improves antioxidant
   defense ability of CHO-k1 cells on titanium surfaces
SO TOXICOLOGY IN VITRO
LA English
DT Article
DE Biomaterial; Titanium; Plasma treatment; Oxidative stress
ID IN-VITRO EVALUATION; OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; DENTAL
   IMPLANTS; BIOCOMPATIBILITY; ENZYMES; DIOXIDE; DAMAGE; ALLOY;
   OSSEOINTEGRATION
AB Titanium is one of the most used materials in implants and changes in its surface can modify the cellular functional response to better implant fixation. An argon plasma treatment generates a surface with improved mechanical proprieties without modifying its chemical composition. Oxidative stress induced by biomaterials is considered one of the major causes of implant failure and studies in this field are fundamental to evaluate the biocompatibility of a new material. Therefore, in this work, induction of oxidative stress by titanium surfaces subjected to plasma treatment (PITS) was evaluated. The viability of CHO-kl cells was higher on PITS discs. Cells grown on titanium surfaces are subjected to intracellular oxidative stress. Titanium discs subjected to the plasma treatment induced less oxidative stress than the untreated ones, which resulted in improved cellular survival. These were associated with improved cellular antioxidant response in Plasma Treated Titanium Surface (PITS). Furthermore, a decrease in protein and DNA oxidative damage was observed on cells grown on the roughed surface when compared to the smooth one. In conclusion, our data suggest that the treatment of titanium with argon plasma may improve its biocompatible, thus improving its performance as implants or as a scaffold in tissue engineering. (C) 2014 Published by Elsevier Ltd.
C1 [Freires de Queiroz, Jana Dara; de Sousa Leal, Angelica Maria; Agnez-Lima, Lucymara Fassarela; Batistuzzo de Medeiros, Silvia Regina] Univ Fed Rio Grande do Norte, CB, Dept Biol Celular & Genet, Natal, RN, Brazil.
   [Terada, Maysa; Costa, Isolda] IPEN CNEN SP, Inst Pesquisas Energet & Nucl, Sao Paulo, Brazil.
   [de Souza Pinto, Nadja Cristhina] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, Brazil.
RP de Medeiros, SRB (reprint author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Biol Celular & Genet, BR-59072970 Natal, RN, Brazil.
EM sbatistu@cb.ufrn.br
RI Terada, Maysa/D-3277-2012; Souza-Pinto, Nadja/C-3462-2013; Agnez-Lima,
   Lucymara/F-9655-2012; Batistuzzo de Medeiros, Silvia/H-2117-2015
OI Terada, Maysa/0000-0002-2011-5759; Souza-Pinto,
   Nadja/0000-0003-4206-964X; Agnez-Lima, Lucymara/0000-0003-0642-3162;
   Batistuzzo de Medeiros, Silvia/0000-0003-2431-0479
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   Brazil
FX Special thanks to Dr. Clodomiro Alves Junior (Department of Material
   Science - UFRN) for providing both titanium surfaces used in this study.
   We thank Deborah Alfonso Cornelio, Susana Moreira and members of my
   laboratory for rich discussions and critically reading this manuscript.
   We also thank Daniel Chaves for preparation of models presented here.
   The research was supported by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) and Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil.
CR Aikawa M, 2002, CIRCULATION, V106, P1390, DOI 10.1161/01.CIR.0000028465.52694.9B
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Barrilet S., 2010, TOXICOL LETT, V198, P324
   Binyamin Gary, 2006, Semin Pediatr Surg, V15, P276, DOI 10.1053/j.sempedsurg.2006.07.007
   Chiesa R, 2007, ORAL SURG ORAL MED O, V103, P745, DOI 10.1016/j.tripleo.2006.09.025
   DAVIES KJA, 1987, J BIOL CHEM, V262, P9902
   Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2
   Freyre-Fonseca V, 2011, TOXICOL LETT, V202, P111, DOI 10.1016/j.toxlet.2011.01.025
   Fujii J, 2003, ASIAN J ANDROL, V5, P231
   Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   GUTTERIDGE JMC, 1985, FEBS LETT, V185, P19, DOI 10.1016/0014-5793(85)80732-8
   Husain K, 2003, MOL CELL BIOCHEM, V247, P37, DOI 10.1023/A:1024112532382
   Jiang J, 2008, BIOMATERIALS, V29, P544, DOI 10.1016/j.biomaterials.2007.10.013
   Jiang J, 2009, BIOMATERIALS, V30, P2661, DOI 10.1016/j.biomaterials.2009.01.044
   Jo J.-H., 2011, J BIOMATER APPL, V27, P469
   Kalbacova M, 2007, BIOMATERIALS, V28, P3263, DOI 10.1016/j.biomaterials.2007.02.026
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lefaix H, 2008, J MATER SCI-MATER M, V19, P1861, DOI 10.1007/s10856-007-3248-6
   Lino-dos-Santos-Franco A, 2011, TOXICOL LETT, V207, P278, DOI 10.1016/j.toxlet.2011.09.026
   Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1
   Tavares JCM, 2009, TOXICOLOGY, V262, P138, DOI 10.1016/j.tox.2009.05.020
   Meilhac O, 2000, J LIPID RES, V41, P1205
   Nygren H, 2001, COLLOID SURFACE B, V22, P87, DOI 10.1016/S0927-7765(00)00216-2
   Ozmen I, 2006, CELL BIOCHEM FUNCT, V24, P275, DOI 10.1027/cbf.1225
   Parrish AR, 1999, TOXICOL SCI, V51, P80, DOI 10.1093/toxsci/51.1.80
   Pereira VG, 2008, CLIN CHIM ACTA, V387, P75, DOI 10.1016/j.cca.2007.09.008
   Rahman Q, 1997, BIOCHEM BIOPH RES CO, V240, P669, DOI 10.1006/bbrc.1997.7373
   Ratner B D, 2001, J Dent Educ, V65, P1340
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Sa JC, 2009, SURF COAT TECH, V203, P1765, DOI 10.1016/j.surfcoat.2008.12.017
   SCHAPIRA RM, 1995, AM J RESP CELL MOL, V12, P220, DOI 10.1165/ajrcmb.12.2.7865220
   Serrano MC, 2005, BIOMATERIALS, V26, P5827, DOI 10.1016/j.biomaterials.2005.02.039
   Shukla RK, 2011, TOXICOL IN VITRO, V25, P231, DOI 10.1016/j.tiv.2010.11.008
   Simon Ziv, 2002, J Can Dent Assoc, V68, P286
   Tsaryk R, 2007, BIOMATERIALS, V28, P806, DOI 10.1016/j.biomaterials.2006.09.033
   Velasco-Ortega E, 2010, MUTAT RES-GEN TOX EN, V702, P17, DOI 10.1016/j.mrgentox.2010.06.013
   Wang RR, 1998, J PROSTHET DENT, V80, P495, DOI 10.1016/S0022-3913(98)70018-6
   Xin XZ, 2012, MATER LETT, V88, P101, DOI 10.1016/j.matlet.2012.08.032
   Yang JH, 2013, GENE, V518, P388, DOI 10.1016/j.gene.2012.12.101
NR 41
TC 2
Z9 2
U1 0
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0887-2333
J9 TOXICOL IN VITRO
JI Toxicol. Vitro
PD APR
PY 2014
VL 28
IS 3
BP 381
EP 387
DI 10.1016/j.tiv.2013.11.012
PG 7
WC Toxicology
SC Toxicology
GA AB8PZ
UT WOS:000332053800006
PM 24296152
OA Bronze
DA 2018-10-19
ER

PT J
AU Idrus, RBH
   Rameli, MAB
   Cheong, LK
   Xian, LJ
   Hui, CK
   Latiff, MB
   Bin Saim, A
AF Idrus, Ruszymah Bt Hj
   Rameli, Mohd Adha Bin P.
   Cheong, Low Kiat
   Xian, Law Jia
   Hui, Chua Kien
   Latiff, Mazlyzam Bin Abdul
   Bin Saim, Aminuddin
TI Allogeneic bilayered tissue-engineered skin promotes full-thickness
   wound healing in ovine model
SO BIOMEDICAL RESEARCH-INDIA
LA English
DT Article
DE Bilayered tissue-engineered skin; allogeneic; keratinocytes;
   fibroblasts; animal model
AB Skin injuries can be treated via grafting. However, since both autologous and allogeneic skin grafts have their own limitations, skin tissue engineering was developed as an alternative approach to promote healing. Autologous tissue-engineered skin requires a few weeks for cell culture and cannot be used for acute treatment. In this study, healing potential of allogeneic bilayered tissue-engineered skin (BTES) was evaluated in sheep. Isolated allogeneic skin cells from the sheep were cultured using a combined medium of DKSFM:F12:DMEM in the ratio 2: 1: 1 supplemented with 5% FBS. Differential trypsinization was later carried out to separate the fibroblasts and keratinocytes. The allogeneic BTES was fabricated using allogeneic fibrin as biomaterial by polymerizing the fibrin-keratinocyte layer with calcium chloride followed by fibrin-fibroblast layer. Half of the wounds were isolated with PVC rings to prevent cell migration. The wounds were treated with allogeneic BTES and silk, as control. Wounds were observed at days 7, 14 and 21 to determine the rate of re-epithelialization. After 3 weeks, the sheep were euthanized. Histological evaluation with H & E, elastin van Gieson and Masson's trichrome staining showed that allogeneic BTES treated wound healed faster compared to the control group. In conclusion, allogeneic BTES has the potential to be developed as off the shelf product for rapid treatment of full thickness wound.
C1 [Idrus, Ruszymah Bt Hj; Rameli, Mohd Adha Bin P.; Xian, Law Jia; Bin Saim, Aminuddin] Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
   [Idrus, Ruszymah Bt Hj; Xian, Law Jia; Hui, Chua Kien] Univ Kebangsaan Malaysia, Fac Med, Dept Physiol, Kuala Lumpur 50300, Malaysia.
   [Cheong, Low Kiat] Univ Kebangsaan Malaysia, Fac Med, Lab Anim Resource Unit, Kuala Lumpur 50300, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Diagnost, Kuala Lumpur 50300, Malaysia.
   [Latiff, Mazlyzam Bin Abdul] Univ Kebangsaan Malaysia, Fac Hlth Sci, Sch Appl Hlth Sci, Kuala Lumpur 50300, Malaysia.
   [Bin Saim, Aminuddin] Ampang Puteri Specialist Hosp, Ear Nose & Throat Consultant Clin, Ampang, Selangor, Malaysia.
RP Idrus, RBH (reprint author), Univ Kebangsaan Malaysia, Med Ctr, Tissue Engn Ctr, Jalan Yaacob Latif, Kuala Lumpur 56000, Malaysia.
RI Law, Jia Xian/M-9728-2017
OI Law, Jia Xian/0000-0001-9045-5145
FU  [06-02-02-0003-BTK/ER/022];  [UKM-AP-2011-26]
FX This work was financially supported by the research grant
   06-02-02-0003-BTK/ER/022 and UKM-AP-2011-26.
CR Benichou G, 2011, IMMUNOTHERAPY-UK, V3, P757, DOI [10.2217/IMT.11.2, 10.2217/imt.11.2]
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Centanni JM, 2011, ANN SURG, V253, P672, DOI 10.1097/SLA.0b013e318210f3bd
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Greaves NS, 2013, WOUND REPAIR REGEN
   Guerret S, 2003, WOUND REPAIR REGEN, V11, P35, DOI 10.1046/j.1524-475X.2003.11107.x
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mazlyzam AL, 2007, BURNS, V33, P355, DOI 10.1016/j.burns.2006.08.022
   Mazlyzam A L, 2008, Med J Malaysia, V63 Suppl A, P32
   Phillips T, 2002, ARCH DERMATOL, V138, P1079, DOI 10.1001/archderm.138.8.1079
   Praveen G, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/9/095102
   Ramos-e-Silva M, 2012, CLIN DERMATOL, V30, P274, DOI 10.1016/j.clindermatol.2011.08.024
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Schurr MJ, 2012, ADV WOUND CARE, V1, P95, DOI 10.1089/wound.2011.0343
   Seet WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040978
   Shevchenko RV, 2010, J R SOC INTERFACE, V7, P229, DOI 10.1098/rsif.2009.0403
   THIVOLET J, 1986, ARCH DERMATOL RES, V278, P252, DOI 10.1007/BF00412936
   Wohlrab Johannes, 2007, J Dtsch Dermatol Ges, V5, P37, DOI 10.1111/j.1610-0387.2007.06073.x
   Zheng Yi-xiong, 2006, J Zhejiang Univ Sci B, V7, P817, DOI 10.1631/jzus.2006.B0817
NR 22
TC 1
Z9 1
U1 0
U2 1
PU SCIENTIFIC PUBLISHERS INDIA
PI ALIGARH
PA 87-GREATER AZAD ENCLAVE, P O QUARSI, ALIGARH, 00000, INDIA
SN 0970-938X
EI 0976-1683
J9 BIOMED RES-INDIA
JI Biomed. Res.-India
PD APR-JUN
PY 2014
VL 25
IS 2
BP 192
EP 198
PG 7
WC Engineering, Biomedical; Medicine, Research & Experimental
SC Engineering; Research & Experimental Medicine
GA V42ZN
UT WOS:000209651800001
DA 2018-10-19
ER

PT J
AU Ganguly, P
   Birch, M
AF Ganguly, Payal
   Birch, Mark
TI MAINTAINING THE STEMNESS OF MESENCHYMAL STEM CELLS IN BIOMATERIAL
   SCAFFOLDS
SO RHEUMATOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the British-Society-for-Rheumatology and
   British-Health-Professionals-in-Rheumatology
CY APR 29-MAY 01, 2014
CL Liverpool, ENGLAND
SP British Soc Rheumatol, British Hlth Profess Rheumatol
C1 [Ganguly, Payal; Birch, Mark] Newcastle Univ, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1462-0324
EI 1462-0332
J9 RHEUMATOLOGY
JI RHEUMATOLOGY
PD APR
PY 2014
VL 53
SU 1
MA 197
BP 133
EP 133
PG 1
WC Rheumatology
SC Rheumatology
GA CV8EM
UT WOS:000364513000371
DA 2018-10-19
ER

PT J
AU Maggini, L
   Ahrens-Jensen, J
   Lo Re, G
   Raquez, JM
   Dubois, P
   Bonifazi, D
AF Maggini, Laura
   Ahrens-Jensen, Jennifer
   Lo Re, Giada
   Raquez, Jean-Marie
   Dubois, Philippe
   Bonifazi, Davide
TI Phenanthroline-functionalized MWCNTs as versatile platform for
   lanthanides complexation
SO CARBON
LA English
DT Article
ID WALLED CARBON NANOTUBES; EU-III COMPLEX; BIOCOMPATIBILITY EVALUATION;
   BIOMEDICAL APPLICATIONS; HYBRID MATERIALS; CANCER-CELLS; NANOCOMPOSITES;
   INTEGRATION; DESTRUCTION; STABILITY
AB A multiwalled carbon nanotube (MWCNT) scaffold was covalently functionalized with phenanthroline moieties capable to chelate tris Eu(III) complexes, such as Eu(III) tris(2-theonyl)-trifluoroacetonate ([EuL3]), yielding a brightly luminescent hybrid (MWCNTs-Phene center dot[EuL3]). The material was thoroughly characterized by means of TGA, XPS, TEM and steady-state UV-Vis absorption and emission investigations. These studies demonstrated both the integrity of the luminescent Eu(III)-based complex in the hybrid, as well. as its high loading. The versatility of the coordinating properties of phenanthroline allowed the anchoring of other lanthanides like Gd(III), producing functional hybrids with potential applicability as magnetic resonance agents. Finally, the developed hybrid revealed to be highly dispersible in biodegradable polymer matrices such as Poly(L-lactide) (PLLA), making it a promising luminophore for applications in biomaterial science. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Maggini, Laura; Ahrens-Jensen, Jennifer; Bonifazi, Davide] Univ Namur UNamur, Namur Res Coll NARC, B-5000 Namur, Belgium.
   [Maggini, Laura; Ahrens-Jensen, Jennifer; Bonifazi, Davide] Univ Namur UNamur, Dept Chem, B-5000 Namur, Belgium.
   [Lo Re, Giada; Raquez, Jean-Marie; Dubois, Philippe] Univ Mons, Serv Mat Polymeres & Composites, CIRMAP, B-7000 Mons, Belgium.
   [Bonifazi, Davide] Univ Trieste, INSTM UdR Trieste, Dept Chem & Pharmaceut Sci, I-34127 Trieste, Italy.
RP Bonifazi, D (reprint author), Univ Namur UNamur, Namur Res Coll NARC, Rue Bruxelles 61, B-5000 Namur, Belgium.
EM davide.bonifazi@unamur.be
RI Bonifazi, Davide/B-2718-2016; Lo Re, Giada/G-8086-2018
OI Bonifazi, Davide/0000-0001-5717-0121; Lo Re, Giada/0000-0001-8840-1172;
   Maggini, Laura/0000-0001-9434-9470; Dubois, Philippe/0000-0003-1534-1564
FU EU through the ERC Starting [GA-310651]; FRS-FNRS (FRFC) [2.4.550.09];
   "TINTIN" ARC project [09/14-023]; MIUR through the FIRB "Futuro in
   Ricerca" [RBFR10DAK6]; Science Policy Office of the Belgian Federal
   Government [PAI-6/27]
FX D.B. gratefully acknowledges the EU through the ERC Starting Grant
   "COLORLANDS" project and the FP7-NMP-2012-SMALL-6 "SACS" network
   (contract no GA-310651), the FRS-FNRS (FRFC contracts no 2.4.550.09),
   the "TINTIN" ARC project (09/14-023), the MIUR through the FIRB "Futuro
   in Ricerca" ("SUPRACARBON", contract no RBFR10DAK6). The Namur - Mons
   collaboration has been supported by the Science Policy Office of the
   Belgian Federal Government (project PAI-6/27). JMR is a Research
   Associate by the FRS-FNRS.
CR Accorsi G, 2007, ADV FUNCT MATER, V17, P2975, DOI 10.1002/adfm.200600696
   Accorsi G, 2009, CHEM SOC REV, V38, P1690, DOI 10.1039/b806408n
   Armentano I, 2011, J BIOMAT SCI-POLYM E, V22, P541, DOI 10.1163/092050610X487873
   Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300
   Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727
   Bahr JL, 2001, CHEM MATER, V13, P3823, DOI 10.1021/cm0109903
   Bazin H., 2002, REV MOL BIOTECHNOL, V82, P233
   Bianco A, 2005, CHEM COMMUN, P571, DOI 10.1039/b410943k
   Binnemans K, 2004, J MATER CHEM, V14, P191, DOI 10.1039/b311128h
   Bunzli JCG, 2010, CHEM REV, V110, P2729, DOI 10.1021/cr900362e
   Bunzli JCG, 2006, ACCOUNTS CHEM RES, V39, P53, DOI 10.1021/ar0400894
   Burlaka A., 2010, Experimental Oncology, V32, P48
   Cheng HM, 2001, CARBON, V39, P1447, DOI 10.1016/S0008-6223(00)00306-7
   Connally RE, 2008, ANN NY ACAD SCI, V1130, P106, DOI 10.1196/annals.1430.032
   Dai HJ, 2002, ACCOUNTS CHEM RES, V35, P1035, DOI 10.1021/ar0101640
   Divya V, 2013, DALTON T, V42, P12317, DOI 10.1039/c3dt51117k
   Divya V, 2013, J MATER CHEM C, V1, P160, DOI 10.1039/c2tc00186a
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   Gannon CJ, 2007, CANCER-AM CANCER SOC, V110, P2654, DOI 10.1002/cncr.23155
   GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5
   Hovinen J, 2009, BIOCONJUGATE CHEM, V20, P404, DOI 10.1021/bc800370s
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Kauffman DR, 2009, NAT CHEM, V1, P500, DOI [10.1038/NCHEM.323, 10.1038/nchem.323]
   Kong LB, 2009, MAT SCI ENG C-BIO S, V29, P85, DOI 10.1016/j.msec.2008.05.012
   Kostarelos K, 2009, NAT NANOTECHNOL, V4, P627, DOI 10.1038/nnano.2009.241
   Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209
   Li HR, 2002, MICROPOR MESOPOR MAT, V55, P103, DOI 10.1016/S1387-1811(02)00410-9
   Li QP, 2012, J COLLOID INTERF SCI, V380, P67, DOI 10.1016/j.jcis.2012.04.038
   Liu ZA, 2011, J MATER CHEM, V21, P586, DOI 10.1039/c0jm02020f
   Maggini L, 2011, CHEM COMMUN, V47, P1626, DOI 10.1039/c0cc02874f
   Maggini L, 2014, NANOSCALE, V6, P2887, DOI 10.1039/c3nr05876j
   Maggini L, 2013, ADV MATER, V25, P2462, DOI 10.1002/adma.201204698
   Maggini L, 2013, CHEMSUSCHEM, V6, P367, DOI 10.1002/cssc.201200413
   Maggini L, 2012, CHEM-EUR J, V18, P5889, DOI 10.1002/chem.201200237
   Maggini L, 2011, CHEMSUSCHEM, V4, P1464, DOI 10.1002/cssc.201100163
   Maggini L, 2011, CHEM-EUR J, V17, P8533, DOI 10.1002/chem.201101216
   Marega R, 2014, NEW J CHEM, V38, P22, DOI 10.1039/c3nj01008b
   Marega R, 2013, ADV FUNCT MATER, V23, P3173, DOI 10.1002/adfm.201202898
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Mirochnik AG, 2000, POLYM SCI SER B+, V42, P271
   Mohanraj J, 2013, J PHYS CHEM LETT, V4, P767, DOI 10.1021/jz302137d
   Moon SI, 2005, MACROMOL SYMP, V224, P287, DOI 10.1002/masy.200550625
   O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631
   Ortiz-Acevedo A, 2005, J AM CHEM SOC, V127, P9512, DOI 10.1021/ja050507f
   Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387
   Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b
   Raffa V, 2008, CARBON, V46, P1600, DOI 10.1016/j.carbon.2008.06.053
   Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7
   Reddy MLP, 2013, DALTON T, V42, P15249, DOI 10.1039/c3dt52238e
   Reetz MT, 2008, CHEMBIOCHEM, V9, P552, DOI 10.1002/cbic.200700413
   SCAFF WL, 1969, J BACTERIOL, V98, P246
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Sitharaman B, 2011, CHEM COMMUN, V47, P1607, DOI 10.1039/c0cc03014g
   SOINI E, 1979, CLIN CHEM, V25, P353
   Sun S, 2006, BIOELECTROCHEMISTRY, V69, P133, DOI 10.1016/j.bioelechem.2005.11.007
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Ventura DN, 2010, CARBON, V48, P987, DOI 10.1016/j.carbon.2009.11.016
   Wang SJ, 2013, J MATER SCI, V48, P805, DOI 10.1007/s10853-012-6799-y
   Wu HX, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/34/345701
   Xin X, 2012, CARBON, V50, P436, DOI 10.1016/j.carbon.2011.08.059
   Yan B, 2012, RSC ADV, V2, P9304, DOI 10.1039/c2ra20976d
   Zhang DH, 2006, J PHYS CHEM B, V110, P12910, DOI 10.1021/jp061628k
   Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j
   Zhao C, 2010, CHEM MATER, V22, P5718, DOI 10.1021/cm101767c
NR 65
TC 1
Z9 1
U1 3
U2 67
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-6223
EI 1873-3891
J9 CARBON
JI Carbon
PD APR
PY 2014
VL 70
BP 22
EP 29
DI 10.1016/j.carbon.2013.12.040
PG 8
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA AB5TJ
UT WOS:000331851300002
DA 2018-10-19
ER

PT J
AU Iqbal, N
   Kadir, MRA
   Mahmood, NH
   Salim, N
   Froemming, GRA
   Balaji, HR
   Kamarul, T
AF Iqbal, Nida
   Kadir, Mohammed Rafiq Abdul
   Mahmood, Nasrul Humaimi
   Salim, Norita
   Froemming, Gabriele R. A.
   Balaji, H. R.
   Kamarul, Tunku
TI Characterization, antibacterial and in vitro compatibility of
   zinc-silver doped hydroxyapatite nanoparticles prepared through
   microwave synthesis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bioactivity; Orthopedics; Antibacterial agent; Microwave
   synthesis
ID SUBSTITUTED HYDROXYAPATITE; TEMPERATURE; NANOPOWDERS; BIOACTIVITY;
   INFECTIONS; SURFACE; ZN
AB We investigated the possibility of enhancing hydroxyapatite (HA) bioactivity by co-substituting it with zinc and silver. Zn-Ag-HA nanoparticles were synthesized by using the microwave-assisted wet precipitation process, and their phase purity, elemental composition, morphology, and particle size were analyzed by X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), and energy dispersive X-ray spectroscopy (EDX). FTIR, XRD, and EDX results showed the characteristic peaks of the Zn-Ag-HA structure, while SEM results demonstrated that the nanoparticles were of spherical shape with a particle size of 70-102 nm. Antibacterial tests of the nanoparticles revealed their antibacterial activity against Staphylococcus aureus and Escherichia colt. By using simulated body fluid (SBF), an apatite layer formation was observed at 28 days. In vitro cell adhesion assay confirmed the cell attachment of normal human osteoblast (NHOst) cells to the disc surface. MTT [(3(4, 5-dimethylthiazol-2-y1)-2, 5 diphenyhetrazolium bromide] assay indicated that the cells were viable, and the cells proliferated faster on the disks than on the control surface due to the presence of metal ions. In conclusion, the novel Zn-Ag-HA nanoparticles were found to be compatible with in vitro experiments and having potential antibacterial properties. Therefore these nanoparticles could be a promising candidate for future biomedical applications. (C) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Iqbal, Nida; Kadir, Mohammed Rafiq Abdul; Mahmood, Nasrul Humaimi] Univ Teknol Malaysia, UTM Skudai, Fac Biosci & Med Engn, Medial Implant Technol Grp MEDITEG, Johor Baharu 81310, Kagawa, Malaysia.
   [Salim, Norita; Froemming, Gabriele R. A.] UiTM Campus Sungai Buloh, Fac Med, IMMB, Selangor, Malaysia.
   [Balaji, H. R.; Kamarul, Tunku] Univ Malaya, Fac Med, Dept Orthopaed Surg, Tissue Engn Grp,NOCERAL, Kuala Lumpur 50603, Malaysia.
RP Kadir, MRA (reprint author), Univ Teknol Malaysia, UTM Skudai, Fac Biosci & Med Engn, Medial Implant Technol Grp MEDITEG, Johor Baharu 81310, Kagawa, Malaysia.
EM nidalchann6@gmail.com; rafiq@biomedical.utm.my; hbr_bala@yahoo.com
RI balaji raghavendran, hanumantha rao/B-8507-2012; Froemming,
   Gabriele/C-3274-2013; Mahmood, Nasrul Humaimi/G-7755-2016; Tunku Zainol
   Abidin, Tunku Kamarul Zaman/B-9633-2011; iqbal, nida/F-8852-2014
OI Froemming, Gabriele/0000-0002-5931-1968; Mahmood, Nasrul
   Humaimi/0000-0002-0004-7613; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/0000-0002-6028-1313; iqbal, nida/0000-0002-8502-4954
FU UTM [45027]; Ministry of Higher Education (MOHE); RMC; University of
   Malaya HIR-MOHE
FX The authors would like to thank Nik Ahmad Nazim Nik Malek (Faculty of
   Biosciences and Medical Engineering, Universiti Teknologi Malaysia (UTM)
   for his support in antibacterial testing. The authors would like to
   acknowledge the Institute of Medical Molecular Biotechnology (IMMB),
   Faculty of Medicine UiTM Campus Sungai Buloh Selangor, Malaysia for
   providing cell culture facilities. The authors would like to acknowledge
   the financial support provided by UTM research Grant science funding
   (Vote: 45027), Ministry of Higher Education (MOHE) and RMC. More than
   one of the authors of this paper was supported under University of
   Malaya HIR-MOHE research grant.
CR Ann LC, 2013, APPL SURF SCI, V265, P137, DOI 10.1016/j.apsusc.2012.10.152
   Bir F, 2012, APPL SURF SCI, V258, P7021, DOI 10.1016/j.apsusc.2012.03.158
   Boanini E, 2010, ACTA BIOMATER, V6, P1882, DOI 10.1016/j.actbio.2009.12.041
   Carsenti-Dellamonica H, 2008, ANTIBIOTIQUES, V10, P3, DOI 10.1016/j.antib.2007.12.006
   Chen X, 2012, MATER LETT, V89, P233, DOI 10.1016/j.matlet.2012.08.115
   Chung RJ, 2005, J SOL-GEL SCI TECHN, V33, P229, DOI 10.1007/s10971-005-5618-1
   Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Iqbal N, 2013, MATER RES BULL, V48, P3172, DOI 10.1016/j.materresbull.2013.04.068
   Iqbal N, 2012, MATER LETT, V89, P118, DOI 10.1016/j.matlet.2012.08.057
   Jansen WTM, 2006, DRUG RESIST UPDATE, V9, P123, DOI 10.1016/j.drup.2006.06.002
   Jenny F., 2011, DRUG RESIST UPDATE, V14, P125, DOI DOI 10.1016/J.DRUP.2011.02.001
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Miao SD, 2005, SURF COAT TECH, V198, P223, DOI 10.1016/j.surfcoat.2004.10.026
   Niranjan R, 2013, INT J BIOL MACROMOL, V54, P24, DOI 10.1016/j.ijbiomac.2012.11.026
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Rameshbabu N, 2006, B MATER SCI, V29, P611, DOI 10.1007/s12034-006-0012-3
   Ravi N.D., 2009, J AM CERAM SOC, V95, P2700
   Saidin S, 2013, MAT SCI ENG C-MATER, V33, P4715, DOI 10.1016/j.msec.2013.07.026
   Samani S, 2013, J BIOMED MATER RES A, V101, P222, DOI 10.1002/jbm.a.34322
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Stanic V, 2010, APPL SURF SCI, V256, P6083, DOI 10.1016/j.apsusc.2010.03.124
   Thian ES, 2013, J MATER SCI-MATER M, V24, P437, DOI 10.1007/s10856-012-4817-x
   Tin O.M., 2007, ARCH OROFACIAL SCI, V2, P41
   Zou ZY, 2012, ULTRASON SONOCHEM, V19, P1174, DOI 10.1016/j.ultsonch.2012.04.002
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 28
TC 32
Z9 32
U1 2
U2 64
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD APR
PY 2014
VL 40
IS 3
BP 4507
EP 4513
DI 10.1016/j.ceramint.2013.08.125
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA AA3TV
UT WOS:000331017500089
DA 2018-10-19
ER

PT J
AU Fan, M
   Liao, JF
   Guo, G
   Ding, QX
   Yang, Y
   Luo, F
   Qian, ZY
AF Fan, Min
   Liao, JinFeng
   Guo, Gang
   Ding, QiuXia
   Yang, Yi
   Luo, Feng
   Qian, ZhiYong
TI Dexamethasone-Loaded Poly(D, L-lactic acid) Microspheres/Poly(ethylene
   glycol)-Poly(epsilon-caprolactone)-Poly(ethylene glycol) Micelles
   Composite for Skin Augmentation
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Microsphere; Dexamethasone; Micelles; Soft-Tissue Augmentation
ID IN-VITRO; TISSUE-RESPONSE; DRUG CARRIER; DELIVERY; MICROSPHERES; PLA;
   BIOCOMPATIBILITY; RESTORATION; NANOFIBERS; COPOLYMERS
AB Soft tissue augmentation using various injectable fillers has gained popularity as more patients seek esthetic improvement through minimally invasive procedures requiring little or no recovery time. The currently available injectable skin fillers can be divided into three categories. With careful assessment, stimulatory fillers are the most ideal fillers. In this study, dexamethasone-loaded poly(D, L-lactic acid) (PLA) microspheres of approximately 90 mu m suspended in poly(ethylene glycol)-poly(epsilon-caprolactone)-poly(ethylene glycol) (PEG-PCL-PEG, PECE) micelles were prepared as stimulatory filler for skin augmentation. The biodegradable PECE copolymer can form nano-sized micelles in water, which instantly turns into a non-flowing gel at body temperature due to micellar aggregation. The PECE micelles (making up 90% of composite) served as vehicle for subcutaneous injection were metabolized within 44 days. At the same time, the dexamethasone-loaded PLA microspheres (10% of composite) merely served as stimulus for connective tissue formation. Dexamethasone-loaded PLA microspheres/PECE micelles composite presented great hemocompatibility in vitro. It was demonstrated in the in vivo study that the composite was biodegradable, biocompatible, nontoxic and nonmigratory. Histopathological studies indicated that the composite could stimulate collagen regeneration. Furthermore, granuloma, the main complication of the stimulatory fillers, did not appear when the composite was injected into the back of SD rats, because of the dexamethasone controlled release from the composite. All results suggested that dexamethasone-loaded PLA microspheres/PECE micelles composite may be an efficient and promising biomaterial for skin augmentation.
C1 [Fan, Min; Liao, JinFeng; Guo, Gang; Ding, QiuXia; Yang, Yi; Luo, Feng; Qian, ZhiYong] Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.
RP Qian, ZY (reprint author), Sichuan Univ, West China Hosp, West China Med Sch, State Key Lab Biotherapy & Canc Ctr, Chengdu 610041, Peoples R China.
EM anderson-qian@163.com
FU National Natural Science Foundation [NSFC31271021, NSFC31222023];
   National Science and Technology Major Project [2011ZX09102-001-10];
   Sichuan University [2011SCU04B18]; Chinese Key Basic Research 973
   Program [2010CB529906]
FX This work was financially supported by National Natural Science
   Foundation (NSFC31271021 and NSFC31222023), National Science and
   Technology Major Project (2011ZX09102-001-10), Distinguished young
   scholars of Sichuan University (2011SCU04B18), and Chinese Key Basic
   Research 973 Program (2010CB529906). We would like to show great thanks
   to Wang Hui (Analytical and Testing Center, Sichuan University) for her
   great help in SEM analysis.
CR Alijotas-Reig J, 2013, SEMIN ARTHRITIS RHEU, V43, P241, DOI 10.1016/j.semarthrit.2013.02.001
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Arras M, 1998, NAT BIOTECHNOL, V16, P159, DOI 10.1038/nbt0298-159
   Buyuktimkin B, 2012, MOL PHARMACEUT, V9, P979, DOI 10.1021/mp200614q
   Cao J, 2013, J BIOMED NANOTECHNOL, V9, P1847, DOI 10.1166/jbn.2013.1686
   Chen Y, 2013, J NANOSCI NANOTECHNO, V13, P2136, DOI 10.1166/jnn.2013.6903
   Deng Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-190
   Deng Y, 2013, NEUROCHEM RES, V38, P504, DOI 10.1007/s11064-012-0942-7
   Dijkhuizen-Radersma RV, 2002, BIOMATERIALS, V23, P4719
   DINARVAND R, 2003, AAPS PHARMSCITECH, V4
   Fan M, 2013, J BIOMATER APPL, V28, P288, DOI 10.1177/0885328212446097
   Fu SZ, 2009, J PHYS CHEM B, V113, P16518, DOI 10.1021/jp907974d
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Gong CY, 2013, J BIOMED NANOTECHNOL, V9, P1984, DOI 10.1166/jbn.2013.1754
   Gong CY, 2011, J NANOPART RES, V13, P721, DOI 10.1007/s11051-010-0071-7
   Gong CY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/21/215103
   Gong CY, 2009, INT J PHARM, V365, P89, DOI 10.1016/j.ijpharm.2008.08.027
   Guo G, 2011, J NANOSCI NANOTECHNO, V11, P4923, DOI 10.1166/jnn.2011.4119
   Hamilton TK, 2007, DERMATOL THER, V20, pS5, DOI 10.1111/j.1529-8019.2007.00100.x
   Ji XY, 2013, J BIOMED NANOTECHNOL, V9, P1672, DOI 10.1166/jbn.2013.1665
   Ji XY, 2013, J BIOMED NANOTECHNOL, V9, P417, DOI 10.1166/jbn.2013.1556
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P779, DOI 10.1166/jbn.2012.1443
   Kim TH, 2013, J NANOSCI NANOTECHNO, V13, P7325, DOI 10.1166/jnn.2013.8084
   Ladewig K, 2012, J BIOMATER TISS ENG, V2, P1, DOI 10.1166/jbt.2012.1028
   Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700
   Lee J, 2013, J NANOSCI NANOTECHNO, V13, P6983, DOI 10.1166/jnn.2013.7747
   Lee JB, 2013, J BIOMED NANOTECHNOL, V9, P424, DOI 10.1166/jbn.2013.1514
   Lemperle G, 2006, PLAST RECONSTR SURG, V118, p92S, DOI 10.1097/01.prs.0000234672.69287.77
   Li JM, 2012, J BIOMED NANOTECHNOL, V8, P809, DOI 10.1166/jbn.2012.1433
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   Park TG, 2006, INT J PHARM, V326, P169, DOI 10.1016/j.ijpharm.2006.06.041
   Peach MS, 2012, J BIOMED NANOTECHNOL, V8, P107, DOI 10.1166/jbn.2012.1368
   Ran Y, 2013, J NANOSCI NANOTECHNO, V13, P3004, DOI 10.1166/jnn.2013.7336
   Rudolph CM, 1999, AM J SURG PATHOL, V23, P113, DOI 10.1097/00000478-199901000-00013
   Schierle CF, 2011, AESTHET SURG J, V31, P95, DOI 10.1177/1090820X10391213
   Shalumon KT, 2012, J BIOMED NANOTECHNOL, V8, P405, DOI 10.1166/jbn.2012.1395
   Swaminathan S, 2013, J BIOMED NANOTECHNOL, V9, P998, DOI 10.1166/jbn.2013.1594
   The American Society for Aesthetic Plastic Surgery, 2011, 15 ANN COSM SURG NAT
   Valantin MA, 2003, AIDS, V17, P2471, DOI 10.1097/00002030-200311210-00009
   Victor S. P., 2013, J NANOPHARM DRUG DEL, V1, P193
   Xue BX, 2012, J BIOMED NANOTECHNOL, V8, P80, DOI 10.1166/jbn.2012.1358
   Yang C, 2013, J NANOSCI NANOTECHNO, V13, P6553, DOI 10.1166/jnn.2013.7520
   Yang WJ, 2009, J BIOMED NANOTECHNOL, V5, P591, DOI 10.1166/jbn.2009.1067
   Zhang LM, 2012, POLYM CHEM-UK, V3, P1958, DOI 10.1039/c2py20201h
NR 45
TC 9
Z9 9
U1 3
U2 66
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1550-7033
EI 1550-7041
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD APR
PY 2014
VL 10
IS 4
BP 592
EP 602
DI 10.1166/jbn.2014.1832
PG 11
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 259AL
UT WOS:000327499700005
PM 24734511
DA 2018-10-19
ER

PT J
AU Rothamel, D
   Benner, M
   Fienitz, T
   Happe, A
   Kreppel, M
   Nickenig, HJ
   Zoller, JE
AF Rothamel, Daniel
   Benner, Marcel
   Fienitz, Tim
   Happe, Arndt
   Kreppel, Matthias
   Nickenig, Hans-Joachim
   Zoeler, Joachim E.
TI Biodegradation pattern and tissue integration of native and cross-linked
   porcine collagen soft tissue augmentation matrices - an experimental
   study in the rat
SO HEAD & FACE MEDICINE
LA English
DT Article
DE Collagen; Soft tissue augmentation; Bone regeneration; Biodegradation;
   Cross-linking; Native type I and III collagen
ID GUIDED BONE REGENERATION; MEMBRANES; DEFECTS; FIBROBLASTS; DEVICES;
   SITES
AB Introduction: Within the last decades, collagen types I and III have been established as a sufficient biomaterial for GBR and GTR procedures. They might also be an adequate matrix for soft tissue augmentations. However, collagen materials differ significantly regarding resorption time, biodegradation pattern and the invasion of inflammatory cells. The aim of the present study was to compare the biodegradation and tissue integration of native, differently processed and cross-linked collagen scaffolds in rats.
   Methods: Four experimental porcine collagen matrices of 1.0 mm thickness, developed for soft tissue augmentation procedures, were tested. Based on the same native dermal Type I and III collagen, native (ND, Mucoderm (R) prototype), specifically defatted (DD), ethylene dioxide cross-linked (ECL) and dehydrothermally cross-linked (DCL) dermis collagen (AAP/Botiss Biomaterials, Berlin, Germany) were evaluated. Two specimens of 1 x 1 cm were fixed around a non-absorbable spacer using non-absorbable sutures. After rehydration, specimens (N = 8) were randomly allocated in unconnected subcutaneous pouches on the back of 40 Wistar rats. Rats were divided into five groups (1, 2, 4, 8 and 12 weeks), including eight animals each. After each period, eight rats were sacrificed and explanted specimens were prepared for histological analysis. The following parameters were evaluated: membrane thickness as a sign of biodegradation and volume stability, cell ingrowth, vascularization, tissue integration and foreign body reaction.
   Results: Biodegradation pattern of the non cross-linked collagen scaffolds differed only slightly in terms of presence of inflammatory cells and cell invasion into the matrix. In terms of biodegradation, ECL displayed a considerable slower resorption than ND, DCL and DD. Chemical cross-linking using ethylene dioxide showed a significant higher invasion of inflammatory cells.
   Conclusion: Within the limits of the present study it was concluded that the processing techniques influenced the collagen properties in a different intensity. Dehydrothermal cross-linking and special defatting did not notably change the biodegradation pattern, whereas cross-linking using ethylene dioxide led to significant higher volume stability of the matrix. However, ECL showed an increased inflammatory response and compromised tissue integration. Therefore, ethylene dioxide seems to be not suitable for stabilization of collagen matrices for soft tissue augmentation procedures.
C1 [Rothamel, Daniel; Benner, Marcel; Fienitz, Tim; Happe, Arndt; Kreppel, Matthias; Nickenig, Hans-Joachim; Zoeler, Joachim E.] Univ Cologne, Dept Oral & Maxillofacial Plast Surg, D-50937 Cologne, Germany.
RP Rothamel, D (reprint author), Univ Cologne, Dept Oral & Maxillofacial Plast Surg, Kerpener Str 62, D-50937 Cologne, Germany.
EM daniel.rothamel@uk-koeln.de
CR Annen BM, 2011, EUR J ORAL IMPLANTOL, V4, P87
   Becker J, 2009, CLIN ORAL IMPLAN RES, V20, P742, DOI 10.1111/j.1600-0501.2008.01689.x
   Caffesse RG, 2002, AM J DENT, V15, P339
   Cranin A Norman, 2002, J Oral Implantol, V28, P230, DOI 10.1563/1548-1336(2002)028<0230:ISTMOS>2.3.CO;2
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Edel A, 1974, J Clin Periodontol, V1, P185, DOI 10.1111/j.1600-051X.1974.tb01257.x
   Gholami Gholam Ali, 2013, Dent Res J (Isfahan), V10, P506
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Hammerle CHF, 1998, PERIODONTOL 2000, V17, P151, DOI 10.1111/j.1600-0757.1998.tb00132.x
   Hammerle CHF, 2001, CLIN ORAL IMPLAN RES, V12, P9, DOI 10.1034/j.1600-0501.2001.012001009.x
   HARDWICK R, 1995, J PERIODONTOL, V66, P495, DOI 10.1902/jop.1995.66.6.495
   HURLEY LA, 1959, J BONE JOINT SURG AM, V41, P1243, DOI 10.2106/00004623-195941070-00007
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   Kassab MM, 2010, CLIN COSMET INVESTIG, V2, P101, DOI 10.2147/CCIDEN.S13478
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Klinge B, 2009, CLIN ORAL IMPLAN RES, V20, P166, DOI 10.1111/j.1600-0501.2009.01774.x
   Locci P, 1997, J PERIODONTOL, V68, P857, DOI 10.1902/jop.1997.68.9.857
   Mahn DH, 2010, DENT TODAY, V96, P98
   Moses O, 2008, J PERIODONTOL, V79, P905, DOI [10.1902/jop.2008.070361, 10.1902/jop.2008.070361 ]
   Owens K W, 2001, Implant Dent, V10, P49
   Park Jun-Beom, 2006, Implant Dent, V15, P275, DOI 10.1097/01.id.0000227078.70869.20
   Paul B F, 1992, Int J Periodontics Restorative Dent, V12, P123
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rothamel D, 2006, ORAL MAXILLOFAC SURG, V10, P148, DOI 10.1007/s10006-006-0681-5
   Rothamel D, 2012, INT J ORAL MAX IMPL, V27, P146
   Sanz M, 2009, J CLIN PERIODONTOL, V36, P868, DOI 10.1111/j.1600-051X.2009.01460.x
   Schlegel AK, 1997, BIOMATERIALS, V18, P535, DOI 10.1016/S0142-9612(96)00175-5
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P402, DOI 10.1111/j.1600-0501.2007.01486.x
   Sela MN, 2003, CLIN ORAL IMPLAN RES, V14, P263, DOI 10.1034/j.1600-0501.2003.140302.x
   Shanmugam M, 2012, J Indian Soc Periodontol, V16, P218, DOI 10.4103/0972-124X.99265
   Sionkowska A, 2013, INT J BIOL MACROMOL, V52, P250, DOI 10.1016/j.ijbiomac.2012.10.002
   Studer SP, 1997, J PERIODONTOL, V68, P145, DOI 10.1902/jop.1997.68.2.145
   SULLIVAN HC, 1969, DENT CLIN N AM, V13, P133
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Thoma DS, 2009, CLIN ORAL IMPLAN RES, V20, P146, DOI 10.1111/j.1600-0501.2009.01784.x
   Wessel JR, 2008, J PERIODONTOL, V79, P425, DOI [10.1902/jop.2008.070325, 10.1902/jop.2008.070325 ]
   YAFFE A, 1984, J PERIODONTOL, V55, P623, DOI 10.1902/jop.1984.55.11.623
NR 39
TC 19
Z9 20
U1 0
U2 9
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-160X
J9 HEAD FACE MED
JI Head Face Med.
PD MAR 27
PY 2014
VL 10
AR 10
DI 10.1186/1746-160X-10-10
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AF7II
UT WOS:000334887700001
PM 24670219
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bendali, A
   Agnes, C
   Meffert, S
   Forster, V
   Bongrain, A
   Arnault, JC
   Sahel, JA
   Offenhausser, A
   Bergonzo, P
   Picaud, S
AF Bendali, Amel
   Agnes, Charles
   Meffert, Simone
   Forster, Valerie
   Bongrain, Alexandre
   Arnault, Jean-Charles
   Sahel, Jose-Alain
   Offenhaeusser, Andreas
   Bergonzo, Philippe
   Picaud, Serge
TI Distinctive Glial and Neuronal Interfacing on Nanocrystalline Diamond
SO PLOS ONE
LA English
DT Article
ID RETINAL GANGLION-CELLS; FILMS; PROSTHESIS; ELECTRODES; LAMININ;
   ADSORPTION; STABILITY; SURFACES; SPECTRA; CULTURE
AB Direct electrode/neuron interfacing is a key challenge to achieve high resolution of neuronal stimulation required for visual prostheses. Neuronal interfacing on biomaterials commonly requires the presence of glial cells and/or protein coating. Nanocrystalline diamond is a highly mechanically stable biomaterial with a remarkably large potential window for the electrical stimulation of tissues. Using adult retinal cell cultures from rats, we found that glial cells and retinal neurons grew equally well on glass and nanocrystalline diamond. The use of a protein coating increased cell survival, particularly for glial cells. However, bipolar neurons appeared to grow even in direct contact with bare diamond. We investigated whether the presence of glial cells contributed to this direct neuron/diamond interface, by using purified adult retinal ganglion cells to seed diamond and glass surfaces with and without protein coatings. Surprisingly, these fully differentiated spiking neurons survived better on nanocrystalline diamond without any protein coating. This greater survival was indicated by larger cell numbers and the presence of longer neurites. When a protein pattern was drawn on diamond, neurons did not grow preferentially on the coated area, by contrast to their behavior on a patterned glass. This study highlights the interesting biocompatibility properties of nanocrystalline diamond, allowing direct neuronal interfacing, whereas a protein coating was required for glial cell growth.
C1 [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] INSERM, U968, Inst Vis, Paris, France.
   [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] Sorbonne Univ, Univ Paris 06, UMR S968, Inst Vis, Paris, France.
   [Bendali, Amel; Forster, Valerie; Sahel, Jose-Alain; Picaud, Serge] CNRS, UMR7210, Inst Vis, Paris, France.
   [Agnes, Charles; Bongrain, Alexandre; Arnault, Jean-Charles; Bergonzo, Philippe] CEA LIST, Diamond Sensors Lab, Gif Sur Yvette, France.
   [Meffert, Simone; Offenhaeusser, Andreas] Forschungszentrum Julich, Inst Bio & Nanosyst Bioelect IBN2, D-52425 Julich, Germany.
   [Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.
   [Sahel, Jose-Alain; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France.
   [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England.
   [Sahel, Jose-Alain] French Acad Sci, Paris, France.
RP Picaud, S (reprint author), INSERM, U968, Inst Vis, Paris, France.
EM serge.picaud@inserm.fr
RI Picaud, Serge/H-4012-2014; Bergonzo, Philippe/A-6567-2015; Sahel,
   Jose-Alain/F-3172-2017; Offenhausser, Andreas/E-7990-2012
OI Picaud, Serge/0000-0002-0548-5145; Bergonzo,
   Philippe/0000-0002-0647-9134; Sahel, Jose-Alain/0000-0002-4831-1153;
   Offenhausser, Andreas/0000-0001-6143-2702
FU INSERM; UPMC (Paris VI); Fondation Ophtalmologique A. de Rothschild
   (Paris); Agence Nationale pour la Recherche (MEDINAS project)
   [ANR-07-TECSAN-014]; Fondation Fighting Blindness; Fondation pour la
   Recherche Medicale; sixth European framework (DREAMS)
   [FP6-NMP-2006-676033345]; sixth European framework (NEUROCARE)
   [FP7-NMP-280433]; IMPLANTS project from ITMO-TecSan; Federation des
   Aveugles de France; IRRP; city of Paris; Regional Council of
   Ile-de-France
FX This work was supported by INSERM, UPMC (Paris VI), the Fondation
   Ophtalmologique A. de Rothschild (Paris), Agence Nationale pour la
   Recherche (MEDINAS project, ANR-07-TECSAN-014), Fondation Fighting
   Blindness, Fondation pour la Recherche Medicale, the sixth European
   framework (DREAMS, project FP6-NMP-2006-676033345; NEUROCARE, project
   FP7-NMP-280433), IMPLANTS project from ITMO-TecSan, Federation des
   Aveugles de France, IRRP, the city of Paris, the Regional Council of
   Ile-de-France. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Ariano P, 2009, BIOSENS BIOELECTRON, V24, P2046, DOI 10.1016/j.bios.2008.10.017
   Aumailley M, 2013, CELL ADHES MIGR, V7, P48, DOI 10.4161/cam.22826
   BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4
   Bates CA, 1997, DEV BIOL, V181, P91, DOI 10.1006/dbio.1996.8438
   Beamson G., 1992, HIGH RESOLUTION XPS
   Butterwick A, 2009, EXP EYE RES, V88, P22, DOI 10.1016/j.exer.2008.09.018
   Chang JC, 2001, BIOSENS BIOELECTRON, V16, P527, DOI 10.1016/S0956-5663(01)00166-X
   Chang WC, 2008, LANGMUIR, V24, P13048, DOI 10.1021/la8021479
   Chen YC, 2010, BIOMATERIALS, V31, P5575, DOI 10.1016/j.biomaterials.2010.03.061
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   Djilas M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046020
   Dobelle WH, 2000, ASAIO J, V46, P3, DOI 10.1097/00002480-200001000-00002
   Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iov.04-1177
   Gao WL, 2010, APPL SURF SCI, V257, P538, DOI 10.1016/j.apsusc.2010.07.029
   Ghodbane S, 2010, DIAM RELAT MATER, V19, P630, DOI 10.1016/j.diamond.2010.01.014
   GI RS, 1995, JPN J APPL PHYS 1, V34, P5550, DOI 10.1143/JJAP.34.5550
   Granger MC, 2000, ANAL CHEM, V72, P3793, DOI 10.1021/ac0000675
   Graupner R, 1998, PHYS REV B, V57, P12397, DOI 10.1103/PhysRevB.57.12397
   Gupta S, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990058
   Hadjinicolaou AE, 2012, BIOMATERIALS, V33, P5812, DOI 10.1016/j.biomaterials.2012.04.063
   Humayun MS, 2012, OPHTHALMOLOGY, V119, P779, DOI 10.1016/j.ophtha.2011.09.028
   Kiran R, 2012, SENSORS-BASEL, V12, P7669, DOI 10.3390/s120607669
   Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004
   Lions M, 2009, PHYS STATUS SOLIDI-R, V3, P205, DOI 10.1002/pssr.200903128
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   Maynard EM, 2000, J NEUROSCI METH, V97, P93, DOI 10.1016/S0165-0270(00)00159-X
   Mehes E, 2005, GLIA, V49, P492, DOI 10.1002/glia.20135
   Romano C, 2007, PROG RETIN EYE RES, V26, P379, DOI 10.1016/j.preteyeres.2007.03.001
   Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4
   Ruiz-Taylor LA, 2001, LANGMUIR, V17, P7313, DOI 10.1021/la010620t
   Snidero E, 2003, J APPL PHYS, V93, P2700, DOI 10.1063/1.1539922
   Specht CG, 2004, BIOMATERIALS, V25, P4073, DOI 10.1016/j.biomaterials.2003.11.006
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Vanhove E, 2007, PHYS STATUS SOLIDI A, V204, P2931, DOI 10.1002/pssa.200776340
   Vanhove E, 2009, PHYS STATUS SOLIDI A, V206, P2063, DOI 10.1002/pssa.200982235
   Wei M, 2009, CHEM COMMUN, P3624, DOI 10.1039/b903284c
   Zrenner E, 2011, P ROY SOC B-BIOL SCI, V278, P1489, DOI 10.1098/rspb.2010.1747
NR 37
TC 19
Z9 19
U1 0
U2 38
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2014
VL 9
IS 3
AR e92562
DI 10.1371/journal.pone.0092562
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD7QO
UT WOS:000333459900075
PM 24664111
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Chang, HH
   Wang, YL
   Chiang, YC
   Chen, YL
   Chuang, YH
   Tsai, SJ
   Heish, KH
   Lin, FH
   Lin, CP
AF Chang, Hao-Hueng
   Wang, Yin-Lin
   Chiang, Yu-Chih
   Chen, Yen-Liang
   Chuang, Yu-Horng
   Tsai, Shang-Jye
   Heish, Kuo-Huang
   Lin, Feng-Huei
   Lin, Chun-Pin
TI A Novel Chitosan-gamma PGA Polyelectrolyte Complex Hydrogel Promotes
   Early New Bone Formation in the Alveolar Socket Following Tooth
   Extraction
SO PLOS ONE
LA English
DT Article
ID RIDGE PRESERVATION; FORMATION ADJACENT; IMPLANTS; TISSUE; SCAFFOLD; DOG;
   RECONSTRUCTION; REGENERATION; BIOCHEMISTRY; BIOMATERIAL
AB A novel chitosan-gamma PGA polyelectrolyte complex hydrogel (C-PGA) has been developed and proven to be an effective dressing for wound healing. The purpose of this study was to evaluate if C-PGA could promote new bone formation in the alveolar socket following tooth extraction. An animal model was proposed using radiography and histomorphology simultaneously to analyze the symmetrical sections of Wistar rats. The upper incisors of Wistar rats were extracted and the extraction sockets were randomly treated with gelatin sponge, neat chitosan, C-PGA, or received no treatment. The extraction sockets of selected rats from each group were evaluated at 1, 2, 4, or 6 wk post-extraction. The results of radiography and histopathology indicated that the extraction sockets treated with C-PGA exhibited lamellar bone formation (6.5%) as early as 2 wk after the extraction was performed. Moreover, the degree of new bone formation was significantly higher (P < 0.05) in the extraction sockets treated with C-PGA at 6 wk post-extraction than that in the other study groups. In this study, we demonstrated that the proposed animal model involving symmetrical sections and simultaneous radiography and histomorphology evaluation is feasible. We also conclude that the novel C-PGA has great potential for new bone formation in the alveolar socket following tooth extraction.
C1 [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Chuang, Yu-Horng; Tsai, Shang-Jye; Lin, Chun-Pin] Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.
   [Chang, Hao-Hueng; Wang, Yin-Lin; Chiang, Yu-Chih; Chen, Yen-Liang; Lin, Chun-Pin] Natl Taiwan Univ, Dept Dent, Taipei 10764, Taiwan.
   [Tsai, Shang-Jye] Cardinal Tien Hosp, Dept Dent, Yonghe Branch, New Taipei, Taiwan.
   [Heish, Kuo-Huang] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan.
   [Lin, Feng-Huei] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.
RP Lin, CP (reprint author), Natl Taiwan Univ, Sch Dent, Taipei 10764, Taiwan.
EM pinlin@ntu.edu.tw
OI CHIANG, YU-CHIH/0000-0001-8110-3033; Lin, Chun-Pin/0000-0002-3498-1113;
   WANG, YIN-LIN/0000-0001-6790-1311
FU National Science Council, Taiwan [98-2314-B-002-070-MY2]
FX The authors also declare this study was supported in part by a grant
   from the National Science Council, Taiwan (98-2314-B-002-070-MY2) and no
   additional or current funding sources for this study. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript. No additional external funding
   received for this study.
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Arruda T, 2012, J BIOMED MATER RES A, V101, P1971
   Badawy Mohamed E. I., 2011, International Journal of Carbohydrate Chemistry, DOI 10.1155/2011/460381
   Berglundh T, 2003, CLIN ORAL IMPLAN RES, V14, P251, DOI 10.1034/j.1600-0501.2003.00972.x
   Boyan BD, 2006, J PERIODONTOL, V77, P1555, DOI 10.1902/jop.2006.060019
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P423, DOI 10.1163/156856203766652048
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Ezoddini-Ardakani Fatemeh, 2012, Dent Res J (Isfahan), V9, P694
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Hsieh CY, 2006, DENT MATER, V22, P622, DOI 10.1016/j.dental.2005.05.012
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   Khanna R, 2011, ACTA BIOMATER, V7, P1173, DOI 10.1016/j.actbio.2010.10.028
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Liu HH, 2013, BIOMATERIALS, V34, P4404, DOI 10.1016/j.biomaterials.2013.02.048
   Miranda SCCC, 2011, ARCH ORAL BIOL, V56, P1, DOI 10.1016/j.archoralbio.2010.08.018
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   Muzzarelli RAA, 1999, EXS, V87, P235
   Muzzarelli RAA, 1999, EXS, V87, P293
   Muzzarelli RAA, 1999, EXS, V87, P251
   Oka S, 2013, TISSUE ENG PT A, V19, P1233, DOI [10.1089/ten.tea.2012.0325, 10.1089/ten.TEA.2012.0325]
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   SCHROEDER HE, 1973, J MICROSC-OXFORD, V99, P301, DOI 10.1111/j.1365-2818.1973.tb04629.x
   Shokrgozar Mohammad Ali, 2012, Iranian Biomedical Journal, V16, P68, DOI 10.6091/ibj.1053.2012
   Tsao CT, 2011, CARBOHYD POLYM, V84, P812, DOI 10.1016/j.carbpol.2010.04.034
   Tsao CT, 2011, CARBOHYD RES, V346, P94, DOI 10.1016/j.carres.2010.10.010
   Tsao CT, 2010, CARBOHYD RES, V345, P1774, DOI 10.1016/j.carres.2010.06.002
   TSUCHIDA E, 1994, J MACROMOL SCI PURE, VA31, P1
   Vignoletti F, 2012, CLIN ORAL IMPLAN RES, V23, P22, DOI 10.1111/j.1600-0501.2011.02331.x
NR 33
TC 9
Z9 9
U1 1
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 21
PY 2014
VL 9
IS 3
AR e92362
DI 10.1371/journal.pone.0092362
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6GL
UT WOS:000333355300075
PM 24658174
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Pilloni, A
   Pompa, G
   Saccucci, M
   Di Carlo, G
   Rimondini, L
   Brama, M
   Zeza, B
   Wannenes, F
   Migliaccio, S
AF Pilloni, Andrea
   Pompa, Giorgio
   Saccucci, Matteo
   Di Carlo, Gabriele
   Rimondini, Lia
   Brama, Marina
   Zeza, Blerina
   Wannenes, Francesca
   Migliaccio, Silvia
TI Analysis of human alveolar osteoblast behavior on a nano-hydroxyapatite
   substrate: an in vitro study
SO BMC ORAL HEALTH
LA English
DT Article
DE Nanohydroxyapatite; Human osteoblasts; Alveolar bone regeneration
ID NANOPHASE CERAMICS; DIFFERENTIATION; RESPONSES; NANOHYDROXYAPATITE;
   PROLIFERATION; OSTEOGENESIS; ROUGHNESS; ADHESION; DEFECTS; CELLS
AB Background: Nano-hydroxyapatite (nHA) is a potential ideal biomaterial for bone regeneration. However, studies have yet to characterize the behavior of human osteoblasts derived from alveolar bone on nHA. Thus, the aim of the present study was to evaluate the influence of nHA on the adhesion, proliferation and differentiation of these alveolar bone-derived cells.
   Methods: Primary human alveolar osteoblasts were collected from the alveolar ridge of a male periodontal patient during osseous resective surgery and grown on culture plates coated with either polylysine or polylysine with nano-hydroxyapatite (POL/nHA) composite. The cells were grown and observed for 14 days, and then assessed for potential modifications to osteoblasts homeostasis as evaluated by quantitative reverse transcriptase-polymerase chain reaction (real time RT-PCR), scanning electron microscopy and atomic force microscopy.
   Results: Real time PCR revealed a significant increase in the expression of the selected markers of osteoblast differentiation (bone morphogenetic protein (BMP)-2,-5,-7, ALP, COLL-1A2, OC, ON) in cells grown on the POL/nHA substrate. In addition, as compared with the POL surface, cells grown on the POL/nHA substrate demonstrated better osteoconductive properties, as demonstrated by the increase in adhesion and spreading, likely as a result of the increased surface roughness of the composite.
   Conclusions: The increased expression of BMPs and osteoinductive biomarkers suggest that nano-hydroxyapatite may stimulate the proliferation and differentiation of local alveolar osteoblasts and thus encourage bone regeneration at sites of alveolar bone regeneration.
C1 [Pilloni, Andrea; Zeza, Blerina] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Periodont Unit, Rome, Italy.
   [Pompa, Giorgio] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Prosthodont Unit, Rome, Italy.
   [Saccucci, Matteo; Di Carlo, Gabriele] Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Pediat Dent Unit, Rome, Italy.
   [Rimondini, Lia] Univ Oriental Piedmont Amedeo Avogadro, Dept Hlth Sci, Lab Biomed & Dent Mat, Novara, Italy.
   [Brama, Marina; Wannenes, Francesca; Migliaccio, Silvia] Sapienza Univ Rome, Dept Expt Med, Med Phatophysiol Endocrinol & Nutr Unit, Rome, Italy.
RP Saccucci, M (reprint author), Sapienza Univ Rome, Dept Oral & Maxillofacial Sci, Pediat Dent Unit, Rome, Italy.
EM matteo.saccucci@uniroma1.it
OI Di Carlo, Gabriele/0000-0002-8039-7022; Migliaccio,
   Silvia/0000-0002-4563-6630
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   American Academy of Periodontology, 2001, GLOSS PER TERMS
   Bouyer E, 2000, J MATER SCI-MATER M, V11, P523, DOI 10.1023/A:1008918110156
   Boyan BD, 2003, EUR CELL MAT
   Carnevale G, 2000, PERIODONTOL 2000, V22, P59, DOI 10.1034/j.1600-0757.2000.2220106.x
   Fragale A, 1999, AM J PATHOL, V154, P1465, DOI 10.1016/S0002-9440(10)65401-6
   Giannobilie WV, CLIN PERIODONTOLOGY
   Heinz B, 2010, CLIN ORAL INVEST, V14, P525, DOI 10.1007/s00784-009-0325-x
   Hi W, 2005, J PERIODONTOL, V76, P1601
   Karring TH, 2008, CLIN PERIODONTOLOGY, P548
   Kasaj A, 2008, J PERIODONTOL, V79, P394, DOI [10.1902/jop.2008.070378, 10.1902/jop.2008.070378 ]
   Kasaj Adrian, 2008, J Oral Sci, V50, P279, DOI 10.2334/josnusd.50.279
   KENNEY EB, 1985, J PERIODONTOL, V56, P82, DOI 10.1902/jop.1985.56.2.82
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Klein MO, 2013, CLIN IMPLANT DENT R, V15, P166, DOI 10.1111/j.1708-8208.2011.00339.x
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lock J, 2011, INT J NANOMED, V6, P2769, DOI 10.2147/IJN.S24493
   Murugan R, 2004, BIOMATERIALS
   Ngiam M, 2011, ANN ACAD MED SINGAP, V40, P213
   Ochsenbein C, 1958, J PERIODONTOL, V29, P15
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Reynolds Mark A, 2010, Dent Clin North Am, V54, P55, DOI 10.1016/j.cden.2009.09.003
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Taranta A, 2002, BONE, V30, P368, DOI 10.1016/S8756-3282(01)00685-8
   Thian ES, 2008, J BIOMED MATER RES A, V85A, P188, DOI 10.1002/jbm.a.31564
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei G, 2004, BIOMATERIALS
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhou H, 2011, ACTA BIOMATER, V7, P2769, DOI 10.1016/j.actbio.2011.03.019
   Zhou Z, 2009, J BIOMED MAT S3, V4, P3500
NR 35
TC 14
Z9 14
U1 0
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1472-6831
J9 BMC ORAL HEALTH
JI BMC Oral Health
PD MAR 20
PY 2014
VL 14
AR 22
DI 10.1186/1472-6831-14-22
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AG1NG
UT WOS:000335181600002
PM 24650194
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tang, J
   Liu, H
   Gao, C
   Mu, LX
   Yang, SL
   Rong, MQ
   Zhang, ZY
   Liu, J
   Ding, Q
   Lai, R
AF Tang, Jing
   Liu, Han
   Gao, Chen
   Mu, Lixian
   Yang, Shilong
   Rong, Mingqiang
   Zhang, Zhiye
   Liu, Jie
   Ding, Qiang
   Lai, Ren
TI A Small Peptide with Potential Ability to Promote Wound Healing
SO PLOS ONE
LA English
DT Article
ID GROWTH-FACTOR-BETA; TISSUE-REPAIR; SKIN; MYOFIBROBLASTS; MIGRATION;
   CYTOKINES; SMAD2; CELLS; MICE
AB Wound-healing represents a major health burden, such as diabetes-induced skin ulcers and burning. Many works are being tried to find ideal clinical wound-healing biomaterials. Especially, small molecules with low cost and function to promote production of endogenous wound healing agents (i.e. transforming growth factor beta, TGF-beta) are excellent candidates. In this study, a small peptide (tiger17, c[WCKPKPKPRCH-NH2]) containing only 11 amino acid residues was designed and proved to be a potent wound healer. It showed strong wound healing-promoting activity in a murine model of full thickness dermal wound. Tiger17 exerted significant effects on three stages of wound healing progresses including (1) the induction of macrophages recruitment to wound site at inflammatory reaction stage; (2) the promotion of the migration and proliferation both keratinocytes and fibroblasts, leading to reepithelialization and granulation tissue formation; and (3) tissue remodeling phase, by promoting the release of transforming TGF-beta 1 and interleukin 6 (IL-6) in murine macrophages and activating mitogen-activated protein kinases (MAPK) signaling pathways. Considering its easy production, store and transfer and function to promote production of endogenous wound healing agents (TGF-beta), tiger17 might be an exciting biomaterial or template for the development of novel wound-healing agents.
C1 [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.
   [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Rong, Mingqiang; Zhang, Zhiye; Liu, Jie; Lai, Ren] Kunming Inst Zool, Kunming, Yunnan, Peoples R China.
   [Ding, Qiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.
   [Gao, Chen] Jiangsu Anim Husb & Vet Coll, Coll Vet Med, Taizhou, Jiangsu, Peoples R China.
   [Tang, Jing; Liu, Han; Mu, Lixian; Yang, Shilong; Zhang, Zhiye; Liu, Jie] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China.
RP Ding, Q (reprint author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.
EM dqnj2000@aliyun.com; rlai@mail.kiz.ac.cn
FU Ministry of Science and Technology [2010CB529800, 2013CB911300];
   National Natural Science Foundation [30830021, 31070701, 31000960,
   31025025, U1132601, 31200590]; Yunnan Province [2011CI139, 2012BC009]
FX This work was supported by Ministry of Science and Technology
   (2010CB529800, 2013CB911300), National Natural Science Foundation
   (30830021, 31025025, 31070701, 31000960, 31025025, U1132601, 31200590),
   and Yunnan Province (2011CI139, 2012BC009). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Badid C, 2000, HISTOL HISTOPATHOL, V15, P269, DOI 10.14670/HH-15.269
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Block ER, 2010, MOL BIOL CELL, V21, P2172, DOI 10.1091/mbc.E09-12-1026
   Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0
   Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   DARBY I, 1990, LAB INVEST, V63, P21
   Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X
   Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006
   Gabbiani G, 1972, PATHOL BIOL PA S DEC, P6
   Geoffrey CG, 2008, NATURE, V453, P314
   Haroon ZA, 2000, ANN SURG, V231, P137, DOI 10.1097/00000658-200001000-00020
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Hosokawa R, 2005, J INVEST DERMATOL, V125, P1302, DOI 10.1111/j.0022-202X.2005.23963.x
   Katherine MM, 1998, J IMMUNOL, V160, P1001
   KIRSNER RS, 1993, DERMATOL CLIN, V11, P629, DOI 10.1016/S0733-8635(18)30216-X
   Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943
   Kondo T, 2010, FORENSIC SCI INT, V203, P93, DOI 10.1016/j.forsciint.2010.07.004
   Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Luckett-Chastain LR, 2009, BRIT J DERMATOL, V161, P237, DOI 10.1111/j.1365-2133.2009.09215.x
   Mahdavian DB, 2011, IMMUNOBIOLOGY, V216, P753, DOI DOI 10.1016/J.IMBIO.2011.01.001
   Malinda KM, 1997, FASEB J, V11, P474
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Mathieu P, 2010, INT J CLIN EXP PATHO, V3, P643
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Nathan BM, 2007, CLIN DERMATOL, V25, P19
   Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341
   Plikus MV, 2012, SEMIN CELL DEV BIOL, V23, P946, DOI 10.1016/j.semcdb.2012.10.001
   RAJA SK, 2007, FRONT BIOSCI, V12, P2849, DOI DOI 10.2741/2277
   Ryoichi M, 2008, J EXP MED, V205, P43
   Song YZ, 2009, PEPTIDES, V30, P1228, DOI 10.1016/j.peptides.2009.03.020
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Tredget EB, 2005, WOUND REPAIR REGEN, V13, P61, DOI 10.1111/j.1067-1927.2005.130108.x
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1
   Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327
   Zhang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072923
NR 39
TC 25
Z9 26
U1 1
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 19
PY 2014
VL 9
IS 3
AR e92082
DI 10.1371/journal.pone.0092082
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AD6ER
UT WOS:000333348500081
PM 24647450
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Belitsky, JM
   Lye, DS
   Gittleman, HR
   Gorlin, TA
   Gorham, AN
   Moore, CA
   Chaves, MB
   Ellowitz, MZ
AF Belitsky, Jason M.
   Lye, Diane S.
   Gittleman, Haley R.
   Gorlin, Thomas A.
   Gorham, Arthur N.
   Moore, Christine A.
   Chaves, Matthew B.
   Ellowitz, Micah Z.
TI Colorimetric metal ion binding of catechol-based coatings inspired by
   melanin and molecular imprinting
SO SUPRAMOLECULAR CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 8th International Symposium of Macrocyclic and Supramolecular Chemistry
   (ISMSC)
CY JUL 07-11, 2013
CL Arlington, VA
DE catechol; melanin; molecular imprinting; colorimetric; metal ions
ID ATOMIC-ABSORPTION-SPECTROMETRY; BISMUTH VANADATE PIGMENTS; GOLD
   NANOPARTICLES; LEAD IONS; MULTIFUNCTIONAL COATINGS; OXIDATIVE
   POLYMERIZATION; SYNTHETIC MELANINS; AQUEOUS-MEDIA; MERCURY IONS;
   HEAVY-METALS
AB Catechol-containing biomolecules and related synthetic materials are of interest for a broad range of applications. Our group has been interested in the potential of eumelanin, a catechol-containing biomaterial and the black-to-brown pigment in humans, and synthetic eumelanin analogues for water purification applications. In an attempt to apply the strategy of molecular imprinting towards lead-binding synthetic eumelanin coatings, we developed a PbO2-mediated synthesis that was subsequently tested with a number of catechols in addition to the eumelanin and polydopamine monomers l-dopa and dopamine. Although this strategy did not provide significant improvements in affinity or selectivity, we found that the PbO2-mediated oxidative polymerisation of 1,2-dihydroxybenzene generates a coating that darkens visibly upon binding Pb2+ and other metal ions. Oxidative polymerisation of catechol with sodium periodate also yields a coating with this colorimetric response. Of eight metal ions tested, the coatings are most responsive to Pb2+ and Cu2+, as analysed by quantitative colorimetry. With further optimisation, these coatings could prove useful for the colorimetric sensing of metal ions.
C1 [Belitsky, Jason M.; Lye, Diane S.; Gittleman, Haley R.; Gorlin, Thomas A.; Gorham, Arthur N.; Moore, Christine A.; Chaves, Matthew B.; Ellowitz, Micah Z.] Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA.
RP Belitsky, JM (reprint author), Oberlin Coll, Dept Chem & Biochem, Oberlin, OH 44074 USA.
EM jason.belitsky@oberlin.edu
OI Lye, Diane/0000-0002-0684-0663
FU Society Petroleum Research Fund; Research Corporation; Oberlin College
FX Acknowledgement is made to the Donors of the American Chemical Society
   Petroleum Research Fund for partial support of this research. We thank
   Research Corporation (Cottrell College Science Award) and Oberlin
   College for additional support. We thank Dr Anna Mapp and members of the
   Mapp lab at the University of Michigan, where a portion of this work was
   performed, and acknowledge the Oberlin-Kalamazoo-University of Michigan
   collaborative programme for partial support of this work. We thank Chris
   Boyd and Christa Wagner (Oberlin College) for preliminary experiments,
   and Lauren Choban, Jessica Hubert, Ryan Hunter, Edmund Korley and Sophie
   Lewandowski (Oberlin College) for ongoing experiments related to those
   reported here.
CR Alexander C, 2006, J MOL RECOGNIT, V19, P106, DOI 10.1002/jmr.760
   Ambrico M, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729754
   Arzillo M, 2012, BIOMACROMOLECULES, V13, P2379, DOI 10.1021/bm3006159
   Basu A., 2008, MOL RECOGNITION POLY, P309
   Belitsky JM, 2012, BIOORG MED CHEM LETT, V22, P5503, DOI 10.1016/j.bmcl.2012.07.027
   Belitsky JM, 2010, BIOORG MED CHEM LETT, V20, P4475, DOI 10.1016/j.bmcl.2010.06.039
   Beqa L, 2011, ACS APPL MATER INTER, V3, P668, DOI 10.1021/am101118h
   Bererok A., 2010, CHEM PHYS LETT, V497, P115
   Bernard J, 2008, REACT FUNCT POLYM, V68, P1362, DOI 10.1016/j.reactfunctpolym.2008.06.014
   Bernard J, 2012, REACT FUNCT POLYM, V72, P98, DOI 10.1016/j.reactfunctpolym.2011.11.001
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Blosi M, 2012, DYES PIGMENTS, V94, P355, DOI 10.1016/j.dyepig.2012.01.006
   Borghetti P, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4719211
   Borghetti P, 2010, LANGMUIR, V26, P19007, DOI 10.1021/la102973u
   Bridelli MG, 2008, ADSORPTION, V14, P101, DOI 10.1007/s10450-007-9059-8
   Brooksby PA, 2008, LANGMUIR, V24, P9074, DOI 10.1021/la8007816
   Brubaker CE, 2011, BIOMACROMOLECULES, V12, P4326, DOI 10.1021/bm201261d
   Chai F, 2010, ACS APPL MATER INTER, V2, P1466, DOI 10.1021/am100107k
   Chen AH, 2009, J HAZARD MATER, V163, P1068, DOI 10.1016/j.jhazmat.2008.07.073
   Chen SG, 2009, BIOINORG CHEM APPL, DOI 10.1155/2009/901563
   Chien SWC, 2007, J AGR FOOD CHEM, V55, P4820, DOI 10.1021/jf070021d
   Christl I, 2005, ENVIRON SCI TECHNOL, V39, P5319, DOI 10.1021/es050018f
   Clancy CMR, 2001, BIOCHEMISTRY-US, V40, P13353, DOI 10.1021/bi010786t
   Colarieti ML, 2006, J HAZARD MATER, V134, P161, DOI 10.1016/j.jhazmat.2005.10.054
   Costa TG, 2012, BIOINORG CHEM APPL, DOI 10.1155/2012/712840
   Cui A, 2002, BIOMACROMOLECULES, V3, P1353, DOI 10.1021/bm025615y
   Czechowski F, 2004, SPECTROCHIM ACTA A, V60, P1387, DOI 10.1016/j.saa.2003.10.037
   d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786
   Dalavi DS, 2012, J SOLID STATE ELECTR, V16, P253, DOI 10.1007/s10008-011-1314-y
   Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127
   Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b
   Fisher OZ, 2012, ADV MATER, V24, P3032, DOI 10.1002/adma.201104437
   FRONCISZ W, 1980, ARCH BIOCHEM BIOPHYS, V202, P289, DOI 10.1016/0003-9861(80)90430-0
   Fujita M, 2006, DENT MATER J, V25, P352, DOI 10.4012/dmj.25.352
   Gallas JM, 1999, BIOPHYS J, V77, P1135, DOI 10.1016/S0006-3495(99)76964-X
   Gardette M, 2011, INVEST NEW DRUG, V29, P1253, DOI 10.1007/s10637-010-9471-x
   Ghosh A, 1998, J PULP PAP SCI, V24, P26
   Goa H., 2013, ACS APPL MATER INTER, V5, P425
   Orive AG, 2009, J PHYS CHEM C, V113, P17097, DOI 10.1021/jp905560d
   Gray KM, 2011, SOFT MATTER, V7, P9601, DOI 10.1039/c1sm05293d
   Guney O, 2010, J APPL POLYM SCI, V117, P2373, DOI 10.1002/app.32077
   Gurnani V, 2003, TALANTA, V61, P889, DOI 10.1016/S0039-9140(03)00373-4
   HANNINEN KI, 1987, SCI TOTAL ENVIRON, V62, P201, DOI 10.1016/0048-9697(87)90502-X
   Hansen DE, 2007, BIOMATERIALS, V28, P4178, DOI 10.1016/j.biomaterials.2007.06.017
   Holten-Andersen N, 2011, P NATL ACAD SCI USA, V108, P2651, DOI 10.1073/pnas.1015862108
   Hong L, 2007, J PHYS CHEM B, V111, P7938, DOI 10.1021/jp071439h
   Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156
   Hong W, 2011, J MATER CHEM, V21, P17193, DOI 10.1039/c1jm12785c
   Howell RC, 2008, NUCL MED BIOL, V35, P353, DOI 10.1016/j.nucmedbio.2007.12.006
   Huang KW, 2010, BIOSENS BIOELECTRON, V25, P984, DOI 10.1016/j.bios.2009.09.006
   Huijser A, 2011, PHYS CHEM CHEM PHYS, V13, P9119, DOI 10.1039/c1cp20131j
   Hung YL, 2010, TALANTA, V82, P516, DOI 10.1016/j.talanta.2010.05.004
   Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x
   Jia XP, 2013, ANALYST, V138, P651, DOI 10.1039/c2an36313e
   Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b
   Kaur N, 2011, TETRAHEDRON, V67, P9233, DOI 10.1016/j.tet.2011.09.003
   Kim E, 2013, ACS CHEM BIOL, V8, P716, DOI 10.1021/cb300605s
   Kim HN, 2012, CHEM SOC REV, V41, P3210, DOI 10.1039/c1cs15245a
   Kulcar R, 2010, DYES PIGMENTS, V86, P271, DOI 10.1016/j.dyepig.2010.01.014
   LARSON RA, 1980, LIMNOL OCEANOGR, V25, P505, DOI 10.4319/lo.1980.25.3.0505
   Latt KK, 2011, ANAL CHIM ACTA, V689, P103, DOI 10.1016/j.aca.2011.01.032
   Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee M, 2012, CHEMPLUSCHEM, V77, P987, DOI 10.1002/cplu.201200209
   Lee YF, 2011, ACS APPL MATER INTER, V3, P2747, DOI 10.1021/am200535s
   Liu TG, 2012, J HAZARD MATER, V201, P155, DOI 10.1016/j.jhazmat.2011.11.060
   Liu Y, 2005, PIGM CELL RES, V18, P42, DOI 10.1111/j.1600-0749.2004.00197.x
   Lodeiro C, 2010, CHEM SOC REV, V39, P2948, DOI 10.1039/b819787n
   Pinheiro SCL, 2012, ANAL BIOANAL CHEM, V402, P3253, DOI 10.1007/s00216-011-5620-0
   Manceau A, 1996, ENVIRON SCI TECHNOL, V30, P1540, DOI 10.1021/es9505154
   Marszall MP, 2011, J CHROMATOGR A, V1218, P229, DOI 10.1016/j.chroma.2010.11.015
   Mayes AG, 2005, ADV DRUG DELIVER REV, V57, P1742, DOI 10.1016/j.addr.2005.07.011
   MCBRIDE MB, 1990, J INORG BIOCHEM, V39, P247, DOI 10.1016/0162-0134(90)84008-D
   MCBRIDE MB, 1988, SOIL SCI SOC AM J, V52, P985, DOI 10.2136/sssaj1988.03615995005200040016x
   Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087
   Mizuguchi H, 2004, ANAL CHIM ACTA, V527, P131, DOI 10.1016/j.aca.2004.09.080
   Muk NS, 2011, ANAL CHIM ACTA, V703, P226, DOI 10.1016/j.aca.2011.07.032
   Nematollahzadeh A, 2013, J COLLOID INTERF SCI, V404, P117, DOI 10.1016/j.jcis.2013.04.004
   Oladoja NA, 2011, DESALINATION, V271, P34, DOI 10.1016/j.desal.2010.12.008
   Orsetti S, 2006, CHEMOSPHERE, V65, P2313, DOI 10.1016/j.chemosphere.2006.05.009
   Oshita K, 2008, ANAL SCI, V24, P665, DOI 10.2116/analsci.24.665
   PALUMBO A, 1988, BIOCHIM BIOPHYS ACTA, V964, P193, DOI 10.1016/0304-4165(88)90166-3
   PALUMBO A, 1991, BIOCHIM BIOPHYS ACTA, V1115, P1, DOI 10.1016/0304-4165(91)90003-Y
   Pandey SS, 2004, J SCI IND RES INDIA, V63, P682
   Parajuli D, 2005, REACT FUNCT POLYM, V62, P129, DOI 10.1016/j.reactfunctpolym.2004.11.003
   Prabhakaran D, 2007, ANAL CHIM ACTA, V601, P108, DOI 10.1016/j.aca.2007.08.032
   Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020
   Rao TP, 2006, ANAL CHIM ACTA, V578, P105, DOI 10.1016/j.aca.2006.06.065
   Russo F, 2005, APPL MICROBIOL BIOT, V68, P131, DOI 10.1007/s00253-005-1890-9
   Schweitzer AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007229
   Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343
   Shanmuganathan K, 2011, MACROMOLECULES, V44, P9499, DOI 10.1021/ma202170n
   Shaw BA, 2011, J SERB CHEM SOC, V76, P903, DOI 10.2298/JSC100601081S
   Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y
   Smejkalova D, 2007, BIOMACROMOLECULES, V8, P737, DOI 10.1021/bm060598o
   Sono K, 2012, BIOINORG CHEM APPL, DOI 10.1155/2012/361803
   Stark KB, 2005, J PHYS CHEM B, V109, P1970, DOI 10.1021/jp046710z
   Szpoganicz B, 2002, J INORG BIOCHEM, V89, P45, DOI 10.1016/S0162-0134(01)00406-8
   Takahashi Y, 2006, ANGEW CHEM INT EDIT, V45, P913, DOI 10.1002/anie.200503015
   Tarley CRT, 2012, REACT FUNCT POLYM, V72, P83, DOI 10.1016/j.reactfunctpolym.2011.10.008
   Tewari PK, 2002, TALANTA, V56, P735, DOI 10.1016/S0039-9140(01)00606-3
   Tucks A, 2005, J SOLID STATE CHEM, V178, P1145, DOI 10.1016/j.jssc.2004.11.025
   Tucks A, 2007, DYES PIGMENTS, V72, P163, DOI 10.1016/j.dyepig.2005.08.027
   Veleshko IE, 2012, FIBRE CHEM+, V44, P83, DOI 10.1007/s10692-012-9404-x
   Venkatesh G, 2004, MICROCHIM ACTA, V144, P233, DOI 10.1007/s00604-003-0132-z
   Wang XJ, 2008, J APPL POLYM SCI, V109, P64, DOI 10.1002/app.26805
   Wang ZH, 2012, APPL SURF SCI, V258, P2017, DOI 10.1016/j.apsusc.2011.05.005
   Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c
   Wei Q, 2010, POLYM CHEM-UK, V1, P1430, DOI 10.1039/c0py00215a
   Wilke P, 2012, ACS MACRO LETT, V1, P871, DOI 10.1021/mz300258m
   Wu X, 2008, MOL RECOGNITION POLY, P395, DOI DOI 10.1002/9780470384053.CH15
   Wu YS, 2013, ACS APPL MATER INTER, V5, P1503, DOI 10.1021/am3030454
   Ye SQ, 2012, ANALYST, V137, P3365, DOI 10.1039/c2an35311c
   Yoon BH, 1999, J PULP PAP SCI, V25, P289
   Yoosaf K, 2007, J PHYS CHEM C, V111, P12839, DOI 10.1021/jp073923q
   Yu XH, 2011, ADV MATER RES-SWITZ, V156-157, P1378, DOI 10.4028/www.scientific.net/AMR.156-157.1378
   Zecca L, 2008, P NATL ACAD SCI USA, V105, P17567, DOI 10.1073/pnas.0808768105
   Zhai YH, 2008, REACT FUNCT POLYM, V68, P284, DOI 10.1016/j.reactfunctpolym.2007.08.013
   Zhai YH, 2007, ANAL CHIM ACTA, V593, P123, DOI 10.1016/j.aca.2007.04.040
   Zhang JF, 2011, CHEM SOC REV, V40, P3416, DOI 10.1039/c1cs15028f
   Zhang M, 2012, ANALYST, V137, P601, DOI 10.1039/c1an15909g
   Zhang XJ, 2012, NEW J CHEM, V36, P1621, DOI 10.1039/c2nj40242d
   Zhou QG, 2005, J ALLOY COMPD, V391, P141, DOI 10.1016/j.jallcom.2004.07.076
   Zhu DR, 2012, BIOSENS BIOELECTRON, V31, P505, DOI 10.1016/j.bios.2011.11.026
NR 124
TC 3
Z9 3
U1 4
U2 69
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1061-0278
EI 1029-0478
J9 SUPRAMOL CHEM
JI Supramol. Chem.
PD MAR 18
PY 2014
VL 26
IS 3-4
SI SI
BP 233
EP 244
DI 10.1080/10610278.2013.852672
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA AE6CR
UT WOS:000334076800014
DA 2018-10-19
ER

PT J
AU Hobbenaghi, R
   Mahboob, P
   Saifzadeh, S
   Javanbakht, J
   Manesh, JYY
   Mortezaee, R
   Touni, SR
   Hosseini, E
   Aghajanshakeri, S
   Moloudizargari, M
   Javaherypour, S
AF Hobbenaghi, Rahim
   Mahboob, Pariya
   Saifzadeh, Siamak
   Javanbakht, Javad
   Manesh, Javad Yaghoobi Yeganeh
   Mortezaee, Rasool
   Touni, Seyed Rashid
   Hosseini, Ehsan
   Aghajanshakeri, Shahin
   Moloudizargari, Milad
   Javaherypour, Soheil
TI RETRACTED: Histopathological features of bone regeneration in a canine
   segmental ulnar defect model(Retracted article. See vol. 11, 2016)
SO DIAGNOSTIC PATHOLOGY
LA English
DT Article; Retracted Publication
DE Bone defect; Bone regeneration; Vascular bone grafting; Histopathology;
   Dog
ID GRAFT SUBSTITUTE; DISTRACTION OSTEOGENESIS; MORPHOGENETIC PROTEIN-2;
   TUMOR-DIAGNOSIS; GROWTH-FACTOR; REPAIR; MODEL; HYDROXYAPATITE;
   RECONSTRUCTION; ANGIOGENESIS
AB Background: Today, finding an ideal biomaterial to treat the large bone defects, delayed unions and non-unions remains a challenge for orthopaedic surgeions and researchers. Several studies have been carried out on the subject of bone regeneration, each having its own advantages. The present study has been designed in vivo to evaluate the effects of cellular auto-transplantation of tail vertebrae on healing of experimental critical bone defect in a dog model.
   Methods: Six indigenous breeds of dog with 32 +/- 3.6 kg average weight from both sexes (5 males and 1 female) received bilateral critical-sized ulnar segmental defects. After determining the health condition, divided to 2 groups: The Group I were kept as control I (n = 1) while in Group II (experimental group; n = 5) bioactive bone implants were inserted. The defects were implanted with either autogeneic coccygeal bone grafts in dogs with 3-4 cm diaphyseal defects in the ulna. Defects were stabilized with internal plate fixation, and the control defects were not stabilized. Animals were euthanized at 16 weeks and analyzed by histopathology.
   Results: Histological evaluation of this new bone at sixteen weeks postoperatively revealed primarily lamellar bone, with the formation of new cortices and normal-appearing marrow elements. And also reformation cortical compartment and reconstitution of marrow space were observed at the graft-host interface together with graft resorption and necrosis responses. Finally, our data were consistent with the osteoconducting function of the tail autograft.
   Conclusions: Our results suggested that the tail vertebrae autograft seemed to be a new source of autogenous cortical bone in order to supporting segmental long bone defects in dogs. Furthermore, cellular autotransplantation was found to be a successful replacement for the tail vertebrae allograft bone at 3-4 cm segmental defects in the canine mid-ulna. Clinical application using graft expanders or bone autotransplantation should be used carefully and requires further investigation.
C1 [Hobbenaghi, Rahim] Urmia Univ, Fac Vet Med, Dept Pathol, Orumiyeh, Iran.
   [Mahboob, Pariya] Univ Tehran, Fac Vet Med, Tehran, Iran.
   [Saifzadeh, Siamak] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Javanbakht, Javad] Univ Tehran, Fac Vet Med, Dept Pathobiol, Tehran, Iran.
   [Manesh, Javad Yaghoobi Yeganeh] Shahrekord Univ, Fac Vet Med, Gradute Islamic Azad Univ Shahrekord, Shahrekord, Iran.
   [Mortezaee, Rasool] Ferdowsi Univ Mashhad, Fac Vet Med, Ferdowsi Univ Mashhad, Mashahd, Iran.
   [Touni, Seyed Rashid] Urmia Univ, Fac Vet Med, Orumiyeh, Iran.
   [Hosseini, Ehsan] Ilam Univ, Fac Vet Med, Ilam, Iran.
   [Aghajanshakeri, Shahin; Moloudizargari, Milad; Javaherypour, Soheil] Urmia Univ, Fac Vet Med, Orumiyeh, Iran.
RP Javanbakht, J (reprint author), Univ Tehran, Fac Vet Med, Dept Pathobiol, Tehran, Iran.
EM javadpatho@gmail.com
RI Saifzadeh, Siamak/J-1240-2012
OI Saifzadeh, Siamak/0000-0002-0295-7477
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Barati F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-120
   BLACK L, 1967, VET REC, V80, P198, DOI 10.1136/vr.80.5.198
   Bojrab JM, 1993, DISEASEMECHANISM SMA, V663-667, P1009
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   Brighton CT, 1997, J ORTHOP TRAUMA, V11, P244, DOI 10.1097/00005131-199705000-00002
   Choupina M, 2004, BRIT J PLAST SURG, V57, P465, DOI 10.1016/j.bjps.2003.12.007
   DELLOYE C, 1992, CLIN ORTHOP RELAT R, P273
   Fossum TW, 2002, TXB SMALL ANIMAL SUR, P381
   Gao TJ, 1997, BIOMATERIALS, V18, P219, DOI 10.1016/S0142-9612(96)00133-0
   Gil-Albarova J, 2004, BIOMATERIALS, V25, P4639, DOI 10.1016/j.biomaterials.2003.12.009
   Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010
   Gogolewski S, 2000, BIOMATERIALS, V21, P2513, DOI 10.1016/S0142-9612(00)00119-8
   GONG JK, 1964, ANAT REC, V149, P319, DOI 10.1002/ar.1091490302
   GRUNDEL RE, 1991, CLIN ORTHOP RELAT R, P244
   GUILLEMIN G, 1987, J BIOMED MATER RES, V21, P557, DOI 10.1002/jbm.820210503
   Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1
   HOLMES RE, 1986, J BONE JOINT SURG AM, V68A, P904, DOI 10.2106/00004623-198668060-00013
   Itoh T, 1998, J VET MED SCI, V60, P451, DOI 10.1292/jvms.60.451
   Jazrawi LM, 1998, J ORTHOP TRAUMA, V12, P111, DOI 10.1097/00005131-199802000-00008
   Kato T, 1998, J ORTHOP RES, V16, P654, DOI 10.1002/jor.1100160605
   Khaki F, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-98
   Kroese-Deutman HC, 2008, INT J ORAL MAX SURG, V37, P542, DOI 10.1016/j.ijom.2008.01.009
   Li G, 1999, J ORTHOP RES, V17, P362, DOI 10.1002/jor.1100170310
   Macedo Nelson Luiz de, 2004, J. Appl. Oral Sci., V12, P137, DOI 10.1590/S1678-77572004000200011
   Mackenzie DJ, 2001, PLAST RECONSTR SURG, V107, P989, DOI 10.1097/00006534-200104010-00013
   Matsuzaki H, 2007, CALCIFIED TISSUE INT, V80, P391, DOI 10.1007/s00223-007-9031-3
   Murakami N, 2002, J BIOMED MATER RES, V62, P169, DOI 10.1002/jbm.10236
   Ongpipattanakul B, 1997, J BIOMED MATER RES, V36, P295, DOI 10.1002/(SICI)1097-4636(19970905)36:3<295::AID-JBM4>3.0.CO;2-9
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Petcu EB, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-78
   Reichert JC, 2009, BIOMATERIALS, V30, P2149, DOI 10.1016/j.biomaterials.2008.12.050
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   Sheller MR, 2004, J ORTHOPAED RES, V22, P1094, DOI 10.1016/j.orthres.2004.03.009
   SHUKLA BP, 1989, THESIS INDIAN VET RE
   Singh S, 2000, INDIAN J ANIM SCI, V70, P276
   Slatter DH, 2002, TXB SMALL ANIMAL SUR, P1785
   Tavasoly A, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-86
   Tseng SS, 2008, J BONE JOINT SURG AM, V90A, P92, DOI 10.2106/JBJS.G.01192
   Vogelin E, 2005, J BONE JOINT SURG AM, V87A, P1323, DOI 10.2106/JBJS.C.00913
NR 40
TC 5
Z9 5
U1 2
U2 10
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1746-1596
J9 DIAGN PATHOL
JI Diagn. Pathol.
PD MAR 17
PY 2014
VL 9
AR 59
DI 10.1186/1746-1596-9-59
PG 7
WC Pathology
SC Pathology
GA AF3KY
UT WOS:000334612400001
PM 24636669
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Preslar, AT
   Parigi, G
   McClendon, MT
   Sefick, SS
   Moyer, TJ
   Haney, C
   Waters, EA
   MacRenaris, KW
   Luchinat, C
   Stupp, SI
   Meade, TJ
AF Preslar, Adam T.
   Parigi, Giacomo
   McClendon, Mark T.
   Sefick, Samantha S.
   Moyer, Tyson J.
   Haney, Chad
   Waters, Emily A.
   MacRenaris, Keith W.
   Luchinat, Claudio
   Stupp, Samuel I.
   Meade, Thomas J.
TI Self-assembling peptide nanofibers modulate water exchange and report
   biomaterial localization in vivo
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 247th National Spring Meeting of the American-Chemical-Society (ACS)
CY MAR 16-20, 2014
CL Dallas, TX
SP Amer Chem Soc
C1 [Preslar, Adam T.; Sefick, Samantha S.; Stupp, Samuel I.; Meade, Thomas J.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.
   [Moyer, Tyson J.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [McClendon, Mark T.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Haney, Chad; Waters, Emily A.; MacRenaris, Keith W.; Meade, Thomas J.] Northwestern Univ, Ctr Adv Mol Imaging, Evanston, IL 60208 USA.
   [Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Dept Chem, I-50019 Florence, Italy.
   [Parigi, Giacomo; Luchinat, Claudio] Univ Florence, Magnet Resonance Ctr CERM, I-50019 Florence, Italy.
   [Meade, Thomas J.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA.
   [Meade, Thomas J.] Northwestern Univ, Dept Radiol, Evanston, IL 60208 USA.
   [Meade, Thomas J.] Northwestern Univ, Evanston, IL 60208 USA.
EM adampreslar@gmail.com
RI Waters, Emily/B-1023-2009; Stupp, Samuel/B-6737-2009
OI Waters, Emily/0000-0003-3479-6054; 
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 16
PY 2014
VL 247
MA 570-INOR
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA AZ8HZ
UT WOS:000348457601650
DA 2018-10-19
ER

PT J
AU Dhanalakshmi, CP
   Vijayalakshmi, L
   Narayanan, V
AF Dhanalakshmi, C. P.
   Vijayalakshmi, L.
   Narayanan, V.
TI Electrochemical Studies of Hydroxyapatitie-Poly Ethylene Glycol
   Nanocomposite
SO SYNTHESIS AND REACTIVITY IN INORGANIC METAL-ORGANIC AND NANO-METAL
   CHEMISTRY
LA English
DT Article
DE 4-nitrophenol; 2-nitrophenol hydroxyapatite; electrochemistry oxidation;
   nanocrystalline; nanocomposite; poly ethylene glycol
ID CARBON-PASTE ELECTRODE; VOLTAMMETRIC DETERMINATION; NITROPHENOL ISOMERS;
   4-NITROPHENOL; PHENOL; SENSOR; FILM
AB Hydroxyapatite(HAp)-poly ethylene glycol (PEG) nanocomposites of varying composition for biomaterial applications have been synthesized. The HAp/PEG nanocomposite materials were characterized by XRD, FTIR, FESEM, and HRTEM. Hydroxyapatite (HAp) nanorod embedded composite was prepared using PEG as a matrix with different weight percentages (wt%). The results indicated that the size and crystallinity of HAp nanoparticles decreases with increase in PEG concentration in the composite. HRTEM confirms the presence of HAp nano rod crystals in PEG matrix. Cyclic voltammograms (CVs) were recorded to evaluate the electrocatalytic behaviors of the modified electrode towards the oxidation of 4-NP in the potential range of 0 to +1.0V. A glassy carbon electrode was modified with HAp-PEG nanocomposite and characterized in terms of electrochemical oxidation of 4-nitrophenol (4-NP) and 2-nitrophenol (2-NP) via cyclic voltammetry. The catalytic reaction facilitates electron transfer between 4-NP and the modified electrode, as a result the electrochemical oxidation of 4-NP becomes easier. The reason for this is that the HAp-PEG 40 can act as a promoter to increase the rate of electron transfer, lower the overpotential of 4-NP and 2-NP at the bare electrode, and the anodic peak shifts less positive potential. Thus, it is clear that HAp-PEG 40 modified GCE can be successfully used for the determination of organic pollutant.
C1 [Dhanalakshmi, C. P.; Narayanan, V.] Univ Madras, Dept Inorgan Chem, Madras 600025, Tamil Nadu, India.
   [Dhanalakshmi, C. P.] Dhanalakshmi Coll Engn, Madras, Tamil Nadu, India.
   [Vijayalakshmi, L.] Annai Veilankannis Coll Women, Madras, Tamil Nadu, India.
RP Narayanan, V (reprint author), Univ Madras, Dept Inorgan Chem, Sch Chem Sci, Guindy Maraimalai Campus, Madras 600025, Tamil Nadu, India.
EM vnnara@yahoo.co.in
CR Choudhury A, 2009, POLYMER, V50, P201, DOI 10.1016/j.polymer.2008.10.044
   Cordero-Rando MD, 1999, MIKROCHIM ACTA, V132, P7
   Dhanalakshmi C. P., 2012, INT J NANOMATER SCI, V1, P81
   El Mhammedi MA, 2009, J HAZARD MATER, V163, P323, DOI 10.1016/j.jhazmat.2008.06.126
   El Mhanunedi MA, 2007, ELECTROANAL, V19, P1727, DOI 10.1002/elan.200703927
   El Mohammedi M. A., 2009, J HAZARD MATER, V161, P55
   Fischer J, 2007, INT J ELECTROCHEM SC, V2, P226
   Galeano-Diaz T, 2000, J AGR FOOD CHEM, V48, P4508, DOI 10.1021/jf000118z
   Guo XF, 2004, TALANTA, V64, P135, DOI 10.1016/j.talanta.2004.01.020
   Hu SS, 2001, TALANTA, V54, P115, DOI 10.1016/S0039-9140(00)00658-5
   Huang WS, 2003, ANAL BIOANAL CHEM, V375, P703, DOI 10.1007/s00216-002-1745-5
   Kafi AKM, 2009, TALANTA, V79, P97, DOI 10.1016/j.talanta.2009.03.015
   Killoy WJ, 1998, INT DENT J, V48, P305, DOI 10.1111/j.1875-595X.1998.tb00721.x
   Li JD, 2009, J MATER SCI-MATER M, V20, P1031, DOI 10.1007/s10856-008-3664-2
   Lin KL, 2009, J HAZARD MATER, V161, P231, DOI 10.1016/j.jhazmat.2008.03.076
   Liu ZN, 2009, ELECTROCHEM COMMUN, V11, P1365, DOI 10.1016/j.elecom.2009.05.004
   Niaz A., 2009, ELECTROANAL, V21, P178
   Niazi A, 2007, J HAZARD MATER, V146, P421, DOI 10.1016/j.jhazmat.2007.03.063
   Nistor C, 2001, ANAL CHIM ACTA, V426, P185, DOI 10.1016/S0003-2670(00)00825-4
   Raynaud S, 2002, BIOMATERIALS, V23, P1073, DOI 10.1016/S0142-9612(01)00219-8
   Thompson MJ, 1996, J CHROMATOGR B, V677, P117, DOI 10.1016/0378-4347(95)00368-1
   Wang B, 2009, BIOSENS BIOELECTRON, V24, P1141, DOI 10.1016/j.bios.2008.06.053
   Yang CH, 2004, MICROCHIM ACTA, V148, P87, DOI 10.1007/s00604-004-0240-4
   Yang X, 2001, MIKROCHIM ACTA, V136, P73, DOI 10.1007/s006040170070
   Yin HS, 2010, MICROCHIM ACTA, V169, P87, DOI 10.1007/s00604-010-0309-1
NR 25
TC 2
Z9 2
U1 1
U2 63
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1553-3174
EI 1553-3182
J9 SYNTH REACT INORG M
JI Synth. React. Inorg. Met.-Org. Nano-Metal Chem.
PD MAR 16
PY 2014
VL 44
IS 3
BP 329
EP 335
DI 10.1080/15533174.2013.770762
PG 7
WC Chemistry, Inorganic & Nuclear; Nanoscience & Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA 247KO
UT WOS:000326616500003
DA 2018-10-19
ER

PT J
AU Konig, K
   Uchugonova, A
   Breunig, HG
AF Koenig, Karsten
   Uchugonova, Aisada
   Breunig, Hans Georg
TI High-resolution multiphoton cryomicroscopy
SO METHODS
LA English
DT Article
DE Cryopreservation; Multiphoton imaging; Cryomicroscope; Freezing;
   Biobank; Two-photon; FLIM
ID CRYOGENIC LIGHT-MICROSCOPY; CRYOELECTRON MICROSCOPY; FLUORESCENCE
   MICROSCOPY; HUMAN SPERM; CELLS; CRYOPRESERVATION; ICE; TEMPERATURE;
   MATRIX; LASERS
AB An ultracompact high-resolution multiphoton cryomicroscope with a femtosecond near infrared fiber laser has been utilized to study the cellular autofluorescence during freezing and thawing of cells. Cooling resulted in an increase of the intracellular fluorescence intensity followed by morphological modifications at temperatures below -10 degrees C, depending on the application of the cryoprotectant DMSO and the cooling rate.
   Furthermore, fluorescence lifetime imaging revealed an increase of the mean lifetime with a decrease in temperature. Non-destructive, label-free optical biopsies of biomaterial in ice can be obtained with sub-20 mW mean powers. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Koenig, Karsten; Breunig, Hans Georg] JenLab GmbH, D-07745 Jena, Germany.
   [Koenig, Karsten; Uchugonova, Aisada; Breunig, Hans Georg] Univ Saarland, Dept Biophoton & Laser Technol, D-66123 Saarbrucken, Germany.
RP Konig, K (reprint author), JenLab GmbH, Schillerstr 1, D-07745 Jena, Germany.
EM koenig@jenlab.de
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Amorim CA, 2009, HUM REPROD, V24, P92, DOI 10.1093/humrep/den343
   An J, 2007, OPT LETT, V32, P2010, DOI 10.1364/OL.32.002010
   Breunig HG, 2013, PROC SPIE, V8588, DOI 10.1117/12.2001994
   Breunig HG, 2012, PROC SPIE, V8225, DOI 10.1117/12.908348
   Breunig H.G., 2012, J BIOPHOTONICS, DOI [10.1002/jbio.201200093, DOI 10.1002/JBI0.201200093]
   BROMWICH P, 1978, BRIT J OBSTET GYNAEC, V85, P641, DOI 10.1111/j.1471-0528.1978.tb14940.x
   Brown CTA, 2008, J BIOPHOTONICS, V1, P183, DOI 10.1002/jbio.200810011
   Bugiel I., 1989, LASER LIFE SCI, V3, P1
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Devireddy RV, 2000, HUM REPROD, V15, P1125, DOI 10.1093/humrep/15.5.1125
   Doerr Daniel, 2009, Biotechnology Journal, V4, P1215, DOI 10.1002/biot.200800212
   GALLY JA, 1962, BIOCHIM BIOPHYS ACTA, V60, P499, DOI 10.1016/0006-3002(62)90869-7
   Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X
   Harris L.W., 1977, CRYOBIOLOGY, P141
   Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872
   ISHIGURO H, 1994, CRYOBIOLOGY, V31, P483, DOI 10.1006/cryo.1994.1059
   Konig K, 2008, J BIOPHOTONICS, V1, P13, DOI 10.1002/jbio.200710022
   Konig K, 1996, J MICROSC-OXFORD, V183, P197
   Konig K., 1994, J FLUORESC, V4, P17
   Konig K., 2012, INTRAVITAL, V1, P11, DOI DOI 10.4161/INTV.21938
   Le Gros MA, 2009, J MICROSC-OXFORD, V235, P1, DOI 10.1111/j.1365-2818.2009.03184.x
   LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0
   MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939
   Mazur P., 1984, CRYOBIOLOGY, V0363, P6143
   Morris GJ, 2006, HUM REPROD, V21, P2075, DOI 10.1093/humrep/del116
   Muller-Thurgau H, 1880, LANDW JB, V9, P133
   NAG KK, 1973, NATURE, V245, P270, DOI 10.1038/245270a0
   Pegg D.E., 2009, PRINCIPLES CRYOPRESE
   PISTON DW, 1992, P SOC PHOTO-OPT INS, V1640, P379, DOI 10.1117/12.58230
   POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0
   QUISTORFF B, 1985, ANAL BIOCHEM, V148, P389, DOI 10.1016/0003-2697(85)90244-1
   Richardson D.J., 2010, J OPT SOC AM B, V27, P30
   Ryan J., 2004, LIFE SCI, P17
   Schenke-Layland K, 2006, ANN THORAC SURG, V81, P918, DOI 10.1016/j.athoracsur.2005.09.016
   Schwartz CL, 2007, J MICROSC-OXFORD, V227, P98, DOI 10.1111/j.1365-2818.2007.01794.x
   Smith D, 1998, WORLD J MICROB BIOT, V14, P49
   Spindler R., 2008, CRYOBIOLOGY, V57, P337
   Stark M, 2007, PROC SPIE, V6628, DOI 10.1117/12.728317
   Tathagata A., 2010, J BIOTECHNOL, V4, P26
   THORPE PE, 1976, CRYOBIOLOGY, V13, P126, DOI 10.1016/0011-2240(76)90123-1
   Warren SG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009744
   Wise FW, 2008, LASER PHOTONICS REV, V2, P58, DOI 10.1002/lpor.200710041
   ZEILMAKER GH, 1984, FERTIL STERIL, V42, P293
NR 44
TC 6
Z9 6
U1 1
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD MAR 15
PY 2014
VL 66
IS 2
BP 230
EP 236
DI 10.1016/j.ymeth.2013.07.006
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AE1ZM
UT WOS:000333773100013
PM 23867337
DA 2018-10-19
ER

PT J
AU Czaja, W
   Kyryliouk, D
   DePaula, CA
   Buechter, DD
AF Czaja, Wojciech
   Kyryliouk, Dmytro
   DePaula, C. Alex
   Buechter, Douglas D.
TI Oxidation of gamma- Irradiated Microbial Cellulose Results in
   Bioresorbable, Highly Conformable Biomaterial
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
ID BACTERIAL CELLULOSE; REGENERATED CELLULOSE; MECHANICAL-PROPERTIES;
   BIODEGRADATION; RADIATION; SCAFFOLD
C1 [Czaja, Wojciech; Kyryliouk, Dmytro; DePaula, C. Alex; Buechter, Douglas D.] DePuy Synthes Biomat, W Chester, PA 19380 USA.
RP Czaja, W (reprint author), DePuy Synthes Biomat, 1230 Wilson Dr, W Chester, PA 19380 USA.
EM czaja.wojciech@synthes.com
CR Alvarez OM, 2004, WOUNDS, V16, P224
   [Anonymous], BACT END TEST
   [Anonymous], 2007, 10993 ISO 6
   Bodin A, 2007, J TISSUE ENG REGEN M, V1, P406, DOI 10.1002/term.51
   Calvini P, 2006, VIB SPECTROSC, V40, P177, DOI 10.1016/j.vibspec.2005.08.004
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   DEVI KS, 1986, BIOMATERIALS, V7, P193
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V195, P247
   DIMITRIJEVICH SD, 1990, CARBOHYD RES, V198, P331
   Driscoll M, 2009, RADIAT PHYS CHEM, V78, P539, DOI 10.1016/j.radphyschem.2009.03.080
   Ershov B. G, 1998, RUSS CHEM REV, V67, P315
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Hu Y, 2011, ACTA BIOMATER, V7, P2835, DOI 10.1016/j.actbio.2011.03.028
   Kim UJ, 2004, CARBOHYD POLYM, V56, P7, DOI 10.1016/j.carbpol.2003.10.013
   Kim UJ, 2000, BIOMACROMOLECULES, V1, P488, DOI 10.1021/bm0000337
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Kovalev GV, 2003, HIGH ENERG CHEM+, V37, P209, DOI 10.1023/A:1024790415083
   Laurence S, 2005, J BIOMED MATER RES A, V73A, P422, DOI 10.1002/jbm.a.30280
   Li J, 2009, MAT SCI ENG C-BIO S, V29, P1635, DOI 10.1016/j.msec.2009.01.006
   Losquadro WD, 2009, ARCH FACIAL PLAST S, V11, P104, DOI 10.1001/archfacial.2008.512
   MARES T, 1969, J POLYM SCI POL LETT, V7, P419, DOI 10.1002/pol.1969.110070603
   Mester L., 1955, ACS, V77, P5452
   Nevell TP, 1963, METHODS CARBOHYDRATE, V3, P164
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   PIERCE AM, 1984, J ORAL PATHOL MED, V13, P661, DOI 10.1111/j.1600-0714.1984.tb01468.x
   POMMERENING K, 1992, CARBOHYD RES, V233, P219, DOI 10.1016/S0008-6215(00)90933-9
   RoyChowdhury P, 2006, J BIOMED MATER RES A, V76A, P300, DOI 10.1002/jbm.a.30503
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   SINGH M, 1982, BIOMATERIALS, V3, P16, DOI 10.1016/0142-9612(82)90055-2
   Stilwell R. L., 1997, HDB BIODEGRADABLE PO, P291
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Vicini S, 2004, THERMOCHIM ACTA, V418, P123, DOI 10.1016/j.tca.2003.11.049
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
   Yamada Y, 2012, J GEN APPL MICROBIOL, V58, P397, DOI 10.2323/jgam.58.397
NR 37
TC 9
Z9 9
U1 0
U2 5
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD MAR 15
PY 2014
VL 131
IS 6
AR 39995
DI 10.1002/app.39995
PG 12
WC Polymer Science
SC Polymer Science
GA AA3PM
UT WOS:000331004800066
DA 2018-10-19
ER

PT J
AU Cakic, SM
   Ristic, IS
   Krakovsky, I
   Stojiljkovic, DT
   Belsky, P
   Kollova, L
AF Cakic, Suzana M.
   Ristic, Ivan S.
   Krakovsky, Ivan
   Stojiljkovic, Dragan T.
   Belsky, Petr
   Kollova, Lucie
TI Crystallization and thermal properties in waterborne polyurethane
   elastomers: Influence of mixed soft segment block
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Elastomers; Chemical synthesis; X-ray scattering; Crystal structure
ID MASS-TRANSFER PROPERTIES; MOLECULAR-WEIGHT; STRUCTURAL-CHARACTERIZATION;
   MELTING TEMPERATURE; CHEMICAL-STRUCTURE; DEGRADATION; DISPERSIONS;
   POLYCARBONATE; GLYCOL); MORPHOLOGY
AB A series of nontoxic biodegradable waterborne polyurethane (WBPUs) elastomers were synthesized by two-step polymerization, using isophorone diisocyanate (IPDI), 1,4-butandiol (BDO) and L-lysine as a chain extender and a range of soft segments with various macrodiols composition. The soft segment was formed by replacing polycaprolactone diol (PCL) as a polyester type polyol with hydrophilic polyether type polyol. Hydrophilic poly(ethylene glycol) (PEG) or poly(propylene glycol) (PPG) different block lengths were used to this purpose.
   Fourier-transformed infrared spectroscopy (FTIR) was used for evaluation of degree of phase separation. The effect of the soft segment composition on the thermal properties of polyurethane elastomeric films was investigated by means of thermogravimetry analysis (TGA) and differential scanning calorimetry (DSC). The thermal stability of materials is influenced by composition of soft segments and it was explained by the effect of oxygen content of polyether polyols, the length polyether block and interaction between the soft and hard segment. The wide-angle X-ray scattering (WAXS) is used to investigate the degree of crystallinity of PCL in soft segment of WBPUs. It was found that the polyether polyol length in the soft segment had a significant influence on degree of microphase separation in the soft and hard segment and crystallization behaviour of the materials. The restriction of the crystallization of the PCL soft segment depends on the hard segment content and length of the polyether polyol.
   The results show that the properties of polyurethanes prepared are directly related to the soft segment composition and can be varied easily for a different set of properties that are significant for biomaterial application. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cakic, Suzana M.; Stojiljkovic, Dragan T.] Univ Nis, Fac Technol, Leskovac 16000, Serbia.
   [Ristic, Ivan S.] Univ Novi Sad, Fac Technol, Novi Sad 21000, Serbia.
   [Krakovsky, Ivan] Charles Univ Prague, Fac Math & Phys, Dept Macromol Phys, CR-18000 Prague 2, Czech Republic.
   [Belsky, Petr; Kollova, Lucie] Univ W Bohemia, New Technol Res Ctr, Plzen 30614, Czech Republic.
RP Cakic, SM (reprint author), Univ Nis, Fac Technol, Bulevar Oslobodjenja 124, Leskovac 16000, Serbia.
EM suzana_cakic@yahoo.com
RI Ristic, Ivan/B-4774-2010; Belsky, Petr/E-7710-2016
OI Ristic, Ivan/0000-0003-4124-4901; Ristic, Ivan/0000-0002-4470-4929
FU Ministry of Education, Science and Technological Development of the
   Republic of Serbia [III 45022, TR 33034]
FX The project was financed by the Ministry of Education, Science and
   Technological Development of the Republic of Serbia (Projects No. III
   45022 and TR 33034).
CR Ayres E, 2007, EUR POLYM J, V43, P3510, DOI 10.1016/j.eurpolymj.2007.05.014
   Bogdanov B, 1999, POLYMER, V40, P3171, DOI 10.1016/S0032-3861(98)00552-7
   Cakic SM, 2013, MATER CHEM PHYS, V138, P277, DOI 10.1016/j.matchemphys.2012.11.057
   Cakic SM, 2013, INT J ADHES ADHES, V41, P132, DOI 10.1016/j.ijadhadh.2012.11.001
   Cakic SM, 2009, POLYM DEGRAD STABIL, V94, P2015, DOI 10.1016/j.polymdegradstab.2009.07.015
   Cakie S. M., 2012, THERMAL ANAL POLYURE, P79
   Chattopadhyay DK, 2009, PROG POLYM SCI, V34, P1068, DOI 10.1016/j.progpolymsci.2009.06.002
   Cometa S, 2010, POLYM DEGRAD STABIL, V95, P2013, DOI 10.1016/j.polymdegradstab.2010.07.007
   Coutinho FMB, 2000, POLYM DEGRAD STABIL, V70, P49, DOI 10.1016/S0141-3910(00)00087-2
   Eceiza A, 2008, POLYM ENG SCI, V48, P297, DOI 10.1002/pen.20905
   Garcia-Pacios V, 2011, INT J ADHES ADHES, V31, P787, DOI 10.1016/j.ijadhadh.2011.05.010
   Jiang X, 2007, EUR POLYM J, V43, P1838, DOI 10.1016/j.eurpolymj.2007.02.029
   Leonardi D, 2007, AAPS PHARMSCITECH, V8, P221
   Lin MC, 2012, MACROMOLECULES, V45, P5114, DOI 10.1021/ma300711k
   Lu MG, 2002, J APPL POLYM SCI, V85, P2552, DOI 10.1002/app.10882
   May-Hernandez L, 2011, J APPL POLYM SCI, V119, P2093, DOI 10.1002/app.32929
   Mondal S, 2006, J MEMBRANE SCI, V276, P16, DOI 10.1016/j.memsci.2005.09.029
   Mondal S, 2006, POLYM INT, V55, P1013, DOI 10.1002/pi.2026
   Mondal S, 2012, POLYM DEGRAD STABIL, V97, P1553, DOI 10.1016/j.polymdegradstab.2012.04.008
   O'Sickey MJ, 2002, J APPL POLYM SCI, V84, P229, DOI 10.1002/app.10168
   Perez-Liminana MA, 2005, INT J ADHES ADHES, V25, P507, DOI 10.1016/j.ijadhadh.2005.02.002
   PETROVIC ZS, 1994, J APPL POLYM SCI, V51, P1087, DOI 10.1002/app.1994.070510615
   Pielichowski K, 1996, THERMOCHIM ACTA, V284, P419, DOI 10.1016/0040-6031(95)02342-9
   Princi E, 2009, MACROMOL CHEM PHYSIC, V210, P879, DOI 10.1002/macp.200900013
   Rafaja D., 2000, MATER STRUCT, V7, P43
   Saralegi A, 2013, POLYM INT, V62, P106, DOI 10.1002/pi.4330
   Waghmare A, 2008, AAPS PHARMSCITECH, V9, P536, DOI 10.1208/s12249-008-9077-1
   Wang TL, 1997, POLYM DEGRAD STABIL, V55, P95, DOI 10.1016/S0141-3910(96)00130-9
   Wen TC, 1999, POLYMER, V40, P3979, DOI 10.1016/S0032-3861(98)00625-9
   Yu LQ, 2011, J COLLOID INTERF SCI, V358, P376, DOI 10.1016/j.jcis.2011.03.007
NR 30
TC 18
Z9 19
U1 13
U2 181
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
EI 1879-3312
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD MAR 14
PY 2014
VL 144
IS 1-2
BP 31
EP 40
DI 10.1016/j.matchemphys.2013.12.008
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB3GD
UT WOS:000331678400005
DA 2018-10-19
ER

PT J
AU de la Puente, P
   Ludena, D
AF de la Puente, Pilar
   Ludena, Dolores
TI Cell culture in autologous fibrin scaffolds for applications in tissue
   engineering
SO EXPERIMENTAL CELL RESEARCH
LA English
DT Review
DE Autologous; Fibrin scaffolds; Tissue engineering; Fibrinogen; Cell
   culture
ID MESENCHYMAL STEM-CELLS; HUMAN DERMAL FIBROBLASTS; IN-VITRO; OSTEOGENIC
   DIFFERENTIATION; THROMBIN CONCENTRATION; VASCULAR CONSTRUCTS;
   CALCIUM-CHLORIDE; COLLAGEN; GEL; GLUE
AB In tissue engineering techniques, three-dimensional scaffolds are needed to adjust and guide cell growth and to allow tissue regeneration. The scaffold must be biocompatible, biodegradable and must benefit the interactions between cells and biomaterial. Some natural biomaterials such as fibrin provide a structure similar to the native extracellular matrix containing the cells. Fibrin was first used as a sealant based on pools of commercial fibrinogen. However, the high risk of viral transmission of these pools led to the development of techniques of viral inactivation and elimination and the use of autologous fibrins. In recent decades, fibrin has been used as a release system and three-dimensional scaffold for cell culture. Fibrin scaffolds have been widely used for the culture of different types of cells, and have found several applications in tissue engineering. The structure and development of scaffolds is a key point for cell culture because scaffolds of autologous fibrin offer an important alternative due to their low fibrinogen concentrations, which are more suitable for cell growth.
   With this review our aim is to follow methods of development analyze the commercial and autologous fibrins available and assess the possible applications of cell culture in tissue engineering in these three-dimensional structures. (C) 2013 Elsevier Inc. All rights reserved.
C1 [de la Puente, Pilar] Washington Univ, St Louis Sch Med, Dept Radiat Oncol, Div Canc Biol, St Louis, MO 63108 USA.
   [Ludena, Dolores] Univ Hosp Salamanca, Pathol Serv, Salamanca, Spain.
RP de la Puente, P (reprint author), Washington Univ, St Louis Sch Med, Dept Radiat Oncol, Div Canc Biol, 4511 Forest Pk Ave,Room 3103, St Louis, MO 63108 USA.
EM ppuente@radonc.wustl.edu
FU Diputacion Provincial of Leon; Tissue Bank San Francisco Clinic
   Foundation of Leon; University of Leon from the Manuel Elkin Patarroyo
   Foundation
FX This research was supported by the Diputacion Provincial of Leon, the
   Tissue Bank San Francisco Clinic Foundation of Leon and the University
   of Leon thanks to a fellowship grant from the Manuel Elkin Patarroyo
   Foundation.
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Alaminos M, 2006, INVEST OPHTH VIS SCI, V47, P3311, DOI 10.1167/iovs.05-1647
   Alston SM, 2007, TRANSL RES, V149, P187, DOI 10.1016/j.trsl.2006.08.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bergel S, 1909, DEUT MED WOCHENSCHR, V35, P663, DOI 10.1055/s-0029-1201395
   Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Bosnakovski D, 2004, EXP HEMATOL, V32, P502, DOI 10.1016/j.exphem.2004.02.009
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Carriel V, 2012, CELLS TISSUES ORGANS, V196, P1, DOI 10.1159/000330682
   Catelas I, 2006, TISSUE ENG, V12, P2385, DOI 10.1089/ten.2006.12.2385
   Chevallay B, 2000, MED BIOL ENG COMPUT, V38, P211, DOI 10.1007/BF02344779
   Cho SW, 2005, BIOMATERIALS, V26, P3577, DOI 10.1016/j.biomaterials.2004.09.013
   Cholewinski E, 2009, TISSUE ENG PT A, V15, P3645, DOI [10.1089/ten.tea.2009.0235, 10.1089/ten.TEA.2009.0235]
   Clark RAF, 2003, J INVEST DERMATOL, V121, pXXI, DOI 10.1046/j.1523-1747.2003.12575.x
   Cornelissen CG, 2012, ANN BIOMED ENG, V40, P679, DOI 10.1007/s10439-011-0437-8
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Cronkite EP, 1944, J AMER MED ASSOC, V124, P976, DOI 10.1001/jama.1944.02850140022006
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   de la Puente P, 2013, EXP CELL RES, V319, P144, DOI 10.1016/j.yexcr.2012.10.009
   de la Puente P, 2011, J BIOMED MATER RES A, V99A, P648, DOI 10.1002/jbm.a.33231
   Demol J, 2011, EUR CELLS MATER, V21, P272, DOI 10.22203/eCM.v021a21
   Dodd RY, 2000, ANN MED, V32, P469, DOI 10.3109/07853890009002022
   Eyrich D, 2007, BIOMATERIALS, V28, P55, DOI 10.1016/j.biomaterials.2006.08.027
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   GIBBLE JW, 1990, TRANSFUSION, V30, P741, DOI 10.1046/j.1537-2995.1990.30891020337.x
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hale BW, 2012, AM J VET RES, V73, P313, DOI 10.2460/ajvr.73.2.313
   Han B, 2002, CORNEA, V21, P505, DOI 10.1097/01.ICO.0000016343.19018.1D
   Hankemeier S, 2007, ARCH ORTHOP TRAUM SU, V127, P815, DOI 10.1007/s00402-007-0366-z
   Henschen A., BLOOD COAGULATION, P171
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   Jackson MR, 1996, BLOOD COAGUL FIBRIN, V7, P737, DOI 10.1097/00001721-199611000-00001
   Jackson MR, 2001, AM J SURG, V182, p1S, DOI 10.1016/S0002-9610(01)00770-X
   Jeon O, 2005, J CONTROL RELEASE, V105, P249, DOI 10.1016/j.jconrel.2005.03.023
   Joch C, 2003, CARDIOVASC SURG, V11, P23, DOI 10.1016/S0967-2109(03)00068-1
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kim DY, 2010, LARYNGOSCOPE, V120, P30, DOI 10.1002/lary.20652
   Kjaergard HK, 2000, THROMB RES, V98, P221, DOI 10.1016/S0049-3848(99)00234-0
   Klin B, 2007, J LAPAROENDOSC ADV S, V17, P342, DOI 10.1089/lap.2006.0165
   Lauricella AM, 2007, ACTA BIOQUIM CLIN L, V41, P7
   Le Guehennec L, 2007, J MATER SCI-MATER M, V18, P1489, DOI 10.1007/s10856-006-0086-x
   Lesman A, 2011, BIOMATERIALS, V32, P7856, DOI 10.1016/j.biomaterials.2011.07.003
   Li B, 2013, J BIOMED MATER RES A, V101, P3097, DOI 10.1002/jbm.a.34618
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI [10.1205/cherd06196, 10.1205/cherd061915]
   Liu J, 2013, ACTA BIOMATER, V9, P4688, DOI 10.1016/j.actbio.2012.08.009
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Ma L, 2004, BIOMATERIALS, V25, P2997, DOI 10.1016/j.biomaterials.2003.09.092
   Macedo A, 2004, J THORAC CARDIOV SUR, V127, P1593, DOI 10.1016/j.jtcvs.2004.01.039
   Makogonenko E, 2002, BIOCHEMISTRY-US, V41, P7907, DOI 10.1021/bi025770x
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   McGill Victoria, 1997, Journal of Burn Care and Rehabilitation, V18, P429, DOI 10.1097/00004630-199709000-00011
   Mosesson M W, 1999, Blood Coagul Fibrinolysis, V10 Suppl 1, pS45
   Mosesson MW, 2005, J THROMB HAEMOST, V3, P1894, DOI 10.1111/j.1538-7836.2005.01365.x
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Page RL, 2011, TISSUE ENG PT A, V17, P2629, DOI [10.1089/ten.tea.2011.0024, 10.1089/ten.TEA.2011.0024]
   Paxton JZ, 2012, TISSUE ENG PT A, V18, P1596, DOI [10.1089/ten.tea.2011.0535, 10.1089/ten.TEA.2011.0535]
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   PREISSNER KT, 1991, THROMB HAEMOSTASIS, V66, P189
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Reiss RF, 1996, TRANSFUS MED REV, V10, P85, DOI 10.1016/S0887-7963(96)80085-X
   Rentsch C, 2010, J BIOMED MATER RES A, V92A, P185, DOI 10.1002/jbm.a.32314
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Sahni A, 2000, BLOOD, V96, P3772
   Sakiyama SE, 1999, FASEB J, V13, P2214
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   SHIBA Y, 1989, CELL STRUCT FUNCT, V14, P473
   Siebenlist KR, 1996, BIOCHEMISTRY-US, V35, P10448, DOI 10.1021/bi9606206
   Siedentop KH, 2001, AM J OTOLARYNG, V22, P230, DOI 10.1053/ajot.2001.24817
   Sierra DH, 2002, J BIOMED MATER RES, V59, P1
   SILVER FH, 1995, BIOMATERIALS, V16, P891, DOI 10.1016/0142-9612(95)93113-R
   Sung HJ, 2005, TISSUE ENG, V11, P267, DOI 10.1089/ten.2005.11.267
   Tabele C, 2012, J PHARM PHARM SCI, V15, P124, DOI 10.18433/J39K5H
   TREDWELL SJ, 1990, SPINE, V15, P913, DOI 10.1097/00007632-199009000-00014
   Vavken P, 2011, KNEE, V18, P42, DOI 10.1016/j.knee.2009.12.008
   Walles T, 2004, J THORAC CARDIOV SUR, V128, P900, DOI 10.1016/j.jtcvs.2004.07.036
   Wang MC, 1995, MAT SCI ENG C-BIOMIM, V3, P131, DOI 10.1016/0928-4931(95)00116-6
   Weber M., 2013, TISSUE ENG PART C-ME, DOI DOI 10.1089/TENSEC.2013.0258
   Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x
   Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang Y. I., 2007, Current Applied Physics, V7, pe103, DOI 10.1016/j.cap.2006.11.026
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Zhang Yun-song, 2008, Zhonghua Yi Xue Za Zhi, V88, P2705
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
   Zhou HZ, 2011, BIOMATERIALS, V32, P7503, DOI 10.1016/j.biomaterials.2011.06.045
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zurita M, 2011, TRAUMA-SPAIN, V22, P38
NR 99
TC 37
Z9 37
U1 0
U2 44
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4827
EI 1090-2422
J9 EXP CELL RES
JI Exp. Cell Res.
PD MAR 10
PY 2014
VL 322
IS 1
BP 1
EP 11
DI 10.1016/j.yexcr.2013.12.017
PG 11
WC Oncology; Cell Biology
SC Oncology; Cell Biology
GA AB8QU
UT WOS:000332055900001
PM 24378385
DA 2018-10-19
ER

PT J
AU Bini, D
   Russo, L
   Battocchio, C
   Natalello, A
   Polzonetti, G
   Doglia, SM
   Nicotra, F
   Cipolla, L
AF Bini, Davide
   Russo, Laura
   Battocchio, Chiara
   Natalello, Antonin
   Polzonetti, Giovanni
   Doglia, Silvia Maria
   Nicotra, Francesco
   Cipolla, Laura
TI Dendron Synthesis and Carbohydrate Immobilization on a Biomaterial
   Surface by a Double-Click Reaction
SO ORGANIC LETTERS
LA English
DT Article
ID BIOLOGICAL-SIGNIFICANCE; CHEMICAL GLYCOBIOLOGY; MULTIVALENT LIGANDS; I
   COLLAGEN; GLYCOSYLATION; BINDING; TOOLS; NANOPARTICLES; GLYCOSCIENCE;
   STABILITY
AB The synthesis of new dendrons and their immobilization on collagen patches via thiol-ene photoclick reaction, followed by chemoselective alkoxyamino-carbonyl conjugation to carbohydrates is presented. XPS, FTIR, and ELLA assays confirmed the effectiveness of the collagen multivalent neoglycosylation.
C1 [Bini, Davide; Russo, Laura; Natalello, Antonin; Doglia, Silvia Maria; Nicotra, Francesco; Cipolla, Laura] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy.
   [Battocchio, Chiara; Polzonetti, Giovanni] Univ Roma Tre, INSTM, Dept Sci, CNISM, I-00146 Rome, Italy.
   [Battocchio, Chiara; Polzonetti, Giovanni] Univ Roma Tre, CISDiC, I-00146 Rome, Italy.
RP Cipolla, L (reprint author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.
EM laura.cipolla@unimib.it
RI Natalello, Antonino/B-9659-2012; battocchio, chiara/M-4686-2015; Russo,
   Laura/I-3237-2014
OI Natalello, Antonino/0000-0002-1489-272X; Russo,
   Laura/0000-0002-5914-766X
FU Cariplo Fundation [2010-0378]; PRIN [2010L9SH3K]
FX This research was financially supported by the Cariplo Fundation under
   Grant No. 2010-0378 and PRIN 2010L9SH3K.
CR Ambrosi M, 2005, ORG BIOMOL CHEM, V3, P1593, DOI 10.1039/b414350g
   Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241
   [Anonymous], N1ST XRAY PHOTOELECT
   Ashton PR, 1996, CHEM-EUR J, V2, P1115, DOI 10.1002/chem.19960020913
   Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012
   Baldini L, 2007, CHEM SOC REV, V36, P254, DOI 10.1039/b603082n
   Barnard A, 2012, ANGEW CHEM INT EDIT, V51, P6572, DOI 10.1002/anie.201200076
   Battocchio C, 2010, MATER SCI ENG B-ADV, V169, P36, DOI 10.1016/j.mseb.2009.12.051
   Beamson G., 1992, HIGH RESOLUTION XPS
   Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820
   Bishop JR, 2007, GLYCOBIOLOGY, V17, p23R, DOI 10.1093/glycob/cwm005
   Chawla K, 2012, BIOMATERIALS, V33, P6052, DOI 10.1016/j.biomaterials.2012.04.058
   Cipolla L, 2012, SPR CARB CH, V38, P416, DOI 10.1039/9781849734769-00416
   De la Fuente JM, 2006, BBA-GEN SUBJECTS, V1760, P636, DOI 10.1016/j.bbagen.2005.12.001
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Guilbert M, 2013, BBA-GEN SUBJECTS, V1830, P3525, DOI 10.1016/j.bbagen.2013.01.016
   Hakomori S, 2001, ADV EXP MED BIOL, V491, P369
   Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008
   Imberty A, 2008, CHEM-EUR J, V14, P7490, DOI 10.1002/chem.200800700
   Irure A, 2013, BIOMATER SCI-UK, V1, P658, DOI 10.1039/c3bm60032g
   Iucci G, 2007, MAT SCI ENG C-BIO S, V27, P1201, DOI 10.1016/j.msec.2006.09.038
   Johnson JL, 2013, TRENDS IMMUNOL, V34, P290, DOI 10.1016/j.it.2013.01.006
   Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692
   Kalia J, 2008, ANGEW CHEM INT EDIT, V47, P7523, DOI 10.1002/anie.200802651
   Kiessling LL, 2006, ANGEW CHEM INT EDIT, V45, P2348, DOI 10.1002/anie.200502794
   Kleene R, 2004, NAT REV NEUROSCI, V5, P195, DOI 10.1038/nrn1349
   Koepsel JT, 2012, CHEMBIOCHEM, V13, P1717, DOI 10.1002/cbic.201200226
   Ledin PA, 2011, CHEM-EUR J, V17, P839, DOI 10.1002/chem.201002052
   Lim Y, 2007, ORG BIOMOL CHEM, V5, P401, DOI 10.1039/b615744k
   Mager MD, 2011, NAT CHEM, V3, P582, DOI [10.1038/NCHEM.1090, 10.1038/nchem.1090]
   Masand SN, 2012, BIOMATERIALS, V33, P790, DOI 10.1016/j.biomaterials.2011.10.013
   MILLER EJ, 1976, MOL CELL BIOCHEM, V13, P165, DOI 10.1007/BF01731779
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Natalello A, 2005, BIOCHEM J, V385, P511, DOI 10.1042/BJ20041296
   Neel E. A. A., 2013, ADV DRUG DELIV REV, V65, P429
   Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019
   Paez JI, 2012, POLYMERS-BASEL, V4, P355, DOI 10.3390/polym4010355
   Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785
   Pieters RJ, 2007, MED RES REV, V27, P796, DOI 10.1002/med.20089
   Pieters RJ, 2009, ORG BIOMOL CHEM, V7, P2013, DOI 10.1039/b901828j
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Roglin L, 2011, ANGEW CHEM INT EDIT, V50, P102, DOI 10.1002/anie.201003968
   Santoyo-Gonzalez F, 2009, CHEM SOC REV, V38, P3449, DOI 10.1039/b909363j
   Sapsford KE, 2013, CHEM REV, V113, P1904, DOI 10.1021/cr300143v
   Seeberger PH, 2009, NAT CHEM BIOL, V5, P368, DOI 10.1038/nchembio0609-368
   Service RF, 2012, SCIENCE, V338, P321, DOI 10.1126/science.338.6105.321
   Sharon N, 2004, GLYCOBIOLOGY, V14, p53R, DOI 10.1093/glycob/cwh122
   Slaney AM, 2011, ACS APPL MATER INTER, V3, P1601, DOI 10.1021/am200158y
   Sricholpech M, 2012, J BIOL CHEM, V287, P22998, DOI 10.1074/jbc.M112.343954
   Stallforth P, 2009, J MED CHEM, V52, P5561, DOI 10.1021/jm900819p
   Stevens J, 2006, NAT REV MICROBIOL, V4, P857, DOI 10.1038/nrmicro1530
   Taga Y, 2013, J PROTEOME RES, V12, P2225, DOI 10.1021/pr400079d
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076
   van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203
   Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499
NR 57
TC 15
Z9 15
U1 4
U2 45
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1523-7060
EI 1523-7052
J9 ORG LETT
JI Org. Lett.
PD MAR 7
PY 2014
VL 16
IS 5
BP 1298
EP 1301
DI 10.1021/ol403476z
PG 4
WC Chemistry, Organic
SC Chemistry
GA AC8AW
UT WOS:000332756400007
PM 24552198
DA 2018-10-19
ER

PT J
AU Li, X
   Fan, DD
   Zhu, CH
   Ma, XX
AF Li, Xian
   Fan, Daidi
   Zhu, Chenhui
   Ma, Xiaoxuan
TI Effects of self-assembled fibers on the synthesis, characteristics and
   biomedical applications of CCAG hydrogels
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID HYALURONIC-ACID; CHITOSAN HYDROGEL; GROWTH; FILMS; HYDROXYAPATITE;
   SCAFFOLDS
AB CS-HLC-HA-beta-GP (chitosan human-like collagen hyaluronic acid-beta-sodium glycerophosphate) hydrogels were prepared based on the self-assembly of CS-HLC-HA (CCA) fibers. The effects of the fibers on the synthesis, characteristics and biomedical applications of CS-HLC-HA-beta-GP (CCAG) hydrogels were studied for various HA contents. The synthesis mechanism of the novel CCAG hydrogel was explored using Fourier transform infrared spectroscopy (FT-IR) and X-ray photoelectron spectroscopy (XPS). The hydrogels were characterized by a swelling test, gelling time and enzymatic treatments. The results indicated that a new amide bond (-CONH) and -NRH2+ were formed. The gelling time and swelling behaviors were dependent on the intertwining, overlap and adsorption of the polymer chains at various temperatures and pH. Furthermore, biomedical applications were evaluated by transmission electron microscopy (TEM), immunohistochemical analysis and haematoxylin and eosin (H&E) staining. The effect of the fibers on the histocompatibility of the hydrogels revealed that the fibers inside the hydrogel pores reduced the quantity of macrophages, decreased the degree of inflammation, and improved the anti-degradation of the modified hydrogels. This type of new hydrogel emerges as an interesting injectable filling biomaterial for tissue engineering.
C1 [Li, Xian; Fan, Daidi; Zhu, Chenhui; Ma, Xiaoxuan] NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Xian 710069, Shaanxi, Peoples R China.
RP Fan, DD (reprint author), NW Univ Xian, Shaanxi Key Lab Degradable Biomed Mat, Dept Chem Engn, Taibai North Rd 229, Xian 710069, Shaanxi, Peoples R China.
EM fandaidi@nwu.edu.cn
RI Fan, daidi/J-1128-2017
FU National Natural Science Foundation of China [21276210, 21106112,
   21206135, 31000019, 21106111]; NWU Graduate Innovation and Creativity
   Funds [YZZ12037]; Shaanxi Key Subject Program, China
FX This study was financially supported by the National Natural Science
   Foundation of China (21276210, 21106112, 21206135, 31000019 and
   21106111), the NWU Graduate Innovation and Creativity Funds (YZZ12037)
   and the Shaanxi Key Subject Program, China.
CR BAKER JP, 1994, MACROMOLECULES, V27, P1446, DOI 10.1021/ma00084a026
   Casettari L, 2012, BIOMATERIALS, V33, P7565, DOI 10.1016/j.biomaterials.2012.06.104
   Chung HJ, 2005, CURR APPL PHYS, V5, P485, DOI 10.1016/j.cap.2005.01.015
   Costa RR, 2011, SMALL, V7, P2640, DOI 10.1002/smll.201100875
   Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   Degano IR, 2009, BIOMATERIALS, V30, P1156, DOI 10.1016/j.biomaterials.2008.11.021
   Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749
   Feng Q, 2005, COLLOID SURFACE A, V257-58, P85, DOI 10.1016/j.colsurfa.2004.10.099
   Ganji F, 2007, J SOL-GEL SCI TECHN, V42, P47, DOI 10.1007/s10971-006-9007-1
   Guo TY, 2005, BIOMATERIALS, V26, P5737, DOI 10.1016/j.biomaterials.2005.02.017
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Li X, 2014, SOFT MATER, V12, P1, DOI 10.1080/1539445X.2011.584269
   Li X, 2012, SOFT MATTER, V8, P3781, DOI 10.1039/c2sm06994f
   Li Y. S., 2009, CHIN J COLLOID POLYM, V27, P9
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5
   Oswaldo A., 2011, BIOMATERIALS, V32, P7389
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   SANTOS PM, 1991, OTOLARYNG HEAD NECK, V105, P12, DOI 10.1177/019459989110500103
   Seda Y., 2011, BIOMATERIALS, V32, P5590
   Soest JJG, 1996, POLYMER, V37, P3543
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   Tjong SC, 1998, POLYM ENG SCI, V38, P392, DOI 10.1002/pen.10200
   Wang Y, 2006, MAT SCI ENG C-BIO S, V26, P635, DOI 10.1016/j.msec.2005.07.019
   WILLIAMS D F, 1992, Clinical Materials, V10, P9, DOI 10.1016/0267-6605(92)90078-8
   Wu H. G., 2008, CHIN J BIOMED ENG, V27, P580
   Yang PF, 2007, BIOCHEM ENG J, V33, P284, DOI 10.1016/j.bej.2006.11.010
   Yang SY, 2003, BIOMACROMOLECULES, V4, P987, DOI 10.1021/bm034035d
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhai Y, 2005, CURR APPL PHYS, V5, P429, DOI 10.1016/j.cap.2005.01.004
   Zhu CH, 2009, J BIOMED MATER RES A, V89A, P829, DOI 10.1002/jbm.a.32256
NR 39
TC 9
Z9 9
U1 3
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD MAR 7
PY 2014
VL 2
IS 9
BP 1234
EP 1249
DI 10.1039/c3tb21628d
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AB6UD
UT WOS:000331924100014
DA 2018-10-19
ER

PT J
AU Jing, Y
   Kunze, A
   Svedhem, S
AF Jing, Yujia
   Kunze, Angelika
   Svedhem, Sofia
TI Phase Transition-Controlled Flip-Flop in Asymmetric Lipid Membranes
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID SUPPORTED PHOSPHOLIPID-BILAYERS; PHOSPHATIDYL SERINE; TITANIUM-DIOXIDE;
   SPECTROSCOPY; KINETICS; ADSORPTION; MOVEMENT; SURFACE; LAYERS; CELLS
AB Lipid membrane asymmetry is of fundamental importance for biological systems and also provides an attractive means for molecular control over biomaterial surface properties (including drug carriers). In particular, temperature-dependent changes of surface properties can be achieved by taking advantage of distinct phase transitions in lipid membrane coatings where lipids exchange (flip-flop) between leaflets. In this study, temperature is used to control flip-flop of lipids in asymmetric lipid membranes on planar solid supports, where the two leaflets of the lipid membrane are in different phase states. More specifically, the lower leaflet is prepared from a supported lipid membrane composed of a high T-m lipid mixture of phosphocholine (PC), phosphatidylserine (PS), and a bioactive lipid on TiO2, followed by selective removal of the top leaflet by detergent. Next, at a lower temperature, where the remaining leaflet is in the gel state, a top leaflet of a different lipid composition and in the fluid phase is formed. Phase transition-induced changes in membrane surface properties following upon temperature-activation of the prepared asymmetric membrane are demonstrated by the detection of biotinylated lipids, which were initially located (thus "hidden") in the lower-gel phase leaflet, at the surface of the top leaflet. These processes were monitored in real-time by the quartz crystal microbalance with dissipation (QCM-D) and the dual polarization interferometry (DPI) techniques, allowing modeling of the mass and the anisotropic property of the lipid structures in different phase states.
C1 [Jing, Yujia; Kunze, Angelika; Svedhem, Sofia] Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
RP Svedhem, S (reprint author), Chalmers, Dept Appl Phys, SE-41296 Gothenburg, Sweden.
EM sofia.svedhem@chalmers.se
FU Swedish Research Council Formas (Nanosphere); Swedish Research Council
   (VR) through the Linneaus program SUPRA; Chinese Scholarship Council
   (CSC)
FX We gratefully acknowledge financial support for this project from the
   Swedish Research Council Formas (Nanosphere), the Swedish Research
   Council (VR) through the Linneaus program SUPRA, and the Chinese
   Scholarship Council (CSC). We would also like to thank Dr. Marcus Swann
   (Biolin Scientific/Farfield group, London, U.K.) for the insightful
   discussions about the DPI data analysis and interpretation, and Gabriel
   Ohlsson, Mokhtar Mapar, and Henrik Frederiksen for their help with the
   modification of the sensors.
CR Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200
   DEFEIJTER JA, 1978, J COLLOID INTERF SCI, V64, P258, DOI 10.1016/0021-9797(78)90361-2
   Edvardsson M., 2008, ANAL CHEM, V81, P349
   Frost R, 2012, NANO LETT, V12, P3356, DOI 10.1021/nl203107k
   Gerelli Y, 2013, LANGMUIR, V29, P12762, DOI 10.1021/la402708u
   Horvath R, 2003, BIOSENS BIOELECTRON, V18, P415, DOI 10.1016/S0956-5663(02)00154-9
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kleinfeld AM, 1997, BIOCHEMISTRY-US, V36, P14146, DOI 10.1021/bi971440e
   Kunze A, 2009, J AM CHEM SOC, V131, P2450, DOI 10.1021/ja809608n
   Lin WC, 2006, BIOPHYS J, V90, P228, DOI 10.1529/biophysj.105.067066
   Liu J, 2004, J AM CHEM SOC, V126, P8376, DOI 10.1021/ja048245p
   Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s
   Ohlsson G, 2011, SOFT MATTER, V7, P10749, DOI 10.1039/c1sm05923h
   PACE RJ, 1982, J CHEM PHYS, V76, P4241, DOI 10.1063/1.443501
   Richter R. P., 2006, LANGMUIR, V22, P3497
   Richter RP, 2005, BIOPHYS J, V89, P3372, DOI 10.1529/biophysj.105.064337
   Rossetti FF, 2006, LANGMUIR, V22, P3467, DOI 10.1021/la053000r
   Rossetti FF, 2005, LANGMUIR, V21, P6443, DOI 10.1021/la0509100
   ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030
   Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43
   Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sharom FJ, 2011, IUBMB LIFE, V63, P736, DOI 10.1002/iub.515
   Sinn CG, 2006, COLLOID SURFACE A, V282, P410, DOI 10.1016/j.colsurfa.2005.10.014
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   Voros J, 2004, BIOPHYS J, V87, P553, DOI 10.1529/biophysj.103.030072
   Wacklin HP, 2011, LANGMUIR, V27, P7698, DOI 10.1021/la200683e
   Williamson P, 2002, BBA-MOL CELL BIOL L, V1585, P53, DOI 10.1016/S1388-1981(02)00324-4
   ZWAAL RFA, 1989, MOL CELL BIOCHEM, V91, P23, DOI 10.1007/BF00228075
NR 29
TC 9
Z9 9
U1 3
U2 39
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAR 6
PY 2014
VL 118
IS 9
BP 2389
EP 2395
DI 10.1021/jp406502b
PG 7
WC Chemistry, Physical
SC Chemistry
GA AC8AU
UT WOS:000332756200010
PM 24364807
DA 2018-10-19
ER

PT J
AU Correia, SI
   Pereira, H
   Silva-Correia, J
   Van Dijk, CN
   Espregueira-Mendes, J
   Oliveira, JM
   Reis, RL
AF Correia, S. I.
   Pereira, H.
   Silva-Correia, J.
   Van Dijk, C. N.
   Espregueira-Mendes, J.
   Oliveira, J. M.
   Reis, R. L.
TI Current concepts: tissue engineering and regenerative medicine
   applications in the ankle joint
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Review
DE ankle; biomaterials; osteochondral lesions; regenerative medicine;
   scaffold; tissue engineering
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS;
   PLATELET-RICH PLASMA; MARROW STROMAL CELLS; ECTOPIC BONE-FORMATION;
   CARBOXYMETHYLCHITOSAN/POLY(AMIDOAMINE) DENDRIMER NANOPARTICLES;
   INTERVERTEBRAL DISC REGENERATION; HUMAN ARTICULAR CHONDROCYTES;
   OSTEOCHONDRAL TALAR LESIONS; CALCIUM-PHOSPHATE CERAMICS
AB Tissue engineering and regenerative medicine (TERM) has caused a revolution in present and future trends of medicine and surgery. In different tissues, advanced TERM approaches bring new therapeutic possibilities in general population as well as in young patients and high-level athletes, improving restoration of biological functions and rehabilitation. The mainstream components required to obtain a functional regeneration of tissues may include biodegradable scaffolds, drugs or growth factors and different cell types (either autologous or heterologous) that can be cultured in bioreactor systems (in vitro) prior to implantation into the patient. Particularly in the ankle, which is subject to many different injuries (e. g. acute, chronic, traumatic and degenerative), there is still no definitive and feasible answer to 'conventional' methods. This review aims to provide current concepts of TERM applications to ankle injuries under preclinical and/or clinical research applied to skin, tendon, bone and cartilage problems. A particular attention has been given to biomaterial design and scaffold processing with potential use in osteochondral ankle lesions.
C1 [Correia, S. I.; Pereira, H.; Silva-Correia, J.; Espregueira-Mendes, J.; Oliveira, J. M.; Reis, R. L.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Group Biomat Biodegradables & Biomimet 3B, P-4806909 Taipas, Guimaraes, Portugal.
   [Correia, S. I.; Pereira, H.; Silva-Correia, J.; Espregueira-Mendes, J.; Oliveira, J. M.; Reis, R. L.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
   [Pereira, H.; Van Dijk, C. N.; Espregueira-Mendes, J.] Univ Minho, Saude Atlantica Sports Ctr FC Porto Stadium, Oporto, Portugal.
   [Pereira, H.; Van Dijk, C. N.; Espregueira-Mendes, J.] Univ Porto, Res Ctr, P-4100 Oporto, Portugal.
   [Pereira, H.] Ctr Hosp Povoa Varzim, Dept Orthoped, Vila Do Conde, Portugal.
   [Van Dijk, C. N.] Amsterdam Med Ctr, Dept Orthoped, Amsterdam, Netherlands.
RP Oliveira, JM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Group Biomat Biodegradables & Biomimet 3B, AvePark, P-4806909 Taipas, Guimaraes, Portugal.
EM miguel.oliveira@dep.uminho.pt
RI Espregueira-Mendes, Joao/N-4752-2015; Reis, Rui L./A-8938-2008;
   Silva-Correia, Joana/D-4980-2012; Oliveira, Joaquim Miguel/H-8636-2012;
   Group, 3Bs/E-4374-2012
OI Espregueira-Mendes, Joao/0000-0001-7429-4900; Reis, Rui
   L./0000-0002-4295-6129; Silva-Correia, Joana/0000-0003-1312-3109;
   Oliveira, Joaquim Miguel/0000-0001-7052-8837; Group,
   3Bs/0000-0002-5195-3456
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM-BPC/115977/2009]
FX The authors acknowledge the Portuguese Foundation for Science and
   Technology (FCT) through the POCTI and FEDER programmes, including
   Project OsteoCart (grant no. PTDC/CTM-BPC/115977/2009) for providing
   funds.
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   Abukawa H, 2004, J ORAL MAXIL SURG, V62, P601, DOI 10.1016/j.joms.2003.11.010
   Agung M, 2004, ARTHROSCOPY, V20, P1075, DOI 10.1016/j.arthro.2004.04.039
   Agung M, 2006, KNEE SURG SPORT TR A, V14, P1307, DOI 10.1007/s00167-006-0124-8
   Anderson DD, 2010, J BONE JOINT SURG AM, V92A, P1490, DOI 10.2106/JBJS.I.00431
   Arnoczky SP, 2011, OPER TECHN SPORT MED, V19, P142, DOI 10.1053/j.otsm.2010.12.001
   Atesok K, 2012, KNEE SURG SPORT TR A, V20, P1366, DOI 10.1007/s00167-012-1940-7
   Augst A, 2008, J R SOC INTERFACE, V5, P929, DOI 10.1098/rsif.2007.1302
   Aurich M, 2011, AM J SPORT MED, V39, P311, DOI 10.1177/0363546510381575
   Badylak SF, 2010, P NATL ACAD SCI USA, V107, P3285, DOI 10.1073/pnas.1000256107
   Balash P, 2010, CARTILAGE, V1, P270, DOI 10.1177/1947603510367913
   Bandyopadhyay A, 2013, BIOCHEM PHARMACOL, V85, P857, DOI 10.1016/j.bcp.2013.01.004
   BATTAGLIA M, 2011, EUR J RADIOL, V80, P132, DOI DOI 10.1016/J.EJRAD.2010.08.008
   Becher C, 2008, KNEE SURG SPORT TR A, V16, P56, DOI 10.1007/s00167-007-0416-7
   Bernstein A, 2013, ACTA BIOMATER, V9, P7490, DOI 10.1016/j.actbio.2013.03.021
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Bitton R, 2009, AM J MANAG CARE, V15, P230
   Brigido Stephen A, 2006, Int Wound J, V3, P181, DOI 10.1111/j.1742-481X.2006.00209.x
   Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Candrian C, 2010, OSTEOARTHR CARTILAGE, V18, P1067, DOI 10.1016/j.joca.2010.04.010
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   Carmont MR, 2009, ARTHROSCOPY, V25, P810, DOI 10.1016/j.arthro.2009.01.023
   Centeno CJ, 2010, CURR STEM CELL RES T, V5, P81, DOI 10.2174/157488810790442796
   Chang J, 2012, J HAND SURG-AM, V37A, P552, DOI 10.1016/j.jhsa.2011.12.028
   Che JH, 2010, KNEE SURG SPORT TR A, V18, P496, DOI 10.1007/s00167-009-0962-2
   Chen HM, 2011, AM J SPORT MED, V39, P1731, DOI 10.1177/0363546511403282
   CHEN K, J TISSUE ENG REGEN M, DOI DOI 10.1002/TERM.1708
   Chen YT, 2011, TISSUE ENG PART C-ME, V17, P1211, DOI 10.1089/ten.tec.2011.0092
   Chou LB, 2007, FOOT ANKLE INT, V28, P199, DOI 10.3113/FAI.2007.0199
   Christensen BB, 2012, KNEE SURG SPORT TR A, V20, P1192, DOI 10.1007/s00167-011-1692-9
   Chung R, 2011, STEM CELLS INT, V2011, DOI DOI 10.4061/2011/570125
   CLAR C, 2005, HEALTH TECHNOL ASSES, V9, P1
   Cohen S, 2010, TISSUE ENG PT A, V16, P3119, DOI [10.1089/ten.tea.2009.0716, 10.1089/ten.TEA.2009.0716]
   Custers RJH, 2009, J BONE JOINT SURG AM, V91A, P900, DOI 10.2106/JBJS.H.00668
   de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877
   de Mos M, 2008, AM J SPORT MED, V36, P1171, DOI 10.1177/0363546508314430
   De Napoli IE, 2011, J MEMBRANE SCI, V379, P341, DOI 10.1016/j.memsci.2011.06.001
   DeCarbo William T, 2009, Foot Ankle Spec, V2, P299, DOI 10.1177/1938640009354041
   DeChellis DM, 2011, TECH REG ANESTH PAIN, V15, P74, DOI DOI 10.1053/J.TRAP.2011.05.002
   Deplaine H, 2013, J BIOMED MATER RES B, V101B, P173, DOI 10.1002/jbm.b.32831
   Dhollander AAM, 2011, KNEE SURG SPORT TR A, V19, P536, DOI 10.1007/s00167-010-1337-4
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Doral MN, 2012, KNEE SURG SPORT TR A, V20, P1398, DOI 10.1007/s00167-011-1856-7
   Duan PG, 2014, J BIOMED MATER RES A, V102, P180, DOI 10.1002/jbm.a.34683
   Ducheyne P, 2012, NAT MATER, V11, P652, DOI 10.1038/nmat3392
   Ebinesan AD, 2008, DISABIL REHABIL, V30, P1721, DOI 10.1080/09638280701786815
   El-Amin SF, 2010, FOOT ANKLE CLIN, V15, P543, DOI 10.1016/j.fcl.2010.08.001
   ENEA D, 2012, KNEE SURG SPORT TR A, V11, P1783, DOI DOI 10.1007/S00167-012-2102-7
   Engebretsen L, 2010, BRIT J SPORT MED, V44, P1072, DOI 10.1136/bjsm.2010.079822
   Espregueira-Mendes J, 2012, KNEE SURG SPORT TR A, V20, P1136, DOI 10.1007/s00167-012-1910-0
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Florczyk SJ, 2013, J BIOMED MATER RES A, V101, P2974, DOI 10.1002/jbm.a.34593
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Giannini S, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.E.00516
   Giannini S, 2008, AM J SPORT MED, V36, P873, DOI 10.1177/0363546507312644
   Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Giza E, 2010, FOOT ANKLE INT, V31, P747, DOI 10.3113/FAI.2010.0747
   Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gotterbarm T, 2006, BIOMATERIALS, V27, P3387, DOI 10.1016/j.biomaterials.2006.01.041
   Gurkan UA, 2012, ADV HEALTHC MATER, V1, P149, DOI 10.1002/adhm.201200011
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Harris JD, 2010, J BONE JOINT SURG AM, V92A, P2220, DOI 10.2106/JBJS.J.00049
   Heijink A, 2012, KNEE SURG SPORT TR A, V20, P423, DOI 10.1007/s00167-011-1818-0
   Hogan MV, 2011, J AM ACAD ORTHOP SUR, V19, P134, DOI 10.5435/00124635-201103000-00002
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Huang X, 2007, BIOMATERIALS, V28, P3091, DOI 10.1016/j.biomaterials.2007.03.017
   Hui JH, 2013, CLIN ORTHOP RELAT R, V471, P1174, DOI 10.1007/s11999-012-2487-0
   Jeong CG, 2012, J BIOMED MATER RES A, V100A, P2088, DOI 10.1002/jbm.a.33249
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Johnson B, 2013, FOOT ANKLE CLIN, V18, P135, DOI 10.1016/j.fcl.2012.12.008
   Kanitkar Medha, 2011, Open Orthop J, V5 Suppl 2, P271, DOI 10.2174/1874325001105010271
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Khaled E G, 2011, Open Orthop J, V5 Suppl 2, P289, DOI 10.2174/1874325001105010289
   Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073
   Kleinschmidt K, 2013, BIOMATERIALS, V34, P5926, DOI 10.1016/j.biomaterials.2013.04.029
   Koestler W, 2008, COMPUT AIDED SURG, V13, P207, DOI 10.1080/10929080802210814
   Kokemueller H, 2010, INT J ORAL MAX SURG, V39, P379, DOI 10.1016/j.ijom.2010.01.010
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kon E, 2014, KNEE SURG SPORT TR A, V22, P1452, DOI 10.1007/s00167-013-2467-2
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2011, AM J SPORT MED, V39, P1668, DOI 10.1177/0363546511404675
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kreuz PC, 2011, AM J SPORT MED, V39, P1697, DOI 10.1177/0363546511403279
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   Kubota K, 2002, BONE, V31, P465, DOI 10.1016/S8756-3282(02)00852-9
   Kurtz CA, 1999, AM J SPORT MED, V27, P363, DOI 10.1177/03635465990270031701
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531
   Lim CT, 2013, TISSUE ENG PT A, V19, P1852, DOI [10.1089/ten.tea.2012.0621, 10.1089/ten.TEA.2012.0621]
   Lloyd J, 2006, FOOT ANKLE INT, V27, P793, DOI 10.1177/107110070602701006
   Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2
   Longo UG, 2009, BRIT J SPORT MED, V43, P603, DOI 10.1136/bjsm.2007.039016
   Longo UG, 2012, STEM CELLS INT, V2012, DOI DOI 10.1155/2012/517165
   Longo UG, 2011, BRIT MED BULL, V98, P31, DOI 10.1093/bmb/ldq030
   Longo UG, 2008, DISABIL REHABIL, V30, P1602, DOI 10.1080/09638280701786120
   Lopez-Vidriero E, 2010, ARTHROSCOPY, V26, P269, DOI 10.1016/j.arthro.2009.11.015
   Luyten FP, 2012, BONE, V51, P289, DOI 10.1016/j.bone.2011.10.007
   Maffulli Nicola, 2007, Foot Ankle Clin, V12, P583, DOI 10.1016/j.fcl.2007.07.007
   Mankani MH, 2006, AM J PATHOL, V168, P542, DOI 10.2353/ajpath.2006.050407
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Martel-Pelletier J, 2012, BONE, V51, P297, DOI 10.1016/j.bone.2011.10.008
   Mayr HO, 2013, ACTA BIOMATER, V9, P4845, DOI 10.1016/j.actbio.2012.07.040
   Miljkovic ND, 2009, KNEE SURG SPORT TR A, V17, P1326, DOI 10.1007/s00167-009-0881-2
   Moshiri A, 2013, J AM COLL SURGEONS, V217, P421, DOI 10.1016/j.jamcollsurg.2013.03.025
   Muramatsu K, 2003, ACTA ORTHOP SCAND, V74, P95, DOI 10.1080/00016470310013734
   Nagata M, 2012, BONE, V50, P1123, DOI 10.1016/j.bone.2012.02.631
   Nagura I, 2007, J BONE JOINT SURG BR, V89B, P258, DOI 10.1302/0301-620X.89B2.17754
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nordsletten L, 2006, CURR MED RES OPIN, V22, pS13, DOI 10.1185/030079906X80585
   O'Loughlin PF, 2010, AM J SPORT MED, V38, P392, DOI 10.1177/0363546509336336
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   Oliveira JM, 2010, BONE, V46, P1424, DOI 10.1016/j.bone.2010.02.007
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI 10.1089/ten.TEA.2009.0117
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oliveira JM, 2011, NANOMED-NANOTECHNOL, V7, P914, DOI 10.1016/j.nano.2011.03.002
   Oliveira JM, 2009, BIOMATERIALS, V30, P804, DOI 10.1016/j.biomaterials.2008.10.024
   Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823
   Orth P, 2011, KNEE SURG SPORT TR A, V19, P2119, DOI 10.1007/s00167-011-1448-6
   Paxton JZ, 2009, TISSUE ENG PT A, V15, P1201, DOI 10.1089/ten.tea.2008.0105
   Pereira DR, 2011, TISSUE ENG PART C-ME, V17, P961, DOI [10.1089/ten.tec.2011.0115, 10.1089/ten.TEC.2011.0115]
   Qi YY, 2014, KNEE SURG SPORT TR A, V22, P1424, DOI 10.1007/s00167-012-2256-3
   Qi YY, 2012, MOL BIOL REP, V39, P5683, DOI 10.1007/s11033-011-1376-z
   Qiu YS, 2003, OSTEOARTHR CARTILAGE, V11, P810, DOI 10.1016/S1063-4584(03)00164-X
   RADIN EL, 1984, SEMIN ARTHRITIS RHEU, V13, P293, DOI 10.1016/0049-0172(84)90031-3
   Ramanujam Crystal L, 2010, Clin Podiatr Med Surg, V27, P327, DOI 10.1016/j.cpm.2009.12.004
   Reddy S, 2007, AM J SPORT MED, V35, P80, DOI 10.1177/0363546506290986
   Reverchon Ernesto, 2012, Muscles Ligaments Tendons J, V2, P181
   Reyes R, 2014, J TISSUE ENG REGEN M, V8, P521, DOI 10.1002/term.1549
   Reyes R, 2014, J BIOMED MATER RES A, V102, P1110, DOI 10.1002/jbma.34769
   Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013
   Rush Shannon M, 2010, Foot Ankle Spec, V3, P140, DOI 10.1177/1938640010369638
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1679, DOI 10.1016/j.addr.2003.08.007
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Savva N, 2007, FOOT ANKLE INT, V28, P669, DOI 10.3113/FAI.2007.0669
   Schachter AK, 2005, J AM ACAD ORTHOP SUR, V13, P152, DOI 10.5435/00124635-200505000-00002
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   SCHLIEPHAKE H, 2013, CLIN IMPLANT DENT R, DOI DOI 10.1111/CID.12114
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Scholz B, 2010, EUR CELLS MATER, V20, P24
   Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850
   Shearer C, 2002, FOOT ANKLE INT, V23, P651, DOI 10.1177/107110070202300712
   Sheth U, 2012, J BONE JOINT SURG AM, V94A, P298, DOI 10.2106/JBJS.K.00154
   Silva-Correia J, 2012, TISSUE ENG PT A, V18, P1203, DOI [10.1089/ten.tea.2011.0632, 10.1089/ten.TEA.2011.0632]
   SILVACORREIA J, 2011, J TISSUE ENG REGEN M, V5, P97, DOI DOI 10.1002/TERM.363
   SILVACORREIA J, 2011, Patent No. 2011119059
   Smith L, 2012, CONNECT TISSUE RES, V53, P95, DOI 10.3109/03008207.2011.650804
   Soomekh DJ, 2011, CLIN PODIATR MED SUR, V28, P155, DOI 10.1016/j.cpm.2010.09.001
   Sotoudeh A, 2013, ACTA CIR BRAS, V28, P340, DOI 10.1590/S0102-86502013000500004
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Steinert AF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2195
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   VALDERRABANO V, 2009, AM J SPORT MED, V37, P105, DOI DOI 10.1177/0363546509351481
   van Bergen CJA, 2011, KNEE SURG SPORT TR A, V19, P999, DOI 10.1007/s00167-011-1465-5
   van Dijk CN, 2011, KNEE SURG SPORT TR A, V19, P835, DOI 10.1007/s00167-010-1374-z
   van Dijk CN, 2008, J AM ACAD ORTHOP SUR, V16, P635
   van Dijk CN, 2010, KNEE SURG SPORT TR A, V18, P570, DOI 10.1007/s00167-010-1064-x
   van Sterkenburg MN, 2011, KNEE SURG SPORT TR A, V19, P513, DOI 10.1007/s00167-011-1415-2
   Vasiliadis HS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003323.pub3
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Wang CC, 2011, BIOMATERIALS, V32, P7118, DOI 10.1016/j.biomaterials.2011.06.018
   Wang H, 2013, ACTA BIOMATER, V9, P8413, DOI 10.1016/j.actbio.2013.05.026
   Weil Lowell Jr, 2011, Foot Ankle Spec, V4, P249, DOI 10.1177/1938640011415373
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Winters Christopher L, 2008, Adv Skin Wound Care, V21, P375, DOI 10.1097/01.ASW.0000323532.98003.26
   Yamada N, 2008, J ARTIF ORGANS, V11, P100, DOI 10.1007/s10047-008-0406-7
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yin Z, 2010, EXPERT OPIN BIOL TH, V10, P689, DOI 10.1517/14712591003769824
   Zengerink M, 2012, KNEE SURG SPORT TR A, V20, P1420, DOI 10.1007/s00167-012-2063-x
   Zengerink M, 2010, KNEE SURG SPORT TR A, V18, P238, DOI 10.1007/s00167-009-0942-6
   Zhang XZ, 2012, J SHOULDER ELB SURG, V21, P266, DOI 10.1016/j.jse.2011.11.016
   Zheng MH, 2007, TISSUE ENG, V13, P737, DOI 10.1089/ten.2006.0246
NR 183
TC 26
Z9 27
U1 2
U2 62
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAR 6
PY 2014
VL 11
IS 92
AR 20130784
DI 10.1098/rsif.2013.0784
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AC2ZL
UT WOS:000332384700001
PM 24352667
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Ashokkumar, S
   Ravi, S
   Kathiravan, V
   Velmurugan, S
AF Ashokkumar, S.
   Ravi, S.
   Kathiravan, V.
   Velmurugan, S.
TI Synthesis, characterization and catalytic activity of silver
   nanoparticles using Tribulus terrestris leaf extract
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Silver nanoparticles; Tribulus terrestris; Catalytic activity; Methylene
   blue
ID METAL NANOPARTICLES; MICROORGANISMS
AB Biomediated silver nanoparticles were synthesized with the aid of an eco-friendly biomaterial, namely, aqueous Tribulus terrestris extract. Silver nanoparticles were synthesized using a rapid, single step, and completely green biosynthetic method employing aqueous T. terrestris leaf extracts as both the reducing and capping agent. Silver ions were rapidly reduced by aqueous T. terrestris leaf extracts, leading to the formation of highly crystalline silver nanoparticles. An attempt has been made and formation of the silver nanoparticles was verified by surface plasmon spectra using an UV-vis (Ultra violet), spectrophotometer. Morphology and crystalline structure of the prepared silver nanoparticles were characterized by TEM (Transmission Electron Microscope) and XRD (X-ray Diffraction), techniques, respectively. FT-IR (Fourier Transform Infrared), analysis suggests that the obtained silver nanoparticles might be stabilized through the interactions of carboxylic groups, carbonyl groups and the flavonoids present in the T. terrestris extract. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ashokkumar, S.; Kathiravan, V.] Annamalai Univ, Dept Phys, Annamalainagar 608002, Tamil Nadu, India.
   [Ravi, S.; Velmurugan, S.] Annamalai Univ, Dept Engg Phys, Annamalainagar 608002, Tamil Nadu, India.
RP Ravi, S (reprint author), Annamalai Univ, Dept Engg Phys, Annamalainagar 608002, Tamil Nadu, India.
EM ambedraviphy@gmail.com
CR Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Krumov N, 2009, CHEM ENG TECHNOL, V32, P1026, DOI 10.1002/ceat.200900046
   Li HM, 2009, FOOD CHEM, V114, P547, DOI 10.1016/j.foodchem.2008.09.085
   Mandal D, 2006, APPL MICROBIOL BIOT, V69, P485, DOI 10.1007/s00253-005-0179-3
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Park Hae-Jun, 2006, The Plant Pathology Journal, V22, P295
   Subash B, 2013, MATER RES BULL, V48, P63, DOI 10.1016/j.materresbull.2012.10.010
   Subash B, 2012, CATAL SCI TECHNOL, V2, P2319, DOI 10.1039/c2cy20254a
NR 9
TC 47
Z9 49
U1 2
U2 25
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD MAR 5
PY 2014
VL 121
BP 88
EP 93
DI 10.1016/j.saa.2013.10.073
PG 6
WC Spectroscopy
SC Spectroscopy
GA AA8JF
UT WOS:000331341100012
PM 24231743
DA 2018-10-19
ER

PT J
AU Sterling, JA
   Guelcher, SA
AF Sterling, Julie A.
   Guelcher, Scott A.
TI Biomaterial Scaffolds for Treating Osteoporotic Bone
SO CURRENT OSTEOPOROSIS REPORTS
LA English
DT Article
DE Scaffold; Bone graft; Osteoporosis; Fracture; Cancer-induced bone
   disease
ID PLATELET-RICH PLASMA; MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2;
   DISTAL RADIUS; MANDIBULAR RECONSTRUCTION; FLAP RECONSTRUCTION;
   CALCIUM-PHOSPHATE; CANCER-PATIENTS; GENE-THERAPY; ORAL-CANCER
AB Healing fractures resulting from osteoporosis or cancer remains a significant clinical challenge. In these populations, healing is often impaired not only due to age and disease, but also by other therapeutic interventions such as radiation, steroids, and chemotherapy. Despite substantial improvements in the treatment of osteoporosis over the last few decades, osteoporotic fractures are still a major clinical challenge in the elderly population due to impaired healing. Similar fractures with impaired healing are also prevalent in cancer patients, especially those with tumor growing in bone. Treatment options for cancer patients are further complicated by the fact that bone anabolic therapies are contraindicated in patients with tumors. Therefore, many patients undergo surgery to repair the fracture, and bone grafts are often used to stabilize orthopedic implants and provide a scaffold for ingrowth of new bone. Both synthetic and naturally occurring biomaterials have been investigated as bone grafts for repair of osteoporotic fractures, including calcium phosphate bone cements, resorbable polymers, and allograft or autograft bone. In order to re-establish normal bone repair, bone grafts have been augmented with anabolic agents, such as mesenchymal stem cells or recombinant human bone morphogenetic protein-2. These developing approaches to bone grafting are anticipated to improve the clinical management of osteoporotic and cancer-induced fractures.
C1 [Sterling, Julie A.] Tennessee Valley Healthcare Syst VISN 9, Dept Vet Affairs, Nashville, TN USA.
   [Sterling, Julie A.] Vanderbilt Univ, Dept Med Clin Pharmacol, Nashville, TN 37235 USA.
   [Sterling, Julie A.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA.
   [Sterling, Julie A.; Guelcher, Scott A.] Vanderbilt Univ, Ctr Bone Biol, Nashville, TN 37235 USA.
   [Guelcher, Scott A.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA.
RP Guelcher, SA (reprint author), Vanderbilt Univ, Dept Chem & Biomol Engn, 2400 Highland Ave,107 Olin Hall, Nashville, TN 37235 USA.
EM julie.sterling@vanderbilt.edu; scott.guelcher@vanderbilt.edu
FU VA; NIH/NCI; NIH/NIAMS
FX JA Sterling has received research support from the VA and NIH/NCI. SA
   Guelcher has had a consultancy with Medtronic and received research
   support from NIH/NCI and NIH/NIAMS.
CR Aboulafia AJ, 2007, SEMIN ONCOL, V34, P206, DOI 10.1053/seminoncol.2007.03.002
   Alam DS, 2009, OTOLARYNG HEAD NECK, V141, P196, DOI 10.1016/j.otohns.2009.03.013
   Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23
   Anne-Gaelle B, 2011, ORAL ONCOL, V47, P1099, DOI 10.1016/j.oraloncology.2011.07.016
   Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   BARRIOS C, 1993, J ORTHOP TRAUMA, V7, P438, DOI 10.1097/00005131-199310000-00006
   Benisch P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045142
   Biau DJ, 2009, J BONE JOINT SURG AM, V91A, P142, DOI 10.2106/JBJS.G.01061
   Boerckel JD, 2011, BIOMATERIALS, V32, P5241, DOI 10.1016/j.biomaterials.2011.03.063
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Brown KV, 2011, TISSUE ENG PT A, V17, P1735, DOI 10.1089/ten.tea.2010.0446
   Cameron K, 2013, J BIOMED MATER RES A, V101, P13, DOI 10.1002/jbm.a.34261
   Cheng N, 2013, J MATER SCI-MATER M, V24, P1963, DOI 10.1007/s10856-013-4945-y
   Cleary J, 2013, BREAST, V22, P616, DOI 10.1016/j.breast.2013.07.052
   Coleman RE, 2012, CURR OPIN SUPPORT PA, V6, P322, DOI 10.1097/SPC.0b013e32835689cd
   Coleman RE, 2010, CANCER TREAT REV, V36, P615, DOI 10.1016/j.ctrv.2010.04.003
   Cornell Charles N, 2003, J Am Acad Orthop Surg, V11, P109
   Cornell CN, 2003, CLIN GERIATR MED, V19, P433, DOI 10.1016/S0749-0690(02)00076-9
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Edwards Claire M, 2008, Int J Med Sci, V5, P263
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS120, DOI 10.1007/s00198-004-1817-9
   Gadre PK, 2011, J CRANIOFAC SURG, V22, P1727, DOI 10.1097/SCS.0b013e31822e633b
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P42
   Guerra MFM, 2003, J ORAL MAXIL SURG, V61, P1289, DOI 10.1016/S0278-2391(03)00730-4
   Hadji P, 2012, CANCER TREAT REV, V38, P798, DOI 10.1016/j.ctrv.2012.02.008
   Hadji P, 2013, INT J CLIN PHARM TH, V51, P868, DOI 10.5414/CP201931
   Hayden RE, 2012, CURR OPIN OTOLARYNGO, V20, P231, DOI 10.1097/MOO.0b013e328355d0f3
   Jacobson AS, 2013, INT J ORAL MAX SURG, V42, P1121, DOI 10.1016/j.ijom.2013.03.022
   Jupiter JB, 1997, J ORTHOP TRAUMA, V11, P110, DOI 10.1097/00005131-199702000-00008
   Kalavrezos ND, 1996, INT J ORAL MAX SURG, V25, P439, DOI 10.1016/S0901-5027(96)80079-8
   Kaner T, 2012, ORTHOP REV, V4, P46, DOI 10.4081/or.2012.e10
   Kim WY, 2001, INT ORTHOP, V25, P360, DOI 10.1007/s002640100287
   Kleeff J, 1999, GASTROENTEROLOGY, V116, P1202, DOI 10.1016/S0016-5085(99)70024-7
   Kokorina NA, 2012, LARYNGOSCOPE, V122, P95, DOI 10.1002/lary.22345
   Kokorina NA, 2011, LARYNGOSCOPE, V121, P1876, DOI 10.1002/lary.21914
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Laitinen M, 1997, INT ORTHOP, V21, P188, DOI 10.1007/s002640050148
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Legname M, 2011, ORTHOP TRAUMATOL-SUR, V97, P762, DOI 10.1016/j.otsr.2011.06.010
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   Liu HY, 2011, BIOMATERIALS, V32, P6773, DOI 10.1016/j.biomaterials.2011.05.080
   Liu YH, 2013, BIOMATERIALS, V34, P9998, DOI 10.1016/j.biomaterials.2013.09.040
   Matsuo A, 2011, J CRANIO MAXILL SURG, V39, P628, DOI 10.1016/j.jcms.2011.01.003
   Moroni A, 2009, J ORTHOP TRAUMA, V23, P422, DOI 10.1097/BOT.0b013e3181771426
   Namdari S, 2012, J SHOULDER ELB SURG, V21, P1787, DOI 10.1016/j.jse.2012.04.003
   Namkung-Matthai H, 2001, BONE, V28, P80, DOI 10.1016/S8756-3282(00)00414-2
   Phillips Frank M, 2006, Spine J, V6, P500, DOI 10.1016/j.spinee.2006.01.014
   Ramachandra ML, 2013, PRIMER METABOLIC BON, P527
   Rao LP, 2012, SURG ONCOL, V21, P109, DOI 10.1016/j.suronc.2011.06.003
   Reid IR., 2013, PRIMER METABOLIC BON, P357
   Rey-Rico A, 2011, EUR CELLS MATER, V21, P317, DOI 10.22203/eCM.v021a24
   Riedel B, 2012, ORTHOPEDICS, V35, pE259, DOI 10.3928/01477447-20120123-20
   Robinson CM, 2003, J BONE JOINT SURG AM, V85A, P1647, DOI 10.2106/00004623-200309000-00001
   Rodriguez JP, 2000, J CELL BIOCHEM, V79, P557, DOI 10.1002/1097-4644(20001215)79:4<557::AID-JCB40>3.0.CO;2-H
   Rodriguez JP, 1999, J CELL BIOCHEM, V75, P414, DOI 10.1002/(SICI)1097-4644(19991201)75:3<414::AID-JCB7>3.3.CO;2-3
   Simman R, 2008, ANN PLAS SURG, V61, P337, DOI 10.1097/SAP.0b013e318157a185
   Simon EN, 2012, INT J ORAL MAXILLOF, V42, P106
   Smolka K, 2008, ORAL ONCOL, V44, P571, DOI 10.1016/j.oraloncology.2007.07.005
   Tang YC, 2008, CELL BIOL INT, V32, P1150, DOI 10.1016/j.cellbi.2008.06.005
   Tei K, 2004, J ORAL MAXIL SURG, V62, P834, DOI 10.1016/j.joms.2003.09.014
   Tidermark J, 2003, J ORTHOP TRAUMA, V17, P193, DOI 10.1097/00005131-200303000-00007
   Urken ML, 1998, ARCH OTOLARYNGOL, V124, P46, DOI 10.1001/archotol.124.1.46
   Utzschneider S, 2011, INT ORTHOP, V35, P731, DOI 10.1007/s00264-010-1074-9
   Vidyadhara S, 2009, INT ORTHOP, V33, P1009, DOI 10.1007/s00264-008-0596-x
   Wegener B, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-232
   YOSHIKAWA H, 1994, CANCER, V73, P85, DOI 10.1002/1097-0142(19940101)73:1<85::AID-CNCR2820730116>3.0.CO;2-8
   Yu ZR, 2012, INT ORTHOP, V36, P2163, DOI 10.1007/s00264-012-1543-4
   Yue B, 2005, CALCIFIED TISSUE INT, V77, P395, DOI 10.1007/s00223-005-0180-y
   Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021
   Zimmermann R, 2003, ARCH ORTHOP TRAUM SU, V123, P22, DOI 10.1007/s00402-002-0458-8
NR 72
TC 21
Z9 21
U1 3
U2 36
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1544-2241
J9 CURR OSTEOPOROS REP
JI Curr. Osteoporos. Rep.
PD MAR
PY 2014
VL 12
IS 1
BP 48
EP 54
DI 10.1007/s11914-014-0187-2
PG 7
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA AY0IZ
UT WOS:000347281700007
PM 24458428
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Coad, BR
   Kidd, SE
   Ellis, DH
   Griesser, HJ
AF Coad, Bryan R.
   Kidd, Sarah E.
   Ellis, David H.
   Griesser, Hans J.
TI Biomaterials surfaces capable of resisting fungal attachment and biofilm
   formation
SO BIOTECHNOLOGY ADVANCES
LA English
DT Review
DE Review; Antifungal; Surface; Biomaterials; Immobilization; Mycology;
   Yeast; Mold; Fungus; Antimicrobial
ID QUATERNARY AMMONIUM-SALTS; AMPHOTERICIN-B; ANTIMICROBIAL ACTIVITY;
   ANTIBACTERIAL SURFACES; CANDIDA-ALBICANS; POLYMERIC MATERIALS; CATIONIC
   SURFACES; PEPTIDES; COATINGS; CELLS
AB Microbial attachment onto biomedical devices and implants leads to biofilm formation and infection; such biofilms can be bacterial, fungal, or mixed. In the past 15 years, there has been an increasing research effort into antimicrobial surfaces but the great majority of these publications present research on bacteria, with some reports also testing resistance to fungi. Very few studies have focused exclusively on antifungal surfaces. However, with increasing recognition of the importance of fungal infections to human health, particularly related to infections at biomaterials, it would seem that the interest in antifungal surfaces is disproportionately low. In studies of both bacteria and fungi, fungi tend to be the minor focus with hypothesized antibacterial mechanisms of action often generalized to also explain the antifungal effect. Yet bacteria and fungi represent two Distinct biological Domains and possess substantially different cellular physiology and structure. Thus it is questionable whether these generalizations are valid. Here we review the scientific literature focusing on surface coatings prepared with antifungal agents covalently attached to the biomaterial surface. We present a critical analysis of generalizations and their evidence. This review should be of interest to researchers of "antimicrobial" surfaces by addressing specific issues that are key to designing and understanding antifungal biomaterials surfaces and their putative mechanisms of action. (C) 2013 Elsevier Inc All rights reserved.
C1 [Coad, Bryan R.] Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
   [Kidd, Sarah E.] Womens & Childrens Hosp, SA Pathol, Natl Mycol Reference Ctr, Adelaide, SA 5006, Australia.
   [Kidd, Sarah E.; Ellis, David H.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia.
   [Griesser, Hans J.] Univ S Australia, Mawson Inst, Mawson Lakes, SA 5095, Australia.
RP Coad, BR (reprint author), Univ S Australia, Ian Wark Res Inst, Mawson Lakes, SA 5095, Australia.
EM bryan.coad@unisa.edu.au
RI Coad, Bryan/B-4505-2009; Griesser, Hans/E-5628-2011
OI Coad, Bryan/0000-0003-3297-3977; Griesser, Hans/0000-0003-1072-7863;
   Kidd, Sarah/0000-0002-5957-4178
CR Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Barratt G, 2007, INT J NANOMED, V2, P301
   BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511
   BEGGS WH, 1994, ANTIMICROB AGENTS CH, V38, P363, DOI 10.1128/AAC.38.2.363
   Benincasa M, 2011, ACS NANO, V5, P199, DOI 10.1021/nn1023522
   BRAJTBURG J, 1990, ANTIMICROB AGENTS CH, V34, P183, DOI 10.1128/AAC.34.2.183
   BRAJTBURG J, 1985, ANTIMICROB AGENTS CH, V27, P172, DOI 10.1128/AAC.27.2.172
   Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Cuellar-Cruz M, 2012, EUR J CLIN MICROBIOL, V31, P2513, DOI 10.1007/s10096-012-1634-6
   Dai TH, 2011, EXPERT REV ANTI-INFE, V9, P857, DOI [10.1586/eri.11.59, 10.1586/ERI.11.59]
   De Prijck K, 2010, MYCOPATHOLOGIA, V170, P213, DOI 10.1007/s11046-010-9316-3
   De Prijck K, 2010, BIOFOULING, V26, P269, DOI 10.1080/08927010903501908
   Dupres V, 2010, ACS NANO, V4, P5498, DOI 10.1021/nn101598v
   ENDO Y, 1987, APPL ENVIRON MICROB, V53, P2050
   Ferreira L, 2009, J MATER CHEM, V19, P7796, DOI 10.1039/b905668h
   Glinel K, 2012, ACTA BIOMATER, V8, P1670, DOI 10.1016/j.actbio.2012.01.011
   Green JBD, 2011, BIOINTERPHASES, V6, pMR13, DOI 10.1116/1.3645195
   Green JBD, 2011, BIOTECHNOL BIOENG, V108, P231, DOI 10.1002/bit.22929
   Hartsel S, 1996, TRENDS PHARMACOL SCI, V17, P445, DOI 10.1016/S0165-6147(96)01012-7
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Ignatova M, 2010, MACROMOL BIOSCI, V10, P944, DOI 10.1002/mabi.200900433
   ISQUITH AJ, 1972, APPL MICROBIOL, V24, P859
   Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103
   Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s
   Klibanov AM, 2007, J MATER CHEM, V17, P2479, DOI 10.1039/b702079a
   Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1111/j.1574-6976.2002.tb00613.x
   Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628
   Kugel A, 2011, PROG ORG COAT, V72, P222, DOI 10.1016/j.porgcoat.2011.07.004
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651
   Lin J, 2003, BIOTECHNOL LETT, V25, P1661, DOI 10.1023/A:1025613814588
   Lipke PN, 1998, J BACTERIOL, V180, P3735
   Marriott D, 2006, INT J INFECT DIS, V10, pS77, DOI 10.1016/S1201-9712(06)80135-9
   Martinez LR, 2010, J INFECT DIS, V201, P1436, DOI 10.1086/651558
   McDonnell G, 1999, CLIN MICROBIOL REV, V12, P147
   Munoz-Bonilla A, 2012, PROG POLYM SCI, V37, P281, DOI 10.1016/j.progpolymsci.2011.08.005
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   MURRAY PR, 1988, J CLIN MICROBIOL, V26, P1884
   NAKAGAWA Y, 1984, APPL ENVIRON MICROB, V47, P513
   Nakagawa Y, 1979, J ANTIBACT ANTIFUNG, V7, P551
   Nikawa H, 2005, DENT MATER J, V24, P570, DOI 10.4012/dmj.24.570
   Onaizi SA, 2011, BIOTECHNOL ADV, V29, P67, DOI 10.1016/j.biotechadv.2010.08.012
   Oosterhof JJH, 2006, APPL ENVIRON MICROB, V72, P3673, DOI 10.1128/AEM.72.5.3673-3677.2006
   Paulo CSO, 2010, BIOMACROMOLECULES, V11, P2810, DOI 10.1021/bm100893r
   PITTMAN CU, 1981, J APPL POLYM SCI, V26, P2403, DOI 10.1002/app.1981.070260726
   Ramage G, 2006, FEMS YEAST RES, V6, P979, DOI 10.1111/j.1567-1364.2006.00117.x
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Roncero C, 2002, CURR GENET, V41, P367, DOI 10.1007/s00294-002-0318-7
   Sedlak M, 2009, MINI-REV MED CHEM, V9, P1306, DOI 10.2174/138955709789878178
   Sheng CQ, 2011, CURR MED CHEM, V18, P733, DOI 10.2174/092986711794480113
   Smits GJ, 1999, CURR OPIN MICROBIOL, V2, P348
   Smits GJ, 2001, MICROBIOL-SGM, V147, P781, DOI 10.1099/00221287-147-4-781
   Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4
   Tiller JC, 2011, ADV POLYM SCI, V240, P193, DOI 10.1007/12_2010_101
   Vasilev K, 2011, PLASMA PROCESS POLYM, V8, P1010, DOI 10.1002/ppap.201100097
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613
   Ye SJ, 2010, LANGMUIR, V26, P16455, DOI 10.1021/la1001539
   Zumbuehl A, 2007, P NATL ACAD SCI USA, V104, P12994, DOI 10.1073/pnas.0705250104
   Zumbuehl A, 2007, ORG BIOMOL CHEM, V5, P1339, DOI 10.1039/b701953j
NR 65
TC 31
Z9 32
U1 5
U2 74
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
EI 1873-1899
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD MAR-APR
PY 2014
VL 32
IS 2
BP 296
EP 307
DI 10.1016/j.biotechadv.2013.10.015
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA AR5RE
UT WOS:000343640400006
PM 24211473
DA 2018-10-19
ER

PT J
AU Ahmad, R
   Mondal, PK
AF Ahmad, Rais
   Mondal, Pijush Kanti
TI BIOREMEDIATION CONTAINING WASTEWATER BY OF P-NITROPHENOL AEROBIC
   GRANULES
SO ENVIRONMENTAL ENGINEERING AND MANAGEMENT JOURNAL
LA English
DT Article
DE aerobic granules; biodegradation; kinetics; p-nitrophenol; SBR
ID SEQUENCING BATCH REACTOR; 4-NITROPHENOL BIODEGRADATION; SLUDGE
AB Aerobic granulation is a novel biotechnique for the treatment of coloured wastewater containing toxic xenobiotics in sequencing batch reactor (SBR). The aerobic granules were investigated as a potential biomaterial for biodegradation of p-nitrophenol. The removal efficiency of p-nitrophenol was 93 % after 65 days of operation at 8 hr hydraulic retention time (HRT). The aerobic granules were cultivated at a p-nitrophenol loading rate of 0.9 kg m(-3) day(-1), with sodium acetate as co-substrate to accelerate the growth of p-nitrophenol degrading biomass. SBR was inoculated with activated sludge that was initially conditioned as a batch culture for a period of 30 days by supplying p-nitrophenol. Optimal pH of 9 was maintained throughout the experimental setup. This study clearly demonstrates that aerobic granules are efficient to degrade up to 300 mgL(-1) of p-nitrophenol to tolerate the toxicity in high-strength wastewater.
C1 [Ahmad, Rais; Mondal, Pijush Kanti] Aligarh Muslim Univ, Fac Engn & Technol, Dept Appl Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India.
RP Ahmad, R (reprint author), Aligarh Muslim Univ, Fac Engn & Technol, Dept Appl Chem, Environm Res Lab, Aligarh 202002, Uttar Pradesh, India.
EM rais45@rediffmail.com
FU UGC (University Grants Commission)
FX The authors are thankful to the Aligarh Muslim University, Aligarh
   (India) for providing research facilities and also thankful to the UGC
   (University Grants Commission) for providing financial assistance to one
   of the author, Pijush Kanti Mondal.
CR Ahmad R, 2010, BIORESOURCE TECHNOL, V101, P3787, DOI 10.1016/j.biortech.2009.12.116
   APHA, 2002, STAND METH EX WAT WA
   *ATSDR, 1992, PUBL HLTH ASS GUID M
   Beun JJ, 1999, WATER RES, V33, P2283, DOI 10.1016/S0043-1354(98)00463-1
   de Kreuk MK, 2006, J ENVIRON ENG-ASCE, V132, P694, DOI 10.1061/(ASCE)0733-9372(2006)132:6(694)
   Gupta Vinod K, 2010, J Colloid Interface Sci, V342, P533, DOI 10.1016/j.jcis.2009.10.074
   IUPAC-NIST, 2006, SOL DAT IUPAC NIST V
   JAIN RK, 1994, APPL ENVIRON MICROB, V60, P3030
   Jiang HL, 2002, LETT APPL MICROBIOL, V35, P439, DOI 10.1046/j.1472-765X.2002.01217.x
   Liu Y, 2004, BIOTECHNOL ADV, V22, P533, DOI 10.1016/j.biotechadv.2004.05.001
   Liu YQ, 2006, APPL MICROBIOL BIOT, V71, P761, DOI 10.1007/s00253-005-0209-1
   Mondal PK, 2010, BIODEGRADATION, V21, P1041, DOI 10.1007/s10532-010-9364-x
   Moy BYP, 2002, LETT APPL MICROBIOL, V34, P407, DOI 10.1046/j.1472-765X.2002.01108.x
   Rogers K. R., 1993, EPA600A93074
   SPAIN JC, 1991, APPL ENVIRON MICROB, V57, P812
   Tomei MC, 2004, WATER RES, V38, P375, DOI 10.1016/j.watres.2003.09.023
   Tomei MC, 2003, WATER RES, V37, P3803, DOI 10.1016/S0043-1354(03)00297-5
NR 17
TC 0
Z9 0
U1 1
U2 6
PU GH ASACHI TECHNICAL UNIV IASI
PI IASI
PA 71 MANGERON BLVD, IASI, 700050, ROMANIA
SN 1582-9596
EI 1843-3707
J9 ENVIRON ENG MANAG J
JI Environ. Eng. Manag. J.
PD MAR
PY 2014
VL 13
IS 3
BP 493
EP 498
DI 10.30638/eemj.2014.052
PG 6
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AN3JD
UT WOS:000340482600001
OA Bronze
DA 2018-10-19
ER

PT J
AU Strang, AC
   Knetsch, MLW
   Idu, MM
   Bisoendial, RJ
   Kramer, G
   Speijer, D
   Koole, LH
   Stroes, ESG
   Rotmans, JI
AF Strang, Aart C.
   Knetsch, Menno L. W.
   Idu, Mirza M.
   Bisoendial, Radjesh J.
   Kramer, Gertjan
   Speijer, Dave
   Koole, Leo. H.
   Stroes, Erik S. G.
   Rotmans, Joris. I.
TI Superior in vivo compatibility of hydrophilic polymer coated prosthetic
   vascular grafts
SO JOURNAL OF VASCULAR ACCESS
LA English
DT Article
DE Endothelialization; Graft; Hydrophilic; Thrombosis; Vascular graft
ID HIGH-DENSITY-LIPOPROTEIN; INFLAMMATORY RESPONSES; THROMBUS FORMATION;
   ENDOTHELIAL-CELLS; BIOMATERIAL SURFACES; SAPHENOUS-VEIN;
   POLYTETRAFLUOROETHYLENE; PROTEIN; BYPASS; ADHESION
AB Purpose: Protein adsorption, cell adhesion and graft patency was compared in hydrophilic versus hydrophobic polymer-coated prosthetic vascular grafts. We hypothesize that in vivo compatibility of hydrophilic polymer-coated prosthetic vascular grafts is superior to in vivo compatibility of hydrophobic grafts.
   Methods: A pairwise side-to-side common carotid artery interposition graft was placed eight female landrace goats ( mean weight 55 kg). Protein adsorption was assessed using Western Blot in two hydrophilic and two hydrophobic grafts harvested after three days. Graft patency was monitored for 28 days in six goats with continuous wave Doppler ultrasonography. Adherence of endothelial cells, leukocytes and platelets was determined with ELISA and compared between the two graft types after 28 days.
   Results: After three days, more ApoA-I, albumin and VEGF and less fibrin adsorbed to hydrophilic grafts. After 28 days, compared to hydrophobic grafts, higher numbers of endothelial cells were present on hydrophilic grafts (P=0.016), and less thrombocytes and leukocytes (P=0.012 and 0.024, respectively). Two out of eight hydrophobic grafts lost patency, while none of the hydrophilic grafts failed (P=0.157).
   Conclusions: Hydrophilic polymer-coated vascular grafts have superior in vivo compatibility when compared to hydrophobic grafts as characterized by reduced platelet and leukocyte adherence as well as higher endothelialization.
C1 [Strang, Aart C.; Bisoendial, Radjesh J.; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands.
   Maastricht Univ, Maastricht, Netherlands.
   [Idu, Mirza M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Surg, NL-1105 AZ Amsterdam, Netherlands.
   [Kramer, Gertjan; Speijer, Dave] Univ Amsterdam, Acad Med Ctr, Dept Biochem, NL-1105 AZ Amsterdam, Netherlands.
   [Rotmans, Joris. I.] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands.
RP Strang, AC (reprint author), Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.
EM a.c.strang@amc.uva.nl
OI Speijer, Dave/0000-0002-2340-2753; Kramer, Gertjan/0000-0002-8541-0337
FU Dutch Heart Association [2008B070]
FX This work was supported by a grant from the Dutch Heart Association
   (2008B070).
CR Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Assmann G, 2003, ANNU REV MED, V54, P321, DOI 10.1146/annurev.med.54.101601.152409
   Awan Z, 2008, CAN J CARDIOL, V24, p27C, DOI 10.1016/S0828-282X(08)71035-3
   Braet F, 1997, J MICROSC-OXFORD, V186, P84, DOI 10.1046/j.1365-2818.1997.1940755.x
   Cines DB, 1998, BLOOD, V91, P3527
   Crombez M, 2005, BIOMATERIALS, V26, P7402, DOI 10.1016/j.biomaterials.2005.05.051
   Griffin JH, 1999, J CLIN INVEST, V103, P219, DOI 10.1172/JCI5006
   Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kaul S, 2003, CIRCULATION, V107, P2551, DOI 10.1161/01.CIR.0000074042.19447.B1
   Klinkert P, 2004, EUR J VASC ENDOVASC, V27, P357, DOI 10.1016/j.ejvs.2003.12.027
   Klinkert P, 2003, J VASC SURG, V37, P149, DOI 10.1067/mva.2002.86
   Knetsch MLW, 2010, J BIOMED MATER RES A, V93A, P77, DOI 10.1002/jbm.a.32538
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   Knetsch MLW, 2004, J BIOMED MATER RES A, V71A, P615, DOI 10.1002/jbm.a.30195
   Kreienberg PB, 2002, J VASC SURG, V35, P299, DOI 10.1067/mva.2002.121208
   Lee T, 2011, NEPHROL DIAL TRANSPL, V26, P2264, DOI 10.1093/ndt/gfq733
   Li DY, 1999, ARTERIOSCL THROM VAS, V19, P378, DOI 10.1161/01.ATV.19.2.378
   Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101
   Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93
   Murphy MO, 2006, J ENDOVASC THER, V13, P389, DOI 10.1583/06-1846.1
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Sayers RD, 1998, BRIT J SURG, V85, P934
   Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b
   Shin YM, 2012, BIOMACROMOLECULES, V13, P2020, DOI 10.1021/bm300194b
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1999, BIOMATERIALS, V20, P1365, DOI 10.1016/S0142-9612(99)00034-4
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Tang LP, 1998, J BIOMED MATER RES, V42, P156, DOI 10.1002/(SICI)1097-4636(199810)42:1<156::AID-JBM19>3.3.CO;2-E
   Van Leuven SI, 2009, J THROMB HAEMOST, V7, P347, DOI 10.1111/j.1538-7836.2008.03175.x
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63
   Wang SH, 2010, CLIN EXP IMMUNOL, V160, P137, DOI 10.1111/j.1365-2249.2009.04068.x
   Xu LC, 2007, BIOMATERIALS, V28, P3273, DOI 10.1016/j.biomaterials.2007.03.032
   Yevzlin AS, 2006, SEMIN DIALYSIS, V19, P535, DOI 10.1111/j.1525-139X.2006.00218.x
   Zhang Q, 2009, INT J CARDIOL, V133, P286, DOI 10.1016/j.ijcard.2008.11.034
NR 41
TC 1
Z9 1
U1 2
U2 13
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 1129-7298
EI 1724-6032
J9 J VASC ACCESS
JI J. Vasc. Access
PD MAR-APR
PY 2014
VL 15
IS 2
BP 95
EP 101
DI 10.5301/jva.5000166
PG 7
WC Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA AM6TD
UT WOS:000339997000005
PM 24170585
DA 2018-10-19
ER

PT J
AU Lu, HX
   Yang, ZQ
   Jiao, Q
   Wang, YY
   Wang, L
   Yang, PB
   Chen, XL
   Zhang, PB
   Wang, P
   Chen, MX
   Lu, XY
   Liu, Y
AF Lu, Hai-xia
   Yang, Zhi-qian
   Jiao, Qian
   Wang, Yuan-yuan
   Wang, Li
   Yang, Peng-bo
   Chen, Xin-lin
   Zhang, Peng-bo
   Wang, Peng
   Chen, Ming-xia
   Lu, Xiao-yun
   Liu, Yong
TI Low concentration of serum helps to maintain the characteristics of
   NSCs/NPCs on alkali-treated PHBHHx film in vitro
SO NEUROLOGICAL RESEARCH
LA English
DT Article
DE Multiple differentiation; NSCs/NPCs; PHBHHx; Self-renewal; Serum
ID NEURAL STEM-CELLS; PERIPHERAL-NERVE REGENERATION; NEURONAL
   DIFFERENTIATION; THERAPY; BRAIN; POLYHYDROXYALKANOATES; TRANSPLANTATION;
   BIOMATERIALS; ENGRAFTMENT; CONDUITS
AB Objective: Efforts have been made by tissue engineers to create a permissive environment for neural regeneration, and to enhance the efficiency of neural stem cell (NSC) transplantation. However, to acquire sufficient number of seed cells on the material appears to be the main obstacle to constructing functional transplantable NSC-biomaterial complexes. A culture system has been optimized in the current study to maintain the specific characteristics of NSCs/neural progenitor cells (NPCs) on the material and achieve sustaining increased multipotent seed cells.
   Methods: The PHBHHx film was selected as biomaterial and the surface was firstly modified with NaOH treatment. The NSCs/NPCs isolated from the cerebral cortex of rat embryos were cultured on the treated PHBHHx films in growth medium containing 1%, 5%, and 10% fetal bovine serum (FBS). Then the attachment, survival, proliferation, and differentiation of NSCs/NPCs were assessed.
   Results: NaOH treatment significantly increased the hydrophilicity of PHBHHx and enhanced NSCs/NPCs attachment. On the treated PHBHHx film, NSCs/NPCs survived well and actively proliferated in the medium containing 1% FBS. After 7-14 days in culture, approximately two-thirds of cells remained as nestin and Sox2 positive NSCs/NPCs. However, in the medium containing 5% and 10% FBS, NSCs/NPCs proliferation was reduced and differentiation, particularly glial differentiation was significantly promoted.
   Conclusion: Growth medium containing low concentration of FBS is favorable for maintaining the characteristics, in terms of self-renewal and multiple differentiation, of NSCs/NPCs on NaOH-treated PHBHHx films. This could be a useful method to construct functional transplantable NSCs/NPCs-biomaterial complex.
C1 [Lu, Hai-xia; Yang, Zhi-qian; Jiao, Qian; Wang, Yuan-yuan; Wang, Li; Yang, Peng-bo; Chen, Xin-lin; Liu, Yong] Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol, Xian 710061, Peoples R China.
   [Yang, Zhi-qian; Lu, Xiao-yun] Xi An Jiao Tong Univ, Sch Life Sci & Technol, Minist Educ, Key Lab Biomed Informat Engn, Xian 710061, Shaanxi, Peoples R China.
   [Wang, Li; Zhang, Peng-bo] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Obstet & Gynecol, Xian 710061, Peoples R China.
   [Wang, Li; Zhang, Peng-bo] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 2, Dept Anesthesiol, Xian 710061, Peoples R China.
   [Wang, Peng; Chen, Ming-xia] Xi An Jiao Tong Univ, Coll Med, Ctr Electron Microscopy, Xian 710061, Shaanxi, Peoples R China.
RP Liu, Y (reprint author), Xi An Jiao Tong Univ, Coll Med, Inst Neurobiol, Xian 710061, Peoples R China.
EM luxy05@mail.xjtu.edu.cn; liuy5599@mail.xjtu.edu.cn
FU National Natural Science Foundation of China [31070943, 31271151,
   81070998, 81172170]; Doctoral Fund of Ministry of Education of China
   [200806981053]; Fundamental Research Funds for the Central Universities
FX The authors would like to thank Prof. GQ Chen from School of Life
   Science, Tsinghua University for the kindly donation of PHBHHx material.
   This work was supported by grants from the National Natural Science
   Foundation of China (31070943, 31271151, 81070998, and 81172170), the
   Doctoral Fund of Ministry of Education of China (200806981053), and the
   Fundamental Research Funds for the Central Universities.
CR Bartlett PF, 1998, IMMUNOL CELL BIOL, V76, P414, DOI 10.1046/j.1440-1711.1998.00762.x
   Bian YZ, 2009, BIOMATERIALS, V30, P217, DOI 10.1016/j.biomaterials.2008.09.036
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Choi SS, 2010, GENES GENOM, V32, P225, DOI 10.1007/s13258-010-1001-x
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Faux CH, 2001, J NEUROSCI, V21, P5587
   GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879
   Gstraunthaler G, 2003, ALTEX-ALTERN TIEREXP, V20, P275
   Hadlock T, 1999, LARYNGOSCOPE, V109, P1412, DOI 10.1097/00005537-199909000-00010
   Hazer B, 2007, APPL MICROBIOL BIOT, V74, P1, DOI 10.1007/s00253-006-0732-8
   Huang YC, 2006, ARTIF ORGANS, V30, P514, DOI 10.1111/j.1525-1594.2006.00253.x
   Joannides AJ, 2008, J NEUROL SCI, V265, P84, DOI 10.1016/j.jns.2007.09.008
   Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006
   Kemp SWP, 2008, NEUROL RES, V30, P1030, DOI 10.1179/174313208X362505
   Lepore A C, 2006, Neuroscience, V142, P287, DOI 10.1016/j.neuroscience.2005.12.067
   Lepore AC, 2005, EXP NEUROL, V194, P230, DOI 10.1016/j.expneurol.2005.02.020
   Lepore AC, 2004, NEURON GLIA BIOL, V1, P113, DOI 10.1017/S1740925X04000213
   Lu HX, 2008, BRAIN RES BULL, V77, P158, DOI 10.1016/j.brainresbull.2008.02.037
   Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908
   MILLER ND, 1987, BIOMATERIALS, V8, P129, DOI 10.1016/0142-9612(87)90102-5
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Okano H, 2007, J NEUROCHEM, V102, P1459, DOI 10.1111/j.1471-4159.2007.04674.x
   Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rossi F, 2002, NAT REV NEUROSCI, V3, P401, DOI 10.1038/nrn809
   Rothstein JD, 2004, NAT BIOTECHNOL, V22, P283, DOI 10.1038/nbt0304-283
   Subramanian A, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-108
   Temple S, 2001, NAT REV NEUROSCI, V2, P513, DOI 10.1038/35081577
   Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013
   Wang Y, 2007, J NEUROIMMUNE PHARM, V2, P243, DOI 10.1007/s11481-007-9074-2
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   YASUDA T, 1994, LANGMUIR, V10, P2435, DOI 10.1021/la00019a068
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
NR 35
TC 2
Z9 5
U1 0
U2 10
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0161-6412
EI 1743-1328
J9 NEUROL RES
JI Neurol. Res.
PD MAR
PY 2014
VL 36
IS 3
BP 207
EP 214
DI 10.1179/1743132813Y.0000000281
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA AI7VL
UT WOS:000337108800003
PM 24512014
DA 2018-10-19
ER

PT J
AU Dai, LH
   He, ZM
   Zhang, X
   Hu, XQ
   Yuan, L
   Qiang, M
   Zhu, JX
   Shao, ZX
   Zhou, CY
   Ao, YF
AF Dai, Linghui
   He, Zhenming
   Zhang, Xin
   Hu, Xiaoqing
   Yuan, Lan
   Qiang, Ming
   Zhu, Jingxian
   Shao, Zhenxing
   Zhou, Chunyan
   Ao, Yingfang
TI One-Step Repair for Cartilage Defects in a Rabbit Model A Technique
   Combining the Perforated Decalcified Cortical-Cancellous Bone Matrix
   Scaffold With Microfracture
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE articular cartilage; cartilage repair; microfracture; decalcified
   cortical-cancellous bone matrix (DCCBM); medical applications
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; THICKNESS CHONDRAL DEFECTS;
   TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; ELASTIC-MODULUS; OSTEOCHONDRAL
   REGENERATION; ABRASION ARTHROPLASTY; FUNCTIONAL-EVALUATION; KNEE;
   NANOINDENTATION
AB Background: Cartilage repair still presents a challenge to clinicians and researchers alike. A more effective, simpler procedure that can produce hyaline-like cartilage is needed for articular cartilage repair.
   Hypothesis: A technique combining microfracture with a biomaterial scaffold of perforated decalcified cortical-cancellous bone matrix (DCCBM; composed of cortical and cancellous parts) would create a 1-step procedure for hyaline-like cartilage repair.
   Study Design: Controlled laboratory study.
   Methods: For the in vitro portion of this study, mesenchymal stem cells (MSCs) were isolated from bone marrow aspirates of New Zealand White rabbits. Scanning electron microscopy (SEM), confocal microscopy, and 1,9-dimethylmethylene blue assay were used to assess the attachment, proliferation, and cartilage matrix production of MSCs grown on a DCCBM scaffold. For the in vivo experiment, full-thickness defects were produced in the articular cartilage of the trochlear groove of 45 New Zealand White rabbits, and the rabbits were then assigned to 1 of 3 treatment groups: perforated DCCBM combined with microfracture (DCCBM+M group), perforated DCCBM alone (DCCBM group), and microfracture alone (M group). Five rabbits in each group were sacrificed at 6, 12, or 24 weeks after the operation, and the repair tissues were analyzed by histological examination, assessment of matrix staining, SEM, and nanoindentation of biomechanical properties.
   Results: The DCCBM+M group showed hyaline-like articular cartilage repair, and the repair tissues appeared to have better matrix staining and revealed biomechanical properties close to those of the normal cartilage. Compared with the DCCBM+M group, there was unsatisfactory repair tissues with less matrix staining in the DCCBM group and no matrix staining in the M group, as well as poor integration with normal cartilage and poor biomechanical properties.
   Conclusion: The DCCBM scaffold is suitable for MSC growth and hyaline-like cartilage repair induction when combined with microfracture.
   Clinical Relevance: Microfracture combined with a DCCBM scaffold is a promising method that can be performed and adopted into clinical treatment for articular cartilage injuries.
C1 [Dai, Linghui; He, Zhenming; Zhang, Xin; Hu, Xiaoqing; Yuan, Lan; Qiang, Ming; Zhu, Jingxian; Shao, Zhenxing; Zhou, Chunyan; Ao, Yingfang] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100191, Peoples R China.
RP Ao, YF (reprint author), Peking Univ, Hosp 3, Inst Sports Med, 49 North Garden Rd, Beijing 100191, Peoples R China.
EM chunyanzhou@bjmu.edu.cn; Yingfang.ao@vip.sina.com
OI Shao, Zhenxing/0000-0001-5811-1254
FU National Natural Science Foundation of China (NFSC) [81101390,
   81071474]; Specialized Research Fund for the Doctoral Program of Higher
   Education [20110001130001, 20090001120117]; Leading Academic Discipline
   Project of Beijing Education Bureau; 111 Project of China [B07001]
FX One or more of the authors has declared the following potential conflict
   of interest or source of funding: This work was supported by National
   Natural Science Foundation of China (NFSC; grants 81101390 and
   81071474), Specialized Research Fund for the Doctoral Program of Higher
   Education (20110001130001 and 20090001120117), Leading Academic
   Discipline Project of Beijing Education Bureau, and the 111 Project of
   China (B07001).
CR Abedi G, 2010, J BIOMATER SCI POLYM
   Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950
   [Anonymous], 2011, PRESCRIRE INT, V20, P122
   Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905
   Behrens P, 2006, KNEE, V13, P194, DOI 10.1016/j.knee.2006.02.012
   Bekkers JEJ, 2009, AM J SPORT MED, V37, p148S, DOI 10.1177/0363546509351143
   Beris AE, 2012, AM J SPORT MED, V40, P562, DOI 10.1177/0363546511428778
   Berninger MT, 2013, JOVE-J VIS EXP, DOI 10.3791/4423
   Bouard D, 2009, BRIT J PHARMACOL, V157, P153, DOI 10.1038/bjp.2008.349
   Bouwmeester PSJM, 2002, J ORTHOPAED RES, V20, P267, DOI 10.1016/S0736-0266(01)00099-7
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Chang NJ, 2012, BIOMATERIALS, V33, P3153, DOI 10.1016/j.biomaterials.2011.12.054
   Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.0031
   Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9
   Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005
   Gelse K, 2008, ARTHRITIS RHEUM-US, V58, P475, DOI 10.1002/art.23124
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Hangody L, 2010, AM J SPORT MED, V38, P1125, DOI 10.1177/0363546509360405
   Johnson LL, 2001, CLIN ORTHOP RELAT R, pS306
   Kitamura N, 2011, AM J SPORT MED, V39, P1160, DOI 10.1177/0363546511399383
   Kon E, 2011, AM J SPORT MED, V39, P1180, DOI 10.1177/0363546510392711
   Kreuz PC, 2006, OSTEOARTHR CARTILAGE, V14, P1119, DOI 10.1016/j.joca.2006.05.003
   Li C, 2006, J BIOMED MATER RES A, V78A, P729, DOI 10.1002/jbm.a.30751
   Lotz M, 2001, CLIN ORTHOP RELAT R, pS108
   Matsunaga D, 2007, KNEE, V14, P465, DOI 10.1016/j.knee.2007.06.008
   Miller Bruce S, 2004, J Knee Surg, V17, P13
   Morille M, 2013, J CONTROL RELEASE, V170, P99, DOI 10.1016/j.jconrel.2013.04.017
   Moseley JB, 2010, AM J SPORT MED, V38, P238, DOI 10.1177/0363546509348000
   Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park JS, 2008, TRANSPLANTATION, V85, P589, DOI 10.1097/TP.0b013e3181639b3a
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   Schindler OS, 2011, ACTA ORTHOP BELG, V77, P709
   Steadman JR, 2003, ARTHROSCOPY, V19, P477, DOI 10.1053/jars.2003.50112
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Williams Riley J 3rd, 2007, Instr Course Lect, V56, P419
   Young LS, 2006, J PATHOL, V208, P299, DOI 10.1002/path.1896
   Zhang X, 2008, BIOMATERIALS, V29, P4616, DOI 10.1016/j.biomaterials.2008.07.051
NR 39
TC 25
Z9 26
U1 2
U2 23
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
EI 1552-3365
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD MAR
PY 2014
VL 42
IS 3
BP 583
EP 591
DI 10.1177/0363546513518415
PG 9
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA AH6EA
UT WOS:000336222300008
PM 24496505
DA 2018-10-19
ER

PT J
AU Mohite, BV
   Patil, SV
AF Mohite, Bhavna V.
   Patil, Satish V.
TI A novel biomaterial: bacterial cellulose and its new era applications
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE microbial cellulose; production; biopolymer; functional material;
   Acetobacter
ID ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE; SKIN SUBSTITUTES;
   GLUCONACETOBACTER-HANSENII; MECHANICAL-PROPERTIES; SILVER NANOPARTICLES;
   DRUG-DELIVERY; CULTURE; NANOCOMPOSITES; MEMBRANES
AB Bacterial cellulose (BC) is a promising natural polymer that is produced by bacteria and that has unique and desirable structural, physical, and chemical properties. From the time when the remarkable properties of BC were found 15 years ago compared with plant cellulose, interest has grown in BC and it has become an article of trade in diverse applications. Following this trend, this paper reviews the progress of relevant studies, including general information about cellulose, production by microorganisms as well as BC cultivation, and its properties. The applications reviewed in the present article comprise biological and nonbiological fields. The latest use of BC in the biomedical, environmental, agricultural, electronic, food, and industrial fields is discussed with its applications in composite form. The present article attempts to amass the assorted uses of BC under one umbrella. Thus, recent advances in BC applications in different fields are thoroughly reviewed. This article concludes with the need for future research of BC to make it commercialized as vital biomaterial.
C1 [Mohite, Bhavna V.; Patil, Satish V.] North Maharashtra Univ, Sch Life Sci, Jalagoan 425001, MS, India.
RP Patil, SV (reprint author), North Maharashtra Univ, Sch Life Sci, POB 80, Jalagoan 425001, MS, India.
EM satish.patil7@gmail.com
OI Mohite, Bhavana/0000-0002-8821-8631
FU University Grants Commission, New Delhi
FX The research fellowship to Bhavna Mohite from the University Grants
   Commission, New Delhi, under the Research Fellowship in Sciences for the
   meritorious students scheme is gratefully acknowledged.
CR Abdelhak M., 2009, THESIS U MENTOURI CO
   Amano Y., 2005, BIOL MACROMOL, V5, P3
   Amin MCIM, 2012, SAINS MALAYS, V41, P561
   Amin MCIM, 2012, CARBOHYD POLYM, V88, P465, DOI 10.1016/j.carbpol.2011.12.022
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Blaker JJ, 2010, COMPOS SCI TECHNOL, V70, P1879, DOI 10.1016/j.compscitech.2010.05.028
   Brown A. J., 1886, CHEM SOC, V49, P432
   Brown A. J., 1886, J CHEM SOC, V49, P172, DOI DOI 10.1039/CT8864900172
   Brown Jr R. M., 2006, Provisional Patent, Patent No. 2914BRO
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   BROWN RM, 1989, CELLULOSE STRUCTURAL, P145
   Budhiono A, 1999, CARBOHYD POLYM, V40, P137, DOI 10.1016/S0144-8617(99)00050-8
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2007, CELLULOSE MOL STRUCT
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   Drogat N, 2011, J NANOPART RES, V13, P1557, DOI 10.1007/s11051-010-9995-1
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Gabriels D., 1990, NATO ASI SER B-PHYS, P557
   Gallin WJ, 1998, BURNS, V24, P613, DOI 10.1016/S0305-4179(98)00089-8
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   George J, 2005, INT J BIOL MACROMOL, V37, P189, DOI 10.1016/j.ijbiomac.2005.10.007
   George J, 2005, WORLD J MICROB BIOT, V21, P1323, DOI 10.1007/s11274-005-3574-0
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   GEYER U, 1994, ACTA BIOTECHNOL, V14, P261, DOI 10.1002/abio.370140308
   GROMETELHANAN Z, 1963, J BACTERIOL, V85, P284
   Hasan N, 2012, INT J ADV SCI ENG IN, V2, P1, DOI DOI 10.18517/IJASEIT.2.4.201
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hu WL, 2009, MAT SCI ENG C-BIO S, V29, P1216, DOI 10.1016/j.msec.2008.09.017
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Isizawa S., 1976, ACTINOMYCETES BOUNDA, P43
   Jeon JH, 2010, SENSOR ACTUAT B-CHEM, V146, P307, DOI 10.1016/j.snb.2010.02.046
   Jiang GP, 2012, INT J HYDROGEN ENERG, V37, P9182, DOI 10.1016/j.ijhydene.2012.02.195
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   Jung JY, 2005, ENZYME MICROB TECH, V37, P347, DOI 10.1016/j.enzmictec.2005.02.019
   Jung R, 2009, J BIOMAT SCI-POLYM E, V20, P311, DOI 10.1163/156856209X412182
   Kawecki M., 2004, P INT REV C BIOT VIE, P14
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2003, US Patent, Patent No. 0013163A1
   Km J. Y., 2007, APPL BIOCHEM BIOTECH, V137, P529
   KUDLICKA K, 1987, PROTOPLASMA, V136, P96, DOI 10.1007/BF01276358
   Kulkarni P.K., 2012, AM J DRUG DISCOV DEV, V2, P72
   Kurisaki H., 1991, US Patent, Patent No. 5024831
   LATARJET J, 1995, BURNS, V21, P221, DOI 10.1016/0305-4179(95)80015-G
   Legendre JY, 2009, US Patent, Patent No. [2009/0041815, 20090041815]
   lguchi M. S., 1988, U.S. Patent, Patent No. 4742164
   Liang HW, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.34
   Lopez-Delgado A, 1998, WATER RES, V32, P989, DOI 10.1016/S0043-1354(97)00304-7
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Min L. U., 2011, CHEM RES CHINESE U, V27, P1031
   Mormino R, 2003, APPL MICROBIOL BIOT, V62, P503, DOI 10.1007/s00253-003-1377-5
   Ng CC, 2004, WORLD J MICROB BIOT, V20, P875, DOI 10.1007/s11274-004-0873-9
   Nge TT, 2010, CELLULOSE, V17, P349, DOI 10.1007/s10570-009-9394-x
   Nguyen D. N., 2009, International Food Research Journal, V16, P59
   Nogi M, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2191667
   Nogi M, 2008, ADV MATER, V20, P1849, DOI 10.1002/adma.200702559
   OSTER GA, 2003, Patent No. 6599518
   Ougiya H, 1997, BIOSCI BIOTECH BIOCH, V61, P1541, DOI 10.1271/bbb.61.1541
   Park JK, 2003, BIOTECHNOL LETT, V25, P2055, DOI 10.1023/B:BILE.0000007065.63682.18
   Patel UD, 2008, J COLLOID INTERF SCI, V319, P462, DOI 10.1016/j.jcis.2007.12.019
   Patil SV, 2011, APPL BIOCHEM BIOTECH, V163, P780, DOI 10.1007/s12010-010-9082-1
   Payen A., 1838, SEANCES ACAD SCI, V7, P1052
   Payen A., 1838, SEANCES ACAD SCI, V7, P1125
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Pirkkalainen K, 2008, EUR PHYS J D, V49, P333, DOI 10.1140/epjd/e2008-00180-5
   Pirkkalainen K, 2007, J APPL CRYSTALLOGR, V40, pS489, DOI 10.1107/S0021889806055804
   Pommet M, 2008, BIOMACROMOLECULES, V9, P1643, DOI 10.1021/bm800169g
   Prasanna M, 2004, BURNS, V30, P169, DOI 10.1016/j.burns.2003.09.028
   Qiu KY, 2012, J MATER SCI, V47, P6066, DOI 10.1007/s10853-012-6517-9
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   REED BE, 1994, J ENVIRON ENG-ASCE, V120, P416, DOI 10.1061/(ASCE)0733-9372(1994)120:2(416)
   Rezaee A., 2008, J BIOL SCI, V8, P209
   Rezaee A, 2008, ENVIRON ENG MANAG J, V7, P589, DOI 10.30638/eemj.2008.082
   Rezaee J. D., 2005, AM J ENV SCI, V1, P102
   Richmond PA, 1999, BIOSYNTHESIS BIODEGR, P5
   Roberts E. M., 1986, European Patent, Patent No. [0186495, 19860186495]
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Schrecker ST, 2005, BIOTECHNOL LETT, V27, P1435, DOI 10.1007/s10529-005-1465-y
   Shah J, 2005, APPL MICROBIOL BIOT, V66, P352, DOI 10.1007/s00253-004-1756-6
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Srivastava SK, 1997, J ENVIRON ENG-ASCE, V123, P461, DOI 10.1061/(ASCE)0733-9372(1997)123:5(461)
   Stephens RS, 1990, Production of cholesterol-absorbing bacterial cellulose for use as dietary fiber, Patent No. [4960763, US 4960763 A, CAN 114:60730]
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Sun DP, 2010, APPL SURF SCI, V256, P2241, DOI 10.1016/j.apsusc.2009.10.034
   Suwannapinunt N., 2007, SURANAREE J SCI TECH, V14, P357
   Teeri T., 1977, TRENDS BIOTECHNOL, V15, P160
   Thanaporn A., 2011, MED DEVICES, V4, P77
   Ton NMN, 2011, INT FOOD RES J, V18, P983
   Tournilhac F, 2003, US patent, Patent No. [US 6534071 B1, 6534071]
   Vandamme EJ, 1998, POLYM DEGRAD STABIL, V59, P93, DOI 10.1016/S0141-3910(97)00185-7
   Vashistha S., 2010, INT C ADV POL TECHN, P56
   Vyjayanthi JP, 2010, WATER ENVIRON RES, V82, P601, DOI 10.2175/106143009X12529484816114
   Wallace A., 1997, HDB SOIL CONDITIONER
   Wan YZ, 2009, COMPOS SCI TECHNOL, V69, P1212, DOI 10.1016/j.compscitech.2009.02.024
   Watanabe K, 1998, BIOSCI BIOTECH BIOCH, V62, P1290, DOI 10.1271/bbb.62.1290
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Watanabe M., 1998, CELLULOSE, V5, P187
   Weimer PJ, 2000, J AGR FOOD CHEM, V48, P1727, DOI 10.1021/jf991372y
   Westland JA, 1994, U. S. Patent, Patent No. [US5350528 A, 5350528]
   WHITE AR, 1981, P NATL ACAD SCI-BIOL, V78, P1047, DOI 10.1073/pnas.78.2.1047
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   YAMANAKA S, 1989, J MATER SCI, V24, P3141, DOI 10.1007/BF01139032
   Yamanaka S., 1990, European Patent, Patent No. [0396344, 19900396344]
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yoon SH, 2006, BIOMACROMOLECULES, V7, P1280, DOI 10.1021/bm050597g
   Yoshinaga F, 1997, BIOSCI BIOTECH BIOCH, V61, P219, DOI 10.1271/bbb.61.219
   Yoshino T, 1996, J FERMENT BIOENG, V81, P32, DOI 10.1016/0922-338X(96)83116-3
   Yu XC, 1996, INT J BIOL MACROMOL, V19, P145, DOI 10.1016/0141-8130(96)01109-9
   ZAAR K, 1977, CYTOBIOLOGIE, V16, P1
   Zhu HX, 2011, BIOTECHNOL BIOTEC EQ, V25, P2233, DOI 10.5504/BBEQ.2011.0010
NR 122
TC 30
Z9 30
U1 7
U2 117
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD MAR
PY 2014
VL 61
IS 2
BP 101
EP 110
DI 10.1002/bab.1148
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AF3KG
UT WOS:000334610400004
PM 24033726
DA 2018-10-19
ER

PT J
AU Mota, A
   Lotfi, AS
   Barzin, J
   Hatam, M
   Adibi, B
   Khalaj, Z
   Massumi, M
AF Mota, Ali
   Lotfi, Abbas Sahebghadam
   Barzin, Jalal
   Hatam, Mostafa
   Adibi, Behzad
   Khalaj, Zahra
   Massumi, Mohammad
TI Human Bone Marrow Mesenchymal Stem Cell Behaviors on PCL/Gelatin
   Nanofibrous Scaffolds Modified with A Collagen IV-Derived RGD-Containing
   Peptide
SO CELL JOURNAL
LA English
DT Article
DE Nanofibers; Polycaprolactone; RGD Peptide; Surface Modification;
   Mesenchymal Stem Cell
ID ELECTROSPUN POLYCAPROLACTONE; FIBROUS SCAFFOLDS; CROSS-LINKING; GELATIN;
   SURFACE; POLYMERS; FILMS; BIOCOMPATIBILITY; DIFFERENTIATION;
   PROLIFERATION
AB Objective: We introduce an RGD (Arg-Gly-Asp)-containing peptide of collagen IV origin that possesses potent cell adhesion and proliferation properties.
   Materials and Methods: In this experimental study, the peptide was immobilized on an electrospun nanofibrous polycaprolactone/gelatin (PCL/Gel) hybrid scaffold by a chemical bonding approach to improve cell adhesion properties of the scaffold. An iodine-modified phenylalanine was introduced in the peptide to track the immobilization process. Native and modified scaffolds were characterized with scanning electron microscopy (SEM) and fourier transform infrared spectroscopy (FTIR). We studied the osteogenic and adipogenic differentiation potential of human bone marrow-derived mesenchymal stem cells (hBMSCs). In addition, cell adhesion and proliferation behaviors of hBMSCs on native and peptide modified scaffolds were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and 4',6-diamidino-2-phenylindole (DAPI) staining, and the results compared with tissue culture plate, as the control.
   Results: FTIR results showed that the peptide successfully immobilized on the scaffold. MU assay and DAPI staining results indicated that peptide immobilization had a dramatic effect on cell adhesion and proliferation.
   Conclusion: This peptide modified nanofibrous scaffold can be a promising biomaterial for tissue engineering and regenerative medicine with the use of hBMSCs.
C1 [Mota, Ali; Lotfi, Abbas Sahebghadam; Adibi, Behzad] Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, Tehran, Iran.
   [Lotfi, Abbas Sahebghadam; Hatam, Mostafa; Khalaj, Zahra; Massumi, Mohammad] Natl Inst Genet Engn & Biotechnol, Tehran, Iran.
   [Barzin, Jalal] Iran Polymer & Petrochem Inst, Tehran, Iran.
RP Lotfi, AS (reprint author), Tarbiat Modares Univ, Fac Med Sci, Dept Clin Biochem, POB 14115-11l, Tehran, Iran.
EM Lotfi_ab@modares.ac.ir
FU Tarbiat Modares University
FX This study was financially supported by Tarbiat Modares University. The
   authors would like to thank Dr. Mozhgan Zandi and Mandi Saeed for
   technical support. The authors declare that there is no conflict of
   interest.
CR Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Eslaminejad MB, 2011, YAKHTEH, V12, P469
   Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Grover CN, 2012, J MECH BEHAV BIOMED, V10, P62, DOI 10.1016/j.jmbbm.2012.02.028
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hunt JA, 2008, NAT MATER, V7, P617, DOI 10.1038/nmat2242
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Jahani H, 2012, CELL J, V14, P31
   Jo S, 2000, POLYMER, V41, P7595, DOI 10.1016/S0032-3861(00)00117-8
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Massumi M, 2012, TISSUE ENG PT A, V18, P609, DOI [10.1089/ten.tea.2011.0368, 10.1089/ten.TEA.2011.0368]
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Park KH, 2002, BIOTECHNOL LETT, V24, P1401, DOI 10.1023/A:1019890229822
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Quirk RA, 2001, BIOMATERIALS, V22, P865, DOI 10.1016/S0142-9612(00)00250-7
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Seo HS, 2010, APPL SURF SCI, V257, P596, DOI 10.1016/j.apsusc.2010.07.040
   Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s
   Songchotikunpan P, 2008, INT J BIOL MACROMOL, V42, P247, DOI 10.1016/j.ijbiomac.2007.11.005
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tomihata K, 1996, Tissue Eng, V2, P307, DOI 10.1089/ten.1996.2.307
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Wang SD, 2009, J APPL POLYM SCI, V113, P2675, DOI 10.1002/app.30346
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 37
TC 11
Z9 11
U1 2
U2 17
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SPR
PY 2014
VL 16
IS 1
BP 1
EP 10
PG 10
WC Cell Biology
SC Cell Biology
GA AH8XF
UT WOS:000336420800001
PM 24511574
DA 2018-10-19
ER

PT J
AU Khayyatan, F
   Nemati, S
   Kiani, S
   Emami, SH
   Baharvand, H
AF Khayyatan, Fahimeh
   Nemati, Shiva
   Kiani, Sahar
   Emami, Shahriar Hojjati
   Baharvand, Hossein
TI Behaviour of Human Induced Pluripotent Stem Cell-Derived Neural
   Progenitors on Collagen Scaffolds Varied in Freezing Temperature and
   Laminin Concentration
SO CELL JOURNAL
LA English
DT Article
DE Collagen; Laminin; Neural Progenitors; Tissue Engineering
ID SPINAL-CORD; DIFFERENTIATION; REGENERATION; INTEGRINS; RECOVERY;
   ADHESION; PROMOTE; REPAIR
AB Objective: Biomaterial technology, when combined with emerging human induced pluripotent stem cell (hiPSC) technology, provides a promising strategy for patient-specific tissue engineering. In this study, we have evaluated the physical effects of collagen scaffolds fabricated at various freezing temperatures on the behavior of hiPSC-derived neural progenitors (hiPSC-NPs). In addition, the coating of scaffolds using different concentrations of laminin was examined on the cells.
   Materials and Methods: Initially, in this experimental study, the collagen scaffolds fabricated from different collagen concentrations and freezing temperatures were characterized by determining the pore size, porosity, swelling ratio, and mechanical properties. Effects of cross-linking on free amine groups, volume shrinkage and mass retention was also assessed. Then, hiPSC-NPs were seeded onto the most stable three-dimensional collagen scaffolds and we evaluated the effect of pore structure. Additionally, the different concentrations of laminin coating of the scaffolds on hiPSC-NPs behavior were assessed.
   Results: Scanning electron micrographs of the scaffolds showed a pore diameter in the range of 23-232 mu m for the scaffolds prepared with different fabrication parameters. Also porosity of all scaffolds was >98% with more than 94% swelling ratio. hiPSC-NPs Were subsequently seeded onto the scaffolds that were made by different freezing temperatures in order to assess for physical effects of the scaffolds. We observed similar proliferation, but more cell infiltration in scaffolds prepared at lower freezing temperatures. The laminin coating of the scaffolds improved NPs proliferation and infiltration in a dose-dependent manner. Immunofluorescence staining and scanning electron microscopy confirmed the compatibility of undifferentiated and differentiated hiPSC-NPs on these scaffolds.
   Conclusion: The results have suggested that the pore structure and laminin coating of collagen scaffolds significantly impact cell behavior. These biocompatible three-dimensional laminin-coated collagen scaffolds are good candidates for future hiPSC-NPs biomedical nerve tissue engineering applications.
C1 [Khayyatan, Fahimeh; Nemati, Shiva; Kiani, Sahar; Baharvand, Hossein] ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, Tehran, Iran.
   [Khayyatan, Fahimeh; Emami, Shahriar Hojjati] Amirkabir Univ Technol, Dept Biomed Engn, Tehran, Iran.
   [Baharvand, Hossein] Univ Sci & Culture, ACECR, Dept Dev Biol, Tehran, Iran.
RP Baharvand, H (reprint author), ACECR, Royan Inst Stem Cell Biol & Technol, Cell Sci Res Ctr, Dept Stem Cells & Dev Biol, POB 16635-148, Tehran, Iran.
EM Baharvand@RoyanInstitute.org
FU Royan Institute
FX This study was funded by a grant provided by Royan Institute. The
   authors have no conflict of interest to declare.
CR Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb
   Buttafoco L, 2006, J BIOMED MATER RES B, V77B, P357, DOI 10.1002/jbm.b.30444
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   Cary LA, 1999, HISTOL HISTOPATHOL, V14, P1001, DOI 10.14670/HH-14.1001
   Chen DC, 2007, J BIOMED MATER RES A, V80A, P399, DOI 10.1002/jbm.a.30932
   Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296
   Ding T, 2010, INJURY, V41, P522, DOI 10.1016/j.injury.2009.04.003
   Flanagan LA, 2006, J NEUROSCI RES, V83, P845, DOI 10.1002/jnr.20778
   Habermehl J, 2005, MACROMOL BIOSCI, V5, P821, DOI 10.1002/mabi.200500102
   Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71
   Hatami M, 2009, CYTOTHERAPY, V11, P618, DOI 10.1080/14653240903005802
   Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jurga M, 2011, BIOMATERIALS, V32, P3423, DOI 10.1016/j.biomaterials.2011.01.049
   Kumada Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010305
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Ma W, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-90
   Mollers S, 2009, TISSUE ENG PT A, V15, P461, DOI 10.1089/ten.tea.2007.0107
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Neal RA, 2009, TISSUE ENG PART C-ME, V15, P11, DOI 10.1089/ten.tec.2007.0366
   Nemati S, 2011, STEM CELLS DEV, V20, P503, DOI 10.1089/scd.2010.0143
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Tatard VM, 2005, CURR DRUG TARGETS, V6, P81, DOI 10.2174/1389450053344885
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Totonchi M, 2010, INT J DEV BIOL, V54, P877, DOI 10.1387/ijdb.092903mt
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 29
TC 10
Z9 10
U1 0
U2 4
PU ROYAN INST
PI TEHRAN
PA PO BOX 19395-4644, TEHRAN, 00000, IRAN
SN 2228-5806
EI 2228-5814
J9 CELL J
JI Cell J.
PD SPR
PY 2014
VL 16
IS 1
BP 53
EP 62
PG 10
WC Cell Biology
SC Cell Biology
GA AH8XF
UT WOS:000336420800007
PM 24518975
DA 2018-10-19
ER

PT J
AU Huang, ZB
   Yin, GF
   Liao, XM
   Gu, JW
AF Huang, Zhong-Bing
   Yin, Guang-Fu
   Liao, Xiao-Ming
   Gu, Jian-Wen
TI Conducting polypyrrole in tissue engineering applications
SO FRONTIERS OF MATERIALS SCIENCE
LA English
DT Review
DE conducting polypyrrole; doping; modification; tissue engineering
ID NEURITE OUTGROWTH; IN-VIVO; ELECTRICAL-STIMULATION; POLYMERIC MATERIALS;
   NERVE REGENERATION; METALLIC POLYMERS; GLUCOSE-OXIDASE; 4TH GENERATION;
   STEM-CELLS; COMPOSITE
AB Polypyrrole (PPy), the earliest prepared conducting polymer, has good biocompatibility, easy synthesis and flexibility in processing. Compared with metal and inorganic materials, doped PPy has better mechanical match with live tissue, resulting in its many applications in biomedical field. This mini-review presents some information on specific PPy properties for tissue engineering applications, including its synthesis, doping, bio-modification. Although some challenges and unanswered problems still remain, PPy as novel biomaterial has promoted the development tissue engineering for its clinical application in the future.
C1 [Huang, Zhong-Bing; Yin, Guang-Fu; Liao, Xiao-Ming] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
   [Gu, Jian-Wen] PLA Gen Hosp Chengdu Mil Reg, Chengdu 610083, Peoples R China.
RP Yin, GF (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
EM nic0700@scu.edu.cn; 2914081083@qq.com
FU National Natural Science Foundation of China [51273122, 51173120,
   51372157]
FX This work was supported by the National Natural Science Foundation of
   China (Grant Nos. 51273122, 51173120 and 51372157).
CR Ahuja T, 2007, BIOMATERIALS, V28, P791, DOI 10.1016/j.biomaterials.2006.09.046
   Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Broda CR, 2011, J BIOMED MATER RES A, V98A, P509, DOI 10.1002/jbm.a.33128
   Castano H, 2004, MACROMOL BIOSCI, V4, P785, DOI 10.1002/mabi.200300123
   Cen L, 2003, BIOSENS BIOELECTRON, V18, P363, DOI 10.1016/S0956-5663(02)00149-5
   Cen Lian, 2004, Biomacromolecules, V5, P2238, DOI 10.1021/bm040048v
   Chen SJ, 2000, J MATER SCI LETT, V19, P2157, DOI 10.1023/A:1026799415199
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Cui XY, 2001, SENSOR ACTUAT A-PHYS, V93, P8, DOI 10.1016/S0924-4247(01)00637-9
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   DIAZ AF, 1986, HDB CONDUCTING POLYM, V1, P81
   Forciniti L, 2014, ACTA BIOMAT IN PRESS, DOI [10.1016/j.actbio.2014.01.030, DOI 10.1016/J.ACTBI0.2014.01.030]
   Garner B, 1999, J MATER SCI-MATER M, V10, P19, DOI 10.1023/A:1008835925998
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Ghasemi-Mobarakeh L, 2011, J TISSUE ENG REGEN M, V5, pE17, DOI 10.1002/term.383
   Gomez N, 2007, ADV FUNCT MATER, V17, P1645, DOI 10.1002/adfm.200600669
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Hardy JG, 2013, CURR OPIN BIOTECH, V24, P847, DOI 10.1016/j.copbio.2013.03.011
   Heeger AJ, 2001, ANGEW CHEM INT EDIT, V40, P2591, DOI 10.1002/1521-3773(20010716)40:14<2591::AID-ANIE2591>3.0.CO;2-0
   Heeger AJ, 2001, J PHYS CHEM B, V105, P8475, DOI 10.1021/jp011611w
   Hodgson AJ, 1996, PROC SPIE, V2716, P164, DOI 10.1117/12.232137
   Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019
   Kim SY, 2011, ACS APPL MATER INTER, V3, P16, DOI 10.1021/am1008369
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee JW, 2006, LANGMUIR, V22, P9816, DOI 10.1021/la062129d
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Miodek A, 2014, BIOSENS BIOELECTRON, V56, P104, DOI 10.1016/j.bios.2013.12.051
   Moon JM, 2014, BIOSENS BIOELECTRON, V57, P157, DOI 10.1016/j.bios.2014.02.016
   Navale ST, 2014, MEASUREMENT, V50, P363, DOI 10.1016/j.measurement.2014.01.012
   Nickels JD, 2013, J BIOMED MATER RES A, V101, P1464, DOI 10.1002/jbm.a.34435
   Pyo M, 1996, CHEM MATER, V8, P128, DOI 10.1021/cm950299y
   Richardson RT, 2007, BIOMATERIALS, V28, P513, DOI 10.1016/j.biomaterials.2006.09.008
   Rivers TJ, 2002, ADV FUNCT MATER, V12, P33, DOI 10.1002/1616-3028(20020101)12:1<33::AID-ADFM33>3.0.CO;2-E
   Sajesh KM, 2013, INT J BIOL MACROMOL, V62, P465, DOI 10.1016/j.ijbiomac.2013.09.028
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Sangian D, 2014, SYNTHETIC MET, V189, P53, DOI 10.1016/j.synthmet.2013.12.021
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Stauffer WR, 2006, BIOMATERIALS, V27, P2405, DOI 10.1016/j.biomaterials.2005.10.024
   Thomas CA, 2000, ADV MATER, V12, P222, DOI 10.1002/(SICI)1521-4095(200002)12:3<222::AID-ADMA222>3.0.CO;2-D
   TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0
   Tonazzini I, 2013, BIOMATERIALS, V34, P6027, DOI 10.1016/j.biomaterials.2013.04.039
   Tourillon G., 1986, HDB CONDUCTING POLYM, V1, P293
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   UMANA M, 1986, ANAL CHEM, V58, P2979, DOI 10.1021/ac00127a018
   Upadhyay J, 2014, SYNTHETIC MET, V189, P119, DOI 10.1016/j.synthmet.2014.01.004
   Vaitkuviene A, 2014, COLLOID SURFACE A, V442, P152, DOI 10.1016/j.colsurfa.2013.06.030
   Vaitkuviene A, 2013, J HAZARD MATER, V250, P167, DOI 10.1016/j.jhazmat.2013.01.038
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wang ZX, 2003, J BIOMED MATER RES A, V66A, P738, DOI 10.1002/jbm.a.10037
   Wang ZX, 2004, J BIOMED MATER RES A, V70A, P28, DOI 10.1002/jbm.a.30047
   Weiland JD, 2000, IEEE T BIO-MED ENG, V47, P911, DOI 10.1109/10.846685
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
   Xu HX, 2014, BIOMATERIALS, V35, P225, DOI 10.1016/j.biomaterials.2013.10.002
   ZELIKIN AN, 2002, ANGEW CHEM, V114, P149
   Zeng J. W., 2013, MAT SCI, V3, P125
   Zeng JW, 2013, COLLOID SURFACE B, V110, P450, DOI 10.1016/j.colsurfb.2013.05.012
NR 64
TC 24
Z9 24
U1 13
U2 121
PU HIGHER EDUCATION PRESS
PI BEIJING
PA SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA
SN 2095-025X
EI 2095-0268
J9 FRONT MATER SCI
JI Front. Mater. Sci.
PD MAR
PY 2014
VL 8
IS 1
BP 39
EP 45
DI 10.1007/s11706-014-0238-8
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH9BL
UT WOS:000336433900005
DA 2018-10-19
ER

PT J
AU Rajendran, K
   Walsh, MF
   de Ruiter, NJA
   Chernoglazov, AI
   Panta, RK
   Butler, APH
   Butler, PH
   Bell, ST
   Anderson, NG
   Woodfield, TBF
   Tredinnick, SJ
   Healy, JL
   Bateman, CJ
   Aamir, R
   Doesburg, RMN
   Renaud, PF
   Gieseg, SP
   Smithies, DJ
   Mohr, JL
   Mandalika, VBH
   Opie, AMT
   Cook, NJ
   Ronaldson, JP
   Nik, SJ
   Atharifard, A
   Clyne, M
   Bones, PJ
   Bartneck, C
   Grasset, R
   Schleich, N
   Billinghurst, M
AF Rajendran, K.
   Walsh, M. F.
   de Ruiter, N. J. A.
   Chernoglazov, A. I.
   Panta, R. K.
   Butler, A. P. H.
   Butler, P. H.
   Bell, S. T.
   Anderson, N. G.
   Woodfield, T. B. F.
   Tredinnick, S. J.
   Healy, J. L.
   Bateman, C. J.
   Aamir, R.
   Doesburg, R. M. N.
   Renaud, P. F.
   Gieseg, S. P.
   Smithies, D. J.
   Mohr, J. L.
   Mandalika, V. B. H.
   Opie, A. M. T.
   Cook, N. J.
   Ronaldson, J. P.
   Nik, S. J.
   Atharifard, A.
   Clyne, M.
   Bones, P. J.
   Bartneck, C.
   Grasset, R.
   Schleich, N.
   Billinghurst, M.
TI Reducing beam hardening effects and metal artefacts in spectral CT using
   Medipix3RX
SO JOURNAL OF INSTRUMENTATION
LA English
DT Article
DE Medical-image reconstruction methods and algorithms, computer-aided
   diagnosis; X-ray detectors; Computerized Tomography (CT) and Computed
   Radiography (CR)
ID COMPUTED-TOMOGRAPHY; REDUCTION; MODEL
AB This paper discusses methods for reducing beam hardening effects and metal artefacts using spectral x-ray information in biomaterial samples. A small-animal spectral scanner was operated in the 15 to 80 keV x-ray energy range for this study. We use the photon-processing features of a CdTe-Medipix3RX ASIC in charge summing mode to reduce beam hardening and associated artefacts. We present spectral data collected for metal alloy samples, its analysis using algebraic 3D reconstruction software and volume visualisation using a custom volume rendering software. The cupping effect and streak artefacts are quantified in the spectral datasets. The results show reduction in beam hardening effects and metal artefacts in the narrow high energy range acquired using the spectroscopic detector. A post-reconstruction comparison between CdTe-Medipix3RX and Si-Medipix3.1 is discussed. The raw data and processed data are made available (http://hdl.handle.net/10092/8851) for testing with other software routines.
C1 [Rajendran, K.; Walsh, M. F.; de Ruiter, N. J. A.; Panta, R. K.; Butler, A. P. H.; Anderson, N. G.; Woodfield, T. B. F.; Bateman, C. J.; Aamir, R.; Mohr, J. L.; Ronaldson, J. P.; Atharifard, A.] Univ Otago, Christchurch 8140, New Zealand.
   [Chernoglazov, A. I.; Butler, A. P. H.; Butler, P. H.; Woodfield, T. B. F.; Tredinnick, S. J.; Healy, J. L.; Doesburg, R. M. N.; Renaud, P. F.; Gieseg, S. P.; Mandalika, V. B. H.; Opie, A. M. T.; Nik, S. J.; Bones, P. J.; Bartneck, C.; Grasset, R.; Billinghurst, M.] Univ Canterbury, Christchurch 8140, New Zealand.
   [Butler, A. P. H.; Butler, P. H.; Doesburg, R. M. N.] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland.
   [Butler, A. P. H.; Butler, P. H.; Bell, S. T.; Smithies, D. J.] MARS Bioimaging Ltd, Christchurch, New Zealand.
   [Cook, N. J.] Canterbury Dist Hlth Board, Christchurch 8140, New Zealand.
   [Clyne, M.] ILR, Christchurch, New Zealand.
   [Schleich, N.] Univ Otago, Wellington 6021, New Zealand.
RP Rajendran, K (reprint author), Univ Otago, 2 Riccarton Ave, Christchurch 8140, New Zealand.
EM kishore.rajendran@canterbury.ac.nz
RI Woodfield, Tim/A-2705-2009; Bartneck, Christoph/B-5699-2008
OI Woodfield, Tim/0000-0002-5428-7575; Bartneck,
   Christoph/0000-0003-4566-4815; Rajendran, Kishore/0000-0002-8314-3642;
   Bateman, Christopher/0000-0002-7512-5583; Mandalika, Veera Bhadra
   Harish/0000-0001-8027-6645; Anderson, Nigel/0000-0003-0518-5625
FU Ministry of Business, Innovation and Employment (MBIE), New Zealand
   [UOCX0805]
FX This project was funded by Ministry of Business, Innovation and
   Employment (MBIE), New Zealand under contract number UOCX0805. The
   authors would like to thank all members of MARS-CT project, the Medipix2
   collaboration, and the Medipix3 collaboration. In particular we
   acknowledge the CERN based designers Michael Campbell, Lukas Tlustos,
   Xavier Llopart, Rafael Ballabriga and Winnie Wong, and the material
   scientists Alex Fauler, Simon Procz, Elias Hamann, Martin Pichotka, and
   Michael Fiederle from Freiburger Materialforschungszentrum (FMF) and
   X-ray Imaging Europe GmbH. We also thank Graeme Kershaw, University of
   Canterbury for preparing the hardware phantom, and Anton Angelo,
   University of Canterbury for co-ordinating access to the data
   repository.
CR Aamir R, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01059
   ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7
   Ballabriga R, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/02/C02016
   Bamberg F, 2011, EUR RADIOL, V21, P1424, DOI 10.1007/s00330-011-2062-1
   Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065
   Berger M, 2011, NIST XCOM PHOTON CRO
   Biemond JE, 2013, J MATER SCI-MATER M, V24, P745, DOI 10.1007/s10856-012-4836-7
   Chmeissani M., 2004, INSTR MEAS TECHN C 2, V1, P787
   Cho HM, 2013, PHYS MED BIOL, V58, P4865, DOI 10.1088/0031-9155/58/14/4865
   Cormode DP, 2010, RADIOLOGY, V256, P774, DOI 10.1148/radiol.10092473
   Feuerlein S, 2008, RADIOLOGY, V249, P1010, DOI 10.1148/radiol.2492080560
   Habibovic P., 2007, TISSUE ENG, V585, P327
   Kroes T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038586
   Meyer E, 2012, MED PHYS, V39, P1904, DOI 10.1118/1.3691902
   Meyer E, 2010, MED PHYS, V37, P5482, DOI 10.1118/1.3484090
   Nguyen TL, 2011, ADV ENG MATER, V13, P872, DOI 10.1002/adem.201100029
   Panta R.K., ENERGY RESOLVI UNPUB
   Procz S, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/01/C01025
   Ronaldson JP, 2012, MED PHYS, V39, P6847, DOI 10.1118/1.4760773
   Sijbers J, 2004, PHYS MED BIOL, V49, pN247, DOI 10.1088/0031-9155/49/14/N06
   Takahashi T, 2001, IEEE T NUCL SCI, V48, P950, DOI 10.1109/23.958705
   Tang N.D., 2012, IVCNZ 12, P216
   Van de Casteele E, 2004, J X-RAY SCI TECHNOL, V12, P43
   Van de Casteele E, 2002, PHYS MED BIOL, V47, P4181, DOI 10.1088/0031-9155/47/23/305
   Walsh MF, 2013, J INSTRUM, V8, DOI 10.1088/1748-0221/8/10/P10012
   Walsh MF, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/01/C01095
   Walsh M.F., 2013, THESIS U OTAGO
   Zainon R, 2012, EUR RADIOL, V22, P2581, DOI 10.1007/s00330-012-2538-7
   Zeller H, 2009, 2009 24TH INTERNATIONAL CONFERENCE IMAGE AND VISION COMPUTING NEW ZEALAND (IVCNZ 2009), P363, DOI 10.1109/IVCNZ.2009.5378381
NR 29
TC 11
Z9 11
U1 2
U2 21
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-0221
J9 J INSTRUM
JI J. Instrum.
PD MAR
PY 2014
VL 9
AR P03015
DI 10.1088/1748-0221/9/03/P03015
PG 13
WC Instruments & Instrumentation
SC Instruments & Instrumentation
GA AH4UE
UT WOS:000336123200075
OA Other Gold
DA 2018-10-19
ER

PT J
AU Li, YH
   Yang, C
   Zhao, HD
   Qu, SG
   Li, XQ
   Li, YY
AF Li, Yuhua
   Yang, Chao
   Zhao, Haidong
   Qu, Shengguan
   Li, Xiaoqiang
   Li, Yuanyuan
TI New Developments of Ti-Based Alloys for Biomedical Applications
SO MATERIALS
LA English
DT Review
DE beta-type Ti-based alloys; porous Ti-based alloys; microstructure;
   mechanical properties
ID SHAPE-MEMORY ALLOYS; TITANIUM DENTAL IMPLANTS; TOTAL HIP-ARTHROPLASTY;
   LOW YOUNGS MODULUS; POWDER-METALLURGY TECHNIQUE; HIGH-TEMPERATURE
   SYNTHESIS; POROUS TI-10MO ALLOY; ZR SYSTEM ALLOYS;
   MECHANICAL-PROPERTIES; BONE-TISSUE
AB Ti-based alloys are finding ever-increasing applications in biomaterials due to their excellent mechanical, physical and biological performance. Nowdays, low modulus beta-type Ti-based alloys are still being developed. Meanwhile, porous Ti-based alloys are being developed as an alternative orthopedic implant material, as they can provide good biological fixation through bone tissue ingrowth into the porous network. This paper focuses on recent developments of biomedical Ti-based alloys. It can be divided into four main sections. The first section focuses on the fundamental requirements titanium biomaterial should fulfill and its market and application prospects. This section is followed by discussing basic phases, alloying elements and mechanical properties of low modulus beta-type Ti-based alloys. Thermal treatment, grain size, texture and properties in Ti-based alloys and their limitations are dicussed in the third section. Finally, the fourth section reviews the influence of microstructural configurations on mechanical properties of porous Ti-based alloys and all known methods for fabricating porous Ti-based alloys. This section also reviews prospects and challenges of porous Ti-based alloys, emphasizing their current status, future opportunities and obstacles for expanded applications. Overall, efforts have been made to reveal the latest scenario of bulk and porous Ti-based materials for biomedical applications.
C1 [Li, Yuhua; Yang, Chao; Zhao, Haidong; Qu, Shengguan; Li, Xiaoqiang; Li, Yuanyuan] S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou 510640, Guangdong, Peoples R China.
RP Yang, C (reprint author), S China Univ Technol, Natl Engn Res Ctr Near Net Shape Forming Metall M, Guangzhou 510640, Guangdong, Peoples R China.
EM liyuhuascut@126.com; cyang@scut.edu.cn; hdzhao@scut.edu.cn;
   qusg@scut.edu.cn; lixq@scut.edu.cn; mehjli@scut.edu.cn
RI Yang, Chao/H-1905-2015
FU Guangdong Natural Science Foundation [S2013010012147]; Science and
   Technology Innovation Project of Higher School of Guangdong Province
   [2012KJCX0010]; Fundamental Research Funds for the Central Universities
   [2013ZZ0008]; Program for New Century Excellent Talents in University
   [NCET-11-0163]; Excellent Young Talents of South China University of
   Technology
FX This work was supported by the Guangdong Natural Science Foundation (No.
   S2013010012147), the Science and Technology Innovation Project of Higher
   School of Guangdong Province (No. 2012KJCX0010), the Fundamental
   Research Funds for the Central Universities (No. 2013ZZ0008), the
   Program for New Century Excellent Talents in University (No.
   NCET-11-0163), and the Excellent Young Talents of South China University
   of Technology.
CR Abdel-Hady M, 2007, SCRIPTA MATER, V57, P1000, DOI 10.1016/j.scriptamat.2007.08.003
   Maya AEA, 2012, MAT SCI ENG C-MATER, V32, P321, DOI 10.1016/j.msec.2011.10.035
   Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Angelo P.C., 2009, POWDER METALLURGY SC, P41
   Arakawa Y, 2012, MATERIALS, V5, P1267, DOI 10.3390/ma5071267
   Arakawa Y, 2011, J JPN I MET, V75, P379, DOI 10.2320/jinstmet.75.379
   Ari-Gur P, 1998, MAT SCI ENG A-STRUCT, V257, P118, DOI 10.1016/S0921-5093(98)00829-6
   ARZT E, 1983, METALL TRANS A, V14, P211, DOI 10.1007/BF02651618
   ASAOKA K, 1985, J BIOMED MATER RES, V19, P699, DOI 10.1002/jbm.820190609
   Ashida S, 2012, MATER SCI FORUM, V706-709, P1943, DOI 10.4028/www.scientific.net/MSF.706-709.1943
   Asthana R, 2006, MATERIALS PROCESSING AND MANUFACTURING SCIENCE, pXVIII, DOI 10.1016/B978-075067716-5/50001-7
   Aydogmus T, 2012, J MECH BEHAV BIOMED, V15, P59, DOI 10.1016/j.jmbbm.2012.05.018
   Aydogmus T, 2009, J ALLOY COMPD, V478, P705, DOI 10.1016/j.jallcom.2008.11.141
   Balla VK, 2010, ACTA BIOMATER, V6, P3349, DOI 10.1016/j.actbio.2010.01.046
   Bandyopadhyay A, 2010, ACTA BIOMATER, V6, P1640, DOI 10.1016/j.actbio.2009.11.011
   Banerjee R, 2003, ACTA MATER, V51, P3277, DOI 10.1016/S1359-6454(03)00158-7
   Banhart J, 2001, PROG MATER SCI, V46, P559, DOI 10.1016/S0079-6425(00)00002-5
   Banhart J., 1999, P INT C METF
   Bannon BP, 1983, TITANIUM ALLOYS SURG, V796, P7
   Bansiddhi A, 2008, ACTA BIOMATER, V4, P1996, DOI 10.1016/j.actbio.2008.06.005
   Barrabes A, 2008, MAT SCI ENG C-BIO S, V28, P23, DOI 10.1016/j.msec.2007.02.001
   Bastawros AF, 2000, J MECH PHYS SOLIDS, V48, P301, DOI 10.1016/S0022-5096(99)00035-6
   Bertheville B, 2006, BIOMATERIALS, V27, P1246, DOI 10.1016/j.biomaterials.2005.09.014
   Biswas A, 2005, ACTA MATER, V53, P1415, DOI 10.1016/j.actamat.2004.11.036
   Black J., 1998, HDB BIOMATERIAL PROP, P16
   Bonisch M, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/055004
   Bothe R., 1940, SURG GYNECOL OBSTET, V71, P598
   Boyer B., 2007, MAT PROPERTIES HDB T, P790
   Brailovski V, 2011, MAT SCI ENG C-MATER, V31, P643, DOI 10.1016/j.msec.2010.12.008
   Brailovski V., 2013, J ALLOY COMPD, V577, pS414
   Bram M, 2000, ADV ENG MATER, V2, P196, DOI 10.1002/(SICI)1527-2648(200004)2:4<196::AID-ADEM196>3.0.CO;2-K
   Branemark R, 2001, J REHABIL RES DEV, V38, P175
   Brizuela M, 2002, J MATER SCI-MATER M, V13, P1129, DOI 10.1023/A:1021129718737
   Burstein A.H., 1993, SURG KNEE, V7, P43
   BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015
   Cachinho SCP, 2007, POWDER TECHNOL, V178, P109, DOI 10.1016/j.powtec.2007.04.014
   Calin M, 2013, MAT SCI ENG C-MATER, V33, P875, DOI 10.1016/j.msec.2012.11.015
   CAMERON HU, 1978, INT J ARTIF ORGANS, V1, P104
   Capela MV, 2008, J ALLOY COMPD, V465, P479, DOI 10.1016/j.jallcom.2007.10.115
   Chen LJ, 2009, T NONFERR METAL SOC, V19, P1174, DOI 10.1016/S1003-6326(08)60424-0
   Chen YJ, 2009, MATER LETT, V63, P2659, DOI 10.1016/j.matlet.2009.09.029
   Chino Y, 2008, ACTA MATER, V56, P105, DOI 10.1016/j.actamat.2007.09.002
   Chu CL, 2004, MAT SCI ENG A-STRUCT, V366, P114, DOI 10.1016/j.msea.2003.08.118
   Chung CY, 2004, MATER LETT, V58, P1683, DOI 10.1016/j.matlet.2003.10.045
   Cleason T.A., 1999, U.S. Patent, Patent No. [5,871,595 A, 5871595A]
   Cochran G.V.B., 1982, PRIMER ORTHOPAEDIC B, P143
   Curodeau A, 2000, J BIOMED MATER RES, V53, P525, DOI 10.1002/1097-4636(200009)53:5<525::AID-JBM12>3.0.CO;2-1
   Ding M, 1997, J BONE JOINT SURG BR, V79B, P995, DOI 10.1302/0301-620X.79B6.7538
   Ducheyne P, 1974, Acta Orthop Belg, V40, P799
   Dunand DC, 2004, ADV ENG MATER, V6, P369, DOI 10.1002/adem.200405576
   Eosoly S, 2010, ACTA BIOMATER, V6, P2511, DOI 10.1016/j.actbio.2009.07.018
   Erk KA, 2008, ACTA MATER, V56, P5147, DOI 10.1016/j.actamat.2008.06.035
   Esen Z, 2007, SCRIPTA MATER, V56, P341, DOI 10.1016/j.scriptamat.2006.11.010
   Esen Z, 2011, MAT SCI ENG A-STRUCT, V528, P3200, DOI 10.1016/j.msea.2011.01.008
   EVANS FG, 1976, ANAT REC, V185, P1, DOI 10.1002/ar.1091850102
   Fang Z, 2005, COMPUT AIDED DESIGN, V37, P65, DOI 10.1016/j.cad.2004.04.002
   Ford CM, 1998, INT J MECH SCI, V40, P521, DOI 10.1016/S0020-7403(97)00064-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gabriel SB, 2012, J ALLOY COMPD, V536, pS208, DOI 10.1016/j.jallcom.2011.11.035
   Gao ZF, 2012, MATER DESIGN, V42, P13, DOI 10.1016/j.matdes.2012.05.041
   Geetha M, 2004, J ALLOY COMPD, V384, P131, DOI 10.1016/j.jallcom.2004.04.113
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Geetha M, 2001, J ALLOY COMPD, V329, P264, DOI 10.1016/S0925-8388(01)01604-8
   Gepreel MAH, 2013, J MECH BEHAV BIOMED, V20, P407, DOI 10.1016/j.jmbbm.2012.11.014
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gilissen R, 2000, MATER DESIGN, V21, P251, DOI 10.1016/S0261-3069(99)00075-8
   Gross S, 2001, J BIOMECH, V34, P995, DOI 10.1016/S0021-9290(01)00072-0
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Guo S, 2013, PROG NAT SCI-MATER, V23, P174, DOI 10.1016/j.pnsc.2013.03.008
   HAHN H, 1970, Journal of Biomedical Materials Research, V4, P571, DOI 10.1002/jbm.820040407
   Hallab NJ, 2005, J ORTHOP RES, V23, P384, DOI 10.1016/j.orthres.2004.09.001
   Hanawa T, 2006, MATER SCI FORUM, V512, P243, DOI 10.4028/www.scientific.net/MSF.512.243
   Hao YL, 2003, METALL MATER TRANS A, V34A, P1007, DOI 10.1007/s11661-003-0230-x
   Hao YL, 2002, METALL MATER TRANS A, V33, P3137, DOI 10.1007/s11661-002-0299-7
   HAYASHI K, 1991, J BIOMED MATER RES, V25, P515, DOI 10.1002/jbm.820250408
   He G, 2006, MAT SCI ENG C-BIO S, V26, P14, DOI 10.1016/j.msec.2005.03.007
   He G, 2012, J MECH BEHAV BIOMED, V5, P16, DOI 10.1016/j.jmbbm.2011.09.016
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Heinl P, 2008, ACTA BIOMATER, V4, P1536, DOI 10.1016/j.actbio.2008.03.013
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   HIRSCHHORN JS, 1971, J BIOMED MATER RES S, V2, P49
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hollander DA, 2006, BIOMATERIALS, V27, P955, DOI 10.1016/j.biomaterials.2005.07.041
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HOMSY CA, 1972, CLIN ORTHOP RELAT R, P220
   Hrabe N.W., 2010, THESIS U WASHINGTON
   Hsu HC, 2013, J ALLOY COMPD, V575, P326, DOI 10.1016/j.jallcom.2013.05.186
   Hsu HC, 2009, J ALLOY COMPD, V488, P279, DOI 10.1016/j.jallcom.2009.08.105
   HULTH A, 1989, CLIN ORTHOP RELAT R, P265
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Hutzschenreuter P., 1980, CURRENT CONCEPTS INT, P244
   Hynowska A, 2012, MAT SCI ENG C-MATER, V32, P2418, DOI 10.1016/j.msec.2012.07.016
   Ibrahim A, 2011, MATER DESIGN, V32, P146, DOI 10.1016/j.matdes.2010.06.019
   Ikeda M, 2012, MATER SCI FORUM, V706-709, P1893, DOI 10.4028/www.scientific.net/MSF.706-709.1893
   Ikeda M, 2009, MATER TRANS, V50, P2737, DOI 10.2320/matertrans.MA200902
   Imwinkelried T, 2007, J BIOMED MATER RES A, V81A, P964, DOI 10.1002/jbm.a.31118
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Jablokov V. R., 2005, J ASTM INT, V2, P1
   Jee CSY, 2000, METALL MATER TRANS B, V31, P1345, DOI 10.1007/s11663-000-0021-3
   Jha N, 2013, MATER DESIGN, V47, P810, DOI 10.1016/j.matdes.2013.01.005
   Jiang HC, 2006, ACTA METALL SIN, V42, P1153
   Josephajr G, 2006, U.S. Patent, Patent No. [2,006,002,810 A1, 2006002810A1]
   Jung HD, 2013, MAT SCI ENG C-MATER, V33, P59, DOI 10.1016/j.msec.2012.08.004
   Jung TK, 2013, MAT SCI ENG C-MATER, V33, P1629, DOI 10.1016/j.msec.2012.12.072
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   KARAGIANES M T, 1973, Biomaterials Medical Devices and Artificial Organs, V1, P171
   Kato K, 2013, ACTA BIOMATER, V9, P5802, DOI 10.1016/j.actbio.2012.11.018
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Klawitter J J, 1974, Acta Orthop Belg, V40, P755
   Kohl M, 2008, POROUS METALS AND METALLIC FOAMS: METFOAM 2007, P295
   Kon M, 2004, J BIOMED MATER RES B, V68B, P88, DOI 10.1002/jbm.b.20004
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   KUHLMAN GW, 1991, MICROSTRUCTURE / PROPERTY RELATIONSHIPS IN TITANIUM ALUMINIDES AND ALLOYS, P465
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kumar S, 2003, JOM-J MIN MET MAT S, V55, P43, DOI 10.1007/s11837-003-0175-y
   Kuroda D, 2005, MAT SCI ENG C-BIO S, V25, P312, DOI 10.1016/j.msec.2005.04.004
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222
   Kusano Y, 2010, MATER SCI FORUM, V654-656, P2118, DOI 10.4028/www.scientific.net/MSF.654-656.2118
   Kutty MG, 2004, J MATER SCI-MATER M, V15, P145, DOI 10.1023/B:JMSM.0000011815.50383.bd
   Laheurte P, 2005, MAT SCI ENG A-STRUCT, V396, P223, DOI 10.1016/j.msea.2005.01.022
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Laptev A, 2005, POWDER METALL, V48, P358, DOI 10.1179/174329005X73838
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Lee DG, 2004, MAT SCI ENG A-STRUCT, V366, P25, DOI 10.1016/j.msea.2003.08.061
   Lee JH, 2010, MATER LETT, V64, P2526, DOI 10.1016/j.matlet.2010.08.038
   LEVENTHAL GS, 1951, J BONE JOINT SURG AM, V33-A, P473, DOI 10.2106/00004623-195133020-00021
   Li BQ, 2013, MATER DESIGN, V50, P613, DOI 10.1016/j.matdes.2013.02.082
   Li BQ, 2012, MAT SCI ENG A-STRUCT, V534, P43, DOI 10.1016/j.msea.2011.11.028
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li BY, 2000, INTERMETALLICS, V8, P881, DOI 10.1016/S0966-9795(00)00024-8
   Li BY, 1998, MAT SCI ENG A-STRUCT, V255, P70, DOI 10.1016/S0921-5093(98)00780-1
   Li CF, 2005, POWDER METALL, V48, P237, DOI 10.1179/174329005X64162
   Li DS, 2009, J ALLOY COMPD, V474, pL1, DOI 10.1016/j.jallcom.2008.06.043
   Li H, 2006, RARE METAL MAT ENG, V35, P154
   Li HL, 2004, MATER TRANS, V45, P1124, DOI 10.2320/matertrans.45.1124
   Li JC, 2011, ACTA MATER, V59, P146, DOI 10.1016/j.actamat.2010.09.019
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Li JP, 2003, KEY ENG MAT, V240-2, P547, DOI 10.4028/www.scientific.net/KEM.240-242.547
   Li JP, 2002, KEY ENG MAT, V218-2, P51, DOI 10.4028/www.scientific.net/KEM.218-220.51
   Li P, 2009, ACTA MATER, V57, P3539, DOI 10.1016/j.actamat.2009.04.008
   Li SJ, 2008, ACTA BIOMATER, V4, P305, DOI 10.1016/j.actbio.2007.09.009
   Li YY, 2013, MAT SCI ENG A-STRUCT, V560, P857, DOI 10.1016/j.msea.2012.09.047
   Li YH, 2001, J ALLOY COMPD, V325, P259, DOI 10.1016/S0925-8388(01)01382-2
   Li YH, 2009, J ALLOY COMPD, V485, P215, DOI 10.1016/j.jallcom.2009.06.003
   LIFLAND MI, 1994, CLIN MATER, V17, P203, DOI 10.1016/0267-6605(94)90037-X
   LINDAHL O, 1976, ACTA ORTHOP SCAND, V47, P11, DOI 10.3109/17453677608998966
   LINDAHL O, 1967, ACTA ORTHOP SCAND, V38, P141, DOI 10.3109/17453676708989628
   Liu P, 2009, MAT SCI ENG A-STRUCT, V509, P69, DOI 10.1016/j.msea.2009.01.014
   Liu WP, 2003, SCRIPTA MATER, V48, P1337, DOI 10.1016/S1359-6462(03)00020-4
   Liu X, 2011, ACTA BIOMATER, V7, P406, DOI 10.1016/j.actbio.2010.08.025
   Liu Y, 2006, MAT SCI ENG A-STRUCT, V418, P25, DOI [10.1016/j.msea.2005.10.057, 10.1016/j.msca.2005.10.057]
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Long M, 1999, ACTA MATER, V47, P661, DOI 10.1016/S1359-6454(98)00343-7
   Lopez-Heredia MA, 2008, BIOMATERIALS, V29, P2608, DOI 10.1016/j.biomaterials.2008.02.021
   LUECK R A, 1969, Surgical Forum (Chicago), V20, P456
   Lutjering G, 1999, MAT SCI ENG A-STRUCT, V263, P117, DOI 10.1016/S0921-5093(98)01169-1
   Lutjering G., 2003, TITANIUM, P20
   Majumdar JD, 2005, APPL SURF SCI, V247, P320, DOI 10.1016/j.apsusc.2005.01.039
   Malinov S, 2001, METALL MATER TRANS A, V32, P879, DOI 10.1007/s11661-001-0345-x
   Mansourighasri A, 2012, J MATER PROCESS TECH, V212, P83, DOI 10.1016/j.jmatprotec.2011.08.008
   Manukyan K, 2010, CHEM ENG J, V162, P406, DOI 10.1016/j.cej.2010.05.042
   Markaki AE, 2001, ACTA MATER, V49, P1677, DOI 10.1016/S1359-6454(01)00072-6
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Matsumoto H., 2006, P MAT PROC MED DEV C
   Mazumder J, 2005, PROC SPIE, V5706, P38, DOI 10.1117/12.601652
   Menini R, 2006, J ELECTROCHEM SOC, V153, pB13, DOI 10.1149/1.2128098
   Mitchell A, 1998, MAT SCI ENG A-STRUCT, V243, P257, DOI 10.1016/S0921-5093(97)00810-1
   Miyao R., 2000, J JAPAN SOC POWDER M, V47, P1239
   Miyazaki S, 2006, MAT SCI ENG A-STRUCT, V438, P18, DOI 10.1016/j.msea.2006.02.054
   MOYEN BJL, 1978, J BONE JOINT SURG AM, V60, P940, DOI 10.2106/00004623-197860070-00012
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2
   Murayama Y., 2009, B NIIGATA I TECH, V14, P1
   Nag S, 2005, MAT SCI ENG C-BIO S, V25, P357, DOI 10.1016/j.msec.2004.12.013
   Nakai M, 2011, MATER LETT, V65, P688, DOI 10.1016/j.matlet.2010.11.006
   Nakai M, 2010, J MECH BEHAV BIOMED, V3, P41, DOI 10.1016/j.jmbbm.2009.03.003
   Narayan R., 2012, ASM HDB, V23, P6
   Neirinck B, 2009, ADV ENG MATER, V11, P633, DOI 10.1002/adem.200900074
   Nicula R, 2007, BIOMOL ENG, V24, P564, DOI 10.1016/j.bioeng.2007.08.008
   Niinomi M, 2011, INT J BIOMATER, DOI 10.1155/2011/836587
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M., 2004, BIOMATERIALS ORTHOPE, P41
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Niinomi M, 2007, MATER SCI FORUM, V539-543, P193, DOI 10.4028/www.scientific.net/MSF.539-543.193
   Niinomi M, 2007, MAT SCI ENG C-BIO S, V27, P154, DOI 10.1016/j.msec.2006.04.008
   Niinomi M, 2003, SCI TECHNOL ADV MAT, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Niinomi M, 2012, ACTA BIOMATER, V8, P3888, DOI 10.1016/j.actbio.2012.06.037
   Niinomi M, 2010, EXPERT REV MED DEVIC, V7, P481, DOI [10.1586/erd.10.16, 10.1586/ERD.10.16]
   Niu WJ, 2010, COMP MATER SCI, V50, P172, DOI 10.1016/j.commatsci.2010.07.022
   Niu WJ, 2009, MAT SCI ENG A-STRUCT, V506, P148, DOI 10.1016/j.msea.2008.11.022
   Nomura N, 2005, MATER SCI FORUM, V475-479, P2313, DOI 10.4028/www.scientific.net/MSF.475-479.2313
   Nugroho AW, 2010, J MATER SCI-MATER M, V21, P3103, DOI 10.1007/s10856-010-4162-x
   Oghbaei M, 2010, J ALLOY COMPD, V494, P175, DOI 10.1016/j.jallcom.2010.01.068
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oh IH, 2007, MATER SCI FORUM, V539-543, P635, DOI 10.4028/www.scientific.net/MSF.539-543.635
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira V., 1998, BRAZ J CHEM ENG, V17, P326
   OTANI T, 1992, ORTHOP CLIN N AM, V23, P335
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   OUCHI C, 1994, METALLURGY AND TECHNOLOGY OF PRACTICAL TITANIUM ALLOYS, P37
   Ozaki T., 2005, ADV MATER PROCESS, V163, P68
   Park J.B., 2000, BIOMEDICAL ENG HDB, V1, pIV1
   Park J.B., 2003, BIOMATERIALS PRINCIP, P1
   Patnaik P., 2003, HDB INORGANIC CHEM
   Perren M.S., 2001, TITANIUM MED, P772
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   PRAKASH O, 1995, MAT SCI ENG A-STRUCT, V199, P195, DOI 10.1016/0921-5093(94)09708-9
   Qazi J, 2003, TITANIUM 2003 SCI TE, V1, P651
   Qazi J.I., 2004, TITANIUM 2003 SCI TE, P1651
   Qazi JI, 2005, ADV ENG MATER, V7, P993, DOI 10.1002/adem.200500060
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Qiu J, 1997, BIOMATERIALS, V18, P153, DOI 10.1016/S0142-9612(96)00097-X
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Raj RE, 2009, J ALLOY COMPD, V467, P550, DOI 10.1016/j.jallcom.2007.12.040
   Rak ZS, 2006, J MATER PROCESS TECH, V175, P358, DOI 10.1016/j.jmatprotec.2005.04.006
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   de Vasconcellos LMR, 2008, MATER RES-IBERO-AM J, V11, P275, DOI 10.1590/S1516-14392008000300008
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Roberts AP, 2000, J AM CERAM SOC, V83, P3041, DOI 10.1111/j.1151-2916.2000.tb01680.x
   Roberts AP, 2001, ACTA MATER, V49, P189, DOI 10.1016/S1359-6454(00)00314-1
   Roberts AP, 2002, J MECH PHYS SOLIDS, V50, P33, DOI 10.1016/S0022-5096(01)00056-4
   ROBERTSON DM, 1976, J BIOMED MATER RES, V10, P335, DOI 10.1002/jbm.820100304
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Saha MC, 2005, MAT SCI ENG A-STRUCT, V406, P328, DOI 10.1016/j.msea.2005.07.006
   Saitou K, 2006, SCRIPTA MATER, V54, P875, DOI 10.1016/j.scriptamat.2005.11.006
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P363, DOI 10.1016/j.msec.2004.12.014
   Sakaguchi N, 2005, MAT SCI ENG C-BIO S, V25, P370, DOI 10.1016/j.msec.2005.04.003
   Sakaguchi N, 2004, MATER SCI FORUM, V449-4, P1269, DOI 10.4028/www.scientific.net/MSF.449-452.1269
   Sakaguchi N, 2003, J JPN I MET, V67, P681, DOI 10.2320/jinstmet1952.67.11_681
   Sakamoto Y, 2006, BIO-MED MATER ENG, V16, P83
   Salito A, 1998, SULZER TECH REV, V1, P34
   Sanchez-Herencia AJ, 2001, ACTA MATER, V49, P645, DOI 10.1016/S1359-6454(00)00347-5
   Sargeant A, 2006, MATER DESIGN, V27, P287, DOI 10.1016/j.matdes.2004.10.028
   SARMIENTO A, 1990, J BONE JOINT SURG BR, V72, P996
   SAUER BW, 1974, J BIOMED MATER RES, V8, P145, DOI 10.1002/jbm.820080315
   Savalani MM, 2012, RAPID PROTOTYPING J, V18, P16, DOI 10.1108/13552541211193467
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   Schneider J.A., 1996, CERAM T, V79, P143
   Schroers J, 2009, JOM-US, V61, P21, DOI 10.1007/s11837-009-0128-1
   Schwendner KI, 2001, SCRIPTA MATER, V45, P1123, DOI 10.1016/S1359-6462(01)01107-1
   SEMLITSCH M, 1980, MED BIOL ENG COMPUT, V18, P511, DOI 10.1007/BF02443329
   Shabalovskaya SA, 2002, BIO-MED MATER ENG, V12, P69
   Shen H, 2008, MECH MATER, V40, P708, DOI 10.1016/j.mechmat.008.03.009
   Shishkovsky IV, 2010, INT J SELF-PROPAG HI, V19, P157, DOI 10.3103/S1061386210020123
   Simancik F., 2002, HDB CELLULAR METALS, P1
   Singh R, 2010, MATER TECHNOL, V25, P127, DOI 10.1179/175355510X12744412709403
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Spoerke ED, 2008, J BIOMED MATER RES A, V84A, P402, DOI 10.1002/jbm.a.31317
   Stephani G., 2009, J PHYS C SER, V165
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   Tan QB, 2009, MAT SCI ENG A-STRUCT, V527, P38, DOI 10.1016/j.msea.2009.07.022
   Tane M, 2008, ACTA MATER, V56, P2856, DOI 10.1016/j.actamat.2008.02.017
   Tang CY, 2013, J ALLOY COMPD, V557, P67, DOI 10.1016/j.jallcom.2012.12.147
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   TAYLOR N, 1993, ACTA METALL MATER, V41, P955, DOI 10.1016/0956-7151(93)90030-V
   Temenoff J.S., 2008, BIOMATERIALS INTERSE, P235
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Thakur SK, 2007, MAT SCI ENG A-STRUCT, V452, P61, DOI 10.1016/j.msea.2006.10.156
   Torres Y, 2012, J MATER PROCESS TECH, V212, P1061, DOI 10.1016/j.jmatprotec.2011.12.015
   Torres Y, 2011, METALL MATER TRANS B, V42, P891, DOI 10.1007/s11663-011-9521-6
   Traini T, 2008, DENT MATER, V24, P1525, DOI 10.1016/j.dental.2008.03.029
   Tuncer N, 2011, MAT SCI ENG A-STRUCT, V530, P633, DOI 10.1016/j.msea.2011.10.036
   Upadhyaya A, 2007, SCRIPTA MATER, V56, P5, DOI 10.1016/j.scriptmat.2006.09.010
   Valiev R.Z., 2004, MED DEVICE MAT, P362
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   Vinz H., 1975, MECH COMPOS MATER, V11, P568
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang L.Q., 2013, TITANIUM ALLOYS FORM, P110
   Wang Xi-han, 2010, Chinese Journal of Nonferrous Metals, V20, ps967
   Wang XJ, 2010, TISSUE ENG PT A, V16, P309, DOI [10.1089/ten.tea.2009.0074, 10.1089/ten.TEA.2009.0074]
   Wang XJ, 2009, ACTA BIOMATER, V5, P3616, DOI 10.1016/j.actbio.2009.06.002
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Watari F., 2002, J JPN SOC POWDER MET, V49, P1063
   WEBER JN, 1972, MATER RES BULL, V7, P1005, DOI 10.1016/0025-5408(72)90092-X
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Wegst UGK, 2010, PHILOS T R SOC A, V368, P2099, DOI 10.1098/rsta.2010.0014
   Wen CE, 2006, MAT SCI ENG C-BIO S, V26, P1439, DOI 10.1016/j.msec.2005.08.006
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2004, MATER LETT, V58, P357, DOI [10.1016/S0167-577X(03)00500-7, 10.1016/S0167-577X(03)004500-7]
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Whitcher FD, 1997, COMPUT STRUCT, V64, P1005, DOI 10.1016/S0045-7949(97)00014-X
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wilson CE, 2004, J BIOMED MATER RES A, V68A, P123, DOI 10.1002/jbm.a.20015
   Wise D.L., 2000, BIOMATERIALS ENG DEV, P205
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Wu X, 2003, J MATER PROCESS TECH, V135, P266, DOI 10.1016/S0924-0136(02)00906-8
   Xie FX, 2013, CORROS SCI, V67, P217, DOI 10.1016/j.corsci.2012.10.036
   Xie KY, 2013, MAT SCI ENG C-MATER, V33, P3530, DOI 10.1016/j.msec.2013.04.044
   Xu Q, 2012, KEY ENG MATER, V520, P330, DOI 10.4028/www.scientific.net/KEM.520.330
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yamada Y, 2000, ADV ENG MATER, V2, P184, DOI 10.1002/(SICI)1527-2648(200004)2:4<184::AID-ADEM184>3.0.CO;2-W
   Yang D.H., 2011, BIOMED MATER, V6, Patent No. 045010:1-045010:8
   Yang DH, 2012, PROCEDIA ENGINEER, V36, P160, DOI 10.1016/j.proeng.2012.03.025
   Yang GJ, 2005, J ALLOY COMPD, V392, P291, DOI 10.1016/j.jallcom.2004.08.099
   Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009
   Yao C., 2004, P 106 ANN M AM CER S
   Yeh CL, 2004, J ALLOY COMPD, V376, P79, DOI 10.1016/j.jallcom.2003.12.016
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yook SW, 2012, ACTA BIOMATER, V8, P2401, DOI 10.1016/j.actbio.2012.03.020
   Yook SW, 2009, MATER LETT, V63, P1502, DOI 10.1016/j.matlet.2009.03.056
   Yoon B.H., 2008, SCRIPTA MATER, V58, P37
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yu ZT, 2006, MAT SCI ENG A-STRUCT, V438, P391, DOI 10.1016/j.msea.2005.12.079
   Yuan B, 2006, METALL MATER TRANS A, V37A, P755, DOI 10.1007/s11661-006-0047-5
   Yuan B, 2004, MAT SCI ENG A-STRUCT, V382, P181, DOI 10.1016/j.msea.2004.04.068
   Zadra M, 2008, POWDER METALL, V51, P59, DOI 10.1179/174329008X277000
   Zhang FM, 2010, ADV ENG MATER, V12, P863, DOI 10.1002/adem.201000106
   Zhang L, 2005, ALGORITHMICA, V43, P1, DOI 10.1007/s00453-005-1154-1
   Zhang LC, 2011, SCRIPTA MATER, V65, P21, DOI 10.1016/j.scriptamat.2011.03.024
   Zhang LC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2766861
   Zhang X, 2001, Biomed Sci Instrum, V37, P463
   Zhang YP, 2007, J MATER PROCESS TECH, V192, P439, DOI 10.1016/j.jmatprotec.2007.04.069
   Zhao CL, 2011, J ALLOY COMPD, V509, P8235, DOI 10.1016/j.jallcom.2011.05.090
   Zhao J, 2008, MATER LETT, V62, P2921, DOI 10.1016/j.matlet.2008.01.075
   Zhao XL, 2011, MAT SCI ENG C-MATER, V31, P1436, DOI 10.1016/j.msec.2011.05.013
   Zhao XL, 2011, ACTA BIOMATER, V7, P3230, DOI 10.1016/j.actbio.2011.04.019
   Zhao XK, 2009, MATER LETT, V63, P2402, DOI 10.1016/j.matlet.2009.07.069
   Zhao YY, 2001, SCRIPTA MATER, V44, P105, DOI 10.1016/S1359-6462(00)00548-0
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhuravleva K, 2013, MAT SCI ENG C-MATER, V33, P2280, DOI 10.1016/j.msec.2013.01.049
   Zou CM, 2008, J MATER SCI-MATER M, V19, P401, DOI 10.1007/s10856-006-0103-0
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
   Zwicker U., 1980, TITANIUM 80 SCI TECH, V1, P505
NR 345
TC 168
Z9 171
U1 25
U2 239
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2014
VL 7
IS 3
BP 1709
EP 1800
DI 10.3390/ma7031709
PG 92
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4IB
UT WOS:000336089500015
PM 28788539
OA DOAJ Gold, Green Published
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Donato, TAG
   de Almeida, LH
   Arana-Chavez, VE
   Grandini, CR
AF Goto Donato, Tatiani Ayako
   de Almeida, Luciano Henrique
   Arana-Chavez, Victor Elias
   Grandini, Carlos Roberto
TI In Vitro Cytotoxicity of a Ti-35Nb-7Zr-5Ta Alloy Doped with Different
   Oxygen Contents
SO MATERIALS
LA English
DT Article
DE Ti-35Nb-7Zr-5Ta alloy; MC3T3-E1 cells; biocompatibility; cell culture
ID BETA-TITANIUM ALLOY; PHASE-TRANSFORMATIONS; MECHANICAL-PROPERTIES;
   CELL-CULTURES; MICROSTRUCTURE; BIOMATERIAL
AB Cp-Ti is the most common material used for dental implants, but its elastic modulus is around five times higher than that of bone. Recently, promising alloys that add Nb, Ta, Zr and Mo to Ti have been developed. The mechanical properties of these alloys are directly related to its microstructure and the presence of interstitial elements, such as oxygen, carbon, nitrogen and hydrogen. In this study, the in vitro cytotoxicity of Ti-35Nb-7Zr-5Ta (TNZT) alloys was analyzed in the as-received condition and after being doped with several small quantities of oxygen on a cultured osteogenic cell. The cell's morphology was also examined by scanning electron microscopy (SEM). The TNZT alloy presented no cytotoxic effects on osteoblastic cells in the studied conditions.
C1 [Goto Donato, Tatiani Ayako; de Almeida, Luciano Henrique; Grandini, Carlos Roberto] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Goto Donato, Tatiani Ayako; Arana-Chavez, Victor Elias] Univ Sao Paulo, Fac Odontol, Dept Biomat & Biol Oral, BR-05508900 Sao Paulo, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM tatianidonato@gmail.com; almeidalh@hotmail.com; vearana@usp.br;
   betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008
OI Grandini, Carlos Roberto/0000-0002-3336-309X
FU Brazilian agency, Coordenacao de Pessoal de Nivel Superior (Capes);
   Brazilian agency, Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq) e Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX The authors would like to thank Rubens Caram for the facilities for the
   sample preparation, Elizabeth F. Martinez and Arnaldo R. Santos Jr. for
   their advice with the cell cultures and Fernanda Barrence for her
   technical assistance. This work was supported by the Brazilian agencies,
   Coordenacao de Pessoal de Nivel Superior (Capes), Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) e Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP).
CR Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   Ankem S, 1999, MAT SCI ENG A-STRUCT, V263, P127, DOI 10.1016/S0921-5093(98)01170-8
   Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6
   Azimzadeh S, 1998, METALL MATER TRANS A, V29, P2455, DOI 10.1007/s11661-998-0217-8
   Bellows CG, 1999, CALCIFIED TISSUE INT, V65, P59, DOI 10.1007/s002239900658
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   Besse M, 2011, ACTA MATER, V59, P5982, DOI 10.1016/j.actamat.2011.06.006
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Duan HP, 2012, INT J MIN MET MATER, V19, P1128, DOI 10.1007/s12613-012-0681-4
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   He WJ, 2009, SCRIPTA MATER, V61, P16, DOI 10.1016/j.scriptamat.2009.02.030
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   ISO, 2009, BIOL EV MED DEV 5
   Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nanci A, 1996, MICROSC RES TECHNIQ, V33, P214
   Niinomi M., 2011, INT J BIOMATER, V2011
   Niinomi M, 2008, MATER TRANS, V49, P2170, DOI 10.2320/matertrans.L-MRA2008828
   Pintao C.A.F., 2006, REV BRASILEIRA APLIC, V25, P189
   Qazi JI, 2005, MAT SCI ENG C-BIO S, V25, P389, DOI 10.1016/j.msec.2005.01.022
   Rack HJ, 2006, MAT SCI ENG C-BIO S, V26, P1269, DOI 10.1016/j.msec.2005.08.032
   Steinemann SG, 1998, PERIODONTOL 2000, V17, P7, DOI 10.1111/j.1600-0757.1998.tb00119.x
   Tane M, 2011, ACTA MATER, V59, P6975, DOI 10.1016/j.actamat.2011.07.050
   Trinkle DR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.025701
   Wang LQ, 2008, MAT SCI ENG A-STRUCT, V490, P421, DOI 10.1016/j.msea.2008.03.003
NR 27
TC 1
Z9 1
U1 3
U2 17
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD MAR
PY 2014
VL 7
IS 3
BP 2183
EP 2193
DI 10.3390/ma7032183
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH4IB
UT WOS:000336089500038
PM 28788562
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Rodrigues, SF
   Silva, ES
   Reis, GS
   de Sousa, RC
   Balancin, O
AF Rodrigues, Samuel Filgueiras
   Silva, Eden Santos
   Reis, Gedeon Silva
   de Sousa, Regina Celia
   Balancin, Oscar
TI Prediction of Hot Flow Plastic Curves of ISO 5832-9 Steel Used as
   Orthopedic Implants
SO MATERIALS RESEARCH-IBERO-AMERICAN JOURNAL OF MATERIALS
LA English
DT Article
DE flow stress curves; modeling of hot deformation; dynamic
   recristalization
ID DYNAMIC RECRYSTALLIZATION; HIGH-TEMPERATURES; INITIATION; WORKING;
   DEFORMATION; BIOMATERIAL
AB An austenitic stainless steel ISO 5832-9 used as a biomaterial was torsion-deformed over the temperature range of 1000-1200 degrees C and strain rates of 0.05, 0.1, 1.0 and 5.0 s(-1). The flow stress curves obtained showed two regions where firstly there is a rising on stress characterized as work hardening mechanism acting and secondly a decreasing in work-softening after a peak stress. The flow curves were modeled by adjusting the experimental data with Zener-Hollomom parameter to construct the constitutive equations that describe the plastic behavior in both regions. The first region was described until the peak stress, taking into consideration the competition between work hardening and recovery while the second one was described applying the softening time of 50% and the Avrami equation. In some hot deformation conditions the simulated curves showed good agreement with the experimental ones while in others conditions the simulated showed differences to experimental curves that was discussed and associated with other mechanisms that acted during hot deformation.
C1 [Rodrigues, Samuel Filgueiras; Reis, Gedeon Silva] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mech & Mat, BR-65030005 Sao Luis, MA, Brazil.
   [Silva, Eden Santos] Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Phys, BR-65030005 Sao Luis, MA, Brazil.
   [de Sousa, Regina Celia] Fed Univ Maranhao UFMA, Dept Phys, BR-65080805 Sao Luis, MA, Brazil.
   [Balancin, Oscar] Fed Univ Sao Carlos UFSCar, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Rodrigues, SF (reprint author), Fed Inst Educ Sci & Technol Maranhao IFMA, Dept Mech & Mat, Av Getulio Vargas 4, BR-65030005 Sao Luis, MA, Brazil.
EM samuel.filgueiras@ifma.edu.br
RI Rodrigues, Samuel/I-2873-2017
OI Rodrigues, Samuel/0000-0003-0002-4566
FU Federal Institute of Education, Science and Technology of Maranhao
   (IFMA); CAPES
FX The financial support of the Federal Institute of Education, Science and
   Technology of Maranhao (IFMA) and CAPES is gratefully acknowledged.
CR Ahlblom B., 1982, INT MET REV, V27, P1
   Barbosa RANM, 1993, MATER SCI FORUM, V113-115, P461
   CAHN RW, 1965, PHYSICAL METALLURGY, P925
   ESTRIN Y, 1984, ACTA METALL MATER, V32, P57, DOI 10.1016/0001-6160(84)90202-5
   Fields D. S., 1957, P AM SOCIETY SOCIETY, V57, P1259
   Giordani EJ, 2006, SCRIPTA MATER, V55, P743, DOI 10.1016/j.scriptamat.2006.05.015
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   Jonas JJ, 1978, ADV DEFORMATION PROC, P215
   Jonas JJ, 2009, ACTA MATER, V57, P2748, DOI 10.1016/j.actamat.2009.02.033
   Jorge Junior Alberto Moreira, 2005, Mat. Res., V8, P309, DOI 10.1590/S1516-14392005000300015
   Kocks UF, 2003, PROG MATER SCI, V48, P171, DOI 10.1016/S0079-6425(02)00003-8
   LAASRAOUI A, 1991, METALL TRANS A, V22, P1545, DOI 10.1007/BF02667368
   McQueen HJ, 2004, MAT SCI ENG A-STRUCT, V387, P203, DOI 10.1016/j.msea.2004.01.064
   MCQUEEN HJ, 1995, J MATER PROCESS TECH, V53, P293, DOI 10.1016/0924-0136(95)01987-P
   McQueen HJ, 2002, MAT SCI ENG A-STRUCT, V322, P43, DOI 10.1016/S0921-5093(01)01117-0
   McQueen HJ, 1976, TREATISE MAT SCI TEC
   Poliak EI, 2003, ISIJ INT, V43, P684, DOI 10.2355/isijinternational.43.684
   Poliak EI, 1996, ACTA MATER, V44, P127, DOI 10.1016/1359-6454(95)00146-7
   Ponge D, 1998, ACTA MATER, V46, P69, DOI 10.1016/S1359-6454(97)00233-4
   RYAN ND, 1990, J MATER PROCESS TECH, V21, P177, DOI 10.1016/0924-0136(90)90005-F
   Sakai T, 1984, ACTA METALL, V32, P198
   SELLARS CM, 1966, MEM ETUD SCI REV MET, V63, P731
   Silva ES, 2012, MAT SCI ENG A-STRUCT, V543, P69, DOI 10.1016/j.msea.2012.02.048
   Sousa R.C., 2012, MAT SCI ENG A-STRUCT, V582, P96
   Stein G, 1995, INT J MATER PROD TEC, V10, P290
   UVIRA JL, 1968, T METALL SOC AIME, V242, P1619
NR 26
TC 6
Z9 6
U1 0
U2 7
PU UNIV FED SAO CARLOS, DEPT ENGENHARIA MATERIALS
PI SAO CARLOS
PA LABORATORIA DE MATERIAIS VITREOS, CAIXA POSTAL 676, SAO CARLOS,
   13565-905SP, BRAZIL
SN 1516-1439
EI 1980-5373
J9 MATER RES-IBERO-AM J
JI Mater. Res.-Ibero-am. J. Mater.
PD MAR-APR
PY 2014
VL 17
IS 2
BP 436
EP 444
DI 10.1590/S1516-14392014005000001
PG 9
WC Materials Science, Multidisciplinary
SC Materials Science
GA AH6QO
UT WOS:000336255900023
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Li, CX
   Zhao, YH
   Peng, F
   Li, LL
   Gao, Y
   Wang, ZF
AF Li, Chunxia
   Zhao, Yuhang
   Peng, Fei
   Li, Lili
   Gao, Ya
   Wang, Zhoufeng
TI Biosynthesis Bacteria Cellulose by Strain of Bacteria Isolated from
   Native Corrupt Fruit
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article; Proceedings Paper
CT 7th International Conference on Multi-Functional Materials and
   Applications (ICMMA)
CY NOV 22-24, 2013
CL Huainan, PEOPLES R CHINA
SP Anhui Univ Sci & Technol, Hanseo Univ, Anhui Jianzhu Univ, Hefei Univ, Anhui Univ, Suzhou Univ Sci Technol, Int Photoscience Soc
DE Bacterial cellulose; Isolate; Yield; Crystal structure
AB Bacterial cellulose (BC) is an interesting biomaterial for widespread applications. However, bacterial cellulose still expensive compared with other popular organic products and limit its widespread commercial applications. We had isolated a high bacterial cellulose producing strain from local corrupt fruit successfully. The yields of bacterial cellulose from three strains isolated-from native corrupt fruit were 3.5, 5.6 and 1.2 g/L, respectively. FT-IR and XRD results indicated the bacterial cellulose fabricated from local strain was typical cellulose I.
C1 [Li, Chunxia; Zhao, Yuhang; Peng, Fei; Li, Lili; Gao, Ya] Anhui Univ Sci & Technol, Coll Med, Huainan 232001, Peoples R China.
   [Wang, Zhoufeng] Anhui Univ Sci & Technol, Sch Mat Sci & Engn, Huainan 232001, Peoples R China.
RP Li, CX (reprint author), Anhui Univ Sci & Technol, Coll Med, Huainan 232001, Peoples R China.
EM springlw@sina.com; zfwang@aust.edu.cn
CR Bielecki S., 2005, BIOPOLYMERS
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Kataoka Y, 1996, MACROMOLECULES, V29, P6356, DOI 10.1021/ma960206d
   NELSON M. L., 1964, J APPL POLYM SCI, V8, P1311, DOI DOI 10.1002/APP.1964.070080322
   Rani MU, 2011, J APPL POLYM SCI, V120, P2835, DOI 10.1002/app.33307
   Ruka DR, 2012, CARBOHYD POLYM, V89, P613, DOI 10.1016/j.carbpol.2012.03.059
   Segal L, 1959, TEXT RES J, V29, P786, DOI [10.1177/004051755902901003, DOI 10.1177/004051755902901003, 10.1177/0040517559029]
   Wu JM, 2013, J BIOSCI BIOENG, V115, P284, DOI 10.1016/j.jbiosc.2012.09.014
   Yamamoto H, 1996, CELLULOSE, V3, P229, DOI 10.1007/BF02228804
   Yang Y, 2013, CARBOHYD POLYM, V92, P2012, DOI 10.1016/j.carbpol.2012.11.065
   Yoshino A, 2013, ACTA BIOMATER, V9, P6116, DOI 10.1016/j.actbio.2012.12.022
NR 11
TC 0
Z9 0
U1 1
U2 3
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
EI 0975-427X
J9 ASIAN J CHEM
JI Asian J. Chem.
PD MAR
PY 2014
VL 26
IS 6
BP 1738
EP 1740
PN B
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA AH2EN
UT WOS:000335934400051
DA 2018-10-19
ER

PT J
AU Kumar, V
   Gupta, PK
   Pawar, VK
   Verma, A
   Khatik, R
   Tripathi, P
   Shukla, P
   Yadav, B
   Parmar, J
   Dixit, R
   Mishra, PR
   Dwivedi, AK
AF Kumar, Vivek
   Gupta, Pramod K.
   Pawar, Vivek K.
   Verma, Ashwni
   Khatik, Renuka
   Tripathi, Priyanka
   Shukla, Prasant
   Yadav, Bholenath
   Parmar, Jeetesh
   Dixit, Rohit
   Mishra, P. R.
   Dwivedi, Anil Kumar
TI In-Vitro and In-Vivo Studies on Novel Chitosan-g-Pluronic F-127
   Copolymer Based Nanocarrier of Amphotericin B for Improved Antifungal
   Activity
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Nanomedicine; Toxicity; Fungizone; Mycosis; Micelles
ID THERMOSENSITIVE CHITOSAN; DRUG-DELIVERY; BLOCK-COPOLYMERS; GENE
   DELIVERY; MICELLES; RELEASE; BIOMATERIAL
AB The present communication is focusing on development of safe nanotemplates for sustained delivery of amphotericin B (AmB). We synthesized a block copolymer based on chitosan and Pluronic F-127 (PEO-b-PPO-b-PEO). Selection of Pluronic F-127 was based upon the criteria's that it has smaller size, higher aqueous solubility and stability whereas; chitosan is a non toxic, biodegradable polysaccharide. AmB loaded micelles were prepared by direct dissolution and pH dependent method. Various formulations were prepared using different drug polymer ratio to optimize the size, size distribution, zeta potential and drug loading efficiency. Optimized formulation was characterized for drug release pattern, haemolytic potential, in-vitro anti fungal activity and, in-vivo toxicity and compared with the marketed formulation (fungizone). The particle size and zeta potential of the micelles were found in the range between 90.2 +/- 10.21 to 148.7 +/- 21.03 and -16.3 +/- 4.24 to +31.1 +/- 6.10, respectively. The drug loading was found between 16.7 +/- 4.76% to 33.3 +/- 2.67% for all the developed formulations. Developed formulations showed negligible hemolytic toxicity with comparison to marketed formulation. In vitro antifungal studies demonstrated that micelles were more active than fungizone against C. albicans and A. fumigatus. Furthermore, AmB showed less nephrotoxicity when encapsulated in micelles in comparison to marketed formulation. These results together revealed that the developed formulation would be a safe and efficacious alternative to current marketed formulation to ameliorate the treatment of fungal infection.
C1 [Kumar, Vivek; Gupta, Pramod K.; Pawar, Vivek K.; Verma, Ashwni; Khatik, Renuka; Tripathi, Priyanka; Shukla, Prasant; Yadav, Bholenath; Parmar, Jeetesh; Dixit, Rohit; Mishra, P. R.; Dwivedi, Anil Kumar] CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India.
RP Dwivedi, AK (reprint author), CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India.
RI Shukla, Prashant/I-7886-2014
OI Shukla, Prashant/0000-0003-1286-4183
FU Council of Scientific and Industrial Research (CSIR), India
FX Author Dr. Anil Kumar Dwivedi is thankful to Indian Institute of
   Technology, Kanpur, India for providing scanning electron microscopy
   (SEM) facility. Vivek Kumar is thankful to Council of Scientific and
   Industrial Research (CSIR), India for providing senior research
   fellowships.
CR Adams ML, 2003, BIOMACROMOLECULES, V4, P750, DOI 10.1021/bm0257614
   Ali Y, 2006, ADV DRUG DELIVER REV, V58, P1258, DOI 10.1016/j.addr.2006.07.022
   Bae JW, 2006, MACROMOL RES, V14, P461, DOI 10.1007/BF03219111
   Cha J, 2006, MACROMOL RES, V14, P573, DOI 10.1007/BF03218726
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Eriksson U, 2001, BRIT MED J, V322, P579, DOI 10.1136/bmj.322.7286.579
   Espuelas MS, 2003, J ANTIMICROB CHEMOTH, V52, P419, DOI 10.1093/jac/dkg351
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Kabanov AV, 2002, J CONTROL RELEASE, V82, P189, DOI 10.1016/S0168-3659(02)00009-3
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P223, DOI 10.1016/S0169-409X(02)00018-2
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   Lee JW, 2004, J BIOMAT SCI-POLYM E, V15, P1065, DOI 10.1163/1568562041526496
   Liu SQ, 2005, BIOMATERIALS, V26, P5064, DOI 10.1016/j.biomaterials.2005.01.030
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Park KM, 2008, COLLOID SURFACE B, V63, P1, DOI 10.1016/j.colsurfb.2007.10.024
   Schroder CP, 1999, J ANTIMICROB CHEMOTH, V43, P741, DOI 10.1093/jac/43.5.741
NR 16
TC 8
Z9 8
U1 0
U2 18
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2014
VL 4
IS 3
BP 210
EP 216
DI 10.1166/jbt.2014.1160
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA AH4DB
UT WOS:000336075900007
DA 2018-10-19
ER

PT J
AU Millas, ALG
   McKean, R
   Stevens, R
   Yusuf, M
   Silveira, JVW
   Puzzi, MB
   Bittencourt, E
AF Millas, Ana Luiza G.
   McKean, Robert
   Stevens, Robert
   Yusuf, Mohammed
   Silveira, Joao V. W.
   Puzzi, Maria Beatriz
   Bittencourt, Edison
TI Fabrication of Electrospun Scaffolds Incorporating an Amazonian
   Therapeutic Oil from the Copaifera Species for Wound Care Application
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Tissue Engineering; Poly(lactic-co-glycolic acid); Skin Regeneration;
   Copaiba; Electrospinning; Fibroblasts
ID SKIN SUBSTITUTES; DUCKEI DWYER; DEGRADATION; TERPENOIDS; OLEORESINS;
   MEMBRANES; PROGRESS; RATS
AB Electrospinning provides an efficient and versatile method to produce novel biomaterials from a range of natural and synthetic polymers, which show excellent biocompatibility due to the very high surface area-to-volume ratio. In addition, the incorporation of bioactive compounds into biodegradable polymers, such as poly(lactic-co-glycolic acid) (PLGA) allows the fabrication of drug releasing bioactive scaffolds for potential use in novel wound care applications. Native to the tropical region of Latin America, Copaiba oil is extracted from material from the Copaifera species. The oil is a FDA approved compound known for its wound healing, anti-inflammatory, analgesics, antifungal and antimicrobial functions. In this study, microfiber non-woven scaffolds were fabricated via electrospinning solutions of PLGA containing copaiba oil. Tests of cell growth with lung fibroblasts reported a strong affinity of the fibroblasts and the biomaterial.
C1 [Millas, Ana Luiza G.; Silveira, Joao V. W.; Bittencourt, Edison] State Univ Campinas UNICAMP, Sch Chem Engn, Dept Mat & Bioproc Engn, BR-13083852 Sao Paulo, Brazil.
   [McKean, Robert] Rutherford Appleton Lab, Electrospinning Co, Harwell Oxford OX11 0QX, England.
   [Stevens, Robert] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG1 4BU, England.
   [Yusuf, Mohammed] UCL, London Ctr Nanotechnol, London OX11 0FA, England.
   [Puzzi, Maria Beatriz] State Univ Campinas UNICAMP, Sch Med Sci, Dept Clin Med, BR-13083852 Sao Paulo, Brazil.
RP Millas, ALG (reprint author), State Univ Campinas UNICAMP, Sch Chem Engn, Dept Mat & Bioproc Engn, BR-13083852 Sao Paulo, Brazil.
FU FAPESP
FX Sincere thanks to Professor Ian Robinson of the Research Complex at
   Harwell (RCaH), United Kingdom. Santander International Students Program
   from Brazil. FAPESP for financial support. And The Elecrospinning
   Company which provided all the infrastructure and materials for the
   scaffolds production.
CR ALI SAM, 1993, BIOMATERIALS, V14, P648, DOI 10.1016/0142-9612(93)90063-8
   Barauna G, 2013, MATER RES-IBERO-AM J, V16, P221, DOI [10.1590/S1516-14392013000100028, 10.1590/S1516-14392012005000154]
   BASILE AC, 1988, J ETHNOPHARMACOL, V22, P101, DOI 10.1016/0378-8741(88)90235-8
   Berthiaume F, 2011, ANNU REV CHEM BIOMOL, V2, P403, DOI 10.1146/annurev-chembioeng-061010-114257
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   BRITO N.M.B., 1998, REV PARA MED, V12, P28
   Carvalho JCT, 2005, PHYTOTHER RES, V19, P946, DOI 10.1002/ptr.1762
   Cascon V, 2000, PHYTOCHEMISTRY, V55, P773, DOI 10.1016/S0031-9422(00)00284-3
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Fernandes R. M., 1989, S BRAS CHIN QUIM FAR
   FERNANDES RM, 1992, REV BRASILEIRA FARMA, V73, P53
   Ji W., 2011, EXPERT REV SPRINGERL, P1261, DOI 10.1007.s11095-010-0320-6
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   KOBAYASHI H, 1992, J BIOMED MATER RES, V26, P1463, DOI 10.1002/jbm.820261106
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Leandro LM, 2012, MOLECULES, V17, P3866, DOI 10.3390/molecules17043866
   MacNeil S., 2008, MAT TODAY, V11
   Masson-Meyers DS, 2013, INT J APPL MICROBIOL, V2, P9
   MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813
   Nichol JW, 2009, SOFT MATTER, V5, P1312, DOI 10.1039/b814285h
   Neto JN, 2011, ACTA CIR BRAS, V26, P20, DOI 10.1590/S0102-86502011000800005
   Oliveira DF, 2007, FITOTERAPIA, V78, P142, DOI 10.1016/j.fitote.2006.09.027
   Paiva LAF, 2002, PHYTOTHER RES, V16, P737, DOI [10.1002/ptr.1049, 10.1002/prt.1049]
   Pontiggia L, 2013, PEDIATR SURG INT, V29, P249, DOI 10.1007/s00383-013-3268-x
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Sander EA, 2004, J BIOMED MATER RES A, V70A, P506, DOI 10.1002/jbm.a.30109
   Tincusi BM, 2002, PLANTA MED, V68, P808, DOI 10.1055/s-2002-34399
   Vieira RC, 2008, PESQUISA VET BRASIL, V28, P358, DOI 10.1590/S0100-736X2008000800002
   Xinhua Z., 2003, BIOMACROMOLECULES, V4, P416
NR 29
TC 5
Z9 5
U1 2
U2 29
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD MAR
PY 2014
VL 4
IS 3
BP 217
EP 220
DI 10.1166/jbt.2014.1162
PG 4
WC Cell & Tissue Engineering
SC Cell Biology
GA AH4DB
UT WOS:000336075900008
DA 2018-10-19
ER

PT J
AU Abedi, G
   Jahanshahi, A
   Fathi, MH
   Haghdost, IS
   Veshkini, A
AF Abedi, Gholamreza
   Jahanshahi, Amirali
   Fathi, Mohamad Hosein
   Haghdost, Iraj Sohrabi
   Veshkini, Abas
TI STUDY OF NANO-HYDROXYAPATITE/ZIRCONIA STABILIZED WITH YTTRIA IN BONE
   HEALING: HISTOPATHOLOGICAL STUDY IN RABBIT MODEL
SO POLISH JOURNAL OF PATHOLOGY
LA English
DT Article
DE zirconia-stabilized yttria; bone healing; histological changes; rabbits
ID GRAFT SUBSTITUTES; ZIRCONIA; IMPLANT; BIOMATERIALS; OSTEOBLAST; CERAMICS
AB Acceleration of bone healing has always been a major challenge in orthopedic surgery, the aim of this study was an evaluation of the biological effects of zirconia-stabilized yttria on bone healing, using an in vivo model.
   Nano-hydroxyapatite powder with zirconia-stabilized yttria were inserted in rabbit tibia and then histologically analyzed and compared with non-treated controls so thirty six. New Zealand white male rabbits randomly divided into two groups of 18 rabbits each. A cortical hole of 4 mm diameter and 8 mm depth in each tibia was drilled. In group I, the defect was left empty, whereas in group II, the bone defect was packed with nano-hydroxyapatite/5% zirconia stabilized with yttria. Histological evaluations were performed at two, four and six weeks after the implantation.
   Microscopic changes on two groups along with the time course were scored and statistical analysis showed that the average scores in group II were significantly higher than the other groups (p < 0.05).
   Histological analysis was shown to be significantly improved by the nano-hydroxy-apatite/5% zirconia stabilized with yttria compared with the control group, suggesting that this biomaterial promote the healing of cortical bone, presumably by acting as an osteoconductive.
C1 [Abedi, Gholamreza; Jahanshahi, Amirali] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Surg, Sci & Res Branch, Tehran 127365634, Iran.
   [Fathi, Mohamad Hosein] Isfahan Univ Technol, Dept Mat Engn, Esfahan, Iran.
   [Haghdost, Iraj Sohrabi] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Pathol, Sci & Res Branch, Tehran 127365634, Iran.
   [Veshkini, Abas] Islamic Azad Univ, Fac Specialized Vet Sci, Dept Radiol, Sci & Res Branch, Tehran 127365634, Iran.
RP Jahanshahi, A (reprint author), Islamic Azad Univ, Fac Specialized Vet Sci, Dept Surg, Sci & Res Branch, Tehran 127365634, Iran.
EM Amirali.jahanshahi@gmail.com
FU Faculty of Specialized Veterinary Sciences, Islamic Azad University,
   Science and Research Branch, Tehran, Iran; Research Council
FX The authors wish to acknowledge the Faculty of Specialized Veterinary
   Sciences, Islamic Azad University, Science and Research Branch, Tehran,
   Iran, Research Council for approval and financial support of this
   research work.
CR Ahmad I, 1998, INT J PERIODONT REST, V18, P455
   Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   AKAGAWA Y, 1993, J PROSTHET DENT, V69, P599, DOI 10.1016/0022-3913(93)90289-Z
   An HS, 2012, DENT MATER, V28, P1221
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BAUER TW, 2000, CLIN ORTHOP RELAT R, V371, P10, DOI DOI 10.1097/00003086-200002000-00003
   Bilkay U, 2004, J CRANIOFAC SURG, V15, P585, DOI 10.1097/00001665-200407000-00011
   BRUDER SP, 1999, CLIN ORTHOP S, V367, P68
   BUCHOLZ RW, 2002, CLIN ORTHOP FEBRUARY, V395, P44
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   HULBERT SF, 1972, J BIOMED MATER RES, V6, P347, DOI 10.1002/jbm.820060505
   ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B
   Inui Atsuyuki, 2011, Sports Med Arthrosc Rehabil Ther Technol, V3, P29, DOI 10.1186/1758-2555-3-29
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Kim BK, 2005, J PROSTHET DENT, V94, P357, DOI 10.1016/j.prosdent.2005.08.012
   Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003
   Kong DJ, 2012, T NONFERR METAL SOC, V22, P104, DOI 10.1016/S1003-6326(11)61147-3
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Kurtz LT, 1989, SPINE, V14, P1324
   Lappalainen R, 1998, CLIN ORTHOP RELAT R, P118
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   Palissery V, 2004, J MATER SCI-MATER M, V15, P61, DOI 10.1023/B:JMSM.0000010098.65572.3b
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   REDDI AH, 1994, J CELL BIOCHEM, V56, P192, DOI 10.1002/jcb.240560213
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Salehi S, 2010, CERAM INT, V36, P1659, DOI 10.1016/j.ceramint.2010.02.045
   Sammarco V James, 2002, Foot Ankle Clin, V7, P19, DOI 10.1016/S1083-7515(01)00003-1
   Sepulveda P, 2000, J AM CERAM SOC, V83, P3021, DOI 10.1111/j.1151-2916.2000.tb01677.x
   Stefanic M, 2013, J EUR CERAM SOC, V33, P3455, DOI 10.1016/j.jeurceramsoc.2013.05.015
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 36
TC 4
Z9 4
U1 0
U2 4
PU VESALIUS UNIV MEDICAL PUBL
PI CRACOW
PA WISLISKO 1, CRACOW, 00000, POLAND
SN 1233-9687
J9 POL J PATHOL
JI Pol. J. Pathol.
PD MAR
PY 2014
VL 65
IS 1
BP 40
EP 47
DI 10.5114/PJP.2014.42668
PG 8
WC Pathology
SC Pathology
GA AH4ON
UT WOS:000336108000006
PM 25119008
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Tuinstra, HM
   Margul, DJ
   Goodman, AG
   Boehler, RM
   Holland, SJ
   Zelivyanskaya, ML
   Cummings, BJ
   Anderson, AJ
   Shea, LD
AF Tuinstra, Hannah M.
   Margul, Daniel J.
   Goodman, Ashley G.
   Boehler, Ryan M.
   Holland, Samantha J.
   Zelivyanskaya, Marina L.
   Cummings, Brian J.
   Anderson, Aileen J.
   Shea, Lonnie D.
TI Long-Term Characterization of Axon Regeneration and Matrix Changes Using
   Multiple Channel Bridges for Spinal Cord Regeneration
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID NERVOUS-SYSTEM INJURY; ADULT-RAT; SCHWANN-CELLS; GUIDANCE SCAFFOLDS;
   CORTICOSPINAL TRACT; FUNCTIONAL RECOVERY; AGAROSE SCAFFOLDS; POLYMER
   SCAFFOLDS; CONTUSION INJURY; CNS INJURY
AB Spinal cord injury (SCI) results in loss of sensory and motor function below the level of injury and has limited available therapies. The host response to SCI is typified by limited endogenous repair, and biomaterial bridges offer the potential to alter the microenvironment to promote regeneration. Porous multiple channel bridges implanted into the injury provide stability to limit secondary damage and support cell infiltration that limits cavity formation. At the same time, the channels provide a path that physically directs axon growth across the injury. Using a rat spinal cord hemisection injury model, we investigated the dynamics of axon growth, myelination, and scar formation within and around the bridge in vivo for 6 months, at which time the bridge has fully degraded. Axons grew into and through the channels, and the density increased overtime, resulting in the greatest axon density at 6 months postimplantation, despite complete degradation of the bridge by that time point. Furthermore, the persistence of these axons contrasts with reports of axonal dieback in other models and is consistent with axon stability resulting from some degree of connectivity. Immunostaining of axons revealed both motor and sensory origins of the axons found in the channels of the bridge. Extensive myelination was observed throughout the bridge at 6 months, with centrally located and peripheral channels seemingly myelinated by oligodendrocytes and Schwann cells, respectively. Chondroitin sulfate proteoglycan deposition was restricted to the edges of the bridge, was greatest at 1 week, and significantly decreased by 6 weeks. The dynamics of collagen I and IV, laminin, and fibronectin deposition varied with time. These studies demonstrate that the bridge structure can support substantial long-term axon growth and myelination with limited scar formation.
C1 [Tuinstra, Hannah M.; Goodman, Ashley G.; Boehler, Ryan M.; Holland, Samantha J.; Zelivyanskaya, Marina L.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Margul, Daniel J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Dept Phys Med & Rehabil, Irvine, CA USA.
   [Cummings, Brian J.; Anderson, Aileen J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA.
   [Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA.
   [Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem Engn, 2145 Sheridan Rd Tech E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Cummings, Brian/C-9180-2012; Shea, Lonnie/B-7615-2009
OI Cummings, Brian/0000-0003-3628-5290; Margul, Daniel/0000-0002-0907-1839
FU NIH [RO1 EB005678, R21 EB006520, RO1 EB003806]
FX Financial support for this research was provided by the NIH (RO1
   EB005678, R21 EB006520, RO1 EB003806). The authors thank the Christopher
   and Dana Reeve Foundation SCI core at UC Irvine.
CR Asher RA, 2000, J NEUROSCI, V20, P2427
   Asher RA, 2002, J NEUROSCI, V22, P2225, DOI 10.1523/JNEUROSCI.22-06-02225.2002
   AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9
   Beattie M. S, 1992, J NEUROTRAUM, V9, P9
   BEATTIE MS, 1992, J NEUROTRAUM, V9, P157, DOI 10.1089/neu.1992.9.157
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197
   BIXBY JL, 1991, ANNU REV CELL BIOL, V7, P117, DOI 10.1146/annurev.cb.07.110191.001001
   BLIGHT AR, 1989, J NEUROL SCI, V91, P15, DOI 10.1016/0022-510X(89)90073-7
   BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0
   Camand E, 2004, EUR J NEUROSCI, V20, P1161, DOI 10.1111/j.1460-9568.2004.03558.x
   Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]
   Chen BKK, 2011, BIOMATERIALS, V32, P8077, DOI 10.1016/j.biomaterials.2011.07.029
   Cheng H, 2007, BIOCHEM BIOPH RES CO, V357, P938, DOI 10.1016/j.bbrc.2007.04.049
   Cholas RH, 2012, BIOMATERIALS, V33, P2050, DOI 10.1016/j.biomaterials.2011.11.028
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034
   De Laporte L, 2009, MOL THER, V17, P318, DOI 10.1038/mt.2008.252
   De Laporte L, 2009, BIOMATERIALS, V30, P2361, DOI 10.1016/j.biomaterials.2008.12.051
   Eyre JA, 2007, NEUROSCI BIOBEHAV R, V31, P1136, DOI 10.1016/j.neubiorev.2007.05.011
   Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Friedman JA, 2002, NEUROSURGERY, V51, P742, DOI 10.1097/00006123-200209000-00024
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   GLEDHILL RF, 1973, EXP NEUROL, V38, P472, DOI 10.1016/0014-4886(73)90169-6
   Hiruma H, 2000, BRAIN RES, V883, P184, DOI 10.1016/S0006-8993(00)02892-4
   Houweling DA, 1998, EXP NEUROL, V153, P49, DOI 10.1006/exnr.1998.6867
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Joosten EAJ, 2012, CELL TISSUE RES, V349, P375, DOI 10.1007/s00441-012-1352-5
   Keirstead HS, 1999, EXP NEUROL, V159, P225, DOI 10.1006/exnr.1999.7100
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   King VR, 2003, EXP NEUROL, V182, P383, DOI 10.1016/S0014-4886(03)00033-5
   Krych AJ, 2009, ACTA BIOMATER, V5, P2551, DOI 10.1016/j.actbio.2009.03.021
   Lonjon N, 2010, J NEUROSURG-SPINE, V12, P106, DOI 10.3171/2009.7.SPINE0989
   Loy DN, 2002, J COMP NEUROL, V445, P308, DOI 10.1002/cne.10168
   MARTIN D, 1992, J NEUROSCI RES, V32, P539, DOI 10.1002/jnr.490320409
   Moon LDF, 2002, NEUROSCIENCE, V109, P101, DOI 10.1016/S0306-4522(01)00457-2
   Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045
   Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309
   Nomura H, 2008, NEUROSURGERY, V63, P127, DOI 10.1227/01.NEU.0000316.143.88403.16
   Okada M, 2007, NEUROSCI RES, V58, P371, DOI 10.1016/j.neures.2007.04.009
   Olson HE, 2009, TISSUE ENG PT A, V15, P1797, DOI 10.1089/ten.tea.2008.0364
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   RICHARDSON PM, 1982, BRAIN RES, V237, P147, DOI 10.1016/0006-8993(82)90563-7
   RICHARDSON PM, 1980, NATURE, V284, P264, DOI 10.1038/284264a0
   Schwab ME, 1996, PHYSIOL REV, V76, P319
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0
   Sroga JM, 2003, J COMP NEUROL, V462, P223, DOI 10.1002/cne.10736
   Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151
   Stokols S, 2006, BIOMATERIALS, V27, P443, DOI 10.1016/j.biomaterials.2005.06.039
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Tang XF, 2003, J NEUROSCI RES, V71, P427, DOI 10.1002/jnr.10523
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   Tuszynski MH, 1998, CELL TRANSPLANT, V7, P187, DOI 10.1016/S0963-6897(97)00166-8
   Vanicky I, 2001, J NEUROTRAUM, V18, P1399, DOI 10.1089/08977150152725687
   Wang MD, 2011, TISSUE ENG PART B-RE, V17, P177, DOI 10.1089/ten.teb.2010.0648
   Weidner N, 1999, J COMP NEUROL, V413, P495, DOI 10.1002/(SICI)1096-9861(19991101)413:4<495::AID-CNE1>3.0.CO;2-Z
   Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798
   Wong DY, 2008, J NEUROTRAUM, V25, P1027, DOI 10.1089/neu.2007.0473
   Yang Y, 2009, TISSUE ENG PT A, V15, P3283, DOI [10.1089/ten.tea.2009.0081, 10.1089/ten.TEA.2009.0081]
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Young W, 2002, PROG BRAIN RES, V137, P231
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002
   Zhang SX, 2011, BRAIN RES, V1399, P1, DOI 10.1016/j.brainres.2011.05.005
   Zhang SX, 2011, HISTOL HISTOPATHOL, V26, P45, DOI 10.14670/HH-26.45
   Zhang SX, 2005, HISTOL HISTOPATHOL, V20, P519, DOI 10.14670/HH-20.519
   Zhou LJ, 2003, J NEUROSCI, V23, P1424
NR 73
TC 7
Z9 10
U1 2
U2 24
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2014
VL 20
IS 5-6
BP 1027
EP 1037
DI 10.1089/ten.tea.2013.0111
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8DZ
UT WOS:000332021600014
PM 24168314
OA Green Published
DA 2018-10-19
ER

PT J
AU Bourke, JL
   Coleman, HA
   Pham, V
   Forsythe, JS
   Parkington, HC
AF Bourke, Justin L.
   Coleman, Harold A.
   Vi Pham
   Forsythe, John S.
   Parkington, Helena C.
TI Neuronal Electrophysiological Function and Control of Neurite Outgrowth
   on Electrospun Polymer Nanofibers Are Cell Type Dependent
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID ROOT GANGLION NEURONS; NEURAL STEM-CELLS; EMBRYONIC HIPPOCAMPAL-NEURONS;
   3-DIMENSIONAL COLLAGEN GELS; MICROPATTERNED SURFACES; SYNAPSE FORMATION;
   CONTACT GUIDANCE; CARBON NANOTUBES; CHANNEL DENSITY; CNS NEUROBLASTS
AB Modeling of cellular environments with nanofabricated biomaterial scaffolds has the potential to improve the growth and functional development of cultured cellular models, as well as assist in tissue engineering efforts. An understanding of how such substrates may alter cellular function is critical. Highly plastic central nervous system hippocampal cells and non-network forming peripheral nervous system dorsal root ganglion (DRG) cells from embryonic rats were cultured upon laminin-coated degradable polycaprolactone (PCL) and nondegradable polystyrene (PS) electrospun nanofibrous scaffolds with fiber diameters similar to those of neuronal processes. The two cell types displayed intrinsically different growth patterns on the nanofibrous scaffolds. Hippocampal neurites grew both parallel and perpendicular to the nanofibers, a property that would increase neurite-to-neurite contacts and maximize potential synapse development, essential for extensive network formation in a highly plastic cell type. In contrast, non-network-forming DRG neurons grew neurites exclusively along fibers, recapitulating the simple direct unbranching pathway between sensory ending and synapse in the spinal cord that occurs in vivo. In addition, the two primary neuronal types showed different functional capacities under patch clamp testing. The substrate composition did not alter the neuronal functional development, supporting electrospun PCL and PS as candidate materials for controlled cellular environments in culture and electrospun PCL for directed neurite outgrowth in tissue engineering applications.
C1 [Bourke, Justin L.; Coleman, Harold A.; Vi Pham; Parkington, Helena C.] Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.
   [Bourke, Justin L.; Forsythe, John S.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
RP Bourke, JL (reprint author), Monash Univ, Dept Physiol, Clayton, Vic 3800, Australia.
EM justin.bourke@monash.edu
RI bourke, justin/A-6900-2008
OI bourke, justin/0000-0003-2584-2127; Forsythe, John/0000-0003-2849-229X
FU National Health and Medical Research Council
FX We thank Monash Micro Imaging for provision of instrumentation and
   training in optical microscopy techniques, and the National Health and
   Medical Research Council for the Dora Lush Biomedical Postgraduate
   Scholarship to J.B.
CR Arhem P, 2006, BIOPHYS J, V90, P4392, DOI 10.1529/biophysj.105.077032
   Arhem P, 2007, BIOSYSTEMS, V89, P117, DOI 10.1016/j.biosystems.2006.03.015
   Bi GQ, 1998, J NEUROSCI, V18, P10464
   Bolgen N, 2005, J BIOMAT SCI-POLYM E, V16, P1537, DOI 10.1163/156856205774576655
   CAFFREY JM, 1992, BRAIN RES, V592, P283, DOI 10.1016/0006-8993(92)91687-A
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/nnano.2008.374, 10.1038/NNANO.2008.374]
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Daud MFB, 2012, BIOMATERIALS, V33, P5901, DOI 10.1016/j.biomaterials.2012.05.008
   Edelman DB, 2005, EXP NEUROL, V192, P1, DOI 10.1016/j.expneurol.2004.10
   Eubanks JH, 1996, NEUROSCI LETT, V204, P5, DOI 10.1016/0304-3940(96)12337-5
   Fozdar DY, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035005
   Heller DA, 2005, BIOMATERIALS, V26, P883, DOI 10.1016/j.biomaterials.2004.03.029
   Ho C, 2011, MOL CELL NEUROSCI, V46, P159, DOI 10.1016/j.mcn.2010.08.017
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hutmacher DW, 2010, NAT MATER, V9, P90, DOI 10.1038/nmat2619
   Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Larsson K, 2012, CELLS TISSUES ORGANS, V196, P82, DOI 10.1159/000330696
   Lee JY, 2010, J BIOMED MATER RES A, V92A, P1398, DOI 10.1002/jbm.a.32471
   Liu QY, 2000, DEV BRAIN RES, V120, P223, DOI 10.1016/S0165-3806(00)00014-6
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   Lutton C, 2008, NAT BIOTECHNOL, V26, P613, DOI 10.1038/nbt0608-613
   Ma W, 2004, EXP NEUROL, V190, P276, DOI 10.1016/j.expneurol.2003.10.016
   Ma W, 1998, DEV BRAIN RES, V111, P231, DOI 10.1016/S0165-3806(98)00142-4
   Magnusson AK, 2008, J NEUROSCI RES, V86, P2363, DOI 10.1002/jnr.21688
   Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   NAGATA I, 1991, DEVELOPMENT, V112, P581
   NAGATA I, 1993, DEVELOPMENT, V117, P401
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   O'Shaughnessy TJ, 2003, NEUROSCI LETT, V340, P169, DOI 10.1016/S0304-3940(03)00083-1
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271
   SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944
   Shahbazi E, 2011, TISSUE ENG PT A, V17, P3021, DOI [10.1089/ten.tea.2011.0121, 10.1089/ten.TEA.2011.0121]
   Shao HJ, 2010, BIOMATERIALS, V31, P4695, DOI 10.1016/j.biomaterials.2010.02.037
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Villiere V, 1996, J NEUROPHYSIOL, V76, P1924
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   Xu HF, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285102
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2009, BIOMATERIALS, V30, P4377, DOI 10.1016/j.biomaterials.2009.04.047
NR 48
TC 16
Z9 16
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD MAR 1
PY 2014
VL 20
IS 5-6
BP 1089
EP 1095
DI 10.1089/ten.tea.2013.0295
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8DZ
UT WOS:000332021600020
PM 24147808
OA Green Published
DA 2018-10-19
ER

PT J
AU Mericli, AF
   Gampper, TJ
AF Mericli, Alexander F.
   Gampper, Thomas J.
TI Treatment of Postsurgical Temporal Hollowing With High- Density Porous
   Polyethylene
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Temporal hollowing; Medpor; highly porous polyethylene
ID CRANIOFACIAL RECONSTRUCTION; BONE; IMPLANTS; SURGERY; BIOMATERIALS;
   CEMENT; CRANIOPLASTY; GRAFTS; FLAP; FACE
AB Temporal hollowing is most frequently an acquired defect and can be caused by a volumetric deficiency of bone, soft tissue, or both. Given high-density porous polyethylene's ease of use, customizability, long-term strength and resiliency, and successful application in other areas of the craniofacial skeleton, the authors have used it as the first-line material for reconstruction of temporal hollowing. Herein, we present 4 illustrative cases demonstrating this technique and further describe subtypes of the temporal defect with appropriate means of reconstruction. The cases were reviewed for comorbidities, intraoperative details, and the postoperative course. There were no complications, and all patients were pleased with their final result. High-density porous polyethylene is a safe, well-studied, and easily handled biomaterial that is useful for the treatment of temporal hollowing.
C1 [Mericli, Alexander F.; Gampper, Thomas J.] Univ Virginia Hlth Syst, Dept Plast Surg, Charlottesville, VA 22908 USA.
RP Gampper, TJ (reprint author), Univ Virginia Hlth Syst, Dept Plast Surg, POB 800376, Charlottesville, VA 22908 USA.
EM tjg6f@virginia.edu
CR Carboni A, 2002, Minerva Chir, V57, P283
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   CHAJCHIR A, 1989, PLAST RECONSTR SURG, V84, P921, DOI 10.1097/00006534-198912000-00009
   Cho YR, 2004, CLIN PLAST SURG, V31, P377, DOI 10.1016/j.cps.2004.03.001
   Coleman SR, 1997, CLIN PLAST SURG, V24, P347
   EDGERTON MT, 1985, ANN SURG, V202, P459, DOI 10.1097/00000658-198510000-00007
   Gosain AK, 1999, J CRANIOFAC SURG, V10, P404, DOI 10.1097/00001665-199909000-00006
   HOMSY C A, 1970, Journal of Biomedical Materials Research, V4, P341, DOI 10.1002/jbm.820040306
   Kim S, 2005, J CRANIOFAC SURG, V16, P651, DOI 10.1097/01.scs.0000168764.48486.a2
   Kim SG, 2001, INT J ORAL MAX SURG, V30, P438, DOI 10.1054/ijom.2001.0104
   Kumar AR, 2011, PLAST RECONSTR SURG, V127, P1279, DOI 10.1097/PRS.0b013e318205f47c
   Lacey M, 1994, J Craniofac Surg, V5, P223, DOI 10.1097/00001665-199409000-00005
   Lee DW, 2010, J CRANIOFAC SURG, V21, P1084, DOI 10.1097/SCS.0b013e3181e1b64b
   Lin AY, 2012, J CRANIOFAC SURG, V23, P67, DOI 10.1097/SCS.0b013e318240c876
   MANSON PN, 1986, PLAST RECONSTR SURG, V77, P888, DOI 10.1097/00006534-198606000-00003
   Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055
   Matic DB, 2008, PLAST RECONSTR SURG, V121, P379
   Menderes A, 2004, J CRANIOFAC SURG, V15, P719, DOI 10.1097/00001665-200409000-00004
   Pryor LS, 2009, CRANIOMAX TRAUM REC, V2, P151, DOI [10.1055/s-0029-1224777, 10.1055/s-0029-1224777.ISSN1943-3875]
   Rapidis AD, 2006, J ORAL MAXIL SURG, V64, P12, DOI 10.1016/j.joms.2005.09.007
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   SPECTOR M, 1975, J BIOMED MATER RES, V9, P537, DOI 10.1002/jbm.820090514
   Tanna N, 2011, PLAST RECONSTR SURG, V127, P802, DOI 10.1097/PRS.0b013e3181fed6e4
   VAANDRAGER JM, 1988, ANN PLAS SURG, V21, P583, DOI 10.1097/00000637-198812000-00016
   WOLFE SA, 1982, CLIN PLAST SURG, V9, P539
   Wong RK, 2011, J CRANIOFAC SURG, V22, P247, DOI 10.1097/SCS.0b013e3181f7b7db
   Xie Y, 2010, J PLAST RECONSTR AES, V63, P270, DOI 10.1016/j.bjps.2008.11.016
   Yaremchuk MJ, 2003, PLAST RECONSTR SURG, V111, P1818, DOI 10.1097/01.PRS.0000056866.80665.7A
NR 28
TC 3
Z9 3
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2014
VL 25
IS 2
BP 563
EP 567
DI 10.1097/SCS.0000000000000506
PG 5
WC Surgery
SC Surgery
GA AG4IB
UT WOS:000335381800108
PM 24514889
DA 2018-10-19
ER

PT J
AU Lopez, MA
   Bassi, MA
   Confalone, L
   Carinci, F
AF Lopez, Michele Antonio
   Bassi, Mirko Andreasi
   Confalone, Luca
   Carinci, Francesco
TI Maxillary Sinus Floor Elevation via Crestal Approach: The Evolution of
   the Hydraulic Pressure Technique
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE Sinus floor elevation; bone graft; hydraulic detachment; hydraulic
   elevation
ID OSTEOTOME TECHNIQUE; MOLAR EXTRACTION; IMPLANTS; AUGMENTATION;
   PLACEMENT; MEMBRANE; SUCCESS; RATES; TIME
AB The current study describes an innovative protocol for the surgical maxillary sinus augmentation via a crestal approach that uses hydraulic pressure to lift the Schneiderian membrane and simultaneously fill the subantral space with a biomaterial for bone regeneration (nanocrystalline hydroxyapatite in aqueous solution). The technique in question combines the advantages of large amounts of grafted biomaterial with reduced trauma, high precision, and predictability.
C1 [Lopez, Michele Antonio; Bassi, Mirko Andreasi; Confalone, Luca; Carinci, Francesco] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept Morphol Surg & Expt Med, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
CR Aimetti M, 2001, INT J PERIODONT REST, V21, P581
   Andreasi Bassi M, 2010, J OSTEOL BIOMAT, V1, P93
   Buser D, 2000, CLIN ORAL IMPLAN RES, V11, P59, DOI 10.1034/j.1600-0501.2000.011S1059.x
   Cavicchia F, 2001, INT J PERIODONT REST, V21, P475
   Coatoam G W, 1997, J Oral Implantol, V23, P117
   Favero GA, 1994, G STOMATOL ORTOGNATO, V1, P57
   Fugazzotto P A, 2001, Implant Dent, V10, P259
   Fugazzotto PA, 1998, INT J ORAL MAX IMPL, V13, P52
   Fugazzotto PA, 2002, INT J ORAL MAX IMPL, V17, P113
   Fugazzotto PA, 2002, J PERIODONTOL, V73, P39, DOI 10.1902/jop.2002.73.1.39
   Fugazzotto PA, 1999, INT J ORAL MAX IMPL, V14, P536
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P595, DOI 10.1034/j.1600-0501.2002.130604.x
   Nkenke E, 2002, INT J ORAL MAX IMPL, V17, P557
   Ozyuvaci H, 2003, J PERIODONTOL, V74, P909, DOI 10.1902/jop.2003.74.6.909
   Reiser GM, 2001, INT J ORAL MAX IMPL, V16, P833
   Smiler DG, 1992, DENT CLIN N AM, V36, P151
   Sotirakis Emmanouil G, 2005, J Oral Implantol, V31, P197, DOI 10.1563/1548-1336(2005)31[197:EOTMSF]2.0.CO;2
   Summers R B, 1994, Compendium, V15, P702
   Summers R B, 1994, Compendium, V15, P154
   Summers R B, 1995, Compend Contin Educ Dent, V16, P1094
   Summers R. B., 1994, COMPENDIUM, V15, P158
   Summers R. B., 1994, COMPENDIUM, V15, P162
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1098
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1099
   Summers RB, 1995, COMPEND CONTIN ED DE, V16, P1092
   Summers RB, 1994, COMPENDIUM, V15, P154
   Summers RB., 1995, COMPEND CONTIN ED DE, V16, P1094
   SUMMERS RB, 1994, COMPENDIUM, V15, P700
   SUMMERS RB, 1994, COMPENDIUM, V15, P702
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tatum H Jr, 1988, CDA J, V16, P71
   Tatum O H Jr, 1989, Fla Dent J, V60, P23
   Vercellotti T, 2001, INT J PERIODONT REST, V21, P561
   Winter AA, 2002, INT J ORAL MAX IMPL, V17, P687
NR 35
TC 10
Z9 10
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1049-2275
EI 1536-3732
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD MAR
PY 2014
VL 25
IS 2
BP E127
EP E132
DI 10.1097/SCS.0000000000000457
PG 6
WC Surgery
SC Surgery
GA AG4IB
UT WOS:000335381800014
PM 24448532
DA 2018-10-19
ER

PT J
AU Yang, JL
   Huang, YJ
   Gao, CM
   Liu, MZ
   Zhang, XJ
AF Yang, Jinlong
   Huang, Yinjuan
   Gao, Chunmei
   Liu, Mingzhu
   Zhang, Xinjie
TI Fabrication and evaluation of the novel reduction-sensitive starch
   nanoparticles for controlled drug release
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Starch nanoparticles; BAC; Reduction-sensitive; Drug release
ID LINKED HIGH AMYLOSE; IN-VITRO; 5-AMINOSALICYLIC ACID; DELIVERY
   PLATFORMS; DISULFIDE; POLYMERS; MICELLES; CHITOSAN; CARRIER; PH
AB A novel type of reduction-sensitive starch nanoparticles was prepared via the reversed-phase microemulsion method by using crosslinker, N,N-bisacryloylcystamine (BAC) with the disulfide linkages, which was specifically cleaved by dithiothreitol (DTT). Starch nanoparticles had a spherical morphology with a small size of 40 nm in the optimal condition. The influences of process parameters (starch amount, surfactant amount and oil/water (O/W) ratio) on the size of starch nanoparticles were studied by dynamic light scattering (DLS). BAC crosslinked starch nanoparticles were degraded into oligomers with the reducing agent of DTT due to the cleavage of the disulfide linkages. A model drug 5-aminosalicylic acid (5-ASA) could be loaded efficiently into starch nanoparticles and the in vitro drug release behaviors were also studied. The results suggested that the disulfide crosslinked starch nanoparticles exhibited an accelerated drug release behavior in the presence of DTT. In vitro methyl thiazolyl tetrazolium (MTT) assays indicated that BAC crosslinked starch nanoparticles had a good biocompatibility when cocultured with human HeLa cancer cells. Hence, with excellent biocompatibility and biodegradability, and rapid drug release in response to DTT, BAC crosslinked starch nanoparticles showed a great potential as a biomaterial carrier for the application of drug controlled release. In contrast to BAC crosslinked starch nanoparticles, N,N-methylenebisacrylamine (MBA) crosslinked starch nanoparticles were prepared as the control without the disulfide linkages. (C) 2013 Elsevier Ky. All rights reserved.
C1 [Liu, Mingzhu] Lanzhou Univ, Key Lab Nonferrous Met Chem & Resources Utilizat, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
   Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
RP Liu, MZ (reprint author), Lanzhou Univ, Key Lab Nonferrous Met Chem & Resources Utilizat, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
EM mzliu@lzu.edu.cn
FU National Natural Science Foundation of China [51273086]; Special
   Doctorial Program Fund from the Ministry of the Education of China
   [20090211110004]
FX The authors acknowledge gratefully the financial support of the National
   Natural Science Foundation of China (Grant No. 51273086) and the Special
   Doctorial Program Fund from the Ministry of the Education of China
   (Grant No. 20090211110004).
CR Antonietti M, 2002, PROG POLYM SCI, V27, P689, DOI 10.1016/S0079-6700(01)00051-X
   Assaad E, 2010, INT J PHARMACEUT, V394, P75, DOI 10.1016/j.ijpharm.2010.04.037
   Bajomo M, 2007, J PHYS CHEM B, V111, P8655, DOI 10.1021/jp070491a
   Chang D, 2012, CARBOHYD POLYM, V88, P663, DOI 10.1016/j.carbpol.2012.01.020
   Cury BSF, 2008, REACT FUNCT POLYM, V68, P1200, DOI 10.1016/j.reactfunctpolym.2008.04.003
   De Graaf RA, 2003, ADV POLYM TECH, V22, P56, DOI 10.1002/adv.10034
   Ding JX, 2011, POLYM CHEM-UK, V2, P2857, DOI 10.1039/c1py00360g
   Fan HL, 2010, POLYMER, V51, P5107, DOI 10.1016/j.polymer.2010.09.004
   Garcia-Gonzalez CA, 2012, CARBOHYD POLYM, V88, P1378, DOI 10.1016/j.carbpol.2012.02.023
   Han SC, 2009, J POLYM SCI POL CHEM, V47, P4074, DOI 10.1002/pola.23468
   Hirayama M, 2011, MOL PHARMACEUT, V8, P1083, DOI 10.1021/mp200088z
   Huang YJ, 2013, CARBOHYD POLYM, V96, P426, DOI 10.1016/j.carbpol.2013.04.013
   Huang YJ, 2012, EUR POLYM J, V48, P1734, DOI 10.1016/j.eurpolymj.2012.06.012
   Huttunen K.M., 2012, MOL PHARM, V10, P532
   Jain JP, 2010, BIOMACROMOLECULES, V11, P1027, DOI 10.1021/bm1000026
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Le Corre D, 2010, BIOMACROMOLECULES, V11, P1139, DOI 10.1021/bm901428y
   Lemieux M, 2009, INT J PHARMACEUT, V382, P172, DOI 10.1016/j.ijpharm.2009.08.030
   Li BZ, 2009, J FOOD ENG, V92, P250, DOI 10.1016/j.jfoodeng.2008.08.011
   Li YT, 2005, MACROMOLECULES, V38, P8155, DOI 10.1021/ma051121s
   Liang K, 2011, ADV MATER, V23, pH273, DOI 10.1002/adma.201101690
   Liu MQ, 2011, J CHROMATOGR A, V1218, P286, DOI 10.1016/j.chroma.2010.11.037
   Marques AP, 2002, BIOMATERIALS, V23, P1471, DOI 10.1016/S0142-9612(01)00272-1
   Meng FH, 2009, BIOMATERIALS, V30, P2180, DOI 10.1016/j.biomaterials.2009.01.026
   Moad G, 2011, PROG POLYM SCI, V36, P218, DOI 10.1016/j.progpolymsci.2010.11.002
   Mura C, 2011, CARBOHYD POLYM, V85, P578, DOI 10.1016/j.carbpol.2011.03.017
   Na K, 2007, BIOCONJUGATE CHEM, V18, P1568, DOI 10.1021/bc070052e
   Oh JK, 2006, J AM CHEM SOC, V128, P5578, DOI 10.1021/ja060586a
   Onofre FO, 2010, INT J PHARMACEUT, V385, P104, DOI 10.1016/j.ijpharm.2009.10.038
   Pan YJ, 2013, POLYM CHEM-UK, V4, P3545, DOI 10.1039/c3py00249g
   Pan YJ, 2012, BIOMATERIALS, V33, P6570, DOI 10.1016/j.biomaterials.2012.05.062
   Shi AM, 2011, CARBOHYD POLYM, V83, P1604, DOI 10.1016/j.carbpol.2010.10.011
   Soares GA, 2013, CARBOHYD POLYM, V91, P135, DOI 10.1016/j.carbpol.2012.08.014
   Sun HL, 2009, BIOMATERIALS, V30, P6358, DOI 10.1016/j.biomaterials.2009.07.051
   Thiele C, 2011, POLYM CHEM-UK, V2, P209, DOI 10.1039/c0py00241k
   Thielemans W, 2006, LANGMUIR, V22, P4804, DOI 10.1021/la053394m
   Tian Z, 2008, POLYMER, V49, P446, DOI 10.1016/j.polymer.2007.11.048
   Tsarevsky NV, 2002, MACROMOLECULES, V35, P9009, DOI 10.1021/ma021061f
   Wang H, 2013, BIOMACROMOLECULES, V14, P3706, DOI 10.1021/bm401086d
   Wu Y, 2009, CARBOHYD POLYM, V76, P299, DOI 10.1016/j.carbpol.2008.10.031
   Wu YH, 2009, J MEMBRANE SCI, V344, P182, DOI 10.1016/j.memsci.2009.07.050
   Xu Y, 2010, CARBOHYD POLYM, V80, P1078, DOI 10.1016/j.carbpol.2010.01.027
   Yan LS, 2012, POLYM CHEM-UK, V3, P2403, DOI 10.1039/c2py20240a
   Yessine MA, 2006, EUR J PHARM BIOPHARM, V63, P1, DOI 10.1016/j.ejpb.2005.10.010
   YU H, 1994, MACROMOLECULES, V27, P4554, DOI 10.1021/ma00094a019
   Yu JH, 2011, SOFT MATTER, V7, P7386, DOI 10.1039/c1sm05426k
   Zhang AP, 2013, SOFT MATTER, V9, P2224, DOI 10.1039/c2sm27189c
   Zhang YR, 2009, CARBOHYD POLYM, V78, P157, DOI 10.1016/j.carbpol.2009.04.023
   Zhou HF, 2010, BIOMACROMOLECULES, V11, P3480, DOI 10.1021/bm100989x
NR 49
TC 23
Z9 24
U1 4
U2 59
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAR 1
PY 2014
VL 115
BP 368
EP 376
DI 10.1016/j.colsurfb.2013.12.007
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA AG0JK
UT WOS:000335101600049
PM 24463097
DA 2018-10-19
ER

PT J
AU Mikhailova, I
   Sandomirsky, B
   Gorlenko, A
AF Mikhailova, Irina
   Sandomirsky, Boris
   Gorlenko, Anna
TI Effect of low temperatures and ionizing irradiation upon
   physical-mechanical properties and connective-tissue structures of
   porcine fibrous pericardium and aortic valve leaflets
SO PERIODICUM BIOLOGORUM
LA English
DT Article
DE fibrous pericardium; aortic valve leaflets; physical and mechanical
   properties; morphological structure; cell-free xenogeneic materials;
   freeze; ionizing irradiation; devitalization
ID GAMMA-IRRADIATION; VASCULAR GRAFTS; COLLAGEN; MATRIX; CRYOPRESERVATION;
   CROSSLINKING; BIOMATERIALS; REACTIVITY
AB Xenogeneic tissue devitalization is one of the creating methods of the tissue-replacing the biocompatible cell-free shells for the regenerative surgery. The work describes the possibility of applying the complex approach based on the continuous usage of cryo and radioactive (electron irradiation exposure) biological tissue damage effects. The pre-implant treatment provides sterilization and a possibility for the low temperature preservation of xenografts. After the transplantation such a cell-free xenoscaffold can be gradually replaced with the autogenic extracellular matrix from the recipient's cells and forms a stable long-term structure of the biological prosthesis.
   Fibrous pericardium (FP) and aortic valve leaflets (AVLs) were extracted from the mature pig. The prepared tissues were rinsed with the sterile normal saline solution and frozen down to the liquid-nitrogen temperature. After one time placing on water-bath (37 degrees C) they were exposed to electron irradiation within dosage range of 25-30 kGray and submerged into the liquid nitrogen vapors. After influence of low temperature and ionizing radiation, tissue morphological structure was assessed using the optical microscopy. Deformations, i.e. longitudinal and transverse monoaxial strength were performed to calculate the physical and mechanical properties of FP and AVLs.
   Such a devitalization method of the FP and AVLs causes significant destructive changes in cell elements, however the spatial arrangement and structural integrity of the connective tissue fiber are preserved. Joint impact of low temperatures and ionizing radiation gives the synergetic effect, increasing the strength and elastic tissue properties. Freezing down to -196 degrees C and electron irradiation initiate formation of the intra- and intermolecular transverse cross-linking due to the binding activity of fibrous proteins. It leads to a more dense arrangement of the collagen fiber, adds strength to the implant and provides the structural tissue stabilization. The authors believe that during the remodeling in the recipient organism, the biomaterial structure modified in such a manner can successfully prevent physiological tension.
C1 [Mikhailova, Irina; Sandomirsky, Boris; Gorlenko, Anna] Natl Acad Sci Ukraine, Inst Problems Cryobiol & Cryomed, Dept Expt Cryomed, UA-61015 Kharkov, Ukraine.
RP Gorlenko, A (reprint author), Dept Expt Cryomed, Klochkovskaya St 105a,23, UA-61145 Kharkov, Ukraine.
EM anna.gorlenko@gmail.com
OI Sandomirsky, Boris/0000-0002-2440-1971
CR BAILEY AJ, 1964, RADIAT RES, V22, P606, DOI 10.2307/3571543
   Borschel GH, 2005, TISSUE ENG, V11, P778, DOI 10.1089/ten.2005.11.778
   BYSOV D V, 2011, VESTNIK TRANSPLANTOL, V12, P81
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   CUI D., 2011, WOLKERS KL, V1, P56
   CUI X, 2002, CELL PRESERV TECHNOL, V1, P121
   GIBERT T, 2006, BIOMATERIALS, V27, P3675
   GRANT RA, 1970, J CELL SCI, V7, P387
   GRANT RA, 1973, J ANAT, V115, P29
   GRASSL E D, 2004, ASME HEAT TRANSFER D, V375, P699
   Gratzer PF, 2006, TISSUE ENG, V12, P2975, DOI 10.1089/ten.2006.12.2975
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   GRODZINSKY A J, 1987, ADV MICROCIRCULAT, V13, P35
   GRODZINSKY AJ, 1983, CRIT REV BIOMED ENG, V9, P133
   HENNER WD, 1983, J BIOL CHEM, V258, P711
   IMPARATO FM, 1992, MODERN VASCULAR SURG, V5, P26
   ITKIN U, 1981, ACTUAL PROBLEMS CRYO, P606
   LUYET B, 1968, CRYOBIOLOGY, V4, P247
   Muratov R, 2010, INTERACT CARDIOV TH, V10, P408, DOI 10.1510/icvts.2009.216549
   Ota T, 2007, ANN THORAC SURG, V83, P1501, DOI 10.1016/j.athoracsur.2006.11.083
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   RAYMOND ZEEMAN, 1998, THESIS U TWENTE ENSC
   ROSS M H, 2011, WOLKERS KL, V6, P158
   Roy S., 2005, AM J PHYSIOL-HEART C, V289, P1567
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Seto A, 2009, CLIN ORTHOP RELAT R, V467, P2994, DOI 10.1007/s11999-009-0934-3
   SOLANESA N, 2004, TRANSPL P, V1, P3288
   SPIRIDONOV S V, 2013, NOVOSTI KHIRURGII, V21, P76
   Sung HW, 1999, J BIOMED MATER RES, V47, P116, DOI 10.1002/(SICI)1097-4636(199911)47:2<116::AID-JBM2>3.0.CO;2-J
   Thakrar RR, 2006, FASEB J, V20, P874, DOI 10.1096/fj.05-5304com
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Vasin SL, 1998, J BIOMED MATER RES, V39, P491, DOI 10.1002/(SICI)1097-4636(19980305)39:3<491::AID-JBM21>3.3.CO;2-Z
   Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Yang J, 2007, BIOMATERIALS, V28, P5033, DOI 10.1016/j.biomaterials.2007.07.052
   YARMONENKO S P, 2004, RADIOBIOLOGIYA CHELO, P549
   Zhu CH, 2008, BIOMATERIALS, V29, P2628, DOI 10.1016/j.biomaterials.2008.03.005
NR 38
TC 1
Z9 1
U1 0
U2 4
PU PERIODICUM BIOLOGORUM
PI ZAGREB
PA HRVATSKO PRIRODOSLOVNO DRUSTVO ILICA 16/111, 41000 ZAGREB, CROATIA
SN 0031-5362
J9 PERIOD BIOL
JI Period. Biol.
PD MAR
PY 2014
VL 116
IS 1
BP 105
EP 114
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AG1VL
UT WOS:000335204200019
DA 2018-10-19
ER

PT J
AU Higuchi, A
   Lin, FL
   Cheng, YK
   Kao, TC
   Kumar, SS
   Ling, QD
   Hou, CH
   Chen, DC
   Hsu, ST
   Wu, GJ
AF Higuchi, Akon
   Lin, Feng-Ling
   Cheng, Yu-Kai
   Kao, Ta-Chun
   Kumar, S. Suresh
   Ling, Qing-Dong
   Hou, Chun-Han
   Chen, Da-Chung
   Hsu, Shih-Tien
   Wu, Gwo-Jang
TI Preparation of induced pluripotent stem cells on dishes grafted on
   oligopeptide under feeder-free conditions
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Induced pluripotent stem cell; Feeder-free culture; Adipose-derived stem
   cell; Vitronectin; Oligopeptide; Biomaterial
ID ADIPOSE-DERIVED CELLS; SYNTHETIC-POLYMER COATINGS; XENO-FREE CONDITIONS;
   TERM SELF-RENEWAL; DIFFERENTIATION ABILITY; EXTRACELLULAR MATRICES;
   MEMBRANE FILTRATION; HUMAN FIBROBLASTS; HUMAN BLASTOCYSTS;
   TEMPORAL-CHANGES
AB Human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) have potentially therapeutic applications in the treatment of many diseases, due to their unique ability to differentiate into any type of somatic cell. However, the clinical potential of hESCs and hiPSCs is restricted by the use of mouse embryonic fibroblasts (MEFs) as a feeder layer for these cells. We report that hiPSCs can be successfully generated without the use of a feeder layer of MEFs. We generated hiPSCs by transducing human adipose-derived stem cells (hADSCs) with a retrovirus containing pluripotency genes, and the hiPSCs were cultured on synthetic dishes grafted with an oligopeptide derived from vitronectin (VN-dish). On the fourth day after transduction, the hADSCs transduced with pluripotency genes were transferred to a MEF layer for culturing as a control condition or to VN-dishes for culture. The hiPSC colonies in the MEF-cultures were clearly observed at day 14 after transduction, whereas hiPSC colonies were detected on the VN-dishes after the cells were passaged. When 105 hADSCs were seeded on the dishes, the number of colonies generated on the MEFs was 120 28, while the number of colonies generated on VN-dishes was 25 +/- 8. Thus, the efficiency of hiPSC generation on the VN-dishes under feeder-free conditions was lower than hiPSCs cultured on MEFs. However, the hiPSC colonies from VN-dishes demonstrated alkaline phosphatase activity, and immunohistochemistry suggested that the hiPSCs generated on VN-dishes expressed the pluripotency protein, stage-specific embryonic antigen-4 (SSEA-4), under feeder-free conditions. (C) 2013 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Higuchi, Akon; Cheng, Yu-Kai; Kao, Ta-Chun; Kumar, S. Suresh] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
   [Higuchi, Akon] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Tokyo 1578535, Japan.
   [Higuchi, Akon; Ling, Qing-Dong] Cathay Gen Hosp, Cathay Med Res Inst, Taipei 10630, Taiwan.
   [Lin, Feng-Ling] Cathay Gen Hosp, Dept Dermatol, Sijhih Branch, Taipei 22174, Taiwan.
   [Kumar, S. Suresh] Univ Putra Malaysia, Dept Med Microbiol & Parasitol, Slangor, Malaysia.
   [Ling, Qing-Dong] Natl Cent Univ, Inst Syst Biol & Bioinformat, Taoyuan 32001, Taiwan.
   [Hou, Chun-Han] Natl Taiwan Univ, Sch Med, Dept Orthoped Surg, Taipei 10051, Taiwan.
   [Chen, Da-Chung] Taiwan Landseed Hosp, Dept Obster & Gynecol, Taoyuan 32405, Taiwan.
   [Hsu, Shih-Tien] Taiwan Landseed Hosp, Dept Community Med, Taoyuan 32405, Taiwan.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Grad Inst Med Sci, Taipei 11490, Taiwan.
   [Wu, Gwo-Jang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Obstet & Gynecol, Taipei 11490, Taiwan.
RP Higuchi, A (reprint author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
EM higuchi@ncu.edu.tw
OI Hou, Chun-han/0000-0002-3850-0997; Higuchi, Akon/0000-0003-2970-8531
CR Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169
   Higuchi A, 2011, CURR NANOSCI, V7, P893, DOI 10.2174/157341311798220592
   Higuchi A, 2011, CHEM REV, V111, P3021, DOI 10.1021/cr1003612
   Higuchi A, 2011, J MEMBRANE SCI, V366, P286, DOI 10.1016/j.memsci.2010.10.009
   Holden C, 2009, SCIENCE, V326, P358, DOI 10.1126/science.326_358
   Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005
   Hoshiba T, 2010, ADV MATER, V22, P3042, DOI 10.1002/adma.201000038
   Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532
   Liu HY, 2012, BIOMATERIALS, V33, P6105, DOI 10.1016/j.biomaterials.2012.05.024
   Liu Y, 2011, BIOMATERIALS, V32, P8058, DOI 10.1016/j.biomaterials.2011.07.052
   Lu HE, 2011, EXP CELL RES, V317, P1895, DOI 10.1016/j.yexcr.2011.05.017
   Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181
   McIntosh K, 2006, STEM CELLS, V24, P1246, DOI 10.1634/stemcells.2005-0235
   Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629
   Meng GL, 2012, STEM CELLS DEV, V21, P2036, DOI 10.1089/scd.2011.0489
   Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234
   Nandivada H, 2011, NAT PROTOC, V6, P1037, DOI 10.1038/nprot.2011.342
   Noguchi H, 2010, CURR DIABETES REV, V6, P184, DOI 10.2174/157339910791162934
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Park IS, 2009, BIOMATERIALS, V30, P6835, DOI 10.1016/j.biomaterials.2009.08.057
   Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248
   Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106
   Swistowski A, 2010, STEM CELLS, V28, P1893, DOI 10.1002/stem.499
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tsai WB, 2013, J TAIWAN INST CHEM E, V44, P1, DOI 10.1016/j.jtice.2012.09.003
   Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084
   Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631
   Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974
   Wu CH, 2012, BIOMATERIALS, V33, P8228, DOI 10.1016/j.biomaterials.2012.08.027
   Yang YI, 2011, ACTA BIOMATER, V7, P4109, DOI 10.1016/j.actbio.2011.07.027
   Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482
   Zou CL, 2012, STEM CELLS DEV, V21, P2298, DOI 10.1089/scd.2011.0688
NR 36
TC 7
Z9 7
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD MAR
PY 2014
VL 45
IS 2
BP 295
EP 301
DI 10.1016/j.jtice.2013.06.022
PG 7
WC Engineering, Chemical
SC Engineering
GA AE5GB
UT WOS:000334014700001
DA 2018-10-19
ER

PT J
AU Lee, SJ
   Yoo, JJ
   Atala, A
AF Lee, Sang Jin
   Yoo, James J.
   Atala, Anthony
TI Recent Applications of Polymeric Biomaterials and Stem Cells in Tissue
   Engineering and Regenerative Medicine
SO POLYMER-KOREA
LA English
DT Review
DE biomaterials; polymers; extracellular matrix; stem cells; tissue
   engineering; regenerative medicine
ID SKELETAL-MUSCLE TISSUE; NEUROMUSCULAR-JUNCTION FORMATION; IN-VITRO
   EVALUATION; COLLAGEN MATRIX; BLOOD-VESSELS; EXTRACELLULAR-MATRIX; BONE
   REGENERATION; AURICULAR RECONSTRUCTION; URETHRAL RECONSTRUCTION;
   SYNTHETIC BIOMATERIALS
AB Tissue engineering and regenerative medicine strategies could offer new hope for patients with serious tissue injuries or end-stage organ failure. Scientists are now applying the principles of cell transplantation, material science, and engineering to create biological substitutes that can restore and maintain normal function in diseased or injured tissues/organs. Specifically, creation of engineered tissue construct requires a polymeric biomaterial scaffold that serves as a cell carrier, which would provide structural support until native tissue forms in vivo. Even though the requirements for scaffolds may be different depending on the target applications, a general function of scaffolds that need to be fulfilled is biodegradability, biological and mechanical properties, and temporal structural integrity. The scaffold's internal architecture should also enhance the permeability of nutrients and neovascularization. In addition, the stem cell field is advancing, and new discoveries in tissue engineering and regenerative medicine will lead to new therapeutic strategies. Although use of stem cells is still in the research phase, some therapies arising from tissue engineering endeavors that make use of autologous adult cells have already entered the clinic. This review discusses these tissue engineering and regenerative medicine strategies for various tissues and organs.
C1 [Lee, Sang Jin; Yoo, James J.; Atala, Anthony] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Lee, SJ (reprint author), Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM sjlee@wakehealth.edu
RI Yoo, James/L-4850-2017
CR AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
   Amiel GE, 2000, WORLD J UROL, V18, P71, DOI 10.1007/s003450050013
   Amiel GE, 2006, TISSUE ENG, V12, P2355, DOI 10.1089/ten.2006.12.2355
   Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583
   Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004890
   Atala A, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.038
   Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003
   Atala A, 2009, UROL CLIN N AM, V36, P199, DOI 10.1016/j.ucl.2009.02.009
   Auchincloss H, 2002, NAT BIOTECHNOL, V20, P665, DOI 10.1038/nbt0702-665
   Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Bach AD, 2003, CELL TISSUE RES, V314, P263, DOI 10.1007/s00441-003-0757-6
   Baguneid MS, 2006, BRIT J SURG, V93, P282, DOI 10.1002/bjs.5256
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   BAZEED MA, 1983, UROLOGY, V21, P53, DOI 10.1016/0090-4295(83)90123-1
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   BERGSMA JE, 1995, BIOMATERIALS, V16, P267, DOI 10.1016/0142-9612(95)93253-A
   Bian WN, 2012, FASEB J, V26, P955, DOI 10.1096/fj.11-187575
   BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2
   Borselli C, 2011, BIOMATERIALS, V32, P8905, DOI 10.1016/j.biomaterials.2011.08.019
   Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940
   Bujan J, 2004, BIOTECHNOL APPL BIOC, V39, P17, DOI 10.1042/BA20030111
   Cao Baohong, 2005, Phys Med Rehabil Clin N Am, V16, P889, DOI 10.1016/j.pmr.2005.08.020
   Cenzi R, 2005, J CRANIOFAC SURG, V16, P526, DOI 10.1097/01.scs.0000168761.46700.dc
   Cesar M, 2008, MUSCLE NERVE, V37, P219, DOI 10.1002/mus.20918
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Cheung C, 2011, J MOL CELL CARDIOL, V51, P651, DOI 10.1016/j.yjmcc.2011.07.014
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   CILENTO BG, 1994, J UROLOGY, V152, P665, DOI 10.1016/S0022-5347(17)32676-9
   Cossu G, 2005, SEMIN CELL DEV BIOL, V16, P623, DOI 10.1016/j.semcdb.2005.07.003
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   De Coppi P, 2005, TISSUE ENG, V11, P1034, DOI 10.1089/ten.2005.11.1034
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   DeRosimo JF, 2000, CELL TRANSPLANT, V9, P369, DOI 10.1177/096368970000900308
   DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cellbio.3.1.443
   Diamond MP, 1996, FERTIL STERIL, V66, P904, DOI 10.1016/S0015-0282(16)58716-0
   DiEdwardo CA, 1999, CLIN PLAST SURG, V26, P647
   Drilling S, 2009, J BIOMED MATER RES A, V88A, P923, DOI 10.1002/jbm.a.31926
   Eberli D, 2007, INT J IMPOT RES, V19, P602, DOI 10.1038/sj.ijir.3901587
   Eberli D., 2010, J MATER SCI-MATER M, V22, P741
   Edelman ER, 1999, CIRC RES, V85, P1115
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Gong ZD, 2006, TRENDS CARDIOVAS MED, V16, P153, DOI 10.1016/j.tcm.2006.02.006
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hoffman AS, 2000, J BIOMED MATER RES, V52, P577, DOI 10.1002/1097-4636(20001215)52:4<577::AID-JBM1>3.3.CO;2-X
   Humes HD, 1999, NAT BIOTECHNOL, V17, P451, DOI 10.1038/8626
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Joki T, 2001, NAT BIOTECHNOL, V19, P35
   Jones Peter Lloyd, 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P137
   Joo S, 2012, ARCH PHARM RES, V35, P271, DOI 10.1007/s12272-012-0207-7
   Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043
   Ju YM, 2010, BIOMATERIALS, V31, P4313, DOI 10.1016/j.biomaterials.2010.02.002
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120
   Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kemper F, 2005, CURR MED RES OPIN, V21, P1261, DOI 10.1185/030079905X56501
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim BS, 2008, WORLD J UROL, V26, P307, DOI 10.1007/s00345-008-0300-1
   Kingham PJ, 2006, J ANAT, V209, P511, DOI 10.1111/j.1469-7580.2006.00623.x
   Ko IK, 2013, BIOMATERIALS, V34, P3246, DOI 10.1016/j.biomaterials.2013.01.029
   Koning M, 2009, J TISSUE ENG REGEN M, V3, P407, DOI 10.1002/term.190
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703
   Le Roux PJ, 2005, J UROLOGY, V173, P140, DOI 10.1097/01.ju.0000146554.79487.7f
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee SJ, 2008, REJUV RES, V11, P747, DOI 10.1089/rej.2008.0691
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Lee SJ, 2006, BIOMATERIALS, V27, P3466, DOI 10.1016/j.biomaterials.2006.01.059
   Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109
   Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999
   Lie KH, 2012, PANCREAS, V41, P54, DOI 10.1097/MPA.0b013e31822362e4
   Liebert M, 1997, DIFFERENTIATION, V61, P177, DOI 10.1046/j.1432-0436.1997.6130177.x
   Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008
   Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902
   Luo XS, 2012, J CRANIOFAC SURG, V23, P654, DOI 10.1097/SCS.0b013e31824db808
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Moorefield EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026535
   Mummery CL, 2012, CIRC RES, V111, P344, DOI 10.1161/CIRCRESAHA.110.227512
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   OLSEN L, 1992, SCAND J UROL NEPHROL, V26, P323, DOI 10.3109/00365599209181220
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Patino Maria G, 2002, J Oral Implantol, V28, P220, DOI 10.1563/1548-1336(2002)028<0220:CAAIMI>2.3.CO;2
   Payumo FC, 2002, CLIN ORTHOP RELAT R, pS228, DOI 10.1097/01.blo.0000031992.92980.6f
   Powell CA, 2002, AM J PHYSIOL-CELL PH, V283, pC1557, DOI 10.1152/ajpcell.00595.2001
   Puthenveettil JA, 1999, ADV EXP MED BIOL, V462, P83
   Raya-Rivera A, 2011, LANCET, V377, P1175, DOI 10.1016/S0140-6736(10)62354-9
   Reid L, 1981, Ann N Y Acad Sci, V372, P354, DOI 10.1111/j.1749-6632.1981.tb15488.x
   Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Rodrigues MT, 2012, TISSUE ENG PT A, V18, P2518, DOI 10.1089/ten.tea.2011.0672
   Rodrigues MT, 2012, BIOMATERIALS, V33, P6069, DOI 10.1016/j.biomaterials.2012.05.016
   Rodrigues MT, 2012, ACTA BIOMATER, V8, P2795, DOI 10.1016/j.actbio.2012.04.013
   ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   Schuch G, 2002, BLOOD, V100, P4622, DOI 10.1182/blood.V100.13.4622
   Schuldiner M, 2001, BRAIN RES, V913, P201, DOI 10.1016/S0006-8993(01)02776-7
   Serrano MC, 2004, BIOMATERIALS, V25, P5603, DOI 10.1016/j.biomaterials.2004.01.037
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Siegert R, 2009, FACIAL PLAST SURG, V25, P169, DOI 10.1055/s-0029-1239449
   Siegert R, 2009, FACIAL PLAST SURG, V25, P149, DOI 10.1055/s-0029-1239451
   Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0
   Solomon LZ, 1998, J LAB CLIN MED, V132, P279, DOI 10.1016/S0022-2143(98)90040-3
   Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Sterodimas A, 2009, J PLAST RECONSTR AES, V62, P447, DOI 10.1016/j.bjps.2008.11.046
   Stitzel J, 2006, BIOMATERIALS, V27, P1088, DOI 10.1016/j.biomaterials.2005.07.048
   Sullivan DC, 2012, BIOMATERIALS, V33, P7756, DOI 10.1016/j.biomaterials.2012.07.023
   Suutarla S, 2009, FACIAL PLAST SURG, V25, P164, DOI 10.1055/s-0029-1239445
   Swain Timothy W 3rd, 2004, Vasc Endovascular Surg, V38, P75, DOI 10.1177/153857440403800110
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   TANZER R C, 1959, Plast Reconstr Surg Transplant Bull, V23, P1
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tillman BW, 2009, BIOMATERIALS, V30, P583, DOI 10.1016/j.biomaterials.2008.10.006
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   van Susante JLC, 2001, BIOMATERIALS, V22, P2359, DOI 10.1016/S0142-9612(00)00423-3
   Waddell David D, 2006, J Surg Orthop Adv, V15, P53
   Waddell David D, 2006, J Knee Surg, V19, P19
   WAKELAM MJO, 1985, BIOCHEM J, V228, P1
   Wernig A., 2000, J PHYSL, V522, P233
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Wilkes GH, 2009, FACIAL PLAST SURG, V25, P158, DOI 10.1055/s-0029-1239452
   Williams JD, 1997, ARCH OTOLARYNGOL, V123, P578
   Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711
   Yamada A, 2007, BURNS, V33, P112, DOI 10.1016/j.burns.2006.04.011
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zaidi N, 2007, ANN NY ACAD SCI, V1117, P62, DOI 10.1196/annals.1402.074
   Zhang QG, 2010, ANN PLAS SURG, V64, P428, DOI 10.1097/SAP.0b013e3181b0bb7e
   Zhao WX, 2013, BIOMATERIALS, V34, P8235, DOI 10.1016/j.biomaterials.2013.07.057
   Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2
NR 165
TC 5
Z9 5
U1 4
U2 57
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 0379-153X
J9 POLYM-KOREA
JI Polym.-Korea
PD MAR
PY 2014
VL 38
IS 2
BP 113
EP 128
DI 10.7317/pk.2014.38.2.113
PG 16
WC Polymer Science
SC Polymer Science
GA AE5GE
UT WOS:000334015000001
OA Bronze
DA 2018-10-19
ER

PT J
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
TI Finite element simulation and experimental validation of residual
   stresses in high speed dry milling of biodegradable magnesium-calcium
   alloys
SO INTERNATIONAL JOURNAL OF MECHANICAL SCIENCES
LA English
DT Article
DE Residual stress; Magnesium; Biomaterial; Finite element simulation; High
   speed machining; Dry cutting
ID MACHINED LAYER; SURFACE; MODEL; TOOL; TEMPERATURE; GEOMETRY; STEEL
AB Magnesium-calcium (Mg-Ca) alloys have become attractive biodegradable orthopedic biomaterials recently. Residual stresses are proven to be very influential on the degradation rate of an Mg-Ca implant in the human body. Due to the time and cost reasons, development of finite element models to predict residual stress profiles in cutting of Mg-Ca implants is highly desirable. In this study, a finite element simulation model of orthogonal cutting without explicit chip formation has been developed by using the plowing depth approach in order to predict process-induced residual stresses in high speed dry cutting of Mg-Ca0.8 (wt%) alloy using diamond tools. Mechanical properties of Mg-Ca0.8 biomaterial at high strain rates and large strains were determined using the split-Hopkinson pressure bar test. The internal state variable (ISV) plasticity model has been implemented to model the dynamic material behavior under cutting regimes. The residual stress evolution and effects of plowing speed and plowing depth on residual stress profiles are studied. Residual stress measurements were also performed utilizing the X-ray diffraction technique for validation purposes. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
FU National Science Foundation [CMMI-1000706]
FX The authors would like to thank National Science Foundation for
   supporting this study under Grant No. CMMI-1000706.
CR Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bammann DJ, 1993, STRUCTURAL CRASHWORT, P1
   Brinksmeier E., 1982, ANN CIRP, V31, P491, DOI DOI 10.1016/S0007-8506(07)60172-3
   Caruso S, 2010, INT J MATER FORM, V3, P515, DOI 10.1007/s12289-010-0820-2
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Ee KC, 2005, INT J MECH SCI, V47, P1611, DOI [10.1016/j.ijmecsci.2005.06.001, 10.1016/j.ijmensci.2005.06.001]
   Fang FZ, 2007, J MATER PROCESS TECH, V184, P407, DOI 10.1016/j.jmatprotec.2006.12.007
   Grzesik W, 2003, INT J MACH TOOL MANU, V43, P1311, DOI 10.1016/S0890-6955(03)00160-3
   Guo YB, 2009, CIRP ANN-MANUF TECHN, V58, P81, DOI 10.1016/j.cirp.2009.03.110
   Guo YB, 2005, TRANS N AMER MANUFAC, V33, P469
   Jacobus K, 2001, J MANUF SCI E-T ASME, V123, P537, DOI 10.1115/1.1372197
   Jacobus K, 2000, J MANUF SCI E-T ASME, V122, P20, DOI 10.1115/1.538906
   Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002
   Liu CR, 2000, INT J MECH SCI, V42, P1069, DOI 10.1016/S0020-7403(99)00042-9
   Ozel T, 2007, INT J ADV MANUF TECH, V35, P255, DOI 10.1007/s00170-006-0720-2
   Outeiro JC, 2008, CIRP ANN-MANUF TECHN, V57, P77, DOI 10.1016/j.cirp.2008.03.076
   Outeiro JC, 2006, INT J MACH TOOL MANU, V46, P1786, DOI 10.1016/j.ijmachtools.2005.11.013
   Palmer W. B., 1963, P 4 INT MACH TOOL DE, P61
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2004, INT J MACH TOOL MANU, V44, P815, DOI 10.1016/j.ijmachtools.2004.01.002
   Sasahara H, 1996, J MATER PROCESS TECH, V62, P448, DOI 10.1016/S0924-0136(96)02451-X
   Schulze V, 2010, CIRP ANN-MANUF TECHN, V59, P117, DOI 10.1016/j.cirp.2010.03.064
   Spear H. E., 1994, SYNTHETIC DIAMOND EM
   STRENKOWSKI JS, 1985, J ENG IND-T ASME, V107, P349, DOI 10.1115/1.3186008
   Ulutan D, 2011, INT J MACH TOOL MANU, V51, P250, DOI 10.1016/j.ijmachtools.2010.11.003
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Zong WJ, 2007, INT J ADV MANUF TECH, V32, P666, DOI 10.1007/s00170-005-0388-z
NR 28
TC 10
Z9 10
U1 4
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0020-7403
EI 1879-2162
J9 INT J MECH SCI
JI Int. J. Mech. Sci.
PD MAR
PY 2014
VL 80
BP 153
EP 159
DI 10.1016/j.ijmecsci.2014.01.010
PG 7
WC Engineering, Mechanical; Mechanics
SC Engineering; Mechanics
GA AE3CI
UT WOS:000333854200014
DA 2018-10-19
ER

PT J
AU Guarnieri, R
   Serra, M
   Bava, L
   Grande, M
   Farronato, D
   Iorio-Siciliano, V
AF Guarnieri, Renzo
   Serra, Mario
   Bava, Luca
   Grande, Maurizio
   Farronato, Davide
   Iorio-Siciliano, Vincenzo
TI The Impact of a Laser-Microtextured Collar on Crestal Bone Level and
   Clinical Parameters Under Various Placement and Loading Protocols
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE delayed loading; delayed placement; immediate nonocclusal loading;
   immediate placement; laser microtexturing
ID SINGLE-TOOTH IMPLANTS; DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE
   ATTACHMENT; FRESH EXTRACTION SITES; ETCHED SLA SURFACE; FOLLOW-UP
   REPORT; DENTAL IMPLANTS; TITANIUM IMPLANTS; HISTOLOGIC EVIDENCE;
   PERIIMPLANT MUCOSA
AB Purpose: Physical attachment of connective tissue fibers to a laser-microtextured (8- and 12-mu m grooves) surface on the collar of an implant has been demonstrated using human histology. Related clinical research has suggested that this microtextured surface may help to decrease initial bone loss after implant placement. The aim of this retrospective study was to compare crestal bone heights and clinical parameters between implants with laser-microtextured and machined collars placed and loaded with different protocols. Materials and Methods: This study evaluated 300 single implants in 300 patients (155 men, 145 women; mean age: 49.3 years; range: 45 to 75 years). One hundred sixty implants with laser-microtextured collars (L) and 140 with machined collars (M) were used. Implants were grouped into the treatment categories of immediate placement, delayed placement, immediate nonocclusal loading, and delayed loading. For all groups, crestal bone level, attachment level (CAL), Plaque Index, and bleeding on probing were recorded at baseline and 6, 12, and 24 months after loading with the definitive restoration. Results: Nine implants were lost (four L and five M). The type of implant and timing of placement and loading showed no significant influence on survival rates. A mean CAL loss of 1.12 mm was observed during the first 2 years in the M group, while the mean CAL loss observed in the L group was 0.55 mm. Radiographically, L group implants showed a mean crestal bone loss of 0.58 mm, compared to 1.09 mm for the M group. Conclusion: A laser-microtextured surface on the implant collar may mitigate the negative sequelae associated with peri-implant bone loss, regardless of the placement and loading protocols used.
C1 [Guarnieri, Renzo] SCS Sci Consulting Serv, I-00144 Rome, Italy.
   [Farronato, Davide] Insubria Univ, Dept Biomat Sci, Varese, Italy.
   [Iorio-Siciliano, Vincenzo] Univ Naples Federico II, Dept Periodontol, Naples, Italy.
RP Guarnieri, R (reprint author), SCS Sci Consulting Serv, Via Paolo Emilio 7-5, I-00144 Rome, Italy.
EM renzoguarnieri@gmail.com
OI Farronato, Davide/0000-0003-0328-470X
CR Abt Elliot, 2008, Evid Based Dent, V9, P51, DOI 10.1038/sj.ebd.6400584
   Alexander H, 2007, J BIOMED MATER RES B, V23, P200
   Andersen E, 2002, CLIN ORAL IMPLAN RES, V13, P281, DOI 10.1034/j.1600-0501.2002.130307.x
   Bader Jim, 2008, J Evid Based Dent Pract, V8, P232, DOI 10.1016/j.jebdp.2008.09.011
   BARZILAY I, 1991, International Journal of Oral and Maxillofacial Implants, V6, P277
   Berglundh T, 1996, J CLIN PERIODONTOL, V23, P971, DOI 10.1111/j.1600-051X.1996.tb00520.x
   Bornstein MM, 2003, INT J ORAL MAX IMPL, V18, P659
   Botos S, 2011, INT J ORAL MAX IMPL, V26, P492
   Branemark P I, 1999, Clin Implant Dent Relat Res, V1, P2, DOI 10.1111/j.1708-8208.1999.tb00086.x
   Calandriello Roberto, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P74, DOI 10.1111/j.1708-8208.2003.tb00018.x
   Chaushu G, 2001, INT J ORAL MAX IMPL, V16, P267
   Chen ST, 2004, INT J ORAL MAX IMPL, V19, P12
   Cochran DL, 2002, CLIN ORAL IMPLAN RES, V13, P144, DOI 10.1034/j.1600-0501.2002.130204.x
   Covani U, 2004, J PERIODONTOL, V75, P982, DOI 10.1902/jop.2004.75.7.982
   Degidi M, 2008, CLIN ORAL IMPLAN RES, V19, P276, DOI 10.1111/j.1600-0501.2007.01449.x
   Ellingsen JE, 1998, PERIODONTOL 2000, V17, P36, DOI 10.1111/j.1600-0757.1998.tb00121.x
   Ericsson I, 2000, CLIN ORAL IMPLAN RES, V11, P26, DOI 10.1034/j.1600-0501.2000.011001026.x
   Esposito M, 2007, INT J ORAL MAX IMPL, V22, P893
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026
   Hermann F, 2007, IMPLANT DENT, V16, P165, DOI 10.1097/ID.0b013e318065aa81
   Hermann JS, 1997, J PERIODONTOL, V68, P1117, DOI 10.1902/jop.1997.68.11.1117
   Hermann JS, 2001, INT J ORAL MAX IMPL, V16, P475
   Hermann JS, 2000, CLIN ORAL IMPLAN RES, V11, P1, DOI 10.1034/j.1600-0501.2000.011001001.x
   Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x
   Lazzara R J, 1989, Int J Periodontics Restorative Dent, V9, P332
   Listgarten MA, 1991, CLIN ORAL IMPLAN RES, V2, P1, DOI 10.1034/j.1600-0501.1991.020101.x
   Lorenzoni M, 2003, CLIN ORAL IMPLAN RES, V14, P180, DOI 10.1034/j.1600-0501.2003.140207.x
   Luongo G, 2005, INT J ORAL MAX IMPL, V20, P84
   Maeda Y, 2007, CLIN ORAL IMPLAN RES, V18, P581, DOI 10.1111/j.1600-0501.2007.01398.x
   Malo P, 2000, Clin Implant Dent Relat Res, V2, P138, DOI 10.1111/j.1708-8208.2000.tb00004.x
   Malo Paulo, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P37, DOI 10.1111/j.1708-8208.2003.tb00014.x
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Nevins M, 2010, INT J PERIODONT REST, V30, P245
   Nikellis I, 2004, INT J ORAL MAX IMPL, V19, P116
   PAREL S M, 1990, International Journal of Oral and Maxillofacial Implants, V5, P337
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Quinlan P, 2005, INT J ORAL MAX IMPL, V20, P360
   QUIRYNEN M, 1992, J PROSTHET DENT, V68, P655, DOI 10.1016/0022-3913(92)90383-L
   Quirynen M, 2007, INT J ORAL MAX IMPL, V22, P203
   Ricci J, 2000, BONE ENG, P282
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   RICHTER EJ, 1989, J PROSTHET DENT, V61, P602, DOI 10.1016/0022-3913(89)90285-0
   Rocci Antonio, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P29, DOI 10.1111/j.1708-8208.2003.tb00013.x
   Roccuzzo M, 2001, CLIN ORAL IMPLAN RES, V12, P572, DOI 10.1034/j.1600-0501.2001.120604.x
   Schropp L, 2008, J ORAL REHABIL, V35, P33, DOI 10.1111/j.1365-2842.2007.01827.x
   Schropp L, 2005, J CLIN PERIODONTOL, V32, P480, DOI 10.1111/j.1600-051X.2005.00699.x
   Schropp L, 2003, INT J ORAL MAX IMPL, V18, P189
   Schulte W, 1978, Dtsch Zahnarztl Z, V33, P319
   Schupbach P, 2008, J PROSTHET DENT, V99, P167
   Schupbach P, 2007, J PROSTHET DENT, V97, pS15, DOI 10.1016/S0022-3913(07)60004-3
   SchwartzArad D, 1997, J PERIODONTOL, V68, P915, DOI 10.1902/jop.1997.68.10.915
   Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P481, DOI 10.1111/j.1600-0501.2007.01341.x
   Shapoff CA, 2010, INT J PERIODONT REST, V30, P129
   Shin SY, 2010, CLIN ORAL IMPLAN RES, V21, P804, DOI 10.1111/j.1600-0501.2010.01917.x
   Tarnow DP, 1997, INT J ORAL MAX IMPL, V12, P319
   van Steenberghe D, 1990, Int J Oral Maxillofac Implants, V5, P272
   Weber HP, 2009, INT J ORAL MAX IMPL, V24, P180
   Weiner S, 2008, IMPLANT DENT, V17, P217, DOI 10.1097/ID.0b013e3181779016
   Werbitt M J, 1992, Int J Periodontics Restorative Dent, V12, P206
   Zafiropoulos GGK, 2010, J PERIODONTOL, V81, P604, DOI 10.1902/jop.2009.090316
NR 62
TC 17
Z9 17
U1 1
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAR-APR
PY 2014
VL 29
IS 2
BP 354
EP 363
DI 10.11607/jomi.3250
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AE0MM
UT WOS:000333660400009
PM 24683561
OA Bronze
DA 2018-10-19
ER

PT J
AU Pezzotti, G
   Yamamoto, K
AF Pezzotti, Giuseppe
   Yamamoto, Kengo
TI Artificial hip joints: The biomaterials challenge
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterial; Artificial hip joint; Wear
ID POLYETHYLENE ACETABULAR LINER; IMPROVED FRACTURE-TOUGHNESS; CROSS-LINKED
   POLYETHYLENE; OXIDIZED ZIRCONIUM KNEE; THERMAL RESIDUAL-STRESS; CERAMIC
   FEMORAL HEADS; SILICON-NITRIDE; MICROSTRUCTURAL DESIGN; RESURFACING
   ARTHROPLASTY; FATIGUE RESISTANCE
AB What is new and what comes next in artificial hip joints? These are the crucial questions we attempt to answer after accurately surveying the state of the art in the field of hip arthroplasty, especially related to non-metallic materials. Summarizing the present situation, one could safely state that the current generation of hard-on-soft and hard-on-hard hip bearings has become quite effective in exhibiting extremely low degrees of wear when compared to traditional implants made of cobalt-chromium alloys coupled with conventional polyethylene materials or to the primitive alumina materials used in the past. Moreover, at a stage of more than 10 years in the clinical follow-up of new generations of hard-on-hard bearings, and more than 10 years follow-up for highly cross-linked polyethylene materials, we should soon be expecting a new set of officially compiled statistics that show significant reductions in failures due to particle-mediated osteolysis as compared to past statistical compilations. However, further important issues (other than wear) remain unsolved, including structural reliability of advanced ceramic and polyethylene components. Severe challenges yet stand in optimizing the biomaterials choice for significantly extended lifetimes and reduced failure risks. Moreover, joint healing trends are expected to evolve more radically in the next few decades. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Pezzotti, Giuseppe] Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
   [Yamamoto, Kengo] Tokyo Med Univ, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1600023, Japan.
RP Pezzotti, G (reprint author), Kyoto Inst Technol, Ceram Phys Lab, Sakyo Ku, Kyoto 6068585, Japan.
EM pezzotti@kit.ac.jp; kengo-y@tkg.att.ne.jp
CR Akiniwa Y, 2000, MATER SCI RES INT, V6, P281
   [Anonymous], 2011, 8 NAT JOINT REG ENGL
   [Anonymous], 2008, ANN REP
   ANTONOV PI, 1981, J CRYST GROWTH, V52, P404, DOI 10.1016/0022-0248(81)90226-8
   Australian Orthopaedic Association National Joint Replacement Registry, 2011, ANN REPORT
   Bal BS, 2008, J BIOMED MATER RES B, V87B, P447, DOI 10.1002/jbm.b.31123
   Becher PF, 1998, J AM CERAM SOC, V81, P2821
   BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x
   Beltran JI, 2003, J EUR CERAM SOC, V23, P2737, DOI 10.1016/S0955-2219(03)00284-X
   Bizot P, 2001, CLIN ORTHOP RELAT R, P85
   Blumenfeld TJ, 2011, J ARTHROPLASTY, V26, P5
   BOUTIN P, 1988, J BIOMED MATER RES, V22, P1203, DOI 10.1002/jbm.820221210
   Bracco P, 2011, CLIN ORTHOP RELAT R, V469, P2286, DOI 10.1007/s11999-010-1717-6
   Campbell DG, 2010, CLIN ORTHOP RELAT R, V468, P2704, DOI 10.1007/s11999-010-1259-y
   Cappi B., 2009, J BIOMED MATER RES A, V93, P67
   Chen JJ, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/3/034001
   Cho HJ, 2004, MATER CHEM PHYS, V88, P9, DOI 10.1016/j.matchemphys.2003.10.021
   CHRISTEL PS, 1992, CLIN ORTHOP RELAT R, P10
   CLARKE DR, 1980, ACTA METALL MATER, V28, P913, DOI 10.1016/0001-6160(80)90107-8
   Clarke MT, 2003, J BONE JOINT SURG BR, V85B, P913, DOI 10.1302/0301-620X.85B6.14166
   D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000194090.77500.b4
   Daniel J, 2007, J BONE JOINT SURG BR, V89B, P169, DOI 10.1302/0301-620X.8982.18519
   Davidson J. A., 1992, BIOCERAMICS, V5, P389
   DORLOT JM, 1992, CLIN ORTHOP RELAT R, P47
   Drory MD, 1996, P ROY SOC A-MATH PHY, V452, P2319, DOI 10.1098/rspa.1996.0124
   Duffy GP, 2009, J ARTHROPLASTY, V24, P15
   Dumbleton JH, 2006, CLIN ORTHOP RELAT R, P265, DOI 10.1097/01.blo.0000238856.61862.7d
   EVANS AG, 1978, ACTA METALL MATER, V26, P1845, DOI 10.1016/0001-6160(78)90097-4
   EVANS AG, 1983, OXID MET, V20, P193, DOI 10.1007/BF00656841
   EYERER P, 1984, J BIOMED MATER RES, V18, P1137, DOI 10.1002/jbm.820180915
   Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9
   Fett T, 2005, J EUR CERAM SOC, V25, P29, DOI 10.1016/j.jeurceramsoc.2004.03.005
   Fett T., 1987, INT J FRACTURE, V33, P47
   Fouad H, 2010, J APPL POLYM SCI, V118, P17, DOI 10.1002/app.32290
   Fu YQ, 1998, SURF COAT TECH, V106, P193, DOI 10.1016/S0257-8972(98)00528-3
   GATES RS, 1989, TRIBOL T, V32, P357, DOI 10.1080/10402008908981900
   GILBERT CJ, 1995, J AM CERAM SOC, V78, P2291, DOI 10.1111/j.1151-2916.1995.tb08660.x
   Glyn-Jones S., 2008, J BONE JOINT SURG BR, V9, P556
   GOODFELLOW JW, 1993, J BONE JOINT SURG AM, V75A, P1423, DOI 10.2106/00004623-199310000-00001
   Grammatopoulos G, 2009, J BONE JOINT SURG BR, V91B, P1019, DOI 10.1302/0301-620X.91B8.22562
   Granchi D, 2003, J BONE JOINT SURG BR, V85B, P758, DOI 10.1302/0301-620X.85B5.13729
   Grigoris P, 2006, P I MECH ENG H, V220, P95, DOI 10.1243/095441105X69042
   GRISS P, 1980, MECH PROPERTIES BIOM, P217
   Hannink RHJ, 2000, J AM CERAM SOC, V83, P461
   Hannouche D, 2003, CLIN ORTHOP RELAT R, P19, DOI 10.1097/01.blo.0000096806.78689.50
   Harlan NR, 2002, J AM CERAM SOC, V85, P2025, DOI 10.1111/j.1151-2916.2002.tb00399.x
   Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P835, DOI 10.1302/0301-620X.91B6.21844
   HIRAO K, 1994, J AM CERAM SOC, V77, P1857, DOI 10.1111/j.1151-2916.1994.tb07062.x
   Hobbs LW, 2005, INT J APPL CERAM TEC, V2, P221, DOI 10.1111/j.1744-7402.2005.02025.x
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   HUTCHINSON JW, 1992, ADV APPL MECH, V29, P63
   Irwin GR, 1957, J APPL MECH, V24, P361, DOI DOI 10.1111/J.1460-2695.2012.01707.X
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P1447, DOI 10.2106/00004623-199810000-00006
   JACOBS JJ, 1996, CLIN ORTHOP S, V329, pS256
   Jazrawi L M, 1998, J Am Acad Orthop Surg, V6, P198
   Kaul G, 2012, KNEE SURG SPORT TR A, V20, P2315, DOI 10.1007/s00167-011-1853-x
   Krell A, 1996, J EUR CERAM SOC, V16, P803, DOI 10.1016/0955-2219(96)00003-9
   Kue R, 1999, BIOMATERIALS, V20, P1195, DOI 10.1016/S0142-9612(99)00007-1
   Kurtz S, 2009, UHMWPE BIOMATERIALS HANDBOOK: ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE IN TOTAL JOINT REPLACEMENT AND MEDICAL DEVICES, 2ND EDITION, P237, DOI 10.1016/B978-0-12-374721-1.00016-X
   LANCASTER JK, 1990, TRIBOL INT, V23, P371, DOI 10.1016/0301-679X(90)90053-R
   Laskin RS, 2003, CLIN ORTHOP RELAT R, P191, DOI 10.1097/01.blo.0000093003.04535.1f
   Lerf R, 2010, BIOMATERIALS, V31, P3643, DOI 10.1016/j.biomaterials.2010.01.076
   Li C.-W., 1989, CERAM ENG SCI P, V105, P632
   Mao WG, 2007, SURF COAT TECH, V201, P6217, DOI 10.1016/j.surfcoat.2006.11.025
   Mazzocchi M, 2008, J MATER SCI-MATER M, V19, P2889, DOI 10.1007/s10856-008-3437-y
   MCKELLOP H, 1978, J BIOMED MATER RES, V12, P895, DOI 10.1002/jbm.820120611
   Mishra A.K., 1993, MATER TECHNOL, V8, P16
   Mont MA, 2008, J BONE JOINT SURG AM, V90A, P3, DOI 10.2106/JBJS.H.00750
   Moon H, 2010, J AM CERAM SOC, V93, P1264, DOI 10.1111/j.1551-2916.2009.03580.x
   Moore KD, 2008, J BONE JOINT SURG AM, V90A, P2499, DOI 10.2106/JBJS.G.01304
   MORI T, 1973, ACTA METALL MATER, V21, P571, DOI 10.1016/0001-6160(73)90064-3
   Morscher E W, 2003, Scand J Surg, V92, P113
   National Joint Registry of England and Wales, 2010, NJR PROSTH US
   National Joint Registry of England and Wales (NJR), 2008, 4 NJR
   Ong KL, 2008, J BONE JOINT SURG AM, V90A, P81, DOI 10.2106/JBJS.H.00574
   Oral E, 2004, BIOMATERIALS, V25, P5515, DOI 10.1016/j.biomaterials.2003.12.048
   Oral E, 2011, INT ORTHOP, V35, P215, DOI 10.1007/s00264-010-1161-y
   Oral E, 2009, J BIOMED MATER RES B, V90B, P720, DOI 10.1002/jbm.b.31340
   ORTIZ M, 1993, J APPL MECH-T ASME, V60, P77, DOI 10.1115/1.2900782
   Parise M, 1998, TEXTURE MICROSTRUCT, V30, P247
   Patel AM, 1995, BIOCERAMICS, V8, P169
   Pezzotti G, 1999, PHYS REV B, V60, P4018, DOI 10.1103/PhysRevB.60.4018
   Pezzotti G, 2001, J AM CERAM SOC, V84, P1785
   Pezzotti G, 1999, J RAMAN SPECTROSC, V30, P867
   Pezzotti G., 2007, J BIOMEDICAL OPTICS, V12
   Pezzotti G, 2007, EXPERT REV MED DEVIC, V4, P165, DOI 10.1586/17434440.4.2.165
   Pezzotti G, 2011, J BIOMAT SCI-POLYM E, V22, P2165, DOI 10.1163/092050610X537129
   Pezzotti G, 2010, BIOMATERIALS, V31, P6901, DOI 10.1016/j.biomaterials.2010.05.035
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Ries MD, 2002, J BONE JOINT SURG AM, V84A, P129, DOI 10.2106/00004623-200200002-00018
   ROSE LRF, 1986, J AM CERAM SOC, V69, P203, DOI 10.1111/j.1151-2916.1986.tb07407.x
   RUHLE M, 1989, MAT SCI ENG A-STRUCT, V107, P187, DOI 10.1016/0921-5093(89)90387-0
   Savarino L, 2006, J BONE JOINT SURG BR, V88B, P472, DOI 10.1302/0301-620X.88B4.17333
   Savarino L, 2003, J BIOMED MATER RES A, V66A, P450, DOI 10.1002/jbm.a.10595
   Seidel J, 1997, J AM CERAM SOC, V80, P433
   Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4
   STEINBRECH RW, 1992, J EUR CERAM SOC, V10, P131, DOI 10.1016/0955-2219(92)90026-A
   Sun EY, 1998, J AM CERAM SOC, V81, P2831
   Takahashi Y, 2011, J MECH BEHAV BIOMED, V4, P993, DOI 10.1016/j.jmbbm.2011.02.014
   Tateiwa Toshiyuki, 2008, Am J Orthop (Belle Mead NJ), V37, pE26
   TAYA M, 1990, J AM CERAM SOC, V73, P1382, DOI 10.1111/j.1151-2916.1990.tb05209.x
   Tomsia AP, 2011, INT J ORAL MAX IMPL, V26, P25
   Tower SS, 2007, J BONE JOINT SURG AM, V89A, P2212, DOI 10.2106/JBJS.F.00758
   Wang L, 2000, WEAR, V246, P159, DOI 10.1016/S0043-1648(00)00504-4
   Weisse B, 2010, P I MECH ENG H, V224, P1051, DOI 10.1243/09544119JEIM743
   WHITE SE, 1994, CLIN ORTHOP RELAT R, P176
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Willmann G, 1998, MATERIALWISS WERKST, V29, P595, DOI 10.1002/mawe.19980291010
   Zhang W, 2010, J MATER SCI-MATER M, V21, P3049, DOI 10.1007/s10856-010-4144-z
NR 109
TC 32
Z9 34
U1 5
U2 76
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD MAR
PY 2014
VL 31
BP 3
EP 20
DI 10.1016/j.jmbbm.2013.06.001
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AE2BQ
UT WOS:000333778700002
PM 23867294
DA 2018-10-19
ER

PT J
AU Demnati, I
   Grossin, D
   Errassifi, F
   Combes, C
   Rey, C
   Le Bolay, N
AF Demnati, I.
   Grossin, D.
   Errassifi, F.
   Combes, C.
   Rey, C.
   Le Bolay, N.
TI Synthesis of fluor-hydroxyapatite powder for plasma sprayed biomedical
   coatings: Characterization and improvement of the powder properties
SO POWDER TECHNOLOGY
LA English
DT Article
DE Fluor-hydroxyapatite powder; Physical-chemical characterization;
   Physical properties; Biomaterial; Surface energy
ID ALKALINE-PHOSPHATASE ACTIVITY; SURFACE; MICROSTRUCTURE; PROLIFERATION;
   CELLS
AB Fluor-hydroxyapatite (FHA) powder was synthesized by double decomposition in a view to produce bioactive and thermally stable coatings by plasma spray process. This work aims at studying the influence of chemical composition, microstructure and surface energy on the flowability of the FHA particles which is known as a determinant property during plasma spraying for the quality of the product in terms of yield and homogeneity of composition. The as-synthesized FHA powder was sieved in order to obtain two ranges of particles size: 50-80 mu m and 80-100 mu m. The phase composition and structure and physical characteristics of FHA particles have been determined by complementary analytical techniques (X-ray diffraction, Fourier transform infrared spectroscopy, scanning electron spectroscopy and laser granulometry). Then, the FHA flowability was determined as recommended by the European Pharmacopeia.
   The results showed that the 80-100 mu m FHA powder has a longer flow time compared to a reference hydroxyapatite powder whereas the 50-80 mu m FHA particles did not flow. We propose a simple treatment of the FHA particles using ethanol as solvent which showed to significantly improve the flowability of FHA powders. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Demnati, I.; Grossin, D.; Errassifi, F.; Combes, C.; Rey, C.] Univ Toulouse, CIRIMAT Carnot Inst, CNRS INPT UPS, ENSIACET, Toulouse, France.
   [Le Bolay, N.] Univ Toulouse, LGC, CNRS INPT UPS, ENSIACET, Toulouse, France.
RP Demnati, I (reprint author), Univ Toulouse, CIRIMAT Carnot Inst, CNRS INPT UPS, ENSIACET, Toulouse, France.
EM imanedemnati@yahoo.fr
RI GROSSIN, David/C-3217-2009
OI GROSSIN, David/0000-0002-4320-2919
CR [Anonymous], 2008, 1377932008 ISO
   Azami Mahmoud, 2012, Key Engineering Materials, V493-494, P626, DOI 10.4028/www.scientific.net/KEM.493-494.626
   Cheang P, 1996, BIOMATERIALS, V17, P537, DOI 10.1016/0142-9612(96)82729-3
   CHRISTOFFERSEN MR, 1984, J CRYST GROWTH, V67, P107, DOI 10.1016/0022-0248(84)90138-6
   De Groot K., 1990, HDB BIOACTIVE CERAMI, P3
   Demnati I, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/054101
   DEMNATI I, 2011, SURF COAT TECH, V206, P2346
   Demnati I., 2011, THESIS I NATL POLYTE
   Dyshlovenko S, 2006, SURF COAT TECH, V200, P3845, DOI 10.1016/j.surfcoat.2004.11.037
   FARLEY JR, 1983, SCIENCE, V222, P330
   FOWKES FM, 1963, J PHYS CHEM-US, V67, P2538, DOI 10.1021/j100806a008
   Frances C, 2001, INT J MINER PROCESS, V61, P41, DOI 10.1016/S0301-7516(00)00025-9
   Freund F., 1977, DALTON T, P1136
   Gross KA, 1998, J BIOMED MATER RES, V39, P580, DOI 10.1002/(SICI)1097-4636(19980315)39:4<580::AID-JBM12>3.3.CO;2-Y
   Gross KA, 2002, J BIOMED MATER RES, V63, P106, DOI 10.1002/jbm.10090
   Gross KA, 2012, ACTA BIOMATER, V8, P1948, DOI 10.1016/j.actbio.2012.01.023
   Heimann RB, 2006, SURF COAT TECH, V201, P2012, DOI 10.1016/j.surfcoat.2006.04.052
   Jaworski R, 2010, J THERM SPRAY TECHN, V19, P240, DOI 10.1007/s11666-009-9425-z
   Kaelble D., 1970, DISPERSION POLAR SUR
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   Nakade O, 1999, ARCH ORAL BIOL, V44, P89, DOI 10.1016/S0003-9969(98)00099-5
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Penel G, 1997, J MATER SCI-MATER M, V8, P271, DOI 10.1023/A:1018504126866
   RANZ X, 1997, BIOCERAMICS, V10, P455
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Young E., 1969, 196984 US GEOL SURV, P84
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
NR 27
TC 6
Z9 6
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0032-5910
EI 1873-328X
J9 POWDER TECHNOL
JI Powder Technol.
PD MAR
PY 2014
VL 255
SI SI
BP 23
EP 28
DI 10.1016/j.powtec.2013.10.022
PG 6
WC Engineering, Chemical
SC Engineering
GA AE2IH
UT WOS:000333796000005
DA 2018-10-19
ER

PT J
AU Wang, L
   Li, YK
   Xu, YQ
   Wang, CQ
AF Wang, Liang
   Li, Ya-Kun
   Xu, Youqian
   Wang, Cai-Qi
TI A facile construction method for pH and oxidation dual-responsive
   assembly based on ferrocene-modified chitooligosaccharide
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE Biodegradable; Chitooligosaccharide; Oxidation-responsive;
   Self-assembly; "Snowflake-like"
ID AMPHIPHILIC GRAFT COPOLYMER; DIBLOCK COPOLYMERS; HYDROGEN-PEROXIDE;
   POLYMERIC MICELLES; BLOCK-COPOLYMER; CHITOSAN; DELIVERY; MICELLIZATION;
   NANOCARRIERS; MORPHOLOGIES
AB Here, we present a novel and facile method for constructing "snowflake-like" assemblies that respond to external stimuli, similar to snowflakes in nature, via the self-organization of ferrocene-modified chitooligosaccharide (FcCOS) in an acid aqueous solution. Interestingly, the snowflakes were sensitive to pH and redox stimuli. They not only formed irregular network-like aggregates when the pH was adjusted to 7.0, they also gradually transformed into loose snowflakes with holes after exposure to air for 5 d and totally collapsed after treatment with hydrogen peroxide. Due to their interesting responses to pH and oxidation, these assemblies are a very interesting and promising system for biomaterial applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wang, Liang; Li, Ya-Kun; Xu, Youqian; Wang, Cai-Qi] Univ Chinese Acad Sci, Sch Chem & Chem Engn, Beijing 100049, Peoples R China.
RP Wang, CQ (reprint author), Univ Chinese Acad Sci, Sch Chem & Chem Engn, 19A Yuquan Rd, Beijing 100049, Peoples R China.
EM wang-caiqi@ucas.ac.cn
FU National Natural Science Foundation of China [20604033]; Foundation of
   Graduate University of Chinese Academy of Sciences
FX This research was financially supported by the National Natural Science
   Foundation of China (No. 20604033) and the Foundation of Graduate
   University of Chinese Academy of Sciences.
CR Bian J, 2013, REACT FUNCT POLYM, V73, P579, DOI 10.1016/j.reactfunctpolym.2012.12.010
   Braga D, 1998, CHEM REV, V98, P1375, DOI 10.1021/cr960091b
   Cao L, 2002, MACROMOLECULES, V35, P8258, DOI 10.1021/ma021068x
   Cao M.Y., 2011, J APPL POLYM SCI, V123, P3137
   Chang KLB, 2001, J AGR FOOD CHEM, V49, P4845, DOI 10.1021/jf001469g
   Dash M, 2011, PROG POLYM SCI, V36, P981, DOI 10.1016/j.progpolymsci.2011.02.001
   Eloi JC, 2011, J AM CHEM SOC, V133, P8903, DOI 10.1021/ja1105656
   Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017
   Garcia A, 2007, MACROMOL BIOSCI, V7, P435, DOI 10.1002/mabi.200700032
   Gohy JF, 2004, CHEM-EUR J, V10, P4315, DOI 10.1002/chem.200400222
   He XH, 2011, REACT FUNCT POLYM, V71, P544, DOI 10.1016/j.reactfunctpolym.2011.02.001
   Holder SJ, 2011, POLYM CHEM-UK, V2, P1018, DOI 10.1039/c0py00379d
   Hu F.Q., 2012, GENE THER, V20, P606
   Janczewski D, 2012, J MATER CHEM, V22, P6429, DOI 10.1039/c2jm15755a
   Jia LJ, 2013, POLYM CHEM-UK, V4, P156, DOI 10.1039/c2py20781h
   Korchagina EV, 2012, LANGMUIR, V28, P7880, DOI 10.1021/la3013409
   Korchagina EV, 2010, BIOMACROMOLECULES, V11, P3457, DOI 10.1021/bm100990u
   Li QH, 2010, COLLOID SURFACE A, V355, P146, DOI 10.1016/j.colsurfa.2009.12.004
   Liu JY, 2010, J SURFACTANTS DETERG, V13, P83, DOI 10.1007/s11743-009-1132-8
   LUBACH J, 1973, RECL TRAV CHIM PAY B, V92, P586
   Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d
   Nie L, 2007, ANGEW CHEM INT EDIT, V46, P6321, DOI 10.1002/anie.200700209
   PAPANAGOPOULOS D, 1995, EUR POLYM J, V31, P977, DOI 10.1016/0014-3057(95)00058-5
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a
   Raez J, 2002, LANGMUIR, V18, P7229, DOI 10.1021/la0200562
   Srinivas G, 2004, NAT MATER, V3, P638, DOI 10.1038/nmat1185
   Tonhauser C, 2012, MACROMOLECULES, V45, P3409, DOI 10.1021/ma3000048
   Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026
   Wang XS, 2007, SCIENCE, V317, P644, DOI 10.1126/science.1141382
   Wu G, 2012, CHEM-EUR J, V18, P12237, DOI 10.1002/chem.201103961
   Xiao ZP, 2010, J MATER CHEM, V20, P8375, DOI 10.1039/c0jm01453b
   Xu ZS, 1998, EUR POLYM J, V34, P1499
   Yang WW, 2007, MACROMOL RAPID COMM, V28, P265, DOI 10.1002/marc.200600654
   Ye YQ, 2008, INT J PHARMACEUT, V352, P294, DOI 10.1016/j.ijpharm.2007.10.035
   You J, 2007, BIOMACROMOLECULES, V8, P2450, DOI 10.1021/bm070365c
   Zhai SJ, 2012, J POLYM SCI POL CHEM, V50, P811, DOI 10.1002/pola.25836
   ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728
   Zhang WA, 2012, REACT FUNCT POLYM, V72, P580, DOI 10.1016/j.reactfunctpolym.2012.04.001
   Zhu LZ, 2010, SOFT MATTER, V6, P5541, DOI 10.1039/c0sm00246a
   Zotti G, 1998, LANGMUIR, V14, P1728, DOI 10.1021/la971092h
NR 41
TC 11
Z9 12
U1 6
U2 66
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
EI 1873-166X
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD MAR
PY 2014
VL 76
BP 1
EP 7
DI 10.1016/j.reactfunctpolym.2013.12.009
PG 7
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA AE3DJ
UT WOS:000333856900001
DA 2018-10-19
ER

PT J
AU Coriolano, MC
   de Melo, CML
   Silva, FD
   Schirato, GV
   Porto, CS
   dos Santos, PJP
   Correia, MTD
   Porto, ALF
   Carneiro-Leo, AMD
   Coelho, LCBB
AF Coriolano, Marilia Cavalcanti
   Lagos de Melo, Cristiane Moutinho
   Silva, Flavio de Oliveira
   Schirato, Giuliana Viegas
   Porto, Camila Souza
   Parreira dos Santos, Paulo Jorge
   dos Santos Correia, Maria Tereza
   Figueiredo Porto, Ana Lucia
   dos Anjos Carneiro-Leo, Ana Maria
   Breitenbach Barroso Coelho, Luana Cassandra
TI Parkia pendula Seed Lectin: Potential Use to Treat Cutaneous Wounds in
   Healthy and Immunocompromised Mice
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Parkia pendula; Lectin; Skin; Cutaneous wound; Immunocompromised mice
ID IN-VITRO; NEUTROPHIL MIGRATION; BINDING LECTIN; CELLS; CD18;
   MACROPHAGES; CYTOKINES; INJURY
AB Parkia pendula seed lectin was used to treat cutaneous wounds of normal and immunocompromised mice, inducing cicatrization. Methotrexate (0.8 mg/kg/week) was used as immunosuppressive drug. Wounds were produced in the dorsal region (1 cm(2)) of female albino Swiss mice (Mus musculus), health and immunocompromised. Wounds were daily topically treated with 100 mu L of the following solutions: (1) control (NaCl 0.15 M), (2) control Im (0.15 M NaCl), (3) P. pendula seed lectin (100 mu g/mL), and (4) P. pendula seed lectin Im (100 mu g/mL). Clinical evaluation was performed during 12 days. Biopsies for histopathology analysis and microbiological examinations were carried out in the second, seventh, and 12th days. The presence of edema and hyperemia was observed in all groups during inflammatory period. The first crust was detected from the second day, only in the groups treated with P. pendula seed lectin. Microbiological analysis of wounds from day 0 to day 2 did not show bacterium at P. pendula seed lectin group; however, Staphylococcus sp. was detected every day in the other groups. The lectin markedly induced a total wound closing at P. pendula seed lectin and P. pendula seed lectin Im groups on 11th day of evolution. The present study suggests that P. pendula seed lectin is a biomaterial potential to show pharmacological effect in the repair process of cutaneous wounds.
C1 [Coriolano, Marilia Cavalcanti; dos Santos Correia, Maria Tereza; Breitenbach Barroso Coelho, Luana Cassandra] Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
   [Lagos de Melo, Cristiane Moutinho; Schirato, Giuliana Viegas] Ctr Pesquisas Aggeu Magalhaes CPqAM FIOCRUZ, BR-50670420 Recife, PE, Brazil.
   [Parreira dos Santos, Paulo Jorge] Univ Fed Pernambuco, Dept Zool, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
   [Silva, Flavio de Oliveira; Porto, Camila Souza; Figueiredo Porto, Ana Lucia] Univ Fed Pernambuco, LIKA, BR-50670420 Recife, PE, Brazil.
   [dos Anjos Carneiro-Leo, Ana Maria] Univ Fed Pernambuco, Dept Morfol & Fisiol Anim, BR-52171030 Recife, PE, Brazil.
RP Coelho, LCBB (reprint author), Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, BR-50670420 Recife, PE, Brazil.
EM lcbbcoelho@gmail.com
RI Santos, Paulo/G-6511-2011; porto, ana/R-4619-2018; Carneiro-Leao, Ana
   Maria/P-9369-2016
OI Santos, Paulo/0000-0003-4826-362X; porto, ana/0000-0001-5561-5158;
   Carneiro-Leao, Ana Maria/0000-0002-8815-8624; Moutinho,
   Cristiane/0000-0002-8831-0163
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
FX The authors express their gratitude to the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico for research grants and
   fellowships (MTSC and LCBBC).
CR Alencar NMN, 2003, INT J BIOCHEM CELL B, V35, P1674, DOI 10.1016/S1357-2725(03)00138-9
   Alencar VBM, 2005, INT J BIOCHEM CELL B, V37, P1805, DOI 10.1016/j.biocel.2005.02.027
   Assreuy AMS, 2003, BIOL REPROD, V68, P1836, DOI 10.1095/biolreprod.102.013425
   Beltrao EIC, 2003, EUR J HISTOCHEM, V47, P139
   CARTER G. R., 1988, FUNDAMENTOS BACTERIO
   Chahud F, 2009, INT J EXP PATHOL, V90, P166, DOI 10.1111/j.1365-2613.2008.00626.x
   Choi S., 2003, SEMIN INTEGR MED, V1, P53, DOI DOI 10.1016/S1543-1150(03)00005-X
   Ciesielski CJ, 1998, TRANSPL IMMUNOL, V6, P122, DOI 10.1016/S0966-3274(98)80027-0
   Coriolano M.C., 2010, 14 INT BIOT S EXH RI, P454
   DAVIS BJ, 1964, ANN NY ACAD SCI, V121, P404, DOI 10.1111/j.1749-6632.1964.tb14213.x
   do Nascimento LG, 2011, MOLECULES, V16, P9298, DOI 10.3390/molecules16119298
   Favacho ARM, 2007, BIOLOGICALS, V35, P189, DOI 10.1016/j.biologicals.2006.09.005
   Figueiredo JG, 2009, TOXICON, V54, P736, DOI 10.1016/j.toxicon.2009.05.037
   Ganiko L, 2005, BBA-GEN SUBJECTS, V1721, P152, DOI 10.1016/j.bbagen.2004.10.012
   Gemeiner P, 2009, BIOTECHNOL ADV, V27, P1, DOI 10.1016/j.biotechadv.2008.07.003
   Gorudko IV, 2008, ARCH MED RES, V39, P674, DOI 10.1016/j.arcmed.2008.06.002
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hall L.W., 1991, PRINCIPLES SEDATION
   Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016
   Kesherwani V, 2007, CYTOKINE, V37, P62, DOI 10.1016/j.cyto.2007.02.018
   Koning B. A. E., 2006, INT IMMUNOL, V18, P941
   de Melo CML, 2011, INT J PHARMACEUT, V408, P113, DOI 10.1016/j.ijpharm.2011.02.011
   Lombardi FR, 1998, PROTEIN PEPTIDE LETT, V5, P117
   Lorenzi H., 1998, ARVORES BRASILEIRAS
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Moller-Kristensen M, 2007, J INVEST DERMATOL, V127, P1524, DOI 10.1038/sj.jid.5700748
   Estevao LRM, 2013, ACTA CIR BRAS, V28, P202, DOI 10.1590/S0102-86502013000300008
   Neto L. G. N., 2012, MARINE DRUGS, V10, P1936
   Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846
   Pereira D.S., 2012, J BIOMEDICINE BIOTEC
   Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011
   Pessoa WS, 2012, ACTA CIR BRAS, V27, P665
   Peters T, 2006, J INVEST DERM SYMP P, V11, P7, DOI 10.1038/sj.jidsymp.5650006
   Pilcher BK, 1999, ANN NY ACAD SCI, V878, P12, DOI 10.1111/j.1749-6632.1999.tb07671.x
   Prata MB, 1988, ACTA CIR BRAS, V3, P43
   Rahier JF, 2009, J CROHNS COLITIS, V3, P47, DOI 10.1016/j.crohns.2009.02.010
   Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427
   Sell AM, 2003, BRAZ ARCH BIOL TECHN, V46, P349, DOI 10.1590/S1516-89132003000300006
   Sindrilaru A, 2007, J INVEST DERMATOL, V127, P447, DOI 10.1038/sj.jid.5700563
   Singer AJ, 2002, WOUND REPAIR REGEN, V10, P372, DOI 10.1046/j.1524-475X.2002.10606.x
   Toegel S, 2007, J CONTROL RELEASE, V117, P121, DOI 10.1016/j.jconrel.2006.10.004
   Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786
NR 42
TC 5
Z9 5
U1 0
U2 10
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD MAR
PY 2014
VL 172
IS 5
BP 2682
EP 2693
DI 10.1007/s12010-013-0692-2
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA AD4VJ
UT WOS:000333249100033
PM 24425299
DA 2018-10-19
ER

PT J
AU Dolci, LS
   Quiroga, SD
   Gherardi, M
   Laurita, R
   Liguori, A
   Sanibondi, P
   Fiorani, A
   Calza, L
   Colombo, V
   Focarete, ML
AF Dolci, Luisa Stella
   Quiroga, Santiago David
   Gherardi, Matteo
   Laurita, Romolo
   Liguori, Anna
   Sanibondi, Paolo
   Fiorani, Andrea
   Calza, Laura
   Colombo, Vittorio
   Focarete, Maria Letizia
TI Carboxyl Surface Functionalization of Poly( L-lactic acid) Electrospun
   Nanofibers through Atmospheric Non-Thermal Plasma Affects Fibroblast
   Morphology
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE atmospheric pressure non-thermal plasma; biocompatibility;
   electrospinning; fibroblast cells; scaffolds
ID TISSUE ENGINEERING APPLICATIONS; GRAFT-COPOLYMERIZATION; DISCHARGE
   PLASMA; GLOW-DISCHARGE; CELL-ADHESION; SCAFFOLDS; BIOMATERIALS;
   IMMOBILIZATION; COMPLEXITY; DEPOSITION
AB In this study, atmospheric pressure non-thermal plasma treatment of electrospun poly(L-lactic acid) scaffolds is used to improve scaffold hydrophilicity and to introduce carboxyl groups on scaffold surface. Thermo-mechanical properties, morphology, hydrophilicity, and water uptake of the plasma-treated scaffolds are studied. The amount of carboxyl functional groups on the scaffold surface is evaluated using fluorescein isothiocyanate conjugation and microdensitometry. The effect of plasma treatment on mouse embryonic fibroblast morphology is assessed through image analysis. Results show an enhancement of scaffold biocompatibility, demonstrating that atmospheric plasma technology is a flexible process that can be integrated in in-line procedures of biomaterial fabrication and functionalization.
C1 [Dolci, Luisa Stella; Quiroga, Santiago David; Calza, Laura; Focarete, Maria Letizia] Univ Bologna, Ctr Ind Res HST ICIR, I-40064 Bologna, Italy.
   [Calza, Laura] IRET Fdn, I-40064 Bologna, Italy.
   [Gherardi, Matteo; Laurita, Romolo; Liguori, Anna; Sanibondi, Paolo; Colombo, Vittorio] Univ Bologna, Dept Ind Engn DIN, I-40123 Bologna, Italy.
   [Colombo, Vittorio] Univ Bologna, Interdept Ctr Ind Res AMM ICIR, I-40123 Bologna, Italy.
   [Fiorani, Andrea; Focarete, Maria Letizia] Univ Bologna, Dept Chem G Ciamician, Natl Consortium Mat Sci & Technol INSTM, RU Bologna, I-40126 Bologna, Italy.
RP Colombo, V (reprint author), Univ Bologna, Interdept Ctr Ind Res AMM ICIR, Via Saragozza 8, I-40123 Bologna, Italy.
EM vittorio.colombo@unibo.it; marialetizia.focarete@unibo.it
RI Calza, Laura/G-1059-2014; Focarete, Maria Letizia/B-2369-2009; Laurita,
   Romolo/U-6968-2017
OI Focarete, Maria Letizia/0000-0002-0458-7836; Laurita,
   Romolo/0000-0003-1744-3329; Quiroga, Santiago David/0000-0002-8904-9809;
   Fiorani, Andrea/0000-0001-8413-6439; COLOMBO,
   VITTORIO/0000-0001-9145-198X
FU Regione Emilia Romagna grant (POR-FESR); Montecatone Rehabilitation
   Institute, Imola, Italy (LC); IRET Foundation; Ozzano dell'Emilia
   (Bologna), Italy; FP7 COST Action [MP1101]
FX This work has been supported by a Regione Emilia Romagna grant (POR-FESR
   2011-2013), by the Montecatone Rehabilitation Institute, Imola, Italy
   (LC), IRET Foundation, Ozzano dell'Emilia (Bologna), Italy, and by FP7
   COST Action MP1101 "BioPlasma".
CR Amornsudthiwat P, 2013, COLLOID SURFACE B, V111, P579, DOI 10.1016/j.colsurfb.2013.07.009
   Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001
   Callebaut T, 2004, PLASMA SOURCES SCI T, V13, P245, DOI 10.1088/0963-0252/13/2/008
   Chan CM, 1996, SURF SCI REP, V24, P3
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Delaittre G, 2012, SOFT MATTER, V8, P7323, DOI 10.1039/c2sm07407a
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Domingos M, 2013, ACTA BIOMATER, V9, P5997, DOI 10.1016/j.actbio.2012.12.031
   Ehlbeck J, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/1/013002
   Fang Z, 2003, J PHYS D APPL PHYS, V36, P2980, DOI 10.1088/0022-3727/36/23/019
   Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Greig B., 2009, NAT REV MOL CELL BIO, V10, P21
   Gu MH, 2012, BIOMATERIALS, V33, P1261, DOI 10.1016/j.biomaterials.2011.11.001
   Gualandi C, 2012, EUR POLYM J, V48, P2008, DOI 10.1016/j.eurpolymj.2012.09.016
   Heo GY, 2012, CARBOHYD POLYM, V88, P562, DOI 10.1016/j.carbpol.2011.12.038
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Hogan B., 1994, MANIPULATING MOUSE E
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hyun-Uk L., 2011, POLYM DEGRAD STABIL, V96, P1204
   Kang YH, 2011, THIN SOLID FILMS, V519, P7090, DOI 10.1016/j.tsf.2011.04.056
   Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004
   Lee HU, 2008, APPL SURF SCI, V254, P5700, DOI 10.1016/j.apsusc.2008.03.049
   Lee HU, 2010, ACTA BIOMATER, V6, P519, DOI 10.1016/j.actbio.2009.07.011
   Lu T, 2012, INTERFACE FOCUS, V2, P325, DOI 10.1098/rsfs.2012.0003
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Mukherjee S, 2011, J MATER SCI-MATER M, V22, P1689, DOI 10.1007/s10856-011-4351-2
   Park H, 2007, MACROMOL RES, V15, P238, DOI 10.1007/BF03218782
   Park H, 2010, COLLOID SURFACE B, V77, P90, DOI 10.1016/j.colsurfb.2010.01.011
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c
   Sarra-Bournet C, 2006, J PHYS D APPL PHYS, V39, P3461, DOI 10.1088/0022-3727/39/16/S03
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Sun FQ, 2010, CHINESE J POLYM SCI, V28, P705, DOI 10.1007/s10118-010-9110-1
   Taraballi F, 2013, J COLLOID INTERF SCI, V394, P590, DOI 10.1016/j.jcis.2012.11.041
   Tsai PP, 2005, TEXT RES J, V75, P819, DOI 10.1177/0040517505057526
   Vasilets VN, 2006, HIGH ENERG CHEM+, V40, P79, DOI 10.1134/S0018143906020032
   Wang JK, 2008, J POLYM SCI POL PHYS, V46, P1594, DOI 10.1002/polb.21496
   Wang XL, 2007, J APPL POLYM SCI, V104, P3614, DOI 10.1002/app.26081
   Wyrwa R, 2011, ADV ENG MATER, V13, pB165, DOI 10.1002/adem.201080116
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zanden C, 2012, EUR POLYM J, V48, P472, DOI 10.1016/j.eurpolymj.2012.01.004
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 52
TC 18
Z9 18
U1 1
U2 50
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD MAR
PY 2014
VL 11
IS 3
BP 203
EP 213
DI 10.1002/ppap.201300104
PG 11
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA AD4BV
UT WOS:000333192000001
DA 2018-10-19
ER

PT J
AU Mangano, C
   Iaculli, F
   Piattelli, A
   Mangano, F
   Shibli, JA
   Perrotti, V
   Iezzi, G
AF Mangano, Carlo
   Iaculli, Flavia
   Piattelli, Adriano
   Mangano, Francesco
   Shibli, Jamil Awad
   Perrotti, Vittoria
   Iezzi, Giovanna
TI Clinical and Histologic Evaluation of Calcium Carbonate in Sinus
   Augmentation: A Case Series
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID GUIDED TISSUE REGENERATION; REPLACEMENT GRAFT MATERIAL; BONE-FORMATION;
   DEFECTS; BIOMATERIAL; IMPLANTS; LIFT
AB The aim of this case series was a clinical, histologic, and histomorphometric evaluation of calcium carbonate in sinus elevation procedures. Sinus augmentation was performed in the atrophic maxillae of 24 subjects using calcium carbonate. Six months after the regeneration procedures, 68 implants were placed and clinically followed for 1 to 5 years, depending on the placement timing. At the last implant placement procedure, 8 bone cores were harvested and processed for histology. After a 6-month healing period, sinuses grafted with calcium carbonate showed a mean vertical bone gain of 6.93 +/- 0.23 mm. The histomorphometric analysis revealed 15% +/- 3% residual grafted biomaterial, 28% +/- 2% newly formed bone, and 57% +/- 2% marrow spaces. The implant survival rate was 98.5%. It can be concluded that calcium carbonate was shown to be clinically suitable for sinus elevation procedures after 1 to 5 years of follow-up and histologically biocompatible and osteoconductive.
C1 [Mangano, Carlo; Mangano, Francesco] Univ Insubria Varese, Dept Surg & Morphol Sci, Varese, Italy.
   [Iaculli, Flavia; Piattelli, Adriano; Perrotti, Vittoria; Iezzi, Giovanna] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Chieti, Italy.
   [Shibli, Jamil Awad] Univ Guarulhos, Dent Res Div, Sao Paulo, Brazil.
RP Iezzi, G (reprint author), Via Vestini 31, I-66100 Chieti, Italy.
EM gio.iezzi@unich.it
OI Mangano, Francesco/0000-0001-5488-4268
FU Ministry of Education, University and Research (MIUR), Rome, Italy; PRIN
   [20102011, 20102ZLNJ5]
FX This work was by supported by PRIN 20102011 (PRIN 20102ZLNJ5), financed
   by the Ministry of Education, University and Research (MIUR), Rome,
   Italy. The funders had no role in study design, data collection or
   analysis, decision to publish, or preparation of the manuscript. The
   authors reported no conflicts of interest related to this study.
CR Artese L, 2011, IMPLANT DENT, V20, P383, DOI 10.1097/ID.0b013e3182310b3d
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Guerra F, 2010, J BIOMED MAT RES B, V92, P409
   Hernandez-Alfaro F, 2008, CLIN ORAL IMPLAN RES, V19, P91, DOI 10.1111/j.1600-0501.2007.01372.x
   Koo KT, 2005, J CLIN PERIODONTOL, V32, P104, DOI 10.1111/j.1600-051X.2004.00632.x
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Leize EM, 1999, J MATER SCI-MATER M, V10, P47, DOI 10.1023/A:1008892027815
   Mangano C, 2009, CLIN IMPLANT DENT R, V11, P92
   Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Piattelli A, 1997, BIOMATERIALS, V18, P577, DOI 10.1016/S0142-9612(96)00177-9
   Polimeni G, 2004, J CLIN PERIODONTOL, V31, P725, DOI 10.1111/j.1600-051X.2004.00542.x
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Sandor GKB, 2003, DENT TRAUMATOL, V19, P221, DOI 10.1034/j.1600-9657.2003.00164.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Simon JL, 2003, J BIOMED MATER RES A, V66A, P275, DOI 10.1002/jbm.a.10569
   TATUM H, 1986, DENT CLIN N AM, V30, P207
   Tschon M, 2009, J BIOMED MATER RES B, V88B, P349, DOI 10.1002/jbm.b.31062
   YUKNA RA, 1994, J PERIODONTOL, V65, P177, DOI 10.1902/jop.1994.65.2.177
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
NR 21
TC 5
Z9 5
U1 0
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
EI 1945-3388
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD MAR-APR
PY 2014
VL 34
IS 2
BP E43
EP E49
DI 10.11607/prd.1832
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA AC8ES
UT WOS:000332766900003
PM 24600666
OA Bronze
DA 2018-10-19
ER

PT J
AU Suganya, S
   Venugopal, J
   Mary, SA
   Ramakrishna, S
   Lakshmi, BS
   Dev, VRG
AF Suganya, S.
   Venugopal, J.
   Mary, S. Agnes
   Ramakrishna, S.
   Lakshmi, B. S.
   Dev, V. R. Giri
TI Aloe vera incorporated biomimetic nanofibrous scaffold: a regenerative
   approach for skin tissue engineering
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE Aloe vera; Polycaprolactone; Electrospinning; Nanomaterials; Tissue
   engineering
ID COMPOSITE NANOFIBERS; IN-VITRO; COLLAGEN; GEL; ANTIBACTERIAL;
   BARBADENSIS
AB Aloe vera (AV) is one of the medicinal herbs with a well-established spectrum of wound healing, antimicrobial and anti-inflammatory property. AV-mediated therapeutics present significant tissue regenerative activity by modulating the inflammatory and proliferative phases of wound healing. The purpose of the present work was to combine the biological properties of AV and the advantages of electrospun meshes to prepare a potent transdermal biomaterial. The polycaprolactone (PCL) containing 5 and 10 wt % of lyophilized powder of AV was studied for electrospinning into nanoscale fiber mats and compared with PCL/Collagen blend for dermal substitutes. SEM revealed the average diameters of PCL, PCL-AV 5 %, PCL-AV 10 % and PCL/Collagen nanofiber scaffolds in the range of 519 +/- 28, 264 +/- 46, 215 +/- 63 and 249 +/- 52 nm, respectively. PCL-AV 10 % nanofiber scaffolds showed finer fiber morphology with improved hydrophilic properties and higher tensile strength of 6.28 MPa with a Young's modulus of 16.11 MPa desirable for skin tissue engineering. The nanofibers were then used to investigate differences in biological responses in terms of proliferation and cell morphology of mice dermal fibroblasts. It was found that PCL-AV 10 % nanofibrous matrix favored cell proliferation compared to other scaffolds which almost increased linearly by (p <= 0.01) 17.79 % and (p <= 0.01) 21.28 % compared to PCL on sixth and ninth day. CMFDA dye expression, secretion of collagen and F-actin expression were significantly increased in PCL-AV 10 % scaffolds compared to other nanofibrous scaffolds. The obtained results proved that the PCL-AV 10 % nanofibrous scaffold is a potential biomaterial for skin tissue regeneration.
C1 [Suganya, S.; Mary, S. Agnes; Dev, V. R. Giri] Anna Univ, AC Tech, Dept Text Technol, Madras 600025, Tamil Nadu, India.
   [Suganya, S.; Lakshmi, B. S.] Anna Univ, Ctr Biotechnol, Madras 600025, Tamil Nadu, India.
   [Venugopal, J.; Ramakrishna, S.] Natl Univ Singapore, Fac Engn, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
RP Dev, VRG (reprint author), Anna Univ, AC Tech, Dept Text Technol, Madras 600025, Tamil Nadu, India.
EM vrgiridev@yahoo.com
OI Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU Department of Textile Technology, Anna University, Chennai, India;
   NUSNNI, National University of Singapore, Singapore
FX This study was supported by the Department of Textile Technology, Anna
   University, Chennai, India and NUSNNI, National University of Singapore,
   Singapore.
CR Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen YW, 2008, BRAZ J CHEM ENG, V25, P321, DOI 10.1590/S0104-66322008000200011
   Chithra P, 1998, MOL CELL BIOCHEM, V181, P71, DOI 10.1023/A:1006813510959
   Choi SW, 2001, BRIT J DERMATOL, V145, P535, DOI 10.1046/j.1365-2133.2001.04410.x
   Driskell RR, 2013, NATURE, V504, P277, DOI 10.1038/nature12783
   Gaspar A, 2011, J Med Life, V4, P172
   He JX, 2013, IRAN POLYM J, V22, P537, DOI 10.1007/s13726-013-0153-3
   HEGGERS JP, 1993, PHYTOTHER RES, V7, pS48, DOI 10.1002/ptr.2650070715
   Hutter JA, 1996, J NAT PROD, V59, P541, DOI 10.1021/np9601519
   Kang MC, 2014, CARBOHYD POLYM, V99, P365, DOI 10.1016/j.carbpol.2013.07.091
   Krishnan P., 2006, CURR ANAESTH CRIT CA, V17, P21
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liu WL, 2009, IRAN POLYM J, V18, P89
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Qian YF, 2010, IRAN POLYM J, V19, P123
   Qin JW, 2013, IRAN POLYM J, V22, P729, DOI 10.1007/s13726-013-0171-1
   Sahu P. K., 2013, Pharmacology and Pharmacy, V4, P599, DOI 10.4236/pp.2013.48086
   Song AR, 2012, ACTA BIOMATER, V8, P41, DOI 10.1016/j.actbio.2011.10.004
   Suganya S, 2014, J BIOMATER TISS ENG, V4, P9, DOI 10.1166/jbt.2014.1139
   Takzare N, 2009, TOXICOL MECH METHOD, V19, P73, DOI 10.1080/15376510802442444
   Tao H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000697
   Tian F, 2008, J BIOMED MATER RES A, V84A, P291, DOI 10.1002/jbm.a.31304
   Vazquez B, 1996, J ETHNOPHARMACOL, V55, P69, DOI 10.1016/S0378-8741(96)01476-6
   Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x
   Vujanovic S, 2013, BURNS, V39, P1031, DOI 10.1016/j.burns.2013.03.016
   Yannas IV, 2007, TISSUE ENG, V13, P1789, DOI 10.1089/ten.2006.0054
   Zargarian SS, 2010, IRAN POLYM J, V19, P457
   Zhang YQ, 2013, COLLOID SURFACE A, V423, P63, DOI 10.1016/j.colsurfa.2013.01.059
   Zheng L, 2013, IRAN POLYM J, V22, P833, DOI 10.1007/s13726-013-0182-y
NR 30
TC 27
Z9 27
U1 2
U2 62
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1026-1265
EI 1735-5265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD MAR
PY 2014
VL 23
IS 3
BP 237
EP 248
DI 10.1007/s13726-013-0219-2
PG 12
WC Polymer Science
SC Polymer Science
GA AD3GW
UT WOS:000333127300008
DA 2018-10-19
ER

PT J
AU Tan, Q
   Chen, B
   Yan, X
   Lin, Y
   Xiao, ZF
   Hou, XL
   Dai, JW
AF Tan, Qian
   Chen, Bing
   Yan, Xin
   Lin, Yue
   Xiao, Zhifeng
   Hou, Xianglin
   Dai, Jianwu
TI Promotion of diabetic wound healing by collagen scaffold with
   collagen-binding vascular endothelial growth factor in a diabetic rat
   model
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE VEGF; collagen scaffolds; healing; wounds
ID FOOT ULCERS; DELIVERY; CLOSURE
AB Aims: Studies show that VEGF can promote tissue regeneration in diabetic wounds. The aim of this study was to evaluate the effects of a new composite biomaterial, a collagen scaffold with CBD-VEGF, for wound healing in a diabetic rat model. Materials and methods: We produced a collagen scaffold loaded with CBD-VEGF, which allowed VEGF to bind to the collagen scaffold. The diabetic rat model was constructed by injecting streptozocin (STZ) peritoneally and removing a 2 x 2.5 cm thick slice of skin from the back of the animal. Animals were randomly divided into 4 groups: blank control (BC Group, n = 24), collagen scaffold loaded with PBS (PBS Group, n = 24), collagen scaffold loaded with NAT-VEGF (NAT-VEGF Group, n = 24), and collagen scaffold loaded with CBD-VEGF (CBD-VEGF Group, n = 24). Wounds of the BC Group were covered with gauze and those of the PBS, NAT-VEGF and CBD-VEGF Groups were grafted by corresponding collagen scaffolds, respectively. Healing rates were calculated and compared among groups. Wound tissue was evaluated by histologic analysis. Results: The CBD-VEGF group showed a higher wound healing rate, better vascularization and higher level of VEGF in the granulation tissue wound compared with NAT-VEGF and PBS groups. Conclusions: The collagen scaffold with CBD-VEGF promoted wound healing in a diabetic rat model, which could potentially provide better therapeutic options for the treatment of diabetic wounds. Copyright (c) 2012 John Wiley & Sons, Ltd.
C1 [Tan, Qian; Yan, Xin; Lin, Yue] Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Burns & Plast Surg, Nanjing 210008, Jiangsu, Peoples R China.
   [Chen, Bing; Xiao, Zhifeng; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100190, Peoples R China.
   [Hou, Xianglin] Yantai Zhenghai Biotechnol Co Ltd, Yantai, Shangdong, Peoples R China.
RP Tan, Q (reprint author), Nanjing Univ, Sch Med, Drum Tower Hosp, Dept Burns & Plast Surg, Nanjing 210008, Jiangsu, Peoples R China.
EM smmutan-qian@sina.com; jwdai@genetics.ac.cn
FU Key Talent Foundation of China, Jiangsu Province [RC2007009]; 333
   Project Talent Foundation of China, Jiangsu Province [NJGL2007116];
   Technology Foundation of China, Jiangsu Province, Nanjing [NJGL2006024];
   National Natural Science Foundation of China [30688002]; K.C. Wong
   Education Foundation
FX This work was supported by grounds from the Key Talent Foundation of
   China, Jiangsu Province (RC2007009); the 333 Project Talent Foundation
   of China, Jiangsu Province (NJGL2007116); the Technology Foundation of
   China, Jiangsu Province, Nanjing (NJGL2006024); the National Natural
   Science Foundation of China (30688002) and the K.C. Wong Education
   Foundation.
CR Chen L, 2010, J MATER SCI-MATER M, V21, P309, DOI 10.1007/s10856-009-3827-9
   Chen W, 2009, J UROLOGY, V183, P2432
   Galkowska H, 2006, WOUND REPAIR REGEN, V14, P558, DOI 10.1111/j.1743-6109.2006.00155.x
   Goodridge D, 2006, FOOT ANKLE INT, V27, P274, DOI 10.1177/107110070602700408
   Gwynne Babs, 2006, Br J Nurs, V15, pS4
   Hang LN, 2006, BIOMATERIALS, V27, P5708
   He JQ, 2002, J ORAL MAXILLOFAC SU, V60, P1449
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   Lee RJ, 2000, CIRCULATION, V102, P898
   Lobmann R, 2003, MED KLIN, V98, P292, DOI 10.1007/s00063-003-1260-2
   Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7
   [陆树良 Lu Shuliang], 2004, [中华创伤杂志, Chinese Journal of Traumatology], V20, P468
   Morykwas MJ, 1997, ANN PLAS SURG, V38, P553, DOI 10.1097/00000637-199706000-00001
   Onodera H, 2004, DIGEST SURG, V21, P146, DOI 10.1159/000078381
   Pradhan L, 2009, EXPERT REV MOL MED, V11, P2
   Rosengart TK, 1999, CIRCULATION, V100, P468, DOI 10.1161/01.CIR.100.5.468
   Shi CY, 2011, BIOMATERIALS, V32, P753, DOI 10.1016/j.biomaterials.2010.09.038
   Testori T, 2008, INT J PERIODONT REST, V28, P9
   Trousdale RK, 2009, J SURG RES, V151, P100, DOI 10.1016/j.jss.2008.01.023
   Wang Zheng, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P505
   Yan X, 2010, DIABETES RES CLIN PR, V90, P66, DOI 10.1016/j.diabres.2010.07.001
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yang YF, 2009, TISSUE ENG PART A, V15, P11
   Zhang J, 2009, CIRCULATION, V119, P1776, DOI 10.1161/CIRCULATIONAHA.108.800565
NR 24
TC 22
Z9 24
U1 6
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
EI 1932-7005
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAR
PY 2014
VL 8
IS 3
BP 195
EP 201
DI 10.1002/term.1513
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA AD1DE
UT WOS:000332973200004
PM 22570298
DA 2018-10-19
ER

PT J
AU Zhou, GH
   Chen, CH
   Zhang, LY
   Guo, XF
   Wang, H
   Ji, XH
   He, ZK
AF Zhou, Guohua
   Chen, Chaohui
   Zhang, Liyun
   Guo, Xiaofeng
   Wang, Hong
   Ji, Xinghu
   He, Zhike
TI Robust Aqueous Quantum Dots Capped with Peptide Ligands as Biomaterials:
   Facile Preparation, Good Stability, and Multipurpose Application
SO PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
LA English
DT Article
DE quantum dots; peptides; biomaterials; graphene; FRET
ID GOLD NANOPARTICLES; PARTICLE-SIZE; BIOLOGICAL APPLICATIONS; SURFACE
   MODIFICATION; CDSE NANOCRYSTALS; ENERGY-TRANSFER; CYTOTOXICITY;
   GRAPHENE; BINDING; CELLS
AB We have obtained robust peptide-capped quantum dots (QDs) using a facile approach. The pentapeptide Cys-Ala-Leu-Asn-Asn (CALNN) is involved as the capping ligand, forming a self-assembly monolayer on the surface of QDs, and solubilization of hydrophobic QDs in water is realized by simply mixing with the ligands in sodium hydroxide solution. All of the characterization results show that the prepared small-sized QDs have excellent stability in acidic and high salt solutions. Additionally, the protein-mimicking surface property of the peptide-capped QDs eliminates the nonspecific cellular interaction, which in combination with the low cytotoxicity promises an ideal biomaterial in the future. Further functionalization and achievement of fluorescence resonance energy transfer (FRET) to graphene also display great potential for analytical applications.
C1 [Zhou, Guohua; Chen, Chaohui; Zhang, Liyun; Guo, Xiaofeng; Wang, Hong; Ji, Xinghu; He, Zhike] Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.
RP Zhou, GH (reprint author), Wuhan Univ, Coll Chem & Mol Sci, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.
EM xhu@whu.edu.cn; zhkhe@whu.edu.cn
OI Zhou, Guohua/0000-0001-6252-959X
FU National Key Scientific Program-Nanoscience and Nanotechnology
   [2011CB933600]; National Science Foundation of China [21075093,
   21275109, 21205089]
FX This work was commercially supported by the National Key Scientific
   Program-Nanoscience and Nanotechnology (2011CB933600), and the National
   Science Foundation of China (21075093, 21275109 and 21205089).
CR Aldana J, 2005, J AM CHEM SOC, V127, P2496, DOI 10.1021/ja047000+
   Aldana J, 2001, J AM CHEM SOC, V123, P8844, DOI 10.1021/ja016424q
   Algar WR, 2007, CHEMPHYSCHEM, V8, P561, DOI 10.1002/cphc.200600686
   Bailey RE, 2003, J AM CHEM SOC, V125, P7100, DOI 10.1021/ja035000o
   Bentzen EL, 2005, BIOCONJUGATE CHEM, V16, P1488, DOI 10.1021/bc0502006
   Biju V, 2010, CHEM SOC REV, V39, P3031, DOI 10.1039/b926512k
   Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013
   Carrillo-Carrion C, 2009, CHEM COMMUN, P5214, DOI 10.1039/b904381k
   Carrillo-Carrion C, 2009, ANAL CHEM, V81, P4730, DOI 10.1021/ac900034h
   Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016
   Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218
   Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI [10.1038/nbt1340, 10.1038/nbtl340]
   Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y
   Daou TJ, 2009, LANGMUIR, V25, P3040, DOI 10.1021/la8035083
   Delehanty JB, 2006, BIOCONJUGATE CHEM, V17, P920, DOI 10.1021/bc060044i
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194
   Duchesne L, 2008, LANGMUIR, V24, P13572, DOI 10.1021/la802876u
   Esteve-Turrillas FA, 2013, BIOSENS BIOELECTRON, V41, P12, DOI 10.1016/j.bios.2012.09.025
   Gaal o., 1980, ELECTROPHORESIS SEPA, P15
   Gao JQ, 2008, ANAL CHEM, V80, P8822, DOI 10.1021/ac8015328
   Gao XH, 2002, J BIOMED OPT, V7, P532, DOI 10.1117/1.1506706
   Gerion D, 2001, J PHYS CHEM B, V105, P8861, DOI 10.1021/jp0105488
   Guzelian AA, 1996, APPL PHYS LETT, V69, P1432, DOI 10.1063/1.117605
   Hines MA, 2003, ADV MATER, V15, P1844, DOI 10.1002/adma.200305395
   Hines MA, 1998, J PHYS CHEM B, V102, P3655, DOI 10.1021/jp9810217
   Hines MA, 1996, J PHYS CHEM-US, V100, P468, DOI 10.1021/jp9530562
   Hoshino A, 2004, NANO LETT, V4, P2163, DOI 10.1021/nl048715d
   Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m
   Lee JS, 2012, ACS NANO, V6, P2978, DOI 10.1021/nn300684d
   LENTZ BR, 1994, CHEM PHYS LIPIDS, V73, P91, DOI 10.1016/0009-3084(94)90176-7
   Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269
   Levy R, 2006, CHEMBIOCHEM, V7, P1141, DOI 10.1002/cbic.200600129
   Liu JA, 2006, SMALL, V2, P999, DOI 10.1002/smll.200500421
   Liu M, 2010, CHEM COMMUN, V46, P7909, DOI 10.1039/c0cc02085k
   Liu XS, 2013, ADV HEALTHC MATER, V2, P352, DOI 10.1002/adhm.201200210
   Liu YS, 2007, J PHYS CHEM C, V111, P2872, DOI 10.1021/jp0654718
   Masilela N, 2012, J PHOTOCH PHOTOBIO A, V247, P82, DOI 10.1016/j.jphotochem.2012.07.016
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Muro E, 2010, J AM CHEM SOC, V132, P4556, DOI 10.1021/ja1005493
   Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a
   Park J, 2011, ADV FUNCT MATER, V21, P1558, DOI 10.1002/adfm.201001924
   Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j
   Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m
   Pinaud F, 2004, J AM CHEM SOC, V126, P6115, DOI 10.1021/ja031691c
   Prasuhn DE, 2010, SMALL, V6, P555, DOI 10.1002/smll.200901845
   Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013
   Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k
   Ryman-Rasmussen JP, 2007, NANO LETT, V7, P1344, DOI 10.1021/nl070375j
   Ryman-Rasmussen JP, 2007, J INVEST DERMATOL, V127, P143, DOI 10.1038/sj.jid.5700508
   Si Y, 2008, NANO LETT, V8, P1679, DOI 10.1021/nl080604h
   Sun LL, 2008, LANGMUIR, V24, P10293, DOI 10.1021/la8015063
   Uyeda HT, 2005, J AM CHEM SOC, V127, P3870, DOI 10.1021/ja044031w
   Wei YF, 2009, BIOCONJUGATE CHEM, V20, P1752, DOI 10.1021/bc8003777
   Yu DH, 2007, ENZYME MICROB TECH, V41, P127, DOI 10.1016/j.enzmictec.2006.12.012
   Yu GH, 2006, CHEM BIOL, V13, P723, DOI 10.1016/j.chembiol.2006.05.007
   Zhao D., 2008, J PHYS CHEM C, V113, P1293, DOI [10.1021/jp808465s, DOI 10.1021/JP808465S]
   Zhou GH, 2013, LANGMUIR, V29, P4697, DOI 10.1021/la400404g
   Zhou GH, 2012, ACS APPL MATER INTER, V4, P5010, DOI 10.1021/am301380q
   Zhou Y, 2009, CHEM MATER, V21, P2950, DOI 10.1021/cm9006603
   Zrazhevskiy P, 2010, CHEM SOC REV, V39, P4326, DOI 10.1039/b915139g
NR 61
TC 4
Z9 4
U1 2
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 0934-0866
EI 1521-4117
J9 PART PART SYST CHAR
JI Part. Part. Syst. Charact.
PD MAR
PY 2014
VL 31
IS 3
BP 382
EP 389
DI 10.1002/ppsc.201300250
PG 8
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA AD0MK
UT WOS:000332928100009
DA 2018-10-19
ER

PT J
AU Veronesi, E
   Murgia, A
   Caselli, A
   Grisendi, G
   Piccinno, MS
   Rasini, V
   Giordano, R
   Montemurro, T
   Bourin, P
   Sensebe, L
   Rojewski, MT
   Schrezenmeier, H
   Layrolle, P
   Ginebra, MP
   Panaitescu, CB
   Gomez-Barrena, E
   Catani, F
   Paolucci, P
   Burns, JS
   Dominici, M
AF Veronesi, Elena
   Murgia, Alba
   Caselli, Anna
   Grisendi, Giulia
   Piccinno, Maria Serena
   Rasini, Valeria
   Giordano, Rosaria
   Montemurro, Tiziana
   Bourin, Philippe
   Sensebe, Luc
   Rojewski, Markus T.
   Schrezenmeier, Hubert
   Layrolle, Pierre
   Pau Ginebra, Maria
   Panaitescu, Carmen Bunu
   Gomez-Barrena, Enrique
   Catani, Fabio
   Paolucci, Paolo
   Burns, Jorge S.
   Dominici, Massimo
TI Transportation Conditions for Prompt Use of Ex Vivo Expanded and Freshly
   Harvested Clinical-Grade Bone Marrow Mesenchymal Stromal/Stem Cells for
   Bone Regeneration
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CALCIUM-PHOSPHATE CERAMICS; TISSUE-ENGINEERED BONE; PLATELET-RICH
   PLASMA; HUMAN SERUM-ALBUMIN; STEM-CELLS; OSTEOCONDUCTIVE SCAFFOLDS;
   IN-VITRO; BIOMATERIALS; EXPANSION; REPAIR
AB Successful preliminary studies have encouraged a more translational phase for stem cell research. Nevertheless, advances in the culture of human bone marrow-derived mesenchymal stromal/stem cells (hBM-MSC) and osteoconductive qualities of combined biomaterials can be undermined if necessary cell transportation procedures prove unviable. We aimed at evaluating the effect of transportation conditions on cell function, including the ability to form bone in vivo, using procedures suited to clinical application. hBM-MSC expanded in current Good Manufacturing Practice (cGMP) facilities (cGMP-hBM-MSC) to numbers suitable for therapy were transported overnight within syringes and subsequently tested for viability. Scaled-down experiments mimicking shipment for 18h at 4 degrees C tested the influence of three different clinical-grade transportation buffers (0.9% saline alone or with 4% human serum albumin [HSA] from two independent sources) compared with cell maintenance medium. Cell viability after shipment was >80% in all cases, enabling evaluation of (1) adhesion to plastic flasks and hydroxyapatite tricalcium phosphate osteoconductive biomaterial (HA/-TCP 3D scaffold); (2) proliferation rate; (3) ex vivo osteogenic differentiation in contexts of 2D monolayers on plastic and 3D HA/-TCP scaffolds; and (4) in vivo ectopic bone formation after subcutaneous implantation of cells with HA/-TCP scaffold into NOD/SCID mice. Von Kossa staining was used to assess ex vivo osteogenic differentiation in 3D cultures, providing a quantifiable test of 3D biomineralization ex vivo as a rapid, cost-effective potency assay. Near-equivalent capacities for cell survival, proliferation, and osteogenic differentiation were found for all transportation buffers. Moreover, cGMP-hBM-MSC transported from a production facility under clinical-grade conditions of 4% HSA in 0.9% saline to a destination 18h away showed prompt adhesion to HA/-TCP 3D scaffold and subsequent in vivo bone formation. A successfully validated transportation protocol extends the applicability of fresh stem cells involving multicentric trials for regenerative medicine.
C1 [Veronesi, Elena; Murgia, Alba; Grisendi, Giulia; Piccinno, Maria Serena; Rasini, Valeria; Catani, Fabio; Paolucci, Paolo; Burns, Jorge S.; Dominici, Massimo] Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Lab Cell Biol & Adv Canc Therapies, I-41124 Modena, Italy.
   [Caselli, Anna] Univ Bari A Moro, Dept Internal Med & Oncol, Bari, Italy.
   [Giordano, Rosaria; Montemurro, Tiziana] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Cell Factory, Milan, Italy.
   [Bourin, Philippe] EFS Pyrenees Mediterranee, Toulouse, France.
   [Sensebe, Luc] Univ Toulouse 3, EFS, INSERM, STROMALab UMR5273 U1031,CNRS, F-31062 Toulouse, France.
   [Rojewski, Markus T.; Schrezenmeier, Hubert] German Red Cross Blood Transfus Serv, Inst Clin Transfus Med & Immungenet Ulm, Ulm, Germany.
   [Rojewski, Markus T.; Schrezenmeier, Hubert] Univ Ulm, D-89069 Ulm, Germany.
   [Layrolle, Pierre] Univ Nantes, Fac Med, Lab Pathophysiol Bone Resorpt, INSERM U957, Nantes, France.
   [Pau Ginebra, Maria] Tech Univ Catalonia, Dept Mat Sci & Met Engn, Barcelona, Spain.
   [Panaitescu, Carmen Bunu] Victor Babes Univ Med & Pharm, Timisoara, Romania.
   [Gomez-Barrena, Enrique] Hosp La Paz IdiPaz, Serv Cirugia Ortoped & Traumatol, Madrid, Spain.
   [Gomez-Barrena, Enrique] Univ Autonoma Madrid, Madrid, Spain.
RP Dominici, M (reprint author), Univ Hosp Modena & Reggio Emilia, Dept Med & Surg Sci Children & Adults, Lab Cell Biol & Adv Canc Therapies, Via Pozzo 71, I-41124 Modena, Italy.
EM massimo.dominici@unimore.it
RI Caselli, Anna/B-9734-2015; Layrolle, Pierre/K-9257-2015; GOMEZ-BARRENA,
   ENRIQUE/A-2799-2008; Burns, Jorge S./J-3395-2012; Giordano,
   Rosaria/N-6565-2015; Catani, Fabio/B-3642-2017; Grisendi,
   Giulia/J-6360-2016; Ginebra, Maria-Pau/J-8149-2017
OI Caselli, Anna/0000-0002-8859-2738; Layrolle, Pierre/0000-0001-9800-5210;
   GOMEZ-BARRENA, ENRIQUE/0000-0003-1065-6137; Burns, Jorge
   S./0000-0002-8602-1536; Giordano, Rosaria/0000-0002-7263-0752; Catani,
   Fabio/0000-0002-1078-7666; Grisendi, Giulia/0000-0002-0120-6129;
   Ginebra, Maria-Pau/0000-0002-4700-5621; Dominici,
   Massimo/0000-0002-4007-1503; Rojewski, Markus/0000-0003-4265-0442;
   PAOLUCCI, PAOLO/0000-0002-0352-1456; Piccinno, Maria
   Serena/0000-0001-5387-3022; Bourin, Philippe/0000-0002-9652-4380
FU European Commission [241879]; REBORNE project; Italian Ministry of
   Health "Bando Cellule Staminali"; Regione Emilia Romagna; Associazione
   ASEOP
FX This work was supported in part by the European Commission Seventh
   Framework Program (FP7/2007-2013) (grant no. 241879), through the
   REBORNE project, the Italian Ministry of Health "Bando Cellule Staminali
   2008" (M. D., P. P.), Regione Emilia Romagna (P. P., M. D.), and the
   Associazione ASEOP (P. P.). The authors are thankful to Flavia Parise
   and Renata Battini for their constant support in preclinical
   investigation studies.
CR Abdallah Basem M., 2008, V455, P89, DOI 10.1007/978-1-59745-104-8_6
   Ahmadbeigi N, 2012, CYTOTHERAPY, V14, P917, DOI 10.3109/14653249.2012.689426
   Baltanas FC, 2009, NEUROSCI LETT, V450, P23, DOI 10.1016/j.neulet.2008.10.108
   Benoit DSW, 2007, J BIOMED MATER RES A, V81A, P259, DOI 10.1002/jbm.a.31292
   Bernardo ME, 2011, BEST PRACT RES CL HA, V24, P73, DOI 10.1016/j.beha.2010.11.002
   Bernhardt A, 2013, CLIN ORAL IMPLAN RES, V24, P441, DOI 10.1111/j.1600-0501.2011.02350.x
   Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Burns JS, 2010, TISSUE ENG PT A, V16, P2331, DOI [10.1089/ten.tea.2009.0735, 10.1089/ten.TEA.2009.0735]
   CALDWELL J, 1991, J CELL PHYSIOL, V147, P344, DOI 10.1002/jcp.1041470221
   Cho HS, 2011, KOREAN J LAB MED, V31, P212, DOI 10.3343/kjlm.2011.31.3.212
   Ciapetti G, 2012, CURR PHARM DESIGN, V18, P1796, DOI 10.2174/138161212799859648
   Cuomo AV, 2009, J BONE JOINT SURG AM, V91A, P1073, DOI 10.2106/JBJS.H.00303
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   Dennis JE, 1998, BIOMATERIALS, V19, P1323, DOI 10.1016/S0142-9612(97)00170-1
   Di GH, 2012, J CELL PHYSIOL, V227, P879, DOI 10.1002/jcp.23066
   Dingari NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032406
   Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459
   Doucet C, 2005, J CELL PHYSIOL, V205, P228, DOI 10.1002/jcp.20391
   Fekete N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043255
   Fekete N, 2012, CYTOTHERAPY, V14, P540, DOI 10.3109/14653249.2012.655420
   Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691
   Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384
   Garcovich M, 2009, BLOOD TRANSFUS-ITALY, V7, P268, DOI 10.2450/2008.0080-08
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Griffon DJ, 2011, J TISSUE ENG REGEN M, V5, P169, DOI 10.1002/term.302
   Hunt CJ, 2011, TRANSFUS MED HEMOTH, V38, P107, DOI 10.1159/000326623
   Impens S, 2010, TISSUE ENG PART C-ME, V16, P1575, DOI 10.1089/ten.TEC.2010.0069
   Jansen J, 2009, CYTOTHERAPY, V11, P79, DOI 10.1080/14653240802666050
   Kuznetsov SA, 2013, J TISSUE ENG REGEN M, V7, P226, DOI 10.1002/term.515
   Lane TA, 2009, TRANSFUSION, V49, P1471, DOI 10.1111/j.1537-2995.2009.02138.x
   Liu GP, 2008, CRYOBIOLOGY, V56, P209, DOI 10.1016/j.cryobiol.2008.02.008
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   Mankani MH, 2008, TISSUE ENG PT A, V14, P1949, DOI 10.1089/ten.tea.2007.0348
   Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190
   Miao D, 2004, TISSUE ENG, V10, P807, DOI 10.1089/1076327041348473
   Muraki K, 2006, TISSUE ENG, V12, P1711, DOI 10.1089/ten.2006.12.1711
   Ng AMH, 2008, J BIOMED MATER RES A, V85A, P301, DOI 10.1002/jbm.a.31324
   Nikolaev NI, 2012, J R SOC INTERFACE, V9, P2503, DOI 10.1098/rsif.2012.0271
   Pamphilon DH, 2010, VOX SANG, V99, P168, DOI 10.1111/j.1423-0410.2010.01329.x
   PUCHTLER H, 1978, HISTOCHEMISTRY, V56, P177, DOI 10.1007/BF00495978
   PUCHTLER H, 1969, J HISTOCHEM CYTOCHEM, V17, P110, DOI 10.1177/17.2.110
   Quan RF, 2012, CHIN J TRAUMATOL, V15, P131, DOI 10.3760/cma.j.issn.1008-1275.2012.03.001
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rasini V, 2013, CYTOTHERAPY, V15, P292, DOI 10.1016/j.jcyt.2012.11.009
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   ROSS DD, 1989, CANCER RES, V49, P3776
   Scaglione S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00274
   Schallmoser K, 2009, BIO-MED MATER ENG, V19, P271, DOI 10.3233/BME-2009-0591
   Schrezenmeier H, 2010, VOX SANG, V99, P1, DOI 10.1111/j.1423-0410.2009.01295.x
   Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197
   Tilley S, 2006, REGEN MED, V1, P685, DOI 10.2217/17460751.1.5.685
   Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867
   Weber Christian, 2007, Open Biomed Eng J, V1, P64, DOI 10.2174/1874120700701010064
   Weszl M, 2012, J ORTHOP RES, V30, P489, DOI 10.1002/jor.21527
   Wiedmann-Al-Ahmad M, 2002, BIOMATERIALS, V23, P3319, DOI 10.1016/S0142-9612(02)00019-4
   Xia WJ, 2011, CELL BIOL INT, V35, P639, DOI 10.1042/CBI20100361
   Xu C, 2009, COLLOID SURFACE B, V73, P360, DOI 10.1016/j.colsurfb.2009.06.001
   Yoshikawa T, 2005, TISSUE ENG, V11, P152, DOI 10.1089/ten.2005.11.152
   Zoellner H, 1996, J CELL SCI, V109, P2571
NR 60
TC 13
Z9 14
U1 0
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAR 1
PY 2014
VL 20
IS 3
BP 239
EP 251
DI 10.1089/ten.tec.2013.0250
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA AB8CV
UT WOS:000332018600007
PM 23845029
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Lupoi, JS
   Singh, S
   Simmons, BA
   Henry, RJ
AF Lupoi, Jason S.
   Singh, Seema
   Simmons, Blake A.
   Henry, Robert J.
TI Assessment of Lignocellulosic Biomass Using Analytical Spectroscopy: an
   Evolution to High-Throughput Techniques
SO BIOENERGY RESEARCH
LA English
DT Article
DE Biomass; Spectroscopy; Raman spectroscopy; Near-infrared spectroscopy;
   Fourier transform infrared spectroscopy; High-throughput; Chemometrics
ID FOURIER-TRANSFORM RAMAN; NEAR-INFRARED SPECTROSCOPY; EUCALYPTUS-GLOBULUS
   WOOD; IONIC LIQUID PRETREATMENT; PLANT-CELL-WALLS; LIGNIN MONOMER
   COMPOSITION; CELLULOSE-I CRYSTALLINITY; CORN STOVER COMPOSITION; CUPRIC
   OXIDE OXIDATION; PINUS-SYLVESTRIS WOOD
AB Lignocellulosic biomass has been proposed as an option for reducing global dependence on nonrenewable energy sources, such as oil. Selection and development of biomass feedstocks that efficiently yield the maximum fuel or biomaterial requires the availability of reliable methods for compositional and structural characterization of plant material. Many standard methods for biomass analysis are laborious and slow, and employ a variety of harsh reagents requiring some degree of remediation. The use of simpler and more rapid spectroscopic methods has proved invaluable in analyzing biomass. In the twenty-first century, researchers have employed techniques such as Raman, mid-infrared, and near-infrared spectroscopy for a wide range of applications in endeavors to further understand biofuel feedstocks. While many methods remain time consuming and expensive, a growing interest in high-throughput spectroscopic techniques has provided faster and larger scale feedstock screening for desirable traits. This review seeks to provide an overview of both high-throughput techniques and those requiring longer analysis times but still providing abundant qualitative and quantitative data. While applications of these instrumental methods have been researched for decades, more recent developments will be discussed here.
C1 [Lupoi, Jason S.; Simmons, Blake A.; Henry, Robert J.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.
   [Lupoi, Jason S.; Singh, Seema; Simmons, Blake A.] Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, Emeryville, CA 94608 USA.
   [Singh, Seema; Simmons, Blake A.] Sandia Natl Labs, Biol & Mat Sci Ctr, Livermore, CA 94551 USA.
RP Lupoi, JS (reprint author), Lawrence Berkeley Natl Lab, Joint BioEnergy Inst, 5885 Hollis St, Emeryville, CA 94608 USA.
EM jslupoi@lbl.gov; seesing@sandia.gov; basimmons@lbl.gov;
   robert.henry@uq.edu.au
RI Henry, Robert/B-5824-2008
OI Henry, Robert/0000-0002-4060-0292; Simmons, Blake/0000-0002-1332-1810
FU Queensland Alliance for Agriculture and Food Innovation; Joint BioEnergy
   Institute; Office of Science, Office of Biological and Environmental
   Research, of the US Department of Energy [DE-AC02-05CH11231]
FX This review was supported as part of a collaboration between the
   Queensland Alliance for Agriculture and Food Innovation and the Joint
   BioEnergy Institute. The work conducted by the Joint BioEnergy Institute
   was supported by the Office of Science, Office of Biological and
   Environmental Research, of the US Department of Energy under contract
   no. DE-AC02-05CH11231.
CR Abdul Khalil HPS, 2009, IND CROP PROD, V31, P113, DOI [10.1016/j.jndcrop.2009.09.008, DOI 10.1016/J.INDCR0P.2009.09.008]
   Adapa P., 2011, J AGR SCI TECH, V1, P177
   Adler PR, 2009, ECOL APPL, V19, P2202, DOI 10.1890/07-2094.1
   Agarwal U. P., 2011, P 16 INT S WOOD FIB, P170
   Agarwal U. P., 2010, LIGNIN LIGNANS ADV C, P103
   Agarwal U.P., 2008, CHARACTERIZATION LIG, P17, DOI [DOI 10.1002/9781444305425.CH2, 10.1002/9781444305425.ch2]
   Agarwal U. P., 1999, ADV LIGNOCELLULOSICS, P201
   Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z
   Agarwal UP, 2013, J AGR FOOD CHEM, V61, P103, DOI 10.1021/jf304465k
   Agarwal UP, 2012, APPL SPECTROSC, V66, P750, DOI 10.1366/11-06563
   Agarwal UP, 2011, J WOOD CHEM TECHNOL, V31, P324, DOI 10.1080/02773813.2011.562338
   Agarwal UP, 2010, CELLULOSE, V17, P721, DOI 10.1007/s10570-010-9420-z
   Agarwal UP, 2009, J RAMAN SPECTROSC, V40, P1527, DOI 10.1002/jrs.2294
   Agarwal UP, 2008, HOLZFORSCHUNG, V62, P667, DOI 10.1515/HF.2008.112
   Agarwal UP, 2005, APPL SPECTROSC, V59, P385, DOI 10.1366/0003702053585327
   Agarwal UP, 1997, APPL SPECTROSC, V51, P1648, DOI 10.1366/0003702971939316
   Agarwal UP, 2003, TAPPI J, V2, P22
   Agarwal UP, 1995, INT S WOOD PULP CHEM, V3, P67
   AGBLEVOR FA, 1994, J ANAL APPL PYROL, V30, P125, DOI 10.1016/0165-2370(94)00808-6
   Akerholm M, 2003, HOLZFORSCHUNG, V57, P459, DOI 10.1515/HF.2003.069
   Albinsson B, 1999, J MOL STRUCT, V508, P19, DOI 10.1016/S0022-2860(98)00913-2
   Allison GG, 2009, BIORESOURCE TECHNOL, V100, P6428, DOI 10.1016/j.biortech.2009.07.015
   Alves A, 2006, J ANAL APPL PYROL, V76, P209, DOI 10.1016/j.jaap.2005.11.004
   Alves A, 2011, J NEAR INFRARED SPEC, V19, P343, DOI 10.1255/jnirs.946
   Alves A, 2009, J ANAL APPL PYROL, V85, P30, DOI 10.1016/j.jaap.2008.09.006
   Alves AMM, 2012, J NEAR INFRARED SPEC, V20, P275, DOI 10.1255/jnirs.987
   Armenta S, 2010, CRIT REV FOOD SCI, V50, P567, DOI 10.1080/10408390802606790
   Atalla RH, 1999, SOLID STATE NUCL MAG, V15, P1, DOI 10.1016/S0926-2040(99)00042-9
   Backa S, 2001, HOLZFORSCHUNG, V55, P225, DOI 10.1515/HF.2001.037
   Bailleres H, 2002, ANN FOR SCI, V59, P479, DOI [10.1051/forest:2002032, 10.1051/forest:20032]
   Balakshin MY, 2003, J AGR FOOD CHEM, V51, P6116, DOI 10.1021/jf034372d
   Bardet M, 2009, PROG NUCL MAG RES SP, V55, P199, DOI 10.1016/j.pnmrs.2009.02.001
   Barsberg S, 2006, BIOPHYS J, V90, P2978, DOI 10.1529/biophysj.105.070391
   Barsberg S, 2005, MACROMOL BIOSCI, V5, P743, DOI 10.1002/mabi.200500042
   Bermello A, 2002, INT J POLYM MATER, V51, P557, DOI [DOI 10.1080/00914030209696301, 10.1080/00914030209696301]
   Biagini E, 2006, IND ENG CHEM RES, V45, P4486, DOI 10.1021/ie0514049
   Bjarnestad S, 2002, ANAL CHEM, V74, P5851, DOI 10.1021/ac025926z
   BLAKENEY AB, 1983, CARBOHYD RES, V113, P291, DOI 10.1016/0008-6215(83)88244-5
   Blanco M, 2002, TRAC-TREND ANAL CHEM, V21, P240, DOI 10.1016/S0165-9936(02)00404-1
   Blanco M, 2004, BIOTECHNOL BIOENG, V88, P536, DOI 10.1002/bit.20214
   BONDAR RJL, 1974, CLIN CHEM, V20, P586
   Browning BL, 1963, CHEM WOOD, P249
   Bunzel M, 2006, J AGR FOOD CHEM, V54, P8352, DOI 10.1021/jf061525z
   Burns DA, 2008, HDB NEAR INFRARED AN, V35, P479
   Cao Y, 2004, J MOL STRUCT, V693, P87, DOI 10.1016/j.molstruc.2004.02.017
   Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b
   Capanema EA, 2005, J AGR FOOD CHEM, V53, P9639, DOI 10.1021/jf0515330
   Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125
   Casas A, 2012, SEP PURIF TECHNOL, V97, P115, DOI 10.1016/j.seppur.2011.12.032
   Castellan A, 2007, HOLZFORSCHUNG, V61, P504, DOI 10.1515/HF.2007.090
   Cetinkol OP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052820
   Cetinkol OP, 2010, BIOFUELS-UK, V1, P33, DOI 10.4155/BFS.09.5
   Chen C.-L., 1992, METHODS LIGNIN CHEM, P409
   Chen C.L, 1992, METHODS LIGNIN CHEM, P301, DOI DOI 10.1007/978-3-642-74065-7_21
   Chen C.-L., 1992, METHODS LIGNIN CHEM, P446
   Chundawat SPS, 2008, BIOTECHNOL BIOENG, V99, P1281, DOI 10.1002/bit.21805
   Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f
   Coates J., 2000, ENCY ANAL CHEM, V12, P10815, DOI DOI 10.1002/9780470027318.A5606
   Cozzani V, 1997, CAN J CHEM ENG, V75, P127, DOI 10.1002/cjce.5450750120
   Dao NQ, 2006, ENCY ANAL CHEM, P13024
   Decker SR, 2009, BIOENERG RES, V2, P179, DOI 10.1007/s12155-009-9051-0
   del Rio JC, 2007, J ANAL APPL PYROL, V79, P39, DOI 10.1016/j.jaap.2006.09.003
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P5922, DOI 10.1021/jf301002n
   del Rio JC, 2012, J AGR FOOD CHEM, V60, P3619, DOI 10.1021/jf300099g
   DeMartini JD, 2011, BIOTECHNOL BIOENG, V108, P306, DOI 10.1002/bit.22937
   Dence CW, 1992, METHODS LIGNIN CHEM, P33
   DENCE CW, 1992, METHODS LIGNIN CHEM, P458
   DeThomas F. A., 2002, HDB VIBRATIONAL SPEC, V1, P383
   Djikanovic D, 2007, RUSS J PHYS CHEM A+, V81, P1425, DOI 10.1134/S0036024407090142
   Dolan JW, 2000, ENCY ANAL CHEM, P11342
   Dorsey JG, 2000, ENCY ANAL CHEM, P11334
   Downes GM, 2012, CAN J FOREST RES, V42, P1577, DOI [10.1139/X2012-083, 10.1139/x2012-083]
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   DUCKWORTH JH, 1998, APPL SPECTROSCOPY CO, P93, DOI DOI 10.1016/B978-012764070-9/50006-8
   Edwards HGM, 2006, ENCY ANAL CHEM, P13058
   Lopes FJF, 2011, J WOOD CHEM TECHNOL, V31, P309, DOI 10.1080/02773813.2010.550379
   Fengel D, 1979, ADV CHEM SERIES AM C, V181, P145
   Foster CE, 2010, JOVE-J VIS EXP, V1837, DOI [10.3791/1837, DOI 10.3791/1837]
   Foster Cliff E, 2010, J Vis Exp, DOI 10.3791/1745
   Fox SC, 2010, BIORESOURCES, V5, P990
   Foyle T, 2007, BIORESOURCE TECHNOL, V98, P3026, DOI 10.1016/j.biortech.2006.10.013
   Freda C, 2012, APPL BIOCHEM BIOTECH, V167, P2283, DOI 10.1007/s12010-012-9756-y
   Fukushima RS, 2001, J AGR FOOD CHEM, V49, P3133, DOI 10.1021/jf010449r
   Gao XD, 2013, BIOTECHNOL BIOENG, V110, P754, DOI 10.1002/bit.24751
   Gierlinger N, 2006, PLANT PHYSIOL, V140, P1246, DOI 10.1104/pp.105.066993
   Godin B, 2011, TALANTA, V85, P2014, DOI 10.1016/j.talanta.2011.07.044
   Goldman D.S., 2000, ENCY ANAL CHEM APPL, V9, P8256
   Gollapalli LE, 2002, APPL BIOCHEM BIOTECH, V98, P23, DOI 10.1385/ABAB:98-100:1-9:23
   Guerra A, 2006, J AGR FOOD CHEM, V54, P9696, DOI 10.1021/jf062433c
   Hall M, 2010, FEBS J, V277, P1571, DOI 10.1111/j.1742-4658.2010.07585.x
   Hallac BB, 2009, J AGR FOOD CHEM, V57, P1275, DOI 10.1021/jf8030277
   Halttunen M, 2001, HOLZFORSCHUNG, V55, P631, DOI 10.1515/HF.2001.103
   Hames BR, 2003, APPL BIOCHEM BIOTECH, V105, P5, DOI 10.1385/ABAB:105:1-3:5
   Harris DC, 2003, QUANTITATIVE CHEM AN, P578
   HARRIS PJ, 1984, CARBOHYD RES, V127, P59, DOI 10.1016/0008-6215(84)85106-X
   Hatfield R, 2005, CROP SCI, V45, P832, DOI 10.2135/cropsci2004.0238
   Hatfield RD, 1999, J AGR FOOD CHEM, V47, P628, DOI 10.1021/jf9808776
   Hedenstrom M, 2009, MOL PLANT, V2, P933, DOI 10.1093/mp/ssp047
   HEDGES JI, 1982, ANAL CHEM, V54, P174, DOI 10.1021/ac00239a007
   Hoareau W, 2004, POLYM DEGRAD STABIL, V86, P567, DOI 10.1016/j.polymdegradstab.2004.07.005
   Hori K, 2000, ACS SYM SER, V742, P172
   Hou S, 2011, J INTEGR PLANT BIOL, V53, P166, DOI 10.1111/j.1744-7909.2010.01003.x
   Houghton TP, 2009, APPL BIOCHEM BIOTECH, V153, P4, DOI 10.1007/s12010-008-8406-x
   Huang F, 2011, J AGR FOOD CHEM, V59, P12910, DOI 10.1021/jf202701b
   Huber R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-42
   International A, 2007, STAND TEST METH DET
   International A, 2007, STAND TEST METH AC I
   Irfan M, 2011, TURK J BIOCHEM, V36, P322
   Jaaskelainen AS, 2006, HOLZFORSCHUNG, V60, P231, DOI 10.1515/HF.2006.038
   Jaaskelainen AS, 2005, J WOOD CHEM TECHNOL, V25, P51, DOI 10.1081/WCT-200058239
   Jaaskelainen AS, 2003, WOOD SCI TECHNOL, V37, P91, DOI 10.1007/s00226-003-0163-y
   Jehlicka J, 2009, J RAMAN SPECTROSC, V40, P1645, DOI 10.1002/jrs.2313
   Jehlicka J, 2009, SPECTROCHIM ACTA A, V73, P410, DOI 10.1016/j.saa.2008.09.004
   Jimare BMT, 2008, APPL SPECTROSC REV, V43, P452, DOI [10.1080/05704920802031382, DOI 10.1080/05704920802031382]
   Jin SY, 2007, IND CROP PROD, V26, P207, DOI 10.1016/j.indcrop.2007.03.004
   Johnson D. B., 1961, TAPPI, V44, P793
   Jones PD, 2006, WOOD SCI TECHNOL, V40, P709, DOI 10.1007/s00226-006-0085-6
   Jones RW, 2002, ANAL CHEM, V74, P453, DOI 10.1021/ac0106445
   Kacurikova M, 1998, FOOD HYDROCOLLOIDS, V13, P35
   Karp A, 2008, NEW PHYTOL, V179, P15, DOI 10.1111/j.1469-8137.2008.02432.x
   Katahira R, 2013, J AGR FOOD CHEM, V61, P3286, DOI 10.1021/jf303727t
   Kataoka Y, 2001, J WOOD SCI, V47, P325, DOI 10.1007/BF00766722
   Kelley SS, 2004, BIOMASS BIOENERG, V27, P77, DOI 10.1016/j.biomboie.2003.11.005
   Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-68
   Kensy F, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-31
   Kihara M, 2002, SPECTROCHIM ACTA A, V58, P2213, DOI 10.1016/S1386-1425(01)00693-X
   Kline LM, 2010, BIORESOURCES, V5, P1366
   Kuroda K, 2005, IND CROP PROD, V22, P223, DOI 10.1016/j.indcrop.2005.01.002
   Labbe N, 2008, BIORESOURCES, V3, P1329
   Lai Y.Z., 1992, METHODS LIGNIN CHEM, P423
   LAPIERRE C, 1985, J WOOD CHEM TECHNOL, V5, P277, DOI 10.1080/02773818508085193
   LAPIERRE C, 1983, HOLZFORSCHUNG, V37, P189, DOI 10.1515/hfsg.1983.37.4.189
   Lapierre C., 2010, LIGNIN LIGNANS ADV C, P11
   Larsen KL, 2010, J PHYS CHEM B, V114, P8009, DOI 10.1021/jp1028239
   Lavine BK, 2013, ANAL CHEM, V85, P705, DOI 10.1021/ac303193j
   Lavine BK, 2001, APPL SPECTROSC, V55, P960, DOI 10.1366/0003702011953108
   Lee SH, 2009, BIOTECHNOL BIOENG, V102, P1368, DOI 10.1002/bit.22179
   Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9
   Lewis IR, 2001, PRACT SPECTROSC SERI, V28, P919
   Li CL, 2013, BIOENERG RES, V6, P14, DOI 10.1007/s12155-012-9220-4
   Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li HJ, 2012, RSC ADV, V2, P4951, DOI 10.1039/c2ra20557b
   Liu L, 2010, CARBOHYD POLYM, V81, P820, DOI 10.1016/j.carbpol.2010.03.058
   Liu YD, 2006, J AGR FOOD CHEM, V54, P2810, DOI 10.1021/jf052889e
   Liukko S, 2007, HOLZFORSCHUNG, V61, P509, DOI 10.1515/HF.2007.107
   Lozovaya VV, 1999, PHYTOCHEMISTRY, V50, P395, DOI 10.1016/S0031-9422(98)00575-5
   Lu FC, 2003, PLANT J, V35, P535, DOI 10.1046/j.1365-313X.2003.01817.x
   Lu FC, 1997, J AGR FOOD CHEM, V45, P2590, DOI 10.1021/jf970258h
   Lu Y, 2012, BIORESOURCE TECHNOL, V116, P114, DOI 10.1016/j.biortech.2012.04.006
   Lupoi JS, 2012, APPL SPECTROSC, V66, P903, DOI 10.1366/12-06621
   Lygin AV, 2011, GCB BIOENERGY, V3, P333, DOI 10.1111/j.1757-1707.2011.01091.x
   Machado AEH, 2001, J PHOTOCH PHOTOBIO A, V138, P253, DOI 10.1016/S1010-6030(00)00413-5
   Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064
   Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592
   Marita JM, 1999, P NATL ACAD SCI USA, V96, P12328, DOI 10.1073/pnas.96.22.12328
   Martin-Sampedro R, 2011, J AGR FOOD CHEM, V59, P8761, DOI 10.1021/jf201605f
   Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001
   Maunu SL, 2002, PROG NUCL MAG RES SP, V40, P151, DOI 10.1016/S0079-6565(01)00041-3
   McCann MC, 2007, PLANT PHYSIOL, V143, P1314, DOI 10.1104/pp.106.093054
   McCreery RL, 2000, RAMAN SPECTROSCOPY C, P448
   McKendry P, 2002, BIORESOURCE TECHNOL, V83, P37, DOI 10.1016/S0960-8524(01)00118-3
   Meder R, 1999, HOLZFORSCHUNG, V53, P261, DOI 10.1515/HF.1999.044
   Meier D., 1992, METHODS LIGNIN CHEM, P177
   Meyer MW, 2011, ANAL CHIM ACTA, V706, P164, DOI 10.1016/j.aca.2011.08.031
   Mononen K, 2005, HOLZFORSCHUNG, V59, P381, DOI 10.1515/HF.2005.063
   Morrison WH, 2003, J AGR FOOD CHEM, V51, P2565, DOI 10.1021/jf020885t
   National Academy of Sciences, 2009, LIQ TRANSP FUELS COA
   Nelson GH, 1957, TAPPI, V40, P846
   Newman RH, 2004, HOLZFORSCHUNG, V58, P91, DOI 10.1515/HF.2004.012
   Nkansah K, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3404181
   Nkansah K, 2010, J RENEW SUSTAIN ENER, V2, DOI 10.1063/1.3290749
   Nousiainen J, 2004, ANIM FEED SCI TECH, V115, P295, DOI 10.1016/j.anifeedsci.2004.03.004
   Nousiainen J, 2003, ANIM FEED SCI TECH, V110, P61, DOI 10.1016/S0377-8401(03)00206-2
   Nuopponen M, 2004, SPECTROCHIM ACTA A, V60, P2963, DOI 10.1016/j.saa.2004.02.007
   Nuopponen M, 2004, SPECTROCHIM ACTA A, V60, P2953, DOI 10.1016/j.saa.2004.02.008
   Nuopponen M, 2004, J WOOD CHEM TECHNOL, V24, P13, DOI 10.1081/WCT-120035941
   Nuopponen MH, 2006, J APPL POLYM SCI, V102, P810, DOI 10.1002/app.24143
   OBST JR, 1986, J WOOD CHEM TECHNOL, V6, P311, DOI 10.1080/02773818608085230
   Ona T, 2003, J PULP PAP SCI, V29, P6
   Ona T, 1997, J WOOD CHEM TECHNOL, V17, P399, DOI 10.1080/02773819708003141
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P367, DOI 10.1080/02773819809349586
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P43, DOI 10.1080/02773819809350124
   Ona T, 1998, J WOOD CHEM TECHNOL, V18, P27, DOI 10.1080/02773819809350123
   Ona T, 2000, J PULP PAP SCI, V26, P43
   OWEN NL, 1989, APPL SPECTROSC, V43, P451, DOI 10.1366/0003702894202760
   Pandey KK, 2008, HOLZFORSCHUNG, V62, P183, DOI 10.1515/HF2008.046
   Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10
   PEPPER JM, 1959, CAN J CHEM, V37, P1241, DOI 10.1139/v59-183
   Perlack RD, 2005, DOEGO1020052135 ORNL
   Perlack RD, 2011, ORNLTM2011224
   Pinto PC, 2005, IND ENG CHEM RES, V44, P9777, DOI 10.1021/ie0580760o
   Pinto PC, 2005, J AGR FOOD CHEM, V53, P7856, DOI 10.1021/jf058081b
   Poke FS, 2004, J WOOD CHEM TECHNOL, V24, P55, DOI 10.1081/WCT-120035944
   Poke FS, 2006, J WOOD CHEM TECHNOL, V26, P187, DOI 10.1080/02773810600732708
   Pordesimo LO, 2005, BIOMASS BIOENERG, V28, P366, DOI 10.1016/j.biombioe.2004.09.003
   Proniewicz LM, 2002, J MOL STRUCT, V614, P345, DOI 10.1016/S0022-2860(02)00275-2
   Rabemanolontsoa H, 2011, BIOMASS BIOENERG, V35, P4630, DOI 10.1016/j.biombioe.2011.09.014
   Ralph J, 1998, P NATL ACAD SCI USA, V95, P12803, DOI 10.1073/pnas.95.22.12803
   Ralph J, 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865-C5
   Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9
   Rencoret J, 2008, HOLZFORSCHUNG, V62, P514, DOI 10.1515/HF.2008.096
   Rencoret J, 2013, J AGR FOOD CHEM, V61, P2434, DOI 10.1021/jf304686x
   Rencoret J, 2011, PLANT PHYSIOL, V155, P667, DOI 10.1104/pp.110.167254
   Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x
   Roder T, 2005, MACROMOL SYMP, V223, P57, DOI 10.1002/masy.200550504
   Rodrigues J, 2001, HOLZFORSCHUNG, V55, P265, DOI 10.1515/HF.2001.044
   Ruiz R., 1996, HPLC ANAL LIQUID FRA
   Rutkowski P, 2012, J ANAL APPL PYROL, V95, P38, DOI 10.1016/j.jaap.2012.01.003
   Saar BG, 2010, ANGEW CHEM INT EDIT, V49, P5476, DOI 10.1002/anie.201000900
   Saariaho AM, 2005, VIB SPECTROSC, V37, P111, DOI 10.1016/j.vibspec.2004.08.001
   Saariaho AM, 2004, HOLZFORSCHUNG, V58, P82, DOI 10.1515/HF.2004.011
   Saariaho AM, 2003, APPL SPECTROSC, V57, P58, DOI 10.1366/000370203321165214
   Samorski M, 2005, BIOTECHNOL BIOENG, V92, P61, DOI 10.1002/bit.20573
   Samuel R, 2010, APPL BIOCHEM BIOTECH, V162, P62, DOI 10.1007/s12010-009-8749-y
   Santos RB, 2012, J AGR FOOD CHEM, V60, P4923, DOI 10.1021/jf301276a
   SARKANEN KV, 1971, LIGNINS OCCURRENCE F, P43
   Sathitsuksanoh N, 2011, BIOTECHNOL BIOENG, V108, P521, DOI 10.1002/bit.22964
   Schenzel K, 2005, CELLULOSE, V12, P223, DOI 10.1007/s10570-004-3885-6
   Schenzel K, 2001, CELLULOSE, V8, P49, DOI 10.1023/A:1016616920539
   Schenzel K, 2009, CELLULOSE, V16, P407, DOI 10.1007/s10570-009-9286-0
   Schimleck LR, 2004, CAN J FOREST RES, V34, P2363, DOI [10.1139/x04-119, 10.1139/X04-119]
   Schmer MR, 2012, AGRON J, V104, P54, DOI 10.2134/agronj2011.0195
   Schmidt J, 2010, LIGNIN LIGNANS ADV C, p[49, 1]
   Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001
   Selig MJ, 2011, BIOTECHNOL LETT, V33, P961, DOI 10.1007/s10529-011-0526-7
   SENE CFB, 1994, PLANT PHYSIOL, V106, P1623, DOI 10.1104/pp.106.4.1623
   Serapiglia MJ, 2008, APPL BIOCHEM BIOTECH, V145, P3, DOI 10.1007/s12010-007-8061-7
   Shaver JM, 2001, PRACT SPECTROSC SERI, V28, P275
   Shepherd M, 2011, BIOFUELS-UK, V2, P639, DOI [10.4155/bfs.11.136, 10.4155/BFS.11.136]
   Shih CJ, 2011, BIORESOURCE TECHNOL, V102, P5169, DOI 10.1016/j.biortech.2011.01.043
   Shih CJ, 2009, ANAL CHIM ACTA, V653, P200, DOI 10.1016/j.aca.2009.09.012
   Simmons BA, 2011, PLANT BIOTECHNOLOGY, P495
   Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046
   Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386
   Sivakesava S, 2001, J IND MICROBIOL BIOT, V26, P185, DOI 10.1038/sj.jim.7000124
   Skoog D.A, 1998, PRINCIPLES INSTRUMEN
   Sluiter JB, 2010, J AGR FOOD CHEM, V58, P9043, DOI 10.1021/jf1008023
   Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1
   Smith M.E., 2000, NUCL MAGN RESON, V29, P251, DOI [DOI 10.1039/9781847553850-00251, 10.1039/9781847553850-00251]
   Smith-Moritz AM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-26
   Sonoda T, 2001, ANAL CHEM, V73, P5429, DOI 10.1021/ac010557c
   Stackpole DJ, 2011, G3-GENES GENOM GENET, V1, P151, DOI 10.1534/g3.111.000372
   Stark E. W., 2002, HDB VIBRATIONAL SPEC, V1, P393
   Sticklen M, 2006, CURR OPIN BIOTECH, V17, P315, DOI 10.1016/j.copbio.2006.05.003
   Studer MH, 2009, BIOTECHNOL BIOENG, V105, P231, DOI [10.1002/bit.22527, DOI 10.1002/BIT.22527]
   Sun L, 2010, BIOTECHNOL BIOENG, V108, P286, DOI [DOI 10.1002/BIT.22931, 10.1002/bit.22931]
   Sun L, 2013, RSC ADV, V3, P2017, DOI 10.1039/c2ra20706k
   Sun L, 2012, BIOTECHNOL BIOENG, V109, P647, DOI 10.1002/bit.24348
   Sun R, 1999, POLYM DEGRAD STABIL, V67, P101, DOI [10.1016/s0141-3910(99)00099-3, DOI 10.1016/S0141-3910]
   Sun RC, 2001, J AGR FOOD CHEM, V49, P5122, DOI 10.1021/jf010500r
   Sun XF, 2004, POLYM DEGRAD STABIL, V86, P245, DOI 10.1016/j.polymdegradstab.2004.05.003
   Sykes R, 2009, METHODS MOL BIOL, V581, P169, DOI 10.1007/978-1-60761-214-8_12
   Takayama M, 1997, SPECTROCHIM ACTA A, V53, P1621, DOI 10.1016/S1386-1425(97)00100-5
   Templeton DW, 2009, CELLULOSE, V16, P621, DOI 10.1007/s10570-009-9325-x
   Templeton David W, 1994, DETERMINATION ETHANO
   Terashima N, 2009, HOLZFORSCHUNG, V63, P379, DOI 10.1515/HF.2009.074
   Thygesen A, 2005, CELLULOSE, V12, P563, DOI 10.1007/s10570-005-9001-8
   Tsuchikawa S, 2007, APPL SPECTROSC REV, V42, P43, DOI 10.1080/05704920601036707
   TSUTSUMI Y, 1995, HOLZFORSCHUNG, V49, P423, DOI 10.1515/hfsg.1995.49.5.423
   Tucker MP, 2000, APPL BIOCHEM BIOTECH, V84-6, P39, DOI 10.1385/ABAB:84-86:1-9:39
   Tuskan G, 1999, APPL BIOCHEM BIOTECH, V77-9, P55, DOI 10.1385/ABAB:77:1-3:55
   UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6
   VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2
   Vester J, 2004, APPL SPECTROSC, V58, P404, DOI 10.1366/000370204773580239
   Vitek P, 2012, SPECTROCHIM ACTA A, V86, P320, DOI 10.1016/j.saa.2011.10.043
   White KE, 2011, GEODERMA, V167-68, P197, DOI 10.1016/j.geoderma.2011.08.009
   Wolfrum EJ, 2009, CELLULOSE, V16, P567, DOI 10.1007/s10570-009-9320-2
   Workman J, 2011, ANAL CHEM, V83, P4557, DOI 10.1021/ac200974w
   Workman JJ, 1996, APPL SPECTROSC REV, V31, P251, DOI 10.1080/05704929608000571
   Workman JJ, 2001, APPL SPECTROSC REV, V36, P139, DOI 10.1081/ASR-100106154
   Workman Jr J, 2008, HDB NEAR INFRARED AN, P123
   Yamada T, 2006, HOLZFORSCHUNG, V60, P24, DOI 10.1515/HF.2006.005
   Yan JH, 2010, BIOMASS BIOENERG, V34, P48, DOI 10.1016/j.biombioe.2009.09.010
   Ye XP, 2008, BIORESOURCE TECHNOL, V99, P7323, DOI 10.1016/j.biortech.2007.12.063
   Yeh TF, 2005, J AGR FOOD CHEM, V53, P3328, DOI 10.1021/jf0480647
   Yeh TF, 2004, J AGR FOOD CHEM, V52, P1435, DOI 10.1021/jf034874r
   Yelle DJ, 2013, BIOENERG RES, V6, P211, DOI 10.1007/s12155-012-9247-6
   Yoshida M, 2008, BIOSCI BIOTECH BIOCH, V72, P805, DOI 10.1271/bbb.70689
   Yuen SN, 2009, FOOD CHEM, V114, P1091, DOI 10.1016/j.foodchem.2008.10.053
   Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052
   Zhang AP, 2009, PLANTA, V229, P1099, DOI 10.1007/s00425-009-0894-6
NR 282
TC 46
Z9 47
U1 1
U2 93
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1939-1234
EI 1939-1242
J9 BIOENERG RES
JI BioEnergy Res.
PD MAR
PY 2014
VL 7
IS 1
BP 1
EP 23
DI 10.1007/s12155-013-9352-1
PG 23
WC Energy & Fuels; Environmental Sciences
SC Energy & Fuels; Environmental Sciences & Ecology
GA AC4IG
UT WOS:000332484000001
DA 2018-10-19
ER

PT J
AU Wu, HF
   Teng, P
   Cai, JF
AF Wu, Haifan
   Teng, Peng
   Cai, Jianfeng
TI Rapid Access to Multiple Classes of Peptidomimetics from Common
   gamma-AApeptide Building Blocks
SO EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
LA English
DT Article
DE Solid-phase synthesis; Acylation; Peptidomimetics; -AApeptides
ID SOLID-PHASE SYNTHESIS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL AGENTS;
   PEPTIDE; OLIGOMERS; DESIGN; POTENT; FOLDAMERS; RNA; PNA
AB Herein we report a highly efficient new method for preparing -AApeptides capable of theoretically containing any functionality; the method uses a few common N-alloc -AApeptide building blocks. More importantly, using the same approach, new classes of peptidomimetics bearing novel backbone scaffolds can also be readily generated. Our results not only demonstrate the versatility of this new synthetic method, but also highlight the possibility that the resulting novel peptidomimetics may find discrete biomedical/biomaterial applications in the future.
C1 [Wu, Haifan; Teng, Peng; Cai, Jianfeng] Univ S Florida, Dept Chem, Tampa, FL 33620 USA.
RP Cai, JF (reprint author), Univ S Florida, Dept Chem, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM jianfengcai@usf.edu
RI Wu, Haifan/F-8818-2014; Wu, Haifan/O-1935-2013; Teng, Peng/K-1046-2015
OI Wu, Haifan/0000-0002-2050-9950; Wu, Haifan/0000-0002-2050-9950; Teng,
   Peng/0000-0002-7412-9646
FU Elsa U. Pardee Foundation (USF start-up fund); Florida Bankhead-Coley
   Cancer Research Program
FX This work was partially supported by the Elsa U. Pardee Foundation (USF
   start-up fund) and by the Florida Bankhead-Coley Cancer Research
   Program.
CR Aguilera J, 2013, EUR J ORG CHEM, P3494, DOI 10.1002/ejoc.201300066
   Bouillere F, 2011, AMINO ACIDS, V41, P687, DOI 10.1007/s00726-011-0893-3
   Cheng PN, 2012, J AM CHEM SOC, V134, P14179, DOI 10.1021/ja305416a
   CHO CY, 1993, SCIENCE, V261, P1303, DOI 10.1126/science.7689747
   Gellman S, 2009, BIOPOLYMERS, V92, P293
   GENNARI C, 1995, ANGEW CHEM INT EDIT, V34, P1763, DOI 10.1002/anie.199517631
   Gennari C, 1998, EUR J ORG CHEM, P2437
   Gennari C., 1995, ANGEW CHEM INT EDIT, V107, P1892
   Gomez-Martinez P, 1999, J CHEM SOC PERK T 1, P2871, DOI 10.1039/a906025a
   Goodman CM, 2007, NAT CHEM BIOL, V3, P252, DOI 10.1038/nchembio876
   Haase HS, 2012, J AM CHEM SOC, V134, P7652, DOI 10.1021/ja302469a
   Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039
   Huang ML, 2012, CHEMMEDCHEM, V7, P114, DOI 10.1002/cmdc.201100358
   Kapoor R, 2011, ANTIMICROB AGENTS CH, V55, P3054, DOI 10.1128/AAC.01516-10
   Kim JM, 1996, TETRAHEDRON LETT, V37, P5305, DOI 10.1016/0040-4039(96)01100-8
   Liu YH, 2001, SYNLETT, P1626
   Mathieu L., 2013, ANGEW CHEM, V125, P6122
   Mathieu L, 2013, ANGEW CHEM INT EDIT, V52, P6006, DOI 10.1002/anie.201302106
   Niu YH, 2012, MACROMOLECULES, V45, P7350, DOI 10.1021/ma3015992
   Niu YH, 2012, MOL PHARMACEUT, V9, P1529, DOI 10.1021/mp300070w
   Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p
   Niu YH, 2011, CHEM COMMUN, V47, P12197, DOI 10.1039/c1cc14476f
   Niu YH, 2011, ORG BIOMOL CHEM, V9, P6604, DOI 10.1039/c1ob05738c
   Niu YH, 2011, NEW J CHEM, V35, P542, DOI 10.1039/c0nj00943a
   Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j
   Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749
   Tamilarasu N, 2001, BIOORG MED CHEM LETT, V11, P505, DOI 10.1016/S0960-894X(00)00709-5
   Wu HF, 2012, CHEM SCI, V3, P2570, DOI 10.1039/c2sc20428b
   Wu HF, 2012, ORG LETT, V14, P3446, DOI 10.1021/ol301406a
   Wu YD, 2008, ACCOUNTS CHEM RES, V41, P1231, DOI 10.1021/ar800216e
   Yang YA, 2012, CHEM COMMUN, V48, P7850, DOI 10.1039/c2cc33620k
NR 31
TC 12
Z9 12
U1 1
U2 17
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1434-193X
EI 1099-0690
J9 EUR J ORG CHEM
JI Eur. J. Org. Chem.
PD MAR
PY 2014
VL 2014
IS 8
BP 1760
EP 1765
DI 10.1002/ejoc.201301841
PG 6
WC Chemistry, Organic
SC Chemistry
GA AC0CH
UT WOS:000332161900021
DA 2018-10-19
ER

PT J
AU Yoon, H
   Kim, EY
   Kim, H
   Park, CH
   Joo, CK
   Khang, G
AF Yoon, Hyeon
   Kim, Eun Young
   Kim, Hyeongseok
   Park, Chan Hum
   Joo, Choun-Ki
   Khang, Gilson
TI Fabrication of transparent silk fibroin film for the regeneration of
   corneal endothelial cells; preliminary study
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE Bombyx mori; silk fibroin; transparent film; cornea endothelial cell
ID STEM-CELLS; IN-VIVO; SERICIN; PROTEIN; BIOMATERIAL; SKIN; PROLIFERATION;
   STRATEGIES; SCAFFOLDS; APOPTOSIS
AB Dystrophies related to the corneal endothelium result in edema, loss of transparency, and finally, blindness. Currently, the only treatment of patients with these corneal endothelial dystrophies is transplantation. However, the limited availability of donor corneas is a main obstacle to transplanting healthy endothelia. In this study, we have chosen silk from the silkworm to make a substratum for corneal endothelial cells (CEnCs). This approach offers the possibility of overcoming the issue of limited supply of donor corneas. Two types of transparent silk films with different sericin contents have been prepared by boiling for 30 min and 1 h, respectively, as delivery vehicles for application on the corneal endothelium. The contents of sericin for high-sericin silk (HSS) and low-sericin silk (LSS) are 9.83% and 6.25%, respectively. Physical and chemical properties were analyzed by contact angle, transparency, tensile strength, FTIR, and DSC. Proliferation assay by MTT was conducted to confirm the viability of the CEnCs. These results demonstrate that the fabricated transparent silk films have sufficient physical and chemical properties as a possible carrier for CEnCs.
C1 [Yoon, Hyeon; Kim, Eun Young; Kim, Hyeongseok; Khang, Gilson] Chonbuk Natl Univ, Dept PolymerNano Sci & Technol, Dept BIN Fus Technol, Jeonju 561756, South Korea.
   [Yoon, Hyeon; Kim, Eun Young; Kim, Hyeongseok; Khang, Gilson] Chonbuk Natl Univ, Polymer BIN Res Ctr, Jeonju 561756, South Korea.
   [Park, Chan Hum] Hallym Univ, Coll Med, Chuncheon Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Gangwon 200702, South Korea.
   [Joo, Choun-Ki] Catholic Univ Korea, Gangnam St Mary Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul 137701, South Korea.
RP Khang, G (reprint author), Chonbuk Natl Univ, Dept PolymerNano Sci & Technol, Dept BIN Fus Technol, Jeonju 561756, South Korea.
EM gskhang@jbnu.ac.kr
RI Khang, Gilson/B-2109-2013
OI Park, Chan Hum/0000-0002-9732-361X
FU Bio & Medical Technology Development Program of the National Research
   Foundation; Korean government [NRF-2012M3A9C6050204]; Bio-industry
   Technology Development Program, Ministry for Food, Agriculture, Forestry
   and Fisheries, Republic of Korea [112007-05-2-SB010]
FX This research was supported by the Bio & Medical Technology Development
   Program of the National Research Foundation funded by the Korean
   government (NRF-2012M3A9C6050204) and Bio-industry Technology
   Development Program (112007-05-2-SB010), Ministry for Food, Agriculture,
   Forestry and Fisheries, Republic of Korea.
CR Aldave A. J., 2013, CLIN GENET
   Aldave AJ, 2007, ARCH OPHTHALMOL-CHIC, V125, P177, DOI 10.1001/archopht.125.2.177
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Baba T, 1996, J DERMATOL SCI, V12, P18, DOI 10.1016/0923-1811(95)00452-1
   Chu C. C., 1981, ANN SURG, P365
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   Joyce NC, 2012, MOL VIS, V18, P547
   Joyce NC, 2012, EXP EYE RES, V95, P16, DOI 10.1016/j.exer.2011.08.014
   Kaewkorn W, 2012, BIOL RES, V45, P45, DOI 10.4067/S0716-97602012000100006
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Khang G, 2000, POLYM-KOREA, V24, P869
   Kim TH, 2011, INT J TISSUE REGEN, V2, P1
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lee O. J., 2010, INT J TISSUE REGEN, V1, P68
   Li MZ, 2003, POLYM ADVAN TECHNOL, V14, P694, DOI 10.1002/pat.409
   Liu JB, 2012, INVEST OPHTH VIS SCI, V53, P4130, DOI 10.1167/iovs.12-9876
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Mimura Tatsuya, 2012, J Funct Biomater, V3, P726, DOI 10.3390/jfb3040726
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Motta A, 2002, MACROMOL CHEM PHYSIC, V203, P1658, DOI 10.1002/1521-3935(200207)203:10/11<1658::AID-MACP1658>3.0.CO;2-3
   MOY RL, 1991, AM FAM PHYSICIAN, V44, P2123
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nishida A, 2011, INT J PHARMACEUT, V414, P193, DOI 10.1016/j.ijpharm.2011.05.033
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Sabater AL, 2013, REGEN MED, V8, P183, DOI [10.2217/rme.13.11, 10.2217/RME.13.11]
   Sah M. K., 2010, International Journal of Environmental Science and Development, V1, P404
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang JH, 2006, BIOMATERIALS, V27, P3441, DOI 10.1016/j.biomaterials.2006.02.002
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yamamoto M., 2013, INT J TISSUE REGEN, V4, P36
   Yang D. H., 2011, INT J TISSUE REGEN, V2, P119
   Zavala J, 2013, EYE, V27, P579, DOI 10.1038/eye.2013.15
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
NR 41
TC 8
Z9 9
U1 0
U2 33
PU POLYMER SOC KOREA
PI SEOUL
PA ROOM 601, HATCHON BUILDING, 831 YEOKSAM-DONG, KANGNAM-KU, SEOUL 135-792,
   SOUTH KOREA
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAR
PY 2014
VL 22
IS 3
BP 297
EP 303
DI 10.1007/s13233-014-2037-6
PG 7
WC Polymer Science
SC Polymer Science
GA AC4JO
UT WOS:000332487400010
DA 2018-10-19
ER

PT J
AU Mahadik, BP
   Wheeler, TD
   Skertich, LJ
   Kenis, PJA
   Harley, BAC
AF Mahadik, Bhushan P.
   Wheeler, Tobias D.
   Skertich, Luke J.
   Kenis, Paul J. A.
   Harley, Brendan A. C.
TI Microfluidic Generation of Gradient Hydrogels to Modulate Hematopoietic
   Stem Cell Culture Environment
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE collagen hydrogels; gradients; hematopoietic progenitor cells;
   microfluidics; stem cell niches
ID EXTRACELLULAR-MATRIX PROTEINS; BONE-MARROW; FLUORESCENCE RECOVERY;
   LIVING CELLS; IN-VITRO; DIFFERENTIATION; MIGRATION; CHEMOTAXIS;
   BEHAVIOR; NICHES
AB The bone marrow provides spatially and temporally variable signals that impact the behavior of hematopoietic stem cells (HSCs). While multiple biomolecular signals and bone marrow cell populations have been proposed as key regulators of HSC fate, new tools are required to probe their importance and mechanisms of action. Here, a novel method based on a microfluidic mixing platform to create small volume, 3D hydrogel constructs containing overlapping patterns of cell and matrix constituents inspired by the HSC niche is described. This approach is used to generate hydrogels containing opposing gradients of fluorescent microspheres, MC3T3-E1 osteoblasts, primary murine hematopoietic stem and progenitor cells (HSPCs), and combinations thereof in a manner independent of hydrogel density and cell/particle size. Three different analytical methods are described to characterize local properties of these hydrogels at multiple scales: 1) whole construct fluorescent analysis; 2) multi-photon imaging of individual cells within the construct; 3) retrieval of discrete sub-regions from the hydrogel post-culture. The approach reported here allows the creation of stable gradients of cell and material cues within a single, optically translucent 3D biomaterial to enable a range of investigations regarding how microenvironmental signals impact cell fate.
C1 [Mahadik, Bhushan P.; Wheeler, Tobias D.; Skertich, Luke J.; Kenis, Paul J. A.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Roger Adams Lab 110, Urbana, IL 61801 USA.
   [Kenis, Paul J. A.; Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Roger Adams Lab 110, 600 S Mathews St, Urbana, IL 61801 USA.
EM bharley@illinois.edu
RI Kenis, Paul/S-7229-2016
OI Kenis, Paul/0000-0001-7348-0381; Mahadik, Bhushan/0000-0001-5989-9880;
   Harley, Brendan/0000-0001-5458-154X
FU American Cancer Society, Illinois Division, Inc. [160673, 189782];
   National Science Foundation [1254738]; Department of Chemical &
   Biomolecular Engineering at the University of Illinois at
   Urbana-Champaign; Institute for Genomic Biology at the University of
   Illinois at Urbana-Champaign
FX The authors would like to acknowledge Barbara Pilas and Bernard Montez
   (Flow Cytometry Facility, UIUC) as well as Sunny Choi (ChBE, UIUC) for
   assistance with bone marrow cell isolation and flow cytometry, Dr.
   Mayandi Sivaguru (IGB, UIUC) for assistance with fluorescence imaging,
   Dr. Peter Yau and Dr. Brian Ismai (Protein Sciences Facility, UIUC) for
   assistant with fluorescence scanner analyses, and Dr. Amit Desai (ChBE,
   UIUC) regarding microfluidic mixer design. This work was partially
   supported by Grants #160673 and #189782 from the American Cancer
   Society, Illinois Division, Inc. This material is based upon work
   supported by the National Science Foundation under Grant No. 1254738.
   The authors are also grateful for additional funding provided by the
   Department of Chemical & Biomolecular Engineering and the Institute for
   Genomic Biology at the University of Illinois at Urbana-Champaign.
CR Aguado BA, 2012, TISSUE ENG PT A, V18, P806, DOI [10.1089/ten.tea.2011.0391, 10.1089/ten.TEA.2011.0391]
   Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054
   Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200
   Beta C, 2008, LAB CHIP, V8, P1087, DOI 10.1039/b801331d
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Caelen I, 2000, LANGMUIR, V16, P9125, DOI 10.1021/la000851k
   Campos DFD, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015003
   Catros S, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/2/025001
   Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Ehninger A, J EXP MED, V208, P421
   Fosser KA, 2003, ANAL CHEM, V75, P5775, DOI 10.1021/ac034634a
   Gruene M, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/015005
   Gunawan RC, 2006, LANGMUIR, V22, P4250, DOI 10.1021/la0531493
   Gunawan RC, 2005, LANGMUIR, V21, P3061, DOI 10.1021/la048303k
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   Hong S, 2013, J BIOSCI BIOENG, V116, P224, DOI 10.1016/j.jbiosc.2013.02.011
   Hosokawa K, 2010, BLOOD, V116, P554, DOI 10.1182/blood-2009-05-224857
   Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h
   JAIN RK, 1990, MICROVASC RES, V39, P77, DOI 10.1016/0026-2862(90)90060-5
   Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001
   Janmey PA, 2009, CELL MOTIL CYTOSKEL, V66, P597, DOI 10.1002/cm.20382
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b
   Ker EDP, 2011, BIOMATERIALS, V32, P8097, DOI 10.1016/j.biomaterials.2011.07.025
   Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381
   Klein RM, 2009, CANCER RES, V69, P2224, DOI 10.1158/0008-5472.CAN-08-3201
   Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657
   Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005
   Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]
   Le Y, 2007, IMMUNITY, V27, P811, DOI 10.1016/j.immuni.2007.09.011
   Lecault V, 2011, NAT METHODS, V8, P581, DOI [10.1038/NMETH.1614, 10.1038/nmeth.1614]
   Liao JH, 2011, J ORTHOP RES, V29, P1544, DOI 10.1002/jor.21436
   Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068
   Magnusson M, 2008, CELL STEM CELL, V2, P302, DOI 10.1016/j.stem.2008.03.017
   Mosadegh B, 2007, LANGMUIR, V23, P10910, DOI 10.1021/la7026835
   OKADA S, 1992, BLOOD, V80, P3044
   Park SY, 2013, J IMMUNOL, V190, P1094, DOI 10.4049/jimmunol.1202639
   Pedron S., 2013, J BIOMED MAT A UNPUB
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615
   Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9
   Selimovic S, 2011, ANAL CHEM, V83, P2020, DOI 10.1021/ac2001737
   Shin Y, 2011, LAB CHIP, V11, P2175, DOI 10.1039/c1lc20039a
   Silvestre J, 2009, LANGMUIR, V25, P10092, DOI 10.1021/la901109e
   SOKAL RR, 1982, CC/AGR BIOL ENVIRON, P22
   Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012
   Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001
   Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765
   Stroock AD, 2004, PHILOS T ROY SOC A, V362, P971, DOI 10.1098/rsta.2003.1357
   Tasoglu S, 2013, TRENDS BIOTECHNOL, V31, P10, DOI 10.1016/j.tibtech.2012.10.005
   Toh C. R., 2009, LANGMUIR
   Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X
   Wheeler TD, 2010, LAB CHIP, V10, P3387, DOI [10.1039/c0lc00162g, 10.1039/c01c00162g]
   Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779
   Xu F, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3580752
   Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159
   Yang YL, 2009, BIOPHYS J, V96, P1566, DOI [10.1016/j.bpj.2008.10.063, 10.1016/j.bpj.20()8.10.063]
   Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568
   Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384
NR 64
TC 39
Z9 39
U1 0
U2 75
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD MAR
PY 2014
VL 3
IS 3
BP 449
EP 458
DI 10.1002/adhm.201300263
PG 10
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AC2MW
UT WOS:000332336400017
PM 23997020
DA 2018-10-19
ER

PT J
AU Nabzdyk, CS
   Chun, MC
   Oliver-Allen, HS
   Pathan, SG
   Phaneuf, MD
   You, JO
   Pradhan-Nabzdyk, LK
   LoGerfo, FW
AF Nabzdyk, Christoph S.
   Chun, Maggie C.
   Oliver-Allen, Hunter S.
   Pathan, Saif G.
   Phaneuf, Matthew D.
   You, Jin-Oh
   Pradhan-Nabzdyk, Leena K.
   LoGerfo, Frank W.
TI Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA
   complexes released from dip-coated electrospun poly(ethylene
   terephthalate) grafts
SO BIOMATERIALS
LA English
DT Article
DE Polyester; Silencing RNA; Transfection reagents; Human aortic smooth
   muscle cells; Thrombospondin-2
ID RNA INTERFERENCE; SUTURE MATERIAL; VASCULAR CELLS; BYPASS GRAFTS;
   IN-VITRO; DACRON; MIGRATION; THROMBOSPONDIN-2; NANOPARTICLES;
   ANASTOMOSIS
AB An excessive tissue response to prosthetic arterial graft material leads to intimal hyperplasia (IH), the leading cause of late graft failure. Seroma and abnormal capsule formation may also occur after prosthetic material implantation. The matricellular protein Thrombospondin-2 (TSP-2) has shown to be upregulated in response to biomaterial implantation. This study evaluates the uptake and release of small interfering RNA (siRNA) from unmodified and surface functionalized electrospun PET graft materials. ePET graft materials were synthesized using electrospinning technology. Subsets of the ePET materials were then chemically modified to create surface functional groups. Unmodified and surface-modified ePET grafts were dip-coated in siRNAs alone or siRNAs complexed with transfection reagents polyethyleneimine (PEI) or Lipofectamine RNAiMax. Further, control and TSP-2 siRNA PEI complex treated ePET samples were placed onto a confluent layer of human aortic smooth muscle cells (AoSMCs).
   Complexation of all siRNAs with PEI led to a significant increase in adsorption to unmodified ePET. TSP-2 siRNA-PEI released from unmodified-ePET silenced TSP-2 in AoSMC. Regardless of the siRNA-PEI complex evaluated, AoSMC migrated into the ePET. siRNA PEI complexes delivered to AoSMC from dip-coated ePET can result in gene knockdown. This methodology for siRNA delivery may improve the tissue response to vascular and other prosthetics. (C) 2013 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Nabzdyk, Christoph S.; Chun, Maggie C.; Oliver-Allen, Hunter S.; Pradhan-Nabzdyk, Leena K.; LoGerfo, Frank W.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Vasc & Endovasc Surg, Sch Med, Boston, MA 02215 USA.
   [Nabzdyk, Christoph S.] Tufts Univ, Sch Med, Tufts Med Ctr, Dept Surg, Boston, MA 02111 USA.
   [Pathan, Saif G.; Phaneuf, Matthew D.] BioSurfaces Inc, Ashland, MA USA.
   [You, Jin-Oh] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [You, Jin-Oh] Chungbuk Natl Univ, Dept Chem Engn, Cheongju, South Korea.
RP Pradhan-Nabzdyk, LK (reprint author), 330 Brookline Ave,Dana 805, Boston, MA 02215 USA.
EM lpradhan@bidmc.harvard.edu; flogerfo@bidmc.harvard.edu
FU National Institutes of Health [NIH 5R01 HL021796, NIH 2R01 HL086741, T32
   HL007734]; William J. von Liebig Foundation
FX This work was supported, in part, by grants from the National Institutes
   of Health (NIH 5R01 HL021796, NIH 2R01 HL086741 and T32 HL007734) and
   the William J. von Liebig Foundation.
CR Abdollahi A, 2010, HERNIA, V14, P569, DOI 10.1007/s10029-010-0685-9
   Andersen ND, 2007, J AM COLL SURGEONS, V204, P399, DOI 10.1016/j.jamcollsurg.2006.12.029
   Andersen ND, 2010, J VASC SURG, V52, P1608, DOI 10.1016/j.jvs.2010.06.169
   Annis D, 1984, POLYURETHANES BIOMED
   Bouillot JL, 2012, J VISC SURG, V149, pE53, DOI 10.1016/j.jviscsurg.2012.07.007
   Coda A, 2003, Hernia, V7, P29
   Cordero JA, 1998, J VASC SURG, V28, P157, DOI 10.1016/S0741-5214(98)70211-3
   DETTINGER GB, 1957, SURGERY, V42, P325
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001
   HAMDAN AD, 1995, J VASC SURG, V21, P228, DOI 10.1016/S0741-5214(95)70264-4
   HENSHAW R E, 1964, J Am Osteopath Assoc, V63, P734
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Junaid Y, 2007, N ENGL SOC VASC SURG
   Kadakol AK, 2011, J VASC SURG, V54, P637, DOI 10.1016/j.jvs.2011.03.258
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z
   Kyriakides TR, 1999, P NATL ACAD SCI USA, V96, P4449, DOI 10.1073/pnas.96.8.4449
   LATIMER EO, 1961, SURG GYNECOL OBSTET, V112, P373
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Mehrabi M, 2010, WORLD J SURG, V34, P1696, DOI 10.1007/s00268-010-0426-3
   Monahan TS, 2007, J VASC SURG, V45, P581, DOI 10.1016/j.jvs.2006.12.016
   Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173
   Nabzdyk CS, 2012, BIOCHEM BIOPH RES CO, V425, P261, DOI 10.1016/j.bbrc.2012.07.078
   Nabzdyk CS, 2011, AM J PHYSIOL-HEART C, V301, pH1841, DOI 10.1152/ajpheart.00089.2011
   NARAT J K, 1957, Surg Forum, V7, P176
   Nimesh S, 2012, CURR CLIN PHARMACOL, V7, P121, DOI 10.2174/157488412800228857
   Nimesh S, 2009, EUR J PHARM BIOPHARM, V73, P43, DOI 10.1016/j.ejpb.2009.04.001
   Nolte A, 2011, MOL MED, V17, P1213, DOI 10.2119/molmed.2011.00143
   PHANEUF MD, 1995, J APPL BIOMATER, V6, P289, DOI 10.1002/jab.770060410
   PHELAN JT, 1958, SURGERY, V43, P969
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Sarkar S, 2006, EUR J VASC ENDOVASC, V31, P627, DOI 10.1016/j.ejvs.2006.01.006
   SHUMACKER HB, 1961, ARCH SURG-CHICAGO, V83, P647
   Stein Andrew J, 2011, Tech Hand Up Extrem Surg, V15, P12, DOI 10.1097/BTH.0b013e3181e71728
   Wang J, 2011, J SURG RES, V169, pE85, DOI 10.1016/j.jss.2011.03.060
   Wang L, 2009, CIRC RES, V104, P688, DOI 10.1161/CIRCRESAHA.108.188425
   Wehbe MA, 2013, HAND CLIN, V29, P27, DOI 10.1016/j.hcl.2012.08.019
   Willis DJ, 2004, J SURG RES, V120, P27, DOI 10.1016/j.jss.2003.12.014
   Yoshida S, 2011, J AM COLL SURGEONS, V213, P668, DOI 10.1016/j.jamcollsurg.2011.07.006
   Zhong T, 2003, BIFUNCTIONAL SURFACE, P24
   Zintchenko A, 2008, BIOCONJUGATE CHEM, V19, P1448, DOI 10.1021/bc800065f
NR 42
TC 16
Z9 16
U1 2
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 9
BP 3071
EP 3079
DI 10.1016/j.biomaterials.2013.12.026
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC0MH
UT WOS:000332188900051
PM 24397987
OA Green Accepted, Other Gold
DA 2018-10-19
ER

PT J
AU Unger, RE
   Peters, K
   Sartoris, A
   Freese, C
   Kirkpatrick, CJ
AF Unger, Ronald E.
   Peters, Kirsten
   Sartoris, Anne
   Freese, Christian
   Kirkpatrick, C. James
TI Human endothelial cell-based assay for endotoxin as sensitive as the
   conventional Limulus Amebocyte Lysate assay
SO BIOMATERIALS
LA English
DT Article
DE Endotoxin; Lipopolysaccharide; Limulus amebocyte assay; Endothelial
ID NANOPARTICLE FORMULATIONS; GENE-REGULATION; HOST RESPONSE; IN-VITRO;
   CONTAMINATION; BIOMATERIALS; COCULTURES; REMOVAL; SEPSIS
AB Endotoxin, also known as lipopolysaccharide (LPS) produced by bacteria can be present in any liquid or on any biomaterial even if the material is sterile. Endotoxin in mammals can cause fever, inflammation, cell and tissue damage and irreversible septic shock and death. In the body, endothelial cells making up the blood vasculature and endothelial cells in vitro rapidly react to minute amounts of endotoxin resulting in a rapid induction of the cell adhesion molecule E-selectin. In this study we have used immunofluorescent staining to evaluate the expression of E-selectin on human microvascular endothelial cells from the skin (HDMEC) and human umbilical vein endothelial cells (HUVEC) exposed to various concentrations of LPS. In addition, the sensitivity of detection was compared with the most widely used assay for the presence of endotoxin, the Limulus Amebocyte Lysate assay (LAL). The detection of E-selectin on endothelial cells in the presence of LPS for 4 h was found to be at least as sensitive in detecting the same concentration using the LAL assay. A cell adhesion molecule-enzyme immunosorbent assay was also developed and used to quantify LPS using the endothelial cell model. A comparison of LAL and the immunofluorescent staining method was carried out with solutions, nanoparticles, biomaterial extracts and endothelial cells grown directly on biomaterials. Under all conditions, the endothelial/E-selectin model system was positive for the test samples that were positive by LAL. Thus, we propose the use of this highly sensitive, rapid, reproducible assay for the routine testing of endotoxin in all steps in the manufacturing process of materials destined for use in humans. This can give a rapid feedback and localization of bacterial contamination sources with the LAL being reserved for the testing of the final product. (C) 2014 The Authors. Published by Elsevier Ltd. All rights reserved.
C1 [Unger, Ronald E.; Sartoris, Anne; Freese, Christian; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
   [Peters, Kirsten] Univ Rostock, Biomed Res Ctr, Med Res Ctr, D-18055 Rostock, Germany.
RP Unger, RE (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, REPAIR Lab, Mainz, Germany.
EM runger@uni-mainz.de
RI Peters, Kirsten/S-3484-2016; Freese, Christian/Q-5540-2016
OI Freese, Christian/0000-0001-8411-1573
FU European Commission, FP6 project 'NanoBioPharmaceutics'
   [NMP4-CT-2006-026723]
FX This work has been supported by the European Commission, FP6 project
   'NanoBioPharmaceutics' (NMP4-CT-2006-026723).
CR [Anonymous], 1987, GUID VAL LIM AM LYS, P1
   BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238
   BEVILACQUA MP, 1987, SEMIN THROMB HEMOST, V13, P425, DOI 10.1055/s-2007-1003519
   Caroff M, 2003, CARBOHYD RES, V338, P2431, DOI 10.1016/j.carres.2003.07.010
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Dobrovolskaia MA, 2010, NANOMEDICINE-UK, V5, P555, DOI [10.2217/nnm.10.29, 10.2217/NNM.10.29]
   Fiske MJ, 2001, J CHROMATOGR B, V753, P269, DOI 10.1016/S0378-4347(00)00561-2
   GLAUSER MP, 1991, LANCET, V338, P732, DOI 10.1016/0140-6736(91)91452-Z
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Greenfield EM, 2005, J BIOMED MATER RES B, V72B, P179, DOI 10.1002/jbm.b.30150
   HURLEY JC, 1995, CLIN MICROBIOL REV, V8, P268
   International Standards Organization, 1996, 10993 INT STAND OR 2
   Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385
   Lieder R, 2013, TISSUE ENG PART B-RE, V19, P391, DOI [10.1089/ten.teb.2012.0636, 10.1089/ten.TEB.2012.0636]
   Lynn WA, 1998, J ANTIMICROB CHEMOTH, V41, P71, DOI 10.1093/jac/41.suppl_1.71
   Magalhaes PO, 2007, J PHARM PHARM SCI, V10, P388
   Maitz MF, 2009, J BIOMED MATER RES B, V90B, P18, DOI 10.1002/jbm.b.31247
   Neun BW, 2011, METHODS MOL BIOL, V697, P121, DOI 10.1007/978-1-60327-198-1_12
   Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414
   Ragab AA, 1999, J ORTHOPAED RES, V17, P803, DOI 10.1002/jor.1100170603
   Rietschel ET, 1996, CURR TOP MICROBIOL, V216, P39
   Smulders S, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-41
   Stoddard MB, 2010, CLIN VACCINE IMMUNOL, V17, P98, DOI 10.1128/CVI.00342-09
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002
   Williams David, 2003, Med Device Technol, V14, P8
NR 32
TC 19
Z9 19
U1 0
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 10
BP 3180
EP 3187
DI 10.1016/j.biomaterials.2013.12.059
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AC0MC
UT WOS:000332188400005
PM 24456607
OA Other Gold
DA 2018-10-19
ER

PT J
AU Vitton, V
   Soudan, D
   Siproudhis, L
   Abramowitz, L
   Bouvier, M
   Faucheron, JL
   Leroi, AM
   Meurette, G
   Pigot, F
   Damon, H
AF Vitton, V.
   Soudan, D.
   Siproudhis, L.
   Abramowitz, L.
   Bouvier, M.
   Faucheron, J. -L.
   Leroi, A. -M.
   Meurette, G.
   Pigot, F.
   Damon, H.
TI Treatments of faecal incontinence: recommendations from the French
   National Society of Coloproctology
SO COLORECTAL DISEASE
LA English
DT Review
DE Faecal incontinence; national recommendations; coloproctology
ID SACRAL NERVE-STIMULATION; RADIOFREQUENCY ENERGY DELIVERY; INJECTABLE
   SILICONE BIOMATERIAL; CONSERVATIVE BOWEL MANAGEMENT; RANDOMIZED
   CONTROLLED-TRIAL; EXTERNAL ANAL-SPHINCTER; PELVIC FLOOR EXERCISES;
   DOUBLE-BLIND CROSSOVER; TOPICAL PHENYLEPHRINE; TRANSANAL IRRIGATION
AB Faecal incontinence is common and significantly affects quality of life. Its treatment involves dietary manipulation, medical treatments, perineal rehabilitation or surgery. In this paper, the French National Society of Coloproctology offers recommendations based on the data in the current literature, including those on recently developed treatments. There is a lack of high quality data and most of the recommendations are therefore based either on grade of recommendation B or expert recommendation (Level 4). However, the literature supports the construction of an algorithm based on the available scientific evidence and expert recommendation which may be useful in clinical practice. The French National Society of Coloproctology proposes a decision-making algorithm that includes recent developments of treatment. The current recommendations support sacral nerve modulation as the key treatment for faecal incontinence. They do not support the use of sphincter substitutions except in certain circumstances. Transanal irrigation is a novel often successful treatment of faecal incontinence due to neurological disorders.
C1 [Vitton, V.; Bouvier, M.] Aix Marseille Univ, Hop Nord, AP HM, Serv Gastroenterol,CRN2M,UMR 7286, F-13915 Marseille 20, France.
   [Soudan, D.] Grp Hosp Paris St Joseph, Inst Proctol Leopold Bellan, Paris, France.
   [Siproudhis, L.] CHU Pontchaillou, Serv Gastroenterol, Rennes, France.
   [Siproudhis, L.] Univ Rennes 1, Rennes, France.
   [Abramowitz, L.] CHU Bichat Claude Bernard, AP HP, Serv Gastroenterol, Unite Proctol Medicochirurgicale, Paris, France.
   [Faucheron, J. -L.] Hop Albert Michallon, Unite Chirurg Colorectale, Serv Chirurg Digest & Urgence, Grenoble, France.
   [Leroi, A. -M.] Ctr Hosp Univ Rouen, INSERM, Serv Physiol Digest Urinaire Resp & Sport, U1073, Rouen, France.
   [Meurette, G.] CHU Nantes Hotel Dieu, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrine, Nantes, France.
   [Pigot, F.] Hop Bagatelle, Talence, France.
   [Damon, H.] Hosp Civils Lyon, Hop Edouard Herriot, Serv Explorat Fonct Digest, Lyon, France.
RP Vitton, V (reprint author), Aix Marseille Univ, Hop Nord, AP HM, Serv Gastroenterol,CRN2M,UMR 7286, Chemin Bourrely, F-13915 Marseille 20, France.
EM vittonv@yahoo.com
RI Meurette, Guillaume/M-1419-2015
CR Badvie S, 2005, CLIN ONCOL-UK, V17, P122, DOI 10.1016/j.clon.2004.07.011
   Beddy P, 2004, J GASTROINTEST SURG, V8, P64, DOI 10.1016/j.gassur.2003.10.005
   Bliss DZ, 2011, NURS RES, V60, pS58, DOI 10.1097/NNR.0b013e3182186d8c
   Bliss DZ, 2001, NURS RES, V50, P203, DOI 10.1097/00006199-200107000-00004
   Bliss DZ, 2000, J WOUND OSTOMY CONT, V27, P3
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Brouwer R, 2010, DIS COLON RECTUM, V53, P273, DOI 10.1007/DCR.0b013e3181ceeb22
   Carapeti EA, 2000, DIS COLON RECTUM, V43, P1059, DOI 10.1007/BF02236550
   Caremel R, 2012, UROLOGY, V79, P80, DOI 10.1016/j.urology.2011.06.013
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Christensen P, 2009, SPINAL CORD, V47, P138, DOI 10.1038/sc.2008.98
   Christensen P, 2006, GASTROENTEROLOGY, V131, P738, DOI 10.1053/j.gastro.2006.06.004
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   CHRISTIANSEN J, 1990, BRIT J SURG, V77, P1039, DOI 10.1002/bjs.1800770928
   Croswell E, 2010, J WOUND OSTOMY CONT, V37, P677, DOI 10.1097/WON.0b013e3181feb017
   Del Popolo G, 2008, SPINAL CORD, V46, P517, DOI 10.1038/sj.sc.3102167
   Donnelly V, 1997, BRIT J OBSTET GYNAEC, V104, P311, DOI 10.1111/j.1471-0528.1997.tb11459.x
   Dudding TC, 2008, COLORECTAL DIS, V10, P249, DOI 10.1111/j.1463-1318.2007.01319.x
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Felt-Bersma RJ, 2007, EUR J GASTROEN HEPAT, V19, P575, DOI 10.1097/MEG.0b013e32811ec010
   Fox M, 2005, DIGEST DIS SCI, V50, P1576, DOI 10.1007/s10620-005-2900-6
   Ganio E, 2001, DIS COLON RECTUM, V44, P1261, DOI 10.1007/BF02234782
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   Gourcerol G, 2011, COLORECTAL DIS, V13, pE203, DOI 10.1111/j.1463-1318.2011.02623.x
   Hansen JL, 2006, J WOUND OSTOMY CONT, V33, P52, DOI 10.1097/00152192-200601000-00007
   Heymen S, 2009, DIS COLON RECTUM, V52, P1730, DOI 10.1007/DCR.0b013e3181b55455
   Holzer B, 2007, BRIT J SURG, V94, P749, DOI 10.1002/bjs.5499
   Jarrett MED, 2005, BRIT J SURG, V92, P734, DOI 10.1002/bjs.4859
   Jarrett MED, 2008, DIS COLON RECTUM, V51, P531, DOI 10.1007/s10350-008-9199-2
   Kenefick NJ, 2002, BRIT J SURG, V89, P896, DOI 10.1046/j.1365-2168.2002.02119.x
   Kenefick NJ, 2002, GUT, V51, P881, DOI 10.1136/gut.51.6.881
   Kim DW, 2009, AM J SURG, V197, P14, DOI 10.1016/j.amjsurg.2007.11.023
   KUMAR D, 1995, BRIT J SURG, V82, P1645, DOI 10.1002/bjs.1800821219
   Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x
   Lehur P A, 1999, Int J Surg Investig, V1, P268
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Leroi AM, 2001, DIS COLON RECTUM, V44, P779, DOI 10.1007/BF02234695
   Maeda K, 2002, Tech Coloproctol, V6, P15, DOI 10.1007/s101510200002
   Maeda Y, 2010, COCHRANE DATABASE SY, V5
   Martinez-Puente Mdel C, 2003, INT J COLORECTAL DIS, V7, P7
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Melenhorst J, 2007, COLORECTAL DIS, V9, P725, DOI 10.1111/j.1463-1318.2007.01241.x
   Mentes B B, 2007, Tech Coloproctol, V11, P115, DOI 10.1007/s10151-007-0340-3
   Norton C, 2006, DIS COLON RECTUM, V49, P190, DOI 10.1007/s10350-005-0251-1
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x
   Pager CK, 2002, DIS COLON RECTUM, V45, P997, DOI 10.1097/01.DCR.0000019495.92696.34
   PALMER KR, 1980, GASTROENTEROLOGY, V79, P1272
   Park JS, 2007, INT J COLORECTAL DIS, V22, P1319, DOI 10.1007/s00384-007-0335-6
   Queralto M, 2006, INT J COLORECTAL DIS, V21, P670, DOI 10.1007/s00384-005-0068-3
   Rasmussen OO, 1999, DIS COLON RECTUM, V42, P193, DOI 10.1007/BF02237126
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Remes-Troche JM, 2008, INT J COLORECTAL DIS, V23, P189, DOI 10.1007/s00384-007-0391-y
   Rosen HR, 2001, GASTROENTEROLOGY, V121, P536, DOI 10.1053/gast.2001.27120
   Santoro GA, 2000, DIS COLON RECTUM, V43, P1676, DOI 10.1007/BF02236848
   SHOJI Y, 1993, SURGERY, V113, P560
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   Sun WM, 1997, SCAND J GASTROENTERO, V32, P34, DOI 10.3109/00365529709025060
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Takahashi-Monroy T, 2008, DIS COLON RECTUM, V51, P355, DOI 10.1007/s10350-007-9169-0
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Veronique V, 2010, INT J COLORECTAL DIS, V25, P1017, DOI 10.1007/s00384-010-0962-1
   Vitton V, 2008, NEUROGASTROENT MOTIL, V20, P407, DOI 10.1111/j.1365-2982.2007.01022.x
   Vitton V, 2008, DIS COLON RECTUM, V51, P924, DOI 10.1007/s10350-008-9209-4
   Vitton V, 2009, INFLAMM BOWEL DIS, V15, P402, DOI 10.1002/ibd.20774
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Young CJ, 1998, DIS COLON RECTUM, V41, P344, DOI 10.1007/BF02237489
NR 73
TC 9
Z9 8
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-8910
EI 1463-1318
J9 COLORECTAL DIS
JI Colorectal Dis.
PD MAR
PY 2014
VL 16
IS 3
BP 159
EP 166
DI 10.1111/codi.12410
PG 8
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA AA3VW
UT WOS:000331024300007
PM 24521273
DA 2018-10-19
ER

PT J
AU Saadaldin, SA
   Rizkalla, AS
AF Saadaldin, Selma A.
   Rizkalla, Amin S.
TI Synthesis and characterization of wollastonite glass-ceramics for dental
   implant applications
SO DENTAL MATERIALS
LA English
DT Article
DE Wollastonite; Cristobalite; Glass-ceramics; Chemical durability;
   Fracture toughness; Machinability; Brittleness index
ID MECHANICAL-PROPERTIES; FRACTURE-TOUGHNESS; ZIRCONIA; BIOMATERIAL;
   DEGRADATION
AB Objectives. To synthesize a glass-ceramic (GC) that is suitable for non-metallic one-piece dental implant application.
   Methods. Three glasses in a SiO2-Al2O3-CaO-CaF2-K2O-B2O3-P2O5-CeO2-Y2O3 system were produced by wet chemistry. Differential thermal analysis (DTA) was carried out to determine the glass crystallization kinetic parameters and the heating schedules that were used for sintering of GCs. Crystalline phases and crystal morphologies were studied by X-ray diffraction (XRD) and scanning electron microscopy (SEM), respectively. Mechanical properties of the GCs were determined by ultrasonic and indentation tests and its machinability were evaluated. Chemical durability was carried out according to ISO 6872, whereas testing chemical degradation in tris buffered solution was executed according to ISO 10993-14.
   Results. XRD of the GC specimens showed that wollastonite was the main crystalline with other secondary phases; GC2 had cristobalite as an additional phase. SEM of the GCs revealed dense acicular interlocking crystals. Young's modulus of elasticity (E), true hardness (H-o) and fracture toughness (K-IC) of the GCs were 89-100 GPa, 4.85-5.17 GPa and 4.62-5.58 MPa m(0.5), respectively. All GCs were demonstrated excellent machinability. The GCs exhibited various chemical durability and degradation rates. K-1C values of the GCs following chemical durability testing were not significantly different from those of the original materials (p > 0.05). GC2 exhibited significantly higher K-1C value compared with GC1 and GC3 (p < 0.05) and its chemical durability satisfied ISO 6872 specification for dental ceramics.
   Significance. Wollastonite-cristobalite GC can be considered as a promising material for one-piece dental implant applications due to its strength, machinability and chemical durability. (C) 2014 Published by Elsevier Ltd on behalf of Academy of Dental Materials. All rights reserved.
C1 [Saadaldin, Selma A.; Rizkalla, Amin S.] Univ Western Ontario, Schulich Sch Med & Dent, Med Biophys Dept, London, ON N6A 5C1, Canada.
   [Saadaldin, Selma A.; Rizkalla, Amin S.] Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
   [Rizkalla, Amin S.] Univ Western Ontario, Fac Engn, London, ON N6A 5C1, Canada.
RP Rizkalla, AS (reprint author), Univ Western Ontario, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada.
EM arizkalla@eng.uwo.ca
RI Rizkalla, Amin/D-8845-2015
OI Rizkalla, Amin/0000-0003-0548-3817
FU Natural Sciences and Engineering Research Council of Canada
FX The authors acknowledge the funding from the Natural Sciences and
   Engineering Research Council of Canada. Also the authors would like to
   thank Tim Goldhawk from the Western Nanofabrication for assistance with
   SEM, and Dr. Peter Canham from the Medical Biophysics Department for his
   valuable and constructive comments on the manuscript.
CR Anusavice K J, 1992, Adv Dent Res, V6, P82
   Anusavice KJ, 1997, DENT MATER, V13, P13, DOI 10.1016/S0109-5641(97)80003-6
   AUGIS JA, 1978, J THERM ANAL, V13, P283, DOI 10.1007/BF01912301
   Boccaccini AR, 1997, J MATER PROCESS TECH, V65, P302, DOI 10.1016/S0924-0136(96)02275-3
   Cannillo V, 2009, J EUR CERAM SOC, V29, P1665, DOI 10.1016/j.jeurceramsoc.2008.09.022
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031
   Esquivel-Upshaw JF, 2013, J DENT RES, V92, P467, DOI 10.1177/0022034513484332
   EVANS AG, 1984, J AM CERAM SOC, V67, P255
   FULTZ B., 2008, TRANSMISSION ELECT M, P1
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Holand W, 2002, GLASS CERAMIC TECHNO
   International Standard, 2001, ISO 10993 14
   International standard, 2008, ISO STANDARD 6782
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   LANKFORD J, 1982, J MATER SCI LETT, V1, P493, DOI 10.1007/BF00721938
   Leyens C., 2003, TITANIUM AND TITANIU
   MORENA R, 1986, DENT MATER, V2, P58, DOI 10.1016/S0109-5641(86)80052-5
   Natali AN., 2003, DENTAL BIOMECHANICS
   O'Brien WJ., 2008, DENTAL MATERIALS AND
   Park JB, 2007, BIOMATERIALS AN INTR
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Rizkalla AS, 1996, J BIOMED MATER RES, V32, P119, DOI 10.1002/(SICI)1097-4636(199609)32:1<119::AID-JBM14>3.0.CO;2-H
   Rizkalla AS, 2004, DENT MATER, V20, P207, DOI 10.1016/S0109-5641(03)00093-9
   Saadaldin SA, 2013, DENT MATER, V29, P645, DOI 10.1016/j.dental.2013.03.013
   San O, 2009, J EUR CERAM SOC, V29, P2945, DOI 10.1016/j.jeurceramsoc.2009.04.013
   Schreiber E, 1973, ELASTIC CONSTANTS AN
   Volpato C. A. M., 2011, ADV CERAMICS ELECT M, P397, DOI DOI 10.5772/21630
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Zhang FM, 2008, J MATER SCI-MATER M, V19, P167, DOI 10.1007/s10856-006-0056-3
   Zhu HL, 2010, MAT SCI ENG C-MATER, V30, P132, DOI 10.1016/j.msec.2009.09.009
NR 32
TC 19
Z9 21
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD MAR
PY 2014
VL 30
IS 3
BP 364
EP 371
DI 10.1016/j.dental.2013.12.007
PG 8
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AB3VQ
UT WOS:000331718700017
PM 24444788
DA 2018-10-19
ER

PT J
AU Skwarek, E
   Janusz, W
   Sternik, D
AF Skwarek, E.
   Janusz, W.
   Sternik, D.
TI Adsorption of citrate ions on hydroxyapatite synthetized by various
   methods
SO JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY
LA English
DT Article
DE Hydroxyapatite; Adsorption; Citric acid; Thermal analysis
ID SYNTHETIC HYDROXYAPATITE; THERMAL-STABILITY; AQUEOUS-SOLUTIONS;
   SURFACE-CHARGE; CITRIC-ACID; TEMPERATURE; MORPHOLOGY; PH
AB The specific adsorption of citric acid ions at hydroxyapatite interface was investigated by the means of radioisotope method (C-14) as a function of citric acid ions concentration, NaCl concentration and pH. Application of the hydroxyapatite has become wide in the biomaterial field as the Ca-10(OH)(2)(PO4)(6) possess biocompatibility with human hard tissue. Hydroxyapatite was synthesized using three different methods. The physical properties of the resulting powder were characterized by DTA/TG, XRD, AFM and SEM microscopy. Physicochemical qualities characterizing the electrical double layer of the hydroxyapatite/NaCl solution interface were determined. The zeta potential and the adsorption of citric acid molecule were studied as a function of pH. The point of zero charge and the isoelectric point of samples were determined. Electrical double layer parameters of hydroxyapatite/NaCl interface are influenced by a synthesis method. The points pH(pzc) and pH(IEP) for sample 1 are pHpzc 7.5 and pH(IEP) 3; for sample 2 pH(pzc) 7.05 and pH(IEP) 3, for smaple 3 pH(pzc) 6.7 and pH(IEP) 3. Temperature has weak influence both on pure substance and with citric acid adsorbed, as derivatographic analysis has shown, and characterization of hydroxyapatite structure may be carried out by this thermal analysis. Two phenomena are responsible for citric acid adsorption: phosphate group's replacement at hydroxyapatite surface by citric ions parallel to intraspherical complexes formation.
C1 [Skwarek, E.; Janusz, W.; Sternik, D.] Marie Curie Sklodowska Univ, Fac Chem, PL-20031 Lublin, Poland.
RP Skwarek, E (reprint author), Marie Curie Sklodowska Univ, Fac Chem, Maria Curie Sklodowska Sq 5, PL-20031 Lublin, Poland.
EM ewunias@hektor.umcs.lublin.pl
CR Bianco A, 2007, J THERM ANAL CALORIM, V88, P237, DOI 10.1007/s10973-006-8011-6
   Dean-Mo L, 1996, BIOMATERIALS, V17, P1955
   Filgueiras MRT, 2006, J CRYST GROWTH, V294, P60, DOI 10.1016/j.jcrysgro.2006.05.077
   Goodwin JW, 1981, SPECIAL PUBLICATION, V43
   Harding IS, 2005, BIOMATERIALS, V26, P6818, DOI 10.1016/j.biomaterials.2005.04.060
   Janusz W, 2008, POL J CHEM, V82, P57
   Jillavenkatesa A, 1998, J MATER SCI, V33, P4111, DOI 10.1023/A:1004436732282
   Krajewski A, 2005, J MOL STRUCT, V744, P221, DOI 10.1016/j.molstruc.2004.10.044
   Liu JB, 2003, CERAM INT, V29, P629, DOI 10.1016/S0272-8842(02)00210-9
   Lopez-Macipe A, 1998, J COLLOID INTERF SCI, V200, P114, DOI 10.1006/jcis.1997.5343
   Lyklema JH, 1995, FUNDAMENTALS INTERFA
   Misra DN, 1998, COLLOID SURFACE A, V141, P173, DOI 10.1016/S0927-7757(98)00332-X
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Predoana L, 2009, J THERM ANAL CALORIM, V98, P361, DOI 10.1007/s10973-009-0315-x
   Riman RE, 2002, SOLID STATE IONICS, V151, P393, DOI 10.1016/S0167-2738(02)00545-3
   Rosskopfova O, 2013, J RADIOANAL NUCL CH, V295, P459, DOI 10.1007/s10967-012-1799-6
   Rosskopfova O, 2012, J RADIOANAL NUCL CH, V293, P641, DOI 10.1007/s10967-012-1711-4
   Rosskopfova O., 2010, J RADIOANAL NUCL CHE, V287, P715
   Skartsila P, 2007, J COLLOID INTERF SCI, V308, P405
   Suzuki S, 1998, J MATER SCI LETT, V17, P381, DOI 10.1023/A:1006526915828
   Tonsuaadu K, 2012, J THERM ANAL CALORIM, V110, P647, DOI 10.1007/s10973-011-1877-y
   Vega ED, 2003, J COLLOID INTERF SCI, V268, P37, DOI 10.1016/j.jcis.2003.07.033
   Wiese GR, 1976, INT REV SCI PHYS CHE, V2
   Yin G, 2002, CHEM ENG J, V87, P181, DOI 10.1016/S1385-8947(01)00248-0
NR 24
TC 21
Z9 21
U1 1
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0236-5731
EI 1588-2780
J9 J RADIOANAL NUCL CH
JI J. Radioanal. Nucl. Chem.
PD MAR
PY 2014
VL 299
IS 3
BP 2027
EP 2036
DI 10.1007/s10967-013-2825-z
PG 10
WC Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science &
   Technology
SC Chemistry; Nuclear Science & Technology
GA AB8IU
UT WOS:000332034400111
OA Other Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kim, YM
   Oh, SH
   Choi, JS
   Lee, S
   Ra, JC
   Lee, JH
   Lim, JY
AF Kim, Young-Mo
   Oh, Se H.
   Choi, Jeong-Seok
   Lee, Songyi
   Ra, Jeong C.
   Lee, Jin H.
   Lim, Jae-Yol
TI Adipose-Derived Stem Cell-Containing Hyaluronic Acid/Alginate Hydrogel
   Improves Vocal Fold Wound Healing
SO LARYNGOSCOPE
LA English
DT Article
DE Mesenchymal stem cells; vocal folds; regeneration; hydrogel; hyaluronic
   acid; alginate
ID STROMAL CELLS; GROWTH-FACTOR; TISSUE REGENERATION; STEM/STROMAL CELLS;
   DIFFERENTIATION; INJECTION; BIOMATERIALS; FIBROBLASTS; SCAFFOLDS; MODEL
AB Objectives/Hypothesis The purpose of this study was to investigate the regenerative efficacy of an injectable hyaluronic acid/mildly cross-linked alginate hydrogel (HA/ALG hydrogel) containing human adipose-derived mesenchymal stem cells (hAdMSCs) for vocal fold (VF) wound healing.
   Study DesignAnimal research.
   MethodsHA/ALG hydrogel containing hAdMSCs was injected into the VFs of rabbits immediately after direct injury. Endoscopic evaluations were performed at 1 and 3 months after injury, and functional evaluations of mucosal vibration and viscoelastic properties were carried out posteuthanization at 3 months after injury. Histopathologic and immunohistochemical evaluations of extracellular matrix (ECM) components and of hepatocyte growth factor (HGF) activity were conducted in injured VFs. The engraftment of implanted hAdMSCs was investigated by detecting fluorescent-labeled cells.
   ResultsThe administration of hAdMSCs and hAdMSCs in HA/ALG hydrogel produced better macroscopic morphologies than the injection of phosphate-buffered saline (PBS). Histologic evaluations revealed that treatment with hAdMSCs in HA/ALG produced more favorable ECM changes than hAdMSC. In particular, the treatment of hAdMSCs in HA/ALG hydrogel ameliorated excessive deposition of collagen type I and increased HGF activity in regenerating VFs. hAdMSCs in HA/ALG-treated VFs also exhibited functional improvements in viscoelastic properties. hAdMSCs in HA/ALG remained viable in recipient VFs at 1 month after transplantation, and some were observed to be fostered to differentiate into fibroblasts.
   ConclusionsThe findings of the present study suggest that HA/ALG hydrogel is a promising biomaterial for prolonging the retention time of stem cells in VFs and for promotion of VF wound healing.
C1 [Kim, Young-Mo; Choi, Jeong-Seok; Lee, Songyi; Lim, Jae-Yol] Inha Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Inchon 400711, South Korea.
   [Kim, Young-Mo; Choi, Jeong-Seok; Lee, Songyi; Lim, Jae-Yol] Inha Univ, Sch Med, Incheon & Translat Res Ctr, Inchon 400711, South Korea.
   [Oh, Se H.] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Oh, Se H.] Dankook Univ, WCU Res Ctr, Cheonan, South Korea.
   [Ra, Jeong C.] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea.
   [Lee, Jin H.] Hannam Univ, Dept Adv Mat, Taejon, South Korea.
RP Lim, JY (reprint author), Inha Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 27 Inhang Ro, Inchon 400711, South Korea.
EM jylim@inha.ac.kr
FU Basic Science Research Program of the National Research Foundation
   (NRF); Korean Ministry of Education, Science, and Technology
   [NRF-2010-0004316]; Inha University
FX This research was supported by the Basic Science Research Program of the
   National Research Foundation (NRF) funded by the Korean Ministry of
   Education, Science, and Technology (NRF-2010-0004316) and by an Inha
   University Research Grant. The funders had no role in study design, data
   collection or analysis, decision to publish, or preparation of this
   manuscript.
CR Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Bless DM, 2010, CURR OPIN OTOLARYNGO, V18, P481, DOI 10.1097/MOO.0b013e3283407d87
   Cedervall J, 2007, LARYNGOSCOPE, V117, P2075, DOI 10.1097/MLG.0b013e3181379c7c
   Chhetri DK, 2004, OTOLARYNG HEAD NECK, V131, P864, DOI 10.1016/j.otohns.2004.07.010
   Choi JS, 2012, OTOLARYNG HEAD NECK, V147, P515, DOI 10.1177/0194599812446913
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Hertegard S, 2006, LARYNGOSCOPE, V116, P1248, DOI 10.1097/01.mlg.0000224548.68499.35
   Hong SJ, 2011, ACTA OTO-LARYNGOL, V131, P1198, DOI 10.3109/00016489.2011.599816
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Johnson BQ, 2010, LARYNGOSCOPE, V120, P537, DOI 10.1002/lary.20782
   Kanemaru S, 2005, ANN OTO RHINOL LARYN, V114, P907, DOI 10.1177/000348940511401203
   Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P915, DOI 10.1177/000348940311201101
   Kim YM, 2013, ANN OTO RHINOL LARYN, V122, P121, DOI 10.1177/000348941312200208
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kumai Y, 2010, LARYNGOSCOPE, V120, P330, DOI 10.1002/lary.20753
   Kumai Y, 2009, LARYNGOSCOPE, V119, P799, DOI 10.1002/lary.20149
   Lee BJ, 2006, CELLS TISSUES ORGANS, V184, P198, DOI 10.1159/000099627
   Liang Q, 2012, LARYNGOSCOPE, V122, P1815, DOI 10.1002/lary.23330
   Lim JY, 2008, EUR ARCH OTO-RHINO-L, V265, P321, DOI 10.1007/s00405-007-0458-y
   LIM JY, 2013, PLOS ONE, V8
   Long JL, 2010, LARYNGOSCOPE, V120, P125, DOI 10.1002/lary.20719
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maytag AL, 2013, J VOICE, V27, P24, DOI 10.1016/j.jvoice.2012.08.004
   Na SY, 2012, J MATER SCI-MATER M, V23, P2303, DOI 10.1007/s10856-012-4689-0
   Oh SH, 2005, J BIOMED MATER RES A, V72A, P306, DOI 10.1002/jbm.a.30239
   Ohno S, 2012, LARYNGOSCOPE, V122, P2503, DOI 10.1002/lary.23543
   Ohno S, 2011, ANN OTO RHINOL LARYN, V120, P401, DOI 10.1177/000348941112000610
   Ohta M, 2004, J BIOMED MATER RES A, V71A, P661, DOI 10.1002/jbm.a.30194
   Park H, 2010, TISSUE ENG PT A, V16, P535, DOI [10.1089/ten.tea.2009.0029, 10.1089/ten.TEA.2009.0029]
   Ra JC, 2011, STEM CELLS DEV, V20, P1297, DOI 10.1089/scd.2010.0466
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q
   Silva CM, 2006, EUR J PHARM SCI, V29, P148, DOI 10.1016/j.ejps.2006.06.008
   Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299
   Tong ZX, 2011, TISSUE ENG PT A, V17, P2773, DOI [10.1089/ten.tea.2011.0219, 10.1089/ten.TEA.2011.0219]
   Vyas B, 2010, ANN OTO RHINOL LARYN, V119, P350, DOI 10.1177/000348941011900513
   Xu W, 2011, ANN OTO RHINOL LARYN, V120, P123, DOI 10.1177/000348941112000209
NR 38
TC 28
Z9 32
U1 3
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0023-852X
EI 1531-4995
J9 LARYNGOSCOPE
JI Laryngoscope
PD MAR
PY 2014
VL 124
IS 3
BP E64
EP E72
DI 10.1002/lary.24405
PG 9
WC Medicine, Research & Experimental; Otorhinolaryngology
SC Research & Experimental Medicine; Otorhinolaryngology
GA AA8VY
UT WOS:000331374300002
PM 24115025
DA 2018-10-19
ER

PT J
AU Francisco, AT
   Hwang, PY
   Jeong, CG
   Jing, LF
   Chen, J
   Setton, LA
AF Francisco, Aubrey T.
   Hwang, Priscilla Y.
   Jeong, Claire G.
   Jing, Liufang
   Chen, Jun
   Setton, Lori A.
TI Photocrosslinkable laminin-functionalized polyethylene glycol hydrogel
   for intervertebral disc regeneration
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nucleus pulposus; Intervertebral disc; Polyethylene glycol;
   Photocrosslinking; Laminin
ID NUCLEUS PULPOSUS CELLS; PROTEIN GENE-EXPRESSION; MESENCHYMAL STEM-CELLS;
   EXTRACELLULAR-MATRIX; NOTOCHORDAL CELLS; PROTEOGLYCAN PRODUCTION; ANULUS
   FIBROSUS; IN-VITRO; DEGENERATION; DIFFERENTIATION
AB Intervertebral disc (IVD) disorders and age-related degeneration are believed to contribute to lower back pain. There is significant interest in cell-based strategies for regenerating the nucleus pulposus (NP) region of the disc; however, few scaffolds have been evaluated for their ability to promote or maintain an immature NP cell phenotype. Previous studies have shown that NP cell-laminin interactions promote cell adhesion and biosynthesis, which suggests a laminin-functionalized biomaterial may be useful for promoting or maintaining the NP cell phenotype. Here, a photocrosslinkable poly(ethylene glycol)-laminin 111 (PEG-LM111) hydrogel was developed. The mechanical properties of PEG-LM111 hydrogel could be tuned within the range of dynamic shear moduli values previously reported for human NP. When primary immature porcine NP cells were seeded onto PEG-LM111 hydrogels of varying stiffnesses, LM111-presenting hydrogels were found to promote cell clustering and increased levels of sGAG production as compared to stiffer LM111-presenting and PEG-only gels. When cells were encapsulated in 3-D gels, hydrogel formulation was found to influence NP cell metabolism and expression of proposed NP phenotypic markers, with higher expression of N-cadherin and cytokeratin 8 observed for cells cultured in softer (<1 kPa) PEG-LM111 hydrogels. Overall, these findings suggest that soft, LM111-functionalized hydrogels may promote or maintain the expression of specific markers characteristic of an immature NP cell phenotype. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Francisco, Aubrey T.; Hwang, Priscilla Y.; Jeong, Claire G.; Jing, Liufang; Setton, Lori A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Chen, Jun; Setton, Lori A.] Duke Univ, Med Ctr, Div Orthopaed Surg, Durham, NC 27710 USA.
RP Setton, LA (reprint author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
EM lori.setton@duke.edu
FU NIH [R01AR047442, R01EB002263, R01AR057410, T32GM008555]
FX This work was completed with support from NIH Grants R01AR047442,
   R01EB002263, R01AR057410 and T32GM008555.
CR Aguiar DJ, 1999, EXP CELL RES, V246, P129, DOI 10.1006/excr.1998.4287
   Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884
   Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Bowles RD, 2011, P NATL ACAD SCI USA, V108, P13106, DOI 10.1073/pnas.1107094108
   Boyd LM, 2004, SPINE, V29, P2217, DOI 10.1097/01.brs.0000142747.90488.1d
   Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395
   BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022
   Chen J, 2002, BIOCHEM BIOPH RES CO, V293, P932, DOI 10.1016/S0006-291X(02)00314-5
   Chen J, 2006, EUR SPINE J, V15, pS303, DOI 10.1007/s00586-006-0088-x
   Chen J, 2009, CONNECT TISSUE RES, V50, P294, DOI 10.3109/03008200802714925
   Choi KS, 2008, DEV DYNAM, V237, P3953, DOI 10.1002/dvdy.21805
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Cloyd JM, 2007, EUR SPINE J, V16, P1892, DOI 10.1007/s00586-007-0443-6
   Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033
   Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5
   Erwin WM, 2006, SPINE, V31, P1094, DOI 10.1097/01.brs.0000216593.97157.dd
   Estes BT, 2008, BIOTECHNOL BIOENG, V99, P986, DOI 10.1002/bit.21662
   Francisco AT, 2013, BIOMATERIALS, V34, P7381, DOI 10.1016/j.biomaterials.2013.06.038
   Gilchrist CL, 2011, EUR CELLS MATER, V21, P523, DOI 10.22203/eCM.v021a39
   Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343
   Gilchrist CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027170
   Gilson A, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2931
   Gonen-Wadmany M, 2007, BIOMATERIALS, V28, P3876, DOI 10.1016/j.biomaterials.2007.05.005
   GOTZ W, 1995, CELL TISSUE RES, V280, P455
   Gruber H E, 2000, BMC Musculoskelet Disord, V1, P1, DOI 10.1186/1471-2474-1-1
   Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X
   Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290
   Hayes AJ, 1999, DEV DYNAM, V215, P179, DOI 10.1002/(SICI)1097-0177(199907)215:3<179::AID-AJA1>3.3.CO;2-H
   HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130
   Hunter CJ, 2004, SPINE, V29, P1099, DOI 10.1097/00007632-200405150-00010
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025
   Korecki CL, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt18
   Lee CR, 2007, EUR SPINE J, V16, P2174, DOI 10.1007/s00586-007-0475-y
   LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1
   Marquardt L, 2011, J BIOMED MATER RES A, V98A, P1, DOI 10.1002/jbm.a.33044
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Minogue BM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2929
   Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27
   Mizuno H, 2004, SPINE, V29, P1297
   Moss IL, 2010, SPINE, V36, P1022
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Nettles DL, 2009, TISSUE ENG PT A, V15, P2113, DOI 10.1089/ten.tea.2008.0448
   Nettles DL, 2004, J ANAT, V204, P515, DOI 10.1111/j.0021-8782.2004.00306.x
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   O'Halloran DM, 2007, TISSUE ENG, V13, P1927, DOI 10.1089/ten.2005.0608
   Peroglio M, 2013, SPINE J, V13, P1627, DOI 10.1016/j.spinee.2013.05.029
   Reza AT, 2010, ACTA BIOMATER, V6, P179, DOI 10.1016/j.actbio.2009.06.004
   Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   RUFAI A, 1995, ANAT EMBRYOL, V192, P53
   Sakai D, 2006, BIOMATERIALS, V27, P346, DOI 10.1016/j.biomaterials.205.06.040
   Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705
   Scott R, 2010, J BIOMED MATER RES A, V93A, P817, DOI 10.1002/jbm.a.32775
   Tang XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052020
   TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 68
TC 20
Z9 20
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1102
EP 1111
DI 10.1016/j.actbio.2013.11.013
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900005
PM 24287160
OA Green Published, Green Accepted
DA 2018-10-19
ER

PT J
AU Battiston, KG
   Ouyang, B
   Labow, RS
   Simmons, CA
   Santerre, JP
AF Battiston, K. G.
   Ouyang, B.
   Labow, R. S.
   Simmons, C. A.
   Santerre, J. P.
TI Monocyte/macrophage cytokine activity regulates vascular smooth muscle
   cell function within a degradable polyurethane scaffold
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Polyurethane; Monocyte; Co-culture; Smooth muscle cell; Cytokines
ID BIOMATERIAL SURFACE-CHEMISTRY; IN-VITRO; GROWTH-FACTORS; BLOOD-VESSELS;
   MACROPHAGE ACTIVATION; HUMAN ARTERIAL; UP-REGULATION; PROLIFERATION;
   DIFFERENTIATION; EXPRESSION
AB Tissue engineering strategies rely on the ability to promote cell proliferation and migration into porous biomaterial constructs, as well as to support specific phenotypic states of the cells in vitro. The present study investigated the use of released factors from monocytes and their derived macrophages (MDM) and the mechanism by which they regulate vascular smooth muscle cell (VSMC) response in a VSMC-monocyte co-culture system within a porous degradable polyurethane (D-PHI) scaffold. VSMCs cultured in monocyte/MDM-conditioned medium (MCM), generated from the culture of monocytes/MDM on D-PHI scaffolds for up to 28 days, similarly affected VSMC contractile marker expression, growth and three-dimensional migration when compared to direct VSMC-monocyte co-culture. Monocyte chemotactic protein-1 (MCP-1) and interleukin-6 (IL-6) were identified as two cytokines present in MCM, at concentrations that have previously been shown to influence VSMC phenotype. VSMCs cultured alone on D-PHI scaffolds and exposed to MCP-1 (5 ng ml(-1)) or IL-6 (1 ng ml(-1)) for 7 days experienced a suppression in contractile marker expression (with MCP-1 or IL-6) and increased growth (with MCP-1) compared to no cytokine medium supplementation. These effects were also observed in VSMC-monocyte co-culture on D-PHI. Neutralization of IL-6, but not MCP-1, was subsequently shown to decrease VSMC growth and enhance calponin expression for VSMC-monocyte co-cultures on D-PHI scaffolds for 7 days, implying that IL-6 mediates VSMC response in monocyte-VSMC co-cultures. This study highlights the use of monocytes and their derived macrophages in conjunction with immunomodulatory biomaterials, such as D-PHI, as agents for regulating VSMC response, and demonstrates the importance of monocyte/MDM-released factors, such as IL-6 in particular, in this process. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Battiston, K. G.; Ouyang, B.; Simmons, C. A.; Santerre, J. P.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [Labow, R. S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Labow, R. S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
   [Simmons, C. A.; Santerre, J. P.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, 124 Edward St, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772
FU Natural Sciences and Engineering Research Council/Canadian Institutes of
   Health Research (NSERC/CIHR) [337246/83459]; CIHR [230762, STP-53877];
   NSERC; Ontario Graduate Scholarship (OGS)
FX This study was funded by an Natural Sciences and Engineering Research
   Council/Canadian Institutes of Health Research (NSERC/CIHR)
   collaborative grant #337246/83459 (J.P.S., R.S.L.) and CIHR operating
   grant #230762 (J.P.S., R.S.L., C.A.S.). B.O. was funded by an NSERC
   Undergraduate Student Research Award (USRA). K.G.B. was funded by a CIHR
   Strategic Training Fellowship (STP-53877) and by an Ontario Graduate
   Scholarship (OGS). Thanks to Feryal Sarraf for help with preparation of
   histology samples and staining and to Gurbaksh Basi for collection of
   the microarray data.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Bajaj MS, 2007, J THROMB HAEMOST, V5, P1493, DOI 10.1111/j.1538-7836.2007.02604.x
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]
   BONIN PD, 1989, EXP CELL RES, V181, P475, DOI 10.1016/0014-4827(89)90104-3
   Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893
   Boyle JJ, 2001, ARTERIOSCL THROM VAS, V21, P1402, DOI 10.1161/hq0901.094279
   Boynton EL, 2000, J BIOMED MATER RES, V52, P239, DOI 10.1002/1097-4636(200011)52:2<239::AID-JBM1>3.0.CO;2-R
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Cai QK, 2004, AM J PHYSIOL-CELL PH, V287, pC707, DOI 10.1152/ajpcell.00170.2004
   Chan-Park MB, 2009, J BIOMED MATER RES A, V88A, P1104, DOI 10.1002/jbm.a.32318
   Daly KA, 2012, TISSUE ENG PT A, V18, P1293, DOI [10.1089/ten.tea.2011.0597, 10.1089/ten.TEA.2011.0597]
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   FRID MG, 1992, DEV BIOL, V153, P185, DOI 10.1016/0012-1606(92)90104-O
   Gong Z, 2009, TISSUE ENG PT A, V15, P319, DOI 10.1089/ten.tea.2008.0161
   Ikeda U, 1998, CARDIOVASC RES, V37, P820, DOI 10.1016/S0008-6363(97)00265-4
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852
   Kunigal S, 2003, BLOOD, V102, P4377, DOI 10.1182/blood-203-12-3872
   Laflamme K, 2006, TISSUE ENG, V12, P2275, DOI 10.1089/ten.2006.12.2275
   Li L, 2011, J CELL BIOCHEM, V112, P289, DOI 10.1002/jcb.22924
   Lin ZQ, 2003, J LEUKOCYTE BIOL, V73, P713, DOI 10.1189/jlb.0802397
   Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McBane JE, 2011, BIOMATERIALS, V32, P6034, DOI 10.1016/j.biomaterials.2011.04.048
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   Mosser DM, 2010, NAT REV IMMUNOL, V10, P460, DOI 10.1038/nri2788
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Nam MH, 2011, BBA-GEN SUBJECTS, V1810, P907, DOI 10.1016/j.bbagen.2011.06.005
   Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871
   Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005
   Postiglione L, 2005, J RHEUMATOL, V32, P656
   Proudfoot D, 1999, ATHEROSCLEROSIS, V145, P157, DOI 10.1016/S0021-9150(99)00028-3
   Ratajska A, 2001, HISTOCHEM CELL BIOL, V116, P79
   Risinger GM, 2010, AM J PHYSIOL-CELL PH, V298, pC191, DOI 10.1152/ajpcell.00417.2008
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184
   Sandbo N, 2007, CARDIOVASC RES, V74, P262, DOI 10.1016/j.cardiores.2007.01.011
   Schatteman GC, 2010, AM J PATHOL, V177, P2002, DOI 10.2353/ajpath.2010.091232
   Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shinozaki M, 2009, ARCH DERMATOL RES, V301, P531, DOI 10.1007/s00403-009-0969-z
   Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003
   Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356
   Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490
   Spinetti G, 2004, ARTERIOSCL THROM VAS, V24, P1397, DOI 10.1161/01.ATV.0000134529.65173.08
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Sudhakaran PR, 2007, GLYCOCONJUGATE J, V24, P49, DOI 10.1007/s10719-006-9011-2
   Syedain ZH, 2011, J BIOMECH, V44, P848, DOI 10.1016/j.jbiomech.2010.12.007
   Syedain ZH, 2011, BIOMATERIALS, V32, P714, DOI 10.1016/j.biomaterials.2010.09.019
   Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765
   Wakelin SJ, 2006, IMMUNOL LETT, V106, P1, DOI 10.1016/j.imlet.2006.04.007
   Wang C, 2010, BIOMATERIALS, V31, P621, DOI 10.1016/j.biomaterials.2009.09.086
   Wang ZB, 2003, J SURG RES, V111, P261, DOI 10.1016/S0022-4804(03)00087-8
   Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.00031.2002
   Yu HX, 2011, ARTERIOSCL THROM VAS, V31, P2402, DOI 10.1161/ATVBAHA.111.235622
   Zhu Y, 2000, J CARDIOVASC PHARM, V36, P152, DOI 10.1097/00005344-200008000-00003
NR 65
TC 12
Z9 12
U1 2
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1146
EP 1155
DI 10.1016/j.actbio.2013.12.022
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900009
PM 24361424
DA 2018-10-19
ER

PT J
AU Jiang, B
   Akar, B
   Waller, TM
   Larson, JC
   Appel, AA
   Brey, EM
AF Jiang, B.
   Akar, B.
   Waller, T. M.
   Larson, J. C.
   Appel, A. A.
   Brey, E. M.
TI Design of a composite biomaterial system for tissue engineering
   applications
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Neovascularization; Tissue engineering; Fibroblast growth factor;
   Platelet-derived growth factor; Poly(lactic-co-glycolic acid)
ID POLY(ETHYLENE GLYCOL) HYDROGELS; FIBROBLAST-GROWTH-FACTOR; SEQUENTIAL
   DELIVERY; PDGF-BB; ANGIOGENESIS
AB Biomaterials that regulate vascularized tissue formation have the potential to contribute to new methods of tissue replacement and reconstruction. The goal of this study was to develop a porous, degradable tissue engineering scaffold that could deliver multiple growth factors and regulate vessel assembly within the porous structure of the material. Porous hydrogels of poly(ethylene glycol)-co-(L-lactic acid) (PEG-PLLA) were prepared via salt leaching. The degradation time of the hydrogels could be controlled between 1 and 7 weeks, based on hydrogel composition. Fibrin was incorporated into the interconnected pores of the hydrogels to promote neovascularization and as a reservoir for rapid (<5 days) growth factor delivery. Poly(lactic-co-glycolic acid) (PLGA) microspheres were incorporated into the degradable polymeric hydrogel scaffold to allow sustained (>30 days) growth factor delivery. Fibroblast growth factor-1 (FGF-1) and platelet-derived growth factor-BB (PDGF-BB) were delivered from the system owing to their roles in the promotion of angiogenesis and vascular stabilization, respectively. Hydrogels tested in vivo with a subcutaneous implantation model were selected based on the results from in vitro degradation and growth factor release kinetics. Dual growth factor delivery promoted significantly more tissue ingrowth in the scaffold compared with blank or single growth factor delivery. The sequential delivery of FGF-1 following PDGF-BB promoted more persistent and mature blood vessels. In conclusion, a biomaterials system was developed to provide structural support for tissue regeneration, as well as delivery of growth factors that stimulate neovascularization within the structure prior to complete degradation. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Jiang, B.; Akar, B.; Waller, T. M.; Larson, J. C.; Appel, A. A.; Brey, E. M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Jiang, B.; Akar, B.; Larson, J. C.; Appel, A. A.; Brey, E. M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL USA.
RP Brey, EM (reprint author), 3255 South Dearborn St,WH 314, Chicago, IL 60616 USA.
EM brey@iit.edu
RI Jiang, Bin/Q-4150-2017
OI Jiang, Bin/0000-0003-2390-4312
FU Veterans Administration; National Science Foundation [IIS-1125412]
FX This work was supported by grants from the Veterans Administration and
   the National Science Foundation (IIS-1125412).
CR Au P, 2009, AM J PATHOL, V175, P294, DOI 10.2353/ajpath.2009.080887
   Buetow BS, 2001, AM J PATHOL, V159, P1869, DOI 10.1016/S0002-9440(10)63033-7
   Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848
   Chen F, 2007, ACTA PHARMACOL SIN, V28, P493, DOI 10.1111/j.1745-7254.2007.00527.x
   Cheng MH, 2009, PLAST RECONSTR SURG, V124, P787, DOI 10.1097/PRS.0b013e3181b17a91
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060728
   Chiu YC, 2012, J FLUORESC, V22, P907, DOI 10.1007/s10895-011-1029-6
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Jiang B, 2011, REGENERATIVE MEDICINE AND TISSUE ENGINEERING - CELLS AND BIOMATERIALS, P477
   Jiang B, 2013, ACTA BIOMATER, V9, P4976, DOI 10.1016/j.actbio.2012.10.005
   Jiang B, 2013, TISSUE ENG PT A, V19, P224, DOI 10.1089/ten.tea.2012.0120
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Tengood JE, 2011, TISSUE ENG PT A, V17, P1181, DOI [10.1089/ten.TEA.2010.0551, 10.1089/ten.tea.2010.0551]
   Tengood JE, 2010, BIOMATERIALS, V31, P7805, DOI 10.1016/j.biomaterials.2010.07.010
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
NR 20
TC 33
Z9 35
U1 1
U2 70
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1177
EP 1186
DI 10.1016/j.actbio.2013.11.029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900012
PM 24321351
DA 2018-10-19
ER

PT J
AU Freitas, SC
   Maia, S
   Figueiredo, AC
   Gomes, P
   Pereira, PJB
   Barbosa, MA
   Martins, MCL
AF Freitas, Sidonio C.
   Maia, Silvia
   Figueiredo, Ana C.
   Gomes, Paula
   Pereira, Pedro J. B.
   Barbosa, Mario A.
   Martins, M. Cristina L.
TI Selective albumin-binding surfaces modified with a thrombin-inhibiting
   peptide
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Blood compatibility; Clotting; Surface modification; Thrombin; Albumin
ID SELF-ASSEMBLED MONOLAYERS; PRO-ARG-CHLOROMETHYLKETONE; PROTEIN
   ADSORPTION; RECOMBINANT HIRUDIN; PLATELET-ADHESION; IN-VITRO; COVALENT
   IMMOBILIZATION; BLOOD COMPATIBILITY; ALPHA-THROMBIN; MODEL SYSTEM
AB Blood-contacting medical devices have been associated with severe clinical complications, such as thrombus formation, triggered by the activation of the coagulation cascade due to the adsorption of certain plasma proteins on the surface of biomaterials. Hence, the coating of such surfaces with antithrombotic agents has been used to increase biomaterial haemocompatibility. Biomaterial-induced clotting may also be decreased by albumin adsorption from blood plasma in a selective and reversible way, since this protein is not involved in the coagulation cascade. In this context, this paper reports that the immobilization of the thrombin inhibitor D-Phe-Pro-D-Arg-D-Thr-CONH2 (fPrt) onto nanostructured surfaces induces selective and reversible adsorption of albumin, delaying the clotting time when compared to peptide-free surfaces. fPrt, synthesized with two glycine residues attached to the N-terminus (GGfPrt), was covalently immobilized onto self-assembled monolayers (SAMs) having different ratios of carboxylate-hexa(ethylene glycol)- and tri(ethylene glycol)-terminated thiols (EG6-COOH/EG3) that were specifically designed to control GGfPrt orientation, exposure and density at the molecular level. In solution, GGfPrt was able to inactivate the enzymatic activity of thrombin and to delay plasma clotting time in a concentration-dependent way. After surface immobilization, and independently of its concentration, GGfPrt lost its selectivity to thrombin and its capacity to inhibit thrombin enzymatic activity against the chromogenic substrate n-p-tosyl-Gly-Pro-Arg-p-nitroanilide. Nevertheless, surfaces with low concentrations of GGfPrt could delay the capacity of adsorbed thrombin to cleave fibrinogen. In contrast, GGfPrt immobilized in high concentrations was found to induce the procoagulant activity of the adsorbed thrombin. However, all surfaces containing GGfPrt have a plasma clotting time similar to the negative control (empty polystyrene wells), showing resistance to coagulation, which is explained by its capacity to adsorb albumin in a selective and reversible way. This work opens new perspectives to the improvement of the haemocompatibility of blood-contacting medical devices. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Freitas, Sidonio C.; Barbosa, Mario A.; Martins, M. Cristina L.] Univ Porto, INEB Inst Engn Biomed, P-4150180 Oporto, Portugal.
   [Freitas, Sidonio C.] Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
   [Maia, Silvia; Gomes, Paula] Univ Porto, Fac Ciencias, CIQ UP Dept Quim & Bioquim, P-4169007 Oporto, Portugal.
   [Figueiredo, Ana C.; Pereira, Pedro J. B.] Univ Porto, IBMC, P-4150180 Oporto, Portugal.
   [Barbosa, Mario A.; Martins, M. Cristina L.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4050313 Oporto, Portugal.
RP Martins, MCL (reprint author), Univ Porto, INEB Inst Engn Biomed, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM cmartins@ineb.up.pt
RI Gomes, Paula/C-6698-2008; Freitas, Sidonio/C-8818-2014; Barbosa,
   Mario/F-5964-2011; Martins, M. Cristina/J-8284-2013; Pereira,
   Pedro/F-8972-2011
OI Gomes, Paula/0000-0002-6018-4724; Freitas, Sidonio/0000-0002-4900-6388;
   Barbosa, Mario/0000-0003-3568-7482; Martins, M.
   Cristina/0000-0002-6574-4794; Pereira, Pedro/0000-0003-0969-5438;
   Figueiredo, Ana/0000-0001-8386-8216; Maia, Silvia/0000-0002-1329-0946
FU FEDER funds through the Programa Operacional Factores de Competitividade
   (COMPETE); Portuguese funds through FCT (Fundacao para a Ciencia e a
   Tecnologia) [PTDC/BIA-PRO/70627/2006, PEst-C/SAU/LA0002/2011]; FCT
   [SFRH/BD/40537/2007]
FX This work was financed by FEDER funds through the Programa Operacional
   Factores de Competitividade (COMPETE) and by Portuguese funds through
   FCT (Fundacao para a Ciencia e a Tecnologia) in the framework of the
   projects PTDC/BIA-PRO/70627/2006 and PEst-C/SAU/LA0002/2011. The authors
   would like to thank to Doctor Carlos Sa and Liliana Alves (CEMUP) for
   assistance in the XPS investigation and IPS for donating the human
   plasma. Sidonio Freitas acknowledges FCT for PhD fellowship
   SFRH/BD/40537/2007.
CR Acharya G, 2007, J AM CHEM SOC, V129, P732, DOI 10.1021/ja0656649
   Alibeik S, 2011, ACTA BIOMATER, V7, P4177, DOI 10.1016/j.actbio.2011.07.022
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   [Anonymous], 1993, IOD 125 GUID RAD TEC
   [Anonymous], 2009, PROP THROMB
   Barrias CC, 2005, BIOMATERIALS, V26, P2695, DOI 10.1016/j.biomaterials.2004.07.033
   Berceli SA, 1998, J VASC SURG, V27, P1117, DOI 10.1016/S0741-5214(98)70014-X
   BODE W, 1989, EMBO J, V8, P3467, DOI 10.1002/j.1460-2075.1989.tb08511.x
   Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027
   Briand E, 2006, COLLOID SURFACE B, V53, P215, DOI 10.1016/j.colsurfb.2006.09.010
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen H, 2009, J BIOMED MATER RES A, V90A, P940, DOI 10.1002/jbm.a.32152
   Clement CC, 2006, UNDERSTANDING BIOLOGY USING PEPTIDES, P553, DOI 10.1007/978-0-387-26575-9_239
   Clement CC, 2009, ADV EXP MED BIOL, V611, P579, DOI 10.1007/978-0-387-73657-0_255
   Clement CC, 2007, FASEB J, V21, pA1013
   Collins JM, 2007, ORG BIOMOL CHEM, V5, P1141, DOI 10.1039/b617084f
   Du YJ, 2000, COLLOID SURFACE B, V17, P59, DOI 10.1016/S0927-7765(99)00053-3
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Figueiredo AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034354
   Figueiredo AC, 2011, ACTA CRYSTALLOGR F, V67, P54, DOI 10.1107/S1744309110043472
   Freitas SC, 2012, ACTA BIOMATER, V8, P4101, DOI 10.1016/j.actbio.2012.07.020
   Freitas SC, 2010, BIOMATERIALS, V31, P3772, DOI 10.1016/j.biomaterials.2010.01.097
   Frey BL, 1996, ANAL CHEM, V68, P3187, DOI 10.1021/ac9605861
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   Goncalves IC, 2011, J MATER SCI-MATER M, P1
   Goncalves IC, 2009, BIOMATERIALS, V30, P5541, DOI 10.1016/j.biomaterials.2009.06.025
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z
   Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y
   HORBETT TA, 1986, TECHNIQUES BIOCOMPAT, P183
   KEOGH JR, 1994, J LAB CLIN MED, V124, P537
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Laux V, 2009, THROMB HAEMOSTASIS, V102, P892, DOI 10.1160/TH09-02-0134
   Lee CJ, 2011, BRIT J CLIN PHARMACO, V72, P581, DOI 10.1111/j.1365-2125.2011.03916.x
   Lestelius M, 1997, LANGMUIR, V13, P5900, DOI 10.1021/la970187g
   Li D, 2009, ACTA BIOMATER, V5, P1864, DOI 10.1016/j.actbio.2009.03.001
   LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341
   Maitz MF, 2010, J BIOMED MATER RES A, V94A, P905, DOI 10.1002/jbm.a.32780
   MARAGANORE JM, 1990, BIOCHEMISTRY-US, V29, P7095, DOI 10.1021/bi00482a021
   Martin MCL, 2003, J MATER SCI-MATER M, V14, P945, DOI 10.1023/A:1026394431100
   Martins MCL, 2009, J BIOMED MATER RES A, V88A, P162, DOI 10.1002/jbm.a.31849
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   Martins MCL, 2003, BIOMATERIALS, V24, P3697, DOI 10.1016/S0142-9612(03)00244-8
   Metallo SJ, 2003, J AM CHEM SOC, V125, P4534, DOI 10.1021/ja030045a
   Molek P, 2011, MOLECULES, V16, P857, DOI 10.3390/molecules16010857
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Phaneuf MD, 1997, BIOMATERIALS, V18, P755, DOI 10.1016/S0142-9612(96)00193-7
   Phaneuf MD, 1998, ARTIF ORGANS, V22, P657, DOI 10.1046/j.1525-1594.1998.05091.x
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Roeges N. P. G., 1994, GUIDE COMPLETE INTER
   SARKAR B, 1968, CAN J BIOCHEM CELL B, V46, P601, DOI 10.1139/o68-092
   Sask KN, 2010, ACTA BIOMATER, V6, P2911, DOI 10.1016/j.actbio.2010.02.043
   Schwienhorst A, 2006, CELL MOL LIFE SCI, V63, P2773, DOI 10.1007/s00018-006-6219-z
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   Subramanian A, 2006, BIOSENS BIOELECTRON, V21, P998, DOI 10.1016/j.bios.2005.03.007
   Sun XL, 2000, J BIOMED MATER RES, V49, P66, DOI 10.1002/(SICI)1097-4636(200001)49:1<66::AID-JBM9>3.3.CO;2-O
   Thakurta SG, 2011, J MATER SCI-MATER M, V22, P137, DOI 10.1007/s10856-010-4169-3
   Wagner P, 1996, BIOPHYS J, V70, P2052, DOI 10.1016/S0006-3495(96)79810-7
   Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Wyers MC, 1999, CARDIOVASC PATHOL, V8, P153, DOI 10.1016/S1054-8807(99)00005-8
   YU XJ, 1993, TEST PROCEDURES BLOO, P287
NR 71
TC 1
Z9 1
U1 6
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1227
EP 1237
DI 10.1016/j.actbio.2013.11.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900017
PM 24316365
OA Green Published
DA 2018-10-19
ER

PT J
AU Yu, L
   Xu, W
   Shen, WJ
   Cao, LP
   Liu, Y
   Li, ZS
   Ding, JD
AF Yu, Lin
   Xu, Wei
   Shen, Wenjia
   Cao, Luping
   Liu, Yan
   Li, Zhaoshen
   Ding, Jiandong
TI Poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic
   acid-co-glycolic acid) thermogel as a novel submucosal cushion for
   endoscopic submucosal dissection
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Endoscopic submucosal dissection (ESD); Submucosal injection;
   Biodegradable thermogel; Perforation; Mucosal elevation
ID COPOLYMER AQUEOUS-SOLUTIONS; BIODEGRADABLE BLOCK-COPOLYMERS; EARLY
   GASTRIC-CANCER; HYALURONIC-ACID; TRIBLOCK COPOLYMER; FLUID CUSHION;
   IN-VIVO; BIOMEDICAL APPLICATIONS; INJECTABLE HYDROGEL;
   CONTROLLED-RELEASE
AB Endoscopic submucosal dissection (ESD) is a clinical therapy for early stage neoplastic lesions in the gastrointestinal tract. It is, however, faced with a crucial problem: the high occurrence of perforation. The formation of a submucosal fluid cushion (SFC) via a fluid injection is the best way to avoid perforation, and thus an appropriate biomaterial is vital for this minimally invasive endoscopic technique. In this study, we introduced an injectable thermogel as a novel submucosal injection substance in ESD. The hydrogel synthesized by us was composed of poly(lactic acid-co-glycolic acid)-poly(ethylene glycol)-poly(lactic acid-co-glycolic acid) (PLGA-PEG-PLGA) triblock copolymers. The polymer/water system was a low-viscosity fluid at room temperature and thus easily injected, and turned into a non-flowing gel at body temperature after injection. The submucosal injection of the thermogel to create SFCs was performed in both resected porcine stomachs and living minipigs. High mucosal elevation with a clear margin was maintained for a long duration. Accurate en bloc resection was achieved with the assistance of the thermogel. The mean procedure time was strikingly reduced. Meanwhile, no obvious bleeding, perforation and tissue damage were observed. The application of the thermogel not only facilitated the ESD procedure, but also increased the efficacy and safety of ESD. Therefore, the PLGA-PEG-PLGA thermogel provides an excellent submucosal injection system, and has great potential to improve the ESD technique significantly. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Yu, Lin; Shen, Wenjia; Cao, Luping; Ding, Jiandong] Fudan Univ, Dept Macromol Sci, Adv Mat Lab, State Key Lab Mol Engn Polymers, Shanghai 200433, Peoples R China.
   [Liu, Yan] 307 Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing 100071, Peoples R China.
   [Xu, Wei; Liu, Yan; Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.
   [Ding, Jiandong] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery, Minist Educ, Shanghai 201203, Peoples R China.
RP Liu, Y (reprint author), 307 Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing 100071, Peoples R China.
EM 13044161270@163.com; jdding1@fudan.edu.cn
FU NSF of China [51273217, 81001074, 91127028, 21034002]; Chinese Ministry
   of Science and Technology (973 Program) [2011CB606203]; Science and
   Technology Developing Foundation of Shanghai [12JC1402600, 13XD1401000]
FX The group was supported by NSF of China (Grants No. 51273217, No.
   81001074, No. 91127028 and No. 21034002), Chinese Ministry of Science
   and Technology (973 Program No. 2011CB606203) and Science and Technology
   Developing Foundation of Shanghai (Grants No. 12JC1402600 and No.
   13XD1401000).
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Bae SJ, 2006, MACROMOLECULES, V39, P4873, DOI 10.1021/ma060153s
   Bearat HH, 2012, ACTA BIOMATER, V8, P3629, DOI 10.1016/j.actbio.2012.06.012
   Chang GT, 2011, J CONTROL RELEASE, V156, P21, DOI 10.1016/j.jconrel.2011.07.008
   Chang GT, 2009, POLYMER, V50, P6111, DOI 10.1016/j.polymer.2009.10.036
   Chen YC, 2013, ACTA BIOMATER, V9, P5181, DOI 10.1016/j.actbio.2012.09.039
   Cho KB, 2011, WORLD J GASTROENTERO, V17, P2611, DOI 10.3748/wjg.v17.i21.2611
   Huynh CT, 2011, MACROMOLECULES, V44, P6629, DOI 10.1021/ma201261m
   Huynh CT, 2011, SOFT MATTER, V7, P4974, DOI 10.1039/c1sm05080j
   Duvall A, 2007, GASTROENTEROLOGY, V132, pA417
   Epstein-Barash H, 2012, ACTA BIOMATER, V8, P1703, DOI 10.1016/j.actbio.2012.01.028
   Feitoza AB, 2003, GASTROINTEST ENDOSC, V57, P41, DOI 10.1067/mge.2003.25
   Fujishiro M, 2005, GASTROINTEST ENDOSC, V62, P933, DOI 10.1016/j.gie.2005.07.052
   Fujishiro M, 2007, DIGEST ENDOSC, V19, P26, DOI 10.1111/j.1443-1661.2007.00682.x
   Gotoda T, 2006, J GASTROENTEROL, V41, P929, DOI 10.1007/s00535-006-1954-3
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Jeong B, 1999, MACROMOLECULES, V32, P7064, DOI 10.1021/ma9908999
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kang EY, 2012, MACROMOLECULES, V45, P2007, DOI 10.1021/ma202809c
   Kang YM, 2011, BIOMATERIALS, V32, P4556, DOI 10.1016/j.biomaterials.2011.03.007
   Kang YM, 2010, BIOMATERIALS, V31, P2453, DOI 10.1016/j.biomaterials.2009.11.115
   Nguyen K, 2013, ACTA BIOMATER, V9, P4487, DOI 10.1016/j.actbio.2012.08.012
   Khashab MA, 2013, GASTROENTEROLOGY, V144, P505, DOI 10.1053/j.gastro.2013.01.005
   Kim JI, 2012, BIOMATERIALS, V33, P4836, DOI 10.1016/j.biomaterials.2012.03.048
   Kumano I, 2012, GASTROINTEST ENDOSC, V75, P841, DOI 10.1016/j.gie.2011.10.035
   Li K, 2013, BIOMATERIALS, V34, P2834, DOI 10.1016/j.biomaterials.2013.01.013
   Loh XJ, 2010, J CONTROL RELEASE, V143, P175, DOI 10.1016/j.jconrel.2009.12.030
   Matsui Y, 2004, GASTROINTEST ENDOSC, V60, P539, DOI 10.1016/S0016-5107(04)01890-5
   Moon HJ, 2012, CHEM SOC REV, V41, P4860, DOI 10.1039/c2cs35078e
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Oka S, 2006, GASTROINTEST ENDOSC, V64, P877, DOI 10.1016/j.gie.2006.03.932
   Peng Q, 2013, ACTA BIOMATER, V9, P5063, DOI 10.1016/j.actbio.2012.09.034
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shim MS, 2002, J BIOMED MATER RES, V61, P188, DOI 10.1002/jbm.10164
   Vermonden T, 2012, CHEM REV, V112, P2853, DOI 10.1021/cr200157d
   Wang WW, 2012, ACTA BIOMATER, V8, P3963, DOI 10.1016/j.actbio.2012.07.021
   Yoshida N, 2011, J GASTROEN HEPATOL, V26, P286, DOI 10.1111/j.1440-1746.2010.06505.x
   Yu L, 2006, ANGEW CHEM INT EDIT, V45, P2232, DOI 10.1002/anie.200503575
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2013, J PHARM SCI-US, V102, P4140, DOI 10.1002/jps.23735
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j
   Yu L, 2010, BIOMACROMOLECULES, V11, P2169, DOI 10.1021/bm100549q
   Yu L, 2009, BIOMACROMOLECULES, V10, P1547, DOI 10.1021/bm900145g
   Yun EJ, 2012, BIOMACROMOLECULES, V13, P1106, DOI 10.1021/bm2018596
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang H, 2010, J BIOMAT SCI-POLYM E, V21, P253, DOI 10.1163/156856209X415747
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
   Zhang Z, 2010, BIOMATERIALS, V31, P7873, DOI 10.1016/j.biomaterials.2010.07.014
NR 52
TC 32
Z9 33
U1 4
U2 119
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1251
EP 1258
DI 10.1016/j.actbio.2013.12.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900019
PM 24345554
DA 2018-10-19
ER

PT J
AU Seras-Franzoso, J
   Peebo, K
   Garcia-Fruitos, E
   Vazquez, E
   Rinas, U
   Villaverde, A
AF Seras-Franzoso, Joaquin
   Peebo, Karl
   Garcia-Fruitos, Elena
   Vazquez, Esther
   Rinas, Ursula
   Villaverde, Antonio
TI Improving protein delivery of fibroblast growth factor-2 from bacterial
   inclusion bodies used as cell culture substrates
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Inclusion bodies; Protein release; Drug delivery; Nanomedicine; Surface
   functionalization
ID ESCHERICHIA-COLI; AMYLOID AGGREGATION; IN-VIVO; POLYPEPTIDES; RELEASE;
   FUSION; DRUGS; SIZE
AB Bacterial inclusion bodies (IBs) have recently been used to generate biocompatible cell culture interfaces, with diverse effects on cultured cells such as cell adhesion enhancement, stimulation of cell growth or induction of mesenchymal stem cell differentiation. Additionally, novel applications of IBs as sustained protein delivery systems with potential applications in regenerative medicine have been successfully explored. In this scenario, with IBs gaining significance in the biomedical field, the fine tuning of this functional biomaterial is crucial. In this work, the effect of temperature on fibroblast growth factor-2 (FGF-2) IB production and performance has been evaluated. FGF-2 was overexpressed in Escherichia coli at 25 and 37 degrees C, producing IBs with differences in size, particle structure and biological activity. Cell culture topographies made with FGF-2 IBs biofabricated at 25 degrees C showed higher levels of biological activity as well as a looser supramolecular structure, enabling a higher protein release from the particles. In addition, the controlled use of FGF-2 protein particles enabled the generation of functional topographies with multiple biological activities being effective on diverse cell types. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain.
   [Seras-Franzoso, Joaquin; Garcia-Fruitos, Elena; Vazquez, Esther; Villaverde, Antonio] CIBER BBN, Barcelona 08193, Spain.
   [Peebo, Karl] Competence Ctr Food & Fermentat Technol, EE-12618 Tallinn, Estonia.
   [Rinas, Ursula] Leibniz Univ Hannover, Inst Tech Chem Life Sci, D-30167 Hannover, Germany.
   [Rinas, Ursula] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.
RP Seras-Franzoso, J (reprint author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.
EM Joaquin.Seras@uab.cat
OI Garcia-Fruitos, Elena/0000-0001-7498-4864; Villaverde,
   Antonio/0000-0002-2615-4521; Seras-Franzoso,
   Joaquin/0000-0002-7893-4773; Vazquez, Esther/0000-0003-1052-0424
FU CIBER de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain);
   VI National RDi Plan; Iniciativa Ingenio; Consolider Program; CIBER
   Actions; Instituto de Salud Carlos III; MINECO [BFU2010-17450]; AGAUR
   [2009SGR-0108]; ICREA ACADEMIA award
FX We are indebted to MINECO (BFU2010-17450), AGAUR (2009SGR-0108) and
   CIBER de Bioingenieria, Biomateriales y Nanomedicina (CIBER-BBN, Spain)
   for funding our research on inclusion bodies. CIBER-BBN is an initiative
   funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010,
   Consolider Program, CIBER Actions and financed by the Instituto de Salud
   Carlos III with assistance from the European Regional Development Fund.
   We also acknowledge technical assistance from the Servei de Cultius
   Cellulars, Produccio d'Anticossos i Citometria (SCAC) at the Universitat
   Autonoma de Barcelona (UAB). A.V. received an ICREA ACADEMIA award. We
   are also indebted to the Protein Production Platform (CIBER-BBN) for
   helpful technical assistance and for protein production and purification
   services
   (http://www.bbn.ciber-bbn.es/programas/plataformas/equipamiento).
CR Arese M, 1999, MOL BIOL CELL, V10, P1429, DOI 10.1091/mbc.10.5.1429
   Bhang SH, 2009, BIOMATERIALS, V30, P126, DOI 10.1016/j.biomaterials.2008.09.021
   Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26
   Carrio MM, 1999, BBA-PROTEIN STRUCT M, V1434, P170, DOI 10.1016/S0167-4838(99)00177-6
   Carrio MM, 1998, FEMS MICROBIOL LETT, V169, P9, DOI 10.1016/S0378-1097(98)00444-3
   Diez-Gil C, 2010, BIOMATERIALS, V31, P5805, DOI 10.1016/j.biomaterials.2010.04.008
   FLORKIEWICZ RZ, 1989, P NATL ACAD SCI USA, V86, P3978, DOI 10.1073/pnas.86.11.3978
   FRIESEL RE, 1995, FASEB J, V9, P919
   Garcia-Fruitos E, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-27
   Garcia-Fruitos E, 2007, J MOL BIOL, V374, P195, DOI 10.1016/j.jmb.2007.09.004
   Garcia-Fruitos E, 2011, FEBS J, V278, P2419, DOI 10.1111/j.1742-4658.2011.08165.x
   Garcia-Fruitos E, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/20/205101
   Garcia-Fruitos E, 2009, ADV MATER, V21, P4249, DOI 10.1002/adma.200900283
   Gonzalez-Montalban N, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-26
   Hoffmann F, 2004, ENZYME MICROB TECH, V34, P235, DOI 10.1016/j.enzmictec.2003.10.011
   Huang ZL, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-25
   Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp[0497839
   Liovic M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-67
   MARSTON FAO, 1986, BIOCHEM J, V240, P1
   Nahalka J, 2008, J IND MICROBIOL BIOT, V35, P219, DOI 10.1007/s10295-007-0287-4
   Nahalka J, 2007, BIOTECHNOL BIOENG, V97, P454, DOI 10.1002/bit.21244
   Pandey N, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-43
   Peternel S, 2008, BIOTECHNOL APPL BIOC, V49, P239, DOI 10.1042/BA20070140
   Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Roessl U, 2010, BIOTECHNOL LETT, V32, P341, DOI 10.1007/s10529-009-0173-4
   Seras-Franzoso J, 2013, NANOMEDICINE LOND
   Seras-Franzoso J, 2013, NANOMEDICINE-UK, V8, P1587, DOI [10.2217/NNM.12.188, 10.2217/nnm.12.188]
   Seras-Franzoso J, 2012, NANOMEDICINE-UK, V7, P79, DOI [10.2217/NNM.11.83, 10.2217/nnm.11.83]
   Talafova K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-16
   TAYLOR G, 1986, BIO-TECHNOL, V4, P553, DOI 10.1038/nbt0686-553
   Vazquez E, 2012, ADV MATER, V24, P1742, DOI 10.1002/adma.201104330
   Villar-Pique A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-55
   Villaverde A, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-76
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Zieris A, 2010, BIOMATERIALS, V31, P7985, DOI 10.1016/j.biomaterials.2010.07.021
NR 36
TC 14
Z9 14
U1 1
U2 20
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAR
PY 2014
VL 10
IS 3
BP 1354
EP 1359
DI 10.1016/j.actbio.2013.12.021
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3AO
UT WOS:000331663900029
PM 24361427
DA 2018-10-19
ER

PT J
AU Koshy, ST
   Ferrante, TC
   Lewin, SA
   Mooney, DJ
AF Koshy, Sandeep T.
   Ferrante, Thomas C.
   Lewin, Sarah A.
   Mooney, David J.
TI Injectable, porous, and cell-responsive gelatin cryogels
SO BIOMATERIALS
LA English
DT Article
DE Injectable; Gelatin; Cryogel; Degradable; Matrix metalloproteinase
ID METHACRYLATE HYDROGELS; DELIVERY; CSF
AB The performance of biomaterials-based therapies can be hindered by complications associated with surgical implant, motivating the development of materials systems that allow minimally invasive introduction into the host. In this study, we created cell-adhesive and degradable gelatin scaffolds that could be injected through a conventional needle while maintaining a predefined geometry and architecture. These scaffolds supported attachment, proliferation, and survival of cells in vitro and could be degraded by recombinant matrix metalloproteinase-2 and -9. Prefabricated gelatin cryogels rapidly resumed their original shape when injected subcutaneously into mice and elicited only a minor host response following injection. Controlled release of granulocyte-macrophage colony-stimulating factor from gelatin cryogels resulted in complete infiltration of the scaffold by immune cells and promoted matrix metalloproteinase production leading to cell-mediated degradation of the cryogel matrix. These findings suggest that gelatin cryogels could serve as a cell-responsive platform for biomaterial-based therapy. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Koshy, Sandeep T.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Koshy, Sandeep T.; Ferrante, Thomas C.; Lewin, Sarah A.; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Koshy, Sandeep T.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
OI Koshy, Sandeep/0000-0003-2836-5813
FU NIH [R01 EB015498]; NSERC PGS-D; HHMI ISRF; National Science Foundation
   under NSF [ECS-0335765]
FX This work was supported by NIH Grant R01 EB015498 to DJM. SK was
   supported by a NSERC PGS-D and a HHMI ISRF. This work was performed in
   part at the Center for Nanoscale Systems (CNS) at Harvard University, a
   member of the National Nanotechnology Infrastructure Network (NNIN),
   which is supported by the National Science Foundation under NSF award
   no. ECS-0335765. The authors would like to thank Alexander Cheung, Dr.
   Manav Mehta, Rajiv Desai, Max Darnell, Anup Tuladhar, Dr. Cathal Kearney
   and Dr. Yevgeny Brudno for scientific discussions. We especially thank
   DE Roderick Bronson of the Harvard Rodent Histopathology Core for his
   pathological assessment of H&E sections, and Charles Sheahan of the
   Harvard Medical School East Quad NMR facility for assistance with NMR.
CR Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bae KH, 2013, J MATER CHEM B, V1, P5371, DOI 10.1039/c3tb20940g
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Benton JA, 2009, TISSUE ENG PT A, V15, P3221, DOI [10.1089/ten.tea.2008.0545, 10.1089/ten.TEA.2008.0545]
   Chen YC, 2012, ADV FUNCT MATER, V22, P2027, DOI 10.1002/adfm.201101662
   Dranoff G, 2002, IMMUNOL REV, V188, P147, DOI 10.1034/j.1600-065X.2002.18813.x
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Henderson TMA, 2013, J MATER CHEM B, V1, P2682, DOI 10.1039/c3tb20280a
   Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI [10.1089/ten.TEA.2010.0666, 10.1089/ten.tea.2010.0666]
   Kang HW, 1999, J BIOACT COMPAT POL, V14, P331, DOI 10.1177/088391159901400404
   Khajah M, 2011, J LEUKOCYTE BIOL, V89, P945, DOI 10.1189/jlb.0809546
   Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI [10.1089/ten.tec.2009.0406, 10.1089/ten.TEC.2009.0406]
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin RZ, 2013, BIOMATERIALS, V34, P6785, DOI 10.1016/j.biomaterials.2013.05.060
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Mollinedo F, 1997, BIOCHEM J, V327, P917, DOI 10.1042/bj3270917
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Qi H, 2010, ADV MATER, V22, P5276, DOI 10.1002/adma.201002873
   Ramon-Azcon J, 2012, LAB CHIP, V12, P2959, DOI 10.1039/c2lc40213k
   Sakai S, 2009, BIOMATERIALS, V30, P3371, DOI 10.1016/j.biomaterials.2009.03.030
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Von den Hoff JW, 2005, BIOTECHNIQUES, V38, P73
   Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zhang YH, 1998, J IMMUNOL, V161, P3071
NR 31
TC 91
Z9 95
U1 4
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAR
PY 2014
VL 35
IS 8
BP 2477
EP 2487
DI 10.1016/j.biomaterials.2013.11.044
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB3GL
UT WOS:000331679200010
PM 24345735
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Acasigua, GAX
   de Olyveira, GM
   Costa, LMM
   Braghirolli, DI
   Fossati, ACM
   Guastaldi, AC
   Pranke, P
   Daltro, GD
   Basmaji, P
AF Xavier Acasigua, Gerson Arisoly
   de Olyveira, Gabriel Molina
   Manzine Costa, Ligia Maria
   Braghirolli, Daikelly Iglesias
   Medeiros Fossati, Anna Christina
   Guastaldi, Antonio Carlos
   Pranke, Patricia
   Daltro, Gildasio de Cerqueira
   Basmaji, Pierre
TI Novel Chemically Modified Bacterial Cellulose Nanocomposite as Potential
   Biomaterial for Stem Cell Therapy Applications
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Article
DE Bacterial cellulose; cell viability study; nanoskin (R); natural
   nanocomposites; regenerative medicine; stem cells
ID DECIDUOUS TEETH; IN-VITRO; REGENERATION; SCAFFOLDS; MATRIX; RESPONSES;
   PULP
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of applied scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of hyaluronic acid and gelatin (1% w/w) to the culture medium before the bacteria is inoculated. Hyaluronic acid and gelatin influence in bacterial cellulose was analyzed using Transmission Infrared Spectroscopy (FTIR) and Scanning Electron Microscopy (SEM). Adhesion and viability studies with human dental pulp stem cells using natural bacterial cellulose/hyaluronic acid as scaffolds for regenerative medicine are presented for the first time in this work. MTT viability assays show higher cell adhesion in bacterial cellulose/gelatin and bacterial cellulose/ hyaluronic acid scaffolds over time with differences due to fiber agglomeration in bacterial cellulose/gelatin. Confocal microscopy images showed that the cell were adhered and well distributed within the fibers in both types of scaffolds.
C1 [Xavier Acasigua, Gerson Arisoly; Medeiros Fossati, Anna Christina] Univ Fed Rio Grande do Sul, Postgrad Program Dent, BR-90610000 Porto Alegre, RS, Brazil.
   [de Olyveira, Gabriel Molina; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
   [Manzine Costa, Ligia Maria] Univ Fed Abc, Dept Nanosci & Adv Mat, BR-09210170 Santo Andre, SP, Brazil.
   [Braghirolli, Daikelly Iglesias; Pranke, Patricia] Univ Fed Rio Grande do Sul, Fac Pharm, Hematol & Stem Cell Lab, BR-90610000 Porto Alegre, RS, Brazil.
   [Braghirolli, Daikelly Iglesias; Pranke, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Physiol, BR-90610000 Porto Alegre, RS, Brazil.
   [Pranke, Patricia] SCRI, BR-90610000 Porto Alegre, RS, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Araraquara, SP, Brazil.
EM gmolyveira@yahoo.com.br
RI Manzine Costa, Ligia Maria/N-1780-2015; Guastaldi, Antonio/O-7379-2014
OI Manzine Costa, Ligia Maria/0000-0001-6483-7633; Guastaldi,
   Antonio/0000-0002-6433-3555
CR Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Bae WJ, 2012, DENT MATER, V28, P1271, DOI 10.1016/j.dental.2012.09.011
   Barbara PF, 1996, J PHYS CHEM-US, V100, P13148, DOI 10.1021/jp9605663
   Bernardi L, 2011, J ENDODONT, V37, P973, DOI 10.1016/j.joen.2011.04.010
   Bunting KD, 2003, BIOL CELL, V95, P563, DOI 10.1016/j.biolcel.2003.10.001
   Cherian B. M., 2013, ADV NATURAL POLYM AD, V18, P337, DOI [10.1007/978-3-642-20940-6_10, DOI 10.1007/978-3-642-20940-6_10]
   Cherian BM, 2012, RSC GREEN CHEM SER, P255, DOI 10.1039/9781849735315-00255
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   Costa L. M. M., 2012, J BIOMATER NANOBIOTE, V3, P92, DOI [10.4236/jbnb.2012.31012, DOI 10.4236/JBNB.2012.31012]
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DENLINGER JL, 1980, EXP EYE RES, V31, P81, DOI 10.1016/0014-4835(80)90092-5
   Dong SJ, 2002, ELECTROANAL, V14, P7, DOI 10.1002/1521-4109(200201)14:1<7::AID-ELAN7>3.0.CO;2-V
   Gilardi G, 2001, TRENDS BIOTECHNOL, V19, P468, DOI 10.1016/S0167-7799(01)01769-3
   Gois P. B. P., 2013, INT REV BIOPHYSICAL, V3, P48
   Han WQ, 2012, J APPL POLYM SCI, V128, P1332
   Hild N, 2012, BIOMED MATER, V7
   Hung HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065738
   Kacurakova M, 2002, CARBOHYD RES, V337, P1145, DOI 10.1016/S0008-6215(02)00102-7
   Kim HW, 2006, J BIOMED MATER RES A, V79A, P698, DOI 10.1002/jbm.a.30848
   Koyama M, 1997, P NATL ACAD SCI USA, V94, P9091, DOI 10.1073/pnas.94.17.9091
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Leong Natalie L, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2651
   Lock J, 2012, J MATER SCI-MATER M, V23, P2543, DOI 10.1007/s10856-012-4709-0
   Lu LX, 2013, ACS APPL MATER INTER, V5, P319, DOI 10.1021/am302146w
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Nie L, 2013, MATER LETT, V92, P25, DOI 10.1016/j.matlet.2012.10.077
   Olyveira G. M., 2011, J NANOTECH ENG MED, V2, P34001
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P1
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Saad B., 2008, EVID-BASED COMPL ALT, V14
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   SIX N, 2004, ORAL BIOSCI MED, V1, P35
   Teixeira AI, 2004, J BIOMED MATER RES A, V71A, P369, DOI 10.1002/jbm.a.30089
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   TOOLE BP, 1977, CLIN ORTHOP RELAT R, P258
   Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013
   Williams SJ, 2009, BIOPOLYMERS, V91, P676, DOI 10.1002/bip.21196
   Xavier L, 2013, J NANOSCI NANOTECHNO, V13, P4715, DOI 10.1166/jnn.2013.7191
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
   Zhou CJ, 2013, ACS APPL MATER INTER, V5, P3847, DOI 10.1021/am4005072
   Zugenmaier P, 2001, PROG POLYM SCI, V26, P1341, DOI 10.1016/S0079-6700(01)00019-3
NR 45
TC 7
Z9 7
U1 0
U2 33
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD MAR
PY 2014
VL 9
IS 2
BP 117
EP 123
DI 10.2174/1574888X08666131124135654
PG 7
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA AB6IE
UT WOS:000331890000006
PM 24266631
DA 2018-10-19
ER

PT J
AU Ulmeanu, M
   Sima, LE
   Ursescu, D
   Enculescu, M
   Bazan, X
   Quintana, I
AF Ulmeanu, M.
   Sima, L. E.
   Ursescu, D.
   Enculescu, M.
   Bazan, X.
   Quintana, I.
TI Cell Adhesion Response on Femtosecond Laser Initiated Liquid Assisted
   Silicon Surface
SO CURRENT TOPICS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE Femtosecond laser; liquid assisted; actin filaments organization
ID MESENCHYMAL STEM-CELLS; NITRIDE TIN FILMS; DIFFERENTIATION;
   NANOTOPOGRAPHY; COMMITMENT; CHEMISTRY; MATRIX
AB Silicon substrates were irradiated at normal incidence with a femtosecond Ti:sapphire laser (Quatronix, 90 fs pulse duration, 1 kHz repetition rate, M-2 similar to 1.2, maximum energy peak 350 mJ) operating at a wavelength of 400 nm and focused via a microscope objective (Newport; UV Objective Model, 37x 0.11 N.A.). The laser scanning was assisted by liquids precursors media such as methanol and 1,1,2-trichlorotrifluoroethane. By altering the processing parameters, such as incident laser energy, scanning speed, and different irradiation media, various surface structures were produced on areas with 1 mm 2 dimensions. We analyzed the dependence of the surface morphology on laser pulse energy, scanning speed and irradiation media. Well ordered areas are developed without imposing any boundary conditions for the capillary waves that coarsens the ripple pattern. To assess biomaterial-driven cell adhesion response we investigated actin filaments organization and cell morphological changes following growth onto processed silicon substrates. Our study of bone cell progenitor interaction with laser nanoprocessed silicon lines has shown that cells anchor mainly to contact points along the nanostructured surface. Consequently, actin filaments are stretched towards the 15 mu m wide parallel lines increasing lateral cell spreading and changing the bipolar shape of mesenchymal stem cells.
C1 [Ulmeanu, M.; Ursescu, D.] Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Magurele 077125, Romania.
   [Sima, L. E.] Acad Romana, Inst Biochem, Dept Mol Cell Biol, Bucharest 060031, Romania.
   [Ursescu, D.] Natl Inst Phys & Nucl Engn, Magurele 077125, Romania.
   [Enculescu, M.] Natl Inst Mat Phys, Magurele 077125, Romania.
   [Bazan, X.; Quintana, I.] Fdn IK4 Tekniker, Ultraprecis Proc Unit, Polo Tecnol Eibar, Gipuzkoa, Spain.
RP Ulmeanu, M (reprint author), Natl Inst Laser Plasma & Radiat Phys, Laser Dept, Atomistilor 409,POB MG-36, Magurele 077125, Romania.
EM magda.ulmeanu@inflpr.ro
RI Enculescu, Monica/C-2091-2011; Ursescu, Daniel/F-2216-2010; Sima,
   Livia/C-2882-2011
OI Enculescu, Monica/0000-0002-4476-5545; Ursescu,
   Daniel/0000-0002-0612-670X; Sima, Livia/0000-0002-3404-4162
FU EUMI-NAFAB [1059]; European Social Fund POSDRU [POSDRU/89/1.5/S/60746]
FX M. U. acknowledges the financial support of the EUMI-NAFAB project no.
   1059. L.E.S. acknowledges the financial support from the European Social
   Fund POSDRU 2007-2013 through the contract POSDRU/89/1.5/S/60746.
CR Anselme K, 2011, INT MATER REV, V56, P243, DOI 10.1179/1743280411Y.0000000001
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2008, J MICROSC-OXFORD, V231, P28, DOI 10.1111/j.1365-2818.2008.02013.x
   Bressan E, 2013, NANOMEDICINE-UK, V8, P469, DOI [10.2217/NNM.13.12, 10.2217/nnm.13.12]
   CLARK P, 1992, J CELL SCI, V103, P287
   Conway A., 2012, STEM CELL RES THER, V3, P1
   Cyster LA, 2003, J BIOMED MATER RES A, V67A, P138, DOI 10.1002/jbm.a.10087
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Devi P., 2011, AIP ADVANCES, V1
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Matei A, 2011, APPL PHYS A-MATER, V104, P821, DOI 10.1007/s00339-011-6421-1
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McNamara LE, 2012, BIOMATERIALS, V33, P2835, DOI 10.1016/j.biomaterials.2011.11.047
   Menendez-Manjon A, 2011, J PHYS CHEM C, V115, P5108, DOI 10.1021/jp109370q
   Miura K., 2011, NANOWIRES FUNDAMENTA, P395
   Ranella A, 2010, ACTA BIOMATER, V6, P2711, DOI 10.1016/j.actbio.2010.01.016
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Salloum DS, 2005, BIOMACROMOLECULES, V6, P161, DOI 10.1021/bm0497015
   Sima LE, 2013, J TISSUE ENG REGEN M, V7, P129, DOI 10.1002/term.507
   Sima LE, 2010, J BIOMED MATER RES A, V95A, P1203, DOI 10.1002/jbm.a.32947
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Ulmeanu M, 2012, APPL SURF SCI, V258, P9314, DOI 10.1016/j.apsusc.2011.08.110
   Wang C., 2010, NANOTECHNOLOGY, V21
   Wanzenboeck H., 2006, PROCEEDINGS OF THE 6
   Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620
   Zervos H., 2006, EUSPEN HEADQUARTERS, P377
NR 28
TC 2
Z9 2
U1 1
U2 26
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1568-0266
EI 1873-4294
J9 CURR TOP MED CHEM
JI Curr. Top. Med. Chem.
PD MAR
PY 2014
VL 14
IS 5
BP 624
EP 629
DI 10.2174/1568026614666140118204946
PG 6
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AB7ZT
UT WOS:000332010600006
PM 24444164
DA 2018-10-19
ER

PT J
AU Ninan, N
   Thomas, S
   Grohens, Y
AF Ninan, Neethu
   Thomas, Sabu
   Grohens, Yves
TI Zeolites incorporated polymeric gel beads-Promising drug carriers
SO MATERIALS LETTERS
LA English
DT Article
DE Pectin; Zeolite; Copper; Bacteria; Gel bead; Biomaterial
ID IN-VITRO; SCAFFOLDS; DELIVERY; RELEASE
AB Novel hybrid gel beads comprising of pectin and copper exchanged zeolites were prepared using ionotropic gelation technique. The prepared beads were transparent and spherical. The egg-box model crosslinking of pectin was visualised on the surface of the bead. The embedded zeolites maintained their crystallinity inspite of their weak interactions with pectin. Their anti-bacterial properties were attributed due to the copper ions leached from the cavities of zeolites incorporated in polymer matrix. The obtained results proved their versatility as promising drug carriers. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Ninan, Neethu; Grohens, Yves] Univ Bretagne Sud, Lab Ingn Mat Bretagne, F-56321 Lorient, France.
   [Ninan, Neethu; Thomas, Sabu] Mahatma Gandhi Univ, Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
   [Ninan, Neethu; Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
RP Ninan, N (reprint author), Univ Bretagne Sud, LIMatB, Ctr Rech Christiaan Huygens, Rue St Maude,BP 92116,Bur 32 Bis, F-56321 Lorient, France.
EM neethuninan85@yahoo.co.in
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746
FU Brittany region; European Union (FEDER); French Ministry for research
FX We are thankful to Brittany region, The European Union (FEDER) and the
   French Ministry for research for rendering financial support for
   conducting the studies.
CR Baran R, 2012, MICROPOR MESOPOR MAT, V163, P122, DOI 10.1016/j.micromeso.2012.06.055
   Chaves TF, 2012, MICROPOR MESOPOR MAT, V161, P67, DOI 10.1016/j.micromeso.2012.05.022
   Climent MJ, 2005, J CATAL, V233, P308, DOI 10.1016/j.jcat.2005.05.003
   Dyer A, 2000, J HELMINTHOL, V74, P137, DOI 10.1017/S0022149X00000184
   Fox S, 2010, ACTA BIOMATER, V6, P1515, DOI 10.1016/j.actbio.2009.10.038
   Ghaffari A, 2007, EUR J PHARM BIOPHARM, V67, P175, DOI 10.1016/j.ejpb.2007.01.013
   Kim YH, 2012, APPL SURF SCI, V258, P3823, DOI 10.1016/j.apsusc.2011.12.036
   Malekian R, 2011, APPL CLAY SCI, V51, P323, DOI 10.1016/j.clay.2010.12.020
   Ninan N, 2013, COLLOIDS SURF B
   Ninan N, 2013, ACS APPL MATER INTER, V5, P11194, DOI 10.1021/am403436y
   Ninan N, 2013, EUR POLYM J, V49, P2433, DOI 10.1016/j.eurpolymj.2013.02.014
   Ninan N, 2013, CARBOHYD POLYM, V98, P877, DOI 10.1016/j.carbpol.2013.06.067
   Ninan N, 2011, THER DELIV, V2, P711, DOI 10.4155/TDE.11.47
   Nguyen S, 2011, COLLOID SURFACE B, V88, P664, DOI 10.1016/j.colsurfb.2011.07.058
   Schurz F, 2009, APPL CATAL A-GEN, V355, P42, DOI 10.1016/j.apcata.2008.11.014
   Shams K, 2013, MICROPOR MESOPOR MAT, V180, P61, DOI 10.1016/j.micromeso.2013.06.019
   Tamura C, 2013, CARBOHYD POLYM, V93, P747, DOI 10.1016/j.carbpol.2012.12.046
   Vilaca N, 2013, COLLOID SURFACE B, V112, P237, DOI 10.1016/j.colsurfb.2013.07.042
   Wei XL, 2006, INT J PHARM, V318, P132, DOI 10.1016/j.ijpharm.2006.03.024
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Zhang YL, 2011, J BIOMAT SCI-POLYM E, V22, P809, DOI 10.1163/092050610X496242
NR 21
TC 7
Z9 7
U1 1
U2 25
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
EI 1873-4979
J9 MATER LETT
JI Mater. Lett.
PD MAR 1
PY 2014
VL 118
BP 12
EP 16
DI 10.1016/j.matlet.2013.12.055
PG 5
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA AB3BP
UT WOS:000331666600004
DA 2018-10-19
ER

PT J
AU Kirubaharan, CJ
   Edayadulla, N
   Kumar, GG
   Nahm, KS
AF Kirubaharan, C. Joseph
   Edayadulla, N.
   Kumar, G. Gnana
   Nahm, Kee Suk
TI The Catalytic Activity of Bio-Mediated Palladium Nanoparticles on Imine
   Formation Reactions
SO SCIENCE OF ADVANCED MATERIALS
LA English
DT Article
DE Active Sites; Nanoparticles; Recyclability; Surface Area; Yield
ID DIRECT REDUCTIVE AMINATION; ASYMMETRIC ADDITION; AZADIRACHTA-INDICA;
   COUPLING REACTIONS; HYDROGEN-PEROXIDE; PD NANOPARTICLES; GREEN
   SYNTHESIS; AMINES; WATER; FABRICATION
AB Bio-mediated palladium nanoparticles were synthesized with the aid of an eco-friendly biomaterial Azadirachta indica extract. The influence of extract volume, temperature and pH on the formation of palladium nanoparticles were analyzed in detail. The morphological and structural properties of the prepared palladium nanoparticles were characterized by TEM and XRD techniques, respectively. Moreover, the bio-mediated palladium nanoparticles were employed as effective catalysts in the preparation of imine derivatives without any surface modification. The excellent yield and high purity of the imine derivatives and prompt recyclability behavior of the prepared green nanocatalysts make them a potential contender in the imine formation reactions.
C1 [Kirubaharan, C. Joseph; Kumar, G. Gnana] Madurai Kamaraj Univ, Dept Phys Chem, Madurai 625021, Tamil Nadu, India.
   [Edayadulla, N.] Mother Teresa Womens Univ, Dept Chem, Kodaikanal 624102, Tamil Nadu, India.
   [Nahm, Kee Suk] Chonbuk Natl Univ, Sch Chem Engn, Jeonju 561756, South Korea.
RP Kumar, GG (reprint author), Madurai Kamaraj Univ, Dept Phys Chem, Madurai 625021, Tamil Nadu, India.
EM kumarg2006@gmail.com; nahmks@jbnu.ac.kr
FU Department of Science and Technology-SERB, New Delhi
   [SR/FT/CS-113/2010(G)]; Human Resources Development Program of the Korea
   Institute of Energy Technology Evaluation and Planning (KETEP)
   [20114030200060]; Korea government Ministry of Trade, Industry and
   Energy; Chonbuk National University
FX This work was supported by Department of Science and Technology-SERB,
   New Delhi, Fast Track Project for Young Scientist Grant No.
   SR/FT/CS-113/2010(G). This work was supported by the Human Resources
   Development Program (No. 20114030200060) of the Korea Institute of
   Energy Technology Evaluation and Planning (KETEP) grant funded by the
   Korea government Ministry of Trade, Industry and Energy and was also
   supported by research grant of Chonbuk National University in 2011.
CR Arpad M, 2011, CHEM REV, V111, P2251, DOI 10.1021/cr100355b
   Balanta A, 2011, CHEM SOC REV, V40, P4973, DOI 10.1039/c1cs15195a
   Bandyopadhyay Debasish, 2011, Org Med Chem Lett, V1, P11, DOI 10.1186/2191-2858-1-11
   Bankar A, 2010, MATER LETT, V64, P1951, DOI 10.1016/j.matlet.2010.06.021
   Bhor MD, 2008, TETRAHEDRON LETT, V49, P965, DOI 10.1016/j.tetlet.2007.12.023
   Bode CA, 2006, TETRAHEDRON, V62, P11499, DOI 10.1016/j.tet.2006.07.071
   Bunzen H, 2013, MOLECULES, V18, P3745, DOI 10.3390/molecules18043745
   Chakraborti AK, 2004, TETRAHEDRON LETT, V45, P7641, DOI 10.1016/j.tetlet.2004.08.097
   Chen L, 2010, J AM CHEM SOC, V132, P9138, DOI 10.1021/ja1028556
   Dalpozzo R, 2010, CHEM REV, V110, P3501, DOI 10.1021/cr9003488
   Guerrero M, 2010, LANGMUIR, V26, P15532, DOI 10.1021/la1016802
   Hadjipavlou-litina DJ, 1996, DRUG DES DISCOV, V15, P199
   Hamza K, 2004, ORG LETT, V6, P925, DOI 10.1021/ol030140o
   KUZNETSOV VV, 1991, ZH ORG KHIM+, V27, P1579
   Largeron M, 2008, CHEM-EUR J, V14, P996, DOI 10.1002/chem.200700876
   Lenardao EJ, 2007, TETRAHEDRON LETT, V48, P7668, DOI 10.1016/j.tetlet.2007.08.094
   Li XH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01743
   Lowry GV, 2012, ENVIRON SCI TECHNOL, V46, P6893, DOI 10.1021/es300839e
   Lu ZL, 2002, CHEM REV, V102, P3543, DOI 10.1021/cr010358t
   Nand P, 2012, J PHARM NEGAT RESULT, V3, P29, DOI 10.4103/0976-9234.99650
   NISHINAGA A, 1988, J MOL CATAL, V48, P249, DOI 10.1016/0304-5102(88)85009-0
   Okitsu K, 2000, CHEM MATER, V12, P3006, DOI 10.1021/cm0001915
   Orito K, 1998, TETRAHEDRON, V54, P8403, DOI 10.1016/S0040-4020(98)00461-X
   Peng QL, 2011, CHEM COMMUN, V47, P6476, DOI 10.1039/c1cc11057h
   Perez-Lorenzo M, 2012, J PHYS CHEM LETT, V3, P167, DOI 10.1021/jz2013984
   Petla RK, 2012, J BIOMATER NANOBIOTE, V3, P14, DOI DOI 10.4236/JBNB.2012.31003
   Pritchard J, 2010, LANGMUIR, V26, P16568, DOI 10.1021/la101597q
   Reier T, 2012, ACS CATAL, V2, P1765, DOI 10.1021/cs3003098
   Roberta B., 2007, J NANOSCI NANOTECHNO, V7, P2696
   Robichaud A, 2006, TETRAHEDRON LETT, V47, P3633, DOI 10.1016/j.tetlet.2006.03.153
   Ross I. A., 2003, MED PLANTS WORLD CHE, V1
   Roucoux A, 2002, CHEM REV, V102, P3757, DOI 10.1021/cr010350j
   Saggiomo V, 2009, TETRAHEDRON LETT, V50, P4663, DOI 10.1016/j.tetlet.2009.05.117
   Sathishkumar M, 2009, J HAZARD MATER, V171, P400, DOI 10.1016/j.jhazmat.2009.06.014
   SCHELLENBERG KA, 1963, J ORG CHEM, V28, P3259, DOI 10.1021/jo01046a537
   SCHROEDER DR, 1987, J NAT PROD, V50, P241, DOI 10.1021/np50050a023
   Sheny DS, 2012, SPECTROCHIM ACTA A, V91, P35, DOI 10.1016/j.saa.2012.01.063
   Shukla VK, 2012, J HAZARD MATER, V213, P161, DOI 10.1016/j.jhazmat.2012.01.071
   Siddiqui BS, 2004, PHYTOCHEMISTRY, V65, P2363, DOI 10.1016/j.phytochem.2004.04.031
   SIDDIQUI S, 1986, PHYTOCHEMISTRY, V25, P2183, DOI 10.1016/0031-9422(86)80087-5
   Tsuge O, 1989, ADV HETEROCYCL CHEM, V45, P231
   Vicini P, 2003, BIOORGAN MED CHEM, V11, P4785, DOI 10.1016/S0968-0896(03)00493-0
   Wei CM, 2004, P NATL ACAD SCI USA, V101, P5749, DOI 10.1073/pnas.0307150101
   Yang X, 2010, J NANOPART RES, V12, P1589, DOI 10.1007/s11051-009-9675-1
   Zhong ZY, 2011, SCI ADV MATER, V3, P968, DOI 10.1166/sam.2011.1223
   Zhou XF, 2013, EUR POLYM J, V49, P1957, DOI 10.1016/j.eurpolymj.2013.04.006
   Zhou XF, 2012, J MATER CHEM, V22, P8862, DOI 10.1039/c2jm16411f
NR 47
TC 1
Z9 1
U1 0
U2 9
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1947-2935
EI 1947-2943
J9 SCI ADV MATER
JI Sci. Adv. Mater.
PD MAR
PY 2014
VL 6
IS 3
BP 483
EP 491
DI 10.1166/sam.2014.1741
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA AB8KG
UT WOS:000332038300009
DA 2018-10-19
ER

PT J
AU Wheeler, DL
   Lane, JM
   Seim, HB
   Puttlitz, CM
   Itescu, S
   Turner, AS
AF Wheeler, Donna L.
   Lane, Joseph M.
   Seim, Howard B., III
   Puttlitz, Christian M.
   Itescu, Silviu
   Turner, A. Simon
TI Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine
   fusion in sheep
SO SPINE JOURNAL
LA English
DT Article
DE Ovine posterolateral lumbar spine fusion; Mesenchymal stem cells; Bone
   graft substitute; Biomechanics; Histology; Computed tomography
ID STEM-CELLS; BONE-MARROW; GROWTH-FACTOR; CANINE MODEL; GRAFT; CERAMICS;
   EFFICACY
AB BACKGROUND CONTEXT: Osteoconductive porous ceramic bone graft materials supplemented with mesenchymal precursor cells (MPC) derived from autologous bone marrow aspirates have been shown to stimulate successful interbody and posterolateral spine fusion in preclinical models. Recent advances in immunomagnetic cell sorting have enabled purification and isolation of pluripotent stem cells from marrow aspirates and have expanded stem cell technology to allogeneic cell sources. Allogeneic MPC technology combined with appropriate synthetic biomaterial carriers could provide both the osteogenic and osteoconductive components needed for successful posterolateral spine fusion without the need for autologous bone harvest or expensive recombinant protein technology.
   PURPOSE: To determine the safety and efficacy of a hydroxyapatite: tricalcium phosphate graft material supplemented with allogeneic mesenchymal precursor cells in posterolateral lumbar spine fusion using an ovine model.
   STUDY DESIGN: Skeletally mature ewes underwent single-level instrumented posterolateral lumbar spine fusion using either autograft (AG), hydroxyapatite: tricalcium phosphate carrier (CP), or CP supplemented with allogeneic mesenchymal progenitor cells (MPCs). Three doses of MPCs were evaluated: 25 x 10(6) cells (low dose, LD), 75 x 10(6) cells (mid dose, MD), and 225 x 10(6) cell (high dose, HD). Animals survived for either 4 or 9 months.
   METHODS: Plain radiographs were acquired and scored for bridging bone at regular intervals during healing to monitor fusion development. Hematology, coagulation, and serum chemistry were monitored at regular intervals throughout the study to monitor animal health. After necropsy, computed tomography, high-resolution radiography, biomechanical testing, organ pathology, bone histopathology, and bone histomorphometry were conducted to monitor the safety and ascertain the efficacy of MPC treatment.
   RESULTS: MPC treatment in this spine fusion model resulted in no observed adverse systemic or local tissue responses. Radiographically, fusion scores for MPC-treated animals were uniformly higher compared with those treated with carrier alone (CP) after 3 months and continued the same trend throughout 9 month of healing. Quantitative computed tomography confirmed better connectivity of the fusion for MPC treatment groups compared with CP. Biomechanical analyses were not able to differentiate between treatment groups. Histomorphometry results confirmed radiographic and quantitative computed tomography results; cell-supplemented treatment groups and autograft had equivalent amounts of bone within the fusion mass and less bony fusion tissue was found within the fusion mass in specimens from the CP treatment group. No conclusive effects of cell dose of fusion efficacy were noted.
   CONCLUSIONS: Adult allogeneic mesenchymal precursor cells delivered via a hydroxyapatite:tricalcium phosphate carrier were both safe and efficacious in this ovine spine fusion model. Results from this preclinical study support that allogeneic mesenchymal precursor cells produced fusion efficacy similar to that achieved using iliac crest autograft, thereby providing a safe and viable option to achieve successful posterolateral spine fusion. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Wheeler, Donna L.] BioSolut Consulting LLC, Santa Rosa, CA 95403 USA.
   [Lane, Joseph M.] Hosp Special Surg, Dept Orthopaed, New York, NY 10021 USA.
   [Seim, Howard B., III; Turner, A. Simon] Colorado State Univ, Coll Vet Med, Dept Clin Sci, Ft Collins, CO 80525 USA.
   [Puttlitz, Christian M.] Colorado State Univ, Coll Engn, Dept Mech Engn, Ft Collins, CO 80525 USA.
   [Itescu, Silviu] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA.
   [Itescu, Silviu] Mesoblast Ltd, New York, NY 10036 USA.
RP Wheeler, DL (reprint author), BioSolut Consulting LLC, 3416 Henderson Cir, Santa Rosa, CA 95403 USA.
EM donna.wheeler@biosoln.com
FU Colorado State University
FX DLW: Nothing to disclose. JML: Stock Ownership: CollPlant, Inc (20,000
   Shares.); Consulting: Amgen (B, Paid directly to institution/employer),
   BioMimetics (B, Paid directly to institution/employer), CollPlant (C,
   Paid directly to institution/employer), DFine (B, Paid directly to
   institution/employer), Graftys (B, Paid directly to
   institution/employer), Zimmer (C, Paid directly to
   institution/employer); Speaking and/orTeaching Arrangements: Eli Lilly
   (D), Novartis (B), Warner Chilcott (B); Trips/Travel: Zimmer (A, Paid
   directly to institution/employer); Scientific Advisory Board: Zimmer
   (A); Research Support - Staff and/or Materials: Cohn Foundation (F).
   HBS: Research Support (Investigator Salary, Staff/Materials): Colorado
   State University (B, Paid directly to institution/employer). CMP:
   Nothing to disclose. SI: Other: Mesoblast (CEO, > 5% stock ownership,
   Paid directly to institution/employer); Stock Ownership: Mesoblast (> 5%
   ownership); Board of Directors: Mesoblast (> 5% stock ownership). AST:
   Nothing to disclose.
CR Anderson James M., 1996, P165
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1995, SPINE, V20, P2633, DOI 10.1097/00007632-199512150-00004
   Bozkus H, 2004, SPINE, V29, P635, DOI 10.1097/01.BRS.0000115126.13081.7D
   Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cui QJ, 2001, SPINE, V26, P2305, DOI 10.1097/00007632-200111010-00003
   Delecrin J, 1997, SPINE, V22, P1683, DOI 10.1097/00007632-199708010-00001
   DELWICHE LD, 2003, LITTLE SAS BOOK
   Emery SE, 1996, SPINE, V21, P2713, DOI 10.1097/00007632-199612010-00003
   Goldschlager T, 2011, SPINE, V36, P615, DOI 10.1097/BRS.0b013e3181dfcec9
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gupta MC, 2007, SPINE, V32, P720, DOI 10.1097/01.brs.0000258863.40984.32
   Kai T, 2003, SPINE, V28, P1653, DOI 10.1097/00007632-200308010-00005
   Kanayama M, 1999, SPINE, V24, P1058, DOI 10.1097/00007632-199906010-00003
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P129, DOI 10.5435/00124635-200503000-00006
   LEGEROS RZ, 2002, CLIN ORTHOP RELAT R, V395, P81, DOI DOI 10.1097/00003086-200202000-00009
   MARINI JA, 2005, ORTH RES SOC FEBR 20
   Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404
   Minamide A, 2005, SPINE, V30, P1134, DOI 10.1097/01.brs.0000162394.75425.04
   Minamide A, 2007, SPINE, V32, P1067, DOI 10.1097/01.brs.0000261626.32999.8a
   Nakajima T, 2007, SPINE, V32, P2432, DOI 10.1097/BRS.0b013e3181573924
   O'Brien FJ, 2002, J BIOMECH, V35, P523, DOI 10.1016/S0021-9290(01)00200-7
   Orii Hisaya, 2005, Journal of Medical and Dental Sciences, V52, P51
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   SCHENK R, 1994, BONE FORMATION REPAI
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Simmons P J, 1994, Prog Clin Biol Res, V389, P271
   Wheeler DL, 2007, SPINE J, V7, P308, DOI 10.1016/j.spinee.2006.01.005
   Wilke HJ, 1997, SPINE, V22, P2365, DOI 10.1097/00007632-199710150-00009
NR 32
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD MAR
PY 2014
VL 14
IS 3
SI SI
BP 435
EP 444
DI 10.1016/j.spinee.2013.09.048
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AB3TY
UT WOS:000331714300008
PM 24438940
DA 2018-10-19
ER

PT J
AU Liang, HX
   Li, XD
   Shimer, AL
   Balian, G
   Shen, FH
AF Liang, Haixiang
   Li, Xudong
   Shimer, Adam L.
   Balian, Gary
   Shen, Francis H.
TI A novel strategy of spine defect repair with a degradable bioactive
   scaffold preloaded with adipose-derived stromal cells
SO SPINE JOURNAL
LA English
DT Article
DE Poly(lactide-co-glycolide) acid; Microspheres; Vertebral body; Bone
   defect; Growth and differentiation factor 5; Bone repair
ID STIMULATES OSTEOGENIC DIFFERENTIATION; FORMATION IN-VIVO; BONE REPAIR;
   PLASMA TREATMENT; TISSUE; VEGF; VITRO; POLY(LACTIDE-CO-GLYCOLIDE);
   TRANSPLANTATION; ANGIOGENESIS
AB BACKGROUND CONTEXT: Although the use of mesenchymal stem cells (MSC) with scaffolds for bone repair has been considered an effective method, the interactions between implanted materials and bone tissues have not been fully elucidated. At some specific sites, such as the vertebral body (VB) of the spine, the process of bone repair with implanted biomaterials is rarely reported. Recently, adipose tissue was found to be an alternative source of MSC besides bone marrow. However, the strategy of using adipose-derived stromal (ADS) cells with bioactive scaffold for the repair of spinal bone defects has seldom been studied.
   PURPOSE: To use a sintered poly(lactide-co-glycolide) acid (PLGA) microspheres scaffold seeded with induced rat ADS cells to repair a bone defect of the VB in a rat model.
   STUDY DESIGN: Basic science and laboratory study.
   METHODS: A sintered porous microspheres scaffold was manufactured by PLGA. ADS cells were isolated from Fischer 344 rats and then induced by osteogenic medium with growth and differentiation factor 5 (GDF5) in vitro. Before implantation, cells were cultured with inductive media for 2 weeks as a monolayer situation and 1 more week on a PLGA scaffold as a three-dimensional structure. These assembled bioactive scaffolds then were implanted in lumbar VB bone defects in Fischer 344 rats. The ex vivo differentiation of the cells was confirmed by von Kossa staining and real-time polymerase chain reaction. The performance of cells on the scaffold was detected by scanning electron microscopy and (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)2-(4-sulfophenyl)-2H-tetrazolium) assay. In vivo bone formation was quantitatively measured by computed tomography study. And the effect of tissue repair was also evaluated by histological studies.
   RESULTS: Proliferation and differentiation of cells were confirmed before in vivo implantation. Quantification of bone formation in vivo through serial three-dimensional computed tomography images revealed that the VB implanted with GDF5-induced cells demonstrated more bone formation than the control groups. Besides the bone formation period that occurred between 2 and 4 weeks in all groups, a second bone formation period was found to occur only in the groups that received cells with previous induction in vitro. This second period of significant bone formation happened simultaneously with collapsing of the scaffolds. It was then demonstrated histologically that vascularization early in the process and cooperation between host bone and implanted cells accompanied by collapse of the scaffold may be the factors that influence bone formation. This study not only provides a therapeutic strategy of using biomaterial for bone repair in the spine, but also may lead to a technological method for studying the relationship between implanted stem cells and host tissue.
   CONCLUSIONS: Adipose-derived stromal cells maintained in culture on a scaffold and treated with osteogenic induction with growth factor ex vivo could be used to enhance bone repair in vivo. (C) 2014 Elsevier Inc. All rights reserved.
C1 [Liang, Haixiang; Li, Xudong; Shimer, Adam L.; Balian, Gary; Shen, Francis H.] Univ Virginia, Sch Med, Dept Orthopaed Surg, Orthopaed Res Labs, Charlottesville, VA 22908 USA.
   [Balian, Gary] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
RP Shen, FH (reprint author), Univ Virginia Hlth Syst, Dept Orthopaed Surg, Box 800159, Charlottesville, VA 22908 USA.
EM fhs2g@virginia.edu
OI Liang, Haixiang/0000-0002-2276-1367
FU Orthopedic Trauma Association; Orthopedic Research and Education
   Foundation
FX Supported by a research grant from the Orthopedic Trauma Association and
   by a Faculty Research Grant and a Clinician Scientist Award (to F.H.S.)
   from the Orthopedic Research and Education Foundation.
CR Borden M, 2004, J BONE JOINT SURG BR, V86B, P1200, DOI 10.1302/0301-620X.86B8.14267
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Borden M, 2002, BIOMATERIALS, V23, P551, DOI 10.1016/S0142-9612(01)00137-5
   Cancedda R, 2007, BIOMATERIALS, V28, P4240, DOI 10.1016/j.biomaterials.2007.06.023
   Cui FA, 2010, GROWTH FACTORS, V28, P306, DOI 10.3109/08977194.2010.484423
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Dicker A, 2005, EXP CELL RES, V308, P283, DOI 10.1016/j.yexcr.2005.04.029
   Hattori H, 2004, CELLS TISSUES ORGANS, V178, P2, DOI 10.1159/000081088
   hen FH, 2006, SPINE J, V6, P615
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   Kim ES, 2010, J ADV PROSTHODONT, V2, P7, DOI [10.4047/jap.2010.2.1.7, 10.4047/jap.2010.2.7-13]
   Liang HX, 2010, BONE, V47, P197, DOI 10.1016/j.bone.2010.05.023
   Oshima Y, 2005, J HISTOCHEM CYTOCHEM, V53, P207, DOI 10.1369/jhc.4A6280.2005
   Scherberich A, 2010, J CELL PHYSIOL, V225, P348, DOI 10.1002/jcp.22313
   Sena K, 2007, CONNECT TISSUE RES, V48, P324, DOI 10.1080/03008200701692743
   Shoji T, 2010, LAB INVEST, V90, P637, DOI 10.1038/labinvest.2010.39
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Tan SH, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3466882
   Wang YJ, 2006, J BIOMED MATER RES A, V76A, P589, DOI 10.1002/jbm.a.30575
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Wernike E, 2010, EUR CELLS MATER, V19, P30
   Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022
   Zeng Q, 2006, CONNECT TISSUE RES, V47, P264, DOI 10.1080/03008200600980769
   Zheng B, 2006, TISSUE ENG, V12, P1891, DOI 10.1089/ten.2006.12.1891
NR 24
TC 8
Z9 9
U1 0
U2 19
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1529-9430
EI 1878-1632
J9 SPINE J
JI Spine Journal
PD MAR
PY 2014
VL 14
IS 3
SI SI
BP 445
EP 454
DI 10.1016/j.spinee.2013.09.045
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AB3TY
UT WOS:000331714300009
PM 24360747
DA 2018-10-19
ER

PT J
AU Ma, M
   Zhang, B
   Lu, WP
   Liu, JL
   Guo, YC
AF Ma, Ming
   Zhang, Bing
   Lu, Weipeng
   Liu, Junli
   Guo, Yanchuan
TI Preparation, thermal stability and biocompatibility studies of
   gelatin-induced hydroxyapatite co-substituted with essential
   physiological trace elements
SO CHINESE SCIENCE BULLETIN
LA English
DT Article
DE Gelatin; Calcium phosphates; Co-substitution; Precipitation; In vitro
   biological tests; MC3T3-E1 cell lines
ID OSTEOCLAST DIFFERENTIATION; NANO-HYDROXYAPATITE; IN-VITRO; BONE;
   CALCIUM; MAGNESIUM; BIOMINERALIZATION; TEMPERATURE; CARBONATE; SODIUM
AB Gelatin-induced hydroxyapatite with combined substitution of essential physiological trace elements (G-FAP) was prepared by a precipitation method. Pure hydroxyapatite (HAP) and ion-substituted hydroxyapatite (FAP) were also prepared for comparison. The characteristics of the precipitated powders were determined using X-ray diffraction (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), Fourier transform infrared spectroscopy (FT-IR), specific surface area measurement (SSA), X-ray fluorescence spectroscopy (XRF), and thermogravimetric (TG) analysis. The biocompatibility was also determined by an in vitro investigation with MC3T3-E1 cells. SEM and TEM results showed that the G-FAP powders were composed of dense aggregates of agglomerated whisker-like crystals of 200-300 nm in length and 10-20 nm in width. XRD and FT-IR analyses indicated the formation of pure apatite phase, and the substituted ions and gelatin did not change the diffraction pattern of the precipitated powders. The SSAs of the precipitated powder were 64.741, 72.492, and 107.745 m(2)/g, for HAP, FAP, and G-FAP, respectively. XRF analysis showed that Na+, Mg2+, and F- were substituted into the crystal lattice. TG results showed a reduced thermal stability of the precipitated G-FAP powders, with an advanced phase transformation beginning at 800 A degrees C and a serious phase transformation from hexagonal apatite phase to rhombohedral beta-TCP phase at 1,200 A degrees C in comparison with HAP and FAP. In vitro biological tests showed non-cytotoxic effects for all powders. However, G-FAP stimulated the proliferation of MC3T3-E1 cells earlier than HAP and FAP. The present G-FAP will therefore be a promising primary biomaterial for bone regeneration, tooth filling, or as a coating for metal artificial limbs.
C1 [Ma, Ming; Zhang, Bing; Lu, Weipeng; Guo, Yanchuan] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing 100190, Peoples R China.
   [Liu, Junli] 306th Hosp Peoples Liberat Army, Beijing 100101, Peoples R China.
RP Guo, YC (reprint author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing 100190, Peoples R China.
EM yanchuanguo@mail.ipc.ac.cn
FU Programs of International Science and Technology Corporation, China
   [S2013ZR0442]; Beijing Municipal Science and Technology Project
   [Z131100005213007]
FX This work was supported by Programs of International Science and
   Technology Corporation, China (S2013ZR0442) and Beijing Municipal
   Science and Technology Project (Z131100005213007).
CR Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bianco A, 2010, CERAM INT, V36, P313, DOI 10.1016/j.ceramint.2009.09.007
   Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Bigi A, 2007, INORG CHIM ACTA, V360, P1009, DOI 10.1016/j.ica.2006.07.074
   BLUMENTHAL NC, 1975, CALC TISS RES, V18, P81, DOI 10.1007/BF02546228
   Braye F, 1996, BIOMATERIALS, V17, P1345, DOI 10.1016/0142-9612(96)88682-0
   Cho JS, 2014, J BIOMED MATER RES A, V102, P455, DOI 10.1002/jbm.a.34722
   CONAWAY HH, 1971, ANAL BIOCHEM, V39, P218, DOI 10.1016/0003-2697(71)90479-9
   Deng Y, 2013, MATER LETT, V104, P8, DOI 10.1016/j.matlet.2013.03.145
   DEVINE A, 1995, AM J CLIN NUTR, V62, P740
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin Sergey V, 2011, Biomatter, V1, P121, DOI 10.4161/biom.18790
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Eiden-Assmann S, 2002, J INORG BIOCHEM, V91, P481, DOI 10.1016/S0162-0134(02)00481-6
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Ergun C, 2008, J EUR CERAM SOC, V28, P2137, DOI 10.1016/j.jeurceramsoc.2008.03.007
   Fujisawa R, 1996, BBA-PROTEIN STRUCT M, V1292, P53, DOI 10.1016/0167-4838(95)00190-5
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   GLOWACKI J, 1991, J CELL BIOCHEM, V45, P292, DOI 10.1002/jcb.240450312
   GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767
   GRUBBS RD, 1987, MAGNESIUM, V6, P113
   Jenkins R, 2012, INTRO XRAY POWDER DI
   KANDORI K, 1992, COLLOID SURFACE, V68, P283, DOI 10.1016/0166-6622(92)80214-M
   Kannan S, 2006, CHEM MATER, V18, P2181, DOI 10.1021/cm052567q
   Kannan S, 2006, J INORG BIOCHEM, V100, P1692, DOI 10.1016/j.jinorgbio.2006.06.005
   Kannan S, 2006, CHEM MATER, V18, P198, DOI 10.1021/cm051966i
   Kleerekoper M, 1998, ENDOCRIN METAB CLIN, V27, P441, DOI 10.1016/S0889-8529(05)70015-3
   Koutsopoulos S, 2002, J BIOMED MATER RES, V62, P600, DOI 10.1002/jbm.10280
   Kumar GS, 2012, MATER CHEM PHYS, V134, P1127, DOI 10.1016/j.matchemphys.2012.04.005
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Laurencin D, 2011, BIOMATERIALS, V32, P1826, DOI 10.1016/j.biomaterials.2010.11.017
   Lijuan X., 2013, MATER LETT, V106, P246
   LIU JK, 2005, EUR J INORG CHEM, V20, P4145
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Nakamura M, 2013, J BIOMED MATER RES A, V101, P3141, DOI 10.1002/jbm.a.34621
   Peng SF, 2001, MACROMOLECULES, V34, P6795, DOI 10.1021/ma010376c
   Schaffner P, 2003, CELL MOL LIFE SCI, V60, P119, DOI 10.1007/s000180300008
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Tucker KL, 1999, AM J CLIN NUTR, V69, P727
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Wang T, 2004, MATER LETT, V58, P3025, DOI 10.1016/j.matlet.2004.05.033
   Yuan H, 2005, CALCIUM PHOSPHATE BI
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
NR 46
TC 4
Z9 4
U1 3
U2 53
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1001-6538
EI 1861-9541
J9 CHINESE SCI BULL
JI Chin. Sci. Bull.
PD MAR
PY 2014
VL 59
IS 7
BP 606
EP 615
DI 10.1007/s11434-013-0091-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AB1PC
UT WOS:000331563700003
DA 2018-10-19
ER

PT J
AU Gaume, B
   Denis, F
   Van Wormhoudt, A
   Huchette, S
   Jackson, DJ
   Avignon, S
   Auzoux-Bordenave, S
AF Gaume, B.
   Denis, F.
   Van Wormhoudt, A.
   Huchette, S.
   Jackson, D. J.
   Avignon, S.
   Auzoux-Bordenave, S.
TI Characterisation and expression of the biomineralising gene Lustrin A
   during shell formation of the European abalone Haliotis tuberculata
SO COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR
   BIOLOGY
LA English
DT Article
DE Biomineralisation; Haliotis tuberculata; Larval development; Lustrin A;
   Shell
ID CALCIUM-CARBONATE CRYSTALS; NACRE PROTEIN; IN-VITRO; DOMAINS; MANTLE;
   IDENTIFICATION; GASTROPODA; LAEVIGATA; ARAGONITE; SEQUENCE
AB The molluscan shell is a remarkable product of a highly coordinated biomineralisation process, and is composed of calcium carbonate most commonly in the form of calcite or aragonite. The exceptional mechanical properties of this biomaterial are imparted by the embedded organic matrix which is secreted by the underlying mantle tissue. While many shell-matrix proteins have already been identified within adult molluscan shell, their presence and role in the early developmental stages of larval shell formation are not well understood. In the European abalone Haliotis tuberculata, the shell first forms in the early trochophore larva and develops into a mineralised protoconch in the veliger. Following metamorphosis, the juvenile shell rapidly changes as it becomes flattened and develops a more complex crystallographic profile including an external granular layer and an internal nacreous layer. Amongst the matrix proteins involved in abalone shell formation, Lustrin A is thought to participate in the formation of the nacreous layer: Here we have identified a partial cDNA coding for the Lustrin A gene in H. tuberculata and have analysed its spatial and temporal expression during abalone development. RTPCR experiments indicate that Lustrin A is first expressed in juvenile (post-metamorphosis) stages, suggesting that Lustrin A is a component of the juvenile shell, but not of the larval shell. We also detect Lustrin A mRNAs in non-nacre forming cells at the distal-most edge of the juvenile mantle as well as in the nacre-forming region of the mantle. Lustrin A was also expressed in 7-day-old post-larvae, prior to the formation of nacre. These results suggest that Lustrin A plays multiple roles in the shell-forming process and further highlight the dynamic ontogenic nature of molluscan shell formation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Gaume, B.; Denis, F.; Van Wormhoudt, A.; Avignon, S.; Auzoux-Bordenave, S.] UPMC, Museum Natl Hist Nat, UMR BOREA Biol Organismes & Ecosyst Aquat, Stn Biol Marine Concarneau,CNRS 7208,IRD 207, F-29900 Concarneau, France.
   [Denis, F.] Univ Maine, F-72085 Le Mans, France.
   [Huchette, S.] Ecloserie France Haliotis, F-29880 Kerazan, Plouguerneau, France.
   [Jackson, D. J.] Univ Gottingen, Courant Res Ctr Geobiol, D-37077 Gottingen, Germany.
   [Auzoux-Bordenave, S.] Univ Paris 06, F-75005 Paris, France.
RP Gaume, B (reprint author), Univ Antilles Guyane, DYNECAR EA 926, Lab Biol Marine, Campus Fouillole, F-97110 Pointe a Pitre, Guadeloupe, Guadeloupe.
EM beatrice-gaume@hotmail.fr; fdenis@mnhn.fr; avw@mnhn.fr;
   sylvain.huchette@wanadoo.fr; djackso@uni-goettingen.de; bordenav@mnhn.fr
RI Jackson, Daniel/J-5158-2012
OI Jackson, Daniel/0000-0001-9045-381X; HUCHETTE,
   Sylvain/0000-0002-9253-6907; AUZOUX-BORDENAVE,
   Stephanie/0000-0001-7429-1654
FU ATM program "Biomineralisation" of the MNHN; Ministere delegue a
   l'Enseignement Superieur et la Recherche (Paris, France); Deutsche
   Forschungsgemeinschaft (DFG) through the CRC for Geobiology; German
   Excellence Initiative; ATM program "Biomineralisation" of the MNHN;
   Ministere delegue a l'Enseignement Superieur et la Recherche (Paris,
   France); Deutsche Forschungsgemeinschaft (DFG) through the CRC for
   Geobiology; German Excellence Initiative
FX This work was financed in part by the ATM program "Biomineralisation" of
   the MNHN funded by the Ministere delegue a l'Enseignement Superieur et
   la Recherche (Paris, France). This work was supported by the Deutsche
   Forschungsgemeinschaft (DFG) funding to DJJ through the CRC for
   Geobiology and the German Excellence Initiative.
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110
   Amos FF, 2009, BIOCHEMISTRY-US, V48, P1332, DOI 10.1021/bi802148r
   Auzoux-Bordenave S, 2010, J STRUCT BIOL, V171, P277, DOI 10.1016/j.jsb.2010.05.012
   Bedouet L, 2012, MAR BIOTECHNOL, V14, P446, DOI 10.1007/s10126-011-9425-0
   Blank S, 2003, J MICROSC-OXFORD, V212, P280, DOI 10.1111/j.1365-2818.2003.01263.x
   de Vicose GC, 2007, J SHELLFISH RES, V26, P847, DOI 10.2983/0730-8000(2007)26[847:EALDOH]2.0.CO;2
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67
   Gaume B, 2011, MAR BIOL, V158, P341, DOI 10.1007/s00227-010-1562-x
   Giusti AF, 2000, EVOL DEV, V2, P294, DOI 10.1046/j.1525-142x.2000.00071.x
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   Jackson DJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-160
   Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40
   Jardillier E, 2008, MAR BIOL, V154, P735, DOI 10.1007/s00227-008-0966-3
   Joubert C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-613
   Le Roy N, 2012, J EXP ZOOL PART B, V318B, P353, DOI 10.1002/jez.b.22452
   Lowenstam H.A., 1989, ON BIOMINERALISATION
   Mann K, 2007, BIOPHYS J, V93, P1246, DOI 10.1529/biophysj.106.100636
   Mann S., 2001, BIOMINERALISATION PR
   Marie B, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-54
   Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8
   McDougall C, 2011, CELLS TISSUES ORGANS, V194, P103, DOI 10.1159/000324213
   Michenfelder M, 2003, BIOPOLYMERS, V70, P522, DOI 10.1002/bip.10536
   Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403
   Sud D, 2002, J SHELLFISH RES, V21, P201
   Treccani L, 2006, BIOPHYS J, V91, P2601, DOI 10.1529/biophysj.106.086108
   Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001
   Weiss IM, 2000, BIOCHEM BIOPH RES CO, V267, P17, DOI 10.1006/bbrc.1999.1907
   Wustman BA, 2004, BIOPOLYMERS, V74, P363, DOI 10.1002/bip.20086
   Wustman BA, 2003, CONNECT TISSUE RES, V44, P10, DOI 10.1080/03008200390152016
   Zhang B, 2002, BIOPOLYMERS, V63, P358, DOI 10.1002/bip.10069
NR 35
TC 8
Z9 9
U1 1
U2 34
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1096-4959
EI 1879-1107
J9 COMP BIOCHEM PHYS B
JI Comp. Biochem. Physiol. B-Biochem. Mol. Biol.
PD MAR
PY 2014
VL 169
BP 1
EP 8
DI 10.1016/j.cbpb.2013.11.010
PG 8
WC Biochemistry & Molecular Biology; Zoology
SC Biochemistry & Molecular Biology; Zoology
GA AB0LZ
UT WOS:000331485100001
PM 24321821
DA 2018-10-19
ER

PT J
AU Costa-Pinto, AR
   Martins, AM
   Castelhano-Carlos, MJ
   Correlo, VM
   Sol, PC
   Longatto, A
   Battacharya, M
   Reis, RL
   Neves, NM
AF Costa-Pinto, Ana R.
   Martins, Ana M.
   Castelhano-Carlos, Magda J.
   Correlo, Vitor M.
   Sol, Paula C.
   Longatto-Filho, Adhemar
   Battacharya, Mrinal
   Reis, Rui L.
   Neves, Nuno M.
TI In vitro degradation and in vivo biocompatibility of
   chitosan-poly(butylene succinate) fiber mesh scaffolds
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE scaffold; biocompatibility; biodegradation; subcutaneous implantation;
   Tissue engineering; chitosan
ID TISSUE ENGINEERING APPLICATIONS; N-ACETYLATED CHITOSANS; OSTEOGENIC
   DIFFERENTIATION; POLY(BUTYLENE SUCCINATE); CHITIN; HYDROLYSIS;
   POLYESTERS; LYSOZYME; CELLS; BIODEGRADATION
AB In tissue engineering, the evaluation of the host response to the biomaterial implantation must be assessed to determine the extent of the inflammatory reaction. We studied the degradation of poly(butylene succinate) and chitosan in vitro using lipase and lysozyme enzymes, respectively. The subcutaneous implantation of the scaffolds was performed to assess tissue response. The type of inflammatory cells present in the surrounding tissue, as well as within the scaffold, was determined histologically and by immunohistochemistry. In the presence of lipase or lysozyme, the water uptake of the scaffolds increased. Based on the weight loss data and scanning electron microscopy analysis, the lysozyme combined with lipase had a notable effect on the in vitro degradation of the scaffolds. The in vivo implantation showed a normal inflammatory response, with presence of neutrophils, in a first stage, and macrophages, lymphocytes, and giant cells in a later stage. Vascularization in the surrounding tissue and within the implant increased with time. Moreover, the collagen deposition increased with time inside the implant. In vivo, the scaffolds maintained the structural integrity. The degradation in vitro was faster and greater compared to that observed in vivo within the same time periods.
C1 [Costa-Pinto, Ana R.; Martins, Ana M.; Correlo, Vitor M.; Sol, Paula C.; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Guimaraes, Portugal.
   [Costa-Pinto, Ana R.; Martins, Ana M.; Castelhano-Carlos, Magda J.; Correlo, Vitor M.; Sol, Paula C.; Longatto-Filho, Adhemar; Reis, Rui L.; Neves, Nuno M.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal.
   [Castelhano-Carlos, Magda J.; Longatto-Filho, Adhemar] Life & Hlth Sci Res Inst ICVS, Braga, Portugal.
   [Battacharya, Mrinal] Univ Minnesota, Dept Biosyst Engn, St Paul, MN 55108 USA.
RP Neves, NM (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nuno@dep.uminho.pt
RI Castelhano Carlos, Magda Joao/Q-9490-2017; Reis, Rui L./A-8938-2008;
   Neves, Nuno/B-4685-2008; Group, 3Bs/E-4374-2012; Correlo,
   Vitor/O-4227-2015; Longatto Filho, Adhemar/A-2889-2016
OI Castelhano Carlos, Magda Joao/0000-0002-5409-5987; Reis, Rui
   L./0000-0002-4295-6129; Neves, Nuno/0000-0003-3041-0687; Group,
   3Bs/0000-0002-5195-3456; Correlo, Vitor/0000-0002-5516-7583; Sol,
   Paula/0000-0003-0512-0928; longatto-filho, adhemar/0000-0002-5779-9752;
   Martins, Ana/0000-0001-5655-5564; Pinto, Ana Rita/0000-0002-4764-8539
FU Portuguese "Fundacao para a Ciencia e a Tecnologia" (FCT)
   [SFRH/24735/2005]; European Network of Excellence EXPERTISSUES
   [NMP3-CT-2004-500283]; FCT [PTDC/SAU-ENB/115179/2009]
FX Ana R Costa-Pinto was supported by the scholarship SFRH/24735/2005 from
   the Portuguese "Fundacao para a Ciencia e a Tecnologia" (FCT). This work
   was partially supported by the European Network of Excellence
   EXPERTISSUES (NMP3-CT-2004-500283) and FCT funded project Maxbone
   (PTDC/SAU-ENB/115179/2009).
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   [Anonymous], 1099361994 ISO
   Azevedo HS, 2005, BIODEGRADABLE SYSTEMS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE, P177
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Balmayor ER, 2008, J MATER SCI-MATER M, V19, P1617, DOI 10.1007/s10856-008-3378-5
   Correlo VM, 2007, MACROMOL BIOSCI, V7, P354, DOI 10.1002/mabi.200600233
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Costa-Pinto AR, 2008, TISSUE ENG PT A, V14, P1049, DOI 10.1089/tea.2007.0153
   Cui ZW, 2013, J BIOACT COMPAT POL, V28, P115, DOI 10.1177/0883911512472278
   Ferreira L, 2004, J BIOMED MATER RES A, V68A, P584, DOI 10.1002/jm.a.20102
   Gomes ME, 2008, J TISSUE ENG REGEN M, V2, P243, DOI 10.1002/term.89
   Grech JMR, 2008, J BIOACT COMPAT POL, V23, P367, DOI 10.1177/0883911508093389
   Griffiths Marie M., 1996, Methods (Orlando), V9, P295, DOI 10.1006/meth.1996.0034
   Hasham SN, 2006, CLIN CHIM ACTA, V372, P179, DOI 10.1016/j.cca.2006.04.020
   Hashitani T, 2002, FUJITSU SCI TECH J, V38, P112
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hirotsu T, 2000, J APPL POLYM SCI, V78, P1121, DOI 10.1002/1097-4628(20001031)78:5<1121::AID-APP210>3.3.CO;2-8
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Ishihara M, 2001, WOUND REPAIR REGEN, V9, P513, DOI 10.1046/j.1524-475x.2001.00513.x
   Katti DS, 2002, ADV DRUG DELIVER REV, V54, P933, DOI 10.1016/S0169-409X(02)00052-2
   Kumar V, 2010, ROBBINS COTRAN PATHO, P43
   Li HY, 2005, MACROMOL BIOSCI, V5, P433, DOI 10.1002/mabi.200400183
   LI Q, 1992, J BIOACT COMPAT POL, V7, P370, DOI 10.1177/088391159200700406
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Malafaya BPP, 2005, J MATER SCI-MATER M, V16, P1077
   Malafaya PB, 2008, BIOMATERIALS, V29, P3914, DOI 10.1016/j.biomaterials.2008.06.023
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marten E, 2003, POLYM DEGRAD STABIL, V80, P485, DOI 10.1016/S0141-3910(03)00032-6
   Martins AM, 2009, TISSUE ENG PT A, V15, P1953, DOI 10.1089/ten.tea.2008.0023
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Nishikawa H, 2000, J ENDODONT, V26, P169, DOI 10.1097/00004770-200003000-00010
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Silva SS, 2013, J BIOACT COMPAT POL, V28, P385, DOI 10.1177/0883911513490361
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   TOKIWA Y, 1977, NATURE, V270, P76, DOI 10.1038/270076a0
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Usami Y, 1998, J BIOMED MATER RES, V42, P517
   van Dijkhuizen-Radersma R, 2008, ACAD PR SER BIOM ENG, P193, DOI 10.1016/B978-0-12-370869-4.00007-0
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
NR 50
TC 31
Z9 31
U1 0
U2 46
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
EI 1530-8030
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD MAR
PY 2014
VL 29
IS 2
BP 137
EP 151
DI 10.1177/0883911514521919
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA AB2JK
UT WOS:000331618800004
DA 2018-10-19
ER

PT J
AU Bojar, W
   Kucharska, M
   Ciach, T
   Koperski, L
   Jastrzebski, Z
   Szalwinski, M
AF Bojar, Witold
   Kucharska, Martyna
   Ciach, Tomasz
   Koperski, Lukasz
   Jastrzebski, Zenon
   Szalwinski, Michal
TI Bone regeneration potential of the new chitosan-based alloplastic
   biomaterial
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE
C1 [Bojar, Witold] Natl Med Inst, Med Devices Dept, PL-00725 Warsaw, Poland.
   [Kucharska, Martyna; Ciach, Tomasz] Warsaw Univ Technol, Fac Chem & Proc Engn, Biomed Engn Lab, PL-00661 Warsaw, Poland.
   [Koperski, Lukasz] Med Univ Warsaw, Dept Pathol, Warsaw, Poland.
   [Jastrzebski, Zenon] Natl Med Inst, Dept Pharmacol, PL-00725 Warsaw, Poland.
   [Szalwinski, Michal] Med Univ Warsaw, Dept Descript & Clin Anat, Warsaw, Poland.
RP Bojar, W (reprint author), Natl Med Inst, Med Devices Dept, Chelmska 30-34, PL-00725 Warsaw, Poland.
EM bojar@il.waw.pl
OI Ciach, Tomasz/0000-0002-8726-8944
FU Foundation of Polish Science in the framework of Innovative Economy
   Operational Programme
FX This work was financially supported by the Foundation of Polish Science
   in the framework of Innovative Economy Operational Programme.
CR Araujo MG, 2010, CLIN ORAL IMPLAN RES, V21, P445, DOI 10.1111/j.1600-0501.2009.01876.x
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Bojar W, 2012, ACTA BIOENG BIOMECH, V14, P39
   Bojar W, 2009, ADV CLIN EXP MED, V18, P615
   Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094
   HOFMANN GO, 1995, ARCH ORTHOP TRAUM SU, V114, P159, DOI 10.1007/BF00443390
   Horovitz RA, 2009, TITANIUM, V1, P1
   Hsu SH, 2004, J POLYM RES, V11, P141, DOI 10.1023/B:JPOL.0000031080.70010.0b
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Lassus J, 1998, CLIN ORTHOP RELAT R, P7
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Marins Lucele Vieira, 2004, J. Appl. Oral Sci., V12, P62, DOI 10.1590/S1678-77572004000100012
   Mendonca T.A., 2008, BRAZ ORAL RES, V22, P5
   Shegarfi Hamid, 2009, J Orthop Surg (Hong Kong), V17, P206
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
NR 17
TC 14
Z9 14
U1 0
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD MAR
PY 2014
VL 28
IS 7
BP 1060
EP 1068
DI 10.1177/0885328213493682
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA6JZ
UT WOS:000331205900010
PM 23796631
DA 2018-10-19
ER

PT J
AU Iqbal, NM
   Amirul, AA
AF Iqbal, Nurhezreen Md.
   Amirul, A. A.
TI Synthesis of P(3HB-co-4HB) copolymer with target-specific 4HB molar
   fractions using combinations of carbon substrates
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Cupriavidus sp; P(3HB-co-4HB); mixture design; copolymer; one-stage
   fermentation
ID COMAMONAS-ACIDOVORANS; CUPRIAVIDUS-NECATOR; RALSTONIA-EUTROPHA; PHA
   SYNTHASE; POLYHYDROXYALKANOATE COPOLYMERS; MICROBIAL SYNTHESIS;
   MOLECULAR-WEIGHT; IN-VITRO;
   POLY(3-HYDROXYBUTYRATE-CO-4-HYDROXYBUTYRATE); BIOSYNTHESIS
AB BACKGROUNDThe incorporation of 4HB units into P(3HB) improves the material application potential as the copolymer exhibits a wide range of physical properties ranging from crystalline plastic to elastic rubber depending on the copolymer composition. Thus, the prospects of synthesizing P(3HB-co-4HB) copolymer with various compositions of 4HB would increase its effectiveness as biomaterial.
   RESULTSThe residual cell dry weight (RCDW) and PHA concentration obtained under optimized conditions, namely C/N ratio 30, K2HPO4 6.1 g L-1, incubation period 66 h, temperature 32 degrees C and volume-to-flask ratio 47/250 mL increased from 2.9 g L-1 to 4.9 g L-1 and 4.2 g L-1 to 7.6 g L-1, respectively. P(3HB-co-4HB) with varied M-n between 26 kDa and 270 kDa were successfully synthesized using combinations of oleic acid, 1,6-hexanediol and/or 1,4-butanediol. The tensile strength and Young's modulus of the copolymers varied from 2 MPa to 24 MPa and 13 MPa to 192 MPa, respectively. T-m and T-g decreased with increasing 4HB molar fractions from 170 degrees C to 68 degrees C and 2.5 degrees C to -31 degrees C, respectively.
   CONCLUSIONOleic acid and (NH4)(2)SO4 was the best carbon and nitrogen source for PHA biosynthesis. P(3HB-co-4HB) copolymer with targeted 4HB molar fractions ranged from 0-65 mol% were synthesized using combinations of two or more carbon substrates by Cupriavidus sp. USMAA2-4 (DSM 19379) using mixture design. (c) 2013 Society of Chemical Industry
C1 [Iqbal, Nurhezreen Md.; Amirul, A. A.] Univ Sains Malaysia, Sch Biol Sci, Minden 11800, Penang, Malaysia.
   [Amirul, A. A.] MOSTI, Malaysian Inst Pharmaceut & Nutraceut, Putrajaya, Malaysia.
RP Amirul, AA (reprint author), Univ Sains Malaysia, Sch Biol Sci, Minden 11800, Penang, Malaysia.
EM amirul@usm.my
OI Abdullah, Amirul Al-Ashraf/0000-0002-5014-1472
FU Ministry of Science Technology and Innovations (MOSTI), Malaysia;
   Universiti Sains Malaysia [1001/PBIOLOGI/821109]; National Science
   Fellowship [MOSTI/BMI/TAJ/1-1/2 Jld 10(4)]
FX The authors acknowledge the research grants provided by the Ministry of
   Science Technology and Innovations (MOSTI), Malaysia, Universiti Sains
   Malaysia (1001/PBIOLOGI/821109) and National Science Fellowship
   [MOSTI/BMI/TAJ/1-1/2 Jld 10(4)].
CR Amirul AA, 2009, WORLD J MICROB BIOT, V25, P1199, DOI 10.1007/s11274-009-0002-x
   [Anonymous], 1995, ANN BOOK ASTM STAND, V08.01
   Bhubalan K, 2008, POLYM DEGRAD STABIL, V93, P17, DOI 10.1016/j.polymdegradstab.2007.11.004
   BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854
   Cavalheiro JMBT, 2012, BIORESOURCE TECHNOL, V111, P391, DOI 10.1016/j.biortech.2012.01.176
   Chanprateep S, 2010, POLYM DEGRAD STABIL, V95, P2003, DOI 10.1016/j.polymdegradstab.2010.07.014
   Chee JW, 2008, BIOCHEM ENG J, V38, P314, DOI 10.1016/j.bej.2007.07.018
   Chia KH, 2010, POLYM DEGRAD STABIL, V95, P2226, DOI 10.1016/j.polymdegradstab.2010.09.011
   DOI Y, 1990, MICROBIAL POLYESTER
   GERNGROSS TU, 1995, P NATL ACAD SCI USA, V92, P6279, DOI 10.1073/pnas.92.14.6279
   HIRAMITSU M, 1993, BIOTECHNOL LETT, V15, P461, DOI 10.1007/BF00129318
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Hsieh WC, 2009, J TAIWAN INST CHEM E, V40, P143, DOI 10.1016/j.jtice.2008.11.004
   HUISMAN GW, 1992, APPL MICROBIOL BIOT, V38, P1
   Imandi SB, 2008, BIORESOURCE TECHNOL, V99, P4445, DOI 10.1016/j.biortech.2007.08.071
   Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006
   Khanna S, 2005, PROCESS BIOCHEM, V40, P2173, DOI 10.1016/j.procbio.2004.08.011
   KUNZ DA, 1983, J BACTERIOL, V156, P567
   Lee WH, 2004, POLYM DEGRAD STABIL, V84, P129, DOI 10.1016/j.polymdegradstab.2003.10.003
   Lee WH, 2008, BIORESOURCE TECHNOL, V99, P6844, DOI 10.1016/j.biortech.2008.01.051
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lo KW, 2005, APPL BIOCHEM BIOTECH, V121, P575
   Lundstedt T, 1998, CHEMOMETR INTELL LAB, V42, P3, DOI 10.1016/S0169-7439(98)00065-3
   Madden LA, 2000, POLYMER, V41, P3499, DOI 10.1016/S0032-3861(99)00611-4
   Marangoni C, 2000, BIOTECHNOL LETT, V22, P1635, DOI 10.1023/A:1005684525264
   Martinko J., 2005, BROCK BIOL MICROORGA
   Mitomo H, 2001, POLYMER, V42, P3455, DOI 10.1016/S0032-3861(00)00678-9
   Myers R. H., 2002, RESPONSE SURFACE MET
   Nomura CT, 2007, APPL MICROBIOL BIOT, V73, P969, DOI 10.1007/s00253-006-0566-4
   Park DH, 2011, NEW BIOTECHNOL, V28, P719, DOI 10.1016/j.nbt.2011.01.007
   Poetter Markus, 2006, V1, P109, DOI 10.1007/7171_005
   Rao U, 2010, BIOCHEM ENG J, V49, P13, DOI 10.1016/j.bej.2009.11.005
   Saito Y, 1996, POLYM INT, V39, P169
   SAITO Y, 1994, INT J BIOL MACROMOL, V16, P99, DOI 10.1016/0141-8130(94)90022-1
   Sim SJ, 1997, NAT BIOTECHNOL, V15, P63, DOI 10.1038/nbt0197-63
   Solaiman DKY, 2006, APPL MICROBIOL BIOT, V71, P783, DOI 10.1007/s00253-006-0451-1
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   TAIDI B, 1994, APPL MICROBIOL BIOT, V40, P786, DOI 10.1007/s002530050067
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Tsuge T, 2007, MACROMOL BIOSCI, V7, P846, DOI 10.1002/mabi.200700023
   Vigneswari S, 2012, J APPL POLYM SCI, V124, P2777, DOI 10.1002/app.35336
   Vigneswari S, 2009, J IND MICROBIOL BIOT, V36, P547, DOI 10.1007/s10295-009-0525-z
   Volova TG, 2011, APPL BIOCHEM MICRO+, V47, P494, DOI 10.1134/S0003683811050152
   Wu Q, 2009, ARTIF CELL BLOOD SUB, V37, P1, DOI 10.1080/10731190802664429
   Ying TH, 2008, BIOMATERIALS, V29, P1307, DOI 10.1016/j.biomaterials.2007.11.031
   Yu J, 2001, J BIOTECHNOL, V86, P105, DOI 10.1016/S0168-1656(00)00405-3
   Zakaria MR, 2010, POLYM DEGRAD STABIL, V95, P1382, DOI 10.1016/j.polymdegradstab.2010.01.020
NR 48
TC 4
Z9 5
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
EI 1097-4660
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD MAR
PY 2014
VL 89
IS 3
BP 407
EP 418
DI 10.1002/jctb.4133
PG 12
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA AA6PB
UT WOS:000331219200008
DA 2018-10-19
ER

PT J
AU Cai, XM
   Yuan, J
   Chen, SC
   Li, PF
   Li, L
   Shen, J
AF Cai, Xianmei
   Yuan, Jiang
   Chen, Shuangchun
   Li, Pengfei
   Li, Li
   Shen, Jian
TI Hemocompatibility improvement of poly(ethylene terephthalate) via
   self-polymerization of dopamine and covalent graft of zwitterions
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Zwitterions; Poly(dopamine); Hemocompatibility; Poly(ethylene
   terephthalate); Surface modification
ID QUINONE-RICH POLYDOPAMINE; PROTEIN ADSORPTION; BLOOD COMPATIBILITY;
   PLATELET-ADHESION; CELL-ADHESION; SURFACE; MEMBRANES; CHEMISTRY;
   FUNCTIONALIZATION; BIOMOLECULES
AB Poly (ethylene terephthalate) (PET) has been widely adopted as a scaffold biomaterial, but further hemocompatibility improvement is still needed for wide biomedical applications. Inspired by the composition of adhesive proteins in mussels, we propose to use self-polymerized dopamine to form a surface-adherent polydopamine layer onto PET sheet, followed by Michael addition with N,N-dimethylethylenediamine (DMDA) to build tertiary amine, and final zwitterions(sulfobetaine and carboxybetaine) construction through ring-opening reaction. Physicochemical properties of substrates were demonstrated by water contact angle measurement, attenuated total reflection Fourier transform infrared spectroscopy (ATR-FTIR) and X-ray photoelectron spectroscopy (XPS). The hemocompatibility was evaluated by platelet adhesion, hemolytic, and protein adsorption. The results showed that the zwitterions immobilized PET endowed with improved resistance to nonspecific protein adsorption and platelet adhesion as well as nonhemolytic. The zwitterions with desirable hemocompatibility can be readily tailored to catheter for various biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Cai, Xianmei; Yuan, Jiang; Chen, Shuangchun; Li, Pengfei; Li, Li; Shen, Jian] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
RP Yuan, J (reprint author), Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210023, Jiangsu, Peoples R China.
EM bioalchem@yahoo.com; lili3@njnu.edu.cn
FU Nanjing Normal University [2011103XGQ0055]; Jiangsu Higher Education
   Institutions of China [11KJD430003, 10KJA430026]; National Natural
   Science Foundation [21274063]; Jiangsu Co-Innovation Center for
   Biomedical Functional Materials
FX This work was supported by the Nanjing Normal University
   (2011103XGQ0055), the Jiangsu Higher Education Institutions of China
   (11KJD430003, 10KJA430026, and PAPD), the National Natural Science
   Foundation (21274063), and the Jiangsu Co-Innovation Center for
   Biomedical Functional Materials.
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Chen C, 2008, J BIOMED MATER RES A, V87A, P290, DOI 10.1002/jbm.a.31719
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Dhahri M, 2011, J BIOMED MATER RES A, V98A, P114, DOI 10.1002/jbm.a.33077
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   Hamerli P, 2003, BIOMATERIALS, V24, P3989, DOI 10.1016/S0142-9612(03)00312-0
   Higuchi A, 2003, BIOMATERIALS, V24, P3235, DOI 10.1016/S0142-9612(03)00186-8
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Jiang JH, 2011, LANGMUIR, V27, P14180, DOI 10.1021/la202877k
   Keuren JFW, 2004, ARTERIOSCL THROM VAS, V24, P613, DOI 10.1161/01.ATV.0000116026.18945.66
   Kim HW, 2013, ACS APPL MATER INTER, V5, P233, DOI 10.1021/am302439g
   Kim YJ, 2000, BIOMATERIALS, V21, P121, DOI 10.1016/S0142-9612(99)00137-4
   Kohri M, 2013, POLYM CHEM-UK, V4, P2696, DOI 10.1039/c3py00181d
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lin Q, 2007, P NATL ACAD SCI USA, V104, P3782, DOI 10.1073/pnas.0607852104
   Luo RF, 2013, COLLOID SURFACE B, V106, P66, DOI 10.1016/j.colsurfb.2013.01.033
   Luo RF, 2013, ACS APPL MATER INTER, V5, P1704, DOI 10.1021/am3027635
   Muthuvijayan V, 2009, ACTA BIOMATER, V5, P3382, DOI 10.1016/j.actbio.2009.05.020
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Sagert J, 2006, BIOLOGICAL ADHESIVES, P125, DOI 10.1007/978-3-540-31049-5_7
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Wu JJ, 2011, LANGMUIR, V27, P13684, DOI 10.1021/la2027237
   Xi ZY, 2009, J MEMBRANE SCI, V327, P244, DOI 10.1016/j.memsci.2008.11.037
   Xu LQ, 2010, MACROMOLECULES, V43, P8336, DOI 10.1021/ma101526k
   Xu Y, 2009, BIOMATERIALS, V30, P4930, DOI 10.1016/j.biomaterials.2009.06.005
   Yuan J, 2003, J BIOMAT SCI-POLYM E, V14, P1339, DOI 10.1163/156856203322599680
   Yuan J, 2003, COLLOID SURFACE B, V30, P147, DOI 10.1016/S0927-7765(03)00082-1
   Zhu BC, 2011, POLYMER, V52, P2141, DOI 10.1016/j.polymer.2011.03.027
NR 30
TC 19
Z9 19
U1 5
U2 119
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD MAR 1
PY 2014
VL 36
BP 42
EP 48
DI 10.1016/j.msec.2013.11.038
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AB0VD
UT WOS:000331509300007
PM 24433885
DA 2018-10-19
ER

PT J
AU Hua, ZK
   Fan, YW
   Jin, ZM
AF Hua, Zikai
   Fan, Yongwei
   Jin, Zhongmin
TI A biotribo-acoustic testing method for ceramic orthopaedic biomaterials
SO TRIBOLOGY INTERNATIONAL
LA English
DT Article; Proceedings Paper
CT 5th World Tribology Congress (WTC)
CY SEP 08-13, 2013
CL Torino, ITALY
DE Biotribology; Acoustic; Squeaking; Artificial joint
ID TOTAL HIP-ARTHROPLASTY; WEAR; SQUEAKING; BEARINGS; SIMULATOR; JOINTS;
   FRICTION
AB A new biotribo-acoustic testing system for orthopaedic biomaterials was developed and validated. Experiments on the biotribo-acoustic testing methodology, especially for ceramic-on-ceramic biomaterial wear couples, were carried out via this testing system. Deionized water and biomimetic synovial fluids (BSF) were chosen as two lubricants in the tests. The results showed that the coefficient of friction agreed well with the sound pressure and sound power. The correlation between the biotribological and acoustic data was established in vitro. The difference in wear mechanisms was distinguished. A potential solution can be provided to investigate the biotribological and acoustic properties of orthopaedic biomaterials in vitro. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Hua, Zikai; Fan, Yongwei] Shanghai Univ, Sch Mechatron Engn & Automat, Shanghai, Peoples R China.
   [Jin, Zhongmin] Xi An Jiao Tong Univ, Sch Mech Engn, Xian, Peoples R China.
   [Jin, Zhongmin] Univ Leeds, Sch Mech Engn, Leeds LS2 9JT, W Yorkshire, England.
RP Hua, ZK (reprint author), Room 321,Mech Bldg,149,Yanchang Rd, Shanghai 200072, Peoples R China.
EM eddie_hua@shu.edu.cn
CR Brockett CL, 2013, J ARTHROPLASTY, V28, P90, DOI 10.1016/j.arth.2012.01.023
   Calonius O, 2003, J BIOMECH, V36, P1719, DOI 10.1016/S0021-9290(03)00166-0
   D'Antonio JA, 2005, CLIN ORTHOP RELAT R, P151, DOI 10.1097/01.blo.0000194084.67364.6c
   Fan N, 2012, TRIBOL INT, V48, P172, DOI 10.1016/j.triboint.2011.11.023
   Grimm G, TRIBOLOGY TOTAL HIP
   Hua ZK, 2007, TRIBOL LETT, V28, P51, DOI 10.1007/s11249-007-9247-4
   Hua ZK, 2010, SCI CHINA TECHNOL SC, V53, P2996, DOI 10.1007/s11431-010-4124-z
   Hua ZK, 2010, P STLE ASME INT JOIN
   Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005
   Keurentjes JC, 2008, CLIN ORTHOP RELAT R, V466, P1438, DOI 10.1007/s11999-008-0177-8
   Korduba LA, 2011, WEAR, V271, P1220, DOI 10.1016/j.wear.2011.01.039
   Liu F, 2013, TRIBOL INT, V63, P105, DOI 10.1016/j.triboint.2012.05.029
   Lusty PJ, 2007, J BONE JOINT SURG AM, V89A, P2676, DOI 10.2106/JBJS.F01466
   Morlock M, 2001, J ARTHROPLASTY, V16, P1071, DOI 10.1054/arth.2001.27233
   Restrepo C, 2010, J BONE JOINT SURG AM, V92A, P550, DOI 10.2106/JBJS.H.01326
   Saikko V, 2005, P I MECH ENG H, V219, P309, DOI 10.1243/095441105X34301
   Saikko V, 2002, J AM CERAM SOC, V85, P2785
   Saikko V, 1998, J BIOMED MATER RES, V41, P58, DOI 10.1002/(SICI)1097-4636(199807)41:1<58::AID-JBM7>3.3.CO;2-U
   Saikko V, 1998, ACTA ORTHOP SCAND, V69, P443, DOI 10.3109/17453679808997776
   Saikko V., 2005, P IMECHE C, V224, P697
   Saikko V, 2009, J TRIBOL-T ASME, V131, DOI 10.1115/1.2991121
   Stewart TD, 2003, J ARTHROPLASTY, V18, P726, DOI 10.1054/S0883-5403(03)00204-3
   Walter WL, 2008, J BONE JOINT SURG AM, V90A, P102, DOI 10.2106/JBJS.H.00867
   Walter WL, 2010, J AM ACAD ORTHOP SUR, V18, P319, DOI 10.5435/00124635-201006000-00004
   Walter WL, 2004, J ARTHROPLASTY, V19, P402, DOI 10.1016/j.arth.2003.09.018
   Weiss C, 2012, J BIOMECH, V45, P297, DOI 10.1016/j.jbiomech.2011.10.025
   Zhang HY, 2013, J MECH BEHAV BIOMED, V20, P209, DOI 10.1016/j.jmbbm.2013.01.001
   Zhang HY, 2012, CLIN BIOMECH, V27, P666, DOI 10.1016/j.clinbiomech.2012.02.008
   Zhang HY, 2013, J TRIBOL-T ASME, V135, DOI 10.1115/1.4023802
   Zywiel MG, 2011, EXPERT REV MED DEVIC, V8, P187, DOI [10.1586/ERD.10.75, 10.1586/erd.10.75]
NR 30
TC 5
Z9 7
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0301-679X
EI 1879-2464
J9 TRIBOL INT
JI Tribol. Int.
PD MAR
PY 2014
VL 71
BP 1
EP 6
DI 10.1016/j.triboint.2013.10.015
PG 6
WC Engineering, Mechanical
SC Engineering
GA AA8MI
UT WOS:000331349200001
DA 2018-10-19
ER

PT J
AU Chen, N
   Hu, WW
   Feng, CP
   Zhang, ZY
AF Chen, Nan
   Hu, Weiwu
   Feng, Chuanping
   Zhang, Zhenya
TI Removal of phosphorus from water using scallop shell synthesized ceramic
   biomaterials
SO ENVIRONMENTAL EARTH SCIENCES
LA English
DT Article
DE Scallop shell; Phosphorus removal; Ceramic biomaterial; Isotherm
   modeling; Sorption
ID PHOSPHATE REMOVAL; WASTE-WATER; AQUEOUS-SOLUTIONS; FLY-ASH; ADSORPTIVE
   REMOVAL; COIR PITH; RED MUD; IONS; MECHANISM; EQUILIBRIUM
AB This study describes the development of scallop shell synthesized ceramic biomaterial for phosphorus removal from water. The synthesized biomaterial was characterized by scanning electron microscope, Brunauer-Emmett-Teller and X-ray diffractometer methods. The influences of contact time, initial phosphate concentration, initial solution pH, co-existing ions and temperature for phosphorus removal were investigated by batch experiments. The results indicated that the equilibrium data can be fitted by the Langmuir isotherm model at temperatures ranging from 15 to 55 A degrees C, with the maximum sorption capacity of 13.6 mg/g. Sorption kinetics followed a pseudo-second-order kinetic equation model. The sorption process was optimal at a wide range of solution pH (above 2.4), with a relatively high sorption capacity level. Phosphorus sorption was slightly impeded by the presence of F-, HCO3 (-) and NH4 (+) ions, and significantly inhibited by Cl-, SO4 (2-) and NO3 (-) ions. Sorption process appeared to be controlled by a chemical precipitation processes. The mechanism may be attributed to ion complexation during subsequent sorption of phosphorus on scallop shell synthesized ceramic biomaterial.
C1 [Chen, Nan; Hu, Weiwu; Feng, Chuanping] China Univ Geosci, Key Lab Groundwater Cycle & Environm Evolut, Minist Educ, Beijing 100083, Peoples R China.
   [Chen, Nan; Feng, Chuanping] China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
   [Hu, Weiwu] China Univ Geosci, Journal Ctr, Beijing 100083, Peoples R China.
   [Zhang, Zhenya] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
RP Chen, N (reprint author), China Univ Geosci, Sch Water Resources & Environm, Beijing 100083, Peoples R China.
EM cnjing2008@hotmail.com; fengchuanping@gmail.com
FU Fundamental Research Funds for the Central Universities [2652013025];
   National Natural Science Foundation [31140082]
FX The authors thank "the Fundamental Research Funds for the Central
   Universities" (No. 2652013025), and the "National Natural Science
   Foundation" (No. 31140082) for financial support of this work.
CR Akhurst DJ, 2006, ENVIRON CHEM, V3, P65, DOI 10.1071/EN05038
   Blaney LM, 2007, WATER RES, V41, P1603, DOI 10.1016/j.watres.2007.01.008
   Chen N, 2011, J HAZARD MATER, V186, P863, DOI 10.1016/j.jhazmat.2010.11.083
   Chen N, 2010, J COLLOID INTERF SCI, V348, P579, DOI 10.1016/j.jcis.2010.04.048
   Chubar NI, 2005, COLLOID SURFACE A, V255, P55, DOI 10.1016/j.colsurfa.2004.12.015
   de-Bashan LE, 2004, WATER RES, V38, P4222, DOI 10.1016/j.watres.2004.07.014
   Ennil-Kose T, 2011, CHEM ENG J, V178, P34
   Feng C, 2003, J HAZARD MATER, V103, P65, DOI 10.1016/S0304-3894(03)00222-X
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Fytianos K, 1998, ENVIRON POLLUT, V101, P123, DOI 10.1016/S0269-7491(98)00007-4
   Georgantas DA, 2007, J COLLOID INTERF SCI, V315, P70, DOI 10.1016/j.jcis.2007.06.058
   Guo HM, 2011, J HAZARD MATER, V186, P1847, DOI 10.1016/j.jhazmat.2010.12.078
   Haghseresht F, 2009, APPL CLAY SCI, V46, P369, DOI 10.1016/j.clay.2009.09.009
   Hanif A, 2009, ECOL ENG, V35, P1427, DOI 10.1016/j.ecoleng.2009.05.013
   Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5
   Huang WW, 2008, J HAZARD MATER, V158, P35, DOI 10.1016/j.jhazmat.2008.01.061
   Huang X, 2009, J HAZARD MATER, V166, P1261, DOI 10.1016/j.jhazmat.2008.12.045
   Jeon DJ, 2009, BIORESOURCE TECHNOL, V100, P2646, DOI 10.1016/j.biortech.2008.11.035
   Karaca S, 2006, J HAZARD MATER, V128, P273, DOI 10.1016/j.jhazmat.2005.08.003
   Krishnan KA, 2008, J HAZARD MATER, V152, P527, DOI 10.1016/j.jhazmat.2007.07.015
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002
   Leofanti G, 1998, CATAL TODAY, V41, P207, DOI 10.1016/S0920-5861(98)00050-9
   Li KQ, 2010, J HAZARD MATER, V178, P553, DOI 10.1016/j.jhazmat.2010.01.120
   Li YZ, 2006, J HAZARD MATER, V137, P374, DOI 10.1016/j.jhazmat.2006.02.011
   Liao XP, 2006, IND ENG CHEM RES, V45, P3896, DOI 10.1021/ie051076c
   Liu HL, 2008, J HAZARD MATER, V151, P616, DOI 10.1016/j.jhazmat.2007.06.033
   Liu RX, 2002, J COLLOID INTERF SCI, V248, P268, DOI 10.1006/jcis.2002.8260
   Lu SG, 2009, J HAZARD MATER, V161, P95, DOI 10.1016/j.jhazmat.2008.02.123
   Morse GK, 1998, SCI TOTAL ENVIRON, V212, P69, DOI 10.1016/S0048-9697(97)00332-X
   Mustafa S, 2008, CHEM ENG J, V141, P51, DOI 10.1016/j.cej.2007.10.020
   Namasivayam C, 2004, J COLLOID INTERF SCI, V280, P359, DOI 10.1016/j.jcis.2004.08.015
   National Environmental Protection Agency of China, 1996, GB89781996 NAT ENV P, V1, P1
   Nowack B, 2006, WATER RES, V40, P2201, DOI 10.1016/j.watres.2006.03.018
   Razmouski R, 2008, ECOL ENG, V34, P179, DOI 10.1016/j.ecoleng.2008.07.020
   Rodrigues LA, 2009, QUIM NOVA, V32, P1206, DOI 10.1590/S0100-40422009000500023
   Shin EW, 2004, ENVIRON SCI TECHNOL, V38, P912, DOI 10.1021/es.030488e
   [宋丹 Song Dan], 2013, [地学前缘, Earth Science Frontiers], V20, P118
   State Environmental Protection Administration, 2002, WAT WAST MON AN METH, V4, P46
   Swain SK, 2011, CHEM ENG J, V171, P1218, DOI 10.1016/j.cej.2011.05.030
   Tian SL, 2009, CHEM ENG J, V151, P141, DOI 10.1016/j.cej.2009.02.006
   Tsai WT, 2008, BIORESOURCE TECHNOL, V99, P1623, DOI 10.1016/j.biortech.2007.04.010
   [王浩然 Wang Haoran], 2013, [地学前缘, Earth Science Frontiers], V20, P147
   [王欣宝 Wang Xinbao], 2012, [地学前缘, Earth Science Frontiers], V19, P243
   Xiong JB, 2008, J HAZARD MATER, V152, P211, DOI 10.1016/j.jhazmat.2007.06.103
   Yildiz E, 2004, SEP PURIF TECHNOL, V35, P241, DOI 10.1016/S1383-5866(03)00145-X
   Zeng L, 2004, WATER RES, V38, P1318, DOI 10.1016/j.watres.2003.12.009
   Zhang JD, 2011, J HAZARD MATER, V186, P76, DOI 10.1016/j.jhazmat.2010.10.076
   Zhou JB, 2011, J HAZARD MATER, V192, P1114, DOI 10.1016/j.jhazmat.2011.06.013
NR 49
TC 4
Z9 5
U1 1
U2 24
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-6280
EI 1866-6299
J9 ENVIRON EARTH SCI
JI Environ. Earth Sci.
PD MAR
PY 2014
VL 71
IS 5
BP 2133
EP 2142
DI 10.1007/s12665-013-2618-2
PG 10
WC Environmental Sciences; Geosciences, Multidisciplinary; Water Resources
SC Environmental Sciences & Ecology; Geology; Water Resources
GA AA3KX
UT WOS:000330992400012
DA 2018-10-19
ER

PT J
AU Cheng, CX
   Alt, V
   Pan, LY
   Thormann, U
   Schnettler, R
   Strauss, LG
   Schumacher, M
   Gelinsky, M
   Dimitrakopoulou-Strauss, A
AF Cheng, Caixia
   Alt, Volker
   Pan, Leyun
   Thormann, Ulrich
   Schnettler, Reinhard
   Strauss, Ludwig G.
   Schumacher, Matthias
   Gelinsky, Michael
   Dimitrakopoulou-Strauss, Antonia
TI Preliminary evaluation of different biomaterials for defect healing in
   an experimental osteoporotic rat model with dynamic PET-CT (dPET-CT)
   using F-18-Sodium Fluoride (NaF)
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE PET-CT; F-18-Sodium Fluoride (NaF); Bone defect; Osteoporosis;
   Biomaterials
ID POSITRON-EMISSION-TOMOGRAPHY; BONE-GRAFT SUBSTITUTES; OSTEOBLAST-LIKE
   CELLS; STRONTIUM RANELATE; CALCIUM-CARBONATE; CEMENT; F-18-FLUORIDE;
   HISTOMORPHOMETRY; RECONSTRUCTION; OSTEOCLAST
AB The aim of the current study was to measure and compare the effect of calcium phosphate cement (CPC) and CPC enriched with strontium (SrCPC) for the healing of osteoporotic bone defects in the rat femur using F-18-Sodium Fluoride dPET-CT. Methods: Osteoporosis was induced by ovariectomy and a calcium restricted diet. After three months, rats were operated to create a 4 mm defect in the distal metaphyseal femur with internal fixation. 7 Rats have been treated either with CPC (Group 2) or with SrCPC (Group 3) for bone replacement and defect healing. Furthermore, a control group of 7 rats without any biomaterial (Group 1) was used for reference. 18 weeks after osteoporosis induction and 6 weeks following femoral surgery, dPET-CT studies scan were performed with 18F-Sodium Fluoride. SUVs and a 2-tissue compartmental learning-machine model (K1-k4, VB, influx) were used for quantitative analysis. Results: VB, reflecting the fractional blood volume and k3, reflecting the formation of fluoroapatite were the most sensitive parameters for the characterisation of healing process and revealed the best differentiation for the control group and the CPC group (Group 2) as well as for the CPC with strontium carbonate group (Group 3) (p < 0.05). VB was decreased by the order of Group1, Group 2 and Group3, while k3 was increased by the same order. Therefore, the data direct to a decreased fractional blood volume and increased fixation of fluoride in rats with these biomaterials. Conclusion: We found PET scanning using F-18-Sodium Fluoride to be a sensitive and useful method for evaluation of bone healing after replacement with CPC or SrCPC. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Cheng, Caixia; Pan, Leyun; Strauss, Ludwig G.; Dimitrakopoulou-Strauss, Antonia] German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
   [Alt, Volker; Thormann, Ulrich; Schnettler, Reinhard] Univ Hosp Giessen Marburg GmbH, Dept Trauma Surg, Giessen, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Tech Univ Dresden, Ctr Translat Bone Joint & Soft Tissue Res, Fac Med, D-01062 Dresden, Germany.
   [Schumacher, Matthias; Gelinsky, Michael] Univ Hosp Carl Gustav Carus, Dresden, Germany.
RP Cheng, CX (reprint author), German Canc Res Ctr, Clin Cooperat Unit Nucl Med, Heidelberg, Germany.
EM c.cheng@dkfz.de
RI Dimitrakopoulou-Strauss, Antonia/E-6314-2014; Schumacher,
   Matthias/I-1530-2013
OI Dimitrakopoulou-Strauss, Antonia/0000-0003-0338-9472; Schumacher,
   Matthias/0000-0001-7207-7355; Gelinsky, Michael/0000-0001-9075-5121
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Alt V, 2013, ACTA BIOMATER, V9, P7035, DOI 10.1016/j.actbio.2013.02.002
   Bonnelye E, 2008, BONE, V42, P129, DOI 10.1016/j.bone.2007.08.043
   Burger C, 1997, J NUCL MED, V38, P1818
   Capuccini C, 2009, J BIOMED MATER RES A, V89A, P594, DOI 10.1002/jbm.a.31975
   Cheng CX, 2013, MOL IMAGING BIOL, V15, P336, DOI 10.1007/s11307-012-0592-9
   Combes C, 2006, J BIOMED MATER RES A, V79A, P318, DOI 10.1002/jbm.a.30795
   Cook GJR, 2002, J BONE MINER RES, V17, P854, DOI 10.1359/jbmr.2002.17.5.854
   Currey J. D., 2002, BONES STRUCTURE MECH
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Dimitrakopoulou-Strauss A, 2001, J NUCL MED, V42, P248
   Dimitrakopoulou-Strauss A, 2003, WORLD J NUCL MED, V2, P306
   GAZDAG AR, 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Heiss C, 2012, MED SCI MONITOR, V18, pBR199, DOI 10.12659/MSM.882895
   Hsu WK, 2007, EUR J NUCL MED MOL I, V34, P1291, DOI 10.1007/s00259-006-0280-6
   Khairoun I, 1997, BIOMATERIALS, V18, P1535, DOI 10.1016/S0142-9612(97)00096-3
   Kokesch-Himmelreich J, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-17
   Koort JK, 2005, ANTIMICROB AGENTS CH, V49, P1502, DOI 10.1128/AAC.49.4.1502-1508.2005
   Li CH, 2010, J BONE MINER RES, V25, P968, DOI 10.1359/jbmr.091038
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Marie PJ, 2006, BONE, V38, P10, DOI 10.1016/j.bone.2005.07.029
   MESSA C, 1993, J CLIN ENDOCR METAB, V77, P949, DOI 10.1210/jc.77.4.949
   Mikolajczyk K, 1998, MED INFORM, V23, P207, DOI 10.3109/14639239809001400
   NARITA N, 1990, CALCIFIED TISSUE INT, V46, P200, DOI 10.1007/BF02555045
   Nkenke E, 2009, CLIN ORAL IMPLAN RES, V20, P124, DOI 10.1111/j.1600-0501.2009.01776.x
   Peltola MJ, 2012, EUR ARCH OTO-RHINO-L, V269, P623, DOI 10.1007/s00405-011-1607-x
   Piert M, 2001, J NUCL MED, V42, P1091
   Schumacher M, 2013, ACTA BIOMATER, V9, P7536, DOI 10.1016/j.actbio.2013.03.014
   Schumacher M, 2013, ACTA BIOMATER, DOI [DOI 10.1016/J.ACTBI0.2013.07.027, 10.1016/j.actbio.2013.07.027]
   Sorensen J, 2003, ACTA ORTHOP SCAND, V74, P633, DOI 10.1080/00016470310018126
   STRAUSS LG, 1991, J NUCL MED, V32, P623
   Strauss LG, 2007, IEEE T MED IMAGING, V26, P804, DOI 10.1109/TMI.2007.892645
   Tadier S, 2012, J BIOMED MATER RES B, V100B, P378, DOI 10.1002/jbm.b.31959
   Tadier S, 2011, J BIOMED MATER RES B, V99B, P302, DOI 10.1002/jbm.b.31899
   Thormann U, 2013, BIOMATERIALS, V34, P8589, DOI 10.1016/j.biomaterials.2013.07.036
   Toegel S, 2006, EUR J NUCL MED MOL I, V33, P491, DOI 10.1007/s00259-005-0026-x
   Ullmark G, 2009, ACTA ORTHOP, V80, P179, DOI 10.3109/17453670902947416
NR 37
TC 7
Z9 7
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD MAR
PY 2014
VL 45
IS 3
BP 501
EP 505
DI 10.1016/j.injury.2013.11.023
PG 5
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 302BH
UT WOS:000330575800007
PM 24332163
DA 2018-10-19
ER

PT J
AU Maerz, T
   Mu, R
   Baker, KC
AF Maerz, Tristan
   Mu, Richard
   Baker, Kevin C.
TI Cell and scaffold surface engineering to enhance cell migration and
   tissue regeneration
SO SURFACE INNOVATIONS
LA English
DT Review
DE biomaterial; bone; cell-surface interaction; drug delivery;
   regeneration; scaffold; soft tissue; tissue engineering
ID MESENCHYMAL STEM-CELLS; GROWTH-FACTOR; IN-VIVO; INFARCTED MYOCARDIUM;
   PROGENITOR CELLS; PLASMA TREATMENT; BONE; TRACKING; NANOPARTICLES;
   AFFINITY
AB The principles of surface engineering can be applied to cells and biomaterial scaffolds in efforts to treat disease, disorder, infection and injury. Although the body's endogenous response to some injuries is limited, cell-based approaches exploiting native physiology, namely, through the use of gene therapy or cell surface receptors hold significant promise in treating injured or diseased tissues. Shifting binding affinities of native receptors, causing expression of non-native receptors, or binding synthetic receptors onto the surfaces of cells are the techniques that increase cellular targeting, migration and engraftment. Scaffold modification techniques that increase a scaffold's bioactivity by providing signaling factors to endogenous cells can be used to elicit a desired response from an otherwise inert polymer. This review summarizes the endogenous homing and targeting response of leukocytes and stem cells to provide context for subsequent sections outlining existing ways of surface-modifying cells and biomaterials.
C1 [Maerz, Tristan; Mu, Richard; Baker, Kevin C.] Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI 48073 USA.
RP Baker, KC (reprint author), Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI 48073 USA.
EM kevin.baker@beaumont.edu
CR Andreas K, 2012, BIOMATERIALS, V33, P4515, DOI 10.1016/j.biomaterials.2012.02.064
   Arabi A, 2014, SURF INNOV, V2, P47, DOI 10.1680/si.13.00018
   Balyasnikova IV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009750
   BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3
   Brentjens RJ, 2007, CLIN CANCER RES, V13, P5426, DOI 10.1158/1078-0432.CCR-07-0674
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Chen YL, 2007, BIOMATERIALS, V28, P2294, DOI 10.1016/j.biomaterials.2007.01.027
   Cheng Q, 2013, TISSUE ENG PT A, V19, P1188, DOI [10.1089/ten.tea.2011.0725, 10.1089/ten.TEA.2011.0725]
   Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374
   Chim H, 2012, CELL TISSUE RES, V350, P89, DOI 10.1007/s00441-012-1449-x
   Chinitz N, 2012, NOVEL STRATEGY ENHAN
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Dennis JE, 2004, J ORTHOPAED RES, V22, P735, DOI 10.1016/j.orthres.2003.12.002
   Fong ELS, 2011, BIOMATERIALS, V32, P395, DOI 10.1016/j.biomaterials.2010.08.101
   Gade TPF, 2005, CANCER RES, V65, P9080, DOI 10.1158/0008-5472.CAN-05-0436
   Goncalves RM, 2012, EUR CELLS MATER, V23, P249, DOI 10.22203/eCM.v023a19
   Guan M, 2012, NAT MED, V18, P456, DOI 10.1038/nm.2665
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030
   Imai K, 1999, BLOOD, V93, P149
   Intranuovo F., 2008, BONE, V15, P16
   Ko IK, 2012, FASEB J, V26, P158, DOI 10.1096/fj.11-182998
   Komarova S, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-12
   Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com
   Lee RJ, 2007, STEM CELLS, V25, P712, DOI 10.1634/stemcells.2005-0602
   Levesque SG, 2006, BIOMATERIALS, V27, P5277, DOI 10.1016/j.biomaterials.2006.06.004
   Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156
   Mahmoudi M, 2011, CHEM REV, V111, P253, DOI 10.1021/cr1001832
   McEver R. P, 2010, ANNU REV CELL DEV BI, V2, P363
   Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988
   Netelenbos T, 2003, J LEUKOCYTE BIOL, V74, P1035, DOI 10.1189/jlb.1202593
   Pek YS, 2008, BIOMATERIALS, V29, P4300, DOI 10.1016/j.biomaterials.2008.07.030
   Pule MA, 2008, NAT MED, V14, P1264, DOI 10.1038/nm.1882
   Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Rogers WJ, 2006, NAT CLIN PRACT CARD, V3, P554, DOI 10.1038/ncpcardio0659
   Sarkar D, 2010, BIOMATERIALS, V31, P5266, DOI 10.1016/j.biomaterials.2010.03.006
   Seo WS, 2006, NAT MATER, V5, P971, DOI 10.1038/nmat1775
   Shao ZX, 2012, BIOMATERIALS, V33, P3375, DOI 10.1016/j.biomaterials.2012.01.033
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Stephan MT, 2010, NAT MED, V16, P1035, DOI 10.1038/nm.2198
   Sun M, 2010, IN VIVO TRACKING MES
   Taylor A, 2012, CHEM SOC REV, V41, P2707, DOI 10.1039/c2cs35031a
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
   Willerth SM, 2008, COMBINING STEM CELLS
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yao W, 2013, STEM CELLS, V31, P2003, DOI 10.1002/stem.1461
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
NR 55
TC 0
Z9 0
U1 1
U2 12
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 17
EP 25
DI 10.1680/si.13.00023
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800003
DA 2018-10-19
ER

PT J
AU McKay, CA
   Gilbert, RJ
AF McKay, Christopher A.
   Gilbert, Ryan J.
TI Design of hydrogel biomaterial interfaces for the injured spinal cord
SO SURFACE INNOVATIONS
LA English
DT Review
DE adhesion; biomimetic; surface modifications
ID HYALURONIC-ACID HYDROGELS; CENTRAL-NERVOUS-SYSTEM; 3-DIMENSIONAL NEURITE
   EXTENSION; MYELIN-ASSOCIATED GLYCOPROTEIN; TENDON CHITOSAN TUBES;
   CROSS-LINKED HYDROGEL; REGENERATION IN-VIVO; 3D COLLAGEN GELS;
   CELL-MIGRATION; GLIAL SCAR
AB Following spinal cord injury, changes in glial cell behavior and the local extracellular environment combine to produce an inhibitory environment for neuronal regeneration. Hydrogel biomaterials are ideal for treating spinal cord injury as many are injectable and conform to irregular lesion geometries. Numerous studies present novel hydrogel systems modified to control the interface between hydrogels and the injury environment and to mitigate detrimental changes in cellular behavior and extracellular composition. The goal for any spinal cord injury treatment is to promote beneficial cellular behavior and reduce the growth inhibitory nature of the extracellular environment to promote regeneration. Hydrogel systems have been designed to target particular problems affecting regeneration following spinal cord injury: (a) promoting neuronal attachment and axonal growth, (b) promoting remyelination, (c) reducing astrocyte reactivity and glial scar formation, (d) limiting inflammatory response and (e) controlling the release of therapeutic drugs. This review presents a summary of hydrogel systems exhibiting surface characteristics designed to elicit a specific cellular or extracellular response relevant to promoting regeneration. The purpose of this review is to provide insight for researchers deciding what components and characteristics to incorporate into a hydrogel scaffold for the treatment of spinal cord injury.
C1 [McKay, Christopher A.; Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
RP Gilbert, RJ (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.
EM gilber2@rpi.edu
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Akeson Wayne H, 2005, Spine J, V5, P180, DOI 10.1016/j.spinee.2004.06.019
   Ananthanarayanan B, 2010, BIOMATERIALS, V31, P8706, DOI 10.1016/j.biomaterials.2010.07.104
   [Anonymous], 2012, SPIN CORD INJ FACTS
   Aurand ER, 2012, NEUROSCI RES, V72, P199, DOI 10.1016/j.neures.2011.12.005
   Austin JW, 2012, BIOMATERIALS, V33, P4555, DOI 10.1016/j.biomaterials.2012.03.022
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Bandtlow CE, 2000, GLIA, V29, P175, DOI 10.1002/(SICI)1098-1136(20000115)29:2<175::AID-GLIA11>3.0.CO;2-F
   Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   Bourguignon LYW, 2007, J NEUROCHEM, V101, P1002, DOI 10.1111/j.1471-4159.2007.04485.x
   Brodbelt AR, 2003, J CLIN NEUROSCI, V10, P401, DOI 10.1016/S0967-5868(02)00326-0
   Brown JM, 2012, P NATL ACAD SCI USA, V109, P4768, DOI 10.1073/pnas.1121318109
   Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004
   Butterfield Karen Chao, 2011, Biomatter, V1, P174, DOI 10.4161/biom.18791
   Caicco MJ, 2013, J BIOMED MATER RES A, V101, P1472, DOI 10.1002/jbm.a.34454
   Cao WL, 2005, J BIOMATER APPL, V20, P157, DOI 10.1177/0885328205049897
   Cao Z, 2009, BIOMACROMOLECULES, V10, P2954, DOI 10.1021/bm900670n
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Cheng S, 2008, MED ENG PHYS, V30, P1318, DOI 10.1016/j.medengphy.2008.06.003
   Connor JR, 1996, GLIA, V17, P83, DOI 10.1002/(SICI)1098-1136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
   Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018
   Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0
   Dhoot NO, 2004, J BIOMED MATER RES A, V71A, P191, DOI 10.1002/jbm.a.30103
   Dillon GP, 2000, J BIOMED MATER RES, V51, P510, DOI 10.1002/1097-4636(20000905)51:3<510::AID-JBM28>3.0.CO;2-G
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002
   ESTES JM, 1993, J PEDIATR SURG, V28, P1227, DOI 10.1016/S0022-3468(05)80303-3
   Farooque M, 1997, J NEUROTRAUM, V14, P469, DOI 10.1089/neu.1997.14.469
   Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371
   Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6
   Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/01.wnr.0000048003.96487.97
   FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Fukushima Kazuyuki, 2008, J Med Dent Sci, V55, P71
   Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114
   Giger RJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001867
   Gilbert RJ, 2005, MOL CELL NEUROSCI, V29, P545, DOI 10.1016/j.mcn.2005.04.006
   GIOVANNI SD, 2009, EXPER OPIN THER TAR, V13, P1387, DOI DOI 10.1517/14728220903307517
   GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hadlock T, 2006, EXPERT OPIN BIOL TH, V6, P1105, DOI 10.1517/14712598.6.11.1105
   HAPPEL RD, 1981, BRAIN RES, V211, P476, DOI 10.1016/0006-8993(81)90976-8
   Hejcl A, 2009, J MATER SCI-MATER M, V20, P1571, DOI 10.1007/s10856-009-3714-4
   Hejcl A, 2008, J NEUROSURG-SPINE, V8, P67, DOI 10.3171/SPI-08/01/067
   Hejcl A, 2013, STEM CELLS DEV, V22, P2794, DOI 10.1089/scd.2012.0616
   Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351
   Horn EM, 2007, J NEUROSURG-SPINE, V6, P133, DOI 10.3171/spi.2007.6.2.133
   Hosseinkhani H, 2013, ACS CHEM NEUROSCI, V4, P1229, DOI 10.1021/cn400075h
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hrapko M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2907746
   Huber AB, 2000, BIOL CHEM, V381, P407, DOI 10.1515/BC.2000.053
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Jiang FX, 2008, ANN BIOMED ENG, V36, P1565, DOI 10.1007/s10439-008-9530-z
   Jiang FX, 2010, TISSUE ENG PT A, V16, P1873, DOI [10.1089/ten.tea.2009.0574, 10.1089/ten.TEA.2009.0574]
   Kang CE, 2013, CELLS TISSUES ORGANS, V197, P55, DOI 10.1159/000339589
   Kang CE, 2010, J CONTROL RELEASE, V144, P25, DOI 10.1016/j.jconrel.2010.01.029
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Karumbaiah L, 2011, GLIA, V59, P981, DOI 10.1002/glia.21170
   Kato Tsuyoshi, 2005, Spine J, V5, P479, DOI 10.1016/j.spinee.2005.01.010
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Khaing ZZ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046033
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Klekamp J, 1997, J NEUROSURG, V86, P233, DOI 10.3171/jns.1997.86.2.0233
   Kostic A, 2007, J CELL SCI, V120, P3895, DOI 10.1242/jcs.009852
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Leach JB, 2007, J NEURAL ENG, V4, P26, DOI 10.1088/1741-2560/4/2/003
   Lee JW, 2011, J CONTROL RELEASE, V152, pE219, DOI 10.1016/j.jconrel.2011.09.021
   Li QQ, 2010, J BIOMED MATER RES A, V94A, P688, DOI 10.1002/jbm.a.32707
   Li XW, 2013, FASEB J, V27, P1127, DOI 10.1096/fj.12-211151
   Lin PW, 2005, J BIOMED MATER RES B, V75B, P146, DOI 10.1002/jbm.b.30276
   Liu BF, 2006, COLLOID SURFACE B, V53, P175, DOI 10.1016/j.colsurfb.2006.08.018
   Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]
   Liverman C.T., 2005, SPINAL CORD INJURY P
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Man AJ, 2011, TISSUE ENG PT A, V17, P2931, DOI 10.1089/ten.tea.2011.0030
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Masand SN, 2012, BIOMATERIALS, V33, P8353, DOI 10.1016/j.biomaterials.2012.08.018
   MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081
   MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Mehrishi JN, 2002, ELECTROPHORESIS, V23, P1984, DOI 10.1002/1522-2683(200207)23:13<1984::AID-ELPS1984>3.0.CO;2-U
   Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032
   Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008
   Meng XL, 2013, J BIOMED MATER RES A, V101, P1095, DOI 10.1002/jbm.a.34400
   MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6
   Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386
   Nelson DM, 2012, J BIOMED MATER RES A, V100A, P776, DOI 10.1002/jbm.a.34015
   Nesathurai S, 1998, J TRAUMA, V45, P1088, DOI 10.1097/00005373-199812000-00021
   Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575
   Oudega M, 2006, J NEUROTRAUM, V23, P453, DOI 10.1089/neu.2006.23.453
   Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Pearse DD, 2007, GLIA, V55, P976, DOI 10.1002/glia.20490
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116
   PITTMAN RN, 1989, DEV NEUROSCI-BASEL, V11, P41, DOI 10.1159/000111884
   Plant GW, 1997, EXP NEUROL, V143, P287, DOI 10.1006/exnr.1997.6407
   Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004
   Puckett WR, 1997, EXP NEUROL, V148, P424, DOI 10.1006/exnr.1997.6692
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Rasouli A, 2009, J ORTHOP RES, V27, P931, DOI 10.1002/jor.20793
   Ray SK, 2003, BRAIN RES REV, V42, P169, DOI 10.1016/S0165-0173(03)00152-8
   Rhodes KE, 2003, NEUROSCIENCE, V120, P41, DOI 10.1016/S0306-4522(03)00285-9
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Sayer Faisal T, 2006, Spine J, V6, P335, DOI 10.1016/j.spinee.2005.11.001
   Seeds NW, 1997, CELL TISSUE RES, V290, P367, DOI 10.1007/s004410050942
   Sehgal RR, 2013, NANOMEDICINE-UK, V8, P521, DOI 10.2217/nnm.13.40
   Shaw D, 2003, J CRANIOFAC SURG, V14, P308, DOI 10.1097/00001665-200305000-00008
   Shepard JA, 2012, BIOTECHNOL BIOENG, V109, P830, DOI 10.1002/bit.24355
   Shoichet MS, 2007, PROG BRAIN RES, V161, P385, DOI 10.1016/S0079-6123(06)61027-3
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+
   Stanwick JC, 2012, J CONTROL RELEASE, V160, P666, DOI 10.1016/j.jconrel.2012.03.024
   Stanwick JC, 2012, INT J PHARMACEUT, V426, P284, DOI 10.1016/j.ijpharm.2012.01.035
   STOKES BT, 1983, EXP NEUROL, V80, P561, DOI 10.1016/0014-4886(83)90307-2
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Struve J, 2005, GLIA, V52, P16, DOI 10.1002/glia.20215
   Sundararaghavan HG, 2011, J NEUROTRAUM, V28, P2377, DOI 10.1089/neu.2010.1606
   Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Sur S, 2012, BIOMATERIALS, V33, P545, DOI 10.1016/j.biomaterials.2011.09.093
   Suzuki M, 2003, J NEUROSCI RES, V72, P646, DOI 10.1002/jnr.10589
   Swindle-Reilly KE, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046007
   Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6
   Tator C H, 1996, J Spinal Cord Med, V19, P206
   Tator CH, 1998, NEUROSURGERY, V42, P696, DOI 10.1097/00006123-199804000-00007
   TATOR CH, 1995, BRAIN PATHOL, V5, P407, DOI 10.1111/j.1750-3639.1995.tb00619.x
   Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373
   Todor D R, 2000, Neurosurg Focus, V8, pE11
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Vulic K, 2012, J AM CHEM SOC, V134, P882, DOI 10.1021/ja210638x
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Wang XH, 2013, J BIOMAT SCI-POLYM E, V24, P1185, DOI 10.1080/09205063.2012.745714
   Wang YF, 2009, J CONTROL RELEASE, V140, P218, DOI 10.1016/j.jconrel.2009.05.025
   Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11
   Wei YT, 2010, J BIOMED MATER RES B, V95B, P110, DOI 10.1002/jbm.b.31689
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Willits RK, 2004, J BIOMAT SCI-POLYM E, V15, P1521, DOI 10.1163/1568562042459698
   Wingrave JM, 2003, J NEUROSCI RES, V73, P95, DOI 10.1002/jnr.10607
   Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   YOUNG W, 1982, BRAIN RES, V253, P105, DOI 10.1016/0006-8993(82)90677-1
   Zawadzka M, 2010, CELL STEM CELL, V6, P578, DOI 10.1016/j.stem.2010.04.002
   Zhang C, 2014, J BIOMED MATER RES A, V102, P170, DOI 10.1002/jbm.a.34687
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
   Zustiak S. P., 2013, BIOTECHNOL PROGR, DOI [10.1021/btpr.1761, DOI 10.1021/BTPR.1761]
NR 164
TC 2
Z9 2
U1 0
U2 18
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 26
EP 46
DI 10.1680/si.13.00016
PG 21
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800004
DA 2018-10-19
ER

PT J
AU Arabi, A
   Boggs, E
   Patel, MR
   Zwiesler-Vollick, J
   Maerz, T
   Baker, K
   Tuck, S
   Corey, J
   Li, YW
AF Arabi, Ahmad
   Boggs, Emily
   Patel, Manan R.
   Zwiesler-Vollick, Julie
   Maerz, Tristan
   Baker, Kevin
   Tuck, Samuel
   Corey, Joseph
   Li, Yawen
TI Surface modification of electrospun polycaprolactone fibers and effect
   on cell proliferation
SO SURFACE INNOVATIONS
LA English
DT Article
DE biocompatibility; hydrophilic; plasma processing; surface
   characterization; surface modification
ID EPIDERMAL-GROWTH-FACTOR; BIOMIMETIC MATERIALS; BINDING-SPECIFICITY;
   ADHESION; POLYMERS; RGD; BIOMATERIALS; OSTEOBLAST; CHEMISTRY; PEPTIDES
AB Surface modification is an essential tool in tissue engineering using synthetic biomaterial scaffolds. The authors report in this study a simple approach to modify the surface hydrophobicity, roughness and chemistry of electrospun polycaprolactone (PCL) fibers using a combination of oxygen plasma treatment, sodium hydroxide treatment and arginine-glycine-aspartic acid (RGD) immobilization. The modified surfaces were characterized using scanning electron microscopy, atomic force microscopy, water contact angle measurement and X-ray photoelectron spectroscopy (XPS). Plasma treatment decreased the water contact angle. Sodium hydroxide treatment further improved the hydrophilicity and increased the surface roughness. XPS analysis confirmed the presence of amide bonds on RGD-treated fibers. The enhancement of proliferation of ligament fibroblasts within 1 week of culturing on both the plasma- and sodium hydroxide-treated fibers was most likely due to improved wettability by the oxygen plasma treatment. The alignment and penetration of cells on PCL fibers suggested that these materials could be potential scaffold materials for the regeneration of fibrous tissues.
C1 [Arabi, Ahmad; Boggs, Emily; Patel, Manan R.; Li, Yawen] Lawrence Technol Univ, Biomed Engn Program, Southfield, MI 48075 USA.
   [Zwiesler-Vollick, Julie] Lawrence Technol Univ, Dept Nat Sci, Southfield, MI USA.
   [Maerz, Tristan; Baker, Kevin] Beaumont Hlth Syst, Orthopaed Res Labs, Royal Oak, MI USA.
   [Tuck, Samuel; Corey, Joseph] Univ Michigan, Dept Neurol, Ann Arbor, MI USA.
RP Li, YW (reprint author), Lawrence Technol Univ, Biomed Engn Program, Southfield, MI 48075 USA.
EM yli@ltu.edu
FU Lawrence Technological University (LTU) Faculty Research Seed Grant; NSF
   MRI program [1040607]
FX This study is supported by the Lawrence Technological University (LTU)
   Faculty Research Seed Grant. The authors thank Dr. Hsiao-Ping Moore for
   providing access to and supplies in the LTU Life Sciences Facilities,
   Dr. Pilar Herrera-Fierro and Dr. Haiping Sun at the University of
   Michigan for assistance with the AFM analysis, as well as Mr.
   Christopher Thrush at Wayne State University for assistance with the XPS
   measurement. The authors also acknowledge the usage of environmental
   scanning electron microscope at LTU funded by the NSF MRI program
   (1040607).
CR Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Causa F, 2010, LANGMUIR, V26, P9875, DOI 10.1021/la100207q
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   JANSEN RJJ, 1995, CARBON, V33, P1021, DOI 10.1016/0008-6223(95)00030-H
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Kim MS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494017
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Landis WJ, 2006, J MATER CHEM, V16, P1495, DOI 10.1039/b505706j
   Luca A. C. D., 2013, J BIOMEDICAL MAT R A, V101, P491
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Ma ZW, 2007, COLLOID SURFACE B, V60, P137, DOI 10.1016/j.colsurfb.2007.06.019
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Sabbatini L., 1993, SURFACE CHARACTERIZA
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tuck SJ, 2012, MAT SCI ENG C-MATER, V32, P1779, DOI 10.1016/j.msec.2012.04.060
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 35
TC 4
Z9 4
U1 5
U2 18
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2050-6252
EI 2050-6260
J9 SURF INNOV
JI Surf. Innov.
PD MAR
PY 2014
VL 2
IS 1
BP 47
EP 59
DI 10.1680/si.13.00018
PG 13
WC Chemistry, Physical; Materials Science, Coatings & Films
SC Chemistry; Materials Science
GA CZ3AG
UT WOS:000366975800005
DA 2018-10-19
ER

PT J
AU Ljunggren, MK
   Elizondo, RA
   Edin, J
   Olsen, D
   Merrett, K
   Lee, CJ
   Salerud, G
   Polarek, J
   Fagerholm, P
   Griffith, M
AF Ljunggren, Monika Kozak
   Elizondo, Rodolfo A.
   Edin, Joel
   Olsen, David
   Merrett, Kimberley
   Lee, Chyan-Jang
   Salerud, Goran
   Polarek, James
   Fagerholm, Per
   Griffith, May
TI Effect of Surgical Technique on Corneal Implant Performance
SO TRANSLATIONAL VISION SCIENCE & TECHNOLOGY
LA English
DT Article
DE biosynthetic cornea; corneal regeneration; biomaterials; recombinant
   human collagen; corneal transplantation
AB Purpose: Our aim was to determine the effect of a surgical technique on biomaterial implant performance, specifically graft retention.
   Methods: Twelve mini pigs were implanted with cell-free, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide (EDC)/N-hydroxysuccinimide (NHS) cross-linked recombinant human collagen type III (RHCIII) hydrogels as substitutes for donor corneal allografts using overlying sutures with or without human amniotic membrane (HAM) versus interrupted sutures with HAM. The effects of the retention method were compared as well as the effects of collagen concentration (13.7% to 15% RHCIII).
   Results: All implanted corneas showed initial haze that cleared with time, resulting in corneas with optical clarity matching those of untreated controls. Biochemical analysis showed that by 12 months post operation, the initial RHCIII implants had been completely remodeled, as type I collagen, was the major collagenous protein detected, whereas no RHCIII could be detected. Histological analysis showed all implanted corneas exhibited regeneration of epithelial and stromal layers as well as nerves, along with touch sensitivity and tear production. Most neovascularization was seen in corneas stabilized by interrupted sutures.
   Conclusions: This showed that the surgical technique used does have a significant effect on the overall performance of corneal implants, overlying sutures caused less vascularization than interrupted sutures.
   Translational Relevance: Understanding the significance of the suturing technique can aid the selection of the most appropriate procedure when implanting artificial corneal substitutes. The same degree of regeneration, despite a higher collagen content indicates that future material development can progress toward stronger, more resistant implants.
C1 [Ljunggren, Monika Kozak; Elizondo, Rodolfo A.; Edin, Joel; Merrett, Kimberley; Lee, Chyan-Jang; Salerud, Goran; Fagerholm, Per; Griffith, May] Linkoping Univ, Integrat Regenerat Med Ctr, S-58185 Linkoping, Sweden.
   [Ljunggren, Monika Kozak; Elizondo, Rodolfo A.; Edin, Joel; Merrett, Kimberley; Lee, Chyan-Jang; Fagerholm, Per; Griffith, May] Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden.
   [Olsen, David; Polarek, James] FibroGen Inc, San Francisco, CA USA.
   [Merrett, Kimberley; Lee, Chyan-Jang; Griffith, May] Ottawa Hosp, Res Inst, Vis Programme, Ottawa, ON, Canada.
   [Salerud, Goran] Linkoping Univ, Dept Biomed Engn, Linkoping, Sweden.
RP Ljunggren, MK (reprint author), Linkoping Univ, Integrat Regenerat Med Ctr, S-58185 Linkoping, Sweden.
EM Monika.Kozak.Ljunggren@liu.se
RI Edin, Joel/H-3227-2017
OI Edin, Joel/0000-0001-8465-1764
CR Altmann S, 2010, INVEST OPHTH VIS SCI, V51, P4531, DOI 10.1167/iovs.09-5106
   Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616
   CHU ML, 1988, J BIOL CHEM, V263, P18601
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P767
   CINTRON C, 1988, INVEST OPHTH VIS SCI, V29, P760
   Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133
   DANA MR, 1995, CORNEA, V14, P604
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   DOANE KJ, 1992, EXP CELL RES, V202, P113, DOI 10.1016/0014-4827(92)90410-A
   Fagerholm P., 2010, TRANSL MED, V2, P46, DOI DOI 10.1126/SCITRANSLMED.3001022
   Griffith M, 2009, EYE, V23, P1985, DOI 10.1038/eye.2008.409
   JANDER R, 1983, EUR J BIOCHEM, V133, P39, DOI 10.1111/j.1432-1033.1983.tb07427.x
   KERN P, 1991, BIOCHEM J, V274, P615, DOI 10.1042/bj2740615
   LEE RE, 1984, EXP EYE RES, V39, P639, DOI 10.1016/0014-4835(84)90063-0
   Lee RMH, 2012, CLIN OPHTHALMOL, V6, P1335, DOI 10.2147/OPTH.S35460
   Liu YW, 2006, INVEST OPHTH VIS SCI, V47, P1869, DOI 10.1167/iovs.05-1339
   McLaughlin CR, 2008, CORNEA, V27, P580, DOI 10.1097/ICO.0b013e3181658408
   Merrett K, 2008, INVEST OPHTH VIS SCI, V49, P3887, DOI 10.1167/iovs.07-1348
   Priest D., 1998, IOVS, V39, pS352
   Richter A, 1997, GER J OPHTHALMOL, V5, P513
   Williams KA, 2006, TRANSPLANTATION, V81, P896, DOI 10.1097/01.tp.0000185197.37824.35
   Wilson SE, 2012, EXP EYE RES, V99, P78, DOI 10.1016/j.exer.2012.03.018
   You LT, 2000, INVEST OPHTH VIS SCI, V41, P692
   ZIMMERMANN DR, 1986, FEBS LETT, V197, P55, DOI 10.1016/0014-5793(86)80297-6
NR 24
TC 5
Z9 5
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 2164-2591
J9 TRANSL VIS SCI TECHN
JI Transl. Vis. Sci. Technol.
PD MAR
PY 2014
VL 3
IS 2
AR 6
DI 10.1167/tvst.3.2.6
PG 13
WC Ophthalmology
SC Ophthalmology
GA V45JS
UT WOS:000209813500006
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Yu, T
   Liu, X
   Ye, JD
   Zhang, M
AF Yu, Tao
   Liu, Xuan
   Ye, Jiandong
   Zhang, Ming
TI Investigation of mechanical behavior of CPC/bone specimens by finite
   element analysis
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Biomaterial; Bone repair; Finite element analysis
ID CALCIUM-PHOSPHATE CEMENT; VERTEBRAL TRABECULAR BONE; IN-VITRO; STRENGTH;
   REINFORCEMENT; SCAFFOLDS; MODELS; VERTEBROPLASTY; KYPHOPLASTY; HYDRATION
AB Calcium phosphate cement (CPC), as an important injectable biomaterial, is extensively used for bone repair in clinical application. If mechanical properties of CPC match well with that of bone tissue, it can create an appropriate mechanical environment for bone repair. In our study, the objective was to investigate the responses of bone tissue to CPC in different series of elastic modulus combinations. Finite element analysis (FEA) was applied to calculate the stress/strain on CPC-bone specimens and to further forecast the potential risky area. The predicted results indicated that CPC materials and bone tissue had different stress distribution patterns under the same loading condition. For CPC material, the Von Mises Stress peak occurred in the bone cement joint area; while for bone tissue, the risky area was located at the bridge area among trabecular bones. The porous and loose structure of cancellous bone induced a greater Von Mises Stress in bone tissue. Quantitative analysis indicated that stress/strain distribution was directly correlated with the elastic modulus of material. When Young's modulus of bone and CPC was 1 GPa and 6.10 GPa respectively, the optimal stress matching between bone and CPC was achieved. In sum, this work confirmed that FE modeling was the ideal method for predicting fracture behavior of bone CPC specimen both qualitatively and quantitatively. (c) 2013 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Yu, Tao; Liu, Xuan; Zhang, Ming] Hong Kong Polytech Univ, Interdisciplinary Div Biomed Engn, Kowloon, Hong Kong, Peoples R China.
   [Yu, Tao; Ye, Jiandong] S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat, Guangzhou 510641, Guangdong, Peoples R China.
   [Yu, Tao; Ye, Jiandong] S China Univ Technol, Sch Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China.
RP Ye, JD (reprint author), S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat, Guangzhou 510641, Guangdong, Peoples R China.
EM jdye@scut.edu.cn; ming.zhang@polyu.edu
RI Zhang, Ming/F-8331-2011
OI Zhang, Ming/0000-0002-6027-4594
FU National Natural Science Foundation of China [51172074, 51302089];
   Natural Science Foundation of Guangdong Province of China [04205786];
   Hong Kong Scholars Program [XJ2011010]; China Postdoctoral Science
   Foundation [2012M511571]; China Postdoctoral Science Foundation (CPSF)
   [201104358]; Guangdong Natural Science Foundation [S2012040007845];
   Fundamental Research Funds for the Central Universities [2013770010]
FX This research was supported by National Natural Science Foundation of
   China, Grant number: 51172074; Natural Science Foundation of Guangdong
   Province of China, Grant number: 04205786; Hong Kong Scholars Program
   (XJ2011010); China Postdoctoral Science Foundation: 2012M511571; China
   Postdoctoral Science Foundation (CPSF): 201104358; Guangdong Natural
   Science Foundation: S2012040007845; Fundamental Research Funds for the
   Central Universities (2013770010); National Natural Science Foundation
   of China (51302089).
CR [Anonymous], 2011, ABAQUS ABAQUS US MAN
   Brown P.W., 1986, CEMENTS RES PROGR, V99, P352
   Brown PW, 1999, CEMENT CONCRETE RES, V29, P1167, DOI 10.1016/S0008-8846(99)00051-4
   Burguera EF, 2005, J BIOMED MATER RES A, V75A, P966, DOI 10.1002/jbm.a.30497
   Carrino JA, 2004, SEMIN ROENTGENOL, V39, P68, DOI 10.1053/j.ro.2003.10.012
   Charriere E, 2001, BIOMATERIALS, V22, P2937, DOI 10.1016/S0142-9612(01)00041-2
   Chow L. C., 1991, J CERAM SOC JPN, V99, P954
   COWIN SC, 1986, J BIOMECH ENG-T ASME, V108, P83, DOI 10.1115/1.3138584
   Dejaco A, 2012, J BIOMECH, V45, P1068, DOI 10.1016/j.jbiomech.2011.12.026
   Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   FERNANDEZ E, 1995, J MATER SCI LETT, V14, P4, DOI 10.1007/BF02565267
   Gong H, 2007, ANN BIOMED ENG, V35, P1622, DOI 10.1007/s10439-007-9332-8
   Gong H, 2009, ACTA MECH SINICA-PRC, V25, P121, DOI 10.1007/s10409-008-0198-2
   GOODSHIP AE, 2001, BONE MECH HDB, P261
   Hadjipavlou AG, 2005, J BONE JOINT SURG BR, V87B, P1595, DOI 10.1302/0301-620X.87B12.16074
   Han B, 2009, ACTA BIOMATER, V5, P3165, DOI 10.1016/j.actbio.2009.04.024
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   KEAVENY TM, 1994, J BIOMECH, V27, P1137, DOI 10.1016/0021-9290(94)90054-X
   Lacroix D, 2006, BIOMATERIALS, V27, P5326, DOI 10.1016/j.biomaterials.2006.06.009
   Liu CS, 2003, BIOMATERIALS, V24, P4103, DOI 10.1016/S0142-9612(03)00238-2
   Luczynski KW, 2012, CMES-COMP MODEL ENG, V87, P505
   Miranda P, 2008, ACTA BIOMATER, V4, P1715, DOI 10.1016/j.actbio.2008.05.020
   Morgan H., 2003, J MATER SCI-MATER M, V14, P647
   Pegoretti A, 2002, BIOMATERIALS, V23, P2667, DOI 10.1016/S0142-9612(01)00407-0
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Ratner BD, 2004, BIOMATERIALS SCI INT, P28
   Scheiner S, 2009, BIOMATERIALS, V30, P2411, DOI 10.1016/j.biomaterials.2008.12.048
   STONE JL, 1983, J BIOMECH, V16, P743, DOI 10.1016/0021-9290(83)90083-0
   Takahashi K, 2004, CERAM INT, V30, P199, DOI 10.1016/S0272-8842(03)00089-0
   Thomson RC, 1998, BIOMATERIALS, V19, P1935, DOI 10.1016/S0142-9612(98)00097-0
   Tozzi G, 2012, J BIOMECH, V45, P356, DOI 10.1016/j.jbiomech.2011.10.011
   Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5
   van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1
   VANRIETBERGEN B, 1995, J BIOMECH, V28, P69
   VOSE G. P., 1959, HUMAN BIOL, V31, P261
   Wang XP, 2007, J AM CERAM SOC, V90, P962, DOI 10.1111/j.1551-2916.2006.01460.x
   Wolff J., 1892, GESETZ TRANSFORMATIO
   Xu HHK, 2000, J BIOMED MATER RES, V52, P107, DOI 10.1002/1097-4636(200010)52:1<107::AID-JBM13>3.3.CO;2-S
   Yamamoto H, 1998, BIOMATERIALS, V19, P1587, DOI 10.1016/S0142-9612(97)00121-X
   YOUSSEF JA, 2003, OPER TECH ORTHOP, V13, P222
   Yu T, 2009, ACTA BIOMATER, V5, P2717, DOI 10.1016/j.actbio.2009.03.015
   Yu T, 2009, J AM CERAM SOC, V92, P949, DOI 10.1111/j.1551-2916.2009.02975.x
   Zainali K, 2013, J BIOMED MATER RES A, V101, P195, DOI 10.1002/jbm.a.34307
   Zhang Y, 2005, J BIOMED MATER RES A, V75A, P832, DOI 10.1002/jbm.a.30461
NR 45
TC 2
Z9 3
U1 3
U2 49
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
EI 1873-3956
J9 CERAM INT
JI Ceram. Int.
PD MAR
PY 2014
VL 40
IS 2
BP 2933
EP 2942
DI 10.1016/j.ceramint.2013.10.018
PG 10
WC Materials Science, Ceramics
SC Materials Science
GA 292DJ
UT WOS:000329882100051
DA 2018-10-19
ER

PT J
AU Hunt, HK
   Armani, AM
AF Hunt, Heather K.
   Armani, Andrea M.
TI Bioconjugation Strategies for Label-Free Optical Microcavity Sensors
SO IEEE JOURNAL OF SELECTED TOPICS IN QUANTUM ELECTRONICS
LA English
DT Article
DE Biophotonics; nanobiotechnology; biological techniques; optical
   resonators; biosensors
ID SELF-ASSEMBLED MONOLAYERS; FREQUENCY COMB GENERATION; SILICON-NITRIDE
   SURFACES; CLICK-CHEMISTRY; PROTEIN ADSORPTION; POLYMER BRUSHES;
   LIPID-BILAYERS; ALKYLSILANE MONOLAYERS; VESICLE ADSORPTION; RESIST
   ADSORPTION
AB Whispering gallery mode optical microcavities have significantly impacted the field of label-free optical biodetection. By combining the evanescent field generated by the microcavity with biomimetic surface chemistries, it is now possible to use the microcavities as not only biosensors, but as analytical tools to explore fundamental chemical and physical interactions of biomolecules and biomaterials. Here, we review the recent advancements of these applications from a surface chemistry perspective. For example, surface chemistries can be generated from a standard coating perspective, where active molecules, such as laser or fluorescent dyes can be embedded in a biomaterial matrix. Alternatively, direct and reverse grafting techniques can be used to tether biomolecules of interest to the surface to tune the surface properties (hydrophobicity/hydrophilicity, protein adsorption, cell adhesion, etc.). Finally, we discuss how to apply advancements in biomimetic chemistry from other sensor approaches to these devices to continue the development of new analytical tools. All of these developments rely on a firm understanding of how proper surface chemistries can be merged with whispering gallery mode optical microcavities to achieve not just a platform, but a precisely defined tool for a given application.
C1 [Hunt, Heather K.] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
   [Armani, Andrea M.] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA.
   [Armani, Andrea M.] Univ So Calif, Ming Hsieh Dept Elect Engn Electrophys, Los Angeles, CA 90089 USA.
RP Hunt, HK (reprint author), Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
EM hunthk@missouri.edu; armani@usc.edu
RI Armani, Andrea/A-8132-2010
OI Armani, Andrea/0000-0001-9890-5104
FU National Institutes of Health through NIH Director's New Innovator Award
   [1DP2OD007391-01]
FX This work was supported by the National Institutes of Health through NIH
   Director's New Innovator Award Program (1DP2OD007391-01).
CR Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921
   Arafat A, 2007, LANGMUIR, V23, P6233, DOI 10.1021/la7007045
   Arlett JL, 2011, NAT NANOTECHNOL, V6, P203, DOI 10.1038/nnano.2011.44
   Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Bhat RR, 2006, ADV POLYM SCI, V198, P51, DOI 10.1007/12_060
   Biggs BW, 2012, J COLLOID INTERF SCI, V369, P477, DOI 10.1016/j.jcis.2011.11.082
   Bocking T, 2006, LANGMUIR, V22, P3494, DOI 10.1021/la030331a
   Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741
   Byeon JY, 2010, LANGMUIR, V26, P15430, DOI 10.1021/la1021824
   Caballero D, 2012, ANAL CHIM ACTA, V720, P43, DOI 10.1016/j.aca.2012.01.031
   Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1
   Castellana ET, 2006, SURF SCI REP, V61, P429, DOI 10.1016/j.surfrep.2006.06.001
   Chang PV, 2010, P NATL ACAD SCI USA, V107, P1821, DOI 10.1073/pnas.0911116107
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chapman RG, 2000, LANGMUIR, V16, P6927, DOI 10.1021/la9915791
   Cheema MI, 2012, OPT EXPRESS, V20, P9090, DOI 10.1364/OE.20.009090
   Chen SF, 2010, POLYMER, V51, P5283, DOI 10.1016/j.polymer.2010.08.022
   Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001
   Chistiakova MV, 2012, OPT LETT, V37, P4068, DOI 10.1364/OL.37.004068
   Ciampi S, 2007, LANGMUIR, V23, P9320, DOI 10.1021/la701035g
   Clare TL, 2005, LANGMUIR, V21, P6344, DOI 10.1021/la050362q
   Cloarec JP, 2002, BIOSENS BIOELECTRON, V17, P405, DOI 10.1016/S0956-5663(01)00282-2
   Daaboul GG, 2012, IEEE J SEL TOP QUANT, V18, P1422, DOI 10.1109/JSTQE.2011.2180516
   Del'Haye P, 2007, NATURE, V450, P1214, DOI 10.1038/nature06401
   Duckworth BP, 2006, BIOCONJUGATE CHEM, V17, P967, DOI 10.1021/bc060125e
   EDWARDS PR, 1995, ANAL BIOCHEM, V231, P210, DOI 10.1006/abio.1995.1522
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   Freeman LM, 2012, IEEE J SEL TOP QUANT, V18, P1160, DOI 10.1109/JSTQE.2011.2166059
   Freeman LM, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3576908
   Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777
   Gelbart WM, 1996, J PHYS CHEM-US, V100, P13169, DOI 10.1021/jp9606570
   Goetz R, 1999, PHYS REV LETT, V82, P221, DOI 10.1103/PhysRevLett.82.221
   Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900
   Gorodetsky ML, 1996, OPT LETT, V21, P453, DOI 10.1364/OL.21.000453
   Grossmann T, 2011, OPT EXPRESS, V19, P10009, DOI 10.1364/OE.19.010009
   GUESDON JL, 1979, J HISTOCHEM CYTOCHEM, V27, P1131, DOI 10.1177/27.8.90074
   Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Hanay MS, 2012, NAT NANOTECHNOL, V7, P602, DOI [10.1038/NNANO.2012.119, 10.1038/nnano.2012.119]
   Harms ZD, 2011, ANAL CHEM, V83, P9573, DOI 10.1021/ac202358t
   Hernandez K, 2011, ENZYME MICROB TECH, V48, P107, DOI 10.1016/j.enzmictec.2010.10.003
   Himo F, 2005, J AM CHEM SOC, V127, P210, DOI 10.1021/ja0471525
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Huang E, 2000, LANGMUIR, V16, P3272, DOI 10.1021/la9910834
   Hunt HK, 2011, OPT LETT, V36, P1092, DOI 10.1364/OL.36.001092
   Hunt HK, 2010, SENSORS-BASEL, V10, P9317, DOI 10.3390/s101009317
   Hunt HK, 2010, NANOSCALE, V2, P1544, DOI 10.1039/c0nr00201a
   Ilic B, 2004, APPL PHYS LETT, V85, P2604, DOI 10.1063/1.1794378
   Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w
   Iqbal SS, 2000, BIOSENS BIOELECTRON, V15, P549, DOI 10.1016/S0956-5663(00)00108-1
   Jiang XS, 2008, BIOSENS BIOELECTRON, V23, P1577, DOI 10.1016/j.bios.2008.01.035
   Keller CA, 1998, BIOPHYS J, V75, P1397, DOI 10.1016/S0006-3495(98)74057-3
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kozma P, 2011, SENSOR ACTUAT B-CHEM, V155, P446, DOI 10.1016/j.snb.2010.12.045
   LANG H, 1994, LANGMUIR, V10, P197, DOI 10.1021/la00013a029
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lee H, 2012, NAT PHOTONICS, V6, P369, DOI [10.1038/nphoton.2012.109, 10.1038/NPHOTON.2012.109]
   Liu RH, 2000, METHOD ENZYMOL, V318, P268
   Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178
   Lofblom J, 2010, FEBS LETT, V584, P2670, DOI 10.1016/j.febslet.2010.04.014
   Luchansky MS, 2012, ANAL CHEM, V84, P793, DOI 10.1021/ac2029024
   Manova RK, 2012, LANGMUIR, V28, P8651, DOI 10.1021/la300921e
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883
   Nitkowski A, 2011, BIOMED OPT EXPRESS, V2, P271, DOI 10.1364/BOE.2.000271
   Okawachi Y, 2011, OPT LETT, V36, P3398, DOI 10.1364/OL.36.003398
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Parvole J, 2003, MACROMOL RAPID COMM, V24, P1074, DOI 10.1002/marc.200300035
   Patel N, 1997, LANGMUIR, V13, P6485, DOI 10.1021/la970933h
   PORSTMANN T, 1992, J IMMUNOL METHODS, V150, P5, DOI 10.1016/0022-1759(92)90061-W
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RAVETCH JV, 1991, ANNU REV IMMUNOL, V9, P457, DOI 10.1146/annurev.iy.09.040191.002325
   Reimhult E, 2003, LANGMUIR, V19, P1681, DOI 10.1021/la0263920
   Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297
   Rye RR, 1997, LANGMUIR, V13, P2965, DOI 10.1021/la960919p
   Salafsky J, 1996, BIOCHEMISTRY-US, V35, P14773, DOI 10.1021/bi961432i
   Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shi C, 2012, OPT LETT, V37, P1643, DOI 10.1364/OL.37.001643
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Soteropulos CE, 2012, LANGMUIR, V28, P15743, DOI 10.1021/la302041d
   Soteropulos CE, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3634023
   Stevens MJ, 1999, LANGMUIR, V15, P2773, DOI 10.1021/la981064e
   Sullivan TP, 2003, EUR J ORG CHEM, P17
   Sun XL, 2006, BIOCONJUGATE CHEM, V17, P52, DOI 10.1021/bc0502311
   Therien-Aubin H, 2011, POLYMER, V52, P5419, DOI 10.1016/j.polymer.2011.09.017
   Vernooy DW, 1998, OPT LETT, V23, P247, DOI 10.1364/OL.23.000247
   Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221
   Walcarius A, 2003, CHEM MATER, V15, P2161, DOI 10.1021/cm021310e
   Washburn AL, 2010, ANAL CHEM, V82, P69, DOI 10.1021/ac902451b
   Wei MY, 2009, PROG CHEM, V21, P492
   Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198
   Wilson KA, 2012, BIOMATERIALS, V33, P225, DOI 10.1016/j.biomaterials.2011.09.036
   Wu HJ, 2012, NAT METHODS, V9, P1189, DOI [10.1038/nmeth.2211, 10.1038/NMETH.2211]
   Wu P, 2004, ANGEW CHEM INT EDIT, V43, P3928, DOI 10.1002/anie.200454078
   Wu T, 2003, MACROMOLECULES, V36, P2448, DOI 10.1021/ma0257189
   Xie P, 2012, NAT NANOTECHNOL, V7, P119, DOI [10.1038/nnano.2011.217, 10.1038/NNANO.2011.217]
   Zhang XM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3398008
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zhao C, 2012, CHEM PAP, V66, P323, DOI 10.2478/s11696-012-0147-1
   Zinoviev KE, 2011, J LIGHTWAVE TECHNOL, V29, P1926, DOI 10.1109/JLT.2011.2150734
NR 106
TC 18
Z9 18
U1 2
U2 72
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1077-260X
EI 1558-4542
J9 IEEE J SEL TOP QUANT
JI IEEE J. Sel. Top. Quantum Electron.
PD MAR-APR
PY 2014
VL 20
IS 2
AR 6900213
DI 10.1109/JSTQE.2013.2272916
PG 13
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 293TS
UT WOS:000329997200013
DA 2018-10-19
ER

PT J
AU Singh, AK
   Srivastava, GK
   Martin, L
   Alonso, M
   Pastor, JC
AF Singh, Amar K.
   Srivastava, Girish K.
   Martin, Laura
   Alonso, Matilde
   Carlos Pastor, J.
TI Bioactive substrates for human retinal pigment epithelial cell growth
   from elastin-like recombinamers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; elastin-like recombinamers; hRPE cells
ID HUMAN BRUCHS MEMBRANE; MACULAR DEGENERATION; RCS RATS; VISUAL FUNCTION;
   RODENT MODEL; RPE CELLS; TRANSPLANTATION; CULTURE; EXPRESSION; RESCUE
AB The aim of this study was to investigate the use of bioactive RGD-containing elastin-like recombinamers (ELR-RGDs) as a substrate that can maintain human retinal pigment epithelial cell (hRPE) phenotype and growth pattern. Results obtained are compared with previously published behavior of ARPE19 cells. The extension of these results to hRPE is required because ARPE19 cells cannot be used clinically to treat age-related macular degeneration. hRPE cells were isolated, cultured, seeded, and grown on surface of glass, treated polystyrene (TCP), and solvent-cast ELR-RGD and ELR-IK film with no specific sequence. Cells were analyzed to study cell adhesion, proliferation, morphology, and RPE65 protein expression by staining with diamidino-2-phenylindole, Rhodamine-Phalloidin, and anti-RPE65 antibody at 12, 24, 72, 120, 168, and 360 h. hRPE cells always grew better on ELR-RGD than on glass and ELR-IK but not on TCP. The kinetic hRPE growth curves confirmed that growth differences started to appear at 24 h for these surfaces in ascending order of cell growths, namely glass, ELR-IK, ELR-RGD, and TCP. There was a clear difference at 360 h. ELR-RGD maintained hRPE cells stable morphology and RPE65 protein expression. ELR-RGD seems to be a good substrate for growing hRPE cells with stable morphology and RPE65 protein expression. As such, this work confirms our hypothesis regarding ELR-RGD substrates viability, which can be used as a Bruch's membrane prosthesis for further studies in animals. However, these results must subsequently be extrapolated to use of hRPE cells in animals to evaluate them as a transplantation vehicle in human. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 639-646, 2014.
C1 [Singh, Amar K.; Srivastava, Girish K.; Carlos Pastor, J.] Univ Valladolid, IOBA Eye Inst, Valladolid, Spain.
   [Srivastava, Girish K.] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Valladolid, Spain.
   [Srivastava, Girish K.; Carlos Pastor, J.] Regenerat Med & Cell Therapy Networking Ctr Casti, Madrid, Spain.
   [Martin, Laura; Alonso, Matilde] Univ Valladolid, BIOFORGE Grp, Valladolid, Spain.
RP Srivastava, GK (reprint author), Univ Valladolid, IOBA Eye Inst, Valladolid, Spain.
EM girish@ioba.med.uva.es
RI ALONSO, MATILDE/G-6719-2017; SINGH, AMAR/H-6569-2016; Martin,
   Laura/J-9291-2017; Srivastava, Girish/L-7608-2014
OI ALONSO, MATILDE/0000-0002-6853-8427; SINGH, AMAR/0000-0002-1767-5907;
   Martin, Laura/0000-0002-6583-8731; Srivastava,
   Girish/0000-0002-9791-4057
CR Al-Hussaini H, 2008, MOL VIS, V14, P1784
   Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t
   Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024
   Burke JM, 1998, INVEST OPHTH VIS SCI, V39, P1478
   CAMPOCHIARO PA, 1986, INVEST OPHTH VIS SCI, V27, P1615
   Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782
   Curcio CA, 2010, J LIPID RES, V51, P451, DOI 10.1194/jlr.R002238
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724
   Girman SV, 2003, VISION RES, V43, P1817, DOI 10.1016/S0042-6989(03)00276-1
   Green W R, 1999, Mol Vis, V5, P27
   Gullapalli VK, 2008, EXP EYE RES, V86, P189, DOI 10.1016/j.exer.2007.10.009
   Gupta SK, 1997, BIOCHEM CELL BIOL, V75, P119, DOI 10.1139/bcb-75-2-119
   Hornof M, 2005, EUR J PHARM BIOPHARM, V60, P207, DOI 10.1016/j.ejpb.2005.01.009
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Ishida M, 1998, CURR EYE RES, V17, P392, DOI 10.1080/02713689808951220
   Kaur Gurvinder, 2012, Spermatogenesis, V2, P1
   Kearns V, 2012, J MATER SCI-MATER M, V23, P2013, DOI 10.1007/s10856-012-4675-6
   Kwan ASL, 1999, EXP NEUROL, V159, P21, DOI 10.1006/exnr.1999.7157
   Lu B, 2012, BIOMED MICRODEVICES, V14, P659, DOI 10.1007/s10544-012-9645-8
   Ma ZZ, 2009, INVEST OPHTH VIS SCI, V50, P2975, DOI 10.1167/iovs.08-2573
   MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Mazumder MAJ, 2012, J BIOMED MATER RES A, V100A, P1877, DOI 10.1002/jbm.a.34021
   Sagdullaev BT, 2003, INVEST OPHTH VIS SCI, V44, P1686, DOI 10.1167/iovs.02-0615
   Schwartz JR, 1998, BIOL REPROD, V59, P1187, DOI 10.1095/biolreprod59.5.1187
   Seiler MJ, 2008, EUR J NEUROSCI, V28, P208, DOI 10.1111/j.1460-9568.2008.06279.x
   Shadforth AMA, 2012, BIOMATERIALS, V33, P4110, DOI 10.1016/j.biomaterials.2012.02.040
   Sheridan C, 2007, EXPERT REV OPHTHALMO, V2, P1
   Srivastava GK, 2013, J IMMUNOL METHODS, V389, P61, DOI 10.1016/j.jim.2013.01.003
   Srivastava GK, 2011, EXP EYE RES, V93, P956, DOI 10.1016/j.exer.2011.07.002
   Srivastava GK, 2011, J BIOMED MATER RES A, V97A, P243, DOI 10.1002/jbm.a.33050
   Subrizi A, 2012, BIOMATERIALS, V33, P8047, DOI 10.1016/j.biomaterials.2012.07.033
   Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P4979, DOI 10.1167/iovs.10-5386
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   van Zeeburg EJT, 2012, AM J OPHTHALMOL, V153, P120, DOI 10.1016/j.ajo.2011.06.007
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P3201, DOI 10.1167/iovs.08-1831
   Wang SM, 2008, INVEST OPHTH VIS SCI, V49, P416, DOI 10.1167/iovs.07-0992
   Zhang L, 2006, EXP EYE RES, V83, P1405, DOI 10.1016/j.exer.2006.07.020
NR 39
TC 7
Z9 7
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 639
EP 646
DI 10.1002/jbm.a.34726
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100004
PM 23554132
DA 2018-10-19
ER

PT J
AU Shie, MY
   Chang, HC
   Ding, SJ
AF Shie, Ming-You
   Chang, Hsien-Chang
   Ding, Shinn-Jyh
TI Composition-dependent protein secretion and integrin level of
   osteoblastic cell on calcium silicate cements
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE calcium silicate; cell adhesion; protein secretion; protein adsorption;
   integrin
ID SI-SUBSTITUTED HYDROXYAPATITE; MESENCHYMAL STEM-CELLS; IN-VITRO;
   OSTEOGENIC DIFFERENTIATION; SIGNAL-TRANSDUCTION; BONE-GRAFTS;
   PROLIFERATION; SURFACE; ADHESION; FIBRONECTIN
AB The purpose of this study was to investigate the responses of the human osteosarcoma cell line MG63 to calcium silicate cements with different Si/Ca molar ratios and different surface roughness. In particular, the study evaluated integrin subunit levels, phosphor-focal adhesion kinase (pFAK) levels and protein production at the cell attachment stage. The results indicated that the surface roughness (variations within a factor of 10) of the cements did not play a prominent role in cell attachment and proliferation, but the effect of composition was highlighted. Increased pFAK and total integrin levels and promoted cell attachment and cell cycle progression were observed upon an increase in cement Si content. Cement with a higher Si content was beneficial for collagen Type I (COL I) adsorption, COL I secretion, and lib3 subintegrin expression, whereas cement with a higher Ca content increased fibronectin (FN) adsorption, FN secretion, and enhanced v1 subintegrin levels. These results establish composition-dependent differences in integrin binding as a mechanism regulating cellular responses to biomaterial surfaces. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 769-780, 2014.
C1 [Shie, Ming-You; Ding, Shinn-Jyh] Chung Shan Med Univ, Inst Oral Sci, Taichung 402, Taiwan.
   [Chang, Hsien-Chang] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
   [Ding, Shinn-Jyh] Chung Shan Med Univ Hosp, Dept Dent, Taichung 402, Taiwan.
RP Chang, HC (reprint author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 701, Taiwan.
EM hcchang@mail.ncku.edu.tw; sjding@csmu.edu.tw
CR Andrade Ângela Leão, 2004, Mat. Res., V7, P631, DOI 10.1590/S1516-14392004000400018
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Au AY, 2010, J BIOMED MATER RES A, V94A, P380, DOI 10.1002/jbm.a.32668
   Blanc K. L., 2003, EXP HEMATOL, V31, P890
   Botelho CM, 2002, J MATER SCI-MATER M, V13, P1123, DOI 10.1023/A:1021177601899
   Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263
   Chen CC, 2011, INT ENDOD J, V44, P836, DOI 10.1111/j.1365-2591.2011.01890.x
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chou L, 1999, BIOMATERIALS, V20, P977, DOI 10.1016/S0142-9612(98)00254-3
   Chow LC, 2000, J BIOMED MATER RES, V53, P511, DOI 10.1002/1097-4636(200009)53:5<511::AID-JBM10>3.3.CO;2-5
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   Davis D, 2010, J BONE JOINT SURG AM, V92A, P129, DOI 10.2106/JBJS.H.01561
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Ding SJ, 2010, TISSUE ENG PT A, V16, P2343, DOI [10.1089/ten.tea.2009.0749, 10.1089/ten.TEA.2009.0749]
   Ding SJ, 2011, ACS APPL MATER INTER, V3, P4142, DOI 10.1021/am201017v
   Ding SJ, 2011, J MATER CHEM, V21, P12793, DOI 10.1039/c1jm11171j
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Hench L L, 1988, Ann N Y Acad Sci, V523, P54, DOI 10.1111/j.1749-6632.1988.tb38500.x
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Jeon H, 2012, LANGMUIR, V28, P13423, DOI 10.1021/la302937k
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522
   Leroy C, 2000, EUR J CELL BIOL, V79, P936, DOI 10.1078/0171-9335-00119
   Lin KL, 2005, CERAM INT, V31, P323, DOI 10.1016/j.ceramint.2004.05.023
   Lu HH, 2000, J BIOMED MATER RES, V51, P80, DOI 10.1002/(SICI)1097-4636(200007)51:1<80::AID-JBM11>3.0.CO;2-6
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Peng WW, 2011, J ENDODONT, V37, P1240, DOI 10.1016/j.joen.2011.05.035
   RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6
   Rosa AL, 2003, DENT MATER, V19, P768, DOI 10.1016/S0109-5641(03)00024-1
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Shie MY, 2012, INT ENDOD J, V45, P337, DOI 10.1111/j.1365-2591.2011.01981.x
   Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   Singh A, 2010, J MATER CHEM, V20, P8832, DOI 10.1039/c0jm01613f
   Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191
   Tian T, 2008, MAT SCI ENG C-BIO S, V28, P57, DOI 10.1016/j.msec.2007.10.049
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Xia LG, 2011, EUR CELLS MATER, V22, P68, DOI 10.22203/eCM.v022a06
   Xu GL, 2003, POWDER TECHNOL, V134, P218, DOI 10.1016/S0032-5910(03)00172-4
   Xue WC, 2009, ACTA BIOMATER, V5, P1686, DOI 10.1016/j.actbio.2009.01.012
   Xynos ID, 2000, J BIOMED MATER RES, V155, P151
   Zhang NL, 2010, BIOMATERIALS, V31, P7653, DOI 10.1016/j.biomaterials.2010.06.043
NR 49
TC 24
Z9 24
U1 0
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 769
EP 780
DI 10.1002/jbm.a.34737
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100017
PM 23554363
DA 2018-10-19
ER

PT J
AU Okabe, M
   Kitagawa, K
   Yoshida, T
   Suzuki, T
   Waki, H
   Koike, C
   Furuichi, E
   Katou, K
   Nomura, Y
   Uji, Y
   Hayashi, A
   Saito, S
   Nikaido, T
AF Okabe, Motonori
   Kitagawa, Kiyotaka
   Yoshida, Toshiko
   Suzuki, Takuma
   Waki, Hiroki
   Koike, Chika
   Furuichi, Etsuko
   Katou, Kiyoshi
   Nomura, Yoshihiro
   Uji, Yoshinori
   Hayashi, Atsushi
   Saito, Shigeru
   Nikaido, Toshio
TI Hyperdry human amniotic membrane is useful material for tissue
   engineering: Physical, morphological properties, and safety as the new
   biological material
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hyperdry human amniotic membrane; biological material; freeze-dried
   human amniotic membrane; clinical use; recurrent pterygium
ID STEM-CELL DEFICIENCY; SURFACE RECONSTRUCTION; CLINICAL-APPLICATION;
   OCULAR SURFACE; FIBRIN GLUE; ORAL-MUCOSA; TRANSPLANTATION;
   VESTIBULOPLASTY; REGENERATION; PERFORATIONS
AB Human amniotic membrane (AM) has been used widely as graft biomaterial for a variety of clinical applications. But, there are some persistent problems related to the preparation, storage, and sterilization. To resolve these problems, we developed hyperdry AM (HD-AM) using far-infrared rays, depression of air, and microwaves and then sterilized by -ray irradiation. To elucidate the benefit of HD-AM as biological materials, compare with the physical and histological properties of HD-AM with a freeze-dried AM (FD-AM) as typical freeze-dried methods, evaluate the safety of HD-AM in vivo experiment used nude mice, and demonstrate the feasibility of HD-AM transplant in pterygium. The water permeability and the sieving coefficient of HD-AM were significantly lower than that of FD-AM. HD-AM has kept the morphological structure of epithelium and connective tissues. At 18 months after transplanted, single and multilayers of HD-AM in the intraperitoneal cavity was degraded without any infiltrated cells. For clinical treatment, recurrence of pterygium and regrowth of the subconjunctival fibrosis were not observed during the 6-month follow-up periods after the surgery. It was proposed that HD-AM was a safe and effective new biological material for clinical use including treatment for recurrent pterygium. (c) 2013 Wiley Periodicals, Inc.
C1 [Okabe, Motonori; Kitagawa, Kiyotaka; Yoshida, Toshiko; Koike, Chika; Furuichi, Etsuko; Nikaido, Toshio] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
   [Suzuki, Takuma; Nomura, Yoshihiro] Tokyo Univ Agr & Technol, Fac Agr, Tokyo, Japan.
   [Waki, Hiroki; Katou, Kiyoshi] Takaoka City Hosp, Dept Obstet & Gynecol, Toyama, Japan.
   [Uji, Yoshinori] Toyama Univ Hosp, Clin Lab Ctr, Toyama, Japan.
   [Hayashi, Atsushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Ophthalmol, Toyama 930, Japan.
   [Saito, Shigeru] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Obstet & Gynecol, Toyama 930, Japan.
RP Nikaido, T (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Regenerat Med, Toyama 930, Japan.
EM tnikaido@med.u-toyama.ac.jp
FU Ministry of Education, Culture, Sports, Science and Technology of Japan
   [22590498, 25460647]
FX Contract grant sponsor: Grant-in-Aid for Scientific Research from the
   Ministry of Education, Culture, Sports, Science and Technology of Japan
   (to MO); contract grant number: 22590498 & 25460647
CR Arai N, 2012, J ORAL MAXIL SURG, V70, P2221, DOI 10.1016/j.joms.2011.09.033
   Barabino S, 2003, OPHTHALMOLOGY, V110, P474, DOI 10.1016/S0160-6420(02)01892-4
   BENNETT JP, 1980, LANCET, V1, P1153
   Bhatia M, 2007, WOUNDS, V19, P207
   BOURNE GL, 1966, P ROY SOC MED, V59, P1127
   COSLET JG, 1980, DENT CLIN N AM, V24, P651
   Espana EM, 2003, OPHTHALMOLOGY, V110, P481, DOI 10.1016/S0161-6420(02)01764-5
   Espana EM, 2003, J CATARACT REFR SURG, V29, P279, DOI 10.1016/S0886-3350(02)01525-0
   Filipas D, 2001, Curr Opin Urol, V11, P267, DOI 10.1097/00042307-200105000-00004
   Fujisato T, 1999, J BIOMAT SCI-POLYM E, V10, P1171, DOI 10.1163/156856299X00829
   Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2
   Graue-Hernandez EO, 2012, CASE REP OPHTHALMOL, V2012
   Hao YX, 2000, CORNEA, V19, P348, DOI 10.1097/00003226-200005000-00018
   He Qingyi, 2002, Chin J Traumatol, V5, P200
   Hick S, 2005, CORNEA, V24, P369, DOI 10.1097/01.ico.0000151547.08113.d1
   Kanazawa Y, 2012, ACTA OTO-LARYNGOL, V132, P1282, DOI 10.3109/00016489.2012.701329
   KIM JC, 1995, CORNEA, V14, P473
   Kinoshita S, 2004, ARTIF ORGANS, V28, P22, DOI 10.1111/j.1525-1594.2004.07319.x
   Kitagawa K, 2009, TOYAMA MED J, V20, P1
   Kitagawa K, 2011, JPN J OPHTHALMOL, V55, P16, DOI 10.1007/s10384-010-0903-0
   Kitagawa K, 2009, AM J OPHTHALMOL, V148, P383, DOI 10.1016/j.ajo.2009.03.030
   Kjaergaard N, 2001, EUR J OBSTET GYN R B, V94, P224, DOI 10.1016/S0301-2115(00)00345-6
   Koizumi N, 2000, CURR EYE RES, V20, P173, DOI 10.1076/0271-3683(200003)20:3;1-9;FT173
   Lim LS, 2010, ARCH OPHTHALMOL-CHIC, V128, P1303, DOI 10.1001/archophthalmol.2010.222
   Mahdy RA, 2010, CUTAN OCUL TOXICOL, V29, P164, DOI 10.3109/15569521003775005
   Maral T, 1999, BURNS, V25, P625, DOI 10.1016/S0305-4179(99)00072-8
   Mligiliche N, 2002, J BIOMED MATER RES, V63, P591, DOI 10.1002/jbm.10349
   Nakamura T, 2006, ACTA OPHTHALMOL SCAN, V84, P401, DOI 10.1111/j.1600-0420.2006.00667.x
   NEI T, 1978, J MICROSC-OXFORD, V112, P197, DOI 10.1111/j.1365-2818.1978.tb01165.x
   Nguyen Huynh, 2007, Cell and Tissue Banking, V8, P81, DOI 10.1007/s10561-006-9019-7
   Nikaido T, 2007, Japan patent, Patent No. [2007-54015, 200754015]
   Okabe M, 2003, APPL SURF SCI, V203, P714, DOI 10.1016/S0169-4332(02)00797-3
   Okabe M, 2013, CLIN OPHTHALMOL, V7, P649, DOI 10.2147/OPTH.S43106
   ROBSON MC, 1973, ANN SURG, V177, P144, DOI 10.1097/00000658-197302000-00003
   SACHS BP, 1979, BRIT J OBSTET GYNAEC, V86, P81, DOI 10.1111/j.1471-0528.1979.tb10572.x
   Samandari MH, 2004, ORAL SURG ORAL MED O, V97, P574, DOI 10.1016/j.tripleo.2003.10.031
   Sekeroglu Hande Taylan, 2011, International Ophthalmology, V31, P433, DOI 10.1007/s10792-011-9488-y
   Sezer B, 2004, QUINTESSENCE INT, V35, P234
   Shojaku H, 2011, LARYNGOSCOPE, V121, P1953, DOI 10.1002/lary.22082
   Szabo A, 2000, EUR SURG RES, V32, P125, DOI 10.1159/000008751
   Takaya K, 2003, APPL SURF SCI, V203, P684, DOI 10.1016/S0169-4332(02)00791-2
   Toda A, 2007, J PHARMACOL SCI, V105, P215, DOI 10.1254/jphs.CP0070034
   Tomita T, 2012, J NEUROL SURG PART B, V73, P302, DOI 10.1055/s-0032-1321506
   TRELFORD JD, 1979, AM J OBSTET GYNECOL, V134, P833, DOI 10.1016/0002-9378(79)90957-8
   Tseng SCG, 1997, AM J OPHTHALMOL, V124, P765, DOI 10.1016/S0002-9394(14)71693-9
   Tsubota K, 1996, AM J OPHTHALMOL, V122, P38, DOI 10.1016/S0002-9394(14)71962-2
   Tsuno H, 2012, ORAL SURG ORAL MED O, DOI 10.1016/j.oooo.2012.05.014
   UEDA M, 1984, J ORAL MAXIL SURG, V42, P213, DOI 10.1016/0278-2391(84)90452-X
   WAIKAKUL S, 1990, B HOSP JOINT DIS ORT, V50, P27
   Yagi S, 2001, Patent US, Patent No. [6,323,471 B1, 6323471]
NR 50
TC 6
Z9 8
U1 0
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 862
EP 870
DI 10.1002/jbm.a.34753
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100026
PM 23589398
DA 2018-10-19
ER

PT J
AU King, SN
   Hanson, SE
   Chen, X
   Kim, J
   Hematti, P
   Thibeault, SL
AF King, Suzanne N.
   Hanson, Summer E.
   Chen, Xia
   Kim, Jaehyup
   Hematti, Peiman
   Thibeault, Susan L.
TI In vitro characterization of macrophage interaction with mesenchymal
   stromal cell-hyaluronan hydrogel constructs
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE mesenchymal stromal/stem cells; immunomodulation; biomaterials; tissue
   engineering; hyaluronic acid
ID SYNTHETIC EXTRACELLULAR-MATRIX; VOCAL FOLD FIBROBLASTS; UMBILICAL-CORD
   BLOOD; STEM-CELLS; ADIPOSE-TISSUE; LAMINA PROPRIA; GROWTH-FACTORS;
   BONE-MARROW; IMMUNOPHENOTYPE; ACTIVATION
AB Macrophages play a critical role in mediating not only normal tissue healing, but also the host reaction against biomaterial scaffolds. There is increasing interest in regenerative medicine to combine mesenchymal stromal/stem cells (MSCs) with biomaterial scaffolds to modulate inflammatory response while restoring tissue architecture. The objective of the current study was to investigate the interaction between MSCs (derived from bone marrow, adipose or vocal fold tissue) encapsulated in hyaluronan-based hydrogel and differentiating macrophages as measured by extracellular matrix (ECM) gene expression and cytokine, chemokine, and growth factor concentrations. Gene expression was analyzed using real-time polymerase chain reaction from MSCs embedded in Carbylan-GSX after 7 days of coculture with or without CD14+ cells. Protein concentrations were measured using a Bio-plex assay from cell culture supernatants on days 3 and 7 for all conditions. Following 7 days, we identified upregulation of collagen-I, collagen-III, procollagen, and matrix metalloproteinase-9 genes compared to control conditions. We demonstrate increased concentrations of immunoregulatory cytokines [interleukin (IL)-1, tumor necrosis factor-, macrophage inflammatory protein-1, IFN-, IL-12, and IL-10] and remodeling growth factors (vascular endothelial growth factor, hepatocyte growth factor) in MSC-3D constructs cocultured with macrophages compared to control conditions, with some temporal variation. Our results indicate an alteration of expression of ECM proteins important to tissue regeneration and cytokines critical to the inflammatory cascade when 3D constructs were cultured with differentiating macrophages. (c) 2013 Wiley Periodicals, Inc.
C1 [King, Suzanne N.; Chen, Xia; Thibeault, Susan L.] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53715 USA.
   [Hanson, Summer E.] Univ Wisconsin, Sch Med & Publ Hlth, Div Plast & Reconstruct Surg, Madison, WI USA.
   [Kim, Jaehyup; Hematti, Peiman] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA.
   [Hematti, Peiman; Thibeault, Susan L.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Madison, WI 53715 USA.
EM pxh@medicine.wisc.edu; thibeaul@surgery.wisc.edu
RI Kim, Jaehyup/N-5800-2015
OI Kim, Jaehyup/0000-0003-0373-5080
FU NIDCD - NIH [R01 DC4336, R01 DC4336S1, T32 DC009401]; NHLBI - NIH [K08
   HL081076]
FX Contract grant sponsor: NIDCD - NIH; contract grant numbers: R01 DC4336;
   R01 DC4336S1 (to SLT); T32 DC009401 (to SNK); Contract grant sponsor:
   NHLBI - NIH; contract grant number: K08 HL081076 (to PH)
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cantu DA, 2012, STEM CELL TRANSL MED, V1, P740, DOI 10.5966/sctm.2012-0061
   Chen X, 2010, ACTA BIOMATER, V6, P2940, DOI 10.1016/j.actbio.2010.01.032
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Hanson SE, 2011, TISSUE ENG PT A, V17, P2463, DOI [10.1089/ten.tea.2010.0716, 10.1089/ten.TEA.2010.0716]
   Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797
   Hattori H, 2012, CELL TRANSPLANT
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781
   Laurila JP, 2009, CYTOTHERAPY, V11, P726, DOI 10.3109/14653240903067299
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x
   Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014
   Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001
   Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272
   Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
NR 31
TC 15
Z9 15
U1 1
U2 47
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAR
PY 2014
VL 102
IS 3
BP 890
EP 902
DI 10.1002/jbm.a.34746
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 289JS
UT WOS:000329679100029
PM 23564555
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Kong, N
   Lin, KL
   Li, HY
   Chang, J
AF Kong, Ni
   Lin, Kaili
   Li, Haiyan
   Chang, Jiang
TI Synergy effects of copper and silicon ions on stimulation of
   vascularization by copper-doped calcium silicate
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; BIOLOGICAL-PROPERTIES;
   ANGIOGENESIS; CELLS; SCAFFOLDS; PROTEIN; OXYGEN; PROLIFERATION;
   CERULOPLASMIN
AB Copper (Cu) has been reported to be able to stimulate vascularization/angiogenesis, which is critical for regeneration of vascularized tissue in tissue engineering. Silicate bioceramics have also been reported to have stimulatory effects on vascularization due to the silicon (Si) ions released from silicate biomaterrals. Therefore, we hypothesize that a combination of Cu and Si ions may show synergy effects on vascularization. Therefore, a copper-doped calcium silicate bioceramic (Cu-CaSiO3, Cu-CS) was designed and synthesized with the purpose to enhance the stimulatory effects of copper salts or pure silicate bioceramics on vascularization by combining the effects of Cu and Si ions. The cytocompatibility of Cu-CS was firstly assessed by testing the influence of Cu-CS ion extracts on proliferation of human umbilical vein endothelial cells (HUVECs). Thereafter, vascularization of HUVECs on ECMatrix (TM) gel or co-cultured with human dermal fibroblasts (HDFs) in Cu-CS extracts was evaluated and expression of angiogenic growth factors was analyzed. Results revealed that, as compared to CS extracts and media containing soluble CuSO4, Cu-CS extracts possessed stronger stimulatory effects on upregulation of angiogenic growth factors, which finally resulted in better stimulatory effects on vascularization. During the vascularization process, paracrine effects dominated in the co-culture system. In addition, lower concentrations of Cu and Si ions released from Cu-CS than those released from pure CS or CuSO4 were enough to stimulate vascularization, which indicated that there were synergy effects between Cu and Si ions during stimulation of vascularization by Cu-CS. Taken together, the designed Cu-CS may be suitable as a new biomaterial for regenerating blood vessels in tissue engineering.
C1 [Kong, Ni; Li, Haiyan; Chang, Jiang] Shanghai Jiao Tong Univ, Med X Res Inst, Sch Biomed Engn, Shanghai 200030, Peoples R China.
   [Lin, Kaili; Chang, Jiang] Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
RP Li, HY (reprint author), Shanghai Jiao Tong Univ, Med X Res Inst, Sch Biomed Engn, 1954 HuaShan Rd, Shanghai 200030, Peoples R China.
EM haiyan.li@sjtu.edu.cn; jchang@mail.sic.ac.cn
FU National Natural Science Foundation of China [81190132, 31200714];
   Natural Science Foundation of Shanghai Municipality [12ZR1413900]; State
   Key Laboratory of High Performance Ceramics and Superfine Structure
   (Shanghai Institute of Ceramics, Chinese Academy of Science)
   [SKL201203SIC]; SMC-"Chenxing" Talent Program in Shanghai Jiaotong
   University
FX This work was supported by National Natural Science Foundation of China
   (Grant no.: 81190132 and 31200714), Natural Science Foundation of
   Shanghai Municipality (Grant no.: 12ZR1413900), the Opening Project of
   State Key Laboratory of High Performance Ceramics and Superfine
   Structure (Shanghai Institute of Ceramics, Chinese Academy of Science)
   (Grant no.: SKL201203SIC) and The 2012 SMC-"Chenxing" Talent Program in
   Shanghai Jiaotong University.
CR ALESSANDRI G, 1984, MICROCIRC ENDOTH LYM, V1, P329
   Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370
   Carmeliet P, 2004, J INTERN MED, V255, P538, DOI 10.1111/j.1365-2796.2003.01297.x
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3
   Day RM, 2005, TISSUE ENG, V11, P768, DOI 10.1089/ten.2005.11.768
   Feng WK, 2009, MOL PHARMACOL, V75, P174, DOI 10.1124/mol.108.051516
   Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019
   Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x
   Gorustovich AA, 2010, TISSUE ENG PART B-RE, V16, P199, DOI [10.1089/ten.teb.2009.0416, 10.1089/ten.TEB.2009.0416]
   Guillotin B, 2008, BONE, V42, P1080, DOI 10.1016/j.bone.2008.01.025
   Haro L. A., 2012, BIOCELL, V36
   Hu GF, 1998, J CELL BIOCHEM, V69, P326, DOI 10.1002/(SICI)1097-4644(19980601)69:3<326::AID-JCB10>3.0.CO;2-A
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI [10.1016/j.biomaterials.2007.12.031, 10.1016/j.biomaterials.2007.12-031]
   Li H, 2013, ACTA BIOMATER, V9, P6981, DOI 10.1016/j.actbio.2013.02.014
   Li HY, 2013, ACTA BIOMATER, V9, P5379, DOI 10.1016/j.actbio.2012.10.019
   Li HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016767
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267
   Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056
   Malda J, 2004, BIOTECHNOL BIOENG, V86, P9, DOI 10.1002/bit.20038
   MARCUS Y, 1988, CHEM REV, V88, P1475, DOI 10.1021/cr00090a003
   Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980
   Maxwell P, 2004, CANCER BIOL THER, V3, P29, DOI 10.4161/cbt.3.1.547
   Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459
   MCAUSLAN BR, 1983, MICROVASC RES, V26, P323, DOI 10.1016/0026-2862(83)90080-8
   OSKARSSON A, 1981, ANN CLIN LAB SCI, V11, P165
   Pepper MS, 2001, ARTERIOSCL THROM VAS, V21, P1104, DOI 10.1161/hq0701.093685
   RAJU KS, 1982, J NATL CANCER I, V69, P1183
   Ramaswamy Y, 2008, BIOMATERIALS, V29, P4392, DOI 10.1016/j.biomaterials.2008.08.006
   Rocha FG, 2008, BIOMATERIALS, V29, P2884, DOI 10.1016/j.biomaterials.2008.03.026
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551
   Sohier J, 2008, EXPERT OPIN DRUG DEL, V5, P543, DOI [10.1517/17425247.5.5.543 , 10.1517/17425240802088033]
   Sorrell JM, 2003, EXP DERMATOL, V12, P315, DOI 10.1034/j.1600-0625.2003.120312.x
   Tang XL, 2005, MATER LETT, V59, P3841, DOI 10.1016/j.matlet.2005.06.060
   Terman BI, 1996, CANCER METAST REV, V15, P159, DOI 10.1007/BF00437468
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   van Heerden D, 2004, AQUAT TOXICOL, V69, P271, DOI 10.1016/j.aquatox.2004.06.002
   Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178
NR 46
TC 42
Z9 42
U1 3
U2 75
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PD FEB 28
PY 2014
VL 2
IS 8
BP 1100
EP 1110
DI 10.1039/c3tb21529f
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AB0RW
UT WOS:000331500800017
DA 2018-10-19
ER

PT J
AU Erakovic, S
   Jankovic, A
   Ristoscu, C
   Duta, L
   Serban, N
   Visan, A
   Mihailescu, IN
   Stan, GE
   Socol, M
   Iordache, O
   Dumitrescu, I
   Luculescu, CR
   Janackovic, D
   Miskovic-Stankovic, V
AF Erakovic, S.
   Jankovic, A.
   Ristoscu, C.
   Duta, L.
   Serban, N.
   Visan, A.
   Mihailescu, I. N.
   Stan, G. E.
   Socol, M.
   Iordache, O.
   Dumitrescu, I.
   Luculescu, C. R.
   Janackovic, Dj.
   Miskovic-Stankovic, V.
TI Antifungal activity of Ag:hydroxyapatite thin films synthesized by
   pulsed laser deposition on Ti and Ti modified by TiO2 nanotubes
   substrates
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Antifungal activity; Ag doped thin films; TiO2 nanotubes;
   Hydroxyapatite; Pulsed laser deposition
ID CALCIUM-PHOSPHATE COATINGS; SIMULATED BODY-FLUID; ANTIMICROBIAL
   ACTIVITY; IMPLANT APPLICATIONS; HYDROXYAPATITE; TITANIUM; SILVER;
   ANTIBACTERIAL; BONE; BIOACTIVITY
AB Hydroxyapatite (HA) is a widely used biomaterial for implant thin films, largely recognized for its excellent capability to chemically bond to hard tissue inducing the osteogenesis without immune response from human tissues. Nowadays, intense research efforts are focused on development of antimicrobial HA doped thin films. In particular, HA doped with Ag (Ag:HA) is expected to inhibit the attachment of microbes and contamination of metallic implant surface. We herewith report on nano-sized HA and Ag:HA thin films synthesized by pulsed laser deposition on pure Ti and Ti modified with 100 nm diameter TiO2 nanotubes (fabricated by anodization of Ti plates) substrates. The HA-based thin films were characterized by SEM, AFM, EDS, FUR, and XRD. The cytotoxic activity was tested with HEp2 cells against controls. The antifungal efficiency of the deposited layers was tested against the Candida albicans and Aspergillus niger strains. The Ti substrates modified with TiO2 nanotubes covered with Ag:HA thin films showed the highest antifungal activity. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Erakovic, S.; Jankovic, A.; Janackovic, Dj.; Miskovic-Stankovic, V.] Univ Belgrade, Fac Technol & Met, Belgrade 11000, Serbia.
   [Ristoscu, C.; Duta, L.; Serban, N.; Visan, A.; Mihailescu, I. N.; Luculescu, C. R.] Natl Inst Lasers Plasma & Radiat Phys, Magurele Ilfov 077125, Romania.
   [Stan, G. E.; Socol, M.] Natl Inst Mat Phys, Magurele Ilfov 077125, Romania.
   [Iordache, O.; Dumitrescu, I.] Natl Inst Text & Leather, Bucharest 030508, Romania.
RP Mihailescu, IN (reprint author), Natl Inst Lasers Plasma & Radiat Phys, 409 Atomistilor St, Magurele Ilfov 077125, Romania.
EM ion.mihailescu@inflpr.ro
RI Stan, George/B-5690-2011; MIHAILESCU (Serban), Natalia/C-5879-2011;
   Erakovic, Sanja/G-9199-2018; Visan, Anita Ioana/I-7288-2016; Luculescu,
   Catalin/A-7999-2010; Duta, Liviu Marian/G-3417-2011; Ristoscu,
   Carmen/B-8628-2011; Socol, Marcela/B-6045-2012
OI Stan, George/0000-0003-0289-8988; Erakovic, Sanja/0000-0003-1188-5177;
   Visan, Anita Ioana/0000-0003-0539-4160; Luculescu,
   Catalin/0000-0001-6852-401X; Duta, Liviu Marian/0000-0002-6408-6056;
   Ristoscu, Carmen/0000-0002-8433-9217; Miskovic-Stankovic,
   Vesna/0000-0001-6525-9820
FU Ministry of Education. Science and Technological Development, Republic
   of Serbia [III - 45019]; UEFISCDI [ID 304/2011, TE49/2011]
FX This research was financed by the Ministry of Education. Science and
   Technological Development, Republic of Serbia, under contract No. III -
   45019.; C.R., L.D., N.S., A.V. and I.N.M. acknowledge with thanks the
   financial support of UEFISCDI under the contract ID 304/2011.; G.E.S,
   gratefully acknowledges the support of UEFISCDI under contract
   TE49/2011.
CR Antonakos A, 2007, BIOMATERIALS, V28, P3043, DOI 10.1016/j.biomaterials.2007.02.028
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Ciobanu CS, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-324
   Djosic MS, 2012, COLLOID SURFACE A, V400, P36, DOI 10.1016/j.colsurfa.2012.02.040
   Erakovic S, 2013, J PHYS CHEM B, V117, P1633, DOI 10.1021/jp305252a
   Erakovic S, 2012, PROG ORG COAT, V75, P275, DOI 10.1016/j.porgcoat.2012.07.005
   Ewald A, 2011, ACTA BIOMATER, V7, P4064, DOI 10.1016/j.actbio.2011.06.049
   Fahim NF, 2009, ELECTROCHIM ACTA, V54, P3255, DOI 10.1016/j.electacta.2008.12.035
   Fielding GA, 2012, ACTA BIOMATER, V8, P3144, DOI 10.1016/j.actbio.2012.04.004
   Gajbhiye M, 2009, NANOMED-NANOTECHNOL, V5, P382, DOI 10.1016/j.nano.2009.06.005
   Hu MZ, 2009, J MATER SCI, V44, P2820, DOI 10.1007/s10853-009-3372-4
   Huang Y, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045003
   Jeyachandran YL, 2006, SURF COAT TECH, V201, P3462, DOI 10.1016/j.surfcoat.2006.07.236
   Kar A, 2006, SURF COAT TECH, V201, P3723, DOI 10.1016/j.surfcoat.2006.09.008
   Khandelwal H, 2013, APPL SURF SCI, V265, P30, DOI 10.1016/j.apsusc.2012.10.072
   Kotharu V, 2012, CERAM INT, V38, P731, DOI 10.1016/j.ceramint.2011.07.065
   Laurel VL, 1999, J CLIN MICROBIOL, V37, P1612
   Li J, 2012, J DENT, V40, P686, DOI 10.1016/j.jdent.2012.04.026
   Macak JM, 2007, CURR OPIN SOLID ST M, V11, P3, DOI 10.1016/j.cossms.2007.08.004
   Markovic M, 2004, J RES NATL INST STAN, V109, P553, DOI 10.6028/jres.109.042
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Mihailescu I. N., 1999, 4 INT COMM OPT ICO B, P201
   Mihailescu IN, 2002, P SOC PHOTO-OPT INS, V4762, P64, DOI 10.1117/12.478666
   Narayanan R, 2008, MAT SCI ENG C-BIO S, V28, P1265, DOI 10.1016/j.msec.2007.11.009
   Nelea V., 2007, PULSED LASER DEPOSIT, P421
   Okada S, 2010, ACTA BIOMATER, V6, P591, DOI 10.1016/j.actbio.2009.07.037
   Pasteris JD, 2004, BIOMATERIALS, V25, P229, DOI 10.1016/S0142-9612(03)00487-3
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Raimondo T, 2010, INT J NANOMED, V5, P647, DOI 10.2147/IJN.S13047
   Rautray TR, 2010, J BIOMED MATER RES B, V93B, P581, DOI 10.1002/jbm.b.31596
   Sadjadi MS, 2011, MATER CHEM PHYS, V130, P67, DOI 10.1016/j.matchemphys.2011.05.033
   Saravanan S, 2011, INT J BIOL MACROMOL, V49, P188, DOI 10.1016/j.ijbiomac.2011.04.010
   Sima LE, 2010, J BIOMED MATER RES A, V95A, P1203, DOI 10.1002/jbm.a.32947
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Smith GC, 2011, ACTA BIOMATER, V7, P3209, DOI 10.1016/j.actbio.2011.05.003
   Socol G, 2012, DIG J NANOMATER BIOS, V7, P563
   Socrates G., 2004, INFRARED RAMAN CHARA
   Spence G, 2008, J BONE JOINT SURG BR, V90B, P1635, DOI 10.1302/0301-620X.90B12.20931
   Stan GE, 2010, THIN SOLID FILMS, V518, P5955, DOI 10.1016/j.tsf.2010.05.104
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   Sygnatowicz M, 2009, MAT SCI ENG C-BIO S, V29, P1071, DOI 10.1016/j.msec.2008.08.036
   Torres N, 2010, ACTA BIOMATER, V6, P3242, DOI 10.1016/j.actbio.2010.02.032
   Trujillo NA, 2012, MAT SCI ENG C-MATER, V32, P2135, DOI 10.1016/j.msec.2012.05.012
   Tuttle PV, 2006, INT J NANOMED, V1, P497, DOI 10.2147/nano.2006.1.4.497
   YOUNG RA, 1984, CALCIFIED TISSUE INT, V36, P60, DOI 10.1007/BF02405294
NR 45
TC 39
Z9 40
U1 2
U2 88
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 28
PY 2014
VL 293
BP 37
EP 45
DI 10.1016/j.apsusc.2013.12.029
PG 9
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 302BP
UT WOS:000330576600005
DA 2018-10-19
ER

PT J
AU Brunner, EW
   Jurewicz, I
   Heister, E
   Fahimi, A
   Bo, C
   Sear, RP
   Donovan, PJ
   Dalton, AB
AF Brunner, Eric W.
   Jurewicz, Izabela
   Heister, Elena
   Fahimi, Azin
   Bo, Chiara
   Sear, Richard P.
   Donovan, Peter J.
   Dalton, Alan B.
TI Growth and Proliferation of Human Embryonic Stem Cells on Fully
   Synthetic Scaffolds Based on Carbon Nanotubes
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE Tissue engineering; human embryonic stem cells; carbon nanotubes; stern
   cell substrates; pluripotency; biomaterial
ID CELLULAR BEHAVIOR; DIFFERENTIATION; COMPOSITE; MATRIX
AB Here we show an industrially scalable and inexpensive method of fabricating entirely synthetic, non-xenogeneic carbon nanotube-based scaffolds by vacuum filtration for the culture of human embryonic stem cells. We show that controlled exposure of carbon nanotubes to sonication and the amount of energy delivered to the dispersion directly impacts the surface properties, allowing for control over the nanotopography of the resulting carbon nanotube films, which in turn has demonstrable effects upon in vitro human embryonic stem cells cultures. By altering the nanotube processing conditions before film fabrication, it is possible to influence cell adherence, proliferation and colony morphology. Such a tunable surface with capabilities of influencing stem cell behaviors, combined with the ability to slow or speed population doubling times, will provide crucial solutions for achieving applications envisioned by stem cell biologists to assist future industrial and clinical implementation of human embryonic stem cells.
C1 [Brunner, Eric W.; Jurewicz, Izabela; Heister, Elena; Fahimi, Azin; Bo, Chiara; Sear, Richard P.; Dalton, Alan B.] Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
   [Brunner, Eric W.; Jurewicz, Izabela; Heister, Elena; Fahimi, Azin; Bo, Chiara; Sear, Richard P.; Dalton, Alan B.] Univ Surrey, Surrey Mat Inst, Guildford GU2 7XH, Surrey, England.
   [Brunner, Eric W.; Donovan, Peter J.] Univ Calif Irvine, Dept Biol Chem, Ctr Mol & Mitochondrial Med & Genet, Dept Dev & Cell Biol,Sue & Bill Gross Stem Cell R, Irvine, CA 92617 USA.
RP Dalton, AB (reprint author), Univ Surrey, Dept Phys, Guildford GU2 7XH, Surrey, England.
EM a.dalton@surrey.ac.uk
RI Dalton, Alan/A-1643-2018; Dalton, Alan/B-3739-2010
OI Dalton, Alan/0000-0001-8043-1377; Dalton, Alan/0000-0001-8043-1377
FU Human Frontier Science Program; Royal Society; Engineering and Physical
   Sciences Research Council; SETsquared; Beckman Coulter Inc.; Engineering
   and Physical Sciences Research Council [EP/G060878/1, EP/K031562/1]
FX The authors gratefully acknowledge financial support from Human Frontier
   Science Program, Royal Society, Engineering and Physical Sciences
   Research Council, SETsquared, and Beckman Coulter Inc.
CR Abarrategi A, 2008, BIOMATERIALS, V29, P94, DOI 10.1016/j.biomaterials.2007.09.021
   Abdullah CAC, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/20/205102
   Akasaka T, 2011, CARBON, V49, P2287, DOI 10.1016/j.carbon.2011.01.061
   Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/nnano.2008.374, 10.1038/NNANO.2008.374]
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Chen Chi-Shuo, 2012, Nanoscale Res Lett, V7, P126, DOI 10.1186/1556-276X-7-126
   Cheng Q, 2013, ANN BIOMED ENG, V41, P904, DOI 10.1007/s10439-012-0728-8
   Edwards SL, 2009, BIOMATERIALS, V30, P1725, DOI 10.1016/j.biomaterials.2008.12.031
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Eroshenko N, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-7
   Han ZZ, 2009, J NANOSCI NANOTECHNO, V9, P1400, DOI 10.1166/jnn.2009.C165
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Liao HH, 2011, COLLOID SURFACE B, V84, P528, DOI 10.1016/j.colsurfb.2011.02.010
   Mih JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019929
   Moon SU, 2012, INT J NANOMED, V7, P2751, DOI 10.2147/IJN.S30273
   Mwenifumbo S, 2007, J MATER CHEM, V17, P1894, DOI 10.1039/b617708e
   Phillips JE, 2010, ACTA BIOMATER, V6, P12, DOI 10.1016/j.actbio.2009.07.023
   Rainaldi G, 1998, J MATER SCI-MATER M, V9, P755, DOI 10.1023/A:1008915305681
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Sebaa M, 2013, MATER LETT, V92, P122, DOI 10.1016/j.matlet.2012.10.035
   Shi XF, 2005, NANOTECHNOLOGY, V16, pS531, DOI 10.1088/0927-4484/16/7/030
   Sridharan I, 2009, BIOCHEM BIOPH RES CO, V381, P508, DOI 10.1016/j.bbrc.2009.02.072
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   Thompson BC, 2009, CARBON, V47, P1282, DOI 10.1016/j.carbon.2009.01.013
   Tutak W, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/31/315102
   WADE LG, 1999, ORGANIC CHEM
   Zawadzak E, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015008
NR 30
TC 16
Z9 16
U1 1
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 26
PY 2014
VL 6
IS 4
BP 2598
EP 2603
DI 10.1021/am405097w
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AB9VU
UT WOS:000332144600053
PM 24456005
DA 2018-10-19
ER

PT J
AU Ruan, CS
   Hu, N
   Hu, Y
   Jiang, LX
   Cai, QQ
   Wang, HY
   Pan, HB
   Lu, WW
   Wang, YL
AF Ruan, Changshun
   Hu, Nan
   Hu, Yang
   Jiang, Lixin
   Cai, Qingqing
   Wang, Huaiyu
   Pan, Haobo
   Lu, William W.
   Wang, Yuanliang
TI Piperazine-based polyurethane-ureas with controllable degradation as
   potential bone scaffolds
SO POLYMER
LA English
DT Article
DE Piperazine-based polyurethane-urea; In vitro degradation; Controllable
   degradation
ID ORTHOPEDIC BIOMATERIALS; MECHANICAL-BEHAVIOR; REGENERATION; ACID);
   COMPOSITES; PRODUCTS; DESIGN; CYTOCOMPATIBILITY; COPOLYMERS; STRATEGIES
AB Piperazine-based polyurethane ureas (P-PUUs) with piperazine (PP) units as the functional ingredients have been designed to explore a novel polymeric biomaterial with the controllable degradation for bone repair in this study. P-PUUs were prepared upon the chain-growth polymerization of poly (D, L -lactic acid) diol (PDLLA diol), 1, 6-hexamethylene diisocyanate (HDI) where PP functioned as the chain extender. The investigation of in vitro degradation of P-PUUs was performed and the mechanical properties of P-PUUs during degradation were calculated. The results revealed that manipulating the ratio of PDLLA diol: HDI: PP could obtain the precise number of PP units (Num(pp)) in P-PUUs which may significantly impact the degradation stability and the degradation rate of P-PUUs. The negative linear correlation between the degradation rate and the Num(pp) of P-PUUs has been proved, suggesting the P-PUUs were endowed with controllable degradation. Such a linear correlation is expected to be applied to bone repair where the specific degradation rate of P-PUUs for the specific bone defect can be precisely predicted once the Num(pp) and the bone repairing period are known. Additionally, P-PUUs with higher Num(pp) exhibited remarkable mechanical properties during degradation which allowed polymers to provide more persistent mechanical support to bone repair. (C) 2014 Elsevier Ltd. All rights reserved.
C1 [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Wang, Huaiyu; Pan, Haobo; Lu, William W.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissue & Organs Degenerat, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
   [Ruan, Changshun; Hu, Yang; Jiang, Lixin; Cai, Qingqing; Wang, Huaiyu; Pan, Haobo; Lu, William W.] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Marine Biomed Mat, Shenzhen 518055, Peoples R China.
   [Hu, Nan; Wang, Yuanliang] Chongqing Univ, Coll Bioengn, Chongqing 400030, Peoples R China.
   [Lu, William W.] Univ Hong Kong, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Pan, HB (reprint author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Ctr Human Tissue & Organs Degenerat, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
EM hb.pan@siat.ac.cn; wyl@cqu.edu.cn
FU National Natural Science Foundation of China [31200723]; Development of
   Strategic Emerging Industries of Shenzhen Basic Research Project
   [JCYJ20120617122433296, JCYJ20120831180118537]; Shenzhen Peacock Program
   [110811003586331]
FX This work was supported by grant from the National Natural Science
   Foundation of China (31200723) and the Development of Strategic Emerging
   Industries of Shenzhen Basic Research Project (JCYJ20120617122433296,
   JCYJ20120831180118537) and the Shenzhen Peacock Program
   (110811003586331).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Cai Q, 2003, BIOMACROMOLECULES, V4, P828, DOI 10.1021/bm034051a
   Cao H, 2010, BONE, V46, P386, DOI 10.1016/j.bone.2009.09.031
   Elliott S, 2002, J BIOMAT SCI-POLYM E, V13, P691, DOI 10.1163/156856202320269166
   FRIEDMAN RJ, 1993, J BONE JOINT SURG AM, V75A, P1086, DOI 10.2106/00004623-199307000-00017
   Gu XZ, 2012, POLYMER, V53, P5924, DOI 10.1016/j.polymer.2012.09.056
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Guo C, 2012, MATER LETT, V74, P197, DOI 10.1016/j.matlet.2012.01.085
   Hakkarainen M, 2007, J AM CHEM SOC, V129, P6308, DOI 10.1021/ja0702871
   He MY, 2013, POLYMER, V54, P4112, DOI 10.1016/j.polymer.2013.05.046
   Hoglund A, 2012, MACROMOL BIOSCI, V12, P260, DOI 10.1002/mabi.201100288
   Hojabri L, 2012, POLYMER, V53, P3762, DOI 10.1016/j.polymer.2012.06.011
   Hu ZG, 2009, POLYMER, V50, P4175, DOI 10.1016/j.polymer.2009.06.073
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Knight PT, 2009, MACROMOLECULES, V42, P6596, DOI 10.1021/ma901237h
   Lei B, 2012, J BIOMED MATER RES B, V100B, P967, DOI 10.1002/jbm.b.32659
   Luo YF, 2008, EUR POLYM J, V44, P1390, DOI 10.1016/j.eurpolymj.2008.01.043
   Ma CF, 2013, J MATER CHEM B, V1, P3099, DOI 10.1039/c3tb20454e
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Niu XF, 2008, J BIOMED MATER RES A, V84A, P908, DOI 10.1002/jbm.a.31360
   Niu X, 2009, POLYM DEGRAD STABIL, V94, P176, DOI 10.1016/j.polymdegradstab.2008.11.008
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Pilliar R, 2004, J BIOMED MATER RES, V13, P799
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Rizvi MS, 2012, ACTA BIOMATER, V8, P4111, DOI 10.1016/j.actbio.2012.07.025
   Ruan CS, 2012, POLYM INT, V61, P524, DOI 10.1002/pi.3197
   Shen YH, 2012, J MATER CHEM, V22, P8662, DOI 10.1039/c2jm16141a
   Shen YH, 2011, LANGMUIR, V27, P2701, DOI 10.1021/la104876w
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Szpalski C, 2012, TISSUE ENG PART B-RE, V18, P246, DOI [10.1089/ten.TEB.2011.0427, 10.1089/ten.teb.2011.0427]
   Tsuji H, 2002, J APPL POLYM SCI, V86, P186, DOI 10.1002/app.10813
   Wang Ching-Sung, 2012, J BIOMED BIOTECHNOL, V2012, P1
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Wang Y., 2011, POLYM DEGRAD STABIL, V95, P1687
   Wang YL, 2010, POLYM DEGRAD STABIL, V95, P549, DOI 10.1016/j.polymdegradstab.2009.12.016
   Wei L, 2011, POLYMER, V52, P5139, DOI 10.1016/j.polymer.2011.09.006
   Wu CS, 2007, POLYMER, V48, P4449, DOI 10.1016/j.polymer.2007.06.004
   Xu SH, 2013, POLYMER, V54, P6589, DOI 10.1016/j.polymer.2013.10.011
NR 41
TC 18
Z9 18
U1 3
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD FEB 25
PY 2014
VL 55
IS 4
BP 1020
EP 1027
DI 10.1016/j.polymer.2014.01.011
PG 8
WC Polymer Science
SC Polymer Science
GA AB6UZ
UT WOS:000331926300006
DA 2018-10-19
ER

PT J
AU Izawa, H
   Nishino, S
   Maeda, H
   Morita, K
   Ifuku, S
   Morimoto, M
   Saimoto, H
   Kadokawa, J
AF Izawa, Hironori
   Nishino, Shoji
   Maeda, Hiroyuki
   Morita, Kohei
   Ifuku, Shinsuke
   Morimoto, Minoru
   Saimoto, Hiroyuki
   Kadokawa, Jun-ichi
TI Mineralization of hydroxyapatite upon a unique xanthan gum hydrogel by
   an alternate soaking process
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Xanthan gum; Hydroxyapatite; Alternate soaking process;
   Inorganic-organic composite hydrogel; Mineralization
ID EXTRACELLULAR POLYSACCHARIDE; BIOMIMETIC MINERALIZATION;
   XANTHOMONAS-CAMPESTRIS; BIOCOMPOSITES; CHEMISTRY; POLYMERS; DELIVERY
AB We previously reported a xanthan gum (Xan) hydrogel showing excellent mechanical properties. Mineralization of hydroxyapatite (Hap) upon the Xan hydrogel would provide a unique biomaterial applicable for bone tissue engineering. Here, we show the mineralization of Hap upon the Xan hydrogel by means of an alternate soaking process. Hap was gradually grown upon the Xan-matrix surface with increasing number of soaking cycles due to the ionic interactions between calcium cations and carboxyl groups. Interestingly, the mineralization induced a microstructure change in the gel-matrix from a layered structure to a porous structure. The mechanical properties of the resulting Hap-Xan composite hydrogels were further investigated by a tensile test, where the Hap-Xan composite hydrogel with an appropriate amount of Hap (Xan/Hap = 2.7) was capable of approximately 370% elongation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Izawa, Hironori; Nishino, Shoji; Maeda, Hiroyuki; Morita, Kohei; Ifuku, Shinsuke; Morimoto, Minoru; Saimoto, Hiroyuki] Tottori Univ, Grad Sch Engn, Tottori 6808550, Japan.
   [Kadokawa, Jun-ichi] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan.
   [Kadokawa, Jun-ichi] Muroran Inst Technol, Res Ctr Environm Friendly Mat Engn, Muroran, Hokkaido 0508585, Japan.
RP Izawa, H (reprint author), Tottori Univ, Grad Sch Engn, Dept Sci & Biotechnol, 4-101 Koyama Minami, Tottori 6808550, Japan.
EM h-izawa@chem.tottori-u.ac.jp
RI Izawa, Hironori/M-7037-2014
OI Izawa, Hironori/0000-0002-8715-8462
FU Tottori Prefecture Environment and Academic Promotion Project
FX This work was in part supported by the Tottori Prefecture Environment
   and Academic Promotion Project.
CR Alistair M. S., 2006, FOOD POLYSACCHARIDES
   Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p
   Brantley JN, 2013, POLYM CHEM-UK, V4, P3916, DOI 10.1039/c3py00001j
   Calvert P, 1996, CHEM MATER, V8, P1715, DOI 10.1021/cm960126o
   Camesano TA, 2001, BIOMACROMOLECULES, V2, P1184, DOI 10.1021/bm015555g
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Colfen H, 2007, TOP CURR CHEM, V271, P1, DOI 10.1007/128_056
   Du MC, 2011, J MATER CHEM, V21, P2228, DOI 10.1039/c0jm02869j
   Dujardin E, 2002, ADV MATER, V14, P775, DOI 10.1002/1521-4095(20020605)14:11<775::AID-ADMA775>3.0.CO;2-0
   Green DW, 2005, ADV FUNCT MATER, V15, P917, DOI 10.1002/adfm.200400322
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Izawa H, 2010, J MATER CHEM, V20, P5235, DOI 10.1039/c0jm00595a
   Izawa H, 2009, J MATER CHEM, V19, P6969, DOI 10.1039/b916864h
   JANSSON PE, 1975, CARBOHYD RES, V45, P275, DOI 10.1016/S0008-6215(00)85885-1
   Kuo CK, 2008, J BIOMED MATER RES A, V84A, P899, DOI 10.1002/jbm.a.31375
   Mann S, 2000, ANGEW CHEM INT EDIT, V39, P3393
   MELTON LD, 1976, CARBOHYD RES, V46, P245, DOI 10.1016/S0008-6215(00)84296-2
   MILLANE RP, 1990, CARBOHYD POLYM, V12, P315, DOI 10.1016/0144-8617(90)90072-Z
   Moorhouse R., 1977, XANTHAN GUM MOL CONF
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Okada M., 2012, SCI TECHNOLOGY ADV M, V13
   Rosalam S, 2006, ENZYME MICROB TECH, V39, P197, DOI 10.1016/j.enzmictec.2005.10.019
   Shi J, 2012, INT J BIOL MACROMOL, V50, P747, DOI 10.1016/j.ijbiomac.2011.12.003
   Shi Y, 2009, CHEM COMMUN, P442, DOI 10.1039/b814095b
   Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002
   TAGUCHI T, 1998, CHEM LETT, V8, P711
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Zhong C, 2012, J MATER CHEM, V22, P6080, DOI 10.1039/c2jm15610e
NR 28
TC 11
Z9 11
U1 1
U2 40
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD FEB 15
PY 2014
VL 102
BP 846
EP 851
DI 10.1016/j.carbpol.2013.10.080
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA AB4SG
UT WOS:000331779600109
PM 24507355
DA 2018-10-19
ER

PT J
AU Cui, Y
   Xiao, ZF
   Chen, T
   Wei, JS
   Chen, L
   Liu, LJ
   Chen, B
   Wang, XJ
   Li, XR
   Dai, JW
AF Cui, Yi
   Xiao, Zhifeng
   Chen, Tong
   Wei, Jianshu
   Chen, Lei
   Liu, Lijun
   Chen, Bing
   Wang, Xiujie
   Li, Xiaoran
   Dai, Jianwu
TI The miR-7 Identified from Collagen Biomaterial-Based Three-Dimensional
   Cultured Cells Regulates Neural Stem Cell Differentiation
SO STEM CELLS AND DEVELOPMENT
LA English
DT Article
ID TISSUE; MICRORNAS; 3D; PROLIFERATION; CANCER; REGENERATION; MAINTENANCE;
   BIOGENESIS; PHENOTYPES; SCAFFOLDS
C1 [Cui, Yi; Wei, Jianshu; Chen, Lei; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100080, Peoples R China.
   [Cui, Yi] Natl Res Inst Family Planning, Reprod & Genet Ctr, Beijing, Peoples R China.
   [Xiao, Zhifeng; Chen, Bing; Dai, Jianwu] Third Mil Med Univ, State Key Lab Trauma Burns & Combined Injury, Inst Combined Injury Burns & Combined Injury, Chongqing Engn Res Ctr Nanomed,Coll Prevent Med, Chongqing, Peoples R China.
   [Chen, Tong; Wei, Jianshu; Chen, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Chen, Tong; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100080, Peoples R China.
   [Liu, Lijun] Xinjiang Med Univ, Affiliated Hosp 1, Dept Oral & Maxillofacial Surg, Sch Stomatol, Urumqi, Xinjiang, Peoples R China.
   [Li, Xiaoran] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Div Nanobiomed, Suzhou, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100080, Peoples R China.
EM jwdai@genetics.ac.cn
FU Ministry of Science and Technology of China [2011CB965001]; National
   Science Foundation of China [30930032]; Chinese Academy of Sciences
   [KSCX2-EW-Q-24]
FX This work was supported by grants from the Ministry of Science and
   Technology of China (2011CB965001), the National Science Foundation of
   China (30930032), and the Chinese Academy of Sciences (KSCX2-EW-Q-24).
CR Akaogi K, 2009, ONCOGENE, V28, P2894, DOI 10.1038/onc.2009.151
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Ayala P, 2010, TISSUE ENG PT A, V16, P2519, DOI [10.1089/ten.tea.2009.0815, 10.1089/ten.TEA.2009.0815]
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434
   Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056
   Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112
   Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116
   Dawson E, 2008, ADV DRUG DELIVER REV, V60, P215, DOI 10.1016/j.addr.2007.08.037
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Han J, 2013, BIOMATERIALS, V34, P1921, DOI 10.1016/j.biomaterials.2012.11.063
   Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07
   Khoshnan A, 2012, PLOS ONE, V7
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Li CL, 2008, ONCOL REP, V20, P1465, DOI 10.3892/or_00000167
   Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040
   Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737
   Palm T, 2013, NUCLEIC ACIDS RES, V41, P3699, DOI 10.1093/nar/gkt070
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109
   Qutub AA, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-13
   Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503
   Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13
   Thiel Gerald, 2013, Biochem J, V450, pe1, DOI 10.1042/BJ20130176
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200
NR 31
TC 21
Z9 21
U1 5
U2 23
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1547-3287
EI 1557-8534
J9 STEM CELLS DEV
JI Stem Cells Dev.
PD FEB 15
PY 2014
VL 23
IS 4
BP 393
EP 405
DI 10.1089/scd.2013.0342
PG 13
WC Cell & Tissue Engineering; Hematology; Medicine, Research &
   Experimental; Transplantation
SC Cell Biology; Hematology; Research & Experimental Medicine;
   Transplantation
GA AA8WD
UT WOS:000331374800007
PM 24200387
OA Green Published
DA 2018-10-19
ER

PT J
AU Senatov, FS
   Gorshenkov, MV
   Kaloshkin, SD
   Tcherdyntsev, VV
   Anisimova, NY
   Kopylov, AN
   Kiselevsky, MV
AF Senatov, F. S.
   Gorshenkov, M. V.
   Kaloshkin, S. D.
   Tcherdyntsev, V. V.
   Anisimova, N. Yu
   Kopylov, A. N.
   Kiselevsky, M. V.
TI Biocompatible polymer composites based on ultrahigh molecular weight
   polyethylene perspective for cartilage defects replacement
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE UHMWPE; Composite; Biomaterial; Wear; Mechanical activation
ID ARTICULAR-CARTILAGE; PROPERTY CHANGES; FRICTION; CRYSTALLIZATION;
   NANOCOMPOSITES; STRESS; BLENDS; WEAR
AB The purpose of this study was to evaluate mechanical properties, microstructure and biocompatibility of nano-compounds obtained by mechanical activation of UHMWPE powder and several types of particulate fillers in a planetary ball mill. The effect of particle shape and concentration of Al2O3 on properties of the composite was investigated. The effectiveness of reinforcing a polyethylene matrix by mechanoactivated alumina in the form of nanopowder or microspheres was shown. Reinforcing of the polymer by nanoparticles significantly improves wear-resistance. No signs of blood serum fibrin deposition on the surface of the samples were observed. Also no signs of pathological changes in physiology or anatomy were noticed on the animals with implanted samples. UHMWPE-based composites obtained by mechanical activation and hot pressing and filled with ceramic particles can be used as a biocompatible material for the replacement of cartilage. (C) 2012 Elsevier B. V. All rights reserved.
C1 [Senatov, F. S.; Gorshenkov, M. V.; Kaloshkin, S. D.; Tcherdyntsev, V. V.] Natl Univ Sci & Technol MISIS, Moscow, Russia.
   [Anisimova, N. Yu; Kopylov, A. N.; Kiselevsky, M. V.] RAMS, NN Blokhin Russian Canc Res Ctr, Moscow, Russia.
RP Gorshenkov, MV (reprint author), Natl Univ Sci & Technol MISIS, Moscow, Russia.
EM mvg@misis.ru
RI Kiselevskiy, Mikhail/D-8822-2017; Anisimova, Natalia/A-6640-2014
OI Kiselevskiy, Mikhail/0000-0002-0132-167X; Anisimova,
   Natalia/0000-0002-4370-6578; Senatov, Fedor/0000-0003-3907-5344;
   Gorshenkov, Mikhail/0000-0001-8780-7584
CR [Anonymous], 2008, HEMATOXYLIN EOSIN ST, DOI DOI 10.1101/PDB.PR0T4986
   Basalo IM, 2007, J BIOMECH, V40, P1847, DOI 10.1016/j.jbiomech.2006.07.007
   BASTIAANSEN CWM, 1990, POLYMER, V31, P1435, DOI 10.1016/0032-3861(90)90147-Q
   Bazhenov S.L., 1998, FILLERS THEIR EFFECT, P252
   Esterly DM, 2004, J POLYM SCI POL PHYS, V42, P91, DOI 10.1002/polb.10613
   Font J, 2001, MATER RES BULL, V36, P1665, DOI 10.1016/S0025-5408(01)00648-1
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   HAN KS, 1981, J MACROMOL SCI PHYS, VB19, P313, DOI 10.1080/00222348108015307
   Hassan Mahfuz, 2004, COMPOSITES, V35, P543
   Huang H, 2000, J APPL POLYM SCI, V78, P2016, DOI 10.1002/1097-4628(20001209)78:11<2016::AID-APP230>3.0.CO;2-6
   Huang H, 1999, J APPL POLYM SCI, V74, P1459, DOI 10.1002/(SICI)1097-4628(19991107)74:6<1459::AID-APP19>3.0.CO;2-D
   Katta J, 2009, OSTEOARTHR CARTILAGE, V17, P662, DOI 10.1016/j.joca.2008.10.008
   Mallikarjuna NN, 2004, J APPL POLYM SCI, V94, P2551, DOI 10.1002/app.21144
   McCann L, 2009, OSTEOARTHR CARTILAGE, V17, P995, DOI 10.1016/j.joca.2009.02.012
   Senatov F.S., 2012, RUSS METALL METALLY, V4, P344
   Stranz M, 2005, J METASTAB NANOCRYST, V24-25, P463, DOI 10.4028/www.scientific.net/JMNM.24-25.463
   Stranz M, 2007, J ALLOY COMPD, V434, P447, DOI 10.1016/j.jallcom.2006.08.097
   Wang GL, 2008, J POLYM SCI POL PHYS, V46, P807, DOI 10.1002/polb.21417
   Xiong DS, 2006, BIOMED MATER, V1, P175, DOI 10.1088/1748-6041/1/3/013
NR 19
TC 7
Z9 8
U1 0
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
EI 1873-4669
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD FEB 15
PY 2014
VL 586
SU 1
BP S544
EP S547
DI 10.1016/j.jallcom.2012.10.014
PG 4
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 268RS
UT WOS:000328188800116
DA 2018-10-19
ER

PT J
AU Perumal, S
   Ramadass, SK
   Madhan, B
AF Perumal, Sathiamurthi
   Ramadass, Satiesh Kumar
   Madhan, Balaraman
TI Sol-gel processed mupirocin silica microspheres loaded collagen
   scaffold: A synergistic bio-composite for wound healing
SO EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Mupirocin; Silica microspheres; Collagen; Burns; Foot ulcers
ID RESISTANT STAPHYLOCOCCUS-AUREUS; SILVER SULFADIAZINE; INFECTION;
   CHLORHEXIDINE; GENTAMICIN; DRESSINGS; DYNAMICS; DELIVERY; RELEASE;
   MATRIX
AB Development of a bio-composite using synergistic combination is a promising strategy to address various pathological manifestations of acute and chronic wounds. In the present work, we have combined three materials viz., mupirocin as an antimicrobial drug, sol-gel processed silica microsphere as drug carrier for sustained delivery of drug and collagen, an established wound healer as scaffold. The mupirocin-loaded silica microspheres (Mu-SM) and Mu-SM loaded collagen scaffold were characterized for surface morphology, entrapment efficiency and distribution homogeneity, in vitro drug release, water uptake capacity, cell proliferation and antibacterial activity. In vivo wound healing efficacy of the bio-composite was experimented using full thickness excision wound model in Wistar albino rats. The Mu-SM incorporated collagen scaffold showed good in vitro characteristics in terms of better water uptake, sustained drug availability and antimicrobial activity. The wound closure analysis revealed that the complete epithelialisation was observed at 14.2 +/- 0.44 days for Mu-SM loaded collagen, whereas this was 17.4 +/- 0.44 days and 20.6 +/- 0.54 days for collagen and control groups, respectively. Consequently, the synergistic strategy of combining mupirocin-loaded silica microspheres and collagen as a Mu-SM loaded collagen dressing material would be an ideal biomaterial for the treatment of surface wounds, burns and foot ulcers. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Perumal, Sathiamurthi; Ramadass, Satiesh Kumar; Madhan, Balaraman] CSIR, Cent Leather Res Inst, Madras 20, Tamil Nadu, India.
   [Perumal, Sathiamurthi] CSIR, Cent Leather Res Inst, Acad Sci & Innovat Res, Madras 20, Tamil Nadu, India.
RP Madhan, B (reprint author), CSIR, Cent Leather Res Inst, Madras 20, Tamil Nadu, India.
EM bmadhan76@yahoo.co.in
RI Madhan, Balaraman/B-3136-2009
OI Madhan, Balaraman/0000-0002-4198-8452
FU CSIR, India under the M2D XII plan Project [CSC 0134]
FX The authors are grateful to CSIR, India for providing financial
   assistance under the M2D XII plan Project (CSC 0134). Authors are
   thankful to Dr. Lawrence D'Cruze, Department of Pathology, Sri
   Ramachandra University for his assistance in histopathological
   interpretation and Mr V. Elango, Senior Technician for his assistance in
   animal experimental study.
CR Adhirajan N, 2009, EUR J PHARM SCI, V36, P235, DOI 10.1016/j.ejps.2008.09.010
   Baharestani MM, 2007, OSTOMY WOUND MANAG, V53, P34
   Chang JS, 2007, ENVIRON SCI TECHNOL, V41, P2064, DOI 10.1021/es062347t
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   CHVAPIL M, 1982, J BIOMED MATER RES, V16, P245, DOI 10.1002/jbm.820160306
   CLARKE AM, 1975, MED J AUSTRALIA, V1, P413
   Dai T, 2010, Recent Pat Antiinfect Drug Discov, V5, P124
   Friess W, 2002, PHARM DEV TECHNOL, V7, P235, DOI 10.1081/PDT-120003491
   Gorham S.D., 1991, BIOMATERIALS
   INMAN RJ, 1984, BURNS, V11, P35, DOI 10.1016/0305-4179(84)90159-1
   LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Muthukumar T, 2013, COLLOID SURFACE B, V102, P694, DOI 10.1016/j.colsurfb.2012.09.041
   Natarajan V, 2013, J BIOMED MATER RES B, V101B, P560, DOI 10.1002/jbm.b.32856
   Newton PM, 2004, INFLAMMATION, V28, P207, DOI 10.1023/B:IFLA.0000049045.41784.59
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Radin S, 2009, BIOMATERIALS, V30, P850, DOI 10.1016/j.biomaterials.2008.09.066
   Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4
   RODE H, 1989, ANTIMICROB AGENTS CH, V33, P1358, DOI 10.1128/AAC.33.8.1358
   Russell R.C.G., 2000, BAILYS LOVES SHORT P
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460
   Spann CT, 2004, DM-DIS MON, V50, P407, DOI 10.1016/j.disamonth.2004.05.011
   Sripriya R, 2007, J BIOMAT SCI-POLYM E, V18, P335, DOI 10.1163/156856207779996913
   Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6
   TANAKA S, 1988, J BIOL CHEM, V263, P17650
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
NR 28
TC 21
Z9 23
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-0987
EI 1879-0720
J9 EUR J PHARM SCI
JI Eur. J. Pharm. Sci.
PD FEB 14
PY 2014
VL 52
BP 26
EP 33
DI 10.1016/j.ejps.2013.10.006
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AA3VF
UT WOS:000331022100004
PM 24514452
DA 2018-10-19
ER

PT J
AU Augustine, R
   Malik, HN
   Singhal, DK
   Mukherjee, A
   Malakar, D
   Kalarikkal, N
   Thomas, S
AF Augustine, Robin
   Malik, Hruda Nanda
   Singhal, Dinesh Kumar
   Mukherjee, Ayan
   Malakar, Dhruba
   Kalarikkal, Nandakumar
   Thomas, Sabu
TI Electrospun polycaprolactone/ZnO nanocomposite membranes as biomaterials
   with antibacterial and cell adhesion properties
SO JOURNAL OF POLYMER RESEARCH
LA English
DT Article
DE Polycaprolactone; ZnO nanoparticles; Scaffolds; Wound healing;
   Antimicrobial; Fibroblasts
ID ZINC-OXIDE; MECHANICAL-PROPERTIES; ZNO NANOPARTICLES; CERAMIC POWDERS;
   PARTICLE-SIZE; POLYMER-FILMS; SCAFFOLD; GROWTH; PHOSPHORYLATION;
   TEMPERATURE
AB In the present study we have investigated the effect of zinc oxide (ZnO) nanoparticles on the fiber diameter, fiber morphology, antibacterial activity, and enhanced cell proliferation of the electrospun polycaprolactone (PCL) non-woven membrane. The effect of the ZnO nanoparticle concentration on the fiber diameter and fiber morphology was investigated using a scanning electron microscope (SEM). Fourier transform infrared spectroscopy (FT-IR) analysis was carried out to determine the nature of the interaction between the PCL and the ZnO nanoparticles. We also investigated the mechanical stability and antibacterial activity of the fabricated material. Interestingly, the membranes with ZnO nanoparticles showed enhanced mechanical stability, antibacterial properties, fibroblast proliferation, and improved metabolic activity of the cells. Further, this is the first report regarding the ability of a biomaterial containing ZnO nanoparticles to enhance cell proliferation.
C1 [Augustine, Robin; Kalarikkal, Nandakumar; Thomas, Sabu] Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
   [Kalarikkal, Nandakumar] Mahatma Gandhi Univ, Sch Pure & Appl Phys, Kottayam 686560, Kerala, India.
   [Thomas, Sabu] Mahatma Gandhi Univ, Sch Chem Sci, Kottayam 686560, Kerala, India.
   [Malik, Hruda Nanda; Singhal, Dinesh Kumar; Mukherjee, Ayan; Malakar, Dhruba] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal 132001, India.
RP Kalarikkal, N (reprint author), Mahatma Gandhi Univ, Int & Inter Univ Ctr Nanosci & Nanotechnol, Kottayam 686560, Kerala, India.
EM nkkalarikkal@mgu.ac.in; sabupolymer@yahoo.com
RI Thomas, Prof. Sabu/G-7310-2016
OI Thomas, Prof. Sabu/0000-0003-4726-5746; KALARIKKAL,
   NANDAKUMAR/0000-0002-4595-6466; Augustine, Robin/0000-0001-9724-8392
FU Department of Science and Technology (DST), Government of India, New
   Delhi through the Nanomission program; Department of Science and
   Technology (DST), Government of India, New Delhi through the PURSE
   program; UGC SAP; DST-FIST
FX The authors acknowledge the Department of Science and Technology (DST),
   Government of India, New Delhi, for the financial support through the
   Nanomission and PURSE programs. Funding from UGC SAP and DST-FIST are
   also gratefully acknowledged.
CR Ashutosh K, 2011, FREE RADICAL BIO MED, V51, P1872
   Aslan S, 2010, NANOSCALE, V2, P1789, DOI 10.1039/c0nr00329h
   Barui AK, 2012, NANOSCALE, V4, P7861, DOI 10.1039/c2nr32369a
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Branda o-Neto J, 1995, NUTR RES, V15, P335
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Cevat E, 2008, BIOMATERIALS, V29, P4065
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Dutta RK, 2012, COLLOID SURFACE B, V94, P143, DOI 10.1016/j.colsurfb.2012.01.046
   Elen K, 2012, POLYM ADVAN TECHNOL, V23, P1422, DOI 10.1002/pat.2062
   Fashandi H, 2012, POLYMER, V53, P5832, DOI 10.1016/j.polymer.2012.10.003
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Francois B, 1995, ADV MATER, V7, P1041, DOI 10.1002/adma.19950071217
   Fujiwara Y, 1997, RES COMMUN MOL PATH, V97, P95
   GAMOU S, 1995, FEBS LETT, V357, P161, DOI 10.1016/0014-5793(94)01335-X
   Goldkorn T, 1998, AM J RESP CELL MOL, V19, P786, DOI 10.1165/ajrcmb.19.5.3249
   Guo DD, 2013, TOXICOL IN VITRO, V27, P731, DOI 10.1016/j.tiv.2012.12.001
   Huo YA, 2009, EXP EYE RES, V89, P876, DOI 10.1016/j.exer.2009.07.012
   Ikada Y, 2006, J R SOC INTERFACE, V3, P589, DOI 10.1098/rsif.2006.0124
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XH, 2010, FOOD SCI TECHNOL INT, V16, P225, DOI 10.1177/1082013209353986
   Li ZH, 2005, SOLID STATE IONICS, V176, P1903, DOI 10.1016/j.ssi.2005.05.006
   Lim CT, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857478
   Limaye AV, 1996, PHYS REV LETT, V76, P3762, DOI 10.1103/PhysRevLett.76.3762
   Luigi C, 2008, BIOMACROMOLECULES, V9, P1527
   Ma GP, 2009, POLYM ADVAN TECHNOL, V20, P147, DOI 10.1002/pat.1180
   MacArthur BD, 2005, NATURE, V433, P19, DOI 10.1038/433019a
   MACK CF, 1993, INT J RADIAT ONCOL, V27, P217, DOI 10.1016/0360-3016(93)90774-P
   Mariappan Premanathan, 2011, NANOTECHNOLOGY BIOL, V7, P184
   Mathieu HJ, 2001, SURF INTERFACE ANAL, V32, P3, DOI 10.1002/sia.995
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Moniruzzaman M, 2007, NANO LETT, V7, P1178, DOI 10.1021/nl062868e
   NEWELL KJ, 1994, MOL CARCINOGEN, V10, P199, DOI 10.1002/mc.2940100404
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Park MS, 2004, LANGMUIR, V20, P5347, DOI 10.1021/la035915g
   Patcharaporn W, 2006, MACROMOL BIOSCI, V6, P70
   Patricia BM, 2007, ADV DRUG DELIV REV, V59, P207
   Peng J, 2004, POLYMER, V45, P447, DOI 10.1016/j.polymer.2003.11.019
   Rajesh V, 2006, INT J NANOMED, V1, P15
   Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324
   Salgueiro MJ, 2002, NUTRITION, V18, P510, DOI 10.1016/S0899-9007(01)00812-7
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Seema A. S., 2008, POLYMER, V49, P5603
   Selahattin A, 1998, T J MED SCI, V28, P595
   Silke M., 2002, MACROMOLECULES, V35, P8456
   Sokolsky PM, 2007, ADV DRUG DELIV REV, V59, P187
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   Stoimenov PK, 2002, LANGMUIR, V18, P6679, DOI 10.1021/la0202374
   Sudheesh Kumar PT, 2013, PHARM RES, P523
   Thandavamoorthy S, 2005, APPL POLY SCI, V96, P557
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Toduka Y, 2012, ENVIRON SCI TECHNOL, V46, P7629, DOI 10.1021/es300433x
   Vlad S, 2011, DIG J NANOMATER BIOS, V6, P921
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 60
TC 61
Z9 62
U1 4
U2 69
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1022-9760
EI 1572-8935
J9 J POLYM RES
JI J. Polym. Res.
PD FEB 13
PY 2014
VL 21
IS 3
AR 347
DI 10.1007/s10965-013-0347-6
PG 17
WC Polymer Science
SC Polymer Science
GA AB3XM
UT WOS:000331723500001
DA 2018-10-19
ER

PT J
AU Carrasco-Sanchez, V
   Vergara-Jaque, A
   Zuniga, M
   Comer, J
   John, A
   Nachtigall, FM
   Valdes, O
   Duran-Lara, EF
   Sandoval, C
   Santos, LS
AF Carrasco-Sanchez, Veronica
   Vergara-Jaque, Ariela
   Zuniga, Matias
   Comer, Jeffrey
   John, Amalraj
   Nachtigall, Fabiane M.
   Valdes, Oscar
   Duran-Lara, Esteban F.
   Sandoval, Claudia
   Santos, Leonardo S.
TI In situ and in silico evaluation of amine- and folate-terminated
   dendrimers as nanocarriers of anesthetics
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE PAMAM dendrimers; Drug delivery; Molecular dynamics; MM-GBSA; MALDI-MS
ID MOLECULAR-DYNAMICS SIMULATION; DRUG-DELIVERY; POLYAMIDOAMINE DENDRIMERS;
   SOLUBILITY ENHANCERS; MAGNETIC-RESONANCE; CELLULAR-TRANSPORT;
   FORCE-FIELDS; ENCAPSULATION; MECHANICS; DIFFUSION
AB The search for new nano-systems for targeted biomedical applications and controlled drug release has attracted significant attention in polymer chemistry, pharmaceutics, and biomaterial science. Controlled drug delivery has many advantages over conventional drug administration, such as reduction of side effects, maintaining a stable plasma level concentration and improving the quality of life of patients. In this study, PAMAM G5 dendrimers and PAMAM G5-folic acid conjugates (PAMAM G5-FA) are synthesized and characterized by mass spectrometry (MALDI-MS). Controlled release studies at different pH values show that PAMAM G5-FA is a good candidate as a carrier for tramadol and morphine, while mathematical modeling is conducted, suggesting that the release process is governed by a diffusion mechanism. In addition, using molecular dynamics simulations, we investigate the structural and energetic properties that facilitate the encapsulation of tramadol and morphine by unmodified and functionalized PAMAM-G5 dendrimers at low, neutral and high pH. Our results correlate well with experimental data, confirming that tramadol and morphine may be encapsulated both by functionalized PAMAM dendrimers and unmodified PAMAM. Moreover, the simulations further reveal that hydrogen-bond and electrostatic interactions govern the affinity the dendrimers for both drugs. This information is envisioned to prove useful for the encapsulation of other drugs and for the design of novel functionalized dendrimers. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Carrasco-Sanchez, Veronica; Vergara-Jaque, Ariela; Zuniga, Matias; John, Amalraj; Nachtigall, Fabiane M.; Valdes, Oscar; Duran-Lara, Esteban F.; Santos, Leonardo S.] Univ Talca, Fraunhofer Chile Res Fdn, Nanobiotechnol Div,Ctr Syst Biotechnol, FCR CSB,Lab Asymmetr Synth,Chem Inst Nat Resource, Talca, Chile.
   [Comer, Jeffrey; Sandoval, Claudia] Univ Andres Bello, Ctr Bioinformat & Integrat Biol, Santiago, Chile.
RP Santos, LS (reprint author), Univ Talca, Fraunhofer Chile Res Fdn, Nanobiotechnol Div,Ctr Syst Biotechnol, FCR CSB,Lab Asymmetr Synth,Chem Inst Nat Resource, POB 747, Talca, Chile.
EM claudia.sandoval@unab.cl; lssantos@utalca.cl
RI Vergara-Jaque, Ariela/H-1275-2017; Santos, Leonardo/A-7953-2008;
   Amalraj, John/L-1564-2013; Valdes Lizama, Oscar/J-9243-2016; Duran-Lara,
   Esteban/G-9053-2017
OI Vergara-Jaque, Ariela/0000-0002-1236-013X; Santos,
   Leonardo/0000-0003-0908-0134; Amalraj, John/0000-0003-1872-5133; Valdes
   Lizama, Oscar/0000-0003-1477-2549; Duran-Lara,
   Esteban/0000-0002-8796-6830
FU CONICYT-Chile; CONICYT [21121007]; University of Talca for Doctoral
   Program in Sciences; Fondecyt postdoctoral grant [3120178]
FX We thank a partial contribution to the Programa Iniciativa Cientifica
   Milenio (ICM) del Ministerio de Economia, Fomento y Turismo, Fraunhofer
   Chile Research Foundation Innova-Chile Corfo (FCR-CSB 09CEII-6991), and
   Proyecto Anillo Cientifico ACT1107. A.V.J. thanks the Doctoral Program
   of Applied Sciences of Talca University, as well as CONICYT-Chile for a
   doctoral fellowship. V.C.S. is in debt to CONICYT for doctoral
   fellowship No. 21121007 and University of Talca for Doctoral Program in
   Sciences. E.D.L. thanks to Fondecyt postdoctoral grant N 3120178.
CR ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503
   Abderrezak A., 2012, PLOS ONE, V7, P33102
   Abroshan H, 2010, J PHYS ORG CHEM, V23, P866, DOI 10.1002/poc.1679
   Aranovich GL, 2009, PHYSICA A, V388, P3355, DOI 10.1016/j.physa.2009.05.012
   Beezer AE, 2003, TETRAHEDRON, V59, P3873, DOI 10.1016/S0040-4020(03)00437-X
   Chandrasekar D, 2007, BIOMATERIALS, V28, P504, DOI 10.1016/j.biomaterials.2006.07.046
   Cheng YY, 2008, FRONT BIOSCI-LANDMRK, V13, P1447, DOI 10.2741/2774
   Cheng YY, 2008, J PHYS CHEM B, V112, P8884, DOI 10.1021/jp801742t
   Cheng YY, 2008, J PHARM SCI-US, V97, P123, DOI 10.1002/jps.21079
   Cheng YY, 2005, EUR J MED CHEM, V40, P1390, DOI 10.1016/j.ejmech.2005.08.002
   Chotia C, 1975, J MOL BIOL, V105, P1
   D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Gillies ER, 2005, DRUG DISCOV TODAY, V10, P35, DOI 10.1016/S1359-6446(04)03276-3
   Grond S, 2004, CLIN PHARMACOKINET, V43, P879, DOI 10.2165/00003088-200443130-00004
   Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Khandare J, 2005, BIOCONJUGATE CHEM, V16, P330, DOI 10.1021/bc0498018
   Kobayashi H, 2003, MAGNET RESON MED, V50, P758, DOI 10.1002/mrm.10583
   Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651
   Kolhe P, 2006, BIOMATERIALS, V27, P660, DOI 10.1016/j.biomaterials.2005.06.007
   Korsmeyer R.W., 1983, SWELLING CONTROLLED, P77
   Lee I, 2002, MACROMOLECULES, V35, P4510, DOI 10.1021/ma010354q
   Liu Y, 2009, J AM CHEM SOC, V131, P2798, DOI 10.1021/ja8100227
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   Maiti K. Prabal, 2005, MACROMOLECULES, V38, P979
   Milhem OM, 2000, INT J PHARM, V197, P239, DOI 10.1016/S0378-5173(99)00463-9
   Morales ME, 2011, MOL PHARMACEUT, V8, P629, DOI 10.1021/mp200019q
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Nakamura K, 2007, BIOL PHARM BULL, V30, P1456, DOI 10.1248/bpb.30.1456
   PEPPAS NA, 1989, INT J PHARM, V57, P169, DOI 10.1016/0378-5173(89)90306-2
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Saam J, 2007, P NATL ACAD SCI USA, V104, P13319, DOI 10.1073/pnas.0702401104
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Svenson S, 2009, EUR J PHARM BIOPHARM, V71, P445, DOI 10.1016/j.ejpb.2008.09.023
   Sweetman S, 2007, MARTINDALE COMPLETE
   Talanov VS, 2006, NANO LETT, V6, P1459, DOI 10.1021/nl060765q
   Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j
   Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007
   TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137
   Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367
   Wang Y, 2011, BIOMATERIALS, V32, P3322, DOI 10.1016/j.biomaterials.2010.12.060
   Zhang YH, 2010, BIOCONJUGATE CHEM, V21, P489, DOI 10.1021/bc9003958
NR 47
TC 11
Z9 12
U1 1
U2 43
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD FEB 12
PY 2014
VL 73
BP 250
EP 257
DI 10.1016/j.ejmech.2013.11.040
PG 8
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AB6RF
UT WOS:000331916500026
PM 24412500
DA 2018-10-19
ER

PT J
AU Collart-Dutilleul, PY
   Secret, E
   Panayotov, I
   de Periere, DD
   Martin-Palma, RJ
   Torres-Costa, V
   Martin, M
   Gergey, C
   Durand, JO
   Cunin, F
   Cuisinier, FJ
AF Collart-Dutilleul, Pierre-Yves
   Secret, Emilie
   Panayotov, Ivan
   de Periere, Dominique Deville
   Martin-Palma, Raul J.
   Torres-Costa, Vicente
   Martin, Marta
   Gergey, Csilla
   Durand, Jean-Olivier
   Cunin, Frederique
   Cuisinier, Frederic J.
TI Adhesion and Proliferation of Human Mesenchymal Stem Cells from Dental
   Pulp on Porous Silicon Scaffolds
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE porous silicon; dental pulp stem cells; cell adhesion; surface
   functionalization; tissue engineering
ID IN-VITRO; GRADIENTS; DIFFERENTIATION; NANOPARTICLES; FABRICATION;
   TOPOGRAPHY; PEPTIDES; SURFACES; BEHAVIOR; NUCLEUS
AB In regenerative medicine, stem-cell-based therapy often requires a scaffold to deliver cells and/or growth factors to the injured site. Porous silicon (pSi) is a promising biomaterial for tissue engineering as it is both nontoxic and bioresorbable. Moreover, surface modification can offer control over the degradation rate of pSi and can also promote cell adhesion. Dental pulp stem cells (DPSC) are pluripotent mesenchymal stem cells found within the teeth and constitute a readily source of stem cells. Thus, coupling the good proliferation and differentiation capacities of DPSC with the textural and chemical properties of the pSi substrates provides an interesting approach for therapeutic use. In this study, the behavior of human DPSC is analyzed on pSi substrates presenting pores of various sizes, 10 +/- 2 nm, 36 +/- 4 nm, and 1.0 +/- 0.1 mu m, and undergoing different chemical treatments, thermal oxidation, silanization with aminopropyltriethoxysilane (APTES), and hydrosilylation with undecenoic acid or semicarbazide. DPSC adhesion and proliferation were followed for up to 72 h by fluorescence microscopy, scanning electron microscopy (SEM), enzymatic activity assay, and BrdU assay for mitotic activity. Porous silicon with 36 nm pore size was found to offer the best adhesion and the fastest growth rate for DPSC compared to pSi comporting smaller pore size (10 nm) or larger pore size (1 mu m), especially after silanization with APTES. Hydrosilylation with semicarbazide favored cell adhesion and proliferation, especially mitosis after cell adhesion, but such chemical modification has been found to led to a scaffold that is stable for only 24-48 h in culture medium. Thus, semicarbazide-treated pSi appeared to be an appropriate scaffold for stem cell adhesion and immediate in vivo transplantation, whereas APTES-treated pSi was found to be more suitable for long-term in vitro culture, for stem cell proliferation and differentiation:
C1 [Collart-Dutilleul, Pierre-Yves; Panayotov, Ivan; de Periere, Dominique Deville; Cuisinier, Frederic J.] Univ Montpellier I, BioNano Lab EA 4203, Montpellier, France.
   [Secret, Emilie; Durand, Jean-Olivier; Cunin, Frederique] Ecole Natl Super Chim Montpellier, Inst Charles Gerhardt Montpellier, UMR CNRS UM2 ENSCM UM1 5253, F-34296 Montpellier, France.
   [Martin-Palma, Raul J.; Torres-Costa, Vicente] Univ Autonoma Madrid, Dept Fis Aplicada, E-28049 Madrid, Spain.
   [Martin, Marta; Gergey, Csilla] Univ Montpellier 2, UMR Lab Charles Coulomb 5221, Montpellier, France.
   [Martin, Marta; Gergey, Csilla] CNRS, Lab Charles Coulomb UMR 5221, Montpellier, France.
RP Cuisinier, FJ (reprint author), Univ Montpellier I, BioNano Lab EA 4203, Montpellier, France.
EM frederic.cuisinier@univ-montp1.fr
RI Martin-Palma, Raul J/L-2720-2013; Torres-Costa, Vicente/L-2379-2013
OI Martin-Palma, Raul J/0000-0003-3434-8331; Torres-Costa,
   Vicente/0000-0001-5066-2799
CR Ainslie KM, 2008, ACS NANO, V2, P1076, DOI 10.1021/nn800071k
   Alvarez SD, 2009, BIOMATERIALS, V30, P26, DOI 10.1016/j.biomaterials.2008.09.005
   Bateman JE, 1997, CHEM COMMUN, P2275, DOI 10.1039/a707107h
   Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Cao D, 2011, COLLOID SURFACE B, V84, P26, DOI 10.1016/j.colsurfb.2010.12.005
   Cheng L, 2008, BRIT J OPHTHALMOL, V92, P705, DOI 10.1136/bjo.2007.133587
   Clements LR, 2012, LAB CHIP, V12, P1480, DOI 10.1039/c2lc20732j
   Coffinier Y, 2005, LANGMUIR, V21, P1489, DOI 10.1021/la047781s
   Coppe C, 2009, PEDIATR DENT, V31, P467
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Frith JE, 2012, J CELL SCI, V125, P317, DOI 10.1242/jcs.087916
   Gentile F, 2012, ACS APPL MATER INTER, V4, P2903, DOI 10.1021/am300519a
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Horner PJ, 2000, J NEUROSCI, V20, P2218
   Jarvis KL, 2011, J COLLOID INTERF SCI, V363, P327, DOI 10.1016/j.jcis.2011.07.063
   Kemoun P, 2007, CELL TISSUE RES, V329, P283, DOI 10.1007/s00441-007-0397-3
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Krishna OD, 2011, BIOMATERIALS, V32, P6412, DOI 10.1016/j.biomaterials.2011.05.034
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Ma Teng, 2010, World J Stem Cells, V2, P13, DOI 10.4252/wjsc.v2.i2.13
   Marolt D, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt10
   Noval AM, 2013, ACTA BIOMATER, V9, P6169, DOI 10.1016/j.actbio.2012.12.008
   Noval AM, 2012, J BIOMED MATER RES A, V100A, P1615, DOI 10.1002/jbm.a.34108
   Naveas N., 2012, ADV MATER, V13
   Park JH, 2009, NAT MATER, V8, P331, DOI [10.1038/NMAT2398, 10.1038/nmat2398]
   Paski J, 2005, PHYS STATUS SOLIDI C, V2, P3379, DOI 10.1002/pssc.200461175
   Patla I, 2010, NAT CELL BIOL, V12, P909, DOI 10.1038/ncb2095
   Sailor M. J., 2012, POROUS SILICON PRACT
   Santos H., 2014, POROUS SILICON BIOME, V68, P486
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Secret E, 2013, ADV HEALTHC MATER, V2, P718, DOI 10.1002/adhm.201200335
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Tirino V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003469
   Torres-Costa V, 2012, INT J NANOMED, V7, P623, DOI 10.2147/IJN.S27745
   UEDA Y, 1994, NEUROSCI LETT, V165, P203, DOI 10.1016/0304-3940(94)90745-5
   Wang PY, 2012, ADV FUNCT MATER, V22, P3414, DOI 10.1002/adfm.201200447
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   Whitehead MA, 2008, TISSUE ENG PT A, V14, P195, DOI 10.1089/ten.a.2006.0370
   Zangooie S, 1997, J ELECTROCHEM SOC, V144, P4027, DOI 10.1149/1.1838130
NR 43
TC 23
Z9 25
U1 10
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD FEB 12
PY 2014
VL 6
IS 3
BP 1719
EP 1728
DI 10.1021/am4046316
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA AB0OY
UT WOS:000331493200052
PM 24428409
DA 2018-10-19
ER

PT J
AU Nazaruk, E
   Szlezak, M
   Gorecka, E
   Bilewicz, R
   Osornio, YM
   Uebelhart, P
   Landau, EM
AF Nazaruk, Ewa
   Szlezak, Monika
   Gorecka, Ewa
   Bilewicz, Renata
   Osornio, Yazmin M.
   Uebelhart, Peter
   Landau, Ehud M.
TI Design and Assembly of pH-Sensitive Lipidic Cubic Phase Matrices for
   Drug Release
SO LANGMUIR
LA English
DT Article
ID LIQUID-CRYSTALLINE PHASES; BUPIVACAINE-LOADED FORMULATIONS;
   X-RAY-DIFFRACTION; MEMBRANE-PROTEINS; MONOOLEIN/WATER SYSTEM; MESOPHASE
   STRUCTURE; ALPHA-CHYMOTRYPSIN; DELIVERY SYSTEMS; WATER CHANNELS; NETWORK
AB Bicontinuous lipidic cubic phases (LCPs) exhibit a combination of material properties that make them highly interesting for various biomaterial applications: they are nontoxic, biodegradable, optically transparent, thermodynamically stable in excess water, and can incorporate active molecules of virtually any polarity. Here we present a molecular system comprising host lipid, water, and designed lipidic additive, which form a structured, pH-sensitive lipidic matrix for hydrophilic as well as hydrophobic drug incorporation and release. The model drug doxorubicin (Dox) was loaded into the LCP. Tunable interactions with the lipidic matrix led to the observed pH-dependent drug release from the phase. The rate of Dox release from the cubic phase at pH 7.4 was low but increased significantly at more acidic pH. A small amount of a tailored diacidic lipid (lipid 1) added to the monoolein LCP modified the release rate of the drug. Phase identity and structural parameters of pure and doped mesophases were characterized by small-angle X-ray scattering (SAXS), and release profiles from the matrix were monitored electrochemically. Analysis of the release kinetics revealed that the total amount of drug released from the LCP matrix is linearly dependent on the square root of time, implying that the release mechanism proceeds according to the Higuchi model.
C1 [Nazaruk, Ewa; Szlezak, Monika; Gorecka, Ewa; Bilewicz, Renata] Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland.
   [Osornio, Yazmin M.; Uebelhart, Peter; Landau, Ehud M.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland.
RP Bilewicz, R (reprint author), Univ Warsaw, Dept Chem, Pasteura 1, PL-02093 Warsaw, Poland.
EM bilewicz@chem.uw.edu.pl; ehud.landau@chem.uzh.ch
RI Gorecka, Ewa/Q-6197-2018
OI Gorecka, Ewa/0000-0002-8076-5489
FU  [PSPB 079/2010]
FX This work was supported by grant PSPB 079/2010 to R.B. and E.M.L.
   through the Swiss Contribution to the enlarged European Union.
CR Addeo R, 2008, CANCER CHEMOTH PHARM, V62, P285, DOI 10.1007/s00280-007-0605-6
   Angelov B, 2003, J AM CHEM SOC, V125, P7188, DOI 10.1021/ja034578v
   Angelova A, 2003, LANGMUIR, V19, P6928, DOI 10.1021/la0345284
   Barauskas J, 2003, LANGMUIR, V19, P9562, DOI 10.1021/la0350812
   Boyd BJ, 2007, INT J PHARM, V340, P52, DOI 10.1016/j.ijpharm.2007.03.020
   Boyd BJ, 2003, INT J PHARMACEUT, V260, P239, DOI 10.1016/S0378-5173(03)00262-X
   Briggs J, 1996, J PHYS II, V6, P723, DOI 10.1051/jp2:1996208
   Caboi F, 1997, LANGMUIR, V13, P5476, DOI 10.1021/la9702188
   Chang CM, 1997, INT J PHARMACEUT, V147, P135, DOI 10.1016/S0378-5173(96)04805-3
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Chiu ML, 2000, ACTA CRYSTALLOGR D, V56, P781, DOI 10.1107/S0907444900004716
   Conn CE, 2013, SOFT MATTER, V9, P3449, DOI 10.1039/c3sm27743g
   Costa P, 2001, EUR J PHARM SCI, V13, P123, DOI 10.1016/S0928-0987(01)00095-1
   Engstrom S, 1999, EUR J PHARM SCI, V8, P243, DOI 10.1016/S0928-0987(99)00012-3
   ENGSTROM S, 1990, ACS POLYM PREP, V31, P157
   Fong C, 2012, CHEM SOC REV, V41, P1297, DOI 10.1039/c1cs15148g
   Guo CY, 2010, DRUG DISCOV TODAY, V15, P1032, DOI 10.1016/j.drudis.2010.09.006
   Komisarski M, 2013, CHEM-EUR J, V19, P1262, DOI 10.1002/chem.201203372
   Komorsky-Lovric S, 2006, BIOELECTROCHEMISTRY, V69, P82, DOI 10.1016/j.bioelechem.2005.10.006
   Kraineva J, 2006, BBA-PROTEINS PROTEOM, V1764, P424, DOI 10.1016/j.bbapap.2005.11.004
   Kulkarni CV, 2010, SOFT MATTER, V6, P3191, DOI 10.1039/c0sm00068j
   Landau E. M., 2005, BICONTINUOUS STRUCTU, P422
   Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532
   LANDAU EM, 1993, J AM CHEM SOC, V115, P2102, DOI 10.1021/ja00059a002
   Lindell K, 1998, PROG COLL POL SCI S, V108, P111
   Lynch M. L., 2005, SURFACTANT SCI SERIE, V127
   Nazaruk E, 2008, J POWER SOURCES, V183, P533, DOI 10.1016/j.jpowsour.2008.05.061
   Nazaruk E, 2012, J COLLOID INTERF SCI, V385, P130, DOI 10.1016/j.jcis.2012.06.087
   Nazaruk E, 2009, ELECTROANAL, V21, P507, DOI 10.1002/elan.200804435
   Negrini R, 2012, LANGMUIR, V28, P16455, DOI 10.1021/la303833s
   Negrini R, 2011, LANGMUIR, V27, P5296, DOI 10.1021/la200591u
   Osornio YM, 2012, J ORG CHEM, V77, P10583, DOI 10.1021/jo301659c
   Peng XS, 2010, AAPS PHARMSCITECH, V11, P1405, DOI 10.1208/s12249-010-9481-1
   Phan S, 2011, INT J PHARMACEUT, V421, P176, DOI 10.1016/j.ijpharm.2011.09.022
   PORTMANN M, 1991, J PHYS CHEM-US, V95, P8437, DOI 10.1021/j100175a006
   Qiu H, 2000, BIOMATERIALS, V21, P223, DOI 10.1016/S0142-9612(99)00126-X
   Razumas V, 1996, J PHYS CHEM-US, V100, P11766, DOI 10.1021/jp952613h
   Rowinski P, 2003, CHEM PHYS LIPIDS, V124, P147, DOI 10.1016/S0009-3084(03)00051-3
   Shah JC, 2001, ADV DRUG DELIVER REV, V47, P229, DOI 10.1016/S0169-409X(01)00108-9
   TARDIEU A, 1970, BIOCHIM BIOPHYS ACTA, V219, P11, DOI 10.1016/0005-2736(70)90056-8
   Wyatt D., 1992, PHARM TECHNOL, V16, P116
   Yaghmur A, 2012, LANGMUIR, V28, P2881, DOI 10.1021/la203577v
   Yaghmur A, 2011, SOFT MATTER, V7, P8291, DOI 10.1039/c1sm05854a
   Zeng N, 2012, INT J NANOMED, V7, P3703, DOI 10.2147/IJN.S32599
NR 44
TC 42
Z9 42
U1 3
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 11
PY 2014
VL 30
IS 5
BP 1383
EP 1390
DI 10.1021/la403694e
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA AA8KI
UT WOS:000331344000025
PM 24443890
DA 2018-10-19
ER

PT J
AU Cohen, B
   Shefy-Peleg, A
   Zilberman, M
AF Cohen, Benny
   Shefy-Peleg, Adaya
   Zilberman, Meital
TI Novel gelatin/alginate soft tissue adhesives loaded with drugs for pain
   management: structure and properties
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE gelatin; alginate; carbodiimide; bupivacaine; ibuprofen; adhesive;
   controlled drug delivery; bonding strength; cytotoxicity
ID POLY(L-GLUTAMIC ACID); BIOLOGICAL GLUE; SODIUM ALGINATE; GELATIN GELS;
   IN-VITRO; RELEASE; MATRIX; MICROSPHERES; BIOMATERIAL; BEHAVIOR
AB Interest in tissue adhesives as alternatives for conventional wound closing applications, such as sutures and staples, has increased in the last few decades due to numerous possible advantages, including less discomfort and lower cost. Novel tissue adhesives based on gelatin, with alginate as a polymeric additive and crosslinked by carbodiimide were developed and loaded with two types of drugs for pain relief, bupivacaine and ibuprofen, in order to improve the therapeutic effect. The release of the drugs from the adhesive matrix was found to be controlled mainly by the adhesive's characteristics, i.e. swelling and hydrophilic group concentration. The drug characteristics, i.e. hydrophilicity and electrical interactions between the drug and the polymeric components, were also found to have some effect. Incorporation of bupivacaine was found to improve the bonding strength of the adhesive due to its inert nature and the reinforcing effect of its fibrous crystals, whereas incorporation of ibuprofen was found to have an adverse effect on the bonding strength, probably due to its reaction with the other adhesive components which increased the crosslinking density. Overall, the novel drug-eluting gelatin-based bioadhesives investigated in this research, especially those loaded with bupivacaine, demonstrated a promising potential for use in wound closing applications.
C1 [Cohen, Benny; Shefy-Peleg, Adaya; Zilberman, Meital] Tel Aviv Univ, Dept Biomed Engn, Fac Engn, IL-69978 Tel Aviv, Israel.
RP Zilberman, M (reprint author), Tel Aviv Univ, Dept Biomed Engn, Fac Engn, IL-69978 Tel Aviv, Israel.
EM meitalz@post.tau.ac.il
FU Office of the Chief Scientist [OCS] in the Israel Ministry of Industry,
   Trade and Labor
FX The authors are grateful to the Office of the Chief Scientist [OCS] in
   the Israel Ministry of Industry, Trade and Labor for supporting this
   research and to Ms Ruth Gottlieb, the Department of Biomedical
   Engineering, Faculty of Engineering, Tel-Aviv University, Israel, for
   her help in the preparation of cell cultures.
CR Ashley Martin, 2005, Dent Update, V32, P169
   Babst C R, 1978, Anesth Prog, V25, P87
   Bae SK, 2002, J ADHES SCI TECHNOL, V16, P361, DOI 10.1163/156856102760067163
   Dawson CW, 2001, INFECTION, V13, P14
   DJABOUROV M, 1983, POLYMER, V24, P537, DOI 10.1016/0032-3861(83)90101-5
   Donkerwolcke M, 1998, BIOMATERIALS, V19, P1461, DOI 10.1016/S0142-9612(98)00059-3
   DRAGET KI, 2002, BIOPOLYMERS, V6, P215
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   GROUSELLE M, 1990, BIOCHEM J, V271, P269, DOI 10.1042/bj2710269
   Heiss C, 2006, EUR J TRAUMA, V32, P141
   HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7
   Jia XQ, 2004, BIOMATERIALS, V25, P4797, DOI 10.1016/j.biomaterials.2003.12.012
   JONAS RA, 1988, J VASC SURG, V7, P414, DOI 10.1067/mva.1988.avs0070414
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Matsuda S, 1999, J BIOMED MATER RES, V45, P20, DOI 10.1002/(SICI)1097-4636(199904)45:1<20::AID-JBM3>3.0.CO;2-6
   MATTHEW IR, 1995, BIOMATERIALS, V16, P275, DOI 10.1016/0142-9612(95)93254-B
   MIZRAHI B, 2011, ACTIVE IMPLANTS SCAF, V8, P39
   NARAYANI R, 1994, J MICROENCAPSUL, V11, P69, DOI 10.3109/02652049409040439
   NISHI C, 1995, J BIOMED MATER RES, V29, P829, DOI 10.1002/jbm.820290707
   OSMOND MH, 1995, J PEDIATR-US, V126, P892, DOI 10.1016/S0022-3476(95)70203-2
   Osmond MH, 1999, PEDIATR EMERG CARE, V15, P137, DOI 10.1097/00006565-199904000-00015
   Otani Y, 1996, J BIOMED MATER RES, V31, P157
   Otani Y, 1996, BIOMATERIALS, V17, P1387, DOI 10.1016/0142-9612(96)87279-6
   Rainsford K. D., 2009, Inflammopharmacology, V17, P275, DOI 10.1007/s10787-009-0016-x
   Reece TB, 2001, AM J SURG, V182, p40S, DOI 10.1016/S0002-9610(01)00742-5
   Ryou M, 2006, TECH GASTROINTEST EN, V8, P33, DOI 10.1016/j.tgie.2005.12.007
   Sells L, 1999, PEDIAT EMERG MED REP, V4, P1
   Shefy-Peleg A, ANTIBIOTIC ELU UNPUB
   SIBERT JR, 1981, ARCH DIS CHILD, V56, P225, DOI 10.1136/adc.56.3.225
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   TABATA Y, 1994, J CONTROL RELEASE, V31, P189, DOI 10.1016/0168-3659(94)00035-2
   Thakur RA, 2008, INT J PHARMACEUT, V364, P87, DOI 10.1016/j.ijpharm.2008.07.033
   Zhang H, 2008, INT J PHARMACEUT, V351, P244, DOI 10.1016/j.ijpharm.2007.10.004
NR 35
TC 8
Z9 8
U1 3
U2 30
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD FEB 11
PY 2014
VL 25
IS 3
BP 224
EP 240
DI 10.1080/09205063.2013.849904
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 286RR
UT WOS:000329486900002
PM 24156311
DA 2018-10-19
ER

PT J
AU Yalcin, O
   Erdem, R
   Ozum, S
AF Yalcin, Orhan
   Erdem, Riza
   Ozum, Songul
TI Origin of the martensitic and austenitic phase transition in
   core-surface smart nanoparticles with size effects and hysteretic
   splitting
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; EMERY-GRIFFITHS MODEL; NICKEL FERRITE;
   BIOMATERIAL SYSTEM; MAGNETIC-BEHAVIOR; ISING-MODEL; ANTIMICROBIAL
   ACTIVITY; PHOTOCATALYTIC SHELL; FINE PARTICLES; TRANSFORMATION
AB Blume-Emery-Griffiths model is used to study the effects of the bilinear and biquadratic exchange interactions as well as crystal field interaction on the magnetic properties of core-surface smart nanoparticles. From the minimization of the free energy in pair approximation in Kikuchi version, a set of equations for the bond variables and magnetization are derived. Based on the numerical solutions of these equations, magnetization and hysteresis curves are obtained. Besides the first-and second-order phase transitions, martensitic and austenitic phase regions are observed in the phase diagrams of homogeneous and composite nanoparticles and the origin of martensitic transitions (MT)-austenitic transitions (AT) is investigated. It is found that MT-AT occurred for a nonzero biquadratic exchange parameter. On the other hand, nonzero single-ion anisotropy caused the hysteretic splitting in core-surface type nanoparticles. Martensitic and austenitic results of nanoparticles agree with the experimental results in literature. (c) 2014 AIP Publishing LLC.
C1 [Yalcin, Orhan] Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
   [Erdem, Riza] Akdeniz Univ, Dept Phys, TR-07058 Antalya, Turkey.
   [Ozum, Songul] Nigde Univ, Inst Sci, TR-51240 Nigde, Turkey.
RP Yalcin, O (reprint author), Nigde Univ, Dept Phys, TR-51240 Nigde, Turkey.
EM o.yalcin@nigde.edu.tr
RI ERDEM, RIZA/C-6996-2016
CR Abou Ghantous M, 2011, J MAGN MAGN MATER, V323, P2504, DOI 10.1016/j.jmmm.2011.05.027
   Babin V, 2003, J APPL PHYS, V94, P4244, DOI 10.1063/1.1604932
   Bakuzis AF, 2004, J MAGN MAGN MATER, V272, pE1161, DOI 10.1016/j.jmmm.2003.12.210
   BERKER AN, 1976, PHYS REV B, V14, P4946, DOI 10.1103/PhysRevB.14.4946
   Bhattacharya K., 2003, MICROSTRUCTURE MARTE
   BLUME M, 1966, PHYS REV, V141, P517, DOI 10.1103/PhysRev.141.517
   BLUME M, 1971, PHYS REV A-GEN PHYS, V4, P1071, DOI 10.1103/PhysRevA.4.1071
   Brailovski V, 2004, PHYS MET METALLOGR+, V97, pS3
   CAPEL HW, 1966, PHYSICA, V32, P966, DOI 10.1016/0031-8914(66)90027-9
   CECH RE, 1956, T AM I MIN MET ENG, V206, P124
   Dhote RP, 2012, COMP MATER SCI, V63, P105, DOI 10.1016/j.commatsci.2012.05.060
   Duman E, 2007, J MAGN MAGN MATER, V309, P40, DOI 10.1016/j.jmmm.2006.06.010
   Ener S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.144305
   Erdinc A, 2002, PHYSICA A, V307, P453, DOI 10.1016/S0378-4371(01)00620-3
   Fraerman AA, 2001, J PHYS-CONDENS MAT, V13, P683, DOI 10.1088/0953-8984/13/4/314
   Frommen C, 2004, J ALLOY COMPD, V377, P232, DOI 10.1016/j.jallcom.2004.01.061
   Funakubu H., 1987, SHAPE MEMORY EFFECT
   Gubbala S, 2006, MATER SCI TECH-LOND, V22, P845, DOI 10.1179/174328406X91096
   Heisenberg W, 1928, Z PHYS, V49, P619, DOI 10.1007/BF01328601
   HOSTON W, 1991, PHYS REV LETT, V67, P1027, DOI 10.1103/PhysRevLett.67.1027
   Kadau K, 2002, COMPUT PHYS COMMUN, V147, P126, DOI 10.1016/S0010-4655(02)00230-8
   KAJIWARA S, 1991, PHILOS MAG A, V63, P625, DOI 10.1080/01418619108213904
   KANEYOSHI T, 1992, J PHYS-CONDENS MAT, V4, pL653, DOI 10.1088/0953-8984/4/49/002
   Kantar E, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40080-9
   Kartopu G., 2010, FABRICATION APPL MET
   Keskin M, 1999, PHYSICA A, V267, P392, DOI 10.1016/S0378-4371(98)00666-9
   KIKUCHI R, 1974, J CHEM PHYS, V60, P1071, DOI 10.1063/1.1681115
   Kim J, 2006, ANGEW CHEM INT EDIT, V45, P7754, DOI 10.1002/anie.200602471
   Kitakami O, 1997, PHYS REV B, V56, P13849, DOI 10.1103/PhysRevB.56.13849
   Krenke T, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.174413
   Krenke T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014412
   Leite V. S., 2004, BRAZ J PHYS, V34, P448
   LIN M, 1993, ACTA METALL MATER, V41, P253, DOI 10.1016/0956-7151(93)90356-W
   Manosa L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830999
   Mutter D, 2011, EUR PHYS J B, V84, P109, DOI 10.1140/epjb/e2011-20661-4
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Perez-Landazabal JI, 2012, J ALLOY COMPD, V536, pS277, DOI 10.1016/j.jallcom.2012.01.015
   Rana S, 2007, ACTA BIOMATER, V3, P233, DOI 10.1016/j.actbio.2006.10.006
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MATER SCI TECH-LOND, V23, P97, DOI 10.1179/174328407X158488
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rego LGC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.144424
   Rosensweig R. E., 1997, FERROHYDRODYNAMICS
   Santamarta R, 2004, SCRIPTA MATER, V50, P1423, DOI 10.1016/j.scriptamat.2004.03.013
   Sasmaz S., 2011, J SUPERCOND NOV MAGN, V24, P757
   SAUL DM, 1974, PHYS REV B, V9, P4964, DOI 10.1103/PhysRevB.9.4964
   STONER EC, 1948, PHILOS TR R SOC S-A, V240, P599, DOI 10.1098/rsta.1948.0007
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Szlaferek A, 2004, PHYS STATUS SOLIDI B, V241, P1312, DOI 10.1002/pssb.200301992
   TSAI JF, 1990, J AM CERAM SOC, V73, P2992, DOI 10.1111/j.1151-2916.1990.tb06706.x
   TU JB, 1994, J MATER SCI, V29, P1662, DOI 10.1007/BF00368942
   Usov NA, 2005, J MAGN MAGN MATER, V290, P727, DOI 10.1016/j.jmmm.2004.11.277
   Venkatasubramanian R, 2008, MATER SCI TECH-LOND, V24, P589, DOI 10.1179/174328408X282065
   Waitz T, 2004, ACTA MATER, V52, P5461, DOI 10.1016/j.actamat.2004.08.003
   Waitz T, 2004, ACTA MATER, V52, P137, DOI 10.1016/j.actamat.2003.08.036
   Yalcin O, 2008, ACTA PHYS POL A, V114, P835, DOI 10.12693/APhysPolA.114.835
   Yalcin O., 2013, FERROMAGNETIC RESONA
   Yalcin O., 2012, NANORODS
   Yalcin O., 2012, SMART NANOPARTICLES
   Zaim A, 2013, J MAGN MAGN MATER, V331, P37, DOI 10.1016/j.jmmm.2012.11.018
   Zaim A, 2013, SOLID STATE COMMUN, V158, P76, DOI 10.1016/j.ssc.2012.10.014
   Zhang J, 2007, ACTA BIOMATER, V3, P838, DOI 10.1016/j.actbio.2007.05.011
   Zhang JL, 2007, LANGMUIR, V23, P6342, DOI 10.1021/la0636199
   Zhang W, 2004, APPL PHYS LETT, V84, P4872, DOI 10.1063/1.1762698
   Zhao XQ, 1996, JPN J APPL PHYS 1, V35, P4468, DOI 10.1143/JJAP.35.4468
   Zhao XQ, 1996, NANOSTRUCT MATER, V7, P313, DOI 10.1016/0965-9773(96)00008-6
NR 67
TC 6
Z9 6
U1 0
U2 14
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
EI 1089-7550
J9 J APPL PHYS
JI J. Appl. Phys.
PD FEB 7
PY 2014
VL 115
IS 5
AR 054316
DI 10.1063/1.4864489
PG 7
WC Physics, Applied
SC Physics
GA AB2TV
UT WOS:000331645900085
DA 2018-10-19
ER

PT J
AU Chiono, V
   Mozetic, P
   Boffito, M
   Sartori, S
   Gioffredi, E
   Silvestri, A
   Rainer, A
   Giannitelli, SM
   Trombetta, M
   Nurzynska, D
   Di Meglio, F
   Castaldo, C
   Miraglia, R
   Montagnani, S
   Ciardelli, G
AF Chiono, Valeria
   Mozetic, Pamela
   Boffito, Monica
   Sartori, Susanna
   Gioffredi, Emilia
   Silvestri, Antonella
   Rainer, Alberto
   Giannitelli, Sara Maria
   Trombetta, Marcella
   Nurzynska, Daria
   Di Meglio, Franca
   Castaldo, Clotilde
   Miraglia, Rita
   Montagnani, Stefania
   Ciardelli, Gianluca
TI Polyurethane-based scaffolds for myocardial tissue engineering
SO INTERFACE FOCUS
LA English
DT Article
DE cardiac progenitor cells; myocardial tissue engineering; polyurethane;
   additive manufacturing
ID TYROSINE-BASED POLYURETHANES; ADULT HUMAN HEART; BIOMATERIAL
   APPLICATIONS; STEM-CELLS; IN-VITRO; ELASTOMERS; BEHAVIOR
AB Bi-layered scaffolds with a 0 degrees/90 degrees lay-down pattern were prepared by melt-extrusion additive manufacturing (AM) using a poly(ester urethane) (PU) synthesized from poly(1-caprolactone) diol, 1,4-butandiisocyanate and L-lysine ethyl ester dihydrochloride chain extender. Rheological analysis and differential scanning calorimetry of the starting material showed that compression moulded PU films were in the molten state at a higher temperature than 155 degrees C. The AMprocessing temperature was set at 155 degrees C after verifying the absence of PU thermal degradation phenomena by isothermal thermogravimetry analysis and rheological characterization performed at 165 degrees C. Scaffolds highly reproduced computer-aided design geometry and showed an elastomeric-like behaviour which is promising for applications in myocardial regeneration. PU scaffolds supported the adhesion and spreading of human cardiac progenitor cells (CPCs), whereas they did not stimulate CPC proliferation after 1-14 days culture time. In the future, scaffold surface functionalization with bioactive peptides/proteins will be performed to specifically guide CPC behaviour.
C1 [Chiono, Valeria; Boffito, Monica; Sartori, Susanna; Gioffredi, Emilia; Silvestri, Antonella; Ciardelli, Gianluca] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy.
   [Mozetic, Pamela; Rainer, Alberto; Giannitelli, Sara Maria; Trombetta, Marcella] Univ Campus Biomed Roma, Tissue Engn Lab, Rome, Italy.
   [Nurzynska, Daria; Di Meglio, Franca; Castaldo, Clotilde; Miraglia, Rita; Montagnani, Stefania] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy.
RP Chiono, V (reprint author), Politecn Torino, Dept Mech & Aerosp Engn, Corso Duca Abruzzi 24, Turin, Italy.
EM valeria.chiono@polito.it
RI Rainer, Alberto/G-8588-2011; Chiono, Valeria/G-3631-2014; Sartori,
   Susanna/C-1277-2010; Boffito, Monica/P-4267-2014
OI Rainer, Alberto/0000-0001-8971-551X; Trombetta,
   Marcella/0000-0002-1357-4885; MONTAGNANI, STEFANIA/0000-0002-7420-372X;
   Mozetic, Pamela/0000-0001-8641-0526; Ciardelli,
   Gianluca/0000-0003-0199-1427; Nurzynska, Daria/0000-0003-1092-6168;
   Boffito, Monica/0000-0001-7637-2001; Castaldo,
   Clotilde/0000-0003-1475-5036; Di Meglio, Franca/0000-0002-9793-9289
FU MIUR (Italian Ministry of Education University and Research)
   [RBFR10L0GK]
FX FIRB 2010 Project 'Bioartificial materials and biomimetic scaffolds for
   a stem cells-based therapy for myocardial regeneration' (grant no.
   RBFR10L0GK) financed by MIUR (Italian Ministry of Education University
   and Research) is acknowledged.
CR Boyle AJ, 2006, CIRCULATION, V114, P339, DOI 10.1161/CIRCULATIONAHA.105.590653
   Castaldo C, 2008, STEM CELLS, V26, P1723, DOI 10.1634/stemcells.2007-0732
   Cesselli D, 2011, AM J PATHOL, V179, P349, DOI 10.1016/j.ajpath.2011.03.036
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Christenson EM, 2005, POLYMER, V46, P11744, DOI 10.1016/j.polymer.2005.08.083
   D'Amario D, 2011, CIRC RES, V108, P857, DOI 10.1161/CIRCRESAHA.111.241380
   DARLAS DF, 2008, POLYM ENG SCI, V48, P519, DOI DOI 10.1002/PEN.20983)
   Di Meglio F, 2010, J MOL CELL CARDIOL, V49, P719, DOI 10.1016/j.yjmcc.2010.05.013
   Ferry J. D., 1980, VISCOELASTIC PROPERT
   Forte G, 2008, STEM CELLS, V26, P2093, DOI 10.1634/stemcells.2008-0061
   French KM, 2012, ACTA BIOMATER, V8, P4357, DOI 10.1016/j.actbio.2012.07.033
   Gaballa MA, 2006, J HEART LUNG TRANSPL, V25, P946, DOI 10.1016/j.healun.2006.04.008
   GIANNITELLI SM, 2013, ACTA BIOMATER, DOI DOI 10.1016/J.ACTBI0.2013.10.024)
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Liu L. Y., 2012, ISRN NANOTECHNOL, V2012, P11, DOI DOI 10.5402/2012/627420)
   Nurzynska D, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0320-2
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Rainer A, 2012, ANN BIOMED ENG, V40, P966, DOI 10.1007/s10439-011-0465-4
   Rechichi A, 2008, J BIOMED MATER RES A, V84A, P847, DOI 10.1002/jbm.a.31349
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Sartori S, 2013, REACT FUNCT POLYM, V73, P1366, DOI 10.1016/j.reactfunctpolym.2013.01.006
   Silvestri A, 2013, MACROMOL BIOSCI, V13, P984, DOI 10.1002/mabi.201200483
   VILELASILVA ACP, 2011, ADV MATER, V23, P514, DOI DOI 10.1002/ADMA.201003479)
   Vozzi G, 2008, MACROMOL BIOSCI, V8, P60, DOI 10.1002/mabi.200700214
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
NR 26
TC 41
Z9 42
U1 5
U2 41
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2014
VL 4
IS 1
SI SI
AR 20130045
DI 10.1098/rsfs.2013.0045
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CI
UT WOS:000332392200003
PM 24501673
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Fadeeva, E
   Deiwick, A
   Chichkov, B
   Schlie-Wolter, S
AF Fadeeva, Elena
   Deiwick, Andrea
   Chichkov, Boris
   Schlie-Wolter, Sabrina
TI Impact of laser-structured biomaterial interfaces on guided cell
   responses
SO INTERFACE FOCUS
LA English
DT Review
DE ultrashort pulse laser structuring; nano- and microsized surface
   topographies; biomaterial-cell interactions; selective cell control
ID ADHESION; SURFACES; TOPOGRAPHY; FEMTOSECOND; DYNAMICS; BEHAVIOR;
   BINDING; SYSTEMS
AB To achieve a perfect integration of biomaterials into the body, tissue formation in contact with the interface has to be controlled. In this connection, a selective cell control is required: fibrotic encapsulation has to be inhibited, while tissue guidance has to be stimulated. As conventional biomaterials do not fulfil this specification, functionalization of the biointerface is under development to mimic the natural environment of the cells. One approach focuses on the fabrication of defined surface topographies. Thereby, ultrashort pulse laser ablation is very beneficial, owing to a large variety of fabricated structures, reduced heat-affected zones, high precision and reproducibility. We demonstrate that nanostructures in platinum and microstructures in silicon selectively control cell behaviour: inhibiting fibroblasts, while stimulating neuronal attachment and differentiation. However, the control of fibroblasts strongly correlates with the created size dimensions of the surface structures. These findings suggest favourable biomaterial interfaces for electronic devices. The mechanisms which are responsible for selective cell control are poorly understood. To give an insight, cell behaviour in dependence of biomaterial interfaces is discussed-including basic research on the role of the extracellular matrix. This knowledge is essential to understand such specific cell responses and to optimize biomaterial interfaces for future biomedical applications.
C1 [Fadeeva, Elena; Deiwick, Andrea; Chichkov, Boris; Schlie-Wolter, Sabrina] Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
   [Chichkov, Boris; Schlie-Wolter, Sabrina] Leibniz Univ Hannover, Inst Quantum Opt, D-30167 Hannover, Germany.
RP Schlie-Wolter, S (reprint author), Laser Zentrum Hannover eV, Hollerithallee 8, D-30419 Hannover, Germany.
EM s.schlie@lzh.de
RI Chichkov, Boris/M-4112-2015
OI Chichkov, Boris/0000-0002-8129-7373
FU German Research Foundation [DFG SFB599]; BMBF
FX This work was partly supported by German Research Foundation Cluster of
   Excellence Rebirth 'From Regenerative Biology to Reconstructive
   Therapy', DFG SFB599 'Sustainable Bioresorbing and Permanent Implants of
   Metallic and Ceramic Materials' and by BMBF project REMEDIS.
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002
   Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Babensee JE, 1998, ADV DRUG DELIVER REV, V33, P111, DOI 10.1016/S0169-409X(98)00023-4
   Baujard-Lamotte L, 2008, COLLOID SURFACE B, V63, P129, DOI [10.1016/j.colsurfb.2007.11.015, 10.1016/j.coisurfb.2007.11.015]
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Fadeeva E, 2009, CONTACT ANGLE, WETTABILITY AND ADHESION, VOL 6, P163
   Fadeeva E, 2010, J ADHES SCI TECHNOL, V24, P2257, DOI 10.1163/016942410X508000
   Fadeeva E., 2009, PHYS STATUS SOLIDI A, V6, P1348, DOI [10.1002/pssa.200881063, DOI 10.1002/PSSA.200881063)]
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Frantz C, 2011, J CELL SCI, V123, P4195, DOI [10.1242/jcs.023820, DOI 10.1242/JCS.023820)]
   Gaggl A, 2000, BIOMATERIALS, V21, P1067, DOI 10.1016/S0142-9612(00)00002-8
   Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Heino J, 2009, INT J BIOCHEM CELL B, V41, P341, DOI 10.1016/j.biocel.2008.08.021
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Koroleva A, 2010, J OPTICS-UK, V12, DOI 10.1088/2040-8978/12/12/124009
   Kovacs G. T. A., 1994, ENABLING TECHNOLOGIE, P121
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029
   Peto G, 2002, APPL SURF SCI, V186, P7, DOI 10.1016/S0169-4332(01)00769-3
   Schlie Sabrina, 2010, Journal of Biomedical Science & Engineering, V3, P884, DOI 10.4236/jbise.2010.39118
   Schlie S, 2011, P 2 INT C TISS ENG L, P51
   Schlie S, 2012, TISSUE ENG PART C-ME, V18, P688, DOI [10.1089/ten.tec.2011.0635, 10.1089/ten.TEC.2011.0635]
   Schlie S, 2012, J MATER SCI-MATER M, V23, P2813, DOI 10.1007/s10856-012-4737-9
   Schlie S, 2011, PHOTONIC NANOSTRUCT, V9, P159, DOI 10.1016/j.photonics.2010.09.006
   Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553
   Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016
   Schlie-Wolter S, 2013, ACS APPL MATER INTER, V5, P1070, DOI 10.1021/am3028487
   SONNENBERG A, 1990, J CELL BIOL, V110, P2145, DOI 10.1083/jcb.110.6.2145
   Stieglitz T, 2004, NEUROPROSTHETICS THE, V2, P475
   Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
NR 44
TC 12
Z9 12
U1 0
U2 37
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2042-8898
EI 2042-8901
J9 INTERFACE FOCUS
JI Interface Focus
PD FEB 6
PY 2014
VL 4
IS 1
SI SI
AR 20130048
DI 10.1098/rsfs.2013.0048
PG 10
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA AC3CI
UT WOS:000332392200006
PM 24501676
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Zhu, ZZ
   Li, XS
AF Zhu, Zongzhe
   Li, Xinsong
TI Silicone Hydrogels Based on a Novel Amphiphilic
   Poly(2-methyl-2-oxazoline)-b-poly(dimethyl siloxane) Copolymer
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biomaterials; hydrophilic polymers; silicone hydrogel;
   photopolymerization
ID POLY(ETHYLENE GLYCOL); SURFACE MODIFICATION; PROTEIN ADSORPTION;
   CONTACT-LENSES; POLYMER; POLYOXAZOLINE; CHEMISTRY; DELIVERY
AB A novel amphiphilic hydrogel based on poly(2-methyl-2-oxazoline)-b-poly(dimethyl siloxane) (PMeOx-PDMS) block copolymer was developed. First of all, PMeOx-PDMS macromonomer was synthesized by coupling mono-hydroxylated PMeOx with PDMS followed by end-capping with methacrylate group. The structures of each step were characterized by NMR and titration. After that, silicone hydrogels were prepared by UV-initiated copolymerization of PMeOx-PDMS macromonomer with monomers such as 2-hydroxyethyl methacrylate in the presence of a crosslinker. Measurements of the hydrogels' water contact angle, equilibrium water content, and tensile properties showed that the hydrogels possessed better hydrophilic surface, higher water content, and better ion permeability with the increase of the content of the macromonomer PMeOx-PDMS. Meanwhile, the tensile strength and Young's modulus of the hydrogels decreased slightly. Protein adsorption tests showed that the hydrogels had strong antifouling ability after the incorporation of PMeOx. This newly described hydrogel demonstrated attractive properties to serve as ophthalmic biomaterial. (c) 2013 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2014, 131, 39867.
C1 [Zhu, Zongzhe; Li, Xinsong] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
RP Li, XS (reprint author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Jiangsu, Peoples R China.
EM lixs@seu.edu.cn
FU National Natural Science Foundation of China [51073036, 51373034];
   Industry-Academic Joint Technological Innovations Project of Jiangsu
   Province, China [BY2010143]
FX This project was support by the National Natural Science Foundation of
   China with the grants no. 51073036, 51373034 and the Industry-Academic
   Joint Technological Innovations Project of Jiangsu Province, China with
   the grant no. BY2010143. The authors thank BianShanshan of the School of
   Chemistry and Chemical Engineering, Fudan University for her help in
   titration tests.
CR Adams N, 2007, ADV DRUG DELIVER REV, V59, P1504, DOI 10.1016/j.addr.2007.08.018
   Antonio L. A., 2002, J BIOMED MATER RES, V63, P319
   Brian T., 1999, OPTICIA, V218, P31
   Cha C, 2010, BIOMATERIALS, V31, P4864, DOI 10.1016/j.biomaterials.2010.02.059
   Chen H, 1999, J APPL POLYM SCI, V72, P1699, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1699::AID-APP6>3.0.CO;2-9
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   CHUJO Y, 1990, MACROMOLECULES, V23, P2693, DOI 10.1021/ma00212a017
   David G, 2008, BIOMACROMOLECULES, V9, P1678, DOI 10.1021/bm800215d
   GODDARD P, 1989, Journal of Controlled Release, V10, P5, DOI 10.1016/0168-3659(89)90013-8
   Guo DJ, 2005, LANGMUIR, V21, P10487, DOI 10.1021/la0514866
   Guo DJ, 2007, COLLOID SURFACE A, V308, P129, DOI 10.1016/j.colsurfa.2007.05.080
   Hoogenboom R, 2009, ANGEW CHEM INT EDIT, V48, P7978, DOI 10.1002/anie.200901607
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   Keogh P., 1981, U. S. Pat., Patent No. [4,260,725, 4260725]
   Kim J, 2008, BIOMATERIALS, V29, P2259, DOI 10.1016/j.biomaterials.2008.01.030
   Konradi R, 2008, LANGMUIR, V24, P613, DOI 10.1021/la702917z
   KUNZLER J, 1995, J APPL POLYM SCI, V55, P611, DOI 10.1002/app.1995.070550408
   LAI YC, 1997, J APPL POLYM SCI, V66, P1475
   Lawton RA, 2005, COLLOID SURFACE A, V253, P213, DOI 10.1016/j.colsurfa.2004.11.010
   Lemechko P, 2012, REACT FUNCT POLYM, V72, P160, DOI 10.1016/j.reactfunctpolym.2011.12.005
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Nicolson P. C., 1998, Patent No. [US5760100, 5760100]
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Read ML, 2009, J BIOMED MATER RES B, V91B, P662, DOI 10.1002/jbm.b.31442
   Simpson TRE, 2003, POLYMER, V44, P4829, DOI 10.1016/S0032-3861(03)00496-8
   Tanaka K., 1979, US patent, Patent No. 4139548
   Viegas TX, 2011, BIOCONJUGATE CHEM, V22, P976, DOI 10.1021/bc200049d
   Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011
   Zhou J., 2008, [No title captured], Patent No. [WO 2008/116,131, 2008116131]
NR 30
TC 1
Z9 1
U1 5
U2 81
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 5
PY 2014
VL 131
IS 3
AR 39867
DI 10.1002/app.39867
PG 7
WC Polymer Science
SC Polymer Science
GA AA7TX
UT WOS:000331300900072
DA 2018-10-19
ER

PT J
AU Soares, LGP
   Marques, AMC
   Guarda, MG
   Aciole, JMS
   dos Santos, JN
   Pinheiro, ALB
AF Soares, Luiz Guilherme P.
   Marques, Aparecida Maria C.
   Guarda, Milena G.
   Aciole, Jouber Mateus S.
   dos Santos, Jean Nunes
   Pinheiro, Antonio Luiz B.
TI Influence of the lambda 780 nm laser light on the repair of surgical
   bone defects grafted or not with biphasic synthetic micro-granular
   hydroxylapatite plus Beta-Calcium triphosphate
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Biomaterial; Bone repair; Hydroxyapatite; Laser phototherapy
ID MINERAL TRIOXIDE AGGREGATE; MORPHOGENETIC PROTEINS; RODENT MODEL;
   IN-VIVO; REGENERATION; PHOTOBIOMODULATION; PHOTOTHERAPY; HYDROXYAPATITE;
   IMPLANTS; THERAPY
AB The treatment of bone loss due to different etiologic factors is difficult and many techniques aim to improve repair, including a wide range of biomaterials and, recently, photobioengineering. This work aimed to assess, through histological analysis The aim of this study was to assess, by light microscopy, the repair of bone defects grafted or not with biphasic synthetic micro-granular Calcium hydroxyapatite (HA) + Beta-TCP associated or not with Laser phototherapy - LPT (lambda 780 nm). Forty rats were divided into 4 groups each subdivided into 2 subgroups according to the time of sacrifice (15 and 30 days). Surgical bone defects were made on femur of each animal with a trephine drill. On animals of Clot group the defect was filled only by blood clot, on Laser group the defect filled with the clot was further irradiated. On animals of Biomaterial and Laser + Biomaterial groups the defect was filled by biomaterial and the last one was further irradiated (2780 nm, 70 mW, spot size similar to 0.4 cm(2), 20 J/cm(2)-session, 140 J/cm(2)-treatment) in four points around the defect at 48-h intervals and repeated for 2 weeks. At both 15th and 30th days following sacrifice, samples were taken and analyzed by light microscopy. Many similarities were observed histologically between groups on regards bone reabsorption and neoformation, inflammatory infiltrate and collagen deposition. The criterion degree of maturation, marked by the presence of basophilic lines, indicated that the use of LPT associated with HA + Beta TCP graft, resulted in more advanced stage of bone repair at the end of the experiment. (C) 2014 Elsevier B.V. All rights reserved.
C1 [Soares, Luiz Guilherme P.; Marques, Aparecida Maria C.; Guarda, Milena G.; Aciole, Jouber Mateus S.; Pinheiro, Antonio Luiz B.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Marques, Aparecida Maria C.; Pinheiro, Antonio Luiz B.] Univ Sao Paulo, Natl Inst Opt & Photon, Phys Inst Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Pinheiro, Antonio Luiz B.] Univ Camilo Castelo Branco, Nucleo Parque Tecnol Sao Jose Campos, BR-12247004 Sao Jose Dos Campos, SP, Brazil.
   [dos Santos, Jean Nunes] Univ Fed Bahia, Lab Surg Pathol, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, Av Araujo Pinho 62, BR-40110150 Salvador, BA, Brazil.
EM luizguilherme_@hotmail.com; cidamarques77@hotmail.com;
   mileguarda@hotmail.com; jouber_aciole@hotmail.com; jeanpatol@gmail.com;
   albp@ufba.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; Pinheiro, Antonio
   Luiz/A-1962-2008
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX We would like to thank the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq) for providing financial support for this
   project.
CR Bossini P., 2011, J TISSUE ENG REGEN M, V12, P52
   Franco GR, 2013, INJURY, V44, P908, DOI 10.1016/j.injury.2012.12.022
   Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   Guzzardella GA, 2003, CLIN ORAL IMPLAN RES, V14, P226, DOI 10.1034/j.1600-0501.2003.00872.x
   KEAVENY TM, 1993, BONE, V7, P285
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Mate-Sanchez V.J.E., 2013, J BIOMED MATER RES A, DOI DOI 10.1002/JBM.A34785
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Oliveira Poliani de, 2012, Rev Bras Ortop, V47, P102, DOI 10.1016/S2255-4971(15)30352-9
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2013, LASER MED SCI, V28, P513, DOI 10.1007/s10103-012-1096-1
   Pinheiro ALB, 2012, LASER MED SCI, V27, P1013, DOI 10.1007/s10103-011-1033-8
   Pinheiro ALB, 2012, LASER MED SCI, V27, P903, DOI 10.1007/s10103-011-1010-2
   Pinheiro ALB, 2011, J BIOMED MATER RES A, V98A, P212, DOI 10.1002/jbm.a.33107
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinto K.N., 2013, PHOTOMED LASER SURG, V31, P260
   Rouvillain JL, 2009, KNEE, V16, P392, DOI 10.1016/j.knee.2008.12.015
   Soares LGP, 2014, LASER MED SCI, V29, P1539, DOI 10.1007/s10103-013-1297-2
   Soares Luiz Guilherme P., 2013, Braz. Dent. J., V24, P218, DOI 10.1590/0103-6440201302186
   Tim CR, 2014, LASER MED SCI, V29, P147, DOI 10.1007/s10103-013-1302-9
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Yang C, 2014, J BIOMED MATER RES B, V102, P80, DOI 10.1002/jbm.b.32984
NR 28
TC 8
Z9 10
U1 0
U2 7
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD FEB 5
PY 2014
VL 131
BP 16
EP 23
DI 10.1016/j.jphotobiol.2013.12.015
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA AE2GA
UT WOS:000333790100002
PM 24463564
DA 2018-10-19
ER

PT J
AU Karacali, O
AF Karacali, O.
TI A Research on Structured Analysis of Biomaterial of Dental Implant in
   Computer Aided Biomechanical Engineering Modelling
SO ACTA PHYSICA POLONICA A
LA English
DT Article; Proceedings Paper
CT 3rd International Congress on Advances in Applied Physics and Materials
   Science
CY APR 24-28, 2013
CL Antalya, TURKEY
SP Doga Nanobiotech Inc, Mega Technol Serv Inc
ID BEHAVIOR
AB The research explained in this paper is about the mechanical principle applications on regulated form and function, forces, motion of teeth and dental implant influencing the implant length and bone quality in biomechanics engineering modeling in dentistry. The non-linear finite element method was employed as an advanced computer technique of structural stress analysis tool for biomechanics modeling using mechanical, mathematical, and biological definitions and concepts. A finite element model of dental implant with accurate geometry and material properties was developed to make realistic investigations on the implant biomaterial properties and mechanical behavior of new dental implant. The finite element models with non-linear contact elements were used to simulate an interface fixation within the implant system and the sliding function of the non-rigid connector. This research showed that implant design influences force transmission characteristics in pen-implant bone and mechanical signals affect bone tissue differentiation. Hence, it is important to control biomechanical loads on dental implants to maintain osseointegration and to promote early bone implant interface healing. The results of this analysis are helpful for implant biomaterial selection and design for clinical interest.
C1 Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
RP Karacali, O (reprint author), Istanbul Univ, Fac Engn, Dept Mech Engn, TR-34320 Istanbul, Turkey.
EM ozdogank@istanbul.edu.tr
RI Karacali, Ozdogan/A-8869-2015
CR [Anonymous], 2013, ANSYS MAN
   Bozkaya D, 2003, J BIOMECH, V36, P1649, DOI 10.1016/S0021-9290(03)00177-5
   Demenko V, 2011, J DENT RES, V90, P1211, DOI 10.1177/0022034511417442
   Deshmukh TR, 2012, COMPUT METHOD BIOMEC, V15, P363, DOI 10.1080/10255842.2010.538385
   Freitas A.C., 2010, IMPLANT DENT, V19, P6
   Jonsdottir SH, 2012, EUR J ORTHODONT, V34, P542, DOI 10.1093/ejo/cjq186
   Koka Pradeep, 2012, Indian J Dent Res, V23, P129, DOI 10.4103/0970-9290.100413
   Tsui WK, 2012, INT J ORAL MAX SURG, V41, P1427, DOI 10.1016/j.ijom.2012.05.011
   Wang RF, 2009, J PROSTHET DENT, V101, P359, DOI 10.1016/S0022-3913(09)60079-2
   Ziegler A, 2005, EUR J ORTHODONT, V27, P333, DOI 10.1093/ejo/cji020
NR 10
TC 0
Z9 0
U1 0
U2 7
PU POLISH ACAD SCIENCES INST PHYSICS
PI WARSAW
PA AL LOTNIKOW 32-46, PL-02-668 WARSAW, POLAND
SN 0587-4246
EI 1898-794X
J9 ACTA PHYS POL A
JI Acta Phys. Pol. A
PD FEB
PY 2014
VL 125
IS 2
BP 186
EP 188
DI 10.12693/APhysPolA.125.186
PG 3
WC Physics, Multidisciplinary
SC Physics
GA AM4LG
UT WOS:000339825400007
OA Bronze
DA 2018-10-19
ER

PT J
AU Misra, RDK
   Nune, C
AF Misra, R. D. K.
   Nune, C.
TI Biological response to self-assembly of preadsorbed proteins at
   biointerfaces: significance, cellular activity and perspective
SO MATERIALS TECHNOLOGY
LA English
DT Article
DE Grain size; Protein adsorption; Osteoblast functions
ID INDUCED STRUCTURAL-CHANGES; ADSORPTION; SURFACES; METAL; INTERFACE;
   TITANIUM; ADHESION; PLASMA; CELLS; SPECTROSCOPY
AB Protein adsorption is the first of a complex series of events that regulate cell adhesion and cellular activity and define the hallmark of biological reactions at the biointerface. In this regard, materials with submicrometre to nanometre sized grains by virtue of their high grain boundary length to grain size ratio are excellent vehicles to fundamentally understand self-assembly of preadsorbed proteins and consequent cellular activity. The model protein (albumin) on a nanograined surface had the resemblance of 'leaf-like' in contrast to 'bare branch of a tree' on the coarse grained counterpart with consequent impact on biological functions, for instance, osteoblast response. This raises a fundamental question on the interplay between grain size and surface induced arrangement of plasma proteins into organised structures. It is envisaged that in a given polycrystalline material, the self-assembly of proteins at a biointerface is governed by grain structure because of differences in surface energy and microrheological behaviour that controls the kinetics and thermodynamics of protein adsorption. Furthermore, our capability to synthesise and process biomaterial surfaces with tailored surface morphology and consequently control assembly of proteins provides the possibility of eliciting specific, timely and desirable response from the surrounding cells and tissues necessary for implant efficiency. Studies on the early stages of protein adsorption are expected to impact interfacial processes including neurobiology, where the assembly of soluble proteins as organised structure is potentially considered to be characteristic of neurodegenerative diseases such as Parkinson's and Alzheimer's disease. This is particularly important when the most important relaxation mechanisms such as desorption and conformational changes alter adsorption and are impacted by grain structure and associated surface energy.
C1 [Misra, R. D. K.; Nune, C.] Univ Louisiana Lafayette, Inst Mat Res & Innovat, Ctr Struct & Funct Mat, Biomats & Biomed Engn Res Lab, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ Louisiana Lafayette, Inst Mat Res & Innovat, Ctr Struct & Funct Mat, Biomats & Biomed Engn Res Lab, POB 44130, Lafayette, LA 70504 USA.
EM rdm6853@louisiana.edu
FU Center for Structural and Functional Materials, Institute for Materials
   Research and Innovation, University of Louisiana at Lafayette, USA
FX The authors acknowledge support from the Center for Structural and
   Functional Materials, Institute for Materials Research and Innovation,
   University of Louisiana at Lafayette, USA.
CR ALBREKTSSON T, 1987, J PROSTHET DENT, V57, P597, DOI 10.1016/0022-3913(87)90344-1
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Arenas MA, 2000, BRIT CORROS J, V35, P232, DOI 10.1179/000705900101501308
   Baier RE, 1975, APPL CHEM PROTEIN IN
   Bantchev GB, 2003, LANGMUIR, V19, P2673, DOI 10.1021/la0262349
   Blomback B, 1976, PLASMA PROTEINS, P43
   Borsari V, 2005, J BIOMED MATER RES B, V75B, P359, DOI 10.1002/jbm.b.30313
   Brash J. L., 1975, PROTEIN INTERFACES P
   BRASH JL, 1995, PROTEINS INTERFACES, P1
   Caren DT, 1997, LANGMUIR, V13, P3404
   Caruso F, 1997, J COLLOID INTERF SCI, V186, P129, DOI 10.1006/jcis.1996.4625
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   COLLIS JJ, 1992, BIOMATERIALS, V13, P548, DOI 10.1016/0142-9612(92)90107-Y
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   Dhar P, 2006, NANO LETT, V6, P66, DOI 10.1021/nl052027s
   Dhar P, 2007, J PHYS CHEM C, V111, P3607, DOI 10.1021/jp067304d
   ELLINGSEN JE, 1991, BIOMATERIALS, V12, P593, DOI 10.1016/0142-9612(91)90057-H
   Fischer TM, 2004, J FLUID MECH, V498, P123, DOI 10.1017/S0022112003006608
   FU FN, 1994, APPL SPECTROSC, V48, P1432, DOI 10.1366/0003702944028065
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   Grinnell F, 1983, BIOCOMPATIBLE POLYM, P674
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Horbett T. A., 1982, BIOMATERIALS INTERFA
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Hornett T. A., 1996, INTERFACIAL PHENOMEN, P351
   Kasemo B., 1999, ADV DENT RES, V13, P1
   LINDON JN, 1986, BLOOD, V68, P355
   Marchin KL, 2003, LANGMUIR, V19, P9883, DOI 10.1021/la035127r
   MAROUDAS NG, 1977, J CELL PHYSIOL, V90, P511, DOI 10.1002/jcp.1040900314
   Misra RDK, 2013, ACTA BIOMATER, V9, P6245, DOI 10.1016/j.actbio.2012.12.003
   Misra RDK, 2012, METALL MATER TRANS A, V43A, P5286, DOI 10.1007/s11661-012-1360-9
   MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042
   Prasad V, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176001
   Rechenddorff K., 2006, THESIS U AARHUS AARH
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   Slack S. M., 1996, BIOMATERIALS SCI INT, P469
   VROMAN L, 1986, J COLLOID INTERF SCI, V111, P391, DOI 10.1016/0021-9797(86)90042-1
   Williams DF, 1981, BIOCOMPATIBILITY CLI
   WILLIAMS RL, 1988, BIOMATERIALS, V9, P206, DOI 10.1016/0142-9612(88)90085-3
   Willmann G, 1999, ADV ENG MATER, V1, P95
   Wu YQ, 2002, APPL SPECTROSC, V56, P1186, DOI 10.1366/000370202760295449
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Yunzhi Y., 2003, J BIOMED MATER RES A, V67A, P344
NR 43
TC 6
Z9 6
U1 0
U2 11
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1066-7857
EI 1753-5557
J9 MATER TECHNOL
JI Mater. Technol.
PD FEB
PY 2014
VL 29
IS B1
SI SI
BP B41
EP B48
DI 10.1179/1753555713Y.0000000110
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AI8EV
UT WOS:000337141500009
DA 2018-10-19
ER

PT J
AU Trinidad, J
   Marco, I
   Arruebarrena, G
   Wendt, J
   Letzig, D
   de Argandona, E
   Goodall, R
AF Trinidad, Javier
   Marco, Inigo
   Arruebarrena, Gurutze
   Wendt, Joachim
   Letzig, Dietmar
   Saenz de Argandona, Eneko
   Goodall, Russell
TI Processing of Magnesium Porous Structures by Infiltration Casting for
   Biomedical Applications
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID CORRODING TUNGSTEN COILS; IN-VIVO CORROSION; FE-MN ALLOYS; VITRO; BONE;
   DEGRADATION; SCAFFOLDS; MG; BIOCOMPATIBILITY; BIOMATERIALS
AB Magnesium and its alloys are currently considered to be a promising metallic biomaterial. The interest in magnesium alloys arises from their biocompatibility, bioabsorbility, and especially from their mechanical properties, which are more compatible to those of human bone than the mechanical properties of other metallic biomaterials, such as stainless steel and titanium. A medical application in which magnesium is gaining interest is regenerative medicine where scaffolds are used to create tissues from cells. For its application in regenerative medicine, the scaffolds have to present a 3D open-cell structure. The main purpose of the present research is to set up the fabrication procedure necessary to manufacture porous magnesium scaffolds; for this the replication (infiltration) process has been used and adapted to process magnesium alloys, processing five different biodegradable magnesium alloys (AZ91E, WE43, ZM20, ZWM200, and ZXM200).
C1 [Trinidad, Javier; Marco, Inigo; Arruebarrena, Gurutze] Mondragon Unibertsitatea, Mech & Mfg Dept, Arrasate Mondragon, Spain.
   [Marco, Inigo; Goodall, Russell] Univ Sheffield, Dept Mat Sci & Engn, Sheffield S1 3JD, S Yorkshire, England.
   [Trinidad, Javier; Letzig, Dietmar] Helmholtz Zentrum Geesthacht, Magnesium Innovat Ctr, D-21502 Geesthacht, Germany.
RP Trinidad, J (reprint author), Mondragon Unibertsitatea, Mech & Mfg Dept, Loramendi 4, Arrasate Mondragon, Spain.
EM jtrinidad@mondragon.edu
OI Wendt, Joachim/0000-0002-6015-0794
FU Department of Industry, Innovation, Trade and Tourism of the Basque
   Government [S-PE12MU012]
FX This work was supported by the Department of Industry, Innovation, Trade
   and Tourism of the Basque Government through the S-PE12MU012 project.
CR ARANDA P, 2000, ARS PHARM, V41, P91
   Bach F. W., 2003, CELLULAR METALS MANU, P215
   Conde Y, 2006, ADV ENG MATER, V8, P795, DOI 10.1002/adem.200600077
   Currey J., 1998, HDB BIOMATERIALS PRO, pA1
   European Technology Platform, 2006, NAN NAN HLTH STRAT R
   Gibson LJ, 1997, CAMBRIDGE SOLID STAT
   Goodall R., 2013, PHYS METALLURGY
   Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Gums JG, 2004, AM J HEALTH-SYST PH, V61, P1569
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hermawan H, 2010, ACTA BIOMATER, V6, P1852, DOI 10.1016/j.actbio.2009.11.025
   Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Iannello S, 2001, PANMINERVA MED, V43, P177
   Jamesh M, 2011, CORROS SCI, V53, P645, DOI 10.1016/j.corsci.2010.10.011
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Keaveny TM, 1998, HDB BIOMATERIALS PRO, pA2
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lu H, 2007, KEY ENG MATER, V330-332, P1185, DOI 10.4028/www.scientific.net/KEM.330-332.1185
   Peng QM, 2010, BIOMATERIALS, V31, P398, DOI 10.1016/j.biomaterials.2009.09.065
   Peuster M, 2003, BIOMATERIALS, V24, P4057, DOI 10.1016/S0142-9612(03)00274-6
   Peuster M, 2003, J BIOMED MATER RES B, V65B, P211, DOI 10.1002/jbm.b.10561
   Peuster M, 2003, BIOMATERIALS, V24, P393, DOI 10.1016/S0142-9612(02)00352-6
   Singer R. F., 2005, CELLULAR METALS POLY, P77
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan CE, 2000, MATER SCI FORUM, V350-3, P359, DOI 10.4028/www.scientific.net/MSF.350-351.359
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wen GW, 2007, KEY ENG MATER, V330-332, P971, DOI 10.4028/www.scientific.net/KEM.330-332.971
   Witte F, 2007, J BIOMED MATER RES A, V81A, P757, DOI 10.1002/jbm.a.31293
   Witte F, 2007, J BIOMED MATER RES A, V81A, P748, DOI 10.1002/jbm.a.31170
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Wu CT, 2007, J MATER SCI-MATER M, V18, P857, DOI [10.1007/s10856-006-0083-0, 10.1007/S10856-006-0083-0]
   Yamada Y, 1999, J MATER SCI LETT, V18, P1477, DOI 10.1023/A:1006677930532
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
NR 40
TC 15
Z9 17
U1 4
U2 32
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD FEB
PY 2014
VL 16
IS 2
BP 241
EP 247
DI 10.1002/adem.201300236
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB7JE
UT WOS:000331965000017
DA 2018-10-19
ER

PT J
AU Wang, XH
   Schroder, HC
   Grebenjuk, V
   Diehl-Seifert, B
   Mailander, V
   Steffen, R
   Schlossmacher, U
   Muller, WEG
AF Wang, Xiaohong
   Schroeder, Heinz C.
   Grebenjuk, Vladislav
   Diehl-Seifert, Baerbel
   Mailaender, Volker
   Steffen, Renate
   Schlossmacher, Ute
   Mueller, Werner E. G.
TI The Marine Sponge-Derived Inorganic Polymers, Biosilica and
   Polyphosphate, as Morphogenetically Active Matrices/Scaffolds for the
   Differentiation of Human Multipotent Stromal Cells: Potential
   Application in 3D Printing and Distraction Osteogenesis
SO MARINE DRUGS
LA English
DT Article
DE biosilica; polyphosphate; multipotent stromal cells; mesenchymal stem
   cells; alkaline phosphatase; 3D cell/tissue printing; distraction
   osteogenesis
AB The two marine inorganic polymers, biosilica (BS), enzymatically synthesized from ortho-silicate, and polyphosphate (polyP), a likewise enzymatically synthesized polymer consisting of 10 to > 100 phosphate residues linked by high-energy phosphoanhydride bonds, have previously been shown to display a morphogenetic effect on osteoblasts. In the present study, the effect of these polymers on the differential differentiation of human multipotent stromal cells (hMSC), mesenchymal stem cells, that had been encapsulated into beads of the biocompatible plant polymer alginate, was studied. The differentiation of the hMSCs in the alginate beads was directed either to the osteogenic cell lineage by exposure to an osteogenic medium (mineralization activation cocktail; differentiation into osteoblasts) or to the chondrogenic cell lineage by incubating in chondrocyte differentiation medium (triggering chondrocyte maturation). Both biosilica and polyP, applied as Ca2+ salts, were found to induce an increased mineralization in osteogenic cells; these inorganic polymers display also morphogenetic potential. The effects were substantiated by gene expression studies, which revealed that biosilica and polyP strongly and significantly increase the expression of bone morphogenetic protein 2 (BMP-2) and alkaline phosphatase (ALP) in osteogenic cells, which was significantly more pronounced in osteogenic versus chondrogenic cells. A differential effect of the two polymers was seen on the expression of the two collagen types, I and II. While collagen Type I is highly expressed in osteogenic cells, but not in chondrogenic cells after exposure to biosilica or polyP, the upregulation of the steady-state level of collagen Type II transcripts in chondrogenic cells is comparably stronger than in osteogenic cells. It is concluded that the two polymers, biosilica and polyP, are morphogenetically active additives for the otherwise biologically inert alginate polymer. It is proposed that alginate, supplemented with polyP and/or biosilica, is a suitable biomaterial that promotes the growth and differentiation of hMSCs and might be beneficial for application in 3D tissue printing of hMSCs and for the delivery of hMSCs in fractures, surgically created during distraction osteogenesis.
C1 [Wang, Xiaohong; Schroeder, Heinz C.; Grebenjuk, Vladislav; Steffen, Renate; Schlossmacher, Ute; Mueller, Werner E. G.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, D-55128 Mainz, Germany.
   [Diehl-Seifert, Baerbel] NanotecMARIN GmbH, D-55128 Mainz, Germany.
   [Mailaender, Volker] Max Planck Inst Polymer Res, D-55129 Mainz, Germany.
   [Mailaender, Volker] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Med Clin, D-55131 Mainz, Germany.
RP Wang, XH (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Investigator Grant Res Grp, Duesbergweg 6, D-55128 Mainz, Germany.
EM wang013@uni-mainz.de; hschroed@uni-mainz.de; grebenyu@uni-mainz.de;
   helmut-baerbel.Seifert@t-online.de; volker.mailaender@mpip-mainz.mpg.de;
   steffen@uni-mainz.de; schlossm@uni-mainz.de; wmueller@uni-mainz.de
RI Mailander, Volker/H-3589-2012
OI Mailander, Volker/0000-0001-6583-8136
FU ERC [268476 BIOSILICA, 324564]; European Commission [311848,
   FP7-KBBE-2010-4-266033, PIRSES-GA-2009-246987]; International Human
   Frontier Science Program; German Bundesministerium fur Bildung und
   Forschung; International Bureau (German-Chinese Joint Lab on
   Bio-Nano-Composites) [CHN 09/1AP]; BiomaTiCS research initiative of the
   University Medical Center, Mainz
FX We thank Sandra Ritz (Max-Planck-Institute for Polymer Research, Mainz,
   Germany) for supplying us with the hMSCs, as well as for introducing us
   to the technique of stem cell cultivation. W. E. G. M. is a holder of an
   ERC Advanced Investigator Grant (no. 268476 BIOSILICA), as well as of an
   ERC proof-of-concept grant (no. 324564; Silica-based nanobiomedical
   approaches for treatment of bone diseases). This work was supported by
   grants from the European Commission (no. 311848 "SPECIAL", and
   large-scale integrating project no. FP7-KBBE-2010-4-266033 "BlueGenics",
   as well as European-Chinese Research Staff Exchange Cluster
   PIRSES-GA-2009-246987 "MarBioTec* EU-CN*"), the International Human
   Frontier Science Program, the German Bundesministerium fur Bildung und
   Forschung, International Bureau (no. CHN 09/1AP, German-Chinese Joint
   Lab on Bio-Nano-Composites), and the BiomaTiCS research initiative of
   the University Medical Center, Mainz.
NR 0
TC 27
Z9 29
U1 2
U2 51
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD FEB
PY 2014
VL 12
IS 2
BP 1131
EP 1147
DI 10.3390/md12021131
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA AG9NC
UT WOS:000335745100032
PM 24566262
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Grunert, P
   Borde, BH
   Hudson, KD
   Macielak, MR
   Bonassar, LJ
   Haartl, R
AF Grunert, Peter
   Borde, Brandon H.
   Hudson, Katherine D.
   Macielak, Michael R.
   Bonassar, Lawrence J.
   Haetl, Roger
TI Annular Repair Using High-Density Collagen Gel
SO SPINE
LA English
DT Article
DE annular repair; intervertebral disc; high-density collagen; disc
   reherniation; disc degeneration; riboflavin cross-linking; needle
   puncture; rat-tail model; T2-relaxation time; animal model
ID INTERVERTEBRAL DISC DEGENERATION; CROSS-LINKING; LUMBAR DISKECTOMY;
   ANULAR DEFECT; FIBROSUS; MODEL; REGENERATION; DEGRADATION; PROGRESSION;
   RIBOFLAVIN
AB Study Design. Animal in vivo study.
   Objective. To test the capability of high-density collagen gel to repair annular defects.
   Summary of Background Data. Annular defects are associated with spontaneous disc herniations and disc degeneration, which can lead to significant morbidity. Persistent annular defects after surgical discectomies can increase reherniation rates. Several synthetic and biological materials have been developed for annular repair. This is the first study to test an injectable biomaterial in vivo.
   Methods. We punctured caudal intervertebral discs in 42 athymic rats, using an 18-gauge needle to create an annular defect. High-density collagen (HDC), either alone or cross-linked with riboflavin (RF), was injected into the defect. There were 4 separate study groups: HDC, HDC cross-linked with either 0.25 mM RF or 0.50 mM RF, and a negative control that was punctured and not treated. The animals were followed for 5 weeks; radiographs were used to assess disc heights and magnetic resonance images were used to evaluate degenerative changes. We developed an algorithm on the basis of T2-relaxation time measurements to assess the size of the nucleus pulposus. Tails were collected for histological analysis to evaluate disc degeneration and measure the cross-sectional area of the nucleus pulposus.
   Results. After 5 weeks, the control and the uncross-linked HDC groups both showed signs of progressive degenerative changes with minimal or no residual nucleus pulposus tissue in the disc space. Cross-linking significantly improved the ability of HDC gels to repair annular defects. The 0.50 mM RF cross-linked group showed only a slight decrease in nuclear tissue when compared with healthy discs, with no signs of intervertebral disc (IVD) degeneration. The annulus fibrosus was partially repaired by a fibrous cap that bridged the defect. Host fibroblasts infiltrated and remodeled the injected collagen.
   Conclusion. HDC is capable of repairing annular defects induced by needle puncture. The stiffness of HDC can be modified by riboflavin cross-linking and seems to positively affect the repair mechanism. These results need to be replicated in a larger animal model.
C1 [Grunert, Peter; Macielak, Michael R.; Haetl, Roger] Weill Cornell Med Coll, Weill Cornell Brain & Spine Inst, Dept Neurol Surg, New York, NY USA.
   [Borde, Brandon H.; Hudson, Katherine D.; Bonassar, Lawrence J.] Cornell Univ, Dept Biomed Engn, Ithaca, NY USA.
   [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Haartl, R (reprint author), New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol Surg, 525 East 68th St,Box 99, New York, NY 10065 USA.
EM roger@hartlmd.net
RI Bonassar, Lawrence/C-2103-2016
OI Bonassar, Lawrence/0000-0003-1094-6433
FU AO Research Fund [F-08-10B]; AOSpine International Hansjorg Wyss Focus
   Award; NFL Medical Charities
FX AO Research Fund grant F-08-10B, the AOSpine International Hansjorg Wyss
   Focus Award 2010, and a grant from NFL Medical Charities funds were
   received to support this work.
CR Ambrossi GLG, 2009, NEUROSURGERY, V65, P574, DOI 10.1227/01.NEU.0000350224.36213.F9
   Borde B.H., 2012, ORTH RES SOC ANN M S
   Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI 10.1089/ten.TEA.2009.0442
   Bron JL, 2010, EUR SPINE J, V19, P1347, DOI 10.1007/s00586-010-1384-z
   Bron J, 2009, EUR SPINE J, V18, P301, DOI 10.1007/s00586-008-0856-x
   Carragee EJ, 2006, SPINE, V31, P653, DOI 10.1097/01.brs.0000203714.76250.68
   Carragee EJ, 2003, J BONE JOINT SURG AM, V85A, P102, DOI 10.2106/00004623-200301000-00016
   Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432
   Cheng NC, 2013, TISSUE ENG PT A, V19, P484, DOI [10.1089/ten.tea.2012.0384, 10.1089/ten.TEA.2012.0384]
   Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072
   Fazzalari NL, 2001, SPINE, V26, P2575, DOI 10.1097/00007632-200112010-00010
   GUIDRY C, 1985, J CELL SCI, V79, P67
   Gullung Gregory B, 2011, Evid Based Spine Care J, V2, P13, DOI 10.1055/s-0031-1274752
   HAMPTON D, 1989, SPINE, V14, P398, DOI 10.1097/00007632-198904000-00009
   Han B, 2008, SPINE, V33, P1925, DOI 10.1097/BRS.0b013e31817c64a9
   Harriger MD, 1997, J BIOMED MATER RES, V35, P137, DOI 10.1002/(SICI)1097-4636(199705)35:2<137::AID-JBM1>3.0.CO;2-O
   Hashemi H, 2013, OPHTHALMOLOGY, V120, P1515, DOI 10.1016/j.ophtha.2013.01.012
   Jarman-Smith ML, 2004, J MATER SCI-MATER M, V15, P925, DOI 10.1023/B:JMSM.0000036281.47596.cc
   Keorochana G, 2010, SPINE J, V10, P1014, DOI 10.1016/j.spinee.2010.08.013
   Lebow RL, 2011, SPINE, V36, P2147, DOI 10.1097/BRS.0b013e3182054595
   Ledet EH, 2009, SPINE, V34, P1457, DOI 10.1097/BRS.0b013e3181a48554
   Lu DS, 1997, SPINE, V22, P1828, DOI 10.1097/00007632-199708150-00006
   Lu DS, 1997, SPINE, V22, P34
   McGirt MJ, 2009, SPINE, V34, P2044, DOI 10.1097/BRS.0b013e3181b34a9a
   Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z
   Schek RM, 2011, EUR CELLS MATER, V21, P373, DOI 10.22203/eCM.v021a28
   Sheikh H, 2009, J NEUROSURG-SPINE, V10, P265, DOI 10.3171/2008.12.SPINE0835
   Staskowski PA, 1998, OTOLARYNG HEAD NECK, V118, P187, DOI 10.1016/S0194-5998(98)80010-7
   Stewart JM, 2009, INVEST OPHTH VIS SCI, V50, P1606, DOI 10.1167/iovs.08-2727
   Tirella A, 2012, MATER LETT, V74, P58, DOI 10.1016/j.matlet.2012.01.036
   Vadala G, 2012, EUR SPINE J, V21, pS20, DOI 10.1007/s00586-012-2235-x
   Yu LP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048074
   Zhang HN, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2861
   Zou F, 2013, MOL MED REP, V8, P118, DOI 10.3892/mmr.2013.1450
NR 34
TC 19
Z9 21
U1 3
U2 13
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0362-2436
EI 1528-1159
J9 SPINE
JI SPINE
PD FEB 1
PY 2014
VL 39
IS 3
BP 198
EP 206
DI 10.1097/BRS.0000000000000103
PG 9
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA AH5ZZ
UT WOS:000336211800017
PM 24253790
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Capasso, C
   Garofalo, M
   Hirvinen, M
   Cerullo, V
AF Capasso, Cristian
   Garofalo, Mariangela
   Hirvinen, Mari
   Cerullo, Vincenzo
TI The Evolution of Adenoviral Vectors through Genetic and Chemical Surface
   Modifications
SO VIRUSES-BASEL
LA English
DT Review
DE gene therapy; adenoviral vectors; genetic modification; chimeric fibers;
   surface modification; pseudotyping; polymers; immunogenicity;
   re-targeting
ID INNATE IMMUNE-RESPONSE; POLYETHYLENE-GLYCOL MODIFICATION; COMPLEMENT
   REGULATORY PROTEINS; HELPER-DEPENDENT ADENOVIRUS; POLYMER-COATED
   ADENOVIRUS; REFRACTORY SOLID TUMORS; GROWTH-FACTOR RECEPTOR; IN-VIVO;
   ONCOLYTIC ADENOVIRUS; RECOMBINANT ADENOVIRUS
AB A long time has passed since the first clinical trial with adenoviral (Ad) vectors. Despite being very promising, Ad vectors soon revealed their limitations in human clinical trials. The pre-existing immunity, the marked liver tropism and the high toxicity of first generation Ad (FG-Ad) vectors have been the main challenges for the development of new approaches. Significant effort toward the development of genetically and chemically modified adenoviral vectors has enabled researchers to create more sophisticated vectors for gene therapy, with an improved safety profile and a higher transduction ability of different tissues. In this review, we will describe the latest findings in the high-speed, evolving field of genetic and chemical modifications of adenoviral vectors, a field in which different disciplines, such as biomaterial research, virology and immunology, co-operate synergistically to create better gene therapy tools for modern challenges.
C1 [Capasso, Cristian; Hirvinen, Mari; Cerullo, Vincenzo] Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Helsinki 00790, Finland.
   [Garofalo, Mariangela] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, I-80131 Naples, Italy.
RP Cerullo, V (reprint author), Univ Helsinki, Fac Pharm, Div Pharmaceut Biosci & CDR, Lab Immunovirotherapy,Bioctr 2, Viikinkaari 5, Helsinki 00790, Finland.
EM cristian.capasso@helsinki.fi; mariangela.garofalo@helsinki.fi;
   mari.hirvinen@helsinki.fi; vincenzo.cerullo@helsinki.fi
RI Garofalo, Mariangela/Q-9469-2018
OI Garofalo, Mariangela/0000-0002-5001-7826; Cerullo,
   Vincenzo/0000-0003-4901-3796
CR Ahn CH, 2004, J CONTROL RELEASE, V97, P567, DOI 10.1016/j.jconrel.2004.04.002
   Alba R, 2012, GENE THER, V19, P109, DOI 10.1038/gt.2011.87
   Alba R, 2010, BLOOD, V116, P2656, DOI 10.1182/blood-2009-12-260026
   Alba R, 2009, BLOOD, V114, P965, DOI 10.1182/blood-2009-03-208835
   Appledorn DM, 2008, GENE THER, V15, P1606, DOI 10.1038/gt.2008.114
   Bayo-Puxan N, 2006, J GEN VIROL, V87, P2487, DOI 10.1099/vir.0.81889-0
   Belousova N, 2008, J VIROL, V82, P630, DOI 10.1128/JVI.01896-07
   Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320
   Black PC, 2007, UROL ONCOL-SEMIN ORI, V25, P433, DOI 10.1016/j.urolonc.2007.05.011
   Bonsted A, 2006, J GENE MED, V8, P286, DOI 10.1002/jgm.853
   Brunetti-Pierri N, 2004, HUM GENE THER, V15, P35, DOI 10.1089/10430340460732445
   Brunetti-Pierri N, 2011, HUM MOL GENET, V20, pR7, DOI 10.1093/hmg/ddr143
   Cerullo V, 2007, MOL THER, V15, P378, DOI 10.1038/sj.mt.6300031
   Cerullo V, 2012, ONCOIMMUNOLOGY, V1, P979, DOI 10.4161/onci.20172
   Choi JW, 2012, ADV DRUG DELIVER REV, V64, P720, DOI 10.1016/j.addr.2011.12.011
   Coughlan L, 2012, HUM GENE THER, V23, P960, DOI 10.1089/hum.2011.218
   Coughlan L, 2009, J VIROL, V83, P6416, DOI 10.1128/JVI.00445-09
   Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441
   Croyle MA, 2002, HUM GENE THER, V13, P1887, DOI 10.1089/104303402760372972
   Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171
   DeWeese TL, 2001, CANCER RES, V61, P7464
   Di BY, 2012, J BIOTECHNOL, V157, P373, DOI 10.1016/j.jbiotec.2011.12.022
   Diaconu I, 2009, HUM GENE THER, V20, P611, DOI 10.1089/hum.2008.108
   Doronin K, 2009, HUM GENE THER, V20, P975, DOI 10.1089/hum.2009.028
   Engesaeter BO, 2005, CANCER GENE THER, V12, P439, DOI 10.1038/sj.cgt.7700808
   Eto Y, 2010, BIOL PHARM BULL, V33, P1540, DOI 10.1248/bpb.33.1540
   Fisher KD, 2010, ADV DRUG DELIVER REV, V62, P240, DOI 10.1016/j.addr.2009.12.003
   FLOMENBERG P, 1994, MOL IMMUNOL, V31, P1277, DOI 10.1016/0161-5890(94)90078-7
   Fu J, 2011, J BIOL CHEM, V286, P17631, DOI 10.1074/jbc.M110.212050
   Gamble Lena J, 2012, J Mol Biochem, V1, P26
   Ginn SL, 2013, J GENE MED, V15, P65, DOI 10.1002/jgm.2698
   Granio O, 2010, HUM GENE THER, V21, P251, DOI 10.1089/hum.2009.056
   Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121
   Green NK, 2004, GENE THER, V11, P1256, DOI 10.1038/sj.gt.3302295
   Grunwald GK, 2013, J NUCL MED, V54, P1450, DOI 10.2967/jnumed.112.115493
   Hall K, 2009, VIROLOGY, V392, P222, DOI 10.1016/j.virol.2009.07.010
   HARA T, 1992, BRIT J HAEMATOL, V82, P368, DOI 10.1111/j.1365-2141.1992.tb06431.x
   Hartman ZC, 2007, VIROLOGY, V358, P357, DOI 10.1016/j.virol.2006.08.041
   Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06
   Hiwasa K, 2012, ANTICANCER RES, V32, P3137
   Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3
   Hofherr SE, 2008, MOL THER, V16, P1276, DOI 10.1038/mt.2008.86
   Hofherr SE, 2007, HUM GENE THER, V18, P837, DOI 10.1089/hum.2007.0051
   Hogg RT, 2011, CANCER GENE THER, V18, P275, DOI 10.1038/cgt.2010.78
   Hogset A, 2002, CANCER GENE THER, V9, P365, DOI 10.1038/sj/cgt/7700447
   Janssen JM, 2013, J GENE MED, V15, P1, DOI 10.1002/jgm.2687
   Jiang H, 2004, MOL THER, V10, P1140, DOI 10.1016/j.ymthe.2004.08.015
   Jonsson MI, 2009, J VIROL, V83, P3816, DOI 10.1128/JVI.02562-08
   KELLY TJ, 1973, J VIROL, V12, P643
   Kiang A, 2006, MOL THER, V14, P588, DOI 10.1016/j.ymthe.2006.03.024
   Kim E, 2003, HUM GENE THER, V14, P1415, DOI 10.1089/104303403769211637
   Kim KH, 2013, GYNECOL ONCOL, V130, P518, DOI 10.1016/j.ygyno.2013.06.003
   Kim KH, 2011, HUM GENE THER, V22, P821, DOI 10.1089/hum.2010.180
   Kim PH, 2011, BIOMATERIALS, V32, P9328, DOI 10.1016/j.biomaterials.2011.08.066
   Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043
   King WJ, 2013, STEM CELLS DEV, V22, P679, DOI 10.1089/scd.2012.0379
   Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264
   Koski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060032
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Kritz AB, 2007, MOL THER, V15, P741, DOI 10.1038/mt.sj.6300094
   Kwon OJ, 2013, J CONTROL RELEASE, V169, P257, DOI 10.1016/j.jconrel.2013.03.030
   Lanciotti J, 2003, MOL THER, V8, P99, DOI 10.1016/S1525-0016(03)00139-4
   Law LK, 2005, MOL THER, V12, P599, DOI 10.1016/j.ymthe.2005.05.017
   Leggiero E, 2013, GENE THER, V20, P1124, DOI 10.1038/gt.2013.38
   Lieber A, 1997, J VIROL, V71, P8798
   Liu Q, 2003, GENE THER, V10, P935, DOI 10.1038/sj.gt.3302036
   Liu TC, 2008, GENE THER, V15, P877, DOI 10.1038/gt.2008.72
   Maksimenko AV, 2003, J GENE MED, V5, P61, DOI 10.1002/jgm.319
   Matsui H, 2012, BIOMATERIALS, V33, P3743, DOI 10.1016/j.biomaterials.2012.02.011
   Matsui H, 2011, VIRUS RES, V155, P48, DOI 10.1016/j.virusres.2010.08.021
   Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj/gt/3301701
   Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015
   Morral N, 2002, HUM GENE THER, V13, P143, DOI 10.1089/10430340152712692
   Morrison J, 2008, MOL THER, V16, P244, DOI 10.1038/sj.mt.6300363
   Murakami M, 2010, PROSTATE, V70, P362, DOI 10.1002/pros.21070
   Muruve DA, 2004, HUM GENE THER, V15, P1157, DOI 10.1089/hum.2004.15.1157
   Muruve DA, 2004, J VIROL, V78, P5966, DOI 10.1128/JVI.78.11.5966-5972.2004
   Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364
   Nakamura T, 2003, J VIROL, V77, P2512, DOI 10.1128/JVI.77.4.2512-2521.2003
   Nazir SA, 2005, J INVEST MED, V53, P292, DOI 10.2310/6650.2005.53605
   Nokisalmi P, 2010, CLIN CANCER RES, V16, P3035, DOI 10.1158/1078-0432.CCR-09-3167
   Palmer Donna J, 2011, Cold Spring Harb Protoc, V2011, P867, DOI 10.1101/pdb.prot5628
   Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510
   Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532
   Pearson S, 2004, NAT BIOTECHNOL, V22, P3, DOI 10.1038/nbt0104-3
   Pesonen S, 2012, INT J CANCER, V130, P1937, DOI 10.1002/ijc.26216
   Piccolo P, 2013, MOL THER, V21, P767, DOI 10.1038/mt.2012.287
   Post DE, 2003, ONCOGENE, V22, P2065, DOI 10.1038/sj.onc.1206464
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Raty J K, 2008, Curr Mol Pharmacol, V1, P13
   Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10
   Rodriguez E, 2013, HUM GENE THER METHOD, V24, P195, DOI 10.1089/hgtb.2012.096
   Rojas JJ, 2012, GENE THER, V19, P453, DOI 10.1038/gt.2011.106
   ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904
   Sapet C, 2012, PHARM RES-DORDR, V29, P1203, DOI 10.1007/s11095-011-0629-9
   Schowalter DB, 1997, GENE THER, V4, P351, DOI 10.1038/sj.gt.3300398
   Seiler MP, 2007, CURR GENE THER, V7, P297, DOI 10.2174/156652307782151452
   Seregin SS, 2010, BLOOD, V116, P1669, DOI 10.1182/blood-2010-03-276949
   Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005
   Silva AC, 2010, CURR GENE THER, V10, P437
   Singh R, 2008, FASEB J, V22, P3389, DOI 10.1096/fj.08-103275
   Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565
   Smith TAG, 2003, HUM GENE THER, V14, P777, DOI 10.1089/104303403765255165
   Steegenga WT, 1999, MOL CELL BIOL, V19, P3885
   Suzuki-Kouyama E, 2011, BIOMATERIALS, V32, P1724, DOI 10.1016/j.biomaterials.2010.10.060
   Tang DC, 1997, HUM GENE THER, V8, P2117, DOI 10.1089/hum.1997.8.17-2117
   Teesalu T., 2013, FRONT ONCOL, V3, DOI [10.3389/fonc.2013.00216, DOI 10.3389/FONC.2013.00216]
   THOMAS GP, 1980, CELL, V22, P523
   Thorsteinsson L, 1998, APMIS, V106, P869, DOI 10.1111/j.1699-0463.1998.tb00233.x
   Toietta G, 2002, MOL THER, V5, P204, DOI 10.1006/mthe.2002.0532
   Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352
   Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545
   van de Ven R, 2009, J IMMUNOTHER, V32, P895, DOI 10.1097/CJI.0b013e3181b56deb
   Vetrini F, 2010, VIRUSES-BASEL, V2, P1886, DOI 10.3390/v2091886
   Vetter A, 2013, MOL PHARMACEUT, V10, P606, DOI 10.1021/mp300366f
   Walters CL, 2013, GYNECOL ONCOL, V131, P493, DOI 10.1016/j.ygyno.2013.07.080
   Wang CHK, 2011, BIOMATERIALS, V32, P9536, DOI 10.1016/j.biomaterials.2011.08.069
   Wang IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012085
   Wang WJ, 2005, J NEUROSURG, V103, P1058, DOI 10.3171/jns.2005.103.6.1058
   WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E
   Wohlleber D, 2012, CELL REP, V2, P478, DOI 10.1016/j.celrep.2012.08.001
   Wonganan P, 2011, MOL PHARMACEUT, V8, P78, DOI 10.1021/mp100216h
   Wonganan P, 2010, VIRUSES-BASEL, V2, P468, DOI 10.3390/v2020468
   Wu E, 2003, J VIROL, V77, P7225, DOI 10.1128/JVI.77.13.7225-7235.2003
   Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005
   Xie M, 2013, INT J NANOMED, V8, P2443, DOI 10.2147/IJN.S46327
   Xiong ZM, 2006, J NUCL MED, V47, P130
   Yamamoto M, 2010, MOL THER, V18, P243, DOI 10.1038/mt.2009.266
   Yang Y, 1996, GENE THER, V3, P412
   Yang Y, 1996, GENE THER, V3, P137
   YANG YP, 1995, J IMMUNOL, V155, P2564
   Yang YP, 1996, J VIROL, V70, P7209
   YANG YP, 1994, IMMUNITY, V1, P433, DOI 10.1016/1074-7613(94)90074-4
   Yao XL, 2012, BIOMACROMOLECULES, V13, P2402, DOI 10.1021/bm300665u
   Yao XL, 2011, MOL THER, V19, P1619, DOI 10.1038/mt.2011.112
   Yilmazer A, 2013, BIOMATERIALS, V34, P1354, DOI 10.1016/j.biomaterials.2012.10.053
   ZAMANIAN M, 1992, EMBO J, V11, P2603, DOI 10.1002/j.1460-2075.1992.tb05325.x
   Zeng Q, 2012, INT J NANOMED, V7, P985, DOI 10.2147/IJN.S27526
   Zhao YG, 2011, MOL CELL BIOCHEM, V353, P93, DOI 10.1007/s11010-011-0778-5
NR 139
TC 19
Z9 19
U1 0
U2 13
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD FEB
PY 2014
VL 6
IS 2
BP 832
EP 855
DI 10.3390/v6020832
PG 24
WC Virology
SC Virology
GA AG9OH
UT WOS:000335748500010
PM 24549268
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Naghavi, N
   Ghoddusi, J
   Sadeghnia, HR
   Asadpour, E
   Asgary, S
AF Naghavi, Neda
   Ghoddusi, Jamileh
   Sadeghnia, Hamid R.
   Asadpour, Elham
   Asgary, Saeed
TI Genotoxicity and cytotoxicity of mineral trioxide aggregate and calcium
   enriched mixture cements on L929 mouse fibroblast cells
SO DENTAL MATERIALS JOURNAL
LA English
DT Article
DE Biocompatible; Calcium enriched mixture; Cytotoxicity; Genotoxicity;
   Mineral trioxide aggregate
ID PERIODONTAL-LIGAMENT FIBROBLASTS; END FILLING MATERIAL; COMET ASSAY;
   DNA-DAMAGE; ENDODONTIC CEMENT; PORTLAND CEMENTS; WHITE; AGENTS; ORGANS;
   MTA
AB Mineral trioxide aggregate (MTA) has shown good biocompatibility in several studies. In the present study, the genotoxic and cytotoxic effects of calcium enriched mixture (CEM) were evaluated compared with MTA using MTT and single-cell gel (comet) assays with serial ascending concentrations (0 to 1,000 mu g/mL) of tested materials. Cytotoxicity data indicated that there is no significant difference between CEM and MTA at all concentrations except for the full concentration (1,000 mu g/mL); CEM had lower cytotoxicity. Genotoxic effects were more evident with CEM at concentrations of 15.6 and 250 mu g/mL; however, was less than that of MTA at concentrations of 500 and 1,000 mu g/mL. The cytotoxicity and genotoxicity effects of the two experimental groups generally increased with consistency. Under the conditions of this study, CEM is biocompatible in terms of cyto- and genotoxicity. It appears to be an alternative to MTA as an endodontic biomaterial offering several advantages.
C1 [Naghavi, Neda; Ghoddusi, Jamileh] MUMS, Dent Res Ctr, Mashhad, Iran.
   [Sadeghnia, Hamid R.; Asadpour, Elham] MUMS, Neurosci Res Ctr, Dept Pharmacol, Dept New Sci & Technol,Fac Med, Mashhad, Iran.
   [Asgary, Saeed] Shahid Beheshti Univ Med Sci, Iranian Ctr Endodont Res, Tehran, Iran.
RP Ghoddusi, J (reprint author), MUMS, Dent Res Ctr, Mashhad, Iran.
EM ghoddusij@mums.ac.ir
RI Asadpour, Elham/J-6352-2015
OI Asadpour, Elham/0000-0002-6858-5311
FU Mashhad University of Medical Sciences (MUMS), Mashhad, Iran; Iranian
   Center for Endodontic Research, Shahid Beheshti University of Medical
   Sciences, Tehran, Iran
FX This study was fully supported by a grant from Vice Chancellor for
   Research of Mashhad University of Medical Sciences (MUMS), Mashhad, Iran
   and Iranian Center for Endodontic Research, Shahid Beheshti University
   of Medical Sciences, Tehran, Iran. The authors deny any conflict of
   interest related to this study.
CR Asgary S, 2009, J CONSERV DENT, V412, P431
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary S, 2010, ODONTOLOGY, V98, P126, DOI 10.1007/s10266-010-0127-2
   Asgary Saeed, 2007, Iran Endod J, V2, P105
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Balto HA, 2004, J ENDODONT, V30, P25, DOI 10.1097/00004770-200401000-00005
   Braz MG, 2006, J ORAL REHABIL, V33, P234, DOI 10.1111/j.1365-2842.2005.01559.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   da Silva Glenda N, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe50, DOI 10.1016/j.tripleo.2006.02.032
   Duarte MAH, 2005, ORAL SURG ORAL MED O, V99, P648, DOI 10.1016/j.tripleo.2004.09.015
   Hartmann A, 2003, MUTAGENESIS, V18, P45, DOI 10.1093/mutage/18.1.45
   Hasan Zarrabi M, 2009, J ORAL SCI, V51, P437
   Hasheminia Mohsen, 2010, Iran Endod J, V5, P151
   Hirschman WR, 2012, J ENDODONT, V38, P385, DOI 10.1016/j.joen.2011.11.012
   Holland Roberto, 2002, Braz Dent J, V13, P23
   Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767
   Hosseinzadeh H, 2007, DNA CELL BIOL, V26, P841, DOI 10.1089/dna.2007.0631
   Keiser K, 2000, J ENDODONT, V26, P288, DOI 10.1097/00004770-200005000-00010
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Koh ET, 1997, J BIOMED MATER RES, V37, P432, DOI 10.1002/(SICI)1097-4636(19971205)37:3<432::AID-JBM14>3.0.CO;2-D
   Kumaravel TS, 2006, MUTAT RES-GEN TOX EN, V605, P7, DOI 10.1016/j.mrgentox.2006.03.002
   Lessa Fernanda Campos Rosetti, 2010, Braz. Dent. J., V21, P24, DOI 10.1590/S0103-64402010000100004
   Menezes R, 2004, ORAL SURG ORAL MED O, V98, P376, DOI 10.1016/j.tripleo.2004.03.008
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Osorio RM, 1998, J ENDODONT, V24, P91, DOI 10.1016/S0099-2399(98)80084-8
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Parirokh M, 2011, INT ENDOD J, V44, P283, DOI 10.1111/j.1365-2591.2010.01808.x
   Ribeiro DA, 2004, J PERIODONTAL RES, V39, P358, DOI 10.1111/j.1600-0765.2004.00759.x
   Ribeiro DA, 2004, J ENDODONT, V30, P593, DOI 10.1097/01.DON.0000121614.10075.A3
   Ribeiro Daniel Araki, 2005, Braz. oral res., V19, P183, DOI 10.1590/S1806-83242005000300005
   Ribeiro Daniel Araki, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, P258, DOI 10.1016/j.tripleo.2005.02.080
   Ribeiro Daniel Araki, 2004, Braz. oral res., V18, P192, DOI 10.1590/S1806-83242004000300003
   Samiee M, 2010, CLIN ORAL INVEST, V14, P653, DOI 10.1007/s00784-009-0351-8
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   Vajrabhaya LO, 2006, ORAL SURG ORAL MED O, V102, P48
   Zeferino EG, 2010, INT ENDOD J, V43, P843, DOI 10.1111/j.1365-2591.2010.01747.x
NR 41
TC 17
Z9 19
U1 0
U2 7
PU JAPANESE SOC DENTAL MATERIALS DEVICES
PI TOKYO
PA C/O KOKU HOKEN KYOKAI, 1-43-9 KOMAGOME TS BDG, KOMAGOME, TOSHIMA-KU,
   TOKYO, 170-0003, JAPAN
SN 0287-4547
J9 DENT MATER J
JI Dent. Mater. J.
PD FEB
PY 2014
VL 33
IS 1
BP 64
EP 69
DI 10.4012/dmj.2013-123
PG 6
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA AD7KJ
UT WOS:000333442400011
PM 24492114
OA Bronze
DA 2018-10-19
ER

PT J
AU Osidak, EO
   Osidak, MS
   Akhmanova, MA
   Domogatskii, SP
AF Osidak, E. O.
   Osidak, M. S.
   Akhmanova, M. A.
   Domogatskii, S. P.
TI Collagen-A biomaterial for delivery of growth factors and tissue
   regeneration
SO RUSSIAN JOURNAL OF GENERAL CHEMISTRY
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN-2; DRUG-DELIVERY; ARTIFICIAL SKIN; IN-VITRO;
   IMPLANTABLE COLLAGEN; RELEASE KINETICS; BINDING DOMAIN; LOCAL-DELIVERY;
   SPINAL-FUSION; MATRICES
AB Research on collagen as a carrier for growth factors and cells is an actual field in modern tissue engineering. The progress in this field of research will make possible approaching the problem of regeneration of injured organs and large tissue fragments.
C1 [Osidak, E. O.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Gamaleya Res Inst Epidemiol & Microbiol, Moscow 123098, Russia.
   [Osidak, M. S.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Hematol Res Ctr, Moscow 125167, Russia.
   [Akhmanova, M. A.] Minist Hlth Russian Federat, Fed State Budgetary Inst, Russian Cardiol Res & Prod Ctr, Moscow 121552, Russia.
   [Domogatskii, S. P.] Imtek OOO, Moscow 121552, Russia.
RP Osidak, EO (reprint author), Minist Hlth Russian Federat, Fed State Budgetary Inst, Gamaleya Res Inst Epidemiol & Microbiol, Ul Gamalei 18, Moscow 123098, Russia.
EM egorosidak@gmail.com
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Aishwarya S, 2008, J MICROENCAPSUL, V25, P298, DOI 10.1080/02652040801972004
   Akhmanova M.A., 2011, THESIS
   Andreadis ST, 2006, TRENDS BIOTECHNOL, V24, P331, DOI 10.1016/j.tibtech.2006.05.001
   [Anonymous], 2000, RP651147 MED DAT INT, P29
   Aro HT, 2011, J BONE JOINT SURG AM, V93A, P801, DOI 10.2106/JBJS.I.01763
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Berthold A, 1998, EUR J PHARM BIOPHARM, V45, P23, DOI 10.1016/S0939-6411(97)00119-7
   Boden SD, 1998, J SPINAL DISORD, V11, P95
   BOYCE ST, 1992, J BIOMED MATER RES, V26, P547, DOI 10.1002/jbm.820260410
   Brown RA, 2007, INT REV CYTOL, V262, P75, DOI 10.1016/S0074-7696(07)62002-6
   BURKE JF, 1981, ANN SURG, V194, P413, DOI 10.1097/00000658-198110000-00005
   Censi R, 2012, J CONTROL RELEASE, V161, P680, DOI 10.1016/j.jconrel.2012.03.002
   Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774
   Chen B, 2007, BIOMATERIALS, V28, P1027, DOI 10.1016/j.biomaterials.2006.10.013
   CHOW AW, 1985, MACROMOLECULES, V18, P793, DOI 10.1021/ma00146a034
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   Cote MF, 2004, BIOMATERIALS, V25, P3761, DOI 10.1016/j.biomaterials.2003.10.026
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   DOILLON CJ, 1986, BIOMATERIALS, V7, P3, DOI 10.1016/0142-9612(86)90080-3
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gao T, 2001, MATERIALWISS WERKST, V32, P953
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   GELMAN RA, 1979, J BIOL CHEM, V254, P1741
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gorham S. D., 1991, BIOMATERIALS, P55
   Grillo H., 1962, J SURG RES, V11, P69
   Hecht BP, 1999, SPINE, V24, P629, DOI 10.1097/00007632-199904010-00004
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hong Y, 2005, BIOMATERIALS, V26, P6305, DOI 10.1016/j.biomaterials.2005.03.038
   Hsu HP, 2006, J ORTHOP RES, V24, P1660, DOI 10.1002/jor.20204
   Ishikawa T, 2003, ARTIF ORGANS, V27, P147, DOI 10.1046/j.1525-1594.2003.07009.x
   KAMMANN JP, 1994, KLIN MONATSBL AUGENH, V205, P201, DOI 10.1055/s-2008-1045517
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Kim H., 2001, J BIOMED MATER RES, V59, P573
   King WJ, 2012, ADV DRUG DELIVER REV, V64, P1239, DOI 10.1016/j.addr.2012.03.004
   Kobsa S, 2008, PEDIATR RES, V63, P513, DOI 10.1203/PDR.0b013e318165f14d
   Koch S, 2006, J MATER SCI-MATER M, V17, P735, DOI 10.1007/s10856-006-9684-x
   Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698
   LANZA RP, 2000, PRINCIPLES TISSUE EN
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   Lee KY, 2000, NATURE, V408, P998
   LEFEBVRE F, 1992, BIOMATERIALS, V13, P28, DOI 10.1016/0142-9612(92)90091-2
   Lefebvre F, 1996, BIOMATERIALS, V17, P1813, DOI 10.1016/0142-9612(95)00346-0
   Lienemann PS, 2012, ADV DRUG DELIVER REV, V64, P1078, DOI 10.1016/j.addr.2012.03.010
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin NC, 2012, BIOMATERIALS, V33, P1801, DOI 10.1016/j.biomaterials.2011.11.038
   Ma J., 2011, CLIN EXP OPHTHALMOL, DOI [10.1111/j.1442-9071.2011.02618, DOI 10.1111/J.1442-9071.2011.02618]
   Maehara H, 2010, J ORTHOP RES, V28, P677, DOI 10.1002/jor.21032
   MARKS MG, 1991, J BIOMED MATER RES, V25, P683, DOI 10.1002/jbm.820250510
   MCPHERSON J M, 1986, Journal of Biomedical Materials Research, V20, P93, DOI 10.1002/jbm.820200109
   MEADE KR, 1990, BIOMATERIALS, V11, P176, DOI 10.1016/0142-9612(90)90151-F
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   MILANI JK, 1993, AM J OPHTHALMOL, V116, P622, DOI 10.1016/S0002-9394(14)73206-4
   Moriyama T, 2001, TISSUE ENG, V7, P415, DOI 10.1089/10763270152436472
   NA GC, 1986, J BIOL CHEM, V261, P2290
   Nagai N, 2010, J MATER SCI-MATER M, V21, P1891, DOI 10.1007/s10856-010-4054-0
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Nishi N, 1998, P NATL ACAD SCI USA, V95, P7018, DOI 10.1073/pnas.95.12.7018
   Noth U, 2010, ADV DRUG DELIVER REV, V62, P765, DOI 10.1016/j.addr.2010.04.004
   Orwin EJ, 2000, TISSUE ENG, V6, P307, DOI 10.1089/107632700418038
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Phillips RJ, 2000, BIOPHYS J, V79, P3350, DOI 10.1016/S0006-3495(00)76566-0
   PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1
   POLAND DE, 1988, J CATARACT REFR SURG, V14, P489, DOI 10.1016/S0886-3350(88)80003-8
   Porter S., 2000, J PHARM SCI, V90, P1
   Princz MA, 2008, J BIOMAT SCI-POLYM E, V19, P1201, DOI 10.1163/156856208785540181
   Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7
   ROSENBLATT J, 1993, J APPL POLYM SCI, V50, P953, DOI 10.1002/app.1993.070500604
   ROSENBLATT J, 1989, J CONTROL RELEASE, V9, P195, DOI 10.1016/0168-3659(89)90088-6
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   ROYCE PM, 1995, J DERMATOL SCI, V10, P42, DOI 10.1016/0923-1811(95)93713-B
   SCHIMANDLE JH, 1995, SPINE, V20, P1326, DOI 10.1097/00007632-199506000-00002
   Schlapp M, 2003, J PHARM SCI-US, V92, P2145, DOI 10.1002/jps.10460
   SchroederTefft JA, 1997, J CONTROL RELEASE, V48, P29, DOI 10.1016/S0168-3659(97)00055-2
   Sieron AL, 2002, CYTOKINE, V18, P214, DOI 10.1006/cyto.2002.1035
   SINGH M, 1993, P INT S CONTR REL BI, V20, P107
   SINGH MA, 1994, THESIS U MARYLAND BA
   Song S.-Z., 1992, European Patent, Patent No. 92305467
   Stegman S, 1988, J DERMATOL SURG O S1, V14, P39
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   Takeda Y, 2005, J BIOMED MATER RES A, V73A, P133, DOI 10.1002/jbm.a.30257
   Timpl R, 1984, EXTRACELLULAR MATRIX, P159
   Ungaro F, 2006, J CONTROL RELEASE, V113, P128, DOI 10.1016/j.jconrel.2006.04.011
   Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d
   Vasita R, 2006, EXPERT REV MED DEVIC, V3, P29, DOI 10.1586/17434440.3.1.29
   Vijaya R.D., 1989, INDIAN J BIOCH BIOPH, V26, P196
   Wallace D., 1988, COLLAGEN BIOTECHNOLO, V3, P118
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Waltraud D., 1977, BIOCHEMISTRY-US, P1
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WEISSMAN BA, 1988, ARCH OPHTHALMOL-CHIC, V106, P1706, DOI 10.1001/archopht.1988.01060140878032
   Wess TJ, 2005, ADV PROTEIN CHEM, V70, P341, DOI 10.1016/S0065-3233(05)70010-3
   Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V67, P141, DOI 10.1016/S0168-3659(00)00202-9
   Yang YF, 2009, TISSUE ENG PT A, V15, P3589, DOI [10.1089/ten.tea.2008.0648, 10.1089/ten.TEA.2008.0648]
   YANNAS IV, 1990, ANGEW CHEM INT EDIT, V29, P20, DOI 10.1002/anie.199000201
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   Zhao YN, 2010, J CONTROL RELEASE, V141, P30, DOI 10.1016/j.jconrel.2009.06.032
NR 104
TC 0
Z9 0
U1 2
U2 10
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1070-3632
EI 1608-3350
J9 RUSS J GEN CHEM+
JI Russ. J. Gen. Chem.
PD FEB
PY 2014
VL 84
IS 2
BP 368
EP 378
DI 10.1134/S107036321402039X
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AD3QU
UT WOS:000333161700039
DA 2018-10-19
ER

PT J
AU Raj, KR
   Saxena, S
   Kardam, A
   Satsangi, SP
   Srivastava, S
AF Raj, Kumar Rohit
   Saxena, Sachin
   Kardam, Abhishek
   Satsangi, Soami P.
   Srivastava, Shalini
TI Voltammetric speciation of arsenic species in plant biomaterial:
   bioremediation
SO CLEAN TECHNOLOGIES AND ENVIRONMENTAL POLICY
LA English
DT Article
DE Chemical speciation; Arsenic; Square wave anodic stripping voltammetry;
   Leucaena leucocephala
ID ANODIC-STRIPPING VOLTAMMETRY; AQUEOUS-SOLUTIONS; COIR PITH; WATER;
   REMOVAL; SAMPLES; ADSORPTION; AS(III)
AB Environmental pollution, as a consequence of the industrialization process, is one of the major problems that have to be solved and controlled. The heightened awareness regarding the high toxicity and biochemical behavior of the different arsenic species required to develop cost effective technologies for the speciation of arsenic species. Electrochemical techniques are found to be comparatively better tools for arsenic speciation. As (III) is electrochemically stable in the presence of ascorbic acid as supporting electrolyte, while As (V) is electrochemically inactive at the electrode surface. The present piece of work is an attempt to measure the two arsenic species in the elution of arsenic sorbed Leucaena leucocephala seed powder (LLSP), using square wave anodic stripping voltammetry. The strategy employed in this work is based on the determination of As (III) directly, while determining As (V) after reduction with sodium thiosulfate into As (III). The removal percentage of As (III) and As (V) using LLSP biomaterial was 83.18 and 95 %, respectively.
C1 [Raj, Kumar Rohit] Sigachi Ind Pvt Ltd, Res & Dev Lab, Hyderabad 502307, Andhra Pradesh, India.
   [Saxena, Sachin; Satsangi, Soami P.] Dayalbagh Educ Inst, USIC, Remote Instrumentat Lab, Agra 282110, Uttar Pradesh, India.
   [Kardam, Abhishek] Amity Univ, Amity Inst Adv Res & Studies, Noida 201303, India.
   [Srivastava, Shalini] Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
RP Srivastava, S (reprint author), Dayalbagh Educ Inst, Fac Sci, Dept Chem, Agra 282110, Uttar Pradesh, India.
EM dei.smohanm@gmail.com
FU University Grant Commission, New Delhi, India [39-736/2010 (SR)]
FX The authors gratefully acknowledge Prof. V. G. Das, Director and Prof.
   L. D. Khemani, Head, Department of Chemistry, Dayalbagh Educational
   Institute, Dayalbagh, Agra. Authors also gratefully acknowledge
   University Grant Commission, New Delhi, India [Project No. 39-736/2010
   (SR)] for providing financial assistance.
CR Alvarado S, 2008, BIORESOURCE TECHNOL, V99, P8436, DOI 10.1016/j.biortech.2008.02.051
   Anirudhan TS, 2007, CHEMOSPHERE, V66, P60, DOI 10.1016/j.chemosphere.2006.05.031
   Bose U., 2011, International Journal of Chemical Technology, V3, P14
   Brusciotti F, 2007, ELECTROCHIM ACTA, V52, P6644, DOI 10.1016/j.electacta.2007.04.071
   Burriel M, 2006, QUIMICA ANALITICA CU
   DANG HQ, 2004, TALANTA, V64, P269
   Dirilgen N, 2006, ANAL LETT, V39, P127, DOI 10.1080/00032710500464264
   Gong ZL, 2002, TALANTA, V58, P77, DOI 10.1016/S0039-9140(02)00258-8
   HAMAM E, 2002, J PHARM BIOMED ANAL, V30, P651
   He Y, 2007, MICROCHEM J, V85, P265, DOI 10.1016/j.microc.2006.06.012
   Junsomboon J, 2009, CHIANG MAI J SCI, V36, P369
   Kardam Abhishek, 2010, Journal of Water Resource and Protection, V2, P339, DOI 10.4236/jwarp.2010.24039
   Le XC, 2004, ANAL CHEM, V76, p26A, DOI 10.1021/ac041492r
   Mahmood S.A.I., 2011, J TOXICOL ENV HLTH S, V3, P65
   Malik AH, 2009, J HAZARD MATER, V168, P1, DOI 10.1016/j.jhazmat.2009.02.031
   Masson P, 2006, MICROCHIM ACTA, V154, P229, DOI 10.1007/s00604-006-0516-y
   Mays DE, 2009, ANAL CHIM ACTA, V646, P6, DOI 10.1016/j.aca.2009.05.006
   Meng XG, 2003, ACS SYM SER, V835, P70
   Munoz E, 2005, TALANTA, V65, P613, DOI 10.1016/j.talanta.2004.07.034
   Nemade PD, 2007, INDIAN JR ENV PROT, V27, P296
   Patil AK, 2010, E-J CHEM, V7, pS377, DOI 10.1155/2010/314961
   Paul SC, 2008, PAK J ANAL ENV CHEM, V9, P49
   Profumo A, 2005, ANAL CHIM ACTA, V539, P245, DOI 10.1016/j.aca.2005.02.062
   Raj Kumar Rohit, 2010, Journal of Water Resource and Protection, V2, P331, DOI 10.4236/jwarp.2010.24038
   Raj KR, 2013, APPL WATER SCI, V3, P327, DOI 10.1007/s13201-012-0057-y
   Ramesh ST, 2012, APPL WATER SCI, V2, P187, DOI 10.1007/s13201-012-0036-3
   Ramesh S. T., 2011, Electronic Journal of Environmental, Agricultural and Food Chemistry, V10, P2487
   Ramesh ST, 2013, ENVIRON ENG SCI, V30, P74, DOI 10.1089/ees.2012.0192
   Ramesh ST, 2011, ENVIRON ENG MANAG J, V10, P1667, DOI 10.30638/eemj.2011.228
   Ranjan D, 2009, IND ENG CHEM RES, V48, P10180, DOI 10.1021/ie9008771
   Rivas BL, 2010, WATER RES, V44, P5730, DOI 10.1016/j.watres.2010.06.031
   Salaun P, 2007, ANAL CHIM ACTA, V585, P312, DOI 10.1016/j.aca.2006.12.048
   Shao WJ, 2008, HYDROMETALLURGY, V91, P138, DOI 10.1016/j.hydromet.2008.01.005
   Srivastava S, 2013, ENVIRON CHEM LETT, V11, P47, DOI 10.1007/s10311-012-0376-0
   Vahidnia A, 2007, HUM EXP TOXICOL, V26, P823, DOI 10.1177/0960327107084539
   Yeneneh M. A., 2011, J APPL SCI, V11, P3555
   Zlatev R, 2010, ELECTROANAL, V22, P1671, DOI 10.1002/elan.201000090
NR 37
TC 2
Z9 2
U1 0
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1618-954X
EI 1618-9558
J9 CLEAN TECHNOL ENVIR
JI Clean Technol. Environ. Policy
PD FEB
PY 2014
VL 16
IS 2
BP 377
EP 384
DI 10.1007/s10098-013-0633-3
PG 8
WC GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY; Engineering, Environmental;
   Environmental Sciences
SC Science & Technology - Other Topics; Engineering; Environmental Sciences
   & Ecology
GA AC9PY
UT WOS:000332867800016
DA 2018-10-19
ER

PT J
AU de Olyveira, GM
   dos Santos, ML
   Daltro, PB
   Basmaji, P
   Daltro, GD
   Guastaldi, AC
AF de Olyveira, Gabriel Molina
   dos Santos, Marcio Luiz
   Daltro, Paula Braga
   Basmaji, Pierre
   Daltro, Gildasio de Cerqueira
   Guastaldi, Antonio Carlos
TI Bacterial Cellulose/Chondroitin Sulfate for Dental Materials Scaffolds
SO JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING
LA English
DT Article
DE Bacterial Cellulose (Nanoskin); Nanocomposites; Scaffolds; Dental
   Scaffolds Materials
ID CELLULOSE NANOCOMPOSITES; BIOMEDICAL APPLICATIONS
AB Bacterial cellulose (BC) has become established as a remarkably versatile biomaterial and can be used in a wide variety of scientific applications, especially for medical devices. In this work, the bacterial cellulose fermentation process is modified by the addition of chondroitin sulfate (1% w/w) to the culture medium before the bacteria are inoculated. Besides, biomimetic precipitation of calcium phosphate of biological interest from simulated body fluid on bacterial cellulose was studied. Chondroitin sulfate influences in bacterial cellulose were analyzed using transmission infrared spectroscopy (FTIR), XRD (X-ray diffraction) and scanning electron microscopy (SEM). FTIR analysis showed interaction between chondroitin sulfate, bacterial cellulose and calcium phosphate and XRD demonstrated amorphous calcium phosphate and carbonated apatite on bacterial cellulose nanocomposites. SEM images confirmed incorporation of calcium phosphate in bacterial celluloe nanocomposite surface and uniform spherical calcium phosphate particles. Future experiments with cells adhesion and viability are in course.
C1 [de Olyveira, Gabriel Molina; dos Santos, Marcio Luiz; Daltro, Paula Braga; Guastaldi, Antonio Carlos] UNESP, Dept Phys Chem, BR-14800900 Sao Jose Do Rio Preto, Brazil.
   [Basmaji, Pierre] Innovatecs Biotechnol Res & Dev, BR-13560042 Sao Carlos, SP, Brazil.
   [Daltro, Gildasio de Cerqueira] Univ Fed Bahia, Coll Hosp Complex Prof Edgard Santos COM HUPES, BR-40110910 Salvador, BA, Brazil.
RP de Olyveira, GM (reprint author), UNESP, Dept Phys Chem, BR-14800900 Sao Jose Do Rio Preto, Brazil.
RI dos Santos, Marcio/D-9905-2014; Guastaldi, Antonio/O-7379-2014
OI dos Santos, Marcio/0000-0002-3385-7516; Guastaldi,
   Antonio/0000-0002-6433-3555
CR ABE Y, 1990, J MATER SCI-MATER M, V1, P233, DOI 10.1007/BF00701082
   Aoki H., 1999, SCI MED APPL HYDROXY, P214
   Aparecida AH, 2009, J MATER SCI-MATER M, V20, P1215, DOI 10.1007/s10856-008-3682-0
   Basmaji P., 2014, J BIOMATER TISS ENG, V4, P1
   BRANEMARK PI, 1983, J PROSTHET DENT, V50, P399, DOI 10.1016/S0022-3913(83)80101-2
   Costa L. M. M., 2011, J BIONANOSCIENCE, V5, P167
   DUCHEYNE P, 1988, Journal of Oral Implantology, V14, P325
   Filho L. X., 2013, J NANOSCI NANOTECHNO, V13, P1
   Grande CJ, 2009, ACTA BIOMATER, V5, P1605, DOI 10.1016/j.actbio.2009.01.022
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P185, DOI 10.1166/jbt.2012.1044
   Costa LMM, 2012, J BIOMATER TISS ENG, V2, P48, DOI 10.1166/jbt.2012.1031
   Million LE, 2008, J BIOMED MATER RES B, V86B, P444, DOI 10.1002/jbm.b.31040
   Olyveira G. M., 2013, J BIOMATER TISS ENG, V2, P31
   Olyveira G. M., 2013, J BIOMEDICAL NANOTEC, V9, P1
   Olyveira GM, 2013, J BIOMATER TISS ENG, V3, P665, DOI 10.1166/jbt.2013.1127
   Ratner D., 1996, BIOMATERIALS SCI INT
   Wan YZ, 2007, MAT SCI ENG C-BIO S, V27, P855, DOI 10.1016/j.msec.2006.10.002
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Willians D. F., 1991, CONCISE ENCY MED DEN
   Willians D. F., 1981, BIOCOMPATIBILITY CLI
   Zhbanko R. G., 1966, INFRARED SPECTRA CEL, P325
NR 23
TC 1
Z9 1
U1 1
U2 35
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 2157-9083
EI 2157-9091
J9 J BIOMATER TISS ENG
JI J. Biomater. Tissue Eng.
PD FEB
PY 2014
VL 4
IS 2
BP 150
EP 154
DI 10.1166/jbt.2014.1155
PG 5
WC Cell & Tissue Engineering
SC Cell Biology
GA AD0IH
UT WOS:000332917200009
DA 2018-10-19
ER

PT J
AU Shanmugam, G
   Reddy, SMM
   Madhan, B
   Rao, JR
AF Shanmugam, Ganesh
   Reddy, Samala Murali Mohan
   Madhan, Balaraman
   Rao, Jonnalagadda Raghava
TI Method of addition of acetonitrile influences the structure and
   stability of collagen
SO PROCESS BIOCHEMISTRY
LA English
DT Article
DE Collagen; Triple helix; Acetonitrile; Denaturation; Circular dichroism
ID TRIPLE-HELIX STABILITY; THERMAL-STABILITY; ORGANIC-SOLVENTS; PEPTIDES;
   HYDROXYPROLINE; STABILIZATION; DENATURATION; GELATIN; TISSUE; MODEL
AB Collagen has been extensively used as a biomaterial in many biomedical applications. Recently, collagen based biomaterials were prepared using organic solvents. In this context, the method of addition of organic solvent described in the present study will be an important contribution in the preparation of collagen-based biomaterials. The effect of acetonitrile on collagen structure and stability was investigated using biophysical methods. Collagen undergoes solvent-induced denaturation with increasing concentration of acetonitrile. It was observed that addition of acetonitrile (50-90%) to a collagen solution in a single shot (method 1) led to precipitation. Contrary, collagen remained in the solution when acetonitrile content was increased to 90% in a collagen solution that had been formerly equilibrated with 20% acetonitrile (method 2). Interestingly, triple helical structure was retained when precipitated collagen, obtained from method 1, was re-dissolved in acetic acid solution. The re-dissolved collagen exhibits comparable melting temperature as that of native collagen. Re-dissolved collagen also showed fibril formation, but with decreased rate. The soluble collagen in 90% acetonitrile, prepared by method 2, is found to be unordered. The above results thus suggest that the method of addition of acetonitrile plays an important role in the folding and unfolding of collagen. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Shanmugam, Ganesh; Reddy, Samala Murali Mohan] CSIR Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
   [Madhan, Balaraman] CSIR Cent Leather Res Inst, CHORD, Madras 600020, Tamil Nadu, India.
   [Rao, Jonnalagadda Raghava] CSIR Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Shanmugam, G (reprint author), CSIR Cent Leather Res Inst, Bioorgan Lab, Madras 600020, Tamil Nadu, India.
EM ganesh@clri.res.in
RI Shanmugam, Ganesh/F-3249-2011; Madhan, Balaraman/B-3136-2009
OI Shanmugam, Ganesh/0000-0003-1096-4201; Madhan,
   Balaraman/0000-0002-4198-8452
FU CSIR under a XII plan project; Council of Scientific and Industrial
   Research (CSIR), India
FX This work was supported by CSIR under a XII plan project (Research
   Initiatives for Waterless Tanning, RIWT, CSIR-CLRI communication number:
   1007). One of the authors, S.M.M.R., thanks Council of Scientific and
   Industrial Research (CSIR), India, for financial support as a Junior
   Research Fellowship (JRF). We thank Mr. Arun, Mr. V. Natarajan and Mr.
   R. Sathiesh, Senior Research Fellow, for their experimental help in
   extraction of collagen.
CR Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   BACHINGER HP, 1990, MATRIX, V10, P331
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   BIANCHI E, 1970, J BIOL CHEM, V245, P3341
   Burck J, 2013, LANGMUIR, V29, P1562
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Chen CC, 2011, ARCH BIOCHEM BIOPHYS, V508, P46, DOI 10.1016/j.abb.2011.01.009
   Chen YS, 2011, BIOPOLYMERS, V96, P60, DOI 10.1002/bip.21470
   Ellender G, 1992, CLIN MATER, V3-4, P201
   GEKKO K, 1983, J BIOCHEM-TOKYO, V94, P199, DOI 10.1093/oxfordjournals.jbchem.a134330
   HART GJ, 1971, BIOCHEM J, V125, P599, DOI 10.1042/bj1250599
   Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2
   Jariashvili K, 2012, BIOPOLYMERS, V97, P189, DOI 10.1002/bip.21725
   KEEFE J, 1992, Clinical Materials, V9, P155, DOI 10.1016/0267-6605(92)90095-B
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   Mattos C, 2001, CURR OPIN STRUC BIOL, V11, P761, DOI 10.1016/S0959-440X(01)00278-0
   MILLER EJ, 1982, METHOD ENZYMOL, V82, P33
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   Mu CD, 2007, BIOPOLYMERS, V86, P282, DOI 10.1002/bip.20742
   Paige MF, 2001, MICRON, V32, P341, DOI 10.1016/S0968-4328(00)00037-8
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Prystupa DA, 1996, POLYM GELS NETW, V4, P87, DOI 10.1016/0966-7822(96)00003-2
   RAMACHAN.GN, 1973, BIOCHIM BIOPHYS ACTA, V322, P166, DOI 10.1016/0005-2795(73)90187-6
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   Ricard-Blum S, 2005, TOP CURR CHEM, V247, P35, DOI 10.1007/b103819
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Shanmugam G, 2013, INT J BIOL MACROMOL, V54, P155, DOI 10.1016/j.ijbiomac.2012.12.014
   Shanmugam G, 2009, CHIRALITY, V21, P152, DOI 10.1002/chir.20598
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Shoulders MD, 2009, BIOORG MED CHEM LETT, V19, P3859, DOI 10.1016/j.bmcl.2009.03.168
   SUZUKI E, 1980, INT J BIOL MACROMOL, V2, P54, DOI 10.1016/0141-8130(80)90013-6
   Tamby MC, 2003, AUTOIMMUN REV, V2, P152, DOI 10.1016/S1568-9972(03)00004-1
   Umashankara M, 2003, CHEM COMMUN, P2606, DOI 10.1039/b308581c
   Usha R, 2006, COLLOID SURFACE B, V48, P101, DOI 10.1016/j.colsurfb.2006.01.015
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Usha R, 1998, J POLYM SCI POL LETT, V37, P1397
   VANDERREST M, 1991, FASEB J, V5, P2814
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Xiong X, 2009, PROCESS BIOCHEM, V44, P1200, DOI 10.1016/j.procbio.2009.06.010
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   Zeugolis DI, 2008, J BIOMAT SCI-POLYM E, V19, P1307, DOI 10.1163/156856208786052344
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhong SP, 2007, MAT SCI ENG C-BIO S, V27, P262, DOI 10.1016/j.msec.2006.05.010
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
NR 47
TC 8
Z9 8
U1 1
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-5113
EI 1873-3298
J9 PROCESS BIOCHEM
JI Process Biochem.
PD FEB
PY 2014
VL 49
IS 2
BP 210
EP 216
DI 10.1016/j.procbio.2013.11.013
PG 7
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering, Chemical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Engineering
GA AC4NO
UT WOS:000332498200005
DA 2018-10-19
ER

PT J
AU Tsai, YT
   Zhou, J
   Weng, H
   Shen, JH
   Tang, LP
   Hu, WJ
AF Tsai, Yi-Ting
   Zhou, Jun
   Weng, Hong
   Shen, Jinhui
   Tang, Liping
   Hu, Wen-Jing
TI Real- Time Noninvasive Monitoring of In Vivo Infl ammatory Responses
   using a pH Ratiometric Fluorescence Imaging Probe
SO ADVANCED HEALTHCARE MATERIALS
LA English
DT Article
DE optical probes; near infrared fluorescence; acidosis; biomaterials;
   inflammatory responses
ID FOREIGN-BODY REACTIONS; RAT C6 GLIOMA; INFLAMMATORY RESPONSES; SILICA
   NANOPARTICLES; BIOMATERIAL IMPLANTS; OPTICAL NANOSENSORS;
   CHEMICAL-ANALYSIS; TISSUE RESPONSES; PEBBLE SENSORS; LIVING CELLS
AB It is often difficult to continuously monitor and quantify inflammatory responses in vivo. These dynamic responses however are often accompanied by specific pH changes. A new ratiometric optical pH probe is developed by combining pH-sensitive (CypHer5E) and pH-insensitive (Oyster800) fluorescent dyes into nanoparticles for in vivo optical imaging. By taking the ratio of fluorescence intensities at different wavelengths, these nanosized sensors provide excellent measurement capabilities, and unique mapping, of the continuous in vivo pH changes for three different inflammation models. In each model a strong positive correlation is found between ratiometric pH changes and the corresponding inflammatory response measured by histological analyses. These results indicate that ratiometric imaging can provide a noninvasive, rapid, and highly sensitive optical readout for the pH-ratio changes in vivo. Furthermore this technique may be used to monitor the real-time dynamics of inflammatory processes.
C1 [Tsai, Yi-Ting; Zhou, Jun; Weng, Hong; Shen, Jinhui; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Hu, Wen-Jing] Progenitec Inc, Arlington, TX 76001 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [R43 GM101776]
FX The authors acknowledge Professor John W. Eaton for his critical review
   of this work. This work is supported by an NIH grant R43 GM101776.
CR Andreev OA, 2007, P NATL ACAD SCI USA, V104, P7893, DOI 10.1073/pnas.0702439104
   Arosio D, 2010, NAT METHODS, V7, P516, DOI [10.1038/NMETH.1471, 10.1038/nmeth.1471]
   Bellocq A, 1998, J BIOL CHEM, V273, P5086, DOI 10.1074/jbc.273.9.5086
   Brasuel M, 2001, ANAL CHEM, V73, P2221, DOI 10.1021/ac0012041
   Cai T, 2007, LANGMUIR, V23, P8663, DOI 10.1021/la700923r
   Cai WB, 2006, NANO LETT, V6, P669, DOI 10.1021/nl052405t
   Carmoa VAS, 2008, NUCL MED COMMUN, V29, P33, DOI 10.1097/MNM.0b013e3282f1bc0d
   Clark HA, 1999, ANAL CHEM, V71, P4837, DOI 10.1021/ac990630n
   DAVIS MH, 1987, BIOCHEM BIOPH RES CO, V149, P40, DOI 10.1016/0006-291X(87)91602-0
   Fehr M, 2002, P NATL ACAD SCI USA, V99, P9846, DOI 10.1073/pnas.142089199
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   Gerweck LE, 2006, MOL CANCER THER, V5, P1275, DOI 10.1158/1535-7163.MCT-06-0024
   Hilderbrand SA, 2008, BIOCONJUGATE CHEM, V19, P1635, DOI 10.1021/bc800188p
   Hoet P. M., 2004, J NANOBIOTECHNOL, V2, P12, DOI DOI 10.1186/1477-3155-2-12
   Horisawa E, 2002, PHARMACEUT RES, V19, P132, DOI 10.1023/A:1014260513728
   Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340
   Ji J, 2000, ANAL CHEM, V72, P3497, DOI 10.1021/ac000080p
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Keyaerts M, 2008, EUR J NUCL MED MOL I, V35, P999, DOI 10.1007/s00259-007-0664-2
   Kim S, 2006, CHEM COMMUN, P2071, DOI 10.1039/b600926c
   Kircher MF, 2004, BIOCONJUGATE CHEM, V15, P242, DOI 10.1021/bc034151d
   La Flamme KE, 2007, BIOMATERIALS, V28, P2638, DOI 10.1016/j.biomaterials.2007.02.010
   Lee H, 2011, BIOCONJUGATE CHEM, V22, P777, DOI 10.1021/bc100584d
   Li L, 2010, J CLIN INVEST, V120, P331, DOI 10.1172/JCI38702
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745
   Mainnemare A, 2004, J DENT RES, V83, P823, DOI 10.1177/154405910408301101
   MARTIN GR, 1994, CANCER RES, V54, P5670
   McNamara KP, 2001, ANAL CHEM, V73, P3240, DOI 10.1021/ac0102314
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Myochin T, 2011, J AM CHEM SOC, V133, P3401, DOI 10.1021/ja1063058
   Nair A, 2011, ACTA BIOMATER, V7, P3887, DOI 10.1016/j.actbio.2011.06.050
   Nair A, 2008, LANGMUIR, V24, P2015, DOI 10.1021/la7025973
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Olmez D, 2008, EXP LUNG RES, V34, P501, DOI 10.1080/01902140802271859
   OVERLY CC, 1995, P NATL ACAD SCI USA, V92, P3156, DOI 10.1073/pnas.92.8.3156
   Pelton R, 2000, ADV COLLOID INTERFAC, V85, P1, DOI 10.1016/S0001-8686(99)00023-8
   PELTON RH, 1986, COLLOID SURFACE, V20, P247, DOI 10.1016/0166-6622(86)80274-8
   PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x
   Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7
   STEEN KH, 1995, J NEUROSCI, V15, P3982
   Sun H, 2006, CHEM MATER, V18, P3381, DOI 10.1021/cm052750j
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748
   Vihola H, 2005, BIOMATERIALS, V26, P3055, DOI 10.1016/j.biomaterials.2004.09.008
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Wang L, 2005, NANO LETT, V5, P37, DOI 10.1021/nl048417g
   Weng H, 2004, J BIOMAT SCI-POLYM E, V15, P1167, DOI 10.1163/1568562041753106
   Xu H, 2001, ANAL CHEM, V73, P4124, DOI 10.1021/ac0102718
   Yu ZQ, 2005, BASIC CLIN PHARMACOL, V97, P222, DOI 10.1111/j.1742-7843.2005.pto_138.x
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2006, LANGMUIR, V22, P863, DOI 10.1021/la0515773
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
   Zhuang HM, 2002, SEMIN NUCL MED, V32, P47, DOI 10.1053/snuc.2002.29278
NR 55
TC 14
Z9 14
U1 5
U2 69
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2192-2640
EI 2192-2659
J9 ADV HEALTHC MATER
JI Adv. Healthc. Mater.
PD FEB
PY 2014
VL 3
IS 2
BP 221
EP 229
DI 10.1002/adhm.201200365
PG 9
WC Engineering, Biomedical; Nanoscience & Nanotechnology; Materials
   Science, Biomaterials
SC Engineering; Science & Technology - Other Topics; Materials Science
GA AB7DH
UT WOS:000331949000008
PM 23828849
DA 2018-10-19
ER

PT J
AU Lv, FK
   Liu, BL
   Li, WJ
   Jaganathan, GK
AF Lv, Fukou
   Liu, Baolin
   Li, Weijie
   Jaganathan, Ganesh K.
TI Devitrification and recrystallization of nanoparticle-containing
   glycerol and PEG-600 solutions
SO CRYOBIOLOGY
LA English
DT Article
DE Hydroxyapatite nanoparticles; Ice crystal geometry; Phase transition;
   Phase separation; Quenched dispersion; Cryopreservation
ID ICE CRYSTAL-GROWTH; SALMON SALMO-SALAR; AQUEOUS-SOLUTIONS;
   DIMETHYL-SULFOXIDE; MOUSE OOCYTES; WARMING RATE; CRYSTALLIZATION; WATER;
   NUCLEATION; CRYOMICROSCOPY
AB Nanoparticles in solution offer unique electrical, mechanical and thermal properties due to their physical presence and interaction with the state of dispersion. This work is aimed to study the effects of hydroxyapatite (HA) nanoparticles on the devitrification and recrystallization events of two important cryoprotective solutions used in cell and tissue preservation namely glycerol (60% w/w) and PEG-600 (50% w/ w). HA nanoparticles (20, 40 or 60 nm) were incorporated into solutions at the content of 0.1% or 0.5% (w/w), and were studied by differential scanning calorimeter (DSC) and cryomicroscopy. The presence of nanoparticles does not change the glass transition temperatures and melting temperatures of quenched solutions, but significantly affects the behavior of devitrification and recrystallization upon warming. Cryomicroscopic investigation showed the complex interactions among solution type, nanoparticle size and nanoparticle content, which apparently influence ice crystal growth or recrystallization in the quenched dispersions. These findings have significant implications for biomaterial cryopreservation, cryosurgery, and food manufacturing. The complexity of ice crystal growth kinetics in nanoparticle-containing dispersions remains to be poorly understood at the moment. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Lv, Fukou; Liu, Baolin; Li, Weijie; Jaganathan, Ganesh K.] Univ Shanghai Sci & Technol, Inst Biothermal Sci & Technol, Shanghai, Peoples R China.
RP Liu, BL (reprint author), Univ Shanghai Sci & Technol, Inst Biothermal Sci & Technol, Shanghai, Peoples R China.
EM blliuk@163.com
OI Jaganathan, Ganesh K./0000-0003-0972-9263
FU Natural Science Foundation of China [51076108]; Shanghai Dongfang
   Scholars Program;  [20103120110005]
FX This work was supported by the Natural Science Foundation of China
   (Grant No. 51076108), the Doctoral Program (Grant No. 20103120110005)
   and the Shanghai Dongfang Scholars Program.
CR Alizadeh E, 2009, FOOD BIOPROCESS TECH, V2, P257, DOI 10.1007/s11947-008-0157-8
   Baust J, 1997, CRYOBIOLOGY, V34, P373, DOI 10.1006/cryo.1997.2017
   BRONSHTEYN VL, 1995, CRYOBIOLOGY, V32, P1, DOI 10.1006/cryo.1995.1001
   Diller K R, 1970, Cryobiology, V7, P191
   FAHY GM, 1984, CRYOBIOLOGY, V21, P407, DOI 10.1016/0011-2240(84)90079-8
   Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115
   Gage AA, 2002, CRYOLETTERS, V23, P69
   Gao D, 2000, ILAR J, V41, P187
   Gonda T, 2005, PROG CRYST GROWTH CH, V51, P70, DOI 10.1016/j.pcrysgrow.2005.10.005
   Hagiwara T, 2006, FOOD BIOPHYS, V1, P74, DOI 10.1007/s11483-006-9009-0
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hao B., 2011, J NANOTECHNOLOGY ENG, V2
   Hey JM, 1997, J NON-CRYST SOLIDS, V211, P262, DOI 10.1016/S0022-3093(96)00637-0
   Hey JM, 1998, CRYOBIOLOGY, V37, P119, DOI 10.1006/cryo.1998.2108
   Hey JM, 1996, CRYOBIOLOGY, V33, P205, DOI 10.1006/cryo.1996.0021
   Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7
   Kang HU, 2006, EXP HEAT TRANSFER, V19, P181, DOI 10.1080/08916150600619281
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Le-Bail A, 2010, FOOD BIOPROCESS TECH, V3, P197, DOI 10.1007/s11947-008-0142-2
   Liu B., 2009, CRYOBIOLOGY, V59, P409
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4
   Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159
   MEHL P, 1989, THERMOCHIM ACTA, V155, P187, DOI 10.1016/0040-6031(89)87145-X
   MEHL PM, 1990, CRYOBIOLOGY, V27, P378, DOI 10.1016/0011-2240(90)90016-W
   MEHL PM, 1992, THERMOCHIM ACTA, V203, P475, DOI 10.1016/0040-6031(92)85218-K
   MEHL PM, 1993, THERMOCHIM ACTA, V223, P157, DOI 10.1016/0040-6031(93)80130-3
   Mishima O, 1998, NATURE, V396, P329
   Muldrew K, 2001, CRYOBIOLOGY, V42, P182, DOI 10.1006/cryo.2001.2321
   Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003
   Petzold G, 2009, FOOD BIOPHYS, V4, P378, DOI 10.1007/s11483-009-9136-5
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   SCHWARTZ GJ, 1982, CRYOBIOLOGY, V19, P529, DOI 10.1016/0011-2240(82)90182-1
   Sei T, 2002, J CRYST GROWTH, V240, P218, DOI 10.1016/S0022-0248(02)00875-8
   Seki S, 2008, BIOL REPROD, V79, P727, DOI 10.1095/biolreprod.108.069401
   Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058
   Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012
   Smith M.J., 1988, HUM REPROD, V3, P795
   Syamaladevi RM, 2012, FOOD BIOPHYS, V7, P57, DOI 10.1007/s11483-011-9243-y
   Teraoka Y, 2002, INT J REFRIG, V25, P218, DOI 10.1016/S0140-7007(01)00082-2
   Uchida T, 2007, J CRYST GROWTH, V299, P125, DOI 10.1016/j.jcrysgro.2006.10.261
   VIGIER G, 1987, J CRYST GROWTH, V84, P309, DOI 10.1016/0022-0248(87)90146-1
   Wang HY, 2009, CRYOBIOLOGY, V59, P83, DOI 10.1016/j.cryobiol.2009.04.013
   Yu SF, 2012, FOOD BIOPROCESS TECH, V5, P391, DOI 10.1007/s11947-011-0526-6
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
NR 45
TC 11
Z9 11
U1 1
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
EI 1090-2392
J9 CRYOBIOLOGY
JI Cryobiology
PD FEB
PY 2014
VL 68
IS 1
BP 84
EP 90
DI 10.1016/j.cryobiol.2013.12.006
PG 7
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA AC0MT
UT WOS:000332190100012
PM 24374134
DA 2018-10-19
ER

PT J
AU Mohamed, KR
   Mousa, SM
   El Bassyouni, GT
AF Mohamed, Khaled R.
   Mousa, Sahar M.
   El Bassyouni, Gehan T.
TI Fabrication of nano structural biphasic materials from phosphogypsum
   waste and their in vitro applications
SO MATERIALS RESEARCH BULLETIN
LA English
DT Article
DE Composites; Nanostructures; Electron microscopy; X-ray diffraction;
   Infrared spectroscopy
ID CALCIUM-PHOSPHATE BIOCERAMICS; ALPHA-TRICALCIUM PHOSPHATE; SOL-GEL
   TECHNIQUE; CRYSTALLINE HYDROXYAPATITE; BIOACTIVITY EVALUATION; DENTIN
   REGENERATION; BONE SUBSTITUTE; CERAMICS; SCAFFOLD; APATITE
AB In this study, a novel process of preparing biphasic calcium phosphate (BCP) is proposed. Also its bioactivity for the utilization of the prepared BCP as a biomaterial is studied. A mixture of calcium hydroxyapatite (HAP) and tricalcium phosphate (beta-TCP) could be obtained by thermal treatment of HAP which was previously prepared from phosphogypsum (PG) waste. The chemical and phase composition, morphology and particle size of prepared samples was characterized by X-ray diffraction (XRD), Infrared spectroscopy (IR), Scanning electron microscopy (SEM) and Transmission electron microscopy (TEM). The bioactivity was investigated by soaking of the calcined samples in simulated body fluid (SBF). Results confirmed that the calcination temperatures played an important role in the formation of calcium phosphate (CP) materials. XRD results indicated that HAP was partially decomposed into beta-TCP. The in vitro data confirmed that the calcined HAP forming BCP besides other phases such as pyrophosphate and silica are bioactive materials. Therefore, BCP will be used as good biomaterials for medical applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mohamed, Khaled R.; El Bassyouni, Gehan T.] Natl Res Ctr, Biomat Dept, Cairo, Egypt.
   [Mousa, Sahar M.] King Abdulaziz Univ, Sci & Art Coll, Dept Chem, Rabigh 21911, Saudi Arabia.
   [Mousa, Sahar M.] Natl Res Ctr, Dept Inorgan Chem, Cairo 11787, Egypt.
   [El Bassyouni, Gehan T.] Taif Univ, Coll Med, Dept Med Phys, At Taif, Saudi Arabia.
RP Mohamed, KR (reprint author), Natl Res Ctr, Biomat Dept, Cairo, Egypt.
EM kh_rezk966@yahoo.com
RI Mousa, Sahar/J-3244-2013
OI El-Bassyouni, Gehan/0000-0001-8438-0570; Mohamed, Khaled
   Rezk/0000-0001-7019-4064; Mousa, Sahar/0000-0003-3790-5084
CR AbdulQader ST, 2013, CERAM INT, V39, P2375, DOI 10.1016/j.ceramint.2012.08.089
   Al-Hwaiti MS, 2010, ACTA GEOCHIM, V29, P261, DOI 10.1007/s11631-010-0455-5
   Ando Y, 2009, NAGOYA J MED SCI, V71, P51
   BLAKESLEE KC, 1971, J AM CERAM SOC, V54, P559, DOI 10.1111/j.1151-2916.1971.tb12207.x
   Boilet L, 2013, CERAM INT, V39, P283, DOI 10.1016/j.ceramint.2012.06.023
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Chen JD, 2011, MATER LETT, V65, P1923, DOI 10.1016/j.matlet.2011.03.076
   Cheng ZH, 1998, LANGMUIR, V14, P6681, DOI 10.1021/la980339n
   Chu KT, 2013, CERAM INT, V39, P1455, DOI 10.1016/j.ceramint.2012.07.089
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   DUCHEYNE P, 1987, J BIOMED MATER RES-A, V21, P219
   El Kady AA, 2009, CERAM INT, V35, P2933, DOI 10.1016/j.ceramint.2009.03.042
   Elfayoumi MAK, 2010, MAT SCI ENG C-MATER, V30, P509, DOI 10.1016/j.msec.2010.01.012
   Farzadi A, 2011, CERAM INT, V37, P65, DOI 10.1016/j.ceramint.2010.08.021
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Fathi MH, 2009, J CRYST GROWTH, V311, P1392, DOI 10.1016/j.jcrysgro.2008.11.100
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   Hanna AA, 1999, J MATER SCI TECHNOL, V15, P431
   HLAVAY J, 1978, CLAY CLAY MINER, V26, P139, DOI 10.1346/CCMN.1978.0260209
   Hui Y., 2008, T NONFERR METAL SOC, V18, P913
   Jaroenworaluck A, 2007, EUROPEAN CELLS MAT, V14, P67
   Kawata M, 2004, J MATER SCI-MATER M, V15, P817, DOI 10.1023/B:JMSM.0000032823.66093.aa
   Klug H.P., 1997, XRAY DIFFRACTION PRO, P637
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Li YB, 2007, ACTA BIOMATER, V3, P251, DOI 10.1016/j.actbio.2006.07.003
   Lobo SE, 2010, MATERIALS, V3, P815, DOI 10.3390/ma3020815
   Lukic M, 2011, J EUR CERAM SOC, V31, P19, DOI 10.1016/j.jeurceramsoc.2010.09.006
   Menon P. R., 1995, Proceedings of the 1995 Fourteenth Southern Biomedical Engineering Conference (Cat. No.95TH0703-9), P95, DOI 10.1109/SBEC.1995.514446
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Mohamed KR, 2011, CERAM INT, V37, P3265, DOI 10.1016/j.ceramint.2011.05.121
   MORTIER A, 1989, THERMOCHIM ACTA, V143, P265, DOI 10.1016/0040-6031(89)85065-8
   Mousa S, 2013, MATER RES BULL, V48, P823, DOI 10.1016/j.materresbull.2012.11.067
   Oyane A, 2003, J BIOMED MATER RES A, V65A, P188, DOI 10.1002/jbm.a.10482
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Rashchi F, 2000, MINER ENG, V13, P1019, DOI 10.1016/S0892-6875(00)00087-X
   Shuai CJ, 2013, MATER CHARACT, V77, P23, DOI 10.1016/j.matchar.2012.12.009
   Tayibi H, 2009, J ENVIRON MANAGE, V90, P2377, DOI 10.1016/j.jenvman.2009.03.007
   Tonomura A, 2010, ANN BIOMED ENG, V38, P1664, DOI 10.1007/s10439-010-9910-z
   Varma HK, 2005, CERAM INT, V31, P109, DOI 10.1016/j.ceramint.2004.03.041
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   Veljovic D, 2010, CERAM INT, V36, P595, DOI 10.1016/j.ceramint.2009.09.038
   Viswanath B, 2008, BIOMATERIALS, V29, P4855, DOI 10.1016/j.biomaterials.2008.09.001
   Wu SC, 2011, MATER CHARACT, V62, P526, DOI 10.1016/j.matchar.2011.03.014
   Yang JK, 2009, CONSTR BUILD MATER, V23, P687, DOI 10.1016/j.conbuildmat.2008.02.011
   Zhang HQ, 2011, MATER CHEM PHYS, V126, P642, DOI 10.1016/j.matchemphys.2010.12.067
   Zhoa H., 2008, MATER CHEM PHYS, V111, P265
   Zhou J, 2012, CONSTR BUILD MATER, V34, P114, DOI 10.1016/j.conbuildmat.2012.02.045
   Zyman ZZ, 2008, J MATER SCI-MATER M, V19, P2819, DOI 10.1007/s10856-008-3402-9
NR 52
TC 8
Z9 9
U1 0
U2 33
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0025-5408
EI 1873-4227
J9 MATER RES BULL
JI Mater. Res. Bull.
PD FEB
PY 2014
VL 50
BP 432
EP 439
DI 10.1016/j.materresbull.2013.11.023
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA AB6ST
UT WOS:000331920500073
DA 2018-10-19
ER

PT J
AU Jeon, HJ
   Lee, H
   Kim, GH
AF Jeon, Ho Jun
   Lee, Hyeongjin
   Kim, Geun Hyung
TI Nano-Sized Surface Patterns on Electrospun Microfibers Fabricated Using
   a Modified Plasma Process for Enhancing Initial Cellular Activities
SO PLASMA PROCESSES AND POLYMERS
LA English
DT Article
DE electrospun fibers; hierarchical surface pattern; biomaterial
ID TISSUE ENGINEERING APPLICATIONS; NANOFIBER MESHES; DIFFERENTIATION;
   NANOSCALE; PROLIFERATION; ORGANIZATION; SCAFFOLDS; ADHESION; MICRO;
   SHAPE
AB An easy and versatile method of generating a nano-sized patterned surface on a nonwoven mat of electrospun poly(E-caprolactone) (PCL) fibers is described. A nano-sized pattern could be achieved on the surface of the microfiber mat using a modified plasma-treatment method with two nano-sized templates (100 and 800nm). Initial cell attachment and proliferation using osteoblast-like-cells (MG63) were enhanced dramatically compared to a conventional plasma-treated fiber mat. This new type of plasma-treated fiber has high potential as a biomaterial, and can be employed for various tissue engineering applications.
C1 [Jeon, Ho Jun; Lee, Hyeongjin; Kim, Geun Hyung] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Biomechatron Engn, Suwon, South Korea.
RP Kim, GH (reprint author), Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Dept Biomechatron Engn, Suwon, South Korea.
EM gkimbme@skku.edu
FU National Research Foundation of Korea grant; Ministry of Education,
   Science, and Technology (MEST) [NRF-2012R1A2A2A01017435]; Korean Health
   Technology R&D Project, Ministry of Health & Welfare, Republic of Korea
   [A120942]
FX This research was financially supported by the National Research
   Foundation of Korea grant funded by the Ministry of Education, Science,
   and Technology (MEST) (Grant No. NRF-2012R1A2A2A01017435) and also was
   partially supported by a grant of the Korean Health Technology R&D
   Project, Ministry of Health & Welfare, Republic of Korea (Grant no.
   A120942).
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Chen JP, 2011, ACTA BIOMATER, V7, P234, DOI 10.1016/j.actbio.2010.08.015
   Chen VJ, 2006, BIOMATERIALS, V27, P3973, DOI 10.1016/j.biomaterials.2006.02.043
   CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Hwang IT, 2009, COLLOID SURFACE B, V74, P375, DOI 10.1016/j.colsurfb.2009.08.007
   Jacobs T, 2012, PLASMA CHEM PLASMA P, V32, P1039, DOI 10.1007/s11090-012-9394-8
   Karuri NW, 2006, IEEE T NANOBIOSCI, V5, P273, DOI 10.1109/TNB.2006.886570
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kumar G, 2012, BIOMATERIALS, V33, P4022, DOI 10.1016/j.biomaterials.2012.02.048
   Lee H, 2013, J MATER CHEM B, V1, P3670, DOI 10.1039/c3tb20424c
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Martins A, 2009, J TISSUE ENG REGEN M, V3, P37, DOI 10.1002/term.132
   Nandakumar A, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/1/015006
   Nandakumar A, 2013, SMALL, V9, P3405, DOI 10.1002/smll.201300220
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Shevach M, 2013, J MATER CHEM B, V1, P5210, DOI 10.1039/c3tb20584c
   Slater JH, 2011, ADV FUNCT MATER, V21, P2876, DOI 10.1002/adfm.201100297
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Yamazoe H, 2008, LANGMUIR, V24, P8402, DOI 10.1021/la801221r
   Yan D, 2013, J BIOMED MATER RES A, V101, P963, DOI 10.1002/jbm.a.34398
   Yildirim ED, 2011, PLASMA PROCESS POLYM, V8, P256, DOI 10.1002/ppap.201000009
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 29
TC 6
Z9 6
U1 0
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1612-8850
EI 1612-8869
J9 PLASMA PROCESS POLYM
JI Plasma Process. Polym.
PD FEB
PY 2014
VL 11
IS 2
BP 142
EP 148
DI 10.1002/ppap.201300144
PG 7
WC Physics, Applied; Physics, Fluids & Plasmas; Physics, Condensed Matter;
   Polymer Science
SC Physics; Polymer Science
GA AB7GE
UT WOS:000331956700007
DA 2018-10-19
ER

PT J
AU Wang, FJ
   Zheng, Z
   Wang, W
   Gu, ZQ
   Wang, J
   Wang, XL
AF Wang, Fangjie
   Zheng, Zhen
   Wang, Wei
   Gu, Zhenqian
   Wang, Jing
   Wang, Xinling
TI Trypsin-inspired poly(urea-urethane)s containing phenylalanine-lysine
   ethyl ester-phenylalanine units
SO POLYMER DEGRADATION AND STABILITY
LA English
DT Article
DE Degradation; Poly(urea-urethane); Tri-peptide; Trypsin; Enzymatic
ID TYROSINE-BASED POLYURETHANES; GROWTH-FACTOR DELIVERY; BIOMATERIAL
   APPLICATIONS; AMINO-ACID; SURFACE FUNCTIONALIZATION; SCAFFOLDS;
   CYTOCOMPATIBILITY; PUTRESCINE
AB A novel tri-peptide derivative phenylalanine-lysine ethyl ester-phenylalanine (PLP) was synthesized by carbodiimide hydrochloride (EDC center dot HCl) mediated coupling reaction from phenylalanine and lysine ethyl ester in the presence of NHS. Then PLP was used as a chain extender to synthesize a kind of trypsin-inspired poly(urea-urethane)s (PLP-PU) with polyethylene glycol (PEG) as soft segment and hexamethylene diisocyanate (HDI) as hard segment. Enzymatic degradation tests showed that PLP unit was very sensitive to trypsin in its solution. Experimental results indicated that the degradability was obviously improved by introducing PLP into the main chain of poly(urea-urethane) because the PLP was effectively broken by the action of trypsin in the process of degradation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Wang, Fangjie; Zheng, Zhen; Wang, Wei; Gu, Zhenqian; Wang, Jing; Wang, Xinling] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
RP Wang, XL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
EM xlwang@sjtu.edu.cn
FU National Science Fund of China [21274085]; Shanghai Leading Academic
   Discipline Project [B202]
FX This project is supported by the National Science Fund of China
   (21274085) and the Shanghai Leading Academic Discipline Project (No.
   B202)
CR Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Brandon C, 1999, INTRO PROTEIN STRUCT, P159
   Buruiana EC, 2004, J BIOMAT SCI-POLYM E, V15, P781, DOI 10.1163/156856204774196162
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   Fung YS, 2001, ANAL CHEM, V73, P5302, DOI 10.1021/ac010655y
   Gao ZY, 2009, NEW CHEM MAT, V3, P74
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Guelcher SA, 2008, BIOMATERIALS, V29, P1762, DOI 10.1016/j.biomaterials.2007.12.046
   Huang M. N., 2009, J BIOMED SCI ENG, V2, P36
   Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005
   Jozwiak AB, 2008, J MATER CHEM, V18, P2240, DOI 10.1039/b719025e
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Leonard JK, 2012, MACROMOLECULES, V45, P677
   Lu HX, 2012, POLYM CHEM-UK, V3, P498, DOI 10.1039/c2py00481j
   Marcos-Fernandez A, 2006, POLYMER, V47, P785, DOI 10.1016/j.polymer.2005.12.007
   MOLLY SS, 2010, MACROMOLECULES, V43, P581
   MORI A, 1985, BIOMATERIALS, V6, P325, DOI 10.1016/0142-9612(85)90088-2
   Nakamura M, 2008, BIOMATERIALS, V29, P2977, DOI 10.1016/j.biomaterials.2008.04.006
   Parrag IC, 2010, J BIOMAT SCI-POLYM E, V21, P843, DOI 10.1163/156856209X446743
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   Sarkar D, 2007, EXPRESS POLYM LETT, V1, P724, DOI 10.3144/expresspolymlett.2007.100
   Sarkar D, 2008, J APPL POLYM SCI, V108, P2345, DOI 10.1002/app.27637
   Sarkar D, 2007, POLYM DEGRAD STABIL, V92, P1994, DOI 10.1016/j.polymdegradstab.2007.08.003
   Sarkar D, 2009, J BIOMED MATER RES A, V90A, P263, DOI 10.1002/jbm.a.32095
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Skarja GA, 2001, J BIOMAT SCI-POLYM E, V12, P851, DOI 10.1163/156856201753113060
   Suzuki Y, 2000, J BIOMED MATER RES, V50, P405, DOI 10.1002/(SICI)1097-4636(20000605)50:3<405::AID-JBM15>3.0.CO;2-Z
   Wang H, 2004, LANGMUIR, V20, P1877, DOI 10.1021/la035376f
   Ward J, 2010, BIOMACROMOLECULES, V11, P3093, DOI 10.1021/bm100898p
   Wei GB, 2006, J CONTROL RELEASE, V112, P103, DOI 10.1016/j.jconrel.2006.01.011
   Woessner J.F., 2000, MATRIX METALLOPROTEI
   Xu XL, 2007, EUR POLYM J, V43, P3187, DOI 10.1016/j.eurpolymj.2007.05.024
   Yue YM, 2008, J APPL POLYM SCI, V6, P3836
   Zhou LJ, 2011, MACROMOLECULES, V44, P857, DOI 10.1021/ma102346a
NR 37
TC 2
Z9 2
U1 2
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0141-3910
EI 1873-2321
J9 POLYM DEGRAD STABIL
JI Polym. Degrad. Stabil.
PD FEB
PY 2014
VL 100
BP 86
EP 92
DI 10.1016/j.polymdegradstab.2013.12.007
PG 7
WC Polymer Science
SC Polymer Science
GA AB6UN
UT WOS:000331925100011
DA 2018-10-19
ER

PT J
AU Garcia, AJ
AF Garcia, Andres J.
TI PEG-Maleimide Hydrogels for Protein and Cell Delivery in Regenerative
   Medicine
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Biomaterial; Integrin; RGD; Cell adhesion; Tissue repair
ID ENDOTHELIAL GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; FACTOR GENE DELIVERY;
   ISLET TRANSPLANTATION; MYOCARDIAL-INFARCTION; PANCREATIC-ISLETS;
   EXTRACELLULAR-MATRIX; PEPTIDE NANOFIBERS; CONTROLLED-RELEASE; MICHAEL
   ADDITION
AB Protein- and cell-based therapies represent highly promising strategies for regenerative medicine, immunotherapy, and oncology. However, these therapies are significantly limited by delivery considerations, particularly in terms of protein stability and dosing kinetics as well as cell survival, engraftment, and function. Hydrogels represent versatile and robust delivery vehicles for proteins and cells due to their high water content that retains protein biological activity, high cytocompatibility and minimal adverse host reactions, flexibility and tunability in terms of chemistry, structure, and polymerization format, ability to incorporate various biomolecules to convey biofunctionality, and opportunity for minimally invasive delivery as injectable carriers. This review highlights recent progress in the engineering of poly(ethylene glycol) hydrogels cross-linked using maleimide reactive groups for protein and cell delivery.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
EM andres.garcia@me.gatech.edu
FU NIH [R01 AR062368, R01 AR062920, DP3 DK094346]; NSF [CBET 0939511];
   Juvenile Diabetes Research Foundation [17-2013-277]
FX AJG is partially supported by the NIH (R01 AR062368, R01 AR062920, DP3
   DK094346), NSF (CBET 0939511) and the Juvenile Diabetes Research
   Foundation (17-2013-277).
CR Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a
   Almeda FQ, 2001, CRIT CARE CLIN, V17, P411, DOI 10.1016/S0749-0704(05)70175-5
   Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068
   Baldwin SP, 1998, ADV DRUG DELIVER REV, V33, P71, DOI 10.1016/S0169-409X(98)00021-0
   Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Brady AC, 2013, TISSUE ENG A
   Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144
   Centers for Disease Control and Prevention, 2005, NAT DIAB FACT SHEET
   Cheng K, 2004, GENE THER, V11, P1105, DOI 10.1038/sj.gt.3302267
   Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589
   Cheng Y, 2007, WORLD J GASTROENTERO, V13, P2862
   Chiu LLY, 2012, REGEN MED, V7, P523, DOI [10.2217/rme.12.35, 10.2217/RME.12.35]
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Cittadini A, 2011, EUR J HEART FAIL, V13, P1264, DOI 10.1093/eurjhf/hfr143
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461
   Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103
   Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663
   Fiorina P, 2008, AM J TRANSPLANT, V8, P1990, DOI 10.1111/j.1600-6143.2008.02353.x
   Fu Y, 2011, J BIOMED MATER RES A, V98A, P201, DOI 10.1002/jbm.a.33106
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hiemstra C, 2007, BIOMACROMOLECULES, V8, P1548, DOI 10.1021/bm061191m
   Hiemstra C, 2007, MACROMOLECULES, V40, P1165, DOI 10.1021/ma062468d
   Hiscox AM, 2008, TISSUE ENG PT A, V14, P433, DOI 10.1089/tea.2007.0099
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Hou JY, 2013, STEM CELL REV REP, V9, P326, DOI 10.1007/s12015-012-9421-4
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hu BH, 2009, BIOMACROMOLECULES, V10, P2194, DOI 10.1021/bm900366e
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Hunt NC, 2013, TISSUE ENG PT A, V19, P905, DOI [10.1089/ten.TEA.2012.0197, 10.1089/ten.tea.2012.0197]
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kim J, 2007, BIOMACROMOLECULES, V8, P3682, DOI 10.1021/bm700756z
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Kopecek J, 2012, ANGEW CHEM INT EDIT, V51, P7396, DOI 10.1002/anie.201201040
   Lakey JRT, 2006, METH MOL B, V333, P47
   Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x
   Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175
   Mathieu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051991
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Narang AS, 2006, PHARMACOL REV, V58, P194, DOI 10.1124/pr.58.2.6
   Narang AS, 2004, PHARM RES, V21, P15, DOI 10.1023/B:PHAM.0000012147.52900.b8
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Phelps EA, 2015, DRUG DELIV TRANSL RE, V5, P125, DOI 10.1007/s13346-013-0142-2
   Phelps EA, 2013, BIOMATERIALS, V34, P4602, DOI 10.1016/j.biomaterials.2013.03.012
   Phelps EA, 2012, ADV MATER, V24, P64, DOI 10.1002/adma.201103574
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Prokoph S, 2012, BIOMATERIALS, V33, P4792, DOI 10.1016/j.biomaterials.2012.03.039
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019
   Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197
   Rizzi SC, 2005, BIOMACROMOLECULES, V6, P1226, DOI 10.1021/bm049614c
   Rizzi SC, 2006, BIOMACROMOLECULES, V7, P3019, DOI 10.1021/bm060504a
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046
   Salimath AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050980
   SAWHNEY AS, 1994, BIOTECHNOL BIOENG, V44, P383, DOI 10.1002/bit.260440317
   Schmidt JJ, 2008, J BIOMED MATER RES A, V87A, P1113, DOI 10.1002/jbm.a.32287
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Sigrist S, 2003, CELL TRANSPLANT, V12, P627, DOI 10.3727/000000003108747109
   Singelyn JM, 2012, J AM COLL CARDIOL, V59, P751, DOI 10.1016/j.jacc.2011.10.888
   Smith R.R., 2013, BIOMATTER, V3
   Stabenfeldt SE, 2010, TISSUE ENG PT A, V16, P3747, DOI [10.1089/ten.tea.2009.0837, 10.1089/ten.TEA.2009.0837]
   Stabler CL, 2007, BIOCONJUGATE CHEM, V18, P1713, DOI 10.1021/bc7002814
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   Vaithilingam V, 2008, CURR OPIN ORGAN TRAN, V13, P633, DOI 10.1097/MOT.0b013e328317a48b
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Weber LM, 2007, CELL TRANSPLANT, V16, P1049, DOI 10.3727/000000007783472336
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Wilson JT, 2008, NANO LETT, V8, P1940, DOI 10.1021/nl080694q
   Yu HQ, 2006, SOFT MATTER, V2, P343, DOI 10.1039/b517206c
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 97
TC 15
Z9 15
U1 7
U2 55
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD FEB
PY 2014
VL 42
IS 2
SI SI
BP 312
EP 322
DI 10.1007/s10439-013-0870-y
PG 11
WC Engineering, Biomedical
SC Engineering
GA AB7ND
UT WOS:000331976300007
PM 23881112
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rapsch, K
   Bier, FF
   Tadros, M
   von Nickisch-Rosenegk, M
AF Rapsch, Karsten
   Bier, Frank F.
   Tadros, Monier
   von Nickisch-Rosenegk, Markus
TI Identification of Antimicrobial Peptides and Immobilization Strategy
   Suitable for a Covalent Surface Coating with Biocompatible Properties
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID IN-VITRO; BACTERIAL; INFECTIONS; CATHETERS; BIOFILMS; RELEASE; DRUGS;
   VIVO
AB Bacterial accumulation on solid material displays a major source of biomaterial associated infections, cross contamination, and spreading. To overcome these problems, different investigations on surface modifications for the containment of bacterial adhesion have been done. The aim of this research is the development of a rapid and efficient screening procedure to identify and investigate biologically active peptides in an immobilized state in order to produce an antimicrobial surface coating. We figured out that the antimicrobial mode of action is the most important parameter because only peptides with pronounced membrane disruption abilities displayed meaningful activity in an immobilized state. In addition, we highlighted the influence of the coupling reaction chemistry on the activity and amount of the immobilized peptide. Thereupon we developed an optimized antimicrobial surface coating with unrestricted antimicrobial properties by adjusting the immobilization strategy in combination with lowering the necessary peptide amount. Moreover we demonstrated that this antimicrobial surface coating displayed no cytotoxic activity against a eukaryotic cell line and thereby indicates a promising biocompatibility. Furthermore, different antimicrobial peptides obtained either by chemical peptide synthesis or by recombinant DNA technology were used in this study and their activities as well as their potential applications were discussed.
C1 [Rapsch, Karsten; Bier, Frank F.; von Nickisch-Rosenegk, Markus] Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam, D-14476 Potsdam, Germany.
   [Tadros, Monier] Int Lab Biotechnol & Consulting GmbH ILBG, D-14473 Potsdam, Germany.
RP Rapsch, K (reprint author), Fraunhofer Inst Biomed Engn IBMT, Branch Potsdam, Muehlenberg 13, D-14476 Potsdam, Germany.
EM karsten.rapsch@ibmt.fraunhofer.de
FU German Federal Ministry of Education and Research [03IS2201A]; Ministry
   of Economy of the Federal State of Brandenburg
   [ILB80139358/ILB80139359]; EU
FX This work was supported by the German Federal Ministry of Education and
   Research Grant 03IS2201A and the Ministry of Economy of the Federal
   State of Brandenburg Grant ILB80139358/ILB80139359 and was cofinanced by
   the EU, European Funds for Regional Development (EFRE). We gratefully
   acknowledge Simone Aubele, Anne Thomas, and Martina Obry for technical
   assistance.
CR Ando T, 1973, Mol Biol Biochem Biophys, V12, P1
   Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Avalos V.I, 2013, BIOINTERPHASES, V8, P22
   Bagheri M, 2012, BIOCONJUGATE CHEM, V23, P66, DOI 10.1021/bc200367f
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Bryers JD, 2006, BIOMATERIALS, V27, P5039, DOI 10.1016/j.biomaterials.2006.05.034
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Clinical and Laboratory Standards Institute, 2006, M100S16CLSI
   Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018
   Costa F, 2011, ACTA BIOMATER, V7, P1431, DOI 10.1016/j.actbio.2010.11.005
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 1999, NEW ENGL J MED, V340, P1, DOI 10.1056/NEJM199901073400101
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Etienne O, 2004, ANTIMICROB AGENTS CH, V48, P3662, DOI 10.1128/AAC.48.10.3662-3669.2004
   European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical M Infectious D, 2003, CLIN MICROBIOL INFEC, V9, pIX, DOI DOI 10.1046/J.1469-0691.2003.00790.X
   Gao GZ, 2011, BIOMATERIALS, V32, P3899, DOI 10.1016/j.biomaterials.2011.02.013
   Gennaro R, 2000, BIOPOLYMERS, V55, P31, DOI 10.1002/1097-0282(2000)55:1<31::AID-BIP40>3.3.CO;2-0
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Hong Y, 2008, LANGMUIR, V24, P5003, DOI 10.1021/la703564q
   Jones JR, 2006, J MATER SCI-MATER M, V17, P989, DOI 10.1007/s10856-006-0434-x
   KAMAL GD, 1991, JAMA-J AM MED ASSOC, V265, P2364, DOI 10.1001/jama.265.18.2364
   Li P, 2011, NAT MATER, V10, P149, DOI [10.1038/nmat2915, 10.1038/NMAT2915]
   Mad F. D., 2008, ANTIMICROB AGENTS CH, V52, P1957
   MAGNUSSON KE, 1989, BIOCHEM SOC T, V17, P454, DOI 10.1042/bst0170454
   Matl FD, 2009, J BIOMAT SCI-POLYM E, V20, P1439, DOI 10.1163/092050609X12457418973107
   Onaizi S. A., 2010, BIOTECHNOL ADV, V29, P67
   Park CB, 2000, P NATL ACAD SCI USA, V97, P8245, DOI 10.1073/pnas.150518097
   Ramstedt M, 2009, BIOMATERIALS, V30, P1524, DOI 10.1016/j.biomaterials.2008.12.008
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Shukla A, 2010, BIOMATERIALS, V31, P2348, DOI 10.1016/j.biomaterials.2009.11.082
   Siedenbiedel F, 2012, POLYMERS-BASEL, V4, P46, DOI 10.3390/polym4010046
   Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375
   Soliman W, 2010, J PHYS CHEM B, V114, P11292, DOI 10.1021/jp104024d
   Tadros M., 2009, U.S. Patent, Patent No. [US 7544483 B2, 7544483]
   Tadros M., 2003, World-wide Patent, Patent No. [WO 2003/106485 A1, 2003106485]
   Thornton J, 1996, ANAESTHESIA, V51, P1018, DOI 10.1111/j.1365-2044.1996.tb14994.x
   UTSUGI T, 1991, CANCER RES, V51, P3062
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
NR 42
TC 18
Z9 19
U1 2
U2 52
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD FEB
PY 2014
VL 25
IS 2
BP 308
EP 319
DI 10.1021/bc4004469
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA AB4SH
UT WOS:000331779700014
PM 24372365
DA 2018-10-19
ER

PT J
AU Thomas, NP
   Tran, N
   Tran, PA
   Walters, JL
   Jarrell, JD
   Hayda, RA
   Born, CT
AF Thomas, Nathan P.
   Nhiem Tran
   Tran, Phong A.
   Walters, Jerry L.
   Jarrell, John D.
   Hayda, Roman A.
   Born, Christopher T.
TI Characterization and bioactive properties of zirconia based polymeric
   hybrid for orthopedic applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MECHANICAL-PROPERTIES; NANOPHASE CERAMICS; IN-VITRO; SURFACE; TITANIUM;
   COATINGS; ADHESION; OXIDE; NANOTECHNOLOGY; BIOMATERIAL
AB Zirconia is a transition metal oxide with current applications to orthopedic implants. It has been shown to up-regulate specific genes involved in bio-integration and injury repair. This study examines the effects of zirconia and polydimethylsiloxane (PDMS) hybrids on the proliferation and viability of human primary osteoblast and fibroblast cells. In this study, zirconia-PDMS hybrid coatings were synthesized using a modified sol gel process. The hybrid material was characterized using optical microscopy, scanning electron microscopy, X-ray photoelectron spectroscopy, and contact angle analysis. This study demonstrates that Zr-PMDS surface materials display hydrophobic surface properties coupled with a preferential deposition of polymer near the surface. Primary osteoblast and fibroblast proliferation and viability on hybrid coated surfaces were evaluated via a rapid screening methodology using WST-1 and calcein AM assays. The cells were seed at 5,000 cells per well in 96-well plates coated with various composition of Zr-PDMS hybrids. The results showed increasing cell proliferation with increasing zirconia concentration, which peaked at 90 % v/v zirconia. Proliferation of osteoblasts and fibroblasts displayed similar trends on the hybrid material, although osteoblasts displayed a bi-phasic dose response by the calcein AM assay. The results of this current study show that Zr-PDMS may be used to influence tissue-implant integration, supporting the use of the hybrid as a promising coating for orthopedic trauma implants.
C1 [Thomas, Nathan P.; Nhiem Tran; Tran, Phong A.; Walters, Jerry L.; Jarrell, John D.; Hayda, Roman A.; Born, Christopher T.] Brown Univ, Dept Orthoped, Alpert Med Sch, Providence, RI 02905 USA.
   [Nhiem Tran; Tran, Phong A.; Hayda, Roman A.; Born, Christopher T.] Rhode Isl Hosp, Weiss Ctr Orthopaed Trauma Res, Providence, RI 02905 USA.
   [Jarrell, John D.; Born, Christopher T.] BioIntraface Inc, North Kingstown, RI 02852 USA.
RP Born, CT (reprint author), Brown Univ, Dept Orthoped, Alpert Med Sch, Suite 200,2 Dudley St, Providence, RI 02905 USA.
EM Christopher_Born@brown.edu
RI Tran, Phong/I-4039-2017
OI Tran, Phong/0000-0003-2820-7399; Jarrell, John/0000-0001-8179-9456
FU RIH Orthopedic Foundation; Stein/Bellet Foundation for Orthopedic Trauma
   Research; Vietnam Education Foundation
FX This project was supported in part by the RIH Orthopedic Foundation, the
   Stein/Bellet Foundation for Orthopedic Trauma Research, and the Vietnam
   Education Foundation. The authors would like to thank Mike Platek for
   the help with XPS. SEM and contact angle measurements were performed at
   the Leduc Imaging Facility and the Tripathi Lab, Brown University
   respectively.
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Jarrell JD, 2010, J BIOMED MATER RES A, V92A, P1094, DOI 10.1002/jbm.a.32435
   Jarrell JD, 2009, J BIOMED MATER RES A, V90A, P272, DOI 10.1002/jbm.a.32093
   Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525
   Kohal RJ, 2011, CLIN ORAL IMPLAN RES, V22, P808, DOI 10.1111/j.1600-0501.2010.02067.x
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kuo WH, 2011, BIOMACROMOLECULES, V12, P4348, DOI 10.1021/bm2013185
   Liu XY, 2006, BIOMATERIALS, V27, P3904, DOI 10.1016/j.biomaterials.2006.03.007
   Martin RA, 2012, PHILOS T R SOC A, V370, P1422, DOI 10.1098/rsta.2011.0308
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Milanesi F, 2010, J PHYS CHEM C, V114, P8287, DOI 10.1021/jp1014669
   Mills KL, 2008, J MATER RES, V23, P37, DOI 10.1557/JMR.2008.0029
   Nakade M, 2004, J MATER SCI, V39, P4131, DOI 10.1023/B:JMSC.0000033393.11687.cf
   Nhiem T, 2011, ACTA BIOMATER, V7, P1298, DOI 10.1016/j.actbio.2010.10.004
   Palmieri A, 2008, CLIN IMPLANT DENT R, V10, P200, DOI 10.1111/j.1708-8208.2007.00078.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Sato M, 2004, EXPERT REV MED DEVIC, V1, P105, DOI 10.1586/17434440.1.1.105
   Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003
   Tran N, 2013, BIOMED RES INT, DOI 10.1155/2013/674378
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wang GC, 2011, COLLOID SURFACE B, V86, P267, DOI 10.1016/j.colsurfb.2011.04.006
   Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xia ZC, 2000, J MECH PHYS SOLIDS, V48, P1107, DOI 10.1016/S0022-5096(99)00081-2
   Yamashita D, 2009, DENT MATER J, V28, P461, DOI 10.4012/dmj.28.461
   Young MD, 2014, J BIOMED MATER RES A, V102, P1478, DOI 10.1002/jbm.a.34832
   Yuan L, 2011, MACROMOL BIOSCI, V11, P1031, DOI 10.1002/mabi.201000464
NR 35
TC 4
Z9 4
U1 1
U2 21
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 347
EP 354
DI 10.1007/s10856-013-5093-0
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400008
PM 24243225
DA 2018-10-19
ER

PT J
AU Floriano, JF
   da Mota, LSLS
   Furtado, EL
   Rossetto, VJV
   Graeff, CFO
AF Floriano, Juliana Ferreira
   Lima Silveira da Mota, Ligia Souza
   Furtado, Edson Luiz
   Vieira Rossetto, Victor Jose
   Graeff, Carlos F. O.
TI Biocompatibility studies of natural rubber latex from different tree
   clones and collection methods
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID HEVEA-BRASILIENSIS; COMET ASSAY; NEUTRAL RED; CYTOTOXICITY;
   BIOMATERIALS; GUIDELINES
AB Natural rubber latex (NRL) has several features that make it an excellent biomaterial to promote the growth and repair of tissues, skin and bones. Most of the research with NRL membranes uses a mixture of different clones and chemical preservatives in the collection process. In this study, we compared five clones that produce NRL, seeking to identify their differences in biocompatibility. The clones studied were RRIM 600, PB 235, GT1, PR 255 and IAN 873 commonly found in plantations in Brazil. We did also study the effect of ammonia used during latex collection. NRL membranes were prepared aseptically and sterilized. In the in vitro tests, the membranes remained in direct contact with mouse fibroblasts cells for three periods, 24, 48 and 72 h. In the in vivo tests, the membranes were implanted subcutaneously in rabbits. The results indicated the biocompatibility of the membranes obtained from all clones. Membranes from the clones RRIM 600 and IAN 873 induced greater cell proliferation, suggesting greater bioactivity. It was found that the membranes made from latex that was in contact with ammonia during collection, showed cytotoxic and genotoxic effects in cultures, as well as necrosis, and increased inflammatory cells in the rabbit's tissues close to the implant.
C1 [Floriano, Juliana Ferreira; Graeff, Carlos F. O.] Univ Estadual Paulista, Dept Fis, BR-17033360 Bauru, SP, Brazil.
   [Lima Silveira da Mota, Ligia Souza] Univ Estadual Paulista, Dept Genet, Botucatu, SP, Brazil.
   [Furtado, Edson Luiz] Univ Estadual Paulista, Dept Prod Vegetal, Botucatu, SP, Brazil.
   [Vieira Rossetto, Victor Jose] Univ Estadual Paulista, Dept Cirurgia Pequenos Anim, Botucatu, SP, Brazil.
RP Floriano, JF (reprint author), Univ Estadual Paulista, Dept Fis, Av Luiz Edmundo Carrijo Coube 14-01, BR-17033360 Bauru, SP, Brazil.
EM juli@ibb.unesp.br; graeff@fc.unesp.br
RI Furtado, Edson/Q-1852-2018; Floriano, Juliana Ferreira/D-9207-2014;
   Mota, Ligia/C-4583-2013; FAPESP, CDMF/J-3591-2015; Graeff,
   Carlos/C-6703-2012
OI Furtado, Edson/0000-0002-6924-835X; Mota, Ligia/0000-0003-4513-753X;
   FAPESP, CDMF/0000-0002-4464-0937; Graeff, Carlos/0000-0003-0162-8273;
   Rossetto, Victor/0000-0001-7693-8108
FU CAPES/Nanobiomed; UNESP
FX This work was supported by CAPES/Nanobiomed and UNESP. We thank
   Professor Lui's Fernando Barbisan for his support regarding the
   histological analysis.
CR Agostini DLS, 2008, J THERM ANAL CALORIM, V91, P703, DOI 10.1007/s10973-007-8351-x
   Albertini RJ, 2000, MUTAT RES-REV MUTAT, V463, P111, DOI 10.1016/S1383-5742(00)00049-1
   Albrech J, 2006, HEPATOLOGY, V9, P994
   [Anonymous], 1992, 109936 ISO
   [Anonymous], 2006, 11137 ISO
   Araujo MM, 2012, ACTA CIR BRAS, V27, P566, DOI 10.1590/S0102-86502012000800009
   Balabanian Claudia A C A, 2006, J Oral Sci, V48, P201, DOI 10.2334/josnusd.48.201
   Banerjee B, 2000, MOL IMMUNOL, V37, P789, DOI 10.1016/S0161-5890(00)00095-X
   Barber HD, 2007, J ORAL MAXIL SURG, V65, P748, DOI 10.1016/j.joms.2006.10.042
   Blackley DC, 1997, POLYM LATTICES GLASG
   BORENFREUND E, 1988, TOXICOL IN VITRO, V2, P1, DOI 10.1016/0887-2333(88)90030-6
   Ciapetti G, 1996, BIOMATERIALS, V17, P1259, DOI 10.1016/0142-9612(96)88670-4
   Dulngali S, 1980, PRESERVATIVE SYSTEM
   FAIRBAIRN DW, 1995, MUTAT RES-REV GENET, V339, P37, DOI 10.1016/0165-1110(94)00013-3
   Ferreira M, 2009, BRAZ J PHYS, V39, P564, DOI 10.1590/S0103-97332009000500010
   Frade MAC, 2001, INT J DERMATOL, V40, P238, DOI 10.1046/j.1365-4362.2001.00977-2.x
   Gilbert NE, 1973, J RUBBER RES I MALAY, V3, P365
   Goldsby A, 2003, IMMUNOLOGY
   Hartmann A, 1997, TOXICOL LETT, V90, P183, DOI 10.1016/S0378-4274(96)03847-7
   Hasma H., 1991, Journal of Natural Rubber Research, V6, P105
   IKARASHI Y, 1992, J BIOMED MATER RES, V26, P339, DOI 10.1002/jbm.820260306
   INTERNATIONAL ORGANIZATION FOR STANDARDIZATION-ISO, 1992, 109933 ISO
   International Standardization Organization, 1992, 109935 ISO
   Issa JPM, 2010, ANAT REC, V293, P794, DOI 10.1002/ar.21097
   Mente ED, 2001, ACTA CIR BRAS, V16, P84
   Mrue Fatima, 2004, Mat. Res., V7, P277, DOI 10.1590/S1516-14392004000200010
   Narayanan E, 1973, J RUBBER RES I MALAY, V23, P332
   NARAYANAN R, 1974, Journal of the Rubber Research Institute of Malaysia, V24, P1
   OTHMAN AB, 1993, PLAST RUB COMPOS PRO, V19, P185
   Park J., 2007, BIOMATERIALS INTRO
   Park JE, 2004, AM J SURG, V187, p11S, DOI 10.1016/S0002-9610(03)00296-4
   Ribeiro YLR, 2003, MUTAGENESE AMBIENTAL
   Rippel MM, 2009, J BRAZIL CHEM SOC, V20, P1024, DOI 10.1590/S0103-50532009000600004
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   SADER SL, 2000, REV BRASILEIRA CIRUR, V15, P338, DOI DOI 10.1590/S0102-76382000000400008
   Sanchez PA, 2001, ALLERGOL IMMUNOPATH, V5, P212
   Silva GA, 2007, J TISSUE ENG REGEN M, V1, P97, DOI 10.1002/term.1
   Souza PG, 2000, PESQUI AGROPECU BRAS, V35, P12
   Stelescu MD, 2013, J APPL POLYM SCI, V128, P2325, DOI 10.1002/app.38231
   Temenoff J. S., 2000, BONE ENG
   Thomazini JA, 1997, ACTA MICROSC, V6, P798
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Yang C, 2003, BIOSENS BIOELECTRON, V19, P51, DOI 10.1016/S0956-5663(03)00131-3
   Zeller JM, 1993, AORN J, V7, P1284
NR 44
TC 10
Z9 11
U1 0
U2 34
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 461
EP 470
DI 10.1007/s10856-013-5089-9
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400020
PM 24202915
DA 2018-10-19
ER

PT J
AU Ruiz, A
   Rathnam, KR
   Masters, KS
AF Ruiz, Amaliris
   Rathnam, Kashmila R.
   Masters, Kristyn S.
TI Effect of hyaluronic acid incorporation method on the stability and
   biological properties of polyurethane-hyaluronic acid biomaterials
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID VITRO BLOOD COMPATIBILITY; EPTFE VASCULAR GRAFTS; IN-VITRO;
   PLATELET-ADHESION; CARDIOVASCULAR GRAFT; BACTERIAL ADHESION;
   SHEAR-STRESS; HEPARIN; SURFACE; IMMOBILIZATION
AB The high failure rate of small diameter vascular grafts continues to drive the development of new materials and modification strategies that address this clinical problem, with biomolecule incorporation typically achieved via surface-based modification of various biomaterials. In this work, we examined whether the method of biomolecule incorporation (i.e., bulk versus surface modification) into a polyurethane (PU) polymer impacted biomaterial performance in the context of vascular applications. Specifically, hyaluronic acid (HA) was incorporated into a poly(ether urethane) via bulk copolymerization or covalent surface tethering, and the resulting PU-HA materials characterized with respect to both physical and biological properties. Modification of PU with HA by either surface or bulk methods yielded materials that, when tested under static conditions, possessed no significant differences in their ability to resist protein adsorption, platelet adhesion, and bacterial adhesion, while supporting endothelial cell culture. However, only bulk-modified PU-HA materials were able to fully retain these characteristics following material exposure to flow, demonstrating a superior ability to retain the incorporated HA and minimize enzymatic degradation, protein adsorption, platelet adhesion, and bacterial adhesion. Thus, despite bulk methods rarely being implemented in the context of biomolecule attachment, these results demonstrate improved performance of PU-HA upon bulk, rather than surface, incorporation of HA. Although explored only in the context of PU-HA, the findings revealed by these experiments have broader implications for the design and evaluation of vascular graft modification strategies.
C1 [Ruiz, Amaliris; Masters, Kristyn S.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Rathnam, Kashmila R.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   [Masters, Kristyn S.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
RP Masters, KS (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr 2152, Madison, WI 53706 USA.
EM kmasters@wisc.edu
FU Graduate Engineering Research Scholars Program; W.H. Coulter Foundation
FX Funding for this work was provided by the Graduate Engineering Research
   Scholars Program and the W.H. Coulter Foundation. The authors are also
   grateful for XPS assistance from Jose R. Sanchez-Perez (University of
   Wisconsin-Madison).
CR Amarnath LP, 2006, BIOMATERIALS, V27, P1416, DOI 10.1016/j.biomaterials.2005.08.008
   AMIJI M, 1993, J BIOMAT SCI-POLYM E, V4, P217, DOI 10.1163/156856293X00537
   Bakhshi H, 2013, J BIOMED MATER RES A, V101, P1599, DOI 10.1002/jbm.a.34461
   Begovac PC, 2003, EUR J VASC ENDOVASC, V25, P432, DOI 10.1053/ejvs.2002.1909
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Bosiers M, 2006, J VASC SURG, V43, P313, DOI 10.1016/j.jvs.2005.10.037
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   DANILICH MJ, 1992, J BIOMAT SCI-POLYM E, V3, P195, DOI 10.1163/156856292X00123
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   Fernandez P, 2007, TISSUE ENG, V13, P1607, DOI 10.1089/ten.2006.0399
   Giudiceandrea A, 1998, EUR J VASC ENDOVASC, V15, P147, DOI 10.1016/S1078-5884(98)80136-6
   GOLDSTONE J, 1974, AM J SURG, V128, P225
   GRASEL TG, 1986, BIOMATERIALS, V7, P315, DOI 10.1016/0142-9612(86)90002-5
   HAN DK, 1989, J BIOMED MATER RES-A, V23, P211
   HERMANSON GT, 1996, BIOCONJUGATE TECHNIQ
   Hoenig MR, 2005, ARTERIOSCL THROM VAS, V25, P1128, DOI 10.1161/01.ATV.0000158996.03867.72
   Hoshi RA, 2013, BIOMATERIALS, V34, P30, DOI 10.1016/j.biomaterials.2012.09.046
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   ITO Y, 1986, J BIOMED MATER RES, V20, P1157, DOI 10.1002/jbm.820200808
   Iwasaki K, 2008, CIRCULATION, V118, pS52, DOI 10.1161/CIRCULATIONAHA.107.757369
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Kim BN, 2011, J NANOSCI NANOTECHNO, V11, P7065, DOI 10.1166/jnn.2011.4859
   KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8
   Korematsu A, 2002, BIOMATERIALS, V23, P263, DOI 10.1016/S0142-9612(01)00104-1
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Li YJ, 1997, J BIOMATER APPL, V12, P167, DOI 10.1177/088532829701200205
   Liang RP, 2008, J COLLOID INTERF SCI, V320, P125, DOI 10.1016/j.jcis.2008.01.001
   Lin PH, 2004, J VASC SURG, V39, P1322, DOI 10.1016/j.jvs.2004.01.046
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Martinez-Gutierrez F, 2013, FUTURE MICROBIOL, V8, P403, DOI [10.2217/FMB.13.5, 10.2217/fmb.13.5]
   Mohammad SF, 2000, ASAIO J, V46, pS63, DOI 10.1097/00002480-200011000-00039
   Nagel JA, 1996, J BIOMAT SCI-POLYM E, V7, P769, DOI 10.1163/156856296X00110
   Nirmala R, 2013, J NANOSCI NANOTECHNO, V13, P4686, DOI 10.1166/jnn.2013.7192
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Park K, 2000, J BIOMAT SCI-POLYM E, V11, P1121, DOI 10.1163/156856200744228
   Rashid ST, 2004, CELL PROLIFERAT, V37, P351, DOI 10.1111/j.1365-2184.2004.00318.x
   Roohpour N, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015007
   Ruiz A, 2013, J BIOMED MATER RES A, V101, P2870, DOI 10.1002/jbm.a.34597
   Salacinski HJ, 2003, J BIOMED MATER RES A, V66A, P688, DOI 10.1002/jbm.a.10020
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   Seifert B, 1997, BIOMATERIALS, V18, P1495, DOI 10.1016/S0142-9612(97)00079-3
   STEPHEN M, 1977, SURGERY, V81, P314
   Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   van der Zijpp Y. J., 2003, Archives of Physiology and Biochemistry, V111, P415, DOI 10.3109/13813450312331342274
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Walluscheck KP, 1996, EUR J VASC ENDOVASC, V12, P321, DOI 10.1016/S1078-5884(96)80251-6
   Walpoth BH, 1998, CIRCULATION, V98, pII319
   Wan M, 2004, J MATER SCI-MATER M, V15, P1079, DOI 10.1023/B:JMSM.0000046389.87287.3f
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Wynne JH, 2011, ACS APPL MATER INTER, V3, P2005, DOI 10.1021/am200250d
   Xu F, 2008, BIOMATERIALS, V29, P150, DOI 10.1016/j.biomaterials.2007.09.028
   Xue L, 2003, J VASC SURG, V37, P472, DOI 10.1067/mva.2003.88
   You I, 2011, BIOCONJUGATE CHEM, V22, P1264, DOI 10.1021/bc2000534
NR 61
TC 4
Z9 4
U1 3
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2014
VL 25
IS 2
BP 487
EP 498
DI 10.1007/s10856-013-5092-1
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB2NW
UT WOS:000331630400023
PM 24276670
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Meurette, G
   Duchalais, E
   Lehur, PA
AF Meurette, G.
   Duchalais, E.
   Lehur, P-A.
TI Surgical approaches to fecal incontinence in the adult
SO JOURNAL OF VISCERAL SURGERY
LA English
DT Review
DE Anal incontinence; Sphincterorraphy; Sacral neurostimulation; Artificial
   sphincter; Antegrade colonic enema; Intra-sphincteric injection
ID ARTIFICIAL BOWEL SPHINCTER; SACRAL NERVE-STIMULATION; ANTEGRADE
   CONTINENCE ENEMA; INJECTABLE SILICONE BIOMATERIAL; ANAL DYNAMIC
   GRACILOPLASTY; QUALITY-OF-LIFE; ANTERIOR SPHINCTEROPLASTY; GRACILIS
   NEOSPHINCTER; VENTRAL RECTOPEXY; OBSTETRIC TRAUMA
AB Surgical treatment of anal incontinence is indicated only for patients who have failed medical treatment. Sphincterorraphy is suitable in case of external sphincter rupture. In the last decade, sacral nerve stimulation has proven to be a scientifically validated solution when no sphincter lesion has been identified and more recently has also been proposed as an alternative in cases of limited sphincter defect. Anal reconstruction using artificial sphincters is still under evaluation in the literature, while indications for dynamic graciloplasty are decreasing due to its complexity and high morbidity. Less risky techniques involving intra-sphincteric injections are being developed, with encouraging preliminary results that need to be confirmed especially in the medium- and long-term. Antegrade colonic enemas instilled via cecostomy (Malone) can be an alternative to permanent stoma in patients who are well instructed in the techniques of colonic lavage. Stomal diversion is a solution of last resort. (C) 2014 Published by Elsevier Masson SAS.
C1 [Meurette, G.; Duchalais, E.; Lehur, P-A.] Hop Hotel Dieu, CHU Nantes, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrinienne, F-44000 Nantes, France.
RP Meurette, G (reprint author), Hop Hotel Dieu, CHU Nantes, Inst Malad Appareil Digestif, Clin Chirurg Digest & Endocrinienne, 1 Pl A Ricordeau, F-44000 Nantes, France.
EM guillaume.meurette@chu-nantes.fr
RI Meurette, Guillaume/M-1419-2015
CR [Anonymous], 2012, TRAITEMENT INCONTINE
   BAETEN CGMI, 1995, NEW ENGL J MED, V332, P1600, DOI 10.1056/NEJM199506153322403
   Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x
   Chereau N, 2011, COLORECTAL DIS, V13, pE238, DOI 10.1111/j.1463-1318.2011.02651.x
   CHRISTIANSEN J, 1992, ANN SURG, V215, P383, DOI 10.1097/00000658-199204000-00013
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   Collinson R, 2010, GASTROEN CLIN BIOL, V34, P584, DOI 10.1016/j.gcb.2010.09.007
   Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x
   Damon H, 2006, GASTROEN CLIN BIOL, V30, P37, DOI 10.1016/S0399-8320(06)73076-7
   Damon H, 2013, INCONTINENCE ANALE A
   Darnis B, 2013, DIS COLON RECTUM, V56, P505, DOI 10.1097/DCR.0b013e3182809490
   ENGEL AF, 1994, EUR J SURG, V160, P633
   ENGEL AF, 1994, BRIT J SURG, V81, P1231, DOI 10.1002/bjs.1800810853
   FANG DT, 1984, DIS COLON RECTUM, V27, P720, DOI 10.1007/BF02554596
   FAUCHERON JL, 1994, DIS COLON RECTUM, V37, P979, DOI 10.1007/BF02049308
   FLESHMAN JW, 1991, DIS COLON RECTUM, V34, P1061, DOI 10.1007/BF02050062
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   Hawley P, 1985, COLOPROCTOLOGY PELVI, P252
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   KONSTEN J, 1993, WORLD J SURG, V17, P404, DOI 10.1007/BF01658712
   KORSGEN S, 1995, DIS COLON RECTUM, V38, P1331, DOI 10.1007/BF02049162
   Lehur PA, 1996, LYON CHIR, V92, P251
   Lehur PA, 2010, DIS COLON RECTUM, V53, P1604, DOI 10.1007/DCR.0b013e3181f5d5f7
   Maeda Y, 2008, COLORECTAL DIS, V10, P268, DOI 10.1111/j.1463-1318.2007.01318.x
   Maeda Y, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007959.pub2
   MALONE PS, 1990, LANCET, V336, P1217, DOI 10.1016/0140-6736(90)92834-5
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   Matzel KE, 2004, LANCET, V363, P1270, DOI 10.1016/S0140-6736(04)15999-0
   Meurette G, 2009, COLORECTAL DIS, V11, P631, DOI 10.1111/j.1463-1318.2008.01633.x
   Oliveira L, 1996, BRIT J SURG, V83, P502, DOI 10.1002/bjs.1800830421
   Portier G, 2011, COLORECTAL DIS, V13, P914, DOI 10.1111/j.1463-1318.2010.02327.x
   Ratto C, 2012, COLORECTAL DIS, V14, pE297, DOI 10.1111/j.1463-1318.2012.03003.x
   Ris F, 2012, COLORECTAL DIS, V14, P1106, DOI 10.1111/j.1463-1318.2011.02904.x
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Teichman JMH, 1998, J UROLOGY, V160, P1278, DOI 10.1016/S0022-5347(01)62515-1
   Teichman JMH, 2003, UROLOGY, V61, P502, DOI 10.1016/S0090-4295(02)02282-3
   Thornton M J, 2004, Colorectal Dis, V6, P470, DOI 10.1111/j.1463-1318.2004.00714.x
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2007, DIS COLON RECTUM, V50, P1497, DOI 10.1007/s10350-007-9001-x
   Wexner SD, 1996, DIS COLON RECTUM, V39, P957, DOI 10.1007/BF02054681
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
   WILLIAMS NS, 1991, LANCET, V338, P1166
   Wong MTC, 2011, ANN SURG, V254, P951, DOI 10.1097/SLA.0b013e31823ac2bc
   Wong MTC, 2011, DIS COLON RECTUM, V54, P773, DOI 10.1007/DCR.0b013e3182182689
   Wong MTC, 2011, DIS COLON RECTUM, V54, P425, DOI 10.1007/DCR.0b013e318200f866
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
   Yerkes EB, 2003, J UROLOGY, V169, P320, DOI 10.1097/01.ju.0000041721.26576.92
   YOSHIOKA K, 1989, DIS COLON RECTUM, V32, P39, DOI 10.1007/BF02554724
NR 51
TC 8
Z9 8
U1 1
U2 8
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1878-7886
J9 J VISC SURG
JI J. Visc. Surg.
PD FEB
PY 2014
VL 151
IS 1
BP 29
EP 39
DI 10.1016/j.jviscsurg.2013.12.011
PG 11
WC Surgery
SC Surgery
GA AB3VL
UT WOS:000331718200006
PM 24440057
DA 2018-10-19
ER

PT J
AU Evans, SM
   Litzenberger, AL
   Ellenberger, AE
   Maneval, JE
   Jablonski, EL
   Vogel, BM
AF Evans, Stephanie M.
   Litzenberger, Andrew L.
   Ellenberger, Anne E.
   Maneval, Juries E.
   Jablonski, Erin L.
   Vogel, Brandon M.
TI A microfluidic method to measure small molecule diffusion in hydrogels
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Microfluidics; Diffusion; Controlled drug delivery; NMR; Hydrogels; PEG
ID POLY(ETHYLENE GLYCOL) HYDROGELS; LASER-SCANNING MICROSCOPY; PEG
   HYDROGELS; DRUG-DELIVERY; INTERPENETRATING NETWORKS; POLY(VINYL
   ALCOHOL); POLY(ACRYLIC ACID); SOLUTE DIFFUSION; COEFFICIENT; SIZE
AB Drug release from a fluid-contacting biomaterial is simulated using a microfluidic device with a channel defined by solute-loaded hydrogel; as water is pumped through the channel, solute transfers from the hydrogel into the water. Optical analysis of in-situ hydrogels, characterization of the microfluidic device effluent, and NMR methods were used to find diffusion coefficients of several dyes (model drugs) in poly( ethylene glycol) diacrylate (PEG-DA) hydrogels. Diffusion coefficients for methylene blue and sulforhodamine 101 in PEG-DA calculated using the three methods are in good agreement; both dyes are mobile in the hydrogel and elute from the hydrogel at the aqueous channel interface. However, the dye acid blue 22 deviates from typical diffusion behavior and does not release as expected from the hydrogel. Importantly, only the microfluidic method is capable of detecting this behavior.
   Characterizing solute diffusion with a combination of NMR, optical and effluent methods offer greater insight into molecular diffusion in hydrogels than employing each technique individually. The NMR method made precise measurements for solute diffusion in all cases. The microfluidic optical method was effective for visualizing diffusion of the optically active solutes. The optical and effluent methods show potential to be used to screen solutes to determine if they elute from a hydrogel in contact with flowing fluid. Our data suggest that when designing a drug delivery device, analyzing the diffusion from the molecular level to the device level is important to establish a complete picture of drug elution, and microfluidic methods to study such diffusion can play a key role. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Evans, Stephanie M.; Litzenberger, Andrew L.; Ellenberger, Anne E.; Maneval, Juries E.; Jablonski, Erin L.; Vogel, Brandon M.] Bucknell Univ, Dept Chem Engn, Lewisburg, PA 17837 USA.
RP Maneval, JE (reprint author), Bucknell Univ, Dept Chem Engn, Lewisburg, PA 17837 USA.
EM james.maneval@bucknell.edu; erin.jablonski@bucknell.edu;
   brandon.vogel@bucknell.edu
FU Jane W. Griffith Foundation
FX BMV would like to thank the Jane W. Griffith Foundation for a Faculty
   Fellowship.
CR Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f
   Bal T, 2013, J BIOMED MAT RES A
   Bell CL, 1996, BIOMATERIALS, V17, P1203, DOI 10.1016/0142-9612(96)84941-6
   Bryant SJ, 2003, J BIOMED MATER RES A, V64A, P70, DOI 10.1002/jbm.a.10319
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Chen RT, 2012, BIOMACROMOLECULES, V13, P889, DOI 10.1021/bm201802w
   Costin CD, 2003, J CHROMATOGR A, V1013, P77, DOI 10.1016/S0021-9673(03)01101-4
   Cuchiara MP, 2010, BIOMATERIALS, V31, P5491, DOI 10.1016/j.biomaterials.2010.03.031
   Culbertson CT, 2002, TALANTA, V56, P365, DOI 10.1016/S0039-9140(01)00602-6
   Flory Paul J., 1953, FLORY PRINCIPLES POL
   Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1
   Hamidi M, 2008, ADV DRUG DELIVER REV, V60, P1638, DOI 10.1016/j.addr.2008.08.002
   Hatch A, 2004, P IEEE, V92, P126, DOI 10.1109/JPROC.2003.820547
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang GY, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/1/012001
   Jerschow A, 1997, J MAGN RESON, V125, P372, DOI 10.1006/jmre.1997.1123
   Khoury C, 2003, BIOMED MICRODEVICES, V5, P35, DOI 10.1023/A:1024411332492
   Kosto KB, 2005, BIOPHYS J, V88, P277, DOI 10.1529/biophysj.104.050302
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Lyons JG, 2009, J MECH BEHAV BIOMED, V2, P485, DOI 10.1016/j.jmbbm.2008.12.003
   MATLAB, 2010, IM PROC TOOLB REL
   Oliveira MB, 2013, ANAL CHEM, V85, P2391, DOI 10.1021/ac303405x
   Pelekani C, 2000, CARBON, V38, P1423, DOI 10.1016/S0008-6223(99)00261-4
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Peppas NA, 1998, EUR J PHARM BIOPHARM, V46, P15, DOI 10.1016/S0939-6411(97)00113-6
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Peppas NA, 1996, MACROMOLECULES, V29, P8798, DOI 10.1021/ma9613392
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Ray E, 2007, AM J PHYS, V75, P903, DOI 10.1119/1.2752819
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Schultz KM, 2013, SOFT MATTER, V9, P1570, DOI 10.1039/c2sm27303a
   Stringer JL, 1996, J CONTROL RELEASE, V42, P195, DOI 10.1016/0168-3659(96)01457-5
   Watkins AW, 2007, ACTA BIOMATER, V3, P439, DOI 10.1016/j.actbio.2006.11.006
   Watkins AW, 2005, MACROMOLECULES, V38, P1326, DOI 10.1021/ma0475232
   Weber LM, 2009, J BIOMED MATER RES A, V90A, P720, DOI 10.1002/jbm.a.32134
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yang T, 2013, J POLYM SCI POL CHEM, V51, P1378, DOI 10.1002/pola.26506
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 43
TC 6
Z9 6
U1 3
U2 47
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD FEB 1
PY 2014
VL 35
BP 322
EP 334
DI 10.1016/j.msec.2013.10.035
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AB2AX
UT WOS:000331596500041
PM 24411384
DA 2018-10-19
ER

PT J
AU Lv, FK
   Liu, BL
   Li, WJ
   Song, XY
AF Lv FuKou
   Liu BaoLin
   Li WeiJie
   Song XiaoYan
TI Effects of nanoparticles on devitrification and recrystallization of
   aqueous glycerol and PEG-600 solutions
SO SCIENCE CHINA-TECHNOLOGICAL SCIENCES
LA English
DT Article
DE nanoparticles; devitrification; recrystallization; ice morphology; ice
   fraction
ID ICE CRYSTALS; CRYSTALLIZATION; CRYOMICROSCOPY; 1,3-BUTANEDIOL;
   TRANSITIONS
AB Nanoparticles in solution offer unique electrical, mechanical and thermal properties due to their physical presence and interaction with the state of dispersion. This work is aimed to study the effects of hydroxyapatite (HA) nanoparticles on the behavior of devitrification and recrystallization of glycerol (60% w/w) and PEG-600 (50% w/w) solutions during warming. HA nanoparticles of different sizes (20, 40, 60 nm) and concentrations (0.1%, 0.5%, w/w) were incorporated into solutions, and were studied by calorimetric analysis coupled with cryomicroscopy. The presence of HA nanoparticles has little effect on the devitrification end temperatures, but affects the devitrification onset temperatures of glycerol and PEG-600 solutions. The investigation with the cryomicroscope observed that the ice morphologies of glycerol and PEG-600 solutions are dendritic and spheric respectively. The ice fraction of glycerol solution containing 0.1% HA with the size of 60 nm decreased to 2/5 of that of the solution without nanoparticles at -45A degrees C. The ice fractions of PEG-600 solutions increased significantly between -64A degrees C and -54A degrees C, and the ice fraction of PEG-600 solution without nanoparticles increased by 92% within the temperature range. The findings have significant implications for biomaterial cryopreservation, cryosurgery, and food manufacturing. The complexity of ice crystal growth kinetics in nanoparticle-containing solutions awaits further study.
C1 [Lv FuKou; Liu BaoLin; Li WeiJie; Song XiaoYan] Shanghai Univ Sci & Technol, Inst Biothermal Sci & Technol, Shanghai 200093, Peoples R China.
RP Liu, BL (reprint author), Shanghai Univ Sci & Technol, Inst Biothermal Sci & Technol, Shanghai 200093, Peoples R China.
EM blliuk@163.com
FU National Natural Science Foundation of China [51076108]; Shanghai
   Dongfang Scholars Program;  [20103120110005]
FX This work was supported by the National Natural Science Foundation of
   China (Grant No. 51076108), the Doctoral Program (Grant No.
   20103120110005) and the Shanghai Dongfang Scholars Program.
CR Diller K R, 1970, Cryobiology, V7, P191
   Gage AA, 2002, CRYOLETTERS, V23, P69
   Gao D, 2000, ILAR J, V41, P18796
   Goff HD, 2003, THERMOCHIM ACTA, V399, P43, DOI 10.1016/S0040-6031(02)00399-4
   Gonda T, 2005, PROG CRYST GROWTH CH, V51, P70, DOI 10.1016/j.pcrysgrow.2005.10.005
   Hagiwara T, 2006, FOOD BIOPHYS, V1, P74, DOI 10.1007/s11483-006-9009-0
   Han X, 2008, MICROFLUID NANOFLUID, V4, P357, DOI 10.1007/s10404-007-0186-z
   Hao B T, 2009, CRYOBIOLOGY, V59, P409
   Kiani H, 2011, TRENDS FOOD SCI TECH, V22, P407, DOI 10.1016/j.tifs.2011.04.011
   Mazur P, 2011, CRYOBIOLOGY, V62, P1, DOI 10.1016/j.cryobiol.2010.10.159
   MEHL P, 1989, THERMOCHIM ACTA, V155, P187, DOI 10.1016/0040-6031(89)87145-X
   MEHL PM, 1990, CRYOBIOLOGY, V27, P378, DOI 10.1016/0011-2240(90)90016-W
   Methl P., 1993, THERMOCHIM ACTA, V223, P157
   Methl P., 1992, THERMOCHIM ACTA, V203, P475
   Muldrew K, 2001, CRYOBIOLOGY, V42, P182, DOI 10.1006/cryo.2001.2321
   Pegg DE, 2010, CRYOBIOLOGY, V60, pS36, DOI 10.1016/j.cryobiol.2010.02.003
   Petzold G, 2009, FOOD BIOPHYS, V4, P378, DOI 10.1007/s11483-009-9136-5
   Schmidt G, 2003, CURR OPIN COLLOID IN, V8, P103, DOI 10.1016/S1359-0294(03)00008-6
   Seki S, 2012, PLOS ONE, V7
   Seki S, 2009, CRYOBIOLOGY, V59, P75, DOI 10.1016/j.cryobiol.2009.04.012
   STEPONKUS PL, 1984, CRYO-LETT, V5, P343
   STEPONKUS PL, 1984, CRYOBIOLOGY, V21, P209, DOI 10.1016/0011-2240(84)90213-X
   Syamaladevi RM, 2012, FOOD BIOPHYS, V7, P57, DOI 10.1007/s11483-011-9243-y
   VIGIER G, 1987, J CRYST GROWTH, V84, P309, DOI 10.1016/0022-0248(87)90146-1
   Yu TH, 2005, CRYOBIOLOGY, V50, P174, DOI 10.1016/j.cryobiol.2005.01.001
NR 25
TC 2
Z9 2
U1 0
U2 7
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7321
EI 1869-1900
J9 SCI CHINA TECHNOL SC
JI Sci. China-Technol. Sci.
PD FEB
PY 2014
VL 57
IS 2
BP 264
EP 269
DI 10.1007/s11431-014-5457-9
PG 6
WC Engineering, Multidisciplinary; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AB2OV
UT WOS:000331632900006
DA 2018-10-19
ER

PT J
AU Nagaoka, H
AF Nagaoka, Hiroyuki
TI Application of a Heme-Binding Protein Eluted from Encapsulated
   Biomaterials to the Catalysis of Enantioselective Oxidation
SO ACS CATALYSIS
LA English
DT Article
DE heme-binding protein; hemophore; asymmetric oxidation; iron
   electron-transfer system; plant HBP; oxygen dependence
ID CYTOCHROME-C PEROXIDASE; SUBSTRATE RECOGNITION; ASYMMETRIC OXIDATION;
   ALPHA-HYDROXYLATION; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE;
   OUTER-MEMBRANE; HEMOPHORE; RESOLUTION; RECEPTOR
AB A protein complex (PX) eluted from an encapsulated pea protein (PP) under aeration can be used as two types of biocatalysts: a polyethylene glycol (PEG) (1000/4000 = 2/1)-aggregated PX (AGPX) and a glutaraldehyde (GA)/compound-modified PX (CMPX). These biocatalysts have the following functional activities: AGPX can catalyze the oxidation of rac-1-(6-methoxynaphthalen-2-yl)ethanol (rac-1) to the corresponding ketone (similar to 95% chemical yield) via the selective oxidation of (S)-(+)-1, leaving highly enantiopure (R)-(-)-1 (>99% ee; similar to 50% chemical yield); CMPX can catalyze the kinetic resolution of (S)-(+)-1 ((S)-naproxen precursor, >99% ee, similar to 50% chemical yield) via the selective oxidation of (R)-(-)-1 to the corresponding ketone. Both reactions occur in the absence of an added cofactor (e.g., NAD(P)) in aqueous media. The specific activities of AGPX and CMPX were determined to be 0.8 +/- 0.03 mU (mean +/- SD) and 0.6 +/- 0.02 mU (mean +/- SD), respectively, and the exact nature of the species engaged in the key reaction was consistent with that of a heme-binding protein (HBP), on the basis of an N-terminal sequence comparison, which showed 93% similarity with a 20.853 kDa hemophore HasA gene product [Pseudomonas fluorescens Pf-S, a plant commensal bacterium]. PP-HBP can be regenerated via successive asymmetric catalytic events using an incorporated iron electron-transfer system (Fe2+ reversible arrow Fe3+) in the presence of oxygen, a process seemingly similar to that utilized by hemoglobin. The use of a raw biomaterial as a PX-catalytic system with an incorporated redox cofactor for asymmetric oxidation overcomes the apparent difficulties in working with pure dehydrogenase enzyme/redox cofactor systems for biotransformation.
C1 Sanyo Shokuhin Co Ltd, R&D, Maebashi, Gumma 3710811, Japan.
RP Nagaoka, H (reprint author), Sanyo Shokuhin Co Ltd, R&D, 555-4 Asakura, Maebashi, Gumma 3710811, Japan.
EM hnagaoka@sanyofoods.co.jp
CR Adam W, 1998, J AM CHEM SOC, V120, P11044, DOI 10.1021/ja981252r
   Afolabi PR, 2001, BIOCHEMISTRY-US, V40, P9799, DOI 10.1021/bi002932l
   Armstrong R. N., 2008, BIOCHEMISTRY-US, V47, P73
   Auld DS, 2008, CELL MOL LIFE SCI, V65, P3961, DOI 10.1007/s00018-008-8593-1
   Barjon C, 2007, J BACTERIOL, V189, P5379, DOI 10.1128/JB.00251-07
   Braun V, 1999, TRENDS BIOCHEM SCI, V24, P104, DOI 10.1016/S0968-0004(99)01359-6
   Chimento DP, 2005, PROTEINS, V59, P240, DOI 10.1002/prot.20416
   Cope LD, 1998, INFECT IMMUN, V66, P4511
   Cwerman H, 2006, J BACTERIOL, V188, P3357, DOI 10.1128/JB.188.9.3357-3364.2006
   Egami H, 2007, J AM CHEM SOC, V129, P8940, DOI 10.1021/ja071916+
   Erman JE, 2002, BBA-PROTEIN STRUCT M, V1597, P193, DOI 10.1016/S0167-4838(02)00317-5
   Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997
   Giles M. N., 2003, BIOPHYS RES COMMUN, V300, P1
   Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1
   Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583
   Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x
   Johansson AL, 2013, BIOCHEMISTRY-US, V52, P827, DOI 10.1021/bi301597a
   Kamezawa M., 1996, LIEBIGS ANN, V1996, P167
   Krieg S, 2009, P NATL ACAD SCI USA, V106, P1045, DOI 10.1073/pnas.0809406106
   Landwehr M, 2006, J AM CHEM SOC, V128, P6058, DOI 10.1021/ja061261x
   Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200
   Letoffe S, 2000, J BACTERIOL, V182, P4401, DOI 10.1128/JB.182.16.4401-4405.2000
   Liu XQ, 2009, MICROBIOL-SGM, V155, P2078, DOI 10.1099/mic.0.027201-0
   McDonald AR, 2010, J AM CHEM SOC, V132, P17118, DOI 10.1021/ja1045428
   Nagaoka H., 2003, Current Topics in Nutraceutical Research, V1, P281
   Nagaoka H, 2005, BIOTECHNOL PROGR, V21, P405, DOI 10.1021/bp0496777
   Nagaoka H, 1999, BIOSCI BIOTECH BIOCH, V63, P1991, DOI 10.1271/bbb.63.1991
   Nagaoka H, 2000, BIOSCI BIOTECH BIOCH, V64, P781, DOI 10.1271/bbb.64.781
   Nagaoka H, 2004, BIOTECHNOL PROGR, V20, P128, DOI 10.1021/bp0342046
   Nagaoka H, 2003, BIOTECHNOL PROGR, V19, P1149, DOI 10.1021/bp034059w
   Nagaoka H., 2001, BIOSCI BIOTECH BIOCH, V65, P634
   Nagaoka H, 2012, BIOTECHNOL PROGR, V28, P953, DOI 10.1002/btpr.1580
   Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264
   Ortiz de Montellano P.R., 2004, CYTOCHROME P450 STRU
   Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110
   Prage B. E., 2011, BIOCHEMISTRY-US, V50, P7684, DOI 10.1021/bi2010448 21805999
   Putnam AMAH, 2009, BIOCHEMISTRY-US, V48, P1, DOI 10.1021/bi8020263
   Schoemaker HE, 2003, SCIENCE, V299, P1694, DOI 10.1126/science.1079237
   Shimizu H, 2001, BIOCHEMISTRY-US, V40, P13483, DOI 10.1021/bi011481h
   Shoji O, 2007, ANGEW CHEM INT EDIT, V46, P3656, DOI 10.1002/anie.200700068
   Sobolov B. S., 1996, J ORG CHEM, V61, P2125, DOI 10.1021/jo951408v
   Thakur VV, 2005, INDIAN J CHEM B, V44, P557
   Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3
   Yosca TH, 2013, SCIENCE, V342, P825, DOI 10.1126/science.1244373
   Zee JM, 2006, BIOCHEM CELL BIOL, V84, P859, DOI 10.1139/O06-201
NR 45
TC 4
Z9 4
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2155-5435
J9 ACS CATAL
JI ACS Catal.
PD FEB
PY 2014
VL 4
IS 2
BP 553
EP 565
DI 10.1021/cs400768x
PG 13
WC Chemistry, Physical
SC Chemistry
GA AA5UB
UT WOS:000331164000023
DA 2018-10-19
ER

PT J
AU Madl, CM
   Mehta, M
   Duda, GN
   Heilshorn, SC
   Mooney, DJ
AF Madl, Christopher M.
   Mehta, Manav
   Duda, Georg N.
   Heilshorn, Sarah C.
   Mooney, David J.
TI Presentation of BMP-2 Mimicking Peptides in 3D Hydrogels Directs Cell
   Fate Commitment in Osteoblasts and Mesenchymal Stem Cells
SO BIOMACROMOLECULES
LA English
DT Article
ID RGD NANOPATTERNED HYDROGELS; ANTERIOR CERVICAL-SPINE; SYNTHETIC PEPTIDE;
   PROGENITOR CELLS; BONE; DIFFERENTIATION; ADHESION; DELIVERY;
   COMPLICATIONS; ACTIVATION
AB Many strategies for controlling the fate of transplanted stem cells rely on the concurrent delivery of soluble growth factors that have the potential to produce undesirable secondary effects in surrounding tissue. Such off target effects could be eliminated by locally presenting growth factor peptide mimics from biomaterial scaffolds to control stem cell fate. Peptide mimics of bone morphogenetic protein 2 (BMP-2) were synthesized by solid phase Fmoc-peptide synthesis and covalently bound to alginate hydrogels via either carbodiimide or sulfhydryl-based coupling strategies. Successful peptide conjugation was confirmed by H-1 NMR spectroscopy and quantified by fluorescently labeling the peptides. Peptides derived from the knuckle epitope of BMP-2, presented from both 2D surfaces and 3D alginate hydrogels, were shown to increase alkaline phosphatase activity in clonally derived murine osteoblasts. Furthermore, when presented in 3D hydrogels, these peptides were shown to initiate Smad signaling, upregulate osteopontin production, and increase mineral deposition with clonally derived murine mesenchymal stem cells. These data suggest that these peptide-conjugated hydrogels may be effective alternatives to local BMP-2 release in directly and spatially eliciting osteogenesis from transplanted or host osteoprogenitors in the future.
C1 [Madl, Christopher M.; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Mehta, Manav; Mooney, David J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Mehta, Manav; Duda, Georg N.] Charite, Julius Wolff Inst, D-13353 Berlin, Germany.
   [Duda, Georg N.] Charite, Ctr Musculoskeletal Surg, D-13353 Berlin, Germany.
   [Heilshorn, Sarah C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
RP Mooney, DJ (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
EM mooneyd@seas.harvard.edu
RI Duda, Georg/H-2085-2016
OI Duda, Georg/0000-0001-7605-3908; Madl, Christopher/0000-0003-3221-5041
FU NIH [R37 DE013033, R01-DK085720]; Harvard College Program for Research
   in Science and Engineering (PRISE); NSF [DMR-0846363]; Einstein
   Foundation Berlin through the Charite-Universitatsmedizin Berlin;
   Berlin-Brandenburg School for Regenerative Therapies [GSC 203]
FX The authors would like to thank Praveen Arany for assistance with
   Western blotting and Shimwoo Lee for assistance with alginate sample
   preparation. This project was supported by funding from the NIH (R37
   DE013033) (to D.J.M.), the Harvard College Program for Research in
   Science and Engineering (PRISE) (to C.M.M.), NSF (DMR-0846363) (to
   S.C.H.), NIH (R01-DK085720) (to S.C.H.), and the award of an Einstein
   Visiting Fellowship by the Einstein Foundation Berlin through the
   Charite-Universitatsmedizin Berlin, Berlin-Brandenburg School for
   Regenerative Therapies GSC 203 (to D.J.M.).
CR Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Colangelo AM, 2008, J NEUROSCI, V28, P2698, DOI 10.1523/JNEUROSCI.5201-07.2008
   Comisar WA, 2006, BIOMATERIALS, V27, P2322, DOI 10.1016/j.biomaterials.2005.10.037
   Comisar WA, 2007, BIOMATERIALS, V28, P4409, DOI 10.1016/j.biomaterials.2007.06.018
   D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102
   de Gorter D. J. J., 2009, ENCY LIFE SCI, P1
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Garrison K., 2007, HLTH TECHNOLOGY ASSE, V11
   Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302
   Haid Regis W Jr, 2004, Spine J, V4, P527, DOI 10.1016/j.spinee.2004.03.025
   Hsiong S. X., 2009, BIOMACROMOLECULES, V9, P1843
   Hsiong SX, 2009, TISSUE ENG PT A, V15, P263, DOI 10.1089/ten.tea.2007.0411
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Kirkwood Keith, 2003, J Oral Implantol, V29, P57, DOI 10.1563/1548-1336(2003)029<0057:IVMSWS>2.3.CO;2
   KUMAGAI H, 1991, BIOCHEM BIOPH RES CO, V177, P74, DOI 10.1016/0006-291X(91)91950-H
   Lee JS, 2010, ACTA BIOMATER, V6, P21, DOI 10.1016/j.actbio.2009.08.003
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Lin X, 2006, INT J MOL MED, V17, P833
   Manfe V, 2010, J NEUROCHEM, V114, P74, DOI 10.1111/j.1471-4159.2010.06718.x
   Mehta M, 2012, ADV DRUG DELIVER REV, V64, P1257, DOI 10.1016/j.addr.2012.05.006
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019
   Patel G, 1999, J PEPT RES, V53, P68, DOI 10.1111/j.1399-3011.1999.tb01618.x
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito A, 2003, BBA-PROTEINS PROTEOM, V1651, P60, DOI 10.1016/S1570-9639(03)00235-8
   Senta H, 2009, CYTOKINE GROWTH F R, V20, P213, DOI 10.1016/j.cytogfr.2009.05.006
   Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sittinger M, 2004, CURR OPIN BIOTECH, V15, P411, DOI 10.1016/j.copbio.2004.08.010
   Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2
   Wall ST, 2008, BIOCONJUGATE CHEM, V19, P806, DOI 10.1021/bc700265k
   Wong DA, 2008, SPINE J, V8, P1011, DOI 10.1016/j.spinee.2007.06.014
NR 39
TC 36
Z9 36
U1 1
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2014
VL 15
IS 2
BP 445
EP 455
DI 10.1021/bm401726u
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AA8JQ
UT WOS:000331342200001
PM 24400664
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lai, CY
   Wu, PJ
   Roffler, SR
   Lee, ST
   Hwang, SM
   Wang, SES
   Wang, K
   Hsieh, PCH
AF Lai, Chia Y.
   Wu, Pei J.
   Roffler, Steve R.
   Lee, Sho T.
   Hwang, Shiaw M.
   Wang, Shoei S.
   Wang, Kuan
   Hsieh, Patrick C. H.
TI Clearance Kinetics of Biomaterials Affects Stem Cell Retention and
   Therapeutic Efficacy
SO BIOMACROMOLECULES
LA English
DT Article
ID PERIPHERAL ARTERIAL-DISEASE; HYALURONIC-ACID; HINDLIMB ISCHEMIA;
   TISSUE-INJURY; RAT MODEL; IN-VIVO; REPAIR; ANGIOGENESIS; FLUORESCENCE;
   DIFFERENTIATION
AB The use of biomaterial carriers to improve the therapeutic efficacy of stem cells is known to augment cell delivery, retention, and viability: However, the way that carrier clearance kinetics boosts stem cell delivery and impacts stem cell function remains poorly characterized. In this study, we designed a platform to simultaneously quantify carrier clearance and stem cell retention to evaluate the impact of carrier clearance kinetics on stem cell retention. Additionally, a murine model of hindlimb ischemia was employed to investigate the effects of various cell retention profiles on mitigating peripheral arterial disease. To image the in vivo behaviors of material and cells, we used biotinylated hyaluronan with fluorescently labeled streptavidin and Discosoma sp. Red (Ds-Red)-expressing human mesenchymal stem cells. We found that the retention of transplanted stem cells was closely related to the remaining biomaterial. Furthermore, therapeutic effectiveness was also affected by stem cell retention. These results demonstrate that low-molecular-weight hyaluronan had a slow clearance and high cell retention profile, improving the therapeutic efficacy of human stem cells.
C1 [Lai, Chia Y.; Wu, Pei J.; Roffler, Steve R.; Lee, Sho T.; Hsieh, Patrick C. H.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.
   [Hwang, Shiaw M.] Food Ind Res & Dev Inst, Hsinchu 300, Taiwan.
   [Wang, Shoei S.] Natl Taiwan Univ & Hosp, Dept Surg, Taipei 100, Taiwan.
   [Wang, Kuan] Acad Sinica, Inst Chem, Taipei 115, Taiwan.
   [Hsieh, Patrick C. H.] Natl Cheng Kung Univ & Hosp, Inst Clin Med, Tainan 701, Taiwan.
RP Hsieh, PCH (reprint author), Acad Sinica, Inst Biomed Sci, 128 Sec 2,Acad Rd, Taipei 115, Taiwan.
EM phsieh5@gmail.com
RI Roffler, Steve/N-7791-2018; Hsieh, Patrick Ching-Ho/H-5108-2015
OI Wang, Shoei-Shen/0000-0003-3201-4143; Hsieh, Patrick
   C.H./0000-0002-8910-3596
FU National Research Program for Biopharmaceuticals , (NRPB)
   [DOH101-TD-PB-111-TM027, DOH101-TD-PB-111-TM028]; National Science
   Council [NSC 100-2314-B-006-046, NSC101-2325-B-006-013]; National Health
   Research Institutes [NHRI-EX101-10123S1]; Academia Sinica Translational
   Medicine Program; NRPB of Taiwan
FX This work was supported by the National Research Program for
   Biopharmaceuticals (NRPB, DOH101-TD-PB-111-TM027, and
   DOH101-TD-PB-111-TM028), the National Science Council (NSC
   100-2314-B-006-046 and NSC101-2325-B-006-013), the National Health
   Research Institutes (NHRI-EX101-10123S1), and the Academia Sinica
   Translational Medicine Program. We also thank the Taiwan Mouse Clinic,
   funded by the NRPB of Taiwan for technical support in MS operation and
   animal housing.
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Berlier JE, 2003, J HISTOCHEM CYTOCHEM, V51, P1699, DOI 10.1177/002215540305101214
   Burdick J. A., 2011, ADV MATER, V23, P41
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Cha C, 2009, ADV FUNCT MATER, V19, P3056, DOI 10.1002/adfm.200900865
   DE SMEDT SC, 1994, MACROMOLECULES, V27, P141, DOI 10.1021/ma00079a021
   Evanko SP, 2007, ADV DRUG DELIVER REV, V59, P1351, DOI 10.1016/j.addr.2007.08.008
   Hankey GJ, 2006, JAMA-J AM MED ASSOC, V295, P547, DOI 10.1001/jama.295.5.547
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hung CJ, 2010, CYTOTHERAPY, V12, P455, DOI 10.3109/14653240903555827
   Ishii M, 2011, ARTERIOSCL THROM VAS, V31, P2210, DOI 10.1161/ATVBAHA.111.231100
   Iwase T, 2005, CARDIOVASC RES, V66, P543, DOI 10.1016/j.cardiores.2005.02.006
   Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337
   Joddar B, 2011, BIOMATERIALS, V32, P8404, DOI 10.1016/j.biomaterials.2011.07.083
   Katare R, 2013, ARTERIOSCL THROM VAS, V33, P1872, DOI 10.1161/ATVBAHA.113.301217
   Kawamoto A, 2009, STEM CELLS, V27, P2857, DOI 10.1002/stem.207
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Lin Y. D., 2010, CIRCULATION, V122, P132
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Madonna R, 2013, CIRC RES, V113, P902, DOI 10.1161/CIRCRESAHA.113.301690
   Menasche P, 2008, J MOL CELL CARDIOL, V45, P545, DOI 10.1016/j.yjmcc.2007.11.009
   MEYER K, 1947, PHYSIOL REV, V27, P335
   Napoli C, 2005, P NATL ACAD SCI USA, V102, P17202, DOI 10.1073/pnas.0508534102
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Park D, 2012, MOL CELLS, V33, P563, DOI 10.1007/s10059-012-2294-1
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pashuck ET, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002717
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P370, DOI 10.1021/bc00028a015
   Prestwich GD, 2011, J CONTROL RELEASE, V155, P193, DOI 10.1016/j.jconrel.2011.04.007
   Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565
   Rosova I., 2008, STEM CELLS, V26, P2173
   Sakata H, 2012, BRAIN, V135, P3298, DOI 10.1093/brain/aws259
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Srinivas M, 2010, ADV DRUG DELIVER REV, V62, P1080, DOI 10.1016/j.addr.2010.08.009
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Tang Z. C., 2011, BIOMATERIALS, V3, P275
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Weinberg MD, 2011, NAT REV CARDIOL, V8, P429, DOI 10.1038/nrcardio.2011.81
   Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110
   Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018
NR 43
TC 4
Z9 4
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2014
VL 15
IS 2
BP 564
EP 573
DI 10.1021/bm401583b
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA AA8JQ
UT WOS:000331342200013
PM 24372561
DA 2018-10-19
ER

PT J
AU Taglietti, A
   Arciola, CR
   D'Agostino, A
   Dacarro, G
   Montanaro, L
   Campoccia, D
   Cucca, L
   Vercellino, M
   Poggi, A
   Pallavicini, P
   Visai, L
AF Taglietti, Angelo
   Arciola, Carla Renata
   D'Agostino, Agnese
   Dacarro, Giacomo
   Montanaro, Lucio
   Campoccia, Davide
   Cucca, Lucia
   Vercellino, Marco
   Poggi, Alessandro
   Pallavicini, Piersandro
   Visai, Livia
TI Antibiofilm activity of a monolayer of silver nanoparticles anchored to
   an amino-silanized glass surface
SO BIOMATERIALS
LA English
DT Article
DE Silver nanoparticles; Anti-infective biomaterials; APTES; Biofilm;
   Staphylococcus epidermidis
ID INFECTION-RESISTANT SURFACES; ANTIBACTERIAL ACTIVITY; COLLOID
   MONOLAYERS; BIOFILM FORMATION; ESCHERICHIA-COLI; IN-SITU; BIOMATERIALS;
   BACTERIA; RELEASE; CAPABILITIES
AB Biofilm production is the crucial pathogenic mechanism of the implant-associated infection and a primary target for new anti-infective strategies. Silver nanoparticles (AgNPs) are attracting interest for their multifaceted potential biomedical applications. As endowed with highest surface/mass ratio and potent antibacterial activity, they can profitably be applied as monolayers at biomaterial surfaces. Desirably, in order to minimize the risks of toxic effects from freely circulating detached nanoparticles, AgNPs should firmly be anchored to the modified biomaterial surfaces. Here we focus on a newly designed glass surface modified with AgNPs and on its antibiofilm properties. Link of a self-assembled monolayer of AgNPs to glass was obtained through preliminary amino-silanization of the glass followed by immersion in an AgNPs colloidal suspension. Static contact angle measure, AFM, TEM, UV-Vis spectroscopy, ICP atomic emission spectroscopy were used for characterization. Antibiofilm activity against the biofilm-producer Staphylococcus epidermidis RP62A was assayed by both CPU method and CLSM. Performances of AgNPs-glasses were: i) excellent stability in aqueous medium; ii) prolonged release and high local concentration of Ag+ without any detaching of AgNPs; iii) strong antibiofilm activity against S. epidermidis RP62A. This AgNPs surface-modification can be applied to a large variety of biomaterials by simply depositing glasslike SiO2 films on their surfaces. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Taglietti, Angelo; D'Agostino, Agnese; Dacarro, Giacomo; Cucca, Lucia; Pallavicini, Piersandro] Univ Pavia, Dept Chem, Inorgan Nanochem Lab, I-27100 Pavia, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio; Campoccia, Davide] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Arciola, Carla Renata; Montanaro, Lucio] Univ Bologna, DIMES, Bologna, Italy.
   [Vercellino, Marco; Visai, Livia] Univ Pavia, INSTM UdR Pavia, Dept Mol Med, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Poggi, Alessandro] Univ Modena & Reggio Emilia, Dept Mother & Child, Pediat Unit, Modena, Italy.
   [Vercellino, Marco; Visai, Livia] IRCCS, Salvatore Maugeri Fdn, Dept Occupat Med Ergon & Disabil, Nanotechnol Lab, Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI taglietti, angelo/D-7111-2011; Campoccia, Davide/K-5348-2018
OI taglietti, angelo/0000-0003-0141-9201; Campoccia,
   Davide/0000-0002-3336-0219; Pallavicini, Piersandro/0000-0002-5223-0233
FU MIUR, PRIN [prot. 2010FPTBSH_009]; Fondazione Cariplo (Bandi Chiusi)
FX LV would like to acknowledge financial support from MIUR, PRIN 2010
   project entitled "Nanomed" (prot. 2010FPTBSH_009). AT would like to
   acknowledge financial support from Fondazione Cariplo (Bandi Chiusi
   2007, "Superfici vetrose a azione antimicrobica basata sul rilascio
   modulato e controllato di cationi metallici"). We are grateful to Dr. P.
   Vaghi and V. Necchi ("Centro Grandi Strumenti", University of Pavia,
   Pavia, Italy). CRA would like to acknowledge financial support from "5
   per mille" contribution for Health Research to the Rizzoli Orthopaedic
   Institute of Bologna.
CR Agnihotri S, 2013, NANOSCALE, V5, P7328, DOI 10.1039/c3nr00024a
   Arciola CR, 2012, BIOMATERIALS, V33, P5967, DOI 10.1016/j.biomaterials.2012.05.031
   Aroca RF, 2005, ANAL CHEM, V77, P378, DOI 10.1021/ac048806v
   Bright RM, 1998, LANGMUIR, V14, P5695, DOI 10.1021/la980138j
   Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a
   BUSTAMANTE C, 1992, BIOCHEMISTRY-US, V31, P22, DOI 10.1021/bi00116a005
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2013, BIOMATERIALS, V34, P8533, DOI 10.1016/j.biomaterials.2013.07.089
   Campoccia D, 2013, BIOMATERIALS, V34, P8018, DOI 10.1016/j.biomaterials.2013.07.048
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Rodriguez-Arguelles MC, 2011, J COLLOID INTERF SCI, V364, P80, DOI 10.1016/j.jcis.2011.08.006
   Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006
   Chen P, 2007, RADIAT PHYS CHEM, V76, P1165, DOI 10.1016/j.radphyschem.2006.11.012
   Chernousova S, 2013, ANGEW CHEM INT EDIT, V52, P1636, DOI 10.1002/anie.201205923
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Dacarro G, 2012, DALTON T, V41, P2456, DOI 10.1039/c1dt11373a
   Damm C, 2008, MATER CHEM PHYS, V108, P61, DOI 10.1016/j.matchemphys.2007.09.002
   De Jong WH, 2013, BIOMATERIALS, V34, P8333, DOI 10.1016/j.biomaterials.2013.06.048
   Di Poto A, 2009, BIOMATERIALS, V30, P3158, DOI 10.1016/j.biomaterials.2009.02.038
   Evanoff DD, 2005, CHEMPHYSCHEM, V6, P1221, DOI 10.1002/cphc.200500113
   Flores CY, 2013, ACS APPL MATER INTER, V5, P3149, DOI 10.1021/am400044e
   Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09
   Grabar KC, 1997, ANAL CHEM, V69, P471, DOI 10.1021/ac9605962
   Graf P, 2009, CHEM-EUR J, V15, P5831, DOI 10.1002/chem.200802329
   Greulich C, 2011, ACTA BIOMATER, V7, P3505, DOI 10.1016/j.actbio.2011.05.030
   Guo DW, 2013, BIOMATERIALS, V34, P7884, DOI 10.1016/j.biomaterials.2013.07.015
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Kim JS, 2007, J IND ENG CHEM, V13, P718
   Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306
   Lepainteur M, 2013, PEDIATR INFECT DIS J, V32, P622, DOI 10.1097/INF.0b013e318289de0f
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Lubick N, 2008, ENVIRON SCI TECHNOL, V42, P8617, DOI 10.1021/es8026314
   Lv YH, 2008, POLYM ADVAN TECHNOL, V19, P1455, DOI 10.1002/pat.1138
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Montanaro L, 2011, FUTURE MICROBIOL, V6, P1329, DOI [10.2217/FMB.11.117, 10.2217/fmb.11.117]
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moores A, 2006, NEW J CHEM, V30, P112
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   NETZER L, 1983, J AM CHEM SOC, V105, P674, DOI 10.1021/ja00341a087
   Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Pallavicini P, 2010, J COLLOID INTERF SCI, V350, P110, DOI 10.1016/j.jcis.2010.06.019
   Peczonka NPW, 2006, J AM CHEM SOC, V128, P12626
   Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Speziale P, 2008, CURR MED CHEM, V15, P3185, DOI 10.2174/092986708786848442
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Taglietti A, 2012, LANGMUIR, V28, P8140, DOI 10.1021/la3003838
   Thurlow LR, 2011, J IMMUNOL, V186, P6585, DOI 10.4049/jimmunol.1002794
   Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s
   Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974
   Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w
   Yliniemi K, 2008, J MATER CHEM, V18, P199, DOI 10.1039/b713313h
   Zhang YW, 2008, J PHYS CHEM C, V112, P2330, DOI 10.1021/jp075436g
   Zhao GQ, 2011, CELL BIOCHEM BIOPHYS, V61, P371, DOI 10.1007/s12013-011-9220-6
NR 57
TC 87
Z9 90
U1 17
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 1779
EP 1788
DI 10.1016/j.biomaterials.2013.11.047
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700001
PM 24315574
DA 2018-10-19
ER

PT J
AU Cameron, AR
   Frith, JE
   Gomez, GA
   Yap, AS
   Cooper-White, JJ
AF Cameron, Andrew R.
   Frith, Jessica E.
   Gomez, Guillermo A.
   Yap, Alpha S.
   Cooper-White, Justin J.
TI The effect of time-dependent deformation of viscoelastic hydrogels on
   myogenic induction and Rac1 activity in mesenchymal stem cells
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Smooth muscle cell; Creep; Viscoelasticity;
   Hydrogel; Mechanotransduction
ID SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; N-CADHERIN; SUBSTRATE
   ELASTICITY; LINEAGE COMMITMENT; EPITHELIAL-CELLS; GENE-EXPRESSION; FOCAL
   ADHESIONS; DOWN-REGULATION; RHO
AB Cell behaviours within tissues are influenced by a broad array of physical and biochemical microenvironmental factors. Whilst 'stiffness' is a recognised physical property of substrates and tissue microenvironments that influences many cellular behaviours, tissues and their extracellular matrices are not purely rigid but 'viscoelastic' materials, composed of both rigid-like (elastic) and dissipative (viscous) elements. This viscoelasticity results in materials displaying increased deformation with time under the imposition of a defined force or stress, a phenomenon referred to as time-dependent deformation or 'creep'. Previously, we compared the behaviour of human mesenchymal stem cells (hMSCs) on hydrogels tailored to have a constant stiffness, but to display varying levels of creep in response to an applied force. Using polyacrylamide as a model material, we showed that on high-creep hydrogels (HCHs), hMSCs displayed increased proliferation, spread area and differentiation towards multiple lineages, compared to their purely stiff analogue, with a particular propensity for differentiation towards a smooth muscle cell (SMC) lineage. In this present study, we investigate the mechanisms behind this phenomenon and show that hMSCs adhered to HCHs have increased expression of SMC induction factors, including soluble factors, ECM proteins and the cell cell adhesion molecule, N-Cadherin. Further, we identify a key role for Rac1 signalling in mediating this increased N-Cadherin expression. Using a real-time Rac1-FRET biosensor, we confirm increased Rac1 activation on HCHs, an observation that is further supported functionally by observed increases in motility and lamellipodial protrusion rates of hMSCs. Increased Rac1 activity in hMSCs on HCHs provides underlying mechanisms for enhanced commitment towards a SMC lineage and the compensatory increase in spread area (isotonic tension) after a creep-induced loss of cytoskeletal tension on viscoelastic substrates, in contrast to previous studies that have consistently demonstrated up-regulation of RhoA activity with increasing substrate stiffness. Tuning substrate viscoelasticity to introduce varying levels of creep thus equips the biomaterial scientist or engineer with a new tool with which to tune and direct stem cell outcomes. Crown Copyright (C) 2013 Published by Elsevier Ltd. All rights reserved.
C1 [Cameron, Andrew R.; Frith, Jessica E.; Cooper-White, Justin J.] Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
   [Gomez, Guillermo A.; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, St Lucia, Qld 4072, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, St Lucia, Qld 4072, Australia.
   [Cooper-White, Justin J.] CSIRO, Div Mat Sci & Engn, Clayton, Vic 3168, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Tissue Engn & Microfluid Lab, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Gomez, Guillermo/J-2993-2014; Frith, Jessica/J-6873-2017; McKenzie,
   Warren/J-2137-2014; Yap, Alpha/J-1554-2014
OI Gomez, Guillermo/0000-0002-0494-2404; Frith,
   Jessica/0000-0002-6558-5412; Yap, Alpha/0000-0002-1038-8956; Cameron,
   Andrew/0000-0002-6341-0379; Cooper-White, Justin/0000-0002-1920-8229
FU Australian Research Council [DP 1095429, DP110104446]; Cooperative
   Research Centre for Polymers; School of Chemical Engineering; Australian
   Institute of Bioengineering and Nanotechnology at The University of
   Queensland
FX We gratefully acknowledge Dr Erik Miller for discussions on
   polyacrylamide mechanical testing and Dr Gary Brooke from the Mater
   Medical Research Institute for providing hMSCs. This study was
   financially supported by the Australian Research Council Discovery
   Grants Scheme (DP 1095429 and DP110104446), the Cooperative Research
   Centre for Polymers as well as the School of Chemical Engineering and
   the Australian Institute of Bioengineering and Nanotechnology at The
   University of Queensland. This work was partly performed at the
   Australian National Fabrication Facility, a company established under
   the National Collaborative Research Infrastructure Strategy to provide
   nano- and micro-fabrication facilities for Australia's researchers.
CR Andalib MN, 2013, ACTA BIOMATER, V9, P7737, DOI 10.1016/j.actbio.2013.04.013
   Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Beqaj S, 2002, J CELL BIOL, V156, P893, DOI 10.1083/jcb.200107049
   Cameron AR, 2011, BIOMATERIALS, V32, P5979, DOI 10.1016/j.biomaterials.2011.04.003
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2009, BIONANOTECHNOLOGY GL, P35
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dyson JA, 2007, TISSUE ENG, V13, P2891, DOI 10.1089/ten.2007.0124
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira MC, 2008, MOL HUM REPROD, V14, P301, DOI 10.1093/molehr/gan016
   Friedland JC, 2007, J CELL SCI, V120, P3700, DOI 10.1242/jcs.03484
   Frith JE, 2009, TISSUE ENG PART C-ME, V16, P735
   Fujiwara H, 2004, EXP CELL RES, V292, P67, DOI 10.1016/j.yexcr.2003.08.010
   Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Gutierrez JA, 1999, AM J PHYSIOL-GASTR L, V277, pG1074, DOI 10.1152/ajpgi.1999.277.5.G1074
   Hudson JE, 2011, STEM CELLS DEV, V20
   INGBER DE, 1993, J CELL SCI, V104, P613
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002
   Katsumi A, 2002, J CELL BIOL, V158, P153, DOI 10.1083/jcb.200201105
   Keung AJ, 2011, STEM CELLS, V29, P1886, DOI 10.1002/stem.746
   Kim TJ, 2009, J CELL PHYSIOL, V218, P285, DOI 10.1002/jcp.21598
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   Kocgozlu L, 2012, BIOMATERIALS, V33, P798, DOI 10.1016/j.biomaterials.2011.10.024
   Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   Lee JS, 2013, BIOCHEM BIOPH RES CO, V435, P696, DOI 10.1016/j.bbrc.2013.05.045
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI DOI 10.1016/S0006-3495(00)76279-5
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095
   Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387
   Murrell M, 2011, BIOPHYS J, V101, P297, DOI 10.1016/j.bpj.2011.05.048
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   O'Callaghan CJ, 2000, HYPERTENSION, V36, P319, DOI 10.1161/01.HYP.36.3.319
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299
   Raines EW, 2000, ANN NY ACAD SCI, V902, P39
   Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532
   Rossol-Allisone J, 2009, CELL SIGNAL, V21, P1559, DOI 10.1016/j.cellsig.2009.05.010
   Rowlands A. S., 2008, AM J PHYSIOL-CELL PH, V295, P1037
   Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009
   SCHWARTZ MA, 2002, NAT CELL BIOL, V4, P65
   Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438
   Suzuki S, 2010, CELLS TISSUES ORGANS, V191, P269, DOI 10.1159/000260061
   Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047
   Tan GK, 2011, BIOMATERIALS, V32, P5600, DOI 10.1016/j.biomaterials.2011.04.033
   Tang AT, 2012, CELL SIGNAL, V24, P1375, DOI 10.1016/j.cellsig.2012.03.005
   Thyberg J, 1997, J HISTOCHEM CYTOCHEM, V45, P837, DOI 10.1177/002215549704500608
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Wang CM, 2011, J BIOMED MATER RES B, V97B, P58, DOI 10.1002/jbm.b.31786
   Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200
   Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Woods A, 2007, J BIOL CHEM, V282, P23500, DOI 10.1074/jbc.M700680200
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Xiao QZ, 2010, THROMB HAEMOSTASIS, V104, P440, DOI 10.1160/TH09-11-0794
   Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008
   Yang FC, 2001, P NATL ACAD SCI USA, V98, P5614, DOI 10.1073/pnas.101546898
   Yasuda T, 1996, J CLIN INVEST, V98, P1991, DOI 10.1172/JCI119003
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
NR 70
TC 50
Z9 52
U1 4
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 1857
EP 1868
DI 10.1016/j.biomaterials.2013.11.023
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700008
PM 24331708
DA 2018-10-19
ER

PT J
AU Kulkarni, M
   O'Loughlin, A
   Vazquez, R
   Mashayekhi, K
   Rooney, P
   Greiser, U
   O'Toole, E
   O'Brien, T
   Malagon, MM
   Pandit, A
AF Kulkarni, M.
   O'Loughlin, A.
   Vazquez, R.
   Mashayekhi, K.
   Rooney, P.
   Greiser, U.
   O'Toole, E.
   O'Brien, T.
   Malagon, Maria M.
   Pandit, A.
TI Use of a fibrin-based system for enhancing angiogenesis and modulating
   inflammation in the treatment of hyperglycemic wounds
SO BIOMATERIALS
LA English
DT Article
DE Gene therapy; Diabetes; Wound healing; Angiogenesis; Inflammation;
   Keratinocyte
ID DIABETIC FOOT ULCERS; OSTEOBLASTIC CELL-DIFFERENTIATION; NITRIC-OXIDE;
   GROWTH-FACTORS; OSTEOGENIC PROTEIN-1; HUMAN KERATINOCYTES; MELLITUS;
   SKIN; PROLIFERATION; FIBROBLASTS
AB The complex pathophysiology of chronic ulceration in diabetic patients is poorly understood; diabetes-related lower limb amputation is a major health issue, which has limited effective treatment regimes in the clinic. This study attempted to understand the complex pathology of hyperglycemic wound healing by showing profound changes in gene expression profiles in wounded human keratinocytes in hyperglycemic conditions compared to normal glucose conditions. In the hyper-secretory wound microenvironment of hyperglycemia, Rab18, a secretory control molecule, was found to be significantly downregulated. Using a biomaterial platform for dual therapy targeting the two distinct pathways, this study aimed to resolve the major dysregulated pathways in hyperglycemic wound healing. To complement Rab18, and promote angiogenesis eNOS was also targeted, and this novel Rab18-eNOS therapy via a dynamically controlled 'fibrin-in-fibrin' delivery system, demonstrated enhanced wound closure, by increasing functional angiogenesis and reducing inflammation, in an alloxan-induced hyperglycemic preclinical ear ulcer model of compromised wound healing. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kulkarni, M.; Rooney, P.; Greiser, U.; Pandit, A.] Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat, Galway, Ireland.
   [O'Loughlin, A.; Mashayekhi, K.; Greiser, U.; O'Brien, T.] Natl Univ Ireland Univ Coll Galway, Regenerat Med Inst, Galway, Ireland.
   [O'Toole, E.] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Cutaneous Res, London, England.
   [Vazquez, R.; Malagon, Maria M.] Univ Cordoba, IMIBIC Reina Sofia Univ Hosp, Dept Cell Biol Physiol & Immunol, Cordoba 14014, Spain.
   [Vazquez, R.; Malagon, Maria M.] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba 14014, Spain.
RP Pandit, A (reprint author), Natl Univ Ireland Univ Coll Galway, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI O'Brien, Timothy/N-7112-2014; Malagon, Maria/L-5386-2014; Pandit,
   Abhay/B-6187-2008
OI O'Brien, Timothy/0000-0001-9028-5481; Pandit, Abhay/0000-0002-6292-4933;
   Rooney, Peadar/0000-0003-3119-3928
FU Research Frontier Project, Science Foundation Ireland [06/RFP/ENM005]
FX Tisseel (TM) kits were kindly donated by Baxter Healthcare, Vienna,
   Austria. This research was funded by the Research Frontier Project,
   Science Foundation Ireland, under Grant Number 06/RFP/ENM005. The
   authors acknowledge Gerry McHale, Charles McHale and Michael Schonfeld
   for their assistance with the in vivo studies. The authors also
   acknowledge Dr. Oliver Carroll for assistance in Rab18 plasmid DNA
   expansion, John Butler (MSD) for assistance in Multiplex ELISA and
   Anthony Sloan for linguistic assistance.
CR Acosta JB, 2008, INT WOUND J, V5, P530, DOI 10.1111/j.1742-481X.2008.00457.x
   Bizzarro MJ, 2004, ENCY BIOMATERIALS BI, P1075
   Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x
   Blakytny R, 2009, INT J LOW EXTR WOUND, V8, P95, DOI 10.1177/1534734609337151
   Brandner JM, 2008, DIABETES CARE, V31, P114, DOI 10.2337/dc07-1304
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169
   Burrow JW, 2007, J SURG RES, V140, P90, DOI 10.1016/j.jss.2006.11.010
   CechowskaPasko M, 1996, MOL CELL BIOCHEM, V154, P1, DOI 10.1007/BF00248454
   Dayem MA, 2003, COMP FUNCT GENOM, V4, P47, DOI 10.1002/cfg.239
   Dejgaard SY, 2008, J CELL SCI, V121, P2768, DOI 10.1242/jcs.021808
   Deveci M, 2005, BRIT J DERMATOL, V152, P217, DOI 10.1111/J.1365-2133.2004.06329.X
   Dhaunsi GS, 2004, CLIN EXP PHARMACOL P, V31, P46, DOI 10.1111/j.1440-1681.2004.03948.x
   Ennis WJ, 2007, CLIN DERMATOL, V25, P63, DOI 10.1016/j.clindermatol.2006.09.008
   Fard AS, 2007, INT J CLIN PRACT, V61, P1931, DOI 10.1111/j.1742-1241.2007.01534.x
   Galkowska H, 2006, WOUND REPAIR REGEN, V14, P558, DOI 10.1111/j.1743-6109.2006.00155.x
   Garcia Y, 2007, BIOMATERIALS, V28, P175, DOI 10.1016/j.biomaterials.2006.08.037
   Hehenberger K, 1998, J DERMATOL SCI, V16, P144, DOI 10.1016/S0923-1811(97)00042-X
   Hink U, 2001, CIRC RES, V88, pE14
   Isenberg JS, 2005, MICROSURG, V25, P442, DOI 10.1002/micr.20166
   Jazwa Agnieszka, 2010, Genet Vaccines Ther, V8, P6, DOI 10.1186/1479-0556-8-6
   Jeschke MG, 2004, GENE THER, V11, P847, DOI 10.1038/sj.gt.3302229
   Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539
   Kulltarni MM, 2011, MOL PHARMACEUT, V8, P439, DOI 10.1021/mp100295z
   Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x
   Lan CCE, 2009, BRIT J DERMATOL, V160, P1206, DOI 10.1111/j.1365-2133.2009.09089.x
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   Li Yong-jun, 2007, Chinese Medical Sciences Journal, V22, P232
   Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30
   Liu ZJ, 2008, ANTIOXID REDOX SIGN, V10, P1869, DOI 10.1089/ars.2008.2121
   Lizarbe TR, 2008, FASEB J, V22, P3207, DOI 10.1096/fj.07-103804
   Lopez-Rivera E, 2005, P NATL ACAD SCI USA, V102, P3685, DOI 10.1073/pnas.0408217102
   Luo JD, 2009, AM J PHYSIOL-ENDOC M, V297, pE525, DOI 10.1152/ajpendo.00308.2009
   LYNCH SE, 1987, P NATL ACAD SCI USA, V84, P7696, DOI 10.1073/pnas.84.21.7696
   Malagon MM, 2009, ANN NY ACAD SCI, V1163, P233, DOI 10.1111/j.1749-6632.2008.03654.x
   Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024
   Mishima Y, 2001, DIABETES RES CLIN PR, V52, P119, DOI 10.1016/S0168-8227(00)00247-3
   Nagoba BS, 2010, INT WOUND J, V7, P153, DOI 10.1111/j.1742-481X.2010.00666.x
   Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x
   Nakai K, 2003, J DERMATOL SCI, V31, P211, DOI 10.1016/S0923-1811(03)00006-9
   Ochoa O, 2007, VASCULAR, V15, P350, DOI 10.2310/6670.2007.00056
   Pradhan L, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000945
   Schaffer MR, 1997, SURGERY, V121, P513, DOI 10.1016/S0039-6060(97)90105-7
   Schaffer MR, 1997, J IMMUNOL, V158, P2375
   Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007
   Silva SY, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-26
   Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627
   SPRUGEL KH, 1987, AM J PATHOL, V129, P601
   Stallmeyer B, 2002, NITRIC OXIDE-BIOL CH, V6, P168, DOI 10.1006/niox.2001.0407
   Sun C, 2011, J CELL PHYSL
   Takita H, 1997, EUR J ORAL SCI, V105, P588, DOI 10.1111/j.1600-0722.1997.tb00222.x
   Teixeira AS, 1999, LIFE SCI, V64, P655, DOI 10.1016/S0024-3205(98)00607-9
   Terashi Hiroto, 2005, Int Wound J, V2, P298, DOI 10.1111/j.1742-4801.2005.00148.x
   Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194
   Vazquez-Martinez R, 2008, J CLIN ENDOCR METAB, V93, P2269, DOI 10.1210/jc.2007-1893
   Vazquez-Martinez R, 2007, TRAFFIC, V8, P867, DOI 10.1111/j.1600-0854.2007.00570.x
   Weller RB, 2009, J INVEST DERMATOL, V129, P2335, DOI 10.1038/jid.2009.149
   Witte MB, 2002, BRIT J SURG, V89, P1594, DOI 10.1046/j.1365-2168.2002.02263.x
   Yeh LCC, 1997, ENDOCRINOLOGY, V138, P4181, DOI 10.1210/en.138.10.4181
   Yeh LCC, 2002, J CELL PHYSIOL, V190, P322, DOI 10.1002/jcp.10064
NR 60
TC 20
Z9 21
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 2001
EP 2010
DI 10.1016/j.biomaterials.2013.11.003
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700022
PM 24331702
DA 2018-10-19
ER

PT J
AU Gower, RM
   Boehler, RM
   Azarin, SM
   Ricci, CF
   Leonard, JN
   Shea, LD
AF Gower, R. Michael
   Boehler, Ryan M.
   Azarin, Samira M.
   Ricci, Christine F.
   Leonard, Joshua N.
   Shea, Lonnie D.
TI Modulation of leukocyte infiltration and phenotype in microporous tissue
   engineering scaffolds via vector induced IL-10 expression
SO BIOMATERIALS
LA English
DT Article
DE Inflammation; Immunomodulation; Gene therapy; Flow cytometry; Scaffold;
   Leukocyte
ID EXTRAHEPATIC ISLET TRANSPLANTATION; SPINAL-CORD-INJURY; IN-VIVO;
   MACROPHAGE DEPLETION; POLYMER SCAFFOLDS; GENE DELIVERY; FUNCTIONALIZED
   SCAFFOLD; ALLOGRAFT SURVIVAL; PLASMID DELIVERY; INFLAMMATION
AB Biomaterial scaffolds are central to many tissue engineering strategies as they create a space for tissue growth and provide a support for cell adhesion and migration. However, biomaterial implantation results in unavoidable injury resulting in an inflammatory response, which can impair integration with the host and tissue regeneration. Toward the goal of reducing inflammation, we investigated the hypothesis that a lentiviral gene therapy-based approach to localized and sustained IL-10 expression at a scaffold could modulate the number, relative proportions, and cytokine production of infiltrating leukocyte populations. Flow cytometry was used to quantify infiltration of six leukocyte populations for 21 days following implantation of PLG scaffolds into intraperitoneal fat. Leukocytes with innate immune functions (i.e., macrophages, dendritic cells, neutrophils) were most prevalent at early time points, while T lymphocytes became prevalent by day 14. Reporter gene delivery indicated that transgene expression persisted at the scaffold for up to 28 days and macrophages were the most common leukocyte transduced, while transduced dendritic cells expressed the greatest levels of transgene. IL-10 delivery decreased leukocyte infiltration by 50% relative to controls, increased macrophage IL-10 expression, and decreased macrophage, dendritic cell, and CD4 T cell IFN-gamma expression. Thus, IL-10 gene delivery significantly decreased inflammation following scaffold implant into the intraperitoneal fat, in part by modulating cytokine expression of infiltrating leukocytes. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Gower, R. Michael; Boehler, Ryan M.; Azarin, Samira M.; Ricci, Christine F.; Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, McCormick Sch Engn, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Evanston, IL 60208 USA.
   [Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
   [Leonard, Joshua N.; Shea, Lonnie D.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd Tech E136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009; Leonard, Joshua/B-7649-2009
OI Leonard, Joshua/0000-0003-4359-6126
FU National Institutes of Biomedical Imaging and Bioengineering (NIBIB) at
   the National Institutes of Health (NIH) [R01 EB009910, R01 EB005678, R01
   CA173745]; Northwestern University RHLCCC Flow Cytometry Facility;
   Cancer Center [NCI CA060553]
FX Financial support for this research was provided by the National
   Institutes of Biomedical Imaging and Bioengineering (NIBIB) at the
   National Institutes of Health (NIH) through grant number R01 EB009910,
   R01 EB005678, and R01 CA173745. This work was also supported by the
   Northwestern University RHLCCC Flow Cytometry Facility and a Cancer
   Center Support Grant (NCI CA060553).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aviles MO, 2011, DRUG DELIV TRANSL RE, V1, P91, DOI 10.1007/s13346-010-0011-1
   Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Boehler RM, 2013, BIOMATERIALS, V34, P5431, DOI 10.1016/j.biomaterials.2013.04.009
   Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009
   Dudler J, 2006, TRANSPLANTATION, V82, P1733, DOI 10.1097/01.tp.0000250757.69384.79
   Gibly RF, 2011, BIOMATERIALS, V32, P9677, DOI 10.1016/j.biomaterials.2011.08.084
   Gonzalez R, 2003, EXP NEUROL, V184, P456, DOI 10.1016/S0014-4886(03)00257-7
   Graham JG, 2013, TISSUE ENG PT A, V19, P1465, DOI [10.1089/ten.tea.2012.0643, 10.1089/ten.TEA.2012.0643]
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hidalgo LG, 2002, CRIT REV IMMUNOL, V22, P317
   Holladay C, 2011, MOL THER, V19, P969, DOI 10.1038/mt.2010.311
   Holladay CA, 2012, BIOMATERIALS, V33, P1303, DOI 10.1016/j.biomaterials.2011.10.019
   Hong YS, 2002, J HEART LUNG TRANSPL, V21, P1188, DOI 10.1016/S1053-2498(02)00417-5
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   KAUFMAN DB, 1990, J EXP MED, V172, P291, DOI 10.1084/jem.172.1.291
   Li SX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061799
   Lopez-Armada MJ, 2002, ANN RHEUM DIS, V61, P1027, DOI 10.1136/ard.61.11.1027
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   Miyoshi H, 1998, J VIROL, V72, P8150
   Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048
   Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Rossi L, 2008, TRANSPLANTATION, V85, P648, DOI 10.1097/TP.0b013e31816360f3
   Salvay DM, 2010, GENE THER, V17, P1134, DOI 10.1038/gt.2010.79
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Staples KJ, 2007, J IMMUNOL, V178, P4779, DOI 10.4049/jimmunol.178.8.4779
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Tuinstra HM, 2012, BIOMATERIALS, V33, P1618, DOI 10.1016/j.biomaterials.2011.11.002
   van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547
   van der Windt DJ, 2008, CELL TRANSPLANT, V17, P1005, DOI 10.3727/096368908786991515
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44
NR 42
TC 32
Z9 32
U1 3
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 6
BP 2024
EP 2031
DI 10.1016/j.biomaterials.2013.11.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA3UD
UT WOS:000331018700024
PM 24309498
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tsai, YT
   Zhou, J
   Weng, H
   Tang, EN
   Baker, DW
   Tang, LP
AF Tsai, Yi-Ting
   Zhou, Jun
   Weng, Hong
   Tang, Ewin N.
   Baker, David W.
   Tang, Liping
TI Optical imaging of fibrin deposition to elucidate participation of mast
   cells in foreign body responses
SO BIOMATERIALS
LA English
DT Article
DE In vivo imaging; Near infrared fluorescence; Fibrin; Biomaterial;
   Inflammation; Biocompatibility
ID ACUTE INFLAMMATORY RESPONSES; IN-VIVO; MOLECULAR DETERMINANTS; CONTRAST
   AGENT; ALPHA-CHAIN; BIOMATERIALS; THROMBIN; ADHESION; THROMBOEMBOLISM;
   POLYMERIZATION
AB Mast cell activation has been shown to be an initiator and a key determinant of foreign body reactions. However, there is no non-invasive method that can quantify the degree of implant-associated mast cell activation. Taking advantage of the fact that fibrin deposition is a hallmark of mast cell activation around biomaterial implants, a near infrared probe was fabricated to have high affinity to fibrin. Subsequent in vitro testing confirmed that this probe has high affinity to fibrin. Using a subcutaneous particle implantation model, we found significant accumulation of fibrin-affinity probes at the implant sites as early as 15 min following particle implantation. The accumulation of fibrin-affinity probes at the implantation sites could also be substantially reduced if anti-coagulant heparin was administered at the implant sites. Further studies have shown that subcutaneous administration of mast cell activator compound 48/80 - prompted the accumulation of fibrin-affinity probes. However, implant-associated fibrin-affinity probe accumulation was substantially reduced in mice with mast cell deficiency. The results show that our fibrin-affinity probes may serve as a powerful tool to monitor and measure the extent of biomaterial-mediated fibrin deposition and mast cell activation in vivo. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tsai, Yi-Ting; Zhou, Jun; Weng, Hong; Tang, Ewin N.; Baker, David W.; Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   [Tang, Liping] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung 807, Taiwan.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, POB 19138, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [R43 GM101776]
FX This work was supported by an NIH grant R43 GM101776.
CR Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P6698, DOI 10.1073/pnas.0303859101
   ALTIERI DC, 1988, J CELL BIOL, V107, P1893, DOI 10.1083/jcb.107.5.1893
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andre P, 2000, P NATL ACAD SCI USA, V97, P13835, DOI 10.1073/pnas.250475997
   Aruva MR, 2006, J NUCL MED, V47, P155
   Aspenberg P, 2004, ACTA ORTHOP SCAND, V75, P93, DOI 10.1080/00016470410001708190
   Botnar RM, 2004, CIRCULATION, V109, P2023, DOI 10.1161/01.CIR.000012703450006.C0
   Bratlie KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010032
   Coleman JW, 2002, CLIN EXP IMMUNOL, V129, P4, DOI 10.1046/j.1365-2249.2002.01918.x
   Cooley BC, 2011, ARTERIOSCL THROM VAS, V31, P1351, DOI 10.1161/ATVBAHA.111.225334
   Dorozhkin Sergey V, 2011, Biomatter, V1, P3, DOI 10.4161/biom.1.1.16782
   Frangioni JV, 2003, CURR OPIN CHEM BIOL, V7, P626, DOI 10.1016/j.cbpa.2003.08.007
   GOMI K, 1990, BLOOD, V75, P1396
   Gray LD, 2011, THROMB RES, V128, P570, DOI 10.1016/j.thromres.2011.04.009
   Hogg PJ, 1996, J BIOL CHEM, V271, P26088, DOI 10.1074/jbc.271.42.26088
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   LANGUINO LR, 1993, CELL, V73, P1423, DOI 10.1016/0092-8674(93)90367-Y
   LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085
   Liu WE, 2011, BIOMATERIALS, V32, P1796, DOI 10.1016/j.biomaterials.2010.11.029
   LOIKE JD, 1991, P NATL ACAD SCI USA, V88, P1044, DOI 10.1073/pnas.88.3.1044
   Ma ML, 2011, ADV MATER, V23, pH189, DOI 10.1002/adma.201100513
   McCarthy JR, 2009, BIOCONJUGATE CHEM, V20, P1251, DOI 10.1021/bc9001163
   Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003
   Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275
   Overoye-Chan K, 2008, J AM CHEM SOC, V130, P6025, DOI 10.1021/ja800834y
   Pan D, 2008, J AM CHEM SOC, V130, P9186, DOI 10.1021/ja801482d
   Pan DPJ, 2009, CHEM COMMUN, P3234, DOI 10.1039/b902875g
   Pereira M, 2001, ANN NY ACAD SCI, V936, P438
   PEREZ RL, 1995, J IMMUNOL, V154, P1879
   RAMOS BF, 1992, EUR J IMMUNOL, V22, P2381, DOI 10.1002/eji.1830220930
   SIMMONS CA, 1987, J SURG RES, V43, P468, DOI 10.1016/0022-4804(87)90106-5
   Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406
   Smiley ST, 2001, J IMMUNOL, V167, P2887, DOI 10.4049/jimmunol.167.5.2887
   Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22
   Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Thakur ML, 2000, J NUCL MED, V41, P161
   Valent P, 1998, INT ARCH ALLERGY IMM, V115, P2, DOI 10.1159/000023823
   van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426
   Yu DG, 2012, INT J NANOMED, V7, P5725, DOI [10.2147/IJN.S37455, 10.2147/IJN.S29961]
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhou J, 2012, FREE RADICAL BIO MED, V52, P218, DOI 10.1016/j.freeradbiomed.2011.10.452
   Zhou J, 2011, BIOMATERIALS, V32, P9383, DOI 10.1016/j.biomaterials.2011.08.064
NR 48
TC 8
Z9 8
U1 1
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2089
EP 2096
DI 10.1016/j.biomaterials.2013.11.040
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300001
PM 24342726
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Tian, HC
   Liu, JQ
   Wei, DX
   Kang, XY
   Zhang, C
   Du, JC
   Yang, B
   Chen, X
   Zhu, HY
   NuLi, YN
   Yang, CS
AF Tian, Hong-Chang
   Liu, Jing-Quan
   Wei, Dai-Xu
   Kang, Xiao-Yang
   Zhang, Chuan
   Du, Jing-Cheng
   Yang, Bin
   Chen, Xiang
   Zhu, Hong-Ying
   NuLi, Yan-Na
   Yang, Chun-Sheng
TI Graphene oxide doped conducting polymer nanocomposite film for
   electrode-tissue interface
SO BIOMATERIALS
LA English
DT Article
DE Graphene oxide; Conducting polymer; Electrode-tissue interface;
   Microelectrode; Electrochemical deposition; Tissue engineering
ID ELECTRICAL-STIMULATION; NEURAL STIMULATION; NANOTUBES;
   POLY(3,4-ETHYLENEDIOXYTHIOPHENE); ADHESION
AB One of the most significant components for implantable bioelectronic devices is the interface between the microelectrodes and the tissue or cells for disease diagnosis or treatment. To make the devices work efficiently and safely in vivo, the electrode-tissue interface should not only be confined in micro scale, but also possesses excellent electrochemical characteristic, stability and biocompatibility. Considering the enhancement of many composite materials by combining graphene oxide (GO) for its multiple advantages, we dope graphene oxide into poly(3,4-ethylenedioxythiophene) (PEDOT) forming a composite film by electrochemical deposition for electrode site modification. As a consequence, not only the enlargement of efficient surface area, but also the development of impedance, charge storage capacity and charge injection limit contribute to the excellent electrochemical performance. Furthermore, the stability and biocompatibility are confirmed by numerously repeated usage test and cell proliferation and attachment examination, respectively. As electrode-tissue interface, this biomaterial opens a new gate for tissue engineering and implantable electrophysiological devices. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tian, Hong-Chang; Liu, Jing-Quan; Kang, Xiao-Yang; Zhang, Chuan; Du, Jing-Cheng; Yang, Bin; Chen, Xiang; Zhu, Hong-Ying; Yang, Chun-Sheng] Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Shanghai 200030, Peoples R China.
   [Wei, Dai-Xu] Natl Engn Res Ctr Nanotechnol, Shanghai, Peoples R China.
   [NuLi, Yan-Na] Shanghai Jiao Tong Univ, Dept Chem Engn, Shanghai 200030, Peoples R China.
RP Liu, JQ (reprint author), Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Shanghai 200030, Peoples R China.
EM jqliu@sjtu.edu.cn
RI Tian, Hong-Chang/E-3580-2015
OI Du, Jingcheng/0000-0002-0322-4566
FU National Natural Science Foundation of China [51035005, 61176104]; 973
   Program [2013CB329401]; Shanghai Municipal Science and Technology
   Commission [11JC1405700, 13511500200]; NDPR Foundation of China
   [9140A26060313JW3385]
FX The authors thank to partly financial support from the National Natural
   Science Foundation of China (No. 51035005, 61176104), 973 Program
   (2013CB329401), Shanghai Municipal Science and Technology Commission
   (No. 11JC1405700, 13511500200), NDPR Foundation of China (No.
   9140A26060313JW3385). The authors are also grateful to the colleagues
   for their essential contribution to this work.
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   Abidian MR, 2006, ADV MATER, V18, P405, DOI 10.1002/adma.200501726
   Asplund M, 2008, BIOINTERPHASES, V3, P83, DOI 10.1116/1.2998407
   Berggren M, 2007, ADV MATER, V19, P3201, DOI 10.1002/adma.200700419
   Chen P, 2013, ADV MATER, V25, P3192, DOI 10.1002/adma.201300515
   Cogan SF, 2004, J NEUROSCI METH, V137, P141, DOI 10.1016/j.jneumeth.2004.02.019
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Danielsson P, 2004, J SOLID STATE ELECTR, V8, P809, DOI 10.1007/s10008-004-0549-2
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047
   Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017
   Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927
   Heo C, 2011, BIOMATERIALS, V32, P19, DOI 10.1016/j.biomaterials.2010.08.095
   Kim S, 2009, BIOMED MICRODEVICES, V11, P453, DOI 10.1007/s10544-008-9251-y
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Kvarnstrom C, 1999, ELECTROCHIM ACTA, V44, P2739, DOI 10.1016/S0013-4686(98)00405-8
   Li D, 2008, NAT NANOTECHNOL, V3, P101, DOI 10.1038/nnano.2007.451
   Liu Y, 2010, LANGMUIR, V26, P6158, DOI 10.1021/la100886x
   Lu Y., 2010, BIOMATERIALS, V22, P3906
   Lu Y, 2009, SENSOR ACTUAT B-CHEM, V137, P334, DOI 10.1016/j.snb.2008.11.036
   Luo XL, 2011, BIOMATERIALS, V32, P5551, DOI 10.1016/j.biomaterials.2011.04.051
   Merrill DR, 2005, J NEUROSCI METH, V141, P171, DOI 10.1016/j.jneumeth.2004.10.020
   Park SY, 2011, ADV MATER, V23, P263
   Perlmutter JS, 2006, ANNU REV NEUROSCI, V29, P229, DOI 10.1146/annurev.neuro.29.051605.112824
   Receveur R. A. M., 2007, J MICROMECH MICROENG, V17, P50
   ROSE TL, 1990, IEEE T BIO-MED ENG, V37, P1118, DOI 10.1109/10.61038
   Rui YF, 2012, BIOMED MICRODEVICES, V14, P367, DOI 10.1007/s10544-011-9613-8
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Ryoo SR, 2010, ACS NANO, V4, P6587, DOI 10.1021/nn1018279
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sodagar AM, 2009, IEEE T MICROW THEORY, V57, P2565, DOI 10.1109/TMTT.2009.2029957
   Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969
   Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P307, DOI 10.1109/TNSRE.2011.2109399
   Waltzman SB, 2006, EXPERT REV MED DEVIC, V3, P647, DOI 10.1586/17434440.3.5.647
   Weiland JD, 2008, P IEEE, V96, P1076, DOI 10.1109/JPROC.2008.922589
   Xu YF, 2009, NANO RES, V2, P343, DOI 10.1007/s12274-009-9032-9
   Xu YX, 2010, ACS NANO, V4, P7358, DOI 10.1021/nn1027104
   Yan H, 2009, SYNTHETIC MET, V159, P2225, DOI 10.1016/j.synthmet.2009.07.032
   Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r
   You B, 2013, CHEM COMMUN, V49, P5016, DOI 10.1039/c3cc41949e
   Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a
   Zhu YW, 2010, ADV MATER, V22, P3906, DOI 10.1002/adma.201001068
NR 45
TC 50
Z9 50
U1 9
U2 111
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2120
EP 2129
DI 10.1016/j.biomaterials.2013.11.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300005
PM 24333027
DA 2018-10-19
ER

PT J
AU Nguyen, EH
   Zanotelli, MR
   Schwartz, MP
   Murphy, WL
AF Nguyen, Eric H.
   Zanotelli, Matthew R.
   Schwartz, Michael P.
   Murphy, William L.
TI Differential effects of cell adhesion, modulus and VEGFR-2 inhibition on
   capillary network formation in synthetic hydrogel arrays
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Cell encapsulation; ECM; Growth factors; Hydrogel
ID VISCOELASTIC SHEAR PROPERTIES; GLYCOL) DIACRYLATE HYDROGELS;
   ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; IN-VITRO; ANGIOGENESIS; GROWTH;
   INTEGRIN; COLLAGEN; TUBULOGENESIS
AB Efficient biomaterial screening platforms can test a wide range of extracellular environments that modulate vascular growth. Here, we used synthetic hydrogel arrays to probe the combined effects of Cys-Arg-Gly-Asp-Ser (CRGDS) cell adhesion peptide concentration, shear modulus and vascular endothelial growth factor receptor 2 (VEGFR2) inhibition on human umbilical vein endothelial cell (HUVEC) viability, proliferation and tubulogenesis. HUVECs were encapsulated in degradable poly(ethylene glycol) (PEG) hydrogels with defined CRGDS concentration and shear modulus. VEGFR2 activity was modulated using the VEGFR2 inhibitor SU5416. We demonstrate that synergy exists between VEGFR2 activity and CRGDS ligand presentation in the context of maintaining HUVEC viability. However, excessive CRGDS disrupts this synergy. HUVEC proliferation significantly decreased with VEGFR2 inhibition and increased modulus, but did not vary monotonically with CRGDS concentration. Capillary-like structure (CLS) formation was highly modulated by CRGDS concentration and modulus, but was largely unaffected by VEGFR2 inhibition. We conclude that the characteristics of the ECM surrounding encapsulated HUVECs significantly influence cell viability, proliferation and CLS formation. Additionally, the ECM modulates the effects of VEGFR2 signaling, ranging from changing the effectiveness of synergistic interactions between integrins and VEGFR2 to determining whether VEGFR2 upregulates, downregulates or has no effect on proliferation and CLS formation. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Nguyen, Eric H.; Zanotelli, Matthew R.; Schwartz, Michael P.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
   [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI 53706 USA.
RP Murphy, WL (reprint author), Univ Wisconsin, Dept Biomed Engn, 1550 Engn Dr, Madison, WI 53706 USA.
EM wlmurphy@wisc.edu
RI Murphy, William/I-4096-2014
OI Schwartz, Michael/0000-0003-3785-6606
FU National Institutes of Health [NIH R01 HL093282-01A1, NIH R21
   EB016381-01, NIH 1UH2 TR000506-01]; Biotechnology Training Program
   [NIGMS 5T32GM08349]; National Magnetic Resonance Facility at Madison;
   NIH (BRTP/NCRR) [P41RR02301]; NIGMS [P41GM10399]; University of
   Wisconsin; NIH [RR02781, RR08438]; NSF [DMB-8415048, OIA-9977486,
   BIR-9214394]; DOE; USDA; NIH (NCRR) [S100RR027000]
FX The authors would like to acknowledge funding from the National
   Institutes of Health (NIH R01 HL093282-01A1, NIH R21 EB016381-01, NIH
   1UH2 TR000506-01 and the Biotechnology Training Program NIGMS
   5T32GM08349) as well as the UW Madison Graduate Engineering Research
   Scholars program. We would like to thank Justin Williams and David Beebe
   for their assistance with soft lithography techniques. This study made
   use of the National Magnetic Resonance Facility at Madison, which is
   supported by NIH grants P41RR02301 (BRTP/NCRR) and P41GM10399 (NIGMS).
   Additional equipment was purchased with funds from the University of
   Wisconsin, the NIH (RR02781, RR08438), the NSF (DMB-8415048,
   OIA-9977486, BIR-9214394), the DOE, and the USDA. Small angle X-ray
   scattering (SAXS) equipment was purchased with funds from NIH grant
   S100RR027000 (NCRR). Mechanical testing data was obtained using the Ares
   LS2 rheometer at the UW Madison Soft Materials Laboratory. Confocal
   Microscopy images were taken using the Nikon AIR-Si Confocal Microscope
   at the Waisman Center Cellular & Molecular Neuroscience Core facility in
   Madison, WI. Special thanks go to Matt Parlato for assistance with
   mechanical testing techniques and Justin Koepsel for helpful discussions
   and technical instruction throughout the course of these studies.
CR Abaci HE, 2011, AM J PHYSIOL-CELL PH, V301, pC431, DOI 10.1152/ajpcell.00074.2011
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Barkefors I, 2008, J BIOL CHEM, V283, P13905, DOI 10.1074/jbc.M704917200
   Beer AJ, 2008, J NUCL MED, V49, P22, DOI 10.2967/jnumed.107.045864
   Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102
   Calvani M, 2006, BLOOD, V107, P2705, DOI 10.1182/blood-2005-09-3541
   Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Charnley M, 2009, INTEGR BIOL-UK, V1, P625, DOI 10.1039/b918172p
   Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076
   Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165
   Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808
   Funahashi Y, 2011, VASC CELL, V3, DOI DOI 10.1186/2040-2384-2-3.AVAILABLE
   Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   Han SW, 2013, CARDIOVASC RES, V98, P73, DOI 10.1093/cvr/cvt019
   Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x
   Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007
   Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Jongpaiboonkit L, 2008, BIOMATERIALS, V29, P3346, DOI 10.1016/j.biomaterials.2008.04.040
   Jongpaiboonkit L, 2009, TISSUE ENG PT A, V15, P343, DOI 10.1089/ten.tea.2008.0096
   Jung JP, 2011, INTEGR BIOL-UK, V3, P185, DOI 10.1039/c0ib00112k
   KAEHLER J, 1989, J VASC SURG, V9, P535, DOI 10.1067/mva.1989.vs0090535
   Khan Zia A., 2005, Angiogenesis, V8, P183, DOI 10.1007/s10456-005-9017-6
   Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.TEC.2011.0150, 10.1089/ten.tec.2011.0150]
   King WJ, 2010, J BIOMED MATER RES A, V93A, P1110, DOI 10.1002/jbm.a.32601
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P1508, DOI 10.1039/c2ib20029e
   Koepsel JT, 2012, INTEGR BIOL-UK, V4, P914, DOI 10.1039/c2ib20055d
   Koepsel JT, 2009, LANGMUIR, V25, P12825, DOI 10.1021/la901938e
   Lafleur MA, 2002, J CELL SCI, V115, P3427
   Le Saux G, 2011, BIOPHYS J, V101, P764, DOI 10.1016/j.bpj.2011.06.064
   Leslie-Barbick JE, 2011, BIOMATERIALS, V32, P5782, DOI 10.1016/j.biomaterials.2011.04.060
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Liu JC, 2008, BIOMACROMOLECULES, V9, P2984, DOI 10.1021/bm800469j
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mendel DB, 2000, CLIN CANCER RES, V6, P4848
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Murphy JF, 2001, FASEB J, V15, P1667, DOI 10.1096/fj.00-0757fje
   Myers KA, 2011, J CELL BIOL, V192, P321, DOI 10.1083/jcb.201006009
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Nelson CM, 2003, J CELL SCI, V116, P3571, DOI 10.1242/jcs.00680
   Ochsner M, 2007, LAB CHIP, V7, P1074, DOI 10.1039/b704449f
   Provenzano P, 2008, BMC MED, V6, DOI DOI 10.1186/1741-7015-6-11.AVAILABLE
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   Roberts OL, 2010, J CELL SCI, V123, P3189, DOI 10.1242/jcs.072801
   Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692
   Saunders RL, 2010, CELL MOL BIOENG, V3, P60, DOI 10.1007/s12195-010-0112-4
   Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017
   Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e
   Shen CJ, 2011, EXP CELL RES, V317, P1860, DOI 10.1016/j.yexcr.2011.05.006
   Sinkus R, 2005, MAGN RESON IMAGING, V23, P159, DOI 10.1016/j.mri.2004.11.060
   Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882
   Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752
   Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451
   Thibault C, 2007, LANGMUIR, V23, P10706, DOI 10.1021/1a701341j
   Toepke MW, 2013, MACROMOL MATER ENG, V298, P699, DOI 10.1002/mame.201200119
   Xu ZH, 2006, INVEST OPHTH VIS SCI, V47, P4059, DOI 10.1167/iovs.05-1528
   Yamamura N, 2007, TISSUE ENG, V13, P1443, DOI 10.1089/ten.2006.0333
NR 67
TC 33
Z9 33
U1 1
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2149
EP 2161
DI 10.1016/j.biomaterials.2013.11.054
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300008
PM 24332391
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ho, KKK
   Chen, RX
   Willcox, MDP
   Rice, SA
   Cole, N
   Iskander, G
   Kumar, N
AF Ho, Kitty K. K.
   Chen, Renxun
   Willcox, Mark D. P.
   Rice, Scott A.
   Cole, Nerida
   Iskander, George
   Kumar, Naresh
TI Quorum sensing inhibitory activities of surface immobilized
   antibacterial dihydropyrrolones via click chemistry
SO BIOMATERIALS
LA English
DT Article
DE Surface modification; Dihydropyrrolone; Quorum sensing; Antibacterial;
   Pseudomonas; Staphylococcus
ID DEVICE-ASSOCIATED INFECTIONS; PSEUDOMONAS-AERUGINOSA-LAS; TO-CELL
   COMMUNICATION; STAPHYLOCOCCUS-AUREUS; GENE-EXPRESSION; DELISEA-PULCHRA;
   IN-VIVO; SWARMING MOTILITY; BIOFILM FORMATION; SYSTEMS
AB Device-related infection remains a major barrier to the use of biomaterial implants as life-saving devices. This study aims to examine the effectiveness and mechanism of action of surface attached dihydropyrrolones (DHPs), a quorum sensing (QS) inhibitor, against bacterial colonization. DHPs were covalently attached on glass surfaces via copper-catalyzed azide-alkyne 1,3-dipolar cycloaddition (CuAAC) click reaction. The covalent attachment of DHP surfaces was confirmed by X-ray photoelectron spectroscopy (XPS) and contact angle measurements, and the antimicrobial efficacy of the DHP coatings was assessed by confocal laser scanning microscopy (CLSM) and image analysis. The results demonstrated that covalently bound DHP compounds are effective in reducing the adhesion by up to 97% (p < 0.05) for both Pseudomonas aeruginosa and Staphylococcus aureus. Furthermore, using the green fluorescent protein (Gfp)-based reporter technology, it is demonstrated that surface attached DHPs were able to repress the expression of a lasB-gfp reporter fusion of P. aeruginosa by 72% (p < 0.001) without affecting cell viability. This demonstrates the ability of the covalently bound QS inhibitor to inhibit QS and suggests the existence of a membrane-based pathway(s) for QS inhibition. Hence, strategies based on incorporation of QS inhibitors such as DHPs represent a potential approach for prevention of device-related infections. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Ho, Kitty K. K.; Chen, Renxun; Iskander, George; Kumar, Naresh] Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
   [Willcox, Mark D. P.; Cole, Nerida] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW 2052, Australia.
   [Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore.
RP Kumar, N (reprint author), Univ New S Wales, Sch Chem, Sydney, NSW 2052, Australia.
EM n.kumar@unsw.edu.au
RI Chen, Renxun/G-7015-2014
OI Chen, Renxun/0000-0003-0828-9980; cole, nerida/0000-0002-9866-4694;
   rice, scott/0000-0002-9486-2343
FU Australian Research Council [DP1095159]; Linkage Project Grant
   [LP110200635]
FX This research was supported by the Australian Research Council's
   Discovery Grant (DP1095159) and Linkage Project Grant (LP110200635).
CR Andresen M, 2007, BIOMACROMOLECULES, V8, P2149, DOI 10.1021/bm070304e
   Buckley BR, 2010, CHEM-EUR J, V16, P6278, DOI 10.1002/chem.201000447
   Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003
   Chen RX, 2012, ACTA BIOMATER, V8, P4371, DOI 10.1016/j.actbio.2012.07.029
   Collman JP, 2006, LANGMUIR, V22, P2457, DOI 10.1021/la052947q
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davey ME, 2003, J BACTERIOL, V185, P1027, DOI 10.1128/JB.185.3.1027-1036.2003
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Davis BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013522
   de Kievit TR, 2002, FEMS MICROBIOL LETT, V212, P101, DOI 10.1016/S0378-1097(02)00735-8
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913
   Gram L, 1996, APPL ENVIRON MICROB, V62, P4284
   Gupta RK, 2011, AM J BIOMED SCI, V3, P116, DOI DOI 10.5099/AJ1102
   Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Ho KKK, 2010, BIOFOULING, V26, P913, DOI 10.1080/08927014.2010.531463
   Ho KKK, 2012, ANTIMICROB AGENTS CH, V56, P1138, DOI 10.1128/AAC.05814-11
   Hume EBH, 2005, IMMUNOL CELL BIOL, V83, P294, DOI 10.1111/j.1440-1711.2005.01326.x
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   Jao CY, 2008, P NATL ACAD SCI USA, V105, P15779, DOI 10.1073/pnas.0808480105
   Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299
   Kjelleberg S, 1997, AQUAT MICROB ECOL, V13, P85, DOI 10.3354/ame013085
   Kjelleberg S, 2002, CURR OPIN MICROBIOL, V5, P254, DOI 10.1016/S1369-5274(02)00325-9
   Kumar N., 2007, WO Patent, Patent No. [WO2007085042, 2007085042]
   Li Y, 2011, CHEM-EUR J, V17, P2656, DOI 10.1002/chem.201001533
   Lintz MJ, 2011, P NATL ACAD SCI USA, V108, P15763, DOI 10.1073/pnas.1112398108
   Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079
   Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283
   Mattmann ME, 2008, BIOORG MED CHEM LETT, V18, P3072, DOI 10.1016/j.bmcl.2007.11.095
   Nelson LK, 2009, MICROBIOL-SGM, V155, P2612, DOI 10.1099/mic.0.028464-0
   Oliveira JR, 2012, CARBOHYD POLYM, V87, P240, DOI 10.1016/j.carbpol.2011.07.043
   Prakash S, 2007, ANAL CHEM, V79, P1661, DOI 10.1021/ac061824n
   Pressly ED, 2011, J POLYM SCI POL CHEM, V49, P814, DOI 10.1002/pola.24504
   Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006
   Quemener D, 2006, CHEM COMMUN, P5051, DOI 10.1039/b611224b
   Rasmussen TB, 2000, MICROBIOL-UK, V146, P3237, DOI 10.1099/00221287-146-12-3237
   SCHULZ A, 1993, ANGEW CHEM INT EDIT, V32, P1610, DOI 10.1002/anie.199316101
   SCHULZE RK, 1990, J VAC SCI TECHNOL A, V8, P2338, DOI 10.1116/1.576760
   Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0
   Stocks SM, 2004, CYTOM PART A, V61A, P189, DOI 10.1002/cyto.a.20069
   Strahl H, 2010, P NATL ACAD SCI USA, V107, P12281, DOI 10.1073/pnas.1005485107
   Tenover FC, 2001, CLIN INFECT DIS, V33, pS108, DOI 10.1086/321834
   Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001
   Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0
   WOLLMAN EW, 1994, J AM CHEM SOC, V116, P4395, DOI 10.1021/ja00089a030
   Wu H, 2001, MICROBIOL-SGM, V147, P1105, DOI 10.1099/00221287-147-5-1105
   Zhu H, 2004, INVEST OPHTH VIS SCI, V45, P1897, DOI 10.1167/iovs.03-0980
NR 49
TC 19
Z9 21
U1 1
U2 76
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2336
EP 2345
DI 10.1016/j.biomaterials.2013.11.072
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300027
PM 24345737
DA 2018-10-19
ER

PT J
AU Zhu, HJ
   Chen, HB
   Zeng, XW
   Wang, ZY
   Zhang, XD
   Wu, YP
   Gao, YF
   Zhang, JX
   Liu, KW
   Liu, RY
   Cai, LT
   Mei, L
   Feng, SS
AF Zhu, Huijun
   Chen, Hongbo
   Zeng, Xiaowei
   Wang, Zhongyuan
   Zhang, Xudong
   Wu, Yanping
   Gao, Yongfeng
   Zhang, Jinxie
   Liu, Kewei
   Liu, Ranyi
   Cai, Lintao
   Mei, Lin
   Feng, Si-Shen
TI Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA
   nanoparticles for enhanced chemotherapy against multi-drug resistance
SO BIOMATERIALS
LA English
DT Article
DE Biodegradable polymers; Cancer nanotechnology; Controlled release;
   Molecular biomaterial; Nanomedicine; Pharmaceutical nanotechnology
ID POLYETHYLENE-GLYCOL; CONTROLLED-RELEASE; HOLLOW MICROSPHERES;
   CANCER-TREATMENT; BREAST-CANCER; COPOLYMER; SUCCINATE; DOXORUBICIN; PEG;
   NANOMEDICINE
AB We report a strategy to make use of poly(lactic-co-glycolic acid) nanoparticle (PLGA NPs) for co-delivery of docetaxel (DTX) as a model anticancer drug together with vitamin E TPGS. The latter plays a dual role as a pore-forming agent in the nanopartides that may result in smaller particle size, higher drug encapsulation efficiency and faster drug release, and also as a bioactive agent that could inhibit P-glycoprotein to overcome multi-drug resistance of the cancer cells, The DTX-loaded PLGA NPs of 0, 10, 20 and 40% TPGS were prepared by the nanoprecipitation method and then characterized for their size and size distribution, surface morphology, physical status and encapsulation efficiency of the drug in the NPs. All four NPs were found of size ranged 100-120 nm and EE ranged 85-95% at drug loading level around 10%. The in vitro evaluation showed that the 48 h IC50 values of the free DTX and the DTX-loaded PLGA NPs of 0, 10,20% TPGS were 2.619 and 0.474, 0.040, 0.009 mu g/mL respectively, which means that the PLGA NPs formulation could be 5.57 fold effective than the free DTX and that the DTX-loaded PLGA NPs of 10 or 20% TPGS further be 11.85 and 52.7 fold effective than the DTX-loaded PLGA NPs of no TPGS (therefore, 66.0 and 284 fold effective than the free DTX). Xenograft tumor model and immunohistological staining analysis further confirmed the advantages of the strategy of co-delivery of anticancer drugs with TPGS by PLGA NPs. (c) 2013 Elsevier Ltd. All rights reserved.
C1 [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch,Shenzhen Key Lab Chem Biol, Shenzhen Key Lab Gene & Antibody Therapy, Minist Prov Jointly Constructed Base State Key La, Shenzhen 518055, Peoples R China.
   [Zhu, Huijun; Chen, Hongbo; Zeng, Xiaowei; Wang, Zhongyuan; Zhang, Xudong; Wu, Yanping; Gao, Yongfeng; Zhang, Jinxie; Liu, Kewei; Mei, Lin; Feng, Si-Shen] Tsinghua Univ, Shenzhen Grad Sch, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
   [Liu, Ranyi] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.
   [Cai, Lintao] Chinese Acad Sci, Shenzhen Inst Adv Technol, Inst Biomed & Biotechnol, Shenzhen 518055, Peoples R China.
   [Feng, Si-Shen] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore.
RP Feng, SS (reprint author), Natl Univ Singapore, Dept Chem & Biomol Engn, Block E5,02-11,4 Engn Dr 4, Singapore 117576, Singapore.
EM mei.lin@sz.tsinghua.edu.cn; chefss@nus.edu.sg
RI Zeng, Xiaowei/A-6506-2015
OI Cai, Lintao/0000-0002-2461-6390
FU National Natural Science Foundation of China [31270019, 51203085,
   81272638]; Program for New Century Excellent Talents in University
   [NCET-11-0275]; Natural Science Foundation of Guangdong Province
   [S2012010010046, S2012040006820]; China Postdoctoral Science Foundation
   [2012M520242]; Science, Technology & Innovation Commission of Shenzhen
   Municipality [JCYJ20120616213729920, JCYJ20120614 191936420,
   KQC201105310021A, JC201005270308A]
FX This work was supported by the National Natural Science Foundation of
   China (No. 31270019, 51203085, 81272638), Program for New Century
   Excellent Talents in University (NCET-11-0275), Natural Science
   Foundation of Guangdong Province (No. S2012010010046, S2012040006820),
   China Postdoctoral Science Foundation (No. 2012M520242) and Science,
   Technology & Innovation Commission of Shenzhen Municipality (No.
   JCYJ20120616213729920, JCYJ20120614 191936420, KQC201105310021A,
   JC201005270308A).
CR Bae SE, 2009, J CONTROL RELEASE, V133, P37, DOI 10.1016/j.jconrel.2008.09.006
   Brigger I, 2002, ADV DRUG DELIV REV, V54, P631
   Buske J, 2012, EUR J PHARM BIOPHARM, V81, P57, DOI 10.1016/j.ejpb.2012.01.009
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Constantinou C, 2008, INT J CANCER, V123, P739, DOI 10.1002/ijc.23689
   Dai XW, 2008, NANOMED-NANOTECHNOL, V4, P49, DOI 10.1016/j.nano.2007.12.002
   Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629
   Dorai T, 2004, CANCER LETT, V215, P129, DOI 10.1016/j.canlet.2004.07.013
   Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105
   Gelperina S, 2005, AM J RESP CRIT CARE, V172, P1487, DOI 10.1164/rccm.200504-613PP
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706
   He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065
   Hu CMJ, 2009, CURR DRUG METAB, V10, P836, DOI 10.2174/138920009790274540
   Kang JC, 2007, MOL PHARMACEUT, V4, P104, DOI 10.1021/mp060041n
   Ke CJ, 2012, BIOMATERIALS, V33, P5156, DOI 10.1016/j.biomaterials.2012.03.056
   Ke CJ, 2011, ANGEW CHEM INT EDIT, V50, P8086, DOI 10.1002/anie.201102852
   Kumbar SG, 2006, J NANOSCI NANOTECHNO, V6, P2591, DOI 10.1166/jnn.2006.462
   Lake DE, 2004, DRUGS, V64, P1851, DOI 10.2165/00003495-200464170-00001
   Ma YD, 2010, NANOSCALE RES LETT, V5, P1161, DOI 10.1007/s11671-010-9620-3
   Mitra S, 2001, J CONTROL RELEASE, V74, P317, DOI 10.1016/S0168-3659(01)00342-X
   Mu L, 2002, J CONTROL RELEASE, V80, P129, DOI 10.1016/S0168-3659(02)00025-1
   Neuzil J, 2007, MOL PHARMACOL, V71, P1185, DOI 10.1124/mol.106.030122
   Park W, 2012, BIOMATERIALS, V33, P8848, DOI 10.1016/j.biomaterials.2012.08.042
   Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y
   Reddy LH, 2007, J CONTROL RELEASE, V124, P20, DOI 10.1016/j.jeonrel.2007.08.018
   Sant S, 2005, J CONTROL RELEASE, V107, P203, DOI 10.1016/j.jconrel.2005.02.017
   Schubert MA, 2005, EUR J PHARM BIOPHARM, V61, P77, DOI 10.1016/j.ejpb.2005.03.006
   Tao W, 2013, ACTA BIOMATER, V9, P8910, DOI 10.1016/j.actbio.2013.06.034
   Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158
   Viswanathan NB, 2001, J MICROENCAPSUL, V18, P783
   Wang JL, 2012, BIOMATERIALS, V33, P6877, DOI 10.1016/j.biomaterials.2012.06.019
   Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050
   Yan F, 2010, NANOMED-NANOTECHNOL, V6, P170, DOI 10.1016/j.nano.2009.05.004
   Yang Y, 2009, BIOMATERIALS, V30, P1947, DOI 10.1016/j.biomaterials.2008.12.044
   Youk HJ, 2005, J CONTROL RELEASE, V107, P43, DOI 10.1016/j.jconrel.2005.05.014
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zhang ZP, 2012, NANOMEDICINE-UK, V7, P1645, DOI [10.2217/NNM.12.117, 10.2217/nnm.12.117]
   Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046
NR 39
TC 115
Z9 123
U1 12
U2 232
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 7
BP 2391
EP 2400
DI 10.1016/j.biomaterials.2013.11.086
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0SL
UT WOS:000331502300033
PM 24360574
DA 2018-10-19
ER

PT J
AU Tan, YN
   Liu, Y
   Grover, L
AF Tan, Yanni
   Liu, Yong
   Grover, Liam
TI Effect of phosphoric acid on the properties of magnesium oxychloride
   cement as a biomaterial
SO CEMENT AND CONCRETE RESEARCH
LA English
DT Article
DE Hydration; Microstructure; Compressive strength; Degradation; MgO
ID MICROSTRUCTURE; MGO-MGCL2-H2O; PHOSPHATES; RESISTANCE; MECHANISM;
   PHASES; PASTES
AB Magnesium oxychloride cement (MOC) has been used in civil engineering for more than 100 years, but its application has been limited by its poor water resistance. This property, however, could be exploited in the formulation of a resorbable orthopaedic biomaterial. In this study, H3PO4 was added to control the degradation process of MOC to provide a predictable and clinically appropriate resorption time. The effects of H3PO4 on the phases, microstructures, mechanical properties, hydration and degradation of MOC have been evaluated. The results revealed that the crystalline phases in MOC before and after adding H3PO4 were the same, but that the needle-like phase 5 (5 Mg(OH)(2) center dot MgCl2 center dot 8H(2)O) crystals were formed more extensively in MOC with H3PO4 than that in MOC without H3PO4. Furthermore, the addition of H3PO4 was shown to retard the hydration process. H3PO4 did significantly improve the water resistance of MOC though its addition resulting in a reduction in compressive strength. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Tan, Yanni] Cent S Univ, Sch Met & Environm, Changsha 410083, Hunan, Peoples R China.
   [Tan, Yanni; Liu, Yong] Cent S Univ, State Key Lab Powder Met, Changsha 410083, Hunan, Peoples R China.
   [Tan, Yanni; Grover, Liam] Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
RP Grover, L (reprint author), Univ Birmingham, Sch Chem Engn, Birmingham B15 2TT, W Midlands, England.
EM l.m.grover@bham.ac.uk
RI Grover, Liam/F-2713-2011
OI Grover, Liam/0000-0002-9774-7412
FU China Scholarship council; Central South University; European Regional
   Development Fund (ERDF)
FX The authors acknowledge the financial support to Tan Yanni from the
   China Scholarship council, the postdoctoral research fund and the
   freedom explore program of Central South University. And the universal
   testing machine used in this research was obtained through Birmingham
   Science City, with support from Advantage West Midlands (AWM) and part
   funded by the European Regional Development Fund (ERDF).
CR Aramendia MA, 1999, J COLLOID INTERF SCI, V217, P288, DOI 10.1006/jcis.1999.6380
   Beaudoin JJ, 1975, CHEM CONCER RES, V5, P617
   BILINSKI H, 1984, J AM CERAM SOC, V67, P266
   Chau CK, 2008, MATER STRUCT, V41, P853, DOI 10.1617/s11527-007-9289-y
   Collier NC, 2008, CEMENT CONCRETE RES, V38, P737, DOI 10.1016/j.cemconres.2008.02.012
   Deng DH, 1999, CEMENT CONCRETE RES, V29, P1365
   Deng DH, 2003, CEMENT CONCRETE RES, V33, P1311, DOI 10.1016/S0008-8846(03)00043-7
   Li ZJ, 2007, CEMENT CONCRETE RES, V37, P866, DOI 10.1016/j.cemconres.2007.03.015
   LU HP, 1994, MATER LETT, V20, P217, DOI 10.1016/0167-577X(94)90090-6
   Mathur R, 2009, E-J CHEM, V6, P412, DOI 10.1155/2009/734185
   MATKOVIC B, 1973, NATURE-PHYS SCI, V246, P79, DOI 10.1038/physci246079a0
   MATKOVIC B, 1977, J AM CERAM SOC, V60, P504, DOI 10.1111/j.1151-2916.1977.tb14093.x
   Misra R.M.A.K., 2007, B MATER SCI, V30, P239
   Paxton J.Z., 2012, 9 WORLD BIOM C, V10, P2010
   Rabiee SM, 2010, J MOL STRUCT, V969, P172, DOI 10.1016/j.molstruc.2010.01.068
   TOOPER B, 1966, NATURE, V211, P64, DOI 10.1038/211064a0
   Wang Peiling, 1990, J INORG MATER, V5, P61
   Yunsong J., 2001, MATER LETT, V50, P28
   Zhang C., 1994, J WUHAN UNIV TECHNOL, V9, P51
NR 19
TC 24
Z9 28
U1 9
U2 52
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0008-8846
EI 1873-3948
J9 CEMENT CONCRETE RES
JI Cem. Concr. Res.
PD FEB
PY 2014
VL 56
BP 69
EP 74
DI 10.1016/j.cemconres.2013.11.001
PG 6
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA AA9PD
UT WOS:000331424500008
DA 2018-10-19
ER

PT J
AU Gasik, M
   Keski-Honkola, A
   Bilotsky, Y
   Friman, M
AF Gasik, Michael
   Keski-Honkola, Anu
   Bilotsky, Yeugen
   Friman, Michael
TI Development and optimisation of hydroxyapatite-beta-TCP functionally
   gradated biomaterial
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Hydroxyapatite; Tricalcium phosphate; Sintering; Stress; Scaffold;
   Coating; Optimisation
ID GRADED MATERIALS; BIOMEDICAL APPLICATIONS; POROUS TITANIUM; IMPLANTS;
   COMPOSITES; DEPOSITION; COATINGS; ANATASE; LAYER
AB Use of hydroxyapatite (HAP) for biomaterials is widely established, often in a combination with titanium alloy substrates in orthopaedic and other implants. Porous HAP-based coatings undergo sintering and heat treatment processes to achieve proper level of density yet avoiding undesirable reactions and phase changes. Thermal expansion mismatch between constituents may also lead to cracking of the coating due to excessive thermal stresses. Thus control of mechanical properties and stress state in the coating during the whole processing cycle represents some challenges when trying to combine conflicting objectives.
   In this work a method of optimisation of mechanical behaviour of an FGM biomaterial coating or scaffold composed of HAP and beta-tricalcium phosphate (beta-TCP) is considered. For coating on titanium-based substrates which have anatase (TiO2) top layer, thermodynamic equilibrium was analysed and the "safe" compositional path was found to ensure preservation of original ceramic phases during processing. Experimental studies of HAP-TCP sintering kinetics of different compositions were carried out with dilatometry to obtain true shrinkage curves and thermal expansion functions. These data were integrated with thermo-mechanical calculations of stresses and strains in HAP-beta-TCP FGM during processing, which were optimised with respect to minimal stresses, stresses derivatives and curvatures. The beneficial effect of compositional gradation on behaviour of these materials is shown. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Gasik, Michael; Keski-Honkola, Anu; Bilotsky, Yeugen; Friman, Michael] Aalto Univ Fdn, Sch Chem Technol, FIN-00076 Aalto, Finland.
RP Gasik, M (reprint author), Aalto Univ Fdn, Sch Chem Technol, POB 16200, FIN-00076 Aalto, Finland.
EM michael.gasik@aalto.fi
RI Gasik, Michael/G-2224-2013
OI Gasik, Michael/0000-0002-5782-7987
FU EU [NMP3-CT-2006-026501]; Finnish national innovation agency (Tekes)
FX Authors acknowledge support from the EU FP6 Project "Med-delcoat"
   (NMP3-CT-2006-026501) and from Finnish national innovation agency
   (Tekes).
CR Balamurugan A, 2007, MAT SCI ENG C-BIO S, V27, P162, DOI 10.1016/j.msec.2006.04.006
   Bouazza S, 2010, MATER SCI FORUM, V631-632, P141, DOI 10.4028/www.scientific.net/MSF.631-632.141
   Braem A, 2011, ADV ENG MATER, V13, P509, DOI 10.1002/adem.201100011
   Drnovsek N, 2009, SURF COAT TECH, V203, P1462, DOI 10.1016/j.surfcoat.2008.11.031
   Duan K, 2006, J MATER CHEM, V16, P2309, DOI 10.1039/b517634d
   Gasik M, 2000, COMP MATER SCI, V18, P93, DOI 10.1016/S0927-0256(00)00090-2
   Gasik M., 2009, P 17 PLANS SEM, V1, P1
   Gasik M, 2012, ADV HEALTHC MATER, V1, P117, DOI 10.1002/adhm.201100006
   Gasik M, 2010, MATER SCI FORUM, V631-632, P79, DOI 10.4028/www.scientific.net/MSF.631-632.79
   Gasik MM, 1998, COMP MATER SCI, V13, P42, DOI 10.1016/S0927-0256(98)00044-5
   Gu Wel Yong, 2005, BASIC ORTHOPAEDIC BI
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Henriques B, 2012, J MECH BEHAV BIOMED, V13, P206, DOI 10.1016/j.jmbbm.2012.04.019
   Katakam S., 2003, TRENDS BIOMATER ARTI, V17, P24
   Laonapakul T, 2012, J MECH BEHAV BIOMED, V15, P153, DOI 10.1016/j.jmbbm.2012.05.017
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Miranda M, 2010, INT J MATER RES, V101, P117, DOI 10.3139/146.110247
   Obata A, 2007, MATER TRANS, V48, P313, DOI 10.2320/matertrans.48.313
   OONISHI H, 1991, BIOMATERIALS, V12, P171, DOI 10.1016/0142-9612(91)90196-H
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x
   Yasuda HY, 2006, MATER TRANS, V47, P2368, DOI 10.2320/matertrans.47.2368
   Zhang BS, 2002, COMP MATER SCI, V25, P264, DOI 10.1016/S0927-0256(02)00271-9
   Zhao CY, 2010, J BIOMED MATER RES B, V95B, P387, DOI 10.1002/jbm.b.31728
NR 25
TC 11
Z9 11
U1 1
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2014
VL 30
BP 266
EP 273
DI 10.1016/j.jmbbm.2013.11.017
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0PF
UT WOS:000331493900027
PM 24361930
DA 2018-10-19
ER

PT J
AU DiRienzo, AL
   Yakacki, CM
   Frensemeier, M
   Schneider, AS
   Safranski, DL
   Hoyt, AJ
   Frick, CP
AF DiRienzo, Amy L.
   Yakacki, Christopher M.
   Frensemeier, Mareike
   Schneider, Andreas S.
   Safranski, David L.
   Hoyt, Anthony J.
   Frick, Carl P.
TI Porous poly(para-phenylene) scaffolds for load-bearing orthopedic
   applications
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Poly(para-phenylenes); Porous biomaterials; Biomedical devices;
   Mechanical behavior; Scanning electron microscopy
ID CRUCIATE LIGAMENT RECONSTRUCTION; EFFECTIVE ELASTIC-MODULI; RIGID
   POLYURETHANE FOAM; MECHANICAL-PROPERTIES; METHACRYLATE COPOLYMERS;
   HYDROXYALKYL ACRYLATE; COMPRESSION BEHAVIOR; SYNTHETIC HYDROGELS;
   CELLULAR MATERIALS; METALLIC IMPLANTS
AB The focus of this study was to fabricate and investigate the mechanical behavior of porous poly(para-phenylene) (PPP) for potential use as a load-bearing orthopedic biomaterial. PPPs are known to have exceptional mechanical properties due to their aromatic backbone; however, the manufacturing and properties of PPP porous structures have not been previously investigated. Tailored porous structures with either small (150-250 mu m) or large (420-500 mu m) pore sizes were manufactured using a powder-sintering/salt-leaching technique. Porosities were systematically varied using 50 to 90 vol%. Micro-computed tomography (mu CT) and scanning electron microscopy (SEM) were used to verify an open-cell structure and investigate pore morphology of the scaffolds. Uniaxial mechanical behavior of solid and porous PPP samples was characterized through tensile and compressive testing. Both modulus and strength decreased with increasing porosity and matched well with foam theory. Porous scaffolds showed a significant decrease in strain-to-failure (<4%) under tensile loading and experienced linear elasticity, plastic deformation, and densification under compressive loading. Over the size ranges tested, pore size did not significantly influence the mechanical behavior of the scaffolds on a consistent basis. These results are discussed in regards to use of porous PPP for orthopedic applications and a prototype porous interbody fusion cage is presented. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [DiRienzo, Amy L.; Hoyt, Anthony J.; Frick, Carl P.] Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
   [Yakacki, Christopher M.] Univ Colorado Denver, Dept Mech Engn, Denver, CO USA.
   [Frensemeier, Mareike] INM Leibniz Inst New Mat, Funct Surfaces Grp, Saarbrucken, Germany.
   [Schneider, Andreas S.] AG Dillinger Huttenwerke, Dev & Plate Design, Dillingen, Germany.
   [Safranski, David L.] MedShape Inc, Dept Res & Dev, Atlanta, GA USA.
RP Frick, CP (reprint author), Univ Wyoming, Dept Mech Engn, Laramie, WY 82071 USA.
EM cfrick@uwyo.edu
OI Frick, Carl/0000-0002-8202-924X
FU Solvay Specialty Polymers, LLC
FX The authors would like to thank Prof. Robert Guldberg, Prof. R. Dana
   Carpenter, and Angela Lin for their help regarding mu CT imaging and
   analysis using direct transformation methods. The authors gratefully
   acknowledge assistance in porous sample fabrication and mechanical
   testing from Jonathan Schlotthauer and Dustin Bales. The authors would
   also like to thank Eric J. Losty and Jac Corless for their help in
   machining prototype implants. CPF and CMY acknowledge Solvay Specialty
   Polymers, LLC for their financial and material support of this work.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Arora KA, 1998, POLYM ENG SCI, V38, P2055, DOI 10.1002/pen.10375
   BARNES A, 1988, POLYMER, V29, P2191, DOI 10.1016/0032-3861(88)90111-5
   Beutler William J, 2003, Spine J, V3, P289, DOI 10.1016/S1529-9430(03)00061-5
   Bobyn J D, 1992, Clin Orthop Relat Res, P79
   Brand J, 2000, AM J SPORT MED, V28, P761, DOI 10.1177/03635465000280052501
   BREZNY R, 1989, J AM CERAM SOC, V72, P1145, DOI 10.1111/j.1151-2916.1989.tb09698.x
   Burstone CJ, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2009.05.030
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chlopek J, 2005, J MATER SCI-MATER M, V16, P1051, DOI 10.1007/s10856-005-4759-7
   Converse GL, 2010, ACTA BIOMATER, V6, P856, DOI 10.1016/j.actbio.2009.08.004
   Converse GL, 2009, J MECH BEHAV BIOMED, V2, P627, DOI 10.1016/j.jmbbm.2009.07.002
   CORKHILL PH, 1987, POLYMER, V28, P1758, DOI 10.1016/0032-3861(87)90021-8
   Demirhan M, 2000, ARTHROSCOPY, V16, P383, DOI 10.1016/S0749-8063(00)90083-5
   Di Prima MA, 2007, SMART MATER STRUCT, V16, P2330, DOI 10.1088/0964-1726/16/6/037
   Di Prima MA, 2010, MECH MATER, V42, P315, DOI 10.1016/j.mechmat.2009.11.002
   DiPaola CP, 2008, J AM ACAD ORTHOP SUR, V16, P130, DOI 10.5435/00124635-200803000-00004
   Drummond JL, 2008, J DENT RES, V87, P710, DOI 10.1177/154405910808700802
   FOWLKES CW, 1974, INT J FRACTURE, V10, P99, DOI 10.1007/BF00955084
   Frick CP, 2014, J BIOMED MATER RES A, V102, P3122, DOI 10.1002/jbm.a.34982
   FRICKE J, 1988, J NON-CRYST SOLIDS, V100, P169, DOI 10.1016/0022-3093(88)90014-2
   Gibson LJ, 2000, ANNU REV MATER SCI, V30, P191, DOI 10.1146/annurev.matsci.30.1.191
   GIBSON LJ, 1989, MAT SCI ENG A-STRUCT, V110, P1, DOI 10.1016/0921-5093(89)90154-8
   GIBSON LJ, 1982, P ROY SOC LOND A MAT, V382, P43, DOI 10.1098/rspa.1982.0088
   GOULET RW, 1994, J BIOMECH, V27, P375, DOI 10.1016/0021-9290(94)90014-0
   Gupta N, 2001, J MATER SCI, V36, P4485, DOI 10.1023/A:1017986820603
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ji SC, 2006, J MATER SCI, V41, P1757, DOI 10.1007/s10853-006-2871-9
   Kabir ME, 2006, MAT SCI ENG A-STRUCT, V429, P225, DOI 10.1016/j.msea.2006.05.133
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013
   LEDERMAN JM, 1971, J APPL POLYM SCI, V15, P693, DOI 10.1002/app.1971.070150314
   Liu QL, 2004, POLYM ENG SCI, V44, P463, DOI 10.1002/pen.20041
   Liu XWS, 2006, J BONE MINER RES, V21, P1608, DOI 10.1359/JBMR.060716
   MCINTYRE A, 1979, POLYMER, V20, P247, DOI 10.1016/0032-3861(79)90229-5
   MEINECKE EA, 1970, J APPL POLYM SCI, V14, P2239, DOI 10.1002/app.1970.070140905
   Morgan SE, 2006, POLYMER, V47, P2865, DOI 10.1016/j.polymer.2006.02.025
   Noshchenko A, 2011, J BIOMED MATER RES B, V98B, P192, DOI 10.1002/jbm.b.31837
   Noshchenko A, 2011, SPINE, V36, P870, DOI 10.1097/BRS.0b013e3181e6ce16
   Pei XQ, 2012, WEAR, V274, P452, DOI 10.1016/j.wear.2011.09.009
   Poukalova M, 2010, J BIOMECH, V43, P1138, DOI 10.1016/j.jbiomech.2009.12.007
   RAMAKRISHNAN N, 1993, J AM CERAM SOC, V76, P2745, DOI 10.1111/j.1151-2916.1993.tb04011.x
   RAMAKRISHNAN N, 1990, J MATER SCI, V25, P3930, DOI 10.1007/BF00582462
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   RUSCH KC, 1969, J APPL POLYM SCI, V13, P2297, DOI 10.1002/app.1969.070131106
   RUSCH KC, 1970, J APPL POLYM SCI, V14, P1263, DOI 10.1002/app.1970.070140514
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   San Marchi C, 2001, ACTA MATER, V49, P3959, DOI 10.1016/S1359-6454(01)00294-4
   SHELLOCK FG, 1992, JMRI-J MAGN RESON IM, V2, P225, DOI 10.1002/jmri.1880020217
   SHERWOOD JA, 1992, POLYM ENG SCI, V32, P1138, DOI 10.1002/pen.760321611
   Sloten JV, 1998, BIOMATERIALS, V19, P1455, DOI 10.1016/S0142-9612(98)00058-1
   Suh JS, 1998, AM J ROENTGENOL, V171, P1207, DOI 10.2214/ajr.171.5.9798849
   Sun HL, 2002, J APPL POLYM SCI, V86, P1692, DOI 10.1002/app-11070
   Vuorinen AM, 2011, J ADHES DENT, V13, P333, DOI 10.3290/j.jad.a19653
   Vuotinen AM, 2008, DENT MATER, V24, P708, DOI 10.1016/j.dental.2007.07.003
   WAGH AS, 1991, J MATER SCI, V26, P3862, DOI 10.1007/BF01184983
   Walter T.R., 2009, J ENG MAT TECHNOL T, V131
   Wang D, 2007, J POLYM SCI POL PHYS, V45, P173, DOI 10.1002/polb.20796
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
NR 64
TC 10
Z9 10
U1 4
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
EI 1878-0180
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD FEB
PY 2014
VL 30
BP 347
EP 357
DI 10.1016/j.jmbbm.2013.10.012
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AB0PF
UT WOS:000331493900035
PM 24374261
DA 2018-10-19
ER

PT J
AU Fiedler, T
   Fisher, M
   Roether, JA
   Belova, IV
   Samtleben, T
   Bernthaler, T
   Murch, GE
   Boccaccini, AR
AF Fiedler, T.
   Fisher, M.
   Roether, J. A.
   Belova, I. V.
   Samtleben, T.
   Bernthaler, T.
   Murch, G. E.
   Boccaccini, A. R.
TI Strengthening mechanism of PDLLA coated titania foam
SO MECHANICS OF MATERIALS
LA English
DT Article
DE Biomaterial; Composite material; Finite element analysis; Micro-computed
   tomography; Micro-structure
ID TISSUE ENGINEERING SCAFFOLDS; COMPOSITE; BIOMATERIALS; COATINGS; STATE
AB This paper addresses the numerical analysis of the mechanical properties of titania foam intended for use in tissue engineering scaffolds. Special focus is given to a PDLLA coating that has been shown to distinctly increase the mechanical strength of the scaffold. Micro-computed tomography (mu CT) data of a real scaffold are obtained and converted into numerical calculation models. Finite element simulations are performed alternately with and without the PDLLA coating. In addition, a strut model containing a single micro-crack is analysed. Numerical results indicate that filling the crack with PDLLA significantly increases the strength of the strut by attenuating stress concentrations. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Fiedler, T.; Fisher, M.; Belova, I. V.; Murch, G. E.] Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia.
   [Roether, J. A.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Polymer Mat, D-91058 Erlangen, Germany.
   [Samtleben, T.; Bernthaler, T.] Univ Appl Sci Aalen, Dept Surface Engn & Mat Sci, Fac Mech & Mat Engn, D-73430 Aalen, Germany.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Dept Mat Sci & Engn, Inst Biomat, D-91058 Erlangen, Germany.
RP Fiedler, T (reprint author), Univ Newcastle, Sch Engn, Callaghan, NSW 2287, Australia.
EM thomas.fiedler@newcastle.edu.au
RI Boccaccini, Aldo/C-7905-2013
OI Fiedler, Thomas/0000-0003-0256-8233
CR CeramTec, 2012, MAT SEL GUID
   Fiedler T, 2012, COMP MATER SCI, V61, P283, DOI 10.1016/j.commatsci.2012.04.043
   Grote K. -H., 2007, DUBBEL TASCHENBUCH M
   Guarino V, 2012, INT MATER REV, V57, P256, DOI 10.1179/0950660812Z.00000000021
   Harrer W, 2012, J EUR CERAM SOC, V32, P27, DOI 10.1016/j.jeurceramsoc.2011.07.019
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Kang YQ, 2011, EUR POLYM J, V47, P1569, DOI 10.1016/j.eurpolymj.2011.05.004
   Kim HJ, 2001, SURF COAT TECH, V139, P75, DOI 10.1016/S0257-8972(00)01132-4
   Kim HW, 2004, BIOMATERIALS, V25, P1279, DOI 10.1016/j.biomaterials.2003.07.003
   Li ZS, 2009, ACTA BIOMATER, V5, P2189, DOI 10.1016/j.actbio.2009.02.013
   Liu B, 2008, J MATER SCI-MATER M, V19, P1203, DOI 10.1007/s10856-007-3216-1
   Magnani G, 2010, J EUR CERAM SOC, V30, P769, DOI 10.1016/j.jeurceramsoc.2009.08.002
   Novak S, 2009, J MATER SCI, V44, P1442, DOI 10.1007/s10853-008-2858-9
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Redondo A, 2004, ANNU REV MATER RES, V34, P279, DOI 10.1146/annurev.matsci.34.070503.123908
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Yang GJ, 2012, MATER LETT, V75, P80, DOI 10.1016/j.matlet.2012.01.122
   Yunos DM, 2008, J MATER SCI, V43, P4433, DOI 10.1007/s10853-008-2552-y
   Zhang JY, 2006, T NONFERR METAL SOC, V16, pS453, DOI 10.1016/S1003-6326(06)60232-X
NR 20
TC 4
Z9 4
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-6636
EI 1872-7743
J9 MECH MATER
JI Mech. Mater.
PD FEB
PY 2014
VL 69
IS 1
BP 35
EP 40
DI 10.1016/j.mechmat.2013.09.007
PG 6
WC Materials Science, Multidisciplinary; Mechanics
SC Materials Science; Mechanics
GA AA8NK
UT WOS:000331352000003
DA 2018-10-19
ER

PT J
AU Kundu, B
   Kurland, NE
   Bano, S
   Patra, C
   Engel, FB
   Yadavalli, VK
   Kundu, SC
AF Kundu, Banani
   Kurland, Nicholas E.
   Bano, Subia
   Patra, Chinmoy
   Engel, Felix B.
   Yadavalli, Vamsi K.
   Kundu, Subhas C.
TI Silk proteins for biomedical applications: Bioengineering perspectives
SO PROGRESS IN POLYMER SCIENCE
LA English
DT Review
DE Silk; Biomedical applications; Films; Scaffolds; Hydrogels
ID MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; TISSUE ENGINEERING
   APPLICATIONS; BIOMIMETIC NANOFIBROUS SCAFFOLDS; PERIPHERAL-NERVE
   REGENERATION; FIBROIN 3D SCAFFOLDS; IN-VITRO EVALUATION; SPIDER SILK;
   CHEMICAL-MODIFICATION; MECHANICAL-PROPERTIES
AB Biomaterials of either natural or synthetic origin are used to fabricate implantable devices, as carriers for bioactive molecules or as substrates to facilitate tissue regeneration. For the design of medical devices it is fundamental to use materials characterized by non-immunogenicity, biocompatibility, slow and/or controllable biodegradability, non-toxicity, and structural integrity. The success of biomaterial-derived biodevices tends to be based on the biomimetic architecture of the materials. Recently, proteins from natural precursors that are essentially structural and functional polymers, have gained popularity as biomaterials. The silks produced by silkworms or spiders are of particular interest as versatile protein polymers. These form the basis for diverse biomedical applications that exploit their unique biochemical nature, biocompatibility and high mechanical strength. This review discusses and summarizes the latest advances in the engineering of silk-based biomaterials, focusing specifically on the fabrication of diverse bio-mimetic structures such as films, hydrogels, scaffolds, nanofibers and nanoparticles; their functionalization and potential for biomedical applications. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Kundu, Banani; Bano, Subia; Kundu, Subhas C.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
   [Kurland, Nicholas E.; Yadavalli, Vamsi K.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.
   [Patra, Chinmoy; Engel, Felix B.] Univ Erlangen Nurnberg, Inst Pathol, Dept Nephropathol, D-97054 Erlangen, Germany.
RP Yadavalli, VK (reprint author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.
EM vyadavalli@vcu.edu; kundu@hijli.iitkgp.ernet.in
RI Kundu, Banani/O-9320-2016; Engel, Felix/A-1767-2008
OI Kundu, Banani/0000-0003-1251-700X; Engel, Felix/0000-0003-2605-3429;
   Yadavalli, Vamsi/0000-0002-8879-1948; Kundu, Subhas
   C./0000-0002-7170-2291
FU Department of Biotechnology and its Bioinformatics Facility; Department
   of Science and Technology; Council of Scientific Industrial Research
   fellowship; Government of India, New Delhi, India; Alexander von
   Humboldt Foundation
FX We are thankful to Ms. Shilpa Pal and Dr. Joydip Kundu for their
   assistance during the initial write up. The work was financially
   supported by the Department of Biotechnology and its Bioinformatics
   Facility, the Department of Science and Technology (SCK), the Council of
   Scientific Industrial Research fellowship (BK), Government of India, New
   Delhi, India and by a grant from the Alexander von Humboldt Foundation
   (FBE).
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Ahn JS, 2001, J APPL POLYM SCI, V80, P274, DOI 10.1002/1097-4628(20010411)80:2<274::AID-APP1096>3.0.CO;2-G
   Akturk O, 2011, J BIOSCI BIOENG, V112, P279, DOI 10.1016/j.jbiosc.2011.05.014
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2002, J APPL POLYM SCI, V84, P1963, DOI 10.1002/app.10491
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Baek HS, 2008, SURF COAT TECH, V202, P5794, DOI 10.1016/j.surfcoat.2008.06.154
   Benfenati V, 2010, BIOMATERIALS, V31, P7883, DOI 10.1016/j.biomaterials.2010.07.013
   Bettinger CJ, 2007, ADV MATER, V19, P2847, DOI 10.1002/adma.200602487
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Bray LJ, 2012, BIOMATERIALS, V33, P3529, DOI 10.1016/j.biomaterials.2012.01.045
   Bray LJ, 2011, BIOMATERIALS, V32, P5086, DOI 10.1016/j.biomaterials.2011.03.068
   Brown CP, 2011, NANOSCALE, V3, P870, DOI 10.1039/c0nr00752h
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Cai ZX, 2010, INT J MOL SCI, V11, P3529, DOI 10.3390/ijms11093529
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Cassinelli C, 2006, INT J ARTIF ORGANS, V29, P881
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen XD, 2010, BIRTH DEFECTS RES C, V90, P45, DOI 10.1002/bdrc.20171
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fang Q, 2009, MAT SCI ENG C-BIO S, V29, P1527, DOI 10.1016/j.msec.2008.12.007
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   FOURNIER A, 1979, BIOCHIMIE, V61, P283, DOI 10.1016/S0300-9084(79)80073-5
   Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603
   Fu CJ, 2009, CHEM COMMUN, P6515, DOI 10.1039/b911049f
   Furuzono T, 2004, J MATER SCI-MATER M, V15, P19, DOI 10.1023/B:JMSM.0000010093.39298.5a
   Furuzono T, 2000, BIOMATERIALS, V21, P327, DOI 10.1016/S0142-9612(99)00177-5
   Ge Z, 2012, INT J ORAL MAX SURG, V41, P673, DOI 10.1016/j.ijom.2011.11.016
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gotoh Y, 1996, INT J BIOL MACROMOL, V18, P19, DOI 10.1016/0141-8130(95)01039-4
   Gulrajani ML, 2008, J APPL POLYM SCI, V108, P614, DOI 10.1002/app.27584
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Harkin DG, 2011, BIOMATERIALS, V32, P2445, DOI 10.1016/j.biomaterials.2010.12.041
   Hermanson KD, 2007, ADV MATER, V19, P1810, DOI 10.1002/adma.200602709
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hirabayashi A, 1990, SEN-I GAKKAISHI, V46, P521
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huang J, 2007, BIOMATERIALS, V28, P2358, DOI 10.1016/j.biomaterials.2006.11.021
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Jones AC, 2009, BIOMATERIALS, V30, P1440, DOI 10.1016/j.biomaterials.2008.10.056
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   Kang M, 2007, J NANOSCI NANOTECHNO, V7, P3888, DOI 10.1166/jnn.2007.056
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karve KA, 2011, J MEMBRANE SCI, V383, P44, DOI 10.1016/j.memsci.2011.08.032
   Kasoju N, 2009, J TISSUE ENG REGEN M, V3, P539, DOI 10.1002/term.196
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/nmat2745, 10.1038/NMAT2745]
   Kim S, 2012, NAT PHOTONICS, V6, P817, DOI [10.1038/NPHOTON.2012.264, 10.1038/nphoton.2012.264]
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kim UJ, 2005, BIOMATERIALS, V26, P2285
   Kim Y-H, 2007, KEY ENG MATER, V342-343, P73
   Kino R, 2007, J BIOSCI BIOENG, V103, P514, DOI 10.1263/jbb.103.514
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI 10.1016/.i.phrs.2008.01.012
   Kundu B, 2010, PROG POLYM SCI, V35, P1116, DOI 10.1016/j.progpolymsci.2010.04.004
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kundu J, 2008, MAT SCI ENG C-BIO S, V28, P1376, DOI 10.1016/j.msec.2008.03.004
   Kundu SC, 2012, BIOPOLYMERS, V97, P455, DOI 10.1002/bip.22024
   Kurland NE, 2012, MICRON, V43, P116, DOI 10.1016/j.micron.2011.07.017
   Lammel A, 2011, BIOMATERIALS, V32, P2233, DOI 10.1016/j.biomaterials.2010.11.060
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee KH, 2007, INT J BIOL MACROMOL, V41, P168, DOI 10.1016/j.ijbiomac.2007.01.011
   Lee KY, 1999, POLYMER, V40, P4131, DOI 10.1016/S0032-3861(98)00611-9
   Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li TF, 2009, EPILEPSY RES, V84, P238, DOI 10.1016/j.eplepsyres.2009.01.002
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Luan XY, 2006, BIOMED MATER, V1, P181, DOI 10.1088/1748-6041/1/4/001
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma PX, 1999, J BIOMED MATER RES, V46, P60, DOI 10.1002/(SICI)1097-4636(199907)46:1<60::AID-JBM7>3.0.CO;2-H
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Madden PW, 2011, BIOMATERIALS, V32, P4076, DOI 10.1016/j.biomaterials.2010.12.034
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mandal BB, 2008, BIOTECHNOL BIOENG, V100, P1237, DOI 10.1002/bit.21835
   Mandal BB, 2010, TISSUE ENG PT A, V16, P2391, DOI [10.1089/ten.tea.2009.0206, 10.1089/ten.TEA.2009.0206]
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mandal BB, 2009, BIOMATERIALS, V30, P5019, DOI 10.1016/j.biomaterials.2009.05.064
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mandal BB, 2009, BIOMATERIALS, V30, P2826, DOI 10.1016/j.biomaterials.2009.01.040
   Mao M, 2012, ACTA BIOMATER, V8, P2175, DOI 10.1016/j.actbio.2011.12.025
   Marelli B, 2012, BIOMATERIALS, V33, P102, DOI 10.1016/j.biomaterials.2011.09.039
   Martino S, 2012, BIOTECHNOL ADV, V30, P338, DOI 10.1016/j.biotechadv.2011.06.015
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Miao YG, 2006, APPL MICROBIOL BIOT, V71, P192, DOI 10.1007/s00253-005-0127-2
   Mieszawska AJ, 2011, ACTA BIOMATER, V7, P3036, DOI 10.1016/j.actbio.2011.04.016
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MITA K, 1994, J MOL EVOL, V38, P583
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nagai N, 2009, BIOL PHARM BULL, V32, P933, DOI 10.1248/bpb.32.933
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Paramonov SE, 2006, J AM CHEM SOC, V128, P7291, DOI 10.1021/ja060573x
   Park K, 1993, BIODEGRADABLE HYDROG, P262
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   Patil Y, 2009, INT J PHARM, V367, P195, DOI 10.1016/j.ijpharm.2008.09.039
   Patra C, 2012, BIOMATERIALS, V33, P2673, DOI 10.1016/j.biomaterials.2011.12.036
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Perez-Rigueiro J, 2002, J APPL POLYM SCI, V84, P1431, DOI 10.1002/app.10366
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Ratner B. D., 2004, BIOMATERIALS SCI INT, P864
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Roohani-Esfahani SI, 2012, ACTA BIOMATER, V8, P302, DOI 10.1016/j.actbio.2011.10.009
   Rujiravanit R, 2003, MACROMOL BIOSCI, V3, P604, DOI 10.1002/mabi.200300027
   Sampaio S, 2011, POLYM INT, V60, P1737, DOI 10.1002/pi.3143
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   She ZD, 2008, J MATER SCI-MATER M, V19, P3545, DOI 10.1007/s10856-008-3526-y
   Shi PJ, 2012, POWDER TECHNOL, V215-16, P85, DOI 10.1016/j.powtec.2011.09.012
   Slotta UK, 2008, ANGEW CHEM INT EDIT, V47, P4592, DOI 10.1002/anie.200800683
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sundar S, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014104
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Talukdar S, 2011, BIOMATERIALS, V32, P2149, DOI 10.1016/j.biomaterials.2010.11.052
   Tamada Y, 2004, J BIOMAT SCI-POLYM E, V15, P971, DOI 10.1163/1568562041526469
   Tao H, 2012, P NATL ACAD SCI USA, V109, P19584, DOI 10.1073/pnas.1209056109
   Tao H, 2012, ADV MATER, V24, P2824, DOI 10.1002/adma.201104477
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Tsang VL, 2004, ADV DRUG DELIVER REV, V56, P1635, DOI 10.1016/j.addr.2004.05.001
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Tsioris K, 2011, ADV MATER, V23, P2015, DOI 10.1002/adma.201004771
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vachiraroj N, 2009, INT J BIOL MACROMOL, V45, P470, DOI 10.1016/j.ijbiomac.2009.07.010
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vollrath F, 2006, APPL PHYS A-MATER, V82, P205, DOI 10.1007/s00339-005-3437-4
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XL, 2012, BIOMATERIALS, V33, P3411, DOI 10.1016/j.biomaterials.2012.01.011
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Wu J, 2012, BIOMATERIALS, V33, P1343, DOI 10.1016/j.biomaterials.2011.10.055
   Wu XW, 2012, CYTOTHERAPY, V14, P555, DOI 10.3109/14653249.2011.638914
   Xia YY, 2008, COMPOS SCI TECHNOL, V68, P1471, DOI 10.1016/j.compscitech.2007.10.044
   Xie RJ, 2007, KEY ENG MATER, V342-343, P241, DOI 10.4028/www.scientific.net/KEM.342-343.241
   Yamamoto K, 2007, BIOMATERIALS, V28, P1838, DOI 10.1016/j.biomaterials.2006.11.045
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yeo IS, 2008, BIOMACROMOLECULES, V9, P1106, DOI 10.1021/bm700875a
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yukuhiro K, 1997, INSECT MOL BIOL, V6, P89, DOI 10.1046/j.1365-2583.1997.00161.x
   Zhang F, 2011, INT J BIOL MACROMOL, V48, P474, DOI 10.1016/j.ijbiomac.2011.01.012
   Zhang JE, 2012, P NATL ACAD SCI USA, V109, P11981, DOI 10.1073/pnas.1206210109
   Zhang JF, 2004, BIOTECHNOL LETT, V26, P753, DOI 10.1023/B:BILE.0000024100.49716.3d
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XZ, 2012, J SHOULDER ELB SURG, V21, P266, DOI 10.1016/j.jse.2011.11.016
   Zhou YS, 2013, INT J BIOL MACROMOL, V53, P88, DOI 10.1016/j.ijbiomac.2012.11.013
   Zhu YR, 2012, MAT SCI ENG C-MATER, V32, P390, DOI 10.1016/j.msec.2011.11.002
   Zou XH, 2010, BIOMATERIALS, V31, P4872, DOI 10.1016/j.biomaterials.2010.02.056
NR 205
TC 140
Z9 145
U1 32
U2 339
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6700
J9 PROG POLYM SCI
JI Prog. Polym. Sci.
PD FEB
PY 2014
VL 39
IS 2
BP 251
EP 267
DI 10.1016/j.progpolymsci.2013.09.002
PG 17
WC Polymer Science
SC Polymer Science
GA AB0VX
UT WOS:000331511300001
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Mattei, G
   Di Patria, V
   Tirella, A
   Alaimo, A
   Elia, G
   Corti, BA
   Paolicchi, A
   Ahluwalia, A
AF Mattei, G.
   Di Patria, V.
   Tirella, A.
   Alaimo, A.
   Elia, G.
   Corti, B. A.
   Paolicchi, A.
   Ahluwalia, A.
TI Mechanostructure and composition of highly reproducible decellularized
   liver matrices
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Extracellular matrix; Decellularization; Biologic three-dimensional
   scaffold; Biomaterial; Tissue engineering
ID TISSUE; STERILIZATION; PERFORMANCE; ALLOGRAFTS; SCAFFOLDS; CULTURE;
   CELLS; GRAFT
AB Despite the increasing number of papers on decellularized scaffolds, there is little consensus on the optimum method of decellularizing biological tissue such that the micro-architecture and protein content of the matrix are conserved as far as possible. Focusing on the liver, the aim of this study was therefore to develop a method for the production of well-characterized and reproducible matrices that best preserves the structure and composition of the native extra cellular matrix (ECM). Given the importance of matrix stiffness in regulating cell response, the mechanical properties of the decellularized tissue were also considered. The testing and analysis framework is based on the characterization of decellularized and untreated samples in the same reproducible initial state (i.e., the equilibrium swollen state). Decellularized ECM (dECM) were characterized using biochemical, histological, mechanical and structural analyses to identify the best procedure to ensure complete cell removal while preserving most of the native ECM structure and composition. Using this method, sterile decellularized porcine ECM with highly conserved intra-lobular micro-structure and protein content were obtained in a consistent and reproducible manner using the equilibrium swollen state of tissue or matrix as a reference. A significant reduction in the compressive elastic modulus was observed for liver dECM with respect to native tissue, suggesting a re-examination of design parameters for ECM-mimicking scaffolds for engineering tissues in vitro. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mattei, G.] Univ Pisa, Dept Civil & Ind Engn, I-56122 Pisa, Italy.
   [Mattei, G.; Di Patria, V.; Alaimo, A.; Elia, G.; Ahluwalia, A.] Univ Pisa, Res Ctr E Piaggio, I-56126 Pisa, Italy.
   [Tirella, A.] IFC, Natl Res Council, I-56124 Pisa, Italy.
   [Corti, B. A.; Paolicchi, A.] Univ Pisa, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy.
RP Mattei, G (reprint author), Univ Pisa, Res Ctr E Piaggio, Largo Lucio Lazzarino 1, I-56126 Pisa, Italy.
EM giorgio.mattei@centropiaggio.unipi.it
RI Paolicchi, Aldo/K-3946-2018
OI Paolicchi, Aldo/0000-0002-9940-8481; Ahluwalia,
   Arti/0000-0001-5370-6750; Mattei, Giorgio/0000-0003-0441-9653
FU European Union Seventh Framework Programme [304961]
FX The authors are grateful to Stefano Mazzoni and Andrea Pirone for the
   histology preparations and to the abattoir Desideri Luciano S.p.A. Via
   Abruzzi, 2 - Pontedera (Pisa), Italy, for kindly supplying fresh hepatic
   tissue. The work leading to these results has received funding from the
   European Union Seventh Framework Programme (FP7/2007-2013) under grant
   agreement 304961 (ReLiver).
CR Badylak SF, 2011, ANNU REV BIOMED ENG, V13, P27, DOI 10.1146/annurev-bioeng-071910-124743
   Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Burch PT, 2010, ANN THORAC SURG, V90, P1301, DOI 10.1016/j.athoracsur.2010.05.024
   Cebotari S, 2010, ARTIF ORGANS, V34, P206, DOI 10.1111/j.1525-1594.2009.00796.x
   Evans DW, 2013, BIOMECH MODEL MECHAN, V12, P569, DOI 10.1007/s10237-012-0426-3
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Harrison M., 1997, GEN TECHNIQUES CELL
   Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294
   Lang R, 2011, BIOMATERIALS, P1
   LEE LT, 1978, J IMMUNOL METHODS, V19, P69, DOI 10.1016/0022-1759(78)90009-1
   Marchesseau S, 2010, PROG BIOPHYS MOL BIO, V103, P185, DOI 10.1016/j.pbiomolbio.2010.09.005
   Mazzei D, 2010, BIOTECHNOL BIOENG, V106, P127, DOI 10.1002/bit.22671
   Montoya CV, 2009, TISSUE ENG PART C-ME, V15, P191, DOI 10.1089/ten.tec.2008.0372
   Nelson CM, 2005, SEMIN CANCER BIOL, V15, P342, DOI 10.1016/j.semcancer.2005.05.001
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Prasertsung I, 2008, J BIOMED MATER RES B, V85B, P210, DOI 10.1002/jbm.b.30938
   Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009
   Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083
   Remlinger NT, 2010, BIOMATERIALS, V31, P3520, DOI 10.1016/j.biomaterials.2010.01.067
   Ross EA, 2009, J AM SOC NEPHROL, V20, P2338, DOI 10.1681/ASN.2008111196
   Scheffler SU, 2008, CLIN ORTHOP RELAT R, V466, P1810, DOI 10.1007/s11999-008-0288-2
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Sohlenius-Sternbeck AK, 2006, TOXICOL IN VITRO, V20, P1582, DOI 10.1016/j.tiv.2006.06.003
   Tamura Atsutaka, 2002, Stapp Car Crash J, V46, P55
   Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170
   Vavken P, 2009, J ORTHOP RES, V27, P1612, DOI 10.1002/jor.20932
   Wang YF, 2011, HEPATOLOGY, V53, P293, DOI 10.1002/hep.24012
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
NR 30
TC 29
Z9 30
U1 0
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 875
EP 882
DI 10.1016/j.actbio.2013.10.023
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700032
PM 24184179
DA 2018-10-19
ER

PT J
AU Han, F
   Liu, S
   Liu, X
   Pei, Y
   Bai, S
   Zhao, H
   Lu, Q
   Ma, F
   Kaplan, DL
   Zhu, H
AF Han, F.
   Liu, S.
   Liu, X.
   Pei, Y.
   Bai, S.
   Zhao, H.
   Lu, Q.
   Ma, F.
   Kaplan, D. L.
   Zhu, H.
TI Woven silk fabric-reinforced silk nanofibrous scaffolds for regenerating
   load-bearing soft tissues
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Dermal substitute; Mechanical properties; Scaffolds; Suture
   retention
ID MESENCHYMAL STEM-CELLS; FIBROIN SCAFFOLDS; IN-VITRO; CARTILAGE; MATRIX;
   BIOMATERIAL; BONE; DIFFERENTIATION; ARCHITECTURE; HYDROGEL
AB Although three-dimensional (3-D) porous regenerated silk scaffolds with outstanding biocompatibility, biodegradability and low inflammatory reactions have promising application in different tissue regeneration, the mechanical properties of regenerated scaffolds, especially suture retention strength, must be further improved to satisfy the requirements of clinical applications. This study presents woven silk fabric-reinforced silk nanofibrous scaffolds aimed at dermal tissue engineering. To improve the mechanical properties, silk scaffolds prepared by lyophilization were reinforced with degummed woven silk fabrics. The ultimate tensile strength, elongation at break and suture retention strength of the scaffolds were significantly improved, providing suitable mechanical properties strong enough for clinical applications. The stiffness and degradation behaviors were then further regulated by different after-treatment processes, making the scaffolds more suitable for dermal tissue regeneration. The in vitro cell culture results indicated that these scaffolds maintained their excellent biocompatibility after being reinforced with woven silk fabrics. Without sacrifice of porous structure and biocompatibility, the fabric-reinforced scaffolds with better mechanical properties could facilitate future clinical applications of silk as matrices in skin repair. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights
C1 [Han, F.; Liu, S.; Liu, X.; Pei, Y.; Bai, S.; Zhao, H.; Lu, Q.] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Han, F.; Ma, F.] Qingdao Univ Sci & Technol, Coll Polymer Sci & Engn, Key Lab Rubber Plast QUST, Minist Educ, Qingdao 266042, Peoples R China.
   [Kaplan, D. L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, H.] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn; fgma@qust.edu.cn
OI Liu, Xi/0000-0003-4927-8292
FU National Basic Research Program of China (973 Program) [2013CB934400];
   NSFC [21174097]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions (PAPD); Excellent Youth Foundation of Jiangsu
   Province [BK2012009]; NIH [EB002520]; Ph.D. Programs Foundation of
   Ministry of Education of China [201032011200009]; Key Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]
FX The authors thank Jiangsu Province Key Laboratory of Stem Cell Research
   for supplying the amniotic fluid stem cells. The authors thank the
   National Basic Research Program of China (973 Program 2013CB934400) and
   NSFC (21174097) for support of this work. They also thank the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD), the Excellent Youth Foundation of Jiangsu Province (BK2012009),
   the NIH (EB002520)), Ph.D. Programs Foundation of Ministry of Education
   of China (201032011200009) and the Key Natural Science Foundation of the
   Jiangsu Higher Education Institutions of China (11KGA430002) for support
   of this work.
CR Agrawal A, 2013, ACTA BIOMATER, V9, P5313, DOI 10.1016/j.actbio.2012.10.011
   Albanna MZ, 2012, J MECH BEHAV BIOMED, V5, P171, DOI 10.1016/j.jmbbm.2011.08.021
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Annaidh AN, 2012, J MECH BEHAV BIOMED, V5, P139, DOI 10.1016/j.jmbbm.2011.08.016
   Cao TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065654
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Hoganson DM, 2010, BIOMATERIALS, V31, P6730, DOI 10.1016/j.biomaterials.2010.05.019
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kang NH, 2012, CANCER GENE THER, V19, P517, DOI 10.1038/cgt.2012.30
   Khatyr F, 2004, SKIN RES TECHNOL, V10, P96, DOI 10.1111/j.1600-0846.2004.00057.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KWAN MK, 1992, ACTA ORTHOP SCAND, V63, P267, DOI 10.3109/17453679209154780
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu HF, 2007, J BIOMED MATER RES B, V82B, P129, DOI 10.1002/jbm.b.30714
   Lu Q, 2008, J MATER SCI-MATER M, V19, P629, DOI 10.1007/s10856-007-3180-9
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Mammadov B, 2012, ACTA BIOMATER, V8, P2077, DOI 10.1016/j.actbio.2012.02.006
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   McCullen SD, 2010, J MATER CHEM, V20, P8776, DOI 10.1039/c0jm01443e
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panas-Perez E, 2013, J MATER SCI-MATER M, V24, P257, DOI 10.1007/s10856-012-4781-5
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Shepherd JH, 2013, J BIOMED MATER RES A, V101, P176, DOI 10.1002/jbm.a.34317
   Shi PJ, 2013, BIOMATERIALS, V34, P5947, DOI 10.1016/j.biomaterials.2013.04.046
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375
   Tutak W, 2013, BIOMATERIALS, V34, P2389, DOI 10.1016/j.biomaterials.2012.12.020
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang YF, 2010, ACTA BIOMATER, V6, P3021, DOI 10.1016/j.actbio.2010.02.030
NR 47
TC 37
Z9 41
U1 12
U2 105
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 921
EP 930
DI 10.1016/j.actbio.2013.09.026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700037
PM 24090985
DA 2018-10-19
ER

PT J
AU Pedimonte, BJ
   Moest, T
   Luxbacher, T
   von Wilmowsky, C
   Fey, T
   Schlegel, KA
   Greil, P
AF Pedimonte, Birgit Joana
   Moest, Tobias
   Luxbacher, Thomas
   von Wilmowsky, Cornelius
   Fey, Tobias
   Schlegel, Karl Andreas
   Greil, Peter
TI Morphological zeta-potential variation of nanoporous anodic alumina
   layers and cell adherence
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanoporous alumina; Zeta potential; Isoelectric point; Cell activity
ID ENHANCED OSTEOBLAST ADHESION; NANO-POROUS ALUMINA; IN-VITRO; ISOELECTRIC
   POINTS; PROTEIN ADSORPTION; SOLUTION INTERFACE; SURFACE; OXIDE;
   DIFFERENTIATION; CONSTANTS
AB Nanoscale surface modification of biomedical implant materials offers enhanced biological activity concerning protein adsorption and cell adherence. Nanoporous anodic alumina oxide (AAO) layers were prepared by electrochemical oxidation of thin Al-seed layers in 0.22 M C2H2O4, applying anodization voltages of 20-60 V. The AAO layers are characterized by a mean pore diameter varying from 15 to 40 nm, a mean pore distance of 40-130 nm, a total porosity of similar to 10% and a thickness of 560 +/- 40 nm. Zeta potential and isoelectric point (iep) were derived from streaming potential measurements and correlated to the topology variation of the nanoporous AAO layers. With decreasing pore diameter a shift of iep from similar to 7.9 (pore diameter 40 nm) to similar to 6.7 (pore diameter 15 nm) was observed. Plain alumina layers, however, possess an iep of similar to 9. Compared to the plain alumina surface an enhanced adherence and activity of hFOB cells was observed on the nanoporous AAO after 24 h culture with a maximum at a pore size of 40 nm. The topology-induced change of the electrochemical surface state may have a strong impact on protein adsorption as well as on cell adhesion, which offers a high potential for the development of bioactive AAO coatings on various biomaterial substrates. (C) 2013 Acta Materialia Inc. Published by Elsevier Ltd. All rights
C1 [Pedimonte, Birgit Joana; Fey, Tobias; Greil, Peter] Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, D-91054 Erlangen, Germany.
   [Moest, Tobias; von Wilmowsky, Cornelius; Schlegel, Karl Andreas] Univ Erlangen Nurnberg, Fac Med, Dept Oral & Maxillofacial Surg, D-91054 Erlangen, Germany.
   [Luxbacher, Thomas] Anton Paar GmbH, A-8054 Graz, Austria.
RP Pedimonte, BJ (reprint author), Univ Erlangen Nurnberg, Dept Mat Sci Glass & Ceram, Martens Str 5, D-91054 Erlangen, Germany.
EM Joana.pedimonte@ww.uni-erlangen.de
RI Fey, Tobias/K-9861-2015
OI Fey, Tobias/0000-0002-6217-0035; Luxbacher, Thomas/0000-0002-5472-8203
FU DFG
FX The authors are thankful for experimental support from Renate Kohl
   (Anton Paar GmbH, Graz, Austria) and from the Chair of Electron Devices.
   Financial support from the DFG funded Cluster of Excellence "Engineering
   of advanced materials" is gratefully acknowledged.
CR Bai A, 2008, ELECTROCHIM ACTA, V53, P2258, DOI 10.1016/j.electacta.2007.09.039
   Beaulieu JF, 1997, J HISTOCHEM CYTOCHEM, V31, P1
   Bryers JD, 2004, ASM NEWS, V70, P232
   CONTESCU C, 1993, LANGMUIR, V9, P1754, DOI 10.1021/la00031a024
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Desai TA, 2000, MED ENG PHYS, V22, P595, DOI 10.1016/S1350-4533(00)00087-4
   DUNN GA, 1982, CELL BEHAVIOUR, P247
   Ferraz N, 2010, INT J BIOMATER, DOI 10.1155/2010/402715
   Franks GV, 2003, COLLOID SURFACE A, V214, P99, DOI 10.1016/S0927-7757(02)00366-7
   Gultepe E, 2010, ADV DRUG DELIVER REV, V62, P305, DOI 10.1016/j.addr.2009.11.003
   Hartvig RA, 2011, LANGMUIR, V27, P2634, DOI 10.1021/la104720n
   HIEMSTRA T, 1989, J COLLOID INTERF SCI, V133, P91, DOI 10.1016/0021-9797(89)90284-1
   Hunter R.J, 1981, ZETA POTENTIALS COLL
   James R. O., 1982, SURF COLLOID SCI, V12, P119
   Josset Y, 1999, J BIOMED MATER RES, V47, P481, DOI 10.1002/(SICI)1097-4636(19991215)47:4<481::AID-JBM4>3.0.CO;2-Y
   Karlsson M, 2006, J MATER SCI-MATER M, V17, P1101, DOI 10.1007/s10856-006-0537-4
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   KNOZINGER H, 1978, CATAL REV, V17, P31, DOI 10.1080/03602457808080878
   Lamblet M, 2007, LANGMUIR, V23, P6966, DOI 10.1021/la063104h
   Li P, 1993, THESIS LEIDEN U
   LI PJ, 1990, J NON-CRYST SOLIDS, V119, P112, DOI 10.1016/0022-3093(90)90247-J
   MANASSIDIS I, 1994, J AM CERAM SOC, V77, P335, DOI 10.1111/j.1151-2916.1994.tb07000.x
   Masuda H, 1998, JPN J APPL PHYS 2, V37, pL1340, DOI 10.1143/JJAP.37.L1340
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   MOLLER K, 1994, CELL MATER, V4, P263
   Nielsch K, 2002, NANO LETT, V2, P677, DOI [10.1021/nl025537k, 10.1021/n1025537k]
   NORDE W, 1986, J COLLOID INTERF SCI, V112, P447, DOI 10.1016/0021-9797(86)90113-X
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   PARKS GA, 1965, CHEM REV, V65, P177, DOI 10.1021/cr60234a002
   Pedimonte J, 2011, ADV ENG MATER, V13, pB306, DOI 10.1002/adem.201180004
   Poinern GEJ, 2011, MATERIALS, V4, P487, DOI 10.3390/ma4030487
   Price RL, 2003, MED BIOL ENG COMPUT, V41, P372, DOI 10.1007/BF02348445
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Scopelliti PE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011862
   Sposito G., 1996, ENV CHEM ALUMINUM
   Sulka G. D., 2008, NANOSTRUCTURED MAT E, P1, DOI DOI 10.1002/9783527621507.CH1
   Sverjensky DA, 1996, GEOCHIM COSMOCHIM AC, V60, P3773, DOI 10.1016/0016-7037(96)00207-4
   Swan EEL, 2005, BIOMATERIALS, V26, P1969, DOI 10.1016/j.biomaterials.2004.07.001
   Teo BK, 2010, METHOD CELL BIOL, V98, P141
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Vandrovcova M, 2011, PHYSIOL RES, V60, P403
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Walpole AR, 2008, J BIOMED MATER RES A, V90, P46
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xu JL, 2011, BIOL EXTRACELL MATR, P41, DOI 10.1007/978-3-642-16555-9_2
NR 46
TC 16
Z9 17
U1 2
U2 44
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD FEB
PY 2014
VL 10
IS 2
BP 968
EP 974
DI 10.1016/j.actbio.2013.09.023
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AA2JU
UT WOS:000330921700042
PM 24080316
DA 2018-10-19
ER

PT J
AU Martinez, S
   Kuhn, ML
   Russell, JT
   Holz, RC
   Elgren, TE
AF Martinez, Salette
   Kuhn, Misty L.
   Russell, James T.
   Holz, Richard C.
   Elgren, Timothy E.
TI Acrylamide production using encapsulated nitrile hydratase from
   Pseudonocardia thermophila in a sol-gel matrix
SO JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC
LA English
DT Article
DE Nitrile hydratase; Sol-gels; Enzyme immobilization; Biomaterials; Cobalt
ID ENZYME IMMOBILIZATION; BIOMOLECULES; CONFINEMENT; BIOSENSORS; PROTEINS
AB The cobalt-type nitrile hydratase from Pseudonocardia thermophila JCM 3095 (PtNHase) was successfully encapsulated in tetramethyl orthosilicate sol-gel matrices to produce a PtNHase:sol-gel biomaterial. The PtNHase:sol-gel biomaterial catalyzed the conversion of 600 mM acrylonitrile to acrylamide in 60 min at 35 degrees C with a yields of >90%. Treatment of the biomaterial with proteases confirmed that the catalytic activity is due to the encapsulated enzyme and not surface bound NHase. The biomaterial retained 50% of its activity after being used for a total of 13 consecutive reactions for the conversion of acrylonitrile to acrylamide. The thermostability and long-term storage of the PtNHase:sol-gel are substantially improved compared to the soluble NHase. Additionally, the biomaterial is significantly more stable at high concentrations of methanol (50% and 70%, v/v) as a co-solvent for the hydration of acrylonitrile than native PtNHase. These data indicate that PtNHase:sol-gel biomaterials can be used to develop new synthetic avenues involving nitriles as starting materials given that the conversion of the nitrite moiety to the corresponding amide occurs under mild temperature and pH conditions. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Martinez, Salette; Kuhn, Misty L.; Holz, Richard C.] Loyola Univ, Dept Chem & Biochem, Chicago, IL 60660 USA.
   [Russell, James T.; Elgren, Timothy E.] Hamilton Coll, Dept Chem, Clinton, NY 13323 USA.
   [Holz, Richard C.] Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.
RP Holz, RC (reprint author), Marquette Univ, Dept Chem, Milwaukee, WI 53201 USA.
EM Richard.holz@marquette.edu; TElgren@Hamilton.edu
FU National Science Foundation [CHE-1058357]; Petroleum Research Fund [ACS
   PRF 50033-ND4]
FX This work was supported by the National Science Foundation (CHE-1058357,
   RCH) and the Petroleum Research Fund (ACS PRF 50033-ND4, RCH). The
   authors gratefully acknowledge Dr. Miguel A. Ballicora and Gregory Rahn
   for assistance with HPLC.
CR Avnir D, 2006, J MATER CHEM, V16, P1013, DOI 10.1039/5512706h
   Banerjee A, 2002, APPL MICROBIOL BIOT, V60, P33, DOI 10.1007/s00253-002-1062-0
   BLYTH DJ, 1995, ANALYST, V120, P2725, DOI 10.1039/an9952002725
   Bornscheuer UT, 2003, ANGEW CHEM INT EDIT, V42, P3336, DOI 10.1002/anie.200301554
   DAVE BC, 1994, ANAL CHEM, V66, pA1120, DOI 10.1021/ac00094a001
   Dunn B, 1998, ACTA MATER, V46, P737, DOI 10.1016/S1359-6454(97)00254-1
   Eggers DK, 2001, PROTEIN SCI, V10, P250, DOI 10.1110/ps.36201
   Elgren TE, 2005, NANO LETT, V5, P2085, DOI 10.1021/nl0512224
   ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257
   Frampton M, 2008, CHEM COMMUN, P5544, DOI 10.1039/b812389f
   Gasteiger E., 2005, PROTEOMICS PROTOCOLS, V571-607, DOI DOI 10.1385/1-59259-890-0:571
   Gill I., 2001, CHEM MATER, V13, P3404
   Gong JS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-142
   Kandimalla VB, 2006, CRIT REV ANAL CHEM, V36, P73, DOI 10.1080/10408340600713652
   Lan EH, 1999, J MATER CHEM, V9, P45, DOI 10.1039/a805541f
   Mitra S, 2007, J BIOL CHEM, V282, P7397, DOI 10.1074/jbc.M604117200
   Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x
   Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897
   Monton MRN, 2012, CHEM MATER, V24, P796, DOI 10.1021/cm202798e
   Pastor I, 2008, J PHYS CHEM B, V112, P15021, DOI 10.1021/jp805368s
   Pierre AC, 2004, BIOCATAL BIOTRANSFOR, V22, P145, DOI 10.1080/10242420412331283314
   Prasad S, 2010, BIOTECHNOL ADV, V28, P725, DOI 10.1016/j.biotechadv.2010.05.020
   Prepachalova I, 2001, APPL MICROBIOL BIOT, V55, P150
   Serdakowski AL, 2008, TRENDS BIOTECHNOL, V26, P48, DOI 10.1016/j.tibtech.2007.10.007
   Sheldon RA, 2007, ADV SYNTH CATAL, V349, P1289, DOI 10.1002/adsc.200700082
   Smith K, 2002, J AM CHEM SOC, V124, P4247, DOI 10.1021/ja012215u
   Velankar H, 2010, TRENDS BIOTECHNOL, V28, P561, DOI 10.1016/j.tibtech.2010.08.004
   Wang MX, 2005, TOP CATAL, V35, P117, DOI 10.1007/s11244-005-3817-1
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   Woodley JM, 2006, BIOCHEM SOC T, V34, P301, DOI 10.1042/BST0340301
   Yamada H, 2001, CHEM REC, V1, P152
   Yamada H, 1996, BIOSCI BIOTECH BIOCH, V60, P1391, DOI 10.1271/bbb.60.1391
   Yamaki T, 1997, J FERMENT BIOENG, V83, P474, DOI 10.1016/S0922-338X(97)83004-8
NR 33
TC 13
Z9 13
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-1177
EI 1873-3158
J9 J MOL CATAL B-ENZYM
JI J. Mol. Catal. B-Enzym.
PD FEB
PY 2014
VL 100
BP 19
EP 24
DI 10.1016/j.molcatb.2013.11.014
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Physical
SC Biochemistry & Molecular Biology; Chemistry
GA AA3XG
UT WOS:000331027900003
DA 2018-10-19
ER

PT J
AU Rosset, P
   Deschaseaux, F
   Layrolle, P
AF Rosset, P.
   Deschaseaux, F.
   Layrolle, P.
TI Cell therapy for bone repair
SO ORTHOPAEDICS & TRAUMATOLOGY-SURGERY & RESEARCH
LA English
DT Review
DE Bone repair; Mesenchymatous stem cells; Cell therapy; Bone tissue
   engineering; Humans
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FEMORAL-HEAD; AUTOLOGOUS
   MARROW; OSTEONECROSIS; TISSUE; INJECTION; FRACTURE; CYSTS; IMPLANTATION
AB When natural bone repair mechanisms fail, autologous bone grafting is the current standard of care. The osteogenic cells and bone matrix in the graft provide the osteo-inductive and osteo-conductive properties required for successful bone repair. Bone marrow (BM) mesenchymal stem cells (MSCs) can differentiate into osteogenic cells. MSC-based cell therapy holds promise for promoting bone repair. The amount of MSCs available from iliac-crest aspirates is too small to be clinically useful, and either concentration or culture must therefore be used to expand the MSC population. MSCs can be administered alone via percutaneous injection or implanted during open surgery with a biomaterial, usually biphasic hydroxyapatite/beta-calcium-triphosphate granules. Encouraging preliminary results have been obtained inpatients with delayed healing of long bone fractures or avascular necrosis of the femoral head. Bone tissue engineering involves in vitro MSC culturing on biomaterials to obtain colonisation of the biomaterial and differentiation of the cells. The biomaterial-cell construct is then implanted into the zone to be treated. Few published data are available on bone tissue engineering. Much work remains to be done before determining whether this method is suitable for the routine filling of bone tissue defects. Increasing cell survival and promoting implant vascularisation are major challenges. Improved expertise with culturing techniques, together with the incorporation of regulatory requirements, will open the way to high-quality clinical trials investigating the usefulness of cell therapy as a method for achieving bone repair. Cell therapy avoids the drawbacks of autologous bone grafting, preserving the bone stock and diminishing treatment invasiveness. (C) 2013 Published by Elsevier Masson SAS.
C1 [Rosset, P.] Univ Tours, CHU Tours, Hop Trousseau, Serv Chirurg Orthoped 2, F-37044 Tours 09, France.
   [Rosset, P.; Layrolle, P.] Univ Nantes, Fac Med, Inserm U957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, Nantes, France.
   [Deschaseaux, F.] Univ Toulouse 3, Etab Francais Sang Pyrenees Mediterranee, UMR CNRS 5273, INSERM,StromaLab,U1031, F-31062 Toulouse, France.
RP Rosset, P (reprint author), Univ Tours, CHU Tours, Hop Trousseau, Serv Chirurg Orthoped 2, F-37044 Tours 09, France.
EM rosset@univ-tours.fr
RI Layrolle, Pierre/K-9257-2015
OI Layrolle, Pierre/0000-0001-9800-5210
FU European Union [241879]
FX We thank the European Union for funding the REBORNE programme, of which
   it is a member (grant #241879), as part of the European Seventh
   Framework Programme for Research (FP7/2007-2013).
CR Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005
   Ateschrang A, 2009, ARCH ORTHOP TRAUM SU, V129, P97, DOI 10.1007/s00402-008-0699-2
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115
   Dallari D, 2007, J BONE JOINT SURG AM, V89A, P2413, DOI 10.2106/JBJS.F.01026
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Gangji V, 2004, J BONE JOINT SURG AM, V86A, P1153, DOI 10.2106/00004623-200406000-00006
   GARG NK, 1993, ACTA ORTHOP SCAND, V64, P671, DOI 10.3109/17453679308994595
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Hernigou P, 1999, J BONE JOINT SURG BR, V81B, P349, DOI 10.1302/0301-620X.81B2.8818
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Hernigou P, 1997, REV CHIR ORTHOP, V83, P33
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Hernigou P, 2009, INDIAN J ORTHOP, V43, P40, DOI 10.4103/0019-5413.45322
   Kim SJ, BMC MUSCULOSKELET DI
   Kitoh Hiroshi, 2009, J Pediatr Orthop, V29, P643, DOI 10.1097/BPO.0b013e3181b2afb2
   Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Mathieu M, 2013, BONE, V53, P391, DOI 10.1016/j.bone.2013.01.005
   Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Ochs BG, 2008, J BONE JOINT SURG BR, V90B, P1164, DOI 10.1302/0301-620X.90B9.20425
   Park IH, 2008, FOOT ANKLE INT, V29, P164, DOI 10.3113/FAI.2008.0164
   Petite H, 2011, OSTEOPOROSIS INT, V22, P2017, DOI 10.1007/s00198-011-1614-1
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004
   Sensebe L, 2011, HUM GENE THER, V22, P19, DOI 10.1089/hum.2010.197
   Tarte K, 2010, BLOOD, V115, P1549, DOI 10.1182/blood-2009-05-219907
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Wright JG, 2008, J BONE JOINT SURG AM, V90A, P722, DOI 10.2106/JBJS.G.00620
   Yamasaki T, 2010, J BONE JOINT SURG BR, V92B, P337, DOI 10.1302/0301-620X.92B3.22483
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
   Zamzam MM, 2009, INT ORTHOP, V33, P1353, DOI 10.1007/s00264-008-0619-7
   Zhao DW, 2012, BONE, V50, P325, DOI 10.1016/j.bone.2011.11.002
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 42
TC 51
Z9 58
U1 1
U2 41
PU ELSEVIER MASSON
PI MILANO
PA VIA PALEOCAPA 7, 20121 MILANO, ITALY
SN 1877-0568
J9 ORTHOP TRAUMATOL-SUR
JI Orthop. Traumatol.-Surg. Res.
PD FEB
PY 2014
VL 100
IS 1
SU S
BP S107
EP S112
DI 10.1016/j.otsr.2013.11.010
PG 6
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 304BM
UT WOS:000330720300012
PM 24411717
OA Bronze
DA 2018-10-19
ER

PT J
AU Binan, L
   Ajji, A
   De Crescenzo, G
   Jolicoeur, M
AF Binan, Loic
   Ajji, Abdellah
   De Crescenzo, Gregory
   Jolicoeur, Mario
TI Approaches for Neural Tissue Regeneration
SO STEM CELL REVIEWS AND REPORTS
LA English
DT Article
DE Nerve; Spinal cord; Stem cell; Regeneration; Biomaterial; Scaffold;
   Hydrogel; Electrospinning; Growth factor
ID NERVE-GROWTH-FACTOR; SPINAL-CORD-INJURY; MESENCHYMAL STEM-CELLS; MARROW
   STROMAL CELLS; PROMOTES FUNCTIONAL RECOVERY; RECOMBINANT SPIDER SILK;
   EPI-CORTICAL DELIVERY; DORSAL-ROOT GANGLIA; AXONAL REGENERATION;
   IN-VITRO
AB There is currently no treatment for neurodegenerative diseases such as Parkinson's or Alzheimer's diseases. While spinal cord injury has no treatment either, nerve injuries are being treated with autologous grafts, a procedure that in turn translates into a loss of function in the donor area. The development of therapies for these pathologies has become urgent as population keeps on ageing. A promising direction of investigation is the use of regenerative techniques to re-grow healthy and functional tissue in the injured area. In this review article, various approaches currently investigated to promote neural regeneration are covered. Those include approaches based on (and many times combining) stem cell therapy, scaffolds made of hydrogel, electrospun fibers and conductive materials as well as the use of soluble or non-diffusible growth factors.
C1 [Binan, Loic; Ajji, Abdellah; De Crescenzo, Gregory; Jolicoeur, Mario] Ecole Polytech, Dept Chem Engn, Montreal, PQ H3C 3A7, Canada.
RP Jolicoeur, M (reprint author), Ecole Polytech, Dept Chem Engn, POB 6079, Montreal, PQ H3C 3A7, Canada.
EM loic.binan@polytechnique.org; mario.jolicoeur@polymtl.ca
FU National Sciences and Engineering Research Council of Canada (NSERC);
   New World Laboratories Inc.
FX Authors wish to thank the National Sciences and Engineering Research
   Council of Canada (NSERC) and New World Laboratories Inc. for their
   financial support through a Research and Development Collaborative
   grant.
CR Aizman I, 2009, J NEUROSCI RES, V87, P3198, DOI 10.1002/jnr.22146
   Alhosseini SN, 2012, INT J NANOMED, V7, P25, DOI 10.2147/IJN.S25376
   Alleva E, 2009, NEUROSCI BIOBEHAV R, V33, P525, DOI 10.1016/j.neubiorev.2008.09.004
   ALTMAN J, 1979, J COMP NEUROL, V188, P455, DOI 10.1002/cne.901880308
   [Anonymous], 2012, J Spinal Cord Med, V35, P480, DOI 10.1179/1079026812Z.000000000124
   Arruda JL, 1998, MOL BRAIN RES, V62, P228, DOI 10.1016/S0169-328X(98)00257-5
   Assal Y, 2013, BIOMATERIALS, V34, P3315, DOI 10.1016/j.biomaterials.2013.01.067
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Beduer A, 2012, BIOMATERIALS, V33, P504, DOI 10.1016/j.biomaterials.2011.09.073
   Belisle JM, 2008, LAB CHIP, V8, P2164, DOI 10.1039/b813897d
   Bella AJ, 2009, J SEX MED, V6, P347, DOI 10.1111/j.1743-6109.2008.01194.x
   Bertram JP, 2010, PHARM RES-DORD, V27, P82, DOI 10.1007/s11095-009-0009-x
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730
   Boyd JG, 2003, EXP NEUROL, V183, P610, DOI 10.1016/S0014-4886(03)00183-3
   Brooks DN, 2012, MICROSURG, V32, P1, DOI 10.1002/micr.20975
   Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002
   Cao JI, 2011, BIOMATERIALS, V32, P3939, DOI 10.1016/j.biomaterials.2011.02.020
   CARONI P, 1990, J CELL BIOL, V110, P1307, DOI 10.1083/jcb.110.4.1307
   Chang Y. J., 2012, NANOMEDICINE
   Chen R, 2010, COLLOID SURFACE B, V79, P315, DOI 10.1016/j.colsurfb.2010.03.043
   Cheng BX, 2011, MOL CELL NEUROSCI, V47, P181, DOI 10.1016/j.mcn.2011.04.002
   Choi Y. K., 2012, LIFE SCI
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Del Gaudio C, 2009, J BIOMED MATER RES A, V89A, P1028, DOI 10.1002/jbm.a.32048
   DELLON AL, 1988, PLAST RECONSTR SURG, V82, P849, DOI 10.1097/00006534-198811000-00020
   Dey ND, 2010, BEHAV BRAIN RES, V214, P193, DOI 10.1016/j.bbr.2010.05.023
   Di Carlo A, 2009, AGE AGEING, V38, P4, DOI 10.1093/ageing/afn282
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Egawa EY, 2011, BIOMATERIALS, V32, P4737, DOI 10.1016/j.biomaterials.2011.03.033
   Ford B., 2010, PARKINSONS DIS Q A
   GARDETTE R, 1982, J HIRNFORSCH, V23, P415
   Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542
   Grassi Mario, 2005, Current Drug Delivery, V2, P97, DOI 10.2174/1567201052772906
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Han N, 2012, J CONTROL RELEASE, V158, P165, DOI 10.1016/j.jconrel.2011.09.094
   Han Ning, 2011, Front Neuroeng, V4, P2, DOI 10.3389/fneng.2011.00002
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Hansmann F., 2012, CELL TRANSPLANT
   He JT, 2005, DRUG DELIV, V12, P251, DOI 10.1080/10717540500176043
   Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014
   Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101
   Huang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039526
   Huang SH, 2011, CURR NANOSCI, V7, P267, DOI 10.2174/157341311794653703
   Huang Y. J., 2012, SMALL
   Huang YJ, 2012, SMALL, V8, P2869, DOI 10.1002/smll.201200715
   Hwang JY, 2013, NANOSCALE, V5, P487, DOI 10.1039/c2nr31581e
   Hwang W., 2012, NEURAL DEV STEM CELL, P149
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Ilkhanizadeh S, 2007, BIOMATERIALS, V28, P3936, DOI 10.1016/j.biomaterials.2007.05.018
   Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005
   Jeong SI, 2008, MACROMOL BIOSCI, V8, P328, DOI 10.1002/mabi.200700107
   Jia C, 2011, NEUROSCIENCE, V177, P335, DOI 10.1016/j.neuroscience.2010.12.039
   Joo NY, 2012, ACTA BIOMATER, V8, P1802, DOI 10.1016/j.actbio.2012.01.026
   Joyce N, 2010, REGEN MED, V5, P933, DOI 10.2217/RME.10.72
   Kabiri M, 2012, BIOTECHNOL LETT, V34, P1357, DOI 10.1007/s10529-012-0889-4
   Kaka GR, 2012, INT J NEUROSCI, V122, P237, DOI 10.3109/00207454.2011.642037
   Kassis I, 2008, ARCH NEUROL-CHICAGO, V65, P753, DOI 10.1001/archneur.65.6.753
   Keenan TM, 2012, INTEGR BIOL-UK, V4, P1522, DOI 10.1039/c2ib20074k
   Kim HW, 2008, J BIOMED MATER RES A, V87A, P25, DOI 10.1002/jbm.a.31677
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   KREWSON CE, 1995, BRAIN RES, V680, P196, DOI 10.1016/0006-8993(95)00261-N
   Kunze A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026187
   Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381
   Lee JY, 2012, IEEE T NANOBIOSCI, V11, P15, DOI 10.1109/TNB.2011.2159621
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013
   Leong W. S., 2012, J TISSUE ENG REGENER
   Lewicka M, 2012, BIOMATERIALS, V33, P7712, DOI 10.1016/j.biomaterials.2012.07.021
   Li BH, 2012, OR SURG OR MED OR PA, V113, pE26, DOI 10.1016/j.tripleo.2011.07.002
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Liu T, 2012, J BIOMED MATER RES A, V100A, P236, DOI 10.1002/jbm.a.33271
   Liu Z, 2011, PEPTIDES, V32, P1244, DOI 10.1016/j.peptides.2011.04.005
   Lowry N, 2012, BIOMATERIALS, V33, P2892, DOI 10.1016/j.biomaterials.2011.12.048
   Luo J, 2009, ACTA NEUROCHIR, V151, P1483, DOI 10.1007/s00701-009-0402-6
   Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014
   Ma QF, 1997, J NEUROSCI, V17, P3644
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Ma ZW, 2009, J CHROMATOGR B, V877, P3686, DOI 10.1016/j.jchromb.2009.09.019
   Macaya D, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012001
   Magnaghi V, 2011, J BIOMED MATER RES A, V98A, P19, DOI 10.1002/jbm.a.33091
   Mahoney MJ, 2006, TISSUE ENG, V12, P1915, DOI 10.1089/ten.2006.12.1915
   MAY M, 1991, OTOLARYNG HEAD NECK, V104, P818, DOI 10.1177/019459989110400609
   McKasson MJ, 2008, EXP NEUROL, V211, P585, DOI 10.1016/j.expneurol.2008.02.015
   MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J
   Miao JJ, 2012, J NANOSCI NANOTECHNO, V12, P2387, DOI 10.1166/jnn.2012.5710
   Miller RH, 2006, BRAIN RES, V1091, P258, DOI 10.1016/j.brainres.2006.01.073
   Mohammed JS, 2006, LANGMUIR, V22, P2738, DOI 10.1021/la0525473
   Montastruc JL, 1999, MOVEMENT DISORD, V14, P725, DOI 10.1002/1531-8257(199909)14:5<725::AID-MDS1003>3.0.CO;2-L
   Munoz JR, 2005, P NATL ACAD SCI USA, V102, P18171, DOI 10.1073/pnas.0508945102
   Mwizerwa O, 2011, DEV DYNAM, V240, P1402, DOI 10.1002/dvdy.22630
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055
   Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011
   Ojha SS, 2008, BIOMACROMOLECULES, V9, P2523, DOI 10.1021/bm800551q
   Park JS, 2012, BIOMATERIALS, V33, P7300, DOI 10.1016/j.biomaterials.2012.06.069
   Park J, 2010, J BIOMED MATER RES A, V93A, P1091, DOI 10.1002/jbm.a.32519
   Park S, 2004, NEUROSCI LETT, V359, P99, DOI 10.1016/j.neulet.2004.01.073
   Pawitan Jeanne Adiwinata, 2011, Anat Cell Biol, V44, P256, DOI 10.5115/acb.2011.44.4.256
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Perale G, 2012, J CONTROL RELEASE, V159, P271, DOI 10.1016/j.jconrel.2011.12.025
   Pfister LA, 2007, J BIOMED MATER RES A, V80A, P932, DOI 10.1002/jbm.a.31052
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rickett TA, 2011, BIOMACROMOLECULES, V12, P57, DOI 10.1021/bm101004r
   Ruiz A, 2008, BIOMATERIALS, V29, P4766, DOI 10.1016/j.biomaterials.2008.08.017
   Sabri F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033242
   Sackett CK, 2011, INT J PHARMACEUT, V418, P104, DOI 10.1016/j.ijpharm.2010.11.048
   Saltzman WM, 1999, PHARMACEUT RES, V16, P232, DOI 10.1023/A:1018824324275
   Sazo REG, 2012, BIOMATERIALS, V33, P8529, DOI 10.1016/j.biomaterials.2012.07.028
   Seyednejad H, 2012, BIOMACROMOLECULES, V13, P3650, DOI 10.1021/bm301101r
   Shanbhag M. S., 2010, BIOMACROMOLECULES
   Sharp KG, 2012, EXP NEUROL, V235, P345, DOI 10.1016/j.expneurol.2012.02.016
   Shen C. C., 2013, J BIOMEDICAL MAT R A
   Shi J, 2010, ACS APPL MATER INTER, V2, P1025, DOI 10.1021/am9007962
   Sirianni RW, 2010, BRAIN RES, V1321, P40, DOI 10.1016/j.brainres.2010.01.041
   Song BB, 2012, BIOMATERIALS, V33, P9105, DOI 10.1016/j.biomaterials.2012.08.060
   Studer L, 2000, J NEUROSCI, V20, P7377
   Subramanian A, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/2/025004
   Sugaya K, 2008, J ALZHEIMERS DIS, V15, P241
   Sulaiman OAR, 2002, GLIA, V37, P206, DOI 10.1002/glia.10022
   Tosi G., 2013, CURRENT MED CHEM
   Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239
   Tzeng SY, 2010, SOFT MATTER, V6, P2208, DOI 10.1039/b923544b
   Uemura M, 2010, J NEUROSCI RES, V88, P542, DOI 10.1002/jnr.22223
   Vincent AM, 2004, NEUROBIOL DIS, V16, P407, DOI 10.1016/j.nbd.2004.03.001
   Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805
   Wang HK, 2012, BIOTECHNOL APPL BIOC, V59, P388, DOI 10.1002/bab.1031
   Wang JX, 2012, J BIOMED MATER RES A, V100A, P632, DOI 10.1002/jbm.a.33291
   Wang SG, 2012, THER DELIV, V3, P1155, DOI 10.4155/TDE.12.103
   Wang Y., 2013, ACTA BIOMATERIALIA
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031
   Widhe M, 2010, BIOMATERIALS, V31, P9575, DOI 10.1016/j.biomaterials.2010.08.061
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Xia L, 2013, CHINESE MED J-PEKING, V126, P909, DOI 10.3760/cma.j.issn.0366-6999.20120476
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Yao L, 2009, J BIOMED MATER RES B, V90B, P483, DOI 10.1002/jbm.b.31308
   Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3
   Yi X, 2011, NEUROENDOCRINOL LETT, V32, P705
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
   Zuidema JM, 2011, ACTA BIOMATER, V7, P1634, DOI 10.1016/j.actbio.2010.11.039
NR 157
TC 16
Z9 18
U1 2
U2 49
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1550-8943
EI 1558-6804
J9 STEM CELL REV REP
JI Stem Cell Rev. Rep.
PD FEB
PY 2014
VL 10
IS 1
BP 44
EP 59
DI 10.1007/s12015-013-9474-z
PG 16
WC Cell & Tissue Engineering; Cell Biology; Medicine, Research &
   Experimental
SC Cell Biology; Research & Experimental Medicine
GA AA3LC
UT WOS:000330992900004
PM 24092527
DA 2018-10-19
ER

PT J
AU Kang, SN
   Jeong, CM
   Jeon, YC
   Byon, ES
   Jeong, YS
   Cho, LR
AF Kang, Sun Nyo
   Jeong, Chang Mo
   Jeon, Young Chan
   Byon, Eung-Sun
   Jeong, Yong-Soo
   Cho, Lee-Ra
TI Effects of Mg-ion and Ca-ion Implantations on P-gingivalis and
   F-nucleatum Adhesion
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE bacterial adhesion; ion implantation; calcium; magnesium; non-specific
   bonding
ID PARTIALLY EDENTULOUS PATIENTS; COMMERCIALLY PURE TITANIUM; BACTERIAL
   ADHESION; BONE RESPONSE; IN-VIVO; SURFACES; CALCIUM; BIOMATERIAL;
   MECHANISMS; ATTACHMENT
AB The purpose of this study was to evaluate the effects of ion implantation on Porphyromonas gingivalis (P. gingivalis) and Fusobacterium nucleatum (F. nucleatum) bacterial adhesion. Titanium (Ti) discs of 15 mm diameter and 1 mm in thickness (n = 42, 7 per group) were fabricated. Magnesium (Mg) and calcium (Ca) ions were implanted into the Ti surfaces using a plasma-source ion-implantation method. The roughness, chemistry, morphology, and contact angle of the titanium surfaces were analyzed using scanning electron microscopy, Rutherford back-scattering spectroscopy, Auger electron spectroscopy, and contact angle meter. P. gingivalis and F. nucleatum strains were cultured in anaerobic conditions at 37 degrees C for 72 hours, and all titanium specimens were dipped in the bacterial suspension at 37 degrees C for 24 hours. Specimens were examined at 1,000x magnification using a fluorescence microscope. The number and total area of bacteria in each of 10 separate fields were determined by computer imaging analysis method. The resulting data was analyzed to assess the significance of observed differences based on the method of the surface treatment, ion implantation. The number of P. gingivalis and F. nucleatum attached to the Mg-(927 and 227, respectively) and Ca-ion-implanted (1325 and 231, respectively) surfaces were greater than those attached to the non-implanted surfaces (306 and 98, p <.001). Total area occupied by P. gingivalis adhesion was greater than those of F. nucleatum in the Mg- and Ca-ion-implanted surfaces (p <.001). The types of ion and bacteria did not affect the amount of bacterial adhesion. Ion implantation enhanced the adhesions of P. gingivalis and F. nucleatum. Non-specific bonding derived from the electrostatic force affected by positively charged ions might be the predominant factor in bacterial adhesion. The possibility of specific bonding could not be ruled out in the Ca-ion-implanted surface.
C1 [Kang, Sun Nyo; Jeong, Chang Mo; Jeon, Young Chan] Pusan Natl Univ, Sch Dent, Dept Prosthodont, Pusan, South Korea.
   [Byon, Eung-Sun; Jeong, Yong-Soo] Korea Inst Mat Sci, Mat Proc Div, Chang Won, South Korea.
   [Cho, Lee-Ra] Gangneung Wonju Natl Univ, Coll Dent, Dept Prosthodont, Kangnung, South Korea.
   [Cho, Lee-Ra] Gangneung Wonju Natl Univ, Coll Dent, Res Inst Oral Sci, Kangnung, South Korea.
RP Cho, LR (reprint author), Gangneung Wonju Natl Univ, Coll Dent, Dept Prosthodont, Kangnung, South Korea.
EM lila@gwnu.ac.kr
CR ABBOTT A, 1983, J GEN MICROBIOL, V129, P439
   Albrektsson T, 1994, P 1 EUR WORKSH PER
   Amano A, 1996, INFECT IMMUN, V64, P1631
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Apella MC, 2008, J ARGENT CHEM SOC, V97, P109
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Cardenas C, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819239
   Cho LR, 2010, CLIN ORAL IMPLAN RES, V21, P848, DOI 10.1111/j.1600-0501.2009.01862.x
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Frojd V, 2008, INT J ORAL MAX SURG, V37, P561, DOI 10.1016/j.ijom.2008.01.020
   Frojd V, 2012, CLIN IMPLANT DENT R, V14, P737, DOI 10.1111/j.1708-8208.2010.00315.x
   Hauslich LB, 2013, CLIN ORAL IMPLAN RES, V24, P49, DOI 10.1111/j.1600-0501.2011.02364.x
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   HOGT AH, 1985, J GEN MICROBIOL, V131, P2485
   Hsiao CL, 2009, NUCLEIC ACIDS RES, V37, P3134, DOI 10.1093/nar/gkp119
   Ichikawa T, 2000, INT J ORAL MAX IMPL, V15, P231
   Jeyachandran YL, 2006, BIOMED MATER, V1, pL1, DOI 10.1088/1748-6041/1/1/L01
   Kiejna A, 2006, J PHYS-CONDENS MAT, V18, P4207, DOI 10.1088/0953-8984/18/17/009
   Kim ML, 2012, CLIN ORAL IMPLAN RES, V23, P245, DOI 10.1111/j.1600-0501.2010.02138.x
   KINDER SA, 1993, J BACTERIOL, V175, P840
   Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007
   Ko KH, 2012, TISSUE ENG REGEN MED, V9, P137, DOI 10.1007/s13770-012-0137-y
   KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993
   Kuula H, 2004, INT J ORAL MAX IMPL, V19, P803
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x
   Mei L, 2009, LANGMUIR, V25, P6227, DOI 10.1021/la9000494
   Nayab SN, 2005, BIOMATERIALS, V26, P4717, DOI 10.1016/j.biomaterials.2004.11.044
   Parikh SJ, 2006, LANGMUIR, V22, P8492, DOI 10.1021/la061359p
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Pongnarisorn NJ, 2007, CLIN ORAL IMPLAN RES, V18, P114, DOI 10.1111/j.1600-0501.2006.01304.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Speranza G, 2004, BIOMATERIALS, V25, P2029, DOI 10.1016/j.biomaterials.2003.08.061
   Sul Young-Taeg, 2004, Clin Implant Dent Relat Res, V6, P101, DOI 10.1111/j.1708-8208.2004.tb00032.x
   van Winkelhoff AJ, 2000, CLIN ORAL IMPLAN RES, V11, P511, DOI 10.1034/j.1600-0501.2000.011006511.x
   Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535
   Wan YZ, 2006, SURF COAT TECH, V201, P2904, DOI 10.1016/j.surfcoat.2006.06.004
   Wu-Yuan CD, 1995, J ORAL IMPLANTOL, V21, P207
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 41
TC 2
Z9 2
U1 2
U2 11
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2014
VL 11
IS 1
BP 39
EP 46
DI 10.1007/s13770-013-1104-y
PG 8
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AA0PK
UT WOS:000330797300006
DA 2018-10-19
ER

PT J
AU Suh, JD
   Lim, KT
   Jin, H
   Kim, J
   Choung, PH
   Chung, JH
AF Suh, Je-Duck
   Lim, Ki Taek
   Jin, Hexiu
   Kim, Jangho
   Choung, Pill-Hoon
   Chung, Jong Hoon
TI Effects of Co-Culture of Dental Pulp Stem Cells and Periodontal Ligament
   Stem Cells on Assembled Dual Disc Scaffolds
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE co-culture; assembled dual disc scaffolds; dental pulp stem cells;
   periodontal ligament stem cells; tooth tissue engineering
ID IN-VITRO; BONE-MARROW; PROLIFERATION; FIBROBLASTS; GROWTH; REGENERATION;
   OSTEOPONTIN; EXPRESSION; MATRIX; MODELS
AB The study of cell-to-cell interaction in experimental co-culture systems is very important and relevant to the context of biomaterial scaffolds used for tissue regeneration. In this study, scaffolds, which allow direct and indirect cell-to-cell contact and separation of each cell type, were developed using one of the most utilized biopolymer, poly-D, L-lactide (PDLLA). The assembled scaffold had enough mechanical strength to withstand experiments and maintain its shape. It is separated easily into core and outer portion for further experiments, which could be conducted to examine the effects of co-culture. Co-culture with dental pulp stem cells (DPSCs) and periodontal ligament stem cells (PDLSCs) increased proliferation of both cell types and dentin sialophosphoprotein (DSPP) mRNA expression in co-cultured PDLSCs. In immunohistochemical examination, dentin sialoprotein (DSP) expression in both cell types was up-regulated in co-culture compared to that of mono-culture. The longer the culture period, the more DSP expressions were up-regulated. Osteopontin (OPN) expression in both cell types was also up-regulated in co-culture. Co-culture of dental stem cells improved cell proliferation and osteogenic differentiation. This study demonstrates that biomimetic co-culture method for tooth tissue engineering may be potentially applied to study dental stem cell behavior in tooth regenerative medicine.
C1 [Suh, Je-Duck; Lim, Ki Taek; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
   [Suh, Je-Duck; Lim, Ki Taek; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea.
   [Suh, Je-Duck; Jin, Hexiu; Choung, Pill-Hoon] Seoul Natl Univ, Sch Dent, Tooth Bioengn Natl Res Lab Post BK21, Seoul, South Korea.
   [Lim, Ki Taek; Kim, Jangho; Chung, Jong Hoon] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151921, South Korea.
   [Chung, Jong Hoon] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea.
RP Choung, PH (reprint author), Seoul Natl Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea.
EM choungph@snu.ac.kr; jchung@snu.ac.kr
FU Technology Development Program for Korea Institute of Planning and
   Evaluation for Technology in Food, Agriculture, Forestry and Fisheries
   (IPET), Republic of Korea [312031-3]; National Research Foundation of
   Korea (NRF); Korea government (MEST) [2011-0028922]
FX This research was supported by Technology Development Program for Korea
   Institute of Planning and Evaluation for Technology in Food,
   Agriculture, Forestry and Fisheries (IPET), Republic of Korea
   (312031-3), and the National Research Foundation of Korea (NRF) grant
   funded by the Korea government (MEST) (2011-0028922).
CR Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M
   Bloemen V, 2010, J CELL PHYSIOL, V222, P565, DOI 10.1002/jcp.21971
   Borden M, 2002, J BIOMED MATER RES, V61, P421, DOI 10.1002/jbm.10201
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   Buma P, 2004, BIOMATERIALS, V25, P1487, DOI 10.1016/S0142-9612(03)00492-7
   Burger R, 2009, MOL CANCER THER, V8, P26, DOI 10.1158/1535-7163.MCT-08-0149
   Cai XX, 2010, INT J ORAL SCI, V2, P74, DOI 10.4248/IJOS10039
   Croft AP, 2009, EXP NEUROL, V216, P329, DOI 10.1016/j.expneurol.2008.12.010
   Crop MJ, 2010, STEM CELLS DEV, V19, P1843, DOI 10.1089/scd.2009.0368
   Douglas T, 2010, CLIN ORAL IMPLAN RES, V21, P262, DOI 10.1111/j.1600-0501.2009.01818.x
   Duffy GP, 2009, TISSUE ENG PT A, V15, P2459, DOI [10.1089/ten.tea.2008.0341, 10.1089/ten.TEA.2008.0341]
   Ferreira CF, 2007, J ORAL REHABIL, V34, P933, DOI 10.1111/j.1365-2842.2007.01785.x
   Gerstenfeld LC, 2003, CONNECT TISSUE RES, V44, P85, DOI 10.1080/03008200390152142
   Geuze RE, 2009, TISSUE ENG PT A, V15, P3669, DOI 10.1089/ten.TEA.2009.0289
   Grant-Tschudy KS, 2005, BIOL REPROD, V72, P814, DOI 10.1095/biolreprod.104.035618
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hendriks J, 2007, J TISSUE ENG REGEN M, V1, P170, DOI 10.1002/term.19
   Hernandez-Guillamon M, 2009, J NEUROSCI RES, V87, P2115, DOI 10.1002/jnr.22034
   Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   James KC, 2007, BIOMATERIALS, V28, P5193
   Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192
   Kacena MA, 2006, BONE, V39, P991, DOI 10.1016/j.bone.2006.05.004
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Ko JA, 2010, INVEST OPHTH VIS SCI, V51, P6286, DOI 10.1167/iovs.09-4753
   Lai N, 2009, TISSUE ENG PT A, V15, P1053, DOI 10.1089/ten.tea.2008.0101
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Marten A, 2002, MOL IMMUNOL, V39, P395, DOI 10.1016/S0161-5890(02)00142-6
   Merluzzi S, 2010, BLOOD, V115, P2810, DOI 10.1182/blood-2009-10-250126
   Mezey E, 2003, P NATL ACAD SCI USA, V100, P1364, DOI 10.1073/pnas.0336479100
   Mishra V, 2009, TOXICOL LETT, V186, P104, DOI 10.1016/j.toxlet.2009.01.006
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Modino SAC, 2005, ARCH ORAL BIOL, V50, P255, DOI 10.1016/j.archoralbio.2005.01.002
   Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Morsczeck C, 2008, CLIN ORAL INVEST, V12, P113, DOI 10.1007/s00784-007-0170-8
   Murphy JM, 2003, ARTHRITIS RHEUM, V48, P3464, DOI 10.1002/art.11365
   Olivera-Martinez I, 2004, INT J DEV BIOL, V48, P107, DOI 10.1387/ijdb.15272376
   Park JB, 2012, TISSUE ENG REGEN MED, V9, P224, DOI 10.1007/s13770-012-0343-7
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302
   Regnier M, 1999, CELL MOL BIOL, V45, P969
   Rincon JC, 2005, J PERIODONTAL RES, V40, P417, DOI 10.1111/j.1600-0765.2005.00823.x
   SANTAVIRTA S, 1990, J BONE JOINT SURG BR, V72, P597
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101
   SODEK J, 1995, ANN NY ACAD SCI, V760, P223, DOI 10.1111/j.1749-6632.1995.tb44633.x
   Sonoyama W, 2006, PLOS ONE, V1, pe79
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Steinhagen J, 2010, TISSUE CELL, V42, P151, DOI 10.1016/j.tice.2010.03.003
   Swierczynski B, 2000, PARASITOL RES, V86, P151, DOI 10.1007/s004360050024
   Terzuoli E, 2010, CLIN CANCER RES, V16, P4207, DOI 10.1158/1078-0432.CCR-10-0156
   Yen AHH, 2008, CELL TISSUE RES, V331, P359, DOI 10.1007/s00441-007-0467-6
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zhang WB, 2010, BIOMATERIALS, V31, P7995, DOI 10.1016/j.biomaterials.2010.07.020
NR 58
TC 3
Z9 4
U1 1
U2 14
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD FEB
PY 2014
VL 11
IS 1
BP 47
EP 58
DI 10.1007/s13770-013-1109-6
PG 12
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AA0PK
UT WOS:000330797300007
DA 2018-10-19
ER

PT J
AU Huang, Y
   Zhu, CL
   Yang, JZ
   Nie, Y
   Chen, CT
   Sun, DP
AF Huang, Yang
   Zhu, Chunlin
   Yang, Jiazhi
   Nie, Ying
   Chen, Chuntao
   Sun, Dongping
TI Recent advances in bacterial cellulose
SO CELLULOSE
LA English
DT Review
DE Bacterial cellulose; Nanobiomaterials; Network architecture;
   Controllable cultivation
ID QUARTZ-CRYSTAL MICROBALANCE; BUBBLE-COLUMN BIOREACTOR; DIFFERENT
   CARBON-SOURCES; ACETOBACTER-XYLINUM; MICROBIAL CELLULOSE;
   GLUCONACETOBACTER-XYLINUS; POLYANILINE NANOCOMPOSITES; STRAIN
   IMPROVEMENT; LIQUID-CRYSTALLINE; VASCULAR GRAFT
AB Bacterial cellulose (BC) produced by some microorganisms has been widely accepted as a multifunctional nano-biomaterial. It is composed of linear glucan molecules attached with hydrogen bonds, which appears similar to plant cellulose. However, when compared with other conventional natural or synthesized counterparts, BC performs better in areas such as biomedicine, functional devices, water treatment, nanofillers, etc. for its distinct superior chemical purity, crystallinity, biocompatibility, and ultrafine network architecture. When BC is incorporated in a material or used as a scaffold, novel features result that are related to BC's intrinsic characteristics mentioned above. This review mainly summarizes the recent developments of the functional products fabricated with BC. Besides, the controllable cultivation conditions should also be discussed for expecting to make a breakthrough in its productivity. We highlight the literatures mainly in last 5 years, exerting ourselves to provide the state-of-the-art opinions in areas wherever are focused on for BC researching.
C1 [Huang, Yang; Zhu, Chunlin; Yang, Jiazhi; Nie, Ying; Chen, Chuntao; Sun, Dongping] Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.
RP Sun, DP (reprint author), Nanjing Univ Sci & Technol, Chemicobiol & Funct Mat Inst, Sch Chem Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM sundpe301@163.com
FU State 863 Projects [2011AA050701]; Fundamental Research Funds for the
   Central Universities [30920130121001]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD, China)
FX We acknowledge the financial support from State 863 Projects
   (2011AA050701), the Fundamental Research Funds for the Central
   Universities (No. 30920130121001), and a Project Funded by the Priority
   Academic Program Development of Jiangsu Higher Education Institutions
   (PAPD, China).
CR Alvarez OM, 2004, WOUNDS, V16, P224
   Amin MCIM, 2012, CARBOHYD POLYM, V88, P465, DOI 10.1016/j.carbpol.2011.12.022
   Andrade FK, 2011, J BIOMED MATER RES A, V98A, P554, DOI 10.1002/jbm.a.33148
   Andrade FK, 2010, ACTA BIOMATER, V6, P4034, DOI 10.1016/j.actbio.2010.04.023
   Astley OM, 2003, INT J BIOL MACROMOL, V32, P28, DOI 10.1016/S0141-8130(03)00022-9
   ATALLA RH, 1984, SCIENCE, V223, P283, DOI 10.1126/science.223.4633.283
   Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Backdahl H, 2008, J TISSUE ENG REGEN M, V2, P320, DOI 10.1002/term.97
   Backdahl H, 2011, MAT SCI ENG C-MATER, V31, P14, DOI 10.1016/j.msec.2010.07.010
   Bapiraju K, 2005, AFR J BIOTECHNOL, V3, P618
   Barud HS, 2008, J SOL-GEL SCI TECHN, V46, P363, DOI 10.1007/s10971-007-1669-9
   Basta AH, 2009, J APPL MICROBIOL, V107, P2098, DOI 10.1111/j.1365-2672.2009.04467.x
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864
   Bielecki S, 2005, BIOPOLYMERS ONLINE, DOI [10.1002/3527600035.bpol5003, DOI 10.1002/3527600035.BP0L5003]
   Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Brown A. J., 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Brown EE, 2012, CELLULOSE, V19, P127, DOI 10.1007/s10570-011-9617-9
   Brown RM, 2004, J POLYM SCI POL CHEM, V42, P487, DOI 10.1002/pola.10877
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Cai Z, 2011, AM SOC MECH ENG, V2
   Cai ZJ, 2011, MATER LETT, V65, P182, DOI 10.1016/j.matlet.2010.09.055
   Cai ZJ, 2011, CURR APPL PHYS, V11, P247, DOI 10.1016/j.cap.2010.07.016
   Carreira P, 2011, BIORESOURCE TECHNOL, V102, P7354, DOI 10.1016/j.biortech.2011.04.081
   CHAN HSO, 1995, J AM CHEM SOC, V117, P8517, DOI 10.1021/ja00138a004
   Chao YP, 2000, BIOTECHNOL BIOENG, V68, P345
   Chen P, 2010, MOL CRYST LIQ CRYST, V519, P169, DOI 10.1080/15421401003613659
   Chen SY, 2010, J APPL POLYM SCI, V117, P8, DOI 10.1002/app.31477
   Chen SY, 2009, POLYM BULL, V63, P283, DOI 10.1007/s00289-009-0088-1
   Chen SY, 2009, J HAZARD MATER, V161, P1355, DOI 10.1016/j.jhazmat.2008.04.098
   Cheng KC, 2011, BIOMACROMOLECULES, V12, P730, DOI 10.1021/bm101363t
   Cheng Kuan-Chen, 2009, J Biol Eng, V3, P12, DOI 10.1186/1754-1611-3-12
   Chiaoprakobkij N, 2011, CARBOHYD POLYM, V85, P548, DOI 10.1016/j.carbpol.2011.03.011
   Choi CN, 2009, KOREAN J CHEM ENG, V26, P136, DOI 10.1007/s11814-009-0021-1
   Conner AH, 1995, SIZE EXCLUSION CHROM, P331
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   De Olyveira G. M., 2011, J BIOMATER NANOBIOTE, V2, P239
   de Souza FC, 2011, J VOICE, V25, P765, DOI 10.1016/j.jvoice.2010.07.005
   Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   El-Saied H, 2008, BIORESOURCES, V3, P1196
   Esguerra M, 2010, J BIOMED MATER RES A, V93A, P140, DOI 10.1002/jbm.a.32516
   Fink H, 2011, J TISSUE ENG REGEN M, V5, P454, DOI 10.1002/term.334
   Fink H, 2010, ACTA BIOMATER, V6, P1125, DOI 10.1016/j.actbio.2009.09.019
   Fujiwara K, 2001, Japanese Patent, Patent No. [01-321164, 01321164]
   Gao C, 2011, CELLULOSE, V18, P1555, DOI 10.1007/s10570-011-9571-6
   Gao CA, 2011, J POROUS MAT, V18, P139, DOI 10.1007/s10934-010-9364-6
   Ge HJ, 2011, APPL BIOCHEM BIOTECH, V165, P1519, DOI 10.1007/s12010-011-9372-2
   George J, 2012, CARBOHYD POLYM, V87, P2031, DOI 10.1016/j.carbpol.2011.10.019
   George J, 2011, INT J BIOL MACROMOL, V48, P50, DOI 10.1016/j.ijbiomac.2010.09.013
   Gimenez J, 2007, J HAZARD MATER, V141, P575, DOI 10.1016/j.jhazmat.2006.07.020
   Gomez H, 2011, J POWER SOURCES, V196, P4102, DOI 10.1016/j.jpowsour.2010.11.002
   Guo J, 2012, CARBOHYD POLYM, V87, P1026, DOI 10.1016/j.carbpol.2011.07.060
   Gusakov AV, 2007, BIOTECHNOL BIOENG, V97, P1028, DOI 10.1002/bit.21329
   Ha JH, 2011, PROCESS BIOCHEM, V46, P1717, DOI 10.1016/j.procbio.2011.05.024
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Hamilton D, 2004, ENCY BIOMATERIALS BI
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345
   Hirai A, 2009, LANGMUIR, V25, P497, DOI 10.1021/la802947m
   Hoenich N, 2006, BIORESOURCES, V1, P270
   HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796
   Hong F, 2011, J CHEM TECHNOL BIOT, V86, P675, DOI 10.1002/jctb.2567
   Hu WL, 2011, SENSOR ACTUAT B-CHEM, V159, P301, DOI 10.1016/j.snb.2011.07.014
   Hu WL, 2011, SENSOR ACTUAT B-CHEM, V157, P554, DOI 10.1016/j.snb.2011.05.021
   Hu WL, 2011, J PHYS CHEM B, V115, P8453, DOI 10.1021/jp204422v
   Hu WL, 2011, CELLULOSE, V18, P655, DOI 10.1007/s10570-011-9520-4
   Hu WL, 2010, MATER SCI ENG B-ADV, V170, P88, DOI 10.1016/j.mseb.2010.02.034
   Hu Y, 2011, J BIOMED MATER RES B, V97B, P114, DOI 10.1002/jbm.b.31792
   Hungund BS, 2010, WORLD J MICROB BIOT, V26, P1823, DOI 10.1007/s11274-010-0363-1
   Hungund BS, 2010, AFR J BIOTECHNOL, V9, P5170
   Iguchi M, 2000, J MATER SCI, V35, P261, DOI 10.1023/A:1004775229149
   Ishihara M, 2002, ENZYME MICROB TECH, V31, P986, DOI 10.1016/S0141-0229(02)00215-6
   Ishkawa A, 1995, BIOSCI BIOTECH BIOCH, V59, P2259
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kadam SR, 2006, PROCESS BIOCHEM, V41, P120, DOI 10.1016/j.procbio.2005.06.007
   Kalashnikova I, 2012, BIOMACROMOLECULES, V13, P267, DOI 10.1021/bm201599j
   Keshk SMAS, 2005, AFR J BIOTECHNOL, V4, P478
   Khomenko V, 2005, ELECTROCHIM ACTA, V50, P2499, DOI 10.1016/j.electacta.2004.10.078
   Kim CW, 2006, POLYMER, V47, P5097, DOI 10.1016/j.polymer.2006.05.033
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kongruang S, 2008, APPL BIOCHEM BIOTECH, V148, P245, DOI 10.1007/s12010-007-8119-6
   Kumagai A, 2011, BIOMACROMOLECULES, V12, P2815, DOI 10.1021/bm2005615
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lee HJ, 2012, CELLULOSE, V19, P1251, DOI 10.1007/s10570-012-9705-5
   Legnani C, 2008, THIN SOLID FILMS, V517, P1016, DOI 10.1016/j.tsf.2008.06.011
   Liang HW, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.34
   Liang Y, 2009, ELECTROCHEM COMMUN, V11, P1018, DOI 10.1016/j.elecom.2009.03.001
   Liao SS, 2003, SPINE, V28, P1954, DOI 10.1097/01.BRS.0000083240.13332.F6
   Lin YK, 2011, J BIOACT COMPAT POL, V26, P508, DOI 10.1177/0883911511415390
   Liu GG, 2011, J MATER CHEM, V21, P10637, DOI 10.1039/c1jm11432h
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002
   Marins JA, 2011, CELLULOSE, V18, P1285, DOI 10.1007/s10570-011-9565-4
   Martinez H, 2012, J BIOMED MATER RES A, V100A, P948, DOI 10.1002/jbm.a.34035
   Martinez-Sanz M, 2012, J APPL POLYM SCI, V124, P1398, DOI 10.1002/app.35052
   Martinez-Sanz M, 2011, CARBOHYD POLYM, V85, P228, DOI 10.1016/j.carbpol.2011.02.021
   Martinez-Sanz M, 2011, CELLULOSE, V18, P335, DOI 10.1007/s10570-010-9471-1
   MASAOKA S, 1993, J FERMENT BIOENG, V75, P18, DOI 10.1016/0922-338X(93)90171-4
   Matsuoka M, 1996, BIOSCI BIOTECH BIOCH, V60, P575, DOI 10.1271/bbb.60.575
   Mikami I, 2003, APPL CATAL B-ENVIRON, V44, P79, DOI 10.1016/S0926-3373(03)00021-3
   Mikkelsen D, 2009, J APPL MICROBIOL, V107, P576, DOI 10.1111/j.1365-2672.2009.04226.x
   Mladenova EK, 2011, ENVIRON SCI POLLUT R, V18, P1633, DOI 10.1007/s11356-011-0529-x
   Mormino R, 2003, APPL MICROBIOL BIOT, V62, P503, DOI 10.1007/s00253-003-1377-5
   Muller D, 2012, CELLULOSE, V19, P1645, DOI 10.1007/s10570-012-9754-9
   Muller D, 2011, SYNTHETIC MET, V161, P106, DOI 10.1016/j.synthmet.2010.11.005
   Murugesan S, 2008, CURR TOP MED CHEM, V8, P80
   Nakayama A, 2004, ADV FUNCT MATER, V14, P1124, DOI 10.1002/adfm.200305197
   Nata IF, 2011, RSC ADV, V1, P625, DOI 10.1039/c1ra00153a
   Nata IF, 2010, GREEN CHEM, V12, P1454, DOI 10.1039/c003479g
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Oliveira GB, 2003, BIOMATERIALS, V24, P4777, DOI 10.1016/S0142-9612(03)00376-4
   Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]
   Olsson RT, 2010, MACROMOLECULES, V43, P4201, DOI 10.1021/ma100217q
   Oshima T, 2008, REACT FUNCT POLYM, V68, P376, DOI 10.1016/j.reactfunctpolym.2007.07.046
   Oshima T, 2011, CARBOHYD POLYM, V83, P953, DOI 10.1016/j.carbpol.2010.09.005
   Padera RF, 2004, BIOMATERIALS SCI, P470
   Peng S, 2012, POLYM BULL, V68, P415, DOI 10.1007/s00289-011-0550-8
   Perepelkin KE, 1997, FIBRE CHEM+, V29, P200, DOI 10.1007/BF02400409
   Pertile RAN, 2012, J BIOMAT SCI-POLYM E, V23, P1339, DOI 10.1163/092050611X581516
   Petersen N, 2011, APPL MICROBIOL BIOT, V91, P1277, DOI 10.1007/s00253-011-3432-y
   Putra A, 2008, POLYMER, V49, P1885, DOI 10.1016/j.polymer.2008.02.022
   Rambo CR, 2008, MAT SCI ENG C-BIO S, V28, P549, DOI 10.1016/j.msec.2007.11.011
   RANBY BG, 1949, ACTA CHEM SCAND, V3, P649, DOI 10.3891/acta.chem.scand.03-0649
   Rani MU, 2011, J APPL POLYM SCI, V120, P2835, DOI 10.1002/app.33307
   Rani MU, 2011, ANN MICROBIOL, V61, P781, DOI 10.1007/s13213-011-0196-7
   Recouvreux DOS, 2011, MAT SCI ENG C-MATER, V31, P151, DOI 10.1016/j.msec.2010.08.004
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Revol J.F., 1997, US, Patent No. [US 5629055 A, 5629055, 5629055A]
   Revol JF, 1998, J PULP PAP SCI, V24, P146
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saikia CN, 1997, WOOD SCI TECHNOL, V31, P467, DOI 10.1007/s002260050053
   Samir MASA, 2004, MACROMOLECULES, V37, P1386, DOI 10.1021/ma030532a
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Sani A, 2010, J CHEM TECHNOL BIOT, V85, P151, DOI 10.1002/jctb.2300
   Shadwick RE, 1999, J EXP BIOL, V202, P3305
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Shen W, 2009, CARBOHYD POLYM, V75, P110, DOI 10.1016/j.carbpol.2008.07.006
   Shoda M, 2005, BIOTECHNOL BIOPROC E, V10, P1, DOI 10.1007/BF02931175
   Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206
   Song HJ, 2009, KOREAN J CHEM ENG, V26, P141, DOI 10.1007/s11814-009-0022-0
   Soykeabkaew N, 2012, COMPOS SCI TECHNOL, V72, P845, DOI 10.1016/j.compscitech.2012.02.015
   SUGIYAMA J, 1985, PLANTA, V166, P161, DOI 10.1007/BF00397343
   Sun D, 2011, TRANS TECH PUBL, P322
   Sun DP, 2010, J ENERG MATER, V28, P85, DOI 10.1080/07370650903222551
   Sun DP, 2007, J WUHAN UNIV TECHNOL, V22, P677, DOI 10.1007/s11595-006-4677-7
   Sun DP, 2010, NANOSCALE, V2, P287, DOI 10.1039/b9nr00158a
   Sun DP, 2010, APPL SURF SCI, V256, P2241, DOI 10.1016/j.apsusc.2009.10.034
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P69
   Surma-Slusarska B, 2008, FIBRES TEXT EAST EUR, V16, P127
   Sutherland IW, 2001, INT DAIRY J, V11, P663, DOI 10.1016/S0958-6946(01)00112-1
   TASHIRO K, 1991, POLYMER, V32, P1516, DOI 10.1016/0032-3861(91)90435-L
   Timko M, 2004, CZECH J PHYS, V54, pD599, DOI 10.1007/s10582-004-0153-9
   Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006
   Vitta S, 2012, CURR SCI INDIA, V102, P1398
   Vitta S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3476058
   Vyjayanthi JP, 2010, WATER ENVIRON RES, V82, P601, DOI 10.2175/106143009X12529484816114
   Wan YZ, 2011, POLYM ADVAN TECHNOL, V22, P2643, DOI 10.1002/pat.1692
   Wan YZ, 2011, SURF COAT TECH, V205, P2938, DOI 10.1016/j.surfcoat.2010.11.006
   Wang HH, 2012, J PHYS CHEM C, V116, P13013, DOI 10.1021/jp301099r
   Wang J, 2010, ACTA BIOMATER, V6, P3004, DOI 10.1016/j.actbio.2010.01.045
   Wang J, 2011, MICRO NANO LETT, V6, P133, DOI 10.1049/mnl.2010.0209
   Wang JP, 2011, J MECH MED BIOL, V11, P285, DOI 10.1142/S0219519411004058
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Wang Y, 2008, CARBOHYD POLYM, V74, P875, DOI 10.1016/j.carbpol.2008.05.007
   Wanichapichart P, 2012, RADIAT PHYS CHEM, V81, P949, DOI 10.1016/j.radphyschem.2012.02.035
   Webster TJ, 2007, ADV BIOCHEM ENG BIOT, V103, P275, DOI 10.1007/10_021
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   White D, 1989, P 10 CELL C
   Williams D. F, 1987, DEF BIOM P CONS C EU, V4
   Wu QJ, 2007, BIOMACROMOLECULES, V8, P3687, DOI 10.1021/bm701061t
   Wu RQ, 2010, CELLULOSE, V17, P399, DOI 10.1007/s10570-009-9388-8
   Wu SQ, 2012, CARBOHYD POLYM, V88, P496, DOI 10.1016/j.carbpol.2011.12.033
   Yang JZ, 2011, J HAZARD MATER, V189, P377, DOI 10.1016/j.jhazmat.2011.02.048
   Yang JZ, 2011, ADV MATER RES-SWITZ, V152-153, P1771, DOI 10.4028/www.scientific.net/AMR.152-153.1771
   Yang JZ, 2009, ELECTROCHIM ACTA, V54, P6300, DOI 10.1016/j.electacta.2009.05.073
   Yang YK, 1998, J FERMENT BIOENG, V85, P312, DOI 10.1016/S0922-338X(97)85681-4
   Yin N, 2011, PROG NAT SCI-MATER, V21, P472, DOI 10.1016/S1002-0071(12)60085-9
   Yin XQ, 2011, POLYM BULL, V67, P401, DOI 10.1007/s00289-010-0388-5
   Yun YS, 2010, MOL CRYST LIQ CRYST, V519, P141, DOI 10.1080/15421401003609897
   ZAAR K, 1979, J CELL BIOL, V80, P773, DOI 10.1083/jcb.80.3.773
   Zhang W, 2011, CARBOHYD POLYM, V86, P1760, DOI 10.1016/j.carbpol.2011.07.015
   Zhang XJ, 2011, SYNTH REACT INORG M, V41, P1141, DOI 10.1080/15533174.2011.591359
   Zhang XJ, 2011, SYNTH REACT INORG M, V41, P997, DOI 10.1080/15533174.2011.591334
   Zhu HX, 2011, CARBOHYD POLYM, V86, P1558, DOI 10.1016/j.carbpol.2011.06.061
   Zimmermann KA, 2011, MAT SCI ENG C-MATER, V31, P43, DOI 10.1016/j.msec.2009.10.007
   Zimmermann T, 2004, ADV ENG MATER, V6, P754, DOI 10.1002/adem.200400097
   Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003
NR 197
TC 89
Z9 94
U1 9
U2 254
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
EI 1572-882X
J9 CELLULOSE
JI Cellulose
PD FEB
PY 2014
VL 21
IS 1
BP 1
EP 30
DI 10.1007/s10570-013-0088-z
PG 30
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA AA0SF
UT WOS:000330807000001
DA 2018-10-19
ER

PT J
AU Mahmoodian, H
   Moradi, O
   Shariatzadeh, B
AF Mahmoodian, Hossein
   Moradi, Omid
   Shariatzadeh, Behnam
TI Grafting chitosan and polyHEMA on carbon nanotubes surfaces: "Grafting
   to" and "Grafting from" methods
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Carbon nanotubes; PolyHEMA; Microwave
ID BIOMEDICAL APPLICATIONS; FUNCTIONALIZATION; POLYMERIZATION; POLYMERS;
   CHITIN; NANOCOMPOSITES; NANOMATERIALS; BIOMATERIAL; CHOLESTEROL;
   BIOSENSORS
AB We report a simple method for engineering chitosan (CS) functionalized multi-walled carbon nanotube (MWCNT) composites with a biomedically important polymer, poly-2-hydroxyethyl methacrylate (polyHEMA), by chemical grafting HEMA monomers via free radical polymerization. Functionalization of CS and polyHEMA occurred in three steps. First, using microwave irradiation, CS was grafted onto the surface and sidewall of the carbon nanotubes. Second, HEMA monomers were grafted onto the polymeric matrix surface. The final step involved free radical polymerization of HEMA monomers. Composite synthesis was confirmed by Fourier transform infrared (FTIR) spectroscopy. Moreover, the presence of polyHEMA on the surface of the CS functionalized carbon nanotubes was confirmed by field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM) and thermo gravimetric analysis (TGA) analyses. Furthermore, in the aqueous phase, our novel composites exhibited higher dispersibility compared with pristine MWCNTs. Considering the biomedical importance of polyHEMA and CS polymers, we expect these materials to be useful in the pharmaceutical industry as novel biomaterial composites with potential applications in drug delivery. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Mahmoodian, Hossein; Moradi, Omid; Shariatzadeh, Behnam] Islamic Azad Univ, Dept Chem, Shahr e Qods Branch, Tehran, Iran.
RP Mahmoodian, H (reprint author), Islamic Azad Univ, Dept Chem, Shahr e Qods Branch, Tehran, Iran.
EM hossein.mahmoodian@gmail.com
CR Abraham S, 2005, BIOMATERIALS, V26, P4767, DOI 10.1016/j.biomaterials.2005.01.031
   AJAYAN PM, 1994, SCIENCE, V265, P1212, DOI 10.1126/science.265.5176.1212
   Bandaru PR, 2007, J NANOSCI NANOTECHNO, V7, P1239, DOI 10.1166/jnn.2007.307
   Baskaran D, 2005, MACROMOL RAPID COMM, V26, P481, DOI 10.1002/marc.200400564
   Cadotte J., 2005, J NEURAL ENG, V2, P114
   CARBONETTO ST, 1982, SCIENCE, V216, P897, DOI 10.1126/science.7079743
   CARENZA M, 1992, RADIAT PHYS CHEM, V39, P485
   Cho JW, 2005, MACROMOL RAPID COMM, V26, P412, DOI 10.1002/marc.200400492
   De Smedt SC, 2000, PHARMACEUT RES, V17, P113, DOI 10.1023/A:1007548826495
   Demirelli K, 1999, POLYM INT, V48, P1244
   Dhand C, 2008, ANAL BIOCHEM, V383, P194, DOI 10.1016/j.ab.2008.08.039
   Ferreira LM, 1998, RADIAT PHYS CHEM, V52, P207, DOI 10.1016/S0969-806X(98)00141-8
   Guldi DM, 2005, ACCOUNTS CHEM RES, V38, P38, DOI 10.1021/ar040222s
   Homenick CM, 2007, POLYM REV, V47, P265, DOI 10.1080/15583720701271237
   Huang WJ, 2002, NANO LETT, V2, P231, DOI [10.1021/nl010083x, 10.1021/n1010083x]
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Kumar NA, 2008, EUR POLYM J, V44, P579, DOI 10.1016/j.eurpolymj.2007.12.009
   Kumar R., 2004, CHEM REV, V104, P6017
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Li JX, 2006, CHEM-EUR J, V12, P3869, DOI 10.1002/chem.200501314
   Lin Y, 2002, J PHYS CHEM B, V106, P1294, DOI 10.1021/jp013501v
   Liu P, 2005, EUR POLYM J, V41, P2693, DOI 10.1016/j.eurpolymj.2005.05.017
   Mahmoodian H., 2013, POLYM COMPOSITES
   Merkoci A, 2005, TRAC-TREND ANAL CHEM, V24, P826, DOI 10.1016/j.trac.2005.03.019
   MONTHEARD JP, 1992, J MACROMOL SCI R M C, VC32, P1, DOI 10.1080/15321799208018377
   Mourya V.K., 2010, ADV MAT LETT, V1, P11, DOI DOI 10.5185/AMLETT.2010.3108
   Ong SY, 2008, BIOMATERIALS, V29, P4323, DOI 10.1016/j.biomaterials.2008.07.034
   Pei XW, 2007, J PHYS CHEM C, V111, P2947, DOI 10.1021/jp0673213
   Punyani S, 2007, J APPL POLYM SCI, V103, P3334, DOI 10.1002/app.25496
   Ramanathan T, 2005, CHEM MATER, V17, P1290, DOI 10.1021/cm048357f
   Riggs JE, 2000, J AM CHEM SOC, V122, P5879, DOI 10.1021/ja9942282
   Riggs JE, 2000, J PHYS CHEM B, V104, P7071, DOI 10.1021/jp0011591
   Roy S, 2006, NANOTECHNOLOGY, V17, pS14, DOI 10.1088/0957-4484/17/4/003
   Sgobba V., 2006, NANOTECHNOLOGY, P329
   Shukla SK, 2013, INT J BIOL MACROMOL, V59, P46, DOI 10.1016/j.ijbiomac.2013.04.043
   Spitalsky Z, 2010, PROG POLYM SCI, V35, P357, DOI 10.1016/j.progpolymsci.2009.09.003
   Srinivasan J, 1999, THEOR CHEM ACC, V101, P426, DOI 10.1007/s002140050460
   Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o
   Trojanowicz M, 2006, TRAC-TREND ANAL CHEM, V25, P480, DOI 10.1016/j.trac.2005.11.008
   Wang CC, 2004, PROG POLYM SCI, V29, P1079, DOI 10.1016/j.progpolymsci.2004.08.001
   Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113
   Wang YB, 2005, CARBON, V43, P1015, DOI 10.1016/j.carbon.2004.11.036
   Yao YL, 2007, ANAL BIOANAL CHEM, V387, P303, DOI 10.1007/s00216-006-0924-1
NR 44
TC 9
Z9 10
U1 3
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD FEB
PY 2014
VL 63
BP 92
EP 97
DI 10.1016/j.ijbiomac.2013.10.030
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 302KQ
UT WOS:000330603800013
PM 24183808
DA 2018-10-19
ER

PT J
AU Yuan, T
   Zhang, L
   Li, KF
   Fan, HS
   Fan, YJ
   Liang, J
   Zhang, XD
AF Yuan, Tun
   Zhang, Li
   Li, Kuifeng
   Fan, Hongsong
   Fan, Yujiang
   Liang, Jie
   Zhang, Xingdong
TI Collagen hydrogel as an immunomodulatory scaffold in cartilage tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cartilage tissue engineering; collagen hydrogel; chondrocyte; MHC;
   lymphocytes reaction
ID MESENCHYMAL STEM-CELLS; IMMUNOLOGICAL-PROPERTIES; IN-VIVO; CHONDROGENIC
   DIFFERENTIATION; ALLOGENEIC CHONDROCYTES; TRANSPLANTATION; DEFECTS;
   REPAIR; HOST; ALLOTRANSPLANTATION
AB A collagen type I hydrogel was constructed and used as the scaffold for cartilage tissue engineering. Neonatal rabbit chondrocytes were seeded into the hydrogel, and the constructs were cultured in vitro for 7, 14, and 28 days. The immunomodulatory effect of the hydrogel on seeded chondrocytes was carefully investigated. The expressions of major histocompatibility complex classes I and II of seeded chondrocytes increased with the time, which indicated that the immunogenicity also increased with the time. Meanwhile, the properly designed collagen type I hydrogel could prompt the chondrogenesis of engineered cartilage. The extracellular matrix (ECM) synthesis ability of seeded chondrocytes and the accumulated ECM in the constructs continuously increased with the culture time. Both the isolation and protection, which come from formed ECM and hydrogel scaffold, can effectively control the adverse immunogenicity of seeded chondrocytes and even help to lessen the immunogenicity of the whole engineered cartilage. As the result, the levels of mixed lymphocyte chondrocyte reactions of seed cells and the constructs decreased gradually. The stimulation on allogeneic lymphocytes of the whole constructs was obviously lower than that of the retrieved cells from the constructs. Therefore, properly designed collagen type I hydrogel can give certain immunogenicity-reducing effects on engineered cartilage based on chondrocytes, and it may be a potential immunomodulatory biomaterial in tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 102B: 337-344, 2014.
C1 [Yuan, Tun; Zhang, Li; Li, Kuifeng; Fan, Hongsong; Fan, Yujiang; Liang, Jie; Zhang, Xingdong] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Liang, J (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, 29 Wangjiang Rd, Chengdu 610064, Peoples R China.
EM Jie_l88@126.com
FU National Natural Science Foundation of China [31100692]; National
   Science & Technology Pillar Program [2012BAI22B01]; National Project 973
   of China [2011CB606201]
FX Contract grant sponsor: National Natural Science Foundation of China;
   contract grant number: 31100692; Contract grant sponsor: National
   Science & Technology Pillar Program; contract grant number:
   2012BAI22B01; Contract grant sponsor: National Project 973 of China;
   contract grant number: 2011CB606201
CR Appleton CTG, 2007, ARTHRITIS RHEUM, V56, P1854, DOI 10.1002/art.22711
   Blakolmer K, 2000, TRANSPLANTATION, V69, P2330, DOI 10.1097/00007890-200006150-00019
   BOLANO L, 1991, ORTHOPEDICS, V14, P987
   Burrage PS, 2006, FRONT BIOSCI, V11, P529, DOI 10.2741/1817
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI [10.1089/ten.teb.2009.0452, 10.1089/ten.TEB.2009.0452]
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Franz S, BIOMATERIALS, V32, P6692
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Jackson D W, 1999, Clin Orthop Relat Res, pS31, DOI 10.1097/00003086-199910001-00005
   Jamali AA, 2005, CLIN ORTHOP RELAT R, P176, DOI 10.1097/01.blo.0000165854.15579.85
   Kim BS, 2004, BIOTECHNOL LETT, V26, P709, DOI 10.1023/B:BILE.0000024093.94151.d8
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Liu H, 2006, J IMMUNOL, V176, P2864, DOI 10.4049/jimmunol.176.5.2864
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Masuoka K, 2005, J BIOMED MATER RES B, V75B, P177, DOI 10.1002/jbm.b.30284
   Mohty M, 2008, CYTOKINE GROWTH F R, V19, P53, DOI 10.1016/j.cytogfr.2007.10.010
   Moskalewski S, 2002, MICROSC RES TECHNIQ, V58, P3, DOI 10.1002/jemt.10110
   Moskalewski S, 2005, ARCH IMMUNOL THER EX, V53, P159
   NIEBAUER GW, 1988, AM J VET RES, V49, P1223
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Revell CM, 2009, TISSUE ENG PART B-RE, V15, P1, DOI 10.1089/ten.teb.2008.0189
   Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003
   Sundelacruz S, 2009, SEMIN CELL DEV BIOL, V20, P646, DOI 10.1016/j.semcdb.2009.03.017
   Swearingen B, 2008, TRANSPLANTATION, V86, P627, DOI 10.1097/TP.0b013e318184ca6a
   Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9
   Watschinger B, 1999, NEPHROL DIAL TRANSPL, V14, P8, DOI 10.1093/ndt/14.1.8
   Whitaker IS, 2008, J PLAST RECONSTR AES, V61, P481, DOI 10.1016/j.bjps.2007.11.019
   Yuan T, 2011, J BIOMED MATER RES A, V98A, P332, DOI 10.1002/jbm.a.33121
   Yuan T, 2011, BIOMATERIALS, V32, P6017, DOI 10.1016/j.biomaterials.2011.04.041
   Yuan T, 2010, BIOTECHNOL PROGR, V26, P1749, DOI 10.1002/btpr.484
   Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588
   Zheng L, 2009, TISSUE ENG PT A, V15, P2145, DOI 10.1089/ten.tea.2008.0268
NR 35
TC 40
Z9 43
U1 11
U2 64
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2014
VL 102
IS 2
BP 337
EP 344
DI 10.1002/jbm.b.33011
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 302XW
UT WOS:000330639400016
PM 24000202
DA 2018-10-19
ER

PT J
AU Zhu, L
   Qin, JM
   Yin, XQ
   Ji, L
   Lin, Q
   Qin, ZY
AF Zhu, Li
   Qin, Jinmin
   Yin, Xueqiong
   Ji, Li
   Lin, Qiang
   Qin, Ziyu
TI Direct sulfation of bacterial cellulose with a ClSO3H/DMF complex and
   structure characterization of the sulfates
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article
DE bacterial cellulose; sulfation; ClSO3H; DMF complex
ID IONIC LIQUIDS; ANTICOAGULATION ACTIVITY; MEDICAL APPLICATIONS; MICROBIAL
   CELLULOSE; POLYSACCHARIDES; POLYMERIZATION; DERIVATIZATION; CHLORIDE
AB Bacterial cellulose (BC) is a form of cellulose synthesized by microorganisms, which has unique structure properties and differs from plant cellulose. Up to now, chemical modification of BC has not been studied widely. This paper aims to prepare sodium bacterial cellulose sulfate (SBS) in N,N-dimethylformamide (DMF) with a ClSO3H/DMF complex as the sulfating agent. SBSs with diverse degree of sulfation (DS, 0.04-0.86) were synthesized. The system could change from heterogeneous to homogeneous during the sulfation. Regarding to the DS, the optimal ClSO3H amount and reaction time were 6 mol/mol anhydroglucose unit and 4 h, respectively. DS increased a little when increasing the temperature, while the yield decreased significantly. SBSs with DS>0.24 were soluble in deionized water. Carbon nuclear magnetic resonance spectroscopy revealed that the sulfation prefers to take place in the order of C-6>C-2>C-3. The X-ray diffraction profiles indicated that the crystalline structure of BC was destroyed during sulfation. BC has better reactivity than microcrystalline cellulose in both sulfation and depolymerization processes. SBS is a potential biomaterial. However, BC depolymerized obviously in present sulfation, which forbids application of SBS in material. Moisture of the reaction mixture should be removed as completely as possible to guarantee efficient sulfation and decrease depolymerization. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Zhu, Li; Qin, Jinmin; Yin, Xueqiong; Ji, Li; Qin, Ziyu] Hainan Univ, Hainan Prov Fine Chem Engn Res Ctr, Haikou 570228, Hainan, Peoples R China.
   [Lin, Qiang] Hainan Normal Univ, Minist Educ, Key Lab Trop Med Plant Chem, Haikou 571158, Hainan Province, Peoples R China.
RP Yin, XQ (reprint author), Hainan Univ, Sch Mat & Chem Engn, Haikou 570228, Hainan, Peoples R China.
EM yxq88@hotmail.com
FU National Science Foundation of China [21264007]; Special Project of
   Hainan Social Development [2012SF019]
FX The authors acknowledge the National Science Foundation of China
   (Project No. 21264007), and the Special Project of Hainan Social
   Development (2012SF019) for the financial support.
CR Baumann H, 2000, MACROMOL CHEM PHYSIC, V201, P1950, DOI 10.1002/1521-3935(20001001)201:15<1950::AID-MACP1950>3.0.CO;2-3
   Cai Z, 2010, CELLULOSE, V17, P83, DOI 10.1007/s10570-009-9362-5
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Cheng KC, 2009, CELLULOSE, V16, P1033, DOI 10.1007/s10570-009-9346-5
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2004, CELLULOSE, V11, P403, DOI 10.1023/B:CELL.0000046412.11983.61
   Gericke M, 2012, MOLECULES, V17, P7458, DOI 10.3390/molecules17067458
   Gericke M, 2009, MACROMOL BIOSCI, V9, P343, DOI 10.1002/mabi.200800329
   GEYER U, 1994, INT J BIOL MACROMOL, V16, P343, DOI 10.1016/0141-8130(94)90067-1
   Groth T, 2001, BIOMATERIALS, V22, P2719, DOI 10.1016/S0142-9612(01)00013-8
   Heinze T, 2003, CELLULOSE, V10, P283, DOI 10.1023/A:1025117327970
   Heinze T., 2006, ESTERIFICATION POLYS
   Heinze T, 2010, POLYM SCI TECHNOL SE, P213
   Hoenich N, 2006, BIORESOURCES, V1, P270
   Ifuku S, 2007, BIOMACROMOLECULES, V8, P1973, DOI 10.1021/bm070113b
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Kim HS, 2008, SMART MATER STRUCT, V17, DOI 10.1088/0964-1726/17/01/015029
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D., 1998, COMPREHENSIVE CELLUL, VI
   Liebert T., 2010, CELLULOSE SOLVENTS A, V1033, P3, DOI DOI 10.1021/BK-2010-1033
   MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010
   Oshima T, 2008, REACT FUNCT POLYM, V68, P376, DOI 10.1016/j.reactfunctpolym.2007.07.046
   Philipp B, 1983, CELL CHEM TECHNOL, V17, P443
   Qin Z., CARBOHYDR P IN PRESS, DOI [10.1016/j.carbpol.2013.09.068, DOI 10.1016/J.CARBP0L.2013.09.068]
   Retegi A, 2010, CELLULOSE, V17, P661, DOI 10.1007/s10570-009-9389-7
   Richter R., 2003, CELLULOSE, V10, P133
   Roy D, 2009, CHEM SOC REV, V38, P2046, DOI 10.1039/b808639g
   Saake B, 2002, CARBOHYD POLYM, V48, P7, DOI 10.1016/S0144-8617(01)00191-6
   Schlufter K, 2006, MACROMOL RAPID COMM, V27, P1670, DOI 10.1002/marc.200600463
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tabuchi M, 1998, BIOSCI BIOTECH BIOCH, V62, P1451, DOI 10.1271/bbb.62.1451
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Wang Y, 2008, CARBOHYD POLYM, V74, P875, DOI 10.1016/j.carbpol.2008.05.007
   Wang ZM, 2007, INT J BIOL MACROMOL, V41, P376, DOI 10.1016/j.ijbiomac.2007.05.007
   Wang ZM, 2009, BIORESOURCE TECHNOL, V100, P1687, DOI 10.1016/j.biortech.2008.09.002
   Yao SJ, 2000, CHEM ENG J, V78, P199, DOI 10.1016/S1385-8947(00)00131-5
   Yin XQ, 2011, POLYM BULL, V67, P401, DOI 10.1007/s00289-010-0388-5
   Yu C., 2010, P 7 NAT C CHIN FUNCT, V1-3, P1339
   Zhang K, 2011, CARBOHYD POLYM, V83, P1659, DOI 10.1016/j.carbpol.2010.10.029
   Zhang K, 2011, POLYMER, V52, P26, DOI 10.1016/j.polymer.2010.11.017
   Zhang K, 2010, CELLULOSE, V17, P427, DOI 10.1007/s10570-009-9375-0
   Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c
NR 42
TC 5
Z9 5
U1 0
U2 45
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1042-7147
EI 1099-1581
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD FEB
PY 2014
VL 25
IS 2
BP 168
EP 172
DI 10.1002/pat.3218
PG 5
WC Polymer Science
SC Polymer Science
GA AA0PW
UT WOS:000330799100004
DA 2018-10-19
ER

PT J
AU Plotkin, M
   Vaibavi, SR
   Rufaihah, AJ
   Nithya, V
   Wang, J
   Shachaf, Y
   Kofidis, T
   Seliktar, D
AF Plotkin, Marian
   Vaibavi, Srirangam Ramanujam
   Rufaihah, Abdul Jalil
   Nithya, Venkateswaran
   Wang, Jing
   Shachaf, Yonatan
   Kofidis, Theo
   Seliktar, Dror
TI The effect of matrix stiffness of injectable hydrogels on the
   preservation of cardiac function after a heart attack
SO BIOMATERIALS
LA English
DT Article
DE Injectable hydrogel; Myocardial infarction; Minimally invasive;
   Mechanical properties; Matrix modulus
ID STEM-CELL TRANSPLANTATION; MYOCARDIAL-INFARCTION; TISSUE; FIBRIN;
   SCAFFOLDS; REPAIR; STABILIZATION; REGENERATION; PROTEOLYSIS; INJECTION
AB This study compares the effect of four injectable hydrogels with different mechanical properties on the post-myocardial infarction left ventricle (LV) remodeling process. The bioactive hydrogels were synthesized from Tetronic-fibrinogen (TF) and PEG fibrinogen (PF) conjugates; each hydrogel was supplemented with two levels of additional cross-linker to increase the matrix stiffness as measured by the shear storage modulus (G'). Infarcts created by ligating the left anterior descending coronary artery in a rodent model were treated with the hydrogels, and all four treatment groups showed an increase in wall thickness, arterial density, and viable cardiac tissue in the pen-infarct areas of the LV. Echocardiography and hemodynamics data of the PF/TF treated groups showed significant improvement of heart function associated with the attenuated effects of the remodeling process. Multi-factorial regression analysis indicated that the group with the highest modulus exhibited the best rescue of heart function and highest neovascularization. The results of this study demonstrate that multiple properties of an injectable bioactive biomaterial, and notably the matrix stiffness, provide the multifaceted stimulation necessary to preserve cardiac function and prevent adverse remodeling following a heart attack. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Plotkin, Marian; Vaibavi, Srirangam Ramanujam; Seliktar, Dror] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
   [Rufaihah, Abdul Jalil; Nithya, Venkateswaran; Wang, Jing; Kofidis, Theo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore 117595, Singapore.
   [Shachaf, Yonatan; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   [Kofidis, Theo] Natl Univ Heart Ctr Singapore, Dept Cardiac Thorac &Vasc Surg, Natl Univ Hlth Syst, Singapore 117548, Singapore.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM surtk@nus.edu.sg; dror@bm.technion.ac.il
RI Kofidis, Theodoros/B-9283-2011; Abdul Jalil, Rufaihah/A-4572-2012
OI Kofidis, Theodoros/0000-0002-9623-6450; Abdul Jalil,
   Rufaihah/0000-0002-9764-8668; Seliktar, Dror/0000-0001-6964-8567
FU National Research Foundation (NRF)-Technion-NUS Grant for Regenerative
   Medicine Initiative in Cardiac Restoration Therapy
FX The authors would like to acknowledge funding support from National
   Research Foundation (NRF)-Technion-NUS Grant for Regenerative Medicine
   Initiative in Cardiac Restoration Therapy.
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Barsotti MC, 2011, BIOTECHNOL APPL BIOC, V58, P301, DOI 10.1002/bab.49
   Bastings MMC, 2014, ADV HEALTHC MATER, V3, P70, DOI 10.1002/adhm.201300076
   Burdick JA, 2013, SCI TRANSL MED, V5
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Di Napoli P, 2003, AM HEART J, V146, P1105, DOI 10.1016/S0002-8703(03)00445-9
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Elbert DL, 2001, BIOMACROMOLECULES, V2, P430, DOI 10.1021/bm0056299
   Grover GN, 2013, ADV MATER, V25, P2937, DOI 10.1002/adma.201205234
   Habib M, 2011, BIOMATERIALS, V32, P7514, DOI 10.1016/j.biomaterials.2011.06.049
   Herrick S, 1999, INT J BIOCHEM CELL B, V31, P741, DOI 10.1016/S1357-2725(99)00032-1
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Johnson TD, 2013, EXPERT OPIN DRUG DEL, V10, P59, DOI 10.1517/17425247.2013.739156
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kofidis T., 2006, ALTERNATIVE CARDIAC
   Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lin Y.D., 2012, SCI TRANSL MED, V4
   Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Pashuck ET, 2012, SCI TRANS MED, V4, p160sr4
   Rane AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021571
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Tous E, 2011, BIOMACROMOLECULES, V12, P4127, DOI 10.1021/bm201198x
   Tous E, 2011, J CARDIOVASC TRANSL, V4, P528, DOI 10.1007/s12265-011-9291-1
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Weytjens C, 2006, EUR J ECHOCARDIOGR, V7, P411, DOI 10.1016/j.euje.2006.03.009
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Ye ZY, 2011, ADV DRUG DELIVER REV, V63, P688, DOI 10.1016/j.addr.2011.02.007
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zhu JM, 2011, EXPERT REV MED DEVIC, V8, P607, DOI [10.1586/ERD.11.27, 10.1586/erd.11.27]
NR 44
TC 32
Z9 34
U1 1
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 5
BP 1429
EP 1438
DI 10.1016/j.biomaterials.2013.10.058
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 295ZY
UT WOS:000330156100009
PM 24268664
DA 2018-10-19
ER

PT J
AU Fan, MR
   Gong, M
   Da, LC
   Bai, L
   Li, XQ
   Chen, KF
   Li-Ling, J
   Yang, ZM
   Xie, HQ
AF Fan, Mei-Rong
   Gong, Mei
   Da, Lin-Cui
   Bai, Lin
   Li, Xiu-Qun
   Chen, Ke-Fei
   Li-Ling, Jesse
   Yang, Zhi-Ming
   Xie, Hui-Qi
TI Tissue engineered esophagus scaffold constructed with porcine small
   intestinal submucosa and synthetic polymers
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE esophagus; tissue engineering; small intestinal mucosa; SIS; PHBHHx;
   PLGA
ID MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; CANINE
   MODEL; STEM-CELLS; IN-VIVO; REPAIR; REPLACEMENT;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE); GRAFTS
AB Acellular porcine small intestinal submucosa (SIS) has been successfully used for reconstructing esophagus with half circumferential defects. However, repairing full circumferential esophageal defects with SIS has been restricted due to the latter's poor mechanical properties. In the present study, synthetic polyesters biomaterial poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) and poly(lactide-co-glycolide) (PLGA) have been used to improve the mechanical properties of SIS. Feasibility of SIS/PHBHHx-PLGA composite material scaffold for esophageal tissue engineering has been assessed through a series of testing. The appropriate mixing ratio of PHBHHx and PLGA polymers has been determined as 5: 5 by mechanical testing and in vitro degradation experiment. The morphology of constructed membranous and tubular scaffolds was also characterized. As confirmed by enzyme-linked immunosorbent assay, the contents of VEGF and TGF-beta have respectively reached 657 +/- 18 ng mL(-1) and 130 +/- 4 pg mL(-1) within the SIS/PHBHHx-PLGA specimens. Biocompatibility of the SIS/PHBHHx-PLGA specimens with rat bone marrow mesenchymal stem cells (MSCs) was also evaluated by scanning electron microscopy and a live-dead cell viability assay. Actin filaments of MSCs on the composite materials were labeled. Biological safety of the extract from SIS/PHBHHx-PLGA specimens, measured as hemolysis rate, was all lower than 5%. Compared with SIS and SIS/PHBHHx-PLGA specimens, inflammatory reaction provoked by the PHBHHx-PLGA specimens in rats was however more severe. Our results have suggested that SIS/PHBHHx-PLGA composite material can offer a new approach for esophageal tissue engineering.
C1 [Fan, Mei-Rong; Yang, Zhi-Ming; Xie, Hui-Qi] Sichuan Univ, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610064, Peoples R China.
   [Gong, Mei; Da, Lin-Cui; Bai, Lin; Li, Xiu-Qun; Chen, Ke-Fei; Xie, Hui-Qi] Sichuan Univ, West China Hosp, Regenerat Med Res Ctr, Chengdu 610064, Peoples R China.
   [Li-Ling, Jesse] Sichuan Univ, State Key Lab Biotherapy, Inst Dis Genom & Bioinformat, Chengdu 610064, Peoples R China.
   [Li-Ling, Jesse] Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Peoples R China.
RP Xie, HQ (reprint author), Sichuan Univ, State Key Lab Biotherapy, Lab Stem Cell & Tissue Engn, Chengdu 610064, Peoples R China.
EM xiehuiqi@scu.edu.cn
FU National Natural Science Foundation of China [31271058, 81100327];
   National High Technology Research and Development Program of China
   [2012AA020503]
FX This work was jointly supported by the National Natural Science
   Foundation of China (31271058, 81100327) and the National High
   Technology Research and Development Program of China (2012AA020503).
CR Badylak S, 2000, J PEDIATR SURG, V35, P1097, DOI 10.1053/jpsu.2000.7834
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Bhrany AD, 2006, TISSUE ENG, V12, P319, DOI 10.1089/ten.2006.12.319
   BOSTMAN OM, 1991, J BONE JOINT SURG AM, V73A, P148
   Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Cheng ML, 2011, POLYMER, V52, P1391, DOI 10.1016/j.polymer.2011.01.039
   D'Journo XB, 2008, DIS ESOPHAGUS, V21, P377, DOI 10.1111/j.1442-2050.2008.00849.x
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Doede T, 2009, ARTIF ORGANS, V33, P328, DOI 10.1111/j.1525-1594.2009.00727.x
   Doki Y, 2008, DIS ESOPHAGUS, V21, P132, DOI 10.1111/j.1442-2050.2007.00738.x
   Ferahkose Z, 2008, DIS ESOPHAGUS, V21, P340, DOI 10.1111/j.1442-2050.2007.00781.x
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Gallo A, 2006, WORLD J GASTROENTERO, V12, P3237, DOI 10.3748/wjg.v12.i20.3237
   Gaujoux S, 2010, SURGERY, V148, P39, DOI 10.1016/j.surg.2009.12.002
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hurst RE, 2001, J BIOMAT SCI-POLYM E, V12, P1267, DOI 10.1163/156856201753395798
   ISO, 2002, 109934 ISO
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Li XT, 2008, J BIOMED MATER RES A, V87A, P832, DOI 10.1002/jbm.a.31890
   Lopes MF, 2006, J INVEST SURG, V19, P105, DOI 10.1080/08941930600569621
   Luo JC, 2011, BIOMATERIALS, V32, P706, DOI 10.1016/j.biomaterials.2010.09.017
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Miki H, 1999, ASAIO J, V45, P502, DOI 10.1097/00002480-199909000-00025
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Nakase Y, 2008, J THORAC CARDIOV SUR, V136, P850, DOI 10.1016/j.jtcvs.2008.05.027
   Prokop A, 2008, J PHARM SCI-US, V97, P3518, DOI 10.1002/jps.21270
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Saxena AK, 2010, EUR SURG, V42, P309, DOI 10.1007/s10353-010-0579-1
   Saxena AK, 2009, J PEDIATR SURG, V44, P896, DOI 10.1016/j.jpedsurg.2009.01.019
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Tan B, 2013, J SURG RES, V182, P40, DOI 10.1016/j.jss.2012.07.054
   Tan JY, 2012, BIOTECHNOL BIOENG, V109, P1, DOI 10.1002/bit.23323
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Wei RQ, 2009, EXP BIOL MED, V234, P453, DOI 10.3181/0901-RM-5
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
   Yu BY, 2008, DESALINATION, V234, P204, DOI 10.1016/j.desal.2007.09.087
   Yu XJ, 2012, J MATER SCI-MATER M, V23, P581, DOI 10.1007/s10856-011-4475-4
   Zani A, 2009, SEMIN PEDIATR SURG, V18, P57, DOI 10.1053/j.sempedsurg.2008.10.011
   Zhang F, 2003, PLAST RECONSTR SURG, V112, P565, DOI 10.1097/01.PRS.0000070966.74429.03
   Zhu Y B, 2012, J TISSUE SCI ENG, V3, P2
NR 43
TC 12
Z9 14
U1 4
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2014
VL 9
IS 1
AR 015012
DI 10.1088/1748-6041/9/1/015012
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296OU
UT WOS:000330195300015
PM 24457267
DA 2018-10-19
ER

PT J
AU Kumar, VA
   Martinez, AW
   Caves, JM
   Naik, N
   Haller, CA
   Chaikof, EL
AF Kumar, Vivek A.
   Martinez, Adam W.
   Caves, Jeffrey M.
   Naik, Nisarga
   Haller, Carolyn A.
   Chaikof, Elliot L.
TI Microablation of collagen-based substrates for soft tissue engineering
SO BIOMEDICAL MATERIALS
LA English
DT Article
DE tissue engineering; excimer laser; mesenchymal stem cells; collagen;
   elastin
ID EXCIMER-LASER ABLATION; PROTEIN POLYMER; MECHANICAL-PROPERTIES; VASCULAR
   GRAFTS; SYNTHETIC COLLAGEN; SCAFFOLDS; FIBER; COMPOSITES; NANOFIBERS;
   RESPONSES
AB Noting the abundance and importance of collagen as a biomaterial, we have developed a facile method for the production of a dense fibrillar extracellular matrix mimicking collagen-elastin hybrids with tunable mechanical properties. Through the use of excimer-laser technology, we have optimized conditions for the ablation of collagen lamellae without denaturation of protein, maintenance of fibrillar ultrastructure and preservation of native D-periodicity. Strengths of collagen-elastin hybrids ranged from 0.6 to 13 MPa, elongation at break from 9 to 70% and stiffness from 2.9 to 94 MPa, allowing for the design of a wide variety of tissue specific scaffolds. Further, large (centimeter scale) lamellae can be fabricated and embedded with recombinant elastin to generate collagen-elastin hybrids. Exposed collagen in hybrids act as cell adhesive sites for rat mesenchymal stem cells that conform to ablate waveforms. The ability to modulate these features allows for the generation of a class of biopolymers that can architecturally and physiologically replicate native tissue.
C1 [Kumar, Vivek A.; Caves, Jeffrey M.; Naik, Nisarga; Haller, Carolyn A.; Chaikof, Elliot L.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
   [Kumar, Vivek A.; Caves, Jeffrey M.; Naik, Nisarga; Haller, Carolyn A.; Chaikof, Elliot L.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA.
   [Kumar, Vivek A.; Martinez, Adam W.; Chaikof, Elliot L.] Emory Univ, Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Kumar, VA (reprint author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg, Boston, MA 02215 USA.
EM echaikof@bidmc.harvard.edu
OI Kumar, Vivek/0000-0001-7536-9281
FU National Institute of Health [R01HL083867, R01HL60464, R01HL71336]
FX This work was supported by grants from the National Institute of Health:
   R01HL083867, R01HL60464, and R01HL71336. Electron microscopy was
   performed at the Center for Nanoscale Systems at Harvard University, and
   the Wyss Institute of Biologically Inspired Design. The authors have no
   conflicts of interest to disclose.
CR Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Caves JM, 2010, BIOMATERIALS, V31, P7175, DOI 10.1016/j.biomaterials.2010.05.014
   Caves JM, 2010, ADV MATER, V22, P2041, DOI 10.1002/adma.200903612
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chollet C, 2010, COLLOID SURFACE B, V75, P107, DOI 10.1016/j.colsurfb.2009.08.024
   Dahlin RL, 2011, TISSUE ENG PART B-RE, V17, P349, DOI [10.1089/ten.teb.2011.0238, 10.1089/ten.TEB.2011.0238]
   Elbischger PJ, 2005, ST HEAL T, V113, P97
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   GLOSSOP ND, 1995, CLIN ORTHOP RELAT R, P72
   Hoshiba T, 2010, EXPERT OPIN BIOL TH, V10, P1717, DOI 10.1517/14712598.2010.534079
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Krueger RR, 2010, J REFRACT SURG, V26, P749, DOI 10.3928/1081597X-20100921-01
   Kumar VA, 2013, BIOMATER SCI-UK, V1, P1193, DOI [10.1039/c3bm60129c, 10.1039/C3BM60129C]
   Kumar VA, 2013, ACTA BIOMATER, V9, P8067, DOI 10.1016/j.actbio.2013.05.024
   Kurane A, 2007, BIOMATERIALS, V28, P2830, DOI 10.1016/j.biomaterials.2007.02.031
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lapolla W, 2011, J AM ACAD DERMATOL, V64, P936, DOI 10.1016/j.jaad.2009.12.054
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   LITVACK F, 1988, AM J CARDIOL, V61, pG81, DOI 10.1016/S0002-9149(88)80038-9
   Matsuda T, 1994, ASAIO J, V40, pM594, DOI 10.1097/00002480-199407000-00068
   Nakayama Y, 1994, ASAIO J, V40, pM590, DOI 10.1097/00002480-199407000-00067
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   PULIAFITO CA, 1985, OPHTHALMOLOGY, V92, P741
   Ravi S, 2013, J BIOMED MATER RES A, V101, P1915, DOI 10.1002/jbm.a.34484
   Ravi S, 2012, BIOMATERIALS, V33, P2431, DOI 10.1016/j.biomaterials.2011.11.055
   Ravi S, 2012, ACTA BIOMATER, V8, P627, DOI 10.1016/j.actbio.2011.10.027
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   Sallach RE, 2009, J BIOMAT SCI-POLYM E, V20, P1629, DOI 10.1163/156856208X386228
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Tandon N, 2010, LAB CHIP, V10, P692, DOI 10.1039/b917743d
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Vacanti JP, 1999, LANCET S1, V354, pSI32
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Webb AR, 2004, EXPERT OPIN BIOL TH, V4, P801, DOI 10.1517/14712598.4.6.801
   Wu XY, 2008, BIOMACROMOLECULES, V9, P1787, DOI 10.1021/bm800012x
   Wu XY, 2005, BIOMACROMOLECULES, V6, P3037, DOI 10.1021/bm0503468
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zorlutuna P, 2009, BIOMACROMOLECULES, V10, P814, DOI 10.1021/bm801307y
NR 43
TC 3
Z9 3
U1 0
U2 31
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD FEB
PY 2014
VL 9
IS 1
AR 011002
DI 10.1088/1748-6041/9/1/011002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 296OU
UT WOS:000330195300003
PM 24457193
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Vanhercke, T
   El Tahchy, A
   Liu, Q
   Zhou, XR
   Shrestha, P
   Divi, UK
   Ral, JP
   Mansour, MP
   Nichols, PD
   James, CN
   Horn, PJ
   Chapman, KD
   Beaudoin, F
   Ruiz-Lopez, N
   Larkin, PJ
   de Feyter, RC
   Singh, SP
   Petrie, JR
AF Vanhercke, Thomas
   El Tahchy, Anna
   Liu, Qing
   Zhou, Xue-Rong
   Shrestha, Pushkar
   Divi, Uday K.
   Ral, Jean-Philippe
   Mansour, Maged P.
   Nichols, Peter D.
   James, Christopher N.
   Horn, Patrick J.
   Chapman, Kent D.
   Beaudoin, Frederic
   Ruiz-Lopez, Noemi
   Larkin, Philip J.
   de Feyter, Robert C.
   Singh, Surinder P.
   Petrie, James R.
TI Metabolic engineering of biomass for high energy density: oilseed-like
   triacylglycerol yields from plant leaves
SO PLANT BIOTECHNOLOGY JOURNAL
LA English
DT Article
DE triacylglycerol; Nicotiana tabacum; leaf; WRI1; DGAT1; oleosin
ID FATTY-ACID BIOSYNTHESIS; ARABIDOPSIS; ACCUMULATION; LIPIDS; OIL;
   EXPRESSION; CARBOXYLASE; TOBACCO; GENES
AB High biomass crops have recently attracted significant attention as an alternative platform for the renewable production of high energy storage lipids such as triacylglycerol (TAG). While TAG typically accumulates in seeds as storage compounds fuelling subsequent germination, levels in vegetative tissues are generally low. Here, we report the accumulation of more than 15% TAG (17.7% total lipids) by dry weight in Nicotiana tabacum (tobacco) leaves by the co-expression of three genes involved in different aspects of TAG production without severely impacting plant development. These yields far exceed the levels found in wild-type leaf tissue as well as previously reported engineered TAG yields in vegetative tissues of Arabidopsis thaliana and N.tabacum. When translated to a high biomass crop, the current levels would translate to an oil yield per hectare that exceeds those of most cultivated oilseed crops. Confocal fluorescence microscopy and mass spectrometry imaging confirmed the accumulation of TAG within leaf mesophyll cells. In addition, we explored the applicability of several existing oil-processing methods using fresh leaf tissue. Our results demonstrate the technical feasibility of a vegetative plant oil production platform and provide for a step change in the bioenergy landscape, opening new prospects for sustainable food, high energy forage, biofuel and biomaterial applications.
C1 [Vanhercke, Thomas; El Tahchy, Anna; Liu, Qing; Shrestha, Pushkar; Divi, Uday K.; Ral, Jean-Philippe; Singh, Surinder P.; Petrie, James R.] CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia.
   [Zhou, Xue-Rong] CSIRO Plant Ind, Canberra, ACT, Australia.
   [Mansour, Maged P.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia.
   [James, Christopher N.; Horn, Patrick J.; Chapman, Kent D.; Beaudoin, Frederic] Univ N Texas, Ctr Plant Lipid Res, Dept Biol Sci, Denton, TX 76203 USA.
   [Beaudoin, Frederic; Larkin, Philip J.] Rothamsted Res, Dept Biol Chem, Harpenden, Herts, England.
RP Petrie, JR (reprint author), CSIRO, Food Futures Natl Res Flagship, Canberra, ACT, Australia.
EM James.Petrie@csiro.au
RI Divi, Uday/H-8010-2012; singh, surinder/C-9528-2009; Larkin,
   Philip/A-9468-2008; Liu, Qing/A-1395-2010; Vanhercke,
   Thomas/B-6647-2011; Shrestha, Pushkar/A-2728-2010; Ruiz-Lopez,
   Noemi/C-5895-2008; Divi, Uday/P-2581-2017; El tahchy, Anna/B-6997-2012;
   Zhou, Xue-Rong/D-4706-2009; Nichols, Peter/C-5128-2011
OI singh, surinder/0000-0003-4488-8147; Larkin, Philip/0000-0002-2608-1924;
   Liu, Qing/0000-0001-6617-6859; Vanhercke, Thomas/0000-0003-1397-7622;
   Shrestha, Pushkar/0000-0001-9642-6636; Ruiz-Lopez,
   Noemi/0000-0002-2169-0210; Divi, Uday/0000-0003-0905-7567; Zhou,
   Xue-Rong/0000-0003-3717-2984; Horn, Patrick/0000-0002-1057-4708
FU U.S. Department of Energy, BER Division [DE-FG02-09ER64812]; Hoblitzelle
   Foundation; US National Science Foundation [112605]; Biotechnology and
   Biological Sciences Research Council [BBS/E/C/00005207]
FX We would like to thank Nathalie Niesner, Anne Mackenzie, Dawar Hussain,
   Anna Mechanicos, Cheryl Blundell, Luch Hac, Alex Miller, Lina Ma, Lijun
   Tian and Jeni Pritchard for technical assistance. We also thank Dr
   Damien Callahan at Metabolomics Australia, University of Melbourne and
   Dr. Matt Taylor at CSIRO Ecosystem Sciences for assistance with LC-MS,
   Dr. Rosemary White for help with microscopy and Dr. Allan Green for
   helpful discussions and advice. This work was funded by the CSIRO Food
   Futures National Research Flagship, CSIRO Plant Industry and the CSIRO
   Office of the Chief Executive Postdoctoral Fellowship Scheme. LC-MS
   analysis was supported by Bioplatforms Australia Services. Research in
   the UNT Center for Plant Research on oil accumulation in leaves is
   supported by a grant from the U.S. Department of Energy, BER Division,
   DE-FG02-09ER64812. Acquisition of the imaging instruments at UNT was
   made possible, in part, by grants from the Hoblitzelle Foundation and
   the US National Science Foundation (MRI#112605).
CR Andrianov V, 2010, PLANT BIOTECHNOL J, V8, P277, DOI 10.1111/j.1467-7652.2009.00458.x
   Bouvier-Nave P, 2000, EUR J BIOCHEM, V267, P85, DOI 10.1046/j.1432-1327.2000.00961.x
   Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032
   Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x
   Chapman KD, 2013, PLANT SCI, V207, P128, DOI 10.1016/j.plantsci.2013.03.003
   Corrado F., 2008, Mutagenized tobacco plant as seed culture for the production of oil for energetic, industrial and alimentary uses, Patent No. [WO 2008110876, 2008110876, WO/2008/110876]
   CORUZZI G, 1984, EMBO J, V3, P1671, DOI 10.1002/j.1460-2075.1984.tb02031.x
   Dyer J, 2012, INFORM, V23, P193
   FAO, 2003, WORLD AGR 2015 2030
   Fogher C, 2011, INFORM, V22, P631
   Gigliotti JC, 2011, FOOD CHEM, V125, P1028, DOI 10.1016/j.foodchem.2010.10.013
   Guelette BS, 2012, J EXP BOT, V63, P3603, DOI 10.1093/jxb/ers028
   Horn PJ, 2012, PLANT CELL, V24, P622, DOI 10.1105/tpc.111.094581
   HORSCH RB, 1985, SCIENCE, V227, P1229
   James CN, 2010, P NATL ACAD SCI USA, V107, P17833, DOI 10.1073/pnas.0911359107
   Kelly AA, 2013, PLANT PHYSIOL, V162, P1282, DOI 10.1104/pp.113.219840
   Klaus D, 2004, PLANTA, V219, P389, DOI 10.1007/s00425-004-1236-3
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mendoza MS, 2005, FEBS LETT, V579, P4666, DOI 10.1016/j.febslet.2005.07.037
   Mu JY, 2008, PLANT PHYSIOL, V148, P1042, DOI 10.1104/pp.108.126342
   Ohlrogge J., 2011, BIOCHEM, V33, P34
   Petrie J., 2012, PLOS ONE, V7
   Rogalski M, 2011, PLANT BIOTECHNOL J, V9, P554, DOI 10.1111/j.1467-7652.2011.00621.x
   Sanjaya, 2013, PLANT CELL, V25, P677, DOI 10.1105/tpc.112.104752
   Sanjaya, 2011, PLANT BIOTECHNOL J, V9, P874, DOI 10.1111/j.1467-7652.2011.00599.x
   Scott RW, 2010, PLANT BIOTECHNOL J, V8, P912, DOI 10.1111/j.1467-7652.2010.00522.x
   Slocombe SP, 2009, PLANT BIOTECHNOL J, V7, P694, DOI 10.1111/j.1467-7652.2009.00435.x
   Stone SL, 2008, P NATL ACAD SCI USA, V105, P3151, DOI 10.1073/pnas.0712364105
   Troncoso-Ponce MA, 2013, PLANT SCI, V205, P13, DOI 10.1016/j.plantsci.2013.01.004
   Vanhercke T, 2013, FEBS LETT, V587, P364, DOI 10.1016/j.febslet.2012.12.018
   Winichayakul S, 2013, PLANT PHYSIOL, V162, P626, DOI 10.1104/pp.113.216820
   Xu CC, 2005, PLANT CELL, V17, P3094, DOI 10.1105/tpc.105.035592
NR 32
TC 98
Z9 102
U1 7
U2 128
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1467-7644
EI 1467-7652
J9 PLANT BIOTECHNOL J
JI Plant Biotechnol. J.
PD FEB
PY 2014
VL 12
IS 2
BP 231
EP 239
DI 10.1111/pbi.12131
PG 9
WC Biotechnology & Applied Microbiology; Plant Sciences
SC Biotechnology & Applied Microbiology; Plant Sciences
GA 295HY
UT WOS:000330108400010
PM 24151938
OA Other Gold, Green Published
HC Y
HP N
DA 2018-10-19
ER

PT J
AU Uzarski, JS
   Van de Walle, AB
   McFetridge, PS
AF Uzarski, Joseph S.
   Van de Walle, Aurore B.
   McFetridge, Peter S.
TI In Vitro Method for Real-Time, Direct Observation of Cell-Vascular Graft
   Interactions under Simulated Blood Flow
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID HUMAN-ENDOTHELIAL-CELLS; VEIN GRAFT; ADHESION; STRESS
AB In the development of engineered vascular grafts, assessing the material's interactive properties with peripheral blood cells and its capacity to endothelialize are important for predicting in vivo graft behavior. Current in vitro techniques used for characterizing cell adhesion at the surface of engineered scaffolds under flow only facilitate a terminal quantification of cell/surface interactions. Here, we present the design of an innovative flow chamber for real-time analysis of blood-biomaterial interactions under controllable hemodynamic conditions. Decellularized human umbilical veins (dHUV) were used as model vascular allografts to characterize platelet, leukocyte, and endothelial cell (EC) adhesion dynamics. Confluent EC monolayers adhered to the lumenal surface of the grafting material were flow conditioned to resist arterial shear stress levels (up to 24 dynes/cm(2)) over a 48h period, and shown to maintain viability over the 1 week assessment period. The basement membrane was imaged while whole blood/neutrophil suspensions were perfused across the HUV surface to quantify cell accumulation. This novel method facilitates live visualization of dynamic events, including cell adhesion, migration, and morphological adaptation at the blood-graft interface on opaque materials, and it can be used for preliminary assessment of clinically relevant biomaterials before implantation.
C1 [Uzarski, Joseph S.; Van de Walle, Aurore B.; McFetridge, Peter S.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
RP McFetridge, PS (reprint author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Biomed Sci Bldg,JG-56,1275 Ctr Dr,POB 116131, Gainesville, FL 32611 USA.
EM pmcfetridge@bme.ufl.edu
OI Van de Walle, Aurore/0000-0003-1579-9145
FU National Institutes of Health [R01-HL088207, R01-HL088207-03S1]
FX The authors would like to acknowledge the National Institutes of Health
   for funding R01-HL088207 and R01-HL088207-03S1. They thank Alan Miles
   for providing flow chamber machining consultation. The authors would
   also like to thank the Electron Microscopy and Bio-imaging Laboratory at
   UF for technical assistance, Christopher Cogle and the UF Clinical and
   Translational Science Institute for their assistance with blood draws.
   They also thank Dr. Cogle for contributing the GFP + HL-60 cells for
   this study.
CR Bacabac RG, 2005, J BIOMECH, V38, P159, DOI 10.1016/j.jbiomech.2004.03.020
   Barthel KU, 2011, INTERACTIVE 3D SURFA
   Bolick DT, 2005, ARTERIOSCL THROM VAS, V25, P976, DOI 10.1161/01.ATV.0000162171.30089.f6
   Bulger M. G., 1979, PRINCIPLES STAT
   Butler PJ, 2000, MICROCIRCULATION, V7, P53, DOI 10.1038/sj.mn.7300093
   Daniel J, 2005, ASAIO J, V51, P252, DOI 10.1097/01.MAT.0000160872.41871.7E
   Dardik H, 2006, J AM COLL SURGEONS, V203, P582, DOI 10.1016/j.jamcollsurg.2006.07.003
   ENTE G, 1991, J ROY SOC HEALTH, V111, P138, DOI 10.1177/146642409111100406
   FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488
   HANSON SR, 1985, ARTERIOSCLEROSIS, V5, P595, DOI 10.1161/01.ATV.5.6.595
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Mehta D, 1997, INT J CARDIOL, V62, pS55, DOI 10.1016/S0167-5273(97)00214-3
   Michell D. L., 2011, J VIS EXP
   Mollinedo F, 2008, GENE, V419, P16, DOI 10.1016/j.gene.2008.04.015
   Reinhart-King CA, 2008, METHOD ENZYMOL, V443, P25, DOI 10.1016/S0076-6879(08)02002-8
   Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Schmidtke DW, 2000, J CELL BIOL, V149, P719, DOI 10.1083/jcb.149.3.719
   Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104
   Tolouei E, 2011, ANN BIOMED ENG, V39, P1403, DOI 10.1007/s10439-010-0239-4
   Tosun Z, 2011, J VASC SURG, V54, P1451, DOI 10.1016/j.jvs.2011.05.050
   Uzarski J. S., 2012, J BIOMED MATER RES A, V101, P123
   Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074
   Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017
NR 28
TC 5
Z9 5
U1 0
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD FEB 1
PY 2014
VL 20
IS 2
BP 116
EP 128
DI 10.1089/ten.tec.2012.0771
PG 13
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 298FX
UT WOS:000330310700003
PM 23679070
OA Green Published
DA 2018-10-19
ER

PT J
AU Bae, MS
   Ohe, JY
   Lee, JB
   Heo, DN
   Byun, W
   Bae, H
   Kwon, YD
   Kwon, IK
AF Bae, Min Soo
   Ohe, Joo-Young
   Lee, Jung Bok
   Heo, Dong Nyoung
   Byun, Wook
   Bae, Hojae
   Kwon, Yong-Dae
   Kwon, Il Keun
TI Photo-cured hyaluronic acid-based hydrogels containing growth and
   differentiation factor 5 (GDF-5) for bone tissue regeneration
SO BONE
LA English
DT Article
DE Photopolymerization; Hyaluronic acid; Hydrogel; Growth and
   differentiation factor 5 (GDF-5); Bone tissue regeneration
ID RECOMBINANT HUMAN GROWTH; BETA-TRICALCIUM PHOSPHATE; SINUS FLOOR
   AUGMENTATION; GOETTINGEN MINIATURE PIG; ENGINEERING APPLICATIONS;
   EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; PHOTOPOLYMERIZATION;
   SCAFFOLD
AB In this study we describe the generation and influences on in vitro and in vivo osteogenesis of photo-cured hyaluronic acid (HA) hydrogels loaded with growth and differentiation factor 5 (GDF-5). Prior to loading GDF-5, we characterized the release profiles from these hydrogels and tested their respective cell viability, differentiation and in vivo bone regeneration. The results from this testing indicated that GDF-5 was observed to release in a sustained manner from the HA hydrogels I-III. MIT and Live/Dead assays showed that the HA hydrogels I-III have good biocompatibility for use as scaffolds for bone tissue regeneration. In vitro cell tests showed a higher level of MOT3-E1 cell proliferation and differentiation on HA hydrogels I-III than on HA hydrogel 0. Moreover, in vivo animal tests showed that the HA hydrogels I and III had a significant improvement on osteogenesis. Overall, our results suggest that the HA-based hydrogel is a good biomaterial to deliver osteogenic differentiation factors such as GDF-5, and GDF-5 can be useful as an effective alternative to aid new bone formation. (C) 2013 Elsevier Inc. All rights reserved.
C1 [Bae, Min Soo; Lee, Jung Bok; Heo, Dong Nyoung; Byun, Wook; Kwon, Il Keun] Kyung Hee Univ, Dept Maxillofacial Biomed Engn, Sch Dent, Seoul 130701, South Korea.
   [Ohe, Joo-Young; Kwon, Yong-Dae] Kyung Hee Univ, Dept Oral & Maxillofacial Surg, Sch Dent, Seoul 130701, South Korea.
   [Kwon, Yong-Dae; Kwon, Il Keun] Kyung Hee Univ, Inst Oral Biol, Sch Dent, Seoul 130701, South Korea.
   [Bae, Hojae] Konkuk Univ, Dept Bioind Technol, Coll Anim Biosci & Technol, Seoul 143701, South Korea.
RP Kwon, YD (reprint author), Kyung Hee Univ, Inst Oral Biol, Sch Dent, 1 Hoegi Dong, Seoul 130701, South Korea.
EM yongdae.kwon@gmail.com; kwoni@khu.ac.kr
OI Kwon, Yong-Dae/0000-0001-9620-4814
FU ITI (International Team for Implantology, Basel, Switzerland) research
   grant program [670-2009]; Pioneer Research Center Program [20120000443]
FX This study was supported by the ITI (International Team for
   Implantology, Basel, Switzerland) research grant program (670-2009) and
   grant no. 20120000443 from the Pioneer Research Center Program.
CR Akkouch A, 2011, J BIOMED MATER RES A, V96A, P693, DOI 10.1002/jbm.a.33033
   Bae MS, 2013, CARBOHYD POLYM, V92, P167, DOI 10.1016/j.carbpol.2012.09.044
   Bae MS, 2011, BIOMATERIALS, V32, P8161, DOI 10.1016/j.biomaterials.2011.07.045
   Bot PT, 2008, CURR MED CHEM, V15, P786, DOI 10.2174/092986708783955554
   Bryant SJ, 2001, BIOMATERIALS, V22, P619, DOI 10.1016/S0142-9612(00)00225-8
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Clapper JD, 2008, CHEM MATER, V20, P768, DOI 10.1021/cm702130r
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Emerton KB, 2011, J DENT RES, V90, P1416, DOI 10.1177/0022034511423665
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Garbern JC, 2010, BIOMACROMOLECULES, V11, P1833, DOI 10.1021/bm100318z
   Grant N, 2011, J COLLOID INTERF SCI, V356, P573, DOI 10.1016/j.jcis.2011.01.056
   Gruber RM, 2008, CLIN ORAL IMPLAN RES, V19, P522, DOI 10.1111/j.1600-0501.2007.01494.x
   Gruber RM, 2009, CLIN ORAL IMPLAN RES, V20, P175, DOI 10.1111/j.1600-0501.2008.01628.x
   Gurkan UA, 2011, TISSUE ENG PT A, V17, P417, DOI [10.1089/ten.tea.2010.0193, 10.1089/ten.TEA.2010.0193]
   Hiemstra C, 2007, J AM CHEM SOC, V129, P9918, DOI 10.1021/ja072113p
   HOTTEN G, 1994, BIOCHEM BIOPH RES CO, V204, P646, DOI 10.1006/bbrc.1994.2508
   Hutchison JB, 2005, CHEM MATER, V17, P4789, DOI 10.1021/cm0504541
   KING SR, 1991, SURGERY, V109, P76
   Koch FP, 2010, CLIN ORAL IMPLAN RES, V21, P1301, DOI 10.1111/j.1600-0501.2010.01949.x
   Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029
   Kyle S, 2010, BIOMATERIALS, V31, P9395, DOI 10.1016/j.biomaterials.2010.08.051
   Laurent Torvard C., 1996, Immunology and Cell Biology, V74, pA1, DOI 10.1038/icb.1996.32
   LEE B, 1994, BIORHEOLOGY, V31, P339
   Lee SJ, 2011, BIOMACROMOLECULES, V12, P306, DOI 10.1021/bm100856g
   Lesley J, 1997, GLYCOCONJUGATE J, V14, P611, DOI 10.1023/A:1018540610858
   LESLEY J, 1993, ADV IMMUNOL, V54, P271, DOI 10.1016/S0065-2776(08)60537-4
   Menzel EJ, 1998, CANCER LETT, V131, P3, DOI 10.1016/S0304-3835(98)00195-5
   Missirlis D, 2005, LANGMUIR, V21, P2605, DOI 10.1021/la047367s
   Morotome Y, 1998, BIOCHEM BIOPH RES CO, V244, P85, DOI 10.1006/bbrc.1998.8213
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Sena K, 2003, J DENT RES, V82, P166, DOI 10.1177/154405910308200304
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4
   Wei HL, 2005, EUR POLYM J, V41, P948, DOI 10.1016/j.eurpolymj.2004.11.041
   Winer I, 2010, CANCER RES, V70, P8674, DOI 10.1158/0008-5472.CAN-10-1917
   YANG BH, 1993, J BIOL CHEM, V268, P8617
   Zhang XZ, 2005, BIOMATERIALS, V26, P3299, DOI 10.1016/j.biomaterials.2004.08.024
NR 40
TC 27
Z9 28
U1 3
U2 29
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
EI 1873-2763
J9 BONE
JI Bone
PD FEB
PY 2014
VL 59
BP 189
EP 198
DI 10.1016/j.bone.2013.11.019
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 287QZ
UT WOS:000329558600025
PM 24291420
DA 2018-10-19
ER

PT J
AU Kizaki, T
   Ogasahara, T
   Sugita, N
   Mitsuishi, M
AF Kizaki, Toru
   Ogasahara, Toshihiro
   Sugita, Naohiko
   Mitsuishi, Mamoru
TI Ultraviolet-laser-assisted precision cutting of yttria-stabilized
   tetragonal zirconia polycrystal
SO JOURNAL OF MATERIALS PROCESSING TECHNOLOGY
LA English
DT Article
DE UV laser-assisted precision cutting; UV laser; Yttria-stabilized
   tetragonal zirconia polycrystal; Biomaterial; Difficult-to-cut material
ID CERAMICS; STEEL
AB Yttria-stabilized tetragonal zirconia polycrystal (Y-TZP) is a promising biomaterial for use in dental and femoral implants. The current method for machining Y-TZP involves grinding after sintering. However, the grinding process is time consuming and therefore costly. To resolve these issues, this paper proposes a precision cutting process that utilizes a UV-laser-assisted machining method that requires no expensive cutting tools such as diamond tools. The UV laser is used to heat the Y-TZP, which improves its machinability. First, we performed experiments to determine that the most suitable machining temperature was 600 degrees C. A simulation was then used to determine the optimal distance between the tool edge and the laser spot. Finally, experiments using a UV laser were conducted to confirm the effectiveness of using a UV laser for machining. In these experiments, a Y-TZP sample was cut, and grooves were generated. The carved grooves were 20 mm long, 100 mu m wide, and approximately 10 mu m deep. Cutting without using a UV laser was also performed as a reference experiment. The results show that the use of the laser significantly decreased the number of large cracks from 14 to 3, the specific cutting energy by 35%, and the breakage of the tool edge. These results demonstrate the possibility of enhancing the productivity of Y-TZP products. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Kizaki, Toru; Sugita, Naohiko; Mitsuishi, Mamoru] Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan.
   [Ogasahara, Toshihiro] Odakyu Elect Railway Co Ltd, Ohno Gen Trains Plant, Minami Ku, Sagamihara, Kanagawa 2520311, Japan.
RP Kizaki, T (reprint author), Univ Tokyo, Sch Engn, Dept Mech Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.
EM kizaki@nml.t.u-tokyo.ac.jp
FU Amada Foundation [AF-2010207]
FX The authors acknowledge the research grant (AF-2010207) awarded by the
   Amada Foundation to conduct this research work.
CR Anderson MC, 2006, P I MECH ENG B-J ENG, V220, P2055, DOI 10.1243/09544054JEM562
   Anderson M, 2006, INT J MACH TOOL MANU, V46, P1879, DOI 10.1016/j.ijmachtools.2005.11.005
   Basu B, 2005, INT MATER REV, V50, P239, DOI 10.1179/174328005X41113
   Chang CW, 2007, INT J MACH TOOL MANU, V47, P452, DOI 10.1016/j.ijmachtools.2006.06.010
   Chryssolouris G, 1997, J MANUF SCI E-T ASME, V119, P766, DOI 10.1115/1.2836822
   Dandekar C.R., 2010, J MANUF SCI E-T ASME, V132
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Dumitrescu P, 2006, INT J MACH TOOL MANU, V46, P2009, DOI 10.1016/j.ijmachtools.2006.01.005
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Hou ZB, 2000, INT J HEAT MASS TRAN, V43, P1679, DOI 10.1016/S0017-9310(99)00271-9
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Larrea A, 2011, J ELECTROCHEM SOC, V158, pB1193, DOI 10.1149/1.3619759
   Masood SH, 2011, INT J MACH TOOL MANU, V51, P450, DOI 10.1016/j.ijmachtools.2011.02.001
   NICOLOSO N, 1992, SENSOR ACTUAT B-CHEM, V8, P253, DOI 10.1016/0925-4005(92)85027-T
   Pfefferkorn FE, 2004, J MANUF SCI E-T ASME, V126, P42, DOI 10.1115/1.1644542
   Rozzi JC, 2000, J MANUF SCI E-T ASME, V122, P666, DOI 10.1115/1.1286556
   Sola D, 2011, APPL SURF SCI, V257, P5413, DOI 10.1016/j.apsusc.2010.09.089
   Stavropoulos P, 2010, International Journal of Nanomanufacturing, V6, P55, DOI 10.1504/IJNM.2010.034772
   THEUNISSEN GSAM, 1992, J MATER SCI, V27, P4429, DOI 10.1007/BF00541576
NR 19
TC 5
Z9 5
U1 0
U2 22
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0924-0136
J9 J MATER PROCESS TECH
JI J. Mater. Process. Technol.
PD FEB
PY 2014
VL 214
IS 2
BP 267
EP 275
DI 10.1016/j.jmatprotec.2013.09.015
PG 9
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA 287RR
UT WOS:000329560400013
DA 2018-10-19
ER

PT J
AU Ameer, MA
   Ghoneim, AA
   Fekry, AM
AF Ameer, M. A.
   Ghoneim, A. A.
   Fekry, A. M.
TI Electrochemical and interface analysis of titanium alloy in simulated
   body fluid
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Article
DE titanium alloy; electrochemical techniques; inhibition
ID INULIN-TYPE FRUCTANS; CORROSION INHIBITION; BONE MINERALIZATION;
   MILD-STEEL; IMPEDANCE; BEHAVIOR; ELECTROLYTE; ZIRCONIUM; MAGNESIUM;
   COMPOUND
AB The effect of raftiline inulin in presence of Ca2+ on titanium alloy as biomaterial was investigated in simulated body fluid solution at 37 degrees C. The behavior of Ti alloy was studied at different concentrations of inulin with immersion time using electrochemical impedance spectroscopy and potentiodynamic polarization tests. Ti alloy was effectively inhibited by the addition of 0.25% by weight raftiline in presence of 10(-5)m calcium levulinate, which reacts with Ti alloy and forms a protective film on its surface. The results were confirmed by surface examination via scanning electron microscope. Copyright (c) 2013 John Wiley & Sons, Ltd.
C1 [Ameer, M. A.; Ghoneim, A. A.; Fekry, A. M.] Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt.
RP Ameer, MA (reprint author), Cairo Univ, Fac Sci, Dept Chem, Giza 12613, Egypt.
EM mameer_eg@yahoo.com
CR Abrams SA, 2005, AM J CLIN NUTR, V82, P471
   Ameer MA, 2012, INT J ELECTROCHEM SC, V7, P4418
   Ameer MA, 2011, PROG ORG COAT, V71, P343, DOI 10.1016/j.porgcoat.2011.04.001
   Ameer MA, 2010, INT J HYDROGEN ENERG, V35, P11387, DOI 10.1016/j.ijhydene.2010.07.071
   Ameer MA, 2010, MATER CHEM PHYS, V122, P321, DOI 10.1016/j.matchemphys.2010.03.021
   Bosscher D, 2006, INT DAIRY J, V16, P1092, DOI 10.1016/j.idairyj.2005.10.028
   Brunette D. M., 2001, TITANIUM MED MAT SCI, P207
   Cashman K. D., 2002, BR J NUTR, V87, P169
   Fekry AM, 2011, INT J ELECTROCHEM SC, V6, P1342
   Fekry AM, 2010, J APPL ELECTROCHEM, V40, P739, DOI 10.1007/s10800-009-0052-7
   Fekry AM, 2009, ELECTROCHIM ACTA, V54, P7280, DOI 10.1016/j.electacta.2009.07.047
   GIBSON GR, 1995, J NUTR, V125, P1401
   Guillemot F, 2005, EXPERT REV MED DEVIC, V2, P741, DOI 10.1586/17434440.2.6.741
   HANAWA T, 1991, BIOMATERIALS, V12, P767, DOI 10.1016/0142-9612(91)90028-9
   Hosny WM, 2013, INT J ELECTROCHEM SC, V8, P8371
   Ian J., 2003, NUTR RES, V23, P901
   KNITTEL DR, 1984, CORROSION, V40, P9, DOI 10.5006/1.3579296
   Kumar S, 2010, CORROS SCI, V52, P1721, DOI 10.1016/j.corsci.2010.01.008
   Macdonald D. D., 1977, TRANSIENT TECHNIQUES
   Macdonald J. R., 1987, IMPEDANCE SPECTROSCO
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   PATRITO EM, 1994, J ELECTROANAL CHEM, V375, P203, DOI 10.1016/0022-0728(94)03405-2
   Popa MV, 2007, BIOELECTROCHEMISTRY, V71, P126, DOI 10.1016/j.bioelechem.2007.02.007
   PROUD WG, 1993, ELECTROCHIM ACTA, V38, P405, DOI 10.1016/0013-4686(93)85158-U
   Roberfroid MB, 1997, ADV EXP MED BIOL, V427, P211
   Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350
   Souza MEP, 2009, J MATER SCI-MATER M, V20, P549, DOI 10.1007/s10856-008-3623-y
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Textor M., 2001, TITANIUM MED, P171
NR 29
TC 1
Z9 1
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0142-2421
EI 1096-9918
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD FEB
PY 2014
VL 46
IS 2
BP 65
EP 71
DI 10.1002/sia.5349
PG 7
WC Chemistry, Physical
SC Chemistry
GA 288PN
UT WOS:000329624000002
DA 2018-10-19
ER

PT J
AU Roy, M
   Kusurkar, TS
   Maurya, SK
   Meena, SK
   Singh, SK
   Sethy, N
   Bhargava, K
   Sharma, RK
   Goswami, D
   Sarkar, S
   Das, M
AF Roy, Manas
   Kusurkar, Tejas Sanjeev
   Maurya, Sandeep Kumar
   Meena, Sunil Kumar
   Singh, Sushil Kumar
   Sethy, Niroj
   Bhargava, Kalpana
   Sharma, Raj Kishore
   Goswami, Debabrata
   Sarkar, Sabyasachi
   Das, Mainak
TI Graphene oxide from silk cocoon: a novel magnetic fluorophore for
   multi-photon imaging
SO 3 BIOTECH
LA English
DT Article
DE Bio-imaging; Fluorophore; Graphene oxide; Magnetism; Multi-photon
   imaging; Silk cocoon
ID LAYER GRAPHENE; SINGLE-LAYER; CARBON; NANOTUBES; SHEETS; FILMS
AB In this work, we synthesized graphene oxide from silk cocoon embarking its new dimension as a magnetic fluorophore when compared with its present technical status, which at best is for extracting silk as a biomaterial for tissue engineering applications. We produced graphene oxide by pyrolysing the silk cocoon in an inert atmosphere. The collected raw carbon is oxidized by nitric acid that readily produces multilayer graphene oxide with nano carbon particulates. Structural properties of the graphene oxide were analyzed using scanning electron microscopy, transmission electron microscopy, Fourier transform infrared spectroscopy, and Raman spectroscopy. The oxidized sample shows remarkable fluorescence, multi-photon imaging and magnetic properties. On increasing the excitation wavelength, the fluorescence emission intensity of the graphene oxide also increases and found maximum emission at 380 nm excitation wavelength. On studying the two photon absorption (TPA) property of aqueous graphene oxide using Z-scan technique, we found significant TPA activity at near infrared wavelength. In addition, the graphene oxide shows ferromagnetic behavior at room temperature. The observed fluorescence and magnetic property were attributed to the defects caused in the graphene oxide structure by introducing oxygen containing hydrophilic groups during the oxidation process. Previously silk cocoon has been used extensively in deriving silk-based tissue engineering materials and as gas filter. Here we show a novel application of silk cocoon by synthesizing graphene oxide based magnetic-fluorophore for bio-imaging applications.
C1 [Roy, Manas; Maurya, Sandeep Kumar; Goswami, Debabrata] Indian Inst Technol, Dept Chem, Kanpur 208016, Uttar Pradesh, India.
   [Kusurkar, Tejas Sanjeev; Das, Mainak] Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
   [Maurya, Sandeep Kumar; Goswami, Debabrata] Indian Inst Technol, Ctr Laser Technol, Kanpur 208016, Uttar Pradesh, India.
   [Meena, Sunil Kumar] Indian Inst Technol, Dept Elect Engn, Kanpur 208016, Uttar Pradesh, India.
   [Singh, Sushil Kumar] Solid State Phys Lab, Def Res Dev Org, MEMS, Delhi 110054, India.
   [Singh, Sushil Kumar] Solid State Phys Lab, Def Res Dev Org, Photon Div, Delhi 110054, India.
   [Sethy, Niroj; Bhargava, Kalpana] Def Res Dev Org, Def Inst Physiol & Allied Sci, Peptide & Prote Div, Delhi 110054, India.
   [Sharma, Raj Kishore] Univ Delhi, Div Phys Chem, Dept Chem, Electrochem Mat Res Grp, Delhi 110007, India.
   [Sarkar, Sabyasachi] Bengal Engn & Sci Univ, Dept Chem, Bot Garden, Howrah 711103, W Bengal, India.
   [Das, Mainak] Indian Inst Technol, Design Program, Kanpur 208016, Uttar Pradesh, India.
RP Das, M (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Bioelect Green Energy Physiol & Sensor Grp, Kanpur 208016, Uttar Pradesh, India.
EM mainakd@iitk.ac.in
RI Maurya, Sandeep/J-3069-2016; Goswami, Debabrata/A-9347-2009
OI Goswami, Debabrata/0000-0002-2052-0594; Sethy, Niroj/0000-0003-0675-1481
FU IITK [IITK/BSBE/20100206]; CSIR, India [09/092(0670)/2009-EMR-I]; IIT K
   PhD fellowship program
FX The work was supported by IITK start-up grant (IITK/BSBE/20100206) of
   MD. MR is a senior research fellow of CSIR, India (Fellowship Number:
   09/092(0670)/2009-EMR-I). TSK is funded by IIT K PhD fellowship program.
   This work is part of MR's and TSK's doctoral thesis. Authors are
   thankful to MMAE, chemistry, nano-science (DST) of IIT Kanpur for
   TEM/VSM, FT-IR/Raman and SEM/EDAX facilities respectively.
CR ALLEMAND PM, 1991, SCIENCE, V253, P301, DOI 10.1126/science.253.5017.301
   Balandin AA, 2008, NANO LETT, V8, P902, DOI 10.1021/nl0731872
   Brodie B. C., 1859, PHILOS T R SOC LONDO, V149, P249, DOI DOI 10.1098/RSTL.1859.0013
   Choi EY, 2010, J MATER CHEM, V20, P1907, DOI 10.1039/b919074k
   Dubey P, 2005, PRAMANA-J PHYS, V65, P681, DOI 10.1007/BF03010456
   Eda G, 2011, J MATER CHEM, V21, P11217, DOI 10.1039/c1jm11266j
   Eda G, 2010, ADV MATER, V22, P505, DOI 10.1002/adma.200901996
   Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401
   Ghosh M, 2011, SMALL, V7, P3170, DOI 10.1002/smll.201101158
   Graf D, 2007, NANO LETT, V7, P238, DOI 10.1021/nl061702a
   Guo SJ, 2011, CHEM SOC REV, V40, P2644, DOI 10.1039/c0cs00079e
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Kim YH, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125420
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Lee C, 2008, SCIENCE, V321, P385, DOI 10.1126/science.1157996
   Loh KP, 2010, NAT CHEM, V2, P1015, DOI 10.1038/NCHEM.907
   Lu C. H., 2009, ANGEW CHEM, V121, P4879, DOI DOI 10.1002/ANGE.200901479
   Makarova TL, 2004, SEMICONDUCTORS+, V38, P615, DOI 10.1134/1.1766362
   Makarova TL, 2001, NATURE, V413, P716, DOI 10.1038/35099527
   Nag A, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/6/065103
   Nag A, 2009, J PHOTOCH PHOTOBIO A, V206, P188, DOI 10.1016/j.jphotochem.2009.06.007
   NEMANICH RJ, 1979, PHYS REV B, V20, P392, DOI 10.1103/PhysRevB.20.392
   Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896
   Pan DY, 2010, ADV MATER, V22, P734, DOI 10.1002/adma.200902825
   Qian J, 2012, ANGEW CHEM INT EDIT, V51, P10570, DOI 10.1002/anie.201206107
   RAMIREZ AP, 1994, SCIENCE, V265, P84, DOI 10.1126/science.265.5168.84
   Roy M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0045-7
   Ruan GD, 2011, ACS NANO, V5, P7601, DOI 10.1021/nn202625c
   Schwierz F, 2010, NAT NANOTECHNOL, V5, P487, DOI [10.1038/NNANO.2010.89, 10.1038/nnano.2010.89]
   Sun ZZ, 2010, NATURE, V468, P549, DOI 10.1038/nature09579
   Tsioris K, 2010, ADV FUNCT MATER, V20, P1083, DOI 10.1002/adfm.200902050
   Wang Y., 2008, NANO LETT, V9, P220
   Xu YX, 2008, J AM CHEM SOC, V130, P5856, DOI 10.1021/ja800745y
   Zhu SJ, 2011, CHEM COMMUN, V47, P6858, DOI 10.1039/c1cc11122a
NR 34
TC 11
Z9 11
U1 2
U2 24
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5738
EI 2190-572X
J9 3 BIOTECH
JI 3 Biotech
PD FEB
PY 2014
VL 4
IS 1
BP 67
EP 75
DI 10.1007/s13205-013-0128-2
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CM9QO
UT WOS:000358044100008
PM 28324464
OA Green Published, Other Gold
DA 2018-10-19
ER

PT J
AU Jadalannagari, S
   Deshmukh, K
   Ramanan, SR
   Kowshik, M
AF Jadalannagari, Sushma
   Deshmukh, Ketaki
   Ramanan, Sutapa Roy
   Kowshik, Meenal
TI Antimicrobial activity of hemocompatible silver doped hydroxyapatite
   nanoparticles synthesized by modified sol-gel technique
SO APPLIED NANOSCIENCE
LA English
DT Article
DE Hydroxyapatite; Silver doping; Antimicrobial activity; Hemocompatibility
AB Silver doped hydroxyapatite (AgxCa100-x (PO4)(6) (OH)(2)) nanorods were synthesized using a modified sol gel method at a low temperature of 100 degrees C. Silver concentration was varied as x = 1, 3 and 5. X-ray diffraction studies showed that the synthesized silver doped hydroxyapatite (Ag-HAp) was fully crystalline with hexagonal structure and an average crystallite size of 25 nm. At all the doping concentrations, the nanoparticles were rod shaped with an average length of 110-180 nm and diameter of 20-25 nm as determined from transmission electron microscopy (TEM) studies. These compounds were tested for their antimicrobial activities against E. coli (MTCC 2345) and S. aureus (MTCC 737). Antimicrobial activity was observed for all the three silver doping concentrations with the highest activity for x = 3, in terms of the zone of inhibition and the percentage reduction in the number of colonies. Hemolysis ratios for x = 1 and 3 Ag-HAp samples were below 2 %, indicating that they are highly hemocompatible and can be a promising biomaterial for tissue engineering applications in orthopedics.
C1 [Jadalannagari, Sushma; Deshmukh, Ketaki; Kowshik, Meenal] Birla Inst Technol & Sci Pilani, Dept Biol Sci, KK Birla Goa Campus, Zuarinagar 403726, Goa, India.
   [Ramanan, Sutapa Roy] Birla Inst Technol & Sci Pilani, Dept Chem Engn, Zuarinagar 403726, Goa, India.
RP Kowshik, M (reprint author), Birla Inst Technol & Sci Pilani, Dept Biol Sci, KK Birla Goa Campus, Zuarinagar 403726, Goa, India.
EM Sushmajp5@gmail.com; Ketaki03@gmail.com; sutapa@goa.bits-pilani.ac.in;
   meenal@goa.bits-pilani.ac.in
CR Babapour A, 2006, NANOTECHNOLOGY, V17, P763, DOI 10.1088/0957-4484/17/3/025
   Bahadir A, 2009, DEFECT DIFFUS FORUM, V283-286, P250, DOI 10.4028/www.scientific.net/DDF.283-286.250
   Bai XA, 2010, ACTA BIOMATER, V6, P2264, DOI 10.1016/j.actbio.2009.12.002
   Borghese R, 2004, APPL ENVIRON MICROB, V70, P6595, DOI 10.1128/AEM.70.11.6595-6602.2004
   BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Chen YK, 2008, J MATER SCI-MATER M, V19, P3603, DOI 10.1007/s10856-008-3529-8
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   Diaz M, 2009, J NANOMATER, DOI 10.1155/2009/498505
   Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002
   Dragieva I, 1999, NANOSTRUCT MATER, V12, P267, DOI 10.1016/S0965-9773(99)00114-2
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   FURR JR, 1994, J HOSP INFECT, V27, P201, DOI 10.1016/0195-6701(94)90128-7
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   Hyung JJ, 2003, BIOMATERIALS, V24, P4921
   Jadalannagari S, 2011, MAT SCI ENG C-MATER, V31, P1534, DOI 10.1016/j.msec.2011.07.001
   Kim Soo-Hwan, 2011, Korean Journal of Microbiology and Biotechnology, V39, P77
   Kim TN, 1998, J MATER SCI-MATER M, V9, P129, DOI 10.1023/A:1008811501734
   Klasen JH, 2006, BURNS, V26, P131
   KRAMER SJ, 1981, CLIN ORTHOP RELAT R, P154
   Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y
   Mo AC, 2008, APPL SURF SCI, V255, P435, DOI 10.1016/j.apsusc.2008.06.083
   Nunez N.V.A., 2009, NANOBIOTECHNOL, V5, P2
   Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rameshbabu N, 2007, J BIOMED MATER RES A, V80A, P581, DOI 10.1002/jbm.a.30958
   Russell SW, 1996, J AM CERAM SOC, V79, P837, DOI 10.1111/j.1151-2916.1996.tb08514.x
   Sambrook J, 2001, MOL CLONING LAB MANU
   Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006
   SCHREURS WJA, 1982, J BACTERIOL, V152, P7
   Simon V, 2008, J NON-CRYST SOLIDS, V354, P1751, DOI 10.1016/j.jnoncrysol.2007.08.063
   Smith BC, 1999, INFRARED SPECTRAL IN
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Stanic V, 2011, APPL SURF SCI, V257, P4510, DOI 10.1016/j.apsusc.2010.12.113
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   WIESSNER J, 1988, CALCIFIED TISSUE INT, V42, P210, DOI 10.1007/BF02553746
   Woo K. J., 2008, APPL ENVIRON MICROB, V74, P2171
   Xia W, 2010, BIOMED MATER, V5
   Xue WC, 2004, BIOMATERIALS, V25, P415, DOI 10.1016/S0142-9612(03)00545-3
   Yoshiki A, 2010, BIOCONTROL SCI, V15, P15
   Zheng X, 2009, J THERM SPRAY TECHN, V16, P463
NR 44
TC 28
Z9 28
U1 1
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 2190-5509
EI 2190-5517
J9 APPL NANOSCI
JI Appl. Nanosci.
PD FEB
PY 2014
VL 4
IS 2
BP 133
EP 141
DI 10.1007/s13204-013-0197-x
PG 9
WC Nanoscience & Nanotechnology
SC Science & Technology - Other Topics
GA V45VD
UT WOS:000209843200002
OA Other Gold
DA 2018-10-19
ER

PT J
AU Chen, ZT
   Wu, CT
   Gu, WY
   Klein, T
   Crawford, R
   Xiao, Y
AF Chen, Zetao
   Wu, Chengtie
   Gu, Wenyi
   Klein, Travis
   Crawford, Ross
   Xiao, Yin
TI Osteogenic differentiation of bone marrow MSCs by beta-tricalcium
   phosphate stimulating macrophages via BMP2 signalling pathway
SO BIOMATERIALS
LA English
DT Article
DE Macrophage; Immunoreaction; Bone substitute; beta-TCP; Osteogenesis
ID MESENCHYMAL STEM-CELLS; MORPHOGENETIC PROTEIN-2; IN-VITRO; IMPLANT
   SURFACES; IMMUNE-SYSTEM; TISSUE; OSTEOIMMUNOLOGY; PROLIFERATION;
   POLARIZATION; SECRETION
AB Immune reactions play important roles in determining the in vivo fate of bone substitute materials, either in new bone formation or inflammatory fibrous tissue encapsulation. The paradigm for the development of bone substitute materials has been shifted from inert to immunomodulatory materials, emphasizing the importance of immune cells in the material evaluation. Macrophages, the major effector cells in the immune reaction to implants, are indispensable for osteogenesis and their heterogeneity and plasticity render macrophages a primer target for immune system modulation. However, there are very few reports about the effects of macrophages on biomaterial-regulated osteogenesis. In this study, we used beta-tricalcium phosphate (beta-TCP) as a model biomaterial to investigate the role of macrophages on the material stimulated osteogenesis. The macrophage phenotype switched to M2 extreme in response to beta-TCP extracts, which was related to the activation of calcium-sensing receptor (CaSR) pathway. Bone morphogenetic protein 2 (BMP2) was also significantly upregulated by the beta-TCP stimulation, indicating that macrophage may participate in the beta-TCP stimulated osteogenesis. Interestingly, when macrophage-conditioned beta-TCP extracts were applied to bone marrow mesenchymal stem cells (BMSCs), the osteogenic differentiation of BMSCs was significantly enhanced, indicating the important role of macrophages in biomaterial-induced osteogenesis. These findings provided valuable insights into the mechanism of material-stimulated osteogenesis, and a strategy to optimize the evaluation system for the in vitro osteogenesis capacity of bone substitute materials. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Chen, Zetao; Gu, Wenyi; Klein, Travis; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Wu, Chengtie] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
   [Gu, Wenyi] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Wu, CT (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, 1295 Dingxi Rd, Shanghai 200050, Peoples R China.
EM chengtiewu@mail.sic.ac.cn; yin.xiao@qutedu.au
OI Klein, Travis/0000-0002-6669-7766; Xiao, Yin/0000-0003-1785-3491;
   Crawford, Ross/0000-0001-6079-1316
FU Australian Research Council [DP120103697]; Recruitment Program of Global
   Young Talent, China; Natural Science Foundation of China [81201202,
   31370963]
FX The study was supported by an Australian Research Council Discovery
   Project (DP120103697), Recruitment Program of Global Young Talent, China
   (Dr. Wu) and Natural Science Foundation of China (Grant 81201202 and
   31370963).
CR Ahluwalia A, 2012, CURR MED CHEM, V19, P90, DOI 10.2174/092986712803413944
   Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354
   Bais MV, 2009, BONE, V45, P254, DOI 10.1016/j.bone.2009.04.239
   Bartneck M, 2012, BIOMATERIALS, V33, P4136, DOI 10.1016/j.biomaterials.2012.02.050
   Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02
   Brown BN, 2013, ACTA BIOMATER, V9, P4948, DOI 10.1016/j.actbio.2012.10.025
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Bryers JD, 2012, BIOTECHNOL BIOENG, V109, P1898, DOI 10.1002/bit.24559
   Chakravorty N, 2012, ACTA BIOMATER, V8, P3516, DOI 10.1016/j.actbio.2012.05.008
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   Chang MK, 2008, J IMMUNOL, V181, P1232, DOI 10.4049/jimmunol.181.2.1232
   Chappard D, 2010, MICRON, V41, P321, DOI 10.1016/j.micron.2009.12.005
   Chen Z, 2013, J BIOMED A IN PRESS
   De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Freytes DO, 2013, J CELL BIOCHEM, V114, P220, DOI 10.1002/jcb.24357
   Fromigue O, 1998, J CELL BIOCHEM, V68, P411, DOI 10.1002/(SICI)1097-4644(19980315)68:4<411::AID-JCB2>3.0.CO;2-T
   Gaasbeek RDA, 2005, BIOMATERIALS, V26, P6713, DOI 10.1016/j.biomaterials.2005.04.056
   Guihard P, 2012, STEM CELLS, V30, P762, DOI 10.1002/stem.1040
   Honda Y, 2006, BIOCHEM BIOPH RES CO, V345, P1155, DOI 10.1016/j.bbrc.2006.05.013
   Jang BJ, 2008, J VET SCI, V9, P387, DOI 10.4142/jvs.2008.9.4.387
   Lang NP, 2011, CLIN ORAL IMPLAN RES, V22, P349, DOI 10.1111/j.1600-0501.2011.02172.x
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Li Y, 2007, BLOOD, V109, P3839, DOI 10.1182/blood-2006-07-037994
   Lorenzo J, 2000, J CLIN INVEST, V106, P749, DOI 10.1172/JCI11089
   MacLeod RJ, 2007, AM J PHYSIOL-GASTR L, V293, pG403, DOI 10.1152/ajpgi.00119.2007
   Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133
   Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Oh SA, 2010, J MATER SCI-MATER M, V21, P3019, DOI 10.1007/s10856-010-4152-z
   Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027
   Peiris D, 2007, AM J PHYSIOL-GASTR L, V292, pG753, DOI 10.1152/ajpgi.00225.2006
   Petit A, 2005, BIOMATERIALS, V26, P4416, DOI 10.1016/j.biomaterials.2004.11.019
   Pettit AR, 2008, BONE, V43, P976, DOI 10.1016/j.bone.2008.08.128
   Rokn Ar, 2012, J Dent (Tehran), V9, P35
   Singh S, 2008, STEM CELLS DEV, V17, P245, DOI 10.1089/scd.2007.0146
   Sitasuwan P, 2012, INTEGR BIOL-UK, V4, P651, DOI 10.1039/c2ib20041d
   Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1
   Sullivan DE, 2005, AM J RESP CELL MOL, V32, P342, DOI 10.1165/rcmb.2004-0288OC
   Takayanagi H, 2005, J PERIODONTAL RES, V40, P287, DOI 10.1111/j.1600-0765.2005.00814.x
   Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062
   Theiss AL, 2005, J BIOL CHEM, V280, P36099, DOI 10.1074/jbc.M505291200
   Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035
   WAHL SM, 1990, ANN NY ACAD SCI, V593, P188, DOI 10.1111/j.1749-6632.1990.tb16111.x
   Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646
   Wu CT, 2012, J MATER CHEM, V22, P12288, DOI 10.1039/c2jm30566f
   Wu CT, 2011, ACTA BIOMATER, V7, P1797, DOI 10.1016/j.actbio.2010.12.018
   Xia ZD, 2006, J BIOMED MATER RES A, V79A, P582, DOI 10.1002/jbm.a.30853
   Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077
   Zhang ML, 2012, J MATER CHEM, V22, P21686, DOI 10.1039/c2jm34395a
   Zhang ML, 2012, J BIOMED MATER RES A, V100A, P2979, DOI 10.1002/jbm.a.34246
   Zhang MY, 2010, J PLAST RECONSTR AES, V63, P227, DOI 10.1016/j.bjps.2008.11.017
   Zheng F, 2010, THESIS OHIO STATE U
NR 57
TC 79
Z9 81
U1 4
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2014
VL 35
IS 5
BP 1507
EP 1518
DI 10.1016/j.biomaterials.2013.11.014
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 295ZY
UT WOS:000330156100016
PM 24268199
DA 2018-10-19
ER

PT J
AU Musson, D
   Street, M
   Dray, M
   Thambayah, A
   Callon, K
   Tuari, D
   Coleman, B
   Cornish, J
AF Musson, David
   Street, Matthew
   Dray, Michael
   Thambayah, Ashvin
   Callon, Karen
   Tuari, Donna
   Coleman, Brendan
   Cornish, Jillian
TI Healing of the bone and tendon interface: an in vivo study using a
   lactoferrin seeded biomaterial scaffold
SO JOURNAL OF BONE AND MINERAL RESEARCH
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Bone-and-Mineral-Research
CY SEP 12-15, 2014
CL Houston, TX
SP Amer Soc Bone & Mineral Res
C1 [Musson, David; Street, Matthew; Thambayah, Ashvin; Callon, Karen; Tuari, Donna; Cornish, Jillian] Univ Auckland, Auckland 1, New Zealand.
   [Dray, Michael] Waikato Dist Hlth Board, Hamilton, New Zealand.
   [Coleman, Brendan] Cty Manukau Dist Hlth Board, Hamilton, New Zealand.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-0431
EI 1523-4681
J9 J BONE MINER RES
JI J. Bone Miner. Res.
PD FEB
PY 2014
VL 29
SU 1
MA MO0096
BP S380
EP S380
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA CK9ZS
UT WOS:000356598702249
DA 2018-10-19
ER

PT J
AU Bell, S
   Ajami, E
   Davies, JE
AF Bell, Spencer
   Ajami, Elnaz
   Davies, John E.
TI An Improved Mechanical Testing Method to Assess Bone-implant Anchorage
SO Jove-Journal of Visualized Experiments
LA English
DT Article
DE Bioengineering; Issue 84; Mechanical test; bone anchorage; disruption
   test; surface topography; peri-implant bone; bone-implant interface;
   bone-bonding; microtopography; nanotopography
ID IN-VIVO; SURFACE; OSSEOINTEGRATION; INTERFACE; STRENGTH
AB Recent advances in material science have led to a substantial increase in the topographical complexity of implant surfaces, both on a microand a nano-scale. As such, traditional methods of describing implant surfaces -namely numerical determinants of surface roughness -are inadequate for predicting in vivo performance. Biomechanical testing provides an accurate and comparative platform to analyze the performance of biomaterial surfaces. An improved mechanical testing method to test the anchorage of bone to candidate implant surfaces is presented. The method is applicable to both early and later stages of healing and can be employed for any range of chemically or mechanically modified surfaces -but not smooth surfaces. Custom rectangular implants are placed bilaterally in the distal femora of male Wistar rats and collected with the surrounding bone. Test specimens are prepared and potted using a novel breakaway mold and the disruption test is conducted using a mechanical testing machine. This method allows for alignment of the disruption force exactly perpendicular, or parallel, to the plane of the implant surface, and provides an accurate and reproducible means for isolating an exact peri-implant region for testing.
C1 [Bell, Spencer; Ajami, Elnaz; Davies, John E.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.
RP Davies, JE (reprint author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.
EM jed.davies@utoronto.ca
FU Biomet 3i; National Sciences and Engineering Research Council of Canada
   (NSERC)
FX The authors would like to thank Biomet 3i for their continued financial
   support, and particularly Randy Goodman for help in the design and
   fabrication of the custom parts. Spencer Bell is a recipient of an
   Industrial Postgraduate Scholarship, provided by the National Sciences
   and Engineering Research Council of Canada (NSERC). We would also like
   to thank Dr. John Brunski for his very valuable feedback during
   manuscript preparation.
CR Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Branemark R, 2011, NANOMED-NANOTECHNOL, V7, P220, DOI 10.1016/j.nano.2010.10.006
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Brunski JB, 2005, OSSEOINTEGRATION BOO, P209
   CURREY JD, 1979, J BIOMECH, V12, P313, DOI 10.1016/0021-9290(79)90073-3
   Davies J.E., 2000, BONE ENG, P1
   Davies JE, 2013, BIOMATERIALS, V34, P3535, DOI 10.1016/j.biomaterials.2013.01.024
   Edwards JT, 1997, J BIOMED MATER RES, V36, P454
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   Hench L. L., 1972, J BIOMED MAT RES S, V1, P117
   Hong L., J BIOMED MAT RES, V26, P7
   Itala A, 2003, J BIOMED MATER RES A, V67A, P496, DOI 10.1002/jbm.a.10501
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Lekholm U, 1985, TISSUE INTEGRATED PR, P199, DOI DOI 10.1111/J.1708-8208.2002.TB00174.X
   MCKEE MD, 1995, ANN NY ACAD SCI, V760, P177, DOI 10.1111/j.1749-6632.1995.tb44629.x
   Mendes VC, 2007, BIOMATERIALS, V28, P4748, DOI 10.1016/j.biomaterials.2007.07.020
   NAKAMURA T, 1985, J BIOMED MATER RES, V19, P685, DOI 10.1002/jbm.820190608
   O'Brien FJ, 2005, J ORTHOP RES, V23, P475, DOI 10.1016/j.orthres.2004.08.005
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Skedros JG, 2005, ANAT REC PART A, V286A, P781, DOI 10.1002/ar.a.20214
   Steflik, 1998, J BIOMED MATER RES, P611
   Sul YT, 2010, J R SOC INTERFACE, V7, P81, DOI 10.1098/rsif.2009.0060
   WELSH RP, 1971, J BONE JOINT SURG AM, VA 53, P963, DOI 10.2106/00004623-197153050-00011
   WONG M, 1995, J BIOMED MATER RES, V29, P1567, DOI 10.1002/jbm.820291213
NR 24
TC 0
Z9 0
U1 0
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD FEB
PY 2014
IS 84
AR e51221
DI 10.3791/51221
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA CA0JL
UT WOS:000348604100054
PM 24561765
OA Green Published
DA 2018-10-19
ER

PT J
AU Burnett, LR
   Richter, JG
   Rahmany, MB
   Soler, R
   Steen, JA
   Orlando, G
   Abouswareb, T
   Van Dyke, ME
AF Burnett, Luke R.
   Richter, Jillian G.
   Rahmany, Maria B.
   Soler, Roberto
   Steen, Julie A.
   Orlando, Giuseppe
   Abouswareb, Tamer
   Van Dyke, Mark E.
TI Novel keratin (KeraStat (TM)) and polyurethane (Nanosan (R)-Sorb)
   biomaterials are hemostatic in a porcine lethal extremity hemorrhage
   model
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Keratin biomaterials; Nanosan; KeraStat; Hemcon; hemostat; hemorrhage;
   arterial bleeding; swine model
ID ARTERIAL HEMORRHAGE; SWINE MODEL; DRESSINGS; INJURY; AGENTS; INTEGRIN;
   CARE; ADHESION; VOLUME; GAUZE
AB Traumatic injury is the leading cause of death in people aged 44 or less in the US. It is also estimated that 82% of deaths from battlefield hemorrhage may be survivable with better treatment options. In this study, two biomaterial hemostats having disparate mechanisms were evaluated in a large animal lethal hemorrhage model and compared to a commercial product and standard cotton gauze. We hypothesized that the biomaterial with a biologically active mechanism, as opposed to a mechanical mechanism, would be the most effective in this model. Using a published study protocol, the femoral artery in swine was punctured and treated. KeraStat (KeraNetics) and Nanosan (R)-Sorb (SNS Nano) hemostats were compared to a commercial chitosan dressing (second generation Hemcon (R)) and cotton gauze. Both KeraStat and Nanosan increased survival, significantly increased mean arterial pressure (MAP), and significantly decreased shock index compared to both controls. The Hemcon dressing was no different than gauze. Platelet adhesion assays suggested that the KeraStat mechanism of action involves 1 integrin mediated platelet adhesion while Nanosan-Sorb operates similar to one reported mechanism for Hemcon, absorbing fluid and concentrating clotting components. The Nanosan also swelled considerably and created pressure within the wound site even after direct pressure was removed.
C1 [Burnett, Luke R.] KeraNetics LLC, Winston Salem, NC USA.
   [Richter, Jillian G.; Soler, Roberto; Steen, Julie A.; Abouswareb, Tamer] Wake Forest Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA.
   [Rahmany, Maria B.; Van Dyke, Mark E.] Wake Forest Sch Med, Dept Orthopaed Surg, Winston Salem, NC USA.
   [Orlando, Giuseppe] Wake Forest Sch Med, Div Surg, Winston Salem, NC USA.
RP Van Dyke, ME (reprint author), Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
EM mvandyk5@vt.edu
RI Soler, Roberto/E-4094-2012
OI Soler, Roberto/0000-0002-1447-670X; Richter, Jillian/0000-0002-2233-1711
FU KeraNetics LLC; SNS Nano
FX Partial funding for this project was provided by KeraNetics LLC and SNS
   Nano.
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Acheson EM, 2005, J TRAUMA, V59, P865, DOI 10.1097/01.ta.0000187655.63698.9f
   Arnaud F, 2009, J VASC SURG, V50, P632, DOI 10.1016/j.jvs.2009.06.010
   BUSH JA, 1955, AM J PHYSIOL, V181, P9
   Clifford C Cloonan, 2004, Mil Med, V169, P8
   Gralnick HR, 1996, THROMB RES, V81, P113, DOI 10.1016/0049-3848(95)00219-7
   Holcomb JB, 1999, J TRAUMA, V47, P233, DOI 10.1097/00005373-199908000-00002
   Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1
   Kheirabadi BS, 2008, J SURG RES, V144, P145, DOI 10.1016/j.jss.2007.02.012
   Kheirabadi BS, 2010, J TRAUMA, V68, P269, DOI 10.1097/TA.0b013e3181c97ef1
   Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99
   Kozen BG, 2008, ACAD EMERG MED, V15, P74, DOI 10.1111/j.1553-2712.2007.00009.x
   Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523
   Littlejohn LF, 2011, ACAD EMERG MED, V18, P340, DOI 10.1111/j.1553-2712.2011.01036.x
   Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618
   Nieswandt B, 2001, EMBO J, V20, P2120, DOI 10.1093/emboj/20.9.2120
   Peake JB, 2005, NEW ENGL J MED, V352, P219, DOI 10.1056/NEJMp048312
   Pusateri AE, 2003, J TRAUMA, V55, P518, DOI 10.1097/01.TA.0000075336.92129.27
   Ran Y, 2010, PREHOSP DISASTER MED, V25, P584, DOI 10.1017/S1049023X00008797
   Sayer NA, 2009, PM&R, V1, P23, DOI 10.1016/j.pmrj.2008.10.003
   Sondeen JL, 2003, J TRAUMA, V54, P280, DOI 10.1097/01.TA.0000037431.19185.B4
   Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474
   Ward KR, 2007, J TRAUMA, V63, P276, DOI 10.1097/%A.0b013e3180eea8a5
   Wright JK, 2004, J TRAUMA, V57, P224, DOI 10.1097/01.TA.0000105916.30158.06
NR 24
TC 19
Z9 19
U1 2
U2 37
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 869
EP 879
DI 10.1177/0885328213484975
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100007
PM 23594681
DA 2018-10-19
ER

PT J
AU Akkouch, A
   Zhang, Z
   Rouabhia, M
AF Akkouch, Adil
   Zhang, Ze
   Rouabhia, Mahmoud
TI Engineering bone tissue using human dental pulp stem cells and an
   osteogenic collagen-hydroxyapatite-poly
   (L-lactide-co-epsilon-caprolactone) scaffold
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Human dental pulp stem cells; differentiation; biomaterial;
   poly(lactide-co--caprolactone); collagen; hydroxyapatite; bone
   regeneration
ID IN-VITRO; CALCIUM-PHOSPHATE; GENE-EXPRESSION; DIFFERENTIATION; VIVO;
   DEFECTS; REGENERATION; ASSOCIATION; OSTEOBLASTS; POPULATION
AB The aim of this study was to design a new natural/synthetic bioactive bone scaffold for potential use in bone replacement applications. We developed a tri-component osteogenic composite scaffold made of collagen (Coll), hydroxyapatite (HA) and poly(l-lactide-co--caprolactone) (PLCL). This Coll/HA/PLCL composite scaffold was combined with human osteoblast-like cells obtained by differentiation of dental pulp stem cells (DPSCs) to engineer bone tissue invitro. Results show that the 3D Coll/HA/PLCL composite scaffold was highly porous, thereby enabling osteoblast-like cell adhesion and growth. Cultured in the Coll/HA/PLCL scaffold, the osteoblast-like cells expressed different osteogenic genes, produced alkaline phosphatase and formed nodules more than did PLCL alone. Micro-CT analyses revealed a significant (30%) increase of tissue mineralisation on the surface as well as inside of the Coll/HA/PLCL scaffold, thus confirming its effectiveness as a bone regeneration platform.
C1 [Akkouch, Adil; Rouabhia, Mahmoud] Univ Laval, Fac Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] Univ Laval, Dept Surg, Quebec City, PQ, Canada.
   [Akkouch, Adil; Zhang, Ze] CHUQ, St Francois dAssise Hosp, Res Ctr, Quebec City, PQ, Canada.
RP Rouabhia, M (reprint author), Univ Laval, Fac Med Dent, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.
EM mahmoud.rouabhia@fmd.ulaval.ca
FU Canadian Institutes of Health Research (CIHR); Natural Science and
   Engineering Research Council of Canada (NSERC); Reseau de recherche en
   sante buccodentaire et osseuse du FRSQ
FX Financial support was provided by the Canadian Institutes of Health
   Research (CIHR), the Natural Science and Engineering Research Council of
   Canada (NSERC) and the Reseau de recherche en sante buccodentaire et
   osseuse du FRSQ.
CR Agarwal R, 2009, J NEUROSURG-SPINE, V11, P729, DOI 10.3171/2009.6.SPINE08669
   Akkouch A, 2010, J BIOMED MATER RES A, V92A, P221, DOI 10.1002/jbm.a.32357
   Atari M, 2012, BONE, V50, P930, DOI 10.1016/j.bone.2012.01.005
   Bottino MC, 2011, ACTA BIOMATER, V7, P216, DOI 10.1016/j.actbio.2010.08.019
   Boukhechba F, 2009, J BONE MINER RES, V24, P1927, DOI [10.1359/JBMR.090517, 10.1359/jbmr.090517]
   Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5
   Del Bue M, 2008, VET RES COMMUN, V32, pS51, DOI 10.1007/s11259-008-9093-3
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gong YH, 2007, ACTA BIOMATER, V3, P531, DOI 10.1016/j.actbio.2006.12.008
   Graham SM, 2010, EXPERT OPIN BIOL TH, V10, P885, DOI 10.1517/14712598.2010.481669
   Granero-Molto F, 2008, EXPERT OPIN BIOL TH, V8, P255, DOI [10.1517/14712598.8.3.255, 10.1517/14712598.8.3.255 ]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Iohara K, 2006, STEM CELLS, V24, P2493, DOI 10.1634/stemcells.2006-0161
   Jiao YP, 2007, BIOMED MATER, V2, pR24, DOI 10.1088/1748-6041/2/4/R02
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   Lim JI, 2008, BIOTECHNOL LETT, V30, P2085, DOI 10.1007/s10529-008-9808-0
   Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721
   Mori G, 2011, ANN NY ACAD SCI, V1237, P47, DOI 10.1111/j.1749-6632.2011.06234.x
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   Nakatsuka R, 2010, ARCH ORAL BIOL, V55, P350, DOI 10.1016/j.archoralbio.2010.03.003
   Niu XF, 2009, J CONTROL RELEASE, V134, P111, DOI 10.1016/j.jconrel.2008.11.020
   Oliver RC, 1998, J PERIODONTOL, V69, P269, DOI 10.1902/jop.1998.69.2.269
   Park BW, 2009, J ORAL MAXIL SURG, V67, P507, DOI 10.1016/j.joms.2008.08.037
   Park IS, 2009, J BIOMAT SCI-POLYM E, V20, P1645, DOI 10.1163/156856208X386237
   Perry BC, 2008, TISSUE ENG PT C-METH, V14, P149, DOI 10.1089/ten.tec.2008.0031
   Phipps MC, 2012, BIOMATERIALS, V33, P524, DOI 10.1016/j.biomaterials.2011.09.080
   Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813
   Riccio M, 2012, TISSUE ENG PT A, V18, P1006, DOI [10.1089/ten.TEA.2011.0542, 10.1089/ten.tea.2011.0542]
   Riekstina U, 2009, STEM CELL REV REP, V5, P378, DOI 10.1007/s12015-009-9094-9
   Sculean A, 2008, J PERIODONTOL, V79, P1991, DOI 10.1902/jop.2008.080009 
   Seong JM, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/6/062001
   Shetty Prathibha, 2010, Asian J Transfus Sci, V4, P14, DOI 10.4103/0973-6247.59386
   Vogt S., 2002, European Cells & Materials, V4, P30
   Xie JW, 2004, J BIOMED MATER RES A, V71A, P108, DOI 10.1002/jbm.a.30140
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 39
TC 32
Z9 33
U1 1
U2 31
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 922
EP 936
DI 10.1177/0885328213486705
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100012
PM 23640860
DA 2018-10-19
ER

PT J
AU Akagi, H
   Iwata, M
   Ichinohe, T
   Amimoto, H
   Hayashi, Y
   Kannno, N
   Ochi, H
   Fujita, Y
   Harada, Y
   Tagawa, M
   Hara, Y
AF Akagi, Hiroyuki
   Iwata, Munetaka
   Ichinohe, Tomu
   Amimoto, Hirokazu
   Hayashi, Yuuta
   Kannno, Nobuo
   Ochi, Hiroki
   Fujita, Yukihiro
   Harada, Yasuji
   Tagawa, Masahiro
   Hara, Yasushi
TI Hydroxyapatite/poly-L-lactide acid screws have better biocompatibility
   and femoral burr hole closure than does poly-L-lactide acid alone
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE Biomaterial; hydroxyapatite; poly-l-lactide; foreign body reaction;
   orthopedics
ID LONG-TERM; INTERNAL-FIXATION; COMPOSITE RODS; BONE-FRACTURES; PIN
   FIXATION; RABBITS; BEHAVIOR; SURGERY
AB Hydroxyapatite (HA)/poly-l-lactide(PLLA) composite biomaterials are available for orthopedic applications, but bioresorption and cell-mediated inflammation in bone cortex are unknown. We conducted an 84-month follow-up study with Beagle dogs that were subjected to implants with either PLLA (left femur) or HA/PLLA (right femur). Histological and radiographic analysis showed that HA/PLLA screws induced significant increases in HA content from 36 months onward and complete burr hole closure at 60 months, whereas PLLA screws did not. Moreover, PLLA screws induced more severe fibrous tissue and histiocyte infiltration. HA/PLLA screws promote earlier burr hole replacement and have superior biocompatibility compared to PLLA screws.
C1 [Akagi, Hiroyuki; Iwata, Munetaka; Ichinohe, Tomu; Amimoto, Hirokazu; Hayashi, Yuuta; Kannno, Nobuo; Harada, Yasuji; Tagawa, Masahiro; Hara, Yasushi] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, Tokyo 1808602, Japan.
   [Ochi, Hiroki] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Microbiol, Tokyo 1808602, Japan.
   [Fujita, Yukihiro] Azabu Univ, Sch Vet Med, Lab Vet Surg, Chuou Ku, Sagamihara, Kanagawa, Japan.
RP Hara, Y (reprint author), Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, 1-7-1 Kyonan Cho, Tokyo 1808602, Japan.
EM hara@nvlu.ac.jp
CR BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   DeOrio JK, 2001, FOOT ANKLE INT, V22, P832, DOI 10.1177/107110070102201010
   HARA Y, 1994, J VET MED SCI, V56, P817, DOI 10.1292/jvms.56.817
   HARA Y, 1994, J VET MED SCI, V56, P1041, DOI 10.1292/jvms.56.1041
   Hasegawa S, 2006, BIOMATERIALS, V27, P1327, DOI 10.1016/j.biomaterials.2005.09.003
   Hasegawa Y, 2002, J BIOMED MATER RES, V63, P679, DOI 10.1002/jbm.10388
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Ishii S, 2003, J BIOMED MATER RES B, V66B, P539, DOI 10.1002/jbm.b.10027
   Matsusue Y, 1996, CLIN ORTHOP RELAT R, P166
   MATSUSUE Y, 1995, CLIN ORTHOP RELAT R, P246
   Pihlajamaki H, 1998, Surg Technol Int, V7, P395
   Pihlajamaki H, 1992, J BONE JOINT SURG, V74-B, P857
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Saito T, 2004, ANN THORAC SURG, V77, P684, DOI 10.1016/S0003-4975(03)01341-9
   Tatsumi A, 1999, ANN THORAC SURG, V67, P765, DOI 10.1016/S0003-4975(98)01264-8
   TEGNANDER A, 1994, ACTA ORTHOP SCAND, V65, P472, DOI 10.3109/17453679408995495
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Yasunaga T, 1999, J BIOMED MATER RES, V47, P412, DOI 10.1002/(SICI)1097-4636(19991205)47:3<412::AID-JBM17>3.0.CO;2-B
NR 20
TC 5
Z9 5
U1 1
U2 14
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
EI 1530-8022
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD FEB
PY 2014
VL 28
IS 6
BP 954
EP 962
DI 10.1177/0885328213487754
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 284KX
UT WOS:000329317100015
PM 23680818
DA 2018-10-19
ER

PT J
AU Putra, N
   Saleh, R
   Septiadi, WN
   Okta, A
   Hamid, Z
AF Putra, Nandy
   Saleh, Rosari
   Septiadi, Wayan Nata
   Okta, Ashar
   Hamid, Zein
TI Thermal performance of biomaterial wick loop heat pipes with water-base
   Al2O3 nanofluids
SO INTERNATIONAL JOURNAL OF THERMAL SCIENCES
LA English
DT Article
DE Loop heat pipe; Wick; Nanofluids; Biomaterial
ID FLAT EVAPORATOR; ELECTRONICS; FLUID
AB Given the increase of heat flux generated by electronic equipment, particular components of a computer (e.g., the CPU) should always be accompanied with good cooling to achieve optimal operating capability and a high level of reliability. The use of loop heat pipes (LHPs) in the thermal management of electronic cooling is a major alternative solution. Before LHPs are implemented as an alternative cooling method for electronic devices, a quantity of reliability factors should be considered and evaluated, such as wick structure, material, and the type of working fluid. In this case, the pore size distribution of a biomaterial (Collar) that is smaller and more homogeneous than pore size distribution of sintered powder was investigated. The purposes of this experimental study are to examine and analyze the application of a biomaterial (Collar) as a wick on a loop heat pipe and the use of the nanofluid Al2O3 water as a working fluid. The performance of the biomaterial as a wick and nanofluid as a working fluid in LHPs was also investigated in this experiment. The temperature differences between the evaporator and condenser sections with the biomaterial wick were less than that using a sintered copper powder wick, and the use of nanofluids over pure water also resulted in lower temperature differences; i.e., the thermal resistance of the LHP was lowered when using the biomaterial wick and nanofluids. These results make the biomaterial (Collar) and nanofluids attractive as wick and working fluid, respectively, in LHP technology. (C) 2013 Elsevier Masson SAS. All rights reserved.
C1 [Putra, Nandy; Septiadi, Wayan Nata; Okta, Ashar; Hamid, Zein] Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Depok 16424, Indonesia.
   [Saleh, Rosari] Univ Indonesia, Fak MIPA, Dept Fis, Depok 15426, Indonesia.
RP Putra, N (reprint author), Univ Indonesia, Dept Mech Engn, Heat Transfer Lab, Kampus UI, Depok 16424, Indonesia.
EM nandyputra@eng.ui.ac.id
OI Septiadi, Wayan Nata/0000-0003-3121-9542
FU Directorate of Higher Education Minister of National Education Republic
   of Indonesia; DRPM University of Indonesia
FX The authors would like to thank Directorate of Higher Education Minister
   of National Education Republic of Indonesia and the DRPM University of
   Indonesia for funding this research.
CR Chang YW, 2008, ENERG CONVERS MANAGE, V49, P3398, DOI 10.1016/j.enconman.2008.05.002
   Do KH, 2010, INT J HEAT MASS TRAN, V53, P5888, DOI 10.1016/j.ijheatmasstransfer.2010.07.050
   Kang SW, 2006, APPL THERM ENG, V26, P2377, DOI 10.1016/j.applthermaleng.2006.02.020
   Kang SW, 2009, APPL THERM ENG, V29, P973, DOI 10.1016/j.applthermaleng.2008.05.010
   Kempers R, 2006, APPL THERM ENG, V26, P589, DOI 10.1016/j.applthermaleng.2005.07.004
   Kempers R, 2008, INT J HEAT MASS TRAN, V51, P6039, DOI 10.1016/j.ijheatmasstransfer.2008.04.001
   Kiseev VM, 2010, APPL THERM ENG, V30, P1312, DOI 10.1016/j.applthermaleng.2010.02.010
   Lefevre F, 2012, APPL THERM ENG, V37, P95, DOI 10.1016/j.applthermaleng.2011.11.022
   Leong KC, 1997, J POROUS MAT, V4, P303, DOI 10.1023/A:1009685508557
   Li J, 2010, APPL THERM ENG, V30, P741, DOI 10.1016/j.applthermaleng.2009.12.004
   Li JW, 2010, EXP THERM FLUID SCI, V34, P1403, DOI 10.1016/j.expthermflusci.2010.06.016
   Lin FC, 2011, INT J HEAT MASS TRAN, V54, P4621, DOI 10.1016/j.ijheatmasstransfer.2011.06.015
   Liu ZH, 2010, INT J THERM SCI, V49, P1680, DOI 10.1016/j.ijthermalsci.2010.03.006
   Liu ZH, 2011, ENERG CONVERS MANAGE, V52, P292, DOI 10.1016/j.enconman.2010.07.001
   Maydanik YF, 2005, IEEE T COMPON PACK T, V28, P290, DOI 10.1109/TCAPT.2005.848487
   Maydanik YF, 2005, APPL THERM ENG, V25, P635, DOI 10.1016/j.applthermaleng.2004.07.010
   Maydanik Y, 2011, APPL THERM ENG, V31, P3533, DOI 10.1016/j.applthermaleng.2011.07.008
   Mishra DK, 2010, ADV POWDER TECHNOL, V21, P658, DOI 10.1016/j.apt.2010.07.011
   Pastukhov VG, 2003, APPL THERM ENG, V23, P1125, DOI 10.1016/S1359-4311(03)00046-2
   Putra N, 2012, EXP THERM FLUID SCI, V40, P10, DOI 10.1016/j.expthermflusci.2012.01.007
   Putra Nandy, 2011, 4 INT M ADV THERM ME
   Riehl RR, 2005, APPL THERM ENG, V25, P101, DOI 10.1016/j.applthermaleng.2004.05.010
   Russel MK, 2011, APPL THERM ENG, V31, P69, DOI 10.1016/j.applthermaleng.2010.08.013
   Tang Y, 2010, EXP THERM FLUID SCI, V34, P190, DOI 10.1016/j.expthermflusci.2009.10.016
   Tsai CY, 2004, MATER LETT, V58, P1461, DOI 10.1016/j.matlet.2003.10.009
   Vasiliev L, 2009, INT J HEAT MASS TRAN, V52, P301, DOI 10.1016/j.ijheatmasstransfer.2008.06.016
   Zan K. J., 2004, Heat Transfer-Asian Research, V33, P515, DOI 10.1002/htj.20034
NR 27
TC 16
Z9 16
U1 0
U2 26
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 1290-0729
EI 1778-4166
J9 INT J THERM SCI
JI Int. J. Therm. Sci.
PD FEB
PY 2014
VL 76
BP 128
EP 136
DI 10.1016/j.ijthermalsci.2013.08.020
PG 9
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA 277FN
UT WOS:000328804500012
DA 2018-10-19
ER

PT J
AU Chung, TW
   Lai, DM
   Chen, SD
   Lin, YI
AF Chung, Tze-Wen
   Lai, Dar-Ming
   Chen, Shin-Der
   Lin, Ya-I
TI Poly (epsilon-caprolactone) scaffolds functionalized by grafting NGF and
   GRGD promote growth and differentiation of PC12 cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE NGF; GRGD; PCL scaffolds; PC12 cell; neural tissue engineering
ID HUMAN ENDOTHELIAL-CELLS; TISSUE ENGINEERING APPLICATIONS;
   PERIPHERAL-NERVE REGENERATION; NEURITE OUTGROWTH; NANOMETER-SCALE;
   REPAIR; RGD; GUIDANCE; SURFACE; PROTEINS
AB Poly(epsilon-caprolactone) (PCL) scaffolds functionalized by grafting nerve growth factor (NGF) and Asp-Arg-Gly-Asp (GRGD)(PCL-NGF/GRGD) for neural tissue engineering. The influences of PCL-NGF/GRGD scaffolds on the growth and differentiation of PC12 cells were investigated. The successfully grafting NGF and GRGD into PCL-CS scaffold were verified by FTIR spectra. The densities of GRGD and NGF in the scaffolds were about 2.10x10(-1) mol/cm(2) and 1.51x10(-3) nmol/cm(2). Growths of PC12 cells in PCL-GRGD and PCL/NGF-GRGD scaffolds via MTS measurements were significantly higher (p < 0.01, n = 4) than that in PCL-CS or PCL-NGF ones for three days of cultivation that was consistent with SEM observations. Moreover, the differentiation of PC12 cells, induced by NGF at 50 ng/mL for four days, in PCL-NGF/GRGD scaffolds were qualitatively more numbers and longer outgrowth of neurites than those in PCL-CS, PCL-GRGD, and PCL-NGF ones by SEM observations. The synergistic effects of grafting both NGF and GRGD ligands to PCL-CS scaffolds on the growth and differentiation of PC12 cells provide a new biomaterial for neural tissue engineering. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 315-323, 2014.
C1 [Chung, Tze-Wen; Chen, Shin-Der; Lin, Ya-I] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
   [Lai, Dar-Ming] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Surg, Taipei 10764, Taiwan.
RP Chung, TW (reprint author), Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Dou Liu 640, Yun Lin, Taiwan.
EM twchung@yuntech.edu.tw
FU NSC of Taiwan, ROC [NSC-100-2221- E-224-007-MY2]
FX This study is supported by NSC of Taiwan, ROC with the project no:
   NSC-100-2221- E-224-007-MY2.
CR Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Brose K, 2000, CURR OPIN NEUROBIOL, V10, P95, DOI 10.1016/S0959-4388(99)00066-5
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Chung TW, 2005, J BIOMED MATER RES A, V72A, P213, DOI 10.1002/jbm.a.30225
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   Chung TW, 2011, BIOMATERIALS, V32, P734, DOI 10.1016/j.biomaterials.2010.09.023
   Chung TW, 2010, J MICROENCAPSUL, V27, P514, DOI 10.3109/02652048.2010.484104
   Chung TW, 2010, J MATER SCI-MATER M, V21, P1343, DOI 10.1007/s10856-009-3876-0
   CORDONCARDO C, 1991, CELL, V66, P173, DOI 10.1016/0092-8674(91)90149-S
   DSOUZA SE, 1991, TRENDS BIOCHEM SCI, V16, P246, DOI 10.1016/0968-0004(91)90096-E
   FUJII DK, 1982, J NEUROSCI, V2, P1157
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Guo Y, 2007, BIOMACROMOLECULES, V8, P3025, DOI 10.1021/bm070266z
   Howe CL, 2003, NEUROSCI LETT, V351, P41, DOI 10.1016/S0304-3940(03)00915-7
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huang YC, 2007, J BIOMED MATER RES A, V82A, P842, DOI 10.1002/jbm.a.31036
   KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549
   Kokai LE, 2009, ACTA BIOMATER, V5, P2540, DOI 10.1016/j.actbio.2009.03.009
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Pankajakshan D, 2008, J BIOMED MATER RES B, V87B, P570, DOI 10.1002/jbm.b.31146
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   Tucker BA, 2005, J COMP NEUROL, V486, P267, DOI 10.1002/cne.20518
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Yan QJ, 2012, BIOMED ENG ONLINE, P11
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
NR 33
TC 4
Z9 4
U1 1
U2 22
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2014
VL 102
IS 2
BP 315
EP 323
DI 10.1002/jbm.a.34693
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269MT
UT WOS:000328246100002
PM 23468336
DA 2018-10-19
ER

PT J
AU Nectow, AR
   Kilmer, ME
   Kaplan, DL
AF Nectow, Alexander R.
   Kilmer, Misha E.
   Kaplan, David L.
TI Quantifying cellular alignment on anisotropic biomaterial platforms
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cellular alignment; algorithm; NCP criterion; silk; PC-12 cells
ID NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; IN-VITRO; SILK; GUIDANCE; CELLS;
   ORIENTATION; SCAFFOLDS; SUBSTRATE; GRADIENT
AB How do we quantify cellular alignment? Cellular alignment is an important technique used to study and promote tissue regeneration in vitro and in vivo. Indeed, regenerative outcomes are often strongly correlated with the efficacy of alignment, making quantitative, automated assessment an important goal for the field of tissue engineering. There currently exist various classes of algorithms, which effectively address the problem of quantifying individual cellular alignments using Fourier methods, kernel methods, and elliptical approximation; however, these algorithms often yield population distributions and are limited by their inability to yield a scalar metric quantifying the efficacy of alignment. The current work builds on these classes of algorithms by adapting the signal processing methods previously used by our group to study the alignment of cellular processes. We use an automated, ellipse-fitting algorithm to approximate cell body alignment with respect to a silk biomaterial scaffold, followed by the application of the normalized cumulative periodogram criterion to produce a scalar value quantifying alignment. The proposed work offers a generalized method for assessing cellular alignment in complex, two-dimensional environments. This method may also offer a novel alternative for assessing the alignment of cell types with polarity, such as fibroblasts, endothelial cells, and mesenchymal stem cells, as well as nuclei. (c) 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 420-428, 2014.
C1 [Nectow, Alexander R.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kilmer, Misha E.] Tufts Univ, Dept Math, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@Tufts.edu
FU NIH [P41EB002520]
FX Contract grant sponsor: NIH; contract grand number: P41EB002520
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bray MAP, 2010, BIOMATERIALS, V31, P5143, DOI 10.1016/j.biomaterials.2010.03.028
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Cecchini M, 2007, NANOTECHNOLOGY, V18, P1
   Chien HW, 2009, BIOMATERIALS, V30, P2209, DOI 10.1016/j.biomaterials.2008.12.060
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fitzgibbon A, 1999, IEEE T PATTERN ANAL, V21, P476, DOI 10.1109/34.765658
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Haines C, 2010, J NEUROSCI METH, V187, P52, DOI 10.1016/j.jneumeth.2009.12.010
   Hansen PC, 2006, BIT, V46, P41, DOI 10.1007/s10543-006-0042-7
   Heath M., 2002, SCI COMPUTING INTRO
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2012, ACTA BIOMATER, V8, P3732, DOI 10.1016/j.actbio.2012.06.009
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li GN, 2008, ANN BIOMED ENG, V36, P889, DOI 10.1007/s10439-008-9486-z
   Li GN, 2008, J NEUROSCI METH, V174, P202, DOI 10.1016/j.jneumeth.2008.07.001
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   Mandal BB, 2011, TISSUE ENG PT A, V17, P2749, DOI [10.1089/ten.tea.2011.0031, 10.1089/ten.TEA.2011.0031]
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Manjon-Herrera JV, 2005, KMEANS IMAGE SEGMENT
   Nectow AR, 2012, TISSUE ENG PART B-RE, V18, P40, DOI [10.1089/ten.teb.2011.0240, 10.1089/ten.TEB.2011.0240]
   Nectow AR, 2013, J BIOMED MATER RES A, V101, P884, DOI 10.1002/jbm.a.34385
   Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Phu D, 2011, TISSUE ENG PT A, V17, P799, DOI [10.1089/ten.tea.2009.0724, 10.1089/ten.TEA.2009.0724]
   Sofia S, 2001, J BIOMED MATER RES, V54, P138
   Song HK, 2006, BIOMATERIALS, V27, P473, DOI 10.1016/j.biomaterials.2005.06.030
   Xu F, 2011, TISSUE ENG PART C-ME, V17, P641, DOI 10.1089/ten.tec.2011.0038
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang YY, 2012, BIOMATERIALS, V33, P2926, DOI 10.1016/j.biomaterials.2012.01.006
NR 39
TC 6
Z9 6
U1 1
U2 21
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2014
VL 102
IS 2
BP 420
EP 428
DI 10.1002/jbm.a.34713
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 269MT
UT WOS:000328246100014
PM 23520051
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Akram, M
   Ahmed, R
   Shakir, I
   Ibrahim, WAW
   Hussain, R
AF Akram, Muhammad
   Ahmed, Rashid
   Shakir, Imran
   Ibrahim, Wan Aini Wan
   Hussain, Rafaqat
TI Extracting hydroxyapatite and its precursors from natural resources
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Review
ID CALCIUM-PHOSPHATE BIOCERAMICS; NANOCRYSTALLINE HYDROXYAPATITE;
   HEAT-TREATMENT; BOVINE BONE; NANOSIZED HYDROXYAPATITE; FISH BONES;
   EGG-SHELL; WASTE; CARBONATE; EGGSHELL
AB Healing of segmental bone defects remain a difficult problem in orthopedic and trauma surgery. One reason for this difficulty is the limited availability of bone material to fill the defect and promote bone growth. Hydroxyapatite (HA) is a synthetic biomaterial, which is chemically similar to the mineral component of bones and hard tissues in mammals and, therefore, it can be used as a filler to replace damaged bone or as a coating on implants to promote bone in-growth into prosthetic implants when used in orthopedic, dental, and maxillofacial applications. HA is a stoichiometric material with a chemical composition of Ca-10(PO4)(6)(OH)(2), while a mineral component of bone is a non-stoichiometric HA with trace amounts of ions such as Na+, Zn2+, Mg2+, K+, Si2+, Ba2+, F-, CO32-, etc. This review looks at the progress being made to extract HA and its precursors containing trace amount of beneficial ions from biological resources like animal bones, eggshells, wood, algae, etc. Properties, such as particle size, morphology, stoichiometry, thermal stability, and the presence of trace ions are studied with respect to the starting material and recovery method used. This review also highlights the importance of extracting HA from natural resources and gives future directions to the researcher so that HA extracted from biological resources can be used clinically as a valuable biomaterial.
C1 [Akram, Muhammad; Ibrahim, Wan Aini Wan] Univ Teknol Malaysia, Fac Sci, Dept Chem, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
   [Ahmed, Rashid] Univ Teknol Malaysia, Fac Sci, Dept Phys, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
   [Shakir, Imran] King Saud Univ, Dept Sustainable Energy, Riyadh, Saudi Arabia.
   [Hussain, Rafaqat] Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
RP Hussain, R (reprint author), Univ Teknol Malaysia, Ibnu Sina Inst Fundamental Sci Studies, Utm Johor Bahru 81310, Johor Darul Taz, Malaysia.
EM rafaqat@kimia.fs.utm.my
OI Hussain, Rafaqat/0000-0003-4810-4776
FU UTM through IDF [UTM. J. 10.01/13. 14/1/128(201105M10019)]
FX Authors would like to acknowledge the financial support from UTM through
   IDF UTM. J. 10.01/13. 14/1/128(201105M10019).
CR Bahrololoom ME, 2009, J CERAM PROCESS RES, V10, P129
   Baig AA, 1996, J COLLOID INTERF SCI, V179, P608, DOI 10.1006/jcis.1996.0255
   Balazsi C, 2007, J EUR CERAM SOC, V27, P1601, DOI 10.1016/j.jeurceramsoc.2006.04.016
   BANKS E, 1977, SCIENCE, V198, P1164, DOI 10.1126/science.929194
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0
   Betancuret ALG, 2013, CURR APPL PHYS, V13, P1383
   Bohner M, 2000, INJURY, V31, pS37
   Boutinguiza M, 2012, MAT SCI ENG C-MATER, V32, P478, DOI 10.1016/j.msec.2011.11.021
   BROWN WE, 1976, ANNU REV MATER SCI, V6, P213, DOI 10.1146/annurev.ms.06.080176.001241
   Cai YL, 2009, THIN SOLID FILMS, V517, P5347, DOI 10.1016/j.tsf.2009.03.071
   Carrodeguas RG, 2011, ACTA BIOMATER, V7, P3536, DOI 10.1016/j.actbio.2011.06.019
   Castro P., 2008, MARINE BIOL
   Chaari K, 2009, MATER CHEM PHYS, V113, P219, DOI 10.1016/j.matchemphys.2008.07.079
   Chaudhuri B, 2013, MATER LETT, V97, P148, DOI 10.1016/j.matlet.2013.01.082
   Coelho TM, 2006, J APPL PHYS, V100, DOI 10.1063/1.2369647
   dePaula SM, 2010, MICRON, V41, P983, DOI 10.1016/j.micron.2010.06.014
   Ribeiro DCD, 2012, MICROSC RES TECHNIQ, V75, P133, DOI 10.1002/jemt.21035
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feki H. E., 1991, CALCIFIED TISSUE INT, V49, P269
   Ferraro V, 2013, MAT SCI ENG C-MATER, V33, P3111, DOI 10.1016/j.msec.2013.04.003
   Figueiredo M, 2010, CERAM INT, V36, P2383, DOI 10.1016/j.ceramint.2010.07.016
   Gergely G, 2010, CERAM INT, V36, P803, DOI 10.1016/j.ceramint.2009.09.020
   Goloshchapov DL, 2013, CERAM INT, V39, P4539, DOI 10.1016/j.ceramint.2012.11.050
   Gutierres M, 2007, J MATER SCI-MATER M, V18, P2377, DOI 10.1007/s10856-007-3171-x
   Haberko K, 2006, J EUR CERAM SOC, V26, P537, DOI 10.1016/j.jeurceramsoc.2005.07.033
   Habib F, 2012, J CHEM SOC PAKISTAN, V34, P584
   Hench L. L., 1993, ADV SERIES CERAMICS
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Huang YC, 2011, CERAM INT, V37, P1825, DOI 10.1016/j.ceramint.2011.01.018
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Ivankovic H, 2010, J MATER SCI-MATER M, V21, P2711, DOI 10.1007/s10856-010-4115-4
   Ivarez-Lloret P, 2010, CRYS GROWTH DES, V10, P5227
   Jaramillo CD, 2010, REV COLOMB CIENC PEC, V23, P471
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kalita SJ, 2007, MAT SCI ENG C-BIO S, V27, P441, DOI 10.1016/j.msec.2006.05.018
   Kannan S, 2006, J MATER CHEM, V16, P286, DOI 10.1039/b511867k
   Kaplan DL, 1998, SCIENCE, V3, P232
   Kim SK, 2006, FOOD RES INT, V39, P383, DOI 10.1016/j.foodres.2005.10.010
   Kim SK, 2001, LIFE SCI J, V11, P97
   Kim YH, 2005, CURR APPL PHYS, V5, P538, DOI 10.1016/j.cap.2005.01.031
   Kongsri S, 2013, CHEM ENG J, V215, P522, DOI 10.1016/j.cej.2012.11.054
   Krishna DSR, 2007, J MATER SCI-MATER M, V18, P1735, DOI 10.1007/s10856-007-3069-7
   Kumar GS, 2012, MATER LETT, V76, P198, DOI 10.1016/j.matlet.2012.02.106
   Kusmanto F, 2008, CHEM ENG J, V139, P398, DOI 10.1016/j.cej.2007.11.041
   Kusrini E, 2012, RADIAT PHYS CHEM, V81, P118, DOI 10.1016/j.radphyschem.2011.10.006
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   LAWTON DM, 1989, J DENT, V17, P21, DOI 10.1016/0300-5712(89)90003-1
   Lee SJ, 2003, MATER LETT, V57, P4570, DOI 10.1016/S0167-577X903)00363-X
   Li SN, 2012, J AM CERAM SOC, V95, P3377, DOI 10.1111/j.1551-2916.2012.05458.x
   Lin FH, 2000, J BIOMED MATER RES, V51, P157, DOI 10.1002/(SICI)1097-4636(200008)51:2<157::AID-JBM3>3.0.CO;2-R
   Lombardi M, 2011, J EUR CERAM SOC, V31, P2513, DOI 10.1016/j.jeurceramsoc.2011.02.017
   Meski S, 2010, J CHEM ENG DATA, V55, P3923, DOI 10.1021/je901070e
   MONROE EA, 1971, J DENT RES, V50, P860, DOI 10.1177/00220345710500041201
   MULYE NV, 1994, DRUG DEV IND PHARM, V20, P2621, DOI 10.3109/03639049409042666
   Murugan R, 2005, CRYST GROWTH DES, V5, P111, DOI 10.1021/cg034227s
   Murugan R, 2006, MATER LETT, V60, P2844, DOI 10.1016/j.matlet.2006.01.104
   Nayar S, 2009, MAT SCI ENG C-BIO S, V29, P1326, DOI 10.1016/j.msec.2008.10.002
   NELSON DGA, 1983, CARIES RES, V17, P200, DOI 10.1159/000260668
   Nirmala R, 2011, J NANOPART RES, V13, P1917, DOI 10.1007/s11051-010-9944-z
   Noh KT, 2010, MATER LETT, V64, P802, DOI 10.1016/j.matlet.2010.01.014
   Ooi CY, 2007, CERAM INT, V33, P1171, DOI 10.1016/j.ceramint.2006.04.001
   Ozawa M, 2002, J AM CERAM SOC, V85, P1315, DOI 10.1111/j.1151-2916.2002.tb00268.x
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Piccirillo C, 2013, MAT SCI ENG C-MATER, V33, P103, DOI 10.1016/j.msec.2012.08.014
   Pramanik N, 2009, INT J BIOMATER, DOI 10.1155/2009/512417
   Pramanik S, 2013, MATERIALS, V6, P65, DOI 10.3390/ma6010065
   Rakmae S, 2013, POLYM-PLAST TECHNOL, V52, P1043, DOI 10.1080/03602559.2013.769580
   Rakmae S, 2012, MAT SCI ENG C-MATER, V32, P1428, DOI 10.1016/j.msec.2012.04.022
   Ramesh S, 2007, SCI TECHNOL ADV MAT, V8, P124, DOI 10.1016/j.stam.2006.11.002
   REJDA BV, 1977, J BIOENG, V1, P93
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Rodrigues CVM, 2003, BIOMATERIALS, V24, P4987, DOI 10.1016/S0142-9612(03)00410-1
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Ruksudjarlt A, 2008, CURR APPL PHYS, V8, P270, DOI 10.1016/j.cap.2007.10.076
   Sakka S., 2013, ADV BIOMATERIALS SCI, P23, DOI DOI 10.5772/53088
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Sellami I, 2000, MATER SCI ENG, V28, P1
   Shaltout AA, 2011, SPECTROCHIM ACTA A, V83, P56, DOI 10.1016/j.saa.2011.07.036
   Shariffuddin JH, 2013, CHEM ENG RES DES, V91, P1693, DOI 10.1016/j.cherd.2013.04.018
   Smolen D, 2013, INT J NANOMED, V8, P653, DOI 10.2147/IJN.S39299
   Sobczak A, 2009, ACTA BIOENG BIOMECH, V11, P23
   Studart AR, 2006, J AM CERAM SOC, V89, P1771, DOI 10.1111/j.1551-2916.2006.01044.x
   Sykaras Nikitas, 2003, J Oral Sci, V45, P57
   Tabrizi BN, 2013, J IND ENG CHEM, DOI [10.1016/j.jiec.2013.03.041, DOI 10.1016/J.JIEC.2013.03.041]
   TAKAGI S, 1987, J DENT RES, V66, P1523, DOI 10.1177/00220345870660100201
   Tampieri A, 2009, J MATER CHEM, V19, P4973, DOI 10.1039/b900333a
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Vecchio KS, 2007, ACTA BIOMATER, V3, P910, DOI 10.1016/j.actbio.2007.06.003
   Venkatesan J, 2011, BIOMAD MAT, V6, P12
   Verdelis K, 2007, BONE, V40, P1399, DOI 10.1016/j.bone.2006.12.061
   Villarreal NE, 2012, WATER AIR SOIL POLL, V223, P3643
   Walsh PJ, 2008, CHEM ENG J, V137, P173, DOI 10.1016/j.cej.2007.10.016
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
   Wu SC, 2011, MATER CHARACT, V62, P1180, DOI 10.1016/j.matchar.2011.09.009
   Xu GF, 2001, J AM CHEM SOC, V123, P2196, DOI 10.1021/ja002537i
   Yoganand CP, 2011, CURR APPL PHYS, V11, P702, DOI 10.1016/j.cap.2010.11.035
   Zhang Y, 2011, J MATER CHEM, V21, P14428, DOI 10.1039/c1jm12544c
NR 103
TC 59
Z9 60
U1 6
U2 109
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0022-2461
EI 1573-4803
J9 J MATER SCI
JI J. Mater. Sci.
PD FEB
PY 2014
VL 49
IS 4
BP 1461
EP 1475
DI 10.1007/s10853-013-7864-x
PG 15
WC Materials Science, Multidisciplinary
SC Materials Science
GA 270OI
UT WOS:000328327600002
DA 2018-10-19
ER

PT J
AU Favi, PM
   Yi, SJ
   Lenaghan, SC
   Xia, LJ
   Zhang, MJ
AF Favi, Pelagie M.
   Yi, Sijia
   Lenaghan, Scott C.
   Xia, Lijin
   Zhang, Mingjun
TI Inspiration from the natural world: from bio-adhesives to bio-inspired
   adhesives
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE bio-adhesive; bio-inspiration; biomaterial; biomimetic;
   micro-nanotechnology
ID BARNACLE BALANUS-AMPHITRITE; ATOMIC-FORCE MICROSCOPY; GLUTARALDEHYDE
   TISSUE ADHESIVE; AMPHIBIAN SKIN SECRETIONS; GREEN-ALGA ENTEROMORPHA;
   FROG NOTADEN-BENNETTI; GECKO FOOT-HAIR; PHRAGMATOPOMA-CALIFORNICA;
   ESCHERICHIA-COLI; ATTACHMENT PADS
AB Advances in materials science and engineering through bio-inspiration, at both the micro- and nanoscales, have flourished over recent years. By understanding principles used in nature to produce adhesives and other substances of interest, the field of bio-inspired engineering has emerged as an important area of innovation. In this review, we will focus on bio-adhesives based on three main mechanisms of generating attachment: dry, wet, and chemical adhesion. Dry adhesion, involving micro- to nanoscale filamentous structures, is used by many insects and reptiles to rapidly climb surfaces. Tree frogs and some insects make use of wet adhesion by leveraging capillary forces through the design of attaching structures that increases liquid drainage, and hence increases frictional contact. Finally, chemical adhesion is used by many plants and mollusks, which secrete adhesives composed of proteins, polysaccharides and carbohydrates to generate the strong forces necessary for adhesion. This paper reviews recent discoveries in animal and plant bio-adhesives, and details the mechanisms used in several representative biological systems. We extend the review to include the fundamental principles functioning in each form of adhesion at the micro- and nanoscales. This fast emerging research area has significant implications in the future design of bio-inspired adhesives, and offers further potential for a variety of applications.
C1 [Favi, Pelagie M.; Yi, Sijia; Lenaghan, Scott C.; Xia, Lijin; Zhang, Mingjun] Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
RP Zhang, MJ (reprint author), Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
EM mjzhang@utk.edu
OI Lenaghan, Scott/0000-0002-7539-1726
FU National Science Foundation [CBET: 0965877, CMMI: 1029953]; Army
   Research Office [W911NF-10-1-0114]; National Institute of Health
   [NIH/NIGMS-IMSD: R25 GM086761]
FX This research was sponsored by the National Science Foundation (CBET:
   0965877, CMMI: 1029953), the Army Research Office (W911NF-10-1-0114),
   and the National Institute of Health (NIH/NIGMS-IMSD: R25 GM086761). The
   authors would like to thank all the sponsors for their financial
   support.
CR Abou B, 2010, J R SOC INTERFACE, V7, P1745, DOI 10.1098/rsif.2010.0075
   Aldred N, 2008, BIOFOULING, V24, P97, DOI 10.1080/08927010801885908
   Arzt E, 2003, P NATL ACAD SCI USA, V100, P10603, DOI 10.1073/pnas.1534701100
   Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469
   Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486
   Autumn K, 2006, J EXP BIOL, V209, P260, DOI 10.1242/jeb.01980
   Autumn K, 2002, INTEGR COMP BIOL, V42, P1081, DOI 10.1093/icb/42.6.1081
   Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799
   Autumn K, 2000, NATURE, V405, P681
   Bar-Cohen Y, 2006, BIOMIMETICS BIOL INS
   Barlow DE, 2010, LANGMUIR, V26, P6549, DOI 10.1021/la9041309
   Barnes WJP, 2007, MRS BULL, V32, P479, DOI 10.1557/mrs2007.81
   BAUCHHENSS E, 1979, ZOOMORPHOLOGIE, V93, P99, DOI 10.1007/BF00994125
   Baudner BC, 2010, J DRUG TARGET, V18, P752, DOI 10.3109/1061186X.2010.529143
   Bell EC, 1996, J EXP BIOL, V199, P1005
   Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x
   Bhushan B., 2008, NANOTRIBOLOGY NANOME
   Bhushan B, 2008, LOTUS EFFECT ROUGHNE, P995
   Bhushan B, 2007, J ADHES SCI TECHNOL, V21, P1213, DOI 10.1163/156856107782328353
   Bhushan B, 2007, MICROSYST TECHNOL, V13, P71, DOI 10.1007/s00542-006-0256-2
   Bhushan B, 2009, PHILOS T R SOC A, V367, P1445, DOI 10.1098/rsta.2009.0011
   Bitton R, 2006, MACROMOL BIOSCI, V6, P737, DOI 10.1002/mabi.200600073
   Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941
   Burzio LA, 2000, BIOCHEMISTRY-US, V39, P11147, DOI 10.1021/bi0002434
   Callow J, 2006, ULVA SPORE ADHESIVE
   Callow JA, 2000, PLANTA, V211, P641, DOI 10.1007/s004250000337
   Callow JA, 2000, BIOFOULING, V16, P141, DOI 10.1080/08927010009378439
   Carre A, 2009, SUPERHYDROPHOBIC SURFACES, pIX
   Chan EP, 2008, ADV MATER, V20, P711, DOI 10.1002/adma.200701530
   Chen B, 2008, P R SOC A, V464, P1639, DOI 10.1098/rspa.2007.0350
   Cho Hyung Joon, 2008, Biotechnology Journal, V3, P631, DOI 10.1002/biot.200700258
   Chung IM, 2008, BIOMATERIALS, V29, P2637, DOI 10.1016/j.biomaterials.2008.03.008
   Chung JY, 2005, J ROY SOC INTERFACE, V2, P55, DOI 10.1098/rsif.2004.0020
   Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045
   Clemente CJ, 2008, P R SOC B, V275, P1329, DOI 10.1098/rspb.2007.1660
   Dirks JH, 2010, J R SOC INTERFACE, V7, P587, DOI 10.1098/rsif.2009.0308
   Dodiuk H, 2005, INT J ADHES ADHES, V25, P211, DOI 10.1016/j.ijadhadh.2004.07.003
   Donovan DA, 1997, J EXP BIOL, V200, P1145
   Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5
   EDWARDS JS, 1970, PROC R ENTOMOL SOC A, V45, P1
   Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568
   EMERSON SB, 1980, BIOL J LINN SOC, V13, P199, DOI 10.1111/j.1095-8312.1980.tb00082.x
   EVANS CM, 1994, J HERPETOL, V28, P499, DOI 10.2307/1564965
   Fan XW, 2005, J AM CHEM SOC, V127, P15843, DOI 10.1021/ja0532638
   Fearing RS, 2007, J ADHES SCI TECHNOL, V21, P1117
   Federle W, 2006, J R SOC INTERFACE, V3, P689, DOI 10.1098/rsif.2006.0135
   Federle W, 2006, J EXP BIOL, V209, P2611, DOI 10.1242/jeb.02323
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Finlay JA, 2002, INTEGR COMP BIOL, V42, P1116, DOI 10.1093/icb/42.6.1116
   Furst W, 2005, ANN THORAC SURG, V79, P1522, DOI 10.1016/j.athoracsur.2004.11.054
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Ge L, 2007, P NATL ACAD SCI USA, V104, P10792, DOI 10.1073/pnas.0703505104
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Geiselhardt SF, 2010, J INSECT PHYSIOL, V56, P398, DOI 10.1016/j.jinsphys.2009.11.016
   Gim Y, 2008, BIOTECHNOL PROGR, V24, P1272, DOI [10.1002/btpr.65, 10.1021/bp.65]
   Goldmann AS, 2010, MACROMOL RAPID COMM, V31, P1608, DOI 10.1002/marc.201000193
   Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135
   Gorb S, 2007, J R SOC INTERFACE, V4, P271, DOI 10.1098/rsif.2006.0164
   Gorb S, 2001, ATTACHMENT DEVICES I
   Gorb SN, 2007, BIOINSPIR BIOMIM, V2, pS117, DOI 10.1088/1748-3182/2/4/S01
   GOWDA DC, 1982, PHYTOCHEMISTRY, V21, P2297, DOI 10.1016/0031-9422(82)85194-7
   Graham L. D., 2006, ADHESIVE SECRETED AU, P207
   Graham LD, 2005, BIOMACROMOLECULES, V6, P3300, DOI 10.1021/bm050335e
   Graham LD, 2010, J BIOMED MATER RES A, V93A, P429, DOI 10.1002/jbm.a.32559
   Gravish N, 2008, J R SOC INTERFACE, V5, P339, DOI 10.1098/rsif.2007.1077
   Haag AP, 2006, MECH PROPERTIES BACT, P1
   Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102
   Hartwig A, 2009, MACROMOL MATER ENG, V294, P363, DOI 10.1002/mame.200900031
   Herget GW, 2001, EUR J CARDIO-THORAC, V19, P4, DOI 10.1016/S1010-7940(00)00613-8
   Hideki T, 2000, J APPL POLYM SCI, V76, P929
   Higgins MJ, 2002, PROTIST, V153, P25, DOI 10.1078/1434-4610-00080
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012
   Howard F., 1998, WILBUR ORVILLE BIOGR
   Huang J, 2008, J AM OIL CHEM SOC, V85, P63, DOI 10.1007/s11746-007-1162-1
   Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102
   Hui CY, 2007, J ADHES SCI TECHNOL, V21, P1259, DOI 10.1163/156856107782328362
   Hutchinson H, 2008, MECH ENG, V130, P42
   Hwang DS, 2010, J BIOL CHEM, V285, P25850, DOI 10.1074/jbc.M110.133157
   Hwang DS, 2010, BIOMATERIALS, V31, P1080, DOI 10.1016/j.biomaterials.2009.10.041
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   Illum L, 2001, INT J PHARM, V222, P109, DOI 10.1016/S0378-5173(01)00708-6
   ISHII S, 1987, APPL ENTOMOL ZOOL, V22, P222, DOI 10.1303/aez.22.222
   Jeong HE, 2010, LANGMUIR, V26, P2223, DOI 10.1021/la904290g
   Kamino K, 2008, MAR BIOTECHNOL, V10, P111, DOI 10.1007/s10126-007-9076-3
   Kamino K, 2006, BIOLOGICAL ADHESIVES, P145, DOI 10.1007/978-3-540-31049-5_8
   Karsten U, 2007, ALGAE CYANOBACTERIA, V11
   Katav T, 2008, J CONTROL RELEASE, V130, P183, DOI 10.1016/j.jconrel.2008.06.002
   Khandeparker L, 2007, INT J ADHES ADHES, V27, P165, DOI 10.1016/j.ijadhadh.2006.03.004
   Khoee S, 2009, J COLLOID INTERF SCI, V336, P872, DOI 10.1016/j.jcis.2009.04.067
   Kim S, 2008, J NANOSCI NANOTECHNO, V8, P4779, DOI 10.1166/jnn.2008.IC45
   Kim TW, 2008, J R SOC INTERFACE, V5, P319, DOI 10.1098/rsif.2007.1078
   Kim TI, 2009, ADV MATER, V21, P2276, DOI 10.1002/adma.200803710
   Koch K, 2009, PROG MATER SCI, V54, P137, DOI 10.1016/j.pmatsci.2008.07.003
   Kosaki A, 1996, JPN J APPL ENTOMOL Z, V40, P47
   Kovacik J, 2012, AMINO ACIDS, V42, P1277, DOI 10.1007/s00726-010-0820-z
   Kuo CFJ, 2006, J APPL POLYM SCI, V102, P5303, DOI 10.1002/app.24827
   Kwaki JS, 2010, INT J PRECIS ENG MAN, V11, P171, DOI [10.1007/s12541-010-0020-5, 10.1007/S12541-010-0020-5]
   Lambuth A., 2006, COATINGS MAT SURFACE
   Langer MG, 2004, P ROY SOC B-BIOL SCI, V271, P2209, DOI 10.1098/rspb.2004.2850
   Lee BP, 2002, BIOMACROMOLECULES, V3, P1038, DOI 10.1021/bm025546n
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee J, 2009, LANGMUIR, V25, P12449, DOI 10.1021/la9029672
   Lee WF, 2006, J APPL POLYM SCI, V100, P3653, DOI 10.1002/app.23171
   Leggat PA, 2007, ANZ J SURG, V77, P209, DOI 10.1111/j.1445-2197.2007.04020.x
   Lehr CM, 2000, J CONTROL RELEASE, V65, P19, DOI 10.1016/S0168-3659(99)00228-X
   Li LL, 2006, J PHARM SCI-US, V95, P326, DOI 10.1002/jps.20541
   Lin AYM, 2009, ACTA MATER, V57, P4178, DOI 10.1016/j.actamat.2009.05.015
   Lin A. Y. M., 2008, THESIS U CALIFORNIA
   Lohbauer U, 2010, ACTA BIOMATER, V6, P4539, DOI 10.1016/j.actbio.2010.07.002
   May M, 2010, INT J ADHES ADHES, V30, P505, DOI 10.1016/j.ijadhadh.2010.05.002
   Melzer B, 2010, J R SOC INTERFACE, V7, P1383, DOI 10.1098/rsif.2010.0140
   Meyers MA, 2011, J MECH BEHAV BIOMED, V4, P626, DOI 10.1016/j.jmbbm.2010.08.005
   Millar NL, 2009, J SHOULDER ELB SURG, V18, P639, DOI 10.1016/j.jse.2008.12.007
   Mizuhira V, 2004, J ELECTRON MICROSC, V53, P63, DOI 10.1093/jmicro/53.1.63
   Mostaert AS, 2006, J BIOL PHYS, V32, P393, DOI 10.1007/s10867-006-9023-y
   Mostaert AS, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044010
   Mulet ME, 2006, BRIT J OPHTHALMOL, V90, P208, DOI 10.1136/bjo.2005.07.076497
   Northen MT, 2008, ADV MATER, V20, P3905, DOI 10.1002/adma.200801340
   Oz MC, 2000, ANN THORAC SURG, V69, P1376, DOI 10.1016/S0003-4975(00)01194-2
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   Pardo J., 1990, Protein Expression and Purification, V1, P147, DOI 10.1016/1046-5928(90)90008-M
   Parris N, 2003, J AGR FOOD CHEM, V51, P3892, DOI 10.1021/jf0212183
   Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104
   Peattie AM, 2007, J R SOC INTERFACE, V4, P1071, DOI 10.1098/rsif.2007.0226
   Peattie AM, 2009, J COMP PHYSIOL B, V179, P231, DOI 10.1007/s00360-008-0310-8
   PERESWETOFFMORATH L, 1995, INT J PHARM, V124, P37, DOI 10.1016/0378-5173(95)00070-Y
   Persson BNJ, 2003, J CHEM PHYS, V119, P11437, DOI 10.1063/1.1621854
   Persson BNJ, 2003, J CHEM PHYS, V118, P7614, DOI 10.1063/1.1562192
   Petrie EM., 2000, HDB ADHESIVES SEALAN
   Pettitt ME, 2004, BIOFOULING, V20, P299, DOI 10.1080/08927010400027068
   Phang I, 2007, NANOS, V1, P35
   Phang IY, 2006, BIOFOULING, V22, P245, DOI 10.1080/08927010600857686
   Plattner VE, 2010, INT J PHARMACEUT, V387, P34, DOI 10.1016/j.ijpharm.2009.11.030
   Prowse MS, 2011, ACTA BIOMATER, V7, P733, DOI 10.1016/j.actbio.2010.09.036
   Puthoff JB, 2010, J EXP BIOL, V213, P3699, DOI 10.1242/jeb.047654
   Qi GY, 2011, J AM OIL CHEM SOC, V88, P271, DOI 10.1007/s11746-010-1666-y
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   ROST K, 1977, PHYTOCHEMISTRY, V16, P1365, DOI 10.1016/S0031-9422(00)88783-X
   Scherge M., 2001, BIOL MICRO NANOTRIBO
   Scholz I, 2009, J EXP BIOL, V212, P155, DOI 10.1242/jeb.019232
   Schulz H, 2008, J DENT, V36, P579, DOI 10.1016/j.jdent.2008.04.010
   Shao H, 2009, MACROMOL BIOSCI, V9, P464, DOI 10.1002/mabi.200800252
   Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006
   Smith DC, 2004, BIOMATERIALS SCI INT, p573 
   Smith JM, 2006, J COMP PHYSIOL A, V192, P1193, DOI 10.1007/s00359-006-0151-4
   Spierer A, 1997, INVEST OPHTH VIS SCI, V38, P543
   Spotnitz WD, 2008, ORTHOPEDIC BIOL MED
   Spotnitz WD, 2010, CLIN APPL THROMB-HEM, V16, P497, DOI 10.1177/1076029610363589
   Steinbrecher T, 2010, ACTA BIOMATER, V6, P1497, DOI 10.1016/j.actbio.2009.10.003
   Stevens MJ, 2007, LANGMUIR, V23, P5045, DOI 10.1021/la063765e
   Stewart RJ, 2004, J EXP BIOL, V207, P4727, DOI 10.1242/jeb.01330
   Stewart RJ, 2011, ADV COLLOID INTERFAC, V167, P85, DOI 10.1016/j.cis.2010.10.009
   STRAUSBERG RL, 1990, TRENDS BIOTECHNOL, V8, P53, DOI 10.1016/0167-7799(90)90134-J
   Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200
   Suszkiw J., 2009, AGR RES MAGAZINE, V57, P2
   Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103
   Tyler MJ, 2002, USA Patent, Patent No. [WO2002022756, 2002022756]
   Unver O, 2010, IEEE T ROBOT, V26, P131, DOI 10.1109/TRO.2009.2033628
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3
   WAITE JH, 1981, SCIENCE, V212, P1038, DOI 10.1126/science.212.4498.1038
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WALKER G, 1985, J ZOOL, V205, P297, DOI 10.1111/j.1469-7998.1985.tb03536.x
   Waychunas GA, 2008, ELEMENTS, V4, P381, DOI 10.2113/gselements.4.6.381
   Weimer PJ, 2003, APPL MICROBIOL BIOT, V63, P29, DOI 10.1007/s00253-003-1334-3
   Wilker JJ, 2010, ANGEW CHEM INT EDIT, V49, P8076, DOI 10.1002/anie.201003171
   Wilker JJ, 2010, CURR OPIN CHEM BIOL, V14, P276, DOI 10.1016/j.cbpa.2009.11.009
   Wu Y, 2010, J COLLOID INTERF SCI, V344, P533, DOI 10.1016/j.jcis.2009.12.041
   Xia F, 2008, ADV MATER, V20, P2842, DOI 10.1002/adma.200800836
   Xia LJ, 2011, J NANOPART RES, V13, P1029, DOI 10.1007/s11051-010-0091-3
   Yamamoto H, 1996, BIOTECHNOL GENET ENG, V13, P133, DOI 10.1080/02648725.1996.10647926
   Yanik MF, 2009, TRENDS BIOTECHNOL, V27, P1, DOI 10.1016/j.tibtech.2008.10.001
   Yao H, 2006, J MECH PHYS SOLIDS, V54, P1120, DOI 10.1016/j.jmps.2006.01.002
   Yao HM, 2007, J ADHES SCI TECHNOL, V21, P1185, DOI 10.1163/156856107782328326
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Zeng HB, 2010, P NATL ACAD SCI USA, V107, P12850, DOI 10.1073/pnas.1007416107
   Zhang MJ, 2008, NANO LETT, V8, P1277, DOI 10.1021/nl0725704
   Zhang Mingjun, 2010, Journal of Nanobiotechnology, V8, P20, DOI 10.1186/1477-3155-8-20
   Zhang XJ, 2009, CHINESE SCI BULL, V54, P1648, DOI [10.1007/s11434-009-0234-z, 10.1007/S11434-009-0234-Z]
   Zhao H, 2005, J BIOL CHEM, V280, P42938, DOI 10.1074/jbc.M508457200
NR 184
TC 17
Z9 17
U1 9
U2 176
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD FEB 1
PY 2014
VL 28
IS 3-4
SI SI
BP 290
EP 319
DI 10.1080/01694243.2012.691809
PG 30
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 254QQ
UT WOS:000327180800006
DA 2018-10-19
ER

PT J
AU Zhang, YL
   Gao, CJ
   Li, XL
   Xu, C
   Zhang, Y
   Sun, ZM
   Liu, Y
   Gao, JP
AF Zhang, Yongli
   Gao, Chunjuan
   Li, Xiulan
   Xu, Chen
   Zhang, Yang
   Sun, Zhiming
   Liu, Yu
   Gao, Jianping
TI Thermosensitive methyl cellulose-based injectable hydrogels for
   post-operation anti-adhesion
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Anti-adhesion; Biomaterial; Methyl cellulose; Chitosan; PEG; Hydrogel
ID HYALURONIC-ACID; GEL; METHYLCELLULOSE; ADHESIONS; TEMPERATURE;
   PREVENTION; CHITOSAN; SURGERY; WATER; SULFATE
AB Thermosensitive methyl cellulose (MC)-based injectable hydrogels for post-operation anti-adhesion were prepared by integrating polyethylene glycol (PEG), carboxymethyl cellulose (CMC) and chitosan sulfate (CS-SO3) with MC sols. The viscosity of the MC-based sols depended on the sol composition, especially the amount of CMC. The gelation temperature of the sols was tuned by adjusting the concentrations of K+ and other components to obtain an MC-based sol that transformed to a gel at body temperature. The composition of the sol also affected the gel strength. Adding PEG decreased the repulsions between the CMC and CS-SO3 macromolecules and thus increased the gel strength. The efficacy of the MC-based injectable hydrogels as barriers for reducing postsurgical adhesions was evaluated using a rat cecal abrasion model. The PEG and CS-SO3 loaded MC-based injectable hydrogels were effective in reducing adhesion formation and reduced adhesiolysis difficulties. (C) 2013 Published by Elsevier Ltd.
C1 [Zhang, Yongli; Sun, Zhiming] Huanhu Hosp, Tianjin 300060, Peoples R China.
   [Gao, Chunjuan; Liu, Yu; Gao, Jianping] Tianjin Univ, Sch Sci, Tianjin 300072, Peoples R China.
   [Li, Xiulan; Zhang, Yang] Tianjin Orthoped Hosp, Tianjin 300211, Peoples R China.
   [Xu, Chen] Beijing 302 Hosp, Beijing 300060, Peoples R China.
RP Sun, ZM (reprint author), Huanhu Hosp, Tianjin 300060, Peoples R China.
EM zmsun@163.com; jianpingg@eyou.com
FU NSFC [50603017]; Science and Technology Developing Plan of the
   Municipality of Tianjin, PR China [06YFGZGX03000]
FX This work was financially supported by the NSFC (50603017) and the
   Science and Technology Developing Plan (06YFGZGX03000) of the
   Municipality of Tianjin, PR China.
CR Al-Musawi J. N. T., 2001, GYNAECOL ENDOSC, V10, P123
   Bain MK, 2012, INT J BIOL MACROMOL, V50, P565, DOI 10.1016/j.ijbiomac.2012.01.025
   Bannikova GE, 2002, APPL BIOCHEM MICRO+, V38, P413, DOI 10.1023/A:1019904131791
   Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1097/01.DCR.0000089117.62296.E4
   Bennett D. A., 2003, J CARDIAC SURG, V18, P494
   Coleman MG, 2000, DIS COLON RECTUM, V43, P1297, DOI 10.1007/BF02237441
   Dhar N, 2012, CARBOHYD POLYM, V87, P101, DOI 10.1016/j.carbpol.2011.07.022
   DIZEREGA GS, 1994, FERTIL STERIL, V61, P219
   ELLIS H, 1982, BRIT J SURG, V69, P241, DOI 10.1002/bjs.1800690502
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   Genevieve M., 2006, J SURG RES, V132, P3
   Ha DI, 2006, MACROMOL RES, V14, P87, DOI 10.1007/BF03219073
   HERSHLAG A, 1991, CLIN OBSTET GYNECOL, V34, P395, DOI 10.1097/00003081-199106000-00023
   Holme KR, 1997, CARBOHYD RES, V302, P7, DOI 10.1016/S0008-6215(97)00117-1
   Huang CB, 2012, BIOMATERIALS, V33, P962, DOI 10.1016/j.biomaterials.2011.10.004
   HURTADOPONCE AQ, 1988, BOT MAR, V31, P171, DOI 10.1515/botm.1988.31.2.171
   Kurisawa M, 2000, J CONTROL RELEASE, V69, P127, DOI 10.1016/S0168-3659(00)00297-2
   Lamoutte H., 2006, MAST BIOSURGERY, V12, P1
   Li L, 2001, LANGMUIR, V17, P8062, DOI 10.1021/la010917r
   Liang HF, 2004, BIOMACROMOLECULES, V5, P1917, DOI 10.1021/bm049831
   Lodge AJ, 2008, ANN THORAC SURG, V86, P614, DOI 10.1016/j.athoracsur.2008.04.103
   Menzies P. M., 2006, ANN ROY COLL SURG, V88, P375
   Miao JJ, 2011, BIOMATERIALS, V32, P9557, DOI 10.1016/j.biomaterials.2011.08.080
   Nishimura S, 1998, CARBOHYD RES, V306, P427, DOI 10.1016/S0008-6215(97)10081-7
   Pressato E. B., 2002, P INT M, P491
   Ray F. N., 1994, J AM COLL SURGEONS, V186, P1
   Rodgers K, 1998, FERTIL STERIL, V69, P403, DOI 10.1016/S0015-0282(97)00574-8
   Rodgers Kathleen E, 2003, Spine J, V3, P277, DOI 10.1016/S1529-9430(03)00035-4
   Sampedro JG, 2002, J BACTERIOL, V184, P4384, DOI 10.1128/JB.184.16.4384-4391.2002
   Tate MC, 2001, BIOMATERIALS, V22, P1113, DOI 10.1016/S0142-9612(00)00348-3
   Tito WA, 1996, SHACKELFORDS SURG AL, P375
   Trew G, 2006, REV GYNAECOL PERINAT, V6, P47, DOI [10.1016/j.rigapp.2006.02.001, DOI 10.1016/J.RIGAPP.2006.02.001]
   Wells MR, 1997, EXP NEUROL, V146, P395, DOI 10.1006/exnr.1997.6543
   WISEMAN D, 1994, POLYM SITE SPECIFIC, P370
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
   Xu Y, 2004, LANGMUIR, V20, P646, DOI 10.1021/la0356295
   Yeo Y, 2006, BIOMATERIALS, V27, P4698, DOI 10.1016/j.biomaterials.2006.04.043
   Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046
NR 38
TC 17
Z9 21
U1 8
U2 129
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 171
EP 178
DI 10.1016/j.carbpol.2013.09.001
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800021
PM 24299762
DA 2018-10-19
ER

PT J
AU Lai, JY
AF Lai, Jui-Yang
TI Relationship between structure and cytocompatibility of divinyl sulfone
   cross-linked hyaluronic acid
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Hyaluronic acid; Divinyl sulfone; Cross-linker concentration; Molecular
   structure; Cytocompatibility; Retinal pigment epithelium
ID PIGMENT EPITHELIAL-CELLS; TISSUE AUGMENTATION; DELIVERY CARRIERS;
   GELATIN MEMBRANES; HYDROGELS; LINKING; SCAFFOLDS; TRANSPLANTATION;
   FUNCTIONALITY; PERFORMANCE
AB Hyaluronic acid (HA), a carbohydrate polymer naturally found in the eye, has been chemically modified by cross-linking to enhance its performance as a drug carrier. Although the treatment of HA with divinyl sulfone (DVS) is reported, the effects of cross-linker concentration on the biomaterial-mediated retinal pigment epithelial (RPE) cellular responses are yet to be investigated. This paper explores, for the first time, the relationship between molecular structure and cytocompatibility of HA hydrogels cross-linked with DVS of varying concentrations (0-100 mM). The results showed that with increasing DVS concentration, the sulfur content and sulfonyl-bis-ethyl cross-link amount are increased and the mechanical stability and resistance against enzymatic degradation are enhanced, indicating the crucial role of crosslinker in the alteration of structure and property of this polysaccharide biomaterial. The cell viability, pro-inflammatory gene and cytokine expression, and glutamate uptake were suggested to be indicative of cytocompatibility and found to be strongly dependent on the cross-linker concentration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Lai, Jui-Yang] Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Biomed Engn Res Ctr, Tao Yuan 33302, Taiwan.
   [Lai, Jui-Yang] Chang Gung Univ, Mol Med Res Ctr, Tao Yuan 33302, Taiwan.
RP Lai, JY (reprint author), Chang Gung Univ, Inst Biochem & Biomed Engn, Tao Yuan 33302, Taiwan.
EM jylai@mail.cgu.edu.tw
OI Lai, Jui-Yang/0000-0002-9227-8549
FU National Science Council of Republic of China
   [NSC102-2628-B-182-017-MY3]; Chang Gung Memorial Hospital [CMRPD2A0111]
FX This work was supported by Grant NSC102-2628-B-182-017-MY3 from the
   National Science Council of Republic of China and Grant CMRPD2A0111 from
   Chang Gung Memorial Hospital. The author is grateful to Ya-Ting Li
   (Institute of Biochemical and Biomedical Engineering, Chang Gung
   University) for technical assistance.
CR Abe T, 1999, TOHOKU J EXP MED, V189, P179, DOI 10.1620/tjem.189.179
   Bhattacharyya S, 2008, BIOMACROMOLECULES, V9, P505, DOI 10.1021/bm7009976
   Burugapalli K, 2009, J BIOMAT SCI-POLYM E, V20, P1049, DOI [10.1163/156856209X444411, 10.1163/156856209X4444111]
   Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4
   Collins MN, 2008, J APPL POLYM SCI, V109, P923, DOI 10.1002/app.27631
   Collins MN, 2013, J APPL POLYM SCI, V130, P145, DOI 10.1002/app.39145
   Collins MN, 2013, CARBOHYD POLYM, V92, P1262, DOI 10.1016/j.carbpol.2012.10.028
   Ellzy MW, 2003, SPECTROCHIM ACTA A, V59, P867, DOI 10.1016/S1386-1425(02)00239-1
   Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707
   GEBBEN B, 1985, POLYMER, V26, P1737, DOI 10.1016/0032-3861(85)90295-2
   Grasman JM, 2012, ACTA BIOMATER, V8, P4020, DOI 10.1016/j.actbio.2012.07.018
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Ibrahim S, 2010, J BIOMED MATER RES A, V94A, P355, DOI 10.1002/jbm.a.32704
   Jeng BH, 2004, J CATARACT REFR SURG, V30, P85, DOI 10.1016/S0886-3350(03)00669-2
   Lai JY, 2006, ARCH OPHTHALMOL-CHIC, V124, P1441, DOI 10.1001/archopht.124.10.1441
   Lai JY, 2006, BIOMACROMOLECULES, V7, P1836, DOI 10.1021/bm0601575
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lai JY, 2012, MATERIALS, V5, P1986, DOI 10.3390/ma5101986
   Lai JY, 2012, INT J NANOMED, V7, P1101, DOI 10.2147/IJN.S28753
   Lai JY, 2012, ACTA BIOMATER, V8, P1068, DOI 10.1016/j.actbio.2011.11.012
   Lai JY, 2011, J MECH MED BIOL, V11, P967, DOI 10.1142/S0219519411004873
   Lai JY, 2012, J MATER CHEM, V22, P1812, DOI 10.1039/c1jm14211a
   Lai JY, 2012, BIOMATERIALS, V33, P2372, DOI 10.1016/j.biomaterials.2011.11.085
   Lai JY, 2010, INT J MOL SCI, V11, P5257, DOI 10.3390/ijms11125256
   Lai JY, 2011, J BIOMAT SCI-POLYM E, V22, P277, DOI 10.1163/092050609X12603600753204
   Lai JY, 2010, MAT SCI ENG C-MATER, V30, P677, DOI 10.1016/j.msec.2010.02.024
   Lai JY, 2010, J MATER SCI-MATER M, V21, P1899, DOI 10.1007/s10856-010-4035-3
   Lai JY, 2010, BIOMACROMOLECULES, V11, P1387, DOI 10.1021/bm100213f
   Lai JY, 2010, J BIOMAT SCI-POLYM E, V21, P359, DOI 10.1163/156856209X416980
   Lai JY, 2009, INT J MOL SCI, V10, P3442, DOI 10.3390/ijms10083442
   Lai JY, 2009, BIOMACROMOLECULES, V10, P310, DOI 10.1021/bm801039n
   Lai JY, 2005, AM J OPHTHALMOL, V139, P1123, DOI 10.1016/j.ajo.2004.11.052
   Lu PL, 2008, J BIOMAT SCI-POLYM E, V19, P1, DOI 10.1163/156856208783227695
   Ma DHK, 2010, BIOMATERIALS, V31, P6647, DOI 10.1016/j.biomaterials.2010.05.034
   McDonald CC, 2002, EYE, V16, P601, DOI 10.1038/sj.eye.6700169
   MIYAMOTO Y, 1994, INVEST OPHTH VIS SCI, V35, P3589
   Murata M, 2005, OPHTHALMOLOGICA, V219, P287, DOI 10.1159/000086113
   Oh EJ, 2008, J BIOMED MATER RES A, V86A, P685, DOI 10.1002/ibm.a.31681
   Sannino A, 2004, BIOMACROMOLECULES, V5, P92, DOI 10.1021/bm0341881
   Singh K, 2012, J MATER SCI-MATER M, V23, P687, DOI 10.1007/s10856-012-4554-1
   SOK DE, 1993, BIOCHEM BIOPH RES CO, V195, P1224, DOI 10.1006/bbrc.1993.2175
   West JD, 2011, CHEM RES TOXICOL, V24, P1457, DOI 10.1021/tx200302w
   Yeom J, 2010, BIOCONJUGATE CHEM, V21, P240, DOI 10.1021/bc9002647
   Yue W, 2012, CARBOHYD POLYM, V89, P709, DOI 10.1016/j.carbpol.2012.03.081
   Zhao X, 2006, J BIOMAT SCI-POLYM E, V17, P419, DOI 10.1163/156856206776374115
NR 45
TC 24
Z9 25
U1 2
U2 53
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 203
EP 212
DI 10.1016/j.carbpol.2013.09.060
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800025
PM 24299766
DA 2018-10-19
ER

PT J
AU Janaswamy, S
AF Janaswamy, Srinivas
TI Encapsulation altered starch digestion: Toward developing starch-based
   delivery systems
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Starch; Encapsulation; Delivery; X-ray diffraction; FT-IR
ID AMYLOSE INCLUSION COMPLEXES; SMALL LIGANDS; DIABETES-MELLITUS;
   CRYSTAL-STRUCTURE; BETA-AMYLOLYSIS; SINGLE-CRYSTALS; GLYCEMIC INDEX;
   CONFORMATION; EPIDEMIC; GRANULES
AB Starch is an abundant biomaterial that forms a vital energy source for humans. Altering its digestion, e.g. increasing the proportions of slowly digestible starch (SOS) and resistant starch (RS), would revolutionize starch utility in addressing a number of health issues related to glucose absorption, glycemic index and colon health. The research reported in this article is based on my hypothesis that water channels present in the B-type starch crystalline matrix, particularly in tuber starches, can embed guest molecules such as nutraceuticals, drugs, flavor compounds and vitamins leading to altered starch digestion. Toward this goal, potato starch has been chosen as the model tuber starch, and ibuprofen, benzocaine, sulfapyridine, curcumin, thymol and ascorbic acid as model guest molecules. X-ray powder diffraction and FT-IR analyses clearly suggest the incorporation of guest molecules in the water channels of potato starch. Furthermore, the in vitro digestion profiles of complexes are intriguing with major variations occurring after 60 min of starch digestion and finally at 120 min. These changes are concomitantly reflected in the SOS and RS amounts, with about 24% decrease in SDS for benzocaine complex and 6% increase in RS for ibuprofen complex, attesting the ability of guest molecule encapsulation in modulating the digestion properties of potato starch. Overall, this research provides an elegant opportunity for the design and development of novel starch-based stable carriers that not only bestow tailored glucose release rates but could also transport health promoting and disease preventing compounds. (C) 2013 Elsevier Ltd. All rights reserved.
C1 Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA.
RP Janaswamy, S (reprint author), Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, 745 Agr Mall Dr, W Lafayette, IN 47907 USA.
EM janaswam@purdue.edu
CR Alberti G, 2004, DIABETES CARE, V27, P1798, DOI 10.2337/diacare.27.7.1798
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   BULEON A, 1990, INT J BIOL MACROMOL, V12, P25, DOI 10.1016/0141-8130(90)90078-O
   Conde-Petit B, 2006, TRENDS FOOD SCI TECH, V17, P227, DOI 10.1016/j.tifs.2005.11.007
   ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33
   Englyst KN, 2003, BRIT J NUTR, V89, P329, DOI 10.1079/BJN2002786
   GIDLEY MJ, 1988, J AM CHEM SOC, V110, P3820, DOI 10.1021/ja00220a016
   Gunaratne A, 2002, CARBOHYD POLYM, V49, P425, DOI 10.1016/S0144-8617(01)00354-X
   Han XZ, 2006, BIOMACROMOLECULES, V7, P1162, DOI 10.1021/bm050991e
   Heinemann C, 2001, J AGR FOOD CHEM, V49, P1370, DOI 10.1021/jf001079u
   Hickman BE, 2009, J AGR FOOD CHEM, V57, P7005, DOI 10.1021/jf9010164
   Hickman BE, 2009, J AGR FOOD CHEM, V57, P666, DOI 10.1021/jf8030698
   Holmes C., 2005, SUMMARY REPORT EUROP
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   IMBERTY A, 1988, J MOL BIOL, V201, P365, DOI 10.1016/0022-2836(88)90144-1
   Itthisoponkul T, 2007, CARBOHYD POLYM, V69, P106, DOI 10.1016/j.carbpol.2006.09.012
   Jacobs H, 1998, J AGR FOOD CHEM, V46, P2895, DOI 10.1021/jf980169k
   Janaswamy S, 2013, CARBOHYD POLYM, V94, P209, DOI 10.1016/j.carbpol.2013.01.008
   Janaswamy S, 2012, FOOD FUNCT, V3, P503, DOI 10.1039/c2fo10281a
   JANE JL, 1984, CARBOHYD RES, V132, P105, DOI 10.1016/0008-6215(84)85068-5
   Jenkins DJA, 2002, AM J CLIN NUTR, V76, p266S
   Le Bail P, 2005, INT J BIOL MACROMOL, V35, P1, DOI 10.1016/j.ijbiomac.2004.09.001
   LeRoith D, 2002, AM J MED, V113, p3S
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Nuessli J, 2003, INT J BIOL MACROMOL, V33, P227, DOI 10.1016/j.ijbiomac.2003.08.009
   Oakley WG, 1962, T MED SOC LONDON, V78, P16
   Palomer X, 2008, DIABETES OBES METAB, V10, P185, DOI 10.1111/j.1463-1326.2007.00710.x
   Patil S. K., 2012, STRATEGIC REV GLOBAL
   Petersen M, 2008, DIABETES CARE, V31, P596, DOI 10.2337/dc08-9017
   Putaux JL, 2008, MACROMOL SYMP, V273, P1, DOI 10.1002/masy.200851301
   Rondeau-Mouro C, 2004, INT J BIOL MACROMOL, V34, P309, DOI 10.1016/j.ijbiomac.2004.09.002
   Sempertegui F, 2011, PUBLIC HEALTH NUTR, V14, P758, DOI 10.1017/S1368980010002636
   Shamai K, 2003, CARBOHYD POLYM, V54, P363, DOI 10.1016/S0144-8617(03)00192-9
   Shea TB, 2005, J ALZHEIMERS DIS, V7, P297
   Shogren RL, 2006, CARBOHYD POLYM, V64, P444, DOI 10.1016/j.carbpol.2005.12.018
   Song W, 2010, J AGR FOOD CHEM, V58, P9753, DOI 10.1021/jf1011769
   Takahashi Y, 2004, MACROMOLECULES, V37, P6827, DOI 10.1021/ma0490956
   Tian YQ, 2010, CARBOHYD POLYM, V80, P581, DOI 10.1016/j.carbpol.2009.12.010
   Venkataraman R, 2004, AM J CARDIOL, V94, P977, DOI 10.1016/j.amjcard.2004.06.048
   Wang TL, 1998, J EXP BOT, V49, P481, DOI 10.1093/jexbot/49.320.481
   Webb G.P., 2006, DIETARY SUPPLEMENTS
   Wild SH, 2004, DIABETES CARE, V27, P2569, DOI 10.2337/diacare.27.10.2569-a
   Wolever TMS, 2003, NUTR REV, V61, pS40, DOI 10.1301/nr.2003.may.S40-S48
   Wulff G, 2005, J CEREAL SCI, V41, P239, DOI 10.1016/j.jcs.2004.06.002
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
NR 45
TC 8
Z9 11
U1 1
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 600
EP 605
DI 10.1016/j.carbpol.2013.09.094
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800075
PM 24299816
DA 2018-10-19
ER

PT J
AU Li, GC
   Zhang, LZ
   Wang, CP
   Zhao, XY
   Zhu, CL
   Zheng, YH
   Wang, YL
   Zhao, YH
   Yang, YM
AF Li, Guicai
   Zhang, Luzhong
   Wang, Caiping
   Zhao, Xueying
   Zhu, Changlai
   Zheng, Yanhong
   Wang, Yaling
   Zhao, Yahong
   Yang, Yumin
TI Effect of silanization on chitosan porous scaffolds for peripheral nerve
   regeneration
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Chitosan porous scaffolds; Silanization; Peripheral nerve regeneration;
   Schwann cells
ID PLURIPOTENT STEM-CELLS; SCHWANN-CELLS; IN-VITRO; IMMOBILIZATION;
   SURFACES; CONDUITS; REPAIR; DIFFERENTIATION; HYDROGELS; FIBERS
AB The aim of this study was to evaluate the feasibility of using 3-aminopropyltriethoxysilane (APTE) silanization treatment for modification and biocompatibility of lyophilized chitosan porous scaffolds. The process is beneficial for biomaterial development due to its low toxicity and simplicity. The silanization treatment with low APTE concentration showed no significant influence on the morphology of chitosan scaffolds, while a skin-like surface was observed for the silanized scaffolds treated with high APTE concentration. The porosity and surface amino densities were increased after silanization whereas the swelling ratio was reduced, and the degradation ratio in PBS and anti-acid degradation properties of the silanized chitosan scaffolds were significantly improved. The in vitro Schwann cells culture demonstrated that the silanized scaffolds with 8% APTE could obviously facilitate the attachment and proliferation of Schwann cells, indicating great potential for the application in peripheral nerve regeneration. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Li, Guicai; Zhang, Luzhong; Wang, Caiping; Zhao, Xueying; Zhu, Changlai; Zheng, Yanhong; Zhao, Yahong; Yang, Yumin] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China.
   [Wang, Yaling] Nantong Univ, Coll Chem & Chem Engn, Nantong 226001, Peoples R China.
RP Yang, YM (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Peoples R China.
EM yangym@ntu.edu.cn
FU Natural Science Research Program of Jiangsu Education Department
   [13KJB310014]; Hi-Tech Research and Development Program of China
   [2012AA020502]; National Natural Science Foundation of China [21242005,
   81130080, 81171457]; Natural Science Foundation of Nantong City
   [BK2012089]; Natural Science Foundation of Jiangsu Province of China
   [BK20130390]; Natural Science Foundation of Nantong University [10Z014]
FX The authors gratefully acknowledge the financial support of the Natural
   Science Research Program of Jiangsu Education Department (No.
   13KJB310014), Hi-Tech Research and Development Program of China (No.
   2012AA020502), National Natural Science Foundation of China (No.
   21242005, 81130080 and 81171457), Natural Science Foundation of Nantong
   City (No. BK2012089), Natural Science Foundation of Jiangsu Province of
   China (No. BK20130390) and the Natural Science Foundation of Nantong
   University (No. 10Z014).
CR Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Baggi L, 1990, Attual Dent, V6, P18
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Byrne EM, 2008, J MATER SCI-MATER M, V19, P3455, DOI 10.1007/s10856-008-3506-2
   Chiono V, 2009, INT REV NEUROBIOL, V87, P173, DOI 10.1016/S0074-7742(09)87009-8
   Gan SH, 2009, BIOMACROMOLECULES, V10, P1238, DOI 10.1021/bm900011h
   Gu Y, 2012, BIOMATERIALS, V33, P6672, DOI 10.1016/j.biomaterials.2012.06.006
   Halliwell CM, 2001, ANAL CHEM, V73, P2476, DOI 10.1021/ac0010633
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Hsu SH, 2011, BIOMATERIALS, V32, P3764, DOI 10.1016/j.biomaterials.2011.01.065
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Kim J, 2011, ACS SYM SER, V1062, P141
   Kuo YC, 2013, COLLOID SURFACE B, V103, P595, DOI 10.1016/j.colsurfb.2012.11.001
   Kuo YC, 2013, COLLOID SURFACE B, V102, P405, DOI 10.1016/j.colsurfb.2012.08.061
   Lapin NA, 2009, J PHYS CHEM B, V113, P8776, DOI 10.1021/jp809096m
   Li GC, 2011, BIOMATERIALS, V32, P4691, DOI 10.1016/j.biomaterials.2011.03.025
   Matinlinna Jukka P, 2007, J Contemp Dent Pract, V8, P1
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Nie X., 2013, CELL BIOCH BIOPHYSIC
   Peng L, 2006, J BIOACT COMPAT POL, V21, P207, DOI 10.1177/0883911506065100
   Pettersson J, 2011, NEUROSCI LETT, V500, P41, DOI 10.1016/j.neulet.2011.06.002
   Qu D, 2013, CARBOHYD POLYM, V92, P545, DOI 10.1016/j.carbpol.2012.08.112
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Salon MCB, 2005, J COLLOID INTERF SCI, V289, P249, DOI 10.1016/j.jcis.2005.03.070
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Wlaszczuk Adam, 2011, Wiad Lek, V64, P208
   Xiao W., 2013, INJURY
   Xu HX, 2011, BIOMATERIALS, V32, P4506, DOI 10.1016/j.biomaterials.2011.02.023
   Yang YM, 2011, EUR J PHARM BIOPHARM, V79, P519, DOI 10.1016/j.ejpb.2011.06.008
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yoshioka T, 2003, BIOMATERIALS, V24, P2889, DOI 10.1016/S0142-9612(03)00127-3
   Yuan Y, 2004, BIOMATERIALS, V25, P4273, DOI 10.1016/j.biomaterials.2003.11.029
   Zhang LZ, 2013, MAT SCI ENG C-MATER, V33, P2626, DOI 10.1016/j.msec.2013.02.024
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 35
TC 25
Z9 26
U1 4
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 718
EP 726
DI 10.1016/j.carbpol.2013.09.064
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800090
PM 24299831
DA 2018-10-19
ER

PT J
AU Miraftab, M
   Masood, R
   Edward-Jones, V
AF Miraftab, M.
   Masood, R.
   Edward-Jones, V.
TI A new carbohydrate-based wound dressing fibre with superior absorption
   and antimicrobial potency
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Absorption; Dressing; Silver; Hybrid; Psyllium
ID SILVER; MANAGEMENT; MODELS
AB Heavily exudating wounds can lead to infection and unnecessary trauma if they are not adequately managed. Manufacturers involved in production and marketing of high absorption silver dressings, besides emphasising high absorptions of their dressings are keen to highlight potent antimicrobial abilities of their products against all kinds of pathogens including MRSA. However, there are little or no credible reports on minimal but potent quantities of silver needed in a dressing to eliminate bacteria spread and growth or how effectively the silver within a dressing is released over time. This paper introduces a new hybrid biomaterial fibre made from polysaccharide-based polymers with inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, it will be reported that the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known Gram positive, Gram negative micro-organisms including MRSA. The paper concludes that the developed hybrid fibre has long lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Miraftab, M.] Univ Bolton, Inst Mat Res & Innovat, Bolton BL3 5AB, England.
   [Masood, R.] Natl Text Univ, Faisalabad, Pakistan.
   [Edward-Jones, V.] Manchester Metropolitan Univ, Fac Sci & Engn, Sch Res Enterprise & Innovat, Manchester M1 5GD, Lancs, England.
RP Miraftab, M (reprint author), Univ Bolton, Inst Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM m.miraftab@bolton.ac.uk
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell Robert E, 2003, Ostomy Wound Manage, V49, P19
   Cooper R, 2004, WORLD WIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Edwards-Jones V, 2002, J MED MICROBIOL, V51, P50, DOI 10.1099/0022-1317-51-1-50
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Fischer MH, 2004, CARBOHYD RES, V339, P2009, DOI 10.1016/j.carres.2004.05.023
   Howe PD, 2002, SILVER SILVER COMPOU
   Kalsen HJ, 2000, BURNS, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   LANDIS SJ, 2008, J PREVENTION HEALING, V21, P531
   MARGARET IP, 2006, J MED MICROBIOL, V55, P59
   MIRAFTAB M, 2011, Patent No. 20110017140201110
   MIRAFTAB M, 2013, J WOUND IN PRESS OCT
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   Qin Y., 2004, TEXT MAG, V31, P14
   Ryan KJ, 2003, SHERRIS MED MICROBIO
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI
   Stashak T. S., 2004, Clinical Techniques in Equine Practice, V3, P148, DOI 10.1053/j.ctep.2004.08.006
   Thomas S., 2004, ONLINE J WORLD WIDE
   WHITE WC, 2004, WOUND CARE
NR 25
TC 17
Z9 18
U1 1
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 30
PY 2014
VL 101
BP 1184
EP 1190
DI 10.1016/j.carbpol.2013.10.058
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 300WN
UT WOS:000330494800149
PM 24299890
DA 2018-10-19
ER

PT J
AU Bao, L
   Liu, JX
   Shi, F
   Jiang, YY
   Liu, GS
AF Bao, Lei
   Liu, Jingxiao
   Shi, Fei
   Jiang, Yanyan
   Liu, Guishan
TI Preparation and characterization of TiO2 and Si-doped octacalcium
   phosphate composite coatings on zirconia ceramics (Y-TZP) for dental
   implant applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Zirconia dental implant; TiO2 coating; Si-doped octacalcium phosphate;
   Biomimetic method
ID LOW-TEMPERATURE DEGRADATION; BIOCOMPATIBILITY; BIOMATERIAL; TITANIUM;
   SILICON
AB In order to prevent the low temperature degradation and improve the bioactivity of zirconia ceramic implants, TiO2 and Si-doped octacalcium phosphate composite coating was prepared on zirconia substrate. The preventive effect on low temperature degradation and surface morphology of the TiO2 layer were studied. Meanwhile, the structure and property changes of the bioactive coating after doping Si were discussed. The results indicate that the dense TiO2 layer, in spite of some microcracks, inhibited the direct contact of the water vapor with the sample's surface and thus prevented the low temperature degradation of zirconia substrates. The acceleration aging test shows that the ratio of the monoclinic phase transition decreased from 10% for the original zirconia substrate to 4% for the TiO2-coated substrate. As to the Si-doped octacalcium phosphate coating prepared by biomimetic method, the main phase composition of the coating was octacalcium phosphate. The morphology of the coating was lamellar-like, and the surface was uniform and continuous with no cracks being observed. It is suggested that Si was added into the coating both through substituting for PO43- and doping as NaSiO3. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Bao, Lei; Liu, Jingxiao; Shi, Fei; Jiang, Yanyan; Liu, Guishan] Dalian Polytech Univ, Sch Text & Mat Engn, Dalian 116034, Peoples R China.
RP Liu, JX (reprint author), Dalian Polytech Univ, Sch Text & Mat Engn, Dalian 116034, Peoples R China.
EM 65786319@qq.com; drliu-shi@dlpu.edu.cn
FU Liaoning Province Doctoral Startup Foundation [20021054]; Liaoning
   Province Ministry Project of Education Grant [202073425]
FX This work was supported by Liaoning Province Doctoral Startup Foundation
   (No. 20021054) and Liaoning Province Ministry Project of Education Grant
   (No. 202073425)
CR CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chrissanthopoulos A, 2008, VIB SPECTROSC, V48, P118, DOI 10.1016/j.vibspec.2007.11.008
   Frandsen CJ, 2013, MAT SCI ENG C-MATER, V33, P2752, DOI 10.1016/j.msec.2013.02.045
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Koh YH, 1999, J AM CERAM SOC, V82, P1456
   Lee TH, 2012, J BIOMED MATER RES B, V100B, P1334, DOI 10.1002/jbm.b.32700
   Liu JX, 2004, J MATER SCI TECHNOL, V20, P550
   Liu JX, 2003, THIN SOLID FILMS, V429, P225, DOI 10.1016/S0040-6090(03)00146-9
   Matsko NB, 2011, J STRUCT BIOL, V174, P180, DOI 10.1016/j.jsb.2010.09.025
   Nakamura K, 2010, INT J PROSTHODONT, V23, P299
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Stefanic M, 2012, APPL SURF SCI, V258, P4649, DOI 10.1016/j.apsusc.2012.01.048
   Zhang E, 2009, MAT SCI ENG C-BIO S, V29, P298, DOI 10.1016/j.msec.2008.07.001
   Zou CM, 2007, RARE METAL MAT ENG, V36, P1905
NR 18
TC 6
Z9 7
U1 1
U2 28
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 30
PY 2014
VL 290
BP 48
EP 52
DI 10.1016/j.apsusc.2013.10.185
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 280VY
UT WOS:000329060100008
DA 2018-10-19
ER

PT J
AU Yavari, SA
   Wauthle, R
   Bottger, AJ
   Schrooten, J
   Weinans, H
   Zadpoor, AA
AF Yavari, S. Amin
   Wauthle, R.
   Bottger, A. J.
   Schrooten, J.
   Weinans, H.
   Zadpoor, A. A.
TI Crystal structure and nanotopographical features on the surface of
   heat-treated and anodized porous titanium biomaterials produced using
   selective laser melting
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous biomaterials; Selective laser melting; Anodizing; Nanotubes; Heat
   treatment
ID TOTAL JOINT REPLACEMENT; SIMULATED BODY-FLUID; TIO2 NANOTUBES; APATITE
   FORMATION; IN-VIVO; BIOCOMPATIBILITY EVALUATION; METALLIC BIOMATERIALS;
   MECHANICAL-PROPERTIES; CORTICAL BONE; SCIENCE
AB Porous titanium biomaterials manufactured using additive manufacturing techniques such as selective laser melting are considered promising materials for orthopedic applications where the biomaterial needs to mimic the properties of bone. Despite their appropriate mechanical properties and the ample pore space they provide for bone ingrowth and osseointegration, porous titanium structures have an intrinsically bioinert surface and need to be subjected to surface bio-functionalizing procedures to enhance their in vivo performance. In this study, we used a specific anodizing process to build a hierarchical oxide layer on the surface of porous titanium structures made by selective laser melting of Ti6Al4V ELI powder. The hierarchical structure included both nanotopographical features (nanotubes) and micro-features (micropits). After anodizing, the biomaterial was heat treated in Argon at different temperatures ranging between 400 and 600 degrees C for either 1 or 2 h to improve its bioactivity. The effects of applied heat treatment on the crystal structure of TiO2 nanotubes and the nanotopographical features of the surface were studied using scanning electron microscopy and X-ray diffraction. It was shown that the transition from the initial crystal structure, i.e. anatase, to rutile occurs between 500 and 600 degrees C and that after 2 h of heat treatment at 600 degrees C the crystal structure is predominantly rutile. The nanotopographical features of the surface were found to be largely unchanged for heat treatments carried out at 500 degrees C or below, whereas they were partially or largely disrupted after heat treatment at 600 degrees C. The possible implications of these findings for the bioactivity of porous titanium structures are discussed. (C) 2013 Elsevier B. V. All rights reserved.
C1 [Yavari, S. Amin; Bottger, A. J.; Weinans, H.; Zadpoor, A. A.] Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, NL-2628 CD Delft, Netherlands.
   [Yavari, S. Amin] FT Innovat BV, NL-5831 PW Boxmeer, Netherlands.
   [Wauthle, R.] Katholieke Univ Leuven, Dept Mech Engn, Sect Prod Engn Machine Design & Automat PMA, B-3001 Louvain, Belgium.
   [Wauthle, R.] LayerWise NV, Louvain, Belgium.
   [Schrooten, J.] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
   [Weinans, H.] UMC Utrecht, Dept Orthoped, NL-3584 CX Utrecht, Netherlands.
   [Weinans, H.] UMC Utrecht, Dept Rheumatol, NL-3584 CX Utrecht, Netherlands.
RP Yavari, SA (reprint author), Delft Univ Technol TU Delft, Fac Mech Maritime & Mat Engn, Mekelweg 2, NL-2628 CD Delft, Netherlands.
EM s.aminyavari@tudelft.nl
RI Zadpoor, Amir A/A-8510-2008; Amin Yavari, Saber/E-5360-2017; Amin
   Yavari, Saber/G-9486-2013
OI Amin Yavari, Saber/0000-0003-1677-5751; Amin Yavari,
   Saber/0000-0003-1677-5751; Zadpoor, Amir Abbas/0000-0003-3234-2112
FU research program of the BioMedical Materials Institute [P2.04 BONE-IP];
   Dutch Ministry of Economic Affairs
FX This research forms part of the Project P2.04 BONE-IP of the research
   program of the BioMedical Materials Institute, co-funded by the Dutch
   Ministry of Economic Affairs. The technical supports of Harry Jansen,
   Patrick van Holst, and Ruud Hendrikx (X-Ray facilities) is also
   acknowledged.
CR Balasundaram G, 2008, J BIOMED MATER RES A, V84A, P447, DOI 10.1002/jbm.a.31388
   Barbas A, 2012, J MECH BEHAV BIOMED, V9, P34, DOI 10.1016/j.jmbbm.2012.01.008
   Bjursten LM, 2010, J BIOMED MATER RES A, V92A, P1218, DOI 10.1002/jbm.a.32463
   Campoli G, 2013, MATER DESIGN, V49, P957, DOI 10.1016/j.matdes.2013.01.071
   Campoli G, 2012, J MECH BEHAV BIOMED, V10, P108, DOI 10.1016/j.jmbbm.2012.02.011
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chong DYR, 2011, J MECH MED BIOL, V11, P55, DOI 10.1142/S0219519410003666
   Crawford GA, 2009, J MATER RES, V24, P1683, DOI 10.1557/JMR.2009.0221
   Crawford GA, 2009, ACTA MATER, V57, P854, DOI 10.1016/j.actamat.2008.10.032
   Cullity B. D., 2001, ELEMENTS XRAY DIFFRA
   Das K, 2009, J BIOMED MATER RES A, V90A, P225, DOI 10.1002/jbm.a.32088
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Diomidis N, 2012, ACTA BIOMATER, V8, P852, DOI 10.1016/j.actbio.2011.09.034
   Duyck J, 2001, CLIN ORAL IMPLAN RES, V12, P207, DOI 10.1034/j.1600-0501.2001.012003207.x
   Fan XP, 2012, J BIOMED MATER RES A, V100A, P3422, DOI 10.1002/jbm.a.34268
   Fang D, 2011, APPL SURF SCI, V257, P6451, DOI 10.1016/j.apsusc.2011.02.037
   Gilbert R., 1991, ASM HDB, V4
   Hanaor DAH, 2011, J MATER SCI, V46, P855, DOI 10.1007/s10853-010-5113-0
   Katti KS, 2004, COLLOID SURFACE B, V39, P133, DOI 10.1016/j.colsurfb.2003.12.002
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kingham E, 2013, SMALL, V9, P2140, DOI 10.1002/smll.201202340
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lamolle SF, 2009, J BIOMED MATER RES A, V88A, P581, DOI 10.1002/jbm.a.31898
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219
   Noyama Y, 2012, MATER TRANS, V53, P565, DOI 10.2320/matertrans.M2011358
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155
   Poelert S, 2013, P I MECH ENG H, V227, P464, DOI 10.1177/0954411912467884
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Pyka G, 2012, ADV ENG MATER, V14, P363, DOI 10.1002/adem.201100344
   Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001
   Regonini D, 2010, SURF INTERFACE ANAL, V42, P139, DOI 10.1002/sia.3183
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   Tirrell M, 2002, SURF SCI, V500, P61, DOI 10.1016/S0039-6028(01)01548-5
   Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677
   TURNER CH, 1994, J BONE MINER RES, V9, P87
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   van der Stok J, 2013, TISSUE ENG PT A, V19, P2605, DOI [10.1089/ten.tea.2013.0181, 10.1089/ten.TEA.2013.0181]
   Van der Stok J, 2013, J ORTHOP RES, V31, P792, DOI 10.1002/jor.22293
   Vandati A, 2013, J BIOMECH, V46, P1554, DOI 10.1016/j.jbiomech.2013.03.019
   Vandenbroucke B, 2007, RAPID PROTOTYPING J, V13, P196, DOI 10.1108/13552540710776142
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Varghese OK, 2003, J MATER RES, V18, P156, DOI 10.1557/JMR.2003.0022
   Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288
   Willie BM, 2010, TISSUE ENG PART C-ME, V16, P1399, DOI [10.1089/ten.tec.2009.0776, 10.1089/ten.TEC.2009.0776]
   Xue W, 2007, ACTA BIOMATER, V3, P1007, DOI 10.1016/j.actbio.2007.05.009
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yavari SA, 2013, MAT SCI ENG C-MATER, V33, P4849, DOI 10.1016/j.msec.2013.08.006
   Zadpoor AA, 2013, APPL MATH MODEL, V37, P5260, DOI 10.1016/j.apm.2012.10.049
   Zhao LZ, 2010, BIOMATERIALS, V31, P5072, DOI 10.1016/j.biomaterials.2010.03.014
NR 55
TC 38
Z9 38
U1 4
U2 90
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 30
PY 2014
VL 290
BP 287
EP 294
DI 10.1016/j.apsusc.2013.11.069
PG 8
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 280VY
UT WOS:000329060100043
DA 2018-10-19
ER

PT J
AU Jacobs, AC
   Blanchard, CE
   Catherman, SC
   Dunman, PM
   Murata, Y
AF Jacobs, Anna C.
   Blanchard, Catlyn E.
   Catherman, Seana C.
   Dunman, Paul M.
   Murata, Yoshihiko
TI An Ribonuclease T2 Family Protein Modulates Acinetobacter baumannii
   Abiotic Surface Colonization
SO PLOS ONE
LA English
DT Article
ID INTENSIVE-CARE-UNIT; BIOFILM FORMATION; ENVIRONMENTAL CONTAMINATION;
   SURVIVAL; CALCOACETICUS; RNASE; RESISTANCE; INFECTION; OUTBREAK;
   BACTERIA
AB Acinetobacter baumannii is an emerging bacterial pathogen of considerable medical concern. The organism's transmission and ability to cause disease has been associated with its propensity to colonize and form biofilms on abiotic surfaces in health care settings. To better understand the genetic determinants that affect biomaterial attachment, we performed a transposon mutagenesis analysis of abiotic surface-colonization using A. baumannii strain 98-37-09. Disruption of an RNase T2 family gene was found to limit the organism's ability to colonize polystyrene, polypropylene, glass, and stainless steel surfaces. DNA microarray analyses revealed that in comparison to wild type and complemented cells, the RNase T2 family mutant exhibited reduced expression of 29 genes, 15 of which are predicted to be associated with bacterial attachment and surface-associated motility. Motility assays confirmed that RNase T2 mutant displays a severe motility defect. Taken together, our results indicate that the RNase T2 family protein identified in this study is a positive regulator of A. baumannii's ability to colonize inanimate surfaces and motility. Moreover, the enzyme may be an effective target for the intervention of biomaterial colonization, and consequently limit the organism's transmission within the hospital setting.
C1 [Jacobs, Anna C.; Blanchard, Catlyn E.; Dunman, Paul M.] Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
   [Catherman, Seana C.; Murata, Yoshihiko] Univ Rochester Sch Med & Dent, Div Infect Dis, Dept Med, Rochester, NY USA.
RP Dunman, PM (reprint author), Univ Rochester Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.
EM paul_dunman@urmc.rochester.edu; yoshihiko_murata@urmc.rochester.edu
FU NIDCR NIH HHS [T90 DE021985]
CR Acquati F, 2013, P NATL ACAD SCI USA, V110, P8140, DOI 10.1073/pnas.1222079110
   Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689
   Aygun G, 2002, J HOSP INFECT, V52, P259, DOI 10.1053/jhin.2002.1300
   Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055
   Choi AHK, 2009, J BACTERIOL, V191, P5953, DOI 10.1128/JB.00647-09
   de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100
   El Shafie SS, 2004, J HOSP INFECT, V56, P101, DOI 10.1016/j.jhin.2003.09.024
   Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013
   Gao P, 2010, J BACTERIOL, V192, P5489, DOI 10.1128/JB.00725-10
   GETCHELLWHITE SI, 1989, INFECT CONT HOSP EP, V10, P402
   Grupper M, 2007, INFECT CONT HOSP EP, V28, P293, DOI 10.1086/512629
   Harding CM, 2013, MBIO, V4
   HIRAI Y, 1991, J HOSP INFECT, V19, P191, DOI 10.1016/0195-6701(91)90223-U
   Hood MI, 2010, ANTIMICROB AGENTS CH, V54, P1029, DOI 10.1128/AAC.00963-09
   HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C
   Jacobs AC, 2012, FEMS IMMUNOL MED MIC, V64, P403, DOI 10.1111/j.1574-695X.2011.00926.x
   Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09
   Lappann M, 2010, MED MICROBIOL IMMUN, V199, P173, DOI 10.1007/s00430-010-0149-y
   Levin AS, 2001, INFECT CONT HOSP EP, V22, P717, DOI 10.1086/501852
   Loehfelm TW, 2008, J BACTERIOL, V190, P1036, DOI 10.1128/JB.01416-07
   Luhtala N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041111
   Luhtala N, 2010, TRENDS BIOCHEM SCI, V35, P253, DOI 10.1016/j.tibs.2010.02.002
   Manian FA, 2013, AM J INFECT CONTROL, V41, P384, DOI 10.1016/j.ajic.2012.04.321
   Markogiannakis A, 2008, INFECT CONT HOSP EP, V29, P410, DOI 10.1086/533545
   Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09
   MURRAY BE, 1982, ANN INTERN MED, V96, P176, DOI 10.7326/0003-4819-96-2-176
   Murray EJ, 2009, MICROBIOL-SGM, V155, P1, DOI 10.1099/mic.0.023903-0
   MUSA EK, 1990, J HOSP INFECT, V15, P219, DOI 10.1016/0195-6701(90)90029-N
   Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10
   Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452
   Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148
   Schwartz B, 2007, CANCER RES, V67, P5258, DOI 10.1158/0008-5472.CAN-07-0129
   Shin JH, 2013, PLOS ONE, V8
   Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0
   Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004
NR 35
TC 10
Z9 14
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2014
VL 9
IS 1
AR e85729
DI 10.1371/journal.pone.0085729
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 301CJ
UT WOS:000330510000017
PM 24489668
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Gopi, D
   Kanimozhi, K
   Bhuvaneshwari, N
   Indira, J
   Kavitha, L
AF Gopi, D.
   Kanimozhi, K.
   Bhuvaneshwari, N.
   Indira, J.
   Kavitha, L.
TI Novel banana peel pectin mediated green route for the synthesis of
   hydroxyapatite nanoparticles and their spectral characterization
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE HAP nanoparticles; Banana peels; Pectin; Green template; Antimicrobial
   activity
ID SOL-GEL TECHNIQUE; SILVER NANOPARTICLES; SPECTROSCOPIC CHARACTERIZATION;
   ANTIBACTERIAL ACTIVITY; BIOMEDICAL APPLICATIONS; HYDROTHERMAL SYNTHESIS;
   H-1-NMR SPECTROSCOPY; LEAF EXTRACT; ESTERIFICATION; TEMPLATE
AB Hydroxyapatite [HAP, Ca-10(PO4)(6)(OH)(2)] is the main inorganic component of natural bone and is widely used in various biomedical applications. In this paper, we have reported the synthesis of HAP nanoparticles by banana peel pectin mediated green template method. The pectin extracted from the peels of banana and its various concentrations were exploited in our study to achieve a controlled crystallinity, particle size as well as uniform morphology of HAP. The extracted pectin was characterized by spectral techniques like Fourier transform infrared spectroscopy (FfIR) for the functional group analysis, proton-1 nuclear magnetic resonance spectroscopy (H-1 NMR) and carbon-13 nuclear magnetic resonance spectroscopy (C-13 NMR) for the identification of H and C atoms in the extracted pectin, respectively. The HAP nanoparticles were synthesized using different concentrations of the as-extracted pectin. The purity, crystallinity and morphology of the as-synthesized HAP nanoparticles were evaluated by FTIR, X-ray diffraction (XRD) and scanning electron microscopy (SEM) with energy dispersive X-ray analysis (EDAX) and transmission electron microscopy (TEM), respectively. Moreover the antibacterial activity of HAP nanoparticles was evaluated against the gram positive and negative bacteria like Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli), respectively. The experimental results revealed that the HAP nanoparticles synthesized in the presence of an optimized concentration of pectin are pure, low crystalline, spherical and discrete particles with reduced size. Also, the HAP sample derived in the presence of pectin showed an enhanced antibacterial activity than that of the HAP synthesized in the absence of pectin. Hence, the HAP nanoparticles synthesized using pectin as a green template can act as a good biomaterial for biomedical applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Gopi, D.; Kanimozhi, K.; Bhuvaneshwari, N.; Indira, J.] Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
   [Gopi, D.; Kavitha, L.] Periyar Univ, Ctr Nanosci & Nanotechnol, Salem 636011, Tamil Nadu, India.
   [Bhuvaneshwari, N.] Chikkaiah Naicker Coll, Dept Chem, Erode 638004, Tamil Nadu, India.
   [Kavitha, L.] Periyar Univ, Dept Phys, Salem 636011, Tamil Nadu, India.
RP Gopi, D (reprint author), Periyar Univ, Dept Chem, Salem 636011, Tamil Nadu, India.
EM dhanaraj_gopi@yahoo.com; louiskavitha@yahoo.co.in
RI Louis, Kavitha/B-9313-2017; Gopi, Dhanaraj/A-9163-2012
OI Louis, Kavitha/0000-0002-8893-2050; Gopi, Dhanaraj/0000-0001-6662-1238
FU Indian Council of Medical Research (ICMR) [2010-08660,
   5/20/11(Bio)/10-NCD-I]; Department of Science and Technology (DST)
   [DST/TSG/NTS/2011/73, SB/EMEQ-185/2013]; Council of Scientific and
   Industrial Research (CSIR), New Delhi, India [01(2547)/11/EMR-II]; ICTP,
   Italy
FX One of the authors D. Gopi acknowledges the major financial support from
   the Indian Council of Medical Research (ICMR, IRIS ID No.: 2010-08660,
   Ref. No.: 5/20/11(Bio)/10-NCD-I), Department of Science and Technology
   (DST, Ref. No.: DST/TSG/NTS/2011/73 and DST-SERB, Ref. No.:
   SB/EMEQ-185/2013), Council of Scientific and Industrial Research (CSIR,
   Ref. No.: 01(2547)/11/EMR-II) New Delhi, India in the form of major
   research projects. Also L. Kavitha acknowledges the financial support
   from ICTP, Italy in the form of Junior Associateship.
CR Abhishek Mathur, 2011, Journal of Chemical and Pharmaceutical Research, V3, P886
   Al-Zoreky NS, 2009, INT J FOOD MICROBIOL, V134, P244, DOI 10.1016/j.ijfoodmicro.2009.07.002
   Azaroff L. V., 1968, ELEMENTS XRAY CRYSTA
   Bae IY, 2009, FOOD HYDROCOLLOID, V23, P1980, DOI 10.1016/j.foodhyd.2009.02.013
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bankar A, 2010, COLLOID SURFACE B, V80, P45, DOI 10.1016/j.colsurfb.2010.05.029
   Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   BODMEIER R, 1994, PHARMACEUT RES, V11, P882, DOI 10.1023/A:1018942127524
   Cao HQ, 2010, J PHYS CHEM C, V114, P18352, DOI 10.1021/jp106078b
   Chanakya HN, 2009, WASTE MANAGE, V29, P1306, DOI 10.1016/j.wasman.2008.09.014
   Chatjigakis AK, 1998, CARBOHYD POLYM, V37, P395, DOI 10.1016/S0144-8617(98)00057-5
   Dharumadurai Dhanasekaran, 2011, Innovative Romanian Food Biotechnology, V8, P26
   Diessens M., 1978, CALCIFIED TISSUE INT, V26, P127
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Edison TJI, 2013, SPECTROCHIM ACTA A, V104, P262, DOI 10.1016/j.saa.2012.11.084
   Ele-Ekouna JP, 2011, CARBOHYD POLYM, V83, P1232, DOI 10.1016/j.carbpol.2010.09.028
   Emaga T.H., 2007, BIORESOURCE TECHNOL, V99, P4346
   Engels C, 2012, FOOD RES INT, V45, P422, DOI 10.1016/j.foodres.2011.11.008
   Fan LH, 2012, CARBOHYD POLYM, V88, P707, DOI 10.1016/j.carbpol.2012.01.021
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feng NC, 2009, J HAZARD MATER, V164, P1286, DOI 10.1016/j.jhazmat.2008.09.096
   Fisher J.P., 2007, TISSUE ENG
   Gaines R. V., 1997, DANAS NEW MINERALOGY, P1819
   Gilbert U.P.A., 2005, REV MINERAL GEOCHEM, V59, P157
   Gnanasambandam R, 2000, FOOD CHEM, V68, P327, DOI 10.1016/S0308-8146(99)00191-0
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gopi D, 2013, SPECTROCHIM ACTA A, V107, P196, DOI 10.1016/j.saa.2013.01.052
   Gopi D, 2013, SPECTROCHIM ACTA A, V104, P292, DOI 10.1016/j.saa.2012.11.092
   Gopi D, 2012, SPECTROCHIM ACTA A, V93, P131, DOI 10.1016/j.saa.2012.02.033
   Gopi D, 2012, SPECTROCHIM ACTA A, V92, P194, DOI 10.1016/j.saa.2012.02.069
   Gopi D, 2012, SPECTROCHIM ACTA A, V87, P245, DOI 10.1016/j.saa.2011.11.047
   Gopi D, 2010, SPECTROCHIM ACTA A, V77, P545, DOI 10.1016/j.saa.2010.06.013
   Gopi D, 2009, SPECTROCHIM ACTA A, V74, P282, DOI 10.1016/j.saa.2009.05.021
   Gopi D., 2010, CURR APPL PHYS, V11, P1
   Green DW, 2006, SOFT MATTER, V2, P732, DOI 10.1039/b604786f
   Hokputsa S, 2004, CARBOHYD RES, V339, P753, DOI 10.1016/j.carres.2003.11.022
   Jain P, 2011, AFR J PHARM PHARMACO, V5, P1398, DOI 10.5897/AJPP11.294
   Jindal M, 2013, CARBOHYD POLYM, V93, P386, DOI 10.1016/j.carbpol.2012.12.012
   Karayil S, 1998, J Postgrad Med, V44, P93
   Kim HM, 2003, CURR OPIN SOLID ST M, V7, P289, DOI 10.1016/j.cossms.2003.09.014
   Kim J.H., 1997, J PHARM SCI, V86, P316
   Klug HP, 1954, XRAY DIFFRACTION PRO, P504
   Kohsuke M., 2004, J AM CHEM SOC, V126, P10657
   Kokkonen H, 2008, BIOMACROMOLECULES, V9, P2369, DOI 10.1021/bm800356b
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Krithika R., 2012, INT J MED RES, V1, P338
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LeGeros R.Z., 2002, J ORAL IMPLANTOL, V28, P290
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Liu L, 2010, BIORESOURCE TECHNOL, V101, P3268, DOI 10.1016/j.biortech.2009.12.062
   Liu LS, 2004, BIOMATERIALS, V25, P3201, DOI 10.1016/j.biomaterials.2003.10.036
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Nadagouda MN, 2009, CRYST GROWTH DES, V9, P4979, DOI 10.1021/cg9007685
   Neirynck N, 2004, FOOD HYDROCOLLOID, V18, P949, DOI 10.1016/j.foodhyd.2004.03.004
   Pappas CS, 2004, CARBOHYD POLYM, V56, P465, DOI 10.1016/j.carbpol.2004.03.014
   Patil RS, 2012, SPECTROCHIM ACTA A, V91, P234, DOI 10.1016/j.saa.2012.02.009
   Perrone P, 2002, PHYTOCHEMISTRY, V60, P67, DOI 10.1016/S0031-9422(02)00039-0
   Rao YS, 2013, SPECTROCHIM ACTA A, V103, P156, DOI 10.1016/j.saa.2012.11.028
   Renard CMGC, 1999, CARBOHYD POLYM, V39, P201, DOI 10.1016/S0144-8617(99)00006-5
   Rodriguez-Ambriz SL, 2008, FOOD CHEM, V107, P1515, DOI 10.1016/j.foodchem.2007,10.007
   Rosenbohm C, 2003, CARBOHYD RES, V338, P637, DOI 10.1016/S0008-6215(02)00440-8
   Roudier MP, 2003, CLIN EXP METASTAS, V20, P171, DOI 10.1023/A:1022627421000
   Semde R, 2000, INT J PHARM, V197, P181, DOI 10.1016/S0378-5173(99)00467-6
   SILVERSTEIN RM, 1991, SPECTROMETRIC IDENTI
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Sun XM, 2004, ANGEW CHEM INT EDIT, V43, P597, DOI 10.1002/anie.200352386
   Tari NE, 2011, MATER CHEM PHYS, V131, P132, DOI 10.1016/j.matchemphys.2011.07.078
   Wang F, 2005, MATER LETT, V59, P916, DOI 10.1016/j.matlet.2004.08.041
   Wang L, 2007, CARBOHYD POLYM, V68, P740, DOI 10.1016/j.carbpol.2006.08.010
   Wang YJ, 2006, MATER LETT, V60, P1484, DOI 10.1016/j.matlet.2005.11.053
   Winning H, 2007, FOOD HYDROCOLLOID, V21, P256, DOI 10.1016/j.foodhyd.2006.03.017
   Yan L, 2001, INT J INORG MATER, V3, P633, DOI 10.1016/S1466-6049(01)00164-7
   Yao WR, 2011, J AGR FOOD CHEM, V59, P5312, DOI 10.1021/jf200211m
   Zhang LF, 2013, ULTRASON SONOCHEM, V20, P222, DOI 10.1016/j.ultsonch.2012.07.021
NR 75
TC 32
Z9 32
U1 5
U2 76
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD JAN 24
PY 2014
VL 118
BP 589
EP 597
DI 10.1016/j.saa.2013.09.034
PG 9
WC Spectroscopy
SC Spectroscopy
GA 266EE
UT WOS:000328005400079
PM 24095769
DA 2018-10-19
ER

PT J
AU Sadeghi, B
AF Sadeghi, Babak
TI Preparation of ZnO/Ag nanocomposite and coating on polymers for
   anti-infection biomaterial application
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE Nanocomposites; Antibacterial activity; Scanning electron microscopy
   (SEM); X-ray diffraction(XRD)
ID TEMPERATURE MODULATION; CARBON NANOTUBES; CRYSTAL-GROWTH; ZINC-OXIDE;
   NANOPARTICLES; NANORODS; PARTICLES; ROUTE
AB ZnO/Ag nanocomposites coated with polyvinyl chloride (PVC) were prepared by chemical reduction method, for anti-infection biomaterial application. There is a growing interest in attempts in using biomolecular as the templates to grow inorganic nanocomposites in controlled morphology and structure. By optimizing the experiment conditions, we successfully fabricated high yield of ZnO/Ag nanocomposite with full coverage of high-density polyvinyl chloride (PVC) coating. More importantly, ZnO/Ag nanocomposites were shown to significantly inhibit the growth of Staphylococcus aureus in solution. It was further shown that ZnO/Ag nanocomposites induced thiol depletion that caused death of S. aureus. The coatings were fully characterized using techniques such as scanning electron microscopy (SEM), transmission electron microscopy (TEM) and X-ray diffraction (XRD). Most importantly, compared to uncoated metals, the coatings on PVC promoted healthy antibacterial activity. Importantly, compared to ZnO-Ag -uncoated PVC, the ZnO/Ag nanocomposites coated was approximately triplet more effective in preventing bacteria attachment. The result of Thermal Gravimetric Analysis (TGA) indicates that, the ZnO/Ag nanocomposites are chemically stable in the temperature range from 50 to 900 degrees C. This result, for the first time, demonstrates the potential of using ZnO/Ag nanocomposites as a coating material for numerous anti-bacterial applications. (C) 2013 Elsevier B.V. All rights reserved.
C1 Islamic Azad Univ, Dept Chem, Tonekabon Branch, Tonekabon, Iran.
RP Sadeghi, B (reprint author), Islamic Azad Univ, Dept Chem, Tonekabon Branch, Tonekabon, Iran.
EM bsadeghi1177@gmail.com
FU Research vice Presidency of Tonekabon Branch, Islamic Azad University;
   Iran-Nanotechnology Organization (Govt. of Iran)
FX The financial and encouragement support provided by the Research vice
   Presidency of Tonekabon Branch, Islamic Azad University and Executive
   Director of Iran-Nanotechnology Organization (Govt. of Iran).
CR Azahar Ali., 2009, MATER LETT, V63, P2473
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Beydoun D, 1999, J NANOPART RES, V1, P439, DOI 10.1023/A:1010044830871
   Chen CL, 2008, J AM CHEM SOC, V130, P13555, DOI 10.1021/ja805683r
   Chen ZT, 2006, J CRYST GROWTH, V293, P522, DOI 10.1016/j.jcrysgro.2006.05.082
   Dev A, 2006, J PHYS CHEM B, V110, P14266, DOI 10.1021/jp0627291
   Djalali R, 2003, J AM CHEM SOC, V125, P5873, DOI 10.1021/ja0299598
   Fu ZP, 2007, MATER LETT, V61, P4832, DOI 10.1016/j.matlet.2007.03.051
   Ge CQ, 2008, MATER LETT, V62, P2307, DOI 10.1016/j.matlet.2007.11.073
   Grosso D, 2001, ADV MATER, V13, P1085, DOI 10.1002/1521-4095(200107)13:14<1085::AID-ADMA1085>3.0.CO;2-Q
   Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367
   Huang MH, 2001, ADV MATER, V13, P113, DOI 10.1002/1521-4095(200101)13:2<113::AID-ADMA113>3.0.CO;2-H
   Huang XJ, 2004, SENSOR ACTUAT B-CHEM, V99, P444, DOI 10.1016/j.snb.2003.12.013
   Kambayashi M, 2005, CRYST GROWTH DES, V5, P81, DOI 10.1021/cg0499156
   Kryukov A.I., 2000, TEOR EKSP KHIM, V36, P69
   Kulak A. I., 1986, ELECTROCHEMISTRY SEM
   Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x
   Lin HM, 1998, NANOSTRUCT MATER, V10, P465, DOI 10.1016/S0965-9773(98)00087-7
   Liu X, 2004, J APPL PHYS, V95, P3141, DOI 10.1063/1.1646440
   Milne WI, 2004, J MATER CHEM, V14, P933, DOI 10.1039/b314155c
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   O'Regan B, 2000, ADV MATER, V12, P1263, DOI 10.1002/1521-4095(200009)12:17<1263::AID-ADMA1263>3.0.CO;2-T
   Park WI, 2002, APPL PHYS LETT, V80, P4232, DOI 10.1063/1.1482800
   Sadeghi B, 2010, INT J NANO DIMENS, V1, P119, DOI 10.7508/ijnd.2010.02.004
   Sadeghi B, 2011, MICRO NANO LETT, V6, P209, DOI 10.1049/mnl.2011.0036
   Sadeghi B, 2012, SPECTROCHIM ACTA A, V97, P326, DOI 10.1016/j.saa.2012.05.082
   Sadeghi B, 2011, ADV POWDER TECHNOL, V22, P669, DOI 10.1016/j.apt.2010.10.001
   Sadeghi B, 2012, ADV POWDER TECHNOL, V23, P22, DOI 10.1016/j.apt.2010.11.011
   Sadeghi B, 2009, SUPERLATTICE MICROST, V46, P858, DOI 10.1016/j.spmi.2009.10.006
   Sadjadi MAS, 2008, PHYSICA E, V40, P3183, DOI 10.1016/j.physe.2008.05.010
   Senda S, 2004, APPL PHYS LETT, V85, P5679, DOI 10.1063/1.1832733
   Shekhar S., NANOTECHNOLOGY, V22
   Sieber F., 2007, US Patent, Patent No. [7,205,002, 7205002]
   Sone ED, 2004, J AM CHEM SOC, V126, P12756, DOI 10.1021/ja0499344
   Tsukazaki A, 2005, NAT MATER, V4, P42, DOI 10.1038/nmat1284
   Umar AA, 2006, CRYST GROWTH DES, V6, P818, DOI 10.1021/cg050548n
   Wood A, 2001, J PHYS CHEM B, V105, P8810, DOI 10.1021/jp011576t
NR 37
TC 18
Z9 18
U1 1
U2 58
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD JAN 24
PY 2014
VL 118
BP 787
EP 792
DI 10.1016/j.saa.2013.09.022
PG 6
WC Spectroscopy
SC Spectroscopy
GA 266EE
UT WOS:000328005400104
PM 24148529
DA 2018-10-19
ER

PT J
AU Hook, ER
   Owen, OJ
   Bellis, CA
   Holder, JA
   O'Sullivan, DJ
   Barbour, ME
AF Hook, Edward R.
   Owen, Olivia J.
   Bellis, Candice A.
   Holder, James A.
   O'Sullivan, Dominic J.
   Barbour, Michele E.
TI Development of a novel antimicrobial-releasing glass ionomer cement
   functionalized with chlorhexidine hexametaphosphate nanoparticles
SO JOURNAL OF NANOBIOTECHNOLOGY
LA English
DT Article
DE Nanoparticles; Nanobiomaterials; Antimicrobial; Dentistry
ID PHYSICAL-PROPERTIES; RESTORATIVE MATERIALS; FLUORIDE RELEASE;
   DENTAL-CARIES; ANTIBACTERIAL; MANAGEMENT
AB Background: Glass ionomer cements (GICs) are a class of dental biomaterials. They have a wide range of uses including permanent restorations (fillings), cavity linings, fissure sealants and adhesives. One of the most common reasons for replacing a dental restoration is recurrent bacterial tooth decay around the margins of the biomaterial. Therefore, a dental biomaterial which creates a sustained antimicrobial environment around the restoration would be of considerable clinical benefit. In this manuscript, the formulation of a GIC containing novel antimicrobial nanoparticles composed of chlorhexidine hexametaphosphate at 1, 2, 5, 10 and 20% powder substitution by mass is reported. The aim is to create GICs which contain chlorhexidine-hexametaphosphate nanoparticles and characterize the nanoparticle size, morphology and charge and the release of chlorhexidine and fluoride, tensile strength and morphology of the GICs.
   Results: The GICs released chlorhexidine, which is a broad spectrum antimicrobial agent effective against a wide range of oral bacteria, over the duration of the experiment in a dose-dependent manner. This was not at the expense of other properties; fluoride release was not significantly affected by the substitution of antimicrobial nanoparticles in most formulations and internal structure appeared unaffected up to and including 10% substitution. Diametral tensile strength decreased numerically with substitutions of 10 and 20% nanoparticles but this difference was not statistically significant.
   Conclusion: A series of GICs functionalized with chlorhexidine-hexametaphosphate nanoparticles were created for the first time. These released chlorhexidine in a dose-dependent manner. These materials may find application in the development of a new generation of antimicrobial dental nanomaterials.
C1 [Hook, Edward R.; Owen, Olivia J.; Bellis, Candice A.; Holder, James A.; O'Sullivan, Dominic J.; Barbour, Michele E.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   [Holder, James A.] Associated Dent Prod Ltd, Kemdent, Purton SN5 4HT, Wilts, England.
RP Barbour, ME (reprint author), Univ Bristol, Sch Oral & Dent Sci, Lower Maudlin St, Bristol BS1 2LY, Avon, England.
EM m.e.barbour@bristol.ac.uk
FU Medical Research Council [1380463]
CR Barbour Michele E, 2013, Int J Nanomedicine, V8, P3507, DOI 10.2147/IJN.S50140
   Billington RW, 2006, J DENT, V34, P544, DOI 10.1016/j.jdent.2005.09.008
   Cheng L, 2012, DENT MATER, V28, P573, DOI 10.1016/j.dental.2012.01.006
   Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x
   GRIFFEN AL, 1991, PEDIATR CLIN N AM, V38, P1209
   Holmgren CJ, 2013, BRIT DENT J, V214, P11, DOI 10.1038/sj.bdj.2012.1175
   Hoszek A, 2008, OPER DENT, V33, P696, DOI 10.2341/08-20
   Korkmaz FM, 2013, J PROSTHET DENT, V110, P107, DOI 10.1016/S0022-3913(13)60349-2
   Lim BS, 2013, EUR J ORAL SCI, V121, P211, DOI 10.1111/eos.12033
   Melo MAS, 2013, TRENDS BIOTECHNOL, V31, P459, DOI 10.1016/j.tibtech.2013.05.010
   Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020
   Palmer G, 2004, BIOMATERIALS, V25, P5423, DOI 10.1016/j.biomaterials.2003.12.051
   Randall RC, 1999, J DENT RES, V78, P628, DOI 10.1177/00220345990780020101
   Sanders BJ, 2002, J ORAL REHABIL, V29, P553, DOI 10.1046/j.1365-2842.2002.00876.x
   Sidhu SK, 2011, AUST DENT J, V56, P23, DOI 10.1111/j.1834-7819.2010.01293.x
   Turkun LS, 2008, J ESTHET RESTOR DENT, V20, P29, DOI 10.1111/j.1708-8240.2008.00146.x
   Wang Z, 2013, DENT MATER, V30, pe1
   Yengopal V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004483.pub2
   Yip HK, 2000, QUINTESSENCE INT, V31, P261
NR 19
TC 19
Z9 20
U1 1
U2 24
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1477-3155
J9 J NANOBIOTECHNOL
JI J. Nanobiotechnol.
PD JAN 23
PY 2014
VL 12
AR 3
DI 10.1186/1477-3155-12-3
PG 9
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA AD4GQ
UT WOS:000333206700001
PM 24456793
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kumar, S
   Jana, AK
   Maiti, M
   Dhamija, I
AF Kumar, Sandeep
   Jana, Asim K.
   Maiti, Mithu
   Dhamija, Isha
TI Carbodiimide-mediated immobilization of serratiopeptidase on amino-,
   carboxyl-functionalized magnetic nanoparticles and characterization for
   target delivery
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Carrageenan-induced paw edema; Characterization; Direct protein binding;
   Immobilization; Magnetic nanoparticles (MNPs); Serratiopeptidase;
   Nanomedicine
ID INDUCED PAW EDEMA; PROTEOLYTIC-ENZYME SERRAPEPTASE; IRON-OXIDE
   NANOPARTICLES; CROSS-LINKING; DRUG-DELIVERY; RELEASE; STABILIZATION;
   CONJUGATION; STABILITY; PROGRESS
AB A hybrid biomaterial of serratiopeptidase enzyme was prepared with magnetic nanoparticles (MNPs) via carboxyl and amino-functionalization and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) for direct immobilization. The average size of prepared MNPs was found to be 15.05 +/- A 3.06 nm. Attachment of amino and carboxyl groups was confirmed by Fourier transform infrared spectroscopy. X-ray diffraction confirmed the purity and phase integrity of Fe3O4. The MNPs and enzyme-loaded-MNPs (EMNPs) were of saturation magnetization 58 and 50 emu g(-1), respectively. Thermogravimetric analysis of EDC-MNPs and EMNPs showed the presence of organic coating over MNPs. Serratiopeptidase immobilized on amino-functionalized magnetic nanoparticles showed loss of enzyme activity due to crosslinking of enzyme, while serratiopeptidase immobilized on carboxyl-functionalized magnetic nanoparticles was better and gave 115.78 mg protein g(-1) MNPs, enzyme loading 168.32 U g(-1) MNPs at optimized MNPs-to-enzyme ratio 1.0 mg mg(-1). In vitro and in vivo studies showed that EMNPs with magnetic targeting is more effective in drug permeation and reduction in edema than free enzyme.
C1 [Kumar, Sandeep; Jana, Asim K.] Dr BR Ambedkar Natl Inst Technol, Dept Biotechnol, Jalandhar 144011, India.
   [Maiti, Mithu] Dr BR Ambedkar Natl Inst Technol, Dept Chem, Jalandhar 144011, India.
   [Dhamija, Isha] Guru Jambhshwar Univ Sci & Technol, Dept Pharmaceut Sci, Hisar, India.
RP Jana, AK (reprint author), Dr BR Ambedkar Natl Inst Technol, Dept Biotechnol, GT Rd Bye Pass, Jalandhar 144011, India.
EM asimkumarjana@gmail.com
FU Ministry of Human Resource Development (MHRD), Govt. of India
FX Mr. Sandeep Kumar gratefully acknowledges Ministry of Human Resource
   Development (MHRD), Govt. of India for providing the fellowship during
   the study. All authors are highly thankful to Advanced Enzyme
   Technologies Ltd, Mumbai, for providing the enzyme serratiopeptidase.
   All authors are thankful for helping in the analysis of the different
   samples to Sophisticated Analytical Instrumentation Facility (TEM,
   FTIR), Punjab University, Chandigarh; Central Research Facility
   (SEM-EDS), Indian Institute of Technology, Ropar; Institute
   Instrumentation Center (AFM, VSM), Indian Institute of Technology,
   Roorkee. All authors are highly thankful to Prof. Samir Kumar Das,
   Director, National Institute of Technology (NIT), Jalandhar, for
   providing all grants for the study.
CR Al-Khateeb TH, 2008, INT J ORAL MAX SURG, V37, P264, DOI 10.1016/j.ijom.2007.11.011
   [Anonymous], 2003, FOOD CHEM COD VE, P923
   Bi F, 2009, BIOMATERIALS, V30, P5125, DOI 10.1016/j.biomaterials.2009.06.006
   Cao HN, 2009, APPL SURF SCI, V255, P7974, DOI 10.1016/j.apsusc.2009.04.199
   Chen JP, 2012, INT J NANOMED, V7, P5137, DOI 10.2147/IJN.S36197
   Chen JP, 2011, CARBOHYD POLYM, V84, P364, DOI 10.1016/j.carbpol.2010.11.052
   Chen Y, 2011, ANAL BIOANAL CHEM, V399, P2503, DOI 10.1007/s00216-010-4622-7
   Cheon YH, 2000, J MOL CATAL B-ENZYM, V11, P29, DOI 10.1016/S1381-1177(00)00193-4
   Chertok B, 2011, J CONTROL RELEASE, V155, P393, DOI 10.1016/j.jconrel.2011.06.033
   Dandamudi S, 2007, BIOMATERIALS, V28, P4673, DOI 10.1016/j.biomaterials.2007.07.024
   El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706
   Faraji M, 2010, J IRAN CHEM SOC, V7, P1, DOI 10.1007/BF03245856
   Gao F., 2012, J NANOPART RES, V14, P1, DOI DOI 10.1007/S11051-012-1160-6
   Hong RY, 2009, APPL SURF SCI, V255, P3485, DOI 10.1016/j.apsusc.2008.09.071
   Hsieh HJ, 2000, BIOTECHNOL LETT, V22, P1459, DOI 10.1023/A:1005602812037
   Hu B, 2009, PROCESS BIOCHEM, V44, P1019, DOI 10.1016/j.procbio.2009.05.001
   Hu FX, 2006, BIOMACROMOLECULES, V7, P809, DOI 10.1021/bm050870e
   Huang GJ, 2012, FOOD CHEM TOXICOL, V50, P1485, DOI 10.1016/j.fct.2012.01.041
   Jiang YY, 2009, J MOL CATAL B-ENZYM, V58, P103, DOI 10.1016/j.molcatb.2008.12.001
   Kalkan NA, 2011, J APPL POLYM SCI, V123, P707
   KEE W H, 1989, SMJ Singapore Medical Journal, V30, P48
   Kouassi G. K., 2005, J NANOBIOTECHNOL, V3
   Krukemeyer MG, 2012, J DRUG TARGET, V20, P185, DOI 10.3109/1061186X.2011.622399
   Kumar R, 2010, MATER RES BULL, V45, P1603, DOI 10.1016/j.materresbull.2010.07.017
   Kumar S, 2013, J DRUG TARGET, DOI [10.3109/1061186X. 1062013.1844157, DOI 10.3109/1061186X.1062013.1844157]
   Kumar S, 2013, EUR J PHARM BIOPHARM, DOI [10.1016/j.ejpb.2013.1006.1019, DOI 10.1016/J.EJPB.2013.1006.1019]
   Kumar S, 2010, BIORESOURCE TECHNOL, V101, P6856, DOI 10.1016/j.biortech.2010.03.084
   KV S, 2007, MOL PHARM, V5, P92
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Li GY, 2008, J ALLOY COMPD, V466, P451, DOI 10.1016/j.jallcom.2007.11.100
   Liang YY, 2007, COLLOID POLYM SCI, V285, P1193, DOI 10.1007/s00396-007-1672-2
   Liang YY, 2007, BIOMACROMOLECULES, V8, P1480, DOI 10.1021/bm061091g
   Lin YL, 2012, MATER RES BULL, V47, P614, DOI 10.1016/j.materresbull.2011.12.042
   Longhi C, 2008, MICROB PATHOGENESIS, V45, P45, DOI 10.1016/j.micpath.2008.01.007
   Lopez RFV, 2000, INT J PHARM, V200, P127, DOI 10.1016/S0378-5173(00)00365-3
   Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30
   Maheshwari M, 2006, AAPS PHARMSCITECH, V7, pE162
   Majumder AB, 2008, BIOCATAL BIOTRANSFOR, V26, P235, DOI 10.1080/10242420701685601
   Marroquin-Segura R, 2009, J ETHNOPHARMACOL, V124, P639, DOI 10.1016/j.jep.2009.06.004
   Maximov V, 2009, J DRUG DELIV SCI TEC, V19, P311, DOI 10.1016/S1773-2247(09)50066-4
   MAZZONE A, 1990, J INT MED RES, V18, P379, DOI 10.1177/030006059001800506
   Nakamura S, 2003, RESPIROLOGY, V8, P316, DOI 10.1046/j.1440-1843.2003.00482.x
   Namdeo M, 2009, J MOL CATAL B-ENZYM, V59, P134, DOI 10.1016/j.molcatb.2009.02.005
   Nigam S, 2011, J MAGN MAGN MATER, V323, P237, DOI 10.1016/j.jmmm.2010.09.009
   Novak L, 2007, BIOMACROMOLECULES, V8, P1624, DOI 10.1021/bm0612182
   Nowicka AM, 2013, BIOMACROMOLECULES, V14, P828, DOI 10.1021/bm301868f
   Panagariya A, 1999, J Assoc Physicians India, V47, P1170
   Pecova M, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/12/125102
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   Petri-Fink A, 2008, EUR J PHARM BIOPHARM, V68, P129, DOI 10.1016/j.ejpb.2007.02.024
   Rath G, 2011, ARTIF CELL BLOOD SUB, V39, P44, DOI 10.3109/10731199.2010.494580
   Ren LL, 2010, J MOL CATAL B-ENZYM, V62, P190, DOI 10.1016/j.molcatb.2009.10.009
   Sadeghi H, 2011, EUR J PHARMACOL, V667, P396, DOI 10.1016/j.ejphar.2011.05.053
   ShiXing W., 2010, J NANOPART RES, V12, P2467
   Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007
   Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0
   Tang TT, 2011, CHEMOSPHERE, V83, P255, DOI 10.1016/j.chemosphere.2010.12.075
   Verma ML, 2013, APPL MICROBIOL BIOT, V97, P23, DOI 10.1007/s00253-012-4535-9
   Vichasilp C, 2012, FOOD CHEM, V134, P1823, DOI 10.1016/j.foodchem.2012.03.086
   Wang N, 2013, J COLLOID INTERF SCI, V395, P50, DOI 10.1016/j.jcis.2012.11.062
   Xu H, 2005, J MAGN MAGN MATER, V293, P514, DOI 10.1016/j.jmmm.2005.01.067
   Yu CC, 2012, BIOCONJUGATE CHEM, V23, P714, DOI 10.1021/bc200396r
   Zheng ZH, 2009, J FIBER BIOENGINEERI, V2, P162
   Zhu H, 2009, J MOL CATAL B-ENZYM, V61, P174, DOI 10.1016/j.molcatb.2009.06.007
   Zhuo Y, 2009, BIOMATERIALS, V30, P2284, DOI 10.1016/j.biomaterials.2009.01.002
   Ziv-Polat O, 2010, BIOMATERIALS, V31, P741, DOI 10.1016/j.biomaterials.2009.09.093
NR 66
TC 8
Z9 9
U1 1
U2 59
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
EI 1572-896X
J9 J NANOPART RES
JI J. Nanopart. Res.
PD JAN 22
PY 2014
VL 16
IS 2
BP 1
EP 23
AR 2233
DI 10.1007/s11051-013-2233-x
PG 23
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 298QH
UT WOS:000330338900001
DA 2018-10-19
ER

PT J
AU Zhang, ZS
   Wu, T
   Wang, Q
   Pan, HH
   Tang, RK
AF Zhang, Zhisen
   Wu, Tao
   Wang, Qi
   Pan, Haihua
   Tang, Ruikang
TI Impact of interfacial high-density water layer on accurate estimation of
   adsorption free energy by Jarzynski's equality
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID STEERED MOLECULAR-DYNAMICS; MONTE-CARLO SIMULATIONS; WALLED CARBON
   NANOTUBES; PROTEIN ADSORPTION; NONEQUILIBRIUM SIMULATIONS;
   HYDROXYAPATITE SURFACES; CONFORMATIONAL-CHANGES; STATISTICAL-MECHANICS;
   BINDING AFFINITIES; CELL-ADHESION
AB The interactions between proteins/peptides and materials are crucial to research and development in many biomedical engineering fields. The energetics of such interactions are key in the evaluation of new proteins/peptides and materials. Much research has recently focused on the quality of free energy profiles by Jarzynski's equality, a widely used equation in biosystems. In the present work, considerable discrepancies were observed between the results obtained by Jarzynski's equality and those derived by umbrella sampling in biomaterial-water model systems. Detailed analyses confirm that such discrepancies turn up only when the target molecule moves in the high-density water layer on a material surface. Then a hybrid scheme was adopted based on this observation. The agreement between the results of the hybrid scheme and umbrella sampling confirms the former observation, which indicates an approach to a fast and accurate estimation of adsorption free energy for large biomaterial interfacial systems. (C) 2014 AIP Publishing LLC.
C1 [Zhang, Zhisen; Wu, Tao; Wang, Qi] Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Zhisen; Wu, Tao; Wang, Qi; Tang, Ruikang] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China.
   [Pan, Haihua] Zhejiang Univ, Qiushi Acad Adv Studies, Hangzhou 310027, Zhejiang, Peoples R China.
   [Zhang, Zhisen; Tang, Ruikang] Zhejiang Univ, Ctr Biomat & Biopathways, Hangzhou 310027, Zhejiang, Peoples R China.
RP Wu, T (reprint author), Zhejiang Univ, Soft Matter Res Ctr, Hangzhou 310027, Zhejiang, Peoples R China.
EM tao_wu@zju.edu.cn; qiwang@zju.edu.cn
FU National Natural Science Foundation of China (NNSFC) [21074115,
   21273200]; MOE [J20091551]; Zhejiang University [2011XZZX002,
   2011QNA3014]
FX This work was supported by the National Natural Science Foundation of
   China (NNSFC) (Grant Nos. 21074115 and 21273200), MOE (Grant No.
   J20091551), and the Zhejiang University (Grant Nos. 2011XZZX002 and
   2011QNA3014).
CR Agnihotri A, 2004, LANGMUIR, V20, P8846, DOI 10.1021/la049239
   Amaro R, 2003, P NATL ACAD SCI USA, V100, P7599, DOI 10.1073/pnas.1331150100
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Bastug T, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2904461
   Bellis SL, 2011, BIOMATERIALS, V32, P4205, DOI 10.1016/j.biomaterials.2011.02.029
   Bertinetti L, 2007, J PHYS CHEM C, V111, P4027, DOI 10.1021/jp066040s
   Chelli R, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4808037
   Chelli R, 2012, J CHEM THEORY COMPUT, V8, P4040, DOI 10.1021/ct300348w
   Chen X, 2008, BIOMATERIALS, V29, P2423, DOI 10.1016/j.biomaterials.2008.02.002
   Corno M, 2009, LANGMUIR, V25, P2188, DOI 10.1021/la803253k
   Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361
   Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Daura X, 2010, CHEMPHYSCHEM, V11, P3734, DOI 10.1002/cphc.201000562
   de Graaf J, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3389481
   de Leeuw NH, 2007, CRYSTENGCOMM, V9, P1178, DOI 10.1039/b710974a
   Echeverria I, 2012, J PHYS CHEM B, V116, P10986, DOI 10.1021/jp300527q
   Essex JW, 1997, J PHYS CHEM B, V101, P9663, DOI 10.1021/jp971990m
   Gore J, 2003, P NATL ACAD SCI USA, V100, P12564, DOI 10.1073/pnas.1635159100
   Harding JH, 2006, J MATER CHEM, V16, P1105, DOI 10.1039/b511650c
   Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y
   Hauptmann S, 2003, PHYS CHEM CHEM PHYS, V5, P635, DOI 10.1039/b208209h
   Hendrix DA, 2001, J CHEM PHYS, V114, P5974, DOI 10.1063/1.1353552
   Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Hummer G, 2001, J CHEM PHYS, V114, P7330, DOI 10.1063/1.1363668
   Ilan B, 2004, PROTEINS, V55, P223, DOI 10.1002/prot.20038
   Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690
   Jensen MO, 2002, P NATL ACAD SCI USA, V99, P6731, DOI 10.1073/pnas.102649299
   JORGENSEN WL, 1989, CHEM PHYS, V129, P193, DOI 10.1016/0301-0104(89)80004-7
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kang Y, 2010, J PHYS CHEM B, V114, P2869, DOI 10.1021/jp905995s
   Kang Y, 2009, BIOMATERIALS, V30, P2807, DOI 10.1016/j.biomaterials.2009.01.024
   Kato M, 2005, J PHYS CHEM B, V109, P19516, DOI 10.1021/jp0532081
   Kato M, 2006, PROTEINS, V64, P829, DOI 10.1002/prot.21012
   Kirkwood JG, 1935, J CHEM PHYS, V3, P300, DOI 10.1063/1.1749657
   Kosztin I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166379
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Larsson A, 2007, BIOMACROMOLECULES, V8, P287, DOI 10.1021/bm060685g
   Lua RC, 2005, J PHYS CHEM B, V109, P6805, DOI 10.1021/jp0455428
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Makarucha AJ, 2011, EUR BIOPHYS J BIOPHY, V40, P103, DOI 10.1007/s00249-010-0651-6
   Mijajlovic M, 2013, LANGMUIR, V29, P2919, DOI 10.1021/la3047966
   Minh DDL, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3242285
   Moradi M, 2013, J PHYS CHEM LETT, V4, P1882, DOI 10.1021/jz400816x
   Nicolini P, 2013, J COMPUT CHEM, V34, P1561, DOI 10.1002/jcc.23286
   Nicolini P, 2011, J CHEM THEORY COMPUT, V7, P582, DOI 10.1021/ct100568n
   Nicolini P, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041124
   Oberhofer H, 2005, J PHYS CHEM B, V109, P6902, DOI 10.1021/jp044556a
   Oostenbrink C, 2006, CHEM PHYS, V323, P102, DOI 10.1016/j.chemphys.2005.08.054
   Pan HH, 2007, LANGMUIR, V23, P8972, DOI 10.1021/la700567r
   Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473
   Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311
   Piccinini E, 2008, J CHEM THEORY COMPUT, V4, P173, DOI 10.1021/ct7001896
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Reid JC, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3486196
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Shen JW, 2008, BIOMATERIALS, V29, P3847, DOI 10.1016/j.biomaterials.2008.06.013
   Shen JW, 2008, BIOMATERIALS, V29, P513, DOI 10.1016/j.biomaterials.2007.10.016
   Shen JW, 2009, CHEMPHYSCHEM, V10, P1260, DOI 10.1002/cphc.200800836
   Spichty M, 2010, J PHYS CHEM LETT, V1, P1922, DOI 10.1021/jz1005016
   Thyparambil AA, 2012, LANGMUIR, V28, P5687, DOI 10.1021/la300315r
   TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007
   Wei Y, 2008, LANGMUIR, V24, P6721, DOI 10.1021/la8005772
   WILLNER I, 1993, ADV MATER, V5, P912, DOI 10.1002/adma.19930051206
   Wilson RM, 1999, AM MINERAL, V84, P1406
   Wright LB, 2012, J PHYS CHEM C, V116, P2933, DOI 10.1021/jp209554g
   Yang G, 2012, BIOMATERIALS, V33, P8757, DOI 10.1016/j.biomaterials.2012.08.053
   Ytreberg FM, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119261
   Ytreberg FM, 2004, J COMPUT CHEM, V25, P1749, DOI 10.1002/jcc.20103
   Zhang DQ, 2006, J AM CHEM SOC, V128, P3019, DOI 10.1021/ja057292u
NR 80
TC 4
Z9 5
U1 1
U2 29
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD JAN 21
PY 2014
VL 140
IS 3
AR 034706
DI 10.1063/1.4858428
PG 9
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 302OM
UT WOS:000330614400052
PM 25669406
DA 2018-10-19
ER

PT J
AU Zhang, BJ
   He, DY
   Fan, Y
   Liu, N
   Chen, YJ
AF Zhang, Baojie
   He, Dongyang
   Fan, Yu
   Liu, Nan
   Chen, Yijun
TI Oral Delivery of Exenatide via Microspheres Prepared by Cross-Linking of
   Alginate and Hyaluronate
SO PLOS ONE
LA English
DT Article
ID SODIUM ALGINATE; DRUG-DELIVERY; GLUTARALDEHYDE; RELEASE; PEPTIDE;
   NANOPARTICLES; EXENDIN-4; BARRIERS; RECEPTOR; AGONIST
AB Exenatide is an FDA-approved glucose-lowering peptide drug for the treatment of type 2 diabetes by subcutaneous injection. To address the issues on the inconvenience for patient use and the difficulty of oral administration of peptide drugs, chemical cross-linking of two pH-responsive biomaterials, alginate and hyaluronate, was carried out to prepare a new material for the encapsulation of exenatide as a form of microspheres. The exenatide-loaded microspheres exhibited spherical structures with excellent loading and release behaviors in the simulated gastrointestinal tract environments. After oral administration of the microspheres in db/db mice, maximum plasma concentration of exenatide appeared at 4 hours, and blood glucose was effectively reduced to a normal level within 2 hours and maintained for another 4 hours. The bioavailability of the exenatide-loaded microspheres, relative to subcutaneous injection of exenatide, reached 10.2%. Collectively, the present study demonstrated the feasibility of orally delivering exenatide with the new cross-linked biomaterial and formulation, and showed therapeutic potential for clinical applications.
C1 [Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.
   [Zhang, Baojie; He, Dongyang; Fan, Yu; Liu, Nan; Chen, Yijun] China Pharmaceut Univ, Biol Chem Lab, Nanjing, Jiangsu, Peoples R China.
RP Liu, N (reprint author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.
EM liunan0428@aliyun.com; yjchen@cpu.edu.cn
OI chen, yijun/0000-0002-4920-152X
FU Ministry of Education of China; State Administration of Foreign Export
   Affairs of China [111-2-07]; National Science and Technology Major
   Projects of China [2012ZX09103-101-030]; State Key Laboratory of Natural
   Medicines, China Pharmaceutical University [SKLNMZZCX201301]
FX This work was supported by the grants from the "111" Project from the
   Ministry of Education of China, and the State Administration of Foreign
   Export Affairs of China (No: 111-2-07), National Science and Technology
   Major Projects of China (2012ZX09103-101-030) and the Research Project
   of State Key Laboratory of Natural Medicines, China Pharmaceutical
   University (No: SKLNMZZCX201301). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Appel EA, 2012, BIOMATERIALS, V33, P4646, DOI 10.1016/j.biomaterials.2012.02.030
   Bajpai SK, 2004, REACT FUNCT POLYM, V59, P129, DOI 10.1016/j.reactfunctpolym.2004.01.002
   Colinet I, 2009, EUR J PHARM BIOPHARM, V73, P345, DOI 10.1016/j.ejpb.2009.07.008
   Davidovich-Pinhas M, 2010, CARBOHYD POLYM, V79, P1020, DOI 10.1016/j.carbpol.2009.10.036
   Davidson MB, 2005, NAT REV DRUG DISCOV, V4, P713, DOI 10.1038/nrd1828
   Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009
   Esposito E, 2005, INT J PHARM, V288, P35, DOI 10.1016/j.ijpharm.2004.09.001
   Fasano A, 1998, TRENDS BIOTECHNOL, V16, P152, DOI 10.1016/S0167-7799(97)01170-0
   FEHMANN HC, 1992, MOL CELL ENDOCRINOL, V85, pC39, DOI 10.1016/0303-7207(92)90118-P
   Fundueanu G, 1998, INT J PHARM, V170, P11, DOI 10.1016/S0378-5173(98)00063-5
   Fundueanu G, 1999, BIOMATERIALS, V20, P1427, DOI 10.1016/S0142-9612(99)00050-2
   Gedulin BR, 2008, INT J PHARM, V356, P231, DOI 10.1016/j.ijpharm.2008.01.015
   GOKE R, 1993, J BIOL CHEM, V268, P19650
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gong NA, 2011, BRIT J PHARMACOL, V163, P399, DOI 10.1111/j.1476-5381.2011.01227.x
   Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003
   Jin CH, 2009, J CONTROL RELEASE, V133, P172, DOI 10.1016/j.jconrel.2008.09.091
   Kim H, 2011, BIOMATERIALS, V32, P1685, DOI 10.1016/j.biomaterials.2010.10.045
   Kulkarni AR, 2000, J CONTROL RELEASE, V63, P97, DOI 10.1016/S0168-3659(99)00176-5
   Li M, 2008, INT J PHARMACEUT, V363, P26, DOI 10.1016/j.ijpharm.2008.07.018
   Liew CV, 2006, INT J PHARM, V309, P25, DOI 10.1016/ijpharm.2005.10.040
   Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a
   Morishita M, 2006, DRUG DISCOV TODAY, V11, P905, DOI 10.1016/j.drudis.2006.08.005
   Nguyen HN, 2011, BIOMATERIALS, V32, P2673, DOI 10.1016/j.biomaterials.2010.12.044
   Norback D, 1998, SCAND J WORK ENV HEA, V14, P366
   Sung HW, 2012, ACCOUNTS CHEM RES, V45, P619, DOI 10.1021/ar200234q
   Yeom CK, 1998, J APPL POLYM SCI, V67, P209, DOI 10.1002/(SICI)1097-4628(19980110)67:2<209::AID-APP3>3.0.CO;2-Y
   Yun YH, 2004, BIOMATERIALS, V25, P147, DOI 10.1016/S0142-9612(03)00467-8
   Zeiger E, 2005, MUTAT RES-REV MUTAT, V589, P136, DOI 10.1016/j.mrrev.2005.01.001
NR 29
TC 7
Z9 11
U1 0
U2 32
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 21
PY 2014
VL 9
IS 1
AR e86064
DI 10.1371/journal.pone.0086064
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 297GT
UT WOS:000330244500171
PM 24465870
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Fernandez-Rodriguez, MA
   Rodriguez-Valverde, MA
   Cabrerizo-Vilchez, MA
AF Fernandez-Rodriguez, M. A.
   Rodriguez-Valverde, M. A.
   Cabrerizo-Vilchez, M. A.
TI Selective desorption of organophosphonates on chemically functionalized
   titanium by Direct Laser Patterning
SO COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS
LA English
DT Article; Proceedings Paper
CT 5th International Workshop Bubble and Drop Interfaces
CY MAY 21-24, 2012
CL Krakow, POLAND
DE Titanium; Chemical functionalization; Organophosphonate; Laser
   patterning; Biomaterial engineering
ID SELF-ASSEMBLED MONOLAYERS; NATIVE-OXIDE SURFACE; SILICON; ACIDS
AB Surface functionalization based on organophosphonate molecules and Direct Laser Patterning (DLP) technique both allow to design chemically patterned titanium surfaces devoted to biomaterial engineering. Ultrapolished surfaces of commercially pure titanium were modified with 16-phosphonohexadecanoic acid and octadecylphosphonic acid. The DLP technique with a green pulsed laser was applied to selectively desorb the organophosphonate molecules on the functionalized titanium surfaces. Three regimes of laser ablation were found on the bare titanium surfaces as the ratio between the spot diameter and the interspot distance. Finally, the organophosphonate functionalized titanium surfaces subjected to DLP revealed different wettability domains with minimum impact on the roughness, validated by XPS, AFM and ESEM. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Fernandez-Rodriguez, M. A.; Rodriguez-Valverde, M. A.; Cabrerizo-Vilchez, M. A.] Univ Granada, Fac Sci, Dept Appl Phys, Biocolloid & Fluid Phys Grp, E-18071 Granada, Spain.
RP Rodriguez-Valverde, MA (reprint author), Univ Granada, Fac Sci, Dept Appl Phys, Biocolloid & Fluid Phys Grp, E-18071 Granada, Spain.
EM marodri@ugr.es
RI Fernandez-Rodriguez, Miguel Angel/J-2923-2015; Cabrerizo-Vilchez,
   Miguel/A-3179-2012; Rodriguez-Valverde, Miguel Angel/B-7938-2009
OI Fernandez-Rodriguez, Miguel Angel/0000-0002-9540-1979;
   Cabrerizo-Vilchez, Miguel/0000-0001-8759-1373; Rodriguez-Valverde,
   Miguel Angel/0000-0003-4361-6721
FU "Ministry of Science and Innovation" [MAT2011-23339]; "Junta de
   Andalucia" [P08-FQM-4325, P09-FQM-4698, P10-FQM-5977]
FX This study was supported by the "Ministry of Science and Innovation"
   (project MAT2011-23339) and by the "Junta de Andalucia" (projects
   P08-FQM-4325, P09-FQM-4698 and P10-FQM-5977). Authors thank to J.A.
   Martin-Perez, who masterly polished the titanium samples, and Y.
   Sanchez-Trevino, C.L. Moraila-Martinez and Dr. F.J. Montes Ruiz-Cabello
   for fruitful discussions.
CR Birch W., 2008, DEV SURFACE CONTAMIN, P1
   Butt HJ, 2003, PHYS CHEM INTERFACES
   Conde JC, 2007, APPL PHYS A-MATER, V88, P667, DOI 10.1007/s00339-007-4024-7
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Danahy MP, 2004, LANGMUIR, V20, P5333, DOI 10.1021/la036084h
   Gawalt ES, 2001, LANGMUIR, V17, P5736, DOI 10.1021/la010649x
   Hanson EL, 2003, J AM CHEM SOC, V125, P16074, DOI 10.1021/ja035956z
   Lawrence J, 2006, SURF COAT TECH, V200, P5581, DOI 10.1016/j.surfcoat.2005.07.107
   Morra M, 2007, EXPERT REV MED DEVIC, V4, P361, DOI 10.1586/17434440.4.3.361
   Shadnam MR, 2004, LANGMUIR, V20, P2667, DOI 10.1021/la0354584
   Tosatti S., 2003, THESIS SWISS FEDERAL
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR
   Welsch G., 1994, MAT PROPERTIES HDB
   Wu J., J BIOMED MAT RES A
NR 14
TC 0
Z9 0
U1 3
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7757
EI 1873-4359
J9 COLLOID SURFACE A
JI Colloid Surf. A-Physicochem. Eng. Asp.
PD JAN 20
PY 2014
VL 441
BP 899
EP 904
DI 10.1016/j.colsurfa.2013.02.047
PG 6
WC Chemistry, Physical
SC Chemistry
GA 283PZ
UT WOS:000329260800116
DA 2018-10-19
ER

PT J
AU Kandasubramanian, B
   Govindaraj, P
AF Kandasubramanian, Balasubramanian
   Govindaraj, Premika
TI Peeling model for cell adhesion on electrospun polymer nanofibres
SO JOURNAL OF ADHESION SCIENCE AND TECHNOLOGY
LA English
DT Article
DE electrospinning; nanofibre; cell adhesion; biocompatibility;
   antibacterial property
ID MEMBRANE-MEMBRANE ADHESION; MOLECULAR CROSS-BRIDGES; DETAILED MECHANICS;
   SEPARATION; DELIVERY; FORCES; STATE
AB Need for controlled drug delivery has gained immense attention over the conventional dosage forms due to improved therapeutic efficacy and reduced toxicity by controlled delivery. Recently, electrospun fibres have gained wide attention particularly for drug delivery systems, tissue engineering and vascular grafts for biomedical application. In the present work, the feasibility of producing fibrous composite of polylactic acid (PLA) and hydroxyapatite with silver nitrate using electrospinning technique was explored to understand the antibacterial property of the dressing. These non-woven fibres were post processed and heat treated with UV radiations. Such heat treatment is known to reduce the ionic silver to silver nanoparticles and also improve the crystalline properties of hydroxyapatite and PLA. Antimicrobial tests show that these fibres have maintained antibacterial properties against Staphylococcos aureus. It was noticed that there was no discolouration in the wound mat. To test the biocompatibility of these fabrics, the electrospun mats were cultured with fibroblasts. The results indicated that the cells attached and proliferated as continuous layers and maintained a healthy morphology. Once the biomaterial is implanted, no control is possible either over the biomaterial characteristics or the healing process. At this point the modelling process takes over. The present study is extended to a mathematical model for a primary step in tissue regeneration-cell adhesion, using a one-dimensional peeling model'.
C1 [Kandasubramanian, Balasubramanian; Govindaraj, Premika] Minist Def, Dept Mat Engn, DIAT DU, Pune, Maharashtra, India.
RP Kandasubramanian, B (reprint author), Minist Def, Dept Mat Engn, DIAT DU, Pune, Maharashtra, India.
EM balask@diat.ac.in
FU Nano project [EPIPR/ER/100 3883/M/01/908/2012/D (RD)/1416]
FX We would like to thank Dr Renuka Gonte for her kind and valuable
   suggestions during the review of the article and Dr Prahlada, vice
   chancellor of Defence Institute of Advanced Technology, for his support
   and encouragement. This work was financially supported by the Nano
   project (EPIPR/ER/100 3883/M/01/908/2012/D (R&D)/1416 Dated:
   28.03.2012).
CR de Velde K. V., 2002, POLYM TEST, V21, P433
   Espinosa-Cristobal LF, 2009, MATER LETT, V63, P2603, DOI 10.1016/j.matlet.2009.09.018
   EVANS EA, 1985, BIOPHYS J, V48, P185, DOI 10.1016/S0006-3495(85)83771-1
   EVANS EA, 1985, BIOPHYS J, V48, P175, DOI 10.1016/S0006-3495(85)83770-X
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Ferraz M P, 2004, J Appl Biomater Biomech, V2, P74
   Garcia AJ, 1998, J BIOL CHEM, V273, P10988, DOI 10.1074/jbc.273.18.10988
   Kong D, 2008, J THEOR BIOL, V250, P75, DOI 10.1016/j.jtbi.2007.09.028
   Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1
   Li FY, 2003, BIOPHYS J, V84, P1252, DOI 10.1016/S0006-3495(03)74940-6
   Mano JF, 2004, COMPOS SCI TECHNOL, V64, P789, DOI 10.1016/j.compscitech.2003.09.001
   Park JH, 2010, ADV DRUG DELIVER REV, V62, P28, DOI 10.1016/j.addr.2009.10.003
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Song L, 2011, MATER LETT, V65, P974, DOI 10.1016/j.matlet.2010.12.051
   Stevanovic MM, 2012, POLYMER, V53, P2818, DOI 10.1016/j.polymer.2012.04.057
   Tripathi BP, 2011, PROG POLYM SCI, V36, P745
   Zhang LF, 2011, J MEMBRANE SCI, V369, P499, DOI 10.1016/j.memsci.2010.12.032
   Zhang Y, 2013, ADV DRUG DELIVER REV, V65, P104, DOI 10.1016/j.addr.2012.10.003
NR 18
TC 1
Z9 1
U1 1
U2 48
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0169-4243
EI 1568-5616
J9 J ADHES SCI TECHNOL
JI J. Adhes. Sci. Technol.
PD JAN 17
PY 2014
VL 28
IS 2
BP 171
EP 185
DI 10.1080/01694243.2013.833402
PG 15
WC Engineering, Chemical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA 249MJ
UT WOS:000326781000005
DA 2018-10-19
ER

PT J
AU Qin, GK
   Panilaitis, BJ
   Kaplan, ZSDL
AF Qin, Guokui
   Panilaitis, Bruce J.
   Kaplan, Zhongyuan Sun David L.
TI A cellulosic responsive "living" membrane
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Living membrane; Bacterial cellulose; Co-cultivation; Gene amplifier;
   Positive feedback
ID CYCLIC DIGUANYLIC ACID; ACETOBACTER-XYLINUM; BACTERIAL CELLULOSE;
   GLUCONACETOBACTER-XYLINUS; HIGHER-PLANTS; BIOSYNTHESIS; SYNTHASE;
   INVITRO; SYSTEM
AB Bacterial cellulose has been demonstrated to be a remarkably versatile biomaterial and widely used in biomedical applications due to its unique physical properties. Here we reported for the first time a "living membrane" system based on recombinant Escherichia coli bacterial strains entrapped in cellulosic membranes produced by Gluconacetobacter xylinus. Biologically driven detection and identification of a range of target molecules presents unique challenges, and requires that detection methods are developed to be rapid, specific and sensitive. The compatibility of G. xylinus and recombinant E. coli strains was first investigated for co-cultivation, and the relationship between the number of entrapped E. coli and the level of inducible signal achieved was further explored by fluorescent signal observation in confocal microscopy. Finally to amplify the response to inducers for maximum fluorescent signal, a positive-feedback genetic amplifier was designed within recombinant E. coli strain entrapped in the living cellulosic membrane system, allowing for the detection mechanism to be extremely sensitive and resulting in a significant fluorescent signal from a single receptor binding event. The living membrane system proposed here will create devices of greater complexity in function for applications in biological and chemical detection. (C) 2013 Published by Elsevier Ltd.
C1 [Qin, Guokui; Panilaitis, Bruce J.; Kaplan, Zhongyuan Sun David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Panilaitis, BJ (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM bruce.panilaitis@tufts.edu
RI Qin, Guokui/B-1520-2012
OI Qin, Guokui/0000-0002-2212-1597
FU Army Research Office [58318-LS]
FX We thank Prof. Kaustubh Bhalerao (University of Illinois at
   Urbana-Champaign, USA) for the plasmid pGN68. We would like to
   acknowledge the assistance of Dr. Yinan Lin for SEM studies. This work
   was supported by grants from the Army Research Office (58318-LS).
CR ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448
   Chao YP, 2000, BIOTECHNOL BIOENG, V68, P345
   Charreau H., 2012, RECENT PATENTS NANOT
   Chepurnykh O E, 1994, Gig Sanit, P36
   Dark PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7886
   GRETZ MR, 1989, NATURWISSENSCHAFTEN, V76, P380, DOI 10.1007/BF00366213
   Henderson L W, 1985, Contrib Nephrol, V44, P112
   Hwang JW, 1999, J BIOSCI BIOENG, V88, P183, DOI 10.1016/S1389-1723(99)80199-6
   Kim JS, 2001, APPL BIOCHEM BIOTECH, V91-3, P331, DOI 10.1385/ABAB:91-93:1-9:331
   Kojima S, 1991, ASAIO Trans, V37, P644
   Lee JW, 2001, APPL ENVIRON MICROB, V67, P3970, DOI 10.1128/AEM.67.9.3970-3975.2001
   Ligon B Lee, 2006, Semin Pediatr Infect Dis, V17, P161, DOI 10.1053/j.spid.2006.07.002
   LIN FC, 1985, SCIENCE, V230, P822, DOI 10.1126/science.230.4727.822
   Mandal BB, 2012, P NATL ACAD SCI USA, V109, P7699, DOI 10.1073/pnas.1119474109
   MAYER R, 1991, P NATL ACAD SCI USA, V88, P5472, DOI 10.1073/pnas.88.12.5472
   Nagai T, 1997, BIOL PHARM BULL, V20, P1082
   Nistala Goutam J, 2010, J Biol Eng, V4, P4, DOI 10.1186/1754-1611-4-4
   Park S. H., 2012, J TISSUE ENG REGENER
   PLUMBRIDGE J, 1995, EMBO J, V14, P3958, DOI 10.1002/j.1460-2075.1995.tb00067.x
   Qin GK, 2011, BIOMATERIALS, V32, P9231, DOI 10.1016/j.biomaterials.2011.06.010
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Ryu JH, 2001, CHEM-EUR J, V7, P1525, DOI 10.1002/1521-3765(20010401)7:7<1525::AID-CHEM1525>3.0.CO;2-U
   Setyawati MI, 2007, J BIOTECHNOL, V132, P38, DOI 10.1016/j.jbiotec.2007.08.012
   Son HJ, 2001, BIOTECHNOL APPL BIOC, V33, P1, DOI 10.1042/BA20000065
   Thomas S, 2008, J Wound Care, V17, P349
   Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008
   Yadav V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018099
   Yadav V, 2010, APPL ENVIRON MICROB, V76, P6257, DOI 10.1128/AEM.00698-10
NR 30
TC 3
Z9 3
U1 3
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 16
PY 2014
VL 100
SI SI
BP 40
EP 45
DI 10.1016/j.carbpol.2013.06.019
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 295BQ
UT WOS:000330092000007
PM 24188836
DA 2018-10-19
ER

PT J
AU Liu, W
   Shang, LR
   Zheng, FY
   Lu, J
   Qian, JL
   Zhao, YJ
   Gu, ZZ
AF Liu, Wei
   Shang, Luoran
   Zheng, Fuyin
   Lu, Jie
   Qian, Jinglian
   Zhao, Yuanjin
   Gu, Zhongze
TI Photonic Crystal Encoded Microcarriers for Biomaterial Evaluation
SO SMALL
LA English
DT Article
DE microcarriers; photonic crystal; cell culture; multiplex analysis
ID 3-DIMENSIONAL CELL-CULTURE; PARTICLES; MICROPARTICLES; MICROSPHERES;
   LITHOGRAPHY; GENERATION; SCAFFOLDS; BIOASSAYS
C1 [Liu, Wei; Shang, Luoran; Zheng, Fuyin; Lu, Jie; Qian, Jinglian; Zhao, Yuanjin; Gu, Zhongze] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
   [Zhao, Yuanjin; Gu, Zhongze] Inst Southeast Univ Suzhou, Lab Environm & Biosafety Res, Suzhou 215123, Peoples R China.
   [Gu, Zhongze] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China.
RP Zhao, YJ (reprint author), Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China.
EM yjzhao@seu.edu.cn; gu@seu.edu.cn
RI Zhao, Yuanjin/I-1861-2013
FU National Science Foundation of China [91227124, 21105011, 50925309];
   National Science Foundation of Jiangsu [BK2012735]; Postdoctoral Science
   Foundation of China [2012M520052, 2013T60484]; State Key Laboratory of
   Pharmaceutical Biotechnology of Nanjing University [KF-GN-201201];
   Program for Changjiang Scholars and Innovative Research Team in
   University [IRT1222]
FX This work was supported by the National Science Foundation of China
   (Grant Nos. 91227124, 21105011 and 50925309), the National Science
   Foundation of Jiangsu (Grant No. BK2012735), the Postdoctoral Science
   Foundation of China (Grant Nos. 2012M520052 and 2013T60484), the State
   Key Laboratory of Pharmaceutical Biotechnology of Nanjing University
   (KF-GN-201201 grant) and the Program for Changjiang Scholars and
   Innovative Research Team in University (IRT1222).
CR Appleyard DC, 2011, NAT PROTOC, V6, P1761, DOI 10.1038/nprot.2011.400
   Bae H., 2012, J TISSUE ENG REGEN M, V6, P1
   Chapin SC, 2009, LAB CHIP, V9, P3100, DOI 10.1039/b909959j
   Chen H.-Y., 2010, LANGMUIR, V27, P34, DOI DOI 10.1021/LA101623N
   Choi SW, 2013, ADV HEALTHC MATER, V2, P145, DOI 10.1002/adhm.201200106
   Doshi N, 2009, P NATL ACAD SCI USA, V106, P21495, DOI 10.1073/pnas.0907127106
   Fayazpour F, 2008, ADV FUNCT MATER, V18, P2716, DOI 10.1002/adfm.200800255
   Ge J., 2011, ANGEW CHEM INT EDIT, V50, P1492
   Gu HC, 2013, SMALL, V9, P2266, DOI 10.1002/smll.201203179
   Jin L, 2012, J BIOMED NANOTECHNOL, V8, P1, DOI 10.1166/jbn.2012.1360
   Khademhosseini A, 2013, ADV HEALTHC MATER, V2, P10, DOI 10.1002/adhm.201200444
   Kim J, 2011, SMALL, V7, P1163, DOI 10.1002/smll.201001822
   Kim LN, 2011, LAB CHIP, V11, P48, DOI [10.1039/c0lc00369g, 10.1039/c01c00369g]
   Kristalyn CB, 2011, J COLLOID INTERF SCI, V353, P322, DOI 10.1016/j.jcis.2010.09.057
   Le Clair SV, 2009, J ADHESION, V85, P484, DOI 10.1080/00218460902996374
   Lee H, 2010, NAT MATER, V9, P745, DOI [10.1038/NMAT2815, 10.1038/nmat2815]
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Liu WY, 2012, ADV HEALTHC MATER, V1, P10, DOI 10.1002/adhm.201100021
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Nichols JE, 2009, BIOMATERIALS, V30, P1071, DOI 10.1016/j.biomaterials.2008.10.041
   Panda P, 2008, LAB CHIP, V8, P1056, DOI 10.1039/b804234a
   Pregibon DC, 2009, ANAL CHEM, V81, P4873, DOI 10.1021/ac9005292
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Tumarkin E, 2009, CHEM SOC REV, V38, P2161, DOI 10.1039/b809915b
   Velasco D, 2012, SMALL, V8, P1633, DOI 10.1002/smll.201102464
   Wheeldon I., 2011, NANOTECHNOLOGY, V22
   Wu J, 2013, ACTA BIOMATER, V9, P7410, DOI 10.1016/j.actbio.2013.03.022
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
   Zhao YJ, 2008, ANAL CHEM, V80, P1598, DOI 10.1021/ac702249a
   Zhao YJ, 2011, J AM CHEM SOC, V133, P8790, DOI 10.1021/ja200729w
   Zhao YJ, 2010, ADV FUNCT MATER, V20, P2970, DOI 10.1002/adfm.201000098
   Zheng WF, 2013, ADV HEALTHC MATER, V2, P95, DOI 10.1002/adhm.201200104
   Zorlutuna P, 2012, ADV MATER, V24, P1782, DOI 10.1002/adma.201104631
NR 33
TC 35
Z9 38
U1 7
U2 96
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD JAN 15
PY 2014
VL 10
IS 1
BP 88
EP 93
DI 10.1002/smll.201301253
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 302SE
UT WOS:000330624400010
PM 23861358
DA 2018-10-19
ER

PT J
AU Chang, SH
   Chen, JZ
   Hsiao, SH
   Lin, GW
AF Chang, Shih-Hang
   Chen, Jian-Zhang
   Hsiao, Sou-Hui
   Lin, Guan-Wei
TI Nanohardness, corrosion and protein adsorption properties of CuAlO2
   films deposited on 316L stainless steel for biomedical applications
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE CuAlO2; Surface modification; Nanoindentation; Electrochemical; Protein
   adsorption
ID SURFACE MODIFICATION; CHITOSAN FILMS; CELL-CULTURES; COATINGS; IMPLANTS;
   BIOMATERIALS; 316-L-STAINLESS-STEEL; RESISTANCE; HARDNESS; DIODES
AB This study preliminarily assesses the biomedical applications of CuAlO2 coatings according to nanoindentation, electrochemical, and protein adsorption tests. Nanoindentation results revealed that the surface hardness of 316L stainless steel increased markedly after coating with CuAlO2 films. Electrochemical tests of corrosion potential, breakdown potential, and corrosion current density showed that the corrosion resistance properties of 316L stainless steel are considerably improved by CuAlO2 coatings. Bicinchoninic acid (BCA) protein assay results revealed that the protein adsorption behavior of 316L stainless steel did not exhibit notable differences with or without CuAlO2 coatings. A CuAlO2 coating of 100nm thickness improved the surface nanohardness and corrosion resistance ability of 316L stainless steel. CuAlO2 is a potential candidate for biomaterial coating applications, particularly for surface modification of fine, delicate implants. (C) 2013 Elsevier B.V. All rights reserved.
C1 [Chang, Shih-Hang; Hsiao, Sou-Hui] Natl Ilan Univ, Dept Chem & Mat Engn, Ilan 260, Taiwan.
   [Chen, Jian-Zhang; Lin, Guan-Wei] Natl Taiwan Univ, Grad Inst Appl Mech, Taipei 106, Taiwan.
RP Chang, SH (reprint author), Natl Ilan Univ, 1,Sec 1,Shen Lung Rd, Ilan 260, Taiwan.
EM shchang@niu.edu.tw
RI Chen, Jian Zhang/D-1469-2012
OI Chen, Jian Zhang/0000-0002-1071-2234; Chang,
   Shih-Hang/0000-0002-2262-0396
FU National Science Council (NSC), Taiwan, Republic of China
   [NSC102-2221-E-197006]
FX The authors gratefully acknowledge the financial support for this
   research provided by the National Science Council (NSC), Taiwan,
   Republic of China, under Grants No. NSC102-2221-E-197006.
CR [Anonymous], 1986, ASTM STAND SPEC, pF138
   Ballarre J, 2010, ACTA BIOMATER, V6, P1601, DOI 10.1016/j.actbio.2009.10.015
   Chang SH, 2013, APPL SURF SCI, V282, P735, DOI 10.1016/j.apsusc.2013.06.044
   Chang SH, 2012, SURF COAT TECH, V206, P4959, DOI 10.1016/j.surfcoat.2012.05.121
   Chen CH, 2008, SURF COAT TECH, V202, P2709, DOI 10.1016/j.surfcoat.2007.09.052
   Chi CT, 2013, J ELECTRON MATER, V42, P1242, DOI 10.1007/s11664-013-2573-4
   Chi CT, 2012, J ALLOY COMPD, V544, P111, DOI 10.1016/j.jallcom.2012.08.004
   Chu PK, 2013, THIN SOLID FILMS, V528, P93, DOI 10.1016/j.tsf.2012.07.144
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Cieslik M, 2011, CORROS SCI, V53, P296, DOI 10.1016/j.corsci.2010.09.034
   Costa MA, 2000, J MATER SCI-MATER M, V11, P141, DOI 10.1023/A:1008975507654
   D'Anto V, 2009, BIOMATERIALS, V30, P1492, DOI 10.1016/j.biomaterials.2008.12.004
   Dong CJ, 2012, J ALLOY COMPD, V512, P195, DOI 10.1016/j.jallcom.2011.09.062
   Fang M, 2011, APPL SURF SCI, V257, P8330, DOI 10.1016/j.apsusc.2011.03.116
   FRIEDMAN RJ, 1995, J APPL BIOMATER, V6, P231, DOI 10.1002/jab.770060403
   Gurappa I, 2002, SURF COAT TECH, V161, P70, DOI 10.1016/S0257-8972(02)00380-8
   Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087
   Kim DS, 2007, THIN SOLID FILMS, V515, P5103, DOI 10.1016/j.tsf.2006.10.044
   Kim TN, 1998, SURF COAT TECH, V99, P20, DOI 10.1016/S0257-8972(97)00121-7
   Malheiro VN, 2011, BIOMATERIALS, V32, P6883, DOI 10.1016/j.biomaterials.2011.06.002
   Nanci A, 1998, J BIOMED MATER RES, V40, P324
   Okazaki Y, 2008, CORROS SCI, V50, P3429, DOI 10.1016/j.corsci.2008.09.002
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Oyen ML, 2006, J BIOMECH, V39, P2699, DOI 10.1016/j.jbiomech.2005.09.011
   Padhy N, 2011, MATER CHEM PHYS, V130, P962, DOI 10.1016/j.matchemphys.2011.08.016
   Ruhi G, 2009, CORROS SCI, V51, P3057, DOI 10.1016/j.corsci.2009.08.037
   Schrooten J, 2000, BIOMATERIALS, V21, P1461, DOI 10.1016/S0142-9612(00)00027-2
   Shan CX, 2008, SURF COAT TECH, V202, P2399, DOI 10.1016/j.surfcoat.2007.08.066
   Shen GX, 2005, THIN SOLID FILMS, V489, P130, DOI 10.1016/j.tsf.2005.05.016
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   SUTOW EJ, 1981, BIOCOMPATIBILITY CLI, P45
   Takahashi H, 2011, INT IMMUNOPHARMACOL, V11, P1534, DOI 10.1016/j.intimp.2011.05.010
   TAKAMURA K, 1994, J BIOMED MATER RES, V28, P583, DOI 10.1002/jbm.820280508
   Tang YC, 2006, ACTA BIOMATER, V2, P709, DOI 10.1016/j.actbio.2006.06.003
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tiwari SK, 2007, SURF COAT TECH, V201, P7582, DOI 10.1016/j.surfcoat.2007.02.026
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   Wanichapichart P, 2009, SURF COAT TECH, V203, P2531, DOI 10.1016/j.surfcoat.2009.02.069
   Zhou ZF, 2007, CORROS SCI, V49, P830, DOI 10.1016/j.corsci.2006.06.019
NR 39
TC 9
Z9 9
U1 0
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD JAN 15
PY 2014
VL 289
BP 455
EP 461
DI 10.1016/j.apsusc.2013.11.004
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 274WA
UT WOS:000328635700066
DA 2018-10-19
ER

PT J
AU Moglia, RS
   Robinson, JL
   Muschenborn, AD
   Touchet, TJ
   Maitland, DJ
   Cosgriff-Hernandez, E
AF Moglia, Robert S.
   Robinson, Jennifer L.
   Muschenborn, Andrea D.
   Touchet, Tyler J.
   Maitland, Duncan J.
   Cosgriff-Hernandez, Elizabeth
TI Injectable polyMIPE scaffolds for soft tissue regeneration
SO POLYMER
LA English
DT Article
DE PolyMIPE; Tissue engineering; Injectable scaffold
ID BIODEGRADABLE POLYURETHANE SCAFFOLDS; BMP-INDUCED OSTEOGENESIS;
   ENGINEERING SCAFFOLDS; WEIGHT-BEARING; MECHANICAL-PROPERTIES;
   SMOOTH-MUSCLE; BONE; POROSITY; ELASTOMERS; COPOLYMERS
AB Injury caused by trauma, burns, surgery, or disease often results in soft tissue loss leading to impaired function and permanent disfiguration. Tissue engineering aims to overcome the lack of viable donor tissue by fabricating synthetic scaffolds with the requisite properties and bioactive cues to regenerate these tissues. Biomaterial scaffolds designed to match soft tissue modulus and strength should also retain the elastomeric and fatigue-resistant properties of the tissue. Of particular design importance is the interconnected porous structure of the scaffold needed to support tissue growth by facilitating mass transport. Adequate mass transport is especially true for newly implanted scaffolds that lack vasculature to provide nutrient flux. Common scaffold fabrication strategies often utilize toxic solvents and high temperatures or pressures to achieve the desired porosity. In this study, a polymerized medium internal phase emulsion (polyMIPE) is used to generate an injectable graft that cures to a porous foam at body temperature without toxic solvents. These poly(ester urethane urea) scaffolds possess elastomeric properties with tunable compressive moduli (20-200 kPa) and strengths (4-60 kPa) as well as high recovery after the first conditioning cycle (97-99%). The resultant pore architecture was highly interconnected with large voids (0.5-2 mm) from carbon dioxide generation surrounded by water-templated pores (50-300 mu m). The ability to modulate both scaffold pore architecture and mechanical properties by altering emulsion chemistry was demonstrated. Permeability and form factor were experimentally measured to determine the effects of polyMIPE composition on pore interconnectivity. Finally, initial human mesenchymal stem cell (hMSC) cytocompatibility testing supported the use of these candidate scaffolds in regenerative applications. Overall, these injectable polyMIPE foams show strong promise as a biomaterial scaffold for soft tissue repair. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Moglia, Robert S.; Robinson, Jennifer L.; Muschenborn, Andrea D.; Touchet, Tyler J.; Maitland, Duncan J.; Cosgriff-Hernandez, Elizabeth] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA.
RP Cosgriff-Hernandez, E (reprint author), Texas A&M Univ, Dept Biomed Engn, 5045 Emerging Technol Bldg,3120 TAMU, College Stn, TX 77843 USA.
EM cosgriff.hernandez@bme.tamu.edu
RI Cosgriff-Hernandez, Elizabeth/E-6391-2016
OI Cosgriff-Hernandez, Elizabeth/0000-0002-4701-5600
FU Texas A&M Health Science Center College of Medicine Institute for
   Regenerative Medicine at Scott & White through a grant from NCRR of the
   NIH [P40RR017447]
FX The human mesenchymal stem cells employed in this work were provided by
   the Texas A&M Health Science Center College of Medicine Institute for
   Regenerative Medicine at Scott & White through a grant from NCRR of the
   NIH, Grant #P40RR017447. We would like to thank Prachi Dhavalikar, Megan
   Brooks, and Nicole Cordner for their assistance in data collection.
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Andrew AB, 1991, J BIOMECH S1, V24, P19
   Barbetta A, 2004, MACROMOLECULES, V37, P3188, DOI 10.1021/ma0359436
   Bear J., 2013, DYNAMICS FLUIDS PORO
   Benhardt H, 2011, MACROMOL BIOSCI, V11, P1020, DOI 10.1002/mabi.201100063
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Busby W, 2001, BIOMACROMOLECULES, V2, P154, DOI 10.1021/bm0000889
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Chandrashekar N, 2006, J BIOMECH, V39, P2943, DOI 10.1016/j.jbiomech.2005.10.031
   Chen J, 1999, J BIOMED MATER RES, V44, P53, DOI 10.1002/(SICI)1097-4636(199901)44:1<53::AID-JBM6>3.0.CO;2-W
   Christenson EM, 2005, POLYMER, V46, P11744, DOI 10.1016/j.polymer.2005.08.083
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   David D, 2009, J POLYM SCI A, V47, P9
   Despois JF, 2005, ACTA MATER, V53, P1381, DOI 10.1016/j.actamat.2004.11.031
   Dhandayuthapani B., 2011, INT J POLYM SCI, V2011
   Duggan M, 2013, J TRAUMA ACUTE CARE, V74, P1462, DOI 10.1097/TA.0b013e31828da937
   Dumas JE, 2013, TISSUE ENG A
   Dumas JE, 2010, ACTA BIOMATER, V6, P2394, DOI 10.1016/j.actbio.2010.01.030
   Dybbs A, 1984, FUNDAMENTALS TRANSPO, P199
   ETTER MC, 1991, J PHYS CHEM-US, V95, P4601, DOI 10.1021/j100165a007
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Garrett P.R., 1993, DEFOAMING THEORY IND
   GEERTSMA J, 1974, SOC PETROL ENG J, V14, P445, DOI 10.2118/4706-PA
   GOGOLEWSKI S, 1989, COLLOID POLYM SCI, V267, P757, DOI 10.1007/BF01410115
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guan JJ, 2004, BIOMATERIALS, V25, P85, DOI 10.1016/S0142-9612(03)00476-9
   Hacker M, 2007, BIOMATERIALS, V28, P3497, DOI 10.1016/j.biomaterials.2007.04.018
   Hafeman AE, 2007, PMSE PREPR, V97, P546
   Hafeman AE, 2008, PHARM RES-DORDR, V25, P2387, DOI 10.1007/s11095-008-9618-z
   Hafeman AE, 2010, J BIOMAT SCI-POLYM E, V21, P95, DOI 10.1163/156856209X410256
   HAMMOND PT, 1990, MAT SCI ENG A-STRUCT, V126, P281, DOI 10.1016/0921-5093(90)90134-O
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hemmrich K, 2005, BIOMATERIALS, V26, P7025, DOI 10.1016/j.biomaterials.2005.04.065
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Kim BS, 2000, J BIOMECH ENG-T ASME, V122, P210, DOI 10.1115/1.429651
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kruyt MC, 2003, TISSUE ENG, V9, P327, DOI 10.1089/107632703764664792
   Kuboki Y, 2002, CONNECT TISSUE RES, V43, P529, DOI 10.1080/03008200290001104
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lage J, 1998, TRANSPORT PHENOMENA, V2
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Landers R, 2002, J MATER SCI, V37, P3107, DOI 10.1023/A:1016189724389
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lepine O, 2005, POLYMER, V46, P9653, DOI 10.1016/j.polymer.2005.07.067
   Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P879, DOI 10.1163/156856200744075
   Liu LS, 1999, BIOMATERIALS, V20, P1097, DOI 10.1016/S0142-9612(99)00006-X
   Lumelsky Y, 2009, MACROMOLECULES, V42, P1627, DOI 10.1021/ma802461m
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   Mistry AS, 2010, J BIOMED MATER RES A, V92A, P451, DOI 10.1002/jbm.a.32371
   Mistry AS, 2009, J BIOMED MATER RES A, V89A, P68, DOI 10.1002/jbm.a.32010
   Moglia RS, 2011, BIOMACROMOLECULES, V12, P3621, DOI 10.1021/bm2008839
   Mullins L, 1957, RUBBER CHEM TECHNOL, V30, P555
   Muschenborn AD, UNPUB
   Patrick CW, 2001, ANAT RECORD, V263, P361, DOI 10.1002/ar.1113
   Peter SJ, 2000, BIOMATERIALS, V21, P1207, DOI 10.1016/S0142-9612(99)00254-9
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Qi HJ, 2005, MECH MATER, V37, P817, DOI 10.1016/j.mechmat.2004.08.001
   Robinson JL, 2013, UNPUB
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Saraf H, 2007, J BIOMECH, V40, P1960, DOI 10.1016/j.jbiomech.2006.09.021
   Scheidegger AE, 1974, PHYS FLOW POROUS MED
   SCHULTZ RJ, 1987, INT ORTHOP, V11, P277, DOI 10.1007/BF00271461
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   TANZI MC, 1994, J MATER SCI-MATER M, V5, P393, DOI 10.1007/BF00058971
   Taylor D, 1998, J ORTHOPAED RES, V16, P163, DOI 10.1002/jor.1100160203
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yeh F, 2003, MACROMOLECULES, V36, P1940, DOI 10.1021/ma0214456
NR 79
TC 15
Z9 15
U1 3
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JAN 14
PY 2014
VL 55
IS 1
SI SI
BP 426
EP 434
DI 10.1016/j.polymer.2013.09.009
PG 9
WC Polymer Science
SC Polymer Science
GA 296TA
UT WOS:000330207100054
PM 24563552
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Boshkovikj, V
   Webb, HK
   Pham, VTH
   Fluke, CJ
   Crawford, RJ
   Ivanova, EP
AF Boshkovikj, Veselin
   Webb, Hayden K.
   Pham, Vy T. H.
   Fluke, Christopher J.
   Crawford, Russell J.
   Ivanova, Elena P.
TI Three-dimensional reconstruction of surface nanoarchitecture from
   two-dimensional datasets
SO AMB EXPRESS
LA English
DT Article
DE Three-dimensional visualization; Scanning electron microscopy; Atomic
   force microscopy; Surface topographical analysis
ID SCANNING-ELECTRON-MICROSCOPY; ATOMIC-FORCE MICROSCOPE; VISUALIZATION;
   ATTACHMENT; IMAGES; CELLS; GPU
AB The design of biomaterial surfaces relies heavily on the ability to accurately measure and visualize the three-dimensional surface nanoarchitecture of substrata. Here, we present a technique for producing three-dimensional surface models using displacement maps that are based on the data obtained from two-dimensional analyses. This technique is particularly useful when applied to scanning electron micrographs that have been calibrated using atomic force microscopy (AFM) roughness data. The evaluation of four different surface types, including thin titanium films, silicon wafers, polystyrene cell culture dishes and dragonfly wings confirmed that this technique is particularly effective for the visualization of conductive surfaces such as metallic titanium. The technique is particularly useful for visualizing surfaces that cannot be easily analyzed using AFM. The speed and ease with which electron micrographs can be recorded, combined with a relatively simple process for generating displacement maps, make this technique useful for the assessment of the surface topography of biomaterials.
C1 [Boshkovikj, Veselin; Webb, Hayden K.; Pham, Vy T. H.; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Fluke, Christopher J.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia.
RP Ivanova, EP (reprint author), Swinburne Univ Technol, Fac Life & Social Sci, POB 218, Hawthorn, Vic 3122, Australia.
EM eivanova@swin.edu.au
OI Crawford, Russell/0000-0003-1054-5285; Fluke,
   Christopher/0000-0003-0961-2321; Webb, Hayden/0000-0003-2858-0177
FU Australian Research Council (ARC)
FX This study was supported in part by Australian Research Council (ARC).
   Autodesk, Maya are registered trademarks or trademarks of Autodesk,
   Inc., and/or its subsidiaries and/or affiliates in the USA and/or other
   countries.
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BRUNE D, 1997, SURFACE CHARACTERIZA
   Cizmar P, 2008, SCANNING, V30, P381, DOI 10.1002/sca.20120
   Coelho PG, 2009, J BIOMED MATER RES B, V88B, P579, DOI 10.1002/jbm.b.31264
   Crawford RJ, 2012, ADV COLLOID INTERFAC, V179, P142, DOI 10.1016/j.cis.2012.06.015
   Cuijpers VMJI, 2011, TISSUE ENG PART C-ME, V17, P663, DOI 10.1089/ten.tec.2010.0455
   Decuzzi P, 2010, BIOMATERIALS, V31, P173, DOI 10.1016/j.biomaterials.2009.09.018
   Dmitriev K, 2011, ACM SPEC INT GROUP C
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Hiraiwa A, 2012, METROLOGY INSPECTION
   Hiraiwa A, 2012, J MICRO-NANOLITH MEM, V11, DOI 10.1117/1.JMM.11.4.043010
   Ivanova EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067893
   Jang H, 2012, COMPUT GRAPH FORUM, V31, P1880, DOI 10.1111/j.1467-8659.2012.03068.x
   Joy DC, 1996, MICRON, V27, P247, DOI 10.1016/0968-4328(96)00023-6
   Kang BS, 2009, ACTA BIOMATER, V5, P2222, DOI 10.1016/j.actbio.2009.01.049
   Lu TK, 2009, 35 GRAPH INT C GI 20, P7
   Marschall HU, 2000, J AM CERAM SOC, V83, P223, DOI 10.1111/j.1151-2916.2000.tb01176.x
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Nguyen SHT, 2013, COLLOID SURFACE B, V106, P126, DOI 10.1016/j.colsurfb.2013.01.042
   Nowell JA, 1980, SCANNING ELECTRON MI, V2, P1
   Ostadi H, 2011, NAN IEEE NANO 2011 1, P770, DOI [10.1109/nano.2011.6144402, DOI 10.1109/NANO.2011.6144402]
   Samak D, 2007, CIRP ANN-MANUF TECHN, V56, P149, DOI 10.1016/j.cirp.2007.05.036
   Schatten H, 2011, MICRON, V42, P175, DOI 10.1016/j.micron.2010.08.008
   Schift H, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355301
   Shiramine KI, 2007, J APPL PHYS, V101, DOI 10.1063/1.2434806
   Stout KJ, 1993, PUBLICATION EUR
   Szirmay-Kalos L, 2008, COMPUT GRAPH FORUM, V27, P1567, DOI 10.1111/j.1467-8659.2007.01108.x
   Tabet MF, 1996, THIN SOLID FILMS, V290, P312, DOI 10.1016/S0040-6090(96)08968-7
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   Wang JY, 2008, THIN SOLID FILMS, V517, P656, DOI 10.1016/j.tsf.2008.07.033
   Webb HK, 2012, ROUGHNESS PARAMET ZE
   Zeiger AS, 2013, ACTA BIOMATER, V9, P7354, DOI 10.1016/j.actbio.2013.02.035
NR 32
TC 1
Z9 1
U1 0
U2 4
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 2191-0855
J9 AMB EXPRESS
JI AMB Express
PD JAN 10
PY 2014
VL 4
AR 3
DI 10.1186/2191-0855-4-3
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA CM9SR
UT WOS:000358049800002
PM 24410821
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Ayoub, A
   Venditti, RA
   Jameel, H
   Chang, HM
AF Ayoub, Ali
   Venditti, Richard A.
   Jameel, Hasan
   Chang, Hou-Min
TI Effect of Irradiation on the Composition and Thermal Properties of
   Softwood Kraft Lignin and Styrene Grafted Lignin
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE cellulose and other wood products; biomaterials; crosslinking;
   irradiation; lignin; glass transition temperature
ID HYDROCHLORIC ACID LIGNIN; INDUSTRIAL APPLICATIONS; UV-IRRADIATION;
   GAMMA-IRRADIATION; CARBON-FIBERS; POLYMERS; POLYCARBONATE; CHEMISTRY;
   PLASTICS; COPOLYMERIZATION
AB Lignin is an abundant, underutilized natural resource that has potential to be used as a biomaterial but is currently hampered in its use by not being uniform in structure and composition and is thermally unstable due to phenolic group. To address these issues and modify its thermal properties, softwood kraft lignin was modified using gamma-irradiation at low doses with and without styrene present and characterized. Irradiation of kraft lignin alone with gamma-radiation shows an initial decrease in molecular weight due to chain scission up to about 10 kGy followed by an increase in molecular weight due to crosslinking. NMR results indicate a decrease of about 15% in the OH content of the lignin with 30 kGy irradiation. Thermal properties such as T-g, free volume and Delta C-p follow accordingly. Irradiation at very low dosages was determined to facilitate the grafting of styrene monomer to lignin, decreasing the OH content by 23%. This effect increased the hydrophobicity of the material, depressed the value of T-g, increased the Delta C-p, increased the mobility in the liquid state, and made the material more thermally stable relative to the lignin alone, thus improving its processability at high temperatures. Both the irradiation of lignin alone and the grafting of styrene to lignin increased the yield of mass during pyrolysis and the activation energy for mass loss relative to untreated lignin alone. This work has demonstrated that the application of low dosages of gamma-irradiation is a promising method to attach functional molecules onto lignin for use in various applications. (C) 2013 Wiley Periodicals, Inc.
C1 [Ayoub, Ali; Venditti, Richard A.; Jameel, Hasan; Chang, Hou-Min] N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
RP Venditti, RA (reprint author), N Carolina State Univ, Coll Nat Resources, Dept Forest Biomat, Raleigh, NC 27695 USA.
EM richard_venditti@ncsu.edu
FU United States Department of Agriculture [1503/2011-0952]; Domtar
   Corporation
FX The authors wish to thank the United States Department of Agriculture
   (Grant number 1503/2011-0952) and Domtar Corporation for their
   sponsorship of this project. We would also like to thank Hasan
   Sadeghifar for his instrumental efforts in the aceto-bromination,
   molecular weight and NMR analysis.
CR ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615
   ARGYROPOULOS DS, 1994, J WOOD CHEM TECHNOL, V14, P45, DOI 10.1080/02773819408003085
   Ayoub A, 2012, J APPL POLYM SCI, V124, P1096, DOI 10.1002/app.35094
   Cui CZ, 2013, BIORESOURCES, V8, P864
   Decker C, 2002, MACROMOL RAPID COMM, V23, P1067, DOI 10.1002/marc.200290014
   DURAN N, 1986, J PHOTOCHEM, V35, P209, DOI 10.1016/0047-2670(86)85029-8
   FANTA GF, 1977, J APPL POLYM SCI, V21, P425, DOI 10.1002/app.1977.070210209
   Fisher K, 1987, MACROMOL S, V12, P303
   Gandini A, 2008, MACROMOLECULES, V41, P9491, DOI 10.1021/ma801735u
   Calvo-Flores FG, 2010, CHEMSUSCHEM, V3, P1227, DOI 10.1002/cssc.201000157
   GEMEI MS, 1980, ANGEW MAKROMOL CHEM, V92, P1, DOI 10.1002/apmc.1980.050920101
   Guerra A, 2006, J AGR FOOD CHEM, V54, P5939, DOI 10.1021/jf060722v
   Kadla J., 2002, J APPL POLYM SCI, V86, P1353
   Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8
   Kawamura Y, 2004, ACS SYM SER, V875, P262
   Kobayashi S, 2003, MACROMOL CHEM PHYSIC, V204, P235, DOI 10.1002/macp.200290084
   KOSHIJIMA T, 1968, J POLYM SCI A1, V6, P1431, DOI 10.1002/pol.1968.150060602
   Kubo S, 2005, J POLYM ENVIRON, V13, P97, DOI 10.1007/s10924-005-2941-0
   Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895
   Mulhaupt R, 2013, MACROMOL CHEM PHYS, V214, P159, DOI 10.1002/macp.201200439
   Murugan P, 2008, ENERG FUEL, V22, P2720, DOI 10.1021/ef700730u
   Mussatto SI, 2007, CARBOHYD POLYM, V70, P218, DOI 10.1016/j.carbpol.2007.03.02
   Nadji H, 2005, MACROMOL MATER ENG, V290, P1009, DOI 10.1002/mame.200500200
   Nitz H, 2001, MACROMOL MATER ENG, V286, P737, DOI 10.1002/1439-2054(20011201)286:12<737::AID-MAME737>3.0.CO;2-2
   Pandey KK, 1999, J APPL POLYM SCI, V71, P1969, DOI 10.1002/(SICI)1097-4628(19990321)71:12<1969::AID-APP6>3.0.CO;2-D
   Peng B, 2008, NAT NANOTECHNOL, V3, P626, DOI 10.1038/nnano.2008.211
   Philips R. B., 1973, J APPL POLYM SCI, V17, P1443
   PHILLIPS RB, 1972, J APPL POLYM SCI, V16, P1, DOI 10.1002/app.1972.070160101
   PHILLIPS RB, 1971, J APPL POLYM SCI, V15, P2929, DOI 10.1002/app.1971.070151203
   Ramani R, 2000, POLYM DEGRAD STABIL, V69, P347, DOI 10.1016/S0141-3910(00)00081-1
   Sadeghifar H, 2012, IND ENG CHEM RES, V51, P16713, DOI 10.1021/ie301848j
   Sanchez CG, 1999, ANGEW MAKROMOL CHEM, V272, P65
   Stewart D, 2008, IND CROP PROD, V27, P202, DOI 10.1016/j.indcrop.2007.07.008
   SUDO K, 1992, J APPL POLYM SCI, V44, P127, DOI 10.1002/app.1992.070440113
   Thielemans W, 2002, J APPL POLYM SCI, V83, P323, DOI 10.1002/app.2247
   Vignon A, 2013, J APPL POLYM SCI, V127, P4168, DOI 10.1002/app.38024
   Vishtal A, 2011, BIORESOURCES, V6, P3547
   WANG YY, 1990, J POLYM SCI POL PHYS, V28, P1431, DOI 10.1002/polb.1990.090280902
   Wei M, 2006, MACROMOL MATER ENG, V291, P524, DOI 10.1002/mame.200500372
   WU LCF, 1984, J APPL POLYM SCI, V29, P1111, DOI 10.1002/app.1984.070290408
NR 40
TC 9
Z9 9
U1 12
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 5
PY 2014
VL 131
IS 1
AR 39743
DI 10.1002/app.39743
PG 10
WC Polymer Science
SC Polymer Science
GA AH6QC
UT WOS:000336254700050
DA 2018-10-19
ER

PT J
AU Chabukswar, VV
   Bhavsar, SV
   Horne, AS
   Dallavalle, S
   Chabukswar, A
   Jagdale, SC
   Mohite, KC
AF Chabukswar, Vasant V.
   Bhavsar, Sanjay V.
   Horne, Amit S.
   Dallavalle, Sabrina
   Chabukswar, Anirudha
   Jagdale, Swati C.
   Mohite, Kakasaheb C.
TI Study of Biological Activity of Conducting Poly(N-Ethylaniline)
   Nanoparticles Doped with Organic Acid
SO INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS
LA English
DT Article
DE Biomaterial; conducting polymers; nanoparticles; photochemical;
   poly-(N-ethylaniline); spectroscopy
ID ACRYLIC-ACID; POLYANILINE; AGGREGATION; COPOLYMER
AB A novel green approach by photocatalytic oxidative polymerization was developed that addresses and resolves current limitations of chemical polymerization of anilines. This process generates nanoparticles of the conducting polymer poly(N-ethylaniline) (PNETA) and poly-(N-methylaniline) (PNMTA) in a single step by using a catalytic amount of the oxidant in the presence of an organic acid such as DL-(+/-)-Tartaric acid. Poly(N-ethylaniline) nanoparticles doped with tartaric acid show exceptional antimicrobial activity at low concentration. Five compounds have been synthesized. Of these, two compounds have been found to exhibit significant activity against Klebsiella pneumoniae. The minimum inhibitory concentration value was observed at 50 mu g/mL. An extremely simple green approach is described that generates bulk quantities of nanoparticles with average diameter 200nm size of the conducting polymer PNETA in one-step photochemical method using a catalytic amount of ammonium persulfate as oxidant in the presence of organic acid dopant, DL-(+/-)-Tartaric acid. The resultant polymer were characterized by UV-visible, FTIR, XRD, and SEM analysis and their antibacterial activity against Klebsiella pneumoniae has been studied. These polymer nanomaterials show a prominent antimicrobial activity against the tested bacteria and therefore have potential applications in biomedical sciences.
C1 [Chabukswar, Vasant V.; Bhavsar, Sanjay V.; Horne, Amit S.] Univ Pune, Dept Chem, Nowrosjee Wadia Coll, Pune 411001, Maharashtra, India.
   [Dallavalle, Sabrina] Univ Milan, Dept Food Environm & Nutr Sci DeFENS, Milan, Italy.
   [Chabukswar, Anirudha; Jagdale, Swati C.] MAEERs Maharashtra Inst Pharm, Pune, Maharashtra, India.
   [Mohite, Kakasaheb C.] Univ Pune, Sch Energy Studies, Pune, Maharashtra, India.
RP Chabukswar, VV (reprint author), Univ Pune, Dept Chem, Nowrosjee Wadia Coll, 19 Joag Path, Pune 411001, Maharashtra, India.
EM vvchabukswar@gmail.com
RI ; of Chem Phy Sciences, InternationalJournal/C-5864-2016
OI Dallavalle, Sabrina/0000-0002-8813-8922; of Chem Phy Sciences,
   InternationalJournal/0000-0003-4314-1308
FU UGC, Nowrosjee Wadia College Pune, BCUD, Pune University; Indian Academy
   of Science Bangalore
FX The authors sincerely acknowledge financial support from UGC, Nowrosjee
   Wadia College Pune, BCUD, Pune University, and Indian Academy of Science
   Bangalore. The authors are very grateful to Dr. Dangat Vijay for
   valuable suggestion and discussion.
CR Athawale AA, 2001, J APPL POLYM SCI, V79, P1994, DOI 10.1002/1097-4628(20010314)79:11<1994::AID-APP1007>3.0.CO;2-R
   Athawale AA, 2002, MATER CHEM PHYS, V73, P106, DOI 10.1016/S0254-0584(01)00338-8
   Bagheri A, 1998, SYNTHETIC MET, V97, P85, DOI 10.1016/S0379-6779(98)00090-3
   Bhumi P., 2013, J COLLOIDS SURF B, V103, P9
   Chabukswar V, 2010, CHEM CHEM TECHOL, V4, P277
   Chabukswar V, 2010, MACROMOL SYMP, V298, P43, DOI 10.1002/masy.201000019
   Chabukswar VV, 2012, J MACROMOL SCI A, V49, P547, DOI 10.1080/10601325.2012.687682
   Chabukswar VV, 2001, SENSOR ACTUAT B-CHEM, V77, P657, DOI 10.1016/S0925-4005(01)00780-8
   Chahukswar V. V., 2012, J MACROMOL SCI CHEM, V49, P547
   Chen S. A., 1993, MACROMOLECULES, V26, P254
   CHEN SA, 1995, MACROMOLECULES, V28, P2858, DOI 10.1021/ma00112a035
   Cullity B.D., 1978, ELEMENTS XRAY DIFFRA
   Das TK, 2012, POLYM-PLAST TECHNOL, V51, P1487, DOI 10.1080/03602559.2012.710697
   DEARMITT C, 1993, POLYMER, V34, P158, DOI 10.1016/0032-3861(93)90299-P
   Ghorbani M, 2012, POLYM-PLAST TECHNOL, V51, P1367, DOI 10.1080/03602559.2012.702362
   Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n
   MACDIARMID AG, 1994, SYNTHETIC MET, V65, P103, DOI 10.1016/0379-6779(94)90171-6
   Mageswari S, 2012, POLYM-PLAST TECHNOL, V51, P1296, DOI 10.1080/03602559.2012.698687
   Mazzanti G, 2000, J ETHNOPHARMACOL, V71, P83, DOI 10.1016/S0378-8741(99)00179-8
   Michira I, 2011, INT J POLYM MATER, V60, P469, DOI 10.1080/00914037.2010.531815
   Paul RK, 1999, SYNTHETIC MET, V104, P189, DOI 10.1016/S0379-6779(99)00063-6
   RIOS JL, 1988, J ETHNOPHARMACOL, V23, P127, DOI 10.1016/0378-8741(88)90001-3
   Roy BC, 1999, SYNTHETIC MET, V100, P233, DOI 10.1016/S0379-6779(98)01505-7
   Singh G., 2010, POLYM-PLAST TECHNOL, V13, P1329
   WEI Y, 1994, MACROMOLECULES, V27, P518, DOI 10.1021/ma00080a028
   Zheng W, 1997, MACROMOLECULES, V30, P7634, DOI 10.1021/ma970933o
NR 26
TC 4
Z9 4
U1 0
U2 38
PU TAYLOR & FRANCIS AS
PI OSLO
PA KARL JOHANS GATE 5, NO-0154 OSLO, NORWAY
SN 0091-4037
EI 1563-535X
J9 INT J POLYM MATER PO
JI Int. J. Polym. Mater. Polym. Biomat.
PD JAN 4
PY 2014
VL 63
IS 1
BP 7
EP 10
DI 10.1080/00914037.2013.769241
PG 4
WC Materials Science, Biomaterials; Polymer Science
SC Materials Science; Polymer Science
GA 220UG
UT WOS:000324611800002
DA 2018-10-19
ER

PT J
AU Mathieu, V
   Vayron, R
   Richard, G
   Lambert, G
   Naili, S
   Meningaud, JP
   Haiat, G
AF Mathieu, Vincent
   Vayron, Romain
   Richard, Gilles
   Lambert, Gregory
   Naili, Salah
   Meningaud, Jean-Paul
   Haiat, Guillaume
TI Biomechanical determinants of the stability of dental implants:
   Influence of the bone-implant interface properties
SO JOURNAL OF BIOMECHANICS
LA English
DT Review
DE Bone; Implant; Osseointegration; Biomechanical properties; Stability
ID RESONANCE FREQUENCY-ANALYSIS; FINITE-ELEMENT-ANALYSIS; SHAPED TITANIUM
   IMPLANT; TOTAL HIP-ARTHROPLASTY; WHOLE-BODY VIBRATION; ORAL IMPLANTS;
   IN-VITRO; NUMERICAL-SIMULATION; ENDOSSEOUS IMPLANTS; QUANTITATIVE
   EXPRESSION
AB Dental implants are now widely used for the replacement of missing teeth in fully or partially edentulous patients and for cranial reconstructions. However, risks of failure, which may have dramatic consequences, are still experienced and remain difficult to anticipate. The stability of biomaterials inserted in bone tissue depends on multiscale phenomena of biomechanical (bone-implant interlocking) and of biological (mechanotransduction) natures. The objective of this review is to provide an overview of the biomechanical behavior of the bone-dental implant interface as a function of its environment by considering in silico, ex vivo and in vivo studies including animal models as well as clinical studies. The biomechanical determinants of osseointegration phenomena are related to bone remodeling in the vicinity of the implants (adaptation of the bone structure to accommodate the presence of a biomaterial). Aspects related to the description of the interface and to its space-time multiscale nature will first be reviewed. Then, the various approaches used in the literature to measure implant stability and the bone-implant interface properties in vitro and in vivo will be described. Quantitative ultrasound methods are promising because they are cheap, non invasive and because of their lower spatial resolution around the implant compared to other biomechanical approaches. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Mathieu, Vincent; Vayron, Romain; Naili, Salah] Univ Paris Est, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, F-94010 Creteil, France.
   [Richard, Gilles; Lambert, Gregory] Septodont, F-94100 St Maur Des Fosses, France.
   [Meningaud, Jean-Paul] CHU H Mondor, Serv Chirurg Plast Reconstruct & Esthet, F-94017 Creteil, France.
   [Haiat, Guillaume] Hop Henri Mondor, CNRS, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, F-94010 Creteil, France.
RP Haiat, G (reprint author), Hop Henri Mondor, CNRS, UMR CNRS 8208, Lab Modelisat & Simulat Multi Echelle, 61 Ave Gen Gaulle, F-94010 Creteil, France.
EM guillaume.haiat@univ-paris-est.fr
FU French National Research Agency (ANR) through EMERGENCE program (project
   WaveImplant) [ANR-11-EMMA-039]
FX This work has been supported by French National Research Agency (ANR)
   through EMERGENCE program (project WaveImplant no. ANR-11-EMMA-039).
CR Abrahamsson I, 2004, CLIN ORAL IMPLAN RES, V15, P381, DOI 10.1111/j.1600-0501.2004.01082.x
   ADAMS RD, 1978, J MECH ENG SCI, V20, P93, DOI 10.1243/JMES_JOUR_1978_020_016_02
   Akca K, 2007, HEAD FACE MED, V16, P3
   ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Albrektsson T, 2008, PERIODONTOL 2000, V47, P15, DOI 10.1111/j.1600-0757.2007.00247.x
   Alsaadi G, 2007, J CLIN PERIODONTOL, V34, P359, DOI 10.1111/j.1600-051X.2007.01047.x
   Andreaus U, 2009, P I MECH ENG H, V223, P589, DOI 10.1243/09544119JEIM559
   Aparicio C, 2006, CLIN ORAL IMPLAN RES, V17, P2, DOI 10.1111/j.1600-0501.2006.01365.x
   Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Atsumi M, 2007, INT J ORAL MAX IMPL, V22, P743
   Balik A, 2012, J ORAL IMPLANTOL, V38, P491, DOI 10.1563/AAID-JOI-D-10-00127
   Balleri Piero, 2002, Clin Implant Dent Relat Res, V4, P128, DOI 10.1111/j.1708-8208.2002.tb00162.x
   Balshi SF, 2005, INT J ORAL MAX IMPL, V20, P584
   Barewal RM, 2003, INT J ORAL MAX IMPL, V18, P641
   Berglundh T, 2007, CLIN ORAL IMPLAN RES, V18, P147, DOI 10.1111/j.1600-0501.2006.01309.x
   Bernakiewicz M, 2002, J BIOMECH, V35, P61, DOI 10.1016/S0021-9290(01)00163-4
   Bernhardt R, 2012, EUR CELLS MATER, V23, P237, DOI 10.22203/eCM.v023a18
   Bischof M, 2004, CLIN ORAL IMPLAN RES, V15, P529, DOI 10.1111/j.1600-0501.2004.01042.x
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Bunger MH, 2006, EUR CELLS MATER, V12, P81
   Caulier H, 1997, INT J ORAL MAX IMPL, V12, P380
   Chai J Y, 1993, J Prosthodont, V2, P9, DOI 10.1111/j.1532-849X.1993.tb00374.x
   Chang MC, 2003, J BIOMECH, V36, P1209, DOI [10.1016/S0021-9290(03)00113-1, 10.1016/S0021-9290(03)001133-1]
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Coelho PG, 2010, J ORAL MAXIL SURG, V68, P1667, DOI 10.1016/j.joms.2010.02.050
   de Almeida MS, 2007, SENSORS-BASEL, V7, P1224, DOI 10.3390/s7071224
   Derhami K, 1995, Int J Oral Maxillofac Implants, V10, P221
   Dong XN, 2006, J BIOMECH ENG-T ASME, V128, P309, DOI 10.1115/1.2187039
   Duyck J, 2006, ARCH ORAL BIOL, V51, P1, DOI 10.1016/j.archoralbio.2005.04.003
   Duyck J, 2007, J CLIN PERIODONTOL, V34, P998, DOI 10.1111/j.1600-051X.2007.01135.x
   Folgado J, 2009, COMPUT METHOD BIOMEC, V12, P135, DOI [10.1080/10255840802546754, 10.1080/10255840903081123]
   Franchi M, 2007, J PERIODONTOL, V78, P879, DOI 10.1902/jop.2007.060280
   Friberg B, 1999, Clin Implant Dent Relat Res, V1, P75, DOI 10.1111/j.1708-8208.1999.tb00095.x
   Geckili O, 2012, J PERIODONTAL RES, V47, P508, DOI 10.1111/j.1600-0765.2011.01462.x
   Geris L, 2004, J BIOMECH, V37, P763, DOI 10.1016/j.jbiomech.2003.09.026
   Ghorayeb SR, 2008, IEEE T ULTRASON FERR, V55, P1256, DOI 10.1109/TUFFC.2008.788
   Gill A, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-3
   Glauser R, 2004, CLIN ORAL IMPLAN RES, V15, P428, DOI 10.1111/j.1600-0501.2004.01036.x
   Glauser Roland, 2003, Clin Implant Dent Relat Res, V5 Suppl 1, P47, DOI 10.1111/j.1708-8208.2003.tb00015.x
   Goto T, 2004, BIO-MED MATER ENG, V14, P537
   Haas R, 1999, J ORAL REHABIL, V26, P19, DOI 10.1046/j.1365-2842.1999.00351.x
   Haiat G, 2009, J BIOMECH, V42, P2033, DOI 10.1016/j.jbiomech.2009.06.008
   Harle J, 2001, J MATER SCI-MATER M, V12, P1001, DOI 10.1023/A:1012825519114
   Hecht S, 2011, VET RADIOL ULTRASOUN, V52, P409, DOI 10.1111/j.1740-8261.2011.01809.x
   Heller A L, 1996, J Oral Implantol, V22, P240
   Hellmich C, 2008, ANN BIOMED ENG, V36, P108, DOI 10.1007/s10439-007-9393-8
   Herrero-Climent M, 2012, MED ORAL PATOL ORAL, V17, pE801, DOI 10.4317/medoral.17861
   Heybeli N, 2002, J ULTRAS MED, V21, P1357, DOI 10.7863/jum.2002.21.12.1357
   Hong J, 2012, CLIN ORAL IMPLAN RES, V23, P1193, DOI 10.1111/j.1600-0501.2011.02285.x
   Hsu JT, 2013, INT J ORAL MAX SURG, V42, P276, DOI 10.1016/j.ijom.2012.07.002
   Hsu JT, 2013, INT J ORAL MAX IMPL, V28, P367, DOI 10.11607/jomi.2407
   Hsu SK, 2011, ULTRASOUND MED BIOL, V37, P403, DOI 10.1016/j.ultrasmedbio.2010.12.004
   Huja SS, 1999, BONE, V25, P217, DOI 10.1016/S8756-3282(99)00151-9
   Huwiler MA, 2007, CLIN ORAL IMPLAN RES, V18, P275, DOI 10.1111/j.1600-0501.2007.01336.x
   Ilic S, 2010, BIOMECH MODEL MECHAN, V9, P87, DOI 10.1007/s10237-009-0161-6
   Isidor F, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2006.01360.x
   Izaguirre JA, 2004, BIOINFORMATICS, V20, P1129, DOI 10.1093/bioinformatics/bth050
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   Kerner S., 2009, J MATER SCI-MATER M, V10, P707
   Keyak JH, 2003, MED ENG PHYS, V25, P781, DOI 10.1016/S1350-4533(03)00081-X
   Laugier P, 2011, BONE QUANTITATIVE ULTRASOUND, P1, DOI 10.1007/978-94-007-0017-8
   Laz PJ, 2006, J BIOMECH, V39, P2303, DOI 10.1016/j.jbiomech.2005.07.029
   Lee CK, 2009, DENT MATER, V25, P1419, DOI 10.1016/j.dental.2009.07.003
   Lin CL, 2006, J BIOMECH, V39, P453, DOI 10.1016/j.jbiomech.2004.12.020
   Lioubavina-Hack N, 2006, CLIN ORAL IMPLAN RES, V17, P244, DOI 10.1111/j.1600-0501.2005.01201.x
   Liu Q, 2012, BRIT J ORAL MAX SURG, V50, P244, DOI 10.1016/j.bjoms.2011.03.001
   Luo GM, 1999, J BIOMECH, V32, P275, DOI 10.1016/S0021-9290(98)00172-9
   Lynch JE, 2002, REV SCI INSTRUM, V73, P2686, DOI 10.1063/1.1484235
   Markovic A, 2013, CLIN IMPLANT DENT R, V15, P341, DOI 10.1111/j.1708-8208.2011.00415.x
   Mathieu V, 2012, J MECH BEHAV BIOMED, V8, P194, DOI 10.1016/j.jmbbm.2011.12.012
   Mathieu V, 2012, ULTRASOUND MED BIOL, V38, P611, DOI 10.1016/j.ultrasmedbio.2011.12.014
   Mathieu V, 2011, J ACOUST SOC AM, V129, P4062, DOI 10.1121/1.3586788
   Mathieu V, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003131
   Mathieu V, 2011, ULTRASOUND MED BIOL, V37, P262, DOI 10.1016/j.ultrasmedbio.2010.10.008
   Maugis D., 2000, FRICTIONLESS ELASTIC, P236
   Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x
   MERICSKESTERN R, 1995, CLIN ORAL IMPLAN RES, V6, P73
   MEUNIER A, 1988, J ORTHOPAED RES, V6, P770, DOI 10.1002/jor.1100060521
   Michiardi A, 2010, ACTA BIOMATER, V6, P667, DOI 10.1016/j.actbio.2009.08.043
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P150, DOI 10.1111/j.1600-0501.2004.00978.x
   Nedir R, 2004, CLIN ORAL IMPLAN RES, V15, P520, DOI 10.1111/j.1600-0501.2004.01059.x
   Nkenke E, 2003, CLIN ORAL IMPLAN RES, V14, P601, DOI 10.1034/j.1600-0501.2003.00937.x
   Nomura T, 2006, J BIOMED MATER RES B, V77B, P213, DOI 10.1002/jbm.b.30431
   Ogawa T, 2011, CLIN ORAL IMPLAN RES, V22, P302, DOI 10.1111/j.1600-0501.2010.02020.x
   Ogawa T, 2011, J CLIN PERIODONTOL, V38, P180, DOI 10.1111/j.1600-051X.2010.01637.x
   Oh JS, 2012, OR SURG OR MED OR PA, V113, pE35, DOI 10.1016/j.tripleo.2011.07.003
   Orlik J, 2003, MED ENG PHYS, V25, P825, DOI 10.1016/S1350-4533(03)00099-7
   Orsini E, 2012, INT J ORAL MAX IMPL, V27, P383
   Ostman PO, 2006, INT J PROSTHODONT, V19, P77
   PALOU ME, 1987, J PERIODONTOL, V58, P262, DOI 10.1902/jop.1987.58.4.262
   Park KJ, 2012, J ORAL REHABIL, V39, P151, DOI 10.1111/j.1365-2842.2011.02255.x
   Pattijn V, 2007, MED ENG PHYS, V29, P182, DOI 10.1016/j.medengphy.2006.02.010
   Perez MA, 2008, J BIOMECH, V41, P316, DOI 10.1016/j.jbiomech.2007.09.013
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Potter HG, 2004, J BONE JOINT SURG AM, V86A, P1947, DOI 10.2106/00004623-200409000-00013
   Quaresma Sergio E T, 2008, J Oral Implantol, V34, P1, DOI 10.1563/1548-1336(2008)34[1:AFEAOT]2.0.CO;2
   Rabel A, 2007, CLIN ORAL INVEST, V11, P257, DOI 10.1007/s00784-007-0115-2
   Raghavendra S, 2005, INT J ORAL MAX IMPL, V20, P425
   Rangert B, 1997, Dent Update, V24, P416
   Riviere J, 2012, J ACOUST SOC AM, V132, pEL202, DOI 10.1121/1.4742138
   Riviere J, 2012, J ACOUST SOC AM, V131, P1922, DOI 10.1121/1.3683251
   Riviere J, 2010, J APPL PHYS, V107, DOI 10.1063/1.3443578
   Ronold HJ, 2003, BIOMATERIALS, V24, P4559, DOI 10.1016/S0142-9612(03)00256-4
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   Ronold HJ, 2003, J MATER SCI-MATER M, V14, P843, DOI 10.1023/A:1025622407727
   Ronold HJ, 2002, BIOMATERIALS, V23, P2201, DOI 10.1016/S0142-9612(01)00353-2
   Ronold HJ, 2002, BIOMATERIALS, V23, P4211, DOI 10.1016/S0142-9612(02)00167-9
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Salawu OS, 1997, ENG STRUCT, V19, P718, DOI 10.1016/S0141-0296(96)00149-6
   Salonen MAM, 1997, J CLIN PERIODONTOL, V24, P272, DOI 10.1111/j.1600-051X.1997.tb01842.x
   Sansalone V, 2010, J BIOMECH, V43, P1857, DOI 10.1016/j.jbiomech.2010.03.034
   SANSALONE V, 2012, BIOMECHANICS MODELIN, V12, P533
   Scarano A, 2006, CLIN IMPLANT DENT R, V8, P218, DOI 10.1111/j.1708-8208.2006.00022.x
   Schulte W, 1983, Zahnarztl Mitt, V73, P1229
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P136, DOI 10.1111/j.1708-8208.2005.tb00057.x
   Seong WJ, 2009, J PROSTHET DENT, V101, P306, DOI 10.1016/S0022-3913(09)60062-7
   Shalabi MM, 2007, J MATER SCI-MATER M, V18, P2033, DOI 10.1007/s10856-007-3160-0
   Simon U, 2003, J BIOMECH, V36, P1079, DOI 10.1016/S0021-9290(03)00114-3
   Singhrao SK, 2012, MICROSC RES TECHNIQ, V75, P576, DOI 10.1002/jemt.21094
   Skripitz R, 1998, ACTA ORTHOP SCAND, V69, P315, DOI 10.3109/17453679809000938
   SOBALLE K, 1992, J ORTHOPAED RES, V10, P285, DOI 10.1002/jor.1100100216
   Sutpideler M, 2004, INT J ORAL MAX IMPL, V19, P819
   Swan CC, 2003, J BIOMECH ENG-T ASME, V125, P25, DOI 10.1115/1.1535191
   Sykaras N, 2000, INT J ORAL MAX IMPL, V15, P675
   Szmukler-Moncler S, 2000, CLIN ORAL IMPLAN RES, V11, P12, DOI 10.1034/j.1600-0501.2000.011001012.x
   Taborelli M, 1997, CLIN ORAL IMPLAN RES, V8, P208, DOI 10.1034/j.1600-0501.1997.080307.x
   Tate MLK, 2008, INT J BIOCHEM CELL B, V40, P2720, DOI 10.1016/j.biocel.2008.05.011
   Tate MLK, 2011, J BIOMECH, V44, P304, DOI 10.1016/j.jbiomech.2010.10.019
   Tricio J, 1995, Int J Oral Maxillofac Implants, V10, P43
   Tsai C L, 1992, Chin J Physiol, V35, P21
   Turkyilmaz I, 2006, J ORAL REHABIL, V33, P754, DOI 10.1111/j.1365-2842.2006.01631.x
   Turkyilmaz I., 2007, J CLIN PERIODONTOL, V34, P716, DOI DOI 10.1111/J.1600-051X.2007.01112.X
   Ustun Yakup, 2008, Eur J Dent, V2, P254
   Valderrama P, 2007, J PERIODONTOL, V78, P262, DOI 10.1902/jop.2007.060143
   Vanegas-Acosta JC, 2011, COMPUT METH PROG BIO, V101, P297, DOI 10.1016/j.cmpb.2010.11.007
   VANSTEENBERGHE D, 1995, CLIN ORAL IMPLAN RES, V6, P31, DOI 10.1034/j.1600-0501.1995.060104.x
   Vayron R, 2011, COMPUT METHOD BIOMEC, V14, P139, DOI 10.1080/10255842.2011.593770
   Vayron R., 2013, ULTRASOUND MED UNPUB
   Vayron R, 2013, J BIOMECH, V46, P1162, DOI 10.1016/j.jbiomech.2013.01.003
   Vayron R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005981
   Vesentini S, 2005, BIOMECH MODEL MECHAN, V3, P224, DOI 10.1007/s10237-004-0064-5
   Viceconti M, 2006, J BIOMECH, V39, P1169, DOI 10.1016/j.jbiomech.2005.03.024
   Viceconti M, 2000, J BIOMECH, V33, P1611, DOI 10.1016/S0021-9290(00)00140-8
   WANG SJ, 1994, J ORTHOP RES, V12, P40, DOI 10.1002/jor.1100120106
   Wenz HJ, 2008, INT J PROSTHODONT, V21, P27
   Winter W, 2004, J BIOMECH, V37, P1861, DOI 10.1016/j.jbiomech.2004.02.033
   Wolff JL, 1892, LAW BONE REMODELING
   Wu SW, 2012, MED ENG PHYS, V34, P797, DOI 10.1016/j.medengphy.2011.09.021
   Yang KH, 1996, J ORTHOP RES, V14, P802, DOI 10.1002/jor.1100140518
   Yosibash Z, 2007, J BIOMECH, V40, P3688, DOI 10.1016/j.jbiomech.2007.06.017
   Younesi M, 2010, J MECH BEHAV BIOMED, V3, P178, DOI 10.1016/j.jmbbm.2009.08.003
   Zhang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040488
   Zhang XL, 2012, J R SOC INTERFACE, V9, P1697, DOI 10.1098/rsif.2011.0820
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 156
TC 45
Z9 46
U1 1
U2 62
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PD JAN 3
PY 2014
VL 47
IS 1
BP 3
EP 13
DI 10.1016/j.jbiomech.2013.09.021
PG 11
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA AA3QU
UT WOS:000331008200002
PM 24268798
DA 2018-10-19
ER

PT J
AU Ludecke, C
   Jandt, KD
   Siegismund, D
   Kujau, MJ
   Zang, E
   Rettenmayr, M
   Bossert, J
   Roth, M
AF Luedecke, Claudia
   Jandt, Klaus D.
   Siegismund, Daniel
   Kujau, Marian J.
   Zang, Emerson
   Rettenmayr, Markus
   Bossert, Joerg
   Roth, Martin
TI Reproducible Biofilm Cultivation of Chemostat-Grown Escherichia coli and
   Investigation of Bacterial Adhesion on Biomaterials Using a
   Non-Constant-Depth Film Fermenter
SO PLOS ONE
LA English
DT Article
ID TITANIUM THIN-FILMS; SURFACE-ROUGHNESS; NANOSCALE ROUGHNESS; MICROBIAL
   ADHESION; IN-VITRO; QUANTIFICATION; ATTACHMENT; INFECTIONS; TOPOGRAPHY;
   PARAMETERS
AB Biomaterials-associated infections are primarily initiated by the adhesion of microorganisms on the biomaterial surfaces and subsequent biofilm formation. Understanding the fundamental microbial adhesion mechanisms and biofilm development is crucial for developing strategies to prevent such infections. Suitable in vitro systems for biofilm cultivation and bacterial adhesion at controllable, constant and reproducible conditions are indispensable. This study aimed (i) to modify the previously described constant-depth film fermenter for the reproducible cultivation of biofilms at non-depth-restricted, constant and low shear conditions and (ii) to use this system to elucidate bacterial adhesion kinetics on different biomaterials, focusing on biomaterials surface nanoroughness and hydrophobicity. Chemostat-grown Escherichia coli were used for biofilm cultivation on titanium oxide and investigating bacterial adhesion over time on titanium oxide, poly(styrene), poly(tetrafluoroethylene) and glass. Using chemostat-grown microbial cells (single-species continuous culture) minimized variations between the biofilms cultivated during different experimental runs. Bacterial adhesion on biomaterials comprised an initial lag-phase I followed by a fast adhesion phase II and a phase of saturation III. With increasing biomaterials surface nanoroughness and increasing hydrophobicity, adhesion rates increased during phases I and II. The influence of materials surface hydrophobicity seemed to exceed that of nanoroughness during the lag-phase I, whereas it was vice versa during adhesion phase II. This study introduces the non-constant-depth film fermenter in combination with a chemostat culture to allow for a controlled approach to reproducibly cultivate biofilms and to investigate bacterial adhesion kinetics at constant and low shear conditions. The findings will support developing and adequate testing of biomaterials surface modifications eventually preventing biomaterial-associated infections.
C1 [Luedecke, Claudia; Kujau, Marian J.; Zang, Emerson; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.
   [Luedecke, Claudia; Jandt, Klaus D.; Bossert, Joerg] Univ Jena, Fac Phys & Astron, Chair Mat Sci, D-07743 Jena, Germany.
   [Siegismund, Daniel; Rettenmayr, Markus] Univ Jena, Dept Metall Mat, Otto Schott Inst Mat Res OSIM, Jena, Germany.
RP Jandt, KD (reprint author), Univ Jena, Fac Phys & Astron, Chair Mat Sci, Max Wien Pl 1, D-07743 Jena, Germany.
EM k.jandt@uni-jena.de; martin.roth@hki-jena.de
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
FU Excellence Graduate School "Jena School for Microbial Communication";
   Thuringer Ministerium fur Bildung, Wissenschaft und Kultur TMBWK);
   German Excellence Initiative; Deutsche Forschungsgemeinschaft (DFG)
   [INST 275/241-1 FUGG]; Thuringer Ministerium fur Bildung, Wissenschaft
   und Kultur (TMBWK) [62-4264 925/1/10/1/01]
FX This work was supported by the Excellence Graduate School "Jena School
   for Microbial Communication" (JSMC MikroInter supported by the Thuringer
   Ministerium fur Bildung, Wissenschaft und Kultur TMBWK) which is funded
   by the German Excellence Initiative. KDJ gratefully acknowledges,
   furthermore, the partial financial support of the Deutsche
   Forschungsgemeinschaft (DFG), grant reference INST 275/241-1 FUGG, and
   of the Thuringer Ministerium fur Bildung, Wissenschaft und Kultur
   (TMBWK), grant reference 62-4264 925/1/10/1/01. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bakker DP, 2004, MICROBIOL-SGM, V150, P1779, DOI 10.1099/mic.0.26983-0
   Bayoudh S, 2006, MAT SCI ENG C-BIO S, V26, P300, DOI 10.1016/j.msec.2005.10.045
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boland T, 2000, HDB BACTERIAL ADHESI, P29
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   BUCKINGHAMMEYER K, 2003, BIOFILM LAB STEP BY, P31
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Cai KY, 2006, COLLOID SURFACE B, V49, P136, DOI 10.1016/j.colsurfb.2006.02.016
   Cai KY, 2005, APPL SURF SCI, V250, P252, DOI 10.1016/j.apsusc.2005.01.013
   Chen MY, 2010, BIOCHEM ENG J, V53, P121, DOI 10.1016/j.bej.2010.10.003
   CHRISTENSEN GD, 2000, HDB BACTERIAL ADHESI, P213
   Coenye T, 2010, J MICROBIOL METH, V83, P89, DOI 10.1016/j.mimet.2010.08.018
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315
   de Paz LEC, 2009, APPL ENVIRON MICROB, V75, P1734, DOI 10.1128/AEM.02000-08
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   GILBERT P, 1991, J ANTIMICROB CHEMOTH, V27, P550, DOI 10.1093/jac/27.4.550
   Goeres DM, 2009, NAT PROTOC, V4, P783, DOI 10.1038/nprot.2009.59
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Heersink J, 2003, BIOFILM LAB STEP BY, P13
   Hoffman A. S., 2004, INTRO MAT MED, P197
   Honraet K, 2005, J MICROBIOL METH, V63, P287, DOI 10.1016/j.mimet.2005.03.014
   Hope CK, 2012, J APPL MICROBIOL, V113, P601, DOI 10.1111/j.1365-2672.2012.05368.x
   Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   JASS J, 1995, J IND MICROBIOL, V15, P283, DOI 10.1007/BF01569981
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kinniment SL, 1996, J APPL BACTERIOL, V81, P120, DOI 10.1111/j.1365-2672.1996.tb04488.x
   Kinniment SL, 1996, MICROBIOL-SGM, V142, P631, DOI 10.1099/13500872-142-3-631
   LIN FYH, 1993, J COLLOID INTERF SCI, V159, P86, DOI 10.1006/jcis.1993.1300
   Lorite GS, 2011, J COLLOID INTERF SCI, V359, P289, DOI 10.1016/j.jcis.2011.03.066
   Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030
   Lynch AS, 2008, ANNU REV MED, V59, P415, DOI 10.1146/annurev.med.59.110106.132000
   MAURER R, 1980, J MOL BIOL, V139, P147, DOI 10.1016/0022-2836(80)90302-2
   McBain AJ, 2003, J APPL MICROBIOL, V94, P655, DOI 10.1046/j.1365-2672.2003.01876.x
   MCCOY WF, 1981, CAN J MICROBIOL, V27, P910, DOI 10.1139/m81-143
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244
   Morgan TD, 2001, J APPL MICROBIOL, V91, P47, DOI 10.1046/j.1365-2672.2001.01338.x
   Necas D, 2012, CENT EUR J PHYS, V10, P181, DOI 10.2478/s11534-011-0096-2
   Noimark S, 2009, CHEM SOC REV, V38, P3435, DOI 10.1039/b908260c
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PETERS AC, 1988, BIOTECHNOL BIOENG, V32, P263, DOI 10.1002/bit.260320302
   Peterson WB, 2012, APPL ENVIRON MICROB, V78, P120
   Poncin-Epaillard F, 2013, MAT SCI ENG C-MATER, V33, P1152, DOI 10.1016/j.msec.2012.12.020
   Pratten Jonathan, 2007, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b05s6
   Puckett SD, 2010, BIOMATERIALS, V31, P706, DOI 10.1016/j.biomaterials.2009.09.081
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh AV, 2013, J NANOSCI NANOTECHNO, V13, P77, DOI 10.1166/jnn.2013.6727
   Stewart PS, 2001, J APPL MICROBIOL, V91, P525, DOI 10.1046/j.1365-2672.2001.01413.x
   Subbiahdoss G, 2011, PLOS ONE, V9
   Taylor J, 1997, INTRO ERROR ANAL STU
   Truong VK, 2010, BIOMATERIALS, V31, P3674, DOI 10.1016/j.biomaterials.2010.01.071
   Webb HK, 2013, BIOFOULING, V29, P163, DOI 10.1080/08927014.2012.757697
   Webb HK, 2012, SCANNING, V34, P257, DOI 10.1002/sca.21002
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Zanin ICJ, 2005, J ANTIMICROB CHEMOTH, V56, P324, DOI 10.1093/jac/dki232
NR 59
TC 17
Z9 18
U1 0
U2 35
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 3
PY 2014
VL 9
IS 1
AR e84837
DI 10.1371/journal.pone.0084837
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 286IH
UT WOS:000329460800071
PM 24404192
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Zhang, YS
   Cai, X
   Yao, JJ
   Xing, WX
   Wang, LHV
   Xia, YN
AF Zhang, Yu Shrike
   Cai, Xin
   Yao, Junjie
   Xing, Wenxin
   Wang, Lihong V.
   Xia, Younan
TI Non-Invasive and In Situ Characterization of the Degradation of
   Biomaterial Scaffolds by Volumetric Photoacoustic Microscopy
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE blood vessels; inverse opal scaffolds; MTT formazan; photoacoustic
   imaging; regenerative medicine
ID INVERSE OPAL SCAFFOLDS; 3-DIMENSIONAL SCAFFOLDS; GOLD NANOCAGES; PORE
   SIZES; TISSUE; VIVO; TOMOGRAPHY; DESIGN; VITRO; RESOLUTION
AB Degradation is among the most important properties of biomaterial scaffolds, which are indispensable for regenerative medicine. The currently used method relies on the measurement of mass loss across different samples and cannot track the degradation of an individual scaffold insitu. Here we report, for the first time, the use of multiscale photoacoustic microscopy to non-invasively monitor the degradation of an individual scaffold. We could observe alterations to the morphology and structure of a scaffold at high spatial resolution and deep penetration, and more significantly, quantify the degradation of an individual scaffold as a function of time, both invitro and invivo. In addition, the remodeling of vasculature inside a scaffold can be visualized simultaneously using a dual-wavelength scanning mode in a label-free manner. This optoacoustic method can be used to monitor the degradation of individual scaffolds, offering a new approach to non-invasively analyze and quantify biomaterial-tissue interactions in conjunction with the assessment of invivo vascular parameters.
C1 [Zhang, Yu Shrike; Xia, Younan] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Zhang, Yu Shrike; Xia, Younan] Emory Univ, Atlanta, GA 30332 USA.
   [Cai, Xin; Yao, Junjie; Xing, Wenxin; Wang, Lihong V.; Xia, Younan] Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
RP Wang, LHV (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA.
EM lhwang@seas.wustl.edu; younan.xia@bme.gatech.edu
RI Xia, Younan/E-8499-2011; Zhang, Yu Shrike/H-4885-2013; Wang,
   Lihong/A-7147-2009; yao, junjie/G-9226-2014
OI Zhang, Yu Shrike/0000-0002-0045-0808; Wang, Lihong/0000-0001-9783-4383;
   yao, junjie/0000-0002-2847-5839
FU NIH [DP1 OD000798, R01 EB000712, R01 EB008085, R01 CA140220, R01
   CA157277, R01 CA159959, U54 CA136398]; Washington University in St.
   Louis; Georgia Institute of Technology
FX We thank Prof. James Ballard for careful reading of the manuscript. This
   work was supported by an NIH Director's Pioneer Award (DP1 OD000798) and
   startup funds from Washington University in St. Louis and Georgia
   Institute of Technology (to Y.X.). This work was also sponsored by NIH
   grants (R01 EB000712, R01 EB008085, R01 CA140220, R01 CA157277, R01
   CA159959, and U54 CA136398, to L.V.W.).
CR Artzi N, 2011, NAT MATER, V10, P704, DOI [10.1038/nmat3095, 10.1038/NMAT3095]
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Cai X, 2013, TISSUE ENG PART C-ME, V19, P196, DOI [10.1089/ten.tec.2012.0326, 10.1089/ten.TEC.2012.0326]
   Cho E. C., 2013, ANGEW CHEM, V125, P1190
   Cho EC, 2013, ANGEW CHEM INT EDIT, V52, P1152, DOI 10.1002/anie.201208096
   Choi SW, 2013, ADV HEALTHC MATER, V2, P145, DOI 10.1002/adhm.201200106
   Choi SW, 2010, LANGMUIR, V26, P19001, DOI 10.1021/la104206h
   Choi SW, 2010, LANGMUIR, V26, P12126, DOI 10.1021/la101519b
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hu S, 2011, OPT LETT, V36, P1134, DOI 10.1364/OL.36.001134
   Janousek L, 2004, TRANSPLANT P, V36, P1099, DOI 10.1016/j.transproceed.2004.04.049
   Jin YD, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1042
   Kim C, 2010, BIOMED OPT EXPRESS, V1, P278, DOI 10.1364/BOE.1.000278
   Kim K, 2008, ACTA BIOMATER, V4, P783, DOI 10.1016/j.actbio.2008.02.010
   Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma WX, 2011, INT J LEGAL MED, V125, P549, DOI 10.1007/s00414-011-0567-4
   Marquez G, 1998, APPL OPTICS, V37, P798, DOI 10.1364/AO.37.000798
   Maslov K, 2008, OPT LETT, V33, P929, DOI 10.1364/OL.33.000929
   Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074
   Ntziachristos V, 2010, NAT METHODS, V7, P603, DOI [10.1038/NMETH.1483, 10.1038/nmeth.1483]
   Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566
   Peyton SR, 2011, BIOTECHNOL BIOENG, V108, P1181, DOI 10.1002/bit.23027
   Razansky D, 2009, NAT PHOTONICS, V3, P412, DOI 10.1038/NPHOTON.2009.98
   SCUDIERO DA, 1988, CANCER RES, V48, P4827
   Shanbhag S, 2005, SMALL, V1, P1208, DOI 10.1002/smll.200500191
   Song KH, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2818045
   Spinelli L, 2004, J BIOMED OPT, V9, P1137, DOI 10.1117/1.1803546
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210
   Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157
   Wang Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061208
   Wang Y, 2011, OPT LETT, V36, P1029, DOI 10.1364/OL.36.001029
   Wang Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3525643
   Wilson K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1627
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao JJ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3594786
   Yao JJ, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3339953
   Yao JJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3251044
   Zhang HF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2435697
   Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V123, P7497
   Zhang Y, 2012, MACROMOL RAPID COMM, V33, P296, DOI 10.1002/marc.201100695
   Zhang Y, 2012, ADV FUNCT MATER, V22, P121, DOI 10.1002/adfm.201101690
   Zhang Y, 2011, ANGEW CHEM INT EDIT, V50, P7359, DOI 10.1002/anie.201101659
   Zhang Y, 2010, BIOMATERIALS, V31, P8651, DOI 10.1016/j.biomaterials.2010.07.089
   Zhang YS, 2013, SOFT MATTER, V9, P9747, DOI 10.1039/c3sm52063c
   Zhang YS, 2013, THERANOSTICS, V3, P532, DOI 10.7150/thno.5369
   Zhang YS, 2013, MACROMOL RAPID COMM, V34, P485, DOI 10.1002/marc.201200740
NR 52
TC 19
Z9 19
U1 2
U2 69
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PD JAN 3
PY 2014
VL 53
IS 1
BP 184
EP 188
DI 10.1002/anie.201306282
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 275YI
UT WOS:000328714900023
PM 24130155
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Beilvert, A
   Chaubet, F
   Chaunier, L
   Guilois, S
   Pavon-Djavid, G
   Letourneur, D
   Meddahi-Pelle, A
   Lourdin, D
AF Beilvert, A.
   Chaubet, F.
   Chaunier, L.
   Guilois, S.
   Pavon-Djavid, G.
   Letourneur, D.
   Meddahi-Pelle, A.
   Lourdin, D.
TI Shape-memory starch for resorbable biomedical devices
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; In vivo implantation; Shape-memory; Starch; Extrusion
ID MECHANICAL-PROPERTIES; MACROMOLECULAR ORIENTATION; POTATO STARCH;
   SCAFFOLDS; BEHAVIOR; CRYSTALLINITY; DEGRADATION; MORPHOLOGY; POLYMERS;
   BIOMATERIALS
AB Shape-memory resorbable materials were obtained by extrusion-cooking of potato starch with 20% glycerol under usual conditions. They presented an efficient shape-memory with a high recovery ratio (Rr > 90%).Their recovery could be triggered at 37 C in water. After water immersion at 37 C, the modulus decreased from 1 GPa to 2.4 MPa and remained almost constant over 21 days. Gamma-ray sterilization did not have a dramatic impact on their mechanical properties, despite a large decrease of molecular mass analyzed by asymmetrical flow field-flow fractionation coupled with multi-angle laser light scattering (AFFFF-MALLS). Samples implanted in a rat model exhibited normal tissue integration with a low inflammatory response. Thus, as previously investigated in the case of shape-memory synthetic polymers, natural starch, without chemical grafting, can now be considered for manufacturing innovative biodegradable devices for less-invasive surgery. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Beilvert, A.; Chaunier, L.; Guilois, S.; Lourdin, D.] INRA, Unite Biopolymeres Interact & Assemblages, UR1268, F-44300 Nantes, France.
   [Chaubet, F.; Pavon-Djavid, G.; Letourneur, D.; Meddahi-Pelle, A.] INSERM, Bioengn Cardiovasc & Therapy Team, U698, F-75877 Paris, France.
   [Chaubet, F.; Pavon-Djavid, G.; Letourneur, D.] Univ Paris 13, Sorbonne Paris Cite, Inst Galilee, F-93430 Villetaneuse, France.
   [Meddahi-Pelle, A.] Univ Paris 13, Sorbonne Paris Cite, Inst Univ Technol St Denis, F-93206 St Denis, France.
RP Lourdin, D (reprint author), INRA, Unite Biopolymeres Interact & Assemblages, UR1268, Rue Geraudiere, F-44300 Nantes, France.
EM anne.beilvert@nantes.inra.fr; frederic.chaubet@univ-paris13.fr;
   laurent.chaunier@nantes.inra.fr; sophie.guilois@nantes.inra.fr;
   graciela.pavon@univ-paris13.fr; didier.letourneur@inserm.fr;
   anne.pelle@inserm.fr; denis.lourdin@nantes.inra.fr
RI Didier, letourneur/H-5268-2012; CHAUNIER, Laurent/D-6924-2017; Chaubet,
   Frederic/L-4570-2017
OI Didier, letourneur/0000-0003-2197-9468; CHAUNIER,
   Laurent/0000-0003-0554-8203; Chaubet, Frederic/0000-0001-7375-0425;
   Pavon-Djavid, Graciela/0000-0001-5819-1071
FU French National Research Agency (ANR) [IRMAS-EMMA-007]
FX The authors would like to thank C. Vechambre, A. Buleon, R. Desirest, M.
   de Carvalho, A-L. Reguerre, A. Rolland-Sabate and B. Pontoire (INRA,
   Nantes) and L. Louedec and F. Medjahed (INSERM, Paris) for their
   technical help and helpful discussions. This work has been funded by the
   French National Research Agency (ANR Emergence IRMAS-EMMA-007).
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Arockianathan PM, 2012, INT J BIOL MACROMOL, V50, P939, DOI 10.1016/j.ijbiomac.2012.02.022
   Bello-Perez LA, 1998, J CEREAL SCI, V27, P267, DOI 10.1006/jcrs.1998.0186
   Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3
   Chaunier L, 2012, FOOD RES INT, V47, P194, DOI 10.1016/j.foodres.2011.05.035
   Chaunier L, 2009, STARCH-STARKE, V61, P116, DOI 10.1002/star.200800074
   Frost K, 2011, CARBOHYD POLYM, V84, P343, DOI 10.1016/j.carbpol.2010.11.042
   Ghosh S, 2008, ACTA BIOMATER, V4, P950, DOI 10.1016/j.actbio.2008.02.001
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Guo BC, 2011, BIOMACROMOLECULES, V12, P1312, DOI 10.1021/bm2000378
   Hayakawa I, 1996, FOOD SCI TECHNOL-LEB, V29, P395
   Kantoglu O, 2002, NUCL INSTRUM METH B, V197, P259, DOI 10.1016/S0168-583X(02)01473-8
   Lan X, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/2/024002
   Lendlein A., 2002, ANGEW CHEM INT EDIT, V41, P2035
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001
   Liu C, 2007, J MATER CHEM, V17, P1543, DOI 10.1039/b615954k
   Lopez OV, 2011, J FOOD ENG, V105, P254, DOI 10.1016/j.jfoodeng.2011.02.029
   Lourdin D, 1997, POLYMER, V38, P5401, DOI 10.1016/S0032-3861(97)00082-7
   Lourdin D, 2009, European patent, Patent No. [WO2009130215, 2009130215, WO/2009/130215]
   Martins AM, 2012, J BIOMED MATER RES A, V100A, P599, DOI 10.1002/jbm.a.33261
   Milicevic D, 2012, RADIAT PHYS CHEM, V81, P1361, DOI 10.1016/j.radphyschem.2011.11.037
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P195, DOI 10.1016/j.msec.2005.01.009
   Oliveira JT, 2007, J MATER SCI-MATER M, V18, P295, DOI 10.1007/s10856-006-0692-7
   Rodrigues A, 2012, CARBOHYD POLYM, V87, P987, DOI 10.1016/j.carbpol.2011.09.044
   Rolland-Sabate A, 2007, BIOMACROMOLECULES, V8, P2520, DOI 10.1021/bm070024z
   Santos TC, 2010, ACTA BIOMATER, V6, P4314, DOI 10.1016/j.actbio.2010.06.020
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Suljovrujic E, 2007, RADIAT PHYS CHEM, V76, P722, DOI 10.1016/j.radphyschem.2006.02.013
   Tamai H, 2000, CIRCULATION, V102, P399
   TOLLIER MT, 1979, ANN TECHNOL AGR, V28, P1
   Torres FG, 2011, MAT SCI ENG C-MATER, V31, P1737, DOI 10.1016/j.msec.2011.08.004
   vanSoest JJG, 1996, CARBOHYD POLYM, V29, P225, DOI 10.1016/0144-8617(96)00011-2
   Vechambre C, 2011, MACROMOLECULES, V44, P9384, DOI 10.1021/ma202019v
   Vechambre C, 2010, MACROMOLECULES, V43, P9854, DOI 10.1021/ma101704k
   Vechambre C, 2010, MACROMOL MATER ENG, V295, P115, DOI 10.1002/mame.200900191
   Xue LA, 2010, BIOMATERIALS, V31, P8132, DOI 10.1016/j.biomaterials.2010.07.043
   Yakacki CM, 2007, BIOMATERIALS, V28, P2255, DOI 10.1016/j.biomaterials.2007.01.030
   Zhang NZ, 2013, CARBOHYD POLYM, V92, P455, DOI 10.1016/j.carbpol.2012.09.048
NR 40
TC 17
Z9 17
U1 4
U2 71
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2014
VL 99
BP 242
EP 248
DI 10.1016/j.carbpol.2013.08.015
PG 7
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 283OM
UT WOS:000329256600030
PM 24274502
DA 2018-10-19
ER

PT J
AU Andersen, T
   Melvik, JE
   Gaserod, O
   Alsberg, E
   Christensen, BE
AF Andersen, Therese
   Melvik, Jan Egil
   Gaserod, Olav
   Alsberg, Eben
   Christensen, Bjorn E.
TI Ionically gelled alginate foams: Physical properties controlled by type,
   amount and source of gelling ions
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Biomaterial; Polysaccharide; Porous; Hydrogel; Gelation; Gelation
   kinetics
ID DRUG-DELIVERY SYSTEMS; CONTROLLED SCAFFOLD DEGRADATION; BIOMEDICAL
   APPLICATIONS; LOADED ALGINATE; SODIUM ALGINATE; BONE-FORMATION;
   STEM-CELLS; IN-VITRO; HYDROGELS; TISSUE
AB A new and flexible method for preparation of dry macroporous alginate foams with the capability of absorbing physiological solutions has been developed, which may find use within areas such as wound healing, cell culture, drug delivery and tissue engineering. The present study demonstrates how the gelation rate of the alginate and degree of ionic crosslinking can be utilized to control the physical foam properties. The rate of released Ca2+/Sr2+ gelling ions available for interaction with the alginate was influenced by the concentration and physical characteristics of CaCO3/SrCO3 particles. The method of preparation of such foams allows, as described herein, tailoring of the pore structure, hydration properties and mechanical integrity in a manner not possible by other techniques. (C) 2013 Elsevier Ltd. All rights reserved.
C1 [Andersen, Therese; Melvik, Jan Egil; Gaserod, Olav] FMC BioPolymer AS NovaMatrix, N-1337 Sandvika, Norway.
   [Andersen, Therese; Christensen, Bjorn E.] Norwegian Univ Sci & Technol, NOBIPOL, Dept Biotechnol, N-7034 Trondheim, Norway.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Dept Orthopaed Surg, Cleveland, OH 44106 USA.
   [Alsberg, Eben] Case Western Reserve Univ, Natl Ctr Regenerat Med, Devis Gen Med Sci, Cleveland, OH 44106 USA.
RP Andersen, T (reprint author), FMC BioPolymer AS NovaMatrix, Ind Veien 33, N-1337 Sandvika, Norway.
EM therese.andersen@fmc.com
RI Christensen, Bjorn E./G-6033-2015
OI Christensen, Bjorn E./0000-0002-1135-9815; Alsberg,
   Eben/0000-0002-3487-4625
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   ALSHAMKHANI A, 1995, J BIOACT COMPAT POL, V10, P4, DOI 10.1177/088391159501000102
   ANDERSEN T, 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227
   Andersen T, 2012, BIOMACROMOLECULES, V13, P3703, DOI 10.1021/bm301194f
   [Anonymous], 2010, D63810 ASTM INT
   Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barbetta A, 2009, BIOMACROMOLECULES, V10, P2328, DOI 10.1021/bm900517q
   Bencherif SA, 2012, P NATL ACAD SCI USA, V109, P19590, DOI 10.1073/pnas.1211516109
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Boontheekul T, 2005, BIOMATERIALS, V26, P2455, DOI 10.1016/j.biomaterials.2004.06.044
   BSI British Standards, 2002, 1372612002 BS EN BSI
   Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e
   DRAGET K I, 1991, Carbohydrate Polymers, V14, P159
   Draget K. I., 2005, POLYSACCHARIDES POLY, V1, P1
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dvir-Ginzberg M, 2008, FASEB J, V22, P1440, DOI 10.1096/fj.07-9277com
   Fang YP, 2007, J PHYS CHEM B, V111, P2456, DOI 10.1021/jp0689870
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Funami T, 2009, FOOD HYDROCOLLOID, V23, P1746, DOI 10.1016/j.foodhyd.2009.02.014
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Haug A., 1970, ACTA CHEM SCAND, V24, P854
   Hegge AB, 2011, J PHARM SCI-US, V100, P174, DOI 10.1002/jps.22263
   Hegge AB, 2010, J PHARM SCI-US, V99, P3499, DOI 10.1002/jps.22119
   Henderson TMA, 2013, J MATER CHEM B, V1, P2682, DOI 10.1039/c3tb20280a
   Holte O, 2006, PHARMAZIE, V61, P30
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/3/035003
   Jain J. P., 2011, BIODEGRADABLE POLYM, P3
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kristiansen KA, 2011, CARBOHYD POLYM, V86, P1595, DOI 10.1016/j.carbpol.2011.06.069
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   KUO CK, 2001, MAT RES SOC S P, V662
   Lai HL, 2003, INT J PHARM, V251, P175, DOI 10.1016/S0378-5173(02)00590-2
   Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003
   Leone G, 2004, J MATER SCI-MATER M, V15, P463, DOI 10.1023/B:JMSM.0000021121.91449.f4
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   Miralles G, 2001, J BIOMED MATER RES, V57, P268, DOI 10.1002/1097-4636(200111)57:2<268::AID-JBM1167>3.0.CO;2-L
   Moe S. T., 1995, FOOD POLYSACCHARIDES, V9, P245
   Morch YA, 2006, BIOMACROMOLECULES, V7, P1471, DOI 10.1021/bm060010d
   Place ES, 2011, TISSUE ENG PT A, V17, P2713, DOI [10.1089/ten.TEA.2011.0059, 10.1089/ten.tea.2011.0059]
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   SMIDSROD O, 1990, TRENDS BIOTECHNOL, V8, P71, DOI 10.1016/0167-7799(90)90139-O
   Thornton AJ, 2004, TRANSPLANTATION, V77, P1798, DOI 10.1097/01.tp.0000131152.71117.0e
   Tonnesen HH, 2002, DRUG DEV IND PHARM, V28, P621, DOI 10.1081/DDC-120003853
   Wee S, 1998, ADV DRUG DELIVERY RE, V4, P267, DOI DOI 10.1016/S0169-409X(97)00124-5
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 53
TC 15
Z9 16
U1 2
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2014
VL 99
BP 249
EP 256
DI 10.1016/j.carbpol.2013.08.036
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 283OM
UT WOS:000329256600031
PM 24274503
DA 2018-10-19
ER

PT J
AU Duncan, NA
   Bruehlmann, SB
   Hunter, CJ
   Shao, XX
   Kelly, EJ
AF Duncan, Neil A.
   Bruehlmann, Sabina B.
   Hunter, Christopher J.
   Shao, Xinxin
   Kelly, Elizabeth J.
TI In situ cell-matrix mechanics in tendon fascicles and seeded collagen
   gels: implications for the multiscale design of biomaterials
SO COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING
LA English
DT Article
DE tendon; micromechanics; collagen gel; confocal microscopy; biomaterials;
   cell-matrix
ID SMOOTH-MUSCLE-CELLS; CONFOCAL MICROSCOPY; ANNULUS FIBROSUS;
   BIOMECHANICAL FUNCTION; 3-DIMENSIONAL CULTURE; INTERVERTEBRAL DISC;
   CONNECTIVE TISSUES; CROSS-LINKING; MODEL; FIBRILS
AB Designing biomaterials to mimic and function within the complex mechanobiological conditions of connective tissues requires a detailed understanding of the micromechanical environment of the cell. The objective of our study was to measure the in situ cell-matrix strains from applied tension in both tendon fascicles and cell-seeded type I collagen scaffolds using laser scanning confocal microscopy techniques. Tendon fascicles and collagen gels were fluorescently labelled to simultaneously visualise the extracellular matrix and cell nuclei under applied tensile strains of 5%. There were significant differences observed in the micromechanics at the cell-matrix scale suggesting that the type I collagen scaffold did not replicate the pattern of native tendon strains. In particular, although the overall in situ tensile strains in the matrix were quite similar (approximate to 2.5%) between the tendon fascicles and the collagen scaffolds, there were significant differences at the cell-matrix boundary with visible shear across cell nuclei of >1m measured in native tendon which was not observed at all in the collagen scaffolds. Similarly, there was significant non-uniformity of intercellular strains with relative sliding observed between cell rows in tendon which again was not observed in the collagen scaffolds where the strain environment was much more uniform. If the native micromechanical environment is not replicated in biomaterial scaffolds, then the cells may receive incorrect or mixed mechanical signals which could affect their biosynthetic response to mechanical load in tissue engineering applications. This study highlights the importance of considering the microscale mechanics in the design of biomaterial scaffolds and the need to incorporate such features in computational models of connective tissues.
C1 [Duncan, Neil A.; Bruehlmann, Sabina B.; Hunter, Christopher J.; Shao, Xinxin; Kelly, Elizabeth J.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 1N4, Canada.
   [Duncan, Neil A.] Univ Calgary, Dept Civil Engn, Calgary, AB T2N 1N4, Canada.
   [Hunter, Christopher J.] Univ Calgary, Dept Mech Engn, Calgary, AB T2N 1N4, Canada.
RP Duncan, NA (reprint author), Univ Calgary, McCaig Inst Bone & Joint Hlth, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.
EM duncan@ucalgary.ca
OI Duncan, Neil/0000-0002-9782-3681
FU Natural Sciences and Engineering Research Council (NSERC); Canadian
   Foundation for Innovation (CFI); Canada Research Chair in Orthopaedic
   Bioengineering
FX This research was supported by the Natural Sciences and Engineering
   Research Council (NSERC), the Canadian Foundation for Innovation (CFI)
   and the Canada Research Chair in Orthopaedic Bioengineering (N.A.D.).
CR Agoram B, 2001, J BIOMECH ENG-T ASME, V123, P362, DOI 10.1115/1.1385843
   Annovazzi L, 2010, J BIOMED MATER RES A, V92A, P254, DOI 10.1002/jbm.a.32352
   Arnoczky SP, 2002, J ORTHOPAED RES, V20, P29, DOI 10.1016/S0736-0266(01)00080-8
   Benjamin M, 2000, INT REV CYTOL, V196, P85
   Bruehlmann SB, 2004, SPINE, V29, P2612, DOI 10.1097/01.brs.0000146465.05972.56
   Bruehlmann SB, 2004, J BIOMECH, V37, P223, DOI 10.1016/S0021-9290(03)00244-6
   Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Buehler MJ, 2010, J COMPUT THEOR NANOS, V7, P1203, DOI 10.1166/jctn.2010.1474
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   Cacho F, 2007, INT J NONLINEAR MECH, V42, P391, DOI 10.1016/j.ijnonlinmec.2007.02.002
   Chandran PL, 2006, J BIOMECH ENG-T ASME, V128, P259, DOI 10.1115/1.2165699
   Chandran PL, 2007, J BIOMECH ENG-T ASME, V129, P137, DOI 10.1115/1.2472369
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Desrochers J, 2010, J BIOMECH, V43, P2141, DOI 10.1016/j.jbiomech.2010.03.045
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Gautieri A, 2010, J CHEM THEORY COMPUT, V6, P1210, DOI 10.1021/ct100015v
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Grytz R, 2009, J MECH BEHAV BIOMED, V2, P522, DOI 10.1016/j.jmbbm.2008.12.009
   Hansen KA, 2002, J BIOMECH ENG-T ASME, V124, P72, DOI 10.1115/1.1427698
   Houssen YG, 2011, J BIOMECH, V44, P2047, DOI 10.1016/j.jbiomech.2011.05.009
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   Kroon M, 2010, J MECH PHYS SOLIDS, V58, P918, DOI 10.1016/j.jmps.2010.03.005
   Langevin HM, 2004, HISTOCHEM CELL BIOL, V122, P7, DOI 10.1007/s00418-004-0667-z
   Levenberg S, 2004, CURR TOP DEV BIOL, V61, P113, DOI 10.1016/S0070-2153(04)61005-2
   Lo IK, 2002, HISTOL HISTOPATHOL, V17, P523, DOI 10.14670/HH-17.523
   Maceri F, 2012, BIOMECH MODEL MECHAN, V11, P505, DOI 10.1007/s10237-011-0329-8
   Maceri F, 2010, J BIOMECH, V43, P355, DOI 10.1016/j.jbiomech.2009.07.040
   Marino M, 2012, COMPUT METHODS BIOME, DOI .10.1080/10255842
   MIJAILOVICH SM, 1993, J APPL PHYSIOL, V74, P665
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Puxkandl R, 2002, PHILOS T R SOC B, V357, P191, DOI 10.1098/rstb.2001.1033
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Reese SP, 2010, J BIOMECH, V43, P1394, DOI 10.1016/j.jbiomech.2010.01.004
   Rigozzi S, 2011, J STRUCT BIOL, V176, P9, DOI 10.1016/j.jsb.2011.07.002
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Roeder BA, 2009, J BIOMECH ENG, V131, P137
   Rong Y, 2002, TISSUE ENG, V8, P1037, DOI 10.1089/107632702320934137
   Sasaki N, 1996, J BIOMECH, V29, P1131, DOI 10.1016/0021-9290(96)00024-3
   Screen HRC, 2008, J MECH BEHAV BIOMED, V1, P51, DOI 10.1016/j.jmbbm.2007.03.002
   Screen HRC, 2006, ACTA BIOMATER, V2, P505, DOI 10.1016/j.actbio.2006.05.008
   Screen HRC, 2010, ADV FUNCT MATER, V20, P738, DOI 10.1002/adfm.200901711
   Screen HRC, 2004, P I MECH ENG H, V218, P109, DOI 10.1243/095441104322984004
   Screen HRC, 2003, BIORHEOLOGY, V40, P361
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Silver Frederick H., 2006
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Snedeker JG, 2009, CELLS TISSUES ORGANS, V190, P111, DOI 10.1159/000189211
   Snedeker JG, 2009, TISSUE ENG PART C-ME, V15, P485, DOI 10.1089/ten.tec.2008.0612
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332
   Stella JA, 2010, ACTA BIOMATER, V6, P2365, DOI 10.1016/j.actbio.2010.01.001
   Stella JA, 2010, J BIOMED MATER RES A, V93A, P1032, DOI 10.1002/jbm.a.32593
   Tang H, 2009, ANN BIOMED ENG, V37, P1117, DOI 10.1007/s10439-009-9679-0
   Tang Y, 2010, J R SOC INTERFACE, V7, P839, DOI 10.1098/rsif.2009.0390
   Thornton GM, 2002, J ORTHOP RES, V20, P967, DOI 10.1016/S0736-0266(02)00028-1
   Upton ML, 2008, BIOPHYS J, V95, P2116, DOI 10.1529/biophysj.107.126938
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
NR 66
TC 9
Z9 10
U1 1
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1025-5842
EI 1476-8259
J9 COMPUT METHOD BIOMEC
JI Comput. Methods Biomech. Biomed. Eng.
PD JAN 2
PY 2014
VL 17
IS 1
SI SI
BP 39
EP 47
DI 10.1080/10255842.2012.742075
PG 9
WC Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical
SC Computer Science; Engineering
GA 273MU
UT WOS:000328539900005
PM 23237459
DA 2018-10-19
ER

PT J
AU Lan, Y
   Li, WC
   Guo, R
   Zhang, Y
   Xue, W
   Zhang, YM
AF Lan, Yong
   Li, Weichang
   Guo, Rui
   Zhang, Yi
   Xue, Wei
   Zhang, Yuanming
TI Preparation and characterisation of vancomycin-impregnated gelatin
   microspheres/silk fibroin scaffold
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE gelatin microsphere; silk fibroin; scaffold; vancomycin; antibacterial
   property
ID FIBROBLAST-GROWTH-FACTOR; DRUG DELIVERY-SYSTEM; SILK FIBROIN;
   CONTROLLED-RELEASE; SKIN; ANTIBIOTICS; BIOMATERIAL; FILMS; REGENERATION;
   MEMBRANES
AB A type of antibacterial silk fibroin (SF) scaffold was developed and characterised as a potential functional wound dressing for acute trauma treatment. To achieve this, SF solution was mixed with previously fabricated vancomycin (Vm)-loaded gelatin (G) microspheres, followed by a freeze-drying step. Some physical and antimicrobial properties of the prepared Vm/G/SF scaffolds were investigated and the results demonstrated that the average pore size and porosity of the composite scaffold were 60-80m and 75%, respectively. The compressive stress and compressive modulus of Vm/G/SF scaffold were 140 and 468KPa, respectively. Compared with Vm/G microspheres and Vm/SF scaffold, the Vm/G/SF scaffold has slower release rate of Vm. In addition, the Vm release rate of Vm/G/SF scaffold matched well with the degradation rate of SF scaffold. With respect to the antimicrobial effect, the results showed that the Vm/G/SF scaffold had good antimicrobial activity against Staphylococcus aureus (gram-positive), which is a gram-positive bacteria commonly found in infected wounds.
C1 [Lan, Yong; Li, Weichang; Guo, Rui; Zhang, Yi; Xue, Wei; Zhang, Yuanming] Jinan Univ, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
   [Lan, Yong] Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Guangdong, Peoples R China.
   [Li, Weichang; Zhang, Yuanming] Jinan Univ, Dept Chem, Guangzhou 510632, Guangdong, Peoples R China.
   [Guo, Rui; Zhang, Yi; Xue, Wei] Jinan Univ, Dept Biomed Engn, Guangzhou 510632, Guangdong, Peoples R China.
RP Guo, R (reprint author), Jinan Univ, Guangdong Higher Educ Inst, Key Lab Biomat, Guangzhou 510632, Guangdong, Peoples R China.
EM guorui@jnu.edu.cn; tzhangym@jnu.edu.cn
RI Yuanming, Zhang/B-9285-2008; zhang, yuanming/A-9839-2014
FU Natural Science Foundation of Guangdong [S2012040008003]; Guangzhou
   Science and Technology Plan Project [11C32070752]; Key Project of DEGP
   [cxzd1109]; PhD Programmes Foundation of Ministry of Education of China;
   Fundamental Research Funds for the Central Universities [21612327]
FX This study is financially supported by the Natural Science Foundation of
   Guangdong (S2012040008003), Guangzhou Science and Technology Plan
   Project (No. 11C32070752), the Key Project of DEGP (cxzd1109), the PhD
   Programmes Foundation of Ministry of Education of China and the
   Fundamental Research Funds for the Central Universities (21612327).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Bin Choy Y, 2008, MACROMOL BIOSCI, V8, P758, DOI 10.1002/mabi.200700316
   Chen DW, 2012, INT J PHARMACEUT, V430, P335, DOI 10.1016/j.ijpharm.2012.04.010
   Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006
   Elsner JJ, 2010, J BIOMED MATER RES B, V93B, P425, DOI 10.1002/jbm.b.31599
   Freiberg S, 2004, INT J PHARM, V282, P1, DOI 10.1016/j.ijpharm.2004.04.013
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kasoju N, 2012, J BIOMED MATER RES B, V100B, P1854, DOI 10.1002/jbm.b.32753
   Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Konishi M, 2005, J CONTROL RELEASE, V103, P7, DOI 10.1016/j.conrel.2004.11.014
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Kundu J, 2008, J MATER SCI-MATER M, V19, P2679, DOI 10.1007/s10856-008-3398-1
   Kundu J, 2012, ACTA BIOMATER, V8, P1720, DOI 10.1016/j.actbio.2012.01.004
   Lee OJ, 2012, J BIOMED MATER RES A, V100A, P2018, DOI 10.1002/jbm.a.33308
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu B, 2003, INT J PHARM, V265, P1, DOI 10.1016/S0378-5173(03)00332-6
   Noel SP, 2008, CLIN ORTHOP RELAT R, V466, P1377, DOI 10.1007/s11999-008-0228-1
   Pica K, 2006, J PHARM SCI-US, V95, P1896, DOI 10.1002/jps.20572
   Roh DH, 2006, J MATER SCI-MATER M, V17, P547, DOI 10.1007/s10856-006-8938-y
   She HD, 2007, J MATER SCI, V42, P8113, DOI 10.1007/s10853-007-1706-7
   Shepherd J, 2011, BIOMATERIALS, V32, P258, DOI 10.1016/j.biomaterials.2010.08.084
   Spizzirri UG, 2012, J MATER SCI, V47, P3648, DOI 10.1007/s10853-011-6211-3
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wei B, 2011, CARBOHYD POLYM, V84, P533, DOI 10.1016/j.carbpol.2010.12.017
   Wongpanit P, 2007, MACROMOL BIOSCI, V7, P1258, DOI 10.1002/mabi.200700074
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhou D, 2012, ARCH PHARM RES, V35, P839, DOI 10.1007/s12272-012-0509-9
   Zhou J, 2012, J BIOMED MATER RES A, V100A, P2295, DOI 10.1002/jbm.a.34170
   Zhou JA, 2011, J MICROENCAPSUL, V28, P99, DOI 10.3109/02652048.2010.534824
   Zhu XH, 2008, TISSUE ENG PT A, V14, P1939, DOI 10.1089/ten.tea.2007.0346
NR 37
TC 10
Z9 10
U1 3
U2 61
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2014
VL 25
IS 1
BP 75
EP 87
DI 10.1080/09205063.2013.836951
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 254RV
UT WOS:000327185600006
PM 24053472
DA 2018-10-19
ER

PT J
AU Kaczmarek, JC
   Tieppo, A
   White, CJ
   Byrne, ME
AF Kaczmarek, James C.
   Tieppo, Arianna
   White, Charles J.
   Byrne, Mark E.
TI Adjusting biomaterial composition to achieve controlled multiple-day
   release of dexamethasone from an extended-wear silicone hydrogel contact
   lens
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE silicone hydrogel contact lenses; drug-eluting contact lens;
   extended-wear contact lens; ocular anti-inflammatory; hydrophobic
   interactions
ID EYE
AB Purpose: To alter the composition and structure of silicone hydrogel contact lenses to achieve controlled release of dexamethasone and evaluate the lens optical and mechanical properties compared to commercial lenses. There is a tremendous need for controlled release of drugs from ocular biomaterials as the majority of ophthalmic drugs are delivered via topical eye drops, which have low bioavailability and patient compliance.Methods: Poly(PDMS-co-TRIS-co-DMA) contact lenses were synthesized with varying PDMS/TRIS:DMA ratios (0.25:1, 0.67:1, 1.5:1) as well as with additional crosslinking monomers. Lenses were characterized via in vitro release studies in a microfluidic device at ocular flowrates and in large well-mixed volumes, optical quality studies over visible wavelengths, mechanical analysis, and determination of polymer volume fraction in the swollen state.Results: Extended and controlled release of therapeutically relevant concentrations of dexamethasone was achieved for multiple day, continuous wear up to 60days at in vitro ocular flowrates. Release was delayed due to a combination of increased hydrophobic to hydrophilic composition and the inclusion of additional structural constraints, both of which decreased the polymer volume fraction in the swollen state. However, decreased mass release rates were at the expense of increased modulus and decreased lens flexibility. All lenses had high optical clarity (approximate to 90% transmittance) and contained highly oxygen permeable siloxane composition similar to those found in commercial silicone hydrogel lenses, but they had poor flexibility for use as soft contact lenses.Conclusions: Based on our results, the lenses described herein likely have too high of a modulus for use as extended-wear, soft contact lenses with drug release. Therefore, other controlled release methods would be better suited for maintaining adequate mechanical properties and achieving controlled and extended release for the duration of wear in soft, silicone hydrogel contact lens biomaterials. However, these biomaterials may find clinical use as more rigid gas permeable contact lenses or inserts.
C1 [Byrne, Mark E.] Auburn Univ, Dept Chem Engn, Biomimet & Biohybrid Mat Lab, Auburn, AL 36849 USA.
   Auburn Univ, Dept Chem Engn, Biomed Devices Lab, Auburn, AL 36849 USA.
   Auburn Univ, Dept Chem Engn, Drug Delivery Lab, Auburn, AL 36849 USA.
RP Byrne, ME (reprint author), Auburn Univ, Dept Chem Engn, Biomimet & Biohybrid Mat Lab, Auburn, AL 36849 USA.
EM byrneme@eng.auburn.edu
RI White, Charles/C-4872-2014
OI White, Charles/0000-0002-2734-3279
FU NSF REU Site in Micro/Nano-Structured Materials, Therapeutics, and
   Devices (EES) [1063107]
FX We acknowledge the NSF REU Site in Micro/Nano-Structured Materials,
   Therapeutics, and Devices (EES Award 1063107) for funding part of this
   research (JCK was an NSF REU Fellow).
CR Douglas JA, 2000, AM J OPHTHALMOL, V130, P469
   Eysteinsson T, 2002, ACTA OPHTHALMOL SCAN, V80, P11, DOI 10.1034/j.1600-0420.2002.800103.x
   Fonn D, 1998, AM J OPTOM PHYSL OPT, V65, P613
   French K, 2005, OPTICIAN, V230, P29
   Ghormley NR, 2005, CONTACT LENS SPECTRU, P20
   Glasson M J, 2006, Cont Lens Anterior Eye, V29, P41, DOI 10.1016/j.clae.2005.12.006
   Hong X, 2001, OPTOMETRY VISION SCI, V78, P872, DOI 10.1097/00006324-200112000-00009
   Jones L, 1996, EYE CONTACT LENS, V22, P258
   Kannurpatti AR, 1998, POLYMER, V39, P213
   Karlgard C C S, 2003, Eye Contact Lens, V29, P83, DOI 10.1097/01.ICL.0000061756.66151.1C
   Karlgard CCS, 2003, INT J PHARM, V257, P141, DOI 10.1016/S0378-5173(03)00124-8
   Kim B, 2002, J BIOMAT SCI-POLYM E, V13, P1271, DOI 10.1163/156856202320893000
   Kim J, 2010, J CONTROL RELEASE, V148, P110, DOI 10.1016/j.jconrel.2010.07.119
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   Rhee DJ, 2007, PHYS DESK REFERENCE
   Saettone MF, 2002, PHARMATECHNOLOGY, P1
   Schoenwald Ronald D., 1997, P119
   Silicone Hydrogels [Internet]. Silicone Hydrogels.org, 2002, PAP E ED EL MOD SIL
   Tieppo A, 2012, J CONTROL RELEASE, V157, P391, DOI 10.1016/j.jconrel.2011.09.087
   Venkatesh S, 2007, BIOMATERIALS, V28, P717, DOI 10.1016/j.biomaterials.2006.09.007
   White CJ, 2011, J DRUG DELIV SCI TEC, V21, P369, DOI 10.1016/S1773-2247(11)50062-0
   White CJ, 2011, BIOMATERIALS, V32, P5698, DOI 10.1016/j.biomaterials.2011.04.044
   White CJ, 2010, EXPERT OPIN DRUG DEL, V7, P765, DOI 10.1517/17425241003770098
   WINFIELD AJ, 1990, BRIT J OPHTHALMOL, V74, P477, DOI 10.1136/bjo.74.8.477
NR 24
TC 14
Z9 15
U1 0
U2 67
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PD JAN 2
PY 2014
VL 25
IS 1
BP 88
EP 100
DI 10.1080/09205063.2013.840228
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 254RV
UT WOS:000327185600007
PM 24070140
DA 2018-10-19
ER

PT S
AU Espolov, T
   Ukibayev, J
   Myrzakozha, D
   Perez-Lopez, P
   Ermolaev, Y
AF Espolov, T.
   Ukibayev, J.
   Myrzakozha, D.
   Perez-Lopez, P.
   Ermolaev, Y.
GP SGEM
TI PHYSICAL AND CHEMICAL PROPERTIES AND CRYSTAL STRUCTURE TRANSFORMATION OF
   BEESWAX DURING HEAT TREATMENT
SO GEOCONFERENCE ON NANO, BIO AND GREEN - TECHNOLOGIES FOR A SUSTAINABLE
   FUTURE, VOL I (SGEM 2014)
SE International Multidisciplinary Scientific GeoConference-SGEM
LA English
DT Proceedings Paper
CT 14th International Multidisciplinary Scientific Geoconference (SGEM)
CY JUN 17-26, 2014
CL Albena, BULGARIA
DE Wax; Composite biomaterial; Radiography; Defect structure
AB The object of research is the wax as a waste product of bees in the steppe and mountain areas of Almaty region of Kazakhstan.
   Purpose - to study the structure parameters and the homologous phase composition, morphology waxes of alpine and mountain areas of Kazakhstan and the establishment temperature - dependent patterns of their atomic-crystalline state.
   Methods: radiography, gas chromatography, scanning electron microscopy and chemical methods of separation of multicomponent systems.
   The results obtained in the atomic crystal and molecular structures of beeswax depending on the districts collect materials.
   The technique of obtaining radiographs after dissolving beeswax in benzene, hexane and xylene. Submitted thermo-radiographic study samples obtained.
   Batch analysis thermo-radiographs waxes after treatment with benzene, hexane and xylene showed that their structure is essentially different from the source and closer to the spectra of the crystallized wax melted and due to annihilation of stacking faults waxes native atoms after their dissolution in hexane, benzene and xylene and subsequent their recrystallization.
   The results obtained allow to expand the amount of information on the physicochemical processes and structural transformations in beeswax as a composite of different genesis biomaterial.
   Scope: beekeeping, plant, structural and analytical chemistry, biotechnology and biocomposites.
C1 [Espolov, T.; Ukibayev, J.; Myrzakozha, D.; Perez-Lopez, P.] Kazakh Natl Agr Univ, Alma Ata, Kazakhstan.
   [Ermolaev, Y.] Kazakh Natl Tech Univ, Alma Ata, Kazakhstan.
RP Espolov, T (reprint author), Kazakh Natl Agr Univ, Alma Ata, Kazakhstan.
CR Asakura T, 2001, BIOPOLYMERS, V58, P521, DOI 10.1002/1097-0282(20010415)58:5<521::AID-BIP1027>3.0.CO;2-T
   Dorset D.L., 1983, ACTA CRYSTALLOGR B, V8, P1021
   Dorset DL, 1999, J PHYS D APPL PHYS, V32, P1276, DOI 10.1088/0022-3727/32/11/315
   Kitaygorodsky A. I., 1971, MOL CRYSTALS, P424
   Kotelnikova E.N., 2002, SAINT PETERSBURG MAG, P352
   Zabelkin O.A., 2003, BEEKEEPING, P352
NR 6
TC 0
Z9 0
U1 0
U2 4
PU STEF92 TECHNOLOGY LTD
PI SOFIA
PA 1 ANDREY LYAPCHEV BLVD, SOFIA, 1797, BULGARIA
SN 1314-2704
BN 978-619-7105-20-9
J9 INT MULTI SCI GEOCO
PY 2014
BP 143
EP 149
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BE0JD
UT WOS:000366136600020
DA 2018-10-19
ER

PT S
AU Barney, LE
   Peyton, SR
AF Barney, Lauren E.
   Peyton, Shelly R.
GP IEEE
TI Integrin Binding Uniquely Regulates Tropic Breast Cancer Cell Phenotypes
   in vitro
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE metastasis; tropism; extracellular matrix; integrins
ID METASTASIS; GENES
AB Breast cancer preferentially spreads to the bone, brain, liver, and lung, and this tissue-specific spread (tropism) is not well understood. The diversity of tissue sites often recipient of metastatic colonization suggests a role for the extracellular matrix (ECM) in tropism. We created a biomaterial platform that varies ECM type and composition, inspired by the bone, brain, and lung tissues, in order to study integrin-mediated adhesion and motility phenotypes. We report that bone, brain, and lung tropic breast cancer cells respond to ECM variations uniquely, implicating integrin binding in tropism. We confirmed these phenotypes in other metastatic cell lines, establishing a connection between in vitro phenotype and in vivo fate. We report that integrin-targeting alters the tropic phenotype, and provide insight toward integrins as druggable targets for metastatic disease. In sum, we emphasize the importance of the ECM and engineered microenvironments in order to understand breast cancer spread.
C1 [Barney, Lauren E.; Peyton, Shelly R.] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
RP Barney, LE (reprint author), Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA.
EM speyton@ecs.umass.edu
CR Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021
   Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6
   Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799
NR 3
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600021
DA 2018-10-19
ER

PT S
AU Choa, R
   Lippens, E
   Mehta, M
   Mooney, DJ
   Lee, K
   Madl, C
AF Choa, Ruth
   Lippens, Evi
   Mehta, Manav
   Mooney, David J.
   Lee, Kangwon
   Madl, Christopher
GP IEEE
TI Hydrogel-based System for Mesenchymal Stem Cell Recruitment
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE mesenchymal stem cells; Thymus-Chemokine-1; alginate hydrogels;
   chemotaxis
AB During the early stages of bone wound healing, mesenchymal stem cells (MSCs) in the bone marrow migrate to an injury site and differentiate into osteoblasts, which actively participate in the bone repair process. We proposed that a biomaterial system which enhances migration of endogenous MSCs may accelerate the tissue healing process. The aims of this study were to 1) identify and characterize an MSC chemoattractant, and 2) quantify the release kinetics of the chemoattractant from alginate hydrogels. Timelapse microscopy of 3D MSC migration was used for real time tracking of cell movement. Quantitative analysis of chemotaxis parameters identified Thymus Chemokine-1 (TCK-1) to be a potent MSC chemoattractant (p-values less than .01 for velocity, directionality, and forward migration index compared to controls). Qualitative receptor staining of MSCs in a transwell membrane assay showed that MSCs which respond chemotactically to gradient of TCK-1 express the TCK-1 cell receptor, CXCR2. An alginate hydrogel was used for controlled release of TCK-1. To characterize the kinetics of this system, an enzyme-linked immunosorbent assay (ELISA) was used to quantify TCK-1 release rates. This approach may be widely applicable to the regeneration of other tissue types and may be more efficient than the current multistep procedures of cell transplantation.
C1 [Choa, Ruth; Lippens, Evi; Mehta, Manav; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
   [Lee, Kangwon] Univ Sci & Technol, Korea Inst Sci & Technol, Seoul, South Korea.
   [Madl, Christopher] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Choa, R (reprint author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
CR Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Drury JL, 2004, BIOMATERIALS, V25, P3187, DOI 10.1016/j.biomaterials.2003.10.002
   Krelow J.D., 2009, ADV MATER, V21, P3368
   Lennon DP, 2006, EXP HEMATOL, V34, P1606, DOI 10.1016/j.exphem.2006.07.015
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Orreffo R., 2005, STEM CELL REV, V1, P169
   Tayalia P, 2011, BIOMATERIALS, V32, P2634, DOI 10.1016/j.biomaterials.2010.12.019
   United States Bone and Joint Initiative, 2011, BURD MUSC DIS US
   Zengel P., 2011, BMC CELL BIOL, V12
NR 9
TC 0
Z9 0
U1 2
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600055
DA 2018-10-19
ER

PT S
AU Dooley, K
   Banta, S
AF Dooley, Kevin
   Banta, Scott
GP IEEE
TI Engineering of Functional Proteinaceous Hydrogels for Biotechnology
   Applications
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE protein hydrogels; bioelectrocatalysis; alpha-helix; RTX domain; beta
   roll domain
ID BUILDING-BLOCKS; PEPTIDE; DOMAIN
AB Hydrogels consisting of 3-D cross-linked polymer networks have emerged as interesting scaffolds for a host of applications including drug delivery, tissue engineering, bioelectronics and biosensors. We have used protein engineering to create hydrogels by genetically appending cross-linking domains to globular proteins, which results in proteinacous biomaterials that exhibit bioactivity. Previously, we have investigated alpha-helical leucine zipper appendages for crosslinking. By genetically fusing these helices to the termini of globular proteins, we have created hydrogels with fluorescent proteins, and more interestingly, with enzymes such as laccase, organophosphate hydrolase (OPH) and alcohol dehydrogenase (AdhD). More recently, we have created a hydrogel from three self-assembling dehygrogenases which results in a biomaterial that is also a synthetic metabolic pathway capable of oxidizing methanol to CO2. Now we are exploring the calcium-responsive repeats-in-toxin (RTX) domain as an alternative cross-linker. In the absence of calcium, the RTX domain is unstructured. In calcium rich environments, it reversibly folds into a beta roll structure. By engineering one face of the beta roll to contain leucines, we created an environmentally-responsive cross-linking domain capable of calcium-triggered self-assembly. The folded beta roll contains a second face, which we have also designed to contain leucines. We are currently characterizing this "doubleface" leucine-rich RTX domain and evaluating is mechanical and biophysical properties. The RTX domains represent a truly "smart" cross-linking strategy in that the addition of a specific effector molecule ( calcium) enables the reversible formation of the hydrogel network.
C1 [Dooley, Kevin; Banta, Scott] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
RP Dooley, K (reprint author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
EM sbanta@columbia.edu
CR Banta S., 2010, ANNU REV BIOMED ENG, V12, P176
   Blenner MA, 2010, J MOL BIOL, V400, P244, DOI 10.1016/j.jmb.2010.04.056
   Dooley K, 2012, BIOMACROMOLECULES, V13, P1758, DOI 10.1021/bm3002446
   Kim YH, 2013, ANGEW CHEM INT EDIT, V52, P1437, DOI 10.1002/anie.201207423
   Lu HD, 2010, PROTEIN ENG DES SEL, V23, P559, DOI 10.1093/protein/gzq026
   Shur O, 2013, BIOTECHNIQUES, V54, P197, DOI 10.2144/000114010
   Shur O, 2013, PROTEIN ENG DES SEL, V26, P171, DOI 10.1093/protein/gzs092
   Shur O, 2011, PROTEIN SCI, V20, P925, DOI 10.1002/pro.625
   Wheeldon IR, 2008, P NATL ACAD SCI USA, V105, P15275, DOI 10.1073/pnas.0805249105
   Wheeldon IR, 2007, BIOMACROMOLECULES, V8, P2990, DOI 10.1021/bm700858p
   Wheeldon IR, 2009, J MOL BIOL, V392, P129, DOI 10.1016/j.jmb.2009.06.075
NR 11
TC 0
Z9 0
U1 0
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600077
DA 2018-10-19
ER

PT S
AU Grasman, JM
   Page, RL
   Dominko, T
   Pins, GD
AF Grasman, Jonathan M.
   Page, Raymond L.
   Dominko, Tanja
   Pins, George D.
GP IEEE
TI Enhancing Cell Recruitment onto Crosslinked Fibrin Microthreads with
   Hepatocyte Growth Factor
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE volumetric muscle loss; hepatocyte growth factor; myoblast migration;
   biomaterial design; tissue engineering
AB Volumetric muscle loss (VML) defects caused by major trauma lead to loss of muscle mass, mobility, and ultimately may result in tissue morbidity. These large-scale injuries destroy native tissue structures such as the basal lamina, which serves as a regenerative template for muscle regeneration. Our approach to the regeneration of VML injuries is to use fibrin microthreads, scaffolds with similar morphology to native muscle, and modulate their mechanical and structural properties to recapitulate cues lost with the destruction of native tissue structures. In this study, we investigated the effect of adsorbing hepatocyte growth factor (HGF) onto crosslinked microthreads on myoblast proliferation and recruitment in an in vitro model designed to mimic in vivo satellite cell recruitment and found that active HGF is released for 1-2 days and is capable of stimulating myoblast migration in both 2D and 3D models. These data suggest that HGF-adsorbed microthreads can recruit myoblasts to the wound site, ultimately leading to an enhanced regenerative response in VML injuries.
C1 [Grasman, Jonathan M.; Page, Raymond L.; Pins, George D.] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
   [Dominko, Tanja] Worcester Polytech Inst, Dept Biol & Biotechnol, Worcester, MA 01609 USA.
   [Grasman, Jonathan M.; Page, Raymond L.; Dominko, Tanja; Pins, George D.] Worcester Polytech Inst, Bioengn Inst, Worcester, MA 01609 USA.
RP Grasman, JM (reprint author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.
CR Cornwell KG, 2007, J BIOMED MATER RES A, V82A, P104, DOI 10.1002/jbm.a.31057
   Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9
   Grasman JM, 2012, ACTA BIOMATER, V8, P4020, DOI 10.1016/j.actbio.2012.07.018
   Miller K. J., 2000, AM J PHYSIOL-CELL PH, V278, P174
   O'Reilly C, 2008, MUSCLE NERVE, V38, P1434, DOI 10.1002/mus.21146
   Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600102
DA 2018-10-19
ER

PT S
AU Koppes, AN
   Carrier, RL
   Oudin, MJ
   Gertler, FB
   Baranov, PY
   Young, MJ
   Miller, MA
   Lauffenburger, DA
AF Koppes, Abigail N.
   Carrier, Rebecca L.
   Oudin, Madeleine J.
   Gertler, Frank B.
   Baranov, Petr Y.
   Young, Michael J.
   Miller, Miles A.
   Lauffenburger, Douglas A.
GP IEEE
TI High-Throughput Screening for Directed Chemotaxis of Retinal Progenitor
   Cells in 3D Hydrogels
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE Retinal Progenitor; Chemotaxis; Hydrogel; High-Throughput Screen
AB This study utilizes high-throughput screening to examine human retinal progenitor cell migration in response to biomaterial and chemokine stimuli. Degenerative diseases of the retina impact millions of people worldwide each year, with no known cure available to date. Implantation of retinal progenitor cells in animal models has shown considerable promise but is limited by extremely low (<5%) levels of integration. We hypothesize that by providing a supportive biomaterial and optimized chemokine concentrations to the subretinal space, directed migration of implanted progenitors could be achieved, aiding cell survival, integration, and differentiation post-implantation. In this work, a high-throughput screen was applied to examine retinal progenitor cell migration in response to two hydrogel compositions (collagen type I, collagen type I: 10% Matrigel (TM)) and three growth factors implicated in migratory cascades: Epidermal Growth Factor (EGF), Fibroblast Growth Factor-2 (FGF-2), and Stromal Cell Derived Factor-1 (SDF-1). After 48 hours, the addition of EGF at various concentrations increased migration in both hydrogel compositions 1.9-2.6-fold compared to chemokine free controls. FGF-2 increased migration 1.4-2.2-fold in collagen gels, however did not impact migration in Matrigel (TM) composites. SDF-1 did not impact migration in Matrigel (TM) composites but increased migration 1.8-3.4-fold in collagen gels with a maximal response at 20 ng/mL. Progenitors penetrate farther in collagen I compared to MatrigelTM composites. These results support the significance of matrix and chemokines to induce migration towards optimizing a rational therapy for retinal degeneration.
C1 [Koppes, Abigail N.; Carrier, Rebecca L.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
   [Oudin, Madeleine J.; Gertler, Frank B.] MIT, David Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.
   [Baranov, Petr Y.; Young, Michael J.] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA.
   [Baranov, Petr Y.; Young, Michael J.] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA.
   [Miller, Miles A.; Lauffenburger, Douglas A.] MIT, Dept Bioengn, Cambridge, MA 02139 USA.
RP Koppes, AN (reprint author), Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
CR Benedict KF, 2013, CURR TOP MICROBIOL, V363, P201, DOI 10.1007/82_2012_249
   Miller S, 2013, PNAS, V110, pE2074
   Stumm R., 2007, J MOL ENDOCRINOL, P3
   Tomita M, 2005, STEM CELLS, V23, P1579, DOI 10.1634/stemcells.2005-0111
   Vugler A, 2007, MECH DEVELOP, V124, P807, DOI 10.1016/j.mod.2007.08.002
NR 5
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600144
DA 2018-10-19
ER

PT S
AU Liu, WW
   Chen, S
   Zhang, ZT
   Webster, TJ
AF Liu, Wenwen
   Chen, Su
   Zhang, Zhenting
   Webster, Thomas J.
GP IEEE
TI Antibacterial Properties of TiO2 nanotubes incorporated with ZnO
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE antibacterial properties; titanium; biomaterial; nano zinc oxide
ID TITANIUM SURFACES; ADHESION
AB To obtain desirable Titanium (Ti) implant materials with antibacterial properties, different concentrations of zinc oxide (ZnO) were incorporated into TiO2 nanotubes by a simple hydrothermal treatment. In vitro experiments showed that Streptococcus mutans and Porphyromonas gingivalis were inhibited on ZnO incorporated samples. S. mutants and P. gingivalis densities were reduced on ZnO incorporated nanotube samples compared to controls after 7 days. In summary, results of this study showed that compared to plain TiO2 nanotubes, the incorporated Ti with ZnO in Ti nanotubes provided great antibacterial ability and this should be further studied.
C1 [Liu, Wenwen; Chen, Su; Zhang, Zhenting] Capital Med Univ, Dept Prosthodont, Sch Stomatol, Beijing 100050, Peoples R China.
   [Liu, Wenwen; Webster, Thomas J.] Northeastern Univ, Dept Chem Engn, Boston, MA 02115 USA.
RP Liu, WW (reprint author), Capital Med Univ, Dept Prosthodont, Sch Stomatol, Tian Tan Xi Li 4, Beijing 100050, Peoples R China.
CR Eaninwene C, 2008, INT J NANOMEDICINE, V3, P257
   Huo KF, 2013, BIOMATERIALS, V34, P3467, DOI 10.1016/j.biomaterials.2013.01.071
   Karla SB, TIO2 NANOTUBES BONE
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Tang YZ, 2009, BIOMATERIALS, V30, P2864, DOI 10.1016/j.biomaterials.2009.01.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 8
TC 0
Z9 0
U1 1
U2 5
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600158
DA 2018-10-19
ER

PT S
AU Rinaldi, AM
   Black, LD
AF Rinaldi, Anthony M.
   Black, Lauren D., III
GP IEEE
TI Evaluation of Anisotropic Silk Sponges Containing Cardiac ECM for
   Cardiac Tissue Engineering
SO 2014 40TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE (NEBEC)
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT 40th Annual Northeast Bioengineering Conference (NEBEC)
CY APR 25-27, 2014
CL Boston, MA
SP Northeastern Univ, Coll Engn, EMB, Biomed Engn Soc, Northeastern Univ, Dept Bioengineering, Northeastern Univ, Dept Chem Engn, Carl Zeiss Microscopy, Northeastern Univ, Dept Elect & Comp Engn, Northeastern Univ, Dept Mech & Ind Engn, ACS Synthet Biol, Merrimach Pharmaceuiticals
DE Cardiac Tissue Engineering; Anisotropy; Cell Adhesion
AB Current biomaterials used in cardiac tissue engineering are insufficient due to the lack of pertinent myocardium characteristics like anisotropy and necessary cardiac extracellular matrix (ECM) proteins. In this study, we take advantage silk, a biomaterial, to analyze effects of 0.2 mg/mL, 0.4 mg/mL or 0.6 mg/mL addition of cardiac ECM to 3% wt/v silk solution prior to scaffold formation. We created 200 mu m thick anisotropic and isotropic silk sponges coated with 100 mu g/mL collagen I solution and seeded them with cardiac fibroblasts. The anisotropic scaffolds exhibited an increase in cell spreading, adhesion and cell count as opposed to the isotropic scaffolds. Also, 0.6 mg/mL cardiac ECM incorporation shows increased cell number and spreading compared to the 0.2 mg/mL and 0.4 mg/mL cardiac ECM/silk composite scaffolds. Thus, pore architecture and ECM concentration play significant roles in the creation of optimized silk constructs for cardiac tissue engineering.
C1 [Rinaldi, Anthony M.; Black, Lauren D., III] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Black, Lauren D., III] Tufts Univ, Sch Med, CMDB Program, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.
RP Rinaldi, AM (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
CR [Anonymous], 2005, SMALL
   Franck D., 2013, PLOS ONE, V8
   Oliveira AL, 2012, ACTA BIOMATER, V8, P1530, DOI 10.1016/j.actbio.2011.12.015
   Omenetto FG, 2010, SCIENCE
   Omenetto FG, 2010, BIOMATERIALS, V31
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2011, BIOMATERIALS, V32, P1856, DOI 10.1016/j.biomaterials.2010.11.032
   Rasband W, 1997, IMAGEJ
   Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379
   Talukdar S, 2011, BIOMATERIALS, V32
   Talukdar S, 2011, BIOMATERIALS, V32
NR 11
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4799-3728-8
J9 NORTHEAST BIOENGIN C
PY 2014
PG 2
WC Engineering, Biomedical
SC Engineering
GA BD8LQ
UT WOS:000364054600218
DA 2018-10-19
ER

PT S
AU Nocera, AD
   Salvatierra, NA
   Cid, MP
AF Diaz Nocera, A.
   Salvatierra, N. A.
   Cid, M. P.
BE Braidot, A
   Hadad, A
TI Printing Collagen 3D Structures
SO VI LATIN AMERICAN CONGRESS ON BIOMEDICAL ENGINEERING (CLAIB 2014)
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 6th Latin American Biomedical Engineering Conference (CLAIB)
CY OCT 29-31, 2014
CL Parana, ARGENTINA
SP Reg Council Biomed Engn Latin America, Argentine Soc Bioengineering, Nacl Univ Entre Rios, Engn Sch, Int Federat Med & Biol Engn, IEEE Engn Med & Biol Soc
DE Biomaterial; Bioprinting; Collagen; Tissue Engineering
ID TISSUE ENGINEERING APPLICATIONS
AB Collagen is a biomaterial with an excellent biocompatibility due to its biodegradability and weak antigenicity. Its main applications in tissue engineering field are in burns -to accelerate wound healing-and drug delivery. Collagen gels and solutions are widely used for building scaffolds or three-dimensional cultures, some of them constructed by three-dimensional bioprinting. This work presents an adaptation of a protocol in order to isolate collagen from bovine tendon and also the development of a three-dimensional bioprinter. The preliminary results we preset are 3D structures constructed by the developed bioprinter, using the collagen obtained from bovine tendon, after application of the proposed protocol. These results are promising as they show the capability of the presented protocol to obtain collagen from bovine tendon and the potential of the bioprinting technique for building biocompatible three-dimensional structures designed by Computer Aided Design (CAD) or replicating anatomical structures from standard medical imagining studies. Further studies are needed in order to assess the mechanical and biochemical properties of the printed structures.
C1 [Diaz Nocera, A.; Salvatierra, N. A.; Cid, M. P.] UNC, FCEFyN, Dept Quim, IIBYT,CONICET, Cordoba, Argentina.
RP Nocera, AD (reprint author), UNC, FCEFyN, Dept Quim, IIBYT,CONICET, Cordoba, Argentina.
EM amdiaz@efn.uncor.edu; nsalvatierra@efn.uncor.edu; manacid@hotmail.com
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Lee V, 2014, TISSUE ENG, V21
   Lodish H., 2000, MOL CELL BIOL, P154
   Mironov V., 2003, TRENDS BIOTECHNOLOGY, V21
   Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863
   Rajan N, 2006, NAT PROTOC, V1, P2753, DOI 10.1038/nprot.2006.430
   Ricard-Blum S, 2011, COLLAGEN FAMILY
   Simoes GS, 2014, MEAT SCI, V96, P1460, DOI 10.1016/j.meatsci.2013.10.038
NR 8
TC 1
Z9 1
U1 1
U2 18
PU SPRINGER INT PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 1680-0737
BN 978-3-319-13116-0; 978-3-319-13117-7
J9 IFMBE PROC
PY 2014
VL 49
BP 136
EP 139
DI 10.1007/978-3-319-13117-7_36
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA BD8BN
UT WOS:000363767200035
DA 2018-10-19
ER

PT S
AU Guha, S
   Jamal, FI
   Schmalz, K
   Wenger, C
   Meliani, E
AF Guha, S.
   Jamal, F. I.
   Schmalz, K.
   Wenger, Ch.
   Meliani, E.
GP IEEE
TI An 8 GHz CMOS Near Field Bio-sensor Array for Imaging Spatial
   Permittivity Distribution of Biomaterials
SO 2014 IEEE MTT-S INTERNATIONAL MICROWAVE SYMPOSIUM (IMS)
SE IEEE MTT-S International Microwave Symposium
LA English
DT Proceedings Paper
CT IEEE MTT-S International Microwave Symposium (IMS)
CY JUN 01-06, 2014
CL Tampa, FL
SP IEEE MTT S
DE Dielectric permittivity; sensor array; imaging; biosensor; biomaterial
AB In this paper a CMOS biosensor array operating around 8 GHz is presented, for characterizing biomaterials by imaging the spatial distribution of permittivity. The sensor is fabricated in standard 250 nm SiGe BiCMOS process. The sensor operation is based on the frequency shift of cross-coupled oscillator circuit due to capacitance change of the core LC tank. Non-uniform four finger interdigitated capacitor is used as the sensor unit. A four element sensor array system is used in this work for the proof of concept of spatial dielectric imaging. Measured sensitivity is observed to be 22 MHz per unit permittivity change. After first sensitivity tests, the spatial discrimination capability of the array is shown by further testing the array with biomaterials of different permittivity on different sensor units, showing unique frequency shift for individual sensors.
C1 [Guha, S.; Jamal, F. I.; Schmalz, K.; Wenger, Ch.; Meliani, E.] IHP, D-15236 Frankfurt, Oder, Germany.
RP Guha, S (reprint author), IHP, Technol Pk 25, D-15236 Frankfurt, Oder, Germany.
EM guha@ihp-microelectronics.com
CR Asami K, 2002, J NON-CRYST SOLIDS, V305, P268, DOI 10.1016/S0022-3093(02)01110-9
   Chen JZ, 2004, LAB CHIP, V4, P473, DOI 10.1039/b315815b
   Chretiennot T, 2013, IEEE T MICROW THEORY, V61, P972, DOI 10.1109/TMTT.2012.2231877
   Goh S., 2010, P 14 INT C MIN SYST, P1556
   Guha S, 2013, EUR MICROW CONF, P471
   Harris C., 1983, BIOELECTROCHEMISTRY, V11, P14
   Krommenhoek EE, 2006, SENSOR ACTUAT B-CHEM, V115, P384, DOI 10.1016/j.snb.2005.09.028
   PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001
   Tibayrenc P., 2010, PROCESS BIOCHEM, V46, P193
NR 9
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0149-645X
BN 978-1-4799-3869-8
J9 IEEE MTT S INT MICR
PY 2014
PG 4
WC Engineering, Electrical & Electronic; Physics, Applied
SC Engineering; Physics
GA BD7MH
UT WOS:000363283700219
DA 2018-10-19
ER

PT B
AU Biscaia, SI
   Viana, TF
   Almeida, HA
   Bartolo, P
AF Biscaia, S. I.
   Viana, T. F.
   Almeida, H. A.
   Bartolo, P.
BE Jorge, RMN
   Campos, JCR
   Vaz, MAP
   Santos, SM
   Tavares, JMRS
TI Reinforced PCL scaffolds with Eggshell powder
SO BIODENTAL ENGINEERING III
LA English
DT Proceedings Paper
CT 3rd International Conference on Biodental Engineering (BIODENTAL)
CY JUN 22-23, 2014
CL Porto, PORTUGAL
ID COMPOSITES; DEGRADATION; CARBONATE; DEFECTS
AB Hen eggshells (ES), a natural biomaterial from bone-like minerals, has been considered a promising bone substitute to be totally resorbable and biocompatible with good osteoconductivity. The ES represents 11% of the total weight of the egg and it is mainly composed of calcium carbonate (94%), magnesium carbonate (1%), tricalcium phosphate (1%), and organic matter (4%).
   The purpose of this study was to investigate the addition of ES powder on poly(epsilon-caprolactone) (PCL) scaffolds. Morphological and physical analyses were performed to investigate the influence of the ES powder on the properties of the PCL scaffolds.
C1 [Biscaia, S. I.; Viana, T. F.; Almeida, H. A.; Bartolo, P.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
   [Bartolo, P.] Univ Manchester, Sch Mech Civil & Aerosp Engn, Manchester M13 9PL, Lancs, England.
RP Biscaia, SI (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Leiria, Portugal.
RI Almeida, Henrique/D-6275-2012
OI Almeida, Henrique/0000-0002-1367-2290
CR Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017
   Asghar W, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/47/475601
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Chen EC, 2007, POLYM DEGRAD STABIL, V92, P1009, DOI 10.1016/j.polymdegradstab.2007.02.019
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Chuenjitkuntaworn B., 2010, J BIOMEDICAL MAT R A, P242
   Domingos M, 2011, VIRTUAL PHYS PROTOTY, V6, P157, DOI 10.1080/17452759.2011.605839
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Esfahani S., 2010, BIOMATERIALS, V31, P5498
   Gao Y, 2012, CATAL TODAY, V190, P107, DOI 10.1016/j.cattod.2011.12.004
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Kang J, 2012, J APPL POLYM SCI, V124, pE83, DOI 10.1002/app.35538
   Kim BS, 2014, J BIOMED MATER RES B, V102, P943, DOI 10.1002/jbm.b.33075
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Liu JY, 2011, EXPRESS POLYM LETT, V5, P742, DOI 10.3144/expresspolymlett.2011.72
   Martinez-Abad A, 2013, FOOD CONTROL, V34, P214, DOI 10.1016/j.foodcont.2013.04.025
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Monteiro MSSB, 2013, POLYM TEST, V32, P553, DOI 10.1016/j.polymertesting.2013.01.016
   Mota C, 2015, J TISSUE ENG REGEN M, V9, P174, DOI 10.1002/term.1635
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Santos RC, 2014, HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID PROTOTYPING, P127
   Sariibrahimoglu K, 2012, J BIOMED MATER RES A, V100A, P712, DOI 10.1002/jbm.a.34009
   Sousa I, 2013, PROCEDIA ENGINEER, V59, P279, DOI 10.1016/j.proeng.2013.05.122
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
NR 25
TC 1
Z9 1
U1 1
U2 1
PU CRC PRESS-TAYLOR & FRANCIS GROUP
PI BOCA RATON
PA 6000 BROKEN SOUND PARKWAY NW, STE 300, BOCA RATON, FL 33487-2742 USA
BN 978-1-315-75178-8; 978-1-138-02671-1
PY 2014
BP 151
EP 154
PG 4
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA BD5UK
UT WOS:000361826500027
DA 2018-10-19
ER

PT B
AU Viana, T
   Biscaia, S
   Almeida, HA
   Bartolo, PJ
AF Viana, Tania
   Biscaia, Sara
   Almeida, Henrique A.
   Bartolo, Paulo J.
GP ASME
TI PCL/EGGSHELL SCAFFOLDS FOR BONE REGENERATION
SO PROCEEDINGS OF THE ASME 12TH BIENNIAL CONFERENCE ON ENGINEERING SYSTEMS
   DESIGN AND ANALYSIS - 2014, VOL 1
LA English
DT Proceedings Paper
CT 12th ASME Biennial Conference on Engineering Systems Design and Analysis
   (ESDA2014)
CY JUN 25-27, 2014
CL Copenhagen, DENMARK
SP ASME
ID TISSUE ENGINEERING SCAFFOLDS; CALCIUM-PHOSPHATE CEMENTS; EGGSHELL
   MEMBRANE; CRANIAL DEFECTS; WASTE EGGSHELL; COMPOSITE; CARBONATE;
   CATALYST; BEHAVIOR; POWDER
AB Eggshell (ES) is one of the most common biomaterials in nature. For instance, the ES represents 11% of the total weight of a hen's egg and it is composed of calcium carbonate, magnesium carbonate, tricalcium phosphate and organic matter. Hen ES are also a major waste product of the food industry worldwide. Recently, ES have been used for many applications such as coating pigments for inkjet printing paper, catalyst for biodiesel synthesis, bio-fillers for polymer composites and matrix lipase immobilization. It is also considered a natural biomaterial with high potential for the synthesis of calcium enriched implants that may be applied in tissue engineering applications, such as bone regeneration. The aim of this research regards the production of poly(epsilon-caprolactone) (PCL) scaffolds enriched with hen ES powder for bone regeneration applications, using an extrusion-based process called Dual-Bioextruder. The main objective is to investigate the influence of the addition of ES powder on the PCL matrix. For this purpose the structures were characterised regarding morphological and chemical properties. Morphological images of the PCL scaffolds enriched with hen ES, demonstrated the interconnectivity of the pores within the scaffold and revealed that the addition of the ES powder combined with the screw rotation velocity has a large influence on the resulting filament diameter and consequently on the porosity of the scaffolds.
C1 [Viana, Tania; Biscaia, Sara; Almeida, Henrique A.] Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Marinha Grande, Portugal.
   [Bartolo, Paulo J.] Polytech Inst Leiria, Marinha Grande, Portugal.
   [Bartolo, Paulo J.] Univ Manchester, Manchester M13 9PL, Lancs, England.
RP Viana, T (reprint author), Polytech Inst Leiria, Ctr Rapid & Sustainable Prod Dev, Marinha Grande, Portugal.
RI Almeida, Henrique/D-6275-2012
OI Almeida, Henrique/0000-0002-1367-2290
CR Abdal-hay A, 2013, SOLID STATE SCI, V18, P131, DOI 10.1016/j.solidstatesciences.2012.11.017
   Annabi N, 2011, J SUPERCRIT FLUID, V59, P157, DOI 10.1016/j.supflu.2011.06.010
   Arifin A, 2014, MATER DESIGN, V55, P165, DOI 10.1016/j.matdes.2013.09.045
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Asghar W., 2012, NANOTECHNOLOGY, V23, P475
   Balaz P, 2013, MATER MANUF PROCESS, V28, P343, DOI 10.1080/10426914.2012.709294
   Bartolo PJ, 2009, VIRTUAL PHYS PROTOTY, V4, P203, DOI 10.1080/17452750903476288
   Bartolo P, 2012, CIRP ANN-MANUF TECHN, V61, P635, DOI 10.1016/j.cirp.2012.05.005
   Bootklad M, 2013, CARBOHYD POLYM, V97, P315, DOI 10.1016/j.carbpol.2013.05.030
   Boschett F, 2008, INT J ARTIF ORGANS, V31, P697
   Cai X, 2013, MATER TODAY, V16, P67, DOI 10.1016/j.mattod.2013.03.007
   Chattopadhyay S, 2012, PROCESS BIOCHEM, V47, P749, DOI 10.1016/j.procbio.2012.02.003
   Chen WC, 2013, BIOMATERIALS, V34, P9917, DOI 10.1016/j.biomaterials.2013.09.002
   Chouzouri G, 2007, ACTA BIOMATER, V3, P745, DOI 10.1016/j.actbio.2007.01.005
   Chuenjitkuntaworn B., 2010, J BIOMEDICAL MAT R A, P242
   Ding CM, 2013, BIOMATERIALS, V34, P6706, DOI 10.1016/j.biomaterials.2013.05.038
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   Elzubair A, 2006, J DENT, V34, P784, DOI 10.1016/j.jdent.2006.03.002
   Engel Y, 2012, MATER TODAY, V15, P478, DOI 10.1016/S1369-7021(12)70217-1
   Ferreira AM, 2012, ACTA BIOMATER, V8, P3191, DOI 10.1016/j.actbio.2012.06.014
   Gao Y, 2012, CATAL TODAY, V190, P107, DOI 10.1016/j.cattod.2011.12.004
   Ghasemi-Mobarakeh L, 2010, MAT SCI ENG C-MATER, V30, P1129, DOI 10.1016/j.msec.2010.06.004
   Han LH, 2013, BIOMATERIALS, V34, P4251, DOI 10.1016/j.biomaterials.2013.02.051
   Hassan S.B., 2013, J KING SAUD U ENG SC
   Ho WF, 2013, CERAM INT, V39, P6467, DOI 10.1016/j.ceramint.2013.01.076
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Holzwarth JM, 2011, J MATER CHEM, V21, P10243, DOI 10.1039/c1jm10522a
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jancar J., 1999, ADV POLYM SCI
   Kang J, 2012, J APPL POLYM SCI, V124, pE83, DOI 10.1002/app.35538
   Khan AF, 2014, MAT SCI ENG C-MATER, V35, P245, DOI 10.1016/j.msec.2013.11.013
   Kim BS, 2014, J BIOMED MATER RES B, V102, P943, DOI 10.1002/jbm.b.33075
   Kim TG, 2012, ADV FUNCT MATER, V22, P2446, DOI 10.1002/adfm.201103083
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   Liang JZ, 2012, POLYM TEST, V31, P149, DOI 10.1016/j.polymertesting.2011.10.006
   Lu HX, 2011, BIOMATERIALS, V32, P2489, DOI 10.1016/j.biomaterials.2010.12.016
   Martinez-Abad A, 2013, FOOD CONTROL, V34, P214, DOI 10.1016/j.foodcont.2013.04.025
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Mosaddegh E, 2013, ULTRASON SONOCHEM, V20, P1436, DOI 10.1016/j.ultsonch.2013.04.008
   Moura C.S., 2013, HIGH VALUE MANUFACTU, P195
   Ni P, 2014, BIOMATERIALS, V35, P236, DOI 10.1016/j.biomaterials.2013.10.016
   Novitskaya E, 2011, ACTA BIOMATER, V7, P3170, DOI 10.1016/j.actbio.2011.04.025
   Okamoto M, 2013, PROG POLYM SCI, V38, P1487, DOI 10.1016/j.progpolymsci.2013.06.001
   Pascu EI, 2013, MAT SCI ENG C-MATER, V33, P4905, DOI 10.1016/j.msec.2013.08.012
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Santos ARC, 2013, VIRTUAL PHYS PROTOTY, V8, P175, DOI 10.1080/17452759.2013.838825
   Sanzana ES, 2008, ACTA BIOMATER, V4, P1924, DOI 10.1016/j.actbio.2008.04.023
   Sariibrahimoglu K, 2012, J BIOMED MATER RES A, V100A, P712, DOI 10.1002/jbm.a.34009
   Soares MAR, 2013, BIORESOURCE TECHNOL, V148, P293, DOI 10.1016/j.biortech.2013.08.151
   Song MJ, 2013, BIOMATERIALS, V34, P5766, DOI 10.1016/j.biomaterials.2013.04.023
   Tojeira A., 2013, HIGH VALUE MANUFACTU, P221
   Tsai WT, 2006, BIORESOURCE TECHNOL, V97, P488, DOI 10.1016/j.biortech.2005.02.050
   Wang XF, 2013, MATER TODAY, V16, P229, DOI 10.1016/j.mattod.2013.06.005
   Wei ZK, 2009, BIORESOURCE TECHNOL, V100, P2883, DOI 10.1016/j.biortech.2008.12.039
   Wu SC, 2013, CERAM INT, V39, P8183, DOI 10.1016/j.ceramint.2013.03.094
   Yew MC, 2013, PROG ORG COAT, V76, P1549, DOI 10.1016/j.porgcoat.2013.06.011
   Yoo S, 2009, BIORESOURCE TECHNOL, V100, P6416, DOI 10.1016/j.biortech.2009.06.112
NR 57
TC 0
Z9 0
U1 1
U2 6
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4583-7
PY 2014
AR V001T03A003
PG 6
WC Engineering, Mechanical
SC Engineering
GA BD5GK
UT WOS:000361402800037
DA 2018-10-19
ER

PT B
AU Brooks, VS
   Guo, YB
AF Brooks, V. S.
   Guo, Y. B.
GP ASME
TI MICROSTRUCTURAL AND DYNAMIC MECHANICAL CHARACTERIZATION OF BIODEGRADABLE
   MAGNESIUM-CALCIUM ALLOY FOR ORTHOPEDIC IMPLANTS
SO PROCEEDINGS OF THE ASME 9TH INTERNATIONAL MANUFACTURING SCIENCE AND
   ENGINEERING CONFERENCE, 2014, VOL 2
LA English
DT Proceedings Paper
CT 9th ASME International Manufacturing Science and Engineering Conference
   (MSEC2014)
CY JUN 09-13, 2014
CL Univ Michigan, Detroit, MI
SP ASME, Mfg Engn Div
HO Univ Michigan
DE Mechanical behavior; Biomaterial; Magnesium-calcium alloy; Biodegradable
   implant
AB Magnesium-Calcium (Mg-Ca) alloy is an emerging metallic biomaterial for manufacturing biodegradable orthopedic implants. However, very few studies have been conducted on mechanical properties of the bi-phase Mg-Ca alloy, especially at the high strain rates often encountered in manufacturing processes. The mechanical properties are critical to design and manufacturing of Mg-Ca implants. The objective of this study is to study the microstructural and mechanical properties of Mg-Ca0.8 (wt %) alloy. Both elastic and plastic behaviors of the Mg-Ca0.8 alloy were characterized at different strains and strain rates in quasi-static tension and compression testing as well as dynamic split-Hopkinson pressure bar (SHPB) testing. It has been shown that Young's modulus of Mg-Ca0.8 alloy in quasi-static compression is much higher than those at high strain rates. Yield strength and ultimate strength of the material are very sensitive to strain rates and increase with strain rate in compression. Strain softening also occurs at large strains in dynamic compression. Furthermore, quasi-static mechanical behavior of the material in tension is very different from that in compression. The stress-strain data was repeatable with reasonable accuracy in both deformation modes. In addition, a set of material constants for the internal state variable plasticity model has been obtained to model the dynamical mechanical behavior of the novel metallic biomaterial.
C1 [Brooks, V. S.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Aksakal B, 2008, J MATER SCI-MATER M, V19, P2097, DOI 10.1007/s10856-007-3304-2
   Avedesian M. M., 1999, MAGNESIUM MAGNESIUM
   Bammann DJ, 1996, J THEOR APPL MECH, V19, P359
   Cao GP, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2823086
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2005, P 5 EUSP INT C MONTP
   eFunda Inc, 2008, PROP TYP MAGN ALL
   El-Magd E., 2000, MAGNESIUM ALLOYS THE, P324
   Emley E. F., 1966, PRINCIPLES MAGNESIUM
   Gama B, 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626
   GRIMM MJ, 2009, BIOMEDICAL ENG DESIG, P421
   Guden M, 2005, MATER CHARACT, V54, P399, DOI 10.1016/j.matchar.2005.01.006
   Guo Y.B., 2010, ANN CIRP, V59, P151
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Guo YB, 2003, J MATER PROCESS TECH, V142, P72, DOI 10.1016/S0924-0136(03)00462-X
   Hassel T, 2007, P 7 INT C MG ALL THE, P789
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wessen M., 2004, P 6 INT C MG ALL THE, P501
   Wuth M., 2000, MG ALLOYS THEIR APP, P296
NR 20
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4581-3
PY 2014
AR V002T02A029
PG 7
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA BD5AD
UT WOS:000361249800029
DA 2018-10-19
ER

PT B
AU Smetana, M
   Capova, K
   Strapacova, T
AF Smetana, Milan
   Capova, Klara
   Strapacova, Tatiana
BE Brida, P
   Dubovan, J
   Markovic, M
TI Evaluation of Biomaterial Stress-Corrosion Cracks by Magnetic Sensors
SO 2014 ELEKTRO
LA English
DT Proceedings Paper
CT ELEKTRO 10th International Conference
CY MAY 19-20, 2014
CL Rajecke Teplice, SLOVAKIA
SP Univ Zilina, Fac Elect Engn, AZD Praha s r o Praha CZ, LiV EPI s r o Bratislava SK, SOITRON s r o Bratislava SK, Freescale Polovodice Ceska Republika s r o Roznov Radhostem CZ, Eltodo a s Praha CZ, Scheidt & Bachmann Slovensko s r o Zilina SK, ELMAX ZILINA a s Zilina SK, Panason Ind Devices Slovakia s r o Trstena SK, HUMUSOFT s r o Praha CZ, JONSON CONTROLS Lucenec s r o Odstepny Zavod Namestovo SK, IEEE, Czechoslovakia Sect, Univ Zilina, Communicat Sci Letters, Adv Elect & Elect Engn
DE non-destructive evaluation; inductance sensor; flluxgate magnetometer;
   giant-magneto-resistive sensor; biomaterial cracks
AB The paper deals with identification of real biomaterial's cracks using electromagnetic non-destructive sensing. Advanced types of the magnetic sensors are used for this purpose. New modular eddy current probe is used for the evaluation. Harmonic excitation is used for the eddy currents induction. The real biomaterial stress corrosion cracks are inspected. Gained results are discussed and presented in the paper. The main aim of the article is to compare the sensitivity of the various magnetic sensors at the same conditions.
C1 [Smetana, Milan; Capova, Klara; Strapacova, Tatiana] Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina 01026, Slovakia.
RP Smetana, M (reprint author), Univ Zilina, Fac Elect Engn, Dept Electromagnet & Biomed Engn, Zilina 01026, Slovakia.
EM milan.smetana@fel.uniza.sk; klara.capova@fel.uniza.sk;
   tatiana.strapacova@fel.uniza.sk
CR Betta G, 2012, IEEE T INSTRUM MEAS, V61, P505, DOI 10.1109/TIM.2011.2161923
   Janousek Ladislav, 2013, Przeglad Elektrotechniczny, V89, P256
   Janousek L., 2012, 2012 Proceedings of the 9th Conference of ELEKTRO (ELEKTRO 2012), P419, DOI 10.1109/ELEKTRO.2012.6225656
   Pernisova V., INT WORKSH EL NOND E
   Reig C., MAGNETIC FIELD SENSO, p7920 
   Ripka P, 2003, SENSOR ACTUAT A-PHYS, V106, P8, DOI 10.1016/S0924-4247(03)00094-3
NR 6
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-3721-9
PY 2014
BP 621
EP 624
PG 4
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic
SC Computer Science; Engineering
GA BD4RM
UT WOS:000361020800124
DA 2018-10-19
ER

PT S
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
BE Axinte, D
   Clare, A
   Kinnell, P
TI Biodegradation control of magnesium-calcium biomaterial via adjusting
   surface integrity by synergistic cutting-burnishing
SO 2ND CIRP CONFERENCE ON SURFACE INTEGRITY (CSI)
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 2nd CIRP Conference on Surface Integrity (CSI)
CY MAY 28-30, 2014
CL Nottingham, ENGLAND
SP CIRP
DE Magnesium; surface integrity; corrosion; implants
ID MECHANICAL-PROPERTIES; RABBIT MODEL; DEGRADATION; ALLOYS; IMPLANTS;
   MGCA0.8
AB Magnesium-calcium (MgCa) alloys are very promising orthopedic biomaterials with biodegradability and suitable biomechanical properties. However, the high corrosion rate of Mg-based alloys in human body environment remains as a big challenge for their successful development as biomaterials. In this study, synergistic cutting-burnishing was developed to control the degradation rate of the novel MgCa0.8 (wt. %) biomaterial by adjusting surface integrity. In-vitro immersion tests were performed in simulated body fluid to measure degradation kinetics of the processed samples. Morphology and elemental composition of the corroded surface layers were also studied. The synergistic process was successful to control biodegradation rate. This enabling process may manufacture biodegradable MgCa0.8 implants with tailored degradation rate to fit various orthopedic applications. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Drynda A, 2010, J BIOMED MATER RES A, V93A, P763, DOI 10.1002/jbm.a.32582
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2012, CIRP ANN-MANUF TECHN, V61, P583, DOI 10.1016/j.cirp.2012.03.125
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kirkland N.T., 2010, J BIOMEDICAL MAT R B, V95, P9
   Krause A, 2010, J MATER SCI, V45, P624, DOI 10.1007/s10853-009-3936-3
   Thomann M, 2009, MATERIALWISS WERKST, V40, P82, DOI 10.1002/mawe.200800412
   Thomann M, 2010, J BIOMED MATER RES A, V93A, P1609, DOI 10.1002/jbm.a.32639
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
NR 11
TC 10
Z9 10
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2014
VL 13
BP 143
EP 149
DI 10.1016/j.procir.2014.04.025
PG 7
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA BD4GS
UT WOS:000360720300025
OA Other Gold
DA 2018-10-19
ER

PT B
AU Munro, T
   Xing, CH
   Ban, H
   Copeland, C
   Lewis, R
AF Munro, Troy
   Xing, Changhu
   Ban, Heng
   Copeland, Cameron
   Lewis, Randolph
GP ASME
TI PROBING THE MYSTERIES OF SPIDER SILK'S UNCHARACTERISTICALLY HIGH THERMAL
   DIFFUSIVITY
SO PROCEEDINGS OF THE ASME SUMMER HEAT TRANSFER CONFERENCE - 2013, VOL 1
LA English
DT Proceedings Paper
CT ASME Summer Heat Transfer Conference (SHTC)
CY JUL 14-19, 2013
CL Univ Minnesota, Minneapolis, MN
SP ASME, Heat Transfer Div
HO Univ Minnesota
AB Spider silks exhibit excellent strength, stiffness, and toughness simultaneously, a feat unachievable in most synthetic, structural materials. It has recently been reported that the thermal conductivity of dragline silk is comparable to copper, which is uncharacteristically high for a biomaterial. In order to develop a fundamental understanding of the high thermal properties of spider silk, further research must be made to explore how the structure and organization of spider silk proteins affects heat transfer characteristics. Synthetically produced silks created from spider silk proteins obtained from transgenic sources can be used to determine these protein structure effects by varying protein content and process treatments. This initial study determined the thermal properties of synthetic spider silk created from transgenic goat's milk proteins using the transient electrothermal method (TET). Results show that the thermal properties of the synthetic silk are lower than the natural spider silk but vary based on the process treatment, and that the annealing of the gold film coated on the fiber has no effect on the measured thermal properties. These results provide a framework for further research on the protein content effect and its role in thermal properties.
C1 [Munro, Troy; Xing, Changhu; Ban, Heng] Utah State Univ, Mech & Aerosp Engn, Logan, UT 84322 USA.
   [Copeland, Cameron; Lewis, Randolph] Utah State Univ, Biol Engn, Biol, Logan, UT 84322 USA.
RP Munro, T (reprint author), Utah State Univ, Mech & Aerosp Engn, Logan, UT 84322 USA.
CR CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Feng B, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3153464
   Feng X, 2011, ACTA MATER, V59, P1934, DOI 10.1016/j.actamat.2010.11.059
   Feng X., 2012, REV SCI INSTRUM, V83
   Guo J., 2007, J APPL PHYS, V101
   Guo JQ, 2007, APPL PHYS A-MATER, V89, P153, DOI 10.1007/s00339-007-4201-8
   Guo L., 2009, J APPL PHYS, V106
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Huang WW, 2012, J THERM ANAL CALORIM, V109, P1193, DOI 10.1007/s10973-012-2283-9
   Huang XP, 2012, ADV MATER, V24, P1482, DOI 10.1002/adma.201104668
   Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Rengasamy RS, 2005, AUTEX RES J, V5, P30
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Wissmann P., 2007, ELECT RESISTIVITY TH, P36
NR 15
TC 0
Z9 0
U1 1
U2 4
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5547-8
PY 2014
AR V001T02A005
PG 6
WC Thermodynamics; Engineering, Mechanical
SC Thermodynamics; Engineering
GA BD4AR
UT WOS:000360414400052
DA 2018-10-19
ER

PT S
AU Winnett, J
   Mallick, KK
AF Winnett, James
   Mallick, Kajal K.
BE Bose, S
   Bandyopadhyay, A
   Narayan, R
TI COMPARATIVE ANALYSIS OF HYDROXYAPATITE AND TITANIUM-BASED BIOSCAFFOLDS
   FABRICATED VIA ADAPTIVE FOAM RETICULATION
SO BIOMATERIALS SCIENCE: PROCESSING, PROPERTIES AND APPLICATIONS IV
SE Ceramic Transactions
LA English
DT Proceedings Paper
CT Materials Science and Technology Conference and Exhibition (MS&T)
CY OCT 27-31, 2013
CL Montreal, CANADA
ID BONE TISSUE REGENERATION; MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS;
   SCAFFOLDS; CERAMICS; MICROSTRUCTURE; BIOMATERIALS; CHEMISTRY; POROSITY
AB Hydroxyapatite, titanium (CP-Ti) and its alloys, in particular titanium-vanadium-aluminium (Ti-6Al-4V), are used as biomaterials due to their structural similarities to native bone, good biocompatibility and inertness in-vivo. It is important to generate porous structures to match the mechanical properties of scaffolds to host tissue and enhance biological activity. Adaptive Foam Reticulation (AFR) has been used to generate such bioscaffolds with enhanced cell behaviour due the generation of macroporous structures with microporous struts that provide routes for cell infiltration as well as attachment sites. For all biomaterials, polyurethane templates of 2 pore sizes (45 and 90 ppi) were coated in water-based biomaterial-slurries containing varying amounts of camphene as a porogen. The resultant macropore sizes related well to the initial template pore size, whilst the camphene produced micropores ranging from 1-10 mu m.
C1 [Winnett, James; Mallick, Kajal K.] Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
RP Winnett, J (reprint author), Univ Warwick, WMG, Coventry CV4 7AL, W Midlands, England.
CR Arcos D, 2010, ACTA BIOMATER, V6, P2874, DOI 10.1016/j.actbio.2010.02.012
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cachinho SCP, 2008, J MATER SCI-MATER M, V19, P451, DOI 10.1007/s10856-006-0052-7
   Chen B, 2008, CERAM INT, V34, P359, DOI 10.1016/j.ceramint.2006.10.021
   Chu P. K., 2008, BIOMATERIALS FABRICA
   Cunningham E., 2011, J TISSUE SCI ENG, VS1, P1, DOI DOI 10.4172/2157-7552.S1-001.
   Dabrowski B, 2010, J BIOMED MATER RES B, V95B, P53, DOI 10.1002/jbm.b.31682
   Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024
   DION I, 1994, J MATER SCI-MATER M, V5, P18, DOI 10.1007/BF00121148
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jo IH, 2009, MATER LETT, V63, P1702, DOI 10.1016/j.matlet.2009.05.017
   Jones JR, 2009, J MATER SCI-MATER M, V20, P463, DOI 10.1007/s10856-008-3597-9
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Langer R, 2009, ADV MATER, V21, P3235, DOI 10.1002/adma.200902589
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Ma P.X., 2005, SCAFFOLDING TISSUE E
   Mahendra A, 2007, INJURY, V38, pS7, DOI 10.1016/S0020-1383(08)70004-4
   Mallick KK, 2012, J BIOMED MATER RES A, V100A, P2948, DOI 10.1002/jbm.a.34238
   Mallick KK, 2009, J AM CERAM SOC, V92, pS85, DOI 10.1111/j.1551-2916.2008.02784.x
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Mikos AG, 2000, ELECTRON J BIOTECHN, V3, P1995
   Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587
   Nan BY, 2011, J AM CERAM SOC, V94, P969, DOI 10.1111/j.1551-2916.2010.04257.x
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   SACHS E, 1992, J ENG IND-T ASME, V114, P481
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Salinas AJ, 2007, Z ANORG ALLG CHEM, V633, P1762, DOI 10.1002/zaac.200700278
   Soon YM, 2011, J EUR CERAM SOC, V31, P415, DOI 10.1016/j.jeurceramsoc.2010.09.019
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yang J, 2011, J EUR CERAM SOC, V31, P2569, DOI 10.1016/j.jeurceramsoc.2010.12.035
NR 35
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1042-1122
BN 978-1-118-99523-5; 978-1-118-99520-4
J9 CERAM TRANS
PY 2014
VL 251
BP 73
EP 84
PG 12
WC Materials Science, Ceramics
SC Materials Science
GA BD3WO
UT WOS:000360244700008
DA 2018-10-19
ER

PT B
AU Gilchrist, CL
   Ruch, DS
   Little, D
   Guilak, F
AF Gilchrist, Christopher L.
   Ruch, David S.
   Little, Dianne
   Guilak, Farshid
GP ASME
TI NANO-SCALE AND MICRO-SCALE SUBSTRATE ARCHITECTURES DIRECT COLLAGEN
   ALIGNMENT IN TENDON NEO-TISSUE FORMATION
SO PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2013, PT B
LA English
DT Proceedings Paper
CT 15th American-Society-Mechanical-Engineering Summer Bioengineering
   Conference (SBC2013)
CY JUN 26-29, 2013
CL Sunriver, OR
SP Amer Soc Mech Engn, Bioengineer Div
AB Biomaterial scaffolds that present defined microenvironmental cues (e.g., nano-topography) to cells have shown promise for a variety of tissue engineering applications. However, the specific cues best suited for promoting the formation of aligned, fibrous tissues such as tendon are not fully understood. In this study, we utilize a microphotopatterning (mu PP) model system to precisely arrange scaffold-mimicking microenvironmental cues and investigate their role in the formation of tendon-like neo-tissues. Our data show that scaffold architectural features at both nano- and micro- length scales may be important parameters for directing tendon-like cell organization and the formation of aligned, fibrillar collagen.
C1 [Gilchrist, Christopher L.] Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
RP Gilchrist, CL (reprint author), Duke Univ, Med Ctr, Dept Orthopaed Surg, Durham, NC 27710 USA.
CR Baker, 2007, BIOMATERIALS, V28, P1967
   Barber JG, 2011, TISSUE ENG A
   Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041
   Garrigues NW, 2010, J MATER CHEM, V20, P8962, DOI 10.1039/c0jm01880e
   Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
NR 7
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-5561-4
PY 2014
AR V01BT39A005
PG 2
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA BD2YI
UT WOS:000359389300100
DA 2018-10-19
ER

PT J
AU Pauksch, L
   Franke, J
   Schnettler, R
   Lips, KS
AF Pauksch, Linda
   Franke, Joerg
   Schnettler, Reinhard
   Lips, Katrin S.
TI Synergistic Toxicity of Gentamicin- and Nanosilver-Doped
   Polymethylmethacrylate Bone Cement on Primary Human Osteoclasts
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Cell differentiation; Gentamicin; Osteoclasts; Polymethylmethacrylate;
   Silver nanoparticles; Titanium alloy
ID ENDOPLASMIC-RETICULUM STRESS; SILVER NANOPARTICLES;
   PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; JOINT ARTHROPLASTY;
   OXIDATIVE STRESS; INFECTION; ANTIBACTERIAL; CYTOTOXICITY; CELLS
AB Bacterial colonization of implant surfaces is a feared complication in surgery and orthopedics. Due to the increasing number of periprosthetic infections caused by multidrugresistant microorganisms, new antibacterial coatings for biomaterials must be developed. The excellent antibacterial properties of silver nanoparticles (AgNPs) against multidrugresistant bacteria, for example, have been repeatedly described. For this reason, we tested a nanosilver-doped polymethylmethacrylate (PMMA) bone cement and a nanosilver-coated titanium alloy regarding their influence on osteoclastogenesis of primary human peripheral blood mononuclear cells. Both implant variants did not inhibit osteoclast differentiation. Excellent cell attachment and unaltered podosomal structures were confirmed. Additionally, no induction of oxidative or endoplasmic reticulum stress could be observed. However, PMMA loaded with gentamicin and nanosilver inhibited preosteoclast fusion and further osteoclastogenesis. The material also led to decreased clathrin-dependent endocytosis as well as decreased levels of endoplasmic reticulum stress. Therefore, biomaterial functionalization with AgNPs did not disturb osteoclastogenesis, while addition of gentamicin reduced the cytocompatibility of nanosilver-doped materials towards human osteoclasts. (C) 2015 S. Karger AG, Basel
C1 [Pauksch, Linda; Schnettler, Reinhard; Lips, Katrin S.] Univ Giessen, Lab Expt Trauma Surg, D-35392 Giessen, Germany.
   [Schnettler, Reinhard] Univ Hosp Giessen & Marburg, Dept Trauma Surg, Giessen, Germany.
   [Franke, Joerg] Elbe Hosp Stade, Clin Trauma Surg & Orthoped, Stade, Germany.
RP Lips, KS (reprint author), Univ Giessen, Lab Expt Trauma Surg, Schubertstr 81, D-35392 Giessen, Germany.
EM Katrin.S.Lips@chiru.med.uni-giessen.de
OI Franke, Joerg/0000-0002-0724-1785
FU Federal Ministry of Education and Research [03X0103D]
FX The authors would like to thank Steffi Weghenkel and Ivonne Bergen from
   the Laboratory for Experimental Trauma Surgery, Justus Liebig University
   Giessen, Germany, for their technical assistance. Our special thanks go
   to aap Biomaterials GmbH, Dieburg, Germany, for providing the different
   PMMA and TiAl<INF>6</INF>V<INF>4</INF> samples used in this study. This
   work was financially supported by the Federal Ministry of Education and
   Research (03X0103D).
CR Albers CE, 2013, NANOTOXICOLOGY, V7, P30, DOI 10.3109/17435390.2011.626538
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Arora M, 2013, WORLD J ORTHOP, V4, P67, DOI 10.5312/wjo.v4.i2.67
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188
   Choi O, 2008, WATER RES, V42, P3066, DOI 10.1016/j.watres.2008.02.021
   Corisdeo S, 2001, BIOCHEM BIOPH RES CO, V285, P335, DOI 10.1006/bbrc.2001.5127
   Galvez-Lopez R, 2014, DIAGN MICR INFEC DIS, V78, P70, DOI 10.1016/j.diagmicrobio.2013.09.014
   Gasqueres C, 2012, SURF COAT TECH, V206, P3410, DOI 10.1016/j.surfcoat.2012.02.015
   Haase A, 2012, TOXICOL SCI, V126, P457, DOI 10.1093/toxsci/kfs003
   Jafari SM, 2010, CLIN ORTHOP RELAT R, V468, P2046, DOI 10.1007/s11999-010-1251-6
   Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008
   Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014
   Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001
   Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2
   Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001
   Kim TH, 2012, J BIOMED MATER RES A, V100A, P1033, DOI 10.1002/jbm.a.34053
   Klein C. L., 2011, JRC SCIENTIFIC AND T
   Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI 10.1186/1477-3155-8-1
   Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3
   Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x
   Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554
   Lu L, 2008, ANTIVIR THER, V13, P253
   Matar WY, 2010, J BONE JOINT SURG AM, V92A, P36, DOI 10.2106/JBJS.J.01046
   Mohanty S, 2012, NANOMED-NANOTECHNOL, V8, P916, DOI 10.1016/j.nano.2011.11.007
   Moreira DM, 2015, ANGLE ORTHOD, V85, P175, DOI 10.2319/022314-127.1
   Nagafusa T, 2007, CELL BIOL INT, V31, P1150, DOI 10.1016/j.cellbi.2007.03.032
   Narducci P, 2010, EUR J HISTOCHEM, V54, P30, DOI 10.4081/ejh.2010.e6
   Oei JD, 2012, J BIOMED MATER RES B, V100B, P409, DOI 10.1002/jbm.b.31963
   Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037
   Peyrou M, 2007, TOXICOL SCI, V99, P346, DOI 10.1093/toxsci/kfm152
   Prokopovich P, 2015, J BIOMED MATER RES B, V103, P273, DOI 10.1002/jbm.b.33196
   Quiros Y, 2011, TOXICOL SCI, V119, P245, DOI 10.1093/toxsci/kfq267
   Renaud A, 2012, CAN J SURG, V55, P394, DOI 10.1503/cjs.033610
   Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522
   Takito J, 2012, J CELL SCI, V125, P662, DOI 10.1242/jcs.090886
   Tian XH, 2013, INT J NANOMED, V8, P2129, DOI [10.2147/IJN.S47488, 10.2147/IJN.S45742]
   Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983
   Wright JB, 1998, AM J INFECT CONTROL, V26, P572, DOI 10.1053/ic.1998.v26.a93527
   Zhang BGX, 2014, INT J MOL SCI, V15, P11878, DOI 10.3390/ijms150711878
   Zhang R, 2012, INT J BIOCHEM CELL B, V44, P224, DOI 10.1016/j.biocel.2011.10.019
   Zheng YH, 2012, INT J NANOMED, V7, P875, DOI 10.2147/IJN.S28450
NR 44
TC 1
Z9 1
U1 1
U2 19
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2014
VL 199
IS 5-6
BP 384
EP 392
DI 10.1159/000371341
PG 9
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA CF5UQ
UT WOS:000352623100008
PM 25678413
DA 2018-10-19
ER

PT S
AU Mas-Ayu, H
   Izman, S
   Abdul-Kadir, MR
   Daud, R
   Shah, A
   Yusoff, MFM
   Shamsiah, MW
   Yong, TM
   Kamarul, T
AF Mas-Ayu, H.
   Izman, S.
   Abdul-Kadir, Mohammed Rafiq
   Daud, Rosdi
   Shah, A.
   Yusoff, Mohd Faiz Mohd
   Shamsiah, M. W.
   Yong, T. M.
   Kamarul, T.
BE Kurniawan, D
TI Influence of Carbon Concentrations in Reducing Co and Cr Ions Release in
   Cobalt Based Implant: A Preliminary Report
SO MATERIALS, INDUSTRIAL, AND MANUFACTURING ENGINEERING RESEARCH ADVANCES
   1.1
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 1st International Materials, Industrial, and Manufacturing Engineering
   Conference
CY DEC 04-06, 2013
CL Johor Bahru, MALAYSIA
DE Biomaterial; Thermal oxidation; Co-Cr-Mo alloy; Metal ions release;
   Tissue engineering
ID ALLOY; OXIDATION; MICROSTRUCTURE; LAYER; WEAR
AB The releases of harmful ions from cobalt based alloy to host tissues have raised significant health concerns. Carbon contents in this alloy may influence ions release but has yet investigated. It is hypothesized that carbon contents in this alloy will help the formation of oxide layer during thermal oxidation process and hence reducing the release of Co/Cr ions after implantation. In this study, Co-Cr-Mo alloy with carbon concentrations of 0.03% and 0.24% were oxidized at 1050 degrees C for 3 hours under atmospheric condition. The oxidized substrates were characterized under FESEM and subjected to circulating immersion test in simulated body fluid (SBF) for 21 days. Metal ions release was measured using inductively coupled plasma-mass spectrometry (ICP-MS) at day 0, 7, 14 and 21. Oxidized high carbon samples show denser and a more uniform oxide layer than samples with low carbon contents. It is found that compact oxide structure promotes less metal ions release during immersion.
C1 [Mas-Ayu, H.; Daud, Rosdi; Shah, A.] Univ Malaysia Pahang, Fac Mech Engn, Pekan, Malaysia.
RP Mas-Ayu, H (reprint author), Univ Malaysia Pahang, Fac Mech Engn, Pekan, Malaysia.
EM masszee@ump.edu.my; izman@mail.fkm.utm.my; rafiq@biomedical.utm.my;
   rosdidaud@ump.edu.my; ashah8@live.utm.my; faiz.mohd.yusoff@gmail.com;
   shamey82@gmail.com; yongtzemi@yahoo.co.uk; tkzrea@ummc.edu.my
RI Abdul Kadir, Mohammed/D-1117-2010; Abdullah, Arman Shah/K-7919-2012;
   Daud, Rosdi/K-2508-2016; Tunku Zainol Abidin, Tunku Kamarul
   Zaman/B-9633-2011
OI Abdullah, Arman Shah/0000-0003-0142-6487; Tunku Zainol Abidin, Tunku
   Kamarul Zaman/0000-0002-6028-1313
CR Aoh JN, 2001, WEAR, V250, P611, DOI 10.1016/S0043-1648(01)00668-8
   Blau PJ, 2009, WEAR, V267, P380, DOI 10.1016/j.wear.2008.12.082
   Buscail H, 2012, CORROS ENG SCI TECHN, V47, P404, DOI 10.1179/1743278212Y.0000000007
   Giacchi JV, 2011, MATER CHARACT, V62, P53, DOI 10.1016/j.matchar.2010.10.011
   Izman S, 2012, ADV MATER RES-SWITZ, V399-401, P1564, DOI 10.4028/www.scientific.net/AMR.399-401.1564
   Izman S, 2011, ADV MATER RES-SWITZ, V197-198, P219, DOI 10.4028/www.scientific.net/AMR.197-198.219
   Karaali A, 2005, COMP MATER SCI, V33, P37, DOI 10.1016/j.commatsci.2004.12.025
   Karaali A, 2005, MAT SCI ENG A-STRUCT, V390, P255, DOI 10.1016/j.msea.2004.08.001
   KILNER T, 1982, J BIOMED MATER RES, V16, P63, DOI 10.1002/jbm.820160109
   Lutz J, 2011, SURF COAT TECH, V205, P3043, DOI 10.1016/j.surfcoat.2010.11.017
   Milosev H.-H. S. I., 2003, ELECTROCHIM ACTA, V48, P2767
   Ozturk O, 2006, SURF COAT TECH, V200, P5687, DOI 10.1016/j.surfcoat.2005.08.113
   Varano R, 2006, P I MECH ENG H, V220, P145, DOI 10.1243/09544119JEIM110
   Wang QL, 2010, J BIONIC ENG, V7, P337, DOI 10.1016/S1672-6529(10)60265-X
NR 14
TC 5
Z9 5
U1 1
U2 12
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03785-936-0
J9 ADV MATER RES-SWITZ
PY 2014
VL 845
BP 462
EP 466
DI 10.4028/www.scientific.net/AMR.845.462
PG 5
WC Engineering, Industrial; Engineering, Manufacturing; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BA8YX
UT WOS:000339040500091
DA 2018-10-19
ER

PT S
AU Tian, HC
   Liu, JQ
   Kang, XY
   Wei, DX
   Zhang, C
   Du, JC
   Yang, B
   Chen, X
   Yang, CS
AF Tian, Hong-Chang
   Liu, Jing-Quan
   Kang, Xiao-Yang
   Wei, Dai-Xu
   Zhang, Chuan
   Du, Jing-Cheng
   Yang, Bin
   Chen, Xiang
   Yang, Chun-Sheng
GP IEEE
TI Poly(3,4-ethylenedioxythiophene)/Graphene Oxide Composite Coating for
   Electrode-Tissue Interface
SO 2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 36th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY AUG 26-30, 2014
CL Chicago, IL
SP IEEE Engn Medicine & Biol Soc
AB Owing to interacting with the living tissue directly, the electrode-tissue interface largely determines the performance of the whole bioelectronics devices. The miniaturization of biomedical electronic components requires interface materials to possess properties including excellent electrical performance, good biocompatibility and compatibility with microelectronic fabrication process. Considering the unique characteristics and wide applications in biomedical domain of conducting polymer and graphene, composite film consists of poly(3,4-ethylenedioxythiophene) (PEDOT) and graphene oxide (GO) is proposed as electrode-tissue interface in this work. The facilely electrochemically synthesized PEDOT/GO coating on microelectrodes shows low impedance, high charge storage capacity and good biocompatibility to act as electrode-tissue interface. As a result, the composite film is a potential biomaterial as electrode-tissue interface for tissue engineering and further implantable electrophysiological devices.
C1 [Tian, Hong-Chang; Liu, Jing-Quan; Kang, Xiao-Yang; Zhang, Chuan; Du, Jing-Cheng; Yang, Bin; Chen, Xiang; Yang, Chun-Sheng] Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Key Lab Thin Film & Microfabricat, Minist Educ,Inst Micronano Sci & Technol, Shanghai 200240, Peoples R China.
   [Wei, Dai-Xu] Natl Engn Res Ctr Nanotechnol, Shanghai 200241, Peoples R China.
RP Liu, JQ (reprint author), Shanghai Jiao Tong Univ, Natl Key Lab Sci & Technol Micro Nano Fabricat, Key Lab Thin Film & Microfabricat, Minist Educ,Inst Micronano Sci & Technol, Shanghai 200240, Peoples R China.
EM jqliu@sjtu.edu.cn
OI Du, Jingcheng/0000-0002-0322-4566
CR Abidian MR, 2010, SMALL, V6, P421, DOI 10.1002/smll.200901868
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017
   Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]
   Lu Y., 2010, BIOMATERIALS, V22, P3906
   Qian T, 2013, CHEM COMMUN, V49, P4610, DOI 10.1039/c3cc00276d
NR 6
TC 1
Z9 1
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-7929-0
J9 IEEE ENG MED BIO
PY 2014
BP 1571
EP 1574
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BC1EL
UT WOS:000350044701140
PM 25570271
DA 2018-10-19
ER

PT S
AU Bayrak, ES
   Mehdizadeh, H
   Akar, B
   Somo, SI
   Brey, EM
   Cinar, A
AF Bayrak, Elif S.
   Mehdizadeh, Hamidreza
   Akar, Banu
   Somo, Sami I.
   Brey, Eric M.
   Cinar, Ali
GP IEEE
TI Agent-Based Modeling of Osteogenic Differentiation of Mesenchymal Stem
   Cells in Porous Biomaterials
SO 2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN
   MEDICINE AND BIOLOGY SOCIETY (EMBC)
SE IEEE Engineering in Medicine and Biology Society Conference Proceedings
LA English
DT Proceedings Paper
CT 36th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society (EMBC)
CY AUG 26-30, 2014
CL Chicago, IL
SP IEEE Engn Medicine & Biol Soc
ID BONE MORPHOGENETIC PROTEIN-2; CHEMOTACTIC MIGRATION; ENDOTHELIAL-CELLS;
   REGENERATION; SCAFFOLDS; PATTERNS; BEHAVIOR; CANCER
AB Mesenchymal stem cells (MSC) have shown promise in tissue engineering applications due to their potential for differentiating into mesenchymal tissues such as osteocytes, chondrocytes, and adipocytes and releasing proteins to promote tissue regeneration. One application involves seeding MSCs in biomaterial scaffolds to promote osteogenesis in the repair of bone defects following implantation. However, predicting in vivo survival and differentiation of MSCs in biomaterials is challenging. Rapid and stable vascularization of scaffolds is required to supply nutrients and oxygen that MSCs need to survive as well as to go through osteogenic differentiation. The objective of this study is to develop an agent-based model and simulator that can be used to investigate the effects of using gradient growth factors on survival and differentiation of MSCs seeded in scaffolds. An agent-based model is developed to simulate the MSC behavior. The effect of vascular endothelial growth factor (VEGF) and bone morphogenic protein-2 (BMP-2) on both survival and osteogenic differentiation is studied. Results showed that the survival ratio of MSCs can be enhanced by increasing VEGF concentration. BMP-2 caused a slight increase on survival ratio. Osteogenesis strongly depends on the VEGF concentration as well because of its effect on vascularization. BMP-2 increased the osteogenic differentiation of MSCs.
C1 [Bayrak, Elif S.; Cinar, Ali] IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.
   [Mehdizadeh, Hamidreza] IIT, Chicago, IL 60616 USA.
   [Akar, Banu; Somo, Sami I.; Brey, Eric M.; Cinar, Ali] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
RP Cinar, A (reprint author), IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.
EM ebayrak@hawk.iit.edu; hmehdiza@hawk.iit.edu; bakar@hawk.iit.edu;
   ssomo@hawk.iit.edu; brey@iit.edu; cinar@iit.edu
OI Cinar, Ali/0000-0002-1607-9943
CR Abbott RG, 2006, ARTIF LIFE, V12, P617, DOI 10.1162/artl.2006.12.4.617
   Artel A, 2011, TISSUE ENG PT A, V17, P2133, DOI [10.1089/ten.tea.2010.0571, 10.1089/ten.TEA.2010.0571]
   Arvidson K, 2011, J CELL MOL MED, V15, P718, DOI 10.1111/j.1582-4934.2010.01224.x
   Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019
   Athale CA, 2006, J THEOR BIOL, V238, P771, DOI 10.1016/j.jtbi.2005.06.029
   Ausk BJ, 2006, J BIOMECH, V39, P2638, DOI 10.1016/j.jbiomech.2005.08.023
   Bailey AM, 2007, ANN BIOMED ENG, V35, P916, DOI 10.1007/s10439-007-9266-1
   D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061
   Deschepper M, 2011, J CELL MOL MED, V15, P1505, DOI 10.1111/j.1582-4934.2010.01138.x
   Druckenbrod NR, 2007, DEV DYNAM, V236, P84, DOI 10.1002/dvdy.20974
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Finkenzeller G, 2012, MICROVASC RES, V84, P81, DOI 10.1016/j.mvr.2012.03.010
   Jeon O, 2008, TISSUE ENG PT A, V14, P1285, DOI 10.1089/ten.tea.2007.0253
   Kadiyala S, 1997, TISSUE ENG, V3, P173, DOI 10.1089/ten.1997.3.173
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Lindhorst D, 2010, J BIOMED MATER RES A, V95A, P783, DOI 10.1002/jbm.a.32902
   Lollini PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-352
   Manassero M, 2013, TISSUE ENG PT A, V19, P1554, DOI [10.1089/ten.tea.2012.0008, 10.1089/ten.TEA.2012.0008]
   MEHDIZADEH H, 2011, AGENTS PRINCIPLE AGE, V7047, P113
   Mehdizadeh H, 2013, BIOMATERIALS, V34, P2875, DOI 10.1016/j.biomaterials.2012.12.047
   Peirce SM, 2004, FASEB J
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215
   Tavassol F, 2011, TISSUE ENG PT A, V17, P1935, DOI [10.1089/ten.TEA.2010.0603, 10.1089/ten.tea.2010.0603]
   Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025
   Walker DC, 2004, IEEE T NANOBIOSCI, V3, P153, DOI 10.1109/TNB.2004.833680
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
NR 28
TC 6
Z9 6
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1557-170X
BN 978-1-4244-7929-0
J9 IEEE ENG MED BIO
PY 2014
BP 2924
EP 2927
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BC1EL
UT WOS:000350044702226
PM 25570603
DA 2018-10-19
ER

PT B
AU Miraftab, M
   Masood, R
   Edward-Jones, V
AF Miraftab, M.
   Masood, R.
   Edward-Jones, V.
BE Pal, M
TI Development and Antimicrobial Assessment of a Novel Hybrid Biomaterial
   Fibre Intended for Wound Dressing Applications
SO INTERNATIONAL CONFERENCE ON MATERIAL SCIENCE AND MATERIAL ENGINEERING
   (MSME 2014)
LA English
DT Proceedings Paper
CT International Conference on Material Science and Material Engineering
   (MSME)
CY MAR 15-16, 2014
CL Adv Informat Sci Res Ctr, Chicago, IL
SP DEStech Publicat Inc, Univ East Asia, Univ Mysore, Reitaku Univ
HO Adv Informat Sci Res Ctr
DE Wound dressing; Alginate; Psyllium; antimicrobial
ID SILVER; MANAGEMENT; MODELS
AB Wound dressings containing silver have been commercially marketed for some time now. On the whole, manufacturers are keen to publicize effective antimicrobial activities of their products against all kinds of pathogens including MRSA. However, there are little or no credible reports on minimal but potent quantities of silver needed in a dressing to eliminate bacteria or how effectively the silver within a dressing is released over time. This paper introduces a new hybrid biomaterial fibre made from polysaccharide-based polymers with inbuilt ability to gel and absorb large quantities of pseudo exudates. Furthermore, it will be reported that the new fibre carries up to six times less silver than it is conventionally used in silver dressings and displays a very slow rate of release whilst maintaining full potency over time against known gram positive/gram negative micro-organisms including MRSA. The paper concludes that the developed biomaterial fibre has long lasting antimicrobial and gelling properties comparable, if not better, than Acticoat AA and Aquacel Ag, two commercially available silver dressings.
C1 [Miraftab, M.] Univ Bolton, Insitute Mat Res & Innovat, Bolton BL3 5AB, England.
   [Masood, R.] Natl Text Univ, Faisalabad, Pakistan.
   [Edward-Jones, V.] Manchester Metropolitan Univ, Res Enterprise & Dev, Manchester M15 6BX, Lancs, England.
RP Miraftab, M (reprint author), Univ Bolton, Insitute Mat Res & Innovat, Deane Rd, Bolton BL3 5AB, England.
EM m.iraftab@bolton.ac.uk; rashid44444@yahoo.com; V.E.Jones@mmu.ac.uk
CR Alloway B.J., 1995, HEAVY METALS SOILS, P324
   Bowler PG, 2004, J BURN CARE REHABIL, V25, P192, DOI 10.1097/01.BCR.0000112331.72232.1B
   Burd A, 2007, WOUND REPAIR REGEN, V15, P94, DOI 10.1111/j.1524-475X.2006.00190.x
   Burrell R.E., 2003, OSTOMY WOUND MANAG, P4919
   Cooper R, 2004, WORLDWIDE WOUNDS
   De SJ, 2003, J CONTROL RELEASE, V89, P101, DOI 10.1016/S0168-3659(03)00098-1
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Dunn Ken, 2004, ROLE ACTICOAT NANOCR, V30, pS1
   Fan LH, 2006, CARBOHYD POLYM, V65, P447, DOI 10.1016/j.carbpol.2006.01.031
   Howe PD, 2002, SILVER SILVER COMPOU
   Jones-Edward V., 2002, J MED MICROBIOL, V51, P50
   Kalsen H. J., 2000, HIST REV SILVER TREA, V26, P117
   Keong LC, 2009, INT J MOL SCI, V10, P1300, DOI 10.3390/ijms10031300
   Landis Stephan J, 2008, Adv Skin Wound Care, V21, P531, DOI 10.1097/01.ASW.0000323578.87700.a5
   MARGARET IP, 2006, J MED MICROBIOL, V55, P59
   Miraftab M., J WOUNDCARE
   Miraftab M., 2012, patent application, Patent No. [WO2012GB 53011 20121205, 5301120121205]
   Poon VKM, 2004, BURNS, V30, P140, DOI 10.1016/j.burns.2003.09.030
   Qin Yimin, TEXTILE MAGAZINE, P23
   Ryan KJ, 2003, SHERRIS MED MICROBIO
   Samadra C., 1997, J CONTROL RELEASE, V44, P201
   Smith E. A., 1947, SAMPLING ASSAY PRECI, P71
   Ted S., 2004, WOUND MANAGEMENT, V3, P148
   Thomas S., 2004, ONLINE J WORLD WIDE
   White W. C, 2005, AEGIS ENV
NR 25
TC 0
Z9 0
U1 1
U2 1
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-60595-171-3
PY 2014
BP 190
EP 200
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA BC2LC
UT WOS:000351041400027
DA 2018-10-19
ER

PT J
AU Naghiu, MA
   Gorea, M
   Kristaly, F
   Tomoaia-Cotisel, M
AF Naghiu, M. A.
   Gorea, M.
   Kristaly, F.
   Tomoaia-Cotisel, M.
TI A NEW METHOD FOR SYNTHESIS OF FORSTERITE NANOMATERIALS FOR BIOIMPLANTS
SO CERAMICS-SILIKATY
LA English
DT Article
DE Magnesium silicates; Biomaterial; Precipitation method; Particle size;
   Thermal analysis
ID SOL-GEL SYNTHESIS; ENSTATITE MGSIO3; MG2SIO4; POWDERS; CRYSTALLIZATION;
   NANOPOWDERS; PRECURSORS; CERAMICS; PHASE
AB Nanocrystalline forsterite (Mg2SiO4) was synthesized by the precipitation method using Mg(NO3)(2)center dot 6H(2)O, C8H20O4Si (TEOS) and sodium hydroxide as pH regulator as starting materials. The thermal behaviour of the mixture was investigated by a MOM derivatograh. According to DTA results the initial crystallization temperature of the forsterite is about 800 degrees C. The powder calcined at 900 degrees C was characterized by X ray diffraction (XRD). The forsterite was noticed as the main crystalline phase besides of small amounts of periclase (MgO). Polycrystalline forsterite with uniform sized particles and spherical shape is evidenced by electronic microscopy (TEM, SEM). Grain size of forsterite powder according to Counter Coulter-type laser granulometer results is in the range of 10 - 42 nm.
C1 [Naghiu, M. A.; Gorea, M.; Tomoaia-Cotisel, M.] Univ Babes Bolyai, Fac Chem & Chem Engn, Dept Chem Engn, R-3400 Cluj Napoca, Romania.
   [Kristaly, F.] Univ Miskolc, Inst Mineral & Geol, Egyetemvaros, Miskolc, Hungary.
RP Naghiu, MA (reprint author), Univ Babes Bolyai, Fac Chem & Chem Engn, Dept Chem Engn, R-3400 Cluj Napoca, Romania.
EM mgorea@chem.ubbcluj.ro
OI Kristaly, Ferenc/0000-0002-0075-5994
FU UEFISCDI [171/2012]
FX The authors thank the UEFISCDI for financial support through grant
   number 171/2012.
CR Ban T, 1999, J AM CERAM SOC, V82, P22
   BANSAL NP, 1988, J AM CERAM SOC, V71, P666, DOI 10.1111/j.1151-2916.1988.tb06386.x
   BURLITCH JM, 1991, CHEM MATER, V3, P692, DOI 10.1021/cm00016a024
   Douy A, 2002, J SOL-GEL SCI TECHN, V24, P221, DOI 10.1023/A:1015332607551
   ECHEVERRIA LM, 1992, J NON-CRYST SOLIDS, V147, P559, DOI 10.1016/S0022-3093(05)80676-3
   El-Didamony H, 2012, CERAM-SILIKATY, V56, P389
   Gorea M, 2013, CERAM-SILIKATY, V57, P87
   HUANG CM, 1994, J AM CERAM SOC, V77, P2625, DOI 10.1111/j.1151-2916.1994.tb04653.x
   Jones SA, 1999, J SOL-GEL SCI TECHN, V15, P201, DOI 10.1023/A:1008728724009
   KAZAKOS A, 1990, MATER LETT, V9, P405, DOI 10.1016/0167-577X(90)90075-W
   Kharaziha M, 2009, CERAM INT, V35, P2449, DOI 10.1016/j.ceramint.2009.02.001
   Klug H. P., 1974, XRAY DIFFRACTION PRO
   LEE WE, 1987, J AM CERAM SOC, V70, P349, DOI 10.1111/j.1151-2916.1987.tb05007.x
   Lin L, 2008, J ALLOY COMPD, V455, P327, DOI 10.1016/j.jallcom.2007.01.059
   Lin X., 2013, BIOMATERIAL
   lurian A. M., 2013, STUDIA UBB CHEMIA, V58, P141
   MARTIN MHE, 1992, J AM CERAM SOC, V75, P1831, DOI 10.1111/j.1151-2916.1992.tb07204.x
   Mielcarek W, 2004, J EUR CERAM SOC, V24, P3817, DOI 10.1016/j.jeurceramsoc.2003.12.030
   Mitchell MBD, 1999, J SOL-GEL SCI TECHN, V15, P211, DOI 10.1023/A:1008732808079
   Mitchell MBD, 1998, J SOL-GEL SCI TECHN, V13, P359, DOI 10.1023/A:1008696522312
   Naghiu MA, 2013, J MATER SCI TECHNOL, V29, P628, DOI 10.1016/j.jmst.2013.04.007
   Popa M, 2012, STUD U BABES-BOL CHE, V57, P167
   Sanosh KP, 2010, J ALLOY COMPD, V495, P113, DOI 10.1016/j.jallcom.2010.01.097
   Sarve J. F., 1962, J AM CERAM SOC, V55, P152
   Tan GL, 2009, J ALLOY COMPD, V468, P421, DOI 10.1016/j.jallcom.2008.01.051
   Tavangarian F, 2011, MATER LETT, V65, P740, DOI 10.1016/j.matlet.2010.11.014
   Tavangarian F., 2010, CERAMICSSILIKATY, V54, P2
   Xie Y., 2009, ACTA BIOMATER, V5, P6
   Zhenglong L., 2009, J ALLOYS COMPOUNDS, V470
NR 29
TC 3
Z9 3
U1 1
U2 5
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
EI 1804-5847
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2014
VL 58
IS 4
BP 303
EP 307
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA CD2RW
UT WOS:000350927700009
OA DOAJ Gold
DA 2018-10-19
ER

PT B
AU Kapustka, K
   Hajduga, M
   Jedrzejczyk, D
   Was-Solipiwo, J
AF Kapustka, Katarzyna
   Hajduga, Maciej
   Jedrzejczyk, Dariusz
   Was-Solipiwo, Joanna
GP TANGER
TI CORROSION CHANGES OF WELDABLE NITINOLS (NiTi) IN AN ENVIRONMENT OD
   PHYSIOLOGICAL LIQUIDS
SO METAL 2014: 23RD INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 23rd International Conference on Metallurgy and Materials
CY MAY 21-23, 2014
CL Brno, CZECH REPUBLIC
SP TANGER Ltd, VSB Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Engn Acad Czech Republic, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Metallurgy & Mat, Italian Assoc Metallurgy, Austrian Soc Metallurgy & Mat, Portuguese Soc Mat, Mat Informat Soc
DE Corrosion; nitinol; argon envelope; soldering; heat sealing
AB From the large number of available metals with the memory of shape only a few of them found clinical application. Biocompatible orthodontic wires, applied in case of false occlusion reconstruction, are made of intelligent materials and components. The phenomenon origins from the material's property called "shape memory". The alloy deformed plastically in the lower temperature regains its initial shape in the higher temperature. Orthodontic wires, due to their purpose and use, succumb to damage. Hence the exploitation in very demanding conditions of oral cavity makes us search for very efficient reparation system. From the large number available materials with a shape memory only few of them complied with clinical application. It is a result of tough criteria measures implemented to implants - targeting fulfilling biological requirements. Austenitic steels, applied in medicine, belong to metallic biomaterials particularly exposed to damage, due to ongoing processes of corrosion strain. It is connected with its weakest resistance to electrochemical corrosion in environment of organism fluids hence lower susceptibility to self-passivation. The appearance of the foreign matter in the organism stimulates many mechanisms aiming its elimination. So if the foreign substance, in this case the wire, is traced by immunological system, the organism starts production of antibodies of strong oxidizing functions. Antibodies consolidate near the implant and absorb into biomaterial. Defensive reaction of the organism is becoming one of the reasons of degradation of biomaterials. The work is devoted to the influence of corrosion environment on the structure and properties stability of NiTi wires after reparation.
C1 [Kapustka, Katarzyna; Hajduga, Maciej; Jedrzejczyk, Dariusz] Univ Bielsko Biala, Bielsko Biala, Poland.
   [Was-Solipiwo, Joanna] BOSMAL Automot Res & Dev Inst, Bielsko Biala, Poland.
RP Kapustka, K (reprint author), Univ Bielsko Biala, Bielsko Biala, Poland.
EM katarzynakapustka@op.pl
OI Jedrzejczyk, Dariusz/0000-0002-0541-1373
CR Bojarski Z., 1989, METALE PAMIECIA KSZT
   HER-HSIUNGHUANG, 2003, BIOMATERIALS, V24, P3585
   KAPUSTKA K., 2013, MOZLIWOSCI LACZENIA
   KAPUSTKA K., 2013, AGH KRAKOW KRYNICA M, P237
   KAPUSTKA K., 2013, 5564 POL TOW INZ STO
   PLASKOTA T., 2004, 3536 INZ BIOM, V7
   RYDZEWSKA O., 2009, KOROZJA DRUTOW ORTOD
   Thierry B, 2000, J BIOMED MATER RES, V51, P685, DOI 10.1002/1097-4636(20000915)51:4<685::AID-JBM17>3.0.CO;2-S
NR 8
TC 0
Z9 0
U1 0
U2 0
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-54-3
PY 2014
BP 831
EP 837
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BC2AA
UT WOS:000350641700136
DA 2018-10-19
ER

PT B
AU Vojtech, D
   Kubasek, J
   Capek, J
   Pospisilova, I
AF Vojtech, Dalibor
   Kubasek, Jiri
   Capek, Jaroslav
   Pospisilova, Iva
GP TANGER
TI MAGNESIUM, ZINC AND IRON ALLOYS FOR MEDICAL APPLICATIONS IN
   BIODEGRADABLE IMPLANTS
SO METAL 2014: 23RD INTERNATIONAL CONFERENCE ON METALLURGY AND MATERIALS
LA English
DT Proceedings Paper
CT 23rd International Conference on Metallurgy and Materials
CY MAY 21-23, 2014
CL Brno, CZECH REPUBLIC
SP TANGER Ltd, VSB Tech Univ Ostrava, Czech Soc New Mat & Technologies, ASM Int, Engn Acad Czech Republic, Mat Res Soc Serbia, Norwegian Co Mat & Technol, French Soc Metallurgy & Mat, Italian Assoc Metallurgy, Austrian Soc Metallurgy & Mat, Portuguese Soc Mat, Mat Informat Soc
DE Magnesium; zinc; iron; biomaterial; implant
ID CORROSION BEHAVIOR; STENTS; ZN
AB Biodegradable materials are developed for designing temporary medical implants, like fixation devices for fractured bones or stents. At present, polymeric biomaterials such as poly-lactic acid (PLA) are currently used in these applications. The disadvantage of polymers is a low mechanical strength, hardness and wear resistance that is the main limitation for the use in load-bearing implants. For this reason, extensive research activities are focused on metallic biodegradable materials showing higher strength, hardness, wear resistance and toughness. Among various biodegradable metals, only magnesium, zinc and iron also meet the basic requirement of a good biocompatibility. In the present work, magnesium, zinc and iron based alloys are compared in terms of biocompatibility, mechanical properties and corrosion behavior in the human body environment. Advantages, disadvantages and potential application areas of the three groups of materials are demonstrated.
C1 [Vojtech, Dalibor; Kubasek, Jiri; Capek, Jaroslav; Pospisilova, Iva] Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague, Czech Republic.
RP Vojtech, D (reprint author), Inst Chem Technol, Dept Met & Corros Engn, CR-16628 Prague, Czech Republic.
EM Dalibor.Vojtech@vscht.cz
RI Kubasek, Jiri/N-4341-2017
OI Kubasek, Jiri/0000-0001-6008-0127
CR Bowen PK, 2013, ADV MATER, V25, P2577, DOI 10.1002/adma.201300226
   Davis J. R., 2003, HDB MAT MED DEVICES, P1, DOI DOI 10.1361/HMMD2003P001
   DAVIS JR, 1990, ASM HDB PROPERTIES S, V2
   GU X.N., 2010, FRONT MAT SCI CHINA, P111
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hermawan H, 2010, ACTA BIOMATER, V6, P1693, DOI 10.1016/j.actbio.2009.10.006
   Hermawan H., 2012, BIODEGRADABLE METALS, DOI [10.1007/978-3-642-31170-3, DOI 10.1007/978-3-642-31170-3]
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   Kubasek J, 2013, T NONFERR METAL SOC, V23, P1215, DOI 10.1016/S1003-6326(13)62586-8
   Kubasek J, 2013, J MATER SCI-MATER M, V24, P1615, DOI 10.1007/s10856-013-4916-3
   Kubasek J, 2013, MAT SCI ENG C-MATER, V33, P2421, DOI 10.1016/j.msec.2013.02.005
   Moravej M, 2010, ACTA BIOMATER, V6, P1726, DOI 10.1016/j.actbio.2010.01.010
   Poinern G. E. J., 2012, AM J BIOMEDICAL ENG, P218
   Schinhammer M, 2010, ACTA BIOMATER, V6, P1705, DOI 10.1016/j.actbio.2009.07.039
   Vojtech D, 2011, ACTA BIOMATER, V7, P3515, DOI 10.1016/j.actbio.2011.05.008
   VOJTECH D., 2013, HUTN LISTY, P66
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Zberg B, 2009, NAT MATER, V8, P887, DOI [10.1038/NMAT2542, 10.1038/nmat2542]
NR 18
TC 0
Z9 0
U1 1
U2 14
PU TANGER LTD
PI SLEZSKA
PA KELTICKOVA 62, SLEZSKA, OSTRAVA 710 00, CZECH REPUBLIC
BN 978-80-87294-54-3
PY 2014
BP 1092
EP 1096
PG 5
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BC2AA
UT WOS:000350641700180
DA 2018-10-19
ER

PT S
AU Johnson, WE
   Koepfli, K
AF Johnson, Warren E.
   Koepfli, Klaus
BE Holt, WV
   Brown, JL
   Comizzoli, P
TI The Role of Genomics in Conservation and Reproductive Sciences
SO REPRODUCTIVE SCIENCES IN ANIMAL CONSERVATION: PROGRESS AND PROSPECTS
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
DE Conservation genetics; Adaptation; Selection; Genomics
ID DETECT CANDIDATE LOCI; PUERTO-RICAN PARROT; LYNX LYNX-PARDINUS;
   WHOLE-GENOME; MICROSATELLITE MARKERS; GENETIC DIVERSITY; TASMANIAN
   DEVIL; LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE;
   FUNDAMENTAL-CONCEPTS
AB Genomics, the study of an organism's genome through DNA analyses, is a central part of the biological sciences and is rapidly changing approaches to animal conservation. The genomes of thousands of organisms, including vertebrates, invertebrates, and plants have been sequenced and the results annotated, augmented and refined through the application of new approaches in transcriptomics, proteomics, and metabolomics that enhance the characterization of messenger RNA, proteins, and metabolites. The same computational advances that are catalyzing "-omic" technologies and novel approaches to address fundamental research questions are facilitating bioinformatic analysis and enabling access of primary and derivative data and results in public and private databases (Zhao and Grant. Curr Pharm Biotechnol 12: 293-305, 2011). These tools will be used to provide fundamental advances in our understanding of reproductive biology across vertebrate species and promise to revolutionize our approach to conservation biology.
   The vulnerability of animal populations and their genetic diversity is well documented, as are the myriad of causes and threats to their persistence, including habitat degradation and loss, overexploitation, pollution, invasive alien species, and climate change. Of the 64,283 vertebrates assessed by the International Union for Conservation of Nature in their 2012 Red List of Threatened Species, 7,250 or similar to 11 % are threatened with extinction, a percentage that has been increasing steadily for at least the last decade (www.iucnredlist.org). Among many of these species, important genetic diversity has been lost, thereby increasing their vulnerability as genetically diverse populations have higher fitness, generally are more resilient to environmental challenges, and have more adaptive potential (Reed and Frankham Conserv Biol 17: 230-237, 2003; Luikart et al. Nat Rev Genet 4: 981-994, 2003). In turn, genetic variation within and among populations may be essential to maintaining functional ecosystems, evolutionary process and will impact future food supplies, human health, biomaterial development and geopolitics (Myers and Knoll Proc Natl Acad Sci U S A 98: 5389-5392, 2001; Templeton et al. Proc Natl Acad Sci U S A 98: 5426-5432, 2001). Therefore, conservation of genetic diversity is a social, cultural, scientific, and economic prerogative and is the key to adaptation in the uncertain future of a human-dominated environment. Once lost, genetic resources are nearly impossible to regain, increasing the urgency of fundamental global approaches (e.g. www.cbd.int/sp/targets).
   In this chapter we provide a review of current research and recent advances in biotechnology and genomic approaches for animal conservation and the management of genetic resources, with an emphasis on reproductive sciences. It is intended to provide information and insights for research and to provoke thoughts on how to take advantage of these opportunities.
C1 [Johnson, Warren E.] Smithsonian Conservat Biol Inst, Front Royal, VA 22630 USA.
   [Koepfli, Klaus] Smithsonian Conservat Biol Inst, Ctr Conservat & Evolutionary Genet, Washington, VA USA.
RP Johnson, WE (reprint author), Smithsonian Conservat Biol Inst, Natl Zool Pk,1500 Remount Rd, Front Royal, VA 22630 USA.
EM johnsonwe@si.edu
RI Johnson, Warren/D-4149-2016
OI Johnson, Warren/0000-0002-5954-186X
CR Aagaard K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036466
   Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844
   Alminana C, 2012, THERIOGENOLOGY, V77, P717, DOI 10.1016/j.theriogenology.2011.11.009
   Amstislavsky S, 2012, REPROD DOMEST ANIM, V47, P164, DOI 10.1111/j.1439-0531.2011.01886.x
   Andrabi SMH, 2007, ANIM REPROD SCI, V99, P223, DOI 10.1016/j.anireprosci.2006.07.002
   Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253
   Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323
   Aydiner F, 2010, CURR MOL MED, V10, P206, DOI 10.2174/156652410790963349
   Baker CS, 2008, MOL ECOL, V17, P3985, DOI 10.1111/j.1365-294X.2008.03867.x
   Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x
   Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031
   Berthouly C, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-1
   Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087
   Bonin A, 2007, CONSERV BIOL, V21, P697, DOI 10.1111/j.1523-1739.2007.00685.x
   Bott K, 2009, N AM J FISH MANAGE, V29, P1636, DOI 10.1577/M08-211.1
   BROCK MK, 1992, P NATL ACAD SCI USA, V89, P11121, DOI 10.1073/pnas.89.23.11121
   Brosnahan MM, 2010, EQUINE VET J, V42, P658, DOI 10.1111/j.2042-3306.2010.00166.x
   Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1
   Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345
   Cain CM, 2011, J MAMMAL, V92, P751, DOI 10.1644/10-MAMM-S-104.1
   Chapman Demian D., 2010, Endangered Species Research, V9, P221, DOI 10.3354/esr00241
   Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664
   Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433
   Chocu S, 2012, SYST BIOL REPROD MED, V58, P179, DOI 10.3109/19396368.2012.691943
   Claw KG, 2012, ANNU REV GENOM HUM G, V13, P109, DOI 10.1146/annurev-genom-090711-163745
   COCKERHAM CC, 1984, BIOMETRICS, V40, P157, DOI 10.2307/2530754
   Comizzoli P, 2009, REPROD DOMEST ANIM, V44, P269, DOI 10.1111/j.1439-0531.2009.01372.x
   DeSalle R, 2004, NAT REV GENET, V75, P04
   Didelot X, 2012, NAT REV GENET, V13, P601, DOI 10.1038/nrg3226
   Dorus S, 2012, SYST BIOL REPROD MED, V58, P218, DOI 10.3109/19396368.2012.700442
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Duran C, 2009, CURR BIOINFORM, V4, P16, DOI 10.2174/157489309787158198
   Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152
   EXCOFFIER L, 1992, GENETICS, V131, P479
   Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03
   Finlay EK, 2007, BIOLOGY LETT, V3, P449, DOI 10.1098/rsbl.2007.0146
   Fitzpatrick BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-176
   Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221
   Frankenberg S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-373
   Frankham R, 2002, INTRO CONSERVATION G
   Fujita MK, 2009, CYTOGENET GENOME RES, V127, P261, DOI 10.1159/000295177
   Ganan N, 2010, REPRODUCTION, V139, P275, DOI 10.1530/REP-09-0259
   Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860
   GEYER CJ, 1993, MOL BIOL EVOL, V10, P571
   Govindaraju A, 2012, CELL TISSUE RES, V349, P783, DOI 10.1007/s00441-012-1452-2
   Grado-Ahuir JA, 2011, J ANIM SCI, V89, P1769, DOI 10.2527/jas.2010-3463
   Grant PR, 2010, PHILOS T R SOC B, V365, P1065, DOI 10.1098/rstb.2009.0283
   Grassa CJ, 2011, INT J EVOL BIOL, V2011, P9
   Griffiths AM, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-31
   Haig SM, 1995, J HERED, V86, P423, DOI 10.1093/oxfordjournals.jhered.a111616
   Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051
   Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0
   Hoffmann B, 2009, VET MICROBIOL, V139, P1, DOI 10.1016/j.vetmic.2009.04.034
   Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611
   Hong CP, 2011, EPIGENOMICS-UK, V3, P73, DOI [10.2217/epi.10.72, 10.2217/ERI.10.72]
   Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-23
   Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855
   Hunter N, 1996, ARCH VIROL, V141, P809, DOI 10.1007/BF01718157
   Johnson WE, 2010, SCIENCE, V329, P1641, DOI 10.1126/science.1192891
   Jones KL, 2002, CONSERV BIOL, V16, P789, DOI 10.1046/j.1523-1739.2002.00001.x
   Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x
   Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514
   Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891
   Kidd AG, 2009, MOL ECOL, V18, P1175, DOI 10.1111/j.1365-294X.2009.04100.x
   Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996
   Kochzius M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012620
   Kohn MH, 2006, TRENDS ECOL EVOL, V21, P629, DOI 10.1016/j.tree.2006.08.001
   Kon T, 2007, MOL PHYLOGENET EVOL, V44, P53, DOI 10.1016/j.ympev.2006.12.007
   Kriger KM, 2006, ECOHEALTH, V3, P171, DOI 10.1007/s10393-006-0027-7
   Lacy RC, 2013, ZOO BIOL, V32, P19, DOI 10.1002/zoo.21029
   Lacy Robert C., 2000, Ecological Bulletins, V48, P191
   LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403
   Laval G, 2002, GENET SEL EVOL, V34, P481, DOI 10.1051/gse:2002019
   Li G, 2012, J DAIRY SCI, V95, P6122, DOI 10.3168/jds.2012-5591
   Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231
   Li JY, 2011, MAR BIOTECHNOL, V13, P232, DOI 10.1007/s10126-010-9284-0
   Li Jieying, 2011, MAR BIOTECHNOL, V13, P232, DOI [10.1007/s10126-010-9284-0, DOI 10.1007/S10126-010-9284-0]
   Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696
   Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103
   Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687
   Loire E, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r136
   Loukovitis D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016599
   Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226
   Luikart G, 1999, TRENDS ECOL EVOL, V14, P253, DOI 10.1016/S0169-5347(99)01632-8
   Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x
   Luo SJ, 2008, CURR BIOL, V18, P592, DOI 10.1016/j.cub.2008.03.053
   MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x
   MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]
   Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9
   Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x
   Mazur P, 2008, BIOL REPROD, V78, P2, DOI 10.1095/biolreprod.107.064113
   McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0
   McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007
   Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072
   Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901
   Miller W, 2012, P NATL ACAD SCI USA, V109, P14295
   Miller W, 2012, P NATL ACAD SCI USA, V109, pE2382, DOI 10.1073/pnas.1210506109
   Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108
   Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368
   Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009
   MORIN PA, 1991, ZOO BIOL, V10, P341, DOI 10.1002/zoo.1430100408
   Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065
   Myers N, 2001, P NATL ACAD SCI USA, V98, P5389, DOI 10.1073/pnas.091092498
   Nakamura Y, 2013, P NATL ACAD SCI USA, V110, P11061, DOI 10.1073/pnas.1302051110
   Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1
   Novak S, 2010, THERIOGENOLOGY, V74, P956, DOI 10.1016/j.theriogenology.2010.04.025
   Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632
   Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x
   Oleksyk TK, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-14
   Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940
   Onteru SK, 2011, J ANIM SCI, V89, P988, DOI 10.2527/jas.2010-3236
   Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001
   Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x
   Parma P, 2012, SEX DEV, V6, P7, DOI 10.1159/000332209
   Pharo EA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-80
   Piferrer F, 2012, MAR BIOTECHNOL, V14, P591, DOI 10.1007/s10126-012-9445-4
   Prasad A, 2008, ANIM GENET, V39, P597, DOI 10.1111/j.1365-2052.2008.01772.x
   Primmer CR, 2009, ANN NY ACAD SCI, V1162, P357, DOI 10.1111/j.1749-6632.2009.04444.x
   Pritchard JK, 2000, GENETICS, V155, P945
   Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128
   Pukazhenthi BS, 2004, REPROD FERT DEVELOP, V16, P33, DOI 10.1071/RD03076
   Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x
   Reinartz GE, 1997, PRIMATE CONSERVATION
   Renfree MB, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r81
   Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485
   Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416
   Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832
   Ryder OA, 2005, CYTOGENET GENOME RES, V108, P6, DOI 10.1159/000080796
   Sarropoulou E, 2011, COMP BIOCHEM PHYS D, V6, P92, DOI 10.1016/j.cbd.2010.09.003
   Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842
   Schlotterer C, 2004, NAT REV GENET, V5, P63, DOI 10.1038/nrg1249
   Schopen GCB, 2008, ANIM GENET, V39, P451, DOI 10.1111/j.1365-2052.2008.01736.x
   Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009
   Scott RT, 2010, FERTIL STERIL, V94, P791, DOI 10.1016/j.fertnstert.2010.03.041
   Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x
   Sironen AI, 2010, J ANIM SCI, V88, P821, DOI 10.2527/jas.2009-2426
   Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361
   Soller M, 2006, POULTRY SCI, V85, P2061, DOI 10.1093/ps/85.12.2061
   Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342
   Steiner CC, 2013, ANNU REV ANIM BIOSCI, V1, P261, DOI 10.1146/annurev-animal-031412-103636
   Stella A, 2008, ANIM GENET, V39, P8, DOI 10.1111/j.1365-2052.2007.01662.x
   Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538
   Swanson W.F., 2007, P417
   Swanson WJ, 2011, MOL BIOL EVOL, V28, P1963, DOI 10.1093/molbev/msr026
   Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733
   Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P2509, DOI 10.1073/pnas.051605998
   Tapio I, 2010, GENET SEL EVOL, P42
   Templeton A.R., 1986, P105
   Templeton AR, 2001, P NATL ACAD SCI USA, V98, P5426, DOI 10.1073/pnas.091093098
   Teneva A., 2009, BIOTECHNOL ANIM HUSB, V25, P1267
   Tobler U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010927
   Toro MA, 2009, LIVEST SCI, V120, P174, DOI 10.1016/j.livsci.2008.07.003
   Ungewitter EK, 2013, SEX DEV, V7, P7, DOI 10.1159/000338612
   Vargas A., 2008, International Zoo Yearbook, V42, P190, DOI 10.1111/j.1748-1090.2007.00036.x
   Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI 10.1051/gse:2002009
   Villanueva B, 2004, J ANIM SCI, V82, P1305
   Wang JL, 2003, GENETICS, V163, P429
   Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x
   Wildt DE, 2010, MOL REPROD DEV, V77, P397, DOI 10.1002/mrd.21137
   Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x
   Zhan XJ, 2013, NAT GENET, V45, P563, DOI 10.1038/ng.2588
   Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042
   Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099
   Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729
   Zhou XM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3708
NR 165
TC 3
Z9 3
U1 5
U2 55
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
EI 2214-8019
BN 978-1-4939-0820-2; 978-1-4939-0819-6
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2014
VL 753
BP 71
EP 96
DI 10.1007/978-1-4939-0820-2_5
D2 10.1007/978-1-4939-0820-2
PG 26
WC Biodiversity Conservation; Reproductive Biology
SC Biodiversity & Conservation; Reproductive Biology
GA BC1SF
UT WOS:000350410000006
PM 25091907
DA 2018-10-19
ER

PT J
AU Lim, DJ
   Andukuri, A
   Vines, JB
   Rahman, SM
   Hwang, PTJ
   Kim, J
   Shalev, A
   Corbett, JA
   Jun, HW
AF Lim, Dong-Jin
   Andukuri, Adinarayana
   Vines, Jeremy B.
   Rahman, Shibli M.
   Hwang, Patrick T. J.
   Kim, Jeonga
   Shalev, Anath
   Corbett, John A.
   Jun, Ho-Wook
TI Enhanced MIN-6 beta cell survival and function on a nitric
   oxide-releasing peptide amphiphile nanomatrix
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nitric oxide; peptide amphiphile; biomimetic; diabetes; beta cells
ID ISLET TRANSPLANTATION; INSULIN-SECRETION; RODENT ISLETS; DYSFUNCTION;
   NANOFIBERS; INTERLEUKIN-1; ANGIOGENESIS; PATHOGENESIS; EXPRESSION;
   LANGERHANS
AB Innovative biomaterial strategies are required to improve islet cell retention, viability, and functionality, and thereby obtain clinically successful outcomes from pancreatic islet cell transplantation. To address this need, we have developed a peptide amphiphile-based nanomatrix that incorporates multifunctional bioactive cues and sustained release of nitric oxide. The goal of this study was to evaluate the effect of this peptide amphiphile nanomatrix on the viability and functionality of MIN-6 islet cells. Additionally, this study provides insight into the role of nitric oxide in islet cell biology, given that conventional nitric oxide donors are unable to release nitric oxide in a controlled, sustained manner, leading to ambiguous results. It was hypothesized that controlled nitric oxide release in synergy with multifunctional bioactive cues would promote islet cell viability and functionality. Nitric oxide-releasing peptide amphiphile nanomatrices within the range of 16.25 mu mol to 130 mu mol were used to analyze MIN-6 cell behavior. Both 32.5 mu mol and 65 mu mol peptide amphiphiles showed improved MIN-6 functionality in response to glucose over a 7-day time period, and the elevated functionality was correlated with both PDX-1 and insulin gene expression. Our results demonstrate that nitric oxide has a beneficial effect on MIN-6 cells in a concentration-dependent manner.
C1 [Lim, Dong-Jin; Andukuri, Adinarayana; Vines, Jeremy B.; Rahman, Shibli M.; Hwang, Patrick T. J.; Jun, Ho-Wook] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA.
   [Vines, Jeremy B.] Nutech Med Inc, Birmingham, AL USA.
   [Kim, Jeonga] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.
   [Shalev, Anath] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.
   [Shalev, Anath; Jun, Ho-Wook] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.
   [Corbett, John A.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA.
RP Jun, HW (reprint author), Univ Alabama Birmingham, Dept Biomed Engn, 806 Shelby Biomed Res Bldg,1825 Univ Blvd, Birmingham, AL 35294 USA.
EM hwjun@uab.edu
FU UAB Diabetes Research Training Center pilot grant [P60 DK-079626];
   American Diabetes Association [1-09-IN-23, 1-09-JF-33, 1-12-BS-99];
   NIDDK [1DP3DK094346-01]; NSF career award [CBET-0952974]; NIH
   [1R03EB017344-01]; American Heart Association [13GRNT17220057]; Wallace
   H Coulter Foundation; Woogok postdoctoral scholarship; Caroline P
   Ireland scholarship; American Heart Association predoctoral fellowship
FX The authors are grateful to Guanlan Xu, who helped to operate the Prism
   7000sequence detection system, and to Eun-Ha Lim, a scientific graphic
   designer who assisted with the graphic summary of this study. The
   authors gratefully acknowledge the MIN-6 cell line provided by Jun-Ichi
   Miyazaki (Osaka University Graduate School of Medicine, Osaka, Japan).
   We also would like to thank Donald F Steiner (Department of
   Biochemistry, University of Chicago, IL, USA) and Wanxing Cui for
   obtaining the MIN-6 cell line. This study was supported by a UAB
   Diabetes Research Training Center pilot grant (P60 DK-079626 to JK),
   grants from the American Diabetes Association (1-09-IN-23 to HWJ;
   1-09-JF-33 and 1-12-BS-99 to JK), NIDDK (1DP3DK094346-01 to HWJ), and an
   NSF career award (CBET-0952974 to HWJ), NIH (1R03EB017344-01 to HWJ),
   and funding from the American Heart Association (13GRNT17220057 to JK),
   the Wallace H Coulter Foundation (to HWJ), a Woogok postdoctoral
   scholarship (to DJL), and a Caroline P Ireland scholarship and American
   Heart Association predoctoral fellowship (both to AA).
CR Anderson JM, 2011, ACS NANO, V5, P9463, DOI 10.1021/nn203247m
   Anderson JM, 2011, ACTA BIOMATER, V7, P675, DOI 10.1016/j.actbio.2010.08.016
   Anderson JM, 2009, ACS NANO, V3, P3447, DOI 10.1021/nn900884n
   Anderson JM, 2009, BIOMACROMOLECULES, V10, P2935, DOI 10.1021/bm9007452
   Andukuri A, 2013, TISSUE ENG PART C-ME, V19, P375, DOI [10.1089/ten.tec.2012.0312, 10.1089/ten.TEC.2012.0312]
   Andukuri A, 2011, ACTA BIOMATER, V7, P225, DOI 10.1016/j.actbio.2010.08.013
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Arnush M, 1998, J CLIN INVEST, V102, P516, DOI 10.1172/JCI844
   Campbell SC, 2007, BIOCHEM BIOPH RES CO, V353, P1011, DOI 10.1016/j.bbrc.2006.12.127
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73
   CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129
   CORBETT JA, 1995, J EXP MED, V181, P559, DOI 10.1084/jem.181.2.559
   Dimmeler S, 1999, CELL DEATH DIFFER, V6, P964, DOI 10.1038/sj.cdd.4400581
   Ding Y, 1998, BIOCHEM BIOPH RES CO, V251, P699, DOI 10.1006/bbrc.1998.9536
   Golocheikine A, 2010, TRANSPLANTATION, V90, P725, DOI 10.1097/TP.0b013e3181ef8a63
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Jun HW, 2005, ADV MATER, V17, P2612, DOI 10.1002/adma.200500855
   Kitiphongspattana K, 2007, AM J PHYSIOL-ENDOC M, V292, pE1543, DOI 10.1152/ajpendo.00620.2006
   Kushwaha M, 2010, BIOMATERIALS, V31, P1502, DOI 10.1016/j.biomaterials.2009.10.051
   Laffranchi R, 1995, BIOCHEM BIOPH RES CO, V217, P584, DOI 10.1006/bbrc.1995.2815
   Lim DJ, 2011, MICRO NANO LETT, V6, P619, DOI 10.1049/mnl.2011.0026
   Lim DJ, 2011, TISSUE ENG PT A, V17, P399, DOI [10.1089/ten.tea.2010.0151, 10.1089/ten.TEA.2010.0151]
   MandrupPoulsen T, 1996, DIABETOLOGIA, V39, P1005, DOI 10.1007/BF00400649
   McDaniel ML, 1997, ADV EXP MED BIOL, V426, P313
   MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Smukler SR, 2002, DIABETES, V51, P3450, DOI 10.2337/diabetes.51.12.3450
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195
   STEVENS RB, 1994, TRANSPLANT P, V26, P692
   Tambralli A, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/025001
   Tejedo JR, 2001, CELL SIGNAL, V13, P809, DOI 10.1016/S0898-6568(01)00206-6
   XENOS ES, 1994, TRANSPLANTATION, V57, P1208, DOI 10.1097/00007890-199404270-00012
NR 37
TC 4
Z9 4
U1 1
U2 9
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
SU 1
BP 13
EP 21
DI 10.2147/IJN.S50873
PG 9
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA CB9OL
UT WOS:000349961100003
PM 24872700
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Wan, WK
   Bannerman, AD
   Yang, LF
   Mak, H
AF Wan, Wankei
   Bannerman, A. Dawn
   Yang, Lifang
   Mak, Helium
BE Okay, O
TI Poly(Vinyl Alcohol) Cryogels for Biomedical Applications
SO POLYMERIC CRYOGELS: MACROPOROUS GELS WITH REMARKABLE PROPERTIES
SE Advances in Polymer Science
LA English
DT Review; Book Chapter
DE Poly(vinyl alcohol); Physical crosslinking; Cryogel; Medical device;
   Controlled release
ID HEART-VALVE PROSTHESIS; SMALL-ANGLE NEUTRON; LOW-BACK-PAIN;
   POLYVINYL-ALCOHOL; MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; POLYMER
   SYSTEMS; DRUG-DELIVERY; INTERVERTEBRAL DISC; CELL COMPATIBILITY
AB Poly(vinyl alcohol) (PVA) is a hydrophilic and biocompatible polymer that can be crosslinked to form a hydrogel. When physically crosslinked using a freeze-thaw cycling process, the product hydrogel or cryogel (PVA-C) possesses unique mechanical properties that can be tuned to closely match those of soft tissues, thus making it an attractive candidate for biomedical and especially medical device applications. We review the freeze-thaw cycling process and processing parameters that impact on the properties of PVA-C and its nanocomposite products. Both the mechanical properties and diffusion properties relevant to biomedical application are discussed. Applications to orthopedic and cardiovascular devices are summarized and discussed. The concept of biomaterial-tissue hybrids that can impart the necessary hemocompatibility to PVA-C for cardiovascular device is introduced and demonstrated.
C1 [Wan, Wankei; Bannerman, A. Dawn; Yang, Lifang; Mak, Helium] Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
   [Wan, Wankei] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
RP Wan, WK (reprint author), Univ Western Ontario, Grad Program Biomed Engn, London, ON N6A 5B9, Canada.
EM wkwan@uwo.ca
CR Abdel-Mohsen AM, 2011, J POLYM ENVIRON, V19, P1005, DOI 10.1007/s10924-011-0334-0
   Abe H., 1996, DATA BOOK MECH PROPE
   Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c
   Berglund L., 2005, NATURAL FIBERS BIOPO, P819
   Bodugoz-Senturk H, 2009, BIOMATERIALS, V30, P589, DOI 10.1016/j.biomaterials.2008.10.010
   BRAY JC, 1973, J BIOMED MATER RES, V7, P431, DOI 10.1002/jbm.820070506
   Briscoe B, 2000, POLYMER, V41, P3851, DOI 10.1016/S0032-3861(99)00550-9
   CASSIDY JJ, 1990, J MATER SCI-MATER M, V1, P69, DOI 10.1007/BF00839071
   Causa F, 2002, J MATER SCI-MATER M, V13, P1277, DOI 10.1023/A:1021143516436
   CHA WI, 1993, MAKROMOL CHEM, V194, P2433
   Chirila TV, 1998, PROG POLYM SCI, V23, P447, DOI 10.1016/S0079-6700(97)00036-1
   Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4
   Cote P, 2008, SPINE, V33, pS192, DOI 10.1097/BRS.0b013e3181644616
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Duboeuf F, 2009, MED PHYS, V36, P656, DOI 10.1118/1.3065031
   Eichhorn SJ, 2001, J MATER SCI, V36, P2107, DOI 10.1023/A:1017512029696
   Fergg F, 2001, COLLOID POLYM SCI, V279, P61, DOI 10.1007/s003960000398
   FICEK BJ, 1993, J CONTROL RELEASE, V27, P259, DOI 10.1016/0168-3659(93)90156-Y
   Fink JK, 2011, HDB ENG SPECIALTY TH
   Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273
   Fung YC, 1993, BIOMECHANICS MECH PR
   Gordon M, 1999, THESIS U W ONTARIO
   Gu Zheng-Qiu, 1998, Bio-Medical Materials and Engineering, V8, P75
   Guhados G, 2005, LANGMUIR, V21, P6642, DOI 10.1021/la0504311
   GUSEV DG, 1990, MAGN RESON CHEM, V28, P651, DOI 10.1002/mrc.1260280717
   Hassan CM, 2000, MACROMOLECULES, V33, P2472, DOI 10.1021/ma9907587
   Hassan CM, 2000, EUR J PHARM BIOPHARM, V49, P161, DOI 10.1016/S0939-6411(99)00056-9
   Hassan CM, 2000, ADV POLYM SCI, V153, P37
   HATAKEYAMA T, 1987, EUR POLYM J, V23, P361, DOI 10.1016/0014-3057(87)90164-9
   HICKEY AS, 1995, J MEMBRANE SCI, V107, P229, DOI 10.1016/0376-7388(95)00119-0
   Holloway JL, 2013, SOFT MATTER, V9, P826, DOI 10.1039/c2sm26763b
   Holloway JL, 2011, ACTA BIOMATER, V7, P2477, DOI 10.1016/j.actbio.2011.02.016
   Hoy D, 2010, BEST PRACT RES CL RH, V24, P155, DOI 10.1016/j.berh.2009.11.002
   Hudson SD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3050096
   Hui AJ, 1998, THESIS U W ONTARIO
   HYON SH, 1987, Patent No. 4663358
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   Jiang T, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025012
   Joshi A, 2006, BIOMATERIALS, V27, P176, DOI 10.1016/j.biomaterials.2005.06.003
   KANAYA T, 1995, MACROMOLECULES, V28, P3168, DOI 10.1021/ma00113a019
   KANAYA T, 1994, MACROMOLECULES, V27, P5609, DOI 10.1021/ma00098a014
   Kennedy KL, 2011, CURR DRUG DELIV, V8, P534
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Kobayashi M, 2005, BIOMATERIALS, V26, P3243, DOI 10.1016/j.biomaterials.2004.08.028
   Kovacs FM, 2004, SPINE, V29, P206, DOI 10.1097/01.BRS.0000107235.47465.08
   Li JK, 1998, J CONTROL RELEASE, V56, P117, DOI 10.1016/S0168-3659(98)00089-3
   Liu KF, 2011, J MECH BEHAV BIOMED, V4, P440, DOI 10.1016/j.jmbbm.2010.12.005
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Liu Y, 2009, J BIOMED MATER RES B, V90B, P492, DOI 10.1002/jbm.b.31310
   Lozinsky VI, 2007, COLLOID J+, V69, P747, DOI 10.1134/S1061933X07060117
   Lozinsky VI, 2012, COLLOID J+, V74, P319, DOI 10.1134/S1061933X12030088
   Lozinsky VI, 2000, J APPL POLYM SCI, V77, P2017, DOI 10.1002/1097-4628(20000829)77:9<2017::AID-APP18>3.0.CO;2-6
   Lozinsky VI, 1998, ENZYME MICROB TECH, V23, P227, DOI 10.1016/S0141-0229(98)00036-2
   Lozinsky VI, 2002, USP KHIM+, V71, P559
   LOZINSKY VI, 1995, J APPL POLYM SCI, V58, P171, DOI 10.1002/app.1995.070580119
   Lozinsky VI, 1996, J APPL POLYM SCI, V61, P1991, DOI 10.1002/(SICI)1097-4628(19960912)61:11<1991::AID-APP13>3.0.CO;2-2
   Lozinsky VI, 2000, J APPL POLYM SCI, V77, P1822, DOI 10.1002/1097-4628(20000822)77:8<1822::AID-APP20>3.0.CO;2-#
   Mansur HS, 2009, MAT SCI ENG C-BIO S, V29, P1574, DOI 10.1016/j.msec.2008.12.012
   Mathews DT, 2008, J BIOMED MATER RES B, V84B, P531, DOI 10.1002/jbm.b.30901
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P305, DOI 10.1002/jbm.b.30543
   Millon LE, 2006, J BIOMED MATER RES B, V79B, P245, DOI 10.1002/jbm.b.30535
   Millon LE, 2006, THESIS U W ONTARIO
   Millon LE, 2007, MACROMOLECULES, V40, P3655, DOI 10.1021/ma062781f
   Millon LE, 2012, J BIOMED MATER RES B, V100B, P1, DOI 10.1002/jbm.b.31860
   Millon LE, 2009, J BIOMED MATER RES B, V90B, P922, DOI 10.1002/jbm.b.31364
   Mohammadi H, 2009, P I MECH ENG H, V223, P697, DOI 10.1243/09544119JEIM493
   Nakaoki T, 2008, J MOL STRUCT, V875, P282, DOI 10.1016/j.molstruc.2007.04.040
   National Toxicology Program, 1998, NATL TOXICOL PROGR T, V474, P1
   Nishinari K, 1996, J CHIM PHYS PCB, V93, P880, DOI 10.1051/jcp/1996930880
   Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008
   Nugent MJD, 2005, J MATER SCI-MATER M, V16, P1149, DOI 10.1007/s10856-005-4722-7
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   OHKURA M, 1992, POLYMER, V33, P3686, DOI 10.1016/0032-3861(92)90656-H
   Oka M, 2000, P I MECH ENG H, V214, P59, DOI 10.1243/0954411001535246
   Padavan DT, 2011, ACTA BIOMATER, V7, P258, DOI 10.1016/j.actbio.2010.07.038
   Pan YS, 2007, WEAR, V262, P1021, DOI 10.1016/j.wear.2006.10.005
   Pan YS, 2007, J MATER SCI, V42, P5129, DOI 10.1007/s10853-006-1264-4
   Pazos V, 2009, J MECH BEHAV BIOMED, V2, P542, DOI 10.1016/j.jmbbm.2009.01.003
   PEPPAS NA, 1991, J CONTROL RELEASE, V16, P305, DOI 10.1016/0168-3659(91)90007-Z
   PEPPAS NA, 1980, BIOMATERIALS, V1, P158, DOI 10.1016/0142-9612(80)90039-3
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   Perie DS, 2006, ANN BIOMED ENG, V34, P769, DOI 10.1007/s10439-006-9091-y
   Ratner B. D, 1976, HYDROGELS MEDICAL RE, V31, P1
   Ricciardi R, 2004, MACROMOLECULES, V37, P1921, DOI 10.1021/ma035663q
   Ricciardi R, 2005, MACROMOLECULES, V38, P6629, DOI 10.1021/ma0506031
   Richardson J, 2006, FRONT BIOSCI-LANDMRK, V11, P1042, DOI 10.2741/1862
   Sailaja GS, 2009, ACTA BIOMATER, V5, P1647, DOI 10.1016/j.actbio.2008.12.005
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   Shaheen SM, 2002, J CONTROL RELEASE, V81, P367, DOI 10.1016/S0168-3659(02)00085-8
   Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   STAUFFER SR, 1992, POLYMER, V33, P3932, DOI 10.1016/0032-3861(92)90385-A
   SUGAWARA T, 1995, J BIOMED MATER RES, V29, P1047, DOI 10.1002/jbm.820290904
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   TADAVARTHY SM, 1975, AM J ROENTGENOL, V125, P609, DOI 10.2214/ajr.125.3.609
   TRIEU H, 1995, POLYMER, V36, P2531, DOI 10.1016/0032-3861(95)91198-G
   URUSHIZAKI F, 1990, INT J PHARM, V58, P135
   VANAARTS.JJ, 1970, EUR POLYM J, V6, P919, DOI 10.1016/0014-3057(70)90026-1
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Wan WK, 2002, J BIOMED MATER RES, V63, P854, DOI 10.1002/jbm.10333
   Wang BH, 2009, SPINE, V34, P2745, DOI 10.1097/BRS.0b013e3181b4abf5
   Wang JH, 2010, MAT SCI ENG C-MATER, V30, P214, DOI 10.1016/j.msec.2009.10.006
   WATASE M, 1983, CRYO-LETT, V4, P197
   WATASE M, 1983, POLYM COMMUN, V24, P52
   Willcox PJ, 1999, J POLYM SCI POL PHYS, V37, P3438
   Wong EYL, 2012, THESIS U W ONTARIO
   YOKOYAMA F, 1986, COLLOID POLYM SCI, V264, P595, DOI 10.1007/BF01412597
   Zajaczkowski MB, 2003, TISSUE ENG, V9, P525, DOI 10.1089/107632703322066705
   Zeng YJ, 2001, J BIOMECH, V34, P533, DOI 10.1016/S0021-9290(00)00219-0
NR 109
TC 21
Z9 21
U1 11
U2 72
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-3195
BN 978-3-319-05846-7; 978-3-319-05845-0
J9 ADV POLYM SCI
JI Adv. Polym. Sci.
PY 2014
VL 263
BP 283
EP 321
DI 10.1007/978-3-319-05846-7_8
D2 10.1007/978-3-319-05846-7
PG 39
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA BB9ZO
UT WOS:000348834500009
DA 2018-10-19
ER

PT J
AU Bornes, TD
   Adesida, AB
   Jomha, NM
AF Bornes, Troy D.
   Adesida, Adetola B.
   Jomha, Nadr M.
TI Mesenchymal stem cells in the treatment of traumatic articular cartilage
   defects: a comprehensive review
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Review
ID MARROW STROMAL CELLS; HUMAN BONE-MARROW; AUTOLOGOUS CHONDROCYTE
   IMPLANTATION; ENHANCES CHONDROGENIC DIFFERENTIATION; RANDOMIZED
   CONTROLLED-TRIAL; FIBROBLAST GROWTH FACTOR-2; OSTEOCHONDRAL LESIONS;
   IN-VIVO; RABBIT MODEL; FEMORAL CONDYLE
AB Articular cartilage has a limited capacity to repair following injury. Early intervention is required to prevent progression of focal traumatic chondral and osteochondral defects to advanced cartilage degeneration and osteoarthritis. Novel cell-based tissue engineering techniques have been proposed with the goal of resurfacing defects with bioengineered tissue that recapitulates the properties of hyaline cartilage and integrates into native tissue. Transplantation of mesenchymal stem cells (MSCs) is a promising strategy given the high proliferative capacity of MSCs and their potential to differentiate into cartilage-producing cells - chondrocytes. MSCs are historically harvested through bone marrow aspiration, which does not require invasive surgical intervention or cartilage extraction from other sites as required by other cell-based strategies. Biomaterial matrices are commonly used in conjunction with MSCs to aid cell delivery and support chondrogenic differentiation, functional extracellular matrix formation and three-dimensional tissue development. A number of specific transplantation protocols have successfully resurfaced articular cartilage in animals and humans to date. In the clinical literature, MSC-seeded scaffolds have filled a majority of defects with integrated hyaline-like cartilage repair tissue based on arthroscopic, histologic and imaging assessment. Positive functional outcomes have been reported at 12 to 48 months post-implantation, but future work is required to assess long-term outcomes with respect to other treatment modalities. Despite relatively positive outcomes, further investigation is required to establish a consensus on techniques for treatment of chondral and osteochondral defects with respect to cell source, isolation and expansion, implantation density, in vitro precultivation, and scaffold composition. This will allow for further optimization of MSC proliferation, chondrogenic differentiation, bioengineered cartilage integration, and clinical outcome.
C1 [Bornes, Troy D.; Adesida, Adetola B.; Jomha, Nadr M.] Univ Alberta, Dept Surg, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB T6G 2E1, Canada.
   [Bornes, Troy D.; Adesida, Adetola B.; Jomha, Nadr M.] Univ Alberta, Dept Surg, Div Orthopaed Surg, Edmonton, AB T6G 2B7, Canada.
RP Adesida, AB (reprint author), Univ Alberta, Dept Surg, Lab Stem Cell Biol & Orthopaed Tissue Engn, Edmonton, AB T6G 2E1, Canada.
EM adesida@ualberta.ca
FU Canadian Institutes of Health Research [125921-1]
CR Acharya C, 2012, J CELL PHYSIOL, V227, P88, DOI 10.1002/jcp.22706
   Adachi N, 2005, J RHEUMATOL, V32, P1615
   Adesida AB, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt100
   Anders S, 2012, INT ORTHOP, V36, P2279, DOI 10.1007/s00264-012-1635-1
   Ando W, 2007, BIOMATERIALS, V28, P5462, DOI 10.1016/j.biomaterials.2007.08.030
   Ando W, 2012, EUR CELLS MATER, V24, P292, DOI 10.22203/eCM.v024a21
   Banfi A, 2000, EXP HEMATOL, V28, P707, DOI 10.1016/S0301-472X(00)00160-0
   Banfi A, 2002, TISSUE ENG, V8, P901, DOI 10.1089/107632702320934001
   Barbour KE, 2013, MMWR-MORBID MORTAL W, V62, P869
   Bekkers JEJ, 2013, AM J SPORT MED, V41, P2158, DOI 10.1177/0363546513494181
   Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F
   Buda R, 2010, J BONE JOINT SURG AM, V92A, P2, DOI 10.2106/JBJS.J.00813
   Chang NJ, 2013, OSTEOARTHR CARTILAGE, V21, P1613, DOI 10.1016/j.joca.2013.07.016
   Choi JW, 2013, ARTIF ORGANS, V37, P648, DOI 10.1111/aor.12041
   Darling EM, 2003, ANN BIOMED ENG, V31, P1114, DOI 10.1114/1.1603752
   Dashtdar H, 2013, KNEE SURG SPORTS TRA
   Dashtdar H, 2011, J ORTHOP RES, V29, P1336, DOI 10.1002/jor.21413
   de Vries-van Melle ML, 2014, TISSUE ENG PT A, V20, P23, DOI [10.1089/ten.tea.2013.0080, 10.1089/ten.TEA.2013.0080]
   Deng J, 2013, J MATER SCI-MATER M, V24, P2037, DOI 10.1007/s10856-013-4944-z
   DENKER AE, 1995, DIFFERENTIATION, V59, P25, DOI 10.1046/j.1432-0436.1995.5910025.x
   DePALMA ANTHONY F., 1966, CLIN ORTHOP RELATED RES, V48, P229
   Dragoo JL, 2007, TISSUE ENG, V13, P1615, DOI 10.1089/ten.2006.0249
   Enea D, 2013, KNEE, V20, P562, DOI 10.1016/j.knee.2013.04.003
   Filardo G, 2013, KNEE, V20, P570, DOI 10.1016/j.knee.2013.05.007
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Gelber AC, 2000, ANN INTERN MED, V133, P321, DOI 10.7326/0003-4819-133-5-200009050-00007
   Giannini S, 2013, AM J SPORT MED, V41, P511, DOI 10.1177/0363546512467622
   Giannini S, 2010, INJURY, V41, P1196, DOI 10.1016/j.injury.2010.09.028
   Giannini S, 2009, CLIN ORTHOP RELAT R, V467, P3307, DOI 10.1007/s11999-009-0885-8
   Gigante A, 2011, INT J IMMUNOPATH PH, V24, P69, DOI 10.1177/03946320110241S213
   Gigante A, 2012, ARTHROSC TEC, V1, pE175, DOI 10.1016/j.eats.2012.07.001
   Gille J, 2010, KNEE SURG SPORT TR A, V18, P1456, DOI 10.1007/s00167-010-1042-3
   Gobbi A, 2006, ARTHROSCOPY, V22, P1085, DOI 10.1016/j.arthro.2006.05.016
   Gobbi A, 2011, CARTILAGE, V2, P286, DOI 10.1177/1947603510392023
   Godara P, 2008, J CHEM TECHNOL BIOT, V83, P408, DOI 10.1002/jctb.1918
   Gudas R, 2012, AM J SPORT MED, V40, P2499, DOI 10.1177/0363546512458763
   Guo XM, 2004, TISSUE ENG, V10, P1818, DOI 10.1089/ten.2004.10.1818
   Haleem AM, 2010, CARTILAGE, V1, P253, DOI 10.1177/1947603510366027
   Han SH, 2008, J BIOMED MATER RES A, V87A, P850, DOI 10.1002/jbm.a.31828
   Harrison P. E., 2000, Cell and Tissue Banking, V1, P255, DOI 10.1023/A:1010131729208
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hori J, 2011, J ORTHOP RES, V29, P531, DOI 10.1002/jor.21267
   Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858
   Jomha NM, 2012, BIOMATERIALS, V33, P6061, DOI 10.1016/j.biomaterials.2012.05.007
   Kafienah W, 2007, ARTHRITIS RHEUM, V56, P177, DOI 10.1002/art.22285
   Kamei G, 2013, AM J SPORT MED, V41, P1255, DOI 10.1177/0363546513483270
   Kasemkijwattana Channarong, 2011, Journal of the Medical Association of Thailand, V94, P395
   Khan WS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2448
   Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5
   Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281
   Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460
   Kon E, 2014, AM J SPORT MED, V42, P158, DOI 10.1177/0363546513505434
   Kon E, 2012, J BONE JOINT SURG AM, V94A, P85
   Kon E, 2011, AM J SPORT MED, V39, P2549, DOI 10.1177/0363546511420688
   Kumai T, 2002, J BONE JOINT SURG BR, V84B, P369, DOI 10.1302/0301-620X.84B3.12373
   Kuroda R, 2007, OSTEOARTHR CARTILAGE, V15, P226, DOI 10.1016/j.joca.2006.08.008
   Lai CH, 2010, ULTRASOUND MED BIOL, V36, P1022, DOI 10.1016/j.ultrasmedbio.2010.03.014
   Lee KBL, 2007, STEM CELLS, V25, P2964, DOI 10.1634/stemcells.2006-0311
   Levy YD, 2013, CLIN ORTHOP RELAT R, V471, P231, DOI 10.1007/s11999-012-2556-4
   Li QA, 2011, ARTIF CELL BLOOD SUB, V39, P31, DOI 10.3109/10731191003776769
   Loken S, 2008, KNEE SURG SPORT TR A, V16, P896, DOI 10.1007/s00167-008-0566-2
   Mahmoudifar N, 2010, BIOMATERIALS, V31, P3858, DOI 10.1016/j.biomaterials.2010.01.090
   Malinin T I, 1994, Clin Orthop Relat Res, P18
   Marquass B, 2011, AM J SPORT MED, V39, P1401, DOI 10.1177/0363546511398646
   Marsano A, 2007, OSTEOARTHR CARTILAGE, V15, P48, DOI 10.1016/j.joca.2006.06.009
   Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172
   Masuoka K, 2006, J BIOMED MATER RES B, V79B, P25, DOI 10.1002/jbm.30507
   Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x
   MAYNE R, 1976, P NATL ACAD SCI USA, V73, P1674, DOI 10.1073/pnas.73.5.1674
   McIlwraith CW, 2011, ARTHROSCOPY, V27, P1552, DOI 10.1016/j.arthro.2011.06.002
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Mo XT, 2009, BONE, V45, P42, DOI 10.1016/j.bone.2008.07.240
   Mukonoweshuro B, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414534255
   Munir S, 2014, CELL TISSUE RES, V355, P89, DOI 10.1007/s00441-013-1732-5
   Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374
   Naderi-Meshkin H, 2014, CELL BIOL INT, V38, P72, DOI 10.1002/cbin.10181
   Nam EK, 2009, AM J SPORT MED, V37, P274, DOI 10.1177/0363546508325670
   Nam HY, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4309
   Nejadnik H, 2010, AM J SPORT MED, V38, P1110, DOI 10.1177/0363546509359067
   NOBLE BS, 1995, BONE, V17, P375, DOI 10.1016/S8756-3282(95)00247-2
   OCEBM Levels of Evidence Working Group, OXF LEV EV 2
   Park J, 2006, J GENE MED, V8, P112, DOI 10.1002/jgm.826
   Pei M, 2009, OSTEOARTHR CARTILAGE, V17, P714, DOI 10.1016/j.joca.2008.11.017
   Peterson L, 2010, AM J SPORT MED, V38, P1117, DOI 10.1177/0363546509357915
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi YY, 2012, MOL BIOL REP, V39, P1231, DOI 10.1007/s11033-011-0853-8
   Ryan Jennifer M, 2005, J Inflamm (Lond), V2, P8, DOI 10.1186/1476-9255-2-8
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Saw KY, 2013, ARTHROSCOPY, V29, P684, DOI 10.1016/j.arthro.2012.12.008
   Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054
   Saw KY, 2009, ARTHROSCOPY, V25, P1391, DOI 10.1016/j.arthro.2009.07.011
   Schinhan M, 2012, J ORTHOP RES, V30, P214, DOI 10.1002/jor.21521
   SCHWARZ RI, 1987, ANN NY ACAD SCI, V498, P172, DOI 10.1111/j.1749-6632.1987.tb23760.x
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Shao XX, 2006, TISSUE ENG, V12, P1539, DOI 10.1089/ten.2006.12.1539
   Shao XX, 2006, BIOMATERIALS, V27, P1071, DOI 10.1016/j.biomaterials.2005.07.040
   Shimomura K, 2014, TISSUE ENG A
   Shimomura K, 2010, BIOMATERIALS, V31, P8004, DOI 10.1016/j.biomaterials.2010.07.017
   Solheim E, 2013, KNEE, V20, P287, DOI 10.1016/j.knee.2013.01.001
   Steinwachs M, 2012, CARTILAGE, V3, P5, DOI 10.1177/1947603511415839
   Stokes DG, 2001, BIOCHEM J, V360, P461, DOI 10.1042/0264-6021:3600461
   Stufkens SA, 2010, J BONE JOINT SURG AM, V92A, P279, DOI 10.2106/JBJS.H.01635
   Tay LX, 2012, AM J SPORT MED, V40, P83, DOI 10.1177/0363546511420819
   Teo BJX, 2013, CLIN ORTHOP RELAT R, V471, P1152, DOI 10.1007/s11999-012-2338-z
   Uematsu K, 2005, BIOMATERIALS, V26, P4273, DOI 10.1016/j.biomaterials.2004.10.037
   Valderrabano V, 2009, AM J SPORT MED, V37, p105S, DOI 10.1177/0363546509351481
   Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wakitani S, 2007, J TISSUE ENG REGEN M, V1, P74, DOI 10.1002/term.8
   Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299
   Wayne JS, 2005, TISSUE ENG, V11, P953, DOI 10.1089/ten.2005.11.953
   Wegener B, 2010, J BIOMED MATER RES A, V95A, P735, DOI 10.1002/jbm.a.32885
   Williams SK, 2003, J BONE JOINT SURG AM, V85A, P2111, DOI 10.2106/00004623-200311000-00008
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   World Health Organization Scientific Group, 2003, WHO TECHN REP SER, V919, P24
   Zhang Y, 2012, INT ORTHOP, V36, P1079, DOI 10.1007/s00264-011-1362-z
   Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212
   Zscharnack M, 2010, AM J SPORT MED, V38, P1857, DOI 10.1177/0363546510365296
NR 121
TC 60
Z9 60
U1 1
U2 21
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-6354
EI 1478-6362
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2014
VL 16
IS 5
AR 432
DI 10.1186/s13075-014-0432-1
PG 19
WC Rheumatology
SC Rheumatology
GA CB8NC
UT WOS:000349885900011
PM 25606595
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Sinha, S
   Pramanik, PC
   Begam, H
   Chanda, A
AF Sinha, Sarmita
   Pramanik, Prabir Chandra
   Begam, Howa
   Chanda, Abhijit
BE Balasubramanian, KR
   Sivapirakasam, SP
   Anand, R
TI Study on the effect of strain rate and temperature on mechanical
   properties of Nitinol
SO DYNAMICS OF MACHINES AND MECHANISMS, INDUSTRIAL RESEARCH
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT 16th International Mechanical Engineering Congress (IMEC)
CY JUN 13-15, 2014
CL Tamil Nadu, INDIA
SP Natl Inst Technol, Dept Mech Engn, Techn Educ Qual Improvement Programme
DE Biomaterial; Super elastic; Nitinol; hysteresis; Heamocompatibility
AB The successful use of Nickel-Titanium (Nitinol) in biomedical applications requires an accurate control of its unique mechanical properties. The purpose of this study is to analyze the effects of a wide range of heat treatments on the mechanical behaviour of Nitinol. We have taken two different grades of Nitinol with different heat treatment history and surface characteristics. Series of tensile tests were performed using universal testing machine to find out various mechanical properties.
C1 [Sinha, Sarmita; Pramanik, Prabir Chandra; Begam, Howa; Chanda, Abhijit] Jadavpur Univ, Sch Biosci & Engn, Kolkata 700032, India.
RP Sinha, S (reprint author), Jadavpur Univ, Sch Biosci & Engn, Kolkata 700032, India.
EM sinha.sarmita@gmail.com; prabirchandra67@gmail.com; howabegam@gmail.com;
   abhijitchanda.biomed@gmail.com
CR Adharapurapu RR, 2010, MAT SCI ENG A-STRUCT, V527, P5255, DOI 10.1016/j.msea.2010.04.076
   Halani PR, 2013, MAT SCI ENG A-STRUCT, V559, P836, DOI 10.1016/j.msea.2012.09.031
   Nayan N, 2009, MAT SCI ENG A-STRUCT, V525, P60, DOI 10.1016/j.msea.2009.07.038
   Pelton AR, 2000, MINIM INVASIV THER, V9, P107, DOI 10.3109/13645700009063057
   Sadiq H., 2010, SMART MAT STRUCT, V19
   Schlun M, 2011, J MATER ENG PERFORM, V20, P684, DOI 10.1007/s11665-010-9790-2
   Shabalovskaya SA, 2013, MAT SCI ENG C-MATER, V33, P127, DOI 10.1016/j.msec.2012.08.018
NR 7
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-163-4
J9 APPL MECH MATER
PY 2014
VL 592-594
BP 1185
EP 1189
DI 10.4028/www.scientific.net/AMM.592-594.1185
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BC0BL
UT WOS:000348897200223
DA 2018-10-19
ER

PT S
AU Ferreira, JRM
   da Rocha, DN
   Louro, LHL
   da Silva, MHP
AF Muniz Ferreira, Jose Ricardo
   da Rocha, Daniel Navarro
   Leme Louro, Luis Henrique
   Prado da Silva, Marcelo H.
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI Phosphating of Calcium Carbonate for Obtaining Hydroxyapatite From the
   Ostrich Egg Shell
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE Synthesis of Hydroxyapatite; Ostrich Eggshell; Phosphating of Calcium
   Carbonate
AB Hydroxyapatite (HA), the major component of the inorganic portion of bones, may be obtained from different sources for use as biomaterial in the reconstruction of critical bone defects. Among these resources, the eggshell appears as a promising alternative since it is a waste material which may be reused as a source of calcium carbonate after adequate treatment, giving rise to mineral hydroxyapatite. After morphological and physicochemical adjustments allowing its standardization and utilization, hydroxyapatite (HA) may turn into a potentially useful biomaterial for different experimental purposes. This paper aims to present a viable method for obtaining a hydroxyapatite from ostrich eggshell by a wet precipitation process. This phosphating technique with emphasis on the issue of sustainable reuse of disposable materials allows the production of a synthetic crystalline material with characteristics similar to those of bone and tooth. The structural characterization was performed by X-ray diffraction and scanning electron microscopy with field emission gun and energy dispersive X-ray in the Military Institute of Engineering.
C1 [Muniz Ferreira, Jose Ricardo; da Rocha, Daniel Navarro; Leme Louro, Luis Henrique; Prado da Silva, Marcelo H.] IME, Rio De Janeiro, RJ, Brazil.
RP Ferreira, JRM (reprint author), IME, Rio De Janeiro, RJ, Brazil.
EM marceloprado@ime.eb.br
RI Navarro da Rocha, Daniel/C-9386-2018
OI Navarro da Rocha, Daniel/0000-0003-2413-345X
CR Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Dupoirieux L, 1999, BRIT J ORAL MAX SURG, V37, P467, DOI 10.1054/bjom.1999.0041
   Garg A. K., 1999, TISSUE ENG APPL MAXI
   JUNQUEIRA LC, 1982, HISTOLOGIA BASICA
   Kokubo T., 2003, BIOMATERIAL IN PRESS
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   Lynch S.E., 1999, TISSUE ENG APPL MAXI
   Misch CA, 1999, CONT IMPLANT DENT
   Nayak AK, 2010, INT J CHEMTECH RES, V2
   Oliveira D.A., 2009, 2 INT WORKSH ADV CLE
   Saadoun A P, 1999, Pract Periodontics Aesthet Dent, V11, P1063
   Vollmer T.M., 2006, THESIS UFRGS
   Yamamoto M.K, 1994, REV ODONTOL U S PAUL, V8, P281
NR 13
TC 0
Z9 0
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 69
EP 73
DI 10.4028/www.scientific.net/KEM.587.69
PG 5
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000011
DA 2018-10-19
ER

PT S
AU Tonoli, MS
   Beppu, MM
AF Tonoli, Marina S.
   Beppu, Marisa M.
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI In situ X-ray diffraction study of phase development during hardening of
   beta- tricalcium phosphate bone cements with chitosan
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE calcium phosphate cements; biomaterial; chitosan; hardening process
ID CALCIUM-PHOSPHATE; CALCIFICATION
AB The aim of this work was to study the phase transformation during the setting reaction of beta tricalcium phosphate (beta-TCP) and phosphoric acid with chitosan solution added. To follow the kinetics of the phase transformation, two methods were used: x-ray diffraction (XRD) was used to study the phase evolution during the hardening process in real time, and was also used in samples where the reaction was supposedly stopped in different times using acetone, as indicated in literature. The setting reaction occurs so fast that the phase transformation could not be observed, but it was possible to invalidate the second mentioned method for this system, as it induces the final product dicalcium phosphate dihydrate DCPD (brushite) to be converted into his anhydrous form dicalcium phosphate DCP (monetite). The addition of chitosan in order to improve biocompatibility was successfully done, it could be observed that chitosan inhibits brushite crystallization in the first moment of the reaction, but the final product was not affected by it.
C1 [Tonoli, Marina S.; Beppu, Marisa M.] Univ Estadual Campinas, BR-13083852 Campinas, SP, Brazil.
RP Tonoli, MS (reprint author), Univ Estadual Campinas, Caixa Postal 6066, BR-13083852 Campinas, SP, Brazil.
EM marinatonoli@gmail.com; beppu@feq.unicamp.br
RI BEPPU, MARISA/E-1057-2012
CR Aimoli CG, 2007, ARTIF ORGANS, V31, P278, DOI 10.1111/j.1525-1594.2007.00376.x
   Aimoli CG, 2006, COLLOID SURFACE B, V53, P15, DOI 10.1016/j.colsurfb.2006.07.012
   Aimoli CG, 2006, MAT SCI ENG C-BIO S, V26, P78, DOI 10.1016/j.msec.2005.06.037
   [Anonymous], ASTMC26604
   Beppu MM, 2004, KEY ENG MAT, V254-2, P311, DOI 10.4028/www.scientific.net/KEM.254-256.311
   Beppu MM, 2003, MAT SCI ENG C-BIO S, V23, P651, DOI 10.1016/j.msec.2003.08.002
   Bohner M, 2000, J MATER SCI-MATER M, V11, P155, DOI 10.1023/A:1008927624493
   Bohner M., 1993, J MAT SCI MAT MED, V8
   Bohner M, 2007, J MATER CHEM, V17, P3980, DOI 10.1039/b706411j
   Dorozhkin S. V., 2009, MATERIALS, V27, P221
   Dosen A, 2011, AM MINERAL, V96, P368, DOI 10.2138/am.2011.3544
   Galembeck F, 1996, NATO ASI 3 HIGH TECH, V12, P267
   Ginebra M.P., 1996, THESIS U POLITECNICA
   Grover LM, 2005, J MATER CHEM, V15, P4955, DOI 10.1039/b507056m
   JINLONG N, 2001, J MATER SYNTH PROC, V9, P235
   LeGeros R. Z., 1982, J DENT RES, V61, P343
   Rau JV, 2008, ACTA BIOMATER, V4, P1089, DOI 10.1016/j.actbio.2008.01.006
   Tonoli MS, 2006, KEY ENG MAT, V309-311, P845, DOI 10.4028/www.scientific.net/KEM.309-311.845
NR 18
TC 1
Z9 1
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 109
EP 114
DI 10.4028/www.scientific.net/KEM.587.109
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000018
DA 2018-10-19
ER

PT S
AU Ion, RM
   Poinescu, AA
   Doncea, SM
AF Ion, Rodica-Mariana
   Poinescu, Aurora Anca
   Doncea, Sanda-Maria
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI Novel three-component composite materials (hydroxyapatite/polymer
   mixtures) for bone regeneration
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE hydroxyapatite/polymer mixtures; chitosan; chitine; collagen;
   carboxmethylcellulose
ID CHITOSAN
AB Biomaterial is a non-drug substance suitable for inclusion in systems which augment or replace the function of body tissues or organs. The nano-hydroxyapatite (HAp) is one of the most applied biomaterial, a popular bone substitute, for coatings and other filler materials due to their ability to promote mineralization. Hydroxyapatite [Ca-10(PO4)(6)(OH)(2)] is one of the most stable forms of calcium phosphate and it occurs in bones as major component (60 to 65%), along with other materials including collagen, chondroitin sulfate, keratin sulfate and lipids.
   In order to improve the bioactivity and mechanical properties of hydroxyapatite, some synthetic and natural polymers (e.g., cellulose, collagen, chitosan, chitine) have been used as excellent candidates for bone/cartilage tissue engineering applications.
   In this paper we propose to synthesize novel three-component composite materials from HAp and cellulose (carboxymethyl cellulose, CMC) with one of the following natural polymers (chitosan (CS), chitine (CT), collagen (CLG), all of them named CX), biocompatible (from CMC) and with excellent antimicrobial activity (from HAp). Similarly to CS, CMC has an extensive network of intra- and inter-molecular hydrogen bonds which makes it insoluble in water or in common organic solvents. To prepare this new composite material, ionic liquids (ILs) have been used as potential green solvents for biopolymers, knowing that 1-butyl-3-methylimidazolium chloride [BMImCl] is able to dissolve up to 10% (w/w) of CMC, and other polysaccharides such as CS. In the studied systems, HAp particles were dispersed uniformly in organic phase, and are present strong chemical interactions between the three phases.. In our case, a highly porous film was prepared and its bioactivity was investigated by in vitro tests in a simulated body fluid (SBF) for 6 months. By ICP-OES, was found a migration of analyzed metals (Fe, Mn, Cr and Ni) in simulated physiological fluids (SBF) analyzed after a period of 6 months, but only in the ppb concentrations range.
   Different system (HAp/CX/CMC) composites with weight ratios of 70/10/20, 70/15/15 and 70/20/10 were prepared. The new composites were characterized by infrared spectroscopy Fourier transformed (FT-IR), scanning electron microscopy (SEM) and ICP-OES.
   Their antimicrobial activity has been tested on Candida albicans, Candida parapsilosis and Staphylococcus aureus, proofing an excellent antimicrobial activity.
C1 [Ion, Rodica-Mariana; Doncea, Sanda-Maria] ICECHIM, Nanomed Res Grp, Bucharest, Romania.
   [Ion, Rodica-Mariana; Poinescu, Aurora Anca; Doncea, Sanda-Maria] Valahia Univ, Mat Engn Fac, Targoviste, Romania.
RP Ion, RM (reprint author), ICECHIM, Nanomed Res Grp, Bucharest, Romania.
EM rodica_ion2000@yahoo.co.uk; poinescua@yahoo.com;
   sandamariadoncea@yahoo.com
OI Ion, Rodica Mariana/0000-0002-9842-3321
CR Bernardi G., 1971, METHOD ENZYMOL, V22, P332
   Chen JD, 2010, COLLOID SURFACE B, V81, P640, DOI 10.1016/j.colsurfb.2010.08.017
   Duri S, 2012, ECS TRANSACTIONS, V50, P573, DOI 10.1149/05011.0573ecst
   El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i
   Finkenstadt VL, 1998, MACROMOLECULES, V31, P7776, DOI 10.1021/ma9804895
   Hench L. L., 2002, BIOMATERIALS, V19, P1429
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   Kajzer W., 2008, J ACHIEVEMENTS MAT M, V31, P247
   Kurita K, 2006, MAR BIOTECHNOL, V8, P203, DOI 10.1007/s10126-005-0097-5
   Liuyun J, 2008, CARBOHYDR POL, V74, P680
   Mututuvari T. M., JBMM34636
   Muzzarelli C, 2002, J INORG BIOCHEM, V92, P89, DOI 10.1016/S0162-0134(02)00486-5
   Pinheiro AG, 2007, POLYM COMPOSITE, V28, P582, DOI 10.1002/pc.20267
   Poinescu AA, 2011, J OPTOELECTRON ADV M, V13, P416
   Poinescu A. A., 2010, P SPIE INT SOC OPTIC, V7821, P1
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Tsioptsias C, 2008, CARBOHYD POLYM, V74, P99, DOI 10.1016/j.carbpol.2008.01.022
   Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Zhang H, 2009, MOD PHYS LETT B, V23, P3967, DOI 10.1142/S0217984909022071
NR 21
TC 1
Z9 1
U1 2
U2 23
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 197
EP +
DI 10.4028/www.scientific.net/KEM.587.197
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000032
DA 2018-10-19
ER

PT S
AU Rimondini, L
   della Valle, C
   Cochis, A
   Azzimonti, B
   Chiesa, R
AF Rimondini, Lia
   della Valle, Cinzia
   Cochis, Andrea
   Azzimonti, Barbara
   Chiesa, Roberto
BE Antoniac, I
   Cavalu, S
   Traistaru, T
TI The biofilm formation onto implants and prosthetic materials may be
   contrasted using Gallium (3(+))
SO BIOCERAMICS, VOL 25
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 25th Symposium and Annual Meeting of the
   International-Society-for-Ceramics-in-Medicine (ISCM)
CY NOV 07-10, 2013
CL Bucharest, ROMANIA
SP Int Soc Ceram Med
DE biomaterials; oral implant; dental materials; oral plaque; oral biofilm;
   functionalized materials; surface modification
ID TRANSITION-METAL GALLIUM; PSEUDOMONAS-AERUGINOSA; IRON-METABOLISM;
   INFECTIONS
AB Bacterial contamination of implanted devices is a common cause of their failure. Microbial contamination of the biomaterials differs from that of natural tissues. In fact, the contamination modalities of medical devices depend on many peculiar factors related to them: the chemistry of the biomaterial, the physical properties of the surface, the design of the medical device, the extension of surgical invasion, and the time of application. The environment and/or the conditions and response of the host also contribute to the development of infection.
   Viruses, fungi, protozoa and bacteria are all involved in biomaterial contamination. They are endogenous commensals of the mouth, not virulent in planktonic form, but pathogens when arranged in biofilm.
   In this paper we review the potency of application of Gallium doping to the surface biomaterials addressed for surgical implantation in order to contrast the bacteria biofilm formation.
C1 [Rimondini, Lia; Cochis, Andrea; Azzimonti, Barbara] Univ Piemonte Orientale Amedeo Avogadro, Via Solaroli 17, I-28100 Novara, Italy.
   [della Valle, Cinzia; Chiesa, Roberto] Politecn Milan, I-20100 Milan, Italy.
RP Rimondini, L (reprint author), Univ Piemonte Orientale Amedeo Avogadro, Via Solaroli 17, I-28100 Novara, Italy.
EM lia.rimondini@med.unipmn.it; cinzia.dellavalle@polimi.it;
   andrea.cochis@med.unipmn.it; barbara.azzimonti@med.unipmn.it;
   roberto.chiesa@polimi.it
RI Chiesa, Roberto/N-2605-2013
OI Chiesa, Roberto/0000-0002-5317-6849; Cochis, Andrea/0000-0003-2455-8239
CR Banin E, 2008, P NATL ACAD SCI USA, V105, P16761, DOI 10.1073/pnas.0808608105
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Bernstein LR, 1998, PHARMACOL REV, V50, P665
   Chen L, 2011, INT J ORAL SCI, V3, P66, DOI 10.4248/IJOS11022
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Halwani M, 2008, J ANTIMICROB CHEMOTH, V62, P1291, DOI 10.1093/jac/dkn422
   Kaneko Y, 2007, J CLIN INVEST, V117, P877, DOI 10.1172/JCI30783
   Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001
   Mantareva V, 2011, PHOTOCH PHOTOBIO SCI, V10, P91, DOI 10.1039/b9pp00154a
   Olakanmi O, 2000, INFECT IMMUN, V68, P5619, DOI 10.1128/IAI.68.10.5619-5627.2000
   Olczak T, 2012, ARCH MICROBIOL, V194, P719, DOI 10.1007/s00203-012-0804-3
   Peeters E, 2008, J ANTIMICROB CHEMOTH, V61, P1062, DOI 10.1093/jac/dkn072
   Pickup DM, 2009, J MATER SCI, V44, P1858, DOI 10.1007/s10853-008-3237-2
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Rimondini L, 2005, J Appl Biomater Biomech, V3, P1
   Seneviratne CJ, 2008, ORAL DIS, V14, P582, DOI 10.1111/j.1601-0825.2007.01424.x
   Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x
   Valappil SP, 2013, DALTON T, V42, P1778, DOI 10.1039/c2dt32235h
   Valappil SP, 2012, ACTA BIOMATER, V8, P1957, DOI 10.1016/j.actbio.2012.01.017
   Yang LA, 2011, INT J ORAL SCI, V3, P74, DOI 10.4248/IJOS11027
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhu YY, 2013, EXP THER MED, V5, P1001, DOI 10.3892/etm.2013.946
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zlowodzki M, 2007, INT ORTHOP, V31, P409, DOI 10.1007/s00264-006-0187-7
NR 26
TC 3
Z9 3
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2014
VL 587
BP 315
EP +
DI 10.4028/www.scientific.net/KEM.587.315
PG 3
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials
SC Materials Science
GA BA4RR
UT WOS:000336185000052
DA 2018-10-19
ER

PT S
AU Shea, LD
   Woodruff, TK
   Shikanov, A
AF Shea, Lonnie D.
   Woodruff, Teresa K.
   Shikanov, Ariella
BE Yarmush, ML
TI Bioengineering the Ovarian Follicle Microenvironment
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE oncofertility; biomaterial; transplantation; oocyte; infertility; tissue
   engineering
ID DEVELOPMENT IN-VITRO; ENCAPSULATED 3-DIMENSIONAL CULTURE; MONOZYGOTIC
   TWINS DISCORDANT; GENE-EXPRESSION PROFILES; MOUSE OOCYTE DEVELOPMENT;
   GROWTH-FACTOR DELIVERY; LONG-TERM CULTURE; FERTILITY PRESERVATION;
   PREANTRAL FOLLICLES; PRIMORDIAL FOLLICLES
AB Chemo- and radiation therapies used to treat cancer can have the unintended effect of making patients infertile. Clinically established fertility preservation methods, such as egg and embryo cryopreservation, are not applicable to all patients, which has motivated the development of strategies that involve ovarian tissue removal and cryopreservation before the first sterilizing treatment. To restore fertility at a later date, the early-stage follicles present in the tissue must be matured to produce functional oocytes, a process that is not possible using existing cell culture technologies. This review describes the application of tissue engineering principles to promote ovarian follicle maturation and produce mature oocytes through either in vitro culture or transplantation. The design principles for these engineered systems are presented, along with identification of emerging opportunities in reproductive biology.
C1 [Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Dept Biomed Engn, McCormick Sch Engn, Evanston, IL 60208 USA.
   [Shea, Lonnie D.] Northwestern Univ, Inst BioNanotechnol Med IBNAM, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, Chem Life Proc Inst CLP, Evanston, IL 60208 USA.
   [Woodruff, Teresa K.] Northwestern Univ, Dept Obstet & Gynecol, Feinberg Sch Med, Evanston, IL 60208 USA.
   [Shea, Lonnie D.; Woodruff, Teresa K.] Northwestern Univ, CRS, Evanston, IL 60208 USA.
   [Shikanov, Ariella] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
   [Shikanov, Ariella] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu; tkw@northwestern.edu; shikanov@umich.edu
OI Woodruff, Teresa/0000-0002-1197-3399; Shikanov,
   Ariella/0000-0003-0159-6419
FU NIBIB NIH HHS [PL1 EB008542]; NICHD NIH HHS [P50 HD076188, U54 HD041857,
   U54 HD076188]
CR Adamson GD, 2013, FERTIL STERIL, V100, pS42, DOI 10.1016/j.fertnstert.2013.07.1807
   Ahn RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058491
   Amsden B, 1999, BIOTECHNOL BIOENG, V65, P605, DOI 10.1002/(SICI)1097-0290(19991205)65:5<605::AID-BIT14>3.0.CO;2-C
   Anderson RA, 2006, HUM REPROD, V21, P2583, DOI 10.1093/humrep/del201
   Ata B, 2010, BEST PRACT RES CL OB, V24, P101, DOI 10.1016/j.bpobgyn.2009.11.007
   Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035
   Barrett SL, 2007, BIOL REPROD, V76, P949, DOI 10.1095/biolreprod.106.057141
   Bhattacharya P, 2012, TOXICOL APPL PHARM, V261, P227, DOI 10.1016/j.taap.2012.04.009
   Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025
   Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006
   Chin KV, 2002, FERTIL STERIL, V77, P1214, DOI 10.1016/S0015-0282(02)03114-X
   Clement F, 2001, AM J PHYSIOL-ENDOC M, V281, pE35
   CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203
   Cortvrindt R, 1996, HUM REPROD, V11, P2656
   Davis VL, 2006, CANCER, V107, P1690, DOI 10.1002/cncr.22105
   Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437
   Dolmans MM, 2013, FERTIL STERIL, V99, P1514, DOI 10.1016/j.fertnstert.2013.03.027
   Dolmans MM, 2010, BLOOD, V116, P2908, DOI 10.1182/blood-2010-01-265751
   Donnez J, 2013, FERTIL STERIL, V99, P1503, DOI 10.1016/j.fertnstert.2013.03.030
   Donnez J, 2013, FERTIL STERIL, V99, P1467, DOI 10.1016/j.fertnstert.2013.03.040
   Duncan FE, 2012, AGING CELL, V11, P1121, DOI 10.1111/j.1474-9726.2012.00866.x
   Duncan FE, 2009, BIOL REPROD, V81, P768, DOI 10.1095/biolreprod.109.077909
   Echenim N, 2005, MATH BIOSCI, V198, P57, DOI 10.1016/j.mbs.2005.05.003
   Eppig JJ, 1996, BIOL REPROD, V54, P197, DOI 10.1095/biolreprod54.1.197
   EPPIG JJ, 1977, DEV BIOL, V60, P371, DOI 10.1016/0012-1606(77)90135-X
   EPPIG JJ, 1989, BIOL REPROD, V41, P268, DOI 10.1095/biolreprod41.2.268
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   GOSDEN RG, 1990, HUM REPROD, V5, P499, DOI 10.1093/oxfordjournals.humrep.a137132
   Gosden Roger G, 2005, J Natl Cancer Inst Monogr, P60
   Gosden RG, 2008, REPRODUCTION, V136, P671, DOI 10.1530/REP-08-0099
   Gutierrez CG, 2000, BIOL REPROD, V62, P1322, DOI 10.1095/biolreprod62.5.1322
   Hasegawa A, 2009, J REPROD IMMUNOL, V83, P40, DOI 10.1016/j.jri.2009.09.002
   Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065
   Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052
   Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420
   Hirshfeld-Cytron JE, 2011, HUM REPROD, V26, P2473, DOI 10.1093/humrep/der183
   Hornick JE, 2013, REPRODUCTION, V145, P19, DOI 10.1530/REP-12-0233
   Hornick JE, 2012, HUM REPROD, V27, P1801, DOI 10.1093/humrep/der468
   Hunt P, 2010, CURR BIOL, V20, pR699, DOI 10.1016/j.cub.2010.08.011
   Jeruss JS, 2009, NEW ENGL J MED, V360, P902, DOI 10.1056/NEJMra0801454
   Jewgenow K, 2006, THERIOGENOLOGY, V66, P93, DOI 10.1016/j.theriogenology.2006.03.010
   Jin SY, 2010, FERTIL STERIL, V93, P2633, DOI 10.1016/j.fertnstert.2009.10.027
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Kreeger PK, 2006, BIOMATERIALS, V27, P714, DOI 10.1016/j.biomaterials.2005.06.016
   Kreeger PK, 2003, MOL CELL ENDOCRINOL, V205, P1, DOI 10.1016/S0303-7207(03)00209-0
   Krotz SP, 2010, J ASSIST REPROD GEN, V27, P743, DOI 10.1007/s10815-010-9468-6
   Ksiazkiewicz Lucyna Katska, 2006, Reprod Biol, V6, P3
   Lawrence N. D., 2010, LEARNING INFERENCE C
   Lenie S, 2004, BIOL REPROD, V71, P1730, DOI 10.1095/biolreprod.104.028415
   Lenie S, 2008, MUTAT RES-GEN TOX EN, V651, P71, DOI 10.1016/j.mrgentox.2007.10.017
   Lintsen AME, 2005, HUM REPROD, V20, P1867, DOI 10.1093/humrep/deh898
   Loren AW, 2013, J CLIN ONCOL, V31, P2500, DOI 10.1200/JCO.2013.49.2678
   Machluf M, 2003, BIOTECHNOL GENET ENG, V20, P183, DOI 10.1080/02648725.2003.10648043
   Malizia BA, 2009, NEW ENGL J MED, V360, P236, DOI 10.1056/NEJMoa0803072
   Malloch L, 2013, FERTIL STERIL, V100, P1740, DOI 10.1016/j.fertnstert.2013.08.040
   Martinovitch PN, 1938, PROC R SOC SER B-BIO, V125, P232, DOI 10.1098/rspb.1938.0024
   McLaughlin M, 2010, MOL HUM REPROD, V16, P644, DOI 10.1093/molehr/gaq021
   Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535
   Memili E, 2007, REPRODUCTION, V133, P1107, DOI 10.1530/REP-06-0149
   Michelmore KF, 1999, CLIN ENDOCRINOL, V51, P779, DOI 10.1046/j.1365-2265.1999.00886.x
   Michelmore KF, 2000, HUM FERTIL, V3, P96
   Natl. Cancer Inst, 2012, SEER DAT 1973 2010
   Nelson SM, 2007, CURR OPIN OBSTET GYN, V19, P384, DOI 10.1097/GCO.0b013e32825e1d70
   Nieman Carrie L, 2006, J Support Oncol, V4, P171
   Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637
   Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3
   O'Brien MJ, 2003, BIOL REPROD, V68, P1682, DOI 10.1095/biolreprod.102.013029
   Oktay K, 2013, AM J OBSTET GYNECOL, V209, P77, DOI 10.1016/j.ajog.2013.05.036
   Osborn SM, 1997, HUM REPROD, V12, pP153
   Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023
   Pan H, 2008, DEV BIOL, V316, P397, DOI 10.1016/j.ydbio.2008.01.048
   Pangas SA, 2003, TISSUE ENG, V9, P1013, DOI 10.1089/107632703322495655
   Parrish EM, 2011, REPRODUCTION, V142, P309, DOI 10.1530/REP-10-0481
   Paulose T, 2012, BIRTH DEFECTS RES B, V95, P219, DOI 10.1002/bdrb.21007
   Peddinti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011240
   Poirot CJ, 2007, PEDIATR BLOOD CANCER, V49, P74, DOI 10.1002/pbc.21027
   Purcell SH, 2011, J ASSIST REPROD GEN, V28, P517, DOI 10.1007/s10815-011-9592-y
   Redding GP, 2007, REPRODUCTION, V133, P1095, DOI 10.1530/REP-06-0171
   Reinecke I, 2007, J THEOR BIOL, V247, P303, DOI 10.1016/j.jtbi.2007.03.011
   Revelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-40
   Robker Rebecca L, 2008, Pathophysiology, V15, P115, DOI 10.1016/j.pathophys.2008.04.004
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   ROY SK, 1993, FERTIL STERIL, V59, P783
   Sasson R, 2003, FASEB J, V17, P1256, DOI 10.1096/fj.02-0740com
   Schover LR, 1999, CANCER, V86, P697, DOI 10.1002/(SICI)1097-0142(19990815)86:4<697::AID-CNCR20>3.0.CO;2-J
   Sharma GT, 2009, ANIM REPROD SCI, V114, P115, DOI 10.1016/j.anireprosci.2008.09.009
   Shikanov Ariella, 2011, J Vis Exp, DOI 10.3791/2695
   Shikanov A, 2011, TISSUE ENG PT A, V17, P3095, DOI [10.1089/ten.tea.2011.0204, 10.1089/ten.TEA.2011.0204]
   Shikanov A, 2011, BIOMATERIALS, V32, P2524, DOI 10.1016/j.biomaterials.2010.12.027
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   Siegelmann-Danieli N, 2003, ANN SURG ONCOL, V10, P1031, DOI 10.1245/ASO.2003.03.068
   Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032
   Silber S, 2010, FERTIL STERIL, V94, P2191, DOI 10.1016/j.fertnstert.2009.12.073
   Silber SJ, 2005, NEW ENGL J MED, V353, P58, DOI 10.1056/NEJMoa043157
   Sittadjody S, 2013, BIOMATERIALS, V34, P2412, DOI 10.1016/j.biomaterials.2012.11.059
   Skinner MK, 2008, MOL REPROD DEV, V75, P1457, DOI 10.1002/mrd.20883
   Smith RM, 2014, TISSUE EN A IN PRESS
   Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056
   Songsasen N, 2011, REPRODUCTION, V142, P113, DOI 10.1530/REP-10-0442
   Sperling LH, 1996, POLYM ADVAN TECHNOL, V7, P197, DOI 10.1002/(SICI)1099-1581(199604)7:4<197::AID-PAT514>3.0.CO;2-4
   Sriraman V, 2006, MOL ENDOCRINOL, V20, P348, DOI 10.1210/me.2005-0317
   Tagler D, 2013, BIOTECHNOL BIOENG, V110, P3258, DOI 10.1002/bit.24986
   Tagler D, 2012, TISSUE ENG PT A, V18, P1229, DOI [10.1089/ten.TEA.2011.0418, 10.1089/ten.tea.2011.0418]
   TAMBE SS, 1993, STEROIDS, V58, P379, DOI 10.1016/0039-128X(93)90041-K
   TANAKA H, 1984, BIOTECHNOL BIOENG, V26, P53, DOI 10.1002/bit.260260111
   Teissier MP, 2000, HUM REPROD, V15, P2471, DOI 10.1093/humrep/15.12.2471
   Telfer EE, 2013, FERTIL STERIL, V99, P1523, DOI 10.1016/j.fertnstert.2013.03.043
   Ting AY, 2011, HUM REPROD, V26, P2461, DOI 10.1093/humrep/der196
   Tingen C, 2009, MOL HUM REPROD, V15, P795, DOI 10.1093/molehr/gap073
   Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483
   TORRANCE C, 1989, J REPROD FERTIL, V87, P367
   Vanacker J, 2012, BIOMATERIALS, V33, P6079, DOI 10.1016/j.biomaterials.2012.05.015
   Vanselow J, 2010, BIOL REPROD, V82, P289, DOI 10.1095/biolreprod.109.079251
   Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772
   Wang L, 2012, TISSUE ENG PT A, V18, P2000, DOI [10.1089/ten.tea.2011.0663, 10.1089/ten.TEA.2011.0663]
   West ER, 2007, BIOMATERIALS, V28, P4439, DOI 10.1016/j.biomaterials.2007.07.001
   West-Farrell ER, 2009, BIOL REPROD, V80, P432, DOI 10.1095/biolreprod.108.071142
   Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200
   Woodruff Teresa K, 2007, Reprod Sci, V14, P6, DOI 10.1177/1933719107309818
   Woodruff TK, 2011, J ASSIST REPROD GEN, V28, P3, DOI 10.1007/s10815-010-9478-4
   Woods DC, 2013, NAT PROTOC, V8, P966, DOI 10.1038/nprot.2013.047
   Xu J, 2013, HUM REPROD, V28, P2187, DOI 10.1093/humrep/det093
   Xu M, 2006, TISSUE ENG, V12, P2739, DOI 10.1089/ten.2006.12.2739
   Xu M, 2006, BIOL REPROD, V75, P916, DOI 10.1095/biolreprod.106.054833
   Xu M, 2011, BIOL REPROD, V84, P689, DOI 10.1095/biolreprod.110.088674
   Xu M, 2009, BIOL REPROD, V81, P587, DOI 10.1095/biolreprod.108.074732
   Xu M, 2009, HUM REPROD, V24, P2531, DOI 10.1093/humrep/dep228
   Yoon SJ, 2006, FERTIL STERIL, V85, P193, DOI 10.1016/j.fertnstert.2005.07.1296
NR 128
TC 48
Z9 49
U1 0
U2 13
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3516-8
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2014
VL 16
BP 29
EP 52
DI 10.1146/annurev-bioeng-071813-105131
PG 24
WC Engineering, Biomedical
SC Engineering
GA BB9LF
UT WOS:000348433000002
PM 24849592
OA Green Accepted
DA 2018-10-19
ER

PT S
AU Bajaj, P
   Schweller, RM
   Khademhosseini, A
   West, JL
   Bashir, R
AF Bajaj, Piyush
   Schweller, Ryan M.
   Khademhosseini, Ali
   West, Jennifer L.
   Bashir, Rashid
BE Yarmush, ML
TI 3D Biofabrication Strategies for Tissue Engineering and Regenerative
   Medicine
SO ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 16
SE Annual Review of Biomedical Engineering
LA English
DT Review; Book Chapter
DE hydrogels; stem cells; scaffolds; bioprinting; photolithography;
   vascularization
ID EMBRYONIC STEM-CELLS; THIOL-ACRYLATE PHOTOPOLYMERS; CLICK-BASED
   HYDROGELS; IN-VITRO; 3-DIMENSIONAL HYDROGELS; POLY(ETHYLENE GLYCOL);
   CROSS-LINKING; COLLAGEN HYDROGEL; VASCULAR NETWORKS; POLYMER SCAFFOLDS
AB Over the past several decades, there has been an ever-increasing demand for organ transplants. However, there is a severe shortage of donor organs, and as a result of the increasing demand, the gap between supply and demand continues to widen. A potential solution to this problem is to grow or fabricate organs using biomaterial scaffolds and a person's own cells. Although the realization of this solution has been limited, the development of new biofabrication approaches has made it more realistic. This review provides an overview of natural and synthetic biomaterials that have been used for organ/tissue development. It then discusses past and current biofabrication techniques, with a brief explanation of the state of the art. Finally, the review highlights the need for combining vascularization strategies with current biofabrication techniques. Given the multitude of applications of biofabrication technologies, from organ/tissue development to drug discovery/screening to development of complex in vitro models of human diseases, these manufacturing technologies can have a significant impact on the future of medicine and health care.
C1 [Bajaj, Piyush; Bashir, Rashid] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
   [Bajaj, Piyush; Bashir, Rashid] Univ Illinois, Micro & Nanotechnol Lab, Urbana, IL 61801 USA.
   [Bashir, Rashid] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.
   [Bajaj, Piyush] Los Alamos Natl Lab, Def Syst & Anal Div, Los Alamos, NM 87545 USA.
   [Schweller, Ryan M.; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Khademhosseini, Ali] Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
   [Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Khademhosseini, Ali] Kyung Hee Univ, Sch Dent, Dept Maxillofacial Biomed Engn, Seoul 130701, South Korea.
   [Khademhosseini, Ali] Kyung Hee Univ, Sch Dent, Inst Oral Biol, Seoul 130701, South Korea.
   [Khademhosseini, Ali] King Abdulaziz Univ, Dept Phys, Jeddah 21569, Saudi Arabia.
RP Bajaj, P (reprint author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.
EM rbashir@illinois.edu
OI Khademhosseini, Ali/0000-0001-6322-8852
FU NHLBI NIH HHS [F32HL120650, F32 HL120650]; NIAID NIH HHS [AI081534, R01
   AI081534]; NIAMS NIH HHS [R01 AR057837, AR057837]; NIBIB NIH HHS
   [EB02597]
CR Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Annabi N, 2010, TISSUE ENG PART B-RE, V16, P371, DOI [10.1089/ten.teb.2009.0639, 10.1089/ten.TEB.2009.0639]
   Annabi N, 2013, ADV FUNCT MATER, V23, P4950, DOI 10.1002/adfm.201300570
   Arcaute K, 2006, ANN BIOMED ENG, V34, P1429, DOI 10.1007/s10439-006-9156-y
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bajaj P, 2006, INT J NANOMED, V1, P361
   Bajaj P, 2013, ADV HEALTHC MATER, V2, P450, DOI 10.1002/adhm.201200318
   Bajaj P, 2011, INTEGR BIOL-UK, V3, P897, DOI 10.1039/c1ib00058f
   Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509
   Barry RA, 2009, ADV MATER, V21, P2407, DOI 10.1002/adma.200803702
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Bryant SJ, 2007, BIOMATERIALS, V28, P2978, DOI 10.1016/j.biomaterials.2006.11.033
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Burdick JA, 2011, ADV MATER, V23, pH41, DOI 10.1002/adma.201003963
   Chan BK, 2012, MACROMOL BIOSCI, V12, P1490, DOI 10.1002/mabi.201200234
   Chan V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00857
   Chan V, 2010, LAB CHIP, V10, P2062, DOI 10.1039/c004285d
   Chen WQ, 2012, ACS NANO, V6, P4094, DOI 10.1021/nn3004923
   Cho E, 2009, J BIOMED MATER RES A, V90A, P1073, DOI 10.1002/jbm.a.32172
   Compton CC, 1998, J INVEST DERMATOL, V110, P908, DOI 10.1046/j.1523-1747.1998.00200.x
   Cuchiara MP, 2012, ADV FUNCT MATER, V22, P4511, DOI 10.1002/adfm.201200976
   Cui XF, 2009, BIOMATERIALS, V30, P6221, DOI 10.1016/j.biomaterials.2009.07.056
   Culver JC, 2012, ADV MATER, V24, P2344, DOI 10.1002/adma.201200395
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2011, NAT CHEM, V3, P925, DOI [10.1038/nchem.1174, 10.1038/NCHEM.1174]
   DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Dhariwala B, 2004, TISSUE ENG, V10, P1316, DOI 10.1089/ten.2004.10.1316
   Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dowling DP, 2011, J BIOMATER APPL, V26, P327, DOI 10.1177/0885328210372148
   Duoss EB, 2007, ADV MATER, V19, P3485, DOI 10.1002/adma.200701372
   Edalat F, 2012, CURR OPIN BIOTECH, V23, P820, DOI 10.1016/j.copbio.2012.05.007
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fairbanks BD, 2009, MACROMOLECULES, V42, P211, DOI 10.1021/ma801903w
   Ford MC, 2006, P NATL ACAD SCI USA, V103, P2512, DOI 10.1073/pnas.0506020102
   Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Gill BJ, 2012, CANCER RES, V72, P6013, DOI 10.1158/0008-5472.CAN-12-0895
   Guvendiren M, 2010, BIOMATERIALS, V31, P6511, DOI 10.1016/j.biomaterials.2010.05.037
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Halstenberg S, 2002, BIOMACROMOLECULES, V3, P710, DOI 10.1021/bm015629o
   Hammoudi TM, 2010, TISSUE ENG PART C-ME, V16, P1621, DOI [10.1089/ten.tec.2010.0146, 10.1089/ten.TEC.2010.0146]
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Haugen H, 2004, J MATER SCI-MATER M, V15, P343, DOI 10.1023/B:JMSM.0000021099.33619.ac
   He JK, 2013, ADV HEALTHC MATER, V2, P1108, DOI 10.1002/adhm.201200404
   Hess LH, 2011, ADV MATER, V23, P5045, DOI 10.1002/adma.201102990
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Hong Y, 2011, BIOMATERIALS, V32, P3387, DOI 10.1016/j.biomaterials.2011.01.025
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758
   Hwang CM, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014105
   Ivanov VV, 2001, POLYM INT, V50, P113, DOI 10.1002/1097-0126(200101)50:1<113::AID-PI594>3.0.CO;2-X
   Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207
   Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110
   Jo YS, 2010, J BIOMED MATER RES A, V93A, P870, DOI 10.1002/jbm.a.32580
   Jungebluth P, 2011, LANCET, V378, P1997, DOI 10.1016/S0140-6736(11)61715-7
   Kaehr B, 2004, P NATL ACAD SCI USA, V101, P16104, DOI 10.1073/pnas.0407204101
   Kang HW, 1999, BIOMATERIALS, V20, P1339, DOI 10.1016/S0142-9612(99)00036-8
   Kang HW, 1999, J BIOACT COMPAT POL, V14, P331, DOI 10.1177/088391159901400404
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Khetan S, 2013, NAT MATER, V12, P458, DOI [10.1038/NMAT3586, 10.1038/nmat3586]
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Killops KL, 2008, J AM CHEM SOC, V130, P5062, DOI 10.1021/ja8006325
   Kim DH, 2012, J CELL BIOL, V197, P351, DOI 10.1083/jcb.201108062
   Kim HJ, 2012, TISSUE ENG REGEN MED, V9, P63, DOI 10.1007/s13770-012-0022-8
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lai JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054058
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lanniel M, 2011, SOFT MATTER, V7, P6501, DOI 10.1039/c1sm05167a
   Lee SJ, 2008, BIOMED MICRODEVICES, V10, P233, DOI 10.1007/s10544-007-9129-4
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Leigh SJ, 2013, BIOMACROMOLECULES, V14, P186, DOI 10.1021/bm3015736
   Lewis JA, 2006, ADV FUNCT MATER, V16, P2193, DOI 10.1002/adfm.200600434
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu YX, 2012, MACROMOL BIOSCI, V12, P1034, DOI 10.1002/mabi.201200043
   Lomba M, 2011, MACROMOL BIOSCI, V11, P1505, DOI 10.1002/mabi.201100123
   Lovett M, 2009, TISSUE ENG PART B-RE, V15, P353, DOI [10.1089/ten.teb.2009.0085, 10.1089/ten.TEB.2009.0085]
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Martens P, 2001, J PHYS CHEM B, V105, P5131, DOI 10.1021/jp004102n
   Maruo S, 2002, SENSOR ACTUAT A-PHYS, V100, P70, DOI 10.1016/S0924-4247(02)00043-2
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McCall AD, 2013, TISSUE ENG PT A, V19, P2215, DOI [10.1089/ten.tea.2012.0674, 10.1089/ten.TEA.2012.0674]
   Mehrabanian M, 2011, INT J NANOMED, V6, P1651, DOI 10.2147/IJN.S21203
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Melchels FPW, 2009, BIOMATERIALS, V30, P3801, DOI 10.1016/j.biomaterials.2009.03.055
   Metters AT, 2000, POLYMER, V41, P3993, DOI 10.1016/S0032-3861(99)00629-1
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Miller GA, 2002, J POLYM SCI POL CHEM, V40, P793, DOI 10.1002/pola.10162
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   MIYATA T, 1971, BIOCHIM BIOPHYS ACTA, V229, P672, DOI 10.1016/0005-2795(71)90283-2
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Musoke-Zawedde P, 2006, BIOMED MATER, V1, P162, DOI 10.1088/1748-6041/1/3/011
   Naito H, 2013, J BIOMED MATER RES A, V101, P2838, DOI 10.1002/jbm.a.34578
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004
   Occhetta P, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/3/035002
   Park JS, 2007, J CONTROL RELEASE, V124, P51, DOI 10.1016/j.jconrel.2007,08.030
   Pataky K, 2012, ADV MATER, V24, P391, DOI 10.1002/adma.201102800
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peng Z., 2010, J MACROMOL SCI B, V50, P340
   Polizzotti BD, 2008, BIOMACROMOLECULES, V9, P1084, DOI 10.1021/bm7012636
   Quirk RA, 2004, CURR OPIN SOLID ST M, V8, P313, DOI 10.1016/j.cossms.2003.12.004
   Ross AM, 2012, SMALL, V8, P336, DOI 10.1002/smll.201100934
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Rydholm AE, 2007, POLYMER, V48, P4589, DOI 10.1016/j.polymer.2007.05.063
   Rydholm AE, 2007, ACTA BIOMATER, V3, P449, DOI 10.1016/j.actbio.2006.12.001
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Schumann P, 2014, J BIOMED MATER RES A, V102, P1652, DOI 10.1002/jbm.a.34826
   Seck TM, 2010, J CONTROL RELEASE, V148, P34, DOI 10.1016/j.jconrel.2010.07.111
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Shepherd JNH, 2011, ADV FUNCT MATER, V21, P47, DOI 10.1002/adfm.201001746
   Shih H, 2012, BIOMACROMOLECULES, V13, P2003, DOI 10.1021/bm300752j
   Shin SR, 2013, ACS NANO, V7, P2369, DOI 10.1021/nn305559j
   Smay JE, 2002, ADV MATER, V14, P1279, DOI 10.1002/1521-4095(20020916)14:18<1279::AID-ADMA1279>3.0.CO;2-A
   Sodunke TR, 2007, BIOMATERIALS, V28, P4006, DOI 10.1016/j.biomaterials.2007.05.021
   Spikes JD, 1999, PHOTOCHEM PHOTOBIOL, V70, P130, DOI 10.1111/j.1751-1097.1999.tb07980.x
   Sui ZJ, 2007, ADV MATER, V19, P3377, DOI 10.1002/adma.200700092
   Sun JG, 2009, CHINESE SCI BULL, V54, P3154, DOI 10.1007/s11434-009-0240-1
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Tekin H, 2012, ADV MATER, V24, P5543, DOI 10.1002/adma.201201805
   Terrones G, 2001, MACROMOLECULES, V34, P8894, DOI 10.1021/ma010678e
   Thomson KS, 2013, TISSUE ENG PT A, V19, P967, DOI 10.1089/ten.tea.2012.0286
   Tian BZ, 2012, NAT MATER, V11, P986, DOI [10.1038/nmat3404, 10.1038/NMAT3404]
   Timko BP, 2009, NANO LETT, V9, P914, DOI 10.1021/nl900096z
   Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com
   US Dep. Health Hum. Serv, 2014, NEED IS REAL DAT DON
   Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495
   Viventi J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000738
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WARD MD, 1995, ANN BIOMED ENG, V23, P322, DOI 10.1007/BF02584432
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Wosnick JH, 2008, CHEM MATER, V20, P55, DOI 10.1021/cm071158m
   Wylie RG, 2008, J MATER CHEM, V18, P2716, DOI 10.1039/b718431j
   Wylie RG, 2011, NAT MATER, V10, P799, DOI [10.1038/nmat3101, 10.1038/NMAT3101]
   Wylie RG, 2011, BIOMACROMOLECULES, V12, P3789, DOI 10.1021/bm201037j
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zellander A, 2013, MAT SCI ENG C-MATER, V33, P3396, DOI 10.1016/j.msec.2013.04.025
   Zhang AP, 2012, ADV MATER, V24, P4266, DOI 10.1002/adma.201202024
   Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194
   Zhang XM, 2012, J BIOMED MATER RES A, V100A, P2960, DOI 10.1002/jbm.a.34243
   Zheng XJ, 2011, LAB CHIP, V11, P3431, DOI 10.1039/c1lc20455f
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899
   Zorlutuna P, 2011, ADV FUNCT MATER, V21, P3642, DOI 10.1002/adfm.201101023
NR 168
TC 169
Z9 172
U1 25
U2 244
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1523-9829
BN 978-0-8243-3516-8
J9 ANNU REV BIOMED ENG
JI Annu. Rev. Biomed. Eng.
PY 2014
VL 16
BP 247
EP 276
DI 10.1146/annurev-bioeng-071813-105155
PG 30
WC Engineering, Biomedical
SC Engineering
GA BB9LF
UT WOS:000348433000010
PM 24905875
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Broderick, JM
   Kelly, DJ
   Mulhall, KJ
AF Broderick, James M.
   Kelly, Daniel J.
   Mulhall, Kevin J.
TI Optimizing Stem Cell Engineering for Orthopaedic Applications
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Article
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; MESENCHYMAL STEM;
   REGENERATION
AB Articular cartilage repair remains a significant challenge in orthopaedic surgery and this has led to increased interest in cell-based therapies for cartilage regeneration. Although autologous chondrocyte implantation has been used with reasonable success, there are several disadvantages associated with this technique, such as donor site availability and morbidity, dedifferentiation of the isolated chondrocytes during monolayer expansion, and poor integration of repair tissue into the native cartilage. This has led to a growing interest in the use of mesenchymal stem cells (MSCs) as an alternative cell source. MSCs are easy to isolate and are self-renewing, have a high expansion potential, and are capable of differentiating into several cell lineages, including chondrocytes and osteoblasts. Here, we highlight recent advances in the field of tissue engineering that seek to combine MSCs, biomaterial scaffolds, and chondrogenic signals (the so-called tissue engineering triad) to create functional cartilage tissue replacements.
C1 [Broderick, James M.; Mulhall, Kevin J.] Mater Misericordiae Univ Hosp, Dublin, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Trinity Ctr Bioengn, Trinity Biomed Sci Inst, Dublin 2, Ireland.
   [Kelly, Daniel J.] Univ Dublin Trinity Coll, Dept Mech & Mfg Engn, Sch Engn, Dublin 2, Ireland.
RP Broderick, JM (reprint author), Mater Misericordiae Univ Hosp, Dublin, Ireland.
OI Kelly, Daniel/0000-0003-4091-0992
CR Coburn JM, 2012, P NATL ACAD SCI USA, V109, P10012, DOI 10.1073/pnas.1121605109
   Huang AH, 2010, EUR CELLS MATER, V19, P72, DOI 10.22203/eCM.v019a08
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Liu YR, 2012, TISSUE ENG PT A, V18, P1531, DOI [10.1089/ten.tea.2011.0575, 10.1089/ten.TEA.2011.0575]
   Nguyen LH, 2011, BIOMATERIALS, V32, P6946, DOI 10.1016/j.biomaterials.2011.06.014
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Re'em T, 2012, ACTA BIOMATER, V8, P3283, DOI 10.1016/j.actbio.2012.05.014
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Thorpe SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060764
   Veronesi F, 2013, J BIOMED MAT RES A
   Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]
NR 11
TC 3
Z9 3
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1067-151X
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PD JAN
PY 2014
VL 22
IS 1
BP 63
EP 65
DI 10.5435/JAAOS-22-01-63
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA CB2IS
UT WOS:000349451200008
PM 24382881
DA 2018-10-19
ER

PT S
AU Liu, P
   Zhong, Y
   Luo, Y
AF Liu, Peng
   Zhong, Yi
   Luo, Yan
BE Tang, F
TI Preparation of PLA and PLGA Magnetic Microspheres with T-Shaped
   Microchannel Reactor
SO MICRO-NANO TECHNOLOGY XV
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 15th Annual Conference of the Chinese-Society-of-Micro-Nano-Technology
   (CSMNT) / 4th International Conference of the
   Chinese-Society-of-Micro-Nano-Technology (CSMNT)
CY NOV 03-06, 2013
CL Tianjin, PEOPLES R CHINA
SP Chinese Soc Micro Nano Technol
DE Biomaterials; Magnetic materials; Composite emulsion; T-Shaped
   microchannel reactor; Monodispersity
ID EMULSIFICATION
AB Monodisperse magnetic microspheres with biomaterial of polylactic acid (PLA) or poly lactic-co-glycolic acid (PLGA) as shell were successfully prepared via T-shaped microchannel reactor in this paper. Hydrophilic ferriferrous oxide (Fe3O4) with highly magnetic responsiveness was obtained by solvothermal method. Aqueous solution of Fe3O4 was then emulsified into a dichloromethane solution of PLA or PLGA to generate water-in-oil (W/O) emulsion. Different stabilizer, i.e. polyvinyl alcohol (PVA), gelatin or gum arabic, was then added into the W/O emulsion for the purpose of more stable system. Subsequently, W/O/W composite emulsion was formed by injecting W/O emulsion into PVA aqueous solution at the T-shaped joint of microchannel reactor. Magnetic microspheres were finally prepared by solvent evaporation in the microchannel. The characteristic functional groups of Fe3O4 were characterized by Fourier transform infrared spectroscopy (FT-IR). The magnetic property was measured with vibrating sample magnetometer (VSM). The morphology of all samples was observed by scanning electron microscopy (SEM). It was found that the magnetic microspheres exhibit a uniform particle size in micro-scale. Therefore, the T-shaped microchannel reactor was expected to create a new approach for fabricating magnetic microspheres.
C1 [Liu, Peng; Zhong, Yi; Luo, Yan] Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
RP Luo, Y (reprint author), Donghua Univ, Coll Chem Chem Engn & Biotechnol, Shanghai 201620, Peoples R China.
EM 2110468@mail.dhu.edu.cn; zhongyi@dhu.edu.cn; luoyan@dhu.edu.cn
CR Fang JH, 2013, MATER LETT, V96, P89, DOI 10.1016/j.matlet.2013.01.016
   Freitas S, 2005, J CONTROL RELEASE, V102, P313, DOI 10.1016/j.jconrel.2004.10.015
   Kalita H, 2013, POLYM ADVAN TECHNOL, V24, P819, DOI 10.1002/pat.3149
   Ke CJ, 2011, ANGEW CHEM INT EDIT, V123, P8236
   Kobayashi I, 2001, J AM OIL CHEM SOC, V78, P797, DOI 10.1007/s11746-001-0345-5
   Okushima S, 2004, LANGMUIR, V20, P9905, DOI 10.1021/la0480336
   Sugiura S, 2002, IND ENG CHEM RES, V41, P4043, DOI 10.1021/ie0201415
   van der Zwan E, 2009, LANGMUIR, V25, P7320, DOI 10.1021/la900379n
   Zhao C-X, 2013, ADV DRUG DELIV REV
NR 9
TC 1
Z9 1
U1 3
U2 18
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-071-2
J9 KEY ENG MATER
PY 2014
VL 609-610
BP 425
EP 429
DI 10.4028/www.scientific.net/KEM.609-610.425
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BB9FX
UT WOS:000348284900071
DA 2018-10-19
ER

PT S
AU Trubitsyn, MA
   Van Dat, D
   Van Thuan, L
   Gabruk, NG
   Oleynikova, II
   Shuteeva, TA
AF Trubitsyn, M. A.
   Van Dat, Doan
   Van Thuan, Le
   Gabruk, N. G.
   Oleynikova, I. I.
   Shuteeva, T. A.
BE Bogdan, A
   Martyushev, N
TI Morphological, Physical and Chemical Characteristics of Biocompatible
   Nano-Sized Carbonate-Substituted Hydroxyapatite
SO HIGH TECHNOLOGY: RESEARCH AND APPLICATIONS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT International Conference for Young Scientists on High Technology -
   Research and Applications
CY MAR 26-28, 2014
CL Tomsk Polytechn Univ, Tomsk, RUSSIA
HO Tomsk Polytechn Univ
DE nano-sized hydroxyapatite; modified hydroxyapatite; degree of
   substitution; morphology; specific surface area; biocompatibility;
   electron microscopy
AB Hydroxyapatite and compounds based on it are important and promising inorganic biomaterials that can be used in dentistry and bone surgery due to its biocompatibility with the bone tissue of a living organism. The paper presents the synthesis of carbonate-substituted hydroxyapatite powders and studies their morphology, physical and chemical characteristics and biocompatibility in vivo. The synthetic carbonate-substituted hydroxyapatite are biocompatible, and they do not cause degenerative changes in the surrounding tissues. The result of this research suggests that the carbonate-substituted hydroxyapatite is promising biomaterial for orthopedic and dental prosthetics.
C1 [Trubitsyn, M. A.] Belgorod State Natl Res Univ, 85 Pobeda Str, Belgorod, Russia.
RP Trubitsyn, MA (reprint author), Belgorod State Natl Res Univ, 85 Pobeda Str, Belgorod, Russia.
EM Troubitsin@bsu.edu.ru; datbelgo@mail.ru; thuansphoa27@mail.ru;
   gabruk@bsu.edu.ru; oleynikova@bsu.edu.ru; tatyana.shuteeva@mail.ru
CR Barinov SM, 2010, RUSS CHEM REV+, V79, P13, DOI 10.1070/RC2010v079n01ABEH004098
   Kolobov Y. R., 2007, RU Patent, Patent No. 2342319
   Porter A, 2005, J MATER SCI-MATER M, V16, P899, DOI 10.1007/s10856-005-4424-1
   Precu E., 2006, DETERMINATION STRUCT
   Roveri N, 2008, ADV MATER RES-SWITZ, V47-50, P821, DOI 10.4028/www.scientific.net/AMR.47-50.821
   Troubitsin M. A., 2011, SYNTHESIS ADV MAT BO, P35
NR 6
TC 0
Z9 0
U1 3
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-3-03835-264-8
J9 ADV MATER RES-SWITZ
PY 2014
VL 1040
BP 97
EP +
DI 10.4028/www.scientific.net/AMR.1040.97
PG 2
WC Materials Science, Multidisciplinary
SC Materials Science
GA BC0BK
UT WOS:000348897100019
DA 2018-10-19
ER

PT J
AU Andorko, JI
   Tostanoski, LH
   Solano, E
   Mukhamedova, M
   Jewell, CM
AF Andorko, James I.
   Tostanoski, Lisa H.
   Solano, Eduardo
   Mukhamedova, Maryam
   Jewell, Christopher M.
TI Intra-lymph Node Injection of Biodegradable Polymer Particles
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 83; biomaterial; immunology; microparticle;
   nanoparticle; vaccine; adjuvant; lymph node; targeting; polymer
ID VACCINES
AB Generation of adaptive immune response relies on efficient drainage or trafficking of antigen to lymph nodes for processing and presentation of these foreign molecules to T and B lymphocytes. Lymph nodes have thus become critical targets for new vaccines and immunotherapies. A recent strategy for targeting these tissues is direct lymph node injection of soluble vaccine components, and clinical trials involving this technique have been promising. Several biomaterial strategies have also been investigated to improve lymph node targeting, for example, tuning particle size for optimal drainage of biomaterial vaccine particles. In this paper we present a new method that combines direct lymph node injection with biodegradable polymer particles that can be laden with antigen, adjuvant, or other vaccine components. In this method polymeric microparticles or nanoparticles are synthesized by a modified double emulsion protocol incorporating lipid stabilizers. Particle properties (e.g. size, cargo loading) are confirmed by laser diffraction and fluorescent microscopy, respectively. Mouse lymph nodes are then identified by peripheral injection of a nontoxic tracer dye that allows visualization of the target injection site and subsequent deposition of polymer particles in lymph nodes. This technique allows direct control over the doses and combinations of biomaterials and vaccine components delivered to lymph nodes and could be harnessed in the development of new biomaterial-based vaccines.
C1 [Andorko, James I.; Tostanoski, Lisa H.; Solano, Eduardo; Mukhamedova, Maryam; Jewell, Christopher M.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
RP Jewell, CM (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM cmjewell@umd.edu
OI Tostanoski, Lisa/0000-0001-9255-5684
FU PhRMA foundation; Research and Scholar Award from the University of
   Maryland, College Park
FX This work was funded in part by the PhRMA foundation and a Research and
   Scholar Award from the University of Maryland, College Park. We thank
   Prof. Darrell Irvine for support of the initial work conducted in the
   completion of "In situ engineering of the lymph node microenvironment
   via intranodal injection of adjuvant-releasing polymer particles."
CR Adamina M, 2010, MOL THER, V18, P651, DOI 10.1038/mt.2009.275
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Bershteyn A, 2008, SOFT MATTER, V4, P1787, DOI 10.1039/b804933e
   Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043
   Donaldson J. G., 2001, CURRENT PROTOCOLS IM
   Harrell MI, 2008, J IMMUNOL METHODS, V332, P170, DOI 10.1016/j.jim.2007.11.012
   He Hong, 2010, J Vis Exp, DOI 10.3791/1743
   Hofman F., 2001, CURRENT PROTOCOLS IM
   Holmes K., 2001, CURRENT PROTOCOLS IM
   Irvine D. J., 2011, COMPREHENSIVE BIOMAT
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Johansen P, 2005, EUR J IMMUNOL, V35, P568, DOI 10.1002/eji.200425599
   Johansen P, 2008, P NATL ACAD SCI USA, V105, P5189, DOI 10.1073/pnas.0706296105
   Matheu M. P., 2007, JOVE-J VIS EXP, pe265, DOI DOI 10.3791/265
   Mohanan D, 2010, J CONTROL RELEASE, V147, P342, DOI 10.1016/j.jconrel.2010.08.012
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Reddy ST, 2008, TISSUE ENG PT A, V14, P734
   Ribas A, 2011, CLIN CANCER RES, V17, P2987, DOI 10.1158/1078-0432.CCR-10-3272
   Salmon H, 2011, JOVE-J VIS EXP, DOI 10.3791/3054
   Senti G, 2008, P NATL ACAD SCI USA, V105, P17908, DOI 10.1073/pnas.0803725105
   Sharrow S. O., 2001, CURRENT PROTOCOLS IM
   Swartz MA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003763
NR 23
TC 14
Z9 14
U1 3
U2 18
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD JAN
PY 2014
IS 83
AR e50984
DI 10.3791/50984
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AZ9DZ
UT WOS:000348513500030
PM 24430972
OA Bronze, Green Published
DA 2018-10-19
ER

PT S
AU Lor Huai, C
   Mim Mim, L
   Naznin, S
AF Lor Huai, Chong
   Mim Mim, Lim
   Naznin, Sultana
BE Sidik, NAC
TI Polycaprolactone(PCL)/Gelatin(Ge)-based Electrospun Nanofibers for
   Tissue engineering and Drug Delivery Application
SO Mechanical and Materials Engineering
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT World Virtual Conference on Advanced Research in Mechanical and
   Materials Engineering
CY MAR 18-22, 2014
CL Kuala Lumpur, MALAYSIA
DE Tissue Engineering; Drug Delivery System; Scaffold;
   Polycaprolactone(PCL); Gelatin(Ge); Electrospinning
ID SCAFFOLD
AB Recent development of tissue engineering has been emphasized on tissue regeneration and repairing in order to solve the limitation of organ and tissue transplantation issues. Biomaterial scaffold, which plays an important role in this development, not only provides a promising alternative in order to improve the efficiency of cell transplantation in tissue engineering but also to deliver cells with growth factors and drugs into injured tissue to increase the survival of cell via drug delivery system. In this study, nanofibers were fabricated through blending of a synthetic polymer, polycaprolactone (PCL) and a natural polymer, Gelatin (Ge) using electrospinning technique. Processing parameters were optimized to determine the most suitable properties of PCL/Ge nanofibers. The surface morphology of PCL/Ge nanofibers were then characterized using Scanning Electron Microscopy (SEM). Six samples of nanofibers from different amount of gelatin mixed with 10% PCL (w/v) were successfully fabricated. Experimental results showed that 18kV of high voltage provided more homogenous and less beaded nanofibers. Meanwhile, the 0.8g of Ge in 10% PCL (w/v) was set as the maximum concentration while 0.2g of Ge in 10% PCL (w/v) was set as the minimum concentration to reduce the bead formation.
C1 [Lor Huai, Chong; Mim Mim, Lim; Naznin, Sultana] Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Clin Sci, Skudai 81310, Malaysia.
RP Lor Huai, C (reprint author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Dept Clin Sci, Skudai 81310, Malaysia.
EM lorhuai@gmail.com; mimmim1289@gmail.com; naznin@biomedical.utm.my
OI LIM, MIM MIM/0000-0002-2841-0971
CR Ba Linh N. T., 2012, J BIOMATERIALS SCI P, V5, P520
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Chakrapani VY, 2012, J APPL POLYM SCI, V125, P3221, DOI 10.1002/app.36504
   Cho WJ, 2009, J BIOMED MATER RES A, V91A, P400, DOI 10.1002/jbm.a.32264
   Chong EJ, 2007, ACTA BIOMATER, V3, P321, DOI 10.1016/j.actbio.2007.01.002
   Cui WG, 2007, J APPL POLYM SCI, V103, P3105, DOI 10.1002/app.25464
   Feng B, 2012, BIOMACROMOLECULES, V13, P3917, DOI 10.1021/bm3009389
   Gautam S, 2013, MAT SCI ENG C-MATER, V33, P1228, DOI 10.1016/j.msec.2012.12.015
   Jose MV, 2009, POLYMER, V50, P3778, DOI 10.1016/j.polymer.2009.05.035
   Kai D., 2012, NANOTECHNOLOGY, V23
   Kai D, 2011, J BIOMED MATER RES A, V99A, P376, DOI 10.1002/jbm.a.33200
   Kim JH, 2009, MAT SCI ENG C-BIO S, V29, P1725, DOI 10.1016/j.msec.2009.01.023
   Kolbuk D, 2013, EUR POLYM J, V49, P2052, DOI 10.1016/j.eurpolymj.2013.04.036
   Kumar P., 2012, EFFECT COLLECTOR ELE
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roozbahani F., 2013, J NANOMATER, V2013, P1
   Sultana N., 2013, J NANOMATER, V2013, P1
   Sultana N, 2013, J BIONANOSCI, V7, P169
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
NR 20
TC 0
Z9 0
U1 2
U2 14
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-109-2
J9 APPL MECH MATER
PY 2014
VL 554
BP 57
EP 61
DI 10.4028/www.scientific.net/AMM.554.57
PG 5
WC Engineering, Mechanical; Materials Science, Multidisciplinary; Mechanics
SC Engineering; Materials Science; Mechanics
GA BB9QI
UT WOS:000348561700012
DA 2018-10-19
ER

PT S
AU Cretan, MS
   Stamate, C
AF Cretan, Monica Stamate
   Stamate, Ciprian
BE Nicoara, M
   Opris, C
TI Synthesis and Characterization of PVA-Ketoprofen Cryogel, Biomaterial
   with Extended Drug Release Properties for Cartilage Replacement
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE cryogel; cartilage replacement; drug release system; ketoprofen
ID GELATIN CRYOGELS
AB The present paper aims to study the possibility to modify the properties of polyvinyl alcohol (pva) cryogels prepared in the presence of ketoprofen in order to replace the damaged articular cartilage. Articular cartilage is the most important part of articulation characterized by very low friction, high wear resistance, and poor regenerative qualities. Polyvinyl alcohol is a non-expensive polymer, versatile and adaptable to various needs, with exceptional properties such as water solubility, biocompatibility, non-toxicity and with capability to form hydrogels by chemical or physical methods. The aims of this paper are the synthesis, the physicochemical characterization and analysis of the tribological properties of pva cryogels for cartilage replacement and the introduction of new concept in medication by creating the cryogel like a controlled drug release system. The morphology of the cryogels, the interaction between the pva macromolecular chains and medicament has been studied by Scanning Electronic Microscopy. The gels swelling in physiologic ser have been monitored by gravimetric method in order to evidence the hydrophilic properties. The mechanical properties of the cryogels have been investigated by dynamic mechanical measurements. In conclusion, the biomaterial obtained provides good swelling properties, mechanical resistance and it is ideal for extended drug release implantable systems.
C1 [Cretan, Monica Stamate] Univ Med & Pharm Gr T Popa, Fac Pharm, Str Univ 16, Iasi 700115, Romania.
   [Stamate, Ciprian] Tech Univ Gheorghe Asachi, Mech Fac, Iasi 700050, Romania.
RP Cretan, MS (reprint author), Univ Med & Pharm Gr T Popa, Fac Pharm, Str Univ 16, Iasi 700115, Romania.
EM cretanmonica@yahoo.com; cip101301@gmail.com
CR Bhat S., 2009, EUROPEAN CELLS MAT J, V18, P46
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
NR 5
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 205
EP 209
DI 10.4028/www.scientific.net/SSP.216.205
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100035
DA 2018-10-19
ER

PT S
AU Stamate, C
   Munteanu, C
   Stamate, MC
AF Stamate, Ciprian
   Munteanu, Corneliu
   Stamate, Monica Cretan
BE Nicoara, M
   Opris, C
TI Wear Particle Analysis, the Result of Tribological Phenomena of
   Biomaterials Couplings-Ultra Hight Molecular Weight Polyethylene and
   Magnesium Aluminosilicate Ceramic
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE wear; polyethylene particles; image analyses
AB Joint prosthesis involves the combination in the form of friction couplings of the different materials such as two metals, metal-polymer and polymer-ceramic. This paper aims to analyze the wear particles produced from the friction between two biomaterials: ultra hight molecular weight polyethylene (uhmwpe) and magnesium aluminosilicate ceramic. To obtain the wear particles using a tribometer cetr umt-2 type that can reproduce the wear phenomena of different biomaterials in different humidity conditions and at various speeds of movement. The tests were performed in dry and lubricated friction conditions using saline solution, the best imitating biological conditions. The movement is similar to the friction torques of the hip joint: a semicircular motion of the polymer piece on the circular surface of the ceramic piece. Movement speed chosen is 0.25 m/s. Wear particles obtained were isolated from biomaterial surfaces and studied using scanning electron microscope. The images obtained are analyzed, particle's dimensions are extracted and then imported into autocad can provide information about the shape, size and surface of the particles. In light of these facts, we can say the inflammatory risk of biomaterial particles. In conclusion, the biomaterial particles are very small and the inflammatory rick is reducing to minimum in lubricated conditions.
C1 [Stamate, Ciprian; Munteanu, Corneliu] Tech Univ Gheorghe Asachi, Mech Fac, Bd Dimitrie Mangeron 67, Iasi 700050, Romania.
   [Stamate, Monica Cretan] Univ Med & Pharm Gr T Popa, Fac Pharm, Iasi 700115, Romania.
RP Stamate, C (reprint author), Tech Univ Gheorghe Asachi, Mech Fac, Bd Dimitrie Mangeron 67, Iasi 700050, Romania.
EM cip101301@gmail.com; cornelmun@gmail.com; cretanmonica@yahoo.com
OI STAMATE, Ciprian/0000-0002-1734-9060
CR Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Plumlee K, 2009, WEAR, V267, P710, DOI 10.1016/j.wear.2008.11.028
   Tsukamoto R, 2006, ACTA ORTHOP, V77, P505, DOI 10.1080/17453670610046479
   Walpole AR, 2003, MATERIALWISS WERKST, V34, P1064, DOI 10.1002/mawe.200300707
NR 4
TC 0
Z9 0
U1 0
U2 11
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 226
EP 230
DI 10.4028/www.scientific.net/SSP.216.226
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100039
DA 2018-10-19
ER

PT S
AU Marius, N
   Iulian, A
   Ana, B
AF Marius, Niculescu
   Iulian, Antoniac
   Ana, Blajan
BE Nicoara, M
   Opris, C
TI Metallic biomaterials processing technologies in order to obtain a new
   design for a hip prosthesis femoral component
SO ADVANCED MATERIALS AND STRUCTURES V
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th International Conference on Advanced Materials and Structures (AMS)
CY OCT 24-25, 2013
CL Timisoara, ROMANIA
SP Politechnica Fdn
DE total hip replacement; hip stem design; processing techniques;
   cytoxicity analysis
ID IN-VITRO; ARTHROPLASTY; STEMS
AB The paper presents the processing technology that could be used in order to obtain a new design of a stem component for a hip prosthesis type "lattice beam". This new design was made based on the analysis of the currently successful stems used in clinical practice and on different biomechanical and biomaterials criteria. Metallic biomaterials used for manufacturing different components for hip prosthesis are usually austenitic stainless steel type 316L, Co-Cr alloy and titanium based alloy. In our study, considering the specific design of the stem, stainless steel type 316L with the nominal compositions (% weight): C < 0.03, Cr 17, Ni 14.5, Mo 2.7, Mn < 2.0, Si < 1.0, P < 0.025, S < 0.010, Fe balance is used. Different mechanical processing techniques were used in order to obtain the experimental prototype. According to the well-known limitation of the stainless steel type 316L as biomaterial for long term implants, we propose for the new stem component to use a TiN coating obtained using magnetron sputtering technique. The cytotoxicity studies were performed using a CCl 81 (VERO) stabilized cellular line, in order to analyse the biocompatibility properties. The samples were examined for the development of the cellular culture, in order to compare the results obtained using direct contact method. From the point of view of these tests, it was not observed an essential modification of cells and the cellular morphology is not affected by the presence of the TiN coated metallic samples. In the conclusion, the new geometry proposed for a stem component of cemented hip prosthesis could be made using different mechanical processing techniques and appears to be a potential solution in order to solve the problems related to the stability of the total hip prosthesis, with improved biocompatibility properties due to the TiN coatings.
C1 [Marius, Niculescu] Clin Hosp Colentina, 19-21 Stefan Cel Mare St, Bucharest, Romania.
   [Iulian, Antoniac; Ana, Blajan] Univ Politehn Bucuresti, Bucharest, Romania.
RP Marius, N (reprint author), Clin Hosp Colentina, 19-21 Stefan Cel Mare St, Bucharest, Romania.
EM mariusniculescu@yahoo.com; antoniac.iulian@gmail.com;
   ai.blajan@gmail.com
RI Antoniac, Iulian/D-4802-2014
OI Antoniac, Iulian/0000-0003-0112-3494
CR BARRACK RL, 1992, J BONE JOINT SURG BR, V74, P385
   Bhamra MS, 2006, P I MECH ENG H, V220, P379, DOI 10.1243/095441105X68971
   Braic M, 2006, SURF COAT TECH, V200, P6505, DOI 10.1016/j.surfcoat.2005.11.057
   Braic V, 2011, SURF COAT TECH, V206, P604, DOI 10.1016/j.surfcoat.2011.03.074
   Cristofolini L, 2003, J BIOMECH, V36, P1603, DOI 10.1016/S0021-9290(03)00191-X
   Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20
   Hopkinson N, 2006, RAPID MANUFACTURING: AN INDUSTRIAL REVOLUTION FOR THE DIGITAL AGE, P1
   Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7
   Malviya A, 2010, J BONE JOINT SURG AM, V92A, P1675, DOI 10.2106/JBJS.I.01426
   Ostbyhaug PO, 2009, J BONE JOINT SURG BR, V91B, P676, DOI 10.1302/0301-620X.91B5.21749
NR 10
TC 1
Z9 1
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-212-9
J9 SOLID STATE PHENOMEN
PY 2014
VL 216
BP 239
EP 242
DI 10.4028/www.scientific.net/SSP.216.239
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB9AE
UT WOS:000347924100041
DA 2018-10-19
ER

PT S
AU Balestra, RM
   Ribeiro, AA
   de Oliveira, JC
   Cavaleiro, A
   Oliveira, MV
AF Balestra, Roseli Marins
   Ribeiro, Alexandre Antunes
   de Oliveira, Joao Carlos
   Cavaleiro, Albano
   Oliveira, Marize Varela
BE Castanho, SM
   Acchar, W
   Hotza, D
TI TITANIUM SUBSTRATE SURFACES COATED WITH HYDROXYAPATITE BY MAGNETRON
   SPUTTERING
SO BRAZILIAN CERAMIC CONFERENCE 57
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 57th Brazilian Ceramic Conference (CBC)
CY MAY 19-22, 2013
CL Natal, BRAZIL
SP Elfusa, Mineracao Jundu, Netzsch
DE Titanium; Hydroxyapatite; Magnetron Sputtering; Powder Metallurgy
ID FILMS
AB The deposition of hydroxyapatite coatings on titanium via sputtering techniques has been quite studied on commercial dense substrates, for use as a biomaterial. In this work, porous titanium samples produced by powder metallurgy and commercially dense titanium sheet, used as control, were used as substrates. The coatings were deposited by radio frequency magnetron sputtering using a hydroxyapatite target in argon atmosphere with different deposition times. Samples characterization was performed by Optical Microscopy, Scanning Electron Microscopy/Energy Dispersive Spectroscopy and low-angle X-ray Diffraction. Hydroxyapatite coating depositions were obtained on both titanium substrates. The results indicated the potential of this methodology for titanium substrates with homogeneous hydroxyapatite coatings.
C1 [Balestra, Roseli Marins] Univ Fed Sao Joao Rei UFSJ, Dept Engn Mecan, Praca Santo Antonio 170,Sala 4-24MP, BR-36307352 Sao Jaol Del Rei, MG, Brazil.
   [Ribeiro, Alexandre Antunes; Oliveira, Marize Varela] Inst Nacl Tecnologia, Div Processamento Caracterizacao Mat, Lab Tecnologia Pos, BR-20081312 Rio De Janeiro, Brazil.
   [de Oliveira, Joao Carlos; Cavaleiro, Albano] Univ Coimbra, Dept Engn Mecan, SEG CEMUC, P-3030788 Coimbra, Portugal.
RP Balestra, RM (reprint author), Univ Fed Sao Joao Rei UFSJ, Dept Engn Mecan, Praca Santo Antonio 170,Sala 4-24MP, BR-36307352 Sao Jaol Del Rei, MG, Brazil.
EM roselibalestra@ufsj.edu.br; alexandre.antunes@int.gov.br;
   joao.oliveira@dem.uc.pt; albano.cavaleiro@dem.uc.pt;
   marize.varela@int.gov.br
OI Cavaleiro, Albano/0000-0001-8251-5099; Oliveira, Joao
   Carlos/0000-0002-6218-3098
CR Kim JU, 2011, THIN SOLID FILMS, V520, P793, DOI 10.1016/j.tsf.2011.04.169
   Li JP, 2007, BIOMATERIALS, V28, P2810, DOI 10.1016/j.biomaterials.2007.02.020
   Nouri A., 2010, BIOMIMETICS LEARNING
   Ong J, 2009, THIN CALCIUM PHOSPHA, P175
   Ribeiro AA, 2013, APPL SURF SCI, V265, P250, DOI 10.1016/j.apsusc.2012.10.189
   SILVA A. F. L., 2012, THESIS
   Stoica TF, 2008, THIN SOLID FILMS, V516, P8112, DOI 10.1016/j.tsf.2008.04.071
   Yamaguchi T, 2006, NUCL INSTRUM METH B, V249, P723, DOI 10.1016/j.nimb.2006.03.126
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
NR 9
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-3-03835-114-6
J9 MATER SCI FORUM
PY 2014
VL 798-799
BP 472
EP +
DI 10.4028/www.scientific.net/MSF.798-799.472
PG 2
WC Materials Science, Ceramics
SC Materials Science
GA BB9AM
UT WOS:000347955400078
DA 2018-10-19
ER

PT S
AU Wladymyr, JBS
   Nascimento, EP
   Almeida, KV
   Farias, KAS
   Cardoso, MJB
   Meneses, RL
   Fook, MVL
AF Wladymyr, J. B. S.
   Nascimento, E. P.
   Almeida, K., V
   Farias, K. A. S.
   Cardoso, M. J. B.
   Meneses, R. L.
   Fook, M. V. L.
BE Castanho, SM
   Acchar, W
   Hotza, D
TI HYBRID MEMBRANES DEVELOPMENT MADE BY CHITOSAN AND CALCIUM PHOSPHATE
SO BRAZILIAN CERAMIC CONFERENCE 57
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 57th Brazilian Ceramic Conference (CBC)
CY MAY 19-22, 2013
CL Natal, BRAZIL
SP Elfusa, Mineracao Jundu, Netzsch
DE hybrid membranes; chitosan and calcium phosphate
AB Medicine seeks increasingly to treat problems related to bone regeneration and tissue in order to minimize surgical trauma and some bone diseases. The technology advancement in the biomaterials field allows develop materials that assist in reconstructive procedures of body parts and increase treatments improving the life quality of human beings. Due to the biodegradability, biocompatibility and biofunctionality characteristics, chitosan has attracted attention of researchers in order to obtain new materials. Its unique features promote the incorporation of other materials such as calcium phosphate ceramics which are used in this bone replacement and bone regeneration due to submit biocompatibility, bioactivity, osteoconductivity in addition to allowing the bone cells proliferation, collagen and proteins in their surfaces, thus allowing tissue regeneration. This study aimed to develop biodegradable chitosan membranes with 1%, 3% and 5% calcium phosphate for use in bone regeneration. The composites were prepared and Characterized by X-ray diffraction (XRD), Fourier Transform Infrared Spectroscopy (FTIR) and angle contact wettability. The results indicates the composite formation and show an increased crystallinity in the chitosan membrane through the phosphate incorporation, besides confirming the composites hydrophilicity. Preliminary results indicates that the composite is a promising biomaterial.
C1 [Wladymyr, J. B. S.; Nascimento, E. P.; Almeida, K., V; Farias, K. A. S.; Cardoso, M. J. B.; Meneses, R. L.; Fook, M. V. L.] Univ Fed Campina Grande, Mat Engn Acad Unit, CERTBIO, Lab Evaluat & Dev Biomat Northeast, Campina Grande, PB, Brazil.
RP Wladymyr, JBS (reprint author), Univ Fed Campina Grande, Mat Engn Acad Unit, CERTBIO, Lab Evaluat & Dev Biomat Northeast, Campina Grande, PB, Brazil.
EM wladymyrjb@yahoo.com.br; emanueluepb@gmail.com
CR AIMOLI C.G., 2007, THESIS U ESTADUAL CA
   [Anonymous], 1997, CALCULATED ICSD USIN
   Aparecida Anahí Herrera, 2007, Quím. Nova, V30, P892, DOI 10.1590/S0100-40422007000400024
   BARBOSA R.C., 2011, THESIS U FEDERAL CAM
   FUKUMURA H, 2009, MOL NANODYAMICS, V1
   FUKUMURA H, 2009, MOL NANODYAMICS, V2
   HOLANDA A. L., 2011, THESIS U FEDERAL CAM
   Kawachi EY, 2000, QUIM NOVA, V23, P518, DOI 10.1590/S0100-40422000000400015
   KHASANOV S, 1994, THESIS U FEDERAL CAM
   LIMA R., 2010, THESIS U FEDERAL CAM
   OLIVEIRA S.V., 2009, REV ELETRONICA MATER, V4, P11
   PONCIANO J.J., 2010, THESIS U FEDERAL CAM
   RATNER B. D., 2005, INTRO MAT MED
   URAGAMI T., 2006, MAT SCI CHITIN CHITO
NR 14
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-3-03835-114-6
J9 MATER SCI FORUM
PY 2014
VL 798-799
BP 682
EP 686
DI 10.4028/www.scientific.net/MSF.798-799.682
PG 5
WC Materials Science, Ceramics
SC Materials Science
GA BB9AM
UT WOS:000347955400114
DA 2018-10-19
ER

PT J
AU Berezina, N
AF Berezina, Nathalie
TI Biotechnological Transformations - The Future of the Organic Chemistry?
SO CURRENT ORGANIC CHEMISTRY
LA English
DT Article
DE Biocatalysis; biomaterial; biotransfomation; chirality; commodities;
   enantiomer; enzyme; monomer; polymer
ID RING-OPENING POLYMERIZATION; ENZYMATIC SURFACE MODIFICATION; ANTARCTICA
   LIPASE-B; PROCESS INTENSIFICATION; ESCHERICHIA-COLI; CYCLIC OLIGOMERS;
   LACTIC-ACID; POLY(BUTYLENE SUCCINATE); TRIMETHYLENE CARBONATE; MICROBIAL
   FERMENTATION
AB In this critical overview of what kind of organic chemistry is currently performed by biotechnology, the examples of the production of high added value molecules for pharmaceutical industry, of biomaterials and their modification as well as of commodities are discussed. The major strengths as well as weaknesses of this kind of approach in comparison to current organic chemistry achievements are discussed. The prospects of future development and collaborative approach between pure organic synthesis and biotechnological transformations are also developed.
C1 Mat Nova R&D Ctr, B-7822 Ghislenghien, Belgium.
RP Berezina, N (reprint author), Mat Nova R&D Ctr, 1 Rue Foudriers, B-7822 Ghislenghien, Belgium.
EM berezina@materianova.be
FU Walloon region; FEDER European Funds
FX The author is thankful to the Walloon region and FEDER European Funds
   for the financial support.
CR Addidle M., 2012, CLIN MICROBIOL NEWSL, V34, P147
   Agrawal PB, 2008, BIOCATAL BIOTRANSFOR, V26, P412, DOI 10.1080/10242420802332558
   Agrawal PB, 2008, ENZYME MICROB TECH, V42, P473, DOI 10.1016/j.enzmictec.2008.01.016
   Akaraonye E, 2012, BIOTECHNOL J, V7, P293, DOI 10.1002/biot.201100122
   Akaraonye E, 2010, J CHEM TECHNOL BIOT, V85, P732, DOI 10.1002/jctb.2392
   Alves A, 2013, J APPL PHYCOL, V25, P407, DOI 10.1007/s10811-012-9875-4
   Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073
   Asrar J, 2002, J APPL POLYM SCI, V83, P457, DOI 10.1002/app.2253
   Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012
   Berezina N, 2002, TETRAHEDRON-ASYMMETR, V13, P1953, DOI 10.1016/S0957-4166(02)00442-1
   Berezina N., 2014, CITRIC ACID OCCURREN, P53
   Berezina N, 2007, ADV SYNTH CATAL, V349, P2049, DOI 10.1002/adsc.200700150
   Berezina N, 2013, NEW BIOTECHNOL, V30, P192, DOI 10.1016/j.nbt.2012.05.002
   Berezina N, 2012, BIOTECHNOL J, V7, P304, DOI 10.1002/biot.201100191
   Bhatia A, 2007, KOREA-AUST RHEOL J, V19, P125
   Bisht KS, 1997, MACROMOLECULES, V30, P7735, DOI 10.1021/ma9708858
   Bolivar-Diaz CL, 2013, APPL CATAL B-ENVIRON, V129, P575, DOI 10.1016/j.apcatb.2012.10.004
   Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c
   Brouk M, 2010, J MOL CATAL B-ENZYM, V66, P72, DOI 10.1016/j.molcatb.2010.03.006
   Brouk M, 2009, FOOD CHEM, V116, P114, DOI 10.1016/j.foodchem.2009.02.020
   Casali M, 2002, BIOTECHNOL BIOENG, V77, P105, DOI 10.1002/bit.10101
   Chanprateep S, 2010, J BIOSCI BIOENG, V110, P621, DOI 10.1016/j.jbiosc.2010.07.014
   Cimini D, 2012, BIOTECHNOL J, V7, P237, DOI 10.1002/biot.201100242
   Conder M.J., 1998, EP Patent, Patent No. [0,532,341, 0532341]
   Cordero OX, 2012, SCIENCE, V337, P1228, DOI 10.1126/science.1219385
   Courtois J, 2009, CURR OPIN MICROBIOL, V12, P261, DOI 10.1016/j.mib.2009.04.007
   Degeest B, 2000, APPL ENVIRON MICROB, V66, P3519, DOI 10.1128/AEM.66.8.3519-3527.2000
   Distel KA, 2005, BIORESOURCE TECHNOL, V96, P617, DOI 10.1016/j.biortech.2004.06.005
   Donelli I, 2010, POLYM DEGRAD STABIL, V95, P1542, DOI 10.1016/j.polymdegradstab.2010.06.011
   Donelli I, 2009, BIOTECHNOL BIOENG, V103, P845, DOI 10.1002/bit.22316
   Du C, 2012, CURR CHEM BIOL, V6, P14, DOI DOI 10.2174/187231312799984394
   Duclohier H, 2007, CHEM BIODIVERS, V4, P1023, DOI 10.1002/cbdv.200790094
   Elboutachfaiti R, 2011, CARBOHYD POLYM, V84, P1, DOI 10.1016/j.carbpol.2010.10.063
   Elboutachfaiti R., 2010, CARBOHYD POLYM, V80, P485
   Erickson B, 2012, BIOTECHNOL J, V7, P176, DOI 10.1002/biot.201100069
   Franks AE, 2009, ENERG ENVIRON SCI, V2, P113, DOI 10.1039/b816445b
   Fu Q, 2003, ANAL CHEM, V75, P191, DOI 10.1021/ac026039z
   Garlotta D, 2001, J POLYM ENVIRON, V9, P63, DOI 10.1023/A:1020200822435
   Gerrits PJ, 2001, TETRAHEDRON-ASYMMETR, V12, P971, DOI 10.1016/S0957-4166(01)00183-5
   Gross R, 2007, BIOTECHNOL BIOENG, V98, P1123, DOI 10.1002/bit.21547
   Gubitz GM, 2003, CURR OPIN BIOTECH, V14, P577, DOI 10.1016/j.copbio.2003.09.010
   Gustavsson MT, 2005, BIOMACROMOLECULES, V6, P196, DOI 10.1021/bm049588i
   Hessel V, 2009, CHEM ENG TECHNOL, V32, P1655, DOI 10.1002/ceat.200900474
   Hickel A, 2001, BIOTECHNOL BIOENG, V74, P18, DOI 10.1002/bit.1091
   Hilker I, 2006, ANGEW CHEM INT EDIT, V45, P2130, DOI 10.1002/anie.200503496
   Hohn M, 2009, CHEMCATCHEM, V1, P42, DOI 10.1002/cctc.200900110
   HOMANN T, 1990, APPL MICROBIOL BIOT, V33, P121
   Ikunaka M, 2004, CATAL TODAY, V96, P93, DOI 10.1016/j.cattod.2004.06.110
   Jang YS, 2012, BIOTECHNOL J, V7, P186, DOI 10.1002/biot.201100059
   Karmee Sanjib Kumar, 2008, Biotechnology Journal, V3, P104, DOI 10.1002/biot.200700199
   Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434
   Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006
   Kircher M, 2012, BIOFUEL BIOPROD BIOR, V6, P240, DOI 10.1002/bbb.1341
   Klein T, 2013, BIOTECHNOL BIOENG, V110, P535, DOI 10.1002/bit.24633
   Kobayashi S, 2001, CHEM REV, V101, P3793, DOI 10.1021/cr990121l
   KOBAYASHI S, 1991, J AM CHEM SOC, V113, P3079, DOI 10.1021/ja00008a042
   Kondo A, 2008, MACROMOL BIOSCI, V8, P533, DOI 10.1002/mabi.200700270
   Kruhne U, 2014, CHEM BIOCHEM ENG Q, V28, P203
   Kumar A, 2000, J AM CHEM SOC, V122, P11767, DOI 10.1021/ja002915j
   Laffend LA, 1997, US Patent, Patent No. 5686276
   Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354
   Li YK, 2013, BIORESOURCE TECHNOL, V149, P333, DOI 10.1016/j.biortech.2013.09.077
   Lopez-Garzon CS, 2014, BIOTECHNOL ADV, V32, P873, DOI 10.1016/j.biotechadv.2014.04.002
   Lopez-Garzon CS, 2014, CHEM ENG J, V235, P52, DOI 10.1016/j.cej.2013.09.017
   Lopez-Garzon CS, 2012, CHEM ENG J, V200, P637, DOI 10.1016/j.cej.2012.06.079
   Luisi PL, 2007, CHEM BIODIVERS, V4, P603, DOI 10.1002/cbdv.200790053
   Mahapatro A, 2004, BIOMACROMOLECULES, V5, P62, DOI 10.1021/bm0342382
   Martelli SM, 2014, RSC POLYM CHEM SER, P349
   Martin GDA, 2010, CURR ORG CHEM, V14, P1
   Matsumura S, 1999, INT J BIOL MACROMOL, V25, P161, DOI 10.1016/S0141-8130(99)00030-6
   Matsuyama A, 2001, J MOL CATAL B-ENZYM, V11, P513, DOI 10.1016/S1381-1177(00)00032-1
   Morlon H, 2012, SCIENCE, V337, P1184, DOI 10.1126/science.1227512
   Musa MM, 2009, CHEMCATCHEM, V1, P89, DOI 10.1002/cctc.200900033
   Naik SN, 2010, RENEW SUST ENERG REV, V14, P578, DOI 10.1016/j.rser.2009.10.003
   Novy V, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-49
   Ohara H, 2003, APPL MICROBIOL BIOT, V62, P474, DOI 10.1007/s00253-003-1383-7
   Okajima S, 2003, BIOMACROMOLECULES, V4, P1514, DOI 10.1021/bm034043u
   Park SJ, 2012, BIOTECHNOL J, V7, P199, DOI 10.1002/biot.201100070
   Peeters J, 2004, BIOMACROMOLECULES, V5, P1862, DOI 10.1021/bm049794q
   Peeters JW, 2005, MACROMOL RAPID COMM, V26, P684, DOI 10.1002/marc.200500011
   Peterman E.A., 1950, U.S. Patent, Patent No. [2,520,255, 2520255]
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pilarek M, 2013, BIOPROC BIOSYST ENG, V36, P1079, DOI 10.1007/s00449-012-0861-7
   Pollard DJ, 2007, TRENDS BIOTECHNOL, V25, P66, DOI 10.1016/j.tibtech.2006.12.005
   Saimura M, 2008, BIOTECHNOL LETT, V30, P377, DOI 10.1007/s10529-007-9563-7
   Sakai H, 2009, ENERG ENVIRON SCI, V2, P133, DOI 10.1039/b809841g
   Schaetzle O, 2009, ENERG ENVIRON SCI, V2, P96, DOI 10.1039/b815331k
   Schmid A, 2002, CURR OPIN BIOTECH, V13, P359, DOI 10.1016/S0958-1669(02)00336-1
   Schmidt W., 1998, US Patent, Patent No. [5,798,433,, 5798433]
   Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198
   SHIGENO T, 1991, BIOTECHNOL LETT, V13, P427, DOI 10.1007/BF01030995
   Shih IL, 2006, BIORESOURCE TECHNOL, V97, P1148, DOI 10.1016/j.biortech.2004.08.012
   Shih IL, 2001, BIORESOURCE TECHNOL, V79, P207, DOI 10.1016/S0960-8524(01)00074-8
   Singh SK, 2003, J ORG CHEM, V68, P5466, DOI 10.1021/jo0204395
   Srivastava RK, 2006, MACROMOLECULES, V39, P46, DOI 10.1021/ma0518508
   Straathof AJJ, 2014, CHEM REV, V114, P1871, DOI 10.1021/cr400309c
   Straathof AJJ, 2002, CURR OPIN BIOTECH, V13, P548, DOI 10.1016/S0958-1669(02)00360-9
   Su W, 2004, TETRAHEDRON-ASYMMETR, V15, P1275, DOI 10.1016/j.tetasy.2004.03.009
   Sugihara S, 2006, MACROMOL RAPID COMM, V27, P203, DOI 10.1002/marc.200500723
   Tanghe A., 2013, Procede continu de synthese d'oligoesters a partir d'un sel d'ammonium d'un diol et dispositif de mise en oeuvre, Patent No. [BE 2013/0042, 20130042]
   Thakker C, 2012, BIOTECHNOL J, V7, P213, DOI 10.1002/biot.201100061
   Thomsen MH, 2005, APPL MICROBIOL BIOT, V68, P598, DOI 10.1007/s00253-005-0056-0
   Tsuji H, 1999, POLYMER, V40, P6699, DOI 10.1016/S0032-3861(99)00004-X
   Uyama H, 2003, BIOCHEM ENG J, V16, P145, DOI 10.1016/S1369-703X(03)00028-7
   Valepyn E, 2011, BIOCATAL BIOTRANSFOR, V29, P25, DOI 10.3109/10242422.2010.548555
   van Beilen JB, 2002, CURR OPIN BIOTECH, V13, P338, DOI 10.1016/S0958-1669(02)00334-8
   Velasco J, 2000, NAT BIOTECHNOL, V18, P857, DOI 10.1038/78467
   Verstraete W, 2007, ENG LIFE SCI, V7, P117, DOI 10.1002/elsc.200620176
   Vertommen MAME, 2005, J BIOTECHNOL, V120, P376, DOI 10.1016/j.jbiotec.2005.06.015
   Wackett LP, 2004, CURR OPIN BIOTECH, V15, P280, DOI 10.1016/j.copbio.2004.05.003
   Wahlberg J, 2003, BIOMACROMOLECULES, V4, P1068, DOI 10.1021/bm0340725
   Wallace S, 2014, CURR OPIN BIOTECH, V30, P1, DOI 10.1016/j.copbio.2014.03.006
   Waltz E, 2008, NAT BIOTECHNOL, V26, P851, DOI 10.1038/nbt0808-851
   Weber SS, 2012, BIOTECHNOL J, V7, P225, DOI 10.1002/biot.201100065
   Wee YJ, 2006, FOOD TECHNOL BIOTECH, V44, P163
   Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a
   Weis R, 2004, J MOL CATAL B-ENZYM, V29, P211, DOI 10.1016/j.molcatb.2003.10.006
   Wenda S, 2011, GREEN CHEM, V13, P3007, DOI 10.1039/c1gc15579b
   Werner M, 2014, ANGEW CHEM INT EDIT, V53, P1704, DOI 10.1002/anie.201309301
   Whitfield C, 2003, CARBOHYD RES, V338, P2491, DOI 10.1016/j.carres.2003.08.010
   Willeman WF, 2002, ENZYME MICROB TECH, V30, P200, DOI 10.1016/S0141-0229(01)00467-7
   Xie NZ, 2014, BIOTECHNOL ADV, V32, P615, DOI 10.1016/j.biotechadv.2014.04.001
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yina J., 2005, J CHROMATOGR A, V1090, P68
   Zhang HR, 2012, BIOTECHNOL PROGR, V28, P292, DOI 10.1002/btpr.702
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 126
TC 0
Z9 0
U1 2
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1385-2728
EI 1875-5348
J9 CURR ORG CHEM
JI Curr. Org. Chem.
PY 2014
VL 18
IS 24
BP 3120
EP 3130
PG 11
WC Chemistry, Organic
SC Chemistry
GA AZ7BZ
UT WOS:000348374500004
DA 2018-10-19
ER

PT J
AU McLellan, J
   Plevin, S
AF McLellan, Jonathan
   Plevin, Sarah
TI Temporal Release of Growth Factors from Platelet-rich Fibrin (PRF) and
   Platelet-rich Rlasma (PRP) in the Horse: A Comparative in vitro Analysis
SO INTERNATIONAL JOURNAL OF APPLIED RESEARCH IN VETERINARY MEDICINE
LA English
DT Article
DE Keywords
ID PLASMA; REPAIR; LEUKOCYTE; MATRIX; TENDON; BETA; GEL
AB Objectives: To evaluate platelet-rich fibrin (PRF) in horses and compare temporal release of growth factors (OF) to platelet-rich plasma (PRP).
   Study Design: In vitro study Animals: Twelve healthy Thoroughbred geldings <5 years of age
   Methods: PRF was created by centrifugation using a human protocol. PRP was processed using a double spin, tube method. Four groups were created for each horse: immediate analysis of PRP (1) and PRF (2); slow-release analysis of PRP (3) and PRF (4) over 5 days. Concentrations of transforming growth factor beta 1 (TGF beta 1) and platelet derived growth factor BB (PDGF-BB) were analyzed using commercial sandwich ELISAs and significance determined using Wilcoxin signed rank and Kruskal-Wallis tests.
   Results: PRP released more OF than PRF upon immediate quantification (p=0.05). TGF beta 1 was increased at all subsequent time points in PRF compared to PRP (p<0.001), although both methods demonstrated an increased cumulative TGF beta 1 yield compared to immediate analysis (p<0.001). PDGF-BB did not show a temporal increase in yield, but release kinetics differed between PRF and PRP, indicating PRF may trap PDGF-BB, leading to a slower release. PRP gel dissolved by day 5in contrast to PRF clots, which remained solid.
   Conclusions: PRF can be easily procured in the horse using standard laboratory equipment. It may present advantages over PRP by providing a solid fibrin biomaterial allowing steady elusion (Author, pls check this word) of OF over time. This slow release of OF may represent a novel treatment modality for surgical conditions in the horse, and future studies should be undertaken to determine appropriate clinical applications.
C1 [McLellan, Jonathan] Florida Equine Vet Associates, Ocala, FL 34482 USA.
RP McLellan, J (reprint author), 10195 N HWY 27, Ocala, FL 34482 USA.
EM jmclellan@fevaocala.com
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Arguelles D, 2006, RES VET SCI, V81, P237, DOI 10.1016/j.rvsc.2005.12.008
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   Brunner G, 2004, THROMB HAEMOSTASIS, V92, P253, DOI 10.1160/TH04-05-0324
   Carter CA, 2003, EXP MOL PATHOL, V74, P244, DOI 10.1016/S0014-4800(03)00017-0
   Cenni E, 2005, J PERIODONTOL, V76, P323, DOI 10.1902/jop.2005.76.3.323
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Clark RAF, 2001, ANN NY ACAD SCI, V936, P355
   Donnelly BP, 2006, AM J VET RES, V67, P1218, DOI 10.2460/ajvr.67.7.1218
   Ehrenfest DMD, 2009, GROWTH FACTORS, V27, P63, DOI 10.1080/08977190802636713
   Everts PAM, 2008, J BIOMED MATER RES A, V85A, P1135, DOI 10.1002/jbm.a.31570
   Fortier LA, 2011, CLIN ORTHOP RELAT R, V469, P2706, DOI 10.1007/s11999-011-1857-3
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   Giraldo CE, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-29
   Graziani F, 2006, CLIN ORAL IMPLAN RES, V17, P212, DOI 10.1111/j.1600-0501.2005.2005.01203.x
   Haupt JL, 2006, AM J VET RES, V67, P1595, DOI 10.2460/ajvr.67.9.1595
   Kobayashi M, 2012, BIOLOGICALS, V40, P323, DOI 10.1016/j.biologicals.2012.07.004
   Laurens N, 2006, J THROMB HAEMOST, V4, P932, DOI 10.1111/j.1538-7836.2006.01861.x
   Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Monteiro SO, 2009, AM J VET RES, V70, P277, DOI 10.2460/ajvr.70.2.277
   Nielsen HJ, 2001, VOX SANG, V80, P170, DOI 10.1046/j.1423-0410.2001.00028.x
   O'Connell SM, 2008, WOUND REPAIR REGEN, V16, P749, DOI 10.1111/j.1524-475X.2008.00426.x
   Pietrzak WS, 2005, J CRANIOFAC SURG, V16, P1043, DOI 10.1097/01.scs.0000186454.07097.bf
   Roberts AB, 1996, MOL CELLULAR BIOL WO, P275
   Sutter WW, 2004, AM J VET RES, V65, P924, DOI 10.2460/ajvr.2004.65.924
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Visser LC, 2011, AM J VET RES, V72, P699, DOI 10.2460/ajvr.72.5.699
   Visser LC, 2010, VET SURG, V39, P811, DOI 10.1111/j.1532-950X.2010.00739.x
   Zachos TA, 2005, AM J VET RES, V66, P727, DOI 10.2460/ajvr.2005.66.727
   Zumstein MA, 2012, CURR PHARM BIOTECHNO, V13, P1196
NR 34
TC 1
Z9 2
U1 0
U2 6
PU VETERINARY SOLUTIONS LLC
PI APOPKA
PA PO BOX 2083, APOPKA, FL 32704-2083 USA
SN 1542-2666
EI 1559-470X
J9 INT J APPL RES VET M
JI Int. J. Appl. Res. Vet. Med.
PY 2014
VL 12
IS 1
BP 44
EP 53
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA CA0OR
UT WOS:000348617300006
DA 2018-10-19
ER

PT S
AU Guo, FY
   Shen, X
   Pei, XH
   Yang, GS
AF Guo, Fang Yuan
   Shen, Xia
   Pei, Xiao Hong
   Yang, Gen Sheng
BE Hegde, G
TI Synthesis and Characterization of Photocurable Biodegradable Elastomers
SO MATERIALS SCIENCE AND PROCESSING, ENVIRONMENTAL ENGINEERING AND
   INFORMATION TECHNOLOGIES
SE Applied Mechanics and Materials
LA English
DT Proceedings Paper
CT International Conference on Application of Materials Science and
   Environmental Materials (AMSEM)
CY JUL 04-06, 2014
CL Yichang, PEOPLES R CHINA
DE elastomer; ring-opening; UV cross-link
ID DEGRADATION
AB The aim of this study was to synthesize a serious of biodegradable elastomers by photocurable reaction as a potential biomaterial for the delivery of protein drugs. The macromonomers was prepared via ring opening reaction at 140 degrees C later methacrylic acylated at 50 degrees C. The optimal conditions were investigated and the property of the two macromonomer precursors were characterized via GPC and 1H-NMR. The cross-link degree of the elastomers can be adjusted by changing the concentration of photoinitiator (DMPA), furthermore influence the elastomers' degradation rate. It could provide more appropriate choice for the elastomers in application.
C1 [Guo, Fang Yuan; Shen, Xia; Pei, Xiao Hong; Yang, Gen Sheng] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China.
RP Guo, FY (reprint author), Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China.
EM guofy.2008@hotmail.com; yanggs@zjut.edu.cn
CR Alauzun JG, 2010, BIOMATERIALS, V31, P3471, DOI 10.1016/j.biomaterials.2010.01.069
   Amsden B., 2009, INT J PHARMACEUT, V388, P32
   Amsden BG, 2004, BIOMACROMOLECULES, V5, P2479, DOI 10.1021/bm049578h
   Chapanian R, 2010, EUR J PHARM BIOPHARM, V74, P172, DOI 10.1016/j.ejpb.2009.11.012
   Chapanian R, 2010, J BIOMED MATER RES A, V92A, P830, DOI 10.1002/jbm.a.32422
   Ilagan BG, 2010, J BIOMED MATER RES A, V93A, P211, DOI 10.1002/jbm.a.32482
   Leader B, 2008, NAT REV DRUG DISCOV, V7, P21, DOI 10.1038/nrd2399
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Strohl WR, 2009, CURR OPIN BIOTECH, V20, P668, DOI 10.1016/j.copbio.2009.10.012
NR 9
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1660-9336
BN 978-3-03835-270-9
J9 APPL MECH MATER
PY 2014
VL 665
BP 359
EP 362
DI 10.4028/www.scientific.net/AMM.665.359
PG 4
WC Engineering, Environmental; Engineering, Mechanical; Materials Science,
   Multidisciplinary
SC Engineering; Materials Science
GA BB9BZ
UT WOS:000348127000077
DA 2018-10-19
ER

PT B
AU Kivevele, T
   Zhang, M
   Huan, ZJ
AF Kivevele, Thomas
   Zhang, Ming
   Huan, Zhongjie
GP IEEE
TI AIR SOURCE HEAT PUMP SYSTEM FOR DRYING BIOMATERIAL
SO PROCEEDINGS OF THE 2014 11TH INTERNATIONAL CONFERENCE ON THE INDUSTRIAL
   AND COMMERCIAL USE OF ENERGY (ICUE)
LA English
DT Proceedings Paper
CT 11th International Conference on the Industrial and Commercial Use of
   Energy (ICUE)
CY AUG 19-20, 2014
CL Cape Town, SOUTH AFRICA
SP Cape Peninsula Univ Technol, Inst Elect & Elect Engineers, S African Assoc Energy Serv Co, So African Assoc Energy Efficiency, S African Inst Elect Engineers, Assoc Municipal Elect Undertakings, Eskom Demand Side Management, Stellenbosch Univ, Univ Cape Town, N W Univ
ID BANANAS; FRUIT
AB Need for a more economic method of drying biomaterial, from paper to fruit, in South Africa has for long been sought. This paper explains research into an advanced air source heat pump drying (ASHPD) system, designed, manufactured and installed for drying South African fruit and taking into account local climactic conditions. The effect of ambient temperature and condenser fan speed on the coefficient of performance (COP) of the heat pump (HP) was evaluated, also the influence of drying temperature and air velocity analysed. Using banana slices (the sample fruit selected for this study) results indicated the moisture content of bananas produced in Mpumalanga Province averaged 75.5 +/- 1.5% on a wet basis. The COP of the HP was found to be significantly high - an average 4.7. The influence of the evaporator temperature on the COP was important since it assisted in temperature control during the drying process. It was also observed the COP increased with an increase in room temperature. Drying process results indicated for drying South African bananas a possible optimal drying temperature range was 30 - 40 degrees C with 1.5 m/s drying air velocity. Generally, the study demonstrated an ASHPD system was suitable for use in South African climatic conditions. Now South Africa has an opportunity to continue research and to design applications for this green and efficient drying technology - especially for drying biomaterial. This could reduce high energy consumption, something all of South Africa is striving towards.
C1 [Kivevele, Thomas; Zhang, Ming; Huan, Zhongjie] Tshwane Univ Technol, Dept Mech Engn, Pretoria, South Africa.
RP Kivevele, T (reprint author), Tshwane Univ Technol, Dept Mech Engn, Pretoria, South Africa.
CR Beck R. A., 1985, FOOD CHEM NUTR BIOCH
   BOWREY RG, 1980, FOOD TECHNOL AUST, V32, P290
   Chua KJ, 2010, APPL ENERG, V87, P3611, DOI 10.1016/j.apenergy.2010.06.014
   Chua KJ, 2002, DRY TECHNOL, V20, P1579, DOI 10.1081/DRT-120014053
   Chua KJ, 2001, FOOD RES INT, V34, P721, DOI 10.1016/S0963-9969(01)00094-1
   Colak N, 2009, ENERG CONVERS MANAGE, V50, P2187, DOI 10.1016/j.enconman.2009.04.037
   Daghigh R, 2010, INT CONF SYST SCI SI, P404
   Daghigh R, 2010, RENEW SUST ENERG REV, V14, P2564, DOI 10.1016/j.rser.2010.04.004
   Department of Agriculture, 2011, PROF S AFR BAN MARK
   GARCIA R, 1988, INT J FOOD SCI TECH, V23, P73
   Karim MA, 2005, INT J HEAT MASS TRAN, V48, P4914, DOI 10.1016/j.ijheatmasstransfer.2005.04.035
   Kivevele T. T., 2013, P 10 IND COMM US EN, P189
   MEYER JP, 1992, INT J ENERG RES, V16, P13, DOI 10.1002/er.4440160103
   MOWLAH G, 1983, LEBENSM WISS TECHNOL, V16, P103
   Perera CO, 1997, TRENDS FOOD SCI TECH, V8, P75, DOI 10.1016/S0924-2244(97)01013-3
   Prabha TN, 1998, PHYTOCHEMISTRY, V48, P915, DOI 10.1016/S0031-9422(97)00931-X
   Prasertsan S, 1998, DRY TECHNOL, V16, P235, DOI 10.1080/07373939808917401
   Robinson A. A., 1980, FOOD ENG
   Rossi S. J., 1992, DRYING 92 MUJUMDAR A
   Sankat CK, 1996, INT J FOOD SCI TECH, V31, P123, DOI 10.1111/j.1365-2621.1996.332-35.x
   Shi QL, 2008, J FOOD ENG, V87, P74, DOI 10.1016/j.jfoodeng.2007.11.010
   WILLS RBH, 1986, FOOD AUST, V38, P118
NR 22
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-0-9922-0416-7
PY 2014
BP 241
EP 247
PG 7
WC Energy & Fuels; Engineering, Electrical & Electronic; Environmental
   Sciences
SC Energy & Fuels; Engineering; Environmental Sciences & Ecology
GA BB8WY
UT WOS:000347703800031
DA 2018-10-19
ER

PT S
AU Tkachenko, MV
   Kamzin, AS
   Ol'khovik, LP
   Tkachenko, TM
   Keshri, S
AF Tkachenko, M. V.
   Kamzin, A. S.
   Ol'khovik, L. P.
   Tkachenko, T. M.
   Keshri, S.
BE Ovchinnikov, S
   Samardak, A
TI Synthesis and Study of the New Class of Magnetic Bioceramics for
   Biomedical Applications: Mossbauer Studies
SO TRENDS IN MAGNETISM: NANOMAGNETISM
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT 5th Euro-Asian Symposium onTrends in MAGnetism - Nanomagnetism (EASTMAG)
CY SEP 15-21, 2013
CL Vladivostok, RUSSIA
SP Far Eastern Fed Univ, Russian Fdn Basic Res, Dynasty Fdn, Far Eastern Branch Russian Acad Sci, TechnoInfo Ltd Co
DE Hexaferrite; Hydroxyapatite; Hybrid Biocompatible Ceramics;
   Ferrimagnetic Hyperthermia
ID HYDROXYAPATITE; PARTICLES; FERRITE; BONE
AB Magnetic bioceramics based on hydroxyapatite Ca-5(PO4)(3)OH and particles of the M-type hexagonal (barium or calcium) ferrite (taken in proportions 5, 10, 20, 25, 40 and 50 wt % of M-ferrite) with a high bioactivity and magnetic characteristics providing hyperthermal treatment of oncology diseases has been developed and studied. The phase composition, microstructure, and magnetic properties of the synthesized bioceramics have been determined by using electron diffraction patterns, electron microscope micrograms and Mossbauer spectroscopy. It has been shown that the synthesized biomaterial consists of the biocompatible matrix with the apatite structure into which particles of hexagonal ferrite are incorporated. The Mossbauer spectra for all the samples clearly indicates that the particles of hexagonal ferrite are in the ferromagnetic state and small part of particles in paramagnetic state. The magnetic parameters of the synthesized ceramics are substantially higher than those of the bioglass ceramics modified by iron oxides that have been used in medicine, which suggests good potential and effectiveness of application of the created ceramics for medical purposes. Thus, a new class of magnetic bioceramics combining hydroxyapatite Ca-5(PO4)(3)OH, which exhibits good properties in biocompatibility and bioactivity, with particles of the M-type hexagonal ferrite, which possess high magnetic characteristics, has been created.
C1 [Tkachenko, M. V.; Ol'khovik, L. P.] Kharkov Natl Univ, Kharkov, Ukraine.
   [Kamzin, A. S.; Tkachenko, T. M.] Russian Acad Sci, Ioffe Phys Tech Inst, St Petersburg 194021, Russia.
   [Keshri, S.] Birla Inst Technol, Dept Appl Phys, Ranchi, Bihar, India.
RP Tkachenko, MV (reprint author), Kharkov Natl Univ, Kharkov, Ukraine.
EM kamzin@mail.ioffe.ru
OI Tkachenko, Mykola/0000-0003-3174-0290
FU Ministry of Education and Scienct of Ukraine [0112U005918]; Russian
   Foundation for Basic Research [12-02-92690-IND-a]
FX This study was supported by the Ministry of Education and Scienct of
   Ukraine (contract 0112U005918) and the Russian Foundation for Basic
   Research (project 12-02-92690-IND-a).
CR Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   Kamzin AS, 1997, J EXP THEOR PHYS+, V84, P788, DOI 10.1134/1.558212
   Kamzin AS, 1996, FIZ TVERD TELA+, V38, P2823
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Ol'khovik L. P., 2011, Bulletin of the Russian Academy of Sciences. Physics, V75, P281, DOI 10.3103/S1062873810031025
   Ol'khovik LP, 2010, TECH PHYS LETT+, V36, P756, DOI 10.1134/S1063785010080237
   Ol'khovik LP, 2010, LOW TEMP PHYS+, V36, P226, DOI 10.1063/1.3331495
   Ol'khovik L.P., 2010, UA Patent, Patent No. 54514
   Ol'khovik L.P., 2010, UA Patent, Patent No. [48 345, 48345]
   Roca AG, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224002
   Ruiz-Hernandez E, 2006, J BIOMED MATER RES A, V79A, P533, DOI 10.1002/jbm.a.30889
   Rusakov VS, 1999, IZV AKAD NAUK FIZ+, V63, P1389
   Singh RK, 2011, J MAGN MAGN MATER, V323, P330, DOI 10.1016/j.jmmm.2010.09.029
   Singh RK, 2010, CERAM INT, V36, P283, DOI 10.1016/j.ceramint.2009.07.028
   Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7
   Zyman Z, 2001, J BIOMED MATER RES, V54, P256, DOI 10.1002/1097-4636(200102)54:2<256::AID-JBM13>3.3.CO;2-2
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
   Zyman Z.Z., 2007, P INT C FUNCT MAT PA, P503
NR 21
TC 1
Z9 1
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-03835-054-5
J9 SOLID STATE PHENOMEN
PY 2014
VL 215
BP 480
EP +
DI 10.4028/www.scientific.net/SSP.215.480
PG 3
WC Physics, Applied; Physics, Condensed Matter
SC Physics
GA BB9BM
UT WOS:000348048400091
DA 2018-10-19
ER

PT S
AU Isik, M
   Niinomi, M
   Cho, K
   Nakai, M
   Hieda, J
   Yilmazer, H
   Horita, Z
   Narushima, T
AF Isik, Murat
   Niinomi, Mitsuo
   Cho, Ken
   Nakai, Masaaki
   Hieda, Junko
   Yilmazer, Hakan
   Horita, Zenji
   Narushima, Takayuki
BE Goto, T
   Fu, Z
   Zhang, L
TI Microstructural analysis of biomedical Co-Cr-Mo alloy subjected to
   high-pressure torsion processing
SO ADVANCED CERAMICS AND NOVEL PROCESSING
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th International Symposium on Advance Ceramics (ISAC) / 3rd
   International Symposium on Advanced Synthesis and Processing Technology
   for Materials (ASPT)
CY DEC 09-12, 2013
CL Wuhan, PEOPLES R CHINA
SP Japan Soc Promot Sci, Wuhan Univ Technol, Adv Inst Mat Sci, Ceram Soc Japan, Chinese Ceram Soc, Japan Inst Metals & Mat, Japan Soc Powder & Powder Metallurgy, Peoples Republ China, Minist Educ, Wuhan Univ Technol, State Key Lab Adv Technol Mat Synthesis & Proc, 124th Comm Adv Ceram Mat
DE Co-Cr-Mo alloys; Metallic biomaterial; High-pressure torsion;
   Strain-induced e martensite phase; Vickers hardness; Grain refinement
ID EVOLUTION
AB The effect of high-pressure torsion (HPT) processing on the microstructure and Vickers hardness of Co-Cr-Mo (CCM) alloys were investigated in this study. The microstructure of initial CCM alloy contains equiaxed grains with a grain diameter of approximately 50 mu m and twins. The clear grain boundaries of equiaxed grains and twins disappear after HPT processing at a rotation number, N, of 10. The phase maps of initial CCM alloy and CCM alloy subjected to HPT processing at N = 5 measured by electron backscatter diffraction exhibit that the ratio of. phase decreases from 93.5% to 34.1% and the ratio of e phase increases from 6.5% to 65.9% by applying HPT processing. These results indicate that the e phase is formed by high-strain, which is induced by the HPT processing. The Vickers hardness values on the surfaces of the CCM alloys subjected to HPT processing at N = 1, 5, and 10 increase with increasing the equivalent strain, epsilon(eq). These results suggest that an increase of Vickers hardness is correlated to an increase of the ratio of epsilon phase and the dislocation density, and grain refinement, which are caused by the high-strain induced by HPT processing.
C1 [Isik, Murat] Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.
   [Niinomi, Mitsuo; Cho, Ken; Nakai, Masaaki; Hieda, Junko; Yilmazer, Hakan] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi, Japan.
   [Horita, Zenji] Kyushu Univ, Fac Engn, Dept Mat Sci & Engn, Nishi Ku, Fukuoka 8190395, Japan.
   [Narushima, Takayuki] Tohoku Univ, Dept Mat Proc, Sendai, Miyagi 9808579, Japan.
RP Isik, M (reprint author), Tohoku Univ, Dept Mat Sci, Sendai, Miyagi 9808579, Japan.
EM murat@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp;
   k_cho@imr.tohoku.ac.jp; nakai@imr.tohoku.ac.jp; hieda@imr.tohoku.ac.jp;
   hakan@imr.tohoku.ac.jp; horita@zaiko.kyushu-u.ac.jp;
   narut@material.tohoku.ac.jp
FU Grants for Excellent Gradate School; MEXT, Japan; Japan Society for the
   Promotion of Science, and Inamori Grants from the Inamori Foundation,
   Japan [24246111]
FX This study was supported in part by The Grants for Excellent Gradate
   School "Materials Integration Center" and "Materials Science Center",
   MEXT, Japan, Grant-in-Aid for Scientific Research (A) No. 24246111 from
   the Japan Society for the Promotion of Science, and Inamori Grants from
   the Inamori Foundation, Japan.
CR CLEMOW AJT, 1979, J BIOMED MATER RES, V13, P265, DOI 10.1002/jbm.820130208
   Hsu HC, 2003, J MATER PROCESS TECH, V138, P231, DOI 10.1016/S0924-0136(03)00077-3
   Hsu RWW, 2005, MATER CHEM PHYS, V93, P531, DOI 10.1016/j.matchemphys.2005.04.007
   Huang P, 1999, MATER LETT, V39, P244, DOI 10.1016/S0167-577X(99)00021-X
   Ito Y, 2009, MAT SCI ENG A-STRUCT, V503, P32, DOI 10.1016/j.msea.2008.03.055
   Koizumi Y, 2013, ACTA MATER, V61, P1648, DOI 10.1016/j.actamat.2012.11.041
   Mori M, 2010, MAT SCI ENG A-STRUCT, V528, P614, DOI 10.1016/j.msea.2010.09.002
   Yamanaka K, 2009, METALL MATER TRANS A, V40A, P1980, DOI 10.1007/s11661-009-9879-0
   Yilmazer H, 2013, MAT SCI ENG C-MATER, V33, P2499, DOI 10.1016/j.msec.2013.01.056
   Zhilyaev AP, 2008, PROG MATER SCI, V53, P893, DOI 10.1016/j.pmatsci.2008.03.002
   Zhilyaev AP, 2003, ACTA MATER, V51, P753, DOI 10.1016/S1359-6454(02)00466-4
NR 11
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-130-6
J9 KEY ENG MATER
PY 2014
VL 616
BP 263
EP 269
DI 10.4028/www.scientific.net/KEM.616.263
PG 7
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA BB8ZR
UT WOS:000347883400046
DA 2018-10-19
ER

PT J
AU Ju, RK
   Wen, YJ
   Gou, RB
   Wang, Y
   Xu, QY
AF Ju, Rongkai
   Wen, Yujun
   Gou, Rongbin
   Wang, Ying
   Xu, Qunyuan
TI The Experimental Therapy on Brain Ischemia by Improvement of Local
   Angiogenesis With Tissue Engineering in the Mouse
SO CELL TRANSPLANTATION
LA English
DT Article
DE Hyaluronic acid (HA) hydrogel; Poly(lactic-co-glycolic acid) (PLGA);
   Neural stem cells (NSCs); Angiogenesis; Ischemic stroke
ID ENDOTHELIAL GROWTH-FACTOR; NEURAL STEM-CELLS; FOCAL CEREBRAL-ISCHEMIA;
   HYALURONIC-ACID HYDROGEL; PROMOTES ANGIOGENESIS; EXPERIMENTAL STROKE;
   RECEPTOR ANTIBODY; VASCULAR NICHE; IN-VITRO; VEGF
AB Neural restoration has proven to be difficult after brain stroke, especially in its chronic stage. This is mainly due to the generation of an unpropitious niche in the injured area, including loss of vascular support but production of numerous inhibitors against neuronal regeneration. Reconstruction of a proper niche for promoting local angiogenesis, therefore, should be a key approach for neural restoration after stroke. In the present study, a new biomaterial composite that could be implanted in the injured area of the brain was created for experimental therapy of brain ischemia in the mouse. This composite was made using a hyaluronic acid (HA)-based biodegradable hydrogel scaffold, mixed with poly(lactic-co-glycolic acid) (PLGA) microspheres containing vascular endothelial growth factor (VEGF) and angiopoietin-1 (Ang1), two factors that stimulate angiogenesis. In addition, the antibody of Nogo receptor (NgR-Ab), which can bind to multiple inhibitory myelin proteins and promote neural regeneration, was covalently attached to the hydrogel, making the hydrogel more bioactive and suitable for neural survival. This composite (HA PLGA) was implanted into the mouse model with middle cerebral artery occlusion (MCAO) to explore a new approach for restoration of brain function after ischemia. A good survival and proliferation of human umbilical artery endothelial cells (HUAECs) and neural stem cells (NSCs) were seen on the HA hydrogel with PLGA microspheres in vitro. This new material was shown to have good compatibility with the brain tissue and inhibition to gnosis and inflammation after its implantation in the normal or ischemic brain of mice. Particularly, good angiogenesis was found around the implanted HA PLGA hydrogel, and the mouse models clearly showed a behavioral improvement. The results in this present study indicate, therefore, that the HA PLGA hydrogel is a promising material, which is able to induce angiogenesis in the ischemic region by releasing VEGF and Ang1, thus creating a suitable niche for neural restoration in later stages of stroke. This manuscript is published as part of the International Association of Neurorestoratology (IANR) special issue of Cell Transplantation.
C1 [Ju, Rongkai; Wen, Yujun; Gou, Rongbin; Wang, Ying; Xu, Qunyuan] Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Inst Brain Disorders, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, Beijing 100069, Peoples R China.
RP Xu, QY (reprint author), Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Beijing Inst Brain Disorders, Dept Neurobiol,Key Lab Neurodegenerat Dis,Minist, 10 Xitoutiao, Beijing 100069, Peoples R China.
EM xuqy@ccmu.edu.cn
FU National Nature Science Foundation of China [81070977, 81200931,
   81271388]; Capital Medical University Key Laboratory Research
   [2011SJZS05, 2012SJZS03]; National Basic Research Program of China
   [2012CBA01307]
FX This work was supported by National Nature Science Foundation of China
   (No. 81070977, No. 81200931, No. 81271388), Capital Medical University
   Key Laboratory Research (No. 2011SJZS05, No. 2012SJZS03), and National
   Basic Research Program of China (No. 2012CBA01307). The authors declare
   no conflicts of interest.
CR Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710
   ERIKSDOTTERNILSSON M, 1986, J NEUROSCI METH, V17, P275, DOI 10.1016/0165-0270(86)90128-7
   Formiga FR, 2010, J CONTROL RELEASE, V147, P30, DOI 10.1016/j.jconrel.2010.07.097
   George ML, 2000, CLIN CANCER RES, V6, P3147
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Hansen TM, 2008, CURR NEUROVASC RES, V5, P236, DOI 10.2174/156720208786413433
   Henderson RD, 2000, STROKE, V31, P128, DOI 10.1161/01.STR.31.1.128
   Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F
   Khan AA, 2011, INT J NANOMED, V6, P1069, DOI 10.2147/IJN.S15054
   Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163
   KRUPINSKI J, 1994, STROKE, V25, P1794, DOI 10.1161/01.STR.25.9.1794
   Li MZ, 2011, GLIA, V59, P108, DOI 10.1002/glia.21080
   Liu XS, 2007, J CEREBR BLOOD F MET, V27, P564, DOI 10.1038/sj.jcbfm.9600371
   Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005
   Macrae IM, 2011, BRIT J PHARMACOL, V164, P1062, DOI 10.1111/j.1476-5381.2011.01398.x
   Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377
   McKhann GM, 2002, ANN NEUROL, V52, P133, DOI 10.1002/ana.10313
   Nakagomi N, 2009, STEM CELLS, V27, P2185, DOI 10.1002/stem.161
   Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006
   Pan LJ, 2009, J NEUROSCI RES, V87, P3207, DOI 10.1002/jnr.22142
   Pan WH, 2006, EXP NEUROL, V198, P222, DOI 10.1016/j.expneurol.2005.11.020
   Peirce SM, 2004, AM J PHYSIOL-HEART C, V286, pH918, DOI 10.1152/ajpheart.00833.2003
   Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015
   Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039
   Shen FX, 2011, J CEREBR BLOOD F MET, V31, P2343, DOI 10.1038/jcbfm.2011.97
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shin SH, 2013, PHARM RES-DORDR, V30, P2157, DOI 10.1007/s11095-013-1076-6
   Su H, 2009, INT J CARDIOL, V133, P191, DOI 10.1016/j.ijcard.2007.12.034
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622
   Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x
   TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6
   Tao ZX, 2011, P NATL ACAD SCI USA, V108, P2064, DOI 10.1073/pnas.1018925108
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Tomita Y, 2005, J CEREBR BLOOD F MET, V25, P858, DOI 10.1038/sj.jcbfm.9600077
   Wang Y, 2011, PHARM RES-DORDR, V28, P1406, DOI 10.1007/s11095-011-0452-3
   Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298
   Yang JP, 2010, J INVEST SURG, V23, P149, DOI 10.3109/08941930903469482
   Yang JP, 2009, NEUROSCI LETT, V461, P212, DOI 10.1016/j.neulet.2009.06.060
   Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369
   Zhao H, 2011, HUM GENE THER, V22, P207, DOI 10.1089/hum.2010.111
NR 53
TC 15
Z9 18
U1 2
U2 16
PU COGNIZANT COMMUNICATION CORP
PI PUTNAM VALLEY
PA 18 PEEKSKILL HOLLOW RD, PO BOX 37, PUTNAM VALLEY, NY 10579 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2014
VL 23
SU 1
BP S83
EP S95
DI 10.3727/096368914X684998
PG 13
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA AY9KT
UT WOS:000347869500010
PM 25302948
OA Bronze
DA 2018-10-19
ER

PT J
AU Bianchera, A
   Salomi, E
   Pezzanera, M
   Ruwet, E
   Bettini, R
   Elviri, L
AF Bianchera, Annalisa
   Salomi, Enrico
   Pezzanera, Matteo
   Ruwet, Elisabeth
   Bettini, Ruggero
   Elviri, Lisa
TI Chitosan Hydrogels for Chondroitin Sulphate Controlled Release: An
   Analytical Characterization
SO JOURNAL OF ANALYTICAL METHODS IN CHEMISTRY
LA English
DT Article
ID ARTIFICIAL EXTRACELLULAR-MATRIX; MESENCHYMAL STEM-CELLS;
   CHITOSAN/CHONDROITIN SULFATE; POLYELECTROLYTE COMPLEXES; TISSUE
   REGENERATION; HYALURONIC-ACID; GROWTH-FACTOR; GLUCOSAMINE; CHONDROCYTES;
   EXPRESSION
AB This paper provides an analytical characterization of chitosan scaffolds obtained by freeze-gelation toward the uptake and the controlled release of chondroitin sulphate (CS), as cartilage repair agent, under different pH conditions. Scanning electron microscopy (SEM), attenuated total reflectance-Fourier transforminfrared spectroscopy (ATR-FTIR), and liquid chromatography-UV spectrophotometry (LC-UV) techniques were exploited to obtain qualitative and quantitative descriptions of polymer and drug behaviour in the biomaterial. As for morphology, SEM analysis allowed the evaluation of scaffold porosity in terms of pore size and distribution both at the surface (Feret diameter 58 + 19 mu m) and on the cross section (Feret diameter 106 + 51 mu m). LC and ATR-FTIR evidenced a pH-dependent CS loading and release behaviour, strongly highlighting the role of electrostatic forces on chitosan/chondroitin sulphate interactions.
C1 [Bianchera, Annalisa; Salomi, Enrico; Pezzanera, Matteo; Ruwet, Elisabeth; Bettini, Ruggero; Elviri, Lisa] Univ Parma, Dept Pharm, I-43124 Parma, Italy.
RP Elviri, L (reprint author), Univ Parma, Dept Pharm, Parco Area Sci 27-A, I-43124 Parma, Italy.
EM lisa.elviri@unipr.it
RI Bettini, Ruggero/O-2693-2013
OI Bettini, Ruggero/0000-0002-3857-7476
CR Abarrategi A, 2010, J BIOMED MATER RES A, V95A, P1132, DOI 10.1002/jbm.a.32912
   Ahmed TAE, 2010, TISSUE ENG PART B-RE, V16, P305, DOI [10.1089/ten.teb.2009.0590, 10.1089/ten.TEB.2009.0590]
   BASSLEER C, 1992, INT J TISSUE REACT, V14, P231
   Busilacchi A, 2013, CARBOHYD POLYM, V98, P665, DOI 10.1016/j.carbpol.2013.06.044
   Calamia V, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4040
   Chen WB, 2005, J BIOMED MATER RES A, V75A, P128, DOI 10.1002/jbm.a.30393
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014
   Fajardo AR, 2011, COLLOID POLYM SCI, V289, P1739, DOI 10.1007/s00396-011-2497-6
   Fajardo AR, 2010, CARBOHYD POLYM, V80, P934, DOI 10.1016/j.carbpol.2010.01.009
   Henson FMD, 2012, AM J VET RES, V73, P306, DOI 10.2460/ajvr.73.2.306
   Huang HJ, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/3/035008
   Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208
   Jou CH, 2008, POLYM ADVAN TECHNOL, V19, P377, DOI 10.1002/pat.1020
   Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.2009.08.005, 10.1016/j.lfs.209.08.005]
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Liang N, 2012, INT J PHARMACEUT, V423, P480, DOI 10.1016/j.ijpharm.2011.12.004
   Lippiello L, 2003, OSTEOARTHR CARTILAGE, V11, P335, DOI 10.1016/S1063-4584(03)00026-8
   Lippiello L, 2000, CLIN ORTHOP RELAT R, P229
   Lovu M, 2008, OSTEOARTHR CARTILAGE, V16, pS14, DOI 10.1016/j.joca.2008.06.008
   Martel-Pelletier J, 2010, OSTEOARTHR CARTILAGE, V18, pS7, DOI 10.1016/j.joca.2010.01.015
   Mi FL, 2006, J BIOMED MATER RES A, V76A, P1, DOI 10.1002/jbm.a.30298
   Mi FL, 2006, J AGR FOOD CHEM, V54, P3290, DOI 10.1021/jf0529868
   Muzzarelli RAA, 2012, CARBOHYD POLYM, V89, P723, DOI 10.1016/j.carbpol.2012.04.057
   Park YJ, 2000, J CONTROL RELEASE, V67, P385, DOI 10.1016/S0168-3659(00)00232-7
   Peng CK, 2006, J APPL POLYM SCI, V99, P2091, DOI 10.1002/app.22730
   Piai JF, 2010, J MOL LIQ, V156, P28, DOI 10.1016/j.molliq.2010.05.017
   Piai JF, 2009, ACTA BIOMATER, V5, P2601, DOI 10.1016/j.actbio.2009.03.035
   PIPITONE VR, 1991, DRUG EXP CLIN RES, V17, P3
   Romani AA, 2008, BIOMED PHARMACOTHER, V62, P491, DOI 10.1016/j.biopha.2008.07.010
   Romani A. A., 2013, ADV BIOMATERIALS SCI
   Ronca F, 1998, OSTEOARTHR CARTILAGE, V6, P14, DOI 10.1016/S1063-4584(98)80006-X
   Ruffell B, 2011, J BIOL CHEM, V286, P19179, DOI 10.1074/jbc.M110.200790
   Schindeler A, 2013, CELL REPROGRAM, V15, P101, DOI 10.1089/cell.2012.0054
   Schwartz Z, 2011, AM J VET RES, V72, P42, DOI 10.2460/ajvr.72.1.42
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Senkoylu A, 2001, J BIOACT COMPAT POL, V16, P136, DOI 10.1106/3EH5-2R73-RC4V-Y9L7
   Shea JE, 2005, ADV DRUG DELIVER REV, V57, P945, DOI 10.1016/j.addr.2004.12.017
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Varghese S, 2007, OSTEOARTHR CARTILAGE, V15, P59, DOI 10.1016/j.joca.2006.06.008
   Yagoubi N., 1996, Annales Pharmaceutiques Francaises, V54, P126
   Yao HB, 2010, ANGEW CHEM INT EDIT, V49, P10127, DOI 10.1002/anie.201004748
   Yeh MK, 2011, ACTA BIOMATER, V7, P3804, DOI 10.1016/j.actbio.2011.06.026
   Yuan NY, 2008, DESALINATION, V234, P166, DOI 10.1016/j.desal.2007.09.083
NR 44
TC 8
Z9 8
U1 0
U2 18
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-8865
EI 2090-8873
J9 J ANAL METHODS CHEM
JI J. Anal. Methods Chem.
PY 2014
AR 808703
DI 10.1155/2014/808703
PG 8
WC Chemistry, Analytical; Engineering, Civil
SC Chemistry; Engineering
GA AY8TS
UT WOS:000347826900001
PM 25614850
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Fangel, R
   Bossini, PS
   Renno, AC
   Granito, RN
   Wang, CC
   Nonaka, KO
   Driusso, P
   Parizotto, NA
   Oishi, J
AF Fangel, Renan
   Bossini, Paulo S.
   Renno, Ana Claudia
   Granito, Renata N.
   Wang, Charles C.
   Nonaka, Keico O.
   Driusso, Patricia
   Parizotto, Nivaldo A.
   Oishi, Jorge
TI Biomechanical properties: effects of low-level laser therapy and
   Biosilicate (R) on tibial bone defects in osteopenic rats
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Biomaterial; Biomechanical properties; Bone healing; Low-level laser
   therapy; Osteopenia
ID INORGANIC BOVINE BONE; IN-VITRO; 830-NM LASER; REPAIR; OSTEOPOROSIS;
   IRRADIATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION; FRACTURES
AB Purpose: The aim of this study was to investigate the effects of laser therapy and Biosilicate (R) on the biomechanical properties of bone callus in osteopenic rats.
   Methods: Fifty female Wistar rats were equally divided into 5 groups (n=10/group): osteopenic rats with intact tibiae (SC); osteopenic rats with unfilled and untreated tibial bone defects (OC); osteopenic rats whose bone defects were treated with Biosilicate (R) (B); osteopenic rats whose bone defects were treated with 830-nm laser, at 120 J/cm(2) (L120) and osteopenic rats whose bone defects were treated with Biosilicate (R) and 830-nm laser, at 120 J/cm(2) (BL120). Ovariectomy (OVX) was used to induce osteopenia. A non-critical bone defect was created on the tibia of the osteopenic animals 8 weeks after OVX. In Biosilicate (R) groups, bone defects were completely filled with the biomaterial. For the laser therapy, an 830-nm laser, 120 J/cm(2) was used. On day 14 postsurgery, rats were euthanized, and tibiae were removed for biomechanical analysis.
   Results: Maximal load and energy absorption were higher in groups B and BL120, according to the indentation test. Animals submitted to low-level laser therapy (LLLT) did not show any significant biomechanical improvement, but the association between Biosilicate (R) and LLLT was shown to be efficient to enhance callus biomechanical properties. Conversely, no differences were found between study groups in the bending test.
   Conclusions: Biosilicate (R) alone or in association with low level laser therapy improves biomechanical properties of tibial bone callus in osteopenic rats.
C1 [Fangel, Renan; Bossini, Paulo S.; Granito, Renata N.; Wang, Charles C.; Driusso, Patricia; Parizotto, Nivaldo A.] Fed Univ Sao Carlos UFSCar, Dept Physiotherapy, Sao Carlos, SP, Brazil.
   [Renno, Ana Claudia] Fed Univ Sao Paulo UNIFESP, Dept Biosci, Santos, SP, Brazil.
   [Nonaka, Keico O.] Fed Univ Sao Carlos UFSCar, Dept Biol, Sao Carlos, SP, Brazil.
   [Oishi, Jorge] Fed Univ Sao Carlos UFSCar, Dept Stat, Sao Carlos, SP, Brazil.
RP Driusso, P (reprint author), Univ Fed Sao Carlos, Dept Physiotherapy, Rod Washington Luiz,Km 235, BR-13565208 Sao Carlos, SP, Brazil.
EM pdriusso@ufscar.br
RI Granito, Renata/F-3407-2014; Bossini, Paulo/G-2333-2014; Renno, Ana
   Claudia/C-1266-2015; Parizotto, Nivaldo/D-5347-2014
OI Parizotto, Nivaldo/0000-0003-1774-9053
FU Brazilian funding agency Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - CAPES
FX This work was funded by the Brazilian funding agency Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - CAPES. CAPES is a
   foundation within the Ministry of Education (MEC).
CR Adachi JD, 2010, MAYO CLIN PROC, V85, P806, DOI 10.4065/mcp.2010.0082
   Pinheiro ALB, 2013, LASER MED SCI, V28, P815, DOI 10.1007/s10103-012-1166-4
   Bossini PS, 2011, J TISSUE ENG REGEN M, V5, P229, DOI 10.1002/term.309
   Bultink IEM, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0328-0
   Buravlev EA, 2013, LASER MED SCI, V28, P785, DOI 10.1007/s10103-012-1155-7
   Calixto RFE, 2007, IMPLANT DENT, V16, P260, DOI 10.1097/ID.0b013e3180500b95
   Comelekoglu U, 2007, CLIN RHEUMATOL, V26, P380, DOI 10.1007/s10067-006-0367-2
   Diniz JS, 2009, LASER MED SCI, V24, P347, DOI 10.1007/s10103-008-0568-9
   Fangel R, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3598847
   Fazil M, 2013, EXPERT OPIN DRUG DEL, V10, P1123, DOI 10.1517/17425247.2013.785518
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Granito RN, 2011, J BIOMED MATER RES B, V97B, P139, DOI 10.1002/jbm.b.31795
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I
   Kamali F, 2007, J PHOTOCH PHOTOBIO B, V88, P11, DOI 10.1016/j.jphotobiol.2007.04.010
   Ke HZ, 1998, BONE, V23, P249, DOI 10.1016/S8756-3282(98)00102-1
   Lirani-Galvao AP, 2006, PHOTOMED LASER SURG, V24, P735, DOI 10.1089/PHO.2006.2003
   Liu XC, 2007, PHOTOMED LASER SURG, V25, P487, DOI 10.1089/pho.2006.2075
   Luger EJ, 1998, LASER SURG MED, V22, P97, DOI 10.1002/(SICI)1096-9101(1998)22:2<97::AID-LSM5>3.0.CO;2-R
   Matsumoto MA, 2009, LASER MED SCI, V24, P195, DOI 10.1007/s10103-008-0544-4
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Muniz Renno AC, 2006, LASER MED SCI, V21, P202, DOI 10.1007/s10103-006-0396-8
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585
   Renno ACM, 2007, PHOTOMED LASER SURG, V25, P275, DOI 10.1089/pho.2007.2055
   Renno ACM, 2006, PHOTOMED LASER SURG, V24, P202, DOI 10.1089/pho.2006.24.202
   Renno ACM, 2009, PHOTOMED LASER SURG, V12, P124
   Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161
   Tim CR, 2014, LASER MED SCI, V29, P147, DOI 10.1007/s10103-013-1302-9
NR 31
TC 5
Z9 5
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2014
VL 12
IS 3
BP 271
EP 277
DI 10.5301/jabfm.5000198
PG 7
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA AY4NB
UT WOS:000347554200020
PM 24700268
DA 2018-10-19
ER

PT S
AU Klocke, F
   Schwade, M
   Klink, A
AF Klocke, Fritz
   Schwade, Max
   Klink, Andreas
BE Larkiola, J
TI Fundamental Analysis of the Process Conditions During Electro Discharge
   Machining of Biodegradable Magnesium
SO MATERIAL FORMING ESAFORM 2014
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 17th Conference of the
   European-Scientific-Association-on-Material-Forming (ESAFORM)
CY MAY 07-09, 2014
CL Espoo, FINLAND
SP European Sci Assoc Mat Forming, VTT
DE EDM; Sinking-EDM; Single Discharge; Process Monitoring
AB Magnesium is one of the most promising materials for the application as degradable biomaterial for load bearing implants due to the initial stability and extraordinary biocompatibility. But up until now magnesium degrades too fast before the ingrowing bone can support itself. One possible approach is the application of an interconnecting channel structure. This design increases the surface area to promote bone regeneration and gives the bone the possibility to build a supporting structure throughout the implant. In combination with a surface modification which increases the corrosion resistance the bone can regain enough stability to support itself before the implant has dissolved noticeably. Due to the low process forces EDM is very suited for the machining of the necessary filigree structures. But up until now there are no standard technologies for the machining of this material available. Therefore a fundamental analysis of the material specific influence of magnesium on the EDM process is necessary. In this paper the machining of three different magnesium alloys are compared to the machining of a tool steel. Due to the numerous influencing factors and their interdependencies it is normally not possible to analyze the impact of each input parameter of a typical EDM technology on the continuous process separately making the correlation of input and output parameters very difficult. Therefore the electrical signals are recorded during the machining process to identify and monitor the resulting discharge conditions and frequency. These results are compared to the fundamental influence of the material derived from single discharge experiments in which the boundary conditions are constant to a large extent. By this method the material removal rate as well as the resulting surface roughness of the continuous process can be linked to the material dependent process conditions. As a result technologies for the machining of new materials can be developed and optimized based on fundamental knowledge.
C1 [Klocke, Fritz; Schwade, Max; Klink, Andreas] Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Aachen, Germany.
RP Schwade, M (reprint author), Rhein Westfal TH Aachen, Lab Machine Tools & Prod Engn WZL, Aachen, Germany.
EM f.klocke@wzl.rwth-aachen.de; m.schwade@wzl.rwth-aachen.de;
   a.klink@wzl.rwth-aachen.de
CR Altpeter F, 2004, J MATER PROCESS TECH, V149, P147, DOI 10.1016/j.jmatprotec.2003.10.033
   GU X.N., 2010, FRONT MAT SCI CHINA, P111
   Klocke F, 2007, FERTIGUNGSVERFAHREN
   Kunieda M., 2005, CIRP ANN-MANUF TECHN, V54, P64, DOI DOI 10.1016/S0007-8506(07)60020-1
   Nasab M. B., 2009, TRENDS BIOMATER ARTI, V24, P69
   Witte F., 2009, CURRENT OPINION SOLI, V12, P63
NR 6
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-3-03835-106-1
J9 KEY ENG MATER
PY 2014
VL 611-612
BP 773
EP 780
DI 10.4028/www.scientific.net/KEM.611-612.773
PG 8
WC Materials Science, Multidisciplinary
SC Materials Science
GA BB8TP
UT WOS:000347481000099
DA 2018-10-19
ER

PT B
AU de Viteri, VS
   Igartua, A
   Bayon, R
   Barandika, G
   Perez-Jorge, C
   Esteban, J
   Martinez, M
AF de Viteri, Virginia Saenz
   Igartua, Amaya
   Bayon, Raquel
   Barandika, Gotzone
   Perez-Jorge, Conchita
   Esteban, Jaime
   Martinez, Marta
GP IEEE
TI Tribocorrosion and antibacterial behaviour of TiO2 coatings obtained by
   PEO technique
SO 2014 IEEE INTERNATIONAL SYMPOSIUM ON MEDICAL MEASUREMENTS AND
   APPLICATIONS (MEMEA)
SE IEEE International Symposium on Medical Measurements and Applications
   Proceedings-MeMeA
LA English
DT Proceedings Paper
CT 9th IEEE International Symposium on Medical Measurements and
   Applications (IEEE MeMeA)
CY JUN 11-12, 2014
CL Univ Lisbon, ISCTE, Lisbon, PORTUGAL
SP IEEE, IEEE Instrumentat & Measurement Soc
HO Univ Lisbon, ISCTE
DE Plasma Electrolytic Oxidation; iodine; titanium; tribocorrosion;
   antibacterial
ID PLASMA ELECTROLYTIC OXIDATION; BACTERIAL ADHESION; TI-6AL-4V ALLOY;
   TITANIUM; GROWTH; FILMS
AB Ti6Al4V (grade 5) is the implant material of choice to be used in stems of hip joint implants due to its good mechanical properties, biocompatibility and its good corrosion resistance. However, it presents poor wear resistance. This effect with the exposure of biomaterial to the body fluids that induce corrosion damage lead to irreversible material degradation, called tribocorrosion process. Another problem present in prostheses is the high risk of bacterial infection. In this work, Plasma Electrolytic Oxidation technique was used to develop TiO2 coatings with high wear resistance and antibacterial properties were developed. Microstructural and chemical characterization has been carried out. Tribocorrosion behavior was analyzed in simulated body fluid, and bacterial adhesion study was performed.
C1 [de Viteri, Virginia Saenz; Igartua, Amaya; Bayon, Raquel] IK4 TEKNIKER, Tribol Unit, Eibar, Spain.
   [Barandika, Gotzone] Univ Basque Country, Dept Inorgan Chem, Vitoria, Spain.
   [Perez-Jorge, Conchita; Esteban, Jaime; Martinez, Marta] IIS Fundac Jimnez Diaz, Dept Clin Microbiol, Madrid, Spain.
RP de Viteri, VS (reprint author), IK4 TEKNIKER, Tribol Unit, Eibar, Spain.
EM virginia.saenzdeviteri@tekniker.es
RI Barandika, Gotzone/N-2157-2014; Esteban, Jaime/S-6554-2018
OI Barandika, Gotzone/0000-0002-6771-6586; Esteban,
   Jaime/0000-0002-8971-3167
FU FUNCOAT [CSD2008- 0023]; Spanish Government; MEC; GV/ EJ; European
   Social
FX Authors thanks to EMAITEK Project, financed by the Basque Country;
   FUNCOAT ( CSD2008- 0023) CONSOLIDER Project, financed by the Spanish
   Government, under contract; and SGIker for their technical support (
   MEC, GV/ EJ, European Social Fund)
CR Al-Radha ASD, 2012, J DENT, V40, P146, DOI 10.1016/j.jdent.2011.12.006
   Chandra A, 2011, J MECH BEHAV BIOMED, V4, P1990, DOI 10.1016/j.jmbbm.2011.06.018
   Han E., 2007, CURR APPL PHYS, P23
   Han Y, 2003, SURF COAT TECH, V168, P249, DOI 10.1016/S0257-8972(03)00016-1
   Kinnari TJ, 2008, J BIOMED MATER RES A, V86A, P760, DOI 10.1002/jbm.a.31643
   Mabbouxa F., 2004, COLLOID SURFACES B, P199
   Matykina E, 2007, ELECTROCHIM ACTA, V53, P1987, DOI 10.1016/j.electacta.2007.08.074
   Neoh KG, 2012, BIOMATERIALS, V33, P2813, DOI 10.1016/j.biomaterials.2012.01.018
   Perez-Tanoira R., 2012, WIDELY ONLINE LIB, DOI [10.1002/ibm.a.34090, DOI 10.1002/IBM.A.34090]
   SANTAVIRTA S, 1992, ACTA ORTHOP SCAND, V63, P225, DOI 10.3109/17453679209154831
   Shirai T, 2011, ACTA BIOMATER, V7, P1928, DOI 10.1016/j.actbio.2010.11.036
   Wang YM, 2004, MATER LETT, V58, P1907, DOI 10.1016/j.matlet.2003.11.026
   Yao ZP, 2008, APPL SURF SCI, V254, P4084, DOI 10.1016/j.apsusc.2007.12.062
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
NR 14
TC 0
Z9 0
U1 4
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4799-2921-4
J9 IEEE INT SYM MED MEA
PY 2014
BP 289
EP 292
PG 4
WC Engineering, Biomedical; Engineering, Electrical & Electronic
SC Engineering
GA BB8JS
UT WOS:000346747000054
DA 2018-10-19
ER

PT J
AU Barenghi, R
   Beke, S
   Romano, I
   Gavazzo, P
   Farkas, B
   Vassalli, M
   Brandi, F
   Scaglione, S
AF Barenghi, Rossella
   Beke, Szabolcs
   Romano, Ilaria
   Gavazzo, Paola
   Farkas, Balazs
   Vassalli, Massimo
   Brandi, Fernando
   Scaglione, Silvia
TI Elastin-Coated Biodegradable Photopolymer Scaffolds for Tissue
   Engineering Applications
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; GRAFTS; STENTS; STEREOLITHOGRAPHY;
   PROLIFERATION; POLYPEPTIDE; BIOMATERIAL; INHIBITION; RETENTION
AB One of the main open issues in modern vascular surgery is the nonbiodegradability of implants used for stent interventions, which can lead to small caliber-related thrombosis and neointimal hyperplasia. Some new, resorbable polymeric materials have been proposed to substitute traditional stainless-steel stents, but so far they were affected by poor mechanical properties and low biocompatibility. In this respect, a new material, polypropylene fumarate (PPF), may be considered as a promising candidate to implement the development of next generation stents, due to its complete biodegradability, and excellent mechanical properties and the ease to be precisely patterned. Besides all these benefits, PPF has not been tested yet for vascular prosthesis, mainly because it proved to be almost inert, while the ability to elicit a specific biological function would be of paramount importance in such critical surgery applications. Here, we propose a biomimetic functionalization process, aimed at obtaining specific bioactivation and thus improved cell-polymer interaction. Porous PPF-based scaffolds produced by deep-UV photocuring were coated by elastin and the functionalized scaffolds were extensively characterized, revealing a stable bound between the protein and the polymer surface. Both 3T3 and HUVEC cell lines were used for in vitro tests displaying an enhancement of cells adhesion and proliferation on the functionalized scaffolds.
C1 [Barenghi, Rossella; Scaglione, Silvia] Natl Res Council Italy CNR, IEIIT Inst, I-16149 Genoa, Italy.
   [Beke, Szabolcs; Romano, Ilaria; Farkas, Balazs; Brandi, Fernando] IIT, Dept Nanophys, I-16163 Genoa, Italy.
   [Gavazzo, Paola; Vassalli, Massimo] Natl Res Council Italy CNR, IBF Inst, I-16149 Genoa, Italy.
   [Brandi, Fernando] Natl Res Council Italy CNR, INO Inst, I-56124 Pisa, Italy.
RP Scaglione, S (reprint author), Natl Res Council Italy CNR, IEIIT Inst, Via Marini 6, I-16149 Genoa, Italy.
EM silvia.scaglione@ieiit.cnr.it
RI Scaglione, Silvia/B-7124-2014; Vassalli, Massimo/F-6762-2011
OI Scaglione, Silvia/0000-0002-9464-3554; Vassalli,
   Massimo/0000-0002-3063-4376; Brandi, Fernando/0000-0003-2717-3748
FU Italian Ministry of Education and Research (MIUR) through the PRIN
   "Innovative Chemical Methodologies for Smart Biomaterials" project
   [2010L9SH3 K_006]; European Community (FP7-NMP-EU-China) [604263]
FX The authors thank Roberto Utzeri (ISMAC-CNR) for FTIR analysis and Alice
   Scarpellini (IIT) for SEM images. This work has been supported by the
   Italian Ministry of Education and Research (MIUR) through the PRIN
   "Innovative Chemical Methodologies for Smart Biomaterials" project
   (Project 2010L9SH3 K_006) and partially by the European Community
   (FP7-NMP-2013-EU-China) Grant agreement no. 604263 (NEUROSCAFFOLDS).
CR Bandiera A, 2010, J BIOTECHNOL, V150, pS440, DOI 10.1016/j.jbiotec.2010.09.627
   Beke S, 2012, J R SOC INTERFACE, V9, P3017, DOI 10.1098/rsif.2012.0300
   BEKE S, 2013, LASER PHYS, V23
   Bekele S, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-20
   Blit PH, 2011, BIOMATERIALS, V32, P5790, DOI 10.1016/j.biomaterials.2011.04.067
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Brandi F, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054007
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007
   Garg S, 2010, J AM COLL CARDIOL, V56, pS43, DOI 10.1016/j.jacc.2010.06.008
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Jordan S. W., 2007, J VASC SURG, V45, P104
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   Lan PX, 2009, J MATER SCI-MATER M, V20, P271, DOI 10.1007/s10856-008-3567-2
   Lee JW, 2009, MICROELECTRON ENG, V86, P1451, DOI 10.1016/j.mee.2008.12.052
   Mathews A, 2012, J TISSUE ENG REGEN M, V6, P451, DOI 10.1002/term.449
   McClure MJ, 2010, ACTA BIOMATER, V6, P2422, DOI 10.1016/j.actbio.2009.12.029
   Naito Y, 2011, ADV DRUG DELIVER REV, V63, P312, DOI 10.1016/j.addr.2011.03.001
   Pennesi G, 2011, CURR PHARM BIOTECHNO, V12, P151, DOI 10.2174/138920111794295684
   Rnjak J, 2009, BIOMATERIALS, V30, P6469, DOI 10.1016/j.biomaterials.2009.08.017
   Rotmans JI, 2006, CAN J CARDIOL, V22, P1113, DOI 10.1016/S0828-282X(06)70946-1
   Sbrana F, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/4/046007
   Scaglione S., 2013, P SPIE, V8792
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sukmana I, 2010, BIOMATERIALS, V31, P5091, DOI 10.1016/j.biomaterials.2010.02.076
   Vassalli M, 2013, LANGMUIR, V29, P15898, DOI 10.1021/la403311x
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019
   Wilson BD, 2011, ANN BIOMED ENG, V39, P337, DOI 10.1007/s10439-010-0142-z
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Yu H, 2003, J VASC SURG, V38, P557, DOI 10.1016/S0741-5214(03)00334-3
NR 34
TC 4
Z9 5
U1 1
U2 21
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 624645
DI 10.1155/2014/624645
PG 9
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AX5TD
UT WOS:000346989400001
PM 25405204
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT S
AU Hassanzadeh, M
AF Hassanzadeh, Masoumeh
BE Ranzi, E
   KohseHoinghaus, K
TI Unique Marine Organism: Identification of some Methods for Biomaterial
   Production
SO ICONBM: INTERNATIONAL CONFERENCE ON BIOMASS, PTS 1 AND 2
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT International Conference on BioMass (iconBM 2014)
CY MAY 04-07, 2014
CL Florence, ITALY
SP Italian Assoc Chem Engn
ID CIONA-INTESTINALIS; CELLULOSE; ASCIDIANS; BIOFUELS
AB In this work, one dominant species of tunicates in Scandinavian Ocean called Ciona intestinalis has been investigated by extraction and characterization of its cellulose, oil, and amino acids. Potential applications have been evaluated for production of pure crystalline cellulose, biodiesel, and by analysis of amino acid composition of the samples. Pure tunicate cellulose (IC) has been prepared via chemical treatment, using acid, alkali, and the subsequent bleaching. The cellulose percentage, and yield for the chemically pure cellulose obtained were around 96% and 54% respectively. Oil extraction has been done using petroleum ether as the extraction solvent, and then chemical structure and fatty acid composition of the obtained oil have been characterized by NMR (Nuclear Magnetic Resonance Spectroscopy), FTIR (Fourier Transform Infrared Spectroscopy), and GC-MS (Gas Chromatography-Mass Spectrometry). Tunicate's oil has shown high content of free fatty acids together with very low content of glycerol, the latter being the common oil from vegetable origins. Moreover, the composition profile of Tunicate fatty acids seems to be similar to fish oil. However, amino acid composition has shown similarity to egg albumin, implying tunicate to have the capability to be considered as other marine organisms' feed in the near future.
C1 KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Fiber & Polymer Technol, SE-10044 Stockholm, Sweden.
RP Hassanzadeh, M (reprint author), KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Fiber & Polymer Technol, SE-10044 Stockholm, Sweden.
EM mashas@kth.se
CR Bratu A, 2013, UNIV POLITEH BUCHAR, V75, P23
   Caponio F, 2011, J FOOD COMPOS ANAL, V24, P1117, DOI 10.1016/j.jfca.2011.01.019
   Carver C.E., 2006, BIOL SYNOPSIS SOLITA, V2746
   GUNNARSSON T, 1986, SOIL BIOL BIOCHEM, V18, P595, DOI 10.1016/0038-0717(86)90081-7
   JACKSON AD, 1993, DEV COMP IMMUNOL, V17, P97, DOI 10.1016/0145-305X(93)90020-Q
   Kimura Satoshi, 2007, P217, DOI 10.1007/978-1-4020-5380-1_13
   LEWIS JC, 1950, J BIOL CHEM, V186, P23
   Okamoto Takashi, 1996, Wood Research, V83, P27
   Palkovits R, 2010, ANGEW CHEM INT EDIT, V49, P4336, DOI 10.1002/anie.201002061
   Pirani S, 2013, CARBOHYD POLYM, V93, P357, DOI 10.1016/j.carbpol.2012.06.063
   Sasakura Y, 2005, P NATL ACAD SCI USA, V102, P15134, DOI 10.1073/pnas.0503640102
   Siqueira G, 2010, POLYMERS-BASEL, V2, P728, DOI 10.3390/polym2040728
   SMITH MJ, 1971, COMP BIOCHEM PHYSIOL, V40, P615, DOI 10.1016/0305-0491(71)90136-2
   van den Berg O, 2007, BIOMACROMOLECULES, V8, P1353, DOI 10.1021/bm061104q
   VANDAELE Y, 1992, BIOL CELL, V76, P87, DOI 10.1016/0248-4900(92)90198-A
   Yang F., 2012, BIOTECHNOL BIOFUELS, V5, P1
   Zhang D., 2013, INT J POLYM SCI, V2013, P1, DOI DOI 10.1109/TC.2013.223
NR 17
TC 0
Z9 0
U1 0
U2 3
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-28-0
J9 CHEM ENGINEER TRANS
PY 2014
VL 37
BP 385
EP 390
DI 10.3303/CET1437065
PG 6
WC Engineering, Chemical
SC Engineering
GA BB8GO
UT WOS:000346540000065
DA 2018-10-19
ER

PT S
AU Palaniappan, N
   Inwati, GK
   Singh, M
AF Palaniappan, N.
   Inwati, Gajendra Kumar
   Singh, Man
GP IOP
TI Biomaterial Co-Cr-Mo Alloys Nano Coating Calcium Phosphate Orthopedic
   Treatment
SO 2ND INTERNATIONAL CONFERENCE ON STRUCTURAL NANO COMPOSITES (NANOSTRUC
   2014)
SE IOP Conference Series-Materials Science and Engineering
LA English
DT Proceedings Paper
CT 2nd International Conference on Structural Nano Composites (NANOSTRUC)
CY MAY 20-21, 2014
CL Madrid, SPAIN
DE implant; Cr; Co; Mo alloys; Ca-phosphate coating; SEM; corrosion;
   nanostructures
AB The modern study a thermal martensitic transformation of biomedical Co-Cr-Mo alloys and ultimately offers large elongation to failure while maintaining high strength. In the future study, structural evolution and dislocation slip as an elementary process in the martensitic transformation in Co-Cr-Mo alloys were investigated to reveal the origin of their enhanced phase stability due to nitrogen addition and coating of calcium phosphate specimens with and without nitrogen addition were prepared. The N-doped alloys had a single-phase matrix, whereas the N-free alloys had a duplex microstructure. Irrespective of the nitrogen content, dislocations frequently dissociated into Shockley partial dislocations with stacking faults. The Nano range coating of calcium phosphate function as obstacles to the glide of partial dislocations and consequently significantly affect the kinetics of the martensitic transformation. As a result, the formation of marten site plays a crucial role in plastic deformation and wear behavior, the developed nanostructures modification associated with nitrogen addition must be a promising strategy for highly durable orthopedic implants.
C1 [Palaniappan, N.; Inwati, Gajendra Kumar; Singh, Man] Cent Univ Gujarat, Gandhinagar, Gujarat, India.
RP Palaniappan, N (reprint author), Cent Univ Gujarat, Gandhinagar, Gujarat, India.
EM palaniappancecri@rediffmail.com
CR Grecu Michaela, 2011, REV CHEM, V62
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Ievlev VM, 2013, RUSS CHEM REV+, V82, P131, DOI 10.1070/RC2013v082n02ABEH004331
   Kazemzadeh-Narbat M, 2010, BIOMATERIALS, V36, P9519
   Overgaard Soren, ACTA ORTHOP SCAND, V71, P1
   Park Jiu H, 2005, SURF COAT TECH, V195
   Ricardo Luiz Perez Teixeira. Geralda Cristina Duraes de Godoy, 2004, MAT RES, V7
   Ueda K., 2007, MAT T, V48, P307
NR 8
TC 0
Z9 0
U1 0
U2 2
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1757-8981
J9 IOP CONF SER-MAT SCI
PY 2014
VL 64
AR UNSP 012026
DI 10.1088/1757-899X/64/1/012026
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Materials Science, Composites
SC Science & Technology - Other Topics; Materials Science
GA BB8JQ
UT WOS:000346741500027
OA Other Gold
DA 2018-10-19
ER

PT S
AU Hristu, R
   Tofail, SAM
   Stanciu, SG
   Tranca, DE
   Stanciu, GA
AF Hristu, Radu
   Tofail, Syed A. M.
   Stanciu, Stefan G.
   Tranca, Denis E.
   Stanciu, George A.
BE Jaworski, M
   Marciniak, M
TI Hydroxyapatite Surface Charge Investigated by Scanning Probe Microscopy
SO 2014 16TH INTERNATIONAL CONFERENCE ON TRANSPARENT OPTICAL NETWORKS
   (ICTON)
SE International Conference on Transparent Optical Networks-ICTON
LA English
DT Proceedings Paper
CT 16th International Conference on Transparent Optical Networks (ICTON)
CY JUL 06-10, 2014
CL Graz, AUSTRIA
SP IEEE, IEEE Photon Soc, Light Tec, Agilent Technologies, Cerebra InformationsSysteme GmbH, IEEE Austria Sect, Inst Engn & Technol, Natl Inst Telecommunicat, IIIE Media Event, ML11, GRAZ, Osterreichischer Verband Elektrotechnik, IEEE Photon Soc, Raiffeisen Meine Bank, GRAZ Stadt, Graz Univ Technology, TEST
DE hydroxyapatite; surface charge; scanning probe microscopy; scattering
   near field optical microscopy
ID ELECTRON-BEAM; OPTICAL MICROSCOPY; CONTRAST
AB It is well known that electrical properties such as local electrostatic charge distribution at biomaterial surface plays a significant role in biological interactions. The methods currently employed in measuring surface charge in biomaterials such as zeta potential or potentiostatic titration, however, can only measure global charge distribution in macroscopic and colloidal state of biomaterials. By using scanning probe microscopy techniques we investigated the surface charge domains placed on the hydroxyapatite surface. Scattering near field optical microscopy (s-SNOM) was used to image electrostatic charge trapped at pre-existing and irradiation induced defects within these domains, while phase imaging in atomic force microscopy was used to image the carbon contamination. The two techniques can be used for nanoscale imaging.
C1 [Hristu, Radu; Stanciu, Stefan G.; Tranca, Denis E.; Stanciu, George A.] Univ Politehn Bucuresti, Ctr Microscopy Microanl & Informat Proc, 313 Splaiul Independentei, Bucharest 060042, Romania.
   [Tofail, Syed A. M.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland.
RP Hristu, R (reprint author), Univ Politehn Bucuresti, Ctr Microscopy Microanl & Informat Proc, 313 Splaiul Independentei, Bucharest 060042, Romania.
EM stanciu@physics.pub.ro
RI Tranca, Denis/C-8429-2015; Tranca, Denis/N-4518-2014; Tranca,
   Denis/P-6928-2018
OI Tranca, Denis/0000-0002-1966-8348; 
FU UEFISCDI [PN-II-PT-PCCA-2011-3.2-1162]; European Commission [EC
   NMP4-SL-2008-212533 -BioElectricSurface]; Sectoral Operational Programme
   Human Resources Development [20072013]; Ministry of European Funds
   through the Financial Agreement [POSDRU/159/1.5/S/132397]
FX This work was suported by the UEFISCDI PN-II-PT-PCCA-2011-3.2-1162
   Research Grant and by the European Commission (EC NMP4-SL-2008-212533
   -BioElectricSurface). This publication reflects the views only of the
   authors, and the Commission cannot be held responsible for any use,
   which may be made of the information contained therein. The work has
   also been funded by the Sectoral Operational Programme Human Resources
   Development 20072013 of the Ministry of European Funds through the
   Financial Agreement POSDRU/159/1.5/S/132397.
CR Aronov D, 2008, SURF COAT TECH, V202, P2093, DOI 10.1016/j.surfcoat.2007.08.060
   Aronov D, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196481
   Hristu R, 2014, MICROSC MICROANAL, V20, P586, DOI 10.1017/S1431927614000191
   Itoh S, 2006, CALCIFIED TISSUE INT, V78, P133, DOI 10.1007/s00223-005-0213-6
   Plecenik T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3567532
   Renoud R, 2002, J PHYS-CONDENS MAT, V14, P231, DOI 10.1088/0953-8984/14/2/310
   Robin S, 2011, LANGMUIR, V27, P14968, DOI 10.1021/la203491q
   Rykaczewski K, 2008, ULTRAMICROSCOPY, V108, P989, DOI 10.1016/j.ultramic.2008.04.006
   Stanciu G.A., 2012, P 14 INT C TRANSP OP
   Stevens-Kalceff MA, 2007, MICROSC RES TECHNIQ, V70, P195, DOI 10.1002/jemt.20399
   Tranca DE, 2014, OPT EXPRESS, V22, P1687, DOI 10.1364/OE.22.001687
   VAEZIRAVANI M, 1993, APPL PHYS LETT, V62, P1044, DOI 10.1063/1.108789
NR 12
TC 0
Z9 0
U1 0
U2 9
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 2162-7339
BN 978-1-4799-5601-2
J9 INT C TRANS OPT NETW
PY 2014
PG 4
WC Engineering, Electrical & Electronic; Telecommunications
SC Engineering; Telecommunications
GA BB8GC
UT WOS:000346516400061
DA 2018-10-19
ER

PT S
AU Esa, F
   Tasirin, SM
   Rahman, NA
AF Esa, Faezah
   Tasirin, Siti Masrinda
   Rahman, Norliza Abd
BE Chin, NL
   Man, HC
   Talib, RA
TI Overview of Bacterial Cellulose Production and Application
SO 2ND INTERNATIONAL CONFERENCE ON AGRICULTURAL AND FOOD ENGINEERING (CAFE
   2014) - NEW TRENDS FORWARD
SE Agriculture and Agricultural Science Procedia
LA English
DT Proceedings Paper
CT 2nd International Conference on Agricultural and Food Engineering (CAFE)
CY DEC 01-03, 2014
CL Kuala Lumpur, MALAYSIA
DE Bacterial cellulose; acetobacter xylinum; fermentation; composite
   material
ID NATA-DE-COCO; ACETOBACTER-XYLINUM; GLUCONACETOBACTER-XYLINUS; COMPOSITE
   MEMBRANES; EPSILON-POLYLYSINE; CULTURE-MEDIA; IN-SITU; NANOFIBERS;
   HANSENII; FILM
AB Bacterial cellulose (BC), produced by aerobic bacteria received ample of attention due to its unique physiochemical properties compared to plant cellulose. Intense researches on BC mainly focus on biosynthetic process to achieve low-cost preparation and high cellulose production. BC has been used as biomaterial for medical field, electrical instrument and food ingredient. However, BC alone has limited capabilities to fulfil current demand on high-performance biomaterials. Hence, BC composite has been introduced to enhance BC properties through addition of reinforcement materials. This review discusses current knowledge in fermentation process and potential application of BC including its application in food industry. (C) 2014 The Authors. Published by Elsevier B.V.
C1 [Esa, Faezah; Tasirin, Siti Masrinda; Rahman, Norliza Abd] Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi 43600, Selangor, Malaysia.
RP Esa, F (reprint author), Univ Kebangsaan Malaysia, Fac Engn & Built Environm, Dept Chem & Proc Engn, Bangi 43600, Selangor, Malaysia.
EM faey_z@yahoo.com.my
CR Arrieta MP, 2014, POLYM DEGRAD STABIL, V107, P139, DOI 10.1016/j.polymdegradstab.2014.05.010
   Bootten TJ, 2008, CARBOHYD RES, V343, P221, DOI 10.1016/j.carres.2007.11.008
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   Brown A.J., 1988, CHEM SOC, V49, P432
   Budhiono A, 1999, CARBOHYD POLYM, V40, P137, DOI 10.1016/S0144-8617(99)00050-8
   Cakar F, 2014, CARBOHYD POLYM, V106, P7, DOI 10.1016/j.carbpol.2014.01.103
   CANNON RE, 1991, CRIT REV MICROBIOL, V17, P435, DOI 10.3109/10408419109115207
   Carreira P, 2011, BIORESOURCE TECHNOL, V102, P7354, DOI 10.1016/j.biortech.2011.04.081
   Castro C, 2011, CARBOHYD POLYM, V84, P96, DOI 10.1016/j.carbpol.2010.10.072
   Chawla PR, 2009, FOOD TECHNOL BIOTECH, V47, P107
   Chen P, 2010, MACROMOL RES, V18, P309, DOI 10.1007/s13233-010-0404-5
   Correa MJ, 2010, FOOD RES INT, V43, P780, DOI 10.1016/j.foodres.2009.11.016
   Dahman Y, 2010, APPL BIOCHEM BIOTECH, V162, P1647, DOI 10.1007/s12010-010-8946-8
   Dahman Y, 2009, J NANOSCI NANOTECHNO, V9, P5105, DOI 10.1166/jnn.2009.1466
   El-Saied H, 2004, POLYM-PLAST TECHNOL, V43, P797, DOI 10.1081/PPT-120038065
   Fernandes SCM, 2009, GREEN CHEM, V11, P2023, DOI 10.1039/b919112g
   Festucci-Buselli Reginaldo A., 2007, Braz. J. Plant Physiol., V19, P1, DOI 10.1590/S1677-04202007000100001
   Gadim TDO, 2014, ACS APPL MATER INTER, V6, P7864, DOI 10.1021/am501191t
   Gao C, 2014, FOOD HYDROCOLLOID, V36, P204, DOI 10.1016/j.foodhyd.2013.09.015
   Gayathry G, 2014, INDIAN J FIBRE TEXT, V39, P93
   Gomes FP, 2013, BIOMASS BIOENERG, V55, P205, DOI 10.1016/j.biombioe.2013.02.004
   Hu Y, 2013, BIOMACROMOLECULES, V14, P3444, DOI 10.1021/bm400744a
   Jagannath A, 2008, WORLD J MICROB BIOT, V24, P2593, DOI 10.1007/s11274-008-9781-8
   Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037
   Keshk S.M., 2014, BIOPROCES BIOTECHNIQ, V4, P2
   Kim J, 2011, J POLYM RES, V18, P739, DOI 10.1007/s10965-010-9470-9
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Kurosumi A, 2009, CARBOHYD POLYM, V76, P333, DOI 10.1016/j.carbpol.2008.11.009
   Lin DH, 2014, BIORESOURCE TECHNOL, V151, P113, DOI 10.1016/j.biortech.2013.10.052
   Lin SB, 2011, J FOOD PROCESS ENG, V34, P1363, DOI 10.1111/j.1745-4530.2009.00533.x
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Maria LCS, 2010, POLIMEROS, V20, P72, DOI 10.1590/S0104-14282010005000001
   Meng N, 2009, APPL CLAY SCI, V42, P667, DOI 10.1016/j.clay.2008.06.016
   Mesomya W., 2006, J SCI TECHNOL, V28, P23
   Montealegre C.M., 2012, CONTINUOUS BIOETHANO
   Moosavi-Nasab M, 2011, IRAN J BIOTECHNOL, V9, P94
   Muangman Pornprom, 2011, J Am Col Certif Wound Spec, V3, P16, DOI 10.1016/j.jcws.2011.04.001
   Nguyen VT, 2008, FOOD MICROBIOL, V25, P471, DOI 10.1016/j.fm.2008.01.004
   Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015
   Park JK, 2003, BIOTECHNOL BIOPROC E, V8, P83, DOI 10.1007/BF02940261
   Perez CD, 2013, J FOOD ENG, V116, P162, DOI 10.1016/j.jfoodeng.2012.11.004
   Rivas B, 2004, INT J FOOD MICROBIOL, V97, P93, DOI 10.1016/j.ijfoodmicro.2004.05.006
   ROSS P, 1991, MICROBIOL REV, V55, P35
   Saibuatong OA, 2010, CARBOHYD POLYM, V79, P455, DOI 10.1016/j.carbpol.2009.08.039
   Sani A, 2010, J CHEM TECHNOL BIOT, V85, P151, DOI 10.1002/jctb.2300
   Santos SM, 2015, CARBOHYD POLYM, V116, P173, DOI 10.1016/j.carbpol.2014.03.064
   Shah N, 2013, CARBOHYD POLYM, V98, P1585, DOI 10.1016/j.carbpol.2013.08.018
   Sheykhnazari S, 2011, CARBOHYD POLYM, V86, P1187, DOI 10.1016/j.carbpol.2011.06.011
   Shi QS, 2013, CELL CHEM TECHNOL, V47, P503
   Sonia A, 2013, J FOOD ENG, V118, P78, DOI 10.1016/j.jfoodeng.2013.03.020
   Sun RC, 2009, BIORESOURCES, V4, P452
   Suppakul P, 2010, J FOOD ENG, V98, P207, DOI 10.1016/j.jfoodeng.2009.12.027
   Tang XZ, 2012, CRIT REV FOOD SCI, V52, P426, DOI 10.1080/10408398.2010.500508
   Tanskul S, 2013, CARBOHYD POLYM, V92, P421, DOI 10.1016/j.carbpol.2012.09.017
   Tazi N, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-61
   Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006
   Ummartyotin S, 2012, IND CROP PROD, V35, P92, DOI 10.1016/j.indcrop.2011.06.025
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
   Wu J, 2014, CARBOHYD POLYM, V102, P762, DOI 10.1016/j.carbpol.2013.10.093
   Wu JM, 2012, CARBOHYD POLYM, V90, P116, DOI 10.1016/j.carbpol.2012.05.003
   Wu SC, 2008, J MOL CATAL B-ENZYM, V54, P103, DOI 10.1016/j.molcatb.2007.12.021
   Yan ZY, 2008, CARBOHYD POLYM, V74, P659, DOI 10.1016/j.carbpol.2008.04.028
   Zaborowska M, 2010, ACTA BIOMATER, V6, P2540, DOI 10.1016/j.actbio.2010.01.004
   Zeng XB, 2011, CARBOHYD POLYM, V85, P506, DOI 10.1016/j.carbpol.2011.02.034
   Zhang XJ, 2013, SYNTH REACT INORG M, V43, P907, DOI 10.1080/15533174.2012.750674
   Zhao QZ, 2009, FOOD HYDROCOLLOID, V23, P2168, DOI 10.1016/j.foodhyd.2009.04.007
   Zhou T, 2013, EXPRESS POLYM LETT, V7, P756, DOI 10.3144/expresspolymlett.2013.73
   Zhu HX, 2010, FOOD SCI BIOTECHNOL, V19, P1479, DOI 10.1007/s10068-010-0211-y
NR 68
TC 47
Z9 47
U1 5
U2 44
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2210-7843
J9 AGRIC AGRIC SCI PROC
PY 2014
VL 2
BP 113
EP 119
DI 10.1016/j.aaspro.2014.11.017
PG 7
WC Agriculture, Multidisciplinary; Food Science & Technology
SC Agriculture; Food Science & Technology
GA BB8CL
UT WOS:000346363800016
OA Other Gold
DA 2018-10-19
ER

PT J
AU Palmer, JA
   Abberton, KM
   Mitchell, GM
   Morrison, WA
AF Palmer, Jason A.
   Abberton, Keren M.
   Mitchell, Geraldine M.
   Morrison, Wayne A.
TI Macrophage Phenotype in Response to Implanted Synthetic Scaffolds: An
   Immunohistochemical Study in the Rat
SO CELLS TISSUES ORGANS
LA English
DT Article
DE Biomaterials; Foreign body response; Macrophage phenotype;
   Polycaprolactone; Rat model
ID FOREIGN-BODY REACTION; SCAVENGER RECEPTOR CD163; IN-VITRO; INFLAMMATORY
   RESPONSE; BIOLOGIC SCAFFOLDS; TISSUE-RESPONSE; BIOMATERIALS; EXPRESSION;
   BIODEGRADATION; ACTIVATION
AB Macrophages predominate among the cells that directly interact with biomaterials and are key orchestrators of host-biomaterial interactions. However, the macrophage response to synthetic scaffolds in particular has not been well studied. The aim of this study was therefore to characterise the macrophage response to several synthetic scaffolds in the rat using immunohistological techniques for a panel of markers of macrophage subclass or activation, including ED1 (CD68), ED2 (CD163), CD80, mannose receptor and inducible nitric oxide synthase (iNOS). Materials were implanted subcutaneously and collected after 6-8 weeks during the chronic phase of the host response. Unmodified polycaprolactone scaffolds uniquely demonstrated a total lack of both macrophage adherence to surfaces and a wider foreign body response compared to scaffolds composed of poly( lactic-co-glycolic acid) (PLGA) and polyurethanes (PURs), with those macrophages present having a clear M2 (MR+, CD80-, iNOS-) phenotype. PLGA scaffolds displayed an M1-dominant (CD80+, iNOS+, MR-) response with substantial foreign body giant cell (FBGC) formation, whilst PUR scaffold FBGCs had a more mixed M1 (CD80+, iNOS+) and M2 (MR+) phenotype. The study also identified that the use of the ED1 antibody in the rat as a pan-macrophage marker is problematic as there is a separate and substantial ED2-positive macrophage population that it does not label, both in response to biomaterials and in normal tissues. The biomaterial-dependent nature of activation for both macrophages and FBGCs was confirmed, and nuanced M1/ M2 phenotypes were described. (C) 2014 S. Karger AG, Basel
C1 [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Univ Melbourne, St Vincents Hosp, OBrien Inst, Melbourne, Vic, Australia.
   [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Univ Melbourne, St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia.
   [Palmer, Jason A.; Abberton, Keren M.; Mitchell, Geraldine M.; Morrison, Wayne A.] Australian Catholic Univ, Fac Hlth Sci, Melbourne, Vic, Australia.
RP Palmer, JA (reprint author), OBrien Inst, 42 Fitzroy St, Fitzroy, Vic 3065, Australia.
EM jpalmer@obi.edu.au
FU Victorian State Government's Department of State Development, Business
   and Innovation's Operational Infrastructure Support Program
FX The authors wish to acknowledge the contributions of Dr. Aurora Messina,
   Dr. Tristan Croll, Sue McKay and the staff of the Experimental Medical
   and Surgical Research Unit at St. Vincent's Hospital. The work was
   supported by the Victorian State Government's Department of State
   Development, Business and Innovation's Operational Infrastructure
   Support Program.
CR Ahn M, 2012, BRAIN RES, V1445, P11, DOI 10.1016/j.brainres.2012.01.045
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Baker SC, 2011, MACROMOL BIOSCI, V11, P618, DOI 10.1002/mabi.201000415
   BEELEN RHJ, 1987, TRANSPLANT P, V19, P3166
   Blackwood KA, 2008, BIOMATERIALS, V29, P3091, DOI 10.1016/j.biomaterials.2008.03.037
   Brown BN, 2012, BIOMATERIALS, V33, P3792, DOI 10.1016/j.biomaterials.2012.02.034
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Byers BA, 2006, J BIOMED MATER RES A, V76A, P646, DOI 10.1002/jbm.a.30549
   Cao Y, 2006, J BIOMAT SCI-POLYM E, V17, P369, DOI 10.1163/156856206776374142
   Cao Y, 2006, BIOMATERIALS, V27, P2854, DOI 10.1016/j.biomaterials.2005.12.015
   Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236
   DAMOISEAUX JGMC, 1994, IMMUNOLOGY, V83, P140
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Hagerty RD, 2000, J BIOMED MATER RES, V49, P489, DOI 10.1002/(SICI)1097-4636(20000315)49:4<489::AID-JBM7>3.0.CO;2-2
   Hamid ZAA, 2010, BIOMATERIALS, V31, P6454, DOI 10.1016/j.biomaterials.2010.05.008
   Hespanhol RC, 2005, J HISTOCHEM CYTOCHEM, V53, P35, DOI 10.1369/jhc.4A6384.2005
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   HONDA H, 1990, IMMUNOLOGY, V70, P272
   Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Lam CXF, 2009, J BIOMED MATER RES A, V90A, P906, DOI 10.1002/jbm.a.32052
   Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6
   Liu XH, 2012, MACROMOL BIOSCI, V12, P911, DOI 10.1002/mabi.201100466
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maniecki MB, 2006, IMMUNOBIOLOGY, V211, P407, DOI 10.1016/j.imbio.2006.05.019
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Matthews KE, 2006, STEM CELLS DEV, V15, P40, DOI 10.1089/scd.2006.15.40
   McNally AK, 2011, ADV EXP MED BIOL, V713, P97, DOI 10.1007/978-94-007-0763-4_7
   Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171
   MOHANTY M, 1992, BIOMATERIALS, V13, P651, DOI 10.1016/0142-9612(92)90123-6
   Mueller CK, 2011, INT J ORAL MAX SURG, V40, P401, DOI 10.1016/j.ijom.2010.10.025
   Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073
   Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015
   Poon CJ, 2013, ACTA BIOMATER, V9, P5609, DOI 10.1016/j.actbio.2012.11.003
   Rhodes NP, 2005, J MATER SCI-MATER M, V16, P1207, DOI 10.1007/s10856-005-4730-7
   Rosengren A, 1997, BIOMATERIALS, V18, P979, DOI 10.1016/S0142-9612(97)00012-4
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Seyednejad H, 2012, BIOMATERIALS, V33, P4309, DOI 10.1016/j.biomaterials.2012.03.002
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Stout RD, 2010, J LEUKOCYTE BIOL, V87, P19, DOI 10.1189/jlb.0509311
   Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008
   van Luyn MJA, 2001, BIOMATERIALS, V22, P1385, DOI 10.1016/S0142-9612(00)00295-7
   van Putten SM, 2013, ACTA BIOMATER, V9, P6502, DOI 10.1016/j.actbio.2013.01.022
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
   Wiggenhauser PS, 2012, CELL TISSUE RES, V347, P747, DOI 10.1007/s00441-011-1226-2
   Yang ZF, 2005, INT IMMUNOL, V17, P1391, DOI 10.1093/intimm/dxh316
NR 53
TC 11
Z9 11
U1 2
U2 27
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1422-6405
EI 1422-6421
J9 CELLS TISSUES ORGANS
JI Cells Tissues Organs
PY 2014
VL 199
IS 2-3
BP 169
EP 183
DI 10.1159/000363693
PG 15
WC Anatomy & Morphology; Cell Biology; Developmental Biology
SC Anatomy & Morphology; Cell Biology; Developmental Biology
GA AW4FG
UT WOS:000346235900008
PM 25412799
DA 2018-10-19
ER

PT S
AU Lopes, MS
   Jardini, AL
   Filho, RM
AF Lopes, Milena S.
   Jardini, Andre L.
   Filho, Rubens M.
BE Bardone, E
   Bravi, M
   Keshavarz, T
TI Synthesis and Characterizations of Poly (Lactic Acid) by Ring-Opening
   Polymerization for Biomedical Applications
SO IBIC2014: 4TH INTERNATIONAL CONFERENCE ON INDUSTRIAL BIOTECHNOLOGY
SE Chemical Engineering Transactions
LA English
DT Proceedings Paper
CT 4th International Conference on Industrial Biotechnology (IBIC2014)
CY JUN 08-11, 2014
CL Rome, ITALY
SP Italian Assoc Chem Engn
ID POLY(LACTIC ACID); SCAFFOLDS; PLA
AB The development of biomaterials for application in medicine is one of the great challenges of research in material science. The poly (a-hydroxy acids) are the principal biodegradable and bioresorbable polymers used in tissue engineering. Among the biomaterials (biopolynners) used in the medical field, the poly (lactic acid) (PLA) has received significant attention. It is produced from lactic acid, a naturally occurring organic acid that can be produced by fermentation. The attractive price and commercial availability of lactic acid are important reasons for PLA development. PLA and its copolymers are being used in biomedical area in the form of implants or devices due to its excellent biocompatibility and biodegradability. In this study, lactide was synthesized and Poly lactic acid produced. The objective of this study was to investigate the PLA production in laboratory scale. Characterization by FTIR of the lactide and PLA production was made to confirm the polymerization and a possible use as biomaterial.
C1 [Lopes, Milena S.; Jardini, Andre L.; Filho, Rubens M.] Univ Estadual Campinas, UNICAMP, Sch Chem Engn, BR-13083970 Campinas, SP, Brazil.
RP Lopes, MS (reprint author), Univ Estadual Campinas, UNICAMP, Sch Chem Engn, POB 6066, BR-13083970 Campinas, SP, Brazil.
EM mil_savioli@hotmail.com
RI Jardini, Andre Luiz/N-9963-2016
OI Jardini, Andre Luiz/0000-0002-9381-9335
CR Auras R, 2004, MACROMOL BIOSCI, V4, P835, DOI 10.1002/mabi.200400043
   BENICEWICZ BC, 1991, J BIOACT COMPAT POL, V6, P64, DOI 10.1177/088391159100600106
   Bouapao L., 2007, POLYMER, V50, P4007
   Cheng Y, 2009, FRONT CHEM CHINA, V4, P259, DOI DOI 10.1007/S11458-009-0092-X
   Davis SS, 1996, CURR OPIN COLLOID IN, V1, P660, DOI 10.1016/S1359-0294(96)80105-1
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.0.CO;2-E
   Freed LE, 2009, ADV MATER, V21, P3410, DOI 10.1002/adma.200900303
   Fukushima K, 2008, J POLYM SCI POL CHEM, V46, P3714, DOI 10.1002/pola.22712
   Griffith LG, 2000, ACTA MATER, V48, P263, DOI 10.1016/S1359-6454(99)00299-2
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hu J., 2012, BIOMATERIALS, V31, P7971
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Nampoothiri KM, 2010, BIORESOURCE TECHNOL, V101, P8493, DOI 10.1016/j.biortech.2010.05.092
   Nikolic L, 2010, SENSORS-BASEL, V10, P5063, DOI 10.3390/s100505063
   Lopes MS, 2012, PROCEDIA ENGINEER, V42, P1402, DOI 10.1016/j.proeng.2012.07.534
   Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092
   Yamane H, 2003, POLYMER, V44, P2569, DOI 10.1016/S0032-3861(03)00092-2
   Yoo DK, 2006, MACROMOL RES, V14, P510, DOI 10.1007/BF03218717
NR 18
TC 6
Z9 6
U1 1
U2 13
PU AIDIC SERVIZI SRL
PI MILANO
PA VIA GIUSEPPE COLOMBO 81/A, MILANO, MI 20133, ITALY
SN 1974-9791
BN 978-88-95608-29-7
J9 CHEM ENGINEER TRANS
PY 2014
VL 38
BP 331
EP 336
DI 10.3303/CET1438056
PG 6
WC Biotechnology & Applied Microbiology; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Engineering
GA BB8GK
UT WOS:000346539600057
DA 2018-10-19
ER

PT S
AU Wallace, GQ
   Pashaee, F
   Hou, R
   Tabatabei, M
   Lagugne-Labarthet, F
AF Wallace, Gregory Q.
   Pashaee, Farshid
   Hou, Renjie
   Tabatabei, Mohammadali
   Lagugne-Labarthet, Francois
BE Andrews, DL
   Nunzi, JM
   Ostendorf, A
TI Plasmonic nanostructures for enhanced Raman spectroscopy: SERS and TERS
   of thiolated monolayers
SO NANOPHOTONICS V
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nanophotonics V
CY APR 13-17, 2014
CL Brussels, BELGIUM
SP SPIE, Brussels Photon Team, Fonds Wetenschappelijk Onderzoek
DE Surface-enhanced Raman spectroscopy (SERS); Nanosphere lithography;
   Finite difference time domain; Tip-enhanced Raman spectroscopy (TERS);
   Surface specificity
ID NANOSPHERE LITHOGRAPHY; ARRAY
AB Although discovered 40 years ago, the interest in surface enhanced Raman spectroscopy (SERS) for a variety of applications in the fields of material and biomaterial has been revived over the past decade mostly due to a better control over the fabrication methods of nanoscale metallic structures. Metallic structures prepared by bottom-up or top-down methods can be tailored for a variety of applications in order to benefit from the best conditions for surface enhancement. SERS platforms made by nanosphere lithography are for example very versatile platforms that show a detection limit in the femtomolar range. Although quantitative measurements are difficult to perform in Raman spectroscopy, the plasmon-mediated enhancement by the metallic nanostructures are of great interest to improve the detection of analytes traces at surfaces. The extension of SERS to tip-enhanced Raman spectroscopy (TERS) is also very valuable to improve spatial resolution of Raman measurements and to yield surface signals, thus making TERS spectroscopy a surface specific technique. Herein we review SERS and TERS measurements of a model molecule (nitrothiophenol) adsorbed onto gold surfaces.
C1 [Wallace, Gregory Q.; Pashaee, Farshid; Hou, Renjie; Tabatabei, Mohammadali; Lagugne-Labarthet, Francois] Univ Western Ontario, Dept Chem, London, ON N6A 5B7, Canada.
RP Wallace, GQ (reprint author), Univ Western Ontario, Dept Chem, 1151 Richmond St, London, ON N6A 5B7, Canada.
RI Lagugne-Labarthet, Francois/U-3835-2017
OI Lagugne-Labarthet, Francois/0000-0001-9882-9367
CR Galarreta BC, 2010, J PHYS CHEM C, V114, P19952, DOI 10.1021/jp108584t
   Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m
   HULTEEN JC, 1995, J VAC SCI TECHNOL A, V13, P1553, DOI 10.1116/1.579726
   Marquestaut N, 2008, LANGMUIR, V24, P11313, DOI 10.1021/la801697u
   Pashaee F, 2013, J PHYS CHEM C, V117, P15639, DOI 10.1021/jp403157v
   Wallace G. Q., 2013, CAN J CHEM, V91, P1
   Wu DY, 2011, CHEM COMMUN, V47, P2520, DOI 10.1039/c0cc05302c
   Xie W, 2013, J AM CHEM SOC, V135, P1657, DOI 10.1021/ja309074a
NR 8
TC 0
Z9 0
U1 1
U2 10
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-1-62841-074-7
J9 PROC SPIE
PY 2014
VL 9126
AR 912610
DI 10.1117/12.2054391
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA BB8BE
UT WOS:000346237300015
DA 2018-10-19
ER

PT B
AU Ghinea, R
   Pecho, O
   Herrera, LJ
   Ionescu, AM
   Cardona, JD
   Sanchez, MP
   Paravina, RD
   Perez, MD
AF Ghinea, Razvan
   Pecho, Oscar
   Javier Herrera, Luis
   Maria Ionescu, Ana
   de la Cruz Cardona, Juan
   Purificacion Sanchez, Maria
   Paravina, Rade D.
   del Mar Perez, Maria
BE Ortuno, F
   Rojas, I
TI Predictive algorithms for determination of reflectance data from
   quantity of pigments within experimental dental resin composites
SO PROCEEDINGS IWBBIO 2014: INTERNATIONAL WORK-CONFERENCE ON BIOINFORMATICS
   AND BIOMEDICAL ENGINEERING, VOLS 1 AND 2
LA English
DT Proceedings Paper
CT 2nd International Work-Conference on Bioinformatics and Biomedical
   Engineering (IWBBIO)
CY APR 07-09, 2014
CL Granada, SPAIN
SP Univ Granada, IEEE Computat Intelligence Soc, Spanish Chapter, BioMed Central, e Health Business Dev BULL Espana S A
DE experimental dental resin composites; MNLR modelling; inorganic
   pigments; reflectance
ID MECHANICAL-PROPERTIES; CAMPHORQUINONE; REGRESSION
AB Being able to estimate (predict) the final spectrum of reflectance of a biomaterial, especially when the final color and appearance are fundamental for their clinical success (as is the case of dental resin composites), could be a very useful tool for the industrial development of these type of materials.. Objective: Development of predictive models which enable the determination of the reflectance spectrum of experimental dental resin composites based on type and quantity of pigments used in their chemical formulation. Materials and Methods: 49 types of experimental dental resin composites were formulated as a mixture of organic matrix, inorganic filler, photo activator and other components in minor quantities (accelerator, inhibitor, fluorescent agent and 4 types of pigments). All samples underwent an artificial chromatic aging, and their reflectance spectrum was measured using a spectroradiometer. A Multiple Nonlinear Regression Model (MNLR) was used to predict the values of the Reflectance Factors values in the visible range (380nm-780nm), before and after aging, from % Pigment (%P1, %P2, %P3 and %P4) within the formulation. Results. The average value of the prediction error of the model was 3.46% (SD: 1.82) across all wavelengths for samples before aging and 3.54% (SD: 1.17) for samples after aging. Conclusion: Within the framework of this pilot study, the nonlinear predictive models developed allow the prediction, with a high degree of accuracy, of the reflectance spectrum of the experimental dental resin composites.
C1 [Ghinea, Razvan; Pecho, Oscar; Maria Ionescu, Ana; de la Cruz Cardona, Juan; del Mar Perez, Maria] Univ Granada, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
   [Javier Herrera, Luis] Univ Granada, Dept Comp Architecture & Comp Technol, Granada 18071, Spain.
   [Purificacion Sanchez, Maria] Univ Granada, Dept Inorgan Chem, Granada 18071, Spain.
   [Ghinea, Razvan; Paravina, Rade D.; del Mar Perez, Maria] Univ Texas, Sch Dent, Houston Ctr Biomat & Biomimet, Dept Restorat Dent & Prosthodont, Houston, TX 77054 USA.
RP Ghinea, R (reprint author), Univ Granada, Dept Opt, Campus Fuentenueva S-N, E-18071 Granada, Spain.
EM rghinea@ugr.es; opey@correo.ugr.es; jherrera@ugr.es; anaionescu@ugr.es;
   cardona@ugr.es; mpsansan@ugr.es; rade.paravina@uth.tmc.edu;
   mmperez@ugr.es
RI Herrera, Luis/L-2392-2014
OI Herrera, Luis/0000-0003-3220-9389
CR [Anonymous], 2013, 489222013 ISO 2
   [Anonymous], 2000, 74912000 ISO
   Atai M, 2004, DENT MATER, V20, P663, DOI 10.1016/j.dental.2003.08.008
   BANERJEE KS, 1971, TECHNOMETRICS, V13, P895, DOI 10.2307/1266967
   Calheiros FC, 2008, DENT MATER, V24, P1164, DOI 10.1016/j.dental.2008.01.006
   CIE (International Commission on Illumination), 2004, TECHNICAL REPORT
   Cramer NB, 2011, J DENT RES, V90, P402, DOI 10.1177/0022034510381263
   FRANK IE, 1993, TECHNOMETRICS, V35, P109, DOI 10.2307/1269656
   Ghinea R. H., 2010, DEV LINEAR MODEL PRE
   Golden RM, 1997, J MATH PSYCHOL, V41, P287, DOI 10.1006/jmps.1997.1164
   Herrera LJ, 2010, APPL OPTICS, V49, P422, DOI 10.1364/AO.49.000422
   Johnston WM, 2009, J DENT, V37, pE2, DOI 10.1016/j.jdent.2009.03.011
   Park MY, 2007, DENT MATER, V23, P731, DOI 10.1016/j.dental.2006.06.028
   Sadowsky SJ, 2006, J PROSTHET DENT, V96, P433, DOI 10.1016/j.prosdent.2006.09.018
   Schneider LFJ, 2012, DENT MATER, V28, P392, DOI 10.1016/j.dental.2011.11.014
   Schneider LFJ, 2009, DENT MATER, V25, P369, DOI 10.1016/j.dental.2008.08.003
   Schunn C. D., 2005, PSYCHOL KOGNITION RE
   Wee AG, 2005, DENT MATER, V21, P665, DOI 10.1016/j.dental.2004.09.003
   Zandinejad AA, 2006, DENT MATER, V22, P382, DOI 10.1016/j.dental.2005.04.027
NR 19
TC 1
Z9 1
U1 0
U2 2
PU COPICENTRO GRANADA S L
PI GRANADA
PA AV ANDALUCIA, 38, GRANADA, GRANADA 18014, SPAIN
BN 978-84-15814-84-9
PY 2014
BP 66
EP 76
PG 11
WC Engineering, Biomedical; Medical Informatics
SC Engineering; Medical Informatics
GA BB8CY
UT WOS:000346381500007
DA 2018-10-19
ER

PT J
AU Liu, DX
   Gu, JJ
   Li, Z
   Zhang, YF
   Zhang, W
   Liu, QL
   Zhang, D
AF Liu, Dingxin
   Gu, Jiajun
   Li, Zhuo
   Zhang, Yafeng
   Zhang, Wang
   Liu, Qinglei
   Zhang, Di
TI The study on the dragonfly's wings and the structural colors
SO BIOINSPIRED BIOMIMETIC AND NANOBIOMATERIALS
LA English
DT Article
DE biomaterial; interface; nanobioscience; nanostructure; optical
ID LIGHT-SCATTERING; SCALES; BUTTERFLIES; INTERFERENCE; COLORATION; INSECTS
AB The authors observed the surface and transection of dragonflies and demonstrated that the surface of dragonflies is a submicrometer multilayer system. The authors showed that the different colors of wing are attributed to multilayer interference, which is confirmed by a finite-difference time domain simulation.
C1 [Liu, Dingxin; Gu, Jiajun; Li, Zhuo; Zhang, Wang; Liu, Qinglei; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   [Zhang, Yafeng] Fudan Univ, Dept Phys & Surface Phys Lab, Shanghai 200433, Peoples R China.
RP Gu, JJ (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM gujiajunn@sjtu.edu.cn; zhangdi@sjtu.edu.cn
RI ZHANG, Wang/E-7470-2010
FU National Natural Science Foundation of China [51271116, 51171110];
   National Basic Research Program of China (973 Program) [2012CB619600];
   Shanghai Science and Technology Committee [10JC1407600]
FX This study was supported by the National Natural Science Foundation of
   China (Grant Numbers 51271116 and 51171110), the National Basic Research
   Program of China (973 Program, Grant Number 2012CB619600) and the
   Shanghai Science and Technology Committee (Grant Number 10JC1407600).
CR Anderson TF, 1942, J APPL PHYS, V13, P748, DOI 10.1063/1.1714827
   Arnold KE, 2002, SCIENCE, V295, P92, DOI 10.1126/science.295.5552.92
   Berthier Serge, 2006, Insect Science, V13, P145, DOI 10.1111/j.1744-7917.2006.00077.x
   Brink DJ, 1999, APPL OPTICS, V38, P5282, DOI 10.1364/AO.38.005282
   Dong BQ, 2010, OPT EXPRESS, V18, P14430, DOI 10.1364/OE.18.014430
   GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214
   Gralak B, 2001, OPT EXPRESS, V9, P567, DOI 10.1364/OE.9.000567
   Hooper IR, 2006, OPT EXPRESS, V14, P4891, DOI 10.1364/OE.14.004891
   LAND MF, 1972, PROGR BIOPHYSICS MOL, V24, P77, DOI DOI 10.1016/0079-6107(72)90004-1
   Large MCJ, 2007, PHYSICA B, V394, P229, DOI 10.1016/j.physb.2006.12.016
   Liu F, 2009, OPT EXPRESS, V17, P16183, DOI 10.1364/OE.17.016183
   Mason CW, 1926, J PHYS CHEM-US, V30, P383, DOI 10.1021/j150261a009
   McPhedran R. C., 2003, PHYSICA B, V338, P183
   Plattner L, 2004, J ROY SOC INTERFACE, V1, P49, DOI 10.1098/rsif.2004.0006
   Prum RO, 1998, NATURE, V396, P28, DOI 10.1038/23838
   Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431
   Richard O. P., 2004, J EXP BIOL, V207, P3999
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Shevtsova E, 2011, P NATL ACAD SCI USA, V108, P668, DOI 10.1073/pnas.1017393108
   Stavenga DG, 2006, OPT EXPRESS, V14, P4880, DOI 10.1364/OE.14.004880
   Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794
   Watanabe K, 2005, JPN J APPL PHYS 2, V44, pL48, DOI 10.1143/JJAP.44.L48
NR 22
TC 1
Z9 1
U1 2
U2 21
PU ICE PUBLISHING
PI WESTMINISTER
PA INST CIVIL ENGINEERS, 1 GREAT GEORGE ST, WESTMINISTER SW 1P 3AA, ENGLAND
SN 2045-9858
EI 2045-9866
J9 BIOINSPIR BIOMIM NAN
JI Bioinspired Biomim. Nanobiomat.
PY 2014
VL 3
IS 4
BP 193
EP 198
DI 10.1680/bbn.14.00003
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AW6GQ
UT WOS:000346368300002
DA 2018-10-19
ER

PT J
AU Markhoff, J
   Mick, E
   Mitrovic, A
   Pasold, J
   Wegner, K
   Bader, R
AF Markhoff, Jana
   Mick, Enrico
   Mitrovic, Aurica
   Pasold, Juliane
   Wegner, Katharina
   Bader, Rainer
TI Surface Modifications of Dental Ceramic Implants with Different Glass
   Solder Matrices: In Vitro Analyses with Human Primary Osteoblasts and
   Epithelial Cells
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID TITANIUM SURFACES; ZIRCONIA CERAMICS; GENE-EXPRESSION; OSSEOINTEGRATION;
   BEHAVIOR; PROLIFERATION; FIBROBLASTS; TOPOGRAPHY; ADHESION; BIOMATERIAL
AB Ceramic materials show excellent esthetic behavior, along with an absence of hypersensitivity, making them a possible alternative implant material in dental surgery. However, their surface properties enable only limited osseointegration compared to titanium implants. Within this study, a novel surface coating technique for enhanced osseointegration was investigated biologically and mechanically. Specimens of tetragonal zirconia polycrystal (TZP) and aluminum toughened zirconia (ATZ) were modified with glass solder matrices in two configurations which mainly consisted of SiO2, Al2O3, K2O, and Na2O. The influence on human osteoblastic and epithelial cell viability was examined by means of a WST-1 assay as well as live/dead staining. A C1CP-ELISA was carried out to verify procollagen type I production. Uncoated/sandblasted ceramic specimens and sandblasted titanium surfaces were investigated as a reference. Furthermore, mechanical investigations of bilaterally coated pellets were conducted with respect to surface roughness and adhesive strength of the different coatings. These tests could demonstrate a mechanically stable implant coating with glass solder matrices. The coated ceramic specimens show enhanced osteoblastic and partly epithelial viability and matrix production compared to the titanium control. Hence, the new glass solder matrix coating could improve bone cell growth as a prerequisite for enhanced osseointegration of ceramic implants.
C1 [Markhoff, Jana; Mick, Enrico; Pasold, Juliane; Wegner, Katharina; Bader, Rainer] Univ Med Rostock, Res Lab Biomech & Implant Technol, Dept Orthopaed, D-18057 Rostock, Germany.
   [Mitrovic, Aurica] ZM Praezisionsdentaltech GmbH, D-18055 Rostock, Germany.
RP Markhoff, J (reprint author), Univ Med Rostock, Res Lab Biomech & Implant Technol, Dept Orthopaed, Doberaner Str 142, D-18057 Rostock, Germany.
EM jana.markhoff@med.uni-rostock.de
OI Ekat, Katharina/0000-0003-2423-201X
FU German Ministry for Economy (BMWi) via Zentrales Innovations programm
   Mittelstand (ZIM)
FX The content of the proposed paper was developed within the framework of
   a project funded by the German Ministry for Economy (BMWi) via Zentrales
   Innovations programm Mittelstand (ZIM). Furthermore, the authors kindly
   thank DOT GmbH (Rostock, Germany) for conditioning the titanium
   cylinders for adhesive testing. The authors also thank Dental Creativ
   Management GmbH(Rostock, Germany) for supplying the glass solders,
   Metoxit AG (Thayngen, Switzerland) for supplying the ceramic specimens,
   and the EMZ, University Medicine Rostock, for enabling FESEM analysis.
CR Aldini NN, 2002, J BIOMED MATER RES, V61, P282, DOI 10.1002/jbm.10162
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Bachle M, 2004, CLIN ORAL IMPLAN RES, V15, P683, DOI 10.1111/j.1600-0501.2004.01054.x
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Depprich Rita, 2008, Head Face Med, V4, P29, DOI 10.1186/1746-160X-4-29
   Gahlert M, 2010, CLIN IMPLANT DENT R, V12, P297, DOI 10.1111/j.1708-8208.2009.00168.x
   Gong SH, 2013, J ADV PROSTHODONT, V5, P416, DOI 10.4047/jap.2013.5.4.416
   Guazzato M, 2005, J DENT, V33, P9, DOI 10.1016/j.jdent.2004.07.001
   Hempel U, 2010, CLIN ORAL IMPLAN RES, V21, P174, DOI 10.1111/j.1600-0501.2009.01797.x
   Herrero-Climent M, 2013, J MATER SCI-MATER M, V24, P2047, DOI 10.1007/s10856-013-4935-0
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Hopp M., 2010, Tech. Rep. DE102009051655B3, Patent No. 102009051655
   Kohal RJ, 2009, CLIN ORAL IMPLAN RES, V20, P1265, DOI 10.1111/j.1600-0501.2009.01735.x
   Kubies D, 2011, PHYSIOL RES, V60, P95
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lochner K, 2011, INT J MOL MED, V28, P1055, DOI 10.3892/ijmm.2011.778
   Marchi J, 2010, J BIOMED MATER RES B, V94B, P305, DOI 10.1002/jbm.b.31652
   Marchi J, 2010, INT J APPL CERAM TEC, V7, P139, DOI 10.1111/j.1744-7402.2009.02388.x
   Marrelli M, 2013, INT J DENT, V2013
   Mick E, 2013, MATERIALS, V6, P4001, DOI 10.3390/ma6094001
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Nishimoto SK, 2008, INT J ORAL MAX IMPL, V23, P675
   Noro A, 2013, J BIOMED MATER RES B, V101B, P355, DOI 10.1002/jbm.b.32846
   Oliva A, 1998, BIOMATERIALS, V19, P1019, DOI 10.1016/S0142-9612(97)00249-4
   Pae A, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025005
   Raffaelli L, 2008, J BIOMED MATER RES A, V86A, P959, DOI 10.1002/jbm.a.31693
   Raisanen L, 2000, J BIOMED MATER RES, V49, P79
   Rocchietta I, 2009, CLIN ORAL IMPLAN RES, V20, P844, DOI 10.1111/j.1600-0501.2009.01727.x
   Rompen E, 2006, CLIN ORAL IMPLAN RES, V17, P55, DOI 10.1111/j.1600-0501.2006.01367.x
   Sammons RL, 2005, CLIN ORAL IMPLAN RES, V16, P657, DOI 10.1111/j.1600-0501.2005.01168.x
   Setzer B, 2009, BIOMATERIALS, V30, P979, DOI 10.1016/j.biomaterials.2008.10.054
   Torricelli P, 2001, BIOMATERIALS, V22, P2535, DOI 10.1016/S0142-9612(00)00444-0
NR 33
TC 0
Z9 0
U1 0
U2 7
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 742180
DI 10.1155/2014/742180
PG 7
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AW4ZO
UT WOS:000346286200001
PM 25295270
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Nair, M
   Krishnan, A
AF Nair, Manitha
   Krishnan, Amit
TI Antibiotic Releasing Biodegradable Scaffolds for Osteomyelitis
SO CURRENT DRUG DELIVERY
LA English
DT Article
DE Bacterial internalization; biodegradable scaffolds; osteomyelitis;
   staphylococcus aureus
ID RESISTANT STAPHYLOCOCCUS-AUREUS; CALCIUM-PHOSPHATE NANOPARTICLES;
   GENTAMICIN-COLLAGEN SPONGE; PHASE-COMPOSITION CONTROL; DRUG-DELIVERY
   KINETICS; IN-VITRO RELEASE; METHICILLIN-RESISTANT; HYDROXYAPATITE
   BLOCKS; SURGICAL DEBRIDEMENT; BONE-CEMENT
AB Osteomyelitis is characterized by progressive inflammatory bone degeneration. In the management of chronic osteomyelitis, it is necessary to remove the infected bone tissue followed by implantation of an antibiotic releasing biomaterial that can release antibiotic locally for long periods of time. The main carrier used in clinics for this application is polymethylmethacrylate (PMMA) (Eg. Septopal beads). However, major drawback is the need of an additional surgery to remove the beads after therapy, as PMMA is not biodegradable. This necessitates the requirement of biodegradable carrier systems that can release antibiotics and simultaneously support debrided bone formation. This review summarizes biodegradable carrier systems that have been reported for the localised treatment and prophylaxis of osteomyelitis.
C1 [Nair, Manitha; Krishnan, Amit] Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Cochin 682041, Kerala, India.
RP Nair, M (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci & Res Ctr, Cochin 682041, Kerala, India.
EM manithanair@aims.amrita.edu
FU Department of Science and Technology, India
FX The authors would like to acknowledge Department of Science and
   Technology, India for financial support.
CR ALBREKTSSON T, 1982, ACTA ORTHOP SCAND, V53, P757, DOI 10.3109/17453678208992288
   Albu M.G., 2011, COLLAGEN GELS MATRIC
   Alexander EH, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-5
   Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   Anagnostakos K, 2006, ACTA ORTHOP, V77, P628, DOI 10.1080/174453670610012719
   BAKER AS, 1988, J BONE JOINT SURG AM, V70A, P1551, DOI 10.2106/00004623-198870100-00015
   Bang K, 1998, SCAND J PLAST RECONS, V32, P129, DOI 10.1080/02844319850158732
   BAYSTON R, 1982, J BONE JOINT SURG BR, V64, P460
   Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138
   Brady R., 2009, CLIN MICROBIOL NEWSL, V28, P65
   Breen A, 2009, TISSUE ENG PART B-RE, V15, P201, DOI [10.1089/ten.teb.2008.0527, 10.1089/ten.TEB.2008.0527]
   Brin YS, 2009, J BIOMAT SCI-POLYM E, V20, P1081, DOI 10.1163/156856209X444439
   Brin YS, 2008, J CONTROL RELEASE, V131, P121, DOI 10.1016/j.jconrel.2008.07.022
   Carek PJ, 2001, AM FAM PHYSICIAN, V63, P2413
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Changez M, 2005, BIOMATERIALS, V26, P2095, DOI 10.1016/j.biomaterials.2004.06.008
   Changez M, 2004, BIOMATERIALS, V25, P139, DOI 10.1016/S0142-9612(03)00466-6
   Changez M, 2003, BIOMATERIALS, V24, P527, DOI 10.1016/S0142-9612(02)00364-2
   Chen AM, 1999, CLIN ORTHOP RELAT R, P239
   Ciery III G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62
   Dankert J., 1996, CRC CRIT R BIOCOMP, V2, P219
   Dax S.L., 1997, ANTIBACTERIAL CHEMOT
   Desai TA, 2013, THER DELIV, V4, P643, DOI [10.4155/TDE.13.33, 10.4155/tde.13.33]
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Elizabeth E, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/11/115101
   Ellington JK, 1999, MICROB PATHOGENESIS, V26, P317, DOI 10.1006/mpat.1999.0272
   Fang TL, 2012, J BIOMED MATER RES B, V100B, P1803, DOI 10.1002/jbm.b.32747
   FITZGERALD RH, 1984, ORTHOP CLIN N AM, V15, P537
   Fraimow Henry S, 2009, Semin Plast Surg, V23, P90, DOI 10.1055/s-0029-1214161
   Franklin T.J., 1989, BIOCH ANTIMICROBIAL
   Garcia EJ, 2013, ORTHOPEDICS, V36, pE986, DOI 10.3928/01477447-20130724-11
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   Gitelis Steven, 2002, J Orthop Surg (Hong Kong), V10, P53
   Gittens RA, 2013, ACTA BIOMATER, V9, P6268, DOI 10.1016/j.actbio.2012.12.002
   GRECO F, 1991, J BIOMED MATER RES, V25, P39, DOI 10.1002/jbm.820250104
   Gursel I, 2001, BIOMATERIALS, V22, P73, DOI 10.1016/S0142-9612(00)00170-8
   HENRY SL, 1995, CLIN PHARMACOKINET, V29, P36, DOI 10.2165/00003088-199529010-00005
   Hou TY, 2008, TISSUE ENG PT A, V14, P1173, DOI 10.1089/ten.tea.2007.0159
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   IPSEN T, 1991, ACTA ORTHOP SCAND, V62, P592, DOI 10.3109/17453679108994503
   ITOKAZU M, 1995, J APPL BIOMATER, V6, P167, DOI 10.1002/jab.770060304
   Itokazu M, 1998, Bull Hosp Jt Dis, V57, P125
   ITOKAZU M, 1994, CLIN MATER, V17, P173, DOI 10.1016/0267-6605(94)90033-7
   Itokazu M, 1997, J MED MICROBIOL, V46, P779, DOI 10.1099/00222615-46-9-779
   Jayakumar R, 2010, BIOTECHNOL ADV, V28, P142, DOI 10.1016/j.biotechadv.2009.11.001
   Jia WT, 2010, ACTA BIOMATER, V6, P812, DOI 10.1016/j.actbio.2009.09.011
   Jia WT, 2010, ANTIMICROB AGENTS CH, V54, P170, DOI 10.1128/AAC.01122-09
   Jiang JL, 2012, INFLAMM RES, V61, P207, DOI 10.1007/s00011-011-0402-x
   Joosten U, 2005, BIOMATERIALS, V26, P5251, DOI 10.1016/j.biomaterials.2005.01.001
   Kanellakopoulou K, 2009, INT J ANTIMICROB AG, V33, P354, DOI 10.1016/j.ijantimicag.2008.09.008
   Karr JC, 2011, J AM PODIAT MED ASSN, V101, P146, DOI 10.7547/1010146
   Katanec B., 2004, COLLEGIUM ANTROPOL, V1, P331
   Kaul G, 2002, PHARM RES-DORDR, V19, P1061, DOI 10.1023/A:1016486910719
   Kaya M, 2012, OR SURG OR MED OR PA, V113, P340, DOI 10.1016/j.tripleo.2011.03.032
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   Kent ME, 2006, ORTHOPEDICS, V29, P599
   Kilian O, 2009, J BIOMED MATER RES B, V90B, P210, DOI 10.1002/jbm.b.31275
   Kluin OS, 2013, EXPERT OPIN DRUG DEL, V10, P341, DOI 10.1517/17425247.2013.751371
   Krasko MY, 2007, J CONTROL RELEASE, V117, P90, DOI 10.1016/j.jconrel.2006.10.010
   Krasko MY, 2005, BIOMACROMOLECULES, V6, P1877, DOI 10.1021/bm049228v
   Lalidou F., 2014, SURG TECHNOL INT, VXXIV
   LAURENCIN C, 1990, J BIOMED MATER RES, V24, P1463, DOI 10.1002/jbm.820241105
   Lazzarini L, 2004, J BONE JOINT SURG AM, V86A, P2305, DOI 10.2106/00004623-200410000-00028
   Letsch R, 1993, Aktuelle Traumatol, V23, P324
   Liu SJ, 2002, J BIOMED MATER RES, V63, P807, DOI 10.1002/jbm.10406
   Lu WJ, 2013, EXP THER MED, V5, P253, DOI 10.3892/etm.2012.762
   Mader J.T., 1992, CLIN INFECT DIS
   Mader JT, 2002, CLIN ORTHOP RELAT R, P58, DOI 10.1097/01.blo.0000030070.92399.4d
   Mader JT, 1997, CLIN INFECT DIS, V25, P1303, DOI 10.1086/516149
   Martinez-Aguilar G, 2003, PEDIATR INFECT DIS J, V22, P593
   Mendel V, 2005, ARCH ORTHOP TRAUM SU, V125, P363, DOI 10.1007/s00402-004-0774-2
   Nair MB, 2011, CURR OPIN BIOTECH, V22, P721, DOI 10.1016/j.copbio.2011.02.005
   Nelson CL, 1997, J ORTHOPAED RES, V15, P249, DOI 10.1002/jor.1100150214
   Nelson CL, 2002, J ORTHOPAED RES, V20, P643, DOI 10.1016/S0736-0266(01)00133-4
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Orhan Z, 2006, J BONE JOINT SURG BR, V88B, P270, DOI 10.1302/0301-620X.88B2.16328
   Pacheco H, 2014, J BIOMED MATER RES A, V102, P4213, DOI 10.1002/jbm.a.35092
   Panduranga K.R., 1995, J BIOMAT SCI-POLYM E, V7, P623
   Pelczar M.J., 1999, MICROBIOLOGY CONCEPT
   PELTIER LF, 1959, AM J SURG, V97, P311, DOI 10.1016/0002-9610(59)90305-8
   REDL H, 1983, BIOMATERIALS, V4, P29, DOI 10.1016/0142-9612(83)90066-2
   Roberts R, 2014, J BIOMED MATER RES B, V102, P667, DOI 10.1002/jbm.b.33045
   Rossi S, 2004, J ANTIMICROB CHEMOTH, V54, P1013, DOI 10.1093/jac/dkh477
   RUSSELL AD, 1996, UNDERSTANDING ANTIBA
   Saito T, 2002, J BIOMED MATER RES, V63, P245, DOI 10.1002/jbm.10179
   SCHMIDT C, 1995, J CONTROL RELEASE, V37, P83, DOI 10.1016/0168-3659(95)00067-I
   Shi PJ, 2010, J BIOMED MATER RES A, V93A, P1020, DOI 10.1002/jbm.a.32598
   Shirtliff ME, 2002, CLIN ORTHOP RELAT R, P239
   Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Tan HX, 2008, APPL SURF SCI, V255, P353, DOI 10.1016/j.apsusc.2008.06.085
   Tang H, 2009, ARCH ORTHOP TRAUM SU, V129, P1301, DOI 10.1007/s00402-008-0782-8
   Tang Shanhua, 2006, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V20, P758
   Tofuku K, 2012, EUR SPINE J, V21, P2027, DOI 10.1007/s00586-012-2435-4
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   Uskokovic V, 2014, J PHARM SCI-US, V103, P567, DOI 10.1002/jps.23824
   Uskokovic V, 2013, MAT SCI ENG C-MATER, V33, P3362, DOI 10.1016/j.msec.2013.04.023
   Uskokovic V, 2013, J BIOMED MATER RES A, V101, P1416, DOI 10.1002/jbm.a.34426
   Uskokovic V, 2013, J BIOMED MATER RES A, V101, P1427, DOI 10.1002/jbm.a.34437
   Virto MR, 2007, BIOMATERIALS, V28, P877, DOI 10.1016/j.biomaterials.2006.09.045
   WacholDrewek Z, 1996, BIOMATERIALS, V17, P1733, DOI 10.1016/0142-9612(96)87654-X
   WALDVOGEL FA, 1970, NEW ENGL J MED, V282, P198, DOI 10.1056/NEJM197001222820406
   Widaa A., 2012, PLOS ONE, V7
   WILSON KJ, 1988, J ORTHOPAED RES, V6, P279, DOI 10.1002/jor.1100060216
   Wininger DA, 1996, ANTIMICROB AGENTS CH, V40, P2675, DOI 10.1128/AAC.40.12.2675
   Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003
   Wu P, 2006, BIOMATERIALS, V27, P2450, DOI 10.1016/j.biomaterials.2005.11.031
   Wu TY, 2013, J MATER CHEM B, V1, P3304, DOI [10.1039/C3TB20261E, 10.1039/c3tb20261e]
   Xie ZP, 2013, ANTIMICROB AGENTS CH, V57, P3293, DOI 10.1128/AAC.00284-13
   Xing JC, 2013, TISSUE ENG PT A, V19, P255, DOI [10.1089/ten.TEA.2012.0262, 10.1089/ten.tea.2012.0262]
   Yagmurlu MF, 1999, J BIOMED MATER RES, V46, P494
   Yang CC, 2013, MAT SCI ENG C-MATER, V33, P2203, DOI 10.1016/j.msec.2013.01.038
   Yu BG, 1996, J CONTROL RELEASE, V39, P65, DOI 10.1016/0168-3659(95)00139-5
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
   Zelken J, 2007, CLIN ORTHOP RELAT R, P190, DOI 10.1097/BLO.0b013e3180ca9521
   Zilberman Meital, 2010, Handb Exp Pharmacol, P299, DOI 10.1007/978-3-642-00477-3_11
NR 117
TC 6
Z9 6
U1 1
U2 18
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2018
EI 1875-5704
J9 CURR DRUG DELIV
JI Curr. Drug Deliv.
PY 2014
VL 11
IS 6
BP 687
EP 700
DI 10.2174/1567201811666140414120002
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA AW0EJ
UT WOS:000345962900003
PM 24730438
DA 2018-10-19
ER

PT J
AU Ren, X
   Zhang, QW
   Liu, KW
   Li, HL
   Zhou, JG
AF Ren, Xiang
   Zhang, Qingwei
   Liu, Kewei
   Li, Ho-lung
   Zhou, Jack G.
TI Modeling of pneumatic valve dispenser for printing viscous biomaterials
   in additive manufacturing
SO RAPID PROTOTYPING JOURNAL
LA English
DT Article
DE 3D printing; Additive manufacturing; Pneumatic valve dispenser
ID 2-PHOTON POLYMERIZATION; CHITOSAN SCAFFOLDS; TISSUE SCAFFOLDS;
   FABRICATION; SYSTEM; LIQUIDS
AB Purpose - The purpose of this paper is establishing a general mathematical model and theoretical design rules for 3D printing of biomaterials. Additive manufacturing of biomaterials provides many opportunities for fabrication of complex tissue structures, which are difficult to fabricate by traditional manufacturing methods. Related problems and research tasks are raised by the study on biomaterials' 3D printing. Most researchers are interested in the materials studies; however, the corresponded additive manufacturing machine is facing some technical problems in printing user-prepared biomaterials. New biomaterials have uncertainty in physical properties, such as viscosity and surface tension coefficient. Therefore, the 3D printing process requires lots of trials to achieve proper printing parameters, such as printing layer thickness, maximum printing line distance and printing nozzle's feeding speed; otherwise, the desired computer-aided design (CAD) file will not be printed successfully in 3D printing.
   Design/methodology/approach - Most additive manufacturing machine for user-prepared bio-material use pneumatic valve dispensers or extruder as printing nozzle, because the air pressure activated valve can print many different materials, which have a wide range of viscosity. We studied the structure inside the pneumatic valve dispenser in our 3D heterogeneous printing machine, and established mathematical models for 3D printing CAD structure and fluid behaviors inside the dispenser during printing process.
   Findings - Based on theoretical modeling, we found that the bio-material's viscosity, surface tension coefficient and pneumatic valve dispenser's dispensing step time will affect the final structure directly. We verified our mathematical model by printing of two kinds of self-prepared biomaterials, and the results supported our modeling and theoretical calculation.
   Research limitations/implications - For a certain kinds of biomaterials, the mathematical model and design rules will have unique solutions to the functions and equations. Therefore, each biomaterial's physical data should be collected and input to the model for specified solutions. However, for each user-made 3D printing machine, the core programming code can be modified to adjust the parameters, which follows our mathematical model and the related CAD design rules.
   Originality - This study will provide a universal mathematical method to set up design rules for new user-prepared biomaterials in 3D printing of a CAD structure.
C1 [Ren, Xiang; Zhang, Qingwei; Liu, Kewei; Li, Ho-lung; Zhou, Jack G.] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
RP Zhou, JG (reprint author), Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA.
EM zhoug@drexel.edu
OI Ren, Xiang/0000-0002-8882-6362
FU National Science Foundation (NSF) [CMMI-0700139]
FX The authors are grateful for the support from National Science
   Foundation (NSF) on award number CMMI-0700139. The authors would also
   like to thank Dr Moses Noh's Lab-On-Chip & BioMEMS Lab and Dr Ying Sun's
   Complex Fluids and Multiphase Transport Lab for their equipment usage.
CR Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   Cumpston BH, 1999, NATURE, V398, P51
   Currie I. G., 2002, FUNDAMENTAL MECH FLU
   Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]
   Geisler C.G., 2011, THERMOSENSITIVE PHOT
   Geng L, 2005, RAPID PROTOTYPING J, V11, P90, DOI 10.1108/13552540510589458
   Kalpakjian S., 2008, MANUFACTURING PROCES
   Khalil S, 2005, RAPID PROTOTYPING J, V11, P9, DOI 10.1108/13552540510573347
   Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729
   Kim GH, 2009, APPL PHYS A-MATER, V94, P781, DOI 10.1007/s00339-008-4959-3
   Lee H, 2011, CARBOHYD POLYM, V85, P817, DOI 10.1016/j.carbpol.2011.04.001
   Lu L, 2010, RAPID PROTOTYPING J, V16, P365, DOI 10.1108/13552541011065768
   Mironov V, 2009, VIRTUAL PHYS PROTOTY, V4, P63, DOI 10.1080/17452750802657202
   PELOFSKY AH, 1966, J CHEM ENG DATA, V11, P394, DOI 10.1021/je60030a031
   SCHONHORN H, 1967, J CHEM ENG DATA, V12, P524, DOI 10.1021/je60035a016
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Shor L, 2007, BIOMATERIALS, V28, P5291, DOI 10.1016/j.biomaterials.2007.08.018
   Snyder J.E., 2011, BIOFABRICATION, V3, P9
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Visconti RP, 2010, EXPERT OPIN BIOL TH, V10, P409, DOI 10.1517/14712590903563352
NR 21
TC 7
Z9 7
U1 4
U2 29
PU EMERALD GROUP PUBLISHING LIMITED
PI BINGLEY
PA HOWARD HOUSE, WAGON LANE, BINGLEY BD16 1WA, W YORKSHIRE, ENGLAND
SN 1355-2546
EI 1758-7670
J9 RAPID PROTOTYPING J
JI Rapid Prototyping J.
PY 2014
VL 20
IS 6
BP 434
EP 443
DI 10.1108/RPJ-03-2013-0025
PG 10
WC Engineering, Mechanical; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA AW2IE
UT WOS:000346110600002
DA 2018-10-19
ER

PT J
AU Yang, J
   Wang, S
   Lee, JH
AF Yang, Jaechang
   Wang, Semyung
   Lee, Jong-Hyun
TI Photovoltaic Detection of Hydrogen Peroxide Employing Potassium
   Ferricyanide as a Catalyst in the Chemiluminescence of Luminol
SO SENSORS AND MATERIALS
LA English
DT Article
DE hydrogen peroxide; photovoltaic detection; luminol; chemiluminescence;
   potassium ferricyanide
AB A photovoltaic measurement system is fabricated to detect hydrogen peroxide (H2O2) in a solution based on the chemiluminescence of luminol with potassium ferricyanide and potassium hydroxide as catalysts. A silicon-based positive/intrinsic/negative (PIN) photodiode is employed to quantitatively measure the chemiluminescent light generated from luminol (5-amino-2, 3-dihydro-1, 4-phthalazinedione). Instead of the mixture of luminol and catalysts (MLC) contained in water, the MLC is prepared in powder form enabling H2O2 detectability at high concentration intended for agricultural applications. Unlike horseradish peroxidase (HRP), potassium ferricyanide (non-biomaterial) can be stored for a longer period at room temperature without being denatured and without any sophisticated equipment for cooling. For various H2O2 concentrations, the peak value, integration value and maximum slope of the output voltage are measured and are discussed in terms of complexity, linearity and measurement speed.
C1 [Yang, Jaechang; Wang, Semyung; Lee, Jong-Hyun] GIST, Sch Mechatron, Kwangju 500712, South Korea.
   [Lee, Jong-Hyun] GIST, Dept Med Syst Engn, Kwangju 500712, South Korea.
RP Lee, JH (reprint author), GIST, Sch Mechatron, Kwangju 500712, South Korea.
EM jonghyun@gist.ac.kr
FU Institute of Medical System Engineering (iMSE) in GIST, Korea
FX This research was supported by a grant from the Institute of Medical
   System Engineering (iMSE) in GIST, Korea.
CR AIZAWA M, 1984, ANAL LETT PT B, V17, P555, DOI 10.1080/00032718408066489
   Bruno D. W., 1994, Aquaculture International, V2, P10, DOI 10.1007/BF00118529
   Byun HongJu, 2003, Journal of the Korean Society for Horticultural Science, V44, P859
   Cho IH, 2009, J BIOENVIRONMENT CON, V18, P297
   Hosono H, 2007, SENSOR MATER, V19, P191
   Kim Hyung-Il, 2003, Journal of the Korean Physical Society, V42, P336
   Luo FB, 2009, MICROCHIM ACTA, V165, P23, DOI 10.1007/s00604-008-0091-5
   Ozaki K, 2009, J PLANT PHYSIOL, V166, P569, DOI 10.1016/j.jplph.2008.08.007
   Rameshkumar P, 2013, J APPL ELECTROCHEM, V43, P1005, DOI 10.1007/s10800-013-0589-3
   Sudakin Daniel L., 2003, Toxicological Reviews, V22, P83, DOI 10.2165/00139709-200322020-00003
   Tensha K., 2006, B YAMAGUCHI PREF FIS, V4, P167
   Vanninen I, 1998, CROP PROT, V17, P547, DOI 10.1016/S0261-2194(98)00060-X
   Wang Q, 2009, MICROCHIM ACTA, V167, P153, DOI 10.1007/s00604-009-0236-1
   Yan ZK, 2013, MICROCHIM ACTA, V180, P145, DOI 10.1007/s00604-012-0916-0
   Yang JC, 2008, JPN J APPL PHYS, V47, P6943, DOI 10.1143/JJAP.47.6943
   Zhang KY, 2010, MICROCHIM ACTA, V171, P139, DOI 10.1007/s00604-010-0409-y
   Zhang Y, 2011, BIOPROC BIOSYST ENG, V34, P215, DOI 10.1007/s00449-010-0463-1
   Zheng J., 2012, ADV OPTICAL MAT, V24, P194
NR 18
TC 0
Z9 0
U1 1
U2 11
PU MYU, SCIENTIFIC PUBLISHING DIVISION
PI TOKYO
PA 1-23-3-303 SENDAGI, TOKYO, 113-0022, JAPAN
SN 0914-4935
J9 SENSOR MATER
JI Sens. Mater.
PY 2014
VL 26
IS 9
BP 677
EP 686
PG 10
WC Instruments & Instrumentation; Materials Science, Multidisciplinary
SC Instruments & Instrumentation; Materials Science
GA AW4BN
UT WOS:000346226600003
DA 2018-10-19
ER

PT S
AU Xie, MB
   Li, Y
   Li, JS
   Chen, AZ
   Zhao, Z
   Li, G
AF Xie, Mao-Bin
   Li, Yi
   Li, Jia-Shen
   Chen, Ai-Zheng
   Zhao, Zheng
   Li, Gang
BE Li, Y
   Xin, JH
   Yoon, KJ
   Li, JS
TI Biomedical Applications of Silk Fibroin
SO TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, 2014, VOLS
   1 AND 2
SE Textile Bioengineering and Informatics Symposium Proceedings
LA English
DT Proceedings Paper
CT 7th Textile Bioengineering and Informatics Symposium (TBIS 2014) / 5th
   Asian Protective Clothing Conference (APCC 2014)
CY AUG 06-08, 2014
CL Hong Kong Polytechn Univ, Hong Kong, PEOPLES R CHINA
SP Inst Text & Cloth, Text Bioengineer & Informat Soc, Hong Kong Res Inst Text & Apparel, SDL ATLAS, Beijing Inst Fash Technol, Aimer Human Engn Res Ctr, Guangdong Hong Kong Int Text Engn Joint Res Ctr, Res Ctr Environm Impact Assessment Text & Apparel, Shaanxi Prov Res Ctr Apparel Engn & Technol, Text Biofunct Mat Ind Technol Innovat Union, Hong Kong Polytechn Univ, Xian Polytechn Univ
HO Hong Kong Polytechn Univ
DE Silk Fibroin; Biomaterial; Wound Healing; Drug Delivery; Tissue
   Engineering
ID TISSUE ENGINEERING APPLICATIONS; BOMBYX-MORI; DRUG-DELIVERY; SURFACE
   MODIFICATION; SCAFFOLDS; FABRICATION; BIOMATERIAL; PROTEIN; FIBERS;
   DIFFERENTIATION
AB In order to seek a natural protein biomaterial alternative with enough mechanical strength for developing demands of biomedical materials, silk fibroin is under reviewed due to its growing attention in biomedicine. Silk fibroin is an insoluble protein produced by the larvae of Bombyx mori, spiders, and other insects. Remarkable properties such as biocompatibility, biodegradable, oxygen and water vapor permeability, and excellent mechanical strength make silk fibroin an ideal biomaterial for biomedical applications. This paper firstly elaborates the chemistry, structure and these unique properties of silk fibroin, and then reviews different silk fibroin-based biomaterials used in biomedicine including hydrogels, nanoparticles, nanofibers, films and scaffolds follow by several emerging advanced silk fibroin-based biomedical products such as micro-needles, implantable electronic devices, resorbable screws and plates.
C1 [Xie, Mao-Bin; Li, Yi; Li, Jia-Shen; Chen, Ai-Zheng; Zhao, Zheng; Li, Gang] Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM yi.li@polyu.edu.hk
RI LI, YI/G-4421-2012; XIE, Maobin/A-1487-2013; Li, Jiashen/E-8571-2015
OI LI, YI/0000-0002-2092-4505; XIE, Maobin/0000-0001-9082-4510; 
CR Asakura T, 2013, PROG NUCL MAG RES SP, V69, P23, DOI 10.1016/j.pnmrs.2012.08.001
   Aznar CS, 2012, BIOELECTROCHEMISTRY, V85, P36
   Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028
   Calabrese R, 2012, BIOMATERIALS, V33, P7375, DOI 10.1016/j.biomaterials.2012.06.043
   Chen CH, 2014, MATERIALS, V7, P2104, DOI 10.3390/ma7032104
   Chen L, 2014, INT J BIOL MACROMOL, V65, P1, DOI 10.1016/j.ijbiomac.2014.01.003
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   DeMuth PC, 2014, ADV HEALTHC MATER, V3, P47, DOI 10.1002/adhm.201300139
   Diab T, 2012, J MECH BEHAV BIOMED, V11, P123, DOI 10.1016/j.jmbbm.2011.11.007
   Dutta S, 2013, BIOPOLYMERS, V99, P326, DOI 10.1002/bip.22168
   Elakkiya T, 2014, POLYM INT, V63, P100, DOI 10.1002/pi.4499
   Farokhi M, 2014, MAT SCI ENG C-MATER, V35, P401, DOI 10.1016/j.msec.2013.11.023
   Gautam S, 2013, J MATER SCI, V49, P1076
   Gautam S, 2014, J MATER SCI, V49, P1076, DOI 10.1007/s10853-013-7785-8
   Ghorbanian L, 2013, INT J BIOL MACROMOL, V58, P275, DOI 10.1016/j.ijbiomac.2013.04.004
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Gil ES, 2013, ADV HEALTHC MATER, V2, P206, DOI 10.1002/adhm.201200192
   Gu ZP, 2013, INT J BIOL MACROMOL, V58, P121, DOI 10.1016/j.ijbiomac.2013.03.059
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Higuchi A, 2000, CYTOTECHNOLOGY, V34, P165, DOI 10.1023/A:1008130223190
   Ho MP, 2012, APPL SURF SCI, V258, P3948, DOI 10.1016/j.apsusc.2011.12.068
   Horan RL, 2009, HERNIA, V13, P189, DOI 10.1007/s10029-008-0459-9
   Hwang SW, 2012, SCIENCE, V337, P1640, DOI 10.1126/science.1226325
   Jiang J, 2013, BIOTECHNOL LETT, V35, P657, DOI 10.1007/s10529-012-1121-2
   Kazemimostaghim M, 2014, POWDER TECHNOL, V254, P488, DOI 10.1016/j.powtec.2014.01.060
   Kimoto M, 2014, DEV BIOL, V386, P64, DOI 10.1016/j.ydbio.2013.12.002
   Kundu B, 2014, PROG POLYM SCI, V39, P251, DOI 10.1016/j.progpolymsci.2013.09.002
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lawrence BD, 2012, J VIS EXP, V62, pe3646, DOI DOI 10.3791/3646
   Lee KB, 2003, J PHARM SCI, V92, P933, DOI 10.1002/jps.10556
   Ling SJ, 2014, PHYS CHEM CHEM PHYS, V16, P7741, DOI 10.1039/c4cp00556b
   Liu L, 2014, RSC ADV, V4, P14304, DOI 10.1039/c4ra01284d
   Lovett M, 2010, ORGANOGENESIS, V6, P217, DOI [10.4161/org.6.4.13407, 10.4161/org6.4.13407]
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Ma L, 2013, PESTIC BIOCHEM PHYS, V107, P391, DOI 10.1016/j.pestbp.2013.10.008
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mazzi S, 2014, J THERM ANAL CALORIM, V116, P1337, DOI 10.1007/s10973-013-3631-0
   Mhuka V, 2013, INT J BIOL MACROMOL, V52, P305, DOI 10.1016/j.ijbiomac.2012.09.010
   Ming JF, 2014, J CRYST GROWTH, V386, P154, DOI 10.1016/j.jcrysgro.2013.09.050
   Ming JF, 2012, J APPL POLYM SCI, V125, P2148, DOI 10.1002/app.36354
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Nawalakhe R, 2012, J FIBER BIOENG INFO, V5, P227
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   Perrone GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4385
   Polo CL, 2014, J NANOSCI NANOTECHNO, V14, P15
   Rajkhowa R, 2000, J APPL POLYM SCI, V77, P2418, DOI 10.1002/1097-4628(20000912)77:11<2418::AID-APP10>3.3.CO;2-H
   Rajkhowa R, 2010, J FIBER BIOENGINEERI, V2, P202
   Reddy N, 2010, INT J BIOL MACROMOL, V46, P419, DOI 10.1016/j.ijbiomac.2010.02.013
   Rnjak-Kovacina J, 2014, ADV FUNCT MATER, V24, P2188, DOI 10.1002/adfm.201302901
   Samal SK, 2013, ACTA BIOMATER, V9, P8192, DOI 10.1016/j.actbio.2013.05.027
   Selmin F, 2014, POLYM ADVAN TECHNOL, V25, P532, DOI 10.1002/pat.3282
   Sheikh FA, 2013, J BIOMED MAT RES A, V00A, P000
   Sheikh FA, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-303
   Shen Y, 2014, BIOMED MATER, V9, P15
   Subia B, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/3/035103
   Subia B, 2014, INTEGR BIOL-UK, V6, P203, DOI 10.1039/c3ib40184g
   Suzuki Y, 2014, BIOMACROMOLECULES, V15, P104, DOI 10.1021/bm401346h
   Taddei P, 2013, MACROMOL BIOSCI, V13, P1492, DOI 10.1002/mabi.201300156
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Teuschl AH, 2014, ACTA BIOMATER, V10, P2506, DOI 10.1016/j.actbio.2014.02.012
   Tsioris K, 2012, ADV FUNCT MATER, V22, P330, DOI 10.1002/adfm.201102012
   Vasconcelos A, 2012, ACTA BIOMATER, V8, P3049, DOI 10.1016/j.actbio.2012.04.035
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2010, BIOMATERIALS, V31, P4672, DOI 10.1016/j.biomaterials.2010.02.006
   Xie MB, 2013, TEXT BIOENG INFORM S, P247
   Xie R., 2008, J FIBER BIOENG INFO, V1, P73
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yang YJ, 2014, BIOMACROMOLECULES, V15, P1390, DOI 10.1021/bm500001n
   Yin GB, 2008, TEXTILE BIOENGINEERING AND INFORMATICS SYMPOSIUM PROCEEDINGS, VOLS 1 AND 2, P659, DOI 10.3993/tbis2008108
   Yoon H, 2013, MACROMOL RES, V22, P297
   Zhang KH, 2013, MACROMOL MATER ENG, V298, P565, DOI 10.1002/mame.201200038
   Zhang Q, 2010, J FIBER BIOENG INFO, V3, P1, DOI DOI 10.1109/ICMTMA.2010.531
   Zhang YP, 2010, J BIOMED BIOTECHNOL, P1, DOI 10.1155/2010/683962
   Zhao HS, 2014, J STRUCT BIOL, V186, P420, DOI 10.1016/j.jsb.2014.02.009
   Zhao Z, 2013, TEXT BIOENG INFORM S, P143
   Zhao Z, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0736-5
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 80
TC 1
Z9 1
U1 0
U2 16
PU TEXTILE BIOENGINEERING & INFORMATICS SOCIETY LTD
PI HONG KONG SAR
PA TBIS 2010 SECRETARIAT MN104, HONG KONG POLYTECHNIC UNIV, HONG KONG SAR,
   0000, PEOPLES R CHINA
SN 1942-3438
J9 TEXT BIOENG INFORM S
PY 2014
BP 207
EP 218
PG 12
WC Materials Science, Textiles
SC Materials Science
GA BB7XZ
UT WOS:000346105500030
DA 2018-10-19
ER

PT J
AU Benni, S
   Avramoglou, T
   Hlawaty, H
   Mora, L
AF Benni, Safiya
   Avramoglou, Thierry
   Hlawaty, Hanna
   Mora, Laurence
TI Dynamic Contact Angle Analysis of Protein Adsorption on Polysaccharide
   Multilayer's Films for Biomaterial Reendothelialization
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID SURFACE MODIFICATION; ENDOTHELIAL-CELLS; DEXTRAN SULFATE;
   POLYELECTROLYTE; FIBROBLASTS; POLYSTYRENE; ADHESION; BEHAVIOR
AB Atherosclerosis is a major cardiovascular disease. One of the side effects is restenosis. The aim of this work was to study the coating of stents by dextran derivates based polyelectrolyte's multilayer (PEM) films in order to increase endothelialization of injured arterial wall after stent implantation. Films were composed with diethylaminoethyl dextran (DEAE) as polycation and dextran sulphate (DS) as polyanion. One film was composed with 4 bilayers of (DEAE-DS)(4) and was labeled D-. The other film was the same as D-but with an added terminal layer of DEAE polycation: (DEAE-DS)(4) -DEAE (labeled D+). The dynamic adsorption/desorption of proteins on the films were characterized by dynamic contact angle (DCA) and atomic force microscopy (AFM). Human endothelial cell (HUVEC) adhesion and proliferation were quantified and correlated to protein adsorption analyzed by DCA for fibronectin, vitronectin, and bovine serum albumin (BSA). Our results showed that the endothelial cell response was optimal for films composed of DS as external layer. Fibronectin was found to be the only protein to exhibit a reversible change in conformation after desorption test. This behavior was only observed for (DEAE-DS)(4) films. (DEAE-DS)(4) films could enhance HUVEC proliferation in agreement with fibronectin ability to easily change from conformation.
C1 [Benni, Safiya; Avramoglou, Thierry; Mora, Laurence] Univ Paris 13, Inst Galilee, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93430 Villetaneuse, France.
   [Hlawaty, Hanna] Univ Paris 13, UFR SMBH, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93000 Bobigny, France.
RP Mora, L (reprint author), Univ Paris 13, Inst Galilee, LVTS, INSERM,U1148,Sorbonne Paris Cite, F-93430 Villetaneuse, France.
EM laurence.mora@univ-paris13.fr
OI Hlawaty, Hanna/0000-0002-4758-0941
CR Alves CM, 2010, SOFT MATTER, V6, P4135, DOI 10.1039/c002972f
   Bordji K, 1996, BIOMATERIALS, V17, P491, DOI 10.1016/0142-9612(96)82723-2
   Bouafsoun A, 2007, MAT SCI ENG C-BIO S, V27, P709, DOI 10.1016/j.msec.2006.06.038
   Cai KY, 2005, BIOMATERIALS, V26, P5960, DOI 10.1016/j.biomaterials.2005.03.020
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   ELFERINK JGR, 1995, CHEM-BIOL INTERACT, V95, P203, DOI 10.1016/0009-2797(94)03360-9
   Hindlet P., 2005, PHARMACOL CLIN, V24, P40
   Ingber DE, 2003, J CELL SCI, V116, P1397, DOI 10.1242/jcs.00360
   Lin WC, 2005, COLLOID SURFACE B, V44, P143, DOI 10.1016/j.colsurfb.2005.06.010
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   Meredith JE, 1997, TRENDS CELL BIOL, V7, P146, DOI 10.1016/S0962-8924(97)01002-7
   Mhamdi L, 2006, MAT SCI ENG C-BIO S, V26, P273, DOI 10.1016/j.msec.2005.10.049
   Miao YH, 2008, COLLOID SURFACE B, V66, P299, DOI 10.1016/j.colsurfb.2008.07.002
   Muller C, 2011, ANAL BIOANAL CHEM, V400, P679, DOI 10.1007/s00216-010-4613-8
   Noh H, 2008, BIOMATERIALS, V29, P2033, DOI 10.1016/j.biomaterials.2008.01.017
   Nolte A, 2013, J BIOMATER APPL, V28, P84, DOI 10.1177/0885328212437610
   Pribat F. Bourdery, 2004, Journal de Pharmacie Clinique, V23, P253
   Rapuano BE, 2004, J ORTHOP RES, V22, P353, DOI 10.1016/S0736-0266(03)00180-3
   Rupp F, 2002, J BIOMED MATER RES, V62, P567, DOI 10.1002/jbm.10198
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Thomas JJ, 2010, INT J PHARMACEUT, V389, P195, DOI 10.1016/j.ijpharm.2010.01.011
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 2012, BIOMATERIALS, V33, P1201, DOI 10.1016/j.biomaterials.2011.10.059
   Xie AF, 2002, MACROMOLECULES, V35, P1805, DOI 10.1021/ma011293z
   Yu DG, 2007, COLLOID SURFACE B, V54, P222, DOI 10.1016/j.colsurfb.2006.10.026
   Zeerleder S, 2002, THROMB RES, V105, P441, DOI 10.1016/S0049-3848(02)00041-5
NR 26
TC 1
Z9 1
U1 0
U2 12
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
AR 679031
DI 10.1155/2014/679031
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AU7KU
UT WOS:000345780200001
PM 25276808
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Tan, AW
   Tay, LL
   Chua, KH
   Ahmad, R
   Akbar, SA
   Pingguan-Murphy, B
AF Tan, Ai Wen
   Tay, Lelia
   Chua, Kien Hui
   Ahmad, Roslina
   Akbar, Sheikh Ali
   Pingguan-Murphy, Belinda
TI Proliferation and stemness preservation of human adipose-derived stem
   cells by surface-modified in situ TiO2 nanofibrous surfaces
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE titania; nanofibers; thermal oxidation; stem cells; pluripotency
ID DIFFERENTIAL REGULATION; CELLULAR-RESPONSE; TITANIUM; NANOTUBES;
   EXPRESSION; SUBSTRATE; GROWTH; REGENERATION; OSTEOBLASTS; FABRICATION
AB Two important criteria of an ideal biomaterial in the field of stem cells research are to regulate the cell proliferation without the loss of its pluripotency and to direct the differentiation into a specific cell lineage when desired. The present study describes the influence of TiO2 nanofibrous surface structures on the regulation of proliferation and stemness preservation of adipose-derived stem cells (ADSCs). TiO2 nanofiber arrays were produced in situ onto Ti-6Al-4V substrate via a thermal oxidation process and the successful fabrication of these nanostructures was confirmed by field emission scanning electron microscopy (FESEM), energy dispersive spectrometer (EDS), X-ray diffractometer (XRD), and contact angle measurement. ADSCs were seeded on two types of Ti-6Al-4V surfaces (TiO2 nanofibers and flat control), and their morphology, proliferation, and stemness expression were analyzed using FESEM, AlamarBlue assay, flow cytometry, and quantitative real-time polymerase chain reaction (qRT-PCR) after 2 weeks of incubation, respectively. The results show that ADSCs exhibit better adhesion and significantly enhanced proliferation on the TiO2 nanofibrous surfaces compared to the flat control surfaces. The greater proliferation ability of TiO2 nanofibrous surfaces was further confirmed by the results of cell cycle assay. More importantly, TiO2 nanofibrous surfaces significantly upregulate the expressions of stemness markers Sox-2, Nanog3, Rex-1, and Nestin. These results demonstrate that TiO2 nanofibrous surfaces can be used to enhance cell adhesion and proliferation while simultaneously maintaining the stemness of ADSCs, thereby representing a promising approach for their potential application in the field of bone tissue engineering as well as regenerative therapies.
C1 [Tan, Ai Wen; Pingguan-Murphy, Belinda] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
   [Tay, Lelia; Chua, Kien Hui] Natl Univ Malaysia, Dept Physiol, Fac Med, Kuala Lumpur, Malaysia.
   [Ahmad, Roslina] Univ Malaya, Dept Mech Engn, Kuala Lumpur, Malaysia.
   [Akbar, Sheikh Ali] Ohio State Univ, Dept Mat Sci & Engn, Columbus, OH 43210 USA.
RP Pingguan-Murphy, B (reprint author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.
EM bpingguan@um.edu.my
RI Tan, Ai Wen/I-6408-2015; CHUA, KEK HENG/B-5261-2010; Akbar,
   Sheikh/J-6170-2013; Pingguan-Murphy, Belinda/B-8332-2010; AHMAD,
   ROSLINA/B-9612-2010
OI Akbar, Sheikh/0000-0003-3567-274X; Pingguan-Murphy,
   Belinda/0000-0001-5567-1141; AHMAD, ROSLINA/0000-0001-9038-8632
FU High Impact Research Grant - Higher Education of Malaysia
   [UM.C/HIR/MOHE/ENG/44]; University of Malaya [PV 102/2012A]
FX The authors gratefully acknowledge support by a High Impact Research
   Grant (UM.C/HIR/MOHE/ENG/44) funded by the Higher Education of Malaysia
   and Postgraduate Research Fund (PV 102/2012A) from the University of
   Malaya.
CR Bauer S, 2008, ACTA BIOMATER, V4, P1576, DOI 10.1016/j.actbio.2008.04.004
   Blanco R, 2013, ISRN BIOMARKERS, V2013
   Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Chen XY, 2012, ADV ENG MATER, V14, pB216, DOI 10.1002/adem.201180073
   Chen XM, 2000, JNCI-J NATL CANCER I, V92, P1999, DOI 10.1093/jnci/92.24.1999
   Cheng D, 2013, J GEN VIROL, V94, P326, DOI 10.1099/vir.0.046052-0
   DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dinan B, 2013, CERAM INT, V39, P5949, DOI 10.1016/j.ceramint.2012.12.004
   Fatimah SS, 2013, MICROVASC RES, V86, P21, DOI 10.1016/j.mvr.2012.12.004
   Fatimah SS, 2012, J BIOSCI BIOENG, V114, P220, DOI 10.1016/j.jbiosc.2012.03.021
   Frandsen CJ, 2014, MAT SCI ENG C-MATER, V37, P332, DOI 10.1016/j.msec.2014.01.014
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Hashemi SM, 2011, BIOMATERIALS, V32, P7363, DOI 10.1016/j.biomaterials.2011.06.048
   Hou YH, 2013, INT J NANOMED, V8, P3619, DOI 10.2147/IJN.S38992
   Hu Y, 2012, BIOMATERIALS, V33, P3515, DOI 10.1016/j.biomaterials.2012.01.040
   Hui CK, 2012, BIOTECHNOL BIOPROC E, V17, P1306, DOI 10.1007/s12257-012-0354-1
   Kaitainen S, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/2/025009
   Lai M, 2012, COLLOID SURFACE B, V97, P211, DOI 10.1016/j.colsurfb.2012.04.029
   Lee H, 2010, J NANOMATER, V2010
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Li D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066623
   Lim JY, 2011, J ORTHOP RES, V29, P1627, DOI 10.1002/jor.21441
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Logan N., 2013, STEM CELLS INT, V2013
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Lu DY, 2014, BIOMATERIALS, V35, P3945, DOI 10.1016/j.biomaterials.2014.01.066
   McNamara LE, 2010, J TISSUE ENG, V1, DOI 10.4061/2010/120623
   Motemani Y, 2014, APPL SURF SCI, V292, P626, DOI 10.1016/j.apsusc.2013.12.022
   Nava MM, 2012, J BIOMED BIOTECHNOL, V2012, DOI DOI 10.1155/2012/797410
   Oh S, 2006, MAT SCI ENG C-BIO S, V26, P1301, DOI 10.1016/j.msec.2005.08.014
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Pittrof A, 2012, ACTA BIOMATER, V8, P2639, DOI 10.1016/j.actbio.2012.03.040
   Ravichandran R, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/015001
   Schreml S, 2009, CYTOTHERAPY, V11, P947, DOI 10.3109/14653240903204322
   Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200
   Tamura RE, 2012, CURR MOL MED, V12, P634
   Tan AW, 2014, CERAM INT, V40, P8301, DOI 10.1016/j.ceramint.2014.01.032
   Tan AW, 2012, CERAM INT, V38, P4421, DOI 10.1016/j.ceramint.2012.03.002
   Tan AW, 2013, J MATER SCI, V48, P8337, DOI 10.1007/s10853-013-7659-0
   Taylor BK, 2000, AM J PHYSIOL-LUNG C, V278, pL1062
   Wang XD, 2013, J MATER RES, V28, P270, DOI 10.1557/jmr.2012.356
   Wu KC, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/5/054401
   Yu JS, 2014, BIOMATERIALS, V35, P3516, DOI 10.1016/j.biomaterials.2014.01.015
   Zhang D, 2013, BIOMATERIALS, V34, P3962, DOI 10.1016/j.biomaterials.2013.02.029
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 50
TC 4
Z9 4
U1 0
U2 15
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 5389
EP 5401
DI 10.2147/IJN.S72659
PG 13
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AU7IP
UT WOS:000345774500001
PM 25473278
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Erfani-Moghadam, V
   Nomani, A
   Zamani, M
   Yazdani, Y
   Najafi, F
   Sadeghizadeh, M
AF Erfani-Moghadam, Vahid
   Nomani, Alireza
   Zamani, Mina
   Yazdani, Yaghoub
   Najafi, Farhood
   Sadeghizadeh, Majid
TI A novel diblock copolymer of (monomethoxy poly [ethylene glycol]-oleate)
   with a small hydrophobic fraction to make stable micelles/polymersomes
   for curcumin delivery to cancer cells
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE anticancer agent; nanocarrier; encapsulation; bioavailability;
   apoptosis; critical micelle concentration
ID AMPHIPHILIC BLOCK-COPOLYMERS; IN-VITRO; POLYMERSOMES; THERAPY;
   SUPPRESSES; APOPTOSIS; PATHWAYS; VESICLES; VIVO
AB Curcumin is a potent natural anticancer agent, but its effectiveness is limited by properties such as very low solubility, high rate of degradation, and low rate of absorption of its hydrophobic molecules in vivo. To date, various nanocarriers have been used to improve the bioavailability of this hydrophobic biomaterial. This study investigates the encapsulation of curcumin in a novel nanostructure of monomethoxy poly(ethylene glycol)-oleate (mPEG-OA) and its anticancer effect. Tests were done to determine the critical micelle concentration (CMC), encapsulation efficiency, drug-loading efficiency, and cytotoxicity (against U87MG brain carcinoma cells and HFSF-PI3 cells as normal human fibroblasts) of some nanodevice preparations. The results of fluorescence microscopy and cell-cycle analyses indicated that the in vitro bioavailability of the encapsulated curcumin was significantly greater than that of free curcumin. Cytotoxicity evaluations showed that half maximal inhibitory concentrations of free curcumin and curcumin-loaded mPEG-OA for the U87MG cancer cell line were 48 mu M and 24 mu M, respectively. The Annexin-V-FLUOS assay was used to quantify the apoptotic effect of the prepared nanostructures. Apoptosis induction was observed in a dose-dependent manner after curcumin-loaded mPEG-OA treatments. Two common self-assembling structures, micelles and polymersomes, were observed by atomic force microscopy and dynamic light scattering, and the abundance of each structure was dependent on the concentration of the diblock copolymer. The mPEG-OA micelles had a very low CMC (13.24 mu M or 0.03 g/L). Moreover, atomic force microscopy and dynamic light scattering showed that the curcumin-loaded mPEG-OA polymersomes had very stable structures, and at concentrations 1,000 times less than the CMC, at which the micelles disappear, polymersomes were the dominant structures in the dispersion with a reduced size distribution below 150 nm. Overall, the results from these tests revealed that this nanocarrier can be considered as an appropriate drug delivery system for delivering curcumin to cancer cells.
C1 [Erfani-Moghadam, Vahid; Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Nanobiotechnol, Tehran, Iran.
   [Nomani, Alireza] Zanjan Univ Med Sci, Dept Pharmaceut, Fac Pharm, Zanjan, Iran.
   [Zamani, Mina; Sadeghizadeh, Majid] Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran, Iran.
   [Yazdani, Yaghoub] Golestan Univ Med Sci, Infect Dis Res Ctr, Gorgan, Golestan, Iran.
   [Yazdani, Yaghoub] Golestan Univ Med Sci, Lab Sci Res Ctr, Gorgan, Golestan, Iran.
   [Najafi, Farhood] Inst Color Sci & Technol, Dept Resin & Addit, Tehran, Iran.
   [Erfani-Moghadam, Vahid] Golestan Univ Med Sci, Fac Adv Med Technol, Dept Biotechnol, Gorgan, Iran.
RP Sadeghizadeh, M (reprint author), Tarbiat Modares Univ, Fac Biol Sci, Dept Genet, Tehran 14115154, Iran.
EM arnomani@zums.ac.ir; sadeghma@modares.ac.ir
RI Yazdani, Yaghoub/I-2343-2016
OI Yazdani, Yaghoub/0000-0003-4005-3521; Nomani,
   Alireza/0000-0003-0028-5870; Erfani-Moghadam, Vahid/0000-0002-6723-5766
FU Faculty of Biological Sciences, Tarbiat Modares University, Tehran,
   Iran; INSF; Zanjan University of Medical Sciences
FX This project was supported by grants from the Faculty of Biological
   Sciences, Tarbiat Modares University, Tehran, Iran and the INSF
   (www.insf.gov.ir). We also acknowledge financial support from the Zanjan
   University of Medical Sciences for this research. We would like to
   express our special thanks to Dr Majid Erfani-Moghadam for his generous
   assistance in manuscript preparation.
CR Adams ML, 2003, J PHARM SCI, V92, P1343, DOI 10.1002/jps.10397
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Aoki H, 2007, MOL PHARMACOL, V72, P29, DOI 10.1124/mol.106.033167
   Babaei E, 2012, INT IMMUNOPHARMACOL, V12, P226, DOI 10.1016/j.intimp.2011.11.015
   Darvishi MH, 2013, INT J PHARMACEUT, V456, P408, DOI 10.1016/j.ijpharm.2013.08.069
   Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143
   Discher DE, 2006, ANNU REV BIOMED ENG, V8, P323, DOI 10.1146/annurev.bioeng.8.061505.095838
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Gou ML, 2011, NANOSCALE, V3, P1558, DOI 10.1039/c0nr00758g
   Hamidi M, 2012, MACROMOL BIOSCI, V12, P144, DOI 10.1002/mabi.201100193
   Hatcher H, 2008, CELL MOL LIFE SCI, V65, P1631, DOI 10.1007/s00018-008-7452-4
   Hillmyer MA, 1996, MACROMOLECULES, V29, P6994, DOI 10.1021/ma960774t
   Karmakar S, 2007, NEUROCHEM RES, V32, P2103, DOI 10.1007/s11064-007-9376-z
   Karmakar S, 2006, NEUROSCI LETT, V407, P53, DOI 10.1016/j.neulet.2006.08.013
   Levine DH, 2008, METHODS, V46, P25, DOI 10.1016/j.ymeth.2008.05.006
   Ma ZS, 2008, J BIOMED MATER RES A, V86A, P300, DOI 10.1002/jbm.a.31584
   Mimeault M, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-31
   Mirgani MT, 2014, INT J NANOMED, V9, P403, DOI 10.2147/IJN.S48136
   Pearson RT, 2013, SMART MAT DRUG DELIV, V1, P179
   Ravindran J, 2009, AAPS J, V11, P495, DOI 10.1208/s12248-009-9128-x
   Robinson BR, 2005, DYNAMICS SURFACTANT, V125, P299
   Sahu A, 2008, ACTA BIOMATER, V4, P1752, DOI 10.1016/j.actbio.2008.04.021
   Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208
   Song L, 2011, COLLOID SURFACE A, V390, P25, DOI 10.1016/j.colsurfa.2011.08.031
   Tong R, 2007, POLYM REV, V47, P345, DOI 10.1080/15583720701455079
   VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503
   Wang YJ, 1997, J PHARMACEUT BIOMED, V15, P1867, DOI 10.1016/S0731-7085(96)02024-9
   Xiong XB, 2012, ACTA BIOMATER, V8, P2017, DOI 10.1016/j.actbio.2012.03.006
   Yallapu MM, 2012, DRUG DISCOV TODAY, V17, P71, DOI 10.1016/j.drudis.2011.09.009
   Zana Raoul, 2005, DYNAMICS SURFACTANT, V125, P1
NR 30
TC 12
Z9 13
U1 1
U2 17
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 5541
EP 5554
DI 10.2147/IJN.S63762
PG 14
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AU7JO
UT WOS:000345777000001
PM 25489242
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Leszczak, V
   Popat, KC
AF Leszczak, Victoria
   Popat, Ketul C.
TI Direct co-culture of endothelial and smooth muscle cells on
   poly(epsilon-caprolactone) nanowire surfaces
SO RSC ADVANCES
LA English
DT Article
ID VASCULAR TISSUE; NITRIC-OXIDE; POLYCAPROLACTONE; INHIBITION; COLLAGEN;
   MODEL; PROLIFERATION; EXPRESSION; GRAFTS; STRESS
AB Current cardiovascular implants cause restenosis, calcification and thrombosis due to insufficient integration with native tissue. A thorough understanding of the interaction between the cells and the biomaterial involved is fundamental in a successful implant that promotes healing and tissue regeneration. In this study, we have developed collagen-immobilized nanostructured surfaces from poly(3-caprolactone) for the growth and maintenance of co-cultures of endothelial and smooth muscle cells. Cell adhesion, morphology and differentiation were investigated using microscopy and western blotting. The results presented here indicate that collagenimmobilized nanostructured surfaces may be good interfaces for use in cardiovascular applications and warrant further investigation.
C1 [Leszczak, Victoria; Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Popat, KC (reprint author), Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
OI Popat, Ketul C./0000-0002-2417-7789
FU National Institute of Arthritis and Musculoskeletal and Skin Diseases of
   the National Institutes of Health under Award [5-R21-AR057341-02]
FX Research reported in this publication was supported by the National
   Institute of Arthritis and Musculoskeletal and Skin Diseases of the
   National Institutes of Health under Award Number 5-R21-AR057341-02. The
   content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health.
CR [Anonymous], 1994, BIDIRECTIONAL ELECT
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Chiu JJ, 2007, BLOOD, V110, P519, DOI 10.1182/blood-2006-08-040097
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Valence S, 2012, BIOMATERIALS, V33, P38, DOI 10.1016/j.biomaterials.2011.09.024
   DICHEK DA, 1989, CIRCULATION, V80, P1347, DOI 10.1161/01.CIR.80.5.1347
   Fillinger MF, 1997, J SURG RES, V67, P169, DOI 10.1006/jsre.1996.4978
   Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   JONES PA, 1979, P NATL ACAD SCI USA, V76, P1882, DOI 10.1073/pnas.76.4.1882
   Leszczak V., 2014, J BIOMED NA IN PRESS
   Leszczak Victoria, 2014, J Funct Biomater, V5, P58, DOI 10.3390/jfb5020058
   Leszczak V, 2013, J BIOMAT SCI-POLYM E, V24, P1529, DOI 10.1080/09205063.2013.777228
   Liu YX, 2012, ACS APPL MATER INTER, V4, P1378, DOI 10.1021/am201648f
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   ORLIDGE A, 1987, J CELL BIOL, V105, P1455, DOI 10.1083/jcb.105.3.1455
   Owens G. K., 2004, MOL REGULATION VASCU
   Parker T, 2010, CURR PHARM DESIGN, V16, P3978, DOI 10.2174/138161210794454897
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Rossello Ricardo A, 2010, Commun Integr Biol, V3, P53
   Sakurai S, 1999, AM J PATHOL, V154, P23, DOI 10.1016/S0002-9440(10)65246-7
   Shirota T, 2003, BIOMATERIALS, V24, P2295, DOI 10.1016/S0142-9612(03)00042-5
   Vernon SM, 1997, AM J PHYSIOL-CELL PH, V272, pC582
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Williamson MR, 2006, TISSUE ENG, V12, P45, DOI 10.1089/ten.2006.12.45
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Wulf K, 2011, J BIOMED MATER RES B, V98B, P89, DOI 10.1002/jbm.b.31836
   Zhu YB, 2009, MAT SCI ENG C-BIO S, V29, P1046, DOI 10.1016/j.msec.2008.09.004
   ZIEGLER T, 1995, ANN BIOMED ENG, V23, P216, DOI 10.1007/BF02584424
   Zuckerbraun BS, 2007, AM J PHYSIOL-CELL PH, V292, pC824, DOI 10.1152/ajpcell.00592.2005
NR 31
TC 0
Z9 0
U1 0
U2 6
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 101
BP 57929
EP 57934
DI 10.1039/c4ra09416f
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5MP
UT WOS:000345651600076
DA 2018-10-19
ER

PT J
AU Chen, Y
   Sun, ZH
   Li, YY
   Hong, YL
AF Chen, Ying
   Sun, Zhihui
   Li, Yanyan
   Hong, Youliang
TI Rapid osteogenic differentiation of mesenchymal stem cells on
   hydroxyapatite nanocrystal clusters-oriented nanotopography
SO RSC ADVANCES
LA English
DT Article
ID BONE; MESOCRYSTALS; ATTACHMENT; NANOSCALE; LITHOGRAPHY; PHENOTYPE;
   SUBSTRATE; SURFACES; ADHESION; NUCLEUS
AB Although it has been well demonstrated that specific nanotopographies alone can direct the fate decision of stem cells, there is still a huge gap, and at the same time, denotes a large challenge to translate this concept into clinical trials. Herein, we reported on using a kind of clinically relative biomaterial, hydroxyapatite, to prepare a kind of specific nanotopography constructed by the randomly oriented hydroxyapatite nanocrystal clusters, through high temperature water vapour treatment of the plasma-sprayed hydroxyapatite slices. Cell experiments demonstrated that bone-marrow mesenchymal stem cells could exert a strong adhesive tension on the nanocrystal clusters-oriented topography, and the formed strong intracytoskeletal stress in turn promoted cells to osteogenic differentiation rapidly; the differentiation process was associated with, but faster than, the model of osteoblastic differentiation. Therefore, our work reported here extremely shortened the gap from the concepts of mechanotransduction, i.e., extracellular physical forces sponsored from materials features can induce mechanochemical conversion to alter the fate decision of stem cells, to the clinical trials.
C1 [Chen, Ying; Hong, Youliang] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
   [Sun, Zhihui; Li, Yanyan] Jilin Univ, Hosp 1, Dept Pharm, Changchun 130012, Peoples R China.
RP Hong, YL (reprint author), Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM hyl@scu.edu.cn
FU National Natural Science Foundation of China [31170928]
FX This work was supported by the National Natural Science Foundation of
   China (Grant 31170928).
CR Alvarez-Barreto JF, 2011, J TISSUE ENG REGEN M, V5, P464, DOI 10.1002/term.338
   Berridge M. J., 2012, CELL SIGNALLING BIOL, DOI [10.1042/csb000100, DOI 10.1042/CSB000100]
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Escudero ND, 2007, BONE, V40, pS7, DOI 10.1016/j.bone.2006.12.022
   Gentile F, 2010, BIOMATERIALS, V31, P7205, DOI 10.1016/j.biomaterials.2010.06.016
   Giachelli C M, 2005, Orthod Craniofac Res, V8, P229, DOI 10.1111/j.1601-6343.2005.00345.x
   Hatakeyama H, 2007, BIOMATERIALS, V28, P3632, DOI 10.1016/j.biomaterials.2007.04.019
   Heimann RB, 1997, J THERM SPRAY TECHN, V6, P145, DOI 10.1007/s11666-997-0005-9
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hong YL, 2010, MAT SCI ENG R, V70, P225, DOI 10.1016/j.mser.2010.06.010
   Hu XL, 2008, ADV FUNCT MATER, V18, P880, DOI 10.1002/adfm.200700671
   HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562
   Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kuo SW, 2012, BIOMATERIALS, V33, P5013, DOI 10.1016/j.biomaterials.2012.03.080
   Li JF, 2011, J ORTHOP RES, V29, P1745, DOI 10.1002/jor.21439
   Manzanares M. V., 2009, NAT REV MOL CELL BIO, V10, P778, DOI DOI 10.1038/NRM2786
   Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McMurray RJ, 2011, NAT MATER, V10, P637, DOI [10.1038/NMAT3058, 10.1038/nmat3058]
   McNamara L. E., 2010, J TISSUE ENG, V2010, DOI DOI 10.4061/2010/120623
   Meili R, 2010, MOL BIOL CELL, V21, P405, DOI 10.1091/mbc.E09-08-0703
   Molnar P, 2007, BIOTECHNOL PROGR, V23, P265, DOI 10.1021/bp060302q
   Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Paletta JRJ, 2010, J MATER SCI-MATER M, V21, P1363, DOI 10.1007/s10856-009-3947-2
   Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957
   Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969
   Prat A. G., 1996, AM J PHYSIOL, V270
   Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Schofer D., 2011, PLOS ONE, V6
   Simon P, 2012, ANGEW CHEM INT EDIT, V51, P10776, DOI 10.1002/anie.201204583
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Song RQ, 2010, ADV MATER, V22, P1301, DOI 10.1002/adma.200901365
   Stamenovic D, 2009, SOFT MATTER, V5, P1137, DOI 10.1039/b806442c
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
   Yin Y, 2005, NATURE, V437, P664, DOI 10.1038/nature04165
   Zhang CG, 2000, J BIOMED MATER RES, V50, P267, DOI 10.1002/(SICI)1097-4636(200005)50:2<267::AID-JBM22>3.0.CO;2-7
NR 46
TC 2
Z9 2
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 101
BP 58019
EP 58026
DI 10.1039/c4ra10027a
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5MP
UT WOS:000345651600088
DA 2018-10-19
ER

PT J
AU Zhang, Y
   Yao, NJ
   Wang, F
   Li, WD
   Jiang, SX
AF Zhang, Yin
   Yao, Nengjian
   Wang, Fei
   Li, Wenda
   Jiang, Shengxiang
TI A novel in situ self foaming method for the synthesis of porous calcium
   metaphosphate biomaterials
SO RSC ADVANCES
LA English
DT Article
ID HYDROXYAPATITE SCAFFOLDS; TRICALCIUM PHOSPHATE; BONE; DEGRADATION;
   CERAMICS; COMBINATION; FABRICATION; COMPOSITE; POWDERS; GROWTH
AB Porous calcium metaphosphate (CMP) ceramics were manufactured using an in situ self-foaming method. The porous CMP ceramics with different porosities and strengths, and the preparation process and the properties of the resulting material were studied. Under the conditions of a low molding pressure (<= 2.0 MPa) or low heating rate (<= 0.5 degrees C min(-1)), green specimens synthesized using only Ca(H2PO4)(2) center dot H2O (MCPM) or Ca(H2PO4)(2) (MCPA) as raw materials can be fabricated into porous bioceramics without deformation and without pore-forming agents. In this study, MCPA specimens were molded at a pressure of 80.0 MPa and the heating rate was controlled at 0.5 degrees C min(-1). The synthetic biomaterial showed a porosity of 38.0% and a strength of 48.0 MPa.
C1 [Zhang, Yin; Yao, Nengjian; Wang, Fei; Li, Wenda; Jiang, Shengxiang] Nanjing Tech Univ, Coll Mat Sci & Engn, Nanjing 210009, Jiangsu, Peoples R China.
   [Zhang, Yin] Nanjing Haoqi Adv Mat Co,Ltd, Nanjing 211300, Jiangsu, Peoples R China.
RP Zhang, Y (reprint author), Nanjing Tech Univ, Coll Mat Sci & Engn, 5 Xinmofan Rd, Nanjing 210009, Jiangsu, Peoples R China.
EM zhang.512@njtech.edu.cn
FU Priority Academic Program Development of Jiangsu Higher Education
   Institutions and "12th Five-Year Plan" [2011BAE30B01]
FX This project was funded by the Priority Academic Program Development of
   Jiangsu Higher Education Institutions and "12th Five-Year Plan" to
   support science and technology key project (no. 2011BAE30B01).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Bitou M, 2008, POLYM DEGRAD STABIL, V93, P1081, DOI 10.1016/j.polymdegradstab.2008.03.014
   Caceres T, 2007, WATER RES, V41, P4497, DOI 10.1016/j.watres.2007.06.025
   Chiara R., 2013, J EUR CERAM SOC, V33, P1553
   CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228
   Correa J, 2003, ENVIRON INT, V29, P459, DOI 10.1016/S0160-4120(03)00002-3
   Deville S, 2006, BIOMATERIALS, V27, P5480, DOI 10.1016/j.biomaterials.2006.06.028
   Engin NO, 1999, J EUR CERAM SOC, V19, P2569
   FUJIU T, 1990, J AM CERAM SOC, V73, P85, DOI 10.1111/j.1151-2916.1990.tb05095.x
   Han JC, 2010, J EUR CERAM SOC, V30, P53, DOI 10.1016/j.jeurceramsoc.2009.08.018
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Hu J, 2001, J MATER SCI LETT, V20, P85, DOI 10.1023/A:1006735319725
   Ignjatovic N, 2001, BIOMATERIALS, V22, P571, DOI 10.1016/S0142-9612(00)00215-5
   Jin HH, 2010, POLYM DEGRAD STABIL, V95, P1856, DOI 10.1016/j.polymdegradstab.2010.04.025
   Koh YH, 2006, J AM CERAM SOC, V89, P3646, DOI 10.1111/j.1551-2916.2006.01311.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Alves HLR, 2008, J MATER SCI-MATER M, V19, P2241, DOI 10.1007/s10856-007-3329-6
   Lu J. X., 1997, BIOCERAMICS, V10, P583
   MCINTOSH AO, 1956, ANAL CHEM, V28, P1424, DOI 10.1021/ac60117a019
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Oh SH, 2007, BIOMATERIALS, V28, P1664, DOI 10.1016/j.biomaterials.2006.11.024
   Omelon S, 2008, MATER RES BULL, V43, P68, DOI 10.1016/j.materresbull.2007.02.015
   Park EK, 2004, BIOMATERIALS, V25, P3403, DOI 10.1016/j.biomaterials.2003.10.031
   PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169
   Popovic L, 2005, J RAMAN SPECTROSC, V36, P2, DOI 10.1002/jrs.1253
   Potoczek M, 2008, MATER LETT, V62, P1055, DOI 10.1016/j.matlet.2007.07.043
   Potoczek M, 2009, CERAM INT, V35, P2249, DOI 10.1016/j.ceramint.2008.12.006
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   Sanchez-Salcedo S, 2008, CHEM ENG J, V137, P62, DOI 10.1016/j.cej.2007.09.01
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   TenHuisen KS, 1999, J AM CERAM SOC, V82, P2813
   TIENEN TG, 2002, BIOMATERIALS, V23, P1731
   Veljovic D, 2009, CERAM INT, V35, P1407, DOI 10.1016/j.ceramint.2008.07.007
   Wang J, 2010, J MOL CATAL A-CHEM, V320, P62, DOI 10.1016/j.molcata.2010.01.004
   Xiao-Feng L., 2010, CHINESE J INORG CHEM, V8, P1404
   Yang YF, 2008, POLYM DEGRAD STABIL, V93, P1838, DOI 10.1016/j.polymdegradstab.2008.07.007
   Zhang Y, 2006, KEY ENG MAT, V317-318, P723, DOI 10.4028/www.scientific.net/KEM.317-318.723
   Zhang Y, 2012, J AM CERAM SOC, V95, P147, DOI 10.1111/j.1551-2916.2011.04859.x
NR 40
TC 5
Z9 5
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 104
BP 60007
EP 60016
DI 10.1039/c4ra11097h
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5NO
UT WOS:000345654000046
DA 2018-10-19
ER

PT J
AU Paska, OM
   Pacurariu, C
   Muntean, SG
AF Paska, Oana Maria
   Pacurariu, Cornelia
   Muntean, Simona Gabriela
TI Kinetic and thermodynamic studies on methylene blue biosorption using
   corn-husk
SO RSC ADVANCES
LA English
DT Article
ID GRANULAR ACTIVATED CARBON; LOW-COST ADSORBENTS; AQUEOUS-SOLUTION; BASIC
   DYE; ADSORPTION-ISOTHERMS; CATIONIC DYES; WOOD SAWDUST; OLIVE POMACE;
   LEAF POWDER; WASTE-WATER
AB A low-cost waste biomass derived from corn plant (husk) was tested as an alternative to other expensive treatment options, for the removal of methylene blue (MB), from aqueous solutions. The effects of different experimental parameters, such as biosorbent dosage, dye concentration, contact time, and temperature, on the adsorption process were investigated. An optimum value of discoloration was observed at pH 6.0 and 2 g L-1 biomass dosage. The amount of dye removed per adsorbent unit decreased with increasing adsorbent dosage, temperature, and increased with increasing contact time, and concentration. Experimental data were modeled using first-order, pseudo-second-order, Elovich, and intraparticle diffusion kinetics models. The adsorption kinetics of MB could be described by the pseudo-second order reaction model. The experimental data were fitted to: Langmuir, Freundlich, Temkin, Redlich-Peterson, Toth, and Sips isotherm models and the best fitting was obtained with the Sips model. The thermodynamic parameters (Delta H degrees, Delta S degrees and Delta G degrees) obtained revealed that MB adsorption is a spontaneous, exothermic and physical process. The obtained results indicated that corn husk as a low-cost biomaterial is an attractive candidate for the removal of basic dye MB from aqueous solutions.
C1 [Paska, Oana Maria; Pacurariu, Cornelia] Politehn Univ Timisoara, Fac Ind Chem & Environm Engn, Timisoara 300006, Romania.
   [Muntean, Simona Gabriela] Romanian Acad, Inst Chem Timisoara, Timisoara 300223, Romania.
RP Muntean, SG (reprint author), Romanian Acad, Inst Chem Timisoara, 24 Mihai Viteazul, Timisoara 300223, Romania.
EM sgmuntean@acad-icht.tm.edu.ro
RI Muntean, Simona/B-9008-2011
FU inside POSDRU Romania [POSDRU 107/1.5/S/77265]; European Social Fund -
   Investing in People; Program 2 of the Institute of Chemistry Timisoara
   of Romanian Academy [2.3]
FX This work was partially supported by the strategic grant POSDRU
   107/1.5/S/77265, inside POSDRU Romania 2007-2013 co-financed by the
   European Social Fund - Investing in People. This work was supported by
   Program 2 of the Institute of Chemistry Timisoara of Romanian Academy
   (Research Project 2.3.).
CR Ahmad A, 2009, J HAZARD MATER, V170, P357, DOI 10.1016/j.jhazmat.2009.04.087
   Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049
   Akar ST, 2009, DESALINATION, V249, P757, DOI 10.1016/j.desal.2008.09.012
   Akar T, 2008, BIORESOURCE TECHNOL, V99, P3057, DOI 10.1016/j.biortech.2007.06.029
   Akar T, 2009, J HAZARD MATER, V166, P1217, DOI 10.1016/j.jhazmat.2008.12.029
   Aksu Z, 2007, CHEM ENG J, V127, P177, DOI 10.1016/j.cej.2006.09.014
   ALzaydien Atef S, 2009, American Journal of Environmental Sciences, V5, P197, DOI 10.3844/ajessp.2009.197.208
   Asgher M, 2010, ECOL ENG, V36, P1660, DOI 10.1016/j.ecoleng.2010.07.003
   Banat F, 2007, BIORESOURCE TECHNOL, V98, P3017, DOI 10.1016/j.biortech.2006.10.023
   Barka N, 2011, J TAIWAN INST CHEM E, V42, P320, DOI 10.1016/j.jtice.2010.07.004
   BARL B, 1991, J SCI FOOD AGR, V56, P195, DOI 10.1002/jsfa.2740560209
   Batzias FA, 2007, J HAZARD MATER, V149, P8, DOI 10.1016/j.jhazmat.2007.03.043
   Belala Z, 2011, DESALINATION, V271, P80, DOI 10.1016/j.desal.2010.12.009
   Bhattacharyya KG, 2005, DYES PIGMENTS, V65, P51, DOI 10.1016/j.dyepig.2004.06.016
   Boeriu CG, 2004, IND CROP PROD, V20, P205, DOI 10.1016/j.indcrop.2004.04.022
   Bulut Y, 2006, DESALINATION, V194, P259, DOI 10.1016/j.desal.2005.10.032
   Chowdhury S, 2011, COLLOID SURFACE B, V84, P520, DOI 10.1016/j.colsurfb.2011.02.009
   Crank J., 1979, MATH DIFFUSION
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Delval F, 2006, BIORESOURCE TECHNOL, V97, P2173, DOI 10.1016/j.biortech.2005.09.022
   Deniz F, 2011, DESALINATION, V270, P199, DOI 10.1016/j.desal.2010.11.046
   Dogan M, 2007, DYES PIGMENTS, V75, P701, DOI 10.1016/j.dyepig.2006.07.023
   Ferrero F, 2007, J HAZARD MATER, V142, P144, DOI 10.1016/j.jhazmat.2006.07.072
   Fiorentin LD, 2010, CHEM ENG J, V163, P68, DOI 10.1016/j.cej.2010.07.043
   Garg VK, 2004, DYES PIGMENTS, V63, P243, DOI 10.1016/j.dyepig.2004.03.005
   Gong RM, 2008, DESALINATION, V230, P220, DOI 10.1016/j.desal.2007.12.002
   Gong RM, 2007, BIORESOURCE TECHNOL, V98, P1319, DOI 10.1016/j.biortech.2006.04.034
   Gurses A, 2006, J HAZARD MATER, V131, P217, DOI 10.1016/j.jhazmat.2005.09.036
   Hamdaoui O, 2007, J HAZARD MATER, V147, P381, DOI 10.1016/j.jhazmat.2007.01.021
   Hamdaoui O, 2007, J HAZARD MATER, V147, P401, DOI 10.1016/j.jhazmat.2007.01.023
   Hameed BH, 2008, J HAZARD MATER, V158, P499, DOI 10.1016/j.jhazmat.2008.01.098
   Hameed BH, 2008, J HAZARD MATER, V158, P65, DOI 10.1016/j.jhazmat.2008.01.034
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Jirekar D. B., 2014, Oriental Journal of Chemistry, V30, P1263, DOI 10.13005/ojc/300342
   Kara S, 2007, DESALINATION, V212, P282, DOI 10.1016/j.desal.2006.09.022
   Khaled A, 2009, DESALINATION, V238, P210, DOI 10.1016/j.desal.2008.02.014
   Khan T, 2010, ADSORPT SCI TECHNOL, V28, P657, DOI 10.1260/0263-6174.28.7.657
   Kumar R, 2011, DESALINATION, V265, P112, DOI 10.1016/j.desal.2010.07.040
   Liu Y, 2010, J ENVIRON SCI-CHINA, V22, P486, DOI 10.1016/S1001-0742(09)60134-0
   Mahmood R., 2013, AFR J PURE APPL CHEM, V7, P173
   Monash P, 2010, KOREAN J CHEM ENG, V27, P1184, DOI 10.1007/s11814-010-0177-8
   Nakanishi K, 1977, INFRARED ABSORPTION
   Nethaji S, 2013, INT J ENVIRON SCI TE, V10, P231, DOI 10.1007/s13762-012-0112-0
   Ofomaja AE, 2008, BIORESOURCE TECHNOL, V99, P5411, DOI 10.1016/j.biortech.2007.11.018
   Oladoja NA, 2008, DESALINATION, V227, P190, DOI 10.1016/j.desal.2007.06.025
   Ong ST, 2007, BIORESOURCE TECHNOL, V98, P2792, DOI 10.1016/j.biortech.2006.05.011
   Osasona I., 2013, British Journal of Applied Science & Technology, V3, P1006
   Padmesh I. V. N., 2006, Bioremediation Journal, V10, P37, DOI 10.1080/10889860600842746
   Patil Satish, 2011, International Journal of Environmental Sciences, V1, P711
   Pavan FA, 2008, J HAZARD MATER, V150, P703, DOI 10.1016/j.jhazmat.2007.05.023
   Reddy MCS, 2012, J HAZARD MATER, V203, P118, DOI 10.1016/j.jhazmat.2011.11.083
   Royer B, 2009, J HAZARD MATER, V164, P1213, DOI 10.1016/j.jhazmat.2008.09.028
   Singh R, 2005, CARBOHYD POLYM, V62, P57, DOI 10.1016/j.carbpol.2005.07.011
   Thangamani KS, 2007, BIORESOURCE TECHNOL, V98, P1265, DOI 10.1016/j.biortech.2006.05.010
   Vadivelan V, 2005, J COLLOID INTERF SCI, V286, P90, DOI 10.1016/j.jcis.2005.01.007
   Vijayaraghavan K, 2006, J HAZARD MATER, V133, P304, DOI 10.1016/j.jhazmat.2005.10.016
   Wang SB, 2005, CHEMOSPHERE, V60, P1401, DOI 10.1016/j.chemosphere.2005.01.091
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Yan TG, 2013, BIORESOURCES, V8, P4722
   Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013
   Zulfikar M. A., 2013, International Journal of ChemTech Research, V5, P1671
NR 62
TC 27
Z9 27
U1 3
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 107
BP 62621
EP 62630
DI 10.1039/c4ra10504d
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5PY
UT WOS:000345660300076
DA 2018-10-19
ER

PT J
AU Deepachitra, R
   Ramnath, V
   Sastry, TP
AF Deepachitra, R.
   Ramnath, V.
   Sastry, T. P.
TI Graphene oxide incorporated collagen-fibrin biofilm as a wound dressing
   material
SO RSC ADVANCES
LA English
DT Article
ID IN-VIVO; GELATIN COMPOSITES; DRUG-DELIVERY; CELLULAR GROWTH; CHROME
   SHAVINGS; HYDROGELS; PROTEIN; CANCER; SKIN; CYTOTOXICITY
AB Functionalized graphene oxide offers many advantages as a biomaterial in various biomedical applications. In the present study, graphene oxide (GO) was incorporated in the collagen-fibrin composite film (CFGO) and used as wound dressing material in both in vitro and in vivo studies. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay using NIH 3T3 cells revealed that CFGO film is biocompatible. CFGO was also used as a wound dressing material on the experimental wounds of rats. Histopathological, biochemical and hematology studies have shown that the CFGO treated wounds healed faster than control and CF treated wounds. Based on the results, CFGO can be used as a wound dressing material in small and large animals.
C1 [Deepachitra, R.; Ramnath, V.; Sastry, T. P.] Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Sastry, TP (reprint author), Cent Leather Res Inst, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sastrytp@hotmail.com
FU Department of Science and Technology (DST)
FX R. Deepachitra gratefully acknowledges the financial support provided by
   the Department of Science and Technology (DST).
CR Adam J., 1999, NEW ENGL J MED, V341, P738
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Bidgoli Sepideh Arbabi, 2013, Acta Med Iran, V51, P203
   Bilgen G, 1999, TURK J VET ANIM SCI, V23, P483
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18
   Cabeza LF, 1998, WASTE MANAGE, V18, P211, DOI 10.1016/S0956-053X(98)00032-4
   Chung C, 2013, ACCOUNTS CHEM RES, V46, P2211, DOI 10.1021/ar300159f
   Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Enoch S, 2008, SURGERY, V26, P31, DOI DOI 10.1016/J.MPSUR.2007.11.005
   Fonseca MJ, 1996, BBA-BIOMEMBRANES, V1279, P259
   Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849
   Gengler R. Y. N., 2009, SMALL, V6, P35
   Goenka S, 2014, J CONTROL RELEASE, V173, P75, DOI 10.1016/j.jconrel.2013.10.017
   Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010
   Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007
   Hu WB, 2011, ACS NANO, V5, P3693, DOI 10.1021/nn200021j
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Khullar P, 2012, J PHYS CHEM C, V116, P8834, DOI 10.1021/jp300585d
   Kim J, 2010, J AM CHEM SOC, V132, P8180, DOI 10.1021/ja102777p
   Lichtenberg D, 2000, BBA-BIOMEMBRANES, V1508, P1, DOI 10.1016/S0304-4157(00)00004-6
   Lu BG, 2012, NANOSCALE, V4, P2978, DOI 10.1039/c2nr11958g
   Maeda M, 1999, J CONTROL RELEASE, V62, P313, DOI 10.1016/S0168-3659(99)00156-X
   MORGAN PW, 1994, VET SURG, V23, P494, DOI 10.1111/j.1532-950X.1994.tb00511.x
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muruthy N., 2001, MACROMOL S, V172, P49
   Nagai T, 2004, INT J FOOD SCI TECH, V39, P239, DOI 10.1111/j.1365-2621.2004.00777.x
   Natarajan N, 2005, J MACROMOL SCI PURE, VA42, P945, DOI 10.1081/MA-200063188
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Noorjahan SE, 2004, J POLYM SCI POL CHEM, V42, P2241, DOI 10.1002/pola.20055
   Noorlander ML, 2002, J HISTOCHEM CYTOCHEM, V50, P1469, DOI 10.1177/002215540205001106
   Pachence JM, 1987, MED DEVICE DIAGN IND, V9, P49
   Park S, 2009, NAT NANOTECHNOL, V4, P217, DOI [10.1038/NNANO.2009.58, 10.1038/nnano.2009.58]
   Peng C, 2010, SMALL, V6, P1686, DOI 10.1002/smll.201000560
   Ramnath V, 2012, J MATER SCI-MATER M, V23, P3083, DOI 10.1007/s10856-012-4765-5
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Ruiz ON, 2011, ACS NANO, V5, P8100, DOI 10.1021/nn202699t
   Sadowska M, 2003, FOOD CHEM, V81, P257, DOI 10.1016/S0308-8146(02)00420-X
   SASTRY TP, 1990, J BIOACT COMPAT POL, V5, P430, DOI 10.1177/088391159000500405
   Sastry TP, 1998, J APPL POLYM SCI, V68, P1109, DOI 10.1002/(SICI)1097-4628(19980516)68:7<1109::AID-APP8>3.0.CO;2-J
   Sathian J, 2003, J BIOMED MATER RES A, V65A, P435, DOI 10.1002/jbm.a.10489
   SCHILLER S, 1961, J BIOL CHEM, V236, P983
   Sun ZC, 2013, NANOSCALE, V5, P6857, DOI 10.1039/c3nr01573d
   Swarnalatha S, 2009, J CHEM TECHNOL BIOT, V84, P751, DOI 10.1002/jctb.2108
   Thubagere A, 2010, ACS NANO, V4, P3611, DOI 10.1021/nn100389a
   TROWBRIDGE JM, 2002, GLYCOBIOLOGY, V12, P117, DOI DOI 10.1093/GLYCOB/CWF066
   Turcheniuk K, 2014, RSC ADV, V4, P865, DOI 10.1039/c3ra46307a
   Venkatesan P, 2011, BIOMATERIALS, V32, P3794, DOI 10.1016/j.biomaterials.2011.01.027
   Wang CC, 2008, J BIOMED MATER RES A, V84A, P1006, DOI 10.1002/jbm.a.31482
   Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6
   Wang TG, 2004, J NEUROCHEM, V88, P939, DOI 10.1046/j.1471-4159.2003.02242.x
   WOESSNER JF, 1962, BIOCHEM J, V83, P304, DOI 10.1042/bj0830304
   Yang K, 2012, BIOMATERIALS, V33, P2206, DOI 10.1016/j.biomaterials.2011.11.064
   Yang K, 2011, ACS NANO, V5, P516, DOI 10.1021/nn1024303
   Yang YQ, 2013, MATER TODAY, V16, P365, DOI 10.1016/j.mattod.2013.09.004
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
NR 58
TC 18
Z9 18
U1 3
U2 63
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 107
BP 62717
EP 62727
DI 10.1039/c4ra10150b
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5PY
UT WOS:000345660300091
DA 2018-10-19
ER

PT J
AU More, P
   Patil, A
   Salunkhe, R
AF More, Pallavi
   Patil, Amol
   Salunkhe, Rajashri
TI Natural surfactant mediated phytosynthesis and solvatochromic
   fluorescence of 2-aminobenzamide derivatives
SO RSC ADVANCES
LA English
DT Article
ID SOLUBILITY ENHANCEMENT; ANTIBACTERIAL ACTIVITY; ORGANIC-CHEMISTRY;
   ANTHRANILIC ACID; WATER; SYSTEM; DESIGN; SILVER; NANOPARTICLES;
   CATALYSIS
AB A green synthesis and intriguing solvatochromic behaviour of 2-aminobenzamide derivatives in varying solvents has been investigated. The biomaterial in the form of an aqueous extract of mesocarp of the fruit of the Balanites roxburghii plant as a natural surfactant reaction medium has been employed for phytosynthesis with quantitative yield at 60 degrees C. The reaction proceeds effortlessly in a short reaction time with easy product formation. The fluorescence property of some synthesized compounds was studied, along with the interesting solvatochromic behaviour of 2-amino-N-benzylbenzamide.
C1 [More, Pallavi; Patil, Amol; Salunkhe, Rajashri] Shivaji Univ, Dept Chem, Kolhapur 416004, Maharashtra, India.
RP Salunkhe, R (reprint author), Shivaji Univ, Dept Chem, Kolhapur 416004, Maharashtra, India.
EM rsschem1@gmail.com
FU Department of Science Technology and University; Department of Science
   Technology, New Delhi, India
FX We gratefully acknowledge the financial support from the Department of
   Science Technology and University Grants Commission for FIST and SAP
   respectively. One of the authors Pallavi More thanks the Department of
   Science Technology, New Delhi, India for the award of PURSE fellowship.
   We also express our thanks to Prof. Dr S. R. Patil, Department of
   Chemistry, Shivaji University, Kolhapur for useful discussion regarding
   the fluorescence spectroscopic studies.
CR Andrade LH, 2006, J MOL CATAL B-ENZYM, V38, P84, DOI 10.1016/j.molcatb.2005.11.009
   Bahrami K, 2010, GREEN CHEM, V12, P1237, DOI 10.1039/c000047g
   Barge M, 2014, RSC ADV, V4, P31177, DOI 10.1039/c4ra04387a
   Basabe-Desmonts L, 2007, CHEM SOC REV, V36, P993, DOI 10.1039/b609548h
   BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468
   Capobianco ML, 2012, MOLECULES, V17, P910, DOI 10.3390/molecules17010910
   COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050
   Deshmukh V. N., 2011, INT J PHARM LIFE SCI, V1, P318
   Dharmaraja J, 2013, SPECTROCHIM ACTA A, V114, P607, DOI 10.1016/j.saa.2013.05.043
   Fonseca AM, 2009, J MOL CATAL B-ENZYM, V57, P78, DOI 10.1016/j.molcatb.2008.06.022
   Gawande MB, 2013, CHEM SOC REV, V42, P5522, DOI 10.1039/c3cs60025d
   Gu YL, 2013, CHEM SOC REV, V42, P9550, DOI 10.1039/c3cs60241a
   Ikejiri M, 2012, ORG LETT, V14, P4406, DOI 10.1021/ol301901e
   JAIN DC, 1987, PHYTOCHEMISTRY, V26, P2223, DOI 10.1016/S0031-9422(00)84687-7
   Kaniskan N., 2012, ARKIVOC, Vviii, P198
   Kim YH, 2005, B KOR CHEM SOC, V26, P47
   Kumar A.M., 2011, ADV BIORESEARCH, V2, P122
   Kumar D, 2013, RSC ADV, V3, P15157, DOI 10.1039/c3ra41038b
   Kumar V, 2009, J CHEM TECHNOL BIOT, V84, P151, DOI 10.1002/jctb.2023
   Lipshutz BH, 2012, ALDRICHIM ACTA, V45, P3
   Liu JZ, 2013, DRUG DISCOV THER, V7, P144, DOI 10.5582/ddt.2013.v7.4.144
   Liu QF, 2009, CATAL LETT, V131, P485, DOI 10.1007/s10562-009-9926-x
   Lutz R, 2005, J DISPER SCI TECHNOL, V26, P535, DOI 10.1081/DIS-200057627
   Mabkhot YN, 2014, INT J MOL SCI, V15, P5115, DOI 10.3390/ijms15035115
   Mahadavi M., 2012, SYNLETT, V23, P2521
   MAHATO SB, 1982, PHYTOCHEMISTRY, V21, P959, DOI 10.1016/S0031-9422(00)82400-0
   Manabe K, 2001, J AM CHEM SOC, V123, P10101, DOI 10.1021/ja016338q
   Manley P. W., 2004, BIOCHIM BIOPHYS ACTA, V17, P1697
   Manley PW, 2002, J MED CHEM, V45, P5687, DOI 10.1021/jm020899q
   MENGER FM, 1975, J ORG CHEM, V40, P3803, DOI 10.1021/jo00913a051
   Rai D, 2011, INDIAN J CHEM B, V50, P931
   Sanderson K, 2011, NATURE, V469, P18, DOI 10.1038/469018a
   Saxena A, 2010, DIG J NANOMATER BIOS, V5, P427
   Song WL, 2003, IND ENG CHEM RES, V42, P949, DOI 10.1021/ie020618c
   Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937
   STAIGER RP, 1959, J ORG CHEM, V24, P1214, DOI 10.1021/jo01091a013
   Suzuki K, 2005, BIOORGAN MED CHEM, V13, P4014, DOI 10.1016/j.bmc.2005.03.053
   TANI J, 1979, J MED CHEM, V22, P95, DOI 10.1021/jm00187a021
   Vemula V. R., 2010, INT J PHARM SCI REV, V5, P41
   Verma A., 2012, ACS MED CHEM LETT, V4, P32
   Wessig P, 2008, J ORG CHEM, V73, P4452, DOI 10.1021/jo800341k
   Xia B, 2013, J ORG CHEM, V78, P1994, DOI 10.1021/jo301942g
   Yadav J.S., 2001, TETRAHEDRON-ASYMMETR, V12, P3381
   Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976
NR 44
TC 1
Z9 1
U1 0
U2 4
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 108
BP 63039
EP 63047
DI 10.1039/c4ra09514f
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU6GJ
UT WOS:000345701500031
DA 2018-10-19
ER

PT J
AU Mendoza-Novelo, B
   Lona-Ramos, MC
   Gonzalez-Garcia, G
   Castellano, LE
   Delgado, J
   Cuellar-Mata, P
   Flores-Moreno, JM
   Vargas, J
   Gutierrez, JA
   Avila, EE
   Mata-Mata, JL
AF Mendoza-Novelo, Birzabith
   Lona-Ramos, Maria C.
   Gonzalez-Garcia, Gerardo
   Castellano, Laura E.
   Delgado, Jorge
   Cuellar-Mata, Patricia
   Mauricio Flores-Moreno, J.
   Vargas, Juan
   Alfredo Gutierrez, J.
   Avila, Eva E.
   Mata-Mata, Jose L.
TI Incorporation of silica particles into decellularized tissue biomaterial
   and its effect on macrophage activation
SO RSC ADVANCES
LA English
DT Article
ID IN-VITRO; MESOPOROUS SILICA; OSTEOGENIC DIFFERENTIATION; ENGINEERING
   SCAFFOLDS; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; DRUG-DELIVERY;
   STEM-CELLS; NANOPARTICLES; POLARIZATION
AB This paper describes an optimized procedure to incorporate silica particles by hydrolysis/ polycondensation of sodium silicate into pericardial (ECM) matrix scaffolds and elucidates the effect of the biocomposites on the in vitro response of macrophages by assessment of the secretion of signaling molecules. Variables (concentration, pH, time) of the sol-gel process allow a gradual incorporation of silica into the ECM scaffolds as confirmed by gravimetry, FT-IR, SEM and EDX microanalysis. The SiO2 incorporation increases the resistance to in vitro degradation but does not alter either the denaturation temperature or content of free amines of non-crosslinked ECM fibrous scaffolds, however, the properties of oligourethane-crosslinked scaffolds are not modified after silica incorporation. Despite the fact that cell viability is gradually decreased for the ECM materials crosslinked with oligourethane and functionalized with silica, murine RAW264.7 macrophages are able to secrete b-FGF, TGF-beta 1 and VEGF. Secretion of growth factors by RAW264.7 macrophages after 6 h of culture on scaffolds containing silica was lower but it was sustained for 24 h as compared to cells cultured on silica-free materials. Human peripheral blood macrophages cultured with materials containing silica show a higher production of IL-6, IL-10 or TNF-alpha than with the silica-free counterparts but in a time-dependent manner from one to four days of culture. Results suggest that stimulation of macrophages is induced by silica particles deposited onto the ECM fibrous network, which represents an opportunity to control the cell response to decellularized tissue-derived biomaterials through strategies intended to stimulate cells via signaling molecules secreted by macrophages.
C1 [Mendoza-Novelo, Birzabith; Lona-Ramos, Maria C.; Delgado, Jorge] Univ Guanajuato, DCI, Dept Ingn Quim Elect & Biomed, Leon 37150, Mexico.
   [Gonzalez-Garcia, Gerardo; Alfredo Gutierrez, J.; Mata-Mata, Jose L.] Univ Guanajuato, DCNE, Dept Quim, Guanajuato 36050, Mexico.
   [Castellano, Laura E.] Univ Guanajuato, DCS, Dept Ciencias Aplicadas Trabajo, Leon 37150, Mexico.
   [Cuellar-Mata, Patricia; Avila, Eva E.] Univ Guanajuato, DCNE, Dept Biol, Guanajuato 36050, Mexico.
   [Mauricio Flores-Moreno, J.] Ctr Invest Opt AC, Leon 37150, Mexico.
   [Vargas, Juan] IPN, Unidad Profes Interdisciplinaria Ingn, Silao De La Victoria 36275, Mexico.
RP Mendoza-Novelo, B (reprint author), Univ Guanajuato, DCI, Dept Ingn Quim Elect & Biomed, Loma Bosque 103, Leon 37150, Mexico.
EM b.mendozanovelo@ugto.mx
RI Mendoza-Novelo, Birzabith/M-8588-2016
OI Mendoza-Novelo, Birzabith/0000-0001-6604-395X; Avila, Eva
   E./0000-0003-2011-688X
FU Consejo Nacional de Ciencia y Tecnologia (Mexico) [CB2011/164440]; Fund
   Convocatoria Interinstitucional CIO-UG
FX We thank to Julio C. Martinez and Mayra C. Rodriguez (UG) for technical
   assistance with fibroblast culture and to Rossana F. Vargas and Prof.
   Juan V. Cauich (Centro de Investigacion Cientifica de Yucatan) for
   technical assistance and facilities with SEM and DSC analyses. GGG
   thanks to MC Dora A. Huerta Q. for technical assistance with SEM
   analysis at LANNBIO Cinvestavunidad Merida Yucatan. This research was
   supported by the Consejo Nacional de Ciencia y Tecnologia (Mexico)
   through the project CB2011/164440 and the Fund Convocatoria
   Interinstitucional CIO-UG 2013.
CR Angelopoulou A, 2012, MATER LETT, V74, P50, DOI 10.1016/j.matlet.2012.01.054
   Ariganello MB, 2011, BIOMATERIALS, V32, P439, DOI 10.1016/j.biomaterials.2010.09.004
   Augustine R, 2014, RSC ADV, V4, P51528, DOI 10.1039/c4ra07361d
   Balaure PC, 2013, INT J PHARMACEUT, V441, P555, DOI 10.1016/j.ijpharm.2012.10.045
   Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002
   Battiston KG, 2014, BIOMATERIALS, V35, P4465, DOI 10.1016/j.biomaterials.2014.02.023
   Bonilla CEP, 2014, MAT SCI ENG C-MATER, V40, P418, DOI 10.1016/j.msec.2014.04.024
   Brown BN, 2012, ACTA BIOMATER, V8, P978, DOI 10.1016/j.actbio.2011.11.031
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen S, 2011, J MATER CHEM, V21, P10942, DOI 10.1039/c1jm10829h
   Cicuendez M, 2014, J MATER CHEM B, V2, P3469, DOI 10.1039/c4tb00106k
   Colilla M, 2013, BIOMATER SCI-UK, V1, P114, DOI 10.1039/c2bm00085g
   Coradin T, 2004, SPECTROSC-INT J, V18, P567, DOI 10.1155/2004/356207
   Day RM, 2005, J BIOMED MATER RES A, V73A, P73, DOI 10.1002/jbm.a.30262
   Desimone MF, 2010, ACTA BIOMATER, V6, P3998, DOI 10.1016/j.actbio.2010.05.014
   Dohle E, 2014, EUR CELLS MATER, V27, P149, DOI 10.22203/eCM.v027a12
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gaharwar AK, 2013, ADV MATER, V25, P3329, DOI 10.1002/adma.201300584
   Grotheer V, 2013, BIOMATERIALS, V34, P7314, DOI 10.1016/j.biomaterials.2013.06.012
   Han PP, 2013, BIOMATER SCI-UK, V1, P379, DOI 10.1039/c2bm00108j
   He QJ, 2010, MICROPOR MESOPOR MAT, V131, P314, DOI 10.1016/j.micromeso.2010.01.009
   Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004
   Hu L., 2011, J NANOSCI LETT, V1, P1
   Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010
   Kajahn Jennifer, 2012, Biomatter, V2, P226, DOI 10.4161/biom.22855
   Kasper J, 2013, ARCH TOXICOL, V87, P1053, DOI 10.1007/s00204-012-0876-5
   Lee KH, 2009, BIOMATERIALS, V30, P3444, DOI 10.1016/j.biomaterials.2009.03.002
   Lee S, 2011, BIOMATERIALS, V32, P9434, DOI 10.1016/j.biomaterials.2011.08.042
   Link T, 2013, RSC ADV, V3, P11140, DOI 10.1039/c2ra22352j
   Maciel J, 2012, ACTA BIOMATER, V8, P3669, DOI 10.1016/j.actbio.2012.06.010
   Mao ZW, 2013, BIOMATER SCI-UK, V1, P896, DOI 10.1039/c3bm00137g
   Mebert AM, 2013, J BIOMATER TISS ENG, V3, P108, DOI 10.1166/jbt.2013.1069
   Mendoza-Novelo B, 2014, J MATER CHEM B, V2, P2874, DOI 10.1039/c3tb21832e
   Mendoza-Novelo B, 2013, MATER LETT, V106, P369, DOI 10.1016/j.matlet.2013.05.088
   Mendoza-Novelo B, 2013, MAT SCI ENG C-MATER, V33, P2392, DOI 10.1016/j.msec.2013.02.001
   Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017
   Mu QX, 2014, CHEM REV, V114, P7740, DOI 10.1021/cr400295a
   Muller WEG, 2013, BIOMATER SCI-UK, V1, P669, DOI 10.1039/c3bm00001j
   Quignard S, 2014, BIOMATER SCI-UK, V2, P484, DOI 10.1039/c3bm60214a
   Quignard S, 2012, BIOMATERIALS, V33, P4431, DOI 10.1016/j.biomaterials.2012.03.004
   Rajabi-Zeleti S, 2014, BIOMATERIALS, V35, P970, DOI 10.1016/j.biomaterials.2013.10.045
   Ren L, 2001, J NON-CRYST SOLIDS, V285, P116, DOI 10.1016/S0022-3093(01)00441-0
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rodrigues AI, 2012, ACTA BIOMATER, V8, P3765, DOI 10.1016/j.actbio.2012.05.025
   Rong Y, 2013, ENVIRON TOXICOL PHAR, V36, P921, DOI 10.1016/j.etap.2013.08.007
   Schlossmacher U, 2013, RSC ADV, V3, P11185, DOI 10.1039/c3ra23341c
   Shirosaki Y, 2005, BIOMATERIALS, V26, P485, DOI 10.1016/j.biomaterials.2004.02.056
   Alvarez GS, 2014, J MATER CHEM B, V2, P4660, DOI 10.1039/c4tb00327f
   Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012
   Tang FQ, 2012, ADV MATER, V24, P1504, DOI 10.1002/adma.201104763
   Tomoaia G, 2014, MAT SCI ENG C-MATER, V37, P37, DOI 10.1016/j.msec.2013.12.027
   Vargas GE, 2013, J MATER SCI-MATER M, V24, P1261, DOI 10.1007/s10856-013-4892-7
   Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060
   Wang XP, 2013, ACTA BIOMATER, V9, P7480, DOI 10.1016/j.actbio.2013.03.031
   Wiens M, 2010, BIOMATERIALS, V31, P7716, DOI 10.1016/j.biomaterials.2010.07.002
   Wu CT, 2011, J MATER CHEM, V21, P18300, DOI 10.1039/c1jm12770e
   Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k
   Yun HS, 2011, ACTA BIOMATER, V7, P2651, DOI 10.1016/j.actbio.2011.02.014
   Zhai WY, 2013, ACTA BIOMATER, V9, P8004, DOI 10.1016/j.actbio.2013.04.024
   Zhai WY, 2012, J BIOMED MATER RES B, V100B, P1397, DOI 10.1002/jbm.b.32711
   Zhang HY, 2012, J AM CHEM SOC, V134, P15790, DOI 10.1021/ja304907c
NR 61
TC 2
Z9 2
U1 0
U2 33
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 108
BP 63457
EP 63465
DI 10.1039/c4ra08984g
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU6GJ
UT WOS:000345701500082
DA 2018-10-19
ER

PT S
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
BE Dornfeld, D
   Helu, M
TI Finite Element Simulation and Experimental Validation of Residual
   Stresses in High Speed Dry Milling of Biodegradable Mg-Ca Alloys
SO 6TH CIRP INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE CUTTING (HPC2014)
SE Procedia CIRP
LA English
DT Proceedings Paper
CT 6th CIRP International Conference on High Performance Cutting (HPC)
CY JUN 23-25, 2014
CL Univ Calif, Berkeley & Davis Campuses, Berkeley, CA
SP CIRP
HO Univ Calif, Berkeley & Davis Campuses
DE Residua stess; dry cutting; magnesium alloy; implants
ID MACHINED LAYER; SURFACE; MODEL; TOOL; TEMPERATURE; GEOMETRY
AB Magnesium-Calcium (Mg-Ca) alloys have become attractive biodegradable orthopedic biomaterials recently. Residual stresses are proven to be very influential on the degradation rate of an Mg-Ca implant in the human body. Due to the time and cost reasons, development of finite element models to predict residual stress profiles in cutting of Mg-Ca implants is highly desirable. In this study, a finite element simulation model of orthogonal cutting without explicit chip formation has been developed by using the plowing depth approach in order to predict process-induced residual stresses in high speed dry cutting of Mg-Ca0.8 (wt %) alloy using diamond tools. Mechanical properties of Mg-Ca0.8 biomaterial at high strain rates and large strains were determined using the split-Hopkinson pressure bar test. The internal state variable (ISV) plasticity model has been implemented to model the dynamic material behavior under cutting regimes. The residual stress evolution and effects of plowing speed and plowing depth on residual stress profiles are studied. Residual stress measurements were also performed utilizing the X-ray diffraction technique for validation purposes. (C) 2014 Elsevier B.V.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
CR Bach F. W., 2007, P 7 INT C MG ALL THE, P1076
   Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   Bammann DJ, 1993, STRUCTURAL CRASHWORT, P1
   Brinksmeier E, 2000, ANN CIRP, V31, P491
   DENKENA B, 2007, ANN CIRP, V56, P113, DOI DOI 10.1016/J.CIRP.2007.05.029
   Ee KC, 2005, INT J MECH SCI, V47, P1611, DOI [10.1016/j.ijmecsci.2005.06.001, 10.1016/j.ijmensci.2005.06.001]
   Fang FZ, 2007, J MATER PROCESS TECH, V184, P407, DOI 10.1016/j.jmatprotec.2006.12.007
   Grzesik W, 2003, INT J MACH TOOL MANU, V43, P1311, DOI 10.1016/S0890-6955(03)00160-3
   Guo YB, 2009, CIRP ANN-MANUF TECHN, V58, P81, DOI 10.1016/j.cirp.2009.03.110
   Guo YB, 2005, TRANS N AMER MANUFAC, V33, P469
   Hashimoto F., 2006, ANN CIRP, V55, P81
   Jacobus K, 2001, J MANUF SCI E-T ASME, V123, P537, DOI 10.1115/1.1372197
   Jacobus K, 2000, J MANUF SCI E-T ASME, V122, P20, DOI 10.1115/1.538906
   Jawahir IS, 2011, CIRP ANN-MANUF TECHN, V60, P603, DOI 10.1016/j.cirp.2011.05.002
   Liu CR, 2000, INT J MECH SCI, V42, P1069, DOI 10.1016/S0020-7403(99)00042-9
   Ozel T, 2007, INT J ADV MANUF TECH, V35, P255, DOI 10.1007/s00170-006-0720-2
   Outeiro JC, 2006, INT J MACH TOOL MANU, V46, P1786, DOI 10.1016/j.ijmachtools.2005.11.013
   Palmer W. B., 1963, P 4 INT MACH TOOL DE, P61
   Salahshoor M, 2011, INT J MACH TOOL MANU, V51, P579, DOI 10.1016/j.ijmachtools.2011.04.004
   Sasahara H, 2004, INT J MACH TOOL MANU, V44, P815, DOI 10.1016/j.ijmachtools.2004.01.002
   Sasahara H, 1996, J MATER PROCESS TECH, V62, P448, DOI 10.1016/S0924-0136(96)02451-X
   Schulze V, 2010, CIRP ANN-MANUF TECHN, V59, P117, DOI 10.1016/j.cirp.2010.03.064
   Spear H. E., 1994, SYNTHETIC DIAMOND EM
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
   Zong WJ, 2007, INT J ADV MANUF TECH, V32, P666, DOI 10.1007/s00170-005-0388-z
NR 25
TC 1
Z9 1
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 2212-8271
J9 PROC CIRP
PY 2014
VL 14
BP 281
EP 286
DI 10.1016/j.procir.2014.03.062
PG 6
WC Engineering, Industrial
SC Engineering
GA BB7ES
UT WOS:000345439400049
OA Other Gold
DA 2018-10-19
ER

PT J
AU Qi, C
   Zhu, YJ
   Lu, BQ
   Ding, GJ
   Sun, TW
   Chen, F
   Wu, J
AF Qi, Chao
   Zhu, Ying-Jie
   Lu, Bing-Qiang
   Ding, Guan-Jun
   Sun, Tuan-Wei
   Chen, Feng
   Wu, Jin
TI Microwave-assisted rapid synthesis of magnesium phosphate hydrate
   nanosheets and their application in drug delivery and protein adsorption
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID BETA-TRICALCIUM PHOSPHATE; HYDROTHERMAL SYNTHESIS; MESOPOROUS SILICA;
   BONE REGENERATION; PHOSPHORUS SOURCE; CALCIUM; NANOSTRUCTURES;
   FABRICATION; MATRICES; RELEASE
AB Magnesium phosphate biomaterial, as an alternative to well-known calcium phosphate biomaterials, is an excellent candidate for biomedical applications, owing to its outstanding biocompatibility and biodegradability. Herein, we report a simple strategy for the rapid synthesis of magnesium phosphate hydrate nanosheets (MPHSs) using the microwave-assisted hydrothermal method. This method is facile, rapid, surfactant-free and environmentally friendly. The product shows an excellent ability to promote osteoblast MC-3T3 adhesion and spreading, which indicates high biocompatibility. Moreover, the as-prepared MPHSs are explored for potential applications in the loading and release of the anticancer drug and protein adsorption, using docetaxel as a model anticancer drug and hemoglobin (Hb) as a model protein. The experiments indicate that the as-prepared MPHSs have a relatively high protein adsorption capacity and a high ability to damage tumor cells after loading docetaxel. Thus, the as-prepared MPHSs are promising for applications in various biomedical fields such as drug delivery and protein adsorption.
C1 [Qi, Chao; Zhu, Ying-Jie; Lu, Bing-Qiang; Ding, Guan-Jun; Sun, Tuan-Wei; Chen, Feng; Wu, Jin] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI Qi, Chao/N-5957-2015; Chen, Feng/D-6406-2012; CHEN, Feng/E-4310-2016
OI Chen, Feng/0000-0002-1162-1684; CHEN, Feng/0000-0002-1162-1684
FU National Basic Research Program of China (973 Program) [2012CB933600];
   National Natural Science Foundation of China [51172260, 51302294];
   Science and Technology Commission of Shanghai [12ZR1452100]
FX Financial support from the National Basic Research Program of China (973
   Program, no. 2012CB933600), the National Natural Science Foundation of
   China (51172260, 51302294), and Science and Technology Commission of
   Shanghai (12ZR1452100) is gratefully acknowledged.
CR Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   Bhakta G, 2005, BIOMATERIALS, V26, P2157, DOI 10.1016/j.biomaterials.2004.06.039
   Bichler KH, 2002, INT J ANTIMICROB AG, V19, P488, DOI 10.1016/S0924-8579(02)00088-2
   Huang Y, 2009, BIOMATERIALS, V30, P5041, DOI 10.1016/j.biomaterials.2009.05.077
   Jia JF, 2010, J R SOC INTERFACE, V7, P1171, DOI 10.1098/rsif.2009.0559
   Klammert U, 2011, ACTA BIOMATER, V7, P3469, DOI 10.1016/j.actbio.2011.05.022
   Klammert U, 2010, J MATER SCI-MATER M, V21, P2947, DOI 10.1007/s10856-010-4148-8
   Lu JX, 2011, J MATER SCI-MATER M, V22, P607, DOI 10.1007/s10856-011-4228-4
   Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972
   Mestres G, 2011, ACTA BIOMATER, V7, P1853, DOI 10.1016/j.actbio.2010.12.008
   Paul W, 2007, J MATER SCI-MATER M, V18, P699, DOI 10.1007/s10856-006-0005-1
   Qi C, 2013, CHEM-EUR J, V19, P5332, DOI 10.1002/chem.201203886
   Qi C, 2012, J MATER CHEM, V22, P22642, DOI 10.1039/c2jm35280j
   Qi C, 2012, MATER LETT, V85, P71, DOI 10.1016/j.matlet.2012.06.106
   Rude RK, 2003, CALCIFIED TISSUE INT, V72, P32, DOI 10.1007/s00223-001-1091-1
   SALIMI MH, 1985, LANGMUIR, V1, P119, DOI 10.1021/la00061a019
   Tamimi F, 2011, ACTA BIOMATER, V7, P2678, DOI 10.1016/j.actbio.2011.02.007
   Tavares DDS, 2013, J APPL ORAL SCI, V21, P37, DOI 10.1590/1678-7757201302138
   Wang SP, 2013, MICROPOR MESOPOR MAT, V179, P172, DOI 10.1016/j.micromeso.2013.06.005
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Xue WC, 2008, J MATER SCI-MATER M, V19, P2669, DOI 10.1007/s10856-008-3395-4
   Yang Q, 2005, CHEM MATER, V17, P5999, DOI 10.1021/cm051198v
   Zhao XY, 2013, CRYSTENGCOMM, V15, P206, DOI 10.1039/c2ce26315g
   Zhou H, 2013, MAT SCI ENG C-MATER, V33, P4288, DOI 10.1016/j.msec.2013.06.034
   Zhu YJ, 2014, CHEM REV, V114, P6462, DOI 10.1021/cr400366s
NR 25
TC 12
Z9 12
U1 2
U2 31
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 48
BP 8576
EP 8586
DI 10.1039/c4tb01473a
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AU3QT
UT WOS:000345529400014
DA 2018-10-19
ER

PT J
AU Nakaji-Hirabayashi, T
   Kitano, H
AF Nakaji-Hirabayashi, T.
   Kitano, H.
TI Interleukin-10 chimeric protein to protect transplanted neural
   progenitor cells from immune responses
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID EPIDERMAL-GROWTH-FACTOR; STEM-CELLS; PARKINSONS-DISEASE;
   DOPAMINERGIC-NEURONS; SELECTIVE EXPANSION; NERVOUS-SYSTEM; RAT MODEL;
   SURVIVAL; DIFFERENTIATION; POLYPEPTIDES
AB The provision of adhesive scaffolding and protection from inflammatory responses are important for enhancing graft survival. We previously developed a functional hydrogel that significantly enhances the survival of cells transplanted into the midbrain striatum. Although graft survival reached approximately 40% using this hydrogel, the survival of transplanted cells required further enhancements because it ultimately produced a decrease in the number of transplanted cells. Therefore, we developed a hydrogel system that can locally prevent the inflammatory response. This hydrogel was modified by the addition of the interleukin 10 chimeric protein (IL10CP), which is selectively released from the hydrogel when triggered by an inflammatory response. This design protects transplanted cells from inflammatory response, while other host cells remain unaffected. The IL10 domains are selectively released from the hydrogel, which act locally on the immune cells to prevent the inflammatory response without the administration of an immune suppressor. The selective release of IL10 domains from the hydrogel and their activity to prevent immune responses were evaluated using various approaches. Moreover, the ability of the IL10CP-modified hydrogel to protect cells was investigated using an in vitro co-culture with activated microglia. The IL10 incorporated into the hydrogel was selectively released by the activity of matrix-metalloproteinase 9 (MMP9), and the neural progenitor cells encapsulated in the IL10CP-immobilized hydrogel were protected from activated microglia by the release of IL10s from the hydrogel by the MMP9, produced by the activated microglia. These results show that the IL10CP-modified hydrogel will be useful as a biomaterial for improving the survival of transplanted cells.
C1 [Nakaji-Hirabayashi, T.] Toyama Univ, Frontier Res Core Life Sci, Toyama 9308555, Japan.
   [Kitano, H.] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Toyama 9308555, Japan.
RP Nakaji-Hirabayashi, T (reprint author), Toyama Univ, Frontier Res Core Life Sci, 3190 Gofuku, Toyama 9308555, Japan.
EM nakaji@ctg.u-toyama.ac.jp
CR Agari T., 2002, NEUROSCI RES, V69, P698
   Arimoto T, 2007, NEUROBIOL AGING, V28, P894, DOI 10.1016/j.neurobiolaging.2006.04.011
   Armstrong RJE, 2000, CELL TRANSPLANT, V9, P139, DOI 10.1177/096368970000900202
   Bigg HF, 2007, FEBS J, V274, P1246, DOI 10.1111/j.1742-4658.2007.05669.x
   Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119
   Halliday GM, 2011, MOVEMENT DISORD, V26, P6, DOI 10.1002/23455
   Kim DE, 2006, RADIOLOGY, V241, P822, DOI 10.1148/radiol.2413050466
   Lauer-Fields JL, 2003, J BIOL CHEM, V278, P18140, DOI 10.1074/jbc.M211330200
   Lepore A C, 2006, Neuroscience, V142, P287, DOI 10.1016/j.neuroscience.2005.12.067
   Marchionini DM, 2003, J COMP NEUROL, V464, P172, DOI 10.1002/cne.10785
   Nakaii-Hirabayashi T, 2008, BIOCONJUGATE CHEM, V19, P516, DOI 10.1021/bc700355t
   Nakaji-Hirabayashi T, 2012, J TISSUE ENG REGEN M, V6, P322
   Nakaji-Hirabayashi T, 2008, BIOMATERIALS, V29, P4403, DOI 10.1016/j.biomaterials.2008.07.048
   Nakaji-Hirabayashi T, 2007, BIOMATERIALS, V28, P3517, DOI 10.1016/j.biomaterials.2007.04.022
   Nakaji-Hirabayashi T, 2013, BIOCONJUGATE CHEM, V24, P1798, DOI 10.1021/bc400005m
   Nakaji-Hirabayashi T, 2012, BIOCONJUGATE CHEM, V23, P212, DOI 10.1021/bc200481v
   Nakaji-Hirabayashi T, 2009, BIOCONJUGATE CHEM, V20, P102, DOI 10.1021/bc800331t
   Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649
   Takagi Y, 2005, J CLIN INVEST, V115, P102, DOI 10.1172/JCI200521137
   Thomas JG, 1997, APPL BIOCHEM BIOTECH, V66, P197, DOI 10.1007/BF02785589
   Wang F, 2011, NEUROSCI RES, V71, P92, DOI 10.1016/j.neures.2011.05.019
   Zhang F, 2011, PROG NEUROBIOL, V95, P373, DOI 10.1016/j.pneurobio.2011.09.001
NR 22
TC 4
Z9 4
U1 1
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 48
BP 8598
EP 8607
DI 10.1039/c4tb01413h
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AU3QT
UT WOS:000345529400016
DA 2018-10-19
ER

PT J
AU Ma, MC
   Xu, XJ
   Shi, LL
   Li, LD
AF Ma, Mingchao
   Xu, Xinjun
   Shi, Leilei
   Li, Lidong
TI Organic field-effect transistors with a low driving voltage using
   albumin as the dielectric layer
SO RSC ADVANCES
LA English
DT Article
ID THIN-FILM TRANSISTORS; PROTEIN MOLECULES; PERFORMANCE; MOISTURE; POLYMER
AB Solution-processed organic field-effect transistors (OFETs) were fabricated based on a hygroscopic biomaterial, egg-white albumin, as the gate dielectric and poly(3-hexylthiophene) as the semiconductor. With increasing humidity, such OFETs can show improved performance exhibiting a very low driving voltage, together with enhanced carrier mobility and suppressed off-state current.
C1 [Ma, Mingchao; Xu, Xinjun; Shi, Leilei; Li, Lidong] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
RP Xu, XJ (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
EM xuxj@mater.ustb.edu.cn; lidong@mater.ustb.edu.cn
RI Li, Lidong/D-7077-2011
OI Shi, Leilei/0000-0002-9427-4357
FU National Natural Science Foundation of China [51273020]; Fundamental
   Research Funds for the Central Universities [FRF-SD-12-005B]; Research
   Fund for the Doctoral Program of Higher Education of China
   [20130006110007]; State Key Lab for Advanced Metals and Materials
   [2012-ZD05]
FX This work is supported by the National Natural Science Foundation of
   China (51273020), the Fundamental Research Funds for the Central
   Universities (FRF-SD-12-005B), Research Fund for the Doctoral Program of
   Higher Education of China (20130006110007), and the State Key Lab for
   Advanced Metals and Materials (2012-ZD05).
CR Arias AC, 2010, CHEM REV, V110, P3, DOI 10.1021/cr900150b
   Capelli R, 2011, ORG ELECTRON, V12, P1146, DOI 10.1016/j.orgel.2011.04.005
   Chang JW, 2011, ADV MATER, V23, P4077, DOI 10.1002/adma.201102124
   Chen HJ, 2012, ADV MATER, V24, P4618, DOI 10.1002/adma.201201318
   Chua LL, 2005, NATURE, V434, P194, DOI 10.1038/nature03376
   Di CA, 2008, ADV MATER, V20, P1286, DOI 10.1002/adma.200701812
   Gelinck G, 2010, ADV MATER, V22, P3778, DOI 10.1002/adma.200903559
   HILL TL, 1956, J PHYS CHEM-US, V60, P1593, DOI 10.1021/j150545a035
   HILL TL, 1956, J PHYS CHEM-US, V60, P358, DOI 10.1021/j150537a026
   Hoshino S, 2004, J APPL PHYS, V95, P5088, DOI 10.1063/1.1691190
   Kaihovirta N, 2010, ADV FUNCT MATER, V20, P2605, DOI 10.1002/adfm.201000586
   Kim YS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299022
   Knipp D, 2007, J APPL PHYS, V101, DOI 10.1063/1.2432369
   Ko SH, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/34/345202
   Komoda T, 2003, JPN J APPL PHYS 1, V42, P3662, DOI 10.1143/JJAP.42.3662
   Leveque J. L., 2005, BIOENGINEERING SKIN, P18
   Livingston J. D., 1999, ELECT PROPERTIES ENG, P39
   Lu GH, 2014, ADV MATER, V26, P2359, DOI 10.1002/adma.201305320
   Mai CK, 2013, ANGEW CHEM INT EDIT, V52, P12874, DOI 10.1002/anie.201307667
   Mao LK, 2013, ORG ELECTRON, V14, P1170, DOI 10.1016/j.orgel.2013.02.010
   Park J, 2010, MOL CRYST LIQ CRYST, V531, P14, DOI 10.1080/15421406.2010.495928
   Shea PB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2115077
   Shi LL, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862198
   Singh B, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220488
   Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741
   Wang CL, 2012, CHEM REV, V112, P2208, DOI 10.1021/cr100380z
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Wen YG, 2011, CHEM REV, V111, P3358, DOI 10.1021/cr1001904
   Yan H, 2009, NATURE, V457, P679, DOI 10.1038/nature07727
   Yumusak C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3278592
   Zhou B, 2011, IEEE ELECTR DEVICE L, V32, P1549, DOI 10.1109/LED.2011.2164612
NR 31
TC 5
Z9 5
U1 1
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 102
BP 58720
EP 58723
DI 10.1039/c4ra11833b
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU2PQ
UT WOS:000345460800079
DA 2018-10-19
ER

PT J
AU Volodina, KV
   Solov'eva, NL
   Vinogradov, VV
   Sobolev, VE
   Vinogradov, AV
   Vinogradov, VV
AF Volodina, K. V.
   Solov'eva, N. L.
   Vinogradov, Vasiliy V.
   Sobolev, V. E.
   Vinogradov, Alexander V.
   Vinogradov, Vladimir V.
TI A synergistic biocomposite for wound healing and decreasing scar size
   based on sol-gel alumina
SO RSC ADVANCES
LA English
DT Article
ID THERMAL-STABILITY; DELIVERY; CHLORHEXIDINE; DRESSINGS; SCAFFOLD; MATRIX
AB The synthesis of new biocomposites exhibiting a synergistic effect is a promising step in the healing of acute and chronic wounds. In the present study we have combined four materials: chlorhexidine digluconate as a antimicrobial agent, lidocaine as a painkiller, chymotrypsin as a necrolytic agent, and sol-gel processed alumina as a carrier for the sustained delivery of drugs and as an established wound healer. Composites were synthesized and characterized for surface morphology, crystalline structure and in vitro drug release. In vivo wound healing efficacy was assessed using a full thickness excision wound model in Wistar rats. The main result, was that a marked decrease in scar size was observed because of the wound healing composite, in fact the area of the scar in the test group of rats was 2.4 times smaller than that in the control group. Wound closure analysis revealed that complete epithelialization was observed after 15 +/- 1 days using the biocomposite, whereas this took 17 +/- 1 days and 19 +/- 1 days using the healing solution alone or pure alumina gel, respectively. It was concluded that the synergistic combination of healing drugs, with sol-gel alumina as dressing material, provides a highly attractive biomaterial for the treatment of surface wounds, burns and foot ulcers.
C1 [Volodina, K. V.; Vinogradov, Vasiliy V.; Sobolev, V. E.; Vinogradov, Alexander V.; Vinogradov, Vladimir V.] ITMO Univ, Lab Solut Chem Adv Mat & Technol, St Petersburg 197101, Russia.
   [Volodina, K. V.] Ivanovo State Univ Chem & Technol, Ivanovo 153000, Russia.
   [Solov'eva, N. L.] Ivanovo State Med Acad, Ivanovo 153012, Russia.
RP Vinogradov, VV (reprint author), ITMO Univ, Lab Solut Chem Adv Mat & Technol, St Petersburg 197101, Russia.
EM Vinogradoffs@mail.ru
RI Vinogradov, Vladimir/H-1166-2014; Vinogradov, Alexandr/I-8294-2017
OI Vinogradov, Vladimir/0000-0002-5081-4876
CR Agarwal A, 2012, BIOMATERIALS, V33, P6783, DOI 10.1016/j.biomaterials.2012.05.068
   Barbe C, 2004, ADV MATER, V16, P1959, DOI 10.1002/adma.200400771
   Ben-Knaz R, 2010, ADV FUNCT MATER, V20, P2324, DOI 10.1002/adfm.200902393
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   Garcia-Esteo F, 2005, HISTOL HISTOPATHOL, V20, P53, DOI 10.14670/HH-20.53
   Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153
   James GA, 2008, WOUND REPAIR REGEN, V16, P37, DOI 10.1111/j.1524-475X.2007.00321.x
   Kerstein M. D., 1994, AM J SURG, V167, P2
   Lee YH, 2012, EXP DIABETES RES, DOI 10.1155/2012/504693
   Li HY, 2011, NAT NANOTECHNOL, V6, P645, DOI [10.1038/nnano.2011.153, 10.1038/NNANO.2011.153]
   Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.1440-1711.2004.01286.x
   Macheras P, 2006, MODELING BIOPHARMACE
   Mi FL, 2002, J BIOMED MATER RES, V59, P438, DOI 10.1002/jbm.1260
   Midwood KS, 2004, INT J BIOCHEM CELL B, V36, P1031, DOI 10.1016/j.biocel.2003.12.003
   Musset JH, 1998, PHARM PRACTICE, P176
   Newton PM, 2004, INFLAMMATION, V28, P207, DOI 10.1023/B:IFLA.0000049045.41784.59
   Park SN, 2003, BIOMATERIALS, V24, P1631, DOI 10.1016/S0142-9612(02)00550-1
   Perumal S, 2014, EUR J PHARM SCI, V52, P26, DOI 10.1016/j.ejps.2013.10.006
   Poinern GEJ, 2010, J BIOMED NANOTECHNOL, V6, P497, DOI 10.1166/jbn.2010.1148
   Rutenberg A, 2013, CHEM COMMUN, V49, P5636, DOI 10.1039/c3cc41696h
   Vinogradov AV, 2014, PHYS CHEM CHEM PHYS, V16, P10614, DOI 10.1039/c4cp00969j
   Vinogradov VV, 2014, J MATER CHEM B, V2, P2868, DOI 10.1039/c3tb21643h
NR 23
TC 5
Z9 5
U1 3
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 105
BP 60445
EP 60450
DI 10.1039/c4ra09015b
PG 6
WC Chemistry, Multidisciplinary
SC Chemistry
GA AU5OE
UT WOS:000345655600002
DA 2018-10-19
ER

PT S
AU Wanyonyi, WC
   Onyari, JM
   Shiundu, PM
AF Wanyonyi, Wycliffe Chisutia
   Onyari, John Mmari
   Shiundu, Paul Mwanza
BE Salame, C
   Aillerie, M
   Papageorgas, P
TI Adsorption of Congo Red Dye from Aqueous Solutions Using Roots of
   Eichhornia crassipes: Kinetic and Equilibrium Studies
SO TECHNOLOGIES AND MATERIALS FOR RENEWABLE ENERGY, ENVIRONMENT AND
   SUSTAINABILITY (TMREES14 - EUMISD)
SE Energy Procedia
LA English
DT Proceedings Paper
CT International Conference on Technologies and Materials for Renewable
   Energy, Environment and Sustainability (TMREES)
CY APR 10-13, 2014
CL Beirut, LEBANON
SP Euro Mediterranean Inst Sustainable Dev
DE Adsorption; Congo red; Eichhornia crassipes; Isotherm; Kinetics
ID METHYLENE-BLUE; REMOVAL
AB Adsorption of Congo red (CR) from aqueous solution using dried roots of Eichhornia crassipes was studied. Batch experiments were carried out for sorption kinetics and isotherms. Experimental results obtained showed that adsorption process was highly dependent on contact time, adsorbent dosage, initial dye concentration and particle size. The sorption equilibrium for Congo red dye by E. crassipes (roots) was reached within 90 minutes and adsorption efficiency of up to 96% achieved. The sorption kinetics followed a pseudo-second-order kinetic model while Freundlich isotherm model was best applicable for obtaining the equilibrium parameters. These results demonstrate that roots of E. crassipes are effective, environmentally friendly and low-cost biomaterial for dye removal from aqueous dye solutions and industrial effluents. (C) 2014 Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Selection and peer-review under responsibility of the Euro-Mediterranean Institute for Sustainable Development (EUMISD)
C1 [Wanyonyi, Wycliffe Chisutia; Onyari, John Mmari; Shiundu, Paul Mwanza] Univ Nairobi, Sch Phys Sci, Dept Chem, Nairobi, Kenya.
RP Wanyonyi, WC (reprint author), Univ Nairobi, Sch Phys Sci, Dept Chem, POB 30197-00100, Nairobi, Kenya.
EM wchisutia@yahoo.com
OI Onyari, john Mmari/0000-0002-7289-6550
CR Chanzu HA, 2012, J POLYM ENVIRON, V20, P665, DOI 10.1007/s10924-012-0479-5
   Cheung WH, 2009, BIORESOURCE TECHNOL, V100, P1143, DOI 10.1016/j.biortech.2008.07.071
   Crini G, 2006, BIORESOURCE TECHNOL, V97, P1061, DOI 10.1016/j.biortech.2005.05.001
   Crini G, 2008, DYES PIGMENTS, V77, P415, DOI 10.1016/j.dyepig.2007.07.001
   Dizge N, 2008, J HAZARD MATER, V150, P737, DOI 10.1016/j.jhazmat.2007.05.027
   dos Santos AB, 2007, BIORESOURCE TECHNOL, V98, P2369, DOI 10.1016/j.biortech.2006.11.013
   Freundlich H. M. F., 1907, J PHYS CHEM-US, V57, P385, DOI DOI 10.1021/JE900585T
   Gao JF, 2010, J HAZARD MATER, V174, P215, DOI 10.1016/j.jhazmat.2009.09.039
   Hameed BH, 2009, J HAZARD MATER, V162, P939, DOI 10.1016/j.jhazmat.2008.05.120
   Hu TL, 2001, BIORESOURCE TECHNOL, V77, P93, DOI 10.1016/S0960-8524(00)00124-3
   Hu ZH, 2010, J HAZARD MATER, V173, P292, DOI 10.1016/j.jhazmat.2009.08.082
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010
   Nemchi F, 2012, ADSORPT SCI TECHNOL, V30, P81, DOI 10.1260/0263-6174.30.1.81
   Pavan FA, 2008, DYES PIGMENTS, V76, P64, DOI 10.1016/j.dyepig.2006.08.027
   Purkait MK, 2007, J HAZARD MATER, V145, P287, DOI 10.1016/j.jhazmat.2006.11.021
   Ren TZ, 2013, ADSORPT SCI TECHNOL, V31, P535, DOI 10.1260/0263-6174.31.6.535
   Sanchez N, 2012, ADSORPT SCI TECHNOL, V30, P881, DOI 10.1260/0263-6174.30.10.881
   Wanyonyi WC, 2013, B ENVIRON CONTAM TOX, V91, P362, DOI 10.1007/s00128-013-1053-0
   Wijetunga S., 2008, BIORESOURCE TECHNOL, V99, P3692
   Zhang WJ, 2011, B ENVIRON CONTAM TOX, V87, P86, DOI 10.1007/s00128-011-0304-1
NR 21
TC 30
Z9 31
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-6102
J9 ENRGY PROCED
PY 2014
VL 50
BP 862
EP 869
DI 10.1016/j.egypro.2014.06.105
PG 8
WC Energy & Fuels
SC Energy & Fuels
GA BB7FA
UT WOS:000345440100105
OA Other Gold
DA 2018-10-19
ER

PT J
AU Zein, R
   Hidayat, DA
   Elfia, M
   Nazarudin, N
   Munaf, E
AF Zein, Rahmiana
   Hidayat, Dian Arrisujaya
   Elfia, Mega
   Nazarudin, Nazris
   Munaf, Edison
TI Sugar palm Arenga pinnata Merr (Magnoliophyta) fruit shell as
   biomaterial to remove Cr(III), Cr(VI), Cd(II) and Zn(II) from aqueous
   solution
SO JOURNAL OF WATER SUPPLY RESEARCH AND TECHNOLOGY-AQUA
LA English
DT Article
DE aqueous solution; Arenga pinnata; biosorption; Fourier transform
   infrared spectroscopy; scanning electron microscope; toxic metals
ID WASTE-WATER; HEAVY-METAL; BIOSORPTION; ADSORPTION; ADSORBENT; ALGAE;
   IONS
AB The removal of toxic heavy metals Cr(III), Cr(VI), Cd(II) and Zn(II) from aqueous solution by sugar palm (Arenga pinnata) fruit shell has been examined. Adsorption factors consisted of solution of pH, mass of biosorbent as well as initial metal concentration. The Langmuir isotherm was used to study the adsorption mechanism. Moreover, characterization of sugar palm fruit shell was investigated using Fourier transform infrared spectroscopy and surface morphology was checked using scanning electron microscope. The removal percentage at maximum conditions were: 0.28, 0.52, 0.43 and 0.58 mg g(-1) for Cr(III), Cr(VI), Cd(II) and Zn(II), respectively. Desorption study was carried out by using nitric acid at a range of pH 1-4. This work shows that the performance of biosorption of metals by A. pinnata has many advantages, such as good removal and deremoval efficiencies.
C1 [Zein, Rahmiana; Hidayat, Dian Arrisujaya; Elfia, Mega; Nazarudin, Nazris; Munaf, Edison] Andalas Univ, Fac Math & Nat Sci, Dept Chem, Analyt Environm Chem Lab, Padang 25163, Indonesia.
RP Zein, R (reprint author), Andalas Univ, Fac Math & Nat Sci, Dept Chem, Analyt Environm Chem Lab, Padang 25163, Indonesia.
EM rzein@fmipa.unand.ac.id
OI Arrisujaya, Dian/0000-0002-9053-756X
FU Andalas University BOPTN research fund from the Directorate General of
   Higher Education of the Ministry of Education and Culture of the
   Republic of Indonesia
FX This research was supported by Andalas University BOPTN research fund
   academic year 2012, from the Directorate General of Higher Education of
   the Ministry of Education and Culture of the Republic of Indonesia.
CR Aguado J, 2009, J HAZARD MATER, V163, P213, DOI 10.1016/j.jhazmat.2008.06.080
   Ahmad R, 2005, WATER QUAL RES J CAN, V40, P462
   Ali I, 2010, SEP PURIF REV, V39, P95, DOI 10.1080/15422119.2010.527802
   Andrade AD, 2005, PROCESS BIOCHEM, V40, P1931, DOI 10.1016/j.procbio.2004.07.007
   Cao J, 2010, BIORESOURCE TECHNOL, V101, P2558, DOI 10.1016/j.biortech.2009.10.069
   Cordero B., 2004, ENV CHEM, V1, P180
   Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8
   Demirbas A, 2008, J HAZARD MATER, V157, P220, DOI 10.1016/j.jhazmat.2008.01.024
   ENZMINGER JD, 1987, J HAZARD MATER, V14, P83, DOI 10.1016/0304-3894(87)87007-3
   Febrianto J, 2009, J HAZARD MATER, V162, P616, DOI 10.1016/j.jhazmat.2008.06.042
   Guo J, 2012, CURR MICROBIOL, V65, P350, DOI 10.1007/s00284-012-0164-x
   Ishak MR, 2012, J THERM ANAL CALORIM, V109, P981, DOI 10.1007/s10973-011-1785-1
   Kok K. H., 2002, PAK J BIOL SCI, V5, P474
   Munaf E, 1997, ENVIRON TECHNOL, V18, P359, DOI 10.1080/09593331808616549
   Munaf E., 1994, HAZARDOUS WASTE CONT
   Naik C., 2012, ENVIRON SCI POLLUT R, V19, P3005
   Pennesi C, 2012, J APPL PHYCOL, V24, P1495, DOI 10.1007/s10811-012-9808-2
   Pennesi C, 2012, WATER ENVIRON RES, V84, P9, DOI 10.2175/106143011X12989211841296
   Sari A, 2010, SEP SCI TECHNOL, V45, P463, DOI 10.1080/01496390903526642
   Silva AC, 2004, CHEMOSPHERE, V55, P207, DOI 10.1016/j.chemosphere.2003.10.013
   Tien CJ, 2002, PROCESS BIOCHEM, V38, P605, DOI 10.1016/S0032-9592(02)00183-8
   Volesky B, 1990, BIOSORPTION METALS
   Volesky B, 2007, WATER RES, V41, P4017, DOI 10.1016/j.watres.2007.05.062
   Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002
   Zein R., 2011, J HAZARD MATER, V181, P52
NR 25
TC 2
Z9 2
U1 2
U2 10
PU IWA PUBLISHING
PI LONDON
PA ALLIANCE HOUSE, 12 CAXTON ST, LONDON SW1H0QS, ENGLAND
SN 0003-7214
EI 1365-2087
J9 J WATER SUPPLY RES T
JI J. Water Supply Res Technol.-Aqua
PY 2014
VL 63
IS 7
BP 553
EP 559
DI 10.2166/aqua.2014.120
PG 7
WC Engineering, Civil; Water Resources
SC Engineering; Water Resources
GA AT7MU
UT WOS:000345122400004
DA 2018-10-19
ER

PT J
AU Hedia, HS
   Fouda, N
AF Hedia, Hassan S.
   Fouda, Noha
TI Improved Stress Shielding of a Coated Cemented Hip Stem by Functionally
   Graded Materials
SO MATERIALS TESTING
LA English
DT Article
DE Materials testing; finite element analysis; FGM; hip replacement;
   coating; stress shielding; interface shear stress
ID FINITE-ELEMENT-ANALYSIS; FATIGUE NOTCH FACTOR; HYDROXYAPATITE COATINGS;
   SHEAR-STRENGTH; DENTAL IMPLANT; FEMUR; DESIGN; BONE; ENDOPROSTHESIS;
   OPTIMIZATION
AB Surfaces are the primary contact zones between a biomaterial and its host organism. Surface treatment or coating provides a means to fulfill demanding structural and mechanical requirements of the prostheses. As well as, a number of studies have been performed on functionally graded materials (FGM) and their suitability for use as the biomaterial of choice in various prostheses. This study investigates the effect of utilizing the two concepts of FGM and coating, in designing new hip stem material. The results of this study concluded that the optimal FGM cemented stem is consisting of titanium at the upper stem layers graded to collagen at lower stem layers. The optimal functionally graded stem coated with collagen reduced the stress shielding by 51 % compared to homogenous titanium stem coated with collagen. However, this optimal graded stem coated with hydroxyapatite showed a reduction of stress shielding by 57 % compared to homogenous titanium stem coated with hydroxyapatite.
C1 [Hedia, Hassan S.] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia.
   [Fouda, Noha] Mansoura Univ, Fac Engn, Mansoura, Egypt.
RP Hedia, HS (reprint author), King Abdulaziz Univ, Vice President Off, POB 80200, Jeddah 21589, Saudi Arabia.
EM hassanhedia87@yahoo.com
RI Fouda, Noha/Q-3612-2018
OI Fouda, Noha/0000-0002-1206-7486
FU Deanship of Scientific Research (DSR), King Abdulaziz University,
   Jeddah, Saudi Arabia [135-004-D1433]; DSR
FX This project was funded by the Deanship of Scientific Research (DSR),
   King Abdulaziz University, Jeddah, Saudi Arabia, under grant No.
   (135-004-D1433). The authors gratefully acknowledge the DSR for the
   technical and financial support.
CR Bareil R. P., 2010, MATERIALS, V3, P1863, DOI [10.3390/ma3031863, DOI 10.3390/MA3031863]
   Darimont GL, 2002, BIOMATERIALS, V23, P2569, DOI 10.1016/S0142-9612(01)00392-1
   Hedia H., 2004, INT J MECH MATER DES, V1, P329, DOI DOI 10.1007/S10999-005-3307-4
   Hedia HS, 2006, J BIOMED MATER RES B, V79B, P42, DOI 10.1002/jbm.30509
   Hedia H. S., 1996, THESIS LEEDS U LEEDS
   Hedia H. S., 2006, INT C PROD ENG DES D, P205
   Hedia HS, 1996, BIO-MED MATER ENG, V6, P199
   Hedia HS, 1996, BIO-MED MATER ENG, V6, P135
   Hedia HS, 2005, J BIOMED MATER RES B, V75B, P74, DOI 10.1002/jbm.b.30275
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Jonkers I, 2008, J BIOMECH, V41, P3405, DOI 10.1016/j.jbiomech.2008.09.011
   KANG YK, 1993, J BIOMED ENG, V15, P497, DOI 10.1016/0141-5425(93)90065-7
   Kim YH, 2012, J ARTHROPLASTY, V27, P559, DOI 10.1016/j.arth.2011.06.020
   KUIPER JH, 1992, RECENT ADVANCES IN COMPUTER METHODS IN BIOMECHANICS & BIOMEDICAL ENGINEERING, P76
   Kuiper JH, 1997, J BIOMECH ENG-T ASME, V119, P166, DOI 10.1115/1.2796076
   Lawson MC, 2010, CLIN ORTHOP RELAT R, V468, P2081, DOI 10.1007/s11999-010-1266-z
   Lee JH, 2011, THIN SOLID FILMS, V519, P4618, DOI 10.1016/j.tsf.2011.01.004
   Narayanan R, 2007, MATER CHEM PHYS, V106, P406, DOI 10.1016/j.matchemphys.2007.06.026
   Niinomi M., 2006, ENCY BIOMATERIALS BI
   Okada M, 2012, SCI TECHNOL ADV MAT, V13, DOI 10.1088/1468-6996/13/6/064103
   Ou KL, 2011, J MECH BEHAV BIOMED, V4, P618, DOI 10.1016/j.jmbbm.2011.02.001
   Race A, 2011, J ARTHROPLASTY, V26, P289, DOI 10.1016/j.arth.2010.02.004
   ROHLMANN A, 1983, J BIOMECH, V16, P727, DOI 10.1016/0021-9290(83)90082-9
   Sam Z, 2006, SURF COAT TECH, V200, P6350, DOI 10.1016/j.surfcoat.2005.11.033
   Svehla M, 2002, J ARTHROPLASTY, V17, P304, DOI 10.1054/arth.2002.30410
   Taylor ME, 1996, MED ENG PHYS, V18, P122, DOI 10.1016/1350-4533(95)00031-3
   Weinrauch PC, 2007, J ARTHROPLASTY, V22, P394, DOI 10.1016/j.arth.2006.04.010
   Xie JH, 2008, SURF COAT TECH, V202, P2960, DOI 10.1016/j.surfcoat.2007.10.040
   Yang J, 2007, J BIOMECH, V40, P2377, DOI 10.1016/j.jbiomech.2006.11.019
   Zhang S, 2007, ENG FRACT MECH, V74, P1884, DOI 10.1016/j.engfracmech.2006.04.021
NR 30
TC 1
Z9 1
U1 1
U2 7
PU CARL HANSER VERLAG
PI MUNICH
PA KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY
SN 0025-5300
J9 MATER TEST
JI Mater. Test.
PY 2014
VL 56
IS 11-12
BP 1021
EP 1028
DI 10.3139/120.110667
PG 8
WC Materials Science, Characterization & Testing
SC Materials Science
GA AT7QF
UT WOS:000345131900017
DA 2018-10-19
ER

PT J
AU Bahl, S
   Suwas, S
   Chatterjee, K
AF Bahl, Sumit
   Suwas, Satyam
   Chatterjee, Kaushik
TI The control of crystallographic texture in the use of magnesium as a
   resorbable biomaterial
SO RSC ADVANCES
LA English
DT Article
ID SIMULATED BODY-FLUID; AZ31 MG ALLOY; CORROSION BEHAVIOR; GRAIN-SIZE;
   TITANIUM; BIOCOMPATIBILITY; DIFFERENTIATION; IMPLANTS
AB Magnesium and its alloys are an emerging class of resorbable materials for orthopedic and cardiovascular applications. The typical strategy underlying the development of these materials involves the control of material processing routes and the addition of alloying elements. Crystallographic texture is known to control bulk mechanical as well as surface properties. However, its role in determining the properties of magnesium for implant materials has not been well studied. In this work, an extruded rod of pure magnesium was cut in multiple directions to generate samples with different textures. It was found that texture significantly affected the strength and ductility of magnesium. Corrosion rates in Hank's solution decreased with the increased presence of low energy basal planes at the surface. In vitro cell studies revealed that changes in texture did not induce cytotoxicity. Thus, the control of texture in magnesium based implants could be used to tailor the mechanical properties and the resorption rates without compromising cytocompatibility. This study elucidates the importance of texture in the use of magnesium as a resorbable biomaterial.
C1 [Bahl, Sumit; Suwas, Satyam; Chatterjee, Kaushik] Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
RP Chatterjee, K (reprint author), Indian Inst Sci, Dept Mat Engn, Bangalore 560012, Karnataka, India.
EM kchatterjee@materials.iisc.ernet.in
OI Chatterjee, Kaushik/0000-0002-7204-2926; Bahl, Sumit/0000-0002-9471-5001
FU Department of Atomic Energy-Board of Research in Nuclear Sciences
   (DAE-BRNS); Ramanujan fellowship from Department of Science and
   Technology (DST), India
FX This work was funded by the Department of Atomic Energy-Board of
   Research in Nuclear Sciences (DAE-BRNS). K. C. was financially supported
   by the Ramanujan fellowship from Department of Science and Technology
   (DST), India. Authors gratefully acknowledge Prof. Subodh Kumar and Mr
   George Raphael for assistance with the corrosion studies and Mr R.
   Deshpande for help with AAS.
CR Argade GR, 2012, CORROS SCI, V58, P145, DOI 10.1016/j.corsci.2012.01.021
   Bahl S, 2014, RSC ADV, V4, P38078, DOI 10.1039/c4ra05440g
   Bostman O, 1996, J TRAUMA, V41, P846, DOI 10.1097/00005373-199611000-00013
   Byer CM, 2010, SCRIPTA MATER, V62, P536, DOI 10.1016/j.scriptamat.2009.12.017
   Chapuis A, 2011, ACTA MATER, V59, P1986, DOI 10.1016/j.actamat.2010.11.064
   del Valle JA, 2006, ACTA MATER, V54, P4247, DOI 10.1016/j.actamat.2006.05.018
   Fu BQ, 2009, APPL SURF SCI, V255, P9348, DOI 10.1016/j.apsusc.2009.07.034
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Hoseini M, 2014, J BIOMED MATER RES A, V102, P3631, DOI 10.1002/jbm.a.35028
   Hoseini M, 2009, CORROS SCI, V51, P3064, DOI 10.1016/j.corsci.2009.08.017
   Hutchinson WB, 2010, SCRIPTA MATER, V63, P737, DOI 10.1016/j.scriptamat.2010.05.047
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kleiner S, 2004, MAT SCI ENG A-STRUCT, V379, P258, DOI 10.1016/j.msea.2004.02.020
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li RW, 2014, J BIOMED MATER RES A, V102, P4346, DOI 10.1002/jbm.a.35111
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Manivasagam G, 2014, MATER SCI TECH-LOND, V30, P515, DOI 10.1179/1743284713Y.0000000500
   O'Brien B, 2009, ACTA BIOMATER, V5, P945, DOI 10.1016/j.actbio.2008.11.012
   Shahab F, 2006, BIOMATERIALS, V27, P3532, DOI 10.1016/j.biomaterials.2006.02.027
   Song GL, 2010, ELECTROCHEM COMMUN, V12, P1009, DOI 10.1016/j.elecom.2010.05.011
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191
   Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028
   Xin RL, 2011, MATER DESIGN, V32, P4548, DOI 10.1016/j.matdes.2011.04.031
   Xin Y, 2011, ACTA BIOMATER, V7, P1452, DOI 10.1016/j.actbio.2010.12.004
   Zhang EL, 2008, MAT SCI ENG A-STRUCT, V497, P111, DOI 10.1016/j.msea.2008.06.019
   Zhao LC, 2010, CORROS SCI, V52, P2228, DOI 10.1016/j.corsci.2010.03.008
NR 29
TC 3
Z9 3
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 99
BP 55677
EP 55684
DI 10.1039/c4ra08484e
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AT5QT
UT WOS:000344997800001
DA 2018-10-19
ER

PT J
AU Robles, L
   Storrs, R
   Lamb, M
   Alexander, M
   Lakey, JRT
AF Robles, Lourdes
   Storrs, Rick
   Lamb, Morgan
   Alexander, Michael
   Lakey, Jonathan R. T.
TI Current Status of Islet Encapsulation
SO CELL TRANSPLANTATION
LA English
DT Review
DE Cell encapsulation; Islets; Stem cells; Xenotransplantation; Cell
   engineering
ID EMBRYONIC STEM-CELLS; MICROENCAPSULATED PORCINE ISLETS; BIOARTIFICIAL
   ENDOCRINE PANCREAS; BIOHYBRID ARTIFICIAL PANCREAS; IMMUNOCOMPETENT
   DIABETIC MICE; PROLONGS XENOGRAFT SURVIVAL; INSULIN-PRODUCING CELLS;
   ALGINATE-PLL CAPSULES; LONG-TERM FUNCTION; IN-VIVO FUNCTION
AB Cell encapsulation is a method of encasing cells in a semipermeable matrix that provides a permeable gradient for the passage of oxygen and nutrients, but effectively blocks immune-regulating cells from reaching the graft, preventing rejection. This concept has been described as early as the 1930s, but it has exhibited substantial achievements over the last decade. Several advances in encapsulation engineering, chemical purification, applications, and cell viability promise to make this a revolutionary technology. Several obstacles still need to be overcome before this process becomes a reality, including developing a reliable source of islets or insulin-producing cells, determining the ideal biomaterial to promote graft function, reducing the host response to the encapsulation device, and ultimately a streamlined, scaled-up process for industry to be able to efficiently and safely produce encapsulated cells for clinical use. This article provides a comprehensive review of cell encapsulation of islets for the treatment of type 1 diabetes, including a historical perspective, current research findings, and future studies.
C1 [Robles, Lourdes; Lamb, Morgan; Alexander, Michael; Lakey, Jonathan R. T.] Univ Calif Irvine, Dept Surg, Irvine, CA 92717 USA.
   [Storrs, Rick] Islet Sheet Med, San Francisco, CA USA.
   [Lakey, Jonathan R. T.] Univ Calif Irvine, Irvine, CA USA.
RP Lakey, JRT (reprint author), Univ Calif Irvine, 333 City Blvd West,Suite 700, Orange, CA 92868 USA.
EM jlakey@uci.edu
CR Abbah SA, 2008, J MATER SCI-MATER M, V19, P2113, DOI 10.1007/s10856-006-0013-1
   Addae C, 2012, DIFFERENTIATION, V83, P233, DOI 10.1016/j.diff.2012.03.001
   Alejandro R, 2008, TRANSPLANTATION, V86, P1783, DOI 10.1097/TP.0b013e3181913f6a
   Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107
   ALTMAN JJ, 1984, T AM SOC ART INT ORG, V30, P382
   Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063
   Baruch L, 2009, BIOMED MICRODEVICES, V11, P1103, DOI 10.1007/s10544-009-9327-3
   Basta G, 2011, DIABETES CARE, V34, P2406, DOI 10.2337/dc11-0731
   Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x
   Bisceglie V., 1993, Z KREBSFORSCHUNG, V40, P122
   Black SP, 2006, BIOCHEM BIOPH RES CO, V340, P236, DOI 10.1016/j.bbrc.2005.11.180
   Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100
   Brendel M. D., 2001, INT ISLET TRANSPLANT, V9, P1
   Bromberg JS, 2007, AM J TRANSPLANT, V7, P2217, DOI 10.1111/j.1600-6143.2007.01957.x
   Bunger CM, 2005, BIOMATERIALS, V26, P2353, DOI 10.1016/j.biomaterials.2004.07.017
   Calafiore R, 2006, DIABETES CARE, V29, P137, DOI 10.2337/diacare.29.01.06.dc05-1270
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Centers for Disease Control and Prevention, 2012, DIAB PUBL HLTH RES
   Check E, 2002, NATURE, V419, P5, DOI 10.1038/419005b
   Chhabra P, 2011, J TRANSPLANT, DOI 10.1155/2011/637692
   CLAYTON HA, 1992, TRANSPLANTATION, V54, P558
   COLE DR, 1992, DIABETOLOGIA, V35, P231, DOI 10.1007/BF00400922
   Cornolti R, 2009, CELL TRANSPLANT, V18, P195, DOI 10.3727/096368909788341252
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   De Vos P, 1999, DIABETES, V48, P1381, DOI 10.2337/diabetes.48.7.1381
   de Vos P, 2002, J BIOMED MATER RES, V62, P430, DOI 10.1002/jbm.10345
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   Diabetes UK, 2012, STAT NAT 2012, P1
   Souza Yngrid Ellyn Dias Maciel de, 2011, Arq. Gastroenterol., V48, P146, DOI 10.1590/S0004-28032011000200011
   Dickson BC, 2003, TRANSPLANTATION, V75, P599, DOI 10.1097/01.TP.0000048226.28357.0D
   DIONNE KE, 1993, DIABETES, V42, P12, DOI 10.2337/diabetes.42.1.12
   Dong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050265
   Dufrane D, 2006, BIOMATERIALS, V27, P3201, DOI 10.1016/j.biomaterials.2006.01.028
   Dufrane D, 2006, TRANSPLANTATION, V81, P1345, DOI 10.1097/01.tp.0000208610.75997.20
   Dufrane D, 2010, TRANSPLANTATION, V90, P1054, DOI 10.1097/TP.0b013e3181f6e267
   Duvivier-Kali VF, 2004, AM J TRANSPLANT, V4, P1991, DOI 10.1111/j.1600-6143.2004.00628.x
   Elliott R. B., 2011, INT PANCR ISL TRANSP
   Elliott R. B., 2010, 70 SCI SESS AM DIAB
   Elliott RB, 2005, TRANSPL P, V37, P3505, DOI 10.1016/j.transproceed.2005.09.038
   Elliott RB, 2007, XENOTRANSPLANTATION, V14, P157, DOI 10.1111/j.1399-3089.2007.00384.x
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   Figliuzzi M, 2005, BIOMATERIALS, V26, P5640, DOI 10.1016/j.biomaterials.2005.02.019
   Foster JL, 2007, TRANSPLANTATION, V83, P1440, DOI 10.1097/01.tp.0000264555.46417.7d
   FRITSCHY WM, 1991, DIABETOLOGIA, V34, P542, DOI 10.1007/BF00400270
   Gao Q, 2010, AM J TRANSPLANT, V10, P1588, DOI 10.1111/j.1600-6143.2010.03151.x
   Garkavenko O, 2004, J CLIN MICROBIOL, V42, P5353, DOI 10.1128/JCM.42.11.5353-5356.2004
   GATES RJ, 1977, LANCET, V2, P1257
   Gotfredsen C F, 1990, Diabetes Res, V15, P157
   Grose S, 2007, NAT MED, V13, P390, DOI 10.1038/nm0407-390b
   Hering B., 1999, GRAFT, V2, P12
   Hirotani S, 1999, CELL TRANSPLANT, V8, P399, DOI 10.1177/096368979900800409
   IWATA H, 1994, J BIOMED MATER RES, V28, P1003, DOI 10.1002/jbm.820280905
   IWATA H, 1994, J BIOMED MATER RES, V28, P1201, DOI 10.1002/jbm.820281010
   JAIN K, 1995, TRANSPLANTATION, V59, P319, DOI 10.1097/00007890-199502150-00002
   Kadam Sachin, 2010, Rev Diabet Stud, V7, P168, DOI 10.1900/RDS.2010.7.168
   Kerby A, 2013, CYTOTHERAPY, V15, P192, DOI 10.1016/j.jcyt.2012.10.018
   Khanna O, 2010, J BIOMED MATER RES A, V95A, P632, DOI 10.1002/jbm.a.32883
   Kin T, 2002, PANCREAS, V25, P94, DOI 10.1097/01.MPA.0000015216.27722.72
   King Aileen, 2003, Diabetes Technol Ther, V5, P653, DOI 10.1089/152091503322250677
   Knippenberg S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036857
   Kobayashi T, 2003, TRANSPLANTATION, V75, P619, DOI 10.1097/01.TP.0000053749.36365.7E
   Kobayashi T, 2006, CELL TRANSPLANT, V15, P359, DOI 10.3727/000000006783981954
   Korbutt GS, 2004, DIABETOLOGIA, V47, P1810, DOI 10.1007/s00125-004-1531-3
   Krishnamurthy N. V., 2011, Critical Reviews in Biomedical Engineering, V39, P473, DOI 10.1615/CritRevBiomedEng.v39.i6.10
   Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393
   Kuhtreiber W M, 1993, ASAIO J, V39, pM247
   Kumagai-Braesch M, 2013, CELL TRANSPLANT, V22, P1137, DOI 10.3727/096368912X657486
   LACY PE, 1991, SCIENCE, V254, P1782, DOI 10.1126/science.1763328
   Langlois G, 2009, ACTA BIOMATER, V5, P3433, DOI 10.1016/j.actbio.2009.05.029
   Lanza RP, 1999, TRANSPLANTATION, V67, P1105, DOI 10.1097/00007890-199904270-00004
   LANZA RP, 1991, P NATL ACAD SCI USA, V88, P11100, DOI 10.1073/pnas.88.24.11100
   LANZA RP, 1993, TRANSPLANTATION, V56, P1067, DOI 10.1097/00007890-199311000-00003
   LANZA RP, 1992, ENDOCRINOLOGY, V131, P637, DOI 10.1210/en.131.2.637
   Lee DY, 2007, BIOMATERIALS, V28, P1957, DOI 10.1016/j.biomaterials.2006.12.015
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SH, 2009, TRANSPLANTATION, V87, P983, DOI 10.1097/TP.0b013e31819c86ea
   Lembert N, 2005, CELL TRANSPLANT, V14, P97, DOI 10.3727/000000005783983232
   Leung A, 2008, J MICROENCAPSUL, V25, P387, DOI 10.1080/02652040802008857
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Ludwig B, 2010, P NATL ACAD SCI USA, V107, P12623, DOI 10.1073/pnas.1005098107
   LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   MAKI T, 1991, TRANSPLANTATION, V51, P43, DOI 10.1097/00007890-199101000-00006
   Maki T, 1996, DIABETES, V45, P342, DOI 10.2337/diabetes.45.3.342
   Matveyenko AV, 2010, AM J PHYSIOL-ENDOC M, V299, pE713, DOI 10.1152/ajpendo.00279.2010
   MAZAHERI R, 1991, TRANSPLANTATION, V51, P750, DOI 10.1097/00007890-199104000-00002
   MONACO AP, 1991, ANN SURG, V214, P339, DOI 10.1097/00000658-199109000-00016
   Moya ML, 2010, J SURG RES, V160, P208, DOI 10.1016/j.jss.2009.06.003
   Muthyala S, 2011, ACTA BIOMATER, V7, P2153, DOI 10.1016/j.actbio.2011.01.036
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8
   Ohyama T, 1998, TRANSPLANT P, V30, P3433, DOI 10.1016/S0041-1345(98)01091-4
   Omer A, 2005, TRANSPLANTATION, V79, P52, DOI 10.1097/01.TP.0000149340.37865.46
   Omer A, 2003, DIABETES, V52, P69, DOI 10.2337/diabetes.52.1.69
   Orive G, 2002, TRENDS BIOTECHNOL, V20, P382, DOI 10.1016/S0167-7799(02)02037-1
   OSHEA GM, 1986, DIABETES, V35, P943, DOI 10.2337/diabetes.35.8.943
   OSHEA GM, 1984, BIOCHIM BIOPHYS ACTA, V804, P133, DOI 10.1016/0167-4889(84)90107-1
   Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236
   Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282
   Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   PETRUZZO P, 1991, TRANSPLANT INT, V4, P200, DOI 10.1007/BF00649103
   Prevost P, 1997, ANN NY ACAD SCI, V831, P344
   Prochorov AV, 2008, ADV MED SCI-POLAND, V53, P240, DOI 10.2478/v10039-008-0045-5
   Qi M, 2008, ARTIF CELL BLOOD SUB, V36, P403, DOI 10.1080/10731190802369755
   Qi Z, 2010, BIOMATERIALS, V31, P4026, DOI 10.1016/j.biomaterials.2010.01.088
   Ricci M, 2005, J CONTROL RELEASE, V107, P395, DOI 10.1016/j.jconrel.2005.06.023
   Safley Susan A, 2008, J Diabetes Sci Technol, V2, P760
   SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167
   Schneider S, 2005, DIABETES, V54, P687, DOI 10.2337/diabetes.54.3.687
   Schneider S, 2003, ARTIF ORGANS, V27, P1053, DOI 10.1046/j.1525-1594.2003.07159.x
   Schulz TC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037004
   Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d
   Shapiro AMJ, 2003, IMMUNOL REV, V196, P219, DOI 10.1046/j.1600-065X.2003.00085.x
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   SIEBERS U, 1993, INT J ARTIF ORGANS, V16, P96
   Sigrist S, 2003, J VASC RES, V40, P359, DOI 10.1159/000072700
   SOONSHIONG P, 1992, TRANSPLANTATION, V54, P769, DOI 10.1097/00007890-199211000-00001
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sorenby AK, 2006, TRANSPLANTATION, V82, P393, DOI 10.1097/01.tp.0000228912.62374.44
   Storrs R, 2001, ANN NY ACAD SCI, V944, P252
   Street C. N., 2003, CAN J DIABETES, V27, P262
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Sun A M, 1992, ASAIO J, V38, P125, DOI 10.1097/00002480-199204000-00012
   Sun YL, 1996, J CLIN INVEST, V98, P1417, DOI 10.1172/JCI118929
   Suzuki K, 1998, TRANSPLANTATION, V66, P21, DOI 10.1097/00007890-199807150-00004
   Sweet IR, 2008, J CELL MOL MED, V12, P2644, DOI 10.1111/j.1582-4934.2008.00322.x
   Tarantal AF, 2009, TRANSPLANTATION, V88, P38, DOI 10.1097/TP.0b013e3181a9ee6c
   Tatarkiewicz K, 1997, Ann Transplant, V2, P20
   Tatarkiewicz K, 2001, DIABETOLOGIA, V44, P646, DOI 10.1007/s001250051672
   Thanos CG, 2009, EXPERT OPIN BIOL TH, V9, P29, DOI 10.1517/14712590802630666 
   Trivedi N, 2001, TRANSPLANTATION, V71, P203, DOI 10.1097/00007890-200101270-00006
   Tuch BE, 2009, DIABETES CARE, V32, P1887, DOI 10.2337/dc09-0744
   Tze WJ, 1998, TRANSPLANT P, V30, P477, DOI 10.1016/S0041-1345(97)01363-8
   U.S. Department of Health and Human Services, 2012, ORG DON
   Vaithilingam V, 2010, AM J TRANSPLANT, V10, P1961, DOI 10.1111/j.1600-6143.2010.03209.x
   Vaithilingam Vijayaganapathy, 2011, Rev Diabet Stud, V8, P51, DOI 10.1900/RDS.2011.8.51
   Valdes-Gonzalez R, 2010, CLIN EXP IMMUNOL, V162, P537, DOI 10.1111/j.1365-2249.2010.04273.x
   Valdes-Gonzalez RA, 2005, EUR J ENDOCRINOL, V153, P419, DOI 10.1530/eje.1.01982
   Wang T, 2008, TRANSPLANTATION, V85, P331, DOI 10.1097/TP.0b013e3181629c25
   Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023
   WU ZG, 1988, INT J PANCREATOL, V3, P91
   Xin ZL, 2005, WORLD J GASTROENTERO, V11, P5714, DOI 10.3748/wjg.v11.i36.5714
   Yang H, 1997, TRANSPLANTATION, V64, P28, DOI 10.1097/00007890-199707150-00006
   Zhi ZI, 2012, DIABETOLOGIA, V55, P1081, DOI 10.1007/s00125-011-2431-y
   Zhou D, 1998, AM J PHYSIOL-CELL PH, V274, pC1356, DOI 10.1152/ajpcell.1998.274.5.C1356
   Zhou MH, 1998, CHINESE MED J-PEKING, V111, P394
   Zimmermann Heiko, 2007, Curr Diab Rep, V7, P314, DOI 10.1007/s11892-007-0051-1
NR 150
TC 6
Z9 6
U1 1
U2 26
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PY 2014
VL 23
IS 11
BP 1321
EP 1348
DI 10.3727/096368913X670949
PG 28
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA AT3IC
UT WOS:000344827900001
PM 23880554
OA Bronze
DA 2018-10-19
ER

PT J
AU Jones, CH
   Hakansson, AP
   Pfeifer, BA
AF Jones, Charles H.
   Hakansson, Anders P.
   Pfeifer, Blaine A.
TI Biomaterials at the interface of nano- and micro-scale vector-cellular
   interactions in genetic vaccine design
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID ATTENUATED SALMONELLA-TYPHIMURIUM; MINICIRCLE DNA VECTORS; TARGETING
   ENZYME/PRODRUG THERAPY; INTERFERON-REGULATORY FACTORS; ADAPTIVE
   IMMUNE-RESPONSES; EXPRESSION IN-VIVO; MAMMALIAN-CELLS; TRANSGENE
   EXPRESSION; ESCHERICHIA-COLI; PLASMID DNA
AB The development of safe and effective vaccines for the prevention of elusive infectious diseases remains a public health priority. Immunization, characterized by adaptive immune responses to specific antigens, can be raised by an array of delivery vectors. However, current commercial vaccination strategies are predicated on the retooling of archaic technology. This review will discuss current and emerging strategies designed to elicit immune responses in the context of genetic vaccination. Selected strategies at the biomaterial-biological interface will be emphasized to illustrate the potential of coupling both fields towards a common goal.
C1 [Jones, Charles H.; Pfeifer, Blaine A.] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
   [Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA.
   [Hakansson, Anders P.] SUNY Buffalo, Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY 14260 USA.
RP Pfeifer, BA (reprint author), SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA.
EM blainepf@buffalo.edu
RI Hakansson, Anders/H-8190-2014
OI Hakansson, Anders/0000-0002-2834-6009
FU NIH [AI088485, DC013554]; SUNY-Buffalo Schomburg fellowship
FX The authors recognize support from NIH awards AI088485 (BAP) and
   DC013554 (APH) and a SUNY-Buffalo Schomburg fellowship (CHJ).
CR Abdul-Wahid A, 2007, VACCINE, V25, P8372, DOI 10.1016/j.vaccine.2007.10.012
   Akin D, 2007, NAT NANOTECHNOL, V2, P441, DOI 10.1038/nnano.2007.149
   Al-Mariri A, 2002, INFECT IMMUN, V70, P1915, DOI 10.1128/IAI.70.4.1915-1923.2002
   Alam S, 2010, EXPERT REV VACCINES, V9, P731, DOI [10.1586/erv.10.64, 10.1586/ERV.10.64]
   Anderson ED, 1996, MOL MAR BIOL BIOTECH, V5, P105
   Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089
   Baban Chwanrow K, 2010, Bioeng Bugs, V1, P385, DOI 10.4161/bbug.1.6.13146
   Barouch DH, 2005, J VIROL, V79, P8828, DOI 10.1128/JVI.79.14.8828-8834.2005
   Barouch DH, 2004, IMMUNOL REV, V202, P266, DOI 10.1111/j.0105-2896.2004.00200.x
   Bartolome A, 2010, VET MICROBIOL, V141, P81, DOI 10.1016/j.vetmic.2009.08.006
   Bergman PJ, 2003, CLIN CANCER RES, V9, P1284
   Blume S, 2000, SCIENCE, V288, P1593, DOI 10.1126/science.288.5471.1593
   Boyle JS, 1998, NATURE, V392, P408
   Bramson JL, 2003, VACCINE, V21, P1363, DOI 10.1016/S0264-410X(02)00694-1
   BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836
   Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027
   Castagliuolo I, 2005, GENE THER, V12, P1070, DOI 10.1038/sj.gt.3302493
   Castaldello A, 2010, J CELL PHYSIOL, V224, P702, DOI 10.1002/jcp.22169
   Chams V, 1999, FEBS LETT, V448, P28, DOI 10.1016/S0014-5793(99)00333-6
   Chart H, 2000, J APPL MICROBIOL, V89, P1048, DOI 10.1046/j.1365-2672.2000.01211.x
   Chatel JM, 2008, GENE THER, V15, P1184, DOI 10.1038/gt.2008.59
   Chatellard P, 2007, BIOTECHNOL BIOENG, V96, P106, DOI 10.1002/bit.21172
   Chen CK, 2013, BIOMATERIALS, V34, P9688, DOI 10.1016/j.biomaterials.2013.08.063
   Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126
   Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0
   Cheng CC, 2014, MOL MED REP, V9, P2239, DOI 10.3892/mmr.2014.2065
   Cho HJ, 2011, BIOMATERIALS, V32, P4621, DOI 10.1016/j.biomaterials.2011.03.004
   Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/nnano.2009.314, 10.1038/NNANO.2009.314]
   Coban C, 2005, J LEUKOCYTE BIOL, V78, P647, DOI 10.1189/jlb.1104627
   COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698
   Corr M, 1997, J IMMUNOL, V159, P4999
   Courvalin P, 1995, CR ACAD SCI III-VIE, V318, P1207
   Darji A, 1997, CELL, V91, P765, DOI 10.1016/S0092-8674(00)80465-1
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   De Geest BG, 2012, ACS NANO, V6, P2136, DOI 10.1021/nn205099c
   Delogu G, 2000, INFECT IMMUN, V68, P3097, DOI 10.1128/IAI.68.6.3097-3102.2000
   Dietrich G, 1998, NAT BIOTECHNOL, V16, P181, DOI 10.1038/nbt0298-181
   Ehreth J, 2003, VACCINE, V21, P596, DOI 10.1016/S0264-410X(02)00623-0
   El-Sayed A, 2013, MOL THER, V21, P1118, DOI 10.1038/mt.2013.54
   Elvang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005139
   Estcourt MJ, 2002, INT IMMUNOL, V14, P31, DOI 10.1093/intimm/14.1.31
   Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Ferreira SA, 2013, NANOMED-NANOTECHNOL, V9, P159, DOI 10.1016/j.nano.2012.06.001
   Flingai S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00354
   Flo J, 2000, IMMUNOLOGY, V100, P259, DOI 10.1046/j.1365-2567.2000.00041.x
   GARMORY HS, 2003, GENET VACCINES THER, V1, P2, DOI DOI 10.1186/1479-0556-1-2
   Geissler M, 1997, J IMMUNOL, V158, P1231
   Gorringe Andrew R, 2012, Hum Vaccin Immunother, V8, P174, DOI 10.4161/hv.18500
   Grillot-Courvalin C, 2002, CELL MICROBIOL, V4, P177, DOI 10.1046/j.1462-5822.2002.00184.x
   Grillot-Courvalin C, 1998, NAT BIOTECHNOL, V16, P862, DOI 10.1038/nbt0998-862
   Grodeland G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080008
   Gujrati V, 2014, ACS NANO, V8, P1525, DOI 10.1021/nn405724x
   Gurunathan S, 2000, ANNU REV IMMUNOL, V18, P927, DOI 10.1146/annurev.immunol.18.1.927
   Gurunathan S, 1998, J IMMUNOL, V161, P4563
   Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006
   Hamaji Y, 2007, BIOSCI BIOTECH BIOCH, V71, P874, DOI 10.1271/bbb.60502
   Hidaka A, 2007, BIOSCI BIOTECH BIOCH, V71, P2921, DOI 10.1271/bbb.70284
   Higgins DE, 1999, MOL MICROBIOL, V31, P1631, DOI 10.1046/j.1365-2958.1999.01272.x
   Hinton HJ, 2008, CURR TOP MICROBIOL, V319, P1
   Hoare M, 2005, BIOTECHNOL PROGR, V21, P1577, DOI 10.1021/bp050190n
   Holmstrom F, 2013, J IMMUNOL, V190, P1113, DOI 10.4049/jimmunol.1201497
   Huang LF, 2013, NAT BIOTECHNOL, V31, P350, DOI 10.1038/nbt.2537
   HUANG MTF, 1990, NUCLEIC ACIDS RES, V18, P937, DOI 10.1093/nar/18.4.937
   Huckriede A, 2003, METHOD ENZYMOL, V373, P74
   Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537
   Jewell CM, 2011, P NATL ACAD SCI USA, V108, P15745, DOI 10.1073/pnas.1105200108
   Jones CH, 2014, P NATL ACAD SCI USA, V111, P12360, DOI 10.1073/pnas.1411355111
   Jones CH, 2013, MOL PHARMACEUT, V10, P4301, DOI 10.1021/mp4003927
   Jones CH, 2013, MOL PHARMACEUT, V10, P4082, DOI 10.1021/mp400467x
   Jones CH, 2013, MOL PHARMACEUT, V10, P1138, DOI 10.1021/mp300666s
   Jones KS, 2008, BIOTECHNOL PROGR, V24, P807, DOI [10.1002/btpr.10, 10.1021/bp.10]
   Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708
   Keswani RK, 2013, MOL PHARMACEUT, V10, P1725, DOI 10.1021/mp300561y
   KETLEY JM, 1993, FEMS MICROBIOL LETT, V111, P15
   Kim JJ, 1997, NAT BIOTECHNOL, V15, P641
   Kim SJ, 2003, VIROLOGY, V314, P84, DOI 10.1016/S0042-6822(03)00417-3
   Ko HJ, 2005, INFECT IMMUN, V73, P5666, DOI 10.1128/IAI.73.9.5666-5674.2005
   Kojima Y, 2002, VACCINE, V20, P2857, DOI 10.1016/S0264-410X(02)00238-4
   Kong W, 2012, P NATL ACAD SCI USA, V109, P19414, DOI 10.1073/pnas.1217554109
   Kumar P, 2011, CURR GENE THER, V11, P144, DOI 10.2174/156652311794940782
   Kumar P, 2013, CURR OPIN IMMUNOL, V25, P373, DOI 10.1016/j.coi.2013.03.011
   Kutzler MA, 2005, J IMMUNOL, V175, P112, DOI 10.4049/jimmunol.175.1.112
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Laner A, 2005, GENE THER, V12, P1559, DOI 10.1038/sj.gt.3302576
   LANIER LL, 1995, J IMMUNOL, V154, P97
   Lee ES, 2008, ANGEW CHEM INT EDIT, V47, P2418, DOI 10.1002/anie.200704121
   Leifert JA, 2004, IMMUNOL REV, V199, P40, DOI 10.1111/j.0105-2896.2004.0135.x
   Li HS, 2007, CHINESE MED J-PEKING, V120, P496
   Li WJ, 2008, VACCINE, V26, P3282, DOI 10.1016/j.vaccine.2008.03.081
   Li ZM, 1999, INFECT IMMUN, V67, P4780
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998
   Liu TY, 2013, BIOMACROMOLECULES, V14, P2798, DOI 10.1021/bm400626w
   Loukinov D, 2006, J CELL BIOCHEM, V98, P1037, DOI 10.1002/jcb.20953
   Lu JM, 2013, MOL THER, V21, P954, DOI 10.1038/mt.2013.33
   Lu JM, 2012, MOL THER, V20, P2111, DOI 10.1038/mt.2012.65
   Lu S, 2009, CURR OPIN IMMUNOL, V21, P346, DOI 10.1016/j.coi.2009.05.016
   Luke JM, 2011, GENE THER, V18, P334, DOI 10.1038/gt.2010.149
   Luke J, 2009, VACCINE, V27, P6454, DOI 10.1016/j.vaccine.2009.06.017
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   Lynn DM, 2000, J AM CHEM SOC, V122, P10761, DOI 10.1021/ja0015388
   MacGregor RR, 2000, J INFECT DIS, V181, P406, DOI 10.1086/315199
   Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Maue AC, 2004, VACCINE, V23, P769, DOI 10.1016/j.vaccine.2004.07.019
   Mendoza RB, 1997, J IMMUNOL, V159, P5777
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/NMAT2344, 10.1038/nmat2344]
   Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107
   Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109
   Mora-Solano C, 2014, J MATER CHEM B, V2, P2409, DOI 10.1039/c3tb21549k
   Moser C, 2013, EXPERT REV VACCINES, V12, P779, DOI 10.1586/14760584.2013.811195
   Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091
   Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678
   Murugaiah C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081817
   Muthumani K, 2002, VACCINE, V20, P1999, DOI 10.1016/S0264-410X(02)00086-5
   Narayanan K, 2013, ANAL BIOCHEM, V439, P142, DOI 10.1016/j.ab.2013.04.010
   Nguyen DN, 2009, ADV MATER, V21, P847, DOI 10.1002/adma.200801478
   Ning JF, 2009, VACCINE, V27, P1127, DOI 10.1016/j.vaccine.2008.11.075
   Noad R, 2003, TRENDS MICROBIOL, V11, P438, DOI 10.1016/S0966-842X(03)00208-7
   Nobiron I, 2000, VET MICROBIOL, V76, P129, DOI 10.1016/S0378-1135(00)00238-8
   O'Hagan D, 2001, J VIROL, V75, P9037, DOI 10.1128/JVI.75.19.9037-9043.2001
   O'Hagan DT, 2012, VACCINE, V30, P4341, DOI 10.1016/j.vaccine.2011.09.061
   Osborn MJ, 2011, MOL THER, V19, P450, DOI 10.1038/mt.2010.249
   Palffy R, 2011, EXP BIOL MED, V236, P177, DOI 10.1258/ebm.2010.010277
   Parsa S, 2008, J BIOTECHNOL, V137, P59, DOI 10.1016/j.jbiotec.2008.07.1815
   Pasetti MF, 2003, J VIROL, V77, P5209, DOI 10.1128/JVI.77.9.5209-5217.2003
   Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g
   Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039
   Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611
   Qin LH, 1997, HUM GENE THER, V8, P2019, DOI 10.1089/hum.1997.8.17-2019
   Qiu L, 2013, J VIROL METHODS, V188, P108, DOI 10.1016/j.jviromet.2012.12.007
   Radford KJ, 2002, GENE THER, V9, P1455, DOI 10.1038/sj.gt.3301812
   Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137
   Ramsey JD, 2010, J CONTROL RELEASE, V144, P39, DOI 10.1016/j.jconrel.2010.01.031
   Ratto-Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045840
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rivas-Aravena A, 2013, BIOL RES, V46, P407, DOI 10.4067/S0716-97602013000400012
   Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010
   Rosenthal JA, 2013, CURR OPIN BIOTECHN C, V28, P51
   Saade F, 2012, EXPERT REV VACCINES, V11, P189, DOI [10.1586/erv.11.188, 10.1586/ERV.11.188]
   Sadler K, 2002, J PEPT RES, V60, P150, DOI 10.1034/j.1399-3011.2002.21009.x
   Sasaki S, 2002, J VIROL, V76, P6652, DOI 10.1128/JVI.76.13.6652-6659.2002
   Sasaki T, 2006, CANCER SCI, V97, P649, DOI 10.1111/j.1349-7006.2006.00221.x
   SCHAFFNER W, 1980, P NATL ACAD SCI-BIOL, V77, P2163, DOI 10.1073/pnas.77.4.2163
   Schmidt C, 2013, NAT BIOTECHNOL, V31, P957, DOI 10.1038/nbt.2733
   Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402
   Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443
   Shata MT, 2000, MOL MED TODAY, V6, P66, DOI 10.1016/S1357-4310(99)01633-0
   Shedlock DJ, 2014, VACCINES, V2, P196, DOI 10.3390/vaccines2020196
   Shen H, 2004, MICROBIOL IMMUNOL, V48, P329, DOI 10.1111/j.1348-0421.2004.tb03514.x
   Singarapu K, 2013, J BIOMED MATER RES A, V101, P1857, DOI 10.1002/jbm.a.34483
   SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299
   Song MY, 2011, J IMMUNOTHER, V34, P297, DOI 10.1097/CJI.0b013e318210ed0e
   Song RJ, 2007, MOL THER, V15, P1007, DOI 10.1038/mt.sj.6300129
   Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908
   Stritzker J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-94
   Su Yan, 2013, Sheng Wu Gong Cheng Xue Bao, V29, P458
   Takeshita F, 2006, J VIROL, V80, P6218, DOI 10.1128/JVI.00121-06
   Tobias J, 2008, VACCINE, V26, P743, DOI 10.1016/j.vaccine.2007.12.009
   Tsuji T, 1997, EUR J IMMUNOL, V27, P782, DOI 10.1002/eji.1830270329
   Ulmer JB, 2006, NAT BIOTECHNOL, V24, P1377, DOI 10.1038/nbt1261
   Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007
   Unal CM, 2011, SEMIN IMMUNOPATHOL, V33, P395, DOI 10.1007/s00281-010-0231-y
   van Pijkeren JP, 2010, HUM GENE THER, V21, P405, DOI 10.1089/hum.2009.022
   Vecino WH, 2002, IMMUNOL LETT, V82, P197, DOI 10.1016/S0165-2478(02)00043-3
   Vyas SP, 2010, METHODS MOL BIOL, V605, P177, DOI 10.1007/978-1-60327-360-2_12
   Wan C, 2010, VET IMMUNOL IMMUNOP, V137, P47, DOI 10.1016/j.vetimm.2010.04.008
   Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476
   Wang Y, 2012, NAT STRUCT MOL BIOL, V19, P1044, DOI 10.1038/nsmb.2377
   Williams JA, 2009, BIOTECHNOL ADV, V27, P353, DOI 10.1016/j.biotechadv.2009.02.003
   Williman J, 2008, VACCINE, V26, P5153, DOI 10.1016/j.vaccine.2008.03.084
   Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009
   WU TC, 1995, P NATL ACAD SCI USA, V92, P11671, DOI 10.1073/pnas.92.25.11671
   Xiang SL, 2006, NAT BIOTECHNOL, V24, P697, DOI 10.1038/nbt.1211
   Xu FF, 2003, VACCINE, V21, P644, DOI 10.1016/S0264-410X(02)00573-X
   Xu HQ, 2010, J GENE MED, V12, P97, DOI 10.1002/jgm.1412
   Xu L, 2002, HUM GENE THER, V13, P469, DOI 10.1089/10430340252792594
   Yang SC, 2008, BIOCONJUGATE CHEM, V19, P1164, DOI 10.1021/bc700442g
   Yao WJ, 2013, MOL PHARMACEUT, V10, P2904, DOI 10.1021/mp4000053
   Yoo JW, 2011, NAT REV DRUG DISCOV, V10, P521, DOI 10.1038/nrd3499
NR 182
TC 5
Z9 5
U1 0
U2 8
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 46
BP 8053
EP 8068
DI 10.1039/c4tb01058b
PG 16
WC Materials Science, Biomaterials
SC Materials Science
GA AT5NQ
UT WOS:000344990000003
PM 29887986
DA 2018-10-19
ER

PT J
AU Sayin, E
   Baran, ET
   Hasirci, V
AF Sayin, Esen
   Baran, Erkan Turker
   Hasirci, Vasif
TI Protein-based materials in load-bearing tissue-engineering applications
SO REGENERATIVE MEDICINE
LA English
DT Review
DE biomaterial; load bearing; protein; regeneration; scaffold; tissue
   engineering
ID SILK FIBROIN SCAFFOLDS; MECHANICAL-PROPERTIES; COLLAGEN SCAFFOLDS;
   STEM-CELLS; BIOMEDICAL APPLICATIONS; REGENERATIVE MEDICINE; FREEFORM
   FABRICATION; COMPOSITE SCAFFOLDS; CHONDROITIN SULFATE;
   ARTICULAR-CARTILAGE
AB Proteins such as collagen and elastin are robust molecules that constitute nanocomponents in the hierarchically organized ultrastructures of bone and tendon as well as in some of the soft tissues that have load-bearing functions. In the present paper, the macromolecular structure and function of the proteins are reviewed and the potential of mammalian and non-mammalian proteins in the engineering of load-bearing tissue substitutes are discussed. Chimeric proteins have become an important structural biomaterial source and their potential in tissue engineering is highlighted. Processing of proteins challenge investigators and in this review rapid prototyping and microfabrication are proposed as methods for obtaining precisely defined custom-built tissue engineered structures with intrinsic microarchitecture.
C1 [Sayin, Esen; Hasirci, Vasif] METU, Dept Biotechnol, Ankara, Turkey.
   [Sayin, Esen; Baran, Erkan Turker; Hasirci, Vasif] METU Ctr Excellence Biomat & Tissue Engn, BIOMATEN, TR-06800 Ankara, Turkey.
   [Hasirci, Vasif] METU, Dept Biol Sci, Ankara, Turkey.
RP Baran, ET (reprint author), METU Ctr Excellence Biomat & Tissue Engn, BIOMATEN, TR-06800 Ankara, Turkey.
EM erkantur@metu.edu.tr
RI Baran, Erkan/B-1055-2016; Baran, Erkan/Q-8482-2017
OI Baran, Erkan/0000-0002-0563-6943; Baran, Erkan/0000-0002-0563-6943
FU METU [BAP-07.02.2013.101]; Scientific and Technological Research Council
   of Turkey (TUBITAK) [2232]
FX The authors acknowledge the support by METU through project
   BAP-07.02.2013.101. ET Baran gratefully acknowledges the Scientific and
   Technological Research Council of Turkey (TUBITAK) for the Post Doctoral
   2232 BIDEP-TUBITAK Fellowship. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript.
CR Achilli M, 2012, MACROMOL MATER ENG, V297, P724, DOI 10.1002/mame.201100363
   Albertson AE, 2014, J MECH BEHAV BIOMED, V29, P225, DOI 10.1016/j.jmbbm.2013.09.002
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2012, J PEDIATR SURG, V47, P17, DOI 10.1016/j.jpedsurg.2011.10.013
   Baker S, 2012, MAT SCI ENG C-MATER, V32, P215, DOI 10.1016/j.msec.2011.10.021
   Balaji S, 2012, POLYM ADVAN TECHNOL, V23, P500, DOI 10.1002/pat.1905
   Balint E, 2012, J BIOMED MATER RES A, V100A, P195, DOI 10.1002/jbm.a.33260
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhattacharjee M, 2012, ACTA BIOMATER, V8, P3313, DOI 10.1016/j.actbio.2012.05.023
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877
   Bracalello A, 2011, BIOMACROMOLECULES, V12, P2957, DOI 10.1021/bm2005388
   Burck J, 2013, LANGMUIR, V29, P1562
   Caves JM, 2011, BIOMATERIALS, V32, P5371, DOI 10.1016/j.biomaterials.2011.04.009
   Chao PHG, 2010, J BIOMED MATER RES B, V95B, P84, DOI 10.1002/jbm.b.31686
   Chen CH, 2014, MATERIALS, V7, P2104, DOI 10.3390/ma7032104
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen X, 2008, BIOMATERIALS, V29, P3683, DOI 10.1016/j.biomaterials.2008.05.017
   Choi BH, 2010, BIOMATERIALS, V31, P8980, DOI 10.1016/j.biomaterials.2010.08.027
   de Moraes MA, 2012, MACROMOL BIOSCI, V12, P1253, DOI 10.1002/mabi.201200060
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dravida S, 2008, J TISSUE ENG REGEN M, V2, P263, DOI 10.1002/term.91
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   Enea D, 2011, J MATER SCI-MATER M, V22, P1569, DOI 10.1007/s10856-011-4336-1
   Engelhardt EM, 2011, BIOMATERIALS, V32, P3969, DOI 10.1016/j.biomaterials.2011.02.012
   Gauvin R, 2012, BIOMATERIALS, V33, P3824, DOI 10.1016/j.biomaterials.2012.01.048
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gomes S, 2011, SOFT MATTER, V7, P4964, DOI 10.1039/c1sm05024a
   Haider M, 2008, PHARM RES, V25, P692, DOI 10.1007/s11095-007-9282-8
   Han JJ, 2011, BIOMACROMOLECULES, V12, P399, DOI 10.1021/bm101149r
   Hendriks FM, 2006, MED ENG PHYS, V28, P259, DOI 10.1016/j.medengphy.2005.07.001
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   Huey DJ, 2012, SCIENCE, V338, P917, DOI 10.1126/science.1222454
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hwang W, 2009, LANGMUIR, V25, P12682, DOI 10.1021/la9015993
   Isikli C, 2012, J TISSUE ENG REGEN M, V6, P135, DOI 10.1002/term.406
   Kew SJ, 2012, ACTA BIOMATER, V8, P3723, DOI 10.1016/j.actbio.2012.06.018
   Kew SJ, 2011, ACTA BIOMATER, V7, P3237, DOI 10.1016/j.actbio.2011.06.002
   Kilic C, 2014, BIOMATER SCI-UK, V2, P318, DOI 10.1039/c3bm60194c
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108
   Kurland NE, 2014, ADV MATER, V26, P4431, DOI 10.1002/adma.201400777
   Lai ES, 2011, ACTA BIOMATER, V7, P2448, DOI 10.1016/j.actbio.2011.03.012
   Lee W, 2009, BIOMATERIALS, V30, P1587, DOI 10.1016/j.biomaterials.2008.12.009
   Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li LQ, 2011, BIOMACROMOLECULES, V12, P2302, DOI 10.1021/bm200373p
   Mandal BB, 2011, BIOMATERIALS, V32, P639, DOI 10.1016/j.biomaterials.2010.08.115
   Mandal BB, 2010, ACTA BIOMATER, V6, P360, DOI 10.1016/j.actbio.2009.08.035
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   McKenna KA, 2012, ACTA BIOMATER, V8, P225, DOI 10.1016/j.actbio.2011.08.001
   McManus M, 2007, BIOMED MATER, V2, P257, DOI 10.1088/1748-6041/2/4/008
   Melchels FPW, 2012, PROG POLYM SCI, V37, P1079, DOI 10.1016/j.progpolymsci.2011.11.007
   Merrett K, 2009, BIOMATERIALS, V30, P5403, DOI 10.1016/j.biomaterials.2009.06.016
   Meyer M, 2010, MAT SCI ENG C-MATER, V30, P1266, DOI 10.1016/j.msec.2010.07.005
   Mieszawska AJ, 2010, CHEM MATER, V22, P5780, DOI 10.1021/cm101940u
   Miwa H, 1993, ASAIO J, V39, P273
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Nayak S, 2012, CELL TISSUE RES, V347, P783, DOI 10.1007/s00441-011-1269-4
   Ner Y, 2009, POLYMER, V50, P5828, DOI 10.1016/j.polymer.2009.09.017
   Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559
   Pallela R, 2011, J BIOMED MATER RES A, V100, P486
   Pataquiva-Mateus AY, 2012, J BIOMED MATER RES B, V100B, P862, DOI 10.1002/jbm.b.32650
   Rahman MM, 2012, POLYM INT, V62, P79
   Reno F, 2012, J MATER SCI-MATER M, V23, P565, DOI 10.1007/s10856-011-4519-9
   Rnjak-Kovacina J, 2012, ACTA BIOMATER, V8, P3714, DOI 10.1016/j.actbio.2012.06.032
   Rnjak-Kovacina J, 2011, BIOMATERIALS, V32, P6729, DOI 10.1016/j.biomaterials.2011.05.065
   Rothamel D, 2005, CLIN ORAL IMPLAN RES, V16, P369, DOI 10.1111/j.1600-0501.2005.01108.x
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Saha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080004
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063
   Shah A, 2008, PEDIATR RES, V63, P535, DOI 10.1203/PDR.0b013e31816bdf54
   Shin H, 2012, BIOMATERIALS, V33, P3143, DOI 10.1016/j.biomaterials.2011.12.050
   Silva SS, 2012, GREEN CHEM, V14, P1463, DOI 10.1039/c2gc16535j
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, P1451
   Talukdar S, 2011, BIOMATERIALS, V32, P8927, DOI 10.1016/j.biomaterials.2011.08.027
   Tanaka Y, 2011, BIOMATERIALS, V32, P3358, DOI 10.1016/j.biomaterials.2010.11.011
   Taylor PM, 2006, BIOMATERIALS, V27, P2733, DOI 10.1016/j.biomaterials.2005.12.003
   Tejeda-Montes E, 2012, ACTA BIOMATER, V8, P998, DOI 10.1016/j.actbio.2011.09.005
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Um IC, 2004, INT J BIOL MACROMOL, V34, P107, DOI 10.1016/j.ijbiomac.2004.03.011
   Uquillas JA, 2012, J MECH BEHAV BIOMED, V15, P176, DOI 10.1016/j.jmbbm.2012.06.012
   Van Lonkhuyzen DR, 2007, GROWTH FACTORS, V25, P295, DOI 10.1080/08977190701803752
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Wang XG, 2011, J MECH BEHAV BIOMED, V4, P922, DOI 10.1016/j.jmbbm.2011.04.009
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wei W, 2011, MAT SCI ENG C-MATER, V31, P1602, DOI 10.1016/j.msec.2011.07.013
   Werkmeister JA, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/1/012002
   Werten MWT, 2009, BIOMACROMOLECULES, V10, P1106, DOI 10.1021/bm801299u
   Xia ZM, 2013, ACTA BIOMATER, V9, P7308, DOI 10.1016/j.actbio.2013.03.038
   Yan LP, 2012, ACTA BIOMATER, V8, P289, DOI 10.1016/j.actbio.2011.09.037
   Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134
   Yu QZ, 2014, J BIOMED MATER RES A, V102, P3828, DOI 10.1002/jbm.a.35051
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zhang L, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045012
   Zou XH, 2010, BIOMATERIALS, V31, P4872, DOI 10.1016/j.biomaterials.2010.02.056
NR 103
TC 9
Z9 9
U1 4
U2 42
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PY 2014
VL 9
IS 5
BP 687
EP 701
DI 10.2217/RME.14.52
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA AS8YE
UT WOS:000344530100011
PM 25372082
DA 2018-10-19
ER

PT J
AU Jayakumar, GC
   Usharani, N
   Kawakami, K
   Rao, JR
   Nair, BU
AF Jayakumar, Gladstone Christopher
   Usharani, Nagarajan
   Kawakami, Kohsaku
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Preparation of antibacterial collagen-pectin particles for
   biotherapeutics
SO RSC ADVANCES
LA English
DT Article
ID POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES
AB Biomaterial microparticles have versatile applications in biomedical formulations in site specific targeting treatment due to their size. There are many types of particulate formulations available in the pharmaceutical industry. But still it is difficult to produce protein solid particles due to their high sensitivity to heat. In this study, collagen-pectin microparticles (solid aerosol) are prepared using an electrospray method under ambient temperature and pressure conditions in a single step process. Pectin is used as a stabilizing and natural antiglycation agent for diabetic wound treatment. Collagen molecules can form various structures and aggregation states in solutions. During microparticle preparation, the electrospray method might affect the particle morphology. The significance of particle morphology was investigated using various analytical techniques. The effect of acetic acid concentration was monitored by viscosity, conductivity, differential scanning calorimetry (DSC), X-ray diffraction (XRD) and Fourier transform infrared spectroscopic (FTIR) measurements. The surface modifications of the microparticles were studied using scanning electron microscopy (SEM) and atomic force microscopy (AFM). The optimized results indicate that the collagen-pectin microparticles are obtained by electrospraying collagen dissolved in 50-80% acetic acid with 0.25% NaCl. Collagen-pectin microparticles are obtained which measure less than 150 mu m in size when sprayed using a 0.65 mm sized nozzle. The prepared microparticles were also tested for antimicrobial activity to ensure high efficiency use during wound infection. Thus, the collagen-pectin microparticles prepared can potentially be used as biomedical particles for clinical applications including wound healing and lung regeneration for diabetic patients.
C1 [Jayakumar, Gladstone Christopher; Rao, Jonnalagadda Raghava; Nair, Balachandran Unni] CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
   [Usharani, Nagarajan] CSIR, Cent Leather Res Inst, CHORD, Madras 600020, Tamil Nadu, India.
   [Jayakumar, Gladstone Christopher; Kawakami, Kohsaku] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.
RP Jayakumar, GC (reprint author), CSIR, Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM clrichem@lycos.com
CR Bowler P G, 1999, J Wound Care, V8, P499
   Chen Y. S., 1980, Proceedings of the 1980 Custom Integrated Circuits Conference, P63
   Clopeau 8 M., 1994, J AEROSOL SCI, V25, P1021
   Cristina B., 2007, BIOINTERPHASES, V4, pMR17
   Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004
   FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315
   Ganan-Calvo AM, 1997, J AEROSOL SCI, V28, P249, DOI 10.1016/S0021-8502(96)00433-8
   Gupta A. K., 2012, J NAT PRODUCTS, V2, P250
   Halbert A R, 1992, Australas J Dermatol, V33, P75, DOI 10.1111/j.1440-0960.1992.tb00083.x
   Jayakumar G. C., 2013, BIOACTIVE CARBOHYDRA, V2, P119
   Jayakumar G. C., 2012, CARBOHYD POLYM, V345, P2213
   Jayakumar GC, 2010, CARBOHYD RES, V345, P2213, DOI 10.1016/j.carres.2010.07.041
   Jayasinghe SN, 2004, NANOTECHNOLOGY, V15, P1519, DOI 10.1088/0957-4484/15/11/025
   JEFFERY H, 1993, PHARMACEUT RES, V10, P362, DOI 10.1023/A:1018980020506
   Jinkeun K., 2005, B KOREAN CHEM SOC, V26, P1083
   Kawakami K, 2010, AAPS PHARMSCITECH, V11, P1202, DOI 10.1208/s12249-010-9498-5
   Pornsak S., 2003, SILPAKORN U SCI TECH, V3, P206
   Raghavan K. V., 2014, RSC ADV, V4, P23642
   Rodrigo M.M., 2012, DRY TECHNOL, V30, P935
   Sai KP, 2001, COMP BIOCHEM PHYS B, V128, P81
   Usharani N., 2014, CHEM PHARM BULL, V62, P422
   Usharani N., 2013, INT J BIOL MACROMOL, V61, P404
   Usharani N., 2014, J MICROSC-OXFORD, V253, P2
   Usharani N, 2014, BIOPOLYMERS, V101, P903, DOI 10.1002/bip.22473
   YAN CH, 1994, J CONTROL RELEASE, V32, P231, DOI 10.1016/0168-3659(94)90233-X
   Zhang SL, 2011, MOL PHARMACEUT, V8, P807, DOI 10.1021/mp100401d
NR 26
TC 8
Z9 8
U1 0
U2 22
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 81
BP 42846
EP 42854
DI 10.1039/c4ra07683d
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS8WI
UT WOS:000344525500011
DA 2018-10-19
ER

PT J
AU Schaap-Oziemlak, AM
   Kuhn, PT
   van Kooten, TG
   van Rijn, P
AF Schaap-Oziemlak, Aneta M.
   Kuhn, Philipp T.
   van Kooten, Theo G.
   van Rijn, Patrick
TI Biomaterial-stem cell interactions and their impact on stem cell
   response
SO RSC ADVANCES
LA English
DT Review
ID SELF-ASSEMBLED MONOLAYERS; HUMAN HEMATOPOIETIC STEM; MESENCHYMAL STEM;
   BONE-MARROW; ADIPOSE-TISSUE; FUNCTIONAL-GROUPS; PROGENITOR CELLS;
   SUBSTRATE STIFFNESS; IN-VITRO; OSTEOGENIC DIFFERENTIATION
AB In this review, current research in the field of biomaterial properties for directing stem cells are discussed and placed in a critical perspective. Regenerative medicine, in which stem cells play a crucial role, has become an interdisciplinary field between cell biology and materials science. New insights are generated, different approaches to determine material features and stem cell properties are implemented, but also many misconceptions exist. According to the current state-of-the-art and combined with basic principles from two different disciplines the topic is critically addressed. We take into account what seem to be the most important material properties and their influence towards stem cells but also the various stem cells available with respect to their origin, tissue source and culturing conditions.
C1 [Schaap-Oziemlak, Aneta M.; Kuhn, Philipp T.; van Kooten, Theo G.; van Rijn, Patrick] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst Biomed Engn & Mat Sci, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
RP van Kooten, TG (reprint author), Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst Biomed Engn & Mat Sci, Dept Biomed Engn, FB40,A Deusinglaan 1, NL-9713 AV Groningen, Netherlands.
EM p.van.rijn@umcg.nl
RI van Rijn, Patrick/B-3792-2014
OI van Rijn, Patrick/0000-0002-2208-5725
FU Graduate School of Medical Sciences (GSMS) of the University of
   Groningen (RuG); University Medical Center Groningen (UMCG)
FX PTK and PvR gratefully acknowledge the Graduate School of Medical
   Sciences (GSMS) of the University of Groningen (RuG) and University
   Medical Center Groningen (UMCG) for financial support.
CR Abe H., 1996, DATA BOOK MECH PROPE
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Ayala R, 2011, BIOMATERIALS, V32, P3700, DOI 10.1016/j.biomaterials.2011.02.004
   Banerjee A, 2009, BIOMATERIALS, V30, P4695, DOI 10.1016/j.biomaterials.2009.05.050
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bass H., 2001, HDB ELASTIC PROPERTI
   Benoit DSW, 2008, NAT MATER, V7, P816, DOI 10.1038/nmat2269
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Blasiak J, 2004, CHEM-BIOL INTERACT, V149, P137, DOI 10.1016/j.cbi.2004.08.002
   Brocher J, 2013, STEM CELL RES, V11, P1393, DOI 10.1016/j.scr.2013.07.008
   Brower J., 2012, ADV SKIN WOUND CARE, V24, P524
   Bucaro MA, 2012, ACS NANO, V6, P6222, DOI 10.1021/nn301654e
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930
   Chen WLK, 2011, ADV DRUG DELIVER REV, V63, P269, DOI 10.1016/j.addr.2011.01.004
   Choi JS, 2012, BIOMATERIALS, V33, P4460, DOI 10.1016/j.biomaterials.2012.03.010
   Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200
   Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   CURTIS ASG, 1983, J CELL BIOL, V97, P1500, DOI 10.1083/jcb.97.5.1500
   DeSimone D. W., 2013, EXTRACELLULAR MATRIX
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Dzierzak E, 2002, IMMUNOL REV, V187, P126, DOI 10.1034/j.1600-065X.2002.18711.x
   Elman JS, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-1
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Ferreira MSV, 2012, BIOMATERIALS, V33, P6987, DOI 10.1016/j.biomaterials.2012.06.029
   Ferreira MV, 2012, J MATER SCI-MATER M, V23, P109, DOI 10.1007/s10856-011-4483-4
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Fitchmun MI, 1998, ANAL BIOCHEM, V265, P1, DOI 10.1006/abio.1998.2877
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Genzer J, 2012, ANNU REV MATER RES, V42, P435, DOI 10.1146/annurev-matsci-070511-155050
   Guvendiren M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1792
   Hao L., 2014, J MATER CHEM B, P4794
   Higuchi A, 2013, CHEM REV, V113, P3297, DOI 10.1021/cr300426x
   Holzapfel BM, 2013, ADV DRUG DELIVER REV, V65, P581, DOI 10.1016/j.addr.2012.07.009
   Inoue H, 2014, EMBO J, V33, P409, DOI 10.1002/embj.201387098
   Irwin EE, 2011, BIOMATERIALS, V32, P6912, DOI 10.1016/j.biomaterials.2011.05.058
   Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jang M, 2013, BIOMATERIALS, V34, P3571, DOI 10.1016/j.biomaterials.2013.01.073
   Jansen BJH, 2010, STEM CELLS DEV, V19, P481, DOI 10.1089/scd.2009.0288
   Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880
   Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094888
   Kassem M, 2004, BASIC CLIN PHARMACOL, V95, P209, DOI 10.1111/j.1742-7843.2004.pto950502.x
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020
   Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60
   Kroupova J, 2006, J BIOMED MATER RES B, V76B, P315, DOI 10.1002/jbm.b.30366
   Lee JH, 1998, J BIOMED MATER RES, V41, P304, DOI 10.1002/(SICI)1097-4636(199808)41:2<304::AID-JBM16>3.0.CO;2-K
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lentz RD, 2008, J ENVIRON QUAL, V37, P2293, DOI 10.2134/jeq2007.0574
   Li XM, 2014, J BIOMED MATER RES A, V102, P1092, DOI 10.1002/jbm.a.34774
   Lopez-Garcia MD, 2010, ANN BIOMED ENG, V38, P2485, DOI 10.1007/s10439-010-0015-5
   MacQueen L, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0179
   Mannello F, 2007, STEM CELLS, V25, P1603, DOI 10.1634/stemcells.2007-0127
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615
   Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262
   Mendicino M, 2014, CELL STEM CELL, V14, P141, DOI 10.1016/j.stem.2014.01.013
   Mierczynska A, 2012, SOFT MATTER, V8, P8399, DOI 10.1039/c2sm25221j
   Musah S, 2012, ACS NANO, V6, P10168, DOI 10.1021/nn3039148
   Niemeyer P, 2010, TISSUE ENG PT A, V16, P33, DOI [10.1089/ten.tea.2009.0190, 10.1089/ten.TEA.2009.0190]
   Niemeyer P, 2010, BIOMATERIALS, V31, P3572, DOI 10.1016/j.biomaterials.2010.01.085
   Ofek G, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127262
   Palchesko RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051499
   Park JS, 2011, BIOMATERIALS, V32, P3921, DOI 10.1016/j.biomaterials.2011.02.019
   Patino JMR, 2007, CURR OPIN COLLOID IN, V12, P187, DOI 10.1016/j.cocis.2007.06.003
   Pendleton C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058198
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007
   Raic A, 2014, BIOMATERIALS, V35, P929, DOI 10.1016/j.biomaterials.2013.10.038
   Ren YJ, 2009, BIOMATERIALS, V30, P1036, DOI 10.1016/j.biomaterials.2008.10.028
   Rippon H., 2004, CELL PROLIFERAT, P23
   Roemeling-van Rhijn M., 2013, J STEM CELL RES THER, P20780
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   SAMBROOK J, 1982, MOL CLONING
   Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278
   Shin YN, 2008, APPL SURF SCI, V255, P293, DOI 10.1016/j.apsusc.2008.06.173
   Steinert AF, 2012, STEM CELL TRANSL MED, V1, P237, DOI 10.5966/sctm.2011-0036
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takahashi K, 2013, DEVELOPMENT, V140, P2457, DOI 10.1242/dev.092551
   TAMADA Y, 1993, J COLLOID INTERF SCI, V155, P334, DOI 10.1006/jcis.1993.1044
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Vacanti C, 2006, J CELL MOL MED, V1, P569
   Vuoristo S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076205
   Wade RJ, 2012, MATER TODAY, V15, P454, DOI 10.1016/S1369-7021(12)70197-9
   Wang PY, 2012, RSC ADV, V2, P12857, DOI 10.1039/c2ra21557h
   Wang PY, 2012, ACTA BIOMATER, V8, P519, DOI 10.1016/j.actbio.2011.09.030
   Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192
   Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Witkowska-Zimny M, 2012, ACTA BIOCHIM POL, V59, P261
   Yang C, 2014, NAT MATER, V13, P645, DOI [10.1038/NMAT3889, 10.1038/nmat3889]
   Yang JJ, 2012, J TISSUE ENG REGEN M, DOI [10.1002/term.1640, DOI 10.1002/TERM.1640]
   Zhai JL, 2013, CURR OPIN COLLOID IN, V18, P257, DOI 10.1016/j.cocis.2013.03.002
   Zhang W, 2013, J DENT RES, V92, P1136, DOI 10.1177/0022034513507581
   Zhang ZL, 2009, BONE MARROW TRANSPL, V43, P69, DOI 10.1038/bmt.2008.260
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 113
TC 19
Z9 19
U1 1
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 95
BP 53307
EP 53320
DI 10.1039/c4ra07915a
PG 14
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6RL
UT WOS:000344390000093
DA 2018-10-19
ER

PT J
AU Yuan, X
   He, B
   Lv, Z
   Luo, SX
AF Yuan, Xiao
   He, Bin
   Lv, Zi
   Luo, Suxin
TI Fabrication of self-assembling peptide nanofiber hydrogels for
   myocardial repair
SO RSC ADVANCES
LA English
DT Review
ID TISSUE-ENGINEERING SCAFFOLDS; IMPROVES CARDIAC-FUNCTION; NATIVE CHEMICAL
   LIGATION; ISCHEMIC-HEART-DISEASE; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR;
   REGENERATIVE MEDICINE; PROGENITOR CELLS; ENDOTHELIAL-CELLS; DESIGNED
   PEPTIDE
AB Myocardial infarction (MI) has become widely spread in clinical medicine, and results in massive loss of myocardium, ventricular remodeling and ultimately heart failure. Many strategies for repairing injured myocardium are under extensive investigation with some early encouraging effects, but cannot effectively prevent disease progression and heart failure. Cardiac tissue engineering has emerged as an increasingly important approach to repair infarcted myocardium. Self-assembling peptide nanofiber hydrogels are regarded as tailored biomaterial scaffolds with the aim to develop cardiac tissue engineering. Their fabrication is based on the principle of molecular self-assembly which allows tailoring of the biological features (e. g. modification with functional motifs and controlled release of signal molecules) of supramolecular structures for cell behaviors and tissue regeneration. This review will outline the potential of combinational treatments of peptide nanofiber hydrogels with cells, growth factors, or both together in myocardial repair.
C1 [Yuan, Xiao; Luo, Suxin] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
   [He, Bin] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped, Chongqing, Peoples R China.
   [Lv, Zi] Sichuan Univ, West China Sch Med, Chengdu 610064, Peoples R China.
RP Luo, SX (reprint author), Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiol, Chongqing, Peoples R China.
EM luosuxin0204@163.com
FU National Natural Science Foundation of China (NSFC) [81270210]; Nature
   Science Foundation of Chongqing (CSTC) [2012JJA0911]
FX S. X. Luo was supported by National Natural Science Foundation of China
   (NSFC, 81270210) and the Nature Science Foundation of Chongqing (CSTC,
   2012JJA0911). We apologize to all the scientists whose work we could not
   cite due to space restrictions.
CR Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206
   Andukuri A, 2010, NANOMED-NANOTECHNOL, V6, P289, DOI 10.1016/j.nano.2009.09.004
   Anversa P, 2000, CIRC RES, V86, P121, DOI 10.1161/01.RES.86.2.121
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Bangalore S, 2013, CIRCULATION, V127, P769, DOI 10.1161/CIRCULATIONAHA.112.131961
   Boopathy AV, 2014, BIOMATERIALS, V35, P8103, DOI 10.1016/j.biomaterials.2014.05.082
   Boopathy AV, 2014, METHODS MOL BIOL, V1141, P159, DOI 10.1007/978-1-4939-0363-4_10
   Botchwey EA, 2003, J BIOMED MATER RES A, V67A, P357, DOI 10.1002/jbm.a.10111
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Choh SY, 2011, BIOMACROMOLECULES, V12, P1126, DOI 10.1021/bm101451k
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0
   Collier JH, 2003, BIOCONJUGATE CHEM, V14, P748, DOI 10.1021/bc034017t
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cui XJ, 2010, TOHOKU J EXP MED, V222, P281, DOI 10.1620/tjem.222.281
   Daskalopoulos E., 2013, EUR HEART J, V34, pP3292
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dhandayuthapani B, 2010, J BIOMED MATER RES B, V94B, P264, DOI 10.1002/jbm.b.31651
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dominguez-Rodriguez A, 2014, WORLD J CARDIOL, V6, P100, DOI 10.4330/wjc.v6.i3.100
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Dvir T, 2011, NANO LETT, V11, P4411, DOI 10.1021/nl2025882
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Fleischer S, 2013, CURR OPIN BIOTECH, V24, P664, DOI 10.1016/j.copbio.2012.10.016
   Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007
   Frederick JR, 2010, CIRCULATION, V122, pS107, DOI [10.1161/C1RCULATIONAHA.109.930404, 10.1161/CIRCULATIONAHA.109.930404]
   Freeman I, 2008, BIOMATERIALS, V29, P3260, DOI 10.1016/j.biomaterials.2008.04.025
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Greenfield MA, 2010, LANGMUIR, V26, P3641, DOI 10.1021/la9030969
   Guo HD, 2012, BIOCHEM BIOPH RES CO, V424, P105, DOI 10.1016/j.bbrc.2012.06.080
   Guo HD, 2010, BIOCHEM BIOPH RES CO, V399, P42, DOI 10.1016/j.bbrc.2010.07.031
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hartgerink JD, 2001, CURR OPIN SOLID ST M, V5, P355, DOI 10.1016/S1359-0286(01)00019-5
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   He B, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.13
   He B, 2014, RSC ADV, V4, P23610, DOI 10.1039/c4ra01826e
   Hockaday LA, 2012, BIOFABRICATION, V4, DOI 10.1088/1758-5082/4/3/035005
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hosseinkhani H, 2013, CHEM REV, V113, P4837, DOI 10.1021/cr300131h
   Hou TY, 2014, BIOMATERIALS, V35, P5689, DOI 10.1016/j.biomaterials.2014.03.079
   Hsieh PCH, 2006, CIRCULATION, V114, P637, DOI 10.1161/CIRCULATIONHA.106.639831
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Hurley JR, 2010, AM J PHYSIOL-CELL PH, V299, pC444, DOI 10.1152/ajpcell.00572.2009
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jeong B, 2002, ADV DRUG DELIVER REV, V54, P37, DOI 10.1016/S0169-409X(01)00242-3
   Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Jung JP, 2008, BIOMATERIALS, V29, P2143, DOI 10.1016/j.biomaterials.2008.01.008
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Karam JP, 2012, BIOMATERIALS, V33, P5683, DOI 10.1016/j.biomaterials.2012.04.028
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kim JH, 2011, BIOMATERIALS, V32, P6080, DOI 10.1016/j.biomaterials.2011.05.003
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106
   Krumholz HM, 2013, JAMA-J AM MED ASSOC, V309, P587, DOI 10.1001/jama.2013.333
   Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lin YD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003841
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Lindenauer PK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f521
   Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Liu YC, 2013, BIOTECHNOL ADV, V31, P688, DOI 10.1016/j.biotechadv.2012.10.003
   Loo Y, 2012, BIOTECHNOL ADV, V30, P593, DOI 10.1016/j.biotechadv.2011.10.004
   Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Luo ZL, 2012, CHEM SOC REV, V41, P4736, DOI 10.1039/c2cs15360b
   Luo ZL, 2011, BIOMATERIALS, V32, P2013, DOI 10.1016/j.biomaterials.2010.11.049
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Martinez-Ramos C, 2014, TISSUE ENG PART C-ME, V20, P817, DOI 10.1089/ten.tec.2013.0489
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Mihardja SS, 2013, BIOMATERIALS, V34, P8869, DOI 10.1016/j.biomaterials.2013.07.028
   Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570
   Nam YJ, 2013, NAT MED, V19, P413, DOI 10.1038/nm.3147
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Ou LL, 2011, J CELL MOL MED, V15, P1310, DOI 10.1111/j.1582-4934.2010.01086.x
   Padin-Iruegas ME, 2009, CIRCULATION, V120, P876, DOI 10.1161/CIRCULATIONAHA.109.852285
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Paramonov SE, 2005, MACROMOLECULES, V38, P7555, DOI 10.1021/ma0514065
   Plotkin M, 2014, BIOMATERIALS, V35, P1429, DOI 10.1016/j.biomaterials.2013.10.058
   Pochan DJ, 2003, J AM CHEM SOC, V125, P11802, DOI 10.1021/ja0353154
   Prat-Vidal C, 2014, INT J CARDIOL, V174, P654, DOI 10.1016/j.ijcard.2014.04.181
   Radhakrishnan J, 2014, BIOTECHNOL ADV, V32, P449, DOI 10.1016/j.biotechadv.2013.12.010
   Rane AA, 2011, J AM COLL CARDIOL, V58, P2615, DOI 10.1016/j.jacc.2011.11.001
   Ravichandran R, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/38/385102
   Rufaihah AJ, 2013, BIOMATERIALS, V34, P8195, DOI 10.1016/j.biomaterials.2013.07.031
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Salem AK, 2002, J BIOMED MATER RES, V61, P212, DOI 10.1002/jbm.10195
   Schneider A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001410
   Schneider JP, 2002, J AM CHEM SOC, V124, P15030, DOI 10.1021/ja027993g
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Segers VFM, 2011, CIRC RES, V109, P910, DOI 10.1161/CIRCRESAHA.111.249052
   Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503
   Seif-Naraghi SB, 2012, ACTA BIOMATER, V8, P3695, DOI 10.1016/j.actbio.2012.06.030
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Soler-Botija C, 2014, AM J TRANSL RES, V6, P291
   Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139
   Stephanopoulos N, 2013, ACTA MATER, V61, P912, DOI 10.1016/j.actamat.2012.10.046
   Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   Tokunaga M, 2010, J MOL CELL CARDIOL, V49, P972, DOI 10.1016/j.yjmcc.2010.09.015
   Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018
   Tuan RS, 2013, NAT REV RHEUMATOL, V9, P74, DOI 10.1038/nrrheum.2012.235
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Ulijn RV, 2008, CHEM SOC REV, V37, P664, DOI 10.1039/b609047h
   Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n
   Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Welt FGP, 2013, CIRC-HEART FAIL, V6, P99, DOI 10.1161/CIRCHEARTFAILURE.112.972273
   Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456
   Wu J, 2012, ADV FUNCT MATER, V22, P3815, DOI 10.1002/adfm.201103147
   Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619
   Yacoub Magdi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS133, DOI 10.1038/ncpcardio0401
   Yang YL, 2009, NANO TODAY, V4, P193, DOI 10.1016/j.nantod.2009.02.009
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu JS, 2010, BIOMATERIALS, V31, P7012, DOI 10.1016/j.biomaterials.2010.05.078
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zhao F, 2009, CHEM SOC REV, V38, P883, DOI 10.1039/b806410p
   Zhao XJ, 2006, CHEM SOC REV, V35, P1105, DOI 10.1039/b511336a
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 143
TC 9
Z9 10
U1 3
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 96
BP 53801
EP 53811
DI 10.1039/c4ra08582e
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS7YW
UT WOS:000344468800052
DA 2018-10-19
ER

PT J
AU Siegismund, D
   Schroeter, A
   Ludecke, C
   Undisz, A
   Jandt, KD
   Roth, M
   Rettenmayr, M
   Schuster, S
   Germerodt, S
AF Siegismund, Daniel
   Schroeter, Anja
   Luedecke, Claudia
   Undisz, Andreas
   Jandt, Klaus D.
   Roth, Martin
   Rettenmayr, Markus
   Schuster, Stefan
   Germerodt, Sebastian
TI Discrimination between random and non-random processes in early
   bacterial colonization on biomaterial surfaces: application of point
   pattern analysis
SO BIOFOULING
LA English
DT Article
DE bacterial colonization; point-pattern analysis; bacterial adhesion;
   biofilm; biomaterials; image processing
ID ORAL STREPTOCOCCAL ADHESION; SELF-ASSEMBLED MONOLAYERS; BIOFILM
   FORMATION; PSEUDOMONAS-AERUGINOSA; HYDROPHOBIC SURFACES;
   SPATIAL-PATTERNS; NANOSCALE ROUGHNESS; MICROBIAL ADHESION; ADHERING
   BACTERIA; IMAGE-ANALYSIS
AB The dynamics of adhesion and growth of bacterial cells on biomaterial surfaces play an important role in the formation of biofilms. The surface properties of biomaterials have a major impact on cell adhesion processes, eg the random/noncooperative adhesion of bacteria. In the present study, the spatial arrangement of Escherichia coli on different biomaterials is investigated in a time series during the first hours after exposure. The micrographs are analyzed via an image processing routine and the resulting point patterns are evaluated using second order statistics. Two main adhesion mechanisms can be identified: random adhesion and non-random processes. Comparison with an appropriate null-model quantifies the transition between the two processes with statistical significance. The fastest transition to non-random processes was found to occur after adhesion on PTFE for 2-3 h. Additionally, determination of cell and cluster parameters via image processing gives insight into surface influenced differences in bacterial micro-colony formation.
C1 [Siegismund, Daniel; Luedecke, Claudia; Undisz, Andreas; Jandt, Klaus D.; Rettenmayr, Markus] Univ Jena, Otto Schott Inst Mat Res OSIM, Jena, Germany.
   [Siegismund, Daniel; Schroeter, Anja; Schuster, Stefan; Germerodt, Sebastian] Univ Jena, Dept Bioinformat, Jena, Germany.
   [Luedecke, Claudia; Roth, Martin] HKI, Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.
RP Germerodt, S (reprint author), Univ Jena, Dept Bioinformat, Jena, Germany.
EM sebastian.germerodt@uni-jena.de
RI Jandt, Klaus/C-8077-2016
OI Jandt, Klaus/0000-0002-7537-5603
FU Jena School for Microbial Communication (JSMC/MikroInter) - DFG; State
   of Thuringia
FX This work was supported by the Jena School for Microbial Communication
   (JSMC/MikroInter) funded by the DFG and the State of Thuringia. Fruitful
   discussions with J. Schleicher and M. Foge are gratefully acknowledged.
CR Azevedo NF, 2007, APPL ENVIRON MICROB, V73, P3423, DOI 10.1128/AEM.00047-07
   Baddeley A, 2005, J STAT SOFTW, V12, P1
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Bell ML, 2004, BIOSTATISTICS, V5, P633, DOI 10.1093/biostatistics/kxh014
   Beloin C, 2008, PLOS BIOL, V6, P1549, DOI 10.1371/journal.pbio.0060167
   Boks NP, 2008, LANGMUIR, V24, P12990, DOI 10.1021/la801824c
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   BOS R, 1994, J MICROBIOL METH, V20, P289, DOI 10.1016/0167-7012(94)90053-1
   Busscher HJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004528
   Busscher HJ, 2012, PLOS PATHOGENS, P8
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Diggle PJ, 2000, ADV APPL PROBAB, V32, P331, DOI 10.1017/S0001867800009952
   Gibiansky ML, 2010, SCIENCE, V330, P197, DOI 10.1126/science.1194238
   Giraldez MJ, 2010, OPTOMETRY VISION SCI, V87, pE426, DOI 10.1097/OPX.0b013e3181da8656
   Gottenbos B, 2000, J BIOMED MATER RES, V50, P208, DOI 10.1002/(SICI)1097-4636(200005)50:2<208::AID-JBM16>3.0.CO;2-D
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Grivet M, 1999, J MICROBIOL METH, V38, P33, DOI 10.1016/S0167-7012(99)00074-3
   Gu H, 2013, LANGMUIR, V29, P11145, DOI 10.1021/la402608z
   Gustafson D. E., 1979, Proceedings of the 1978 IEEE Conference on Decision and Control Including the 17th Symposium on Adaptive Processes, P761
   HAMILTON MA, 1995, BIOMETRICAL J, V37, P393, DOI 10.1002/bimj.4710370403
   Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12
   Ivanova EP, 2010, LANGMUIR, V26, P1973, DOI 10.1021/la902623c
   JAMES GA, 1995, J BACTERIOL, V177, P907, DOI 10.1128/jb.177.4.907-915.1995
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x
   Ludecke C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084837
   Ludecke C, 2013, APPL SURF SCI, V280, P578, DOI 10.1016/j.apsusc.2013.05.030
   Mc Quarrie D. A., 1975, STAT MECH
   Medilanski E, 2002, BIOFOULING, V18, P193, DOI 10.1080/08927010290011370
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Parreira P, 2011, J BIOMED MATER RES A, V99A, P344, DOI 10.1002/jbm.a.33178
   Perni S, 2013, SOFT MATTER, V9, P1844, DOI 10.1039/c2sm26828k
   Ploux L, 2007, COLLOID SURFACE B, V57, P174, DOI 10.1016/j.colsurfb.2007.01.018
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Renner LD, 2011, MRS BULL, V36, P347, DOI 10.1557/mrs.2011.65
   RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172
   Schillinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037583
   Schleicher J, 2011, J ARID ENVIRON, V75, P270, DOI 10.1016/j.jaridenv.2010.10.003
   Siegismund D, 2014, ACTA BIOMATER, V10, P267, DOI 10.1016/j.actbio.2013.09.016
   Singh AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025029
   SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263
   SJOLLEMA J, 1990, COLLOID SURFACE, V47, P337, DOI 10.1016/0166-6622(90)80082-F
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Taylor J, 1997, INTRO ERROR ANAL STU
   Tegoulia VA, 2002, COLLOID SURFACE B, V24, P217, DOI 10.1016/S0927-7765(01)00240-5
   van der Mei HC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002821
   VANDERMEI HC, 1993, J GEN MICROBIOL, V139, P937, DOI 10.1099/00221287-139-5-937
   Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x
   Wiegand T, 2006, J ECOL, V94, P825, DOI 10.1111/j.1365-2745.2006.01113.x
   Young KD, 2006, MICROBIOL MOL BIOL R, V70, P660, DOI 10.1128/MMBR.00001-06
   Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155
NR 55
TC 2
Z9 3
U1 2
U2 28
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0892-7014
EI 1029-2454
J9 BIOFOULING
JI Biofouling
PY 2014
VL 30
IS 9
BP 1023
EP 1033
DI 10.1080/08927014.2014.958999
PG 11
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA AS5OO
UT WOS:000344320100001
PM 25329612
DA 2018-10-19
ER

PT J
AU Wang, C
   Lyu, GJ
   Yang, GH
   Chen, JC
   Jiang, WK
AF Wang, Chao
   Lyu, Gaojin
   Yang, Guihua
   Chen, Jiachuan
   Jiang, Weikun
TI Characterization and Hydrothermal Conversion of Lignin Produced from
   Corncob Acid Hydrolysis Residue
SO BIORESOURCES
LA English
DT Article
DE Corncob acid hydrolysis residue; Enzymatic/mild acidolysis lignin;
   Hydrothermal conversion; Phenolic compounds
ID ALKALI LIGNIN; WATER; DEPOLYMERIZATION; LIQUEFACTION; DEGRADATION;
   PYROLYSIS; ETHANOL; BIOMASS
AB Lignin is one of the main components of corncob acid hydrolysis residue (CAHR). It can be used as a feedstock for biomaterial and biochemical production via biorefining. In this study, CAHR lignin was extracted, and enzymatic/mild acidolysis lignin (EMAL) was produced to ensure efficient lignin recovery. Next, hydrothermal conversion of the EMAL was carried out. The influences of process conditions including the temperature, time, and mass ratio of deionized water to EMAL on the hydrothermal conversion were thoroughly investigated to quantify analysis of the aromatics. EMAL produced from CAHR had a structure of the G-S-H type, in which the p-hydroxyphenyl unit was the primary structural unit, followed by the guaiacyl structural unit. The syringyl structural unit was less common. The yields (wt. %) of phenol, guaiacol, and 4-ethyl-phenol reached maxima of 1.26%, 0.75%, and 1.16%, respectively, at a reaction temperature of 310 degrees C and time of 30 min with a mass ratio of 80:1.
C1 [Wang, Chao; Lyu, Gaojin; Yang, Guihua; Chen, Jiachuan; Jiang, Weikun] Qilu Univ Technol, Key Lab Pulp & Paper Sci & Technol, Minist Educ, Jinan 250353, Shandong, Peoples R China.
RP Lyu, GJ (reprint author), Qilu Univ Technol, Key Lab Pulp & Paper Sci & Technol, Minist Educ, Jinan 250353, Shandong, Peoples R China.
EM gaojinlv@qlu.edu.cn; ygh2626@126.com
FU National Science Foundation of China [31170547, 31270627, 31370580,
   31270626]; Natural Science Foundation of Shandong Province [ZR2010CM065,
   ZR2011CM011]; Outstanding Young Scientist Award Fund of Shandong
   province [BS2013NJ014]; Director Fund of KLPPST [08031334]
FX The authors are grateful for the financial support from the National
   Science Foundation of China (Grant Nos. 31170547, 31270627, 31370580,
   31270626), the Natural Science Foundation of Shandong Province (Grant
   Nos. ZR2010CM065, ZR2011CM011), the Outstanding Young Scientist Award
   Fund of Shandong province (BS2013NJ014), and the Director Fund of KLPPST
   (No. 08031334).
CR [Anonymous], 1975, T9WD75 TAPPI
   [Anonymous], 1988, T222OM88 TAPPI
   [Anonymous], 1999, T203CM99 TAPPI
   Bozell JJ, 2010, SCIENCE, V329, P522, DOI 10.1126/science.1191662
   Cheng SN, 2012, POLYM DEGRAD STABIL, V97, P839, DOI 10.1016/j.polymdegradstab.2012.03.044
   Cox BJ, 2012, BIORESOURCE TECHNOL, V118, P584, DOI 10.1016/j.biortech.2012.05.012
   Crestini C, 1997, J AGR FOOD CHEM, V45, P1212, DOI 10.1021/jf960568k
   Dizhbite T, 2011, J ANAL APPL PYROL, V90, P126, DOI 10.1016/j.jaap.2010.11.004
   FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21
   Gosselink R. J., 2011, BIORESOURCE TECHNOL, V106, P173
   Sobrino FH, 2010, RENEW SUST ENERG REV, V14, P772, DOI 10.1016/j.rser.2009.10.021
   Hoekman SK, 2011, ENERG FUEL, V25, P1802, DOI 10.1021/ef101745n
   Huang YQ, 2012, J ANAL APPL PYROL, V93, P153, DOI 10.1016/j.jaap.2011.10.011
   Jin YQ, 2011, BIORESOURCE TECHNOL, V102, P3581, DOI 10.1016/j.biortech.2010.10.050
   Kleinert M, 2008, ENERG FUEL, V22, P1371, DOI 10.1021/ef700631w
   Lou R, 2011, APPL ENERG, V88, P316, DOI 10.1016/j.apenergy.2010.06.028
   Pandey MP, 2011, CHEM ENG TECHNOL, V34, P29, DOI 10.1002/ceat.201000270
   Pinkowska H, 2012, CHEM ENG J, V187, P410, DOI 10.1016/j.cej.2012.01.092
   Toor SS, 2011, ENERGY, V36, P2328, DOI 10.1016/j.energy.2011.03.013
   Wahyudiono Sasaki M., 2008, CHEM ENG PROCESS, V47, P1609
   Wu S. B., 2006, FORESTRY STUDIES CHI, V8, P34
   Yang GH, 2013, CURR ORG CHEM, V17, P1589, DOI 10.2174/13852728113179990068
   Ye YY, 2012, J ANAL APPL PYROL, V94, P190, DOI 10.1016/j.jaap.2011.12.005
   Yuan ZS, 2010, BIORESOURCE TECHNOL, V101, P9308, DOI 10.1016/j.biortech.2010.06.140
NR 24
TC 10
Z9 10
U1 0
U2 12
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 3
BP 4596
EP 4607
PG 12
WC Materials Science, Paper & Wood
SC Materials Science
GA AS3NG
UT WOS:000344184300071
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Namvar, F
   Jawaid, M
   Tahir, PM
   Mohamad, R
   Azizi, S
   Khodavandi, A
   Rahman, HS
   Nayeri, MD
AF Namvar, Farideh
   Jawaid, Mohammad
   Tahir, Paridah Md
   Mohamad, Rosfarizan
   Azizi, Susan
   Khodavandi, Alireza
   Rahman, Heshu Sulaiman
   Nayeri, Majid Dehghan
TI Potential Use of Plant Fibres and their Composites for Biomedical
   Applications
SO BIORESOURCES
LA English
DT Article
DE Fibres; Polymers; Biocomposites; Biomedical applications
ID REINFORCED COMPOSITES; NATURAL FIBERS; HYBRID COMPOSITES;
   MECHANICAL-PROPERTIES; BIO-COMPOSITES; NANOCELLULOSE; BIOMATERIALS;
   CELLULOSE; BEHAVIOR
AB Plant-based fibers such as flax, jute, sisal, hemp, and kenaf have been frequently used in the manufacturing of biocomposites. Natural fibres possess a high strength to weight ratio, non-corrosive nature, high fracture toughness, renewability, and sustainability, which give them unique advantages over other materials. The development of biocomposites by reinforcing natural fibres has attracted attention of scientists and researchers due to environmental benefits and improved mechanical performance. Manufacturing of biocomposites from renewable sources is a challenging task, involving metals, polymers, and ceramics. Biocomposites are already utilized in biomedical applications such as drug/gene delivery, tissue engineering, orthopedics, and cosmetic orthodontics. The first essential requirement of materials to be used as biomaterial is its acceptability by the human body. A biomaterial should obtain some important common properties in order to be applied in the human body either for use alone or in combination. Biocomposites have potential to replace or serve as a framework allowing the regeneration of traumatized or degenerated tissues or organs, thus improving the patients' quality of life. This review paper addresses the utilization of plant fibres and its composites in biomedical applications and considers potential future research directed at environment-friendly biodegradable composites for biomedical applications.
C1 [Namvar, Farideh; Jawaid, Mohammad; Tahir, Paridah Md; Mohamad, Rosfarizan; Nayeri, Majid Dehghan] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang 43400, Selangor, Malaysia.
   [Namvar, Farideh] Islamic Azad Univ, Mashhad Branch, Mashhad, Iran.
   [Mohamad, Rosfarizan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang 43400, Malaysia.
   [Azizi, Susan] Univ Putra Malaysia, Fac Chem, Serdang 43400, Malaysia.
   [Khodavandi, Alireza] Islamic Azad Univ, Gachsaran Branch, Dept Paramed Sci, Gachsaran, Iran.
   [Rahman, Heshu Sulaiman] Univ Putra Malaysia, Fac Vet Med, Dept Pathol & Microbiol, Serdang 43400, Malaysia.
   [Jawaid, Mohammad] King Saud Univ, Coll Engn, Dept Chem Engn, Riyadh 11421, Saudi Arabia.
RP Namvar, F (reprint author), Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Upm Serdang 43400, Selangor, Malaysia.
EM farideh.namvar@gmail.com
RI Jawaid, Mohammad/E-2116-2011
OI Jawaid, Mohammad/0000-0001-5348-5740; Khodavandi,
   Alireza/0000-0001-9498-9822; MD. TAHIR, PARIDAH/0000-0002-2961-6031;
   Mohamad, Rosfarizan/0000-0001-5672-1905
CR Abraham E, 2011, CARBOHYD POLYM, V86, P1468, DOI 10.1016/j.carbpol.2011.06.034
   Aggerholm S., 2013, WIPO patent, Patent No. [WO/2013/148399, 2437616]
   Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   Asokan P, 2012, REV ADV MATER SCI, V30, P254
   Barthelat F, 2007, PHILOS T R SOC A, V365, P2907, DOI 10.1098/rsta.2007.0006
   Bhatnagar A, 2005, J REINF PLAST COMP, V24, P1259, DOI 10.1177/0731684405049864
   Biagiotti J, 2004, J NAT FIBERS, V1, P37, DOI DOI 10.1300/J395V01N02_04
   Bledzki A., 2010, COMPOS SCI TECHNOL, V70, P1
   Bodros E, 2007, COMPOS SCI TECHNOL, V67, P462, DOI 10.1016/j.compscitech.2006.08.024
   Chandramohan D, 2011, ACTA BIOENG BIOMECH, V13, P77
   Cheng G., 2010, China Patent, Patent No. [CN 101703317, 102677504]
   Cherian BM, 2010, CARBOHYD POLYM, V81, P720, DOI 10.1016/j.carbpol.2010.03.046
   Cheung HY, 2009, COMPOS PART B-ENG, V40, P655, DOI 10.1016/j.compositesb.2009.04.014
   Corbie T., 2001, Life cycle assessment of biofibres replacing glass fibres as reinforcement in plastics, V33, P267, Patent No. 0818184
   Cottenceau J. P., 1998, European Patent EP, Patent No. [0818184, 101703317]
   Cullen Richard K., 2013, Journal of Composites, DOI 10.1155/2013/416501
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Daunton C., 2012, WOUND MANAGEMENT, V20
   Dhandayuthapani B, 2011, INT J POLYM SCI, DOI 10.1155/2011/290602
   DiGregorio BE, 2009, CHEM BIOL, V16, P1, DOI 10.1016/j.chembiol.2009.01.001
   Eichhorn SJ, 2009, J MATER SCI, V45, P1, DOI DOI 10.1007/S10853-009-3874-0
   Everitt N. M., 2013, C PAPERS MAT SCI, DOI [10.1155/2013/141204, DOI 10.1155/2013/141204]
   Flory A., 2013, DEV GREEN BINDER SYS
   Garcia M. I., 2007, J APPL POLYM SCI, V107, P2994
   Giri J, 2013, NEPAL J ONLINE, V9, P81, DOI [10.3126/bibechana.v9i0.7179, DOI 10.3126/BIBECHANA.V9I0.7179]
   GOLDSTEIN SA, 1991, J BIOMECH, V24, P135, DOI 10.1016/0021-9290(91)90384-Y
   Hin T. S., 2004, ENG MAT BIOMEDICAL A, DOI [10.1142/5673, DOI 10.1142/5673]
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Jawaid M, 2011, CARBOHYD POLYM, V86, P1, DOI 10.1016/j.carbpol.2011.04.043
   Joshi SV, 2004, COMPOS PART A-APPL S, V35, P371, DOI 10.1016/j.compositesa.2003.09.016
   Kabir M., 2011, P 1 INT POSTGR C ENG
   Kalia S, 2011, INT J POLYM SCI, DOI 10.1155/2011/837875
   Kalia S, 2009, POLYM ENG SCI, V49, P1253, DOI 10.1002/pen.21328
   Kutz M., 2003, STANDARD HDB BIOMEDI, P1
   Lund S. S., 2008, U.S Patent US, Patent No. [20090234459, 2002054998]
   Majeed K, 2013, MATER DESIGN, V46, P391, DOI 10.1016/j.matdes.2012.10.044
   Mao Z., 2012, China Patent CN, Patent No. [102715804, 1461827]
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Milanese AC, 2011, PROCEDIA ENGINEER, V10, DOI 10.1016/j.proeng.2011.04.335
   Mohanty A. K., 2002, J POLYM ENVIRON, V10, P18
   Morgan C, 2013, ANGIOGENESIS, V16, P493, DOI 10.1007/s10456-013-9341-1
   Mueller D., 2004, INT NONWOVENS J, V13, P31
   Mukhopadhyay S, 2009, J THERMOPLAST COMPOS, V22, P135, DOI 10.1177/0892705708091860
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Oksman K, 2003, COMPOS SCI TECHNOL, V63, P1317, DOI 10.1016/S0266-3538(03)00103-9
   Patel N. R., 2012, INT J EMERGING TECHN, V2, P91
   Puglia D., 2005, J NATURAL FIBERS, V1
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ratner B. D., 2004, BIOMATERIALS SCI MUL
   Romanzini D, 2012, MATER RES-IBERO-AM J, V15, P415, DOI [10.1590/S1516-14392012000300012, 10.1590/S1516-14392012005000050]
   Sarasini F, 2013, J POLYM ENVIRON, V21, P881, DOI 10.1007/s10924-013-0594-y
   Strandqvist M, 2012, Patent No. [CN102665510, 102715983]
   Taniguchi K., 2006, WIPO patent, Patent No. [W0/2002/054998, 2013148399]
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   Ticoalu A, 2010, P SO REG ENG C 2010
   Verma D., 2013, J MAT ENV SCI, V4, P263
   Wirawan R, 2009, SAINS MALAYS, V38, P531
   Wu TM, 2006, POLYM DEGRAD STABIL, V91, P2198, DOI 10.1016/j.polymdegradstab.2006.01.004
   Xiang Q., 2012, China Patent CN, Patent No. [102715983, 102715804]
   Xue Q., 2012, China Patent CN, Patent No. [102677504, 102665510]
   Yang HS, 2006, POLYM TEST, V25, P668, DOI 10.1016/j.polymertesting.2006.03.013
   Yu G, 2003, China Patent CN, Patent No. [1461827, 1609336]
   Zhou S., 2006, China Patent, Patent No. [CN 1609336, 20090234459]
   Zhu JC, 2013, MATERIALS, V6, P5171, DOI 10.3390/ma6115171
NR 64
TC 7
Z9 8
U1 0
U2 20
PU NORTH CAROLINA STATE UNIV DEPT WOOD & PAPER SCI
PI RALEIGH
PA CAMPUS BOX 8005, RALEIGH, NC 27695-8005 USA
SN 1930-2126
J9 BIORESOURCES
JI BioResources
PY 2014
VL 9
IS 3
BP 5688
EP 5706
PG 19
WC Materials Science, Paper & Wood
SC Materials Science
GA AS3NG
UT WOS:000344184300157
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Hiebl, B
   Hopperdietzel, C
   Hunigen, H
   Dietze, K
   Jung, F
   Niehues, SM
AF Hiebl, B.
   Hopperdietzel, C.
   Huenigen, H.
   Dietze, K.
   Jung, F.
   Niehues, S. M.
TI Tissue reaction induced by implanted venous access ports in adult
   patients after infection of the implantation site
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Encapsulation; infection; central venous access system; biomaterial
ID SOFT-TISSUE; FOLLOW-UP; COMPLICATIONS; DEVICES; TITANIUM; SYSTEMS;
   CHEMOTHERAPY; MALIGNANCIES; BIOMATERIAL; EXPERIENCE
AB Implantable long-term central venous port systems (CVPS) are widely used as a permanent means of accessing the vascular system for intravenous delivery of drugs, parenteral nutrition, blood transfusion, and blood sampling. These systems allow easy and repetitive puncture without causing much damage to the vessels. However, the body foreign surface of CVPS induces an inflammatory response with varying intensity (depending on the implant materials) that leads to formation of a fibrous tissue capsule around the implant. This study was designed to investigate the influence of bacterial infection on the tissue reaction induced by implanted CVPS in adult patients. 20 patients (9 women, 11 men, 58 +/- 14 yrs of age) were included in this study. These patients received explantation of a polysulfone based CVPS (ChemoSite (TM), Covidien, Mansfield, USA) due to port related infections (patients with bacterial infections at the implantation site: group A, 5 men, 1 women) or to other reasons such as termination of treatment, thrombosis, or CVPS dysfunction (patients without bacterial infections, group B, 6 men, 8 women) 299.9 +/- 261.2 days after CVPS implantation. A sample of the encapsulating tissue covering the CVPS together with surrounding tissue (at least 1x1 cm(2)) was placed in a small container with fixing agent, a buffered neutral 4% formalin solution (pH 7). Histological sections of the samples were prepared for light microscopic analysis after paraffin embedding. Sections of 3 mu m were cut and stained with haematoxylin and eosin, Weigert's elastic stain, and Heidenhain's azan stain. There was no difference in thickness, collagen and elastin content, or cell and capillary density of the fibrous capsule between both groups. Due to the wound healing reaction involving angiogenesis and fibroblast activation cell density and number of capillaries in the capsule tissue of all patients showed a positive correlation (r = 0.45, p < 0.05). However, the study demonstrated that at the end of the foreign body reaction the artificial tissue layer which covers the CVPS after implantation due to foreign body reaction shows only low reactivity towards infections.
C1 [Hiebl, B.] Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Saale, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Teltow, Germany.
   [Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Teltow, Germany.
   [Hopperdietzel, C.; Huenigen, H.; Dietze, K.] Free Univ Berlin, Inst Vet Anat, Fac Vet Med, Berlin, Germany.
   [Niehues, S. M.] Charite, Dept Radiol, D-13353 Berlin, Germany.
RP Hiebl, B (reprint author), Univ Halle Wittenberg, Ctr Med Basic Res, D-06108 Halle, Saale, Germany.
EM bernhard.hiebl@medizin.uni-halle.de
RI Jung, Friedrich/L-1301-2013
OI Jung, Friedrich/0000-0001-8098-7180; Hiebl, Bernhard/0000-0002-6450-0675
CR Al-Banna NA, 2013, CLIN HEMORHEOL MICRO, V55, P423, DOI 10.3233/CH-131780
   BARRIOS CH, 1992, ONCOLOGY, V49, P474
   BEHLING CA, 1986, J BIOMED MATER RES, V20, P653, DOI 10.1002/jbm.820200509
   Biffi R, 1998, ANN ONCOL, V9, P767, DOI 10.1023/A:1008392423469
   Boersma RS, 2008, ANN ONCOL, V19, P433, DOI 10.1093/annonc/mdm350
   Bouza E, 2002, CLIN MICROBIOL INFEC, V8, P265, DOI 10.1046/j.1469-0691.2002.00385.x
   Bow EJ, 1999, J CLIN ONCOL, V17, P1267, DOI 10.1200/JCO.1999.17.4.1267
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   BROTHERS TE, 1988, SURG GYNECOL OBSTET, V166, P295
   Gebauer B, 2009, EUR J RADIOL, V69, P517, DOI 10.1016/j.ejrad.2007.10.018
   Groebli Y, 1999, PANMINERVA MED, V41, P89
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   KEUNG YK, 1994, CANCER, V73, P2832, DOI 10.1002/1097-0142(19940601)73:11<2832::AID-CNCR2820731128>3.0.CO;2-V
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Kock HJ, 1998, WORLD J SURG, V22, P12, DOI 10.1007/s002689900342
   Lemmers NWM, 1996, J CLIN ONCOL, V14, P2916, DOI 10.1200/JCO.1996.14.11.2916
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   MCNAMARA A, 1981, BIOMATERIALS, V2, P33, DOI 10.1016/0142-9612(81)90085-5
   Mulisch M, 2010, MIKROSKOPISCHE TECHN
   Paquay YCGJ, 1996, BIOMATERIALS, V17, P1251, DOI 10.1016/0142-9612(96)84946-5
   Prantl L., 2014, CLIN HEMORHEOL MICRO, DOI [10.3233/CH-141812.25, DOI 10.3233/CH-141812.25]
   RAAF JH, 1994, SUPPORT CARE CANCER, V2, P335, DOI 10.1007/BF00344046
   Rosengren A, 1998, J MATER SCI-MATER M, V9, P415, DOI 10.1023/A:1013239731256
   SARIEGO J, 1993, AM J SURG, V165, P249, DOI 10.1016/S0002-9610(05)80520-3
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766
   TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202
   Teichgraber UKM, 2011, EUR RADIOL, V21, P1224, DOI 10.1007/s00330-010-2045-7
   THERIN M, 1991, J MATER SCI-MATER M, V2, P1, DOI 10.1007/BF00701681
   Vescia S, 2008, ANN ONCOL, V19, P9, DOI 10.1093/annonc/mdm272
   WOOD N K, 1970, Journal of Biomedical Materials Research, V4, P1, DOI 10.1002/jbm.820040102
   Yildizeli B, 2004, J Vasc Access, V5, P174
NR 32
TC 1
Z9 2
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 107
EP 113
DI 10.3233/CH-141881
PG 7
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900009
PM 25227193
DA 2018-10-19
ER

PT J
AU Braune, S
   Walter, M
   Schulze, F
   Lendlein, A
   Jung, F
AF Braune, S.
   Walter, M.
   Schulze, F.
   Lendlein, A.
   Jung, F.
TI Changes in platelet morphology and function during 24 hours of storage
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Platelet; platelet function; platelet rich plasma; whole blood; platelet
   aging; platelet storage; hemocompatibility; biomaterials
ID ALPHA-GRANULE PROTEINS; FUNCTION ANALYZER; VASCULAR-DISEASE;
   BLEEDING-TIME; BLOOD; MICROPARTICLES; HEMOSTASIS; BIOMATERIALS;
   AGGREGATION; COLLECTION
AB For in vitro studies assessing the interaction of platelets with implant materials, common and standardized protocols for the preparation of platelet rich plasma (PRP) are lacking, which may lead to non-matching results due to the diversity of applied protocols. Particularly, the aging of platelets during prolonged preparation and storage times is discussed to lead to an underestimation of the material thrombogenicity. Here, we study the influence of whole blood-and PRP-storage times on changes in platelet morphology and function.
   Blood from apparently healthy subjects was collected according to a standardized protocol and examined immediately after blood collection, four hours and twenty four hours later. The capability of platelets to adhere and form stable aggregates (PFA100, closure time) was examined in sodium citrate anticoagulated whole blood (WB) using the agonists equine type I collagen and epinephrine bitartrate (collagen/epinephrine) as well as equine type I collagen and adenosine-5'-diphosphate (collagen/ADP). Circulating platelets were quantified at each time point. Morphology of platelets and platelet aggregates were visualized microscopically and measured using an electric field multi-channel counting system (CASY). The percentage of activated platelets was assessed by means of P-selectin (CD62P) expression of circulating platelets. Furthermore, platelet factor 4 (PF4) release was measured in platelet poor plasma (PPP) at each time point.
   Whole blood PFA100 closure times increased after stimulation with collagen/ADP and collagen/epinephrine. Twenty four hours after blood collection, both parameters were prolonged pathologically above the upper limit of the reference range. Numbers of circulating platelets, measured in PRP, decreased after four hours, but no longer after twenty four hours. Mean platelet volumes (MPV) and platelet large cell ratios (P-LCR, 12 fL - 40 fL) decreased over time. Immediately after blood collection, no debris or platelet aggregates could be visualized microscopically. After four hours, first debris and very small aggregates occurred. After 24 hours, platelet aggregates and also debris progressively increased. In accordance to this, the CASY system revealed an increase of platelet aggregates (up to 90 mu m diameter)with increasing storage time.
   The percentage of CD62P positive platelets and PF4 increased significantly with storage time in resting PRP. When soluble ADP was added to stored PRP samples, the number of activatable platelets decreased significantly over storage time. The present study reveals the importance of a consequent standardization in the preparation of WB and PRP. Platelet morphology and function, particularly platelet reactivity to adherent or soluble agonists in their surrounding milieu, changed rapidly outside the vascular system. This knowledge is of crucial interest, particularly in the field of biomaterial development for cardiovascular applications, and may help to define common standards in the in vitro hemocompatibility testing of biomaterials.
C1 [Braune, S.; Walter, M.; Schulze, F.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Braune, S.; Walter, M.; Schulze, F.; Lendlein, A.; Jung, F.] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Braune, S.; Walter, M.; Lendlein, A.] Univ Potsdam, Inst Chem, Potsdam, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM friedrich.jung@hzg.de
RI Lendlein, Andreas/K-9553-2013; Braune, Steffen/D-2315-2015; Jung,
   Friedrich/L-1301-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180
CR BACH R, 1994, THROMB RES, V74, pS55
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-33
   Braune S, 2013, CLIN HEMORHEOL MICRO, V54, P235, DOI 10.3233/CH-131729
   BROWN AS, 1994, EUR J CLIN INVEST, V24, P9, DOI 10.1111/j.1365-2362.1994.tb02419.x
   CAPITANIO AM, 1985, BIOCHIM BIOPHYS ACTA, V839, P161, DOI 10.1016/0304-4165(85)90033-9
   Cattaneo M, 2013, J THROMB HAEMOST, V11, P1183, DOI 10.1111/jth.12231
   Devine DV, 2010, CLIN LAB MED, V30, P475, DOI 10.1016/j.cll.2010.02.002
   Erlandsen SL, 2001, J HISTOCHEM CYTOCHEM, V49, P809, DOI 10.1177/002215540104900702
   Favaloro EJ, 2010, CLIN CHEM LAB MED, V48, P579, DOI 10.1515/CCLM.2010.121
   Favaloro EJ, 2008, SEMIN THROMB HEMOST, V34, P709, DOI 10.1055/s-0029-1145254
   Ferroni P, 2012, THROMB HAEMOSTASIS, V108, P1109, DOI 10.1160/TH12-08-0550
   Francis J, 1999, PLATELETS, V10, P132, DOI 10.1080/09537109976194
   GEORGE JN, 1990, BLOOD, V76, P859
   GROTEMEYER KH, 1993, THROMB RES, V71, P397, DOI 10.1016/0049-3848(93)90164-J
   Hayward CPM, 2009, SEMIN THROMB HEMOST, V35, P127, DOI 10.1055/s-0029-1220320
   Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee
   Jennings I, 2008, J CLIN PATHOL, V61, P950, DOI 10.1136/jcp.2008.057174
   Jensen EA, 2008, CLIN CHEM LAB MED, V46, P225, DOI 10.1515/CCLM.2008.053
   Jung F, 2013, CLIN HEMORHEOL MICRO, V53, P97, DOI 10.3233/CH-2012-1579
   Jung F., 2011, MRS BULL, V35, P607
   Kalb ML, 2009, PLATELETS, V20, P7, DOI 10.1080/09537100802364076
   KAPLAN KL, 1979, BLOOD, V53, P604
   Kehrel BE, 2013, TRANSFUS MED HEMOTH, V40, P73, DOI 10.1159/000350469
   KINLOUGHRATHBONE RL, 1995, THROMB HAEMOSTASIS, V74, P958
   Klinger MHF, 1996, ANN HEMATOL, V73, P103, DOI 10.1007/s002770050210
   Knehtl M, 2013, INT J ARTIF ORGANS, V36, P717, DOI 10.5301/ijao.5000239
   Koscielny J, 2005, SEMIN THROMB HEMOST, V31, P464, DOI 10.1055/s-2005-916682
   KUNDU SK, 1995, SEMIN THROMB HEMOST, V21, P106
   Latza R, 2000, INFUS THER TRANSFUS, V27, P94
   Lima-Oliveira G., 2014, J MED BIOCHEM, P1
   Lindl T, 2005, ATLA-ALTERN LAB ANIM, V33, P591
   Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961
   Mackie I, 2013, INT J LAB HEMATOL, V35, P1, DOI 10.1111/ijlh.12004
   MARTIN JF, 1983, THROMB RES, V32, P443, DOI 10.1016/0049-3848(83)90255-4
   MISSELWITZ F, 1987, THROMB RES, V46, P233, DOI 10.1016/0049-3848(87)90285-4
   Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003
   Reinhart WH, 2013, CLIN HEMORHEOL MICRO, V53, P71, DOI 10.3233/CH-2012-1577
   Shrivastava M, 2009, TRANSFUS APHER SCI, V41, P105, DOI 10.1016/j.transci.2009.07.002
   Sikara MP, 2010, BLOOD, V115, P713, DOI 10.1182/blood-2009-03-206367
   Siljander PRM, 2011, THROMB RES, V127, pS30, DOI 10.1016/S0049-3848(10)70152-3
   THOMSON JM, 1983, CLIN LAB HAEMATOL, V5, P413
   Van der Zee PM, 2006, CLIN CHEM, V52, P657, DOI 10.1373/clinchem.2005.057414
   Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011
   Wenzel F, 2012, PLATELETS, V23, P150, DOI 10.3109/09537104.2011.599897
NR 45
TC 13
Z9 13
U1 1
U2 13
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 159
EP 170
DI 10.3233/CH-141876
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900013
PM 25227196
DA 2018-10-19
ER

PT J
AU Kruger, A
   Mayer, A
   Roch, T
   Schulz, C
   Lendlein, A
   Jung, F
AF Krueger, Anne
   Mayer, Anke
   Roch, Toralf
   Schulz, Christian
   Lendlein, Andreas
   Jung, Friedrich
TI Angiogenically stimulated alternative monocytes maintain their
   pro-angiogenic and non-inflammatory phenotype in long-term co-cultures
   with HUVEC
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Angiogenically stimulated alternative monocytes; endothelialization;
   biomaterials; hemocompatible surface
ID ENDOTHELIAL GROWTH-FACTOR; POLY(N-BUTYL ACRYLATE) NETWORKS; PROGENITOR
   CELLS; ESSENTIAL MEDIATORS; OXIDATIVE STRESS; VEIN GRAFT; IN-VITRO;
   BIOMATERIALS; ADHESION; MONOCYTES/MACROPHAGES
AB Angiogenically stimulated alternative monocytes (aMO2) could be established as cellular release system accelerating the endothelialization of polymers rendering their surfaces hemocompatibility in a short-term study. However, for their clinical application it is essential that aMO2 do not switch back to the MO1 state sustaining their capability as cellular release system over an extended period of time.
   We explored whether aMO2 can maintain their differentiation state over 21 days in a mono-and in a co-culture with HUVEC. In comparison, the influence of recombinant VEGF-A(165) on the endothelialization of biomaterials was assessed including endothelial cell (HUVEC) density, organisation of the endothelial cytoskeleton, cytokine secretion profile and release of prostacyclin, thromboxane A2 and matrix metalloproteinases.
   In mono-culture aMO2 secreted high amounts of VEGF and other growth factors/cytokines. Co-cultured with HUVEC, aMO2 accelerated the formation of a confluent HUVEC monolayer. Furthermore, no pro-inflammatory cytokines were found, neither in aMO2-mono, nor in co-cultures with HUVEC indicating that the majority of the aMO2 remained stable in their aMO2 state during the 21 days of cultivation.
   In contrast, the addition of recombinant VEGF-A(165) instead of the co-culture with aMO2 resulted in the formation of stress fibres, dissociated marginal filament bands, and a detachment of HUVEC. In addition, the profile of bioactive agents of HUVEC (e. g. prostacyclin, thromboxane A2, matrix metalloproteinases, IFN-gamma and TNF-alpha) was influenced by the VEGF-A(165) treatment inducing the detachment of HUVEC.
   In conclusion, in co-culture with HUVEC aMO2 remained stable in their type 2 state over 21 days confirming the suitability of aMO2 as biological release system for the endothelialization of biomaterial surfaces with constant release of angiogenic factors but without secretion of pro-inflammatory cytokines over three weeks. Therefore, this endothelialization approach seems to be appropriate to improve the hemocompatibility of cardiovascular implant materials in vitro, and proved to be superior to the use of recombinant VEGF-A(165).
C1 [Krueger, Anne; Mayer, Anke; Roch, Toralf; Schulz, Christian; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Inst Biomat Sci, D-14513 Teltow, Germany.
   [Krueger, Anne; Mayer, Anke; Roch, Toralf; Schulz, Christian; Lendlein, Andreas; Jung, Friedrich] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, D-14513 Teltow, Germany.
   [Roch, Toralf; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Lendlein, Andreas; Jung, Friedrich] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Jung, F (reprint author), Helmholtz Zentrum Geesthacht, Inst Biomat Sci, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de; friedrich.jung@hzg.de
RI Lendlein, Andreas/K-9553-2013; Jung, Friedrich/L-1301-2013
OI Lendlein, Andreas/0000-0003-4126-4670; Jung,
   Friedrich/0000-0001-8098-7180; Roch, Toralf/0000-0003-2948-8700
FU Bundesministerium fur Bildung und Forschung (BMBF) [0315696A]
FX The authors thank Stefanie Dietze and Angela Ritschel for assistance and
   the Bundesministerium fur Bildung und Forschung (BMBF, project number
   0315696A "Poly4Bio") for funding this study.
CR ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Avci-Adali M, 2011, EUR CELLS MATER, V21, P157, DOI 10.22203/eCM.v021a13
   Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   Chiarugi P, 2003, J CELL BIOL, V161, P933, DOI 10.1083/jcb.200211118
   Fadini GP, 2012, CLIN HEMORHEOL MICRO, V50, P293, DOI 10.3233/CH-2011-1437
   Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358
   Forte A, 2014, CLIN SCI, V127, P615, DOI 10.1042/CS20140131
   Funahashi Y, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-2
   Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008
   Hoepken S, 2009, CLIN HEMORHEOL MICRO, V43, P157, DOI 10.3233/CH-2009-1230
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kruger A, 2012, CLIN HEMORHEOL MICRO, V52, P283, DOI 10.3233/CH-2012-1605
   Li BW, 2013, CLIN HEMORHEOL MICRO, V54, P345, DOI 10.3233/CH-121647
   Li S, 2011, ANNU REV BIOMED ENG, V13, P451, DOI 10.1146/annurev-bioeng-071910-124733
   Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5
   Maulucci G, 2010, BIOPHYS J, V98, p576A, DOI 10.1016/j.bpj.2009.12.3131
   Mayer A, 2011, CLIN HEMORHEOL MICRO, V49, P423, DOI 10.3233/CH-2011-1492
   Mayer A, 2010, CLIN HEMORHEOL MICRO, V46, P217, DOI 10.3233/CH-2010-1348
   Mayer A, 2012, ACTA BIOMATER, V8, P4253, DOI 10.1016/j.actbio.2012.08.011
   Mayer A, 2012, ARTIF ORGANS, V36, pE28, DOI 10.1111/j.1525-1594.2011.01410.x
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   Menu P, 2012, BIO-MED MATER ENG, V22, P17, DOI 10.3233/BME-2012-0685
   Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5
   Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894
   Monahan TS, 2009, SEMIN VASC SURG, V22, P216, DOI 10.1053/j.semvascsurg.2009.10.003
   Munzel T, 2010, EUR HEART J, V31, P2741, DOI 10.1093/eurheartj/ehq396
   Ozaki CK, 2007, J VASC SURG, V45, p92A, DOI 10.1016/j.jvs.2007.02.032
   Pernagallo S, 2012, ADV HEALTHC MATER, V1, P646, DOI 10.1002/adhm.201200130
   Piret G, 2011, SOFT MATTER, V7, P8642, DOI 10.1039/c1sm05838j
   Prasad CK, 2008, ACTA BIOMATER, V4, P182, DOI 10.1016/j.actbio.2007.05.012
   Pries A. R., 2006, V176, P1
   Re F, 2010, J BIOTECHNOL, V156, P341
   Rocher C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084009
   Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661
   Saeidnia S, 2013, TOXICOL APPL PHARM, V273, P442, DOI 10.1016/j.taap.2013.09.031
   Stannard AK, 2007, ARTERIOSCL THROM VAS, V27, P494, DOI 10.1161/01.ATV.000025309.38699.6c
   Stoltz JF, 1999, J MAL VASCUL, V24, P99
   Tan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077112
   Trescher K, 2013, J BIOTECHNOL, V166, P58, DOI 10.1016/j.jbiotec.2013.04.012
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Veremeyko T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081774
   Vouret-Craviari V, 2002, J CELL SCI, V115, P2475
   Wischke C, 2013, EUR J PHARM BIOPHARM, V84, P288, DOI 10.1016/j.ejpb.2013.01.025
   Wu KK, 1996, ANNU REV MED, V47, P315
NR 46
TC 1
Z9 1
U1 1
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 58
IS 1
BP 229
EP 240
DI 10.3233/CH-141875
PG 12
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AS3GP
UT WOS:000344165900019
PM 25227195
DA 2018-10-19
ER

PT J
AU Routray, W
   Orsat, V
   Gariepy, Y
AF Routray, Winny
   Orsat, Valerie
   Gariepy, Yvan
TI Effect of Different Drying Methods on the Microwave Extraction of
   Phenolic Components and Antioxidant Activity of Highbush Blueberry
   Leaves
SO DRYING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 19th International Drying Symposium (IDS)
CY AUG 24-27, 2014
CL Lyon, FRANCE
DE Antioxidant activity; Blueberry leaf; Drying; Drying rate; Phenolic
   compound
ID GRAPE POMACE; PLANT-EXTRACTS; BAY LEAVES; ANTHOCYANINS; CAPACITY;
   STABILITY; STRAWBERRIES; PARAMETERS; VEGETABLES; RETENTION
AB In the last few decades, researchers have found blueberry leaves to be an interesting source of different phenolic compounds, and drying is an important part of their postharvest and sample preparation processes. In the current study, blueberry leaves were dried using microwave-assisted hot air drying or hot air drying alone at 45, 60, and 75 degrees C to 10-15% wet basis. Corresponding drying characteristics were determined by fitting the moisture ratio obtained in each case with eight theoretical and semitheoretical models for hot air and microwave drying stages. It was observed that best fitting drying models for blueberry leaves depended not only on the nature of the biomaterial but also on the method of drying and the temperature of drying. Phenolic content, monomeric anthocyanin content, and the corresponding antioxidant activity in terms of 2,2-diphenyl-1-picrylhydrazyl (DPPH) inhibition activity and ferric reducing ability of plasma (FRAP) activity were evaluated for the leaf extract obtained following microwave extraction of the dried samples obtained using the above-mentioned drying methods and were compared to the corresponding bioactive compositional characteristics of freeze-dried blueberry leaves. It was observed that the freeze-dried sample had the highest content of total phenolics and total monomeric anthocyanins along with high antioxidant activity. Furthermore, extracts obtained from the microwave-dried leaf samples obtained with a drying temperature of 60 degrees C had highest total phenolic content and highest total monomeric anthocyanin content among all other drying methods and the extract had an antioxidant activity similar to the freeze-dried blueberry leaf samples, implying that microwave drying at 60 degrees C is a potential alternative to freeze drying for preservation of the phenolic components and antioxidant activity of dried blueberry leaves.
C1 [Routray, Winny; Orsat, Valerie; Gariepy, Yvan] McGill Univ, Dept Bioresource Engn, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
RP Routray, W (reprint author), McGill Univ, Dept Bioresource Engn, Macdonald Campus,21111 Lakeshore Rd, Ste Anne De Bellevue, PQ H9X 3V9, Canada.
EM routrayw@yahoo.com
RI Orsat, Valerie/L-4875-2015
OI Routray, Winny/0000-0003-3761-7592
FU Natural Sciences and Engineering Research Council of Canada
FX The authors acknowledge financial support from the Natural Sciences and
   Engineering Research Council of Canada.
CR ADAMS GDJ, 1991, DRY TECHNOL, V9, P891, DOI 10.1080/07373939108916727
   Akpinar EK, 2006, J FOOD ENG, V77, P864, DOI 10.1016/j.jfoodeng.2005.08.014
   Alibas I, 2009, DRY TECHNOL, V27, P1266, DOI 10.1080/07373930903267773
   Asami DK, 2003, J AGR FOOD CHEM, V51, P1237, DOI 10.1021/jf020635c
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6
   Chatterjee A, 2004, MOL CELL BIOCHEM, V265, P19, DOI 10.1023/B:MCBI.0000044310.92444.ec
   Chen YG, 2013, DRY TECHNOL, V31, P1114, DOI 10.1080/07373937.2013.775587
   Cyboran S, 2013, FOOD BIOPHYS, V8, P321, DOI 10.1007/s11483-013-9309-0
   Del B C., 2012, J AGR FOOD CHEM, V60, P9298
   Demir V, 2004, BIOSYST ENG, V88, P325, DOI 10.1016/j.biosystemseng.2004.04.005
   Doymaz, 2013, HEAT MASS TRANSFER, V49, P835
   Doymaz, 2006, J FOOD ENG, V77, P559
   Doymaz I, 2006, J FOOD ENG, V74, P370, DOI 10.1016/j.jfoodeng.2005.03.009
   Doymaz I, 2009, J FOOD PROCESS ENG, V32, P112, DOI 10.1111/j.1745-4530.2007.00205.x
   Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r
   Duy JC, 1999, THESIS ACADIA U WOLF
   Ehlenfeldt MK, 2001, J AGR FOOD CHEM, V49, P2222, DOI 10.1021/jf0013656
   Gabriel C, 1998, CHEM SOC REV, V27, P213, DOI 10.1039/a827213z
   Giusti M. M., 2005, HDB FOOD ANAL CHEM P
   Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018
   Gunhan T, 2005, ENERG CONVERS MANAGE, V46, P1667, DOI 10.1016/j.enconman.2004.10.001
   Hellstrom J, 2013, J FOOD COMPOS ANAL, V31, P12, DOI 10.1016/j.jfca.2013.02.010
   Hoch WA, 2001, TREE PHYSIOL, V21, P1
   Hokkanen J, 2009, J AGR FOOD CHEM, V57, P9437, DOI 10.1021/jf9022542
   Keinanen M, 1996, J AGR FOOD CHEM, V44, P2724, DOI 10.1021/jf960168x
   Kelebek H, 2013, J SCI FOOD AGR, V93, P2963, DOI 10.1002/jsfa.6125
   Khanal RC, 2010, FOOD RES INT, V43, P1464, DOI 10.1016/j.foodres.2010.04.018
   Kratchanova M, 2004, CARBOHYD POLYM, V56, P181, DOI 10.1016/j.carbpol.2004.01.009
   Kubrakova IV, 2008, INORG MATER+, V44, P1509, DOI 10.1134/S0020168508140069
   Larrauri JA, 1997, J AGR FOOD CHEM, V45, P1390, DOI 10.1021/jf960282f
   Martineau LC, 2006, PHYTOMEDICINE, V13, P612, DOI 10.1016/j.phymed.2006.08.005
   Matsuo Y, 2010, FOOD CHEM, V121, P1073, DOI 10.1016/j.foodchem.2010.01.052
   Midilli A, 2003, ENERG CONVERS MANAGE, V44, P1111, DOI 10.1016/S0196-8904(02)00099-7
   Miliauskas G, 2004, FOOD CHEM, V85, P231, DOI 10.1016/j.foodchem.2003.05.007
   Mishra DK, 2008, J FOOD SCI, V73, pE9, DOI 10.1111/j.1750-3841.2007.00598.x
   Mujumdar A, 2006, HDB IND DRYING
   Nemes S. M., 2012, PRACTICAL METHODS LI
   Neto CC, 2007, MOL NUTR FOOD RES, V51, P652, DOI 10.1002/mnfr.200600279
   Orsat V, 2007, FOOD BIOPROD PROCESS, V85, P255, DOI 10.1205/fbp07019
   Ozdemir M, 1999, J FOOD ENG, V42, P225, DOI 10.1016/S0260-8774(99)00126-0
   Ozsen D, 2013, FOOD BIOPROCESS TECH, V6, P2261, DOI 10.1007/s11947-012-0910-x
   Park YJ, 2011, J FOOD SCI, V76, pM101, DOI 10.1111/j.1750-3841.2010.01974.x
   Piljac-Zegarac J, 2009, J MED FOOD, V12, P608, DOI 10.1089/jmf.2008.0081
   Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698
   Proestos C, 2008, LWT-FOOD SCI TECHNOL, V41, P652, DOI 10.1016/j.lwt.2007.04.013
   Raghavan GSV, 2001, DRY TECHNOL, V19, P405, DOI 10.1081/DRT-100102913
   Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025
   Routray W., 2012, IND CROP PROD, V58, P36
   Routray W, 2014, PHYS CHEM LIQ, V52, P209, DOI 10.1080/00319104.2013.812022
   Routray W, 2012, FOOD BIOPROCESS TECH, V5, P409, DOI 10.1007/s11947-011-0573-z
   Routray W, 2011, COMPR REV FOOD SCI F, V10, P303, DOI 10.1111/j.1541-4337.2011.00164.x
   Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008
   SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144
   Soysal Y, 2004, BIOSYST ENG, V89, P167, DOI 10.1016/j.biosystemseng.2004.07.008
   Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945
   Therdthai N, 2009, J FOOD ENG, V91, P482, DOI 10.1016/j.jfoodeng.2008.09.031
   Tseng A, 2012, J FOOD SCI, V77, pH192, DOI 10.1111/j.1750-3841.2012.02840.x
   Velioglu YS, 1998, J AGR FOOD CHEM, V46, P4113, DOI 10.1021/jf9801973
   Venkatachalapathy K, 1999, DRY TECHNOL, V17, P837, DOI 10.1080/07373939908917573
   Vivekananda Mandal, 2007, Pharmacognosy Reviews, V1, P7
   Vyas P, 2013, J AGR FOOD CHEM, V61, P7769, DOI 10.1021/jf401158a
   Waterhouse A. L., 2005, HDB FOOD ANAL CHEM P
   Wojdylo A, 2009, J AGR FOOD CHEM, V57, P1337, DOI 10.1021/jf802507j
   Yaldiz O, 2001, DRY TECHNOL, V19, P583, DOI 10.1081/DRT-100103936
NR 65
TC 16
Z9 16
U1 2
U2 33
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0737-3937
EI 1532-2300
J9 DRY TECHNOL
JI Dry. Technol.
PY 2014
VL 32
IS 16
BP 1888
EP 1904
DI 10.1080/07373937.2014.919002
PG 17
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA AS1TL
UT WOS:000344064100002
DA 2018-10-19
ER

PT J
AU Diez-Pascual, AM
   Diez-Vicente, AL
AF Diez-Pascual, Ana M.
   Diez-Vicente, Angel L.
TI Effect of TiO2 nanoparticles on the performance of polyphenylsulfone
   biomaterial for orthopaedic implants
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID THERMOMECHANICAL BEHAVIOR; ANTIBACTERIAL PROPERTIES;
   MECHANICAL-PROPERTIES; NANOCOMPOSITES; MEMBRANES; TITANIUM;
   BIONANOCOMPOSITES; COMPOSITES; POLYSULFONES; NANOTUBES
AB Nanocomposites of biocompatible polyphenylsulfone (PPSU) and titanium dioxide (TiO2) nanoparticles have been prepared via ultrasonication and solution casting. Their structure, surface morphology, water uptake, thermal, mechanical, tribological and antibacterial properties have been investigated in detail. FT-IR analysis revealed the existence of strong hydrogen bonding interactions between the sulfone group of PPSU and the hydroxyl moieties of the nanoparticles, which were homogenously dispersed within the matrix without adding coupling agents. The incorporation of TiO2 reduced the water absorption and increased the thermal stability of the polymer under both inert and oxidative conditions. Furthermore, the nanocomposites exhibited greatly enhanced mechanical performance (storage and Young's moduli, tensile strength and toughness, glass transition and heat distortion temperature) compared to neat PPSU, confirming the formation of a strong nanofiller-matrix interface necessary for an efficient load transfer. Moreover, their tensile properties were retained after exposure to several cycles of steam sterilization or to simulated body fluid (SBF) at physiological temperature. Outstanding improvements in the tribological performance under both dry and SBF conditions were also attained, demonstrating the suitability of these nanoparticles for providing wear resistance to the matrix. The nanocomposites exhibited inhibition against both Gram-positive and Gram-negative bacteria with and without UV illumination, which was progressively enhanced with increasing TiO2 loading. These biomaterials are very promising for use in biomedical applications like orthopaedic and trauma implants.
C1 [Diez-Pascual, Ana M.] Univ Alcala de Henares, Fac Biol Environm Sci & Chem, Analyt Chem Phys Chem & Chem Engn Dept, E-28871 Alcala De Henares, Spain.
   [Diez-Pascual, Ana M.] CSIC, ICTP, Inst Polymer Sci & Technol, E-28006 Madrid, Spain.
   [Diez-Vicente, Angel L.] Airbus Operat SL, Madrid 28906, Spain.
RP Diez-Pascual, AM (reprint author), Univ Alcala de Henares, Fac Biol Environm Sci & Chem, Analyt Chem Phys Chem & Chem Engn Dept, E-28871 Alcala De Henares, Spain.
EM am.diez@uah.es
FU Ministerio de Economia y Competitividad (MINECO); EU
FX Dr Ana Diez-Pascual wishes to acknowledge the Ministerio de Economia y
   Competitividad (MINECO) for the "Ramon y Cajal" Senior Research
   Fellowship co-financed by the EU.
CR Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004
   Alexander L. E., 1969, XRAY DIFFRACTION MET
   Ashokkumar M, 2013, PROG BIOMATER, V2, P1, DOI [10.1186/2194-0517-2-2, DOI 10.1186/2194-0517-2-2]
   Barnard AS, 2008, ACS NANO, V2, P2237, DOI 10.1021/nn800446w
   Belfer S, 2000, J MEMBRANE SCI, V172, P113, DOI 10.1016/S0376-7388(00)00316-1
   Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205
   CALLEJA FJB, 1985, ADV POLYM SCI, V66, P117
   Chang L, 2006, WEAR, V260, P869, DOI 10.1016/j.wear.2005.04.002
   Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535
   Colthup N. B., 1990, INTRO INFRARED RAMAN
   Dalai S, 2014, B MATER SCI, V37, P371, DOI 10.1007/s12034-014-0680-3
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P10132, DOI 10.1021/am501610p
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P9822, DOI 10.1021/am502261e
   Diez-Pascual AM, 2014, INT J MOL SCI, V15, P10950, DOI 10.3390/ijms150610950
   Diez-Pascual AM, 2014, J MATER CHEM B, V2, P3065, DOI 10.1039/c3tb21800g
   Diez-Pascual AM, 2014, ACS APPL MATER INTER, V6, P3729, DOI 10.1021/am500171x
   Diez-Pascual AM, 2013, COMPOS PART A-APPL S, V54, P10, DOI 10.1016/j.compositesa.2013.06.018
   Diez-Pascual AM, 2013, MATERIALS, V6, P3171, DOI 10.3390/ma6083171
   Diez-Pascual AM, 2012, PROG MATER SCI, V57, P1106, DOI 10.1016/j.pmatsci.2012.03.003
   Diez-Pascual AM, 2010, CARBON, V48, P3500, DOI 10.1016/j.carbon.2010.05.050
   Duan YJ, 2009, J MACROMOL SCI B, V48, P604, DOI 10.1080/00222340902837899
   El-Hibri M. Jj, 2000, POLYM CONTAINING SUL
   Forati T, 2014, POLYM ADVAN TECHNOL, V25, P322, DOI 10.1002/pat.3243
   Gaur MS, 2013, J THERM ANAL CALORIM, V111, P743, DOI 10.1007/s10973-012-2357-8
   Gonzalez-Benito J, 2013, EUR POLYM J, V49, P1747, DOI 10.1016/j.eurpolymj.2013.04.023
   HANKS JH, 1949, P SOC EXP BIOL MED, V71, P196
   Jaszkiewicz A, 2013, J APPL POLYM SCI, V130, P3175, DOI 10.1002/app.39562
   Jones PJ, 2011, J APPL POLYM SCI, V121, P2945, DOI 10.1002/app.33852
   Jose AJ, 2013, APPL CLAY SCI, V71, P64, DOI 10.1016/j.clay.2012.11.003
   Jose AJ, 2012, INT J POLYM MATER, V61, P544, DOI 10.1080/00914037.2011.593065
   Kubacka A, 2012, TITANIUM DIOXIDE POL, P119
   Li JF, 2009, APPL SURF SCI, V255, P4725, DOI 10.1016/j.apsusc.2008.07.139
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mallakpour S, 2013, J CHIL CHEM SOC, V58, P1603, DOI 10.4067/S0717-97072013000100022
   Mital G. S., 2011, CHINESE SCI BULL, V56, P1639
   Molnar G, 2005, POLYM DEGRAD STABIL, V89, P410, DOI 10.1016/j.polymdegradstab.2005.01.031
   Murayama T, 1978, DYNAMIC MECH ANAL PO
   Naffakh M, 2014, J MATER CHEM B, V2, P4509, DOI 10.1039/c4tb00557k
   Nayak L, 2011, POLYM BULL, V67, P1029, DOI 10.1007/s00289-011-0479-y
   Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x
   Nyquist R. A., 1971, INFRARED SPECTRA INO, P214
   Perego C, 2010, SOLID STATE SCI, V12, P989, DOI 10.1016/j.solidstatesciences.2009.07.021
   Richards H.L., 2012, J SURF ENG MAT ADV T, V2, P183, DOI DOI 10.4236/JSEMAT.2012.223029
   Sagomonyants KB, 2008, BIOMATERIALS, V29, P1563, DOI 10.1016/j.biomaterials.2007.12.001
   Sayes CM, 2006, TOXICOL SCI, V92, P174, DOI 10.1093/toxsci/kfj197
   Schank K., 1988, CHEM SULPHONES SULPH, P54
   Touloukian Y. S., 1970, THERMOPHYSICAL PROPE, V2, P208
   Van der Bruggen B, 2009, J APPL POLYM SCI, V114, P630, DOI 10.1002/app.30578
   VANKREVELEN DW, 1975, POLYMER, V16, P615, DOI 10.1016/0032-3861(75)90157-3
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Wang HT, 2009, FIBER POLYM, V10, P1, DOI 10.1007/s12221-009-0001-4
   Wang M, 1998, J BIOMED MATER RES, V42, P577, DOI 10.1002/(SICI)1097-4636(19981215)42:4<577::AID-JBM14>3.0.CO;2-2
   WELLINGHOFF ST, 1978, J APPL POLYM SCI, V22, P2025, DOI 10.1002/app.1978.070220723
   Williams D. F., 1973, IMPLANTS SURG, P173
   Wu GP, 2008, APPL SURF SCI, V254, P7080, DOI 10.1016/j.apsusc.2008.05.221
   Wu JY, 2014, NANOMED-NANOTECHNOL, V10, P1097, DOI 10.1016/j.nano.2014.01.002
   Yang YN, 2007, J MEMBRANE SCI, V288, P231, DOI 10.1016/j.memsci.2006.11.019
   Zhang MY, 2012, WATER RES, V46, P2077, DOI 10.1016/j.watres.2012.01.015
NR 58
TC 20
Z9 20
U1 4
U2 29
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 43
BP 7502
EP 7514
DI 10.1039/c4tb01101e
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AS0TZ
UT WOS:000343992700004
DA 2018-10-19
ER

PT J
AU Robert-Nicoud, G
   Donno, R
   Cadman, CJ
   Alexander, MR
   Tirelli, N
AF Robert-Nicoud, Ghislaine
   Donno, Roberto
   Cadman, Christopher J.
   Alexander, Morgan R.
   Tirelli, Nicola
TI Surface modification of silicone via colloidal deposition of amphiphilic
   block copolymers
SO POLYMER CHEMISTRY
LA English
DT Article
ID IMPLANTABLE GLUCOSE SENSORS; HYDROPHOBIC RECOVERY; BACTERIAL ATTACHMENT;
   PROTEIN ADSORPTION; CELL-ADHESION; POLY(DIMETHYLSILOXANE); POLYMERS;
   BIOCOMPATIBILITY; HYDROGELS; COATINGS
AB We report here on a method to functionalize silicone surfaces, which is based on the deposition of silicone-containing amphiphilic block copolymers from a colloidal water-ethanol dispersion. Using crosslinked silicones (Sylgard 184) as substrates, copolymers composed of two poly(glycerol monomethacrylate) (PGMMA) terminal blocks and a central poly(dimethylsiloxane) (PDMS) block can be effectively deposited when the PDMS content is >= 46 wt%. (>= 65 mol%); the deposition provides smooth and stable surfaces, which significantly affected the protein adsorption behaviour of the substrate, suggesting a possible application in biomaterial coating. In air, the block copolymer surface films underwent a reorganization, which differs from the classical hydrophobic recovery of silicones and may be related to a disordered folding of lamellar structures. This led to a predominant surface coverage by thin, possibly monomolecular layers, which displayed a non-restructuring polar surface. However, as a consequence of the reorganization also larger aggregates were produced, albeit in relatively small numbers; these aggregates underwent a progressive hydrophobization (in this case a hydrophobic recovery) and probably dominated the contact angle behaviour of the material. In summary, the colloidal deposition of amphiphilic silicone-based block copolymers successfully modifies the surface properties of silicone substrates; however, attention must paid to reorganization phenomena in order to maximize the stability of the coating.
C1 [Robert-Nicoud, Ghislaine; Donno, Roberto; Tirelli, Nicola] Univ Manchester, Inst Inflammat & Repair, Sch Med, Manchester M13 9PT, Lancs, England.
   [Cadman, Christopher J.] Univ Manchester, Sch Pharm, Manchester M13 9PT, Lancs, England.
   [Alexander, Morgan R.] Univ Nottingham, Sch Pharm, Nottingham NG7 2RD, England.
   [Tirelli, Nicola] Univ Manchester, Sch Mat, Manchester M13 9PT, Lancs, England.
RP Tirelli, N (reprint author), Univ Manchester, Inst Inflammat & Repair, Sch Med, Oxford Rd, Manchester M13 9PT, Lancs, England.
EM nicola.tirelli@manchester.ac.uk
RI Tirelli, Nicola/P-7210-2014; Tirelli, Nicola/P-3604-2018; Alexander,
   Morgan/C-2506-2009
OI Tirelli, Nicola/0000-0002-4879-3949; Tirelli,
   Nicola/0000-0002-4879-3949; Alexander, Morgan/0000-0001-5182-493X;
   Donno, Roberto/0000-0003-3175-2742
FU EPSRC [EP/F019750/1]; Engineering and Physical Sciences Research Council
   [EP/F019750/1]
FX Dr Christopher Cadman and Dr Roberto Donno gratefully acknowledge EPSRC
   for PhD studentships, the latter in the framework of the EPSRC-funded
   North West Nanoscience Doctoral Training Centre (NoWNano DTC). Finally,
   the authors wish to also acknowledge the support from the EPSRC grant
   EP/F019750/1 (A coordinated open-access centre for comprehensive
   materials analysis) to perform XPS measurements.
CR Abbasi F, 2003, J POLYM SCI POL PHYS, V41, P2145, DOI 10.1002/polb.10559
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Beamson G., 2000, XPS POLYM DATABASE
   Campbell DJ, 1999, J CHEM EDUC, V76, P1205
   Chen H, 2005, BIOMATERIALS, V26, P2391, DOI 10.1016/j.biomaterials.2004.07.068
   CHINN JA, 1992, J BIOMED MATER RES, V26, P757, DOI 10.1002/jbm.820260606
   Clifford CA, 2005, APPL SURF SCI, V252, P1915, DOI 10.1016/j.apsusc.2005.08.090
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Everaert EP, 1996, J ADHES SCI TECHNOL, V10, P351, DOI 10.1163/156856196X00751
   FreijLarsson C, 1996, BIOMATERIALS, V17, P2199, DOI 10.1016/0142-9612(96)00050-6
   Galler N, 2011, APPL PHYS B-LASERS O, V104, P931, DOI 10.1007/s00340-011-4664-3
   Geelhood SJ, 2007, J BIOMED MATER RES B, V81B, P251, DOI 10.1002/jbm.b.30660
   Giacomelli C, 2007, MACROMOLECULES, V40, P2148, DOI 10.1021/ma062562u
   Goncalves IC, 2011, J MATER SCI-MATER M, V22, P2053, DOI 10.1007/s10856-011-4381-9
   Haigh R, 2000, BIOMATERIALS, V21, P735, DOI 10.1016/S0142-9612(99)00245-8
   Hao XJ, 2010, BIOMATERIALS, V31, P8153, DOI 10.1016/j.biomaterials.2010.07.065
   HARDING JW, 1945, P CAMB PHILOS SOC, V41, P16
   Hillborg H, 2004, LANGMUIR, V20, P785, DOI 10.1021/la035552k
   Hillborg H, 1998, POLYMER, V39, P1991, DOI 10.1016/S0032-3861(97)00484-9
   Hook AL, 2013, ADV MATER, V25, P2542, DOI 10.1002/adma.201204936
   Hook AL, 2012, NAT BIOTECHNOL, V30, P868, DOI 10.1038/nbt.2316
   Hsu HL, 2010, ADV MATER, V22, P2177, DOI 10.1002/adma.200903413
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Johnson C, 2010, MACROMOL SYMP, V291-292, P314, DOI 10.1002/masy.201050537
   KOTTKEMARCHANT K, 1989, BIOMATERIALS, V10, P147, DOI 10.1016/0142-9612(89)90017-3
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Lee S, 2004, MACROMOLECULES, V37, P8349, DOI 10.1021/ma049076w
   Li M, 2012, LANGMUIR, V28, P16408, DOI 10.1021/la303438t
   Lopez AI, 2011, BIOMATERIALS, V32, P4336, DOI 10.1016/j.biomaterials.2011.02.056
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Mequanint K, 2006, BIOMACROMOLECULES, V7, P883, DOI 10.1021/bm0507047
   Merel P, 1998, APPL SURF SCI, V136, P105, DOI 10.1016/S0169-4332(98)00319-5
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   O'Hare LA, 2007, SURF INTERFACE ANAL, V39, P926, DOI 10.1002/sia.2634
   Olah A, 2005, APPL SURF SCI, V239, P410, DOI 10.1016/j.apsusc.2004.06.005
   Patrucco E, 2009, BIOMACROMOLECULES, V10, P3130, DOI 10.1021/bm900856r
   QUINN KJ, 1988, BRIT POLYM J, V20, P25, DOI 10.1002/pi.4980200106
   Rambarran T, 2012, MACROMOLECULES, V45, P2276, DOI 10.1021/ma202785x
   Rimmer S, 2007, BIOMATERIALS, V28, P5319, DOI 10.1016/j.biomaterials.2007.08.028
   Robert-Nicoud G, 2013, POLYM CHEM-UK, V4, P3458, DOI 10.1039/c3py00273j
   Roberts R. F., 1980, Surface and Interface Analysis, V2, P5, DOI 10.1002/sia.740020103
   Rozada R, 2013, NANO RES, V6, P216, DOI 10.1007/s12274-013-0298-6
   Sam SS, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-412
   Seo JH, 2008, BIOMATERIALS, V29, P1367, DOI 10.1016/j.biomaterials.2007.11.039
   Seo JH, 2011, SOFT MATTER, V7, P2968, DOI 10.1039/c0sm01292k
   Sivaraman B, 2010, BIOMATERIALS, V31, P1036, DOI 10.1016/j.biomaterials.2009.10.017
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   SODERQUIST ME, 1980, J COLLOID INTERF SCI, V75, P386, DOI 10.1016/0021-9797(80)90463-4
   Tugulu S, 2009, MACROMOL SYMP, V279, P103, DOI 10.1002/masy.200950516
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   Wan F, 2012, ACS APPL MATER INTER, V4, P4557, DOI 10.1021/am300912w
   Wang C, 2008, BIOMACROMOLECULES, V9, P561, DOI 10.1021/bm701102y
   Wang JJ, 2011, J MATER SCI-MATER M, V22, P2651, DOI 10.1007/s10856-011-4452-y
   Wolfram Dolores, 2004, J Autoimmun, V23, P81
   Wu MH, 2009, SURF INTERFACE ANAL, V41, P11, DOI 10.1002/sia.2964
   Wu ZQ, 2012, COLLOID SURFACE B, V96, P37, DOI 10.1016/j.colsurfb.2012.03.016
   Wu ZG, 2009, LAB CHIP, V9, P1500, DOI 10.1039/b901651a
   Yu K, 2006, SOFT MATTER, V2, P705, DOI 10.1039/b602880m
   Zhang ZY, 2011, COLLOID SURFACE B, V88, P85, DOI 10.1016/j.colsurfb.2011.06.019
NR 61
TC 5
Z9 5
U1 2
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9954
EI 1759-9962
J9 POLYM CHEM-UK
JI Polym. Chem.
PY 2014
VL 5
IS 23
BP 6687
EP 6701
DI 10.1039/c4py00941j
PG 15
WC Polymer Science
SC Polymer Science
GA AS6LG
UT WOS:000344374500009
OA Bronze
DA 2018-10-19
ER

PT J
AU Rubert, M
   Li, YF
   Dehli, J
   Taskin, MB
   Besenbacher, F
   Chen, ML
AF Rubert, Marina
   Li, Yan-Fang
   Dehli, Jeppe
   Taskin, Mehmet Berat
   Besenbacher, Flemming
   Chen, Menglin
TI Dexamethasone encapsulated coaxial electrospun PCL/PEO hollow
   microfibers for inflammation regulation
SO RSC ADVANCES
LA English
DT Article
ID FOREIGN-BODY RESPONSE; GLUCOCORTICOID-RECEPTOR; CONTROLLED-RELEASE;
   SCAFFOLDS; DELIVERY; FIBERS; DRUG; MECHANISMS; NANOFIBERS; SURFACES
AB One of the major challenges in the field of biomaterials is to develop strategies to regulate the innate host inflammatory response. Coaxial electrospun PCL/PEO hollow fibers containing dexamethasone were evaluated for a local delivery of dexamethasone to reduce adverse inflammation responses often resulting from biomaterial implantation. Core-shell PCL/PEO hollow fibers with a highly porous surface were successfully developed using coaxial electrospinning. The release of dexamethasone exhibited a burst release during the first 0.5-3 h followed by a sustained release over more than 12 days. In vitro study showed that the dexamethasone encapsulated coaxial PCL/PEO hollow fibers significantly reduced cell proliferation of LPS-stimulated macrophages and meanwhile significantly decreased the mRNA expression levels of the pro-inflammatory cytokines TNF-alpha and IL-1 beta. The dexamethasone encapsulated coaxial PCL/PEO hollow microfibers are promising biomaterials for implantation to combat the acute inflammation responses which take place during first 24-48 h after biomaterial implantation and meanwhile to regulate possible hostile chronic inflammations, thus increasing the efficacy and longevity of the implants in vivo.
C1 [Rubert, Marina; Li, Yan-Fang; Dehli, Jeppe; Taskin, Mehmet Berat; Besenbacher, Flemming; Chen, Menglin] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
   [Li, Yan-Fang] Cent China Normal Univ, Inst Nanosci & Nanotechnol, Wuhan 430079, Peoples R China.
RP Chen, ML (reprint author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark.
EM menglin@inano.au.dk
RI Rubert, Marina/A-3935-2010; Li, Yanfang/I-9370-2016
OI Li, Yanfang/0000-0002-1487-365X; Chen, Menglin/0000-0002-2721-651X;
   Taskin, Mehmet Berat/0000-0002-4836-1097
FU Danish Council for Strategic Research; Lundbeck Foundation; Carlsberg
   Foundation
FX We gratefully acknowledge the Danish Council for Strategic Research for
   the funding to the ElectroMed Project at the iNANO Center, and the
   Lundbeck Foundation and the Carlsberg Foundation for their financial
   support. Marina Rubert and Yan-Fang Li contributed equally.
CR Almawi WY, 2002, J LEUKOCYTE BIOL, V71, P9
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Bridges Amanda W, 2008, J Diabetes Sci Technol, V2, P984
   Casper CL, 2004, MACROMOLECULES, V37, P573, DOI 10.1021/ma0351975
   Cui WG, 2006, BIOMACROMOLECULES, V7, P1623, DOI 10.1021/bm060057z
   Dalton PD, 2013, BIOMATER SCI-UK, V1, P171, DOI 10.1039/c2bm00039c
   Dawes GJS, 2010, J MATER SCI-MATER M, V21, P215, DOI 10.1007/s10856-009-3846-6
   Dror Y, 2007, SMALL, V3, P1064, DOI 10.1002/smll.200600536
   Ghag AK, 2014, BIOMATER SCI-UK, V2, P233, DOI 10.1039/c3bm60188a
   Gugutkov D, 2013, BIOMATER SCI-UK, V1, P1065, DOI 10.1039/c3bm60124b
   Hickey T, 2002, BIOMATERIALS, V23, P1649, DOI 10.1016/S0142-9612(01)00291-5
   Ito T, 2007, BIOMATERIALS, V28, P1778, DOI 10.1016/j.biomaterials.2006.12.012
   Ji W., 2010, PHARM RES, V28, P1259
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Li YF, 2014, NANOSCALE, V6, P3392, DOI 10.1039/c3nr06197c
   Man ZT, 2014, BIOMATERIALS, V35, P5250, DOI 10.1016/j.biomaterials.2014.03.031
   Moghe AK, 2008, POLYM REV, V48, P353, DOI 10.1080/15583720802022257
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nakatani Y, 2013, BIOL PHARM BULL, V36, P592
   Rujitanaroj PO, 2014, BIOMATER SCI-UK, V2, P843, DOI 10.1039/c3bm60245a
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009
   Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010
   Srouji S, 2010, TISSUE ENG PART A, V17, P269
   Vacanti NM, 2012, BIOMACROMOLECULES, V13, P3031, DOI 10.1021/bm300520u
   Wang XH, 2009, J ENDOCRINOL, V200, P35, DOI 10.1677/JOE-08-0340
   Webber MJ, 2012, BIOMATERIALS, V33, P6823, DOI 10.1016/j.biomaterials.2012.06.003
   Worz A, 2012, J MATER CHEM, V22, P19547, DOI 10.1039/c2jm30820g
   Yoon JJ, 2003, BIOMATERIALS, V24, P2323, DOI 10.1016/S0142-9612(03)00024-3
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
NR 33
TC 7
Z9 7
U1 1
U2 51
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 93
BP 51537
EP 51543
DI 10.1039/c4ra08358j
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6QK
UT WOS:000344387400063
DA 2018-10-19
ER

PT J
AU Panja, S
   Nayak, S
   Ghosh, SK
   Selvakumar, M
   Chattopadhyay, S
AF Panja, S.
   Nayak, S.
   Ghosh, S. K.
   Selvakumar, M.
   Chattopadhyay, S.
TI Self-assembly of a biodegradable branched PE-PCL-b-PEC amphiphilic
   polymer: synthesis, characterization and targeted delivery of
   doxorubicin to cancer cells
SO RSC ADVANCES
LA English
DT Article
ID BLOCK-COPOLYMER MICELLES; ANTICANCER DRUG-DELIVERY; PH-SENSITIVE
   MICELLES; TRIBLOCK COPOLYMERS; NANOPARTICLES; RELEASE; CARRIER;
   FUNCTIONALIZATION; BIOMATERIAL; CARBONATE)
AB A novel biodegradable branched block copolymer was synthesized by the ring-opening polymerization of ethylene carbonate using pre-synthesized four-armed pentaerythretol poly(epsilon-caprolactone) (PE-PCL) as a macro initiator. Folic acid was conjugated with the end-group of the block copolymer and self-assembled in water to form polymer micelles (PMs). The very low critical micelle concentration of the block copolymer suggests its potential application in advanced drug delivery systems. The PMs are spherical in shape and have an average size of 80 nm, which is suitable for the delivery of drugs. The hydrophobicity of pentaerythretol poly(epsilon-caprolactone) and its branched structure can accommodate high amounts of doxorubicin. Compared with a blank sample, PMs containing encapsulated doxorubicin show a much higher cytotoxicity towards HeLa cells. A high rate of release of doxorubicin in vitro at pH 5.0 shows that the system is responsive to pH. Confocal laser scanning microscopy showed that the doxorubicin-loaded PMs were internalized into the HeLa cells.
C1 [Panja, S.; Selvakumar, M.; Chattopadhyay, S.] Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
   [Nayak, S.; Ghosh, S. K.] Indian Inst Technol, Dept Biotechnol, Kharagpur 721302, W Bengal, India.
RP Chattopadhyay, S (reprint author), Indian Inst Technol, Ctr Rubber Technol, Kharagpur 721302, W Bengal, India.
EM santanuchat71@yahoo.com
FU UGC, New Delhi
FX SP is grateful to the UGC, New Delhi for sponsoring a fellowship. We
   acknowledge Mithu Baidya and Somnath Maji for their valuable
   suggestions.
CR Chan P, 2007, BIOMATERIALS, V28, P540, DOI 10.1016/j.biomaterials.2006.08.046
   Chang LL, 2012, BIOMACROMOLECULES, V13, P3301, DOI 10.1021/bm301086c
   Chen JI, 2013, MACROMOL BIOSCI, V13, P623, DOI 10.1002/mabi.201200396
   Chen JC, 2014, RSC ADV, V4, P9684, DOI 10.1039/c3ra47026a
   Chen S, 2008, BIOMACROMOLECULES, V9, P2578, DOI 10.1021/bm800371n
   Chen T, 2012, ACS APPL MATER INTER, V4, P5766, DOI 10.1021/am301223n
   Cheng YX, 2012, BIOMACROMOLECULES, V13, P2163, DOI 10.1021/bm300823y
   Esfandiar A. K. S. Behravesh, 2002, BIOMACROMOLECULES, V3, P153
   Fan JQ, 2012, BIOMACROMOLECULES, V13, P4126, DOI 10.1021/bm301424r
   Feng H, 2006, BIOMACROMOLECULES, V7, P3069, DOI 10.1021/bm060568l
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Hao Y, 2014, J MATER CHEM B, V2, P4237, DOI 10.1039/c4tb00334a
   Hu XL, 2008, J POLYM SCI POL CHEM, V46, P1852, DOI 10.1002/pola.22530
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Ishida T, 2005, J CONTROL RELEASE, V105, P305, DOI 10.1016/j.jconrel.2005.04.003
   Jin Y, 2011, BIOMACROMOLECULES, V12, P3460, DOI 10.1021/bm200956u
   Kelsch A, 2012, BIOMACROMOLECULES, V13, P4179, DOI 10.1021/bm301453g
   Li LY, 2010, BIOMACROMOLECULES, V11, P1882, DOI 10.1021/bm1004383
   Li Y, 2011, POLYMER, V52, P3304, DOI 10.1016/j.polymer.2011.05.049
   Li YY, 2006, BIOMACROMOLECULES, V7, P2956, DOI 10.1021/bm060080k
   Licciardi Y. T. M., 2005, BIOMACROMOLECULES, V6, P1085
   Lin WJ, 2014, J MATER CHEM B, V2, P4008, DOI 10.1039/c3tb21694b
   Liu Q, 2012, INT J PHARMACEUT, V430, P350, DOI 10.1016/j.ijpharm.2012.04.008
   Mi Y, 2011, BIOMATERIALS, V32, P4058, DOI 10.1016/j.biomaterials.2011.02.022
   Murat Acemoglu F. N., 1997, J CONTROL RELEASE, V49, P263
   Panja S, 2013, LANGMUIR, V29, P12530, DOI 10.1021/la401811c
   Park SH, 2008, MACROMOLECULES, V41, P6486, DOI 10.1021/ma800562s
   Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008
   Patil YB, 2009, BIOMATERIALS, V30, P859, DOI 10.1016/j.biomaterials.2008.09.056
   Prabaharan M, 2009, MACROMOL BIOSCI, V9, P515, DOI 10.1002/mabi.200800269
   Prateek Singh U. G., 2008, BIOCONJUGATE CHEM, V19, P2239
   Shim WS, 2006, MACROMOL BIOSCI, V6, P179, DOI 10.1002/mabi.200500182
   Sulistio A, 2011, BIOMACROMOLECULES, V12, P3469, DOI 10.1021/bm200604h
   Sun J, 2009, POLYMER, V50, P455, DOI 10.1016/j.polymer.2008.11.015
   Szebeni J, 2005, TOXICOLOGY, V216, P106, DOI 10.1016/j.tox.2005.07.023
   Unger F, 2007, J CONTROL RELEASE, V117, P312, DOI 10.1016/j.jconrel.2006.11.003
   Vincent Pourcelle S. D., 2007, BIOMACROMOLECULES, V8, P3977
   Wang DL, 2011, BIOMACROMOLECULES, V12, P1370, DOI 10.1021/bm200155t
   Wang YP, 2014, RSC ADV, V4, P24810, DOI 10.1039/c4ra03566f
   Wang Y, 2010, BIOMACROMOLECULES, V11, P3531, DOI 10.1021/bm101013s
   Wenjun Du Z. X., 2008, BIOCONJUGATE CHEM, V19, P2492
   Xu ZG, 2012, ACS APPL MATER INTER, V4, P3424, DOI 10.1021/am300877v
   Yang YQ, 2013, ACTA BIOMATER, V9, P7679, DOI 10.1016/j.actbio.2013.05.006
   Yu L, 2007, J POLYM SCI POL CHEM, V45, P1122, DOI 10.1002/pola.21876
   Yu L, 2013, BIOMATER SCI-UK, V1, P411, DOI 10.1039/c2bm00159d
   Yue J, 2012, SOFT MATTER, V8, P7426, DOI 10.1039/c2sm25456e
   Zhang CQ, 2014, ACS APPL MATER INTER, V6, P5212, DOI 10.1021/am5005267
   Zhang JX, 2006, J BIOMED MATER RES A, V76A, P773, DOI 10.1002/jbm.a.30604
   Zhou YF, 2009, CHEM COMMUN, P1172, DOI 10.1039/b814560c
   Zhu FX, 2014, POLYMER, V55, P2977, DOI 10.1016/j.polymer.2014.05.010
NR 50
TC 9
Z9 9
U1 2
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 93
BP 51766
EP 51775
DI 10.1039/c4ra08351b
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA AS6QK
UT WOS:000344387400095
DA 2018-10-19
ER

PT S
AU Cho, EH
   Boico, A
   Wisniewski, NA
   Gant, R
   Helton, KL
   Brown, NL
   Register, JK
   Vo-Dinh, T
   Schroeder, T
   Klitzman, B
AF Cho, Eugenia H.
   Boico, Alina
   Wisniewski, Natalie A.
   Gant, Rebecca
   Helton, Kristen L.
   Brown, Nga L.
   Register, Janna K.
   Vo-Dinh, Tuan
   Schroeder, Thies
   Klitzman, Bruce
BE Lee, LP
   Rogers, JA
   Yun, SHA
TI Microvascular Integration into Porous PolyHEMA Scaffold
SO BIOINSPIRED, BIOINTEGRATED, BIOENGINEERED PHOTONIC DEVICES II
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Bioinspired, Biointegrated, Bioengineered Photonic Devices
   II
CY FEB 01-02, 2014
CL San Francisco, CA
SP SPIE, SAMSUNG
DE biocompatibility; vascularization; mass transport; foreign body response
AB Biomaterials elicit foreign body responses when implanted into living tissue. While biocompatibility has been improved, the fundamental aspects of tissue responses to biomaterials and their in vivo evaluation remain poorly appreciated. Here, we quantified vascularization of porous poly2-hydroxyethylmethacrylate (polyHEMA) with 40 and 80 mu m nominal pore sizes at various time points after implantation in rat subcutis. Solid polyHEMA, silicone, and cotton materials were also studied for comparison. We observed vascularization into the material one week after implantation for both 40 and 80 mu m porous polyHEMA. The rate of vascularization was greater in 80 mu m polyHEMA, with higher vascular density in the material and adjacent tissues one week and one month post-implantation. The vascular density inside 80 mu m polyHEMA reached a maximum one month after implantation. In 40 mu m polyHEMA, the vascular density increased gradually over the two months following implantation. After two months, vascularization in the material was similar for both 40 and 80 mu m polyHEMA. Notably, despite similar levels of vascularization inside both porous materials at two months, the 80 mu m polyHEMA elicited greater vascularization in the critical 100 mu m margin of tissue around the implant, compared to other materials. In all materials except 80 mu m polyHEMA, we observed a narrow margin of significantly reduced vascularity at the implant-tissue interface. We conclude that implanted 80 mu m polyHEMA encourages vascularization, underscoring the importance of rigorous evaluation metrics to assess long-term performance of implanted biomaterials and guide future biomaterial optimization.
C1 [Cho, Eugenia H.; Boico, Alina; Brown, Nga L.; Register, Janna K.; Vo-Dinh, Tuan; Schroeder, Thies; Klitzman, Bruce] Duke Univ, Durham, NC 27710 USA.
   [Wisniewski, Natalie A.; Gant, Rebecca; Helton, Kristen L.] PROFUSA Corp, San Francisco, CA USA.
RP Cho, EH (reprint author), Duke Univ, Durham, NC 27710 USA.
EM klitz@duke.edu
RI Cho, Eugenia/G-2342-2015
OI Cho, Eugenia/0000-0001-5448-7895
FU Defense Advanced Research Projects Agency [W911NF-11-1-0119,
   HR0011-13-2-0003]; Fitzpatrick Institute for Photonics; Robert Jones
   Fund, Duke University
FX Funding: Supported in part by Defense Advanced Research Projects Agency
   grant numbers W911NF-11-1-0119 and HR0011-13-2-0003, the Fitzpatrick
   Institute for Photonics and the Robert Jones Fund, Duke University. The
   content of the information does not necessarily reflect the position or
   the policy of the Government, and no official endorsement should be
   inferred.
CR Ruckh T. T., 2013, ANAL CHEM
   Wang XD, 2013, ANAL CHEM, V85, P487, DOI 10.1021/ac303159b
   Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4
NR 3
TC 1
Z9 1
U1 0
U2 4
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-9871-7
J9 PROC SPIE
PY 2014
VL 8958
AR UNSP 89580B
DI 10.1117/12.2037950
PG 4
WC Biophysics; Engineering, Biomedical; Optics
SC Biophysics; Engineering; Optics
GA BB4XL
UT WOS:000343461700003
DA 2018-10-19
ER

PT J
AU Sokic, S
   Christenson, MC
   Larson, JC
   Appel, AA
   Brey, EM
   Papavasiliou, G
AF Sokic, S.
   Christenson, M. C.
   Larson, J. C.
   Appel, A. A.
   Brey, E. M.
   Papavasiliou, G.
TI Evaluation of MMP substrate concentration and specificity for
   neovascularization of hydrogel scaffolds
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) HYDROGELS; BIOMIMETIC PEGDA HYDROGELS; CLEAVAGE
   SITE PRESENTATION; CELL-MIGRATION; IN-VITRO; GROWTH; DEGRADATION;
   VASCULARIZATION; ANGIOGENESIS; INVASION
AB Controlled vascular response in scaffolds following implantation remains a significant clinical challenge. A critical biomaterial design criterion is the synchronization of the rates of scaffold degradation and vascularized tissue formation. Matrix metalloproteinases (MMPs) are key enzymes that regulate neovascularization and extracellular matrix remodelling. Synthetic protease-sensitive hydrogels offer controllable environments for investigating the role of matrix degradation on neovascularization. In this study, PEG hydrogels containing MMP-sensitive peptides with increased catalytic activity for MMPs expressed during neovascularization were investigated. Scaffolds were functionalized with MMP-2-, MMP-14- or general collagenase-sensitive peptides and with varying peptide concentration using crosslinkers containing one (SSite) or multiple (TSite) repeats of each protease-sensitive sequence. Increasing peptide concentration enhanced the degradation kinetics of scaffolds functionalized with MMP-specific sequences while 80% of the collagenase-sensitive scaffolds remained upon exposure to MMP-2 and MMP-14. In vitro neovascularization was consistent with in vivo tissue invasion with significantly increased invasion occurring within SSite MMP-specific as compared to collagenase-sensitive hydrogels and with further invasion in TSite as compared to SSite hydrogels regardless of peptide specificity. All scaffolds supported in vivo neovascularization; however, this was not dependent on peptide specificity. These findings demonstrate that peptide concentration and specificity regulate in vivo scaffold degradation, neovascularization and matrix remodelling.
C1 [Sokic, S.; Christenson, M. C.; Larson, J. C.; Appel, A. A.; Brey, E. M.; Papavasiliou, G.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Appel, A. A.; Brey, E. M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL USA.
RP Sokic, S (reprint author), IIT, Dept Biomed Engn, 3255 South Dearborn St,Wishnick Hall Room 314, Chicago, IL 60616 USA.
EM papavasiliou@iit.edu
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R21HL094916]; Veterans Administration; Illinois Institute of
   Technology Educational Research Initiative Fund
FX This research was supported by the financial support of the National
   Heart, Lung, and Blood Institute of the National Institutes of Health
   (Award Number R21HL094916), the Veterans Administration and the Illinois
   Institute of Technology Educational Research Initiative Fund. The
   authors would like to thank the laboratory of Professor David Venerus in
   the Department of Chemical and Biological Engineering at the Illinois
   Institute of Technology for providing access for mechanical testing of
   our samples as well as the laboratory of Professor Joseph Orgel in the
   College of Science and Letters at the Illinois Institute of Technology
   for access to HPLC for peptide purification.
CR Bracher M, 2013, BIOMATERIALS, V34, P6797, DOI 10.1016/j.biomaterials.2013.05.057
   Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Chiu YC, 2011, BIOMATERIALS, V32, P6045, DOI 10.1016/j.biomaterials.2011.04.066
   DeKosky BJ, 2010, TISSUE ENG PART C-ME, V16, P1533, DOI 10.1089/ten.tec.2009.0761
   Kraehenbuehl TP, 2009, BIOMATERIALS, V30, P4318, DOI 10.1016/j.biomaterials.2009.04.057
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Nagase N., 1996, BIOPOLYMERS, V40, P399
   Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Sokic S, 2012, TISSUE ENG PT A, V18, P2477, DOI [10.1089/ten.tea.2012.0173, 10.1089/ten.TEA.2012.0173]
   Sokic S, 2012, ACTA BIOMATER, V8, P2213, DOI 10.1016/j.actbio.2012.03.017
   Sounni NE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00111
   Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273
   Turturro MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058897
   West JL, 1999, MACROMOLECULES, V32, P241, DOI 10.1021/ma981296k
NR 25
TC 9
Z9 9
U1 3
U2 28
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 10
BP 1343
EP 1354
DI 10.1039/c4bm00088a
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XP
UT WOS:000343034000004
PM 28553543
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rooney, MK
   Woodhouse, KA
AF Rooney, M. K.
   Woodhouse, K. A.
TI Decreased tissue factor expression with increased CD11b upregulation on
   elastin-based biomaterial coatings
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID LEUKOCYTE ACTIVATION; NEUTROPHIL ADHESION; POLYSTYRENE BEADS;
   PLATELET-ADHESION; WHOLE-BLOOD; P-SELECTIN; IN-VIVO; FIBRINOGEN;
   COMPLEMENT; FLOW
AB Elastin-like polypeptide (ELP) coatings have been shown to have non-thrombogenic properties both in vitro and in vivo. In this work, we expand our understanding of this phenomenon by investigating the interaction of these coatings with leukocytes. Citrated whole blood was exposed to a shear rate of 300 s(-1) for 2 hours at 37 degrees C on ELP1- and ELP4-coated polyethylene terephthalate (Mylar T) surfaces in a cone and plate device. Scanning electron microscopy and flow cytometry were used to measure leukocyte activation and platelet-leukocyte aggregation in response to the ELP1 and ELP4 coatings on the surface and in the bulk, respectively. Surface analysis showed little leukocyte activity on the surface of uncoated positive controls. Both the tissue factor (TF) expression (indicative of leukocyte activation) and CD61 expression (indicative of platelet-leukocyte aggregates), in the bulk were decreased by 40% and 20%, respectively, with the ELP coating of Mylar T, while a two- to three-fold increase in CD11b upregulation (indicative of leukocyte activation) for ELP1 and ELP4 was determined. Two of three bulk markers indicated that ELP-coated Mylar T decreased the leukocyte response compared to the uncoated Mylar T, while the third, CD11b, indicated an increase in leukocyte response to the ELP coatings.
C1 [Rooney, M. K.; Woodhouse, K. A.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
RP Rooney, MK (reprint author), Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
EM kim.woodhouse@queensu.ca
FU Science Foundation Ireland (SFI) [07/SRC/B1163]; Natural Sciences and
   Engineering Research Council (NSERC); Queen's University
FX Funding for this project was provided by Science Foundation Ireland
   (SFI) (07/SRC/B1163), Natural Sciences and Engineering Research Council
   (NSERC), and Queen's University. The authors would like to thank Dr
   Lillicrap's research group (Queen's University) for their assistance in
   blood collection and Mr Matt Gordon (Queen's University) for his
   expertise in flow cytometry. They would also like to thank Dr Brian
   Amsden for his support.
CR BACH R, 1990, P NATL ACAD SCI USA, V87, P6995, DOI 10.1073/pnas.87.18.6995
   BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Bournazos S, 2008, ARTERIOSCL THROM VAS, V28, pE2, DOI 10.1161/ATVBAHA.107.153387
   CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767
   Chang X., 2012, J BIOMATER APPL, V0, P1
   Darling R. C., 1971, SURGERY, P472
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Egorina EM, 2008, BLOOD, V111, P1208, DOI 10.1182/blood-2007-08-107698
   Eilertsen KE, 2004, BLOOD COAGUL FIBRIN, V15, P521, DOI 10.1097/00001721-200410000-00001
   ElHabbal MH, 1995, CARDIOVASC RES, V30, P676, DOI 10.1016/0008-6363(95)00069-0
   Eriksson C, 2001, J LAB CLIN MED, V137, P296, DOI 10.1067/mlc.2001.114066
   FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Gorbet M. B., 2006, HEMOSTASIS THROMBOSI, P751
   Gorbet MB, 2005, J BIOMED MATER RES A, V74A, P511, DOI 10.1002/jbm.a.30354
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gorbet MB, 2001, J LAB CLIN MED, V137, P345, DOI 10.1067/mlc.2001.114677
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   Hathcock JJ, 2006, ARTERIOSCL THROM VAS, V26, P1729, DOI 10.1161/01.ATV.0000229658.76797.30
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Jaisson S, 2006, CHEM BIOL, V13, P149, DOI 10.1016/j.chembiol.2005.11.005
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   KAZATCHKINE MD, 1988, BIOMATERIALS, V9, P30, DOI 10.1016/0142-9612(88)90066-X
   Kuijper PHM, 1997, BLOOD, V89, P2131
   LORANT DE, 1993, J CLIN INVEST, V92, P559, DOI 10.1172/JCI116623
   Lwaleed BA, 2006, J PATHOL, V208, P327, DOI 10.1002/path.1871
   Lytle BW, 2004, NEW ENGL J MED, V351, P2262, DOI 10.1056/NEJMp048238
   MORGAN BP, 1994, EUR J CLIN INVEST, V24, P219, DOI 10.1111/j.1365-2362.1994.tb01078.x
   Peerschke EIB, 1998, IMMUNOBIOLOGY, V199, P239, DOI 10.1016/S0171-2985(98)80030-2
   REPO H, 1995, J IMMUNOL METHODS, V185, P65, DOI 10.1016/0022-1759(95)00105-J
   Ross M. H., 2006, HISTOLOGY, P247
   SEMERARO N, 1983, IMMUNOLOGY, V50, P529
   SHEPPARD JI, 1994, J BIOMED MATER RES, V28, P1175, DOI 10.1002/jbm.820281008
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Srokowski EM, 2011, J BIOMAT SCI-POLYM E, V22, P41, DOI 10.1163/092050609X12578498935594
   Srokowski E. M., 2013, J BIOMED MATER RES A, P1
   Tedesco F., 1999, MOL IMMUNOL, V36, P26
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   TURITTO VT, 1980, MICROVASC RES, V19, P352, DOI 10.1016/0026-2862(80)90054-0
   VROMAN L, 1980, BLOOD, V55, P156
   Walpoth BH, 2005, EXPERT REV MED DEVIC, V2, P647, DOI 10.1586/17434440.2.6.647
   Waterhouse A, 2011, TISSUE ENG PART B-RE, V17, P93, DOI [10.1089/ten.teb.2010.0432, 10.1089/ten.TEB.2010.0432]
   Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Zhong D, 2013, BIOMATERIALS, V34, P294, DOI 10.1016/j.biomaterials.2012.09.060
NR 49
TC 0
Z9 0
U1 2
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 10
BP 1377
EP 1383
DI 10.1039/c4bm00099d
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XP
UT WOS:000343034000007
DA 2018-10-19
ER

PT J
AU Wei, WL
   Xu, C
   Gao, N
   Ren, JS
   Qu, XG
AF Wei, Weili
   Xu, Can
   Gao, Nan
   Ren, Jinsong
   Qu, Xiaogang
TI Opposing enantiomers of tartaric acid anchored on a surface generate
   different insulin assemblies and hence contrasting cellular responses
SO CHEMICAL SCIENCE
LA English
DT Article
ID AMYLOID FIBRIL FORMATION; NERVE GROWTH-FACTOR; PROTEIN ADSORPTION;
   DESIGNING MATERIALS; ADHESION BEHAVIOR; MASS-SPECTROMETRY; NEURITE
   FORMATION; FACTOR-II; CELLS; PROLIFERATION
AB Chirality plays a pivotal role in biomolecule recognition, which is one of the key aspects of cell responses to a biomaterial surface. Generally, the effects of the properties of a biomaterial surface on cellular responses are modulated by adsorbed proteins. Surface chemistry, such as charge and hydrophobicity, has a profound effect on protein adsorption. Nevertheless, chirality has been seldom considered in biomaterial surface chemistry. Herein, using the classical biogenic chiral molecules, D-and L-tartaric acid, assembled into monolayers as a model chiral surface, we reported for the first time that surface chirality modulated insulin assembly, including the dynamics of adsorption, kinetics of the conformational transition and fibril formation, on D-and L-surfaces and determined the cellular effect of insulin on neuronal PC12 cells. On the D-surface, insulin retained its bioactivity; however, on the L-surface, insulin formed amyloid fibrils with lost bioactivity. Previous reports have demonstrated that insulin can act as growth and neuronal differentiation factors. The chiral surfaces that were preassembled with insulin exhibited contrasting cellular behaviours in proliferation and differentiation. High proliferation and a high differentiation rate were observed for PC12 cells on the insulin-adsorbed D-surface, whereas neither proliferation nor differentiation were observed for PC12 cells on the insulin-adsorbed L-surface. Since protein surface adsorption is ubiquitous for tissue engineering and cell adhesion, our work provides new insights into engineering novel biomaterials by taking into account surface chirality. Surface chirality is important and may determine cell fate on a chiral surface.
C1 [Wei, Weili; Xu, Can; Gao, Nan; Ren, Jinsong; Qu, Xiaogang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Lab Chem Biol,Div Biol Inorgan Chem, Changchun 130022, Jilin, Peoples R China.
RP Qu, XG (reprint author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Lab Chem Biol,Div Biol Inorgan Chem, Changchun 130022, Jilin, Peoples R China.
EM xqu@ciac.ac.cn
RI Wei, Weili/F-8112-2018; Qu, xiaogang/M-9472-2016
OI Wei, Weili/0000-0001-6363-3591; 
FU 973 Project [2011CB936004, 2012CB720602]; NSFC [21210002, 91213302,
   21303179]
FX This work was supported by the 973 Project (2011CB936004, 2012CB720602),
   and NSFC (21210002, 91213302, 21303179).
CR Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Benson K, 2014, MACROMOL BIOSCI, V14, P793, DOI 10.1002/mabi.201300485
   Bruce IJ, 2005, LANGMUIR, V21, P7029, DOI 10.1021/la050553t
   Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110
   Curran JM, 2005, BIOMATERIALS, V26, P7057, DOI 10.1016/j.biomaterials.2005.05.008
   Dai B, 2013, P NATL ACAD SCI USA, V110, P8543, DOI 10.1073/pnas.1220711110
   DIKIC I, 1994, CURR BIOL, V4, P702, DOI 10.1016/S0960-9822(00)00155-X
   El-Gindi J, 2012, ANGEW CHEM INT EDIT, V51, P3716, DOI 10.1002/anie.201109144
   Evers F, 2010, PHYS CHEM CHEM PHYS, V12, P4375, DOI 10.1039/b925134k
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Groenning M, 2007, J STRUCT BIOL, V159, P483, DOI 10.1016/j.jsb.2007.06.004
   Guo SL, 2006, BIOMACROMOLECULES, V7, P1630, DOI 10.1021/bm0600724
   HANEIN D, 1994, SCIENCE, V263, P1413, DOI 10.1126/science.8128221
   Hatakeyama H, 2005, BIOMATERIALS, V26, P5167, DOI 10.1016/j.biomaterials.2004.11.061
   Hatakeyama H, 2006, BIOMATERIALS, V27, P5069, DOI 10.1016/j.biomaterials.2006.05.019
   Howson SE, 2012, NAT CHEM, V4, P31, DOI 10.1038/nchem.1206
   Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LEVINE H, 1993, PROTEIN SCI, V2, P404
   Li YY, 2011, ANGEW CHEM INT EDIT, V50, P5860, DOI 10.1002/anie.201008206
   Li Z, 2013, ADV HEALTHC MATER, V2, P1377, DOI 10.1002/adhm.201200402
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Nettleton EJ, 2000, BIOPHYS J, V79, P1053, DOI 10.1016/S0006-3495(00)76359-4
   Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983
   Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200
   OKUSA H, 1994, LANGMUIR, V10, P3577, DOI 10.1021/la00022a034
   PARKER JL, 1989, J PHYS CHEM-US, V93, P6121, DOI 10.1021/j100353a034
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   RECIOPINTO E, 1984, P NATL ACAD SCI-BIOL, V81, P2562, DOI 10.1073/pnas.81.8.2562
   RECIOPINTO E, 1986, J NEUROSCI, V6, P1211
   Reichhart C, 2009, LANGMUIR, V25, P1047, DOI 10.1021/la802905s
   Roach P, 2007, J MATER SCI-MATER M, V18, P1263, DOI 10.1007/s10856-006-0064-3
   Secundo F, 2013, CHEM SOC REV, V42, P6250, DOI 10.1039/c3cs35495d
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith MI, 2007, BIOPHYS J, V93, P2143, DOI 10.1529/biophysj.107.105338
   Sun TL, 2007, J AM CHEM SOC, V129, P1496, DOI 10.1021/ja0686155
   Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Wang X, 2011, ADV FUNCT MATER, V21, P3276, DOI 10.1002/adfm.201101032
   Xia YH, 2011, NANOSCALE, V3, P1374, DOI 10.1039/c0nr00903b
   Xiang S, 2012, ANALYST, V137, P1669, DOI 10.1039/c2an15983j
   Zako T., 2008, BIOPHYS J, V96, P3331
   Zhou F, 2012, COLLOID SURFACE B, V90, P97, DOI 10.1016/j.colsurfb.2011.10.016
   Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200
NR 47
TC 11
Z9 11
U1 6
U2 43
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2041-6520
EI 2041-6539
J9 CHEM SCI
JI Chem. Sci.
PY 2014
VL 5
IS 11
BP 4367
EP 4374
DI 10.1039/c4sc01386g
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA AQ7NK
UT WOS:000343004300032
DA 2018-10-19
ER

PT J
AU Rao, L
   Ma, Y
   Zhuang, MJ
   Luo, TJ
   Wang, YY
   Hong, A
AF Rao, Lei
   Ma, Yi
   Zhuang, Manjiao
   Luo, Tianjie
   Wang, Yayu
   Hong, An
TI Chitosan-decorated selenium nanoparticles as protein carriers to improve
   the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2
   diabetes mellitus
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE BAY 55-9837; selenium nanoparticles; clearance; half-life; type 2
   diabetes
ID CYCLASE-ACTIVATING POLYPEPTIDE; ADENYLATE-CYCLASE; BIOPHARMACEUTICAL
   BENCHMARKS; DRUG-DELIVERY; TOXICITY; CELLS; AGONISTS; RELEASE; SYSTEM;
   SERUM
AB Purpose: As a potential protein therapeutic for type 2 diabetes mellitus (T2DM), BAY 55-9837 is limited by poor stability and a very short half-life in vivo. The purpose of this study was to construct a novel nanostructured biomaterial by conjugating BAY 55-9837 to chitosan-decorated selenium nanoparticles (CS-SeNPs) to prolong the in vivo half-life of BAY 55-9837 by reducing its renal clearance rate.
   Materials and methods: BAY 55-9837-loaded CS-SeNPs (BAY-CS-SeNPs) were prepared, and their surface morphology, particle size, zeta potential, and structure were characterized. The stability, protein-loading rate, and in vitro release of BAY 55-9837 from CS-SeNPs were also quantified. Additionally, a sensitive high-performance liquid chromatography (HPLC) assay was developed for the quantification of BAY 55-9837 in mouse plasma. Thereafter, mice were injected via the tail vein with either BAY 55-9837 or BAY-CS-SeNPs, and the plasma concentration of BAY 55-9837 was determined via our validated HPLC method at different time intervals postinjection. Relevant in vivo pharmacokinetic parameters (half-life, area under the curve from time 0 to last sampling point, observed clearance) were then calculated and analyzed.
   Results: BAY-CS-SeNPs were successfully synthesized, with diameters of approximately 200 nm. BAY-CS-SeNPs displayed good stability with a high protein-loading rate, and the release process of BAY 55-9837 from the CS-SeNPs lasted for over 70 hours, with the cumulative release reaching 78.9%. Moreover, the conjugation of CS-SeNPs to BAY 55-9837 significantly reduced its renal clearance to a rate of 1.56 mL/h and extended its half-life to 20.81 hours.
   Conclusion: In summary, our work provides a simple method for reducing the renal clearance rate and extending the half-life of BAY 55-9837 in vivo by utilizing CS-SeNPs as nanocarriers.
C1 [Rao, Lei; Ma, Yi; Zhuang, Manjiao; Luo, Tianjie; Wang, Yayu; Hong, An] Jinan Univ, Dept Cell Biol, Inst Med Biol, Guangdong Prov Key Lab Bioengn Med,Natl Engn Res, Guangzhou 510632, Guangdong, Peoples R China.
RP Hong, A (reprint author), Jinan Univ, Dept Cell Biol, Inst Med Biol, 601 Huangpu West Ave, Guangzhou 510632, Guangdong, Peoples R China.
EM anhong0881@163.com
FU NSFC [81373314]; Doctoral Program of Higher Education of China
   [20124401120012]; Natural Science Foundation of Guangdong Province
   [S2012010008756]; Special Fund for Subject Construction of Guangdong
   Province [2012KJCX0015]; Cooperation Project in Industry, Education and
   Research of Guangdong Province [2010B090400544]; National Technical
   Innovation Fund for Medium and Small-Size Enterprise, China
   [11C26214413218]; National 863 Project [2006AA02Z125]; Major Science and
   Technology Projects of Guangdong Province [2007B060310212]; National
   Project for Significant New Drug Development of the Ministry of Science
   and Technology of China [2012ZX09202301]; Ministry of Education in China
FX This work was supported by the grants from the NSFC (No 81373314), the
   Doctoral Program of Higher Education of China (No 20124401120012), the
   Natural Science Foundation of Guangdong Province (No S2012010008756),
   Special Fund for Subject Construction of Guangdong Province (No
   2012KJCX0015), the Cooperation Project in Industry, Education and
   Research of Guangdong Province and Ministry of Education in China (No
   2010B090400544), and the National Technical Innovation Fund for Medium
   and Small-Size Enterprise, China (No 11C26214413218). We also gratefully
   acknowledge financial support from the National 863 Project
   (2006AA02Z125), the Major Science and Technology Projects of Guangdong
   Province (2007B060310212), and the National Project for Significant New
   Drug Development of the Ministry of Science and Technology of China
   (2012ZX09202301). We would also like to thank Professor Tianfeng Chen
   from the Materials Chemistry Department of Jinan University for the
   FT-IR analysis.
CR ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3582
   Bertrand G, 1996, BRIT J PHARMACOL, V117, P764, DOI 10.1111/j.1476-5381.1996.tb15256.x
   Borboni P, 1999, ENDOCRINOLOGY, V140, P5530, DOI 10.1210/en.140.12.5530
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m
   Gao XY, 2002, ADV MATER, V14, P290, DOI 10.1002/1521-4095(20020219)14:4<290::AID-ADMA290>3.0.CO;2-U
   Gates B, 2002, ADV FUNCT MATER, V12, P219, DOI 10.1002/1616-3028(200203)12:3<219::AID-ADFM219>3.0.CO;2-U
   Imani M, 2010, AAPS PHARMSCITECH, V11, P1268, DOI 10.1208/s12249-010-9494-9
   Kljai K, 2001, BIOL TRACE ELEM RES, V83, P223, DOI 10.1385/BTER:83:3:223
   Lee C, 2013, INT J NANOMED, V8, P2975, DOI 10.2147/IJN.S48197
   Li YH, 2011, BIOMATERIALS, V32, P9068, DOI 10.1016/j.biomaterials.2011.08.001
   Liu W, 2012, ACS NANO, V6, P6578, DOI 10.1021/nn202452c
   Makhluf SBD, 2008, SMALL, V4, P1453, DOI 10.1002/smll.200701308
   MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x
   MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9
   MIYATA A, 1990, BIOCHEM BIOPH RES CO, V170, P643, DOI 10.1016/0006-291X(90)92140-U
   Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a
   Navarro-Alarcon M, 1999, SCI TOTAL ENVIRON, V228, P79, DOI 10.1016/S0048-9697(99)00034-0
   Pan CQ, 2007, J PHARMACOL EXP THER, V320, P900, DOI 10.1124/jpet.106.112276
   Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Singh Y, 2012, PHARM RES-DORDR, V29, P2377, DOI 10.1007/s11095-012-0763-z
   Torres SK, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1236-3
   Tran Phong A, 2011, Int J Nanomedicine, V6, P1553, DOI 10.2147/IJN.S21729
   Tsutsumi M, 2002, DIABETES, V51, P1453, DOI 10.2337/diabetes.51.5.1453
   Walsh G, 2000, NAT BIOTECHNOL, V18, P831, DOI 10.1038/78720
   Walsh G, 2010, NAT BIOTECHNOL, V28, P917, DOI 10.1038/nbt0910-917
   Wang HL, 2007, FREE RADICAL BIO MED, V42, P1524, DOI 10.1016/j.freeradbiomed.2007.02.013
   Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047
   Winzell MS, 2007, PEPTIDES, V28, P1805, DOI 10.1016/j.peptides.2007.04.024
   Yu B, 2012, INORG CHEM, V51, P8956, DOI 10.1021/ic301050v
   Yung SL, 2003, J BIOL CHEM, V278, P10273, DOI 10.1074/jbc.M211945200
   Zhang ES, 2005, LIFE SCI, V76, P1099, DOI 10.1016/j.lfs.2004.08.015
   Zhang SY, 2004, MATER LETT, V58, P2590, DOI 10.1016/j.matlet.2004.03.031
   Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007
NR 36
TC 11
Z9 11
U1 6
U2 52
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 4819
EP 4828
DI 10.2147/IJN.S67871
PG 10
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AQ9JI
UT WOS:000343167900001
PM 25378923
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Khandelwal, PC
   Agrawal, SS
   Namboothiry, MAG
   Gundiah, N
AF Khandelwal, Pranav C.
   Agrawal, Suchi S.
   Namboothiry, Manoj A. G.
   Gundiah, Namrata
TI Fabrication of a novel biomaterial with enhanced mechanical and
   conducting properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID POLY(VINYL ALCOHOL); THIN-FILMS; PEDOT-PSS; NETWORKS
AB Conducting polymers have the combined advantages of metal conductivity with ease in processing and biocompatibility; making them extremely versatile for biosensor and tissue engineering applications. However, the inherent brittle property of conducting polymers limits their direct use in such applications which generally warrant soft and flexible material responses. Addition of fillers increases the material compliance, but is achieved at the cost of reduced electrical conductivity. To retain suitable conductivity without compromising the mechanical properties, we fabricate an electroactive blend (dPEDOT) using low grade PEDOT: PSS as the base conducting polymer with polyvinyl alcohol as filler and glycerol as a dopant. Bulk dPEDOT films show a thermally stable response till 110 degrees C with over seven fold increase in room temperature conductivity as compared to 0.002 S cm(-1) for pristine PEDOT: PSS. We characterize the nonlinear stress-strain response of dPEDOT, well described using a Mooney-Rivlin hyperelastic model, and report elastomer-like moduli with ductility similar to fives times its original length. Dynamic mechanical analysis shows constant storage moduli over a large range of frequencies with corresponding linear increase in tan(delta). We relate the enhanced performance of dPEDOT with the underlying structural constituents using FTIR and AFM microscopy. These data demonstrate specific interactions between individual components of dPEDOT, and their effect on surface topography and material properties. Finally, we show biocompatibility of dPEDOT using fibroblasts that have comparable cell morphologies and viability as the control, which make dPEDOT attractive as a biomaterial.
C1 [Khandelwal, Pranav C.; Agrawal, Suchi S.; Gundiah, Namrata] Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.
   [Khandelwal, Pranav C.; Namboothiry, Manoj A. G.] Indian Inst Sci Educ & Res, Coll Engn Trivandrum Campus, Sch Phys, Thiruvananthapuram 695016, Kerala, India.
RP Gundiah, N (reprint author), Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.
EM namrata@mecheng.iisc.ernet.in
OI Namboothiry, Manoj/0000-0002-7805-1962
FU Department of Science (DST) and Technology for the Ramanujan fellowship
   [RJN-42]; DST [DST/TM/SERI/2k11/73(G)]; Ministry of Human Resources and
   Development, Government of India, through Indian Institute of Science
   Education and Research, Thiruvananthapuram;  [MERC/91]
FX 3T3 cells used in this study were obtained from Prof. P. Kondaiah's
   laboratory (IISc) for which we are grateful. We thank folks in the
   Biomechanics lab for help with various aspects of the study. We thank Dr
   Girish Kunte (CeNSE) for help with FTIR experiments and Prof Praveen
   Ramamurthy (IISc) for discussions. NG acknowledges Department of Science
   (DST) and Technology for the Ramanujan fellowship (RJN-42) and research
   grant (MERC/91) that supported this work. MAGN acknowledges DST for
   generous funding through the research project (DST/TM/SERI/2k11/73(G))
   and Ministry of Human Resources and Development, Government of India,
   through Indian Institute of Science Education and Research,
   Thiruvananthapuram.
CR Ahmad F, 2013, J ADV RES, V4, P155, DOI 10.1016/j.jare.2012.05.001
   Attia G, 2013, INT J ELECTROCHEM SC, V8, P5672
   Babu AR, 2014, EXP MECH, V54, P1177, DOI 10.1007/s11340-014-9895-x
   Balint R, 2014, ACTA BIOMATER, V10, P2341, DOI 10.1016/j.actbio.2014.02.015
   Chen CH, 2012, J APPL POLYM SCI, V125, P3134, DOI 10.1002/app.36474
   Chen CH, 2011, SYNTHETIC MET, V161, P2259, DOI 10.1016/j.synthmet.2011.08.031
   Choi JW, 2004, SYNTHETIC MET, V141, P293, DOI 10.1016/S0379-6779(03)00419-3
   Collazos-Castro JE, 2010, BIOMATERIALS, V31, P9244, DOI 10.1016/j.biomaterials.2010.08.057
   Ghosh S, 2001, SYNTHETIC MET, V121, P1321, DOI 10.1016/S0379-6779(00)01523-X
   Heraeus C. P. D., 2010, CLEVIOS TM P VP 4083
   Hidawati EN, 2011, INT J CHEM ENV ENG, V2, P309
   Karagkiozaki V, 2013, BBA-GEN SUBJECTS, V1830, P4294, DOI 10.1016/j.bbagen.2012.12.019
   Khandelwal P. K., 2014, THESIS INDIAN I SCI
   Kirchmeyer S, 2005, J MATER CHEM, V15, P2077, DOI 10.1039/b417803n
   Lang U, 2009, ADV FUNCT MATER, V19, P1215, DOI 10.1002/adfm.200801258
   Lang U, 2009, SYNTHETIC MET, V159, P473, DOI 10.1016/j.synthmet.2008.11.005
   Luo SC, 2008, LANGMUIR, V24, P8071, DOI 10.1021/la800333g
   Nardes AM, 2007, ADV MATER, V19, P1196, DOI 10.1002/adma.200602575
   Okuzaki H, 2003, MACROMOL RAPID COMM, V24, P261, DOI 10.1002/marc.200390038
   Ouyang J, 2004, POLYMER, V45, P8443, DOI 10.1016/j.polymer.2004.10.001
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   Rodriguez AB, 2011, J MATER CHEM, V21, P19324, DOI 10.1039/c1jm13107a
   Romyen N, 2013, J MATER SCI-MATER EL, V24, P2897, DOI 10.1007/s10854-013-1188-0
   Sheha E, 2013, PHYS SCRIPTA, V88, DOI 10.1088/0031-8949/88/03/035701
   Suarez-Vargas J., 2014, REV LATINAM METAL MA, V35
   Vieyres A, 2013, MACROMOLECULES, V46, P889, DOI 10.1021/ma302563z
   Yang XM, 2010, RADIAT PHYS CHEM, V79, P606, DOI 10.1016/j.radphyschem.2009.12.017
   Zhang XT, 2010, J MATER CHEM, V20, P5080, DOI 10.1039/c0jm00050g
NR 28
TC 2
Z9 2
U1 0
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 42
BP 7327
EP 7333
DI 10.1039/c4tb01029a
PG 7
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7ZD
UT WOS:000343038600004
DA 2018-10-19
ER

PT J
AU Patel, SP
   Vaishya, R
   Yang, XY
   Pal, D
   Mitra, AK
AF Patel, Sulabh P.
   Vaishya, Ravi
   Yang, Xiaoyan
   Pal, Dhananjay
   Mitra, Ashim K.
TI Novel Thermosensitive Pentablock Copolymers for Sustained Delivery of
   Proteins in the Treatment of Posterior Segment Diseases
SO PROTEIN AND PEPTIDE LETTERS
LA English
DT Article
DE Block copolymers; controlled drug delivery; in situ gelling system;
   intravitreal; ocular delivery; pentablock copolymers; posterior segment;
   sol-gel transition; sustained drug delivery; thermosensitive gel
ID PEG-PCL-PEG; TRIBLOCK COPOLYMER; AQUEOUS-SOLUTIONS; PLGA; DEGRADATION;
   INJECTION; COMPLICATIONS; BEVACIZUMAB; PEPTIDES; HYDROGEL
AB Biodegradable and injectable in situ thermosensitive hydrogels were investigated for sustained delivery of protein therapeutics in the treatment of ocular posterior segment neovascular diseases. A series of triblock (TB, polycaprolactone- polyethylene glycol-polycaprolactone (PCL-PEG-PCL), B-A-B) and pentablock copolymers (PBCs) (polylactic acid (PLA)-PCL-PEG-PCL-PLA (C-B-A-B-C) and PEG-PCL-PLA-PCL-PEG (A-B-C-B-A)) were synthesized and evaluated for their thermosensitive behavior. Effects of molecular weight, hydrophobicity and block arrangement on polymer crystallinity, sol-gel transition, micelle size, viscosity and in vitro drug release were examined. Results from sol-gel transition studies demonstrated that aqueous solutions of block copolymers can immediately transform to hydrogel upon exposure to physiological temperature. PBC provide significantly longer sustained release (more than 20 days) of IgG relative to TB copolymers. Moreover, kinematic viscosity of aqueous solution at 25 degrees C for A-B-C-B-A type of PBCs was noticeably lower than the TB (B-A-B) copolymers and other PBCs with C-B-A-B-C block arrangements suggesting desired syringe-ability. The presence of PLA blocks in PBCs (C-B-A-B-C and A-B-C-B-A) significantly reduces crystallinity. Hence, it is anticipated that PBCs will have a faster rate of degradation relative to PCL-PEG-PCL based TB copolymers. PBCs also exhibited excellent cell viability and biocompatibility on ARPE-19 (human retinal pigment epithelial cell line) and RAW-264.7 (mouse macrophage cells), likely rendering it safe for ocular applications. Owing to biodegradability, thermosensitivity, ease of handling and biocompatibility PBC hydrogels can be considered as promising biomaterial for sustained delivery of protein therapeutics to the back of the eye.
C1 [Patel, Sulabh P.; Vaishya, Ravi; Yang, Xiaoyan; Pal, Dhananjay; Mitra, Ashim K.] Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64108 USA.
RP Mitra, AK (reprint author), Univ Missouri, Sch Pharm, Div Pharmaceut Sci, Kansas City, MO 64108 USA.
EM mitraa@umkc.edu
RI Vaishya, Ravi/F-6498-2016
OI Vaishya, Ravi/0000-0002-7909-5019
FU NIH [R01 EY09171-14, RO1 EY10659-12]
FX This study was supported by NIH R01 EY09171-14 and NIH RO1 EY10659-12.
CR Barot M, 2013, FUTURE MED CHEM, V5, P301, DOI [10.4155/FMC.12.206, 10.4155/fmc.12.206]
   Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570
   Gong CY, 2009, ACTA BIOMATER, V5, P3358, DOI 10.1016/j.actbio.2009.05.025
   Gou ML, 2010, J BIOMED MATER RES A, V93A, P219, DOI 10.1002/jbm.a.32546
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   Huang MH, 2004, POLYMER, V45, P8675, DOI 10.1016/j.polymer.2004.10.054
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jager RD, 2004, RETINA-J RET VIT DIS, V24, P676, DOI 10.1097/00006982-200410000-00002
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Kulkarni AD, 2005, ADV DRUG DELIVER REV, V57, P1994, DOI 10.1016/j.addr.2005.09.003
   Lee DS, 2001, MACROMOL RAPID COMM, V22, P587, DOI 10.1002/1521-3927(20010501)22:8<587::AID-MARC587>3.0.CO;2-8
   Liu CB, 2008, J BIOMED MATER RES B, V84B, P165, DOI 10.1002/jbm.30858
   Peyman GA, 2009, RETINA-J RET VIT DIS, V29, P875, DOI 10.1097/IAE.0b013e3181a94f01
   Prabhu A, 1998, J BIOMED MATER RES, V42, P655, DOI 10.1002/(SICI)1097-4636(19981215)42:4<655::AID-JBM23>3.3.CO;2-2
   Sampat KM, 2010, CURR OPIN OPHTHALMOL, V21, P178, DOI 10.1097/ICU.0b013e328338679a
   Singh S, 2007, INT J PHARM, V341, P68, DOI 10.1016/j.ijpharm.2007.03.054
   Alforja MS, 2011, JPN J OPHTHALMOL, V55, P425, DOI 10.1007/s10384-011-0038-y
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   Zhang Y, 2012, J CONTROL RELEASE, V162, P119, DOI 10.1016/j.jconrel.2012.04.022
NR 20
TC 11
Z9 11
U1 4
U2 36
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 0929-8665
EI 1875-5305
J9 PROTEIN PEPTIDE LETT
JI Protein Pept. Lett.
PY 2014
VL 21
IS 11
BP 1185
EP 1200
DI 10.2174/092986652111141001122054
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AR0DF
UT WOS:000343235900011
PM 25315374
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lee, HV
   Hamid, SBA
   Zain, SK
AF Lee, H. V.
   Hamid, S. B. A.
   Zain, S. K.
TI Conversion of Lignocellulosic Biomass to Nanocellulose: Structure and
   Chemical Process
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Review
ID IONIC LIQUID PRETREATMENT; TEMPO-MEDIATED OXIDATION;
   ENZYMATIC-HYDROLYSIS; CORN STOVER; SUGARCANE BAGASSE; SOLID ACID;
   ETHANOL-PRODUCTION; MICROFIBRILLATED CELLULOSE; NANOCRYSTALLINE
   CELLULOSE; CATALYTIC CONVERSION
AB Lignocellulosic biomass is a complex biopolymer that is primary composed of cellulose, hemicellulose, and lignin. The presence of cellulose in biomass is able to depolymerise into nanodimension biomaterial, with exceptional mechanical properties for biocomposites, pharmaceutical carriers, and electronic substrate's application. However, the entangled biomass ultrastructure consists of inherent properties, such as strong lignin layers, low cellulose accessibility to chemicals, and high cellulose crystallinity, which inhibit the digestibility of the biomass for cellulose extraction. This situation offers both challenges and promises for the biomass biorefinery development to utilize the cellulose from lignocellulosic biomass. Thus, multistep biorefinery processes are necessary to ensure the deconstruction of noncellulosic content in lignocellulosic biomass, while maintaining cellulose product for further hydrolysis into nanocellulose material. In this review, we discuss the molecular structure basis for biomass recalcitrance, reengineering process of lignocellulosic biomass into nanocellulose via chemical, and novel catalytic approaches. Furthermore, review on catalyst design to overcome key barriers regarding the natural resistance of biomass will be presented herein.
C1 [Lee, H. V.; Hamid, S. B. A.; Zain, S. K.] Univ Malaya, IPS, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur 50603, Malaysia.
RP Lee, HV (reprint author), Univ Malaya, IPS, Nanotechnol & Catalysis Res Ctr NANOCAT, 3rd Floor,Block A, Kuala Lumpur 50603, Malaysia.
EM leehweivoon@um.edu.my
RI ABD HAMID, SHARIFAH BEE/B-9749-2010
OI ABD HAMID, SHARIFAH BEE/0000-0002-5104-3938
FU Ministry of Higher Education Malaysia for Fundamental Research Grant
   Scheme (FRGS) [FP056-2013B]; High Impact Research (University of Malaya)
   [HIR F-000032]
FX The authors are grateful for cordial support from Ministry of Higher
   Education Malaysia for Fundamental Research Grant Scheme (FRGS, Project
   number: FP056-2013B) and High Impact Research (University of Malaya)
   (HIR F-000032).
CR Abdel-Halim ES, 2011, CARBOHYD POLYM, V86, P988, DOI 10.1016/j.carbpol.2011.05.051
   Abraham E, 2011, CARBOHYD POLYM, V86, P1468, DOI 10.1016/j.carbpol.2011.06.034
   Agbor VB, 2011, BIOTECHNOL ADV, V29, P675, DOI 10.1016/j.biotechadv.2011.05.005
   Alila S, 2013, IND CROP PROD, V41, P250, DOI 10.1016/j.indcrop.2012.04.028
   Melero JA, 2012, ENERG ENVIRON SCI, V5, P7393, DOI 10.1039/c2ee21231e
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Biao H., PREPARATION NANOCELL
   Bozell JJ, 2011, J AGR FOOD CHEM, V59, P9232, DOI 10.1021/jf201850b
   Brinchi L, 2013, CARBOHYD POLYM, V94, P154, DOI 10.1016/j.carbpol.2013.01.033
   Brodeur Gary, 2011, Enzyme Res, V2011, P787532, DOI 10.4061/2011/787532
   Cabiac A, 2011, APPL CATAL A-GEN, V402, P1, DOI 10.1016/j.apcata.2011.05.029
   Chen WS, 2011, CARBOHYD POLYM, V83, P1804, DOI 10.1016/j.carbpol.2010.10.040
   Chundawat SPS, 2011, ENERG ENVIRON SCI, V4, P973, DOI 10.1039/c0ee00574f
   Cybulska I, 2012, BIORESOURCE TECHNOL, V118, P30, DOI 10.1016/j.biortech.2012.05.073
   Correia JAD, 2013, BIORESOURCE TECHNOL, V139, P249, DOI 10.1016/j.biortech.2013.03.153
   de Campos A, 2013, CELLULOSE, V20, P1491, DOI 10.1007/s10570-013-9909-3
   Dutta S, 2012, RSC ADV, V2, P12575, DOI 10.1039/c2ra20922e
   FAN LT, 1980, BIOTECHNOL BIOENG, V22, P177, DOI 10.1002/bit.260220113
   Feng G., 2013, PRETREATMENT TECHNIQ, V115, P339, DOI DOI 10.1007/978-3-642-32735-3_15
   Fu DB, 2011, BIORESOURCE TECHNOL, V102, P7008, DOI 10.1016/j.biortech.2011.04.049
   Gindl W, 2004, APPL PHYS A-MATER, V79, P2069, DOI 10.1007/s00339-004-2864-y
   Grabber J. H., 2003, P CSSA ANN M LIGN FO, V45, P820
   Gullon P., 2010, The Open Agriculture Journal, V4, P135
   Guo F, 2012, PROG ENERG COMBUST, V38, P672, DOI 10.1016/j.pecs.2012.04.001
   Habibi Y, 2014, CHEM SOC REV, V43, P1519, DOI 10.1039/c3cs60204d
   Harmsen P, 2010, LIT REV PHYS CHEM PR
   Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027
   Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016
   [黄海 Huang Hai], 2013, [南京农业大学学报, Journal of Nanjing Agricultural University], V36, P1
   Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386
   [张帆 Zhang Fan], 2011, [石油化工, Petrochemical Technology], V40, P43
   Jiang F, 2013, CARBOHYD POLYM, V95, P32, DOI 10.1016/j.carbpol.2013.02.022
   JIMENEZ A, 1988, CHEM ENG J BIOCH ENG, V37, pB1, DOI 10.1016/0300-9467(88)80011-X
   Kamiya Y., 2013, COMPREHENSIVE INORGA, VII, P185
   Karimi K., 2013, BIOFUEL TECHNOLOGIES, P53, DOI DOI 10.1007/978-3-642-34519-7_3
   Khalil HPSA, 2012, CARBOHYD POLYM, V87, P963, DOI 10.1016/j.carbpol.2011.08.078
   Ko FK, 2004, NATO SCI SER II MATH, V169, P1, DOI 10.1007/978-1-4020-2550-1_1
   Kumar P, 2009, IND ENG CHEM RES, V48, P3713, DOI 10.1021/ie801542g
   Lai DM, 2011, ENERG ENVIRON SCI, V4, P3552, DOI 10.1039/c1ee01526e
   Lange J.-P., 2010, SUSTAINABLE DEV PROC, P171
   Lange J.P., 2007, CATALYSIS RENEWABLES
   Lanzafame P, 2012, CATAL TODAY, V179, P178, DOI 10.1016/j.cattod.2011.07.018
   Lavoine N, 2012, CARBOHYD POLYM, V90, P735, DOI 10.1016/j.carbpol.2012.05.026
   Lee JW, 2011, BIORESOURCE TECHNOL, V102, P5884, DOI 10.1016/j.biortech.2011.02.048
   Lee SH, 2009, BIOTECHNOL BIOENG, V102, P1368, DOI 10.1002/bit.22179
   Li CL, 2010, BIORESOURCE TECHNOL, V101, P4900, DOI 10.1016/j.biortech.2009.10.066
   Li JH, 2012, CARBOHYD POLYM, V90, P1609, DOI 10.1016/j.carbpol.2012.07.038
   Li RJ, 2009, CARBOHYD POLYM, V76, P94, DOI 10.1016/j.carbpol.2008.09.034
   Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002
   Lin L. Q., 2014, SCI TECHNOLOGY REV, V32, P56
   Lin YC, 2009, ENERG ENVIRON SCI, V2, P68, DOI 10.1039/b814955k
   Liu CG, 2006, CARBOHYD RES, V341, P2550, DOI 10.1016/j.carres.2006.07.017
   Liu HB, 2010, J PHYS CHEM B, V114, P4293, DOI 10.1021/jp9117437
   Liu L, 2009, BIORESOURCE TECHNOL, V100, P5865, DOI 10.1016/j.biortech.2009.06.048
   Liu ZS, 2012, BIORESOURCE TECHNOL, V119, P224, DOI 10.1016/j.biortech.2012.05.107
   Lopez-Linares JC, 2013, IND CROP PROD, V50, P525, DOI 10.1016/j.indcrop.2013.08.028
   Mandal A, 2011, CARBOHYD POLYM, V86, P1291, DOI 10.1016/j.carbpol.2011.06.030
   McDonough T. J., 1992, CHEM ORGANOSOLY DELI
   McIntosh S, 2010, BIORESOURCE TECHNOL, V101, P6718, DOI 10.1016/j.biortech.2010.03.116
   Metzger JO, 2009, NATURWISSENSCHAFTEN, V96, P279, DOI 10.1007/s00114-008-0479-4
   MIRON J, 1982, EUR J APPL MICROBIOL, V15, P83, DOI 10.1007/BF00499511
   Misono M, 2001, CHEM COMMUN, P1141, DOI 10.1039/b102573m
   Moe ST, 2012, ENRGY PROCED, V20, P50, DOI 10.1016/j.egypro.2012.03.007
   Mood SH, 2013, RENEW SUST ENERG REV, V27, P77, DOI 10.1016/j.rser.2013.06.033
   Mora-Pale M, 2011, BIOTECHNOL BIOENG, V108, P1229, DOI 10.1002/bit.23108
   Morales-delaRosa S, 2012, CHEM ENG J, V181, P538, DOI 10.1016/j.cej.2011.11.061
   Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025
   Palkovits R, 2011, CHEM COMMUN, V47, P576, DOI 10.1039/c0cc02263b
   Pedersen M, 2010, NEW BIOTECHNOL, V27, P739, DOI 10.1016/j.nbt.2010.05.003
   Peng BL, 2011, CAN J CHEM ENG, V89, P1191, DOI 10.1002/cjce.20554
   Perego C, 2010, CHEM ENG J, V161, P314, DOI 10.1016/j.cej.2010.01.036
   Perez J., 2002, International Microbiology, V5, P53
   Quievy N, 2010, POLYM DEGRAD STABIL, V95, P306, DOI 10.1016/j.polymdegradstab.2009.11.020
   Quiroz-Castañeda Rosa E, 2011, Biotecnol Apl, V28, P205
   Ramos LP, 2003, QUIM NOVA, V26, P863, DOI 10.1590/S0100-40422003000600015
   Refaat AA, 2012, COMPREHENSIVE RENEWABLE ENERGY, VOL 5: BIOMASS AND BIOFUEL PRODUCTION, P217, DOI 10.1016/B978-0-08-087872-0.00518-7
   Rinaldi R, 2009, ENERG ENVIRON SCI, V2, P610, DOI 10.1039/b902668a
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970
   Sanchez O., 2011, DELIGNIFICATION PROC
   Morais JPS, 2013, CARBOHYD POLYM, V91, P229, DOI 10.1016/j.carbpol.2012.08.010
   Saratale G. D., 2012, African Journal of Biotechnology, V11, P1002
   Sathitsuksanoh N, 2012, CELLULOSE, V19, P1161, DOI 10.1007/s10570-012-9719-z
   Satyamurthy P, 2013, ENZYME MICROB TECH, V52, P20, DOI 10.1016/j.enzmictec.2012.09.002
   Sills DL, 2011, BIORESOURCE TECHNOL, V102, P1389, DOI 10.1016/j.biortech.2010.09.035
   Siro I, 2010, CELLULOSE, V17, P459, DOI 10.1007/s10570-010-9405-y
   Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7
   Sun ZY, 2011, BIORESOURCE TECHNOL, V102, P10929, DOI 10.1016/j.biortech.2011.09.071
   Tadesse H, 2011, ENERG ENVIRON SCI, V4, P3913, DOI 10.1039/c0ee00667j
   Taherdanak M, 2014, FUEL, V115, P714, DOI 10.1016/j.fuel.2013.07.094
   Tian JA, 2011, CHEM ENG TECHNOL, V34, P482, DOI 10.1002/ceat.201000409
   Tian J, 2010, CELLULOSE, V17, P587, DOI 10.1007/s10570-009-9391-0
   Tonoli GHD, 2012, CARBOHYD POLYM, V89, P80, DOI 10.1016/j.carbpol.2012.02.052
   Wang HY, 2012, J ENVIRON SCI-CHINA, V24, P473, DOI 10.1016/S1001-0742(11)60795-X
   Wendy PQN, 2012, J CLEAN PROD, V34, P57, DOI 10.1016/j.jclepro.2012.04.004
   Wettstein SG, 2012, CURR OPIN CHEM ENG, V1, P218, DOI 10.1016/j.coche.2012.04.002
   Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010
   Xiong R, 2012, CELLULOSE, V19, P1189, DOI 10.1007/s10570-012-9730-4
   Xiong Y, 2014, CHEM ENG J, V235, P349, DOI 10.1016/j.cej.2013.09.031
   Xu JL, 2010, BIORESOURCE TECHNOL, V101, P2900, DOI 10.1016/j.biortech.2009.12.015
   Yan YJ, 1996, BIORESOURCE TECHNOL, V57, P269, DOI 10.1016/S0960-8524(96)00103-4
   Yang B, 2011, BIOFUELS-UK, V2, P421, DOI 10.4155/BFS.11.116
   Yang HP, 2006, ENERG FUEL, V20, P388, DOI 10.1021/ef0580117
   Yang PF, 2011, CHINESE J CATAL, V32, P716, DOI 10.1016/S1872-2067(10)60232-X
   Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068
   Yin DL, 2011, BIORESOURCE TECHNOL, V102, P5183, DOI 10.1016/j.biortech.2011.01.079
   Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052
   Zhang CB, 2013, CELLULOSE, V20, P127, DOI 10.1007/s10570-012-9839-5
   Zhang Q, 2013, RENEW ENERG, V60, P127, DOI 10.1016/j.renene.2013.04.012
   Zhang ZY, 2012, BIORESOURCE TECHNOL, V120, P149, DOI 10.1016/j.biortech.2012.06.035
   Zhao JQ, 2013, CARBOHYD POLYM, V97, P695, DOI 10.1016/j.carbpol.2013.05.050
   Zhao J, 2011, BIOCHEM ENG J, V56, P158, DOI 10.1016/j.bej.2011.06.002
   Zhao XB, 2009, APPL MICROBIOL BIOT, V82, P815, DOI 10.1007/s00253-009-1883-1
   Zheng Y, 2013, APPL ENERG, V105, P1, DOI 10.1016/j.apenergy.2012.11.070
   Zhou CH, 2011, CHEM SOC REV, V40, P5588, DOI 10.1039/c1cs15124j
   Zhu L, 2008, BIORESOURCE TECHNOL, V99, P3817, DOI 10.1016/j.biortech.2007.07.033
NR 116
TC 29
Z9 30
U1 12
U2 131
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, WIT 5HE, ENGLAND
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2014
AR 631013
DI 10.1155/2014/631013
PG 20
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR2WU
UT WOS:000343449400001
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Shahabi, S
   Najafi, F
   Majdabadi, A
   Hooshmand, T
   Nazarpak, MH
   Karimi, B
   Fatemi, SM
AF Shahabi, Sima
   Najafi, Farhood
   Majdabadi, Abbas
   Hooshmand, Tabassom
   Nazarpak, Masoumeh Haghbin
   Karimi, Batool
   Fatemi, Seyyed Mostafa
TI Effect of Gamma Irradiation on Structural and Biological Properties of a
   PLGA-PEG-Hydroxyapatite Composite
SO SCIENTIFIC WORLD JOURNAL
LA English
DT Article
ID MOLECULAR-WEIGHT; MECHANICAL-PROPERTIES; SURFACE MODIFICATION; RAY
   IRRADIATION; ION IRRADIATION; FT-RAMAN; RADIATION; MICROSPHERES; BONE;
   DEGRADATION
AB Gamma irradiation is able to affect various structural and biological properties of biomaterials In this study, a composite of Hap/PLGA-PEG and their ingredients were submitted to gamma irradiation doses of 25 and 50 KGy. Various properties such as molecular weight (GPC), thermal behavior (DSC), wettability (contact angle), cell viability (MTT assay), and alkaline phosphatase activity were studied for the composites and each of their ingredients. The results showed a decrease in molecular weight of copolymer with no change in the glass transition and melting temperatures after gamma irradiation. In general gamma irradiation can increase the activation energy Delta H of the composites and their ingredients. While gamma irradiation had no effect on the wettability of copolymer samples, there was a significant decrease in contact angle of hydroxyapatite and composites with increase in gamma irradiation dose. This study showed an increase in biocompatibility of hydroxyapatite with gamma irradiation with no significant effect on cell viability in copolymer and composite samples. In spite of the fact that no change occurred in alkaline phosphatase activity of composite samples, results indicated a decrease in alkaline phosphatase activity in irradiated hydroxyapatites. These effects on the properties of PLGA-PEG-hydroxyapatite can enhance the composite application as a biomaterial.
C1 [Shahabi, Sima; Hooshmand, Tabassom; Fatemi, Seyyed Mostafa] Univ Tehran Med Sci, Sch Dent, Dept Dent Biomat, Tehran, Iran.
   [Najafi, Farhood] Inst Color Sci & Technol, Dept Resin & Addit, Tehran, Iran.
   [Majdabadi, Abbas] Univ Tehran Med Sci, Sch Dent, Laser Res Ctr Dent, Tehran, Iran.
   [Nazarpak, Masoumeh Haghbin] Amirkabir Univ Technol, NTRC, Tehran, Iran.
   [Karimi, Batool] Iranian Ctr Med Laser Res, ACECR Tehran Med Sci Branch, Tehran, Iran.
RP Fatemi, SM (reprint author), Univ Tehran Med Sci, Sch Dent, Dept Dent Biomat, End North Kargar St, Tehran, Iran.
EM fatemi_m@razi.tums.ac.ir
RI Hooshmand, Tabassom/N-2949-2018
OI Hooshmand, Tabassom/0000-0002-4552-6861; Shahabi,
   Sima/0000-0001-7666-3204
CR Albano C, 2006, MOL CRYST LIQ CRYST, V448, P243, DOI 10.1080/15421400500403283
   Alothman OY, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-95
   Angelova N, 1999, TRENDS BIOTECHNOL, V17, P409, DOI 10.1016/S0167-7799(99)01356-6
   Bittner B, 1999, J CONTROL RELEASE, V59, P23, DOI 10.1016/S0168-3659(98)00170-9
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   CHAPIRO A, 1988, NUCL INSTRUM METH B, V32, P111, DOI 10.1016/0168-583X(88)90191-7
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Colaco R., 2006, MATER SCI FORUM, V514-516, P1054
   Dadbin S, 2014, POLYM INT, V63, P1063, DOI 10.1002/pi.4611
   Dorati R, 2008, AAPS PHARMSCITECH, V9, P718, DOI 10.1208/s12249-008-9103-3
   Dorati R, 2012, J BIOMAT SCI-POLYM E, V23, P2223, DOI 10.1163/156856211X613915
   Eslaminejad Mohamadreza Baghaban, 2010, Iranian Journal of Biotechnology, V8, P234
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Girija EK, 2008, J CERAM SOC JPN, V116, P320, DOI 10.2109/jcersj2.116.320
   Gorna K, 2003, POLYM DEGRAD STABIL, V79, P465, DOI 10.1016/S0141-3910(02)00362-2
   Guo XY, 2007, J BIOMED MATER RES A, V82A, P1022, DOI 10.1002/jbm.a.31200
   HAUSBERGER AG, 1995, PHARMACEUT RES, V12, P851, DOI 10.1023/A:1016256903322
   Herrero-Vanrell R, 2001, ADV DRUG DELIVER REV, V52, P5, DOI 10.1016/S0169-409X(01)00200-9
   Ignjatovic N., 2007, MATER SCI FORUM, P497
   JACOBS GP, 1995, J BIOMATER APPL, V10, P59, DOI 10.1177/088532829501000104
   Jo SY, 2012, RADIAT PHYS CHEM, V81, P846, DOI 10.1016/j.radphyschem.2012.03.013
   Kawasaki Y, 2010, J BIOMED MATER RES B, V92B, P161, DOI 10.1002/jbm.b.31502
   Kizil R, 2002, J AGR FOOD CHEM, V50, P3912, DOI 10.1021/jf011652p
   Kizil R, 2007, J SCI FOOD AGR, V87, P1244, DOI 10.1002/jsfa.2830
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Kubisz L, 2003, INT J BIOL MACROMOL, V33, P89, DOI 10.1016/S0141-8130(03)00071-0
   Milicevic D, 2010, NUCL INSTRUM METH B, V268, P2744, DOI 10.1016/j.nimb.2010.06.036
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Montanari L, 2003, J CONTROL RELEASE, V90, P281, DOI 10.1016/S0168-3659(03)00153-6
   Nechifor CD, 2009, ROM J PHYS, V54, P349
   Parthiban SP, 2008, NUCL INSTRUM METH B, V266, P911, DOI 10.1016/j.nimb.2008.02.026
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Sagari ARA, 2008, NUCL INSTRUM METH B, V266, P2515, DOI 10.1016/j.nimb.2008.03.069
   Sayyah S. M., 2003, INT J POLYM MATER PO, V52, P1059
   Sen M, 2003, NUCL INSTRUM METH B, V208, P480, DOI 10.1016/S0168-583X(03)01111-X
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Sonkawade RG, 2010, INDIAN J PURE AP PHY, V48, P453
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   Takeuchi N, 2011, DENT MATER J, V30, P730, DOI 10.4012/dmj.2011-075
   Thanigaiarul K, 2013, CERAM INT, V39, P3027, DOI 10.1016/j.ceramint.2012.09.081
   VOLLAND C, 1994, J CONTROL RELEASE, V31, P293, DOI 10.1016/0168-3659(94)90012-4
   Yildirim Y, 2014, RADIAT PHYS CHEM, V96, P69, DOI 10.1016/j.radphyschem.2013.08.016
   You F., 2013, SCI WORLD J, V2013
NR 43
TC 7
Z9 7
U1 1
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1537-744X
J9 SCI WORLD J
JI Sci. World J.
PY 2014
AR 420616
DI 10.1155/2014/420616
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AR4NM
UT WOS:000343563500001
PM 25574485
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Mirzasadeghi, A
   Narayanan, SS
   Ng, MH
   Sanaei, R
   Cheng, CH
   Bajuri, MY
   Shukur, MH
AF Mirzasadeghi, Alireza
   Narayanan, Sri Subanesh
   Ng, Min Hwei
   Sanaei, Reza
   Cheng, Chen Hui
   Bajuri, Mohd Yazid
   Shukur, Mohammad Hassan
TI Intramedullary cement osteosynthesis (IMCO): A pilot study in sheep
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Intramedullary cement osteosynthesis (IMCO); calcium phosphate cement
   (CPC); biomaterial; fracture; impending fracture; osteoporosis; internal
   fixation
ID BONE-CEMENT; BIOCOMPATIBILITY; FRACTURES; FIXATION
AB The application of bone substitutes and cements has a long standing history in augmenting fractures as a complement to routine fracture fixation techniques. Nevertheless, such use is almost always in conjunction with definite means of fracture fixation such as intramedullary pins or bone plates. The idea of using biomaterials as the primary fixation bears the possibility of simultaneous fixation and bone enhancement. Intramedullary recruitment of bone cements is suggested in this study to achieve this goal. However, as the method needs primary testings in animal models before human implementation, and since the degree of ambulation is not predictable in animals, this pilot study only evaluates the outcomes regarding the feasibility and safety of this method in the presence of primary bone fixators. A number of two sheep were used in this study. Tibial transverse osteotomies were performed in both animals followed by external skeletal fixation. The medullary canals, which have already been prepared by removing the marrow through proximal and distal drill holes, were then injected with calcium phosphate cement (CPC). The outcomes were evaluated postoperatively by standard survey radiographs, morphology, histology and biomechanical testings. Healing processes appeared uncomplicated until week four where one bone fracture recurred due to external fixator failure. The results showed 56% and 48% cortical thickening, compared to the opposite site, in the fracture site and proximal and distal diaphyses respectively. This bone augmentative effect resulted in 264% increase in bending strength of the fracture site and 148% increase of the same value in the adjacent areas of diaphyses. In conclusion, IMCO, using CPC in tibia of sheep, is safe and biocompatible with bone physiology and healing. It possibly can carry the osteopromotive effect of the CPCs to provide a sustained source of bone augmentation throughout the diaphysis. Although the results must be considered preliminary, this method has possible advantages over conventional methods of bone fixation at least in bones with compromised quality (i.e. osteoporosis and bone cysts), where rigid metal implants may jeopardize eggshell cortices.
C1 [Mirzasadeghi, Alireza] Taylors Univ, Sch Med, Dept Orthoped, Hosp Sungai Buloh, Sungai Buloh 47000, Selangor, Malaysia.
   [Narayanan, Sri Subanesh; Bajuri, Mohd Yazid; Shukur, Mohammad Hassan] Univ Kebangsaan Malaysia, Natl Univ Malaysia, Med Ctr UKMMC, Dept Orthoped & Traumatol, Kuala Lumpur 56000, Malaysia.
   [Ng, Min Hwei] Univ Kebangsaan Malaysia, Natl Univ Malaysia, Med Ctr UKMMC, Tissue Engeenering Ctr, Kuala Lumpur 56000, Malaysia.
   [Sanaei, Reza; Cheng, Chen Hui] Univ Putra Malaysia, Dept Veterinay Clin Studies, Serdang 43400, Selangor, Malaysia.
RP Mirzasadeghi, A (reprint author), Taylors Univ, Sch Med, Dept Orthoped, Hosp Sungai Buloh, Level 9D, Sungai Buloh 47000, Selangor, Malaysia.
EM alireza.mirzasadeghi@taylors.edu.my
OI Chen, Hui Cheng/0000-0003-3717-0831
CR Benzel EC, 1995, BIOMECHANICS SPINE S
   Buckwalter J.A., 2005, TUREKS ORTHOPAEDICS, P28
   Cohen M S, 1997, AORN J, V65, P958, DOI 10.1016/S0001-2092(06)62978-5
   Completo A, 2008, KNEE, V15, P227, DOI 10.1016/j.knee.2008.01.008
   Elizabeth P.F., 1998, J BONE JOINT SURG AM, V80, P1112
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3
   JOHNSON RW, 1968, CLIN ORTHOP RELAT R, P5
   KUZMA AB, 1991, J AM ANIM HOSP ASSOC, V27, P239
   Lind P. J., 1989, Journal of the Association of Avian Veterinarians, V3, P203, DOI 10.2307/27670893
   Link DP, 2008, J BIOMED MATER RES A, V87A, P760, DOI 10.1002/jbm.a.31831
   Lobenhoffer P, 2002, J ORTHOP TRAUMA, V16, P143, DOI 10.1097/00005131-200203000-00001
   Mitzner E, 2009, MATER RES-IBERO-AM J, V12, P447, DOI 10.1590/S1516-14392009000400013
   Moore WR, 2001, AUST NZ J SURG, V71, P354, DOI 10.1046/j.1440-1622.2001.2128.x
   NEWMAN E, 1995, BONE, V16, pS277, DOI 10.1016/8756-3282(95)00026-A
   PUTNEY DL, 1983, J AM ANIM HOSP ASSOC, V19, P773
   Saffar Kaveh Pour Akbar, 2009, American Journal of Applied Sciences, V6, P463
   Simpson D, 2004, INJURY, V35, P913, DOI 10.1016/S0020-1383(03)00109-8
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   Varner KE, 2005, AM J SPORT MED, V33, P1071, DOI 10.1177/0363546504271968
NR 20
TC 4
Z9 4
U1 0
U2 9
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 6
BP 2177
EP 2186
DI 10.3233/BME-141029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7NW
UT WOS:000343005700032
PM 25226916
DA 2018-10-19
ER

PT J
AU Ye, X
   Wang, Z
   Zhang, XH
   Zhou, M
   Cai, L
AF Ye, Xia
   Wang, Ze
   Zhang, Xianghua
   Zhou, Ming
   Cai, Lan
TI Hemocompatibility research on the micro-structure surface of a bionic
   heart valve
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE Hemocompatibility; micro-structure surface; polyurethane; periodic
   space; bionic heart valve
ID NANOCRYSTALLINE DIAMOND; MECHANICAL-PROPERTIES; COMPATIBILITY;
   TRANSPARENT
AB In order to study how the geometric parameters and shape of the micro-structure surface of a bionic heart valve affects hemocompatibility, mastoid micro-structures with different periodic space were fabricated using a femtosecond laser on a polyurethane (PU) surface. The apparent contact angles of droplets on the micro-structure surfaces were measured to characterize their wettability. Then a series of blood compatibility experiments, including platelet adhesion, dynamic coagulation and hemolysis were completed. The experimental results showed that the micr-ostructure on the biomaterial surface helped improve its hydrophobicity and hemocompatibility. Also, the periodic space affected not only the hydrophobicity but also the hemocompatibility of the biomaterial. With the increasing of the periodic space, the apparent contact angle increased, the number of platelet adhesion decreased, the dynamic clotting time became longer and the hemolysis ratio reduced. In addition, the shape of the micro-structure also affected the hemocompatibility of the biomaterial.
C1 [Ye, Xia; Wang, Ze; Zhang, Xianghua] Jiangsu Univ Technol, Sch Mech Engn, Changzhou 213001, Jiangsu, Peoples R China.
   [Zhou, Ming; Cai, Lan] Jiangsu Univ, Ctr Photon Fabricat, Zhenjiang 212013, Jiangsu, Peoples R China.
RP Ye, X (reprint author), Jiangsu Univ Technol, Sch Mech Engn, Changzhou 213001, Jiangsu, Peoples R China.
EM yexia@jsut.edu.cn
FU Natural Science foundation of Jiangsu Province [BK2010203]; Key
   Laboratory Opening foundation of Jiangsu Province [GZ201109]; Jiangsu
   Overseas Research & Training Program for University Prominent Young &
   Middle-aged Teachers and Presidents
FX This research is supported by the Natural Science foundation of Jiangsu
   Province (BK2010203) and the Key Laboratory Opening foundation of
   Jiangsu Province (GZ201109) and Jiangsu Overseas Research & Training
   Program for University Prominent Young & Middle-aged Teachers and
   Presidents.
CR All N., 2006, THIN SOLID FILMS, V515, P59
   BOLZ A, 1990, ARTIF ORGANS, V14, P260, DOI 10.1111/j.1525-1594.1990.tb02967.x
   Cao LL, 2010, FARADAY DISCUSS, V146, P57, DOI 10.1039/c003392h
   Cho KL, 2010, J PHYS CHEM C, V114, P11228, DOI 10.1021/jp103479k
   Ebert D, 2012, J COLLOID INTERF SCI, V368, P584, DOI 10.1016/j.jcis.2011.09.049
   Hung JM, 2012, PHYSCS PROC, V32, P696, DOI 10.1016/j.phpro.2012.03.620
   Hung JM, 2011, APPL SURF SCI, V257, P5508, DOI 10.1016/j.apsusc.2010.12.134
   Im M, 2010, SOFT MATTER, V6, P1401, DOI 10.1039/b925970h
   Jung YC, 2009, ACS NANO, V3, P4155, DOI 10.1021/nn901509r
   Krzysztof J., 2007, DIAM RELAT MATER, V16, P1004
   Leng YX, 2006, SURF COAT TECH, V201, P1012, DOI 10.1016/j.surfcoat.2006.01.024
   Narayan RJ, 2006, DIAM RELAT MATER, V15, P1935, DOI 10.1016/j.diamond.2006.08.024
   Xu LB, 2012, ACS APPL MATER INTER, V4, P1118, DOI 10.1021/am201750h
   Ye X, 2009, APPL SURF SCI, V255, P6686, DOI 10.1016/j.apsusc.2009.02.068
   Zhang JH, 2011, ADV MATER RES-SWITZ, V230-232, P420, DOI 10.4028/www.scientific.net/AMR.230-232.420
NR 15
TC 0
Z9 0
U1 1
U2 17
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
EI 1878-3619
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2014
VL 24
IS 6
BP 2361
EP 2369
DI 10.3233/BME-141049
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA AQ7NW
UT WOS:000343005700052
PM 25226936
DA 2018-10-19
ER

PT J
AU Putnam, AJ
AF Putnam, Andrew J.
TI The instructive role of the vasculature in stem cell niches
SO BIOMATERIALS SCIENCE
LA English
DT Review
ID MICROVASCULAR ENDOTHELIAL-CELLS; GROWTH-FACTOR DELIVERY; MARROW STROMAL
   CELLS; MESENCHYMAL STEM; HEMATOPOIETIC STEM; BONE-MARROW; IN-VIVO;
   SELF-RENEWAL; PROGENITOR CELLS; CAPILLARY MORPHOGENESIS
AB An important hallmark of many adult stem cell niches is their proximity to the vasculature in vivo, a feature common to neural stem cells (NSCs), mesenchymal stem cells (MSCs) from bone marrow, adipose, and other tissues, hematopoietic stem cells (HSCs), and many tumor stem cells. This review summarizes key studies supporting the vasculature's instructive role in adult stem cell niches, and the putative underlying molecular mechanisms by which blood vessels in these niches exert control over progenitor cell fates. The importance of the perivascular niche for pathology, notably tumor metastasis and dormancy, is also highlighted. Finally, the implications of the perivascular regulation of stem and progenitor cells on biomaterial design and the impact on future research directions are discussed.
C1 Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
RP Putnam, AJ (reprint author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.
EM putnam@umich.edu
OI Putnam, Andrew/0000-0002-1262-4377
FU National Heart, Lung, and Blood Institute of the National Institutes of
   Health [R01HL085339, R01HL118259]
FX The author gratefully acknowledges financial support from the National
   Heart, Lung, and Blood Institute of the National Institutes of Health
   under award numbers R01HL085339 and R01HL118259.
CR Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027
   Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389
   Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437
   Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444
   Beckermann BM, 2008, BRIT J CANCER, V99, P622, DOI 10.1038/sj.bjc.6604508
   Blocki A, 2013, STEM CELLS DEV, V22, P2347, DOI 10.1089/scd.2012.0415
   Bordignon C, 2006, NATURE, V441, P1100, DOI 10.1038/nature04962
   Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001
   Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791
   Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Caplan AI, 2010, TISSUE ENG PT A, V16, P2415, DOI [10.1089/ten.tea.2010.0216, 10.1089/ten.TEA.2010.0216]
   Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444
   Carrion B, 2013, EXP CELL RES, V319, P2964, DOI 10.1016/j.yexcr.2013.09.007
   Carrion B, 2010, BIOTECHNOL BIOENG, V107, P1020, DOI 10.1002/bit.22891
   Chen XF, 2010, TISSUE ENG PT A, V16, P585, DOI [10.1089/ten.tea.2009.0491, 10.1089/ten.TEA.2009.0491]
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chow A, 2013, NAT MED, V19, P429, DOI 10.1038/nm.3057
   Codega P, 2014, NEURON, V82, P545, DOI 10.1016/j.neuron.2014.02.039
   Conway A, 2014, STEM CELLS, V32, P1220, DOI 10.1002/stem.1650
   Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003
   Dardik A, 2005, J VASC SURG, V41, P321, DOI 10.1016/j.jvs.2004.11.016
   Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Doorn J, 2012, TISSUE ENG PART B-RE, V18, P101, DOI [10.1089/ten.teb.2011.0488, 10.1089/ten.TEB.2011.0488]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Ferreira LS, 2007, BIOMATERIALS, V28, P2706, DOI 10.1016/j.biomaterials.2007.01.021
   FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27
   Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542
   FRIEDENSTEIN AJ, 1978, EXP HEMATOL, V6, P440
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Ghajar CM, 2008, BIOPHYS J, V94, P1930, DOI 10.1529/biophysj.107.120774
   Ghajar CM, 2006, TISSUE ENG, V12, P2875, DOI 10.1089/ten.2006.12.2875
   Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767
   Ghajar CM, 2010, EXP CELL RES, V316, P813, DOI 10.1016/j.yexcr.2010.01.013
   Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035
   Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959
   Gobaa S, 2011, NAT METHODS, V8, P949, DOI [10.1038/NMETH.1732, 10.1038/nmeth.1732]
   GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390
   Goldman SA, 2011, NAT NEUROSCI, V14, P1382, DOI 10.1038/nn.2963
   Grainger SJ, 2013, TISSUE ENG PT A, V19, P1209, DOI [10.1089/ten.tea.2012.0281, 10.1089/ten.TEA.2012.0281]
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224
   Hanjaya-Putra D, 2011, BLOOD, V118, P804, DOI 10.1182/blood-2010-12-327338
   Holst J, 2010, NAT BIOTECHNOL, V28, P1123, DOI 10.1038/nbt.1687
   Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Indraccolo S, 2009, CANCER RES, V69, P1314, DOI 10.1158/0008-5472.CAN-08-2791
   Infanger DW, 2013, ANNU REV BIOMED ENG, V15, P29, DOI 10.1146/annurev-bioeng-071811-150028
   Jackson WM, 2010, EXPERT OPIN BIOL TH, V10, P505, DOI 10.1517/14712591003610606
   Jeon JS, 2014, INTEGR BIOL-UK, V6, P555, DOI 10.1039/c3ib40267c
   Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279
   Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026
   Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57
   Kniazeva E, 2011, TISSUE ENG PT A, V17, P905, DOI [10.1089/ten.tea.2010.0275, 10.1089/ten.TEA.2010.0275]
   Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108
   Kobel S, 2011, CURR OPIN BIOTECH, V22, P690, DOI 10.1016/j.copbio.2011.07.001
   Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a
   Kokovay E, 2006, J CEREBR BLOOD F MET, V26, P545, DOI 10.1038/sj.jcbfm.9600214
   Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019
   Kolf CM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2116
   KOLLER MR, 1993, BIOTECHNOL BIOENG, V42, P909, DOI 10.1002/bit.260420802
   Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612
   Lee HJ, 2013, DIFFERENTIATION, V86, P92, DOI 10.1016/j.diff.2013.06.004
   Lee J, 2012, P NATL ACAD SCI USA, V109, P19638, DOI 10.1073/pnas.1208384109
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762
   Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5
   Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mason S, 2014, J DENT RES, V93, P55, DOI 10.1177/0022034513510530
   Mathieu C, 2008, MOL CELL NEUROSCI, V38, P569, DOI 10.1016/j.mcn.2008.05.005
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002
   Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590
   Miller JS, 2012, NAT MATER, V11, P768, DOI [10.1038/NMAT3357, 10.1038/nmat3357]
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542
   Moore MAS, 2012, NAT MED, V18, P1613, DOI 10.1038/nm.2992
   Nagaya N, 2005, CIRCULATION, V112, P1128, DOI 10.1161/CIRCULATIONAHA.104.500447
   NEHLS V, 1995, HISTOCHEM CELL BIOL, V104, P459, DOI 10.1007/BF01464336
   Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100
   Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Poulos MG, 2013, CELL REP, V4, P1022, DOI 10.1016/j.celrep.2013.07.048
   RAFII S, 1994, BLOOD, V84, P10
   RAFII S, 1995, BLOOD, V86, P3353
   Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957
   Schechner JS, 2000, P NATL ACAD SCI USA, V97, P9191, DOI 10.1073/pnas.150242297
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Scotti C, 2013, P NATL ACAD SCI USA, V110, P3997, DOI 10.1073/pnas.1220108110
   Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0
   Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Singh RK, 2013, BIOMATERIALS, V34, P9331, DOI 10.1016/j.biomaterials.2013.08.016
   Song JH, 2010, BLOOD, V115, P2592, DOI 10.1182/blood-2009-01-200071
   Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0
   Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/NMAT3339, 10.1038/nmat3339]
   Urschel K, 2012, CLIN HEMORHEOL MICRO, V50, P143, DOI 10.3233/CH-2011-1450
   Vazin T, 2010, TRENDS BIOTECHNOL, V28, P117, DOI 10.1016/j.tibtech.2009.11.008
   Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009
   Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220
   Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969
   Wong KHK, 2012, ANNU REV BIOMED ENG, V14, P205, DOI [10.1146/annurev-bioeng-071811-150052, 10.1146/annurev.bioeng-071811-150052]
   Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang QZ, 2012, J DENT RES, V91, P1011, DOI 10.1177/0022034512461016
   Zheng Y, 2012, P NATL ACAD SCI USA, V109, P9342, DOI 10.1073/pnas.1201240109
   Zhou J, 2014, ARTERIOSCL THROM VAS, V34, P2191, DOI 10.1161/ATVBAHA.114.303422
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 126
TC 10
Z9 9
U1 1
U2 16
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 11
BP 1562
EP 1573
DI 10.1039/c4bm00200h
PG 12
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XR
UT WOS:000343034200003
PM 25530848
OA Green Accepted
DA 2018-10-19
ER

PT J
AU McCreedy, DA
   Wilems, TS
   Xu, H
   Butts, JC
   Brown, CR
   Smith, AW
   Sakiyama-Elbert, SE
AF McCreedy, D. A.
   Wilems, T. S.
   Xu, H.
   Butts, J. C.
   Brown, C. R.
   Smith, A. W.
   Sakiyama-Elbert, S. E.
TI Survival, differentiation, and migration of high-purity mouse embryonic
   stem cell-derived progenitor motor neurons in fibrin scaffolds after
   sub-acute spinal cord injury
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID PROMOTE LOCOMOTOR RECOVERY; STEM/PROGENITOR CELLS; CONTROLLED-RELEASE;
   GROWTH-FACTOR; TRANSGENIC ENRICHMENT; FUNCTIONAL RECOVERY; PRECURSOR
   CELLS; RAT; TRANSPLANTATION; OLIGODENDROCYTES
AB Embryonic stem (ES) cells can be differentiated into many neural cell types that hold great potential in cell replacement therapies following spinal cord injury (SCI). Coupling stem cell transplantation with biomaterial scaffolds can produce a unified combination therapy with several potential advantages including enhanced cell survival, greater transplant retention, reduced scarring, and improved integration at the transplant/host interface. Undesired cell types, however, are commonly present in ES-cell derived cultures due to the limited efficiency of most ES cell induction protocols. Heterogeneous cell populations can confound the interaction between the biomaterial and specific neural populations leading to undesired outcomes. In particular, biomaterial scaffolds may enhance tumor formation by promoting survival and proliferation of undifferentiated ES cells that can persist after induction. Methods for purification of specific ES cell-derived neural populations are necessary to recognize the full potential of combination therapies involving biomaterials and ES cell-derived neural populations. We previously developed a method for enriching ES cell-derived progenitor motor neurons (pMNs) induced from mouse ES cells via antibiotic selection and showed that the enriched cell populations are depleted of pluripotent stem cells. In this study, we demonstrate the survival and differentiation of enriched pMNs within three dimensional (3D) fibrin scaffolds in vitro and when transplanted into a sub-acute dorsal hemisection model of SCI into neurons, oligodendrocytes and astrocytes.
C1 [McCreedy, D. A.; Wilems, T. S.; Xu, H.; Butts, J. C.; Brown, C. R.; Smith, A. W.; Sakiyama-Elbert, S. E.] Washington Univ, Dept Biomed Engn, St Louis, MO 63112 USA.
RP McCreedy, DA (reprint author), Washington Univ, Dept Biomed Engn, St Louis, MO 63112 USA.
EM sakiyama@wustl.edu
RI Sakiyama-Elbert, Shelly/A-6753-2008
OI Sakiyama-Elbert, Shelly/0000-0003-4832-5851
FU NIH RO1 grant [5R01NS051454]; NSF GRFP [DGE-1143954]
FX The authors were funded by the NIH RO1 grant 5R01NS051454. Support was
   provided for Dylan McCreedy by the NSF GRFP DGE-1143954.
CR Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029
   Anderson D, 2007, MOL THER, V15, P2027, DOI 10.1038/sj.mt.6300303
   BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085
   BANIK NL, 1982, NEUROCHEM RES, V7, P1465, DOI 10.1007/BF00965089
   Bjorklund LM, 2002, P NATL ACAD SCI USA, V99, P2344, DOI 10.1073/pnas.022438099
   Bozkurt G, 2010, NEUROSURGERY, V67, P1733, DOI 10.1227/NEU.0b013e3181f9af35
   Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536
   Cao QL, 2002, EXP NEUROL, V177, P349, DOI 10.1006/exner.2002.7981
   Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8
   Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73
   Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102
   Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489
   Erdo F, 2003, J CEREBR BLOOD F MET, V23, P780, DOI 10.1097/01.WCB.0000071886.63724.FB
   Guest JD, 2005, EXP NEUROL, V192, P384, DOI 10.1016/j.expneurol.2004.11.033
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Iwata A, 2006, TISSUE ENG, V12, P101, DOI 10.1089/ten.2006.12.101
   Johnson PJ, 2010, SOFT MATTER, V6, P5127, DOI 10.1039/c0sm00173b
   Johnson PJ, 2010, CELL TRANSPLANT, V19, P89, DOI 10.3727/096368909X477273
   Johnson PJ, 2010, J BIOMED MATER RES A, V92A, P152, DOI 10.1002/jbm.a.32343
   Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006
   Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Liu XZ, 1997, J NEUROSCI, V17, P5395
   Lu P, 2012, CELL, V150, P1264, DOI 10.1016/j.cell.2012.08.020
   McCreedy DA, 2014, BIOTECHNOL BIOENG, V111, P2041, DOI 10.1002/bit.25260
   McCreedy DA, 2012, STEM CELL RES, V8, P368, DOI 10.1016/j.scr.2011.12.003
   Meijer DH, 2012, NAT REV NEUROSCI, V13, P819, DOI 10.1038/nrn3386
   Mothe AJ, 2008, CELL TRANSPLANT, V17, P735, DOI 10.3727/096368908786516756
   Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108
   Parr AM, 2008, NEUROSCIENCE, V155, P760, DOI 10.1016/j.neuroscience.2008.05.042
   Patel V, 2010, J NEUROTRAUM, V27, P789, DOI 10.1089/neu.2008.0809
   QUITSCHKE WW, 1989, J BIOL CHEM, V264, P9539
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schumacher PA, 2000, J NEUROCHEM, V74, P1646, DOI 10.1046/j.1471-4159.2000.0741646.x
   SEILERTUYNS A, 1984, P NATL ACAD SCI-BIOL, V81, P2980, DOI 10.1073/pnas.81.10.2980
   Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245
   Smith AW, 2013, BIOMATERIALS, V34, P6559, DOI 10.1016/j.biomaterials.2013.05.050
   Taylor SJ, 2006, J CONTROL RELEASE, V113, P226, DOI 10.1016/j.jconrel.2006.05.005
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Willerth SM, 2007, STEM CELLS, V25, P2235, DOI 10.1634/stemcells.2007-0111
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   Willerth SM, 2008, STEM CELL RES, V1, P205, DOI 10.1016/j.scr.2008.05.006
   Woerly S, 2004, J NEUROSCI RES, V75, P262, DOI 10.1002/jnr.10774
NR 44
TC 29
Z9 29
U1 1
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 11
BP 1672
EP 1682
DI 10.1039/c4bm00106k
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AQ7XR
UT WOS:000343034200012
PM 25346848
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Bang, LT
   Othman, R
AF Le Thi Bang
   Othman, Radzali
TI AGING TIME AND SYNTHESIS PARAMETERS OF NANOCYSTALLINE SINGLE PHASE
   HYDROXYAPATITE PRODUCED BY A PRECIPITATION METHOD
SO CERAMICS-SILIKATY
LA English
DT Article
DE Hydroxyapatite; Aging time; Calcinations; Phase purity; Biomaterial
ID THERMAL-STABILITY; NANOCRYSTALLINE HYDROXYAPATITE; ROUTE; BONE;
   TEMPERATURE; SCAFFOLDS
AB Hydroxyapatite (HA) is the major inorganic component in hard tissue of the human body, such as dental and bone. However, there is a great challenge to produce high purity phase HA with nano-size particles. In this research work, precipitation method is a successful route to synthesize purity nanocrystalite hydroxyapatite (HA) at low temperature. The effects of stirring speed and aging time during the precipitation process on the formation of nanocrystalline HA were investigated. The results indicated that the stoichiometric pure HA powders with nano-sized, rod-like particles of about 8.7 - 20.7 nm in width and 44.2 - 107.0 nm in length were successfully produced. In order to study the thermal stability, as-prepared HA powders were calcined at different temperatures of 850, 1000 and 1200 degrees C for 1 hour It was concluded that purity HA had excellent thermal stability up to 1200 degrees C when the aging time is prolonged to 24 hours.
C1 [Le Thi Bang; Othman, Radzali] Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
   [Le Thi Bang] Univ Malaya, Ctr Adv Mfg & Mat Proc, Dept Mech Engn, Kuala Lumpur 50603, Malaysia.
RP Bang, LT (reprint author), Univ Sains Malaysia, Sch Mat & Mineral Resources Engn, Nibong Tebal 14300, Penang, Malaysia.
EM lebang@um.edu.my
FU Japan International Cooperation Agency (JICA); Ministry of Higher
   Education Malaysia
FX This study was in part supported by the AUN/SEED-Net project under the
   Japan International Cooperation Agency (JICA) and by the Ministry of
   Higher Education Malaysia grants.
CR Afshar A, 2003, MATER DESIGN, V24, P197, DOI 10.1016/S0261-3069(03)00003-7
   Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Binnaz H., 2009, DIG J NANOMATER BIOS, V4, P73
   Cabrera JL, 2011, J NANOSCI NANOTECHNO, V11, P5555, DOI 10.1166/jnn.2011.3433
   Donadel K, 2005, J AM CERAM SOC, V88, P2230, DOI 10.1111/j.1551-2916.2005.00433.x
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Feng W, 2005, MATER LETT, V59, P916, DOI DOI 10.1016/J.MATLET.2004.08.041
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Iwasaki T, 2013, INT J MOL SCI, V14, P9365, DOI 10.3390/ijms14059365
   Joyce Y, 2007, BIOMATERIALS
   Kothapalli C, 2004, ACTA MATER, V52, P5655, DOI 10.1016/j.actamat.2004.08.027
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Lazic S, 2001, THERMOCHIM ACTA, V374, P13, DOI 10.1016/S0040-6031(01)00453-1
   Liu CS, 2001, BIOMATERIALS, V22, P301, DOI 10.1016/S0142-9612(00)00166-6
   Maria V. R., 2005, J MATER CHEM, V15, P1509
   Meejoo S, 2006, THERMOCHIM ACTA, V447, P115, DOI 10.1016/j.tca.2006.04.013
   Miller F.A, 2004, COURSE NOTES INTERPR, P300
   Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018
   Padmanabhan SK, 2009, PARTICUOLOGY, V7, P466, DOI 10.1016/j.partic.2009.06.008
   Ramanan SR, 2004, MATER LETT, V58, P3320, DOI 10.1016/j.matlet.2004.06.030
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rhee SH, 2002, BIOMATERIALS, V23, P1147, DOI 10.1016/S0142-9612(01)00229-0
   Sadat-Shojai M, 2013, ACTA BIOMATER, V9, P7591, DOI 10.1016/j.actbio.2013.04.012
   Saeri MR, 2003, MATER LETT, V57, P4064, DOI 10.1016/S0167-577X(03)00266-0
   Shinnosuke O., 2010, ACTA BIOMATER, V6, P591
   Tang XL, 2005, MATER LETT, V59, P3841, DOI 10.1016/j.matlet.2005.06.060
   Xie ML, 2010, ACTA BIOMATER, V6, P3665, DOI 10.1016/j.actbio.2010.03.034
   Yang ZW, 2004, MATER LETT, V58, P3586, DOI 10.1016/j.matlet.2004.06.046
NR 28
TC 2
Z9 2
U1 0
U2 1
PU INST CHEMICAL TECHNOLOGY, DEPT GLASS CERAMICS
PI PRAGUE
PA TECHNICKA 5, PRAGUE 166 28, CZECH REPUBLIC
SN 0862-5468
EI 1804-5847
J9 CERAM-SILIKATY
JI Ceram.-Silik.
PY 2014
VL 58
IS 2
BP 157
EP 164
PG 8
WC Materials Science, Ceramics
SC Materials Science
GA AQ4AY
UT WOS:000342735800012
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Zilm, ME
   Staruch, M
   Jain, M
   Wei, M
AF Zilm, M. E.
   Staruch, M.
   Jain, M.
   Wei, Mei
TI An intrinsically magnetic biomaterial with tunable magnetic properties
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID IRON-OXIDE NANOPARTICLES; PHOSPHATE-GLASSES; SUBSTITUTED HYDROXYAPATITE;
   CANCER-THERAPY; SPECTROSCOPY; FLUORAPATITE; PARTICLE; IONS
AB Many magnetic materials lack intrinsic biocompatibility and require surface functionalization for in vivo applications. In this study, we fabricated an intrinsically biocompatible, biodegradable magnetic material through iron substitution into hydroxyapatite (FeHA) via ion-exchange. Controlling the oxidation state of iron in the ion exchange solution resulted in 'tunable' magnetic properties. Superparamagnetic behavior was observed in Fe(2+)HA and Fe(2+3+)HA and paramagnetism in Fe(3+)HA. FeHA powders were characterized using field emission scanning electron microscopy (FESEM), X-ray diffraction (XRD), Fourier transform infra-red (FTIR) and X-ray photoelectron spectroscopy (XPS) with no detection of iron oxide phases. The as-synthesized HA and Fe(2+3+)HA samples were characterized in vitro using MC3T3-E1 cells. Cellular proliferation of Fe(2+3+)HA was found comparable to HA, while our cytotoxicity results from a lactate dehydrogenase assay showed Fe(2+3+)HA to be less toxic than pure HA, a widely used implantable biomaterial. Thus, these results collectively suggest that we have fabricated a magnetic biomaterial with intrinsic biocompatibility.
C1 [Zilm, M. E.; Staruch, M.; Jain, M.; Wei, Mei] Univ Connecticut, Dept Mat Sci & Engn, Storrs, CT 06268 USA.
RP Wei, M (reprint author), Univ Connecticut, Dept Mat Sci & Engn, 97 N Eagleville Rd,Unit 3136, Storrs, CT 06268 USA.
EM meiwei@engr.uconn.edu
RI Staruch, Margo/M-9260-2015
OI Staruch, Margo/0000-0003-3088-2553; Jain, Menka/0000-0002-2264-6895
FU NSF [CBET-1133883, CBET-1347130, DMR 1310149]; NSF GK-12 program
   [0947869]
FX The authors would like to thank NSF grants (CBET-1133883 and
   CBET-1347130) and the NSF GK-12 program (0947869) for their support. For
   magnetic measurements, author MJ would like to thank the support from
   the NSF grant (DMR 1310149). The authors would also like to thank Dr.
   Heng Zhang for his aid in XPS experiments.
CR Capuccini C, 2008, ACTA BIOMATER, V4, P1885, DOI 10.1016/j.actbio.2008.05.005
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Ernsting MJ, 2013, J CONTROL RELEASE, V172, P782, DOI 10.1016/j.jconrel.2013.09.013
   Fortune WB, 1938, IND ENG CHEM, V10, P0060, DOI 10.1021/ac50118a004
   Goya GF, 2008, CURR NANOSCI, V4, P1, DOI 10.2174/157341308783591861
   Gross K.A., 2002, EUR CELLS MATER, V3, P114
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hou C., 2009, BIOMATERIALS, V20, P1
   Huang J, 2010, ACS NANO, V4, P7151, DOI 10.1021/nn101643u
   Hughes S, 2005, MED ENG PHYS, V27, P754, DOI 10.1016/j.medengphy.2005.04.006
   Hughes S, 2007, J BIOMECH, V40, pS96, DOI 10.1016/j.jbiomech.2007.03.002
   Issa B, 2013, INT J MOL SCI, V14, P21266, DOI 10.3390/ijms141121266
   Jiang M, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224107
   Khachani M, 2010, APPL CATAL A-GEN, V388, P113, DOI 10.1016/j.apcata.2010.08.043
   Kim DK, 2003, CHEM MATER, V15, P1617, DOI 10.1021/cm021349j
   Kolhatkar AG, 2013, INT J MOL SCI, V14, P15977, DOI 10.3390/ijms140815977
   Korzenski MB, 1999, J SOLID STATE CHEM, V147, P390, DOI 10.1006/jssc.1999.8392
   Kramer E. R., 2012, J MATER SCI, V48, P665
   Lee J, 2008, SMALL, V4, P143, DOI 10.1002/smll.200700456
   Lee Y, 2005, ADV FUNCT MATER, V15, P503, DOI 10.1002/adfm.200400187
   Li Y, 2012, J MATER SCI, V47, P754, DOI 10.1007/s10853-011-5851-7
   Liu ZL, 2004, J MAGN MAGN MATER, V283, P258, DOI 10.1016/j.jmmm.2004.05.031
   Marasinghe GK, 1997, J NON-CRYST SOLIDS, V222, P144, DOI 10.1016/S0022-3093(97)00393-1
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Nath S, 2009, CHEM MATER, V21, P1761, DOI 10.1021/cm8031863
   Panseri S., 2012, J NANOBIOTECHNOL, V10
   POSNER AS, 1958, ACTA CRYSTALLOGR, V11, P308, DOI 10.1107/S0365110X58000815
   REGNIER P, 1994, AM MINERAL, V79, P809
   Ribeiro CC, 2006, BIOMATERIALS, V27, P1749, DOI 10.1016/j.biomaterials.2005.09.043
   Salim MA, 2001, J NON-CRYST SOLIDS, V289, P185, DOI 10.1016/S0022-3093(01)00727-X
   Silva AKA, 2013, ACS NANO, V7, P4954, DOI 10.1021/nn400269x
   Soenen SJH, 2011, BIOMATERIALS, V32, P195, DOI 10.1016/j.biomaterials.2010.08.075
   Song YN, 2002, INORG CHEM, V41, P5778, DOI 10.1021/ic025688q
   Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011
   TANIZAWA Y, 1990, J CHEM SOC FARADAY T, V86, P1071, DOI 10.1039/ft9908601071
   Thomas CR, 2010, J AM CHEM SOC, V132, P10623, DOI 10.1021/ja1022267
   Wei M, 2003, J MATER SCI-MATER M, V14, P311, DOI 10.1023/A:1022975730730
   Wu H.-C., 2007, NONOTECHNOLOGY, V18, P9
   Wu HC, 2010, ADV FUNCT MATER, V20, P67, DOI 10.1002/adfm.200901108
   Yu DH, 2007, J PHYS CHEM C, V111, P14394, DOI 10.1021/jp072893o
   Yu X., 2013, BIOMED RES INT, V2013, P1
   Yu XY, 1997, J NON-CRYST SOLIDS, V215, P21, DOI 10.1016/S0022-3093(97)00022-7
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
   Zakaria SM, 2013, TISSUE ENG PART B-RE, V19, P431, DOI [10.1089/ten.teb.2012.0624, 10.1089/ten.TEB.2012.0624]
NR 45
TC 12
Z9 12
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 41
BP 7176
EP 7185
DI 10.1039/c4tb00925h
PG 10
WC Materials Science, Biomaterials
SC Materials Science
GA AQ4KA
UT WOS:000342763700011
DA 2018-10-19
ER

PT J
AU Keremidarska, M
   Radeva, E
   Pramatarova, L
   Krasteva, N
AF Keremidarska, Milena
   Radeva, Ekaterina
   Pramatarova, Lilyana
   Krasteva, Natalia
TI ALTERATION IN MORPHOLOGY AND CYTOSKELETON ORGANISATION OF MESENCHYMAL
   STEM CELLS CULTURED ON PLASMA MODIFIED POLYMER FILMS
SO COMPTES RENDUS DE L ACADEMIE BULGARE DES SCIENCES
LA English
DT Article
DE mesenchymal stem cells; plasma modification; cell morphology
ID SURFACES; BONE; BIOMATERIALS; ATTACHMENT; ADHESION; ALLOY
AB Cell morphology and organisation of actin cytoskeleton are closely related to all essential for cells processes including adhesion, growth and differentiation. Therefore, both cell characteristics can be used to assess the tissue compatibility of a biomaterial. Many approaches have been used to modify biomaterials surface in order to improve their interactions with cells. In the present work, we have modified the surface of a synthetic polymer, plasma polymerised hexamethyldisiloxane (PPHMDS) using two approaches: treatment in ammonia plasma and plasma deposition of detonation nanodiamond (DND) particles, and have studied the alteration in cell morphology, adhesion and actin cytoskeleton organisation in rat mesenchymal stem cells (rMSCs) in order to assess suitability of plasma modified polymer films as cell adhesion substrata for tissue engineering application.
C1 [Keremidarska, Milena; Krasteva, Natalia] Bulgarian Acad Sci, Inst Biophys & Biomed Engn, BU-1113 Sofia, Bulgaria.
   [Radeva, Ekaterina; Pramatarova, Lilyana] Bulgarian Acad Sci, Georgi Nadjakov Inst Solid State Phys, BU-1784 Sofia, Bulgaria.
RP Keremidarska, M (reprint author), Bulgarian Acad Sci, Inst Biophys & Biomed Engn, Acad G Bonchev St,Bl 21, BU-1113 Sofia, Bulgaria.
EM m_keremidarska@abv.bg; nataly@bio21.bas.bg
OI Radeva, Ekaterina/0000-0001-5543-252X; Keremidarska-Markova,
   Milena/0000-0001-9385-6593
FU Bulgarian Science Fund [DFNI BO-18]
FX This work was supported by Bulgarian Science Fund, Grant No DFNI BO-18.
CR Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brett P. M., 2013, STEM CELLS INT, DOI [10.1155/2013/361637, DOI 10.1155/2013/361637]
   Dobson KR, 1999, CALCIFIED TISSUE INT, V65, P411, DOI 10.1007/s002239900723
   Guo YY, 2013, INT J MOL MED, V31, P689, DOI 10.3892/ijmm.2013.1249
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   Krasteva NA, 2010, J PHYS CONF SER, V253, DOI 10.1088/1742-6596/253/1/012079
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marcotte L, 2008, IRBM, V29, P77, DOI 10.1016/j.rbmret.2007.11.019
   Pramatarova L., 2011, BIOMIMETICS, P271
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   TAKATSUKA K, 1995, J BIOMED MATER RES, V29, P157, DOI 10.1002/jbm.820290204
   Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3
   Wei JH, 2007, J BIOMED MATER RES B, V81B, P66, DOI 10.1002/jbm.b.30638
   Yoshinari M, 2006, BIOMED RES-TOKYO, V27, P29, DOI 10.2220/biomedres.27.29
NR 15
TC 1
Z9 1
U1 0
U2 6
PU PUBL HOUSE BULGARIAN ACAD SCI
PI SOFIA
PA ACADEMICIAN G BONCEV ST, 1113 SOFIA, BULGARIA
SN 1310-1331
J9 CR ACAD BULG SCI
JI C. R. Acad. Bulg. Sci.
PY 2014
VL 67
IS 8
BP 1113
EP 1118
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA AQ2GC
UT WOS:000342602800011
DA 2018-10-19
ER

PT J
AU Bernards, M
   He, Y
AF Bernards, Matthew
   He, Yi
TI Polyampholyte polymers as a versatile zwitterionic biomaterial platform
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE polyampholytes; mixed charge; nonfouling; multifunctional
ID TRANSFER RADICAL POLYMERIZATION; NONSPECIFIC PROTEIN ADSORPTION;
   SELF-ASSEMBLED MONOLAYERS; CONJUGATION CAPACITY; FILM THICKNESS;
   BLOOD-PLASMA; BRUSHES; HYDROGELS; SURFACES; IMMOBILIZATION
AB Polyampholyte polymers are a subclass of zwitterionic materials that are composed of mixtures of charged monomer subunits. These materials have properties that mimic those of the more widely characterized zwitterionic polymers as long as their polymer chemistry has been well controlled. In particular, overall neutral polyampholyte polymers have been shown to have resistance to nonspecific protein adsorption and protein conjugation capability. This has been demonstrated for both polymer brush and hydrogel-based platforms. In this review, our recent work demonstrating these characteristics will be summarized and placed into the broader context of zwitterionic materials.
C1 [Bernards, Matthew] Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
   [Bernards, Matthew] Univ Missouri, Dept Bioengn, Columbia, MO 65211 USA.
   [He, Yi] Zhejiang Univ, Dept Chem & Biol Engn, Hangzhou 310003, Zhejiang, Peoples R China.
RP Bernards, M (reprint author), Univ Missouri, Dept Chem Engn, Columbia, MO 65211 USA.
EM bernardsm@missouri.edu
OI Bernards, Matthew/0000-0002-5234-1910
FU National Natural Science Foundation of China [31350110223]; Scientific
   Research Fund of the Zhejiang Provincial Education Department
   [Y201329422]
FX This research was supported in part by a grant from the National Natural
   Science Foundation of China through [grant number 31350110223];
   Scientific Research Fund of the Zhejiang Provincial Education Department
   through [grant number Y201329422].
CR ALFREY T, 1950, J AM CHEM SOC, V72, P1864, DOI 10.1021/ja01160a532
   Azzaroni O, 2006, ANGEW CHEM INT EDIT, V45, P1770, DOI 10.1002/anie.200503264
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Cao B, 2013, ADV HEALTHC MATER, V2, P1096, DOI 10.1002/adhm.201200359
   Carr L, 2010, LANGMUIR, V26, P14793, DOI 10.1021/la1028004
   Carr LR, 2011, BIOMATERIALS, V32, P961, DOI 10.1016/j.biomaterials.2010.09.067
   Chang Y., 2009, LANGMUIR, V26, P3522
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Chen SF, 2009, BIOMATERIALS, V30, P5892, DOI 10.1016/j.biomaterials.2009.07.001
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cui JW, 2014, SOFT MATTER, V10, P2656, DOI 10.1039/c3sm53056f
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Dobbins SC, 2012, J PHYS CHEM B, V116, P14346, DOI 10.1021/jp307588b
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Hoffman AS, 1999, J BIOMAT SCI-POLYM E, V10, P1011, DOI 10.1163/156856299X00658
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hu H, 2012, J MATER CHEM, V22, P15362, DOI 10.1039/c2jm32720a
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   Jiang H, 2011, LANGMUIR, V27, P11575, DOI 10.1021/la202101q
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Li GZ, 2010, MACROMOLECULES, V43, P14, DOI 10.1021/ma902029s
   Li LY, 2007, J BIOMAT SCI-POLYM E, V18, P1415, DOI 10.1163/156856207782246795
   Ma HW, 2004, ADV MATER, V16, P338, DOI 10.1002/adma.200305830
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Nowinski AK, 2014, LANGMUIR, V30, P1864, DOI 10.1021/la404980g
   Nowinski AK, 2012, J AM CHEM SOC, V134, P6000, DOI 10.1021/ja3006868
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Sanjuan S, 2008, MACROMOLECULES, V41, P8721, DOI 10.1021/ma8018798
   Sanjuan S, 2008, J POLYM SCI POL CHEM, V46, P4305, DOI 10.1002/pola.22726
   Schroeder ME, 2013, BIOMACROMOLECULES, V14, P3112, DOI 10.1021/bm4007369
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Tah T, 2012, COLLOID SURFACE B, V93, P195, DOI 10.1016/j.colsurfb.2012.01.004
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Vaisocherova H, 2008, ANAL CHEM, V80, P7894, DOI 10.1021/ac8015888
   Vaisocherova H, 2009, BIOSENS BIOELECTRON, V24, P1924, DOI 10.1016/j.bios.2008.09.035
   Yang W, 2008, LANGMUIR, V24, P9211, DOI 10.1021/la801487f
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhao C, 2011, LANGMUIR, V27, P4906, DOI 10.1021/la200061h
   Zurick KM, 2014, J APPL POLYM SCI, V131, DOI 10.1002/app.40069
NR 43
TC 12
Z9 13
U1 6
U2 83
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1479
EP 1488
DI 10.1080/09205063.2014.938976
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500003
PM 25050648
DA 2018-10-19
ER

PT J
AU Pauthe, E
   Van Tassel, PR
AF Pauthe, Emmanuel
   Van Tassel, Paul R.
TI Layer-by-layer films as biomaterials: bioactivity and mechanics
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Review
DE nanofilm; biomaterial; layer-by-layer; polyelectrolyte; chemical
   cross-linking
ID POLYELECTROLYTE MULTILAYER FILMS; CELL-ADHESION; CROSS-LINKING;
   IN-VITRO; BIOMEDICAL APPLICATIONS; THIN-FILMS; DELIVERY; TISSUE;
   ELASTICITY; SURFACES
AB Layer-by-layer (LbL) assembly offers a facile approach toward biomaterials of nanoscale thickness. Bioactivity may be realized through incorporation of biomolecular species within the film architecture, and film mechanics may be controlled through post-formation chemical cross-linking steps. This short review focuses on recent efforts toward the simultaneous control of LbL film bioactive and mechanical properties, with a particular focus on approaches yielding cellular outcomes dependent on both of these properties. Challenges and opportunities toward the independent control of film rigidity and bioactivity are highlighted.
C1 [Pauthe, Emmanuel] Univ Cergy Pontoise, Dept Biol, ERRMECe, I Mat, F-95302 Cergy Pontoise, France.
   [Van Tassel, Paul R.] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
RP Van Tassel, PR (reprint author), Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06520 USA.
EM paul.vantassel@yale.edu
RI Van Tassel, Paul/D-1087-2017
FU National Science Foundation [CBET-0756323, CBET-1066994]
FX The authors acknowledge funding from the National Science Foundation
   through CBET-0756323 and CBET-1066994.
CR Almodovar J, 2013, LAB CHIP, V13, P1562, DOI 10.1039/c3lc41407h
   Bechler SL, 2013, BIOMATERIALS, V34, P226, DOI 10.1016/j.biomaterials.2012.09.010
   Benkirane-Jessel N, 2005, ADV FUNCT MATER, V15, P648, DOI 10.1002/adfm.200400129
   Benkirane-Jessel N, 2004, ADV MATER, V16, P1507, DOI 10.1002/adma.200306613
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Blacklock J, 2010, BIOMATERIALS, V31, P7167, DOI 10.1016/j.biomaterials.2010.06.002
   Blacklock J, 2010, J PHYS CHEM B, V114, P5283, DOI 10.1021/jp100486h
   Boudou T, 2011, MACROMOL BIOSCI, V11, P77, DOI 10.1002/mabi.201000301
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Buxboim A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194116
   Chaubaroux C, 2012, BIOMACROMOLECULES, V13, P2128, DOI 10.1021/bm300529a
   Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055
   Crouzier T, 2011, BIOMATERIALS, V32, P7543, DOI 10.1016/j.biomaterials.2011.06.062
   Crouzier T, 2011, ADV MATER, V23, pH111, DOI 10.1002/adma.201004637
   Crouzier T, 2010, SMALL, V6, P651, DOI 10.1002/smll.200901728
   Crouzier T, 2009, SMALL, V5, P598, DOI 10.1002/smll.200800804
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Etienne O, 2005, BIOMACROMOLECULES, V6, P726, DOI 10.1021/bm049425u
   Flessner RM, 2011, CHEM COMMUN, V47, P550, DOI 10.1039/c0cc02926b
   Francius G, 2006, MICROSC RES TECHNIQ, V69, P84, DOI 10.1002/jemt.20275
   Gand Adeline, 2014, Biomatter, V4, pe28823, DOI 10.4161/biom.28823
   Gribova V, 2012, CHEM MATER, V24, P854, DOI 10.1021/cm2032459
   Guillot R, 2013, BIOMATERIALS, V34, P5737, DOI 10.1016/j.biomaterials.2013.03.067
   Hammond PT, 2011, AICHE J, V57, P2928, DOI 10.1002/aic.12769
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   Harris JJ, 1999, J AM CHEM SOC, V121, P1978, DOI 10.1021/ja9833467
   He LM, 2012, J MATER CHEM, V22, P13187, DOI 10.1039/c2jm32332j
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   Hu X, 2011, BIOMATERIALS, V32, P8979, DOI 10.1016/j.biomaterials.2011.08.037
   IWASAKI S, 1995, J BIOL CHEM, V270, P5476, DOI 10.1074/jbc.270.10.5476
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Keeney M, 2013, BIOMACROMOLECULES, V14, P794, DOI 10.1021/bm3018559
   Larkin AL, 2010, BIOMACROMOLECULES, V11, P2788, DOI 10.1021/bm100867h
   Liu XH, 2008, ADV MATER, V20, P4148, DOI 10.1002/adma.200800881
   Logeart-Avramoglou D, 2006, ANAL BIOCHEM, V349, P78, DOI 10.1016/j.ab.2005.10.030
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Manna U, 2013, ADV MATER, V25, P6405, DOI 10.1002/adma.201302561
   Mehrotra S, 2010, LANGMUIR, V26, P12794, DOI 10.1021/la101689z
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Min J, 2014, BIOMATERIALS, V35, P2507, DOI 10.1016/j.biomaterials.2013.12.009
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Olenych SG, 2005, BIOMACROMOLECULES, V6, P3252, DOI 10.1021/bm050298r
   Pavlukhina S, 2011, ADV DRUG DELIVER REV, V63, P822, DOI 10.1016/j.addr.2011.03.017
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Phelps JA, 2011, LANGMUIR, V27, P1123, DOI 10.1021/la104156c
   Picart C, 2005, ADV FUNCT MATER, V15, P83, DOI 10.1002/adfm.200400106
   Picart C, 2005, ADV FUNCT MATER, V15, P1771, DOI 10.1002/adfm.200400588
   Picart C, 2008, CURR MED CHEM, V15, P685, DOI 10.2174/092986708783885219
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Ren KF, 2008, ADV FUNCT MATER, V18, P1378, DOI 10.1002/adfm.200701297
   Richert L, 2004, BIOMACROMOLECULES, V5, P284, DOI 10.1021/bm0342281
   Richert L, 2004, BIOMACROMOLECULES, V5, P1908, DOI 10.1021/bm0498023
   Ricotti L, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/3/031001
   Saurer EM, 2013, BIOMACROMOLECULES, V14, P1696, DOI 10.1021/bm4005222
   Schneider A, 2006, LANGMUIR, V22, P1193, DOI 10.1021/la0521802
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Schneider A, 2007, BIOMACROMOLECULES, V8, P139, DOI 10.1021/bm060765k
   Schuetz P, 2003, ADV FUNCT MATER, V13, P929, DOI 10.1002/adfm.200304483
   Semler EJ, 2005, BIOTECHNOL BIOENG, V89, P296, DOI 10.1002/bit.20328
   Seo J, 2009, BIOMACROMOLECULES, V10, P2254, DOI 10.1021/bm900439r
   Shah NJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005576
   Shah NJ, 2012, ADV MATER, V24, P1445, DOI 10.1002/adma.201104475
   Sun XJ, 2011, TISSUE ENG PT A, V17, P2369, DOI [10.1089/ten.tea.2011.0027, 10.1089/ten.TEA.2011.0027]
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thompson MT, 2005, BIOMATERIALS, V26, P6836, DOI 10.1016/j.biomaterials.2005.05.003
   Vodouhe C, 2006, BIOMATERIALS, V27, P4149, DOI 10.1016/j.biomaterials.2006.03.024
   Vrana NE, 2014, J MATER CHEM B, V2, P999, DOI 10.1039/c3tb21304h
   Wittmer CR, 2008, BIOMATERIALS, V29, P4082, DOI 10.1016/j.biomaterials.2008.06.027
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Wu C, 2013, ADV FUNCT MATER, V23, P66, DOI 10.1002/adfm.201201042
   Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613
NR 78
TC 2
Z9 2
U1 1
U2 58
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1489
EP 1501
DI 10.1080/09205063.2014.921096
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500004
PM 24894809
DA 2018-10-19
ER

PT J
AU Jhong, JF
   Sin, MC
   Kung, HH
   Chinnathambi, A
   Alharbi, SA
   Chang, Y
AF Jhong, Jheng-Fong
   Sin, Mei-Chan
   Kung, Hsiao-Han
   Chinnathambi, Arunachalam
   Alharbi, Sulaiman Ali
   Chang, Yung
TI Hemocompatibility of pseudozwitterionic polymer brushes with a
   systematic well-defined charge-bias control
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hemocompatibility; mixed charge; pseudozwitterionization; atom transfer
   radical polymerization; charge bias
ID SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; BLOOD COMPATIBILITY;
   ZWITTERIONIC MATERIALS; PLATELET-ADHESION; COPOLYMER BRUSHES; SURFACES;
   PLASMA; PHOSPHORYLCHOLINE; RESISTANCE
AB In this study, a pseudozwitterionic surface bearing positively and negatively mixed charged moieties was developed as a potential hemocompatible material for biomedical applications. In this work, hemocompatility of pseudozwitterionic surface prepared from copolymerization of negatively charged 3-sulfopropyl methacrylate (SA) and positively charged [2-(methacryloyloxy) ethyl] trimethylammonium (TMA) was delineated. Mixed charge distribution in the prepared poly(TMA-co-SA)-grafted surface can be controlled by regulating TMA and SA monomer ratios via surface-initiated atom transfer radical polymerization. The effects of grafting composition and charge bias variations on blood compatibility of poly(TMA-co-SA)-grafted surface were reported. The protein adsorption on different poly(TMA-co-SA)-grafted surfaces from human plasma protein (fibrinogen, HSA, and gamma-globulin) solutions was evaluated using an enzyme-linked immunosorbent assay. Blood platelet adhesion and time measurements on plasma clotting were conducted to determine the platelet activation on the grafted surface. It was found that the protein resistance and anti-blood cell adhesion of prepared surface can be precisely controlled by controlling the charge balance of TMA/SA compositions. In addition, different charge bias variations on the poly (TMA-co-SA)-grafted surface would induce electrostatic interactions between plasma proteins and prepared surfaces which lead to adsorptions of interfacial protein and blood cells, plasma clotting, and blood cell hemolysis. Results from this study suggest that the hemocompatility of mixed charged poly(TMA-co-SA)-grafted surface depends on the charge bias level. This provides a great potential for designing biomaterial with unique surface chemical structure which could be used in contact with human blood.
C1 [Jhong, Jheng-Fong; Sin, Mei-Chan; Kung, Hsiao-Han; Chang, Yung] Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
   [Jhong, Jheng-Fong; Sin, Mei-Chan; Kung, Hsiao-Han; Chang, Yung] Chung Yuan Christian Univ, R&D Ctr Membrane Technol, Taoyuan 320, Taiwan.
   [Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Chang, Yung] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
RP Chang, Y (reprint author), Chung Yuan Christian Univ, Dept Chem Engn, Taoyuan 320, Taiwan.
EM ychang@cycu.edu.tw
RI Chinnathambi, Arunachalam/E-7808-2016
OI Chinnathambi, Arunachalam/0000-0002-7126-8421
FU Center-of-Excellence (COE) Program on Membrane Technology from Ministry
   of Education (MOE), R.O.C.; project of Outstanding Professor Research
   Program in the Chung Yuan Christian University, Taiwan
   [CYCU-00RD-RA002-11,757]; Ministry of Science and Technology
   [100-2628-E-033-001-MY3, 102-2221-E-033-009-MY3]
FX The authors would like to acknowledge the Center-of-Excellence (COE)
   Program on Membrane Technology from the Ministry of Education (MOE),
   R.O.C., the project of Outstanding Professor Research Program in the
   Chung Yuan Christian University, Taiwan (CYCU-00RD-RA002-11,757), and
   the Ministry of Science and Technology (100-2628-E-033-001-MY3 and
   102-2221-E-033-009-MY3) for their financial support. Deanship of
   Scientific Research, College of Science Research Center, King Saud
   University, and Kingdom of Saudi Arabia are also acknowledged. Yung
   Chang thanks the King Saud University, Riyadh, Kingdom of Saudi Arabia,
   for the Visiting Professorship.
CR Banerjee I, 2011, ADV MATER, V23, P690, DOI 10.1002/adma.201001215
   Bernards MT, 2008, MACROMOLECULES, V41, P4216, DOI 10.1021/ma800185y
   Brault ND, 2012, BIOMACROMOLECULES, V13, P589, DOI 10.1021/bm3001217
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chang Y, 2007, BIOMACROMOLECULES, V8, P122, DOI 10.1021/bm060739m
   Chang Y, 2013, ADV FUNCT MATER, V23, P1100, DOI 10.1002/adfm.201201386
   Chang Y, 2011, ACS APPL MATER INTER, V3, P1228, DOI 10.1021/am200055k
   Chang Y, 2010, BIOMACROMOLECULES, V11, P1101, DOI 10.1021/bm100093g
   Chang Y, 2010, LANGMUIR, V26, P3522, DOI 10.1021/la903172j
   Chang Y, 2009, BIOMACROMOLECULES, V10, P2092, DOI 10.1021/bm900208u
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Dabkowska M, 2012, J COLLOID INTERF SCI, V366, P105, DOI 10.1016/j.jcis.2011.09.030
   He Y, 2008, LANGMUIR, V24, P10358, DOI 10.1021/la8013046
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383
   ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355
   Iwasaki Y, 2005, ANAL BIOANAL CHEM, V381, P534, DOI 10.1007/s00216-004-2805-9
   Jiang SY, 2010, ADV MATER, V22, P920, DOI 10.1002/adma.200901407
   Kwak D, 2005, J BIOMED MATER RES A, V74A, P69, DOI 10.1002/jbm.a.30365
   Ladd J, 2008, BIOMACROMOLECULES, V9, P1357, DOI 10.1021/bm701301s
   Mi L, 2010, BIOMATERIALS, V31, P2919, DOI 10.1016/j.biomaterials.2009.12.038
   Michael J, 2011, FUNDAMENTALS MED PHY
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Shen MC, 2003, LANGMUIR, V19, P1692, DOI 10.1021/la0259297
   Shih YJ, 2012, BIOMACROMOLECULES, V13, P2849, DOI 10.1021/bm3008764
   Shih YJ, 2010, LANGMUIR, V26, P17286, DOI 10.1021/la103186y
   Sin MC, 2014, ACS APPL MATER INTER, V6, P861, DOI 10.1021/am4041256
   Storey K. B., 2004, FUNCTIONAL METABOLIS
   Tokumasu F, 2012, EXP PARASITOL, V131, P245, DOI 10.1016/j.exppara.2012.03.005
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   Unsworth LD, 2005, LANGMUIR, V21, P1036, DOI 10.1021/la047672d
   Yu B, 2009, BIOMACROMOLECULES, V10, P950, DOI 10.1021/bm8014945
   Yusa SI, 2005, BIOMACROMOLECULES, V6, P663, DOI 10.1021/bm0495553
   Zhang Z, 2008, BIOMATERIALS, V29, P4285, DOI 10.1016/j.biomaterials.2008.07.039
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
NR 41
TC 4
Z9 4
U1 3
U2 22
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0920-5063
EI 1568-5624
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2014
VL 25
IS 14-15
SI SI
BP 1558
EP 1572
DI 10.1080/09205063.2014.921754
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA AP8CA
UT WOS:000342304500009
PM 24894872
DA 2018-10-19
ER

PT J
AU Joslin, JM
   Neufeld, BH
   Reynolds, MM
AF Joslin, J. M.
   Neufeld, B. H.
   Reynolds, Melissa M.
TI Correlating S-nitrosothiol decomposition and NO release for modified
   poly(lactic-co-glycolic acid) polymer films
SO RSC ADVANCES
LA English
DT Article
ID NITRIC-OXIDE RELEASE; BIOMEDICAL APPLICATIONS; PHOTOCHEMICAL RELEASE;
   MODIFIED XEROGELS; NITROSOGLUTATHIONE; BIOMATERIALS; NITROSATION;
   POLYESTERS; CHEMISTRY; MECHANISM
AB This study marks the first parallel measurements where S-nitrosothiol behaviour is directly correlated to nitric oxide (NO) release for an established polymer system under exposure conditions that are specific to S-nitrosothiol decomposition (i.e. heat, light, pH). These methods are intended to be applied to confirm the NO source in any biomaterial system.
C1 [Joslin, J. M.; Neufeld, B. H.; Reynolds, Melissa M.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Reynolds, Melissa M.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Reynolds, MM (reprint author), Colorado State Univ, Dept Chem, 1872 Campus Delivery, Ft Collins, CO 80523 USA.
EM melissa.reynolds@colostate.edu
FU Colorado State University; Department of Defense Congressionally
   Directed Medical Research Program (DOD-CDMPRP); Boettcher Foundation's
   Webb-Waring Biomedical Research Program
FX We would like to acknowledge Colorado State University and the
   Department of Defense Congressionally Directed Medical Research Program
   (DOD-CDMPRP) for financial support. This research was supported by funds
   from the Boettcher Foundation's Webb-Waring Biomedical Research Program.
   We would like to further acknowledge Dr Vinod Damodaran for providing
   the PLGH-cysteine material for these studies.
CR BARNETT DJ, 1994, J CHEM SOC PERK T 2, P1131, DOI 10.1039/p29940001131
   Bohl KS, 2000, BIOMATERIALS, V21, P2273, DOI 10.1016/S0142-9612(00)00153-8
   Coneski PN, 2011, POLYM CHEM-UK, V2, P906, DOI 10.1039/c0py00269k
   Coneski PN, 2010, BIOMACROMOLECULES, V11, P3208, DOI 10.1021/bm1006823
   Damodaran VB, 2012, J MATER CHEM, V22, P5990, DOI 10.1039/c2jm16554f
   Feelisch M, 1996, METHODS NITRIC OXIDE
   Frost MC, 2005, J BIOMED MATER RES A, V72A, P409, DOI 10.1002/jbm.a.30275
   Frost MC, 2004, J AM CHEM SOC, V126, P1348, DOI 10.1021/ja039466i
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Grossi L, 2002, CHEM-EUR J, V8, P380, DOI 10.1002/1521-3765(20020118)8:2<380::AID-CHEM380>3.3.CO;2-G
   Hrabie JA, 2002, CHEM REV, V102, P1135, DOI 10.1021/cr000028t
   Jen MC, 2012, ADV FUNCT MATER, V22, P239, DOI 10.1002/adfm.201101707
   Johnson TA, 2010, NITRIC OXIDE-BIOL CH, V22, P30, DOI 10.1016/j.niox.2009.11.002
   Joslin JM, 2013, RSC ADV, V3, P15035, DOI 10.1039/c3ra41988f
   Joslin JM, 2012, ACS APPL MATER INTER, V4, P1126, DOI 10.1021/am201807c
   Li Y, 2010, MOL PHARMACEUT, V7, P254, DOI [10.1021/mp900237f, 10.1021/mp900237t]
   MATHEWS WR, 1993, J PHARMACOL EXP THER, V267, P1529
   Riccio DA, 2012, CHEM SOC REV, V41, P3731, DOI 10.1039/c2cs15272j
   Riccio DA, 2012, ACS APPL MATER INTER, V4, P796, DOI 10.1021/am201443r
   Riccio DA, 2011, CHEM MATER, V23, P1727, DOI 10.1021/cm102510q
   Riccio DA, 2009, BIOMATERIALS, V30, P4494, DOI 10.1016/j.biomaterials.2009.05.006
   Seabra AB, 2005, BIOMACROMOLECULES, V6, P2512, DOI 10.1021/bm050216z
   Seabra AB, 2008, ARTIF ORGANS, V32, P262, DOI 10.1111/j.1525-1594.2008.00540.x
   Seabra AB, 2010, J MATER CHEM, V20, P1624, DOI 10.1039/b912493b
   SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x
   Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596
   STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444
   Stasko NA, 2008, BIOMACROMOLECULES, V9, P834, DOI 10.1021/bm7011746
   Varu VN, 2009, VASC ENDOVASC SURG, V43, P121, DOI 10.1177/1538574408322752
   Williams D. L. H., 2004, NITROSATION REACTION
   Williams DLH, 1999, ACCOUNTS CHEM RES, V32, P869, DOI 10.1021/ar9800439
   Wood PD, 1996, PHOTOCHEM PHOTOBIOL, V64, P518, DOI 10.1111/j.1751-1097.1996.tb03099.x
   Zhelyaskov VR, 1998, PHOTOCHEM PHOTOBIOL, V67, P282, DOI 10.1111/j.1751-1097.1998.tb05200.x
NR 33
TC 5
Z9 5
U1 0
U2 14
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2014
VL 4
IS 79
BP 42039
EP 42043
DI 10.1039/c4ra04817b
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA AP6BD
UT WOS:000342161600046
DA 2018-10-19
ER

PT J
AU Monteiro, N
   Martins, A
   Pires, R
   Faria, S
   Fonseca, NA
   Moreira, JN
   Reisa, RL
   Neves, NM
AF Monteiro, Nelson
   Martins, Albino
   Pires, Ricardo
   Faria, Susana
   Fonseca, Nuno A.
   Moreira, Joao N.
   Reisa, Rui L.
   Neves, Nuno M.
TI Immobilization of bioactive factor-loaded liposomes on the surface of
   electrospun nanofibers targeting tissue engineering
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; FIBRIN ENCAPSULATED LIPOSOMES; IN-VITRO;
   DELIVERY-SYSTEM; DRUG-DELIVERY; STEALTH LIPOSOMES; FIBROUS SCAFFOLDS;
   BONE REGENERATION; RELEASE; DIFFERENTIATION
AB Electrospun nanofiber meshes (NFM), due to their morphology and fibrous structure, are extensively proposed as biomedical devices, for tissue engineering on scaffolds and also as drug delivery systems. Liposomes are nanoparticles prepared from a biologically derived material (phospholipid), which are already in clinical use as a drug release device. Liposomes may be combined with biomaterial scaffolds to promote a local and sustained delivery of loaded bioactive agents. The main objective of the present study is to evaluate the efficacy of dexamethasone (Dex)-loaded liposomes immobilized on the surface of electrospun polycaprolactone (PCL) NFM for promoting the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). The in vitro release profile demonstrates a sustained release of Dex over 21 days, after an initial burst release over 12 h. Biological assays show that Dex-loaded liposomes immobilized on the surface of electrospun PCL NFMs do not exhibit any cytotoxic effect, being able to successfully promote the osteogenic differentiation of hBMSCs. We herein validate the concept of using liposomes immobilized on the surface of a nanostructured fibrous system to be used as an advanced cell carrier device with autonomous release of growth/differentiation factors relevant for tissue engineering and regenerative medicine strategies.
C1 [Monteiro, Nelson; Martins, Albino; Pires, Ricardo; Reisa, Rui L.; Neves, Nuno M.] Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Monteiro, Nelson; Martins, Albino; Pires, Ricardo; Reisa, Rui L.; Neves, Nuno M.] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal.
   [Faria, Susana] Univ Minho, Res CMAT, Dept Math Sci & Technol, P-4800058 Guimaraes, Portugal.
   [Fonseca, Nuno A.; Moreira, Joao N.] Univ Coimbra, FFUC Fac Pharm, CNC Ctr Neurosci & Cell Biol, P-3000 Coimbra, Portugal.
RP Monteiro, N (reprint author), Univ Minho, European Inst Excellence Tissue Engn & Regenerat, Dept Polymer Engn, 3Bs Res Grp Biomat Biodegradables & Biomimet, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nelson.monteiro@dep.uminho.pt; amartins@dep.uminho.pt;
   rpires@dep.uminho.pt; sfaria@math.uminho.pt; nuno.a.c.fonseca@gmail.com;
   jmoreira@ff.uc.pt; rgreis@dep.uminho.pt; nuno@dep.uminho.pt
RI Faria, Susana/C-2176-2015; Group, 3Bs/E-4374-2012; Martins,
   Albino/C-8432-2012; Pires, Ricardo/A-1595-2009; Moreira, Joao
   Nuno/F-3180-2010; Neves, Nuno/B-4685-2008
OI Faria, Susana/0000-0001-8014-9902; Group, 3Bs/0000-0002-5195-3456;
   Martins, Albino/0000-0003-3868-0251; Pires, Ricardo/0000-0002-9197-0138;
   Moreira, Joao Nuno/0000-0003-3449-0522; Neves, Nuno/0000-0003-3041-0687;
   Fonseca, Nuno A. C./0000-0003-4970-7288; Reis, Rui
   L./0000-0002-4295-6129
FU Portuguese Foundation for Science and Technology [SFRH/BD/62465/2009,
   SFRH/BPD/70669/2010, SFRH/BPD/39333/2007, PTDC/EME-MFE/2008]; FIND BIND
   project [NMP4-SL-2009-229292]; MaxBone project
   [PTDC/SAU-ENB/115179/2009/FCOMP-01-0124-FEDER-015729]
FX The authors thank the Portuguese Foundation for Science and Technology
   for the Ph.D. grant of N. S. Monteiro (SFRH/BD/62465/2009), the Post-Doc
   grants of A. Martins (SFRH/BPD/70669/2010) and R. A. Pires
   (SFRH/BPD/39333/2007), and the OsteoGraphy project (PTDC/EME-MFE/2008).
   This work was partly supported by the FIND & BIND (NMP4-SL-2009-229292)
   and MaxBone (PTDC/SAU-ENB/115179/2009/FCOMP-01-0124-FEDER-015729)
   projects.
CR Ami D, 2008, BBA-MOL CELL RES, V1783, P98, DOI 10.1016/j.bbamcr.2007.08.003
   Anitua E, 2008, TRENDS PHARMACOL SCI, V29, P37, DOI 10.1016/j.tips.2007.10.010
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bhardwaj U, 2010, INT J PHARMACEUT, V388, P181, DOI 10.1016/j.ijpharm.2010.01.003
   Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   Cao HQ, 2010, J CONTROL RELEASE, V144, P203, DOI 10.1016/j.jconrel.2010.02.003
   Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Chung TW, 2006, INT J PHARM, V311, P122, DOI 10.1016/j.ijpharm.2005.12.038
   Curran JM, 2006, BIOMATERIALS, V27, P4783, DOI 10.1016/j.biomaterials.2006.05.001
   Darain F, 2011, SOFT MATER, V9, P64, DOI 10.1080/1539445X.2010.520797
   Delorme Bruno, 2007, V140, P67
   Duarte ARC, 2009, ACTA BIOMATER, V5, P2054, DOI 10.1016/j.actbio.2009.01.047
   Ghag AK, 2014, BIOMATER SCI-UK, V2, P233, DOI 10.1039/c3bm60188a
   Giannoni P, 2003, BIOTECHNOL BIOENG, V83, P121, DOI 10.1002/bit.10639
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   HRISTOVA K, 1995, MACROMOLECULES, V28, P7693, DOI 10.1021/ma00127a015
   Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kim TG, 2008, MACROMOL RAPID COMM, V29, P1231, DOI 10.1002/marc.200800094
   Kulkarni M, 2010, TRENDS BIOTECHNOL, V28, P28, DOI 10.1016/j.tibtech.2009.10.003
   Liu Y, 2012, SOFT MATTER, V8, P4517, DOI 10.1039/c2sm25092f
   Longobardi L, 2006, J BONE MINER RES, V21, P626, DOI 10.1359/JBMR.051213
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lynge ME, 2013, BIOMATER SCI-UK, V1, P1181, DOI 10.1039/c3bm60107b
   Martins A, 2008, INT MATER REV, V53, P257, DOI 10.1179/174328008X353547
   Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010
   Martins A, 2009, SMALL, V5, P1195, DOI 10.1002/smll.200801648
   Mattanavee W, 2009, ACS APPL MATER INTER, V1, P1076, DOI 10.1021/am900048t
   Meyenburg S, 2000, J CONTROL RELEASE, V69, P159, DOI 10.1016/S0168-3659(00)00295-9
   Mickova A, 2012, BIOMACROMOLECULES, V13, P952, DOI 10.1021/bm2018118
   Monteiro N, 2012, J TISSUE ENG REGEN M, V6, P33
   Monteiro N, 2015, J TISSUE ENG REGEN M, V9, P1056, DOI 10.1002/term.1817
   Moreira JN, 2002, PHARMACEUT RES, V19, P265, DOI 10.1023/A:1014434732752
   MORI M, 1994, J POLYM SCI POL CHEM, V32, P1683, DOI 10.1002/pola.1994.080320910
   Mourtas S, 2011, COLLOID SURFACE B, V84, P214, DOI 10.1016/j.colsurfb.2011.01.002
   Park JS, 2009, TISSUE ENG PT A, V15, P2163, DOI 10.1089/ten.tea.2008.0532
   Poulsson AHC, 2009, LANGMUIR, V25, P3718, DOI 10.1021/la801820s
   Pulavendran S, 2011, BIOTECHNOL BIOPROC E, V16, P393, DOI 10.1007/s12257-009-3155-4
   Ruggeri F, 2013, SOFT MATTER, V9, P8862, DOI 10.1039/c3sm50603g
   Santo VE, 2012, J TISSUE ENG REGEN M, V6, P330
   Santo VE, 2012, NANOMEDICINE-UK, V7, P1045, DOI [10.2217/NNM.12.78, 10.2217/nnm.12.78]
   Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462
   Shi JJ, 2010, NANO LETT, V10, P3223, DOI 10.1021/nl102184c
   Shimada K, 2000, INT J PHARMACEUT, V203, P255, DOI 10.1016/S0378-5173(00)00466-X
   Smith LA, 2008, SOFT MATTER, V4, P2144, DOI 10.1039/b807088c
   Tan Q, 2011, INT J NANOMED, V6, P929, DOI 10.2147/IJN.S18753
   Teo WE, 2009, COMPOS SCI TECHNOL, V69, P1804, DOI 10.1016/j.compscitech.2009.04.015
   Thire RMSM, 2007, MACROMOL SYMP, V258, P38, DOI 10.1002/masy.200751205
   Torchilin V, 2003, LIPOSOMES PRACTICAL
   TYLLIANAKIS PE, 1993, APPL BIOCHEM BIOTECH, V38, P15, DOI 10.1007/BF02916409
   Wang G, 2011, MOL PHARMACEUT, V8, P1025, DOI 10.1021/mp200028w
   Wang SS, 2008, DRUG DELIV, V15, P149, DOI [10.1080/10717540801952456, 10.1080/10717540801952456 ]
   Wang YY, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/5/054112
   Yousefi A., 2008, SCI PHARM, V77, P453
   Yu XH, 2014, BIOMATER SCI-UK, V2, P242, DOI 10.1039/c3bm60173k
   Zhang SF, 2009, PHARM RES-DORDR, V26, P1561, DOI 10.1007/s11095-009-9897-z
NR 57
TC 17
Z9 17
U1 2
U2 38
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1195
EP 1209
DI 10.1039/c4bm00069b
PG 15
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500006
DA 2018-10-19
ER

PT J
AU Gouveia, RM
   Jones, RR
   Hamley, IW
   Connon, CJ
AF Gouveia, Ricardo M.
   Jones, Roanne R.
   Hamley, Ian W.
   Connon, Che J.
TI The bioactivity of composite Fmoc-RGDS-collagen gels
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID FIBROBLAST CONTRACTION; PEPTIDE-AMPHIPHILES; FIBRIL FORMATION;
   CELL-ADHESION; TISSUE; BIOMATERIALS; INTEGRIN; SCAFFOLDS; HYDROGELS;
   GROWTH
AB The incorporation of small bioactive peptide motifs within robust hydrogels constitutes a facile procedure to chemically functionalise cell and tissue scaffolds. In this study, a novel approach to utilise Fmoc-linked peptide amphiphiles comprising the bio-functional cell-adhesion RGDS motif within biomimetic collagen gels was developed. The composite scaffolds thus created were shown to maintain the mechanical properties of the collagen gel while presenting additional bio-activity. In particular, these materials enhanced the adhesion and proliferation of viable human corneal stromal fibroblasts by 300% compared to non-functionalised gels. Furthermore, the incorporation of Fmoc-RGDS nanostructures within the collagen matrix significantly suppressed gel shrinkage resulting from the contractile action of encapsulated fibroblasts once activated by serum proteins. These mechanical and biological properties demonstrate that the incorporation of peptide amphiphiles provides a suitable and easy method to circumvent specific biomaterial limitations, such as cell-derived shrinkage, for improved performance in tissue engineering and regenerative medicine applications.
C1 [Gouveia, Ricardo M.; Jones, Roanne R.; Hamley, Ian W.; Connon, Che J.] Univ Reading, Sch Chem Food Biosci & Pharm, Reading RG6 6AD, Berks, England.
RP Gouveia, RM (reprint author), Univ Reading, Sch Chem Food Biosci & Pharm, Reading RG6 6AD, Berks, England.
EM che.connon@gmail.com
RI Hamley, Ian/D-1643-2009; Connon, Che/B-3128-2012
OI Hamley, Ian/0000-0002-4549-0926; Connon, Che/0000-0001-8264-6531;
   Gouveia, Ricardo/0000-0002-2968-1298
FU BBSRC [BB/I008187/1]; Biotechnology and Biological Sciences Research
   Council [BB/I008187/2, BB/I008187/1]
FX We are grateful to the BBSRC (grant number BB/I008187/1) for financial
   support. We kindly acknowledge M. Leyland, Royal Berkshire Hospital for
   supplying the post-mortem corneal rings.
CR Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Brown RA, 2002, EXP CELL RES, V274, P310, DOI 10.1006/excr.2002.5471
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Castelletto V, 2011, SOFT MATTER, V7, P11405, DOI 10.1039/c1sm06550e
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Chen QZ, 2013, PROG POLYM SCI, V38, P584, DOI 10.1016/j.progpolymsci.2012.05.003
   Cheng G, 2011, SOFT MATTER, V7, P1326, DOI 10.1039/c0sm00408a
   Cooper TP, 2011, ACTA BIOMATER, V7, P1072, DOI 10.1016/j.actbio.2010.11.008
   Funderburgh JL, 2003, J BIOL CHEM, V278, P45629, DOI 10.1074/jbc.M303292200
   Garcia-Gareta E, 2013, BIORESEARCH OPEN ACC, V2, P412, DOI 10.1089/biores.2013.0043
   Gomes S, 2012, PROG POLYM SCI, V37, P1, DOI 10.1016/j.progpolymsci.2011.07.003
   Gouveia RM, 2013, J MATER CHEM B, V1, P6157, DOI 10.1039/c3tb21031f
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136
   Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994
   HARPER PA, 1980, J CELL BIOL, V87, P755, DOI 10.1083/jcb.87.3.755
   Harrington DA, 2006, J BIOMED MATER RES A, V78A, P157, DOI 10.1002/jbm.a.30718
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hsu WC, 2000, INVEST OPHTH VIS SCI, V41, P2404
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jayawarna V, 2009, ACTA BIOMATER, V5, P934, DOI 10.1016/j.actbio.2009.01.006
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kagami S, 1999, J AM SOC NEPHROL, V10, P779
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Lee SY, 2003, BIOMATERIALS, V24, P5049, DOI 10.1016/S0142-9612(03)00411-3
   Liebmann T., 2007, BMC BIOTECHNOL, P7
   Lin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085672
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   Mason TG, 2000, J RHEOL, V44, P917, DOI 10.1122/1.551113
   MASUR SK, 1993, INVEST OPHTH VIS SCI, V34, P2690
   Matson JB, 2012, CHEM COMMUN, V48, P26, DOI 10.1039/c1cc15551b
   Mi SL, 2012, TISSUE ENG PT A, V18, P373, DOI [10.1089/ten.tea.2011.0194, 10.1089/ten.TEA.2011.0194]
   Patterson JM, 2011, EUR UROL, V60, P856, DOI 10.1016/j.eururo.2011.07.045
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Qi W., 2007, NEW J PHYS, V9, P428
   Sarin V, 2005, J PHYSIOL-LONDON, V564, P603, DOI 10.1113/jphysiol.2005.083238
   Sarrazy V, 2014, CARDIOVASC RES, V102, P407, DOI 10.1093/cvr/cvu053
   Schopferer M, 2009, J MOL BIOL, V388, P133, DOI 10.1016/j.jmb.2009.03.005
   Sottile J, 1998, J CELL SCI, V111, P2933
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Thornton K, 2009, BIOCHEM SOC T, V37, P660, DOI 10.1042/BST0370660
   Tuin A, 2012, EUR CELLS MATER, V24, P320, DOI 10.22203/eCM.v024a23
   von der Mark K, 2013, PROG MATER SCI, V58, P327, DOI 10.1016/j.pmatsci.2012.09.002
   Wang YQ, 2013, COLLOID SURFACE B, V104, P163, DOI 10.1016/j.colsurfb.2012.11.038
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Xin XJ, 2004, J BIOMAT SCI-POLYM E, V15, P1223, DOI 10.1163/1568562041753025
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 51
TC 17
Z9 17
U1 1
U2 13
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1222
EP 1229
DI 10.1039/c4bm00121d
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500008
DA 2018-10-19
ER

PT J
AU Tao, W
   Zeng, XW
   Zhang, JX
   Zhu, HJ
   Chang, DF
   Zhang, XD
   Gao, YF
   Tang, J
   Huang, LQ
   Mei, L
AF Tao, Wei
   Zeng, Xiaowei
   Zhang, Jinxie
   Zhu, Huijun
   Chang, Danfeng
   Zhang, Xudong
   Gao, Yongfeng
   Tang, Jiao
   Huang, Laiqiang
   Mei, Lin
TI Synthesis of cholic acid-core
   poly(epsilon-caprolactone-ran-lactide)-b-poly(ethylene glycol) 1000
   random copolymer as a chemotherapeutic nanocarrier for liver cancer
   treatment
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID DOCETAXEL-LOADED NANOPARTICLES; STAR-SHAPED POLYMER; DRUG-DELIVERY;
   BLOCK-COPOLYMERS; CELLULAR INTERNALIZATION; IN-VITRO; BIOMEDICAL
   APPLICATIONS; TARGETED NANOPARTICLES; DIBLOCK COPOLYMER; PEG
AB A star-shaped random copolymer, cholic acid functionalized poly(e-caprolactone-ran-lactide)-b-poly-(ethylene glycol) 1000 (CA-(PCL-ran-PLA)-b-PEG(1k)), was synthesized by a core-first approach involving three stages of chemical reactions, and was characterized by hydrogen-1 nuclear magnetic resonance (H-1 NMR), gel permeation chromatography and thermogravimetric analysis. The docetaxel-loaded nanoparticles (NPs) were prepared by a modified nano-precipitation method. The formation and characterization of these NPs were confirmed through dynamic light scattering, zeta potential measurements, field emission scanning electron microscopy, and transmission electron microscopy. The in vitro release profiles indicated that CA-(PCL-ran-PLA)-b-PEG(1k) NPs had excellent sustained and controlled drug release properties. Both confocal laser scanning microscope and flow cytometric results showed that the coumarin-6 loaded CA-(PCL-ran-PLA)-b-PEG(1k) NPs had the highest cellular uptake efficiency compared with PEG(1k)-b-(PCL-ran-PLA) NPs and CA-(PCL-ran-PLA) NPs in human hepatic carcinoma cells. The docetaxel-loaded CA-(PCL-ran-PLA)-b-PEG(1k) NPs were also proved to have the highest drug loading content, encapsulation efficiency, and the best anti-tumor efficacy both in vitro and in vivo. In conclusion, the star-shaped CA-(PCL-ran-PLA)-b-PEG(1k) copolymer was successfully synthesized and could be used as a promising drug-loaded biomaterial for liver cancer chemotherapy.
C1 [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Chang, Danfeng; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Minist Prov Jointly Constructed Base State Key La, Shenzhen Key Lab Chem Biol, Shenzhen Key Lab Gene & Antibody Therapy, Shenzhen 518055, Peoples R China.
   [Tao, Wei; Zeng, Xiaowei; Zhang, Jinxie; Zhu, Huijun; Chang, Danfeng; Zhang, Xudong; Gao, Yongfeng; Huang, Laiqiang; Mei, Lin] Tsinghua Univ, Grad Sch Shenzhen, Div Life & Hlth Sci, Shenzhen 518055, Peoples R China.
   [Chang, Danfeng] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China.
   [Tang, Jiao] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.
RP Mei, L (reprint author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
EM huanglq@sz.tsinghua.edu.cn; mei.lin@sz.tsinghua.edu.cn
RI Zeng, Xiaowei/A-6506-2015
OI Tao, Wei/0000-0002-4277-3728; Tao, Wei/0000-0001-8818-5326
FU National Natural Science Foundation of China [31270019, 51203085];
   Natural Science Foundation of Guangdong Province [S2012010010046,
   S2012040006820]; Science, Technology & Innovation Commission of Shenzhen
   Municipality [JCYJ20120616213729920, JCYJ20120614191936420,
   KQC201105310021A, JC201005270308A]; Program for New Century Excellent
   Talents in University [NCET-11-0275]
FX The authors are grateful for financial support from the National Natural
   Science Foundation of China (no. 31270019, 51203085), the Natural
   Science Foundation of Guangdong Province (no. S2012010010046,
   S2012040006820), the Science, Technology & Innovation Commission of
   Shenzhen Municipality (no. JCYJ20120616213729920, JCYJ20120614191936420,
   KQC201105310021A, JC201005270308A), and the Program for New Century
   Excellent Talents in University (NCET-11-0275).
CR Aw MS, 2014, BIOMATER SCI-UK, V2, P10, DOI 10.1039/c3bm60196j
   Bawarski WE, 2008, NANOMED-NANOTECHNOL, V4, P273, DOI 10.1016/j.nano.2008.06.002
   Buxton DB, 2009, NANOMEDICINE-UK, V4, P331, DOI 10.2217/NNM.09.8
   Claesson H, 2002, POLYMER, V43, P3511, DOI 10.1016/S0032-3861(02)00073-3
   Colilla M, 2013, BIOMATER SCI-UK, V1, P114, DOI 10.1039/c2bm00085g
   Csiszar E, 2013, CARBOHYD POLYM, V94, P927, DOI 10.1016/j.carbpol.2013.02.026
   de Espinosa LM, 2013, MACROMOL RAPID COMM, V34, P1381, DOI 10.1002/marc.201300472
   Delplace V, 2014, POLYM CHEM-UK, V5, P1529, DOI 10.1039/c3py01384g
   Ding JX, 2013, J CONTROL RELEASE, V169, P193, DOI 10.1016/j.jconrel.2012.12.006
   Duan XP, 2013, SMALL, V9, P1521, DOI 10.1002/smll.201201390
   Fokong S, 2012, J CONTROL RELEASE, V163, P75, DOI 10.1016/j.jconrel.2012.05.007
   Fu HL, 2007, J BIOMED MATER RES A, V81A, P186, DOI 10.1002/jbm.a.30924
   Fujii K, 2009, BIOCONJUGATE CHEM, V20, P1553, DOI 10.1021/bc900094g
   Hu KL, 2009, J CONTROL RELEASE, V134, P55, DOI 10.1016/j.jconrel.2008.10.016
   Huang LQ, 2011, INTEGR BIOL-UK, V3, P993, DOI 10.1039/c1ib00026h
   Inglis AJ, 2010, SOFT MATTER, V6, P82, DOI 10.1039/b920806m
   Kelleher SM, 2014, BIOMATER SCI-UK, V2, P410, DOI 10.1039/c3bm60218d
   Kim DG, 2012, J POLYM SCI POL CHEM, V50, P3618, DOI 10.1002/pola.26151
   Li TH, 2011, MACROMOL BIOSCI, V11, P1570, DOI 10.1002/mabi.201100147
   Liu YL, 2007, ANAL CHEM, V79, P2221, DOI 10.1021/ac061578f
   Loo YH, 2012, J CONTROL RELEASE, V160, P48, DOI 10.1016/j.jconrel.2012.01.041
   Lozano R, 2013, LANCET, V381, P628, DOI 10.1016/S0140-6736(12)61728-0
   Lv MQ, 2013, J APPL POLYM SCI, V128, P332, DOI 10.1002/app.38173
   Ma D, 2013, MACROMOL RAPID COMM, V34, P548, DOI 10.1002/marc.201200742
   Ma YD, 2010, POLYMER, V51, P5952, DOI 10.1016/j.polymer.2010.10.029
   Maeda H, 2012, P JPN ACAD B-PHYS, V88, P53, DOI 10.2183/pjab.88.53
   Mao ZW, 2013, BIOMATER SCI-UK, V1, P896, DOI 10.1039/c3bm00137g
   Mei L, 2013, J CONTROL RELEASE, V172, pE55, DOI 10.1016/j.jconrel.2013.08.114
   Mei L, 2013, ADV DRUG DELIVER REV, V65, P880, DOI 10.1016/j.addr.2012.11.005
   Mei L, 2009, NANOSCALE RES LETT, V4, P1530, DOI 10.1007/s11671-009-9431-6
   Mi Y, 2012, BIOMATERIALS, V33, P7519, DOI 10.1016/j.biomaterials.2012.06.100
   Nabid MR, 2011, POLYMER, V52, P2799, DOI 10.1016/j.polymer.2011.04.054
   Newland B, 2013, BIOMATER SCI-UK, V1, P556, DOI 10.1039/c3bm60030k
   Onyuksel H, 2009, CANCER LETT, V274, P327, DOI 10.1016/j.canlet.2008.09.041
   Shi JJ, 2011, ACCOUNTS CHEM RES, V44, P1123, DOI 10.1021/ar200054n
   Swinarew A, 2011, MACROMOL SYMP, V308, P8, DOI 10.1002/masy.201151002
   Synatschke CV, 2013, NACHR CHEM, V61, P1008, DOI 10.1002/nadc.201390313
   Tan BH, 2013, POLYM CHEM-UK, V4, P1250, DOI 10.1039/c2py20823g
   Tao W, 2013, ACTA BIOMATER, V9, P8910, DOI 10.1016/j.actbio.2013.06.034
   Valencia PM, 2011, BIOMATERIALS, V32, P6226, DOI 10.1016/j.biomaterials.2011.04.078
   Vollrath A, 2012, MACROMOL RAPID COMM, V33, P1791, DOI 10.1002/marc.201200329
   Wagner E, 2013, BIOMATER SCI-UK, V1, P804, DOI 10.1039/c3bm60071h
   Wan YM, 2014, POLYM CHEM-UK, V5, P1720, DOI 10.1039/c3py01281f
   Wang J, 2013, J MATER CHEM B, V1, P2324, DOI 10.1039/c3tb20100g
   Yallapu MM, 2010, J COLLOID INTERF SCI, V351, P19, DOI 10.1016/j.jcis.2010.05.022
   Yang CM, 2013, J BIOMED NANOTECHNOL, V9, P1617, DOI 10.1166/jbn.2013.1646
   Yang Y, 2013, POLYM CHEM-UK, V4, P2651, DOI 10.1039/c3py00049d
   Yue YN, 2013, BIOMATER SCI-UK, V1, P152, DOI 10.1039/c2bm00030j
   Yue ZG, 2013, J MATER CHEM B, V1, P3239, DOI 10.1039/c3tb20406e
   Zeng XW, 2013, BIOMATERIALS, V34, P6058, DOI 10.1016/j.biomaterials.2013.04.052
   Zhang CN, 2012, BIOMATERIALS, V33, P2187, DOI 10.1016/j.biomaterials.2011.11.045
   Zhang YQ, 2010, ACTA BIOMATER, V6, P2045, DOI 10.1016/j.actbio.2009.11.035
   Zou T, 2007, J BIOMED MATER RES B, V82B, P400, DOI 10.1002/jbm.b.30745
NR 53
TC 24
Z9 24
U1 3
U2 47
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1262
EP 1274
DI 10.1039/c4bm00134f
PG 13
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500012
DA 2018-10-19
ER

PT J
AU Pence, JC
   Gonnerman, EA
   Bailey, RC
   Harley, BAC
AF Pence, Jacquelyn C.
   Gonnerman, Emily A.
   Bailey, Ryan C.
   Harley, Brendan A. C.
TI Strategies to balance covalent and non-covalent biomolecule attachment
   within collagen-GAG biomaterials
SO BIOMATERIALS SCIENCE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; GROWTH-FACTOR ACTIVITY; CROSS-LINKING;
   GLYCOSAMINOGLYCAN SCAFFOLDS; IN-VITRO; EXTRACELLULAR-MATRIX; FACTOR
   SUPPLEMENTATION; TENOCYTE BIOACTIVITY; WOUND CONTRACTION;
   PERIPHERAL-NERVES
AB Strategies to integrate instructive biomolecular signals into a biomaterial are becoming increasingly complex and bioinspired. While a large majority of reports still use repeated treatments with soluble factors, this approach can be prohibitively costly and difficult to translate in vivo for applications where spatial control over signal presentation is necessary. Recent efforts have explored the use of covalent immobilization of biomolecules to the biomaterial, via both bulk (ubiquitous) as well as spatially-selective light-based crosslinking, as a means to both enhance stability and bioactivity. However, little is known about how processing conditions during immobilization impact the degree of unintended non-covalent interactions, or fouling, that takes place between the biomaterial and the biomolecule of interest. Here we demonstrate the impact of processing conditions for bulk carbodiimide (EDC) and photolithography-based benzophenone (BP) crosslinking on specific attachment vs. fouling of a model protein (concanavalin A, ConA) within collagen-glycosaminoglycan (CG) scaffolds. Collagen source significantly impacts the selectivity of biomolecule immobilization. EDC crosslinking intensity and ligand concentration significantly impacted selective immobilization. For benzophenone photoimmobilization we observed that increased UV exposure time leads to increased ConA immobilization. Immobilization efficiency for both EDC and BP strategies was maximal at physiological pH. Increasing ligand concentration during immobilization process led to enhanced immobilization for EDC chemistry, no impact on BP immobilization, but significant increases in non-specific fouling. Given recent efforts to covalently immobilize biomolecules to a biomaterial surface to enhance bioactivity, improved understanding of the impact of crosslinking conditions on selective attachment versus non-specific fouling will inform the design of instructive biomaterials for applications across tissue engineering.
C1 [Pence, Jacquelyn C.; Gonnerman, Emily A.; Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
   [Bailey, Ryan C.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA.
   [Harley, Brendan A. C.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.
RP Pence, JC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Bailey, Ryan/0000-0003-1021-4267; Harley, Brendan/0000-0001-5458-154X
FU National Science Foundation [1105300]; National Institute of Arthritis
   and Musculoskeletal and Skin Diseases of the National Institutes of
   Health [R03 AR062811]; Chemical and Biomolecular Engineering Dept.;
   Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign
FX The authors would like to acknowledge Aurora Alsop (UIUC) for assistance
   with BP-photopatterning. This material is based upon work supported by
   the National Science Foundation under grant no. 1105300. Research
   reported in this publication was supported by the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases of the National
   Institutes of Health under Award numbers R03 AR062811. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health. We
   are grateful for additional funding for this study provided by the
   Chemical and Biomolecular Engineering Dept. (BAH) and the Institute for
   Genomic Biology (BAH) at the University of Illinois at Urbana-Champaign.
CR Alsop A. T., 2014, ACTA BIOMAT IN PRESS
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Caliari S. R., 2014, TISSUE ENG PART A, DOI [10.1089/ten.TEA.2013.0400, DOI 10.1089/TEN.TEA.2013.0400]
   Caliari SR, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400252
   Caliari SR, 2014, ADV HEALTHC MATER, V3, P1086, DOI 10.1002/adhm.201300646
   Caliari SR, 2013, TISSUE ENG PT A, V19, P1100, DOI [10.1089/ten.TEA.2012.0497, 10.1089/ten.tea.2012.0497]
   Caliari SR, 2012, J MECH BEHAV BIOMED, V11, P27, DOI 10.1016/j.jmbbm.2011.12.004
   Caliari SR, 2011, BIOMATERIALS, V32, P5330, DOI 10.1016/j.biomaterials.2011.04.021
   Capito RM, 2006, OSTEOARTHR CARTILAGE, V14, P1203, DOI 10.1016/j.joca.2006.06.001
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Cornwell KG, 2007, J BIOMED MATER RES A, V82A, P104, DOI 10.1002/jbm.a.31057
   Cornwell KG, 2007, J BIOMED MATER RES A, V80A, P362, DOI 10.1002/jbm.a.30893
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DeForest CA, 2012, ANGEW CHEM INT EDIT, V51, P1816, DOI 10.1002/anie.201106463
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Getgood AMJ, 2012, KNEE, V19, P422, DOI 10.1016/j.knee.2011.03.011
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Haugh MG, 2011, TISSUE ENG PT A, V17, P1201, DOI [10.1089/ten.tea.2010.0590, 10.1089/ten.TEA.2010.0590]
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Hortensius RA, 2013, BIOMATERIALS, V34, P7645, DOI 10.1016/j.biomaterials.2013.06.056
   Hudalla GA, 2011, ADV MATER, V23, P5415, DOI 10.1002/adma.201103046
   Hudalla GA, 2011, INTEGR BIOL-UK, V3, P832, DOI 10.1039/c1ib00021g
   Hudalla GA, 2011, ADV FUNCT MATER, V21, P1754, DOI 10.1002/adfm.201002468
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   Lim JJ, 2013, BIOMATERIALS, V34, P5007, DOI 10.1016/j.biomaterials.2013.03.037
   Lyons FG, 2014, CLIN ORTHOP RELAT R, V472, P1318, DOI 10.1007/s11999-013-3438-0
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Masters KS, 2011, MACROMOL BIOSCI, V11, P1149, DOI 10.1002/mabi.201000505
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Osborne CS, 1998, MED BIOL ENG COMPUT, V36, P129, DOI 10.1007/BF02522870
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Rossetto VJV, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-39
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   SILVER FH, 1978, THROMB RES, V13, P267, DOI 10.1016/0049-3848(78)90014-2
   SODERSTROM KO, 1987, HISTOCHEMISTRY, V87, P557, DOI 10.1007/BF00492470
   Soller EC, 2012, BIOMATERIALS, V33, P4783, DOI 10.1016/j.biomaterials.2012.03.068
   Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wu JM, 2011, J MATER SCI-MATER M, V22, P107, DOI 10.1007/s10856-010-4176-4
   Wu SF, 2011, BIOMATERIALS, V32, P1317, DOI 10.1016/j.biomaterials.2010.10.006
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yannas IV, 1975, POLYM PREPR AM CH PC, V16, P209
   Zhang YY, 2005, BJU INT, V96, P1120, DOI 10.1111/j.1464-410X.2005.05741.x
NR 58
TC 6
Z9 6
U1 0
U2 12
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2047-4830
EI 2047-4849
J9 BIOMATER SCI-UK
JI Biomater. Sci.
PY 2014
VL 2
IS 9
BP 1296
EP 1304
DI 10.1039/c4bm00193a
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA AO7GC
UT WOS:000341519500015
PM 25147727
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Ye, H
   Tong, JS
   Wu, JZ
   Xu, X
   Wu, SJ
   Tan, BT
   Shi, MJ
   Wang, JG
   Zhao, WB
   Jiang, H
   Jin, S
AF Ye, Hui
   Tong, Jiansong
   Wu, Jianzhang
   Xu, Xia
   Wu, Shenjie
   Tan, Botao
   Shi, Mengjing
   Wang, Jianguang
   Zhao, Weibo
   Jiang, Heng
   Jin, Sha
TI Preclinical evaluation of recombinant human IFN alpha(2)b-containing
   magnetoliposomes for treating hepatocellular carcinoma
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE recombinant human interferon-alpha(2)b; magnetoliposome; hepatocellular
   carcinoma
ID MAGNETIC FE3O4 NANOPARTICLES; PROGRAMMED CELL-DEATH; INTERFERON-ALPHA;
   IFN-ALPHA; ANTITUMOR-ACTIVITY; DRUG-DELIVERY; CANCER CELLS; PHASE-I;
   APOPTOSIS; DIFFERENTIATION
AB Magnetoliposomes are phospholipid vesicles encapsulating magnetic nanoparticles that can be used to encapsulate therapeutic drugs for delivery into specific organs. Herein, we developed magnetoliposomes containing recombinant human IFN alpha(2)b, designated as MIL, and evaluated this combination's biological safety and therapeutic effect on both cellular and animal hepatocellular carcinoma models. Our data showed that MIL neither hemolyzed erythrocytes nor affected platelet-aggregation rates in blood. Nitroblue tetrazolium-reducing testing showed that MIL did not change the absolute numbers or phagocytic activities of leukocytes. Acutetoxicity testing also showed that MIL had no devastating effect on mice behaviors. All the results indicated that the nanoparticles could be a safe biomaterial. Pharmacokinetic analysis and tissue-distribution studies showed that MIL maintained stable and sustained drug concentrations in target organs under a magnetic field, helped to increase bioavailability, and reduced administration time. MIL also dramatically inhibited the growth of hepatoma cells. Targeting of MIL in the livers of nude mice bearing human hepatocellular carcinoma showed that MIL significantly reduced the tumor size to 38% of that of the control group. Further studies proved that growth inhibition of cells or tumors was due to apoptosis-signaling pathway activation by human IFN alpha(2)b.
C1 [Ye, Hui; Wang, Jianguang] Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou 325035, Zhejiang, Peoples R China.
   [Ye, Hui; Tong, Jiansong] Scripps Res Inst, Dept Cellular & Mol Biol, La Jolla, CA 92037 USA.
   [Wu, Jianzhang] Wenzhou Med Univ, Pharmaceut Coll, Wenzhou 325035, Zhejiang, Peoples R China.
   [Xu, Xia] Zhejiang Univ, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.
   [Wu, Shenjie; Shi, Mengjing; Zhao, Weibo; Jiang, Heng; Jin, Sha] Wenzhou Med Univ, Sch Clin Med Sci 1, Wenzhou 325035, Zhejiang, Peoples R China.
   [Tan, Botao] Lishui Univ, Sch Med, Lishui, Peoples R China.
RP Ye, H (reprint author), Wenzhou Med Univ, Sch Basic Med Sci, Wenzhou 325035, Zhejiang, Peoples R China.
EM huiye1109@gmail.com
FU China Scholarship Council [201208330266]; Natural Science Foundation of
   Zhejiang Province, PRC [Y4110029, Y4090379]; Natural Science Foundation
   of Wenzhou Science Technology Bureau, Zhejiang, PRC [Y20100018]
FX This work was partly supported by grants from the China Scholarship
   Council (201208330266), the Natural Science Foundation of Zhejiang
   Province, PRC (Y4110029 and Y4090379), and the Natural Science
   Foundation of Wenzhou Science Technology Bureau, Zhejiang, PRC
   (Y20100018). We appreciate Dr Matthew Wheeler at the Scripps Institute
   for editing the manuscript.
CR Amendola V, 2011, J MATER CHEM, V21, P3803, DOI 10.1039/c0jm03863f
   Azzimonti B, 2004, HISTOPATHOLOGY, V45, P560, DOI 10.1111/j.1365-2559.2004.02000.x
   Breitenstein S, 2009, BRIT J SURG, V96, P975, DOI 10.1002/bjs.6731
   Bukowski R, 2002, J CLIN ONCOL, V20, P3841, DOI 10.1200/JCO.2002.02.051
   Carvalho A, 2013, MAGN RESON IMAGING, V31, P610, DOI 10.1016/j.mri.2012.10.024
   Chua CW, 2011, INT J HEPATOL, V2011, P1
   Cinti C, 2011, PLOS ONE, V6, P17132
   Colletier Jacques-Philippe, 2002, BMC Biotechnol, V2, P9, DOI 10.1186/1472-6750-2-9
   Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534
   EINAT M, 1985, NATURE, V313, P597, DOI 10.1038/313597a0
   Galor A, 2010, BRIT J OPHTHALMOL, V94, P551, DOI 10.1136/bjo.2008.153197
   Garcia-Jimeno S, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-452
   HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0
   Jahnke A, 2007, J VET MED A, V54, P599, DOI 10.1111/j.1439-0442.2007.01002.x
   Jing HM, 2010, INT J NANOMED, V5, P999, DOI 10.2147/IJN.S14957
   Kawaguchi E, 2008, COLLOID SURFACE B, V62, P130, DOI 10.1016/j.colsurfb.2007.09.027
   Kim MJ, 2011, J NANOSCI NANOTECHNO, V11, P889, DOI 10.1166/jnn.2011.3267
   Le Buanec H, 2011, P NATL ACAD SCI USA, V108, P18995, DOI 10.1073/pnas.1113301108
   Lesinski GB, 2008, CANCER RES, V68, P8351, DOI 10.1158/0008-5472.CAN-08-0426
   Matsui W, 2003, BRIT J HAEMATOL, V121, P251, DOI 10.1046/j.1365-2141.2003.04255.x
   Mejias R, 2011, BIOMATERIALS, V32, P2938, DOI 10.1016/j.biomaterials.2011.01.008
   OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O
   Rudel T, 1999, HERZ, V24, P236, DOI 10.1007/BF03044967
   Satthaporn S, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-32
   Shinohara N, 2012, JPN J CLIN ONCOL, V42, P113, DOI 10.1093/jjco/hyr176
   Singal AK, 2010, ALIMENT PHARM THER, V32, P851, DOI 10.1111/j.1365-2036.2010.04414.x
   Singh R, 2011, J BIOMED NANOTECHNOL, V7, P489, DOI 10.1166/jbn.2011.1324
   Solomon M, 2011, CURR OPIN PEDIATR, V23, P215, DOI 10.1097/MOP.0b013e32834456a5
   Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05
   Wang BX, 2011, J INTERF CYTOK RES, V31, P545, DOI 10.1089/jir.2010.0158
   Wang CL, 2011, INT J NANOMED, V6, P1929, DOI 10.2147/IJN.S24707
   Wang J, 2010, INT J NANOMED, V5, P861, DOI 10.2147/IJN.S13662
   Wang YS, 2002, ADV DRUG DELIVER REV, V54, P547, DOI 10.1016/S0169-409X(02)00027-3
   Xu DW, 2000, BLOOD, V96, P4313
   Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555
   Yamamoto-Yamaguchi Y, 2003, ANTICANCER RES, V23, P2537
   Yang E, 1996, BLOOD, V88, P386
   Yang JD, 2010, INFECT DIS CLIN N AM, V24, P899, DOI 10.1016/j.idc.2010.07.004
   Yi TL, 2011, ONCOTARGET, V2, P1155
   Yuen MF, 2002, J CLIN GASTROENTEROL, V35, P272, DOI 10.1097/01.MCG.0000024791.18323.99
NR 40
TC 5
Z9 5
U1 1
U2 11
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1178-2013
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2014
VL 9
BP 4533
EP 4550
DI 10.2147/IJN.S67228
PG 18
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA AP5OY
UT WOS:000342129700001
PM 25288882
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Bavbek, AB
   Ozcan, M
   Eskitascioglu, G
AF Bavbek, Andac Barkin
   Oezcan, Mutlu
   Eskitascioglu, Gurcan
TI Radioactive potential of zirconium-dioxide used for dental applications
SO JOURNAL OF APPLIED BIOMATERIALS & FUNCTIONAL MATERIALS
LA English
DT Article
DE Radioactivity; XRF; Zirconium-dioxide
ID IN-VITRO EVALUATION; STABILIZED ZIRCONIA; CERAMICS; BIOMATERIAL;
   RADIATION; IMPLANTS; POWDERS
AB Purpose: The purpose of this study was to investigate the possible radioactive potential of zirconium dioxide (ZrO2) dental ceramics. Such information is necessary since they became an integral part of routine prosthetic rehabilitations and devoid of scientific information about their radioactivity creates some concern in the dental community.
   Methods: Four different types of commercial ZrO2 ceramics, namely Lava, Cercon, ICE Zirkon, and Everest Bio ZS were investigated before and after the sintering process. Sintering temperatures were applied according to each manufacturer's instructions. The compositions of the presintered and sintered specimens were analyzed using x-ray fluorescence spectrometer (XRF). Concentrations of the elements and compounds were also measured by this method. Determination of radioactivity continued with gamma-spectrometry measurements and gross alpha/beta analyses.
   Results: The activity of gamma and gross alpha/beta was below minimum detection limits (MDL) for presintered and sintered ZrO2. The MDLs of gross alpha/beta counting system were 0.02 Bq/g and 0.01 Bq/g for alpha and beta radioactivity, respectively. The sintering process played only a minor role in the composition of the compounds.
   Conclusions: Radioactivity of the ZrO2 ceramics studied showed negligible radionuclide activity that can be considered lower than many hazardous radioactive appliances in our environment.
C1 [Bavbek, Andac Barkin; Eskitascioglu, Gurcan] Yuzuncu Yil Univ, Fac Dent, Dept Prosthodont, TR-65080 Van, Turkey.
   [Oezcan, Mutlu] Univ Zurich, Ctr Dent & Oral Med, Dent Mat Unit, Clin Fixed & Removable Prosthodont & Dent Mat Sci, Zurich, Switzerland.
RP Bavbek, AB (reprint author), Yuzuncu Yil Univ, Fac Dent, Dept Prosthodont, TR-65080 Van, Turkey.
EM bavbekab@yahoo.com
CR Akagawa Y, 1998, J PROSTHET DENT, V80, P551, DOI 10.1016/S0022-3913(98)70031-9
   [Anonymous], 2007, SAF REP SER INT AT E, V51
   [Anonymous], DOE FUND HDB NUCL PH, V1
   Anusavice K J, 1992, Adv Dent Res, V6, P82
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Christensen GJ, 2009, J AM DENT ASSOC, V140, P1036, DOI 10.14219/jada.archive.2009.0316
   Conrad HJ, 2007, J PROSTHET DENT, V98, P389, DOI 10.1016/S0022-3913(07)60124-3
   Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Gilmore GR, 2008, PRACTICAL GAMMA RAY, P39
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Lazar DRR, 2008, DENT MATER, V24, P1676, DOI 10.1016/j.dental.2008.04.002
   Liang XJ, 2008, J UNIV SCI TECHNOL B, V15, P764, DOI 10.1016/S1005-8850(08)60284-4
   LINDELL B, 1987, B WORLD HEALTH ORGAN, V65, P139
   Mackert J R Jr, 1992, Adv Dent Res, V6, P90
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Papanagiotou HP, 2006, J PROSTHET DENT, V96, P154, DOI 10.1016/j.prosdent.2006.08.004
   PAPASTEFANOU C, 1987, RADIAT PROT DOSIM, V19, P49
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Porstendorfer J, 1996, J BIOMED MATER RES, V32, P663, DOI 10.1002/(SICI)1097-4636(199612)32:4<663::AID-JBM20>3.0.CO;2-D
   Schmalz G., 2008, BIOCOMPATIBILITY DEN, P183
   Sickafus KE, 1999, J NUCL MATER, V274, P66, DOI 10.1016/S0022-3115(99)00041-0
   TINKER RA, 1995, J RADIOAN NUCL CH AR, V193, P329, DOI 10.1007/BF02039890
   Vagkopoulou T, 2009, INT J ESTHET DENT, V4, P130
   Veronese I, 2006, J ENVIRON RADIOACTIV, V91, P15, DOI 10.1016/j.jenvrad.2006.08.002
   Willmann G, 1998, ORTHOPEDICS, V21, P173
NR 27
TC 1
Z9 1
U1 0
U2 7
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 2280-8000
J9 J APPL BIOMATER FUNC
JI J. Appl. Biomater. Funct. Mater.
PY 2014
VL 12
IS 1
BP 35
EP 40
DI 10.5301/JABFM.2012.9341
PG 6
WC Biophysics; Engineering, Biomedical; Materials Science, Biomaterials
SC Biophysics; Engineering; Materials Science
GA AP7LC
UT WOS:000342257800005
PM 22865573
DA 2018-10-19
ER

PT J
AU Bai, SM
   Zhang, WM
   Lu, Q
   Ma, QH
   Kaplanad, DL
   Zhu, HS
AF Bai, ShuMeng
   Zhang, WenMin
   Lu, Qiang
   Ma, QuanHong
   Kaplanad, David L.
   Zhu, Hesun
TI Silk nanofiber hydrogels with tunable modulus to regulate nerve stem
   cell fate
SO JOURNAL OF MATERIALS CHEMISTRY B
LA English
DT Article
ID SELF-ASSEMBLY PROCESS; NEURAL TISSUE; MECHANICAL-PROPERTIES;
   EXTRACELLULAR-MATRIX; HIPPOCAMPAL-NEURONS; SPIDER SILK; SPINAL-CORD;
   FIBROIN; DIFFERENTIATION; SCAFFOLDS
AB Reconstruction of damaged nerves remains a significant unmet challenge in clinical medicine. To foster improvements, the control of neural stem cell (NSC) behaviors, including migration, proliferation and differentiation, is a critical factor to consider. Topographical and mechanical stimulations based on the control of biomaterial features are promising approaches, which are usually studied separately. The synergy between topography and mechanical rigidity could offer new insights into the control of neural cell fate if they could be utilized concurrently in studies. To achieve this need, silk fibroin self-assembled nanofibers with a beta-sheet-enriched structure are formed into hydrogels. Stiffness is tuned using different annealing processes to enable mechanical control without impacting the nanofiber topography. Compared with nonannealed nanofibers, NSCs on methanol annealed nanofibers with stiffness similar to that of nerve tissues differentiate into neurons with the restraint of glial differentiation, without the influence of specific differentiation biochemical factors. These results demonstrate that combining topographic and mechanical cues provides the control of nerve cell behaviors, with potential for neurogenerative repair strategies.
C1 [Bai, ShuMeng; Lu, Qiang; Kaplanad, David L.] Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Bai, ShuMeng; Lu, Qiang; Kaplanad, David L.] Soochow Univ, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China.
   [Zhang, WenMin; Ma, QuanHong] Soochow Univ, Affiliated Hosp 2, Inst Neurosci, Jiangsu Key Lab Translat Res & Therapy Neuro Psyc, Suzhou 215123, Peoples R China.
   [Lu, Qiang] Soochow Univ, Coll Med, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
   [Kaplanad, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn; h999.judy@gmail.com
FU National Basic Research Program of China (973 Program) [2013CB934400,
   2012CB22302]; NSFC [21174097, 81272106]; Priority Academic Program
   Development of Jiangsu Higher Education Institutions (PAPD); Excellent
   Youth Foundation of Jiangsu Province [BK2012009]; Youth Foundation of
   Jiangsu Province [BK20140397]; NIH [P41 EB002520]; Key Natural Science
   Foundation of the Jiangsu Higher Education Institutions of China
   [11KGA430002]; National Programme on Key Basic Research Project
   [2013CB945602]; National Natural Science Foundation of China [31171313,
   81271424]; Research Fund for the Doctoral Program of Higher Education of
   China [20113201120018]; Soochow University Start up foundation
   [Q421500110]
FX We thank grants from the National Basic Research Program of China (973
   Program 2013CB934400, 2012CB22302), and NSFC (21174097, 81272106) for
   support of this work. We also thank grants from the Priority Academic
   Program Development of Jiangsu Higher Education Institutions (PAPD), the
   Excellent Youth Foundation of Jiangsu Province (BK2012009), the Youth
   Foundation of Jiangsu Province (BK20140397), the NIH (P41 EB002520), and
   the Key Natural Science Foundation of the Jiangsu Higher Education
   Institutions of China (11KGA430002) for support of this work. We thank
   grants to Quan-hong Ma from the National Programme on Key Basic Research
   Project (2013CB945602), the National Natural Science Foundation of China
   (31171313, 81271424), Research Fund for the Doctoral Program of Higher
   Education of China (20113201120018) and Soochow University Start up
   foundation (Q421500110).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bai S, 2013, ACTA BIOMATER, V9, P7806, DOI 10.1016/j.actbio.2013.04.033
   Benfenati V, 2012, ADV FUNCT MATER, V22, P1871, DOI 10.1002/adfm.201102310
   Callahan LAS, 2013, BIOMATERIALS, V34, P9089, DOI 10.1016/j.biomaterials.2013.08.028
   Eng G, 2013, P NATL ACAD SCI USA, V110, P4551, DOI 10.1073/pnas.1300569110
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037
   Georgiou M, 2013, BIOMATERIALS, V34, P7335, DOI 10.1016/j.biomaterials.2013.06.025
   Giesa T, 2011, NANO LETT, V11, P5038, DOI 10.1021/nl203108t
   Giobbe GG, 2012, BIOTECHNOL BIOENG, V109, P3119, DOI 10.1002/bit.24571
   Gong ZG, 2010, SOFT MATTER, V6, P1217, DOI 10.1039/b913510c
   Gong ZG, 2009, CHEM COMMUN, P7506, DOI 10.1039/b914218e
   Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Han F, 2014, ACTA BIOMATER, V10, P921, DOI 10.1016/j.actbio.2013.09.026
   Hensley K, 2010, J ALZHEIMERS DIS, V21, P1, DOI 10.3233/JAD-2010-1414
   Hopkins AM, 2013, ADV FUNCT MATER, V23, P5140, DOI 10.1002/adfm.201300435
   Hronik-Tupaj M, 2013, J BIOMED MATER RES A, V101, P2559, DOI 10.1002/jbm.a.34565
   Hu X, 2013, ADV FUNCT MATER, V23, P3875, DOI 10.1002/adfm.201202685
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Huang W, 2012, BIOMATERIALS, V33, P59, DOI 10.1016/j.biomaterials.2011.09.030
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Joddar B, 2013, J BIOTECHNOL, V168, P218, DOI 10.1016/j.jbiotec.2013.04.021
   Kasoju N, 2012, ADV HEALTHC MATER, V1, P393, DOI 10.1002/adhm.201200097
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]
   Kong H, 2008, J CELL SCI, V121, P4029, DOI 10.1242/jcs.035758
   Kundu B, 2013, ADV DRUG DELIVER REV, V65, P457, DOI 10.1016/j.addr.2012.09.043
   Lampe KJ, 2013, ACTA BIOMATER, V9, P5590, DOI 10.1016/j.actbio.2012.10.033
   Lee J, 2012, P NATL ACAD SCI USA, V109, P19638, DOI 10.1073/pnas.1208384109
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Li YC, 2014, BIOMATERIALS, V35, P1192, DOI 10.1016/j.biomaterials.2013.10.066
   Li YC, 2012, ACTA BIOMATER, V8, P3035, DOI 10.1016/j.actbio.2012.04.036
   Lu GZ, 2014, COLLOID SURFACE B, V120, P28, DOI 10.1016/j.colsurfb.2014.03.027
   Lu Q, 2012, BIOMACROMOLECULES, V13, P826, DOI 10.1021/bm201731e
   Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Mauney JR, 2005, TISSUE ENG, V11, P787, DOI 10.1089/ten.2005.11.787
   Mawad D, 2012, ADV FUNCT MATER, V22, P2692, DOI 10.1002/adfm.201102373
   Meamar R, 2013, J CLIN NEUROSCI, V20, P1659, DOI 10.1016/j.jocn.2013.04.024
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Neirinckx V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064723
   Numata K, 2014, MACROMOL BIOSCI, V14, P799, DOI 10.1002/mabi.201300482
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Prewitz MC, 2013, NAT METHODS, V10, P788, DOI [10.1038/nmeth.2523, 10.1038/NMETH.2523]
   Purcell EK, 2012, BIOMACROMOLECULES, V13, P3427, DOI 10.1021/bm301220k
   Qu J, 2013, J BIOMED MATER RES A, V101, P2667, DOI 10.1002/jbm.a.34551
   Sandoe J, 2013, NAT NEUROSCI, V16, P780, DOI 10.1038/nn.3425
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Shibuya S., 2009, CELL ADHES MIGR, V3, P1
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stabenfeldt SE, 2011, ACTA BIOMATER, V7, P4102, DOI 10.1016/j.actbio.2011.07.026
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Volpato FZ, 2013, BIOMATERIALS, V34, P4945, DOI 10.1016/j.biomaterials.2013.03.057
   Wei GJ, 2013, INT J NANOMED, V8, P3217, DOI 10.2147/IJN.S43681
   Wittmer CR, 2011, ADV FUNCT MATER, V21, P4232, DOI 10.1002/adfm.201100755
   Xie H, 2013, ACTA BIOMATER, V9, P7845, DOI 10.1016/j.actbio.2013.04.038
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yao DY, 2012, BIOMACROMOLECULES, V13, P3723, DOI 10.1021/bm301197h
   Yoo J, 2013, J CELL BIOCHEM, V114, P743, DOI 10.1002/jcb.24427
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhao YH, 2013, BIO-MED MATER ENG, V23, P545, DOI 10.3233/BME-130775
NR 70
TC 20
Z9 21
U1 15
U2 60
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2050-750X
EI 2050-7518
J9 J MATER CHEM B
JI J. Mat. Chem. B
PY 2014
VL 2
IS 38
BP 6590
EP 6600
DI 10.1039/c4tb00878b
PG 11
WC Materials Science, Biomaterials
SC Materials Science
GA AP4WJ
UT WOS:000342079900016
PM 25530851
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Lopez, C
   Carmona, JU
   Giraldo, CE
   Alvarez, ME
AF Lopez, C.
   Carmona, J. U.
   Giraldo, C. E.
   Alvarez, M. E.
TI Bacteriostatic effect of equine pure platelet-rich plasma and other
   blood products against methicillin-sensitive Staphylococcus aureus
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE Growth factor; leukocyte-reduced platelet concentrate; platelet factor
   4; wound infection
ID GROWTH-FACTOR-BETA; ANTIMICROBIAL ACTIVITY; IN-VITRO; HORSES; GEL;
   OSTEOMYELITIS; INFECTION; ELISA
AB Objectives: 1) To evaluate the bacteriostatic in vitro effect of pure platelet-rich plasma (P-PRP), pure platelet-rich gel (P-PRG), leukocyte-poor gel (LPG), platelet-poor plasma (PPP), and heat inactivated plasma (IP) against methicillin-sensitive Staphylococcus aureus (MSSA) over a period of 24 hours. 2) To determine the degradation of platelet factor-4 (PF-4), transforming growth factor beta 1 (TGF-beta(1)), and platelet-derived growth factor isoform BB (PDGF-BB) in these equine blood components. 3) To establish correlations between platelet and leukocyte counts, PF-4 concentrations, and MSSA growth.
   Methods: Fourteen horses were used. Blood components were obtained by a manual protocol. Every blood component was mixed with MSSA and Muller-Hinton Broth and cultured at 37 C for 24 hours. Samples for the determination of bacterial growth (colony-forming units) and PF-4, TGF-beta(1) and PDGF-BB concentrations were taken at one, four, eight, 12 and 24 hours.
   Results: The bacterial growth was significantly (p = 0.01) inhibited for P-PRP, P-PRG, LPG and PPP in comparison with IP and, the positive control group during the first 12 hours. The P-PRG had higher and sustained TGF-beta(1) and PDGF-BB concentrations over time in comparison with the other blood components.
   Clinical significance: The plasma complement could be one of the most responsible components of the in vitro bacteriostatic effect of P-PRP, P-PRG, LPG and PPP against MSSA. Additionally, P-PRG was the better biomaterial because it had an acceptable bacteriostatic effect and the highest concentration of growth factors.
C1 [Lopez, C.; Carmona, J. U.; Giraldo, C. E.; Alvarez, M. E.] Univ Caldas, Dept Salud Anim, Grp Invest Terapia Regenerat, Manizales, Colombia.
RP Carmona, JU (reprint author), Univ Caldas, Dept Salud Anim, Calle 65,26-10, Manizales, Colombia.
EM carmona@ucaldas.edu.co
OI LOPEZ, CATALINA/0000-0003-4954-1601; Carmona, Jorge
   U./0000-0002-6917-8451
FU Vicerrectoria de Investigaciones y Postgrados of the Universidad de
   Caldas, Manizales, Colombia [1295210]
FX This research was supported by a research grant (No 1295210) of the
   Vicerrectoria de Investigaciones y Postgrados of the Universidad de
   Caldas, Manizales, Colombia.
CR Alsousou J, 2013, PLATELETS, V24, P173, DOI 10.3109/09537104.2012.684730
   Alvarez ME, 2011, ARCH MED VET, V43, P155, DOI 10.4067/S0301-732X2011000200008
   Alvarez ME, 2010, EQUINE VET J, V42, P63, DOI 10.2746/042516409X455221
   Anitua E, 2012, CLIN EXP DERMATOL, V37, P652, DOI 10.1111/j.1365-2230.2011.04303.x
   Arguelles D, 2008, VET REC, V162, P208, DOI 10.1136/vr.162.7.208
   Arguelles D, 2006, RES VET SCI, V81, P237, DOI 10.1016/j.rvsc.2005.12.008
   Bielecki TM, 2007, J BONE JOINT SURG BR, V89B, P417, DOI 10.1302/0301-620X.89B3.18491
   Blair P, 2009, BLOOD REV, V23, P177, DOI 10.1016/j.blre.2009.04.001
   Burnouf T, 2013, TRANSFUSION, V53, P138, DOI 10.1111/j.1537-2995.2012.03668.x
   Burton S, 2008, CAN VET J, V49, P797
   Carmona JU, 2007, J EQUINE VET SCI, V27, P167, DOI 10.1016/j.jevs.2007.02.007
   Carmona JU, 2013, REC PAT REG MED, V3, P148
   Chen LH, 2013, J DIABETES RES, DOI 10.1155/2013/269527
   Cieslik-Bielecka A, 2009, TRANSFUS APHER SCI, V41, P9, DOI 10.1016/j.transci.2009.05.006
   Delesalle C, 2008, EQUINE VET J, V40, P326, DOI 10.2746/042516408X293583
   Donnelly BP, 2006, AM J VET RES, V67, P1218, DOI 10.2460/ajvr.67.7.1218
   Drago L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-47
   GILBERT P, 1987, J ANTIMICROB CHEMOTH, V20, P147, DOI 10.1093/jac/20.2.147
   Giraldo CE, 2013, BMC VET RES, V12, P9
   Haenni M, 2010, J VET DIAGN INVEST, V22, P953, DOI 10.1177/104063871002200617
   Hnasko R, 2011, BIOCHEM BIOPH RES CO, V410, P726, DOI 10.1016/j.bbrc.2011.06.005
   IngleFehr JE, 1997, VET SURG, V26, P7, DOI 10.1111/j.1532-950X.1997.tb01456.x
   Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623
   LEDUR A, 1995, J IMMUNOL METHODS, V186, P171, DOI 10.1016/0022-1759(95)00184-C
   Lopez C, 2010, ARCH MED VET, V42, P209, DOI 10.4067/S0301-732X2010000300013
   MACDONALD DG, 1994, EQUINE VET J, V26, P323, DOI 10.1111/j.2042-3306.1994.tb04394.x
   Maciel FB, 2012, BURNS, V38, P1058, DOI 10.1016/j.burns.2012.02.029
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519
   Moor AN, 2009, WOUND REPAIR REGEN, V17, P832, DOI 10.1111/j.1524-475X.2009.00547.x
   Payne WG, 2003, J APPL RES, V3, P35
   Penha-Goncalves MN, 1997, DNA SEQUENCE, V7, P375, DOI 10.3109/10425179709034059
   Schraw T, 2005, TRANSFUSION, V45, P717, DOI 10.1111/j.1537-2995.2005.04243.x
   Shenkman B, 1999, PLATELETS, V10, P36, DOI 10.1080/09537109976338
   Sutter WW, 2004, AM J VET RES, V65, P924, DOI 10.2460/ajvr.2004.65.924
   Tang YQ, 2002, INFECT IMMUN, V70, P6524, DOI 10.1128/IAI.70.12.6524.6533.2002
   Taylor AH, 2010, EQUINE VET J, V42, P213, DOI 10.2746/042516409X480403
   Wang HF, 2013, INT WOUND J, V10, P105, DOI 10.1111/j.1742-481X.2012.00951.x
   Xiong YQ, 2002, J INFECT DIS, V185, P348, DOI 10.1086/338514
   Yavuz SS, 2013, J HOSP INFECT, V85, P206, DOI 10.1016/j.jhin.2013.07.010
   Yeaman MR, 2010, CELL MOL LIFE SCI, V67, P525, DOI 10.1007/s00018-009-0210-4
   Yount NY, 2004, ANTIMICROB AGENTS CH, V48, P4395, DOI 10.1128/AAC.48.11.4395-4404.2004
   Yuan T, 2008, TRANSFUS APHER SCI, V38, P167, DOI 10.1016/j.transci.2008.01.006
NR 43
TC 7
Z9 7
U1 1
U2 8
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2014
VL 27
IS 5
BP 372
EP 378
DI 10.3415/VCOT-14-04-0054
PG 7
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA AP4GN
UT WOS:000342035300008
PM 25088784
DA 2018-10-19
ER

PT J
AU Roch, T
   Schulz, C
   Jung, F
   Ma, N
   Lendlein, A
AF Roch, Toralf
   Schulz, Christian
   Jung, Friedrich
   Ma, Nan
   Lendlein, Andreas
TI Interaction of poly(ether imide) films with early immune mechanisms
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE Immuno-compatibility; endotoxins; biomaterial; poly(ether imide);
   cardiovascular implants
ID COMPLEMENT ACTIVATION; ENDOTHELIAL-CELLS; BIOMATERIALS; COAGULATION;
   POLYSTYRENE; INDUCTION; IMPLANTS; SURFACES; PATTERN; SEPSIS
AB With the worldwide increase of atherosclerosis, the need for new engineered patient specific implants such as stents or vascular grafts is still emerging. Recently, very smooth poly(ether imide) (PEI) films were, based on their hemocompatibility and compatibility with endothelial cells, suggested as potential biomaterial for cardiovascular applications. In atherosclerosis, immune mechanisms such as complement activation, but also cellular responses such as monocytes and neutrophils activation, can mediate the inflammatory response. Therefore, it is important that the implant material itself does not trigger the inflammatory response. Early immune mechanisms - e.g. macrophage activation, complement induction, generation of reactive oxygen species (ROS), and the secretion of inflammatory cytokines by leukocytes - could potentiate the inflammatory responses, and may thereby alter endothelial cells behaviour or facilitate platelet activation. Therefore, it is important to evaluate the immuno-compatibility of PEI-films.
   The PEI-films were fabricated from commercially available PEI, which was dissolved in dichloromethane and pulled out on a cleaned, smooth glass surface and subsequently, solvent residues were removed during the drying procedure.
   Using a murine macrophage reporter cell line possible material bound microbial contaminations and material intrinsic immunostimulatory properties were investigated. The macrophages were viable after adhering on the PEI-films and did not show signs of activation, indicating that the used PEI-film was free of microbial contaminations. To determine whether PEI-films induced complement activation, the release of C5a in pooled human plasma was analyzed. The detected C5a levels did not differ between PEI-films and tissue culture plates (TCP), which served as control material. Furthermore, in whole human blood, the generation of ROS as well as the cytokine production were investigated by flow cytometry and by multiplex bead arrays, respectively. The production of IL-6 and TNF-alpha as well as the generation of ROS by immune cells of the whole blood was not induced upon contact with PEI-films.
   The immunological evaluation of PEI-films revealed that no substantial activation of the investigated early immune mechanisms occurred. Altogether, this data demonstrate that PEI is immuno-compatible and from that perspective may be a suitable biomaterial for cardiovascular applications.
C1 [Roch, Toralf; Schulz, Christian; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Regenerat Therapies, Inst Biomaterial Sci & Berlin Brandenburg, D-14513 Teltow, Germany.
   [Roch, Toralf; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Teltow, Germany.
   [Roch, Toralf; Jung, Friedrich; Ma, Nan; Lendlein, Andreas] Helmholtz Virtual Inst Multifunct Biomat Med, Berlin, Germany.
RP Roch, T (reprint author), Helmholtz Zentrum Geesthacht, Ctr Regenerat Therapies, Inst Biomaterial Sci & Berlin Brandenburg, Kantstr 55, D-14513 Teltow, Germany.
EM toralf.roch@hzg.de; andreas.lendlein@hzg.de
RI Jung, Friedrich/L-1301-2013; Lendlein, Andreas/K-9553-2013
OI Jung, Friedrich/0000-0001-8098-7180; Lendlein,
   Andreas/0000-0003-4126-4670; Roch, Toralf/0000-0003-2948-8700
FU German Federal Ministry of Education and Research (BMBF) [0315696A]
FX The authors thank Ruth Hesse, Anja Muller-Heyn, and Angelika Ritschel
   for the technical support and the German Federal Ministry of Education
   and Research (BMBF) for funding within project number 0315696A
   ,,Poly4Bio BB".
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Aslam R, 2006, BLOOD, V107, P637, DOI 10.1182/blood-2005-06-2202
   BERG B, 1981, REFERENCE VALUES LAB, P55
   Braune S, 2010, CLIN HEMORHEOL MICRO, V46, P239, DOI 10.3233/CH-2010-1351
   Butler D, 2011, NATURE, V477, P260, DOI 10.1038/477260a
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grasbeck R., 1981, REFERENCE VALUES LAB
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kader KN, 2007, J BIOMED MATER RES B, V83B, P138, DOI 10.1002/jbm.b.30777
   Lange M, 2012, MACROMOL RAPID COMM, V33, P1487, DOI 10.1002/marc.201200426
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lumadue JA, 1996, AM J CLIN PATHOL, V106, P795
   Mako V, 2010, CYTOM PART A, V77A, P962, DOI 10.1002/cyto.a.20952
   NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0
   Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854
   Opal SM, 2010, CONTRIB NEPHROL, V167, P14, DOI 10.1159/000315915
   Roch T, 2012, CLIN HEMORHEOL MICRO, V52, P375, DOI 10.3233/CH-2012-1612
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Schulz C, 2012, CLIN HEMORHEOL MICRO, V52, P267, DOI 10.3233/CH-2012-1604
   Seifu DG, 2013, NAT REV CARDIOL, V10, P410, DOI 10.1038/nrcardio.2013.77
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Toda M, 2008, BIOMATERIALS, V29, P407, DOI 10.1016/j.biomaterials.2007.10.005
   Vijayakumar R., 2012, EUROPEAN J PARENTERA, V17, P4
   Wischke C, 2013, EUR J PHARM BIOPHARM, V84, P288, DOI 10.1016/j.ejpb.2013.01.025
   Wischke C, 2012, J CONTROL RELEASE, V164, P299, DOI 10.1016/j.jconrel.2012.06.034
NR 30
TC 4
Z9 4
U1 1
U2 6
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
EI 1875-8622
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2014
VL 57
IS 2
BP 203
EP 212
DI 10.3233/CH-141831
PG 10
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA AP2TH
UT WOS:000341927400013
PM 24584324
DA 2018-10-19
ER

PT J
AU Yao, ZT
   Xia, MS
   Li, HY
   Chen, T
   Ye, Y
   Zheng, H
AF Yao, Zhitong
   Xia, Meisheng
   Li, Haiyan
   Chen, Tao
   Ye, Ying
   Zheng, Hao
TI Bivalve Shell: Not an Abundant Useless Waste but a Functional and
   Versatile Biomaterial
SO CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY
LA English
DT Review
DE biomaterial; bivalve shell; calcium carbonate; filler; mineralization;
   organic matrix
ID OYSTER-PINCTADA-FUCATA; WATER MUSSEL AMBLEMA; OSTEOBLASTS MAINTAINED
   INVITRO; ALKALINE-PHOSPHATASE ACTIVITY; SCANNING-ELECTRON-MICROSCOPY;
   JAPANESE PEARL OYSTER; SOLID BASE CATALYST; BIODIESEL PRODUCTION;
   PRISMATIC LAYER; MATRIX PROTEIN
AB Bivalve shells, available in abundance, have no eminent use and are commonly regarded as waste. Their improper disposal causes a significant level of environmental concern and also results in a waste of natural resources. Bivalve shell is formed by biomineralization and consists mainly of CaCO3 with a small amount of organic matrix, giving it a potential for use as raw material. Recycling shell waste could potentially eliminate the disposal problem, and also turn an otherwise useless waste into high value-added products. The present paper first describes the microstructure and physicochemical properties of bivalve shell, then focuses on its current applications. Finally, the current status of bivalve shell studies and directions for future research are considered.
C1 [Yao, Zhitong] Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
   [Xia, Meisheng; Chen, Tao; Ye, Ying; Zheng, Hao] Zhejiang Univ, Dept Ocean Sci & Engn, Hangzhou 310058, Zhejiang, Peoples R China.
   [Li, Haiyan] Zhejiang Univ, Zhoushan Ocean Res Inst, Zhoushan, Peoples R China.
RP Yao, ZT (reprint author), Hangzhou Dianzi Univ, Coll Mat Sci & Environm Engn, Hangzhou 310018, Zhejiang, Peoples R China.
EM sxyzt@126.com; msxia@zju.edu.cn
FU Zhejiang Provincial Natural Science Foundation of China [LQ13B070005];
   Marine Scientific Research Foundation of Zhejiang University
   [2012HY001B]; Key Laboratory for Solid Waste Management and Environment
   Safety Open Fund [SWMES 2011-07]; Scientific Research Foundation of
   Hangzhou Dianzi University [KYS205612029]
FX We gratefully acknowledge financial support from the Zhejiang Provincial
   Natural Science Foundation of China (Grant no. LQ13B070005), Marine
   Scientific Research Foundation of Zhejiang University (Grant no.
   2012HY001B), the Key Laboratory for Solid Waste Management and
   Environment Safety Open Fund (Grant no. SWMES 2011-07), and Scientific
   Research Foundation of Hangzhou Dianzi University (Grant no.
   KYS205612029).
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Ahmad H. A., 2003, Journal of Applied Poultry Research, V12, P509
   ALBECK S, 1993, J AM CHEM SOC, V115, P11691, DOI 10.1021/ja00078a005
   Almeida MJ, 2001, J BIOMED MATER RES, V57, P306, DOI 10.1002/1097-4636(200111)57:2<306::AID-JBM1172>3.0.CO;2-H
   Alvarez E, 2012, PEDOSPHERE, V22, P152, DOI 10.1016/S1002-0160(12)60002-2
   Asaoka S, 2009, BIORESOURCE TECHNOL, V100, P4127, DOI 10.1016/j.biortech.2009.03.075
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   Azizi H, 2009, POLYM COMPOSITE, V30, P1743, DOI 10.1002/pc.20685
   Bae DH, 2006, ARCH PHARM RES, V29, P298, DOI 10.1007/BF02968574
   BEEDHAM GE, 1958, Q J MICROSC SCI, V99, P181
   Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019
   BERMAN A, 1993, SCIENCE, V259, P776, DOI 10.1126/science.259.5096.776
   Boey PL, 2011, FUEL, V90, P2353, DOI 10.1016/j.fuel.2011.03.002
   Boggild OB, 1930, K DAN VIDENSK SELSK, V9, P233
   Bolan NS, 2003, ADV AGRON, V78, P215, DOI 10.1016/S0065-2113(02)78006-1
   Boro J, 2012, RENEW SUST ENERG REV, V16, P904, DOI 10.1016/j.rser.2011.09.011
   Bowerbank J. S., 1844, T MICROSC SOC LONDON, V1, P123
   Bureau of Fisheries Ministry of Agriculture., 2011, CHIN FISH YB 2011
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   CARTER JG, 1975, LETHAIA, V8, P315, DOI 10.1111/j.1502-3931.1975.tb00936.x
   CATALANO CR, 1994, J FOOD PROTECT, V57, P587, DOI 10.4315/0362-028X-57.7.587
   Chang F, 2007, FOOD CHEM, V104, P1171, DOI 10.1016/j.foodchem.2007.01.032
   Checa A, 2000, TISSUE CELL, V32, P405, DOI 10.1054/tice.2000.0129
   Checa AG, 2005, BIOMATERIALS, V26, P6404, DOI 10.1016/j.biomaterials.2005.04.016
   Checa AG, 2011, J STRUCT BIOL, V176, P330, DOI 10.1016/j.jsb.2011.09.011
   Checa AG, 2009, J STRUCT BIOL, V167, P261, DOI 10.1016/j.jsb.2009.06.009
   Chen B, 2005, J METASTAB NANOCRYST, V23, P83, DOI 10.4028/www.scientific.net/JMNM.23.83
   Chen B, 2004, CERAM INT, V30, P2011, DOI 10.1016/j.ceramint.2003.12.169
   Cheng P. Y., 2009, THESIS KAOHSIUNG MAR
   Cheon S. M., 2003, J KOREAN CERAM SOC, V40, P1235
   Choi YM, 2006, FOOD CONTROL, V17, P695, DOI 10.1016/j.foodcont.2005.04.005
   Chong MH, 2006, J APPL POLYM SCI, V99, P1583, DOI 10.1002/app.22484
   Chou J, 2010, ENVIRON POLLUT, V158, P2230, DOI 10.1016/j.envpol.2010.02.015
   CURREY JD, 1977, PROC R SOC SER B-BIO, V196, P443, DOI 10.1098/rspb.1977.0050
   Currey JD, 2001, P ROY SOC B-BIOL SCI, V268, P107, DOI 10.1098/rspb.2000.1337
   Di Serio M, 2008, ENERG FUEL, V22, P207, DOI 10.1021/ef700250g
   Effiong G. S., 2009, AM EURASIAN J AGRON, V2, P144
   Etelaaho P, 2011, POLYM COMPOSITE, V32, P464, DOI 10.1002/pc.21065
   Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860
   FAO, 2010, YB FISH AQ STAT 2008
   FAO, 2011, GLOB AQ PROD 1950 20
   Feng QL, 2000, J MATER SCI, V35, P3337, DOI 10.1023/A:1004843900161
   FINKELSTEIN AD, 1993, J DAIRY SCI, V76, P582, DOI 10.3168/jds.S0022-0302(93)77378-6
   Freer A., 2009, CRYST GROWTH DES, V10, P344
   de Alvarenga RAF, 2012, J ENVIRON MANAGE, V106, P102, DOI 10.1016/j.jenvman.2012.04.017
   Funabashi M, 2010, J POLYM ENVIRON, V18, P85, DOI 10.1007/s10924-010-0166-3
   Gilbert PUPA, 2011, P NATL ACAD SCI USA, V108, P11350, DOI 10.1073/pnas.1107917108
   Glover EA, 2010, J MOLLUS STUD, V76, P157, DOI 10.1093/mollus/eyp054
   Gryglewicz S, 1999, BIORESOURCE TECHNOL, V70, P249, DOI 10.1016/S0960-8524(99)00042-5
   GUINOTTE F, 1991, POULTRY SCI, V70, P583, DOI 10.3382/ps.0700583
   Hashidate Y. T., 1993, P 33 JAP NAT C GEOT, P869
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Hu SY, 2011, BIOMASS BIOENERG, V35, P3627, DOI 10.1016/j.biombioe.2011.05.009
   JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056
   JACKSON AP, 1990, J MATER SCI, V25, P3173, DOI 10.1007/BF00587670
   Jipa S, 2010, POLYM BULL, V64, P783, DOI 10.1007/s00289-009-0213-1
   JOZEWICZ W, 1987, ENVIRON SCI TECHNOL, V21, P664, DOI 10.1021/es00161a007
   Jung JH, 2005, KOREAN J CHEM ENG, V22, P566, DOI 10.1007/BF02706644
   Jung JH, 2000, KOREAN J CHEM ENG, V17, P585, DOI 10.1007/BF02707171
   Jung JH, 2007, J IND ENG CHEM, V13, P512
   Jung SH, 2012, FUEL PROCESS TECHNOL, V96, P265, DOI 10.1016/j.fuproc.2011.12.039
   Kaplan DL, 1998, CURR OPIN SOLID ST M, V3, P232, DOI 10.1016/S1359-0286(98)80096-X
   Kawashima A, 2009, BIORESOURCE TECHNOL, V100, P696, DOI 10.1016/j.biortech.2008.06.049
   KINNER JA, 1981, POULTRY SCI, V60, P761, DOI 10.3382/ps.0600761
   Kong YW, 2009, J BIOL CHEM, V284, P10841, DOI 10.1074/jbc.M808357200
   Kouzu M., 2006, J JPN I ENERGY, V85, P135
   Kouzu M, 2008, APPL CATAL A-GEN, V334, P357, DOI 10.1016/j.apcata.2007.10.023
   Kurunczi S, 2001, MIKROCHIM ACTA, V137, P41, DOI 10.1007/s006040170026
   Kusterko S. K., 2006, VALORIZACAO RESIDUOS
   Kwon HB, 2004, RESOUR CONSERV RECY, V41, P75, DOI 10.1016/j.resconrec.2003.08.005
   Lee CH, 2008, WASTE MANAGE, V28, P2702, DOI 10.1016/j.wasman.2007.12.005
   Lee G. H., 1998, P 33 JAP NAT C GEOT, P423
   Levi-Kalisman Y, 2001, J STRUCT BIOL, V135, P8, DOI 10.1006/jsbi.2001.4372
   LEVIN M, 1978, J WATER POLLUT CON F, V50, P1377
   Li H. Y., 2013, J CENT S U IN PRESS
   Li HY, 2012, J HAZARD MATER, V217, P256, DOI 10.1016/j.jhazmat.2012.03.028
   [李海晏 Li Haiyan], 2012, [硅酸盐学报, Journal of the Chinese Silicate Society], V40, P1671
   [李海晏 Li Haiyan], 2012, [功能材料, Journal of Functional Materials], V43, P1519
   [李花帅 Li Huashuai], 2012, [中国粮油学报, Journal of the Chinese Cereals and Oils Association], V27, P1
   Lim B. P., 2009, EUR J SCI RES, V33, P347
   Lin AYM, 2008, ACTA BIOMATER, V4, P131, DOI 10.1016/j.actbio.2007.05.005
   Lin AYM, 2009, J MECH BEHAV BIOMED, V2, P607, DOI 10.1016/j.jmbbm.2009.04.003
   Lin CY, 2006, FUEL, V85, P1743, DOI 10.1016/j.fuel.2006.03.010
   Liu J., 1992, MATER RES SOC S P, V255, P9
   Liu XJ, 2008, FUEL, V87, P216, DOI 10.1016/j.fuel.2007.04.013
   Lopez E, 2000, TISSUE CELL, V32, P95, DOI 10.1054/tice.1999.0091
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Granados ML, 2007, APPL CATAL B-ENVIRON, V73, P317, DOI 10.1016/j.apcatb.2006.12.017
   Lopez-Urionabarrenechea A, 2011, FUEL PROCESS TECHNOL, V92, P253, DOI 10.1016/j.fuproc.2010.05.008
   LUTTS A, 1960, ARCH INT PHYS BIOCH, V68, P829, DOI 10.3109/13813456009075173
   MacDonald J, 2010, CRYST GROWTH DES, V10, P1243, DOI 10.1021/cg901263p
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286
   Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200
   Meher LC, 2006, RENEW SUST ENERG REV, V10, P248, DOI 10.1016/j.rser.2004.09.002
   Mihara Y., 2008, J CERAM SOC JPN, V116, ps1
   Miyaji Y., 2000, P COAST GEOT ENG PRA, P675
   Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657
   Monagheddu M, 1999, ENVIRON SCI TECHNOL, V33, P2485, DOI 10.1021/es9809206
   MORSE DE, 1993, MATER RES SOC SYMP P, V292, P59
   Moutahir-Belqasmi F, 2001, J MATER SCI-MATER M, V12, P1, DOI 10.1023/A:1026759431595
   Mustata F, 2012, COMPOS PART B-ENG, V43, P702, DOI 10.1016/j.compositesb.2011.11.047
   Nakatani N, 2009, BIORESOURCE TECHNOL, V100, P1510, DOI 10.1016/j.biortech.2008.09.007
   National Bureau of Statistics of the People's Republic of China, 2010, CHIN STAT YB 2010
   Oikawa K, 2000, J HEALTH SCI, V46, P98
   Okouchi S., 1996, INORG MATER, V261, P111
   Okouchi S., 1995, J ANTIBACTERIAL ANTI, V26, P109
   Oliveira DV, 2012, SCI WORLD J, DOI 10.1100/2012/765909
   Park WH, 2008, ECOL ENG, V34, P50, DOI 10.1016/j.ecoleng.2008.05.014
   PEARSON J, 1987, APPL ENVIRON MICROB, V53, P2060
   PETERSON GR, 1984, J AM OIL CHEM SOC, V61, P1593, DOI 10.1007/BF02541639
   PETIT H, 1980, TISSUE CELL, V12, P13, DOI 10.1016/0040-8166(80)90049-X
   PETIT H, 1978, TISSUE CELL, V10, P619, DOI 10.1016/0040-8166(78)90050-2
   PETIT H, 1980, TISSUE CELL, V12, P581, DOI 10.1016/0040-8166(80)90046-4
   PETIT H, 1979, TISSUE CELL, V11, P633, DOI 10.1016/0040-8166(79)90020-X
   PHILLIPS DJH, 1985, MAR ECOL PROG SER, V21, P251, DOI 10.3354/meps021251
   ROLAND DA, 1986, WORLD POULTRY SCI J, V42, P166, DOI 10.1079/WPS19860013
   Roland Sr D. A., 1999, FEEDSTUFFS, V71, P18
   SALEUDDIN ASM, 1983, MOLLUSCA, V4, P199
   Samata T, 1999, FEBS LETT, V462, P225, DOI 10.1016/S0014-5793(99)01387-3
   Sawai J, 1996, J CHEM ENG JPN, V29, P251, DOI 10.1252/jcej.29.251
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Sawai J, 2001, INT J FOOD MICROBIOL, V71, P211, DOI 10.1016/S0168-1605(01)00619-5
   SAWAI J, 1995, J CHEM ENG JPN, V28, P556, DOI 10.1252/jcej.28.556
   Schaffer T. E., CHEM MAT, V9, P1731
   Shanks B., 2004, NRELSR51036244
   Shen XY, 1997, J BIOL CHEM, V272, P32472, DOI 10.1074/jbc.272.51.32472
   Shono M, 2008, BIOSCI BIOTECH BIOCH, V72, P2761, DOI 10.1271/bbb.80267
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   Solidum J. N., 2011, 5 INT C BIOINF BIOM
   Song F, 2003, BIOMATERIALS, V24, P3623, DOI 10.1016/S0142-9612(03)00215-1
   SOUTHAM G, 1987, J FOOD PROTECT, V50, P103, DOI 10.4315/0362-028X-50.2.103
   Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391
   Suppes GJ, 2004, APPL CATAL A-GEN, V257, P213, DOI 10.1016/j.apcata.2003.07.010
   Suzuki M, 2004, BIOCHEM J, V382, P205, DOI 10.1042/BJ20040319
   Suzuki M, 2007, BIOSCI BIOTECH BIOCH, V71, P1735, DOI 10.1271/bbb.70140
   TAYLOR JD, 1969, CALC TISS RES, V3, P274, DOI 10.1007/BF02058669
   Tongamp W, 2008, WASTE MANAGE, V28, P484, DOI 10.1016/j.wasman.2007.01.022
   Tongamp W, 2009, J MATER CYCLES WASTE, V11, P32, DOI 10.1007/s10163-008-0216-2
   Tsai HC, 2011, BIORESOURCE TECHNOL, V102, P7802, DOI 10.1016/j.biortech.2011.06.036
   Tsai W. T., 2009, J ENV ENG MANAGE, V19, P165
   Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072
   Van Gerpen J, 2005, FUEL PROCESS TECHNOL, V86, P1097, DOI 10.1016/j.fuproc.2004.11.005
   Watabe N., 1988, MOLLUSCA, V11, P69
   WATABE N, 1976, MECHANISMS MINERALIZ, P283
   WEINER S, 1991, TRENDS BIOCHEM SCI, V16, P252, DOI 10.1016/0968-0004(91)90098-G
   WEINER S, 1976, P NATL ACAD SCI USA, V73, P2541, DOI 10.1073/pnas.73.8.2541
   Yamada M., 2005, Journal of the Society of Materials Science, Japan, V54, P1117, DOI 10.2472/jsms.54.1117
   Yan ZG, 2008, CHEMBIOCHEM, V9, P1093, DOI 10.1002/cbic.200700553
   Yan ZG, 2011, ACTA OCEANOL SIN, V30, P87, DOI 10.1007/s13131-011-0094-7
   Yang CM, 1996, HAZARD WASTE HAZARD, V13, P445, DOI 10.1089/hwm.1996.13.445
   Yang EI, 2005, CEMENT CONCRETE RES, V35, P2175, DOI 10.1016/j.cemconres.2005.03.016
   Yano M, 2006, COMP BIOCHEM PHYS B, V144, P254, DOI 10.1016/j.cpbp.2006.03.004
   Yoon GL, 2003, WASTE MANAGE, V23, P825, DOI 10.1016/S0956-053X(02)00159-9
   Yoon H, 2004, WASTE MANAGE RES, V22, P158, DOI 10.1177/0734242X04042456
   Yuangsawad R., 2011, 21 THAI I CHEM ENG A
   Yusof AM, 2004, J RADIOANAL NUCL CH, V259, P119, DOI 10.1023/B:JRNC.0000015816.16869.6f
   Zhang J, 2011, J APPL POLYM SCI, V119, P3560, DOI 10.1002/app.33037
NR 158
TC 21
Z9 21
U1 2
U2 34
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1064-3389
EI 1547-6537
J9 CRIT REV ENV SCI TEC
JI Crit. Rev. Environ. Sci. Technol.
PY 2014
VL 44
IS 22
BP 2502
EP 2530
DI 10.1080/10643389.2013.829763
PG 29
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA AP1GW
UT WOS:000341817100002
DA 2018-10-19
ER

EF